PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ogbonnaya, A; Middleton, B; Cady, T; Ho, C				Ogbonnaya, Amara; Middleton, Brittany; Cady, Tiffany; Ho, Cynthia			Osteopoikilosis	LANCET			English	Editorial Material									[Ogbonnaya, Amara; Middleton, Brittany; Cady, Tiffany; Ho, Cynthia] Dept Pediat, Los Angeles, CA USA; [Ogbonnaya, Amara; Middleton, Brittany; Cady, Tiffany; Ho, Cynthia] Univ So Calif, Med Ctr, Los Angeles, CA 90033 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California	Ho, C (corresponding author), 2020 Zonal Ave,IRD Room 109, Los Angeles, CA 90033 USA.	cynho@usc.edu		Ho, Cynthia/0000-0002-9317-0070				Carpintero P, 2004, CLIN RHEUMATOL, V23, P505, DOI 10.1007/s10067-004-0935-2; Paraskevas G, 2009, J RADIOL CASE REP, V3, P38, DOI 10.3941/jrcr.v3i12.260; Tuncel M, 2012, REV ESP MED NUCL IMA, V31, P93, DOI [10.1016/j.remn.2011.04.010, 10.1016/j.remnie.2012.03.006]; Woyciechowsky TG, 2012, CLIN RHEUMATOL, V31, P745, DOI 10.1007/s10067-011-1916-x	4	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					E4	E4		10.1016/S0140-6736(13)60674-1	http://dx.doi.org/10.1016/S0140-6736(13)60674-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	23910432	Bronze			2022-12-28	WOS:000329579600002
J	Galloway, KE; Franco, E; Smolke, CD				Galloway, Kate E.; Franco, Elisa; Smolke, Christina D.			Dynamically Reshaping Signaling Networks to Program Cell Fate via Genetic Controllers	SCIENCE			English	Article							MAP KINASE; DIFFERENTIAL REGULATION; CANCER-CELLS; SCAFFOLD; PHOSPHATASE; ROBUSTNESS; YEAST; SPECIFICITY; HOMEOSTASIS; EXPRESSION	Engineering of cell fate through synthetic gene circuits requires methods to precisely implement control around native decision-making pathways and offers the potential to direct cell processes. We demonstrate a class of genetic control systems, molecular network diverters, that interface with a native signaling pathway to route cells to divergent fates in response to environmental signals without modification of native genetic material. A method for identifying control points within natural networks is described that enables the construction of synthetic control systems that activate or attenuate native pathways to direct cell fate. We integrate opposing genetic programs by developing network architectures for reduced antagonism and demonstrate rational tuning of performance. Extension of these control strategies to mammalian systems should facilitate the engineering of complex cellular signaling systems.	[Galloway, Kate E.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Franco, Elisa] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; University of California System; University of California Riverside; Stanford University	Smolke, CD (corresponding author), Stanford Univ, Dept Bioengn, 473 Via Ortega,MC 4201, Stanford, CA 94305 USA.	christina.smolke@stanford.edu		Galloway, Kate E/0000-0001-7416-3193	NIH; NSF; Defense Advanced Research Projects Agency; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Endy, J. Michener, A. Chang, and Y.-H. Wang for comments on the manuscript; J. Liang for technical guidance with RNA transducers; and R. Yu and S. Chapman for discussions on mating assays. This work was supported by funds from the NIH (grant to C.D.S.), NSF (grant to C.D.S.), Defense Advanced Research Projects Agency (grant to C.D.S.), and the Bill and Melinda Gates Foundation (grant to C.D.S.). K.E.G. and C.D.S. designed the study and experiments; K.E.G. performed experiments; E.F. and K.E.G. designed and constructed the model; and C.D.S. and K.E.G. analyzed and discussed all results and wrote the manuscript.	Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beisel CL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000363; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Chapman SA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.73; Chen YY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-240; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Franco E, 2013, J MATH BIOL, V67, P1633, DOI 10.1007/s00285-012-0606-x; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Liang JC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks636; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCormick F, 1999, TRENDS BIOCHEM SCI, V24, pM53, DOI 10.1016/S0968-0004(99)01480-2; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Osterberg M, 2006, P NATL ACAD SCI USA, V103, P11148, DOI 10.1073/pnas.0604078103; Palpant Rebecca G, 2006, Prev Chronic Dis, V3, pA62; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SPRAGUE G F JR, 1991, P77; Srikanth S, 1999, MOL CELL BIOCHEM, V199, P169, DOI 10.1023/A:1006980326855; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Stoll G, 2010, BIOSYSTEMS, V102, P3, DOI 10.1016/j.biosystems.2010.07.014; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Wu W, 2005, J BIOL CHEM, V280, P4117, DOI 10.1074/jbc.M411200200; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Yuan YA, 2009, P NATL ACAD SCI USA, V106, P22020, DOI 10.1073/pnas.0906869106; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	52	48	49	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1358	+	1235005	10.1126/science.1235005	http://dx.doi.org/10.1126/science.1235005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	23950497	Green Accepted			2022-12-28	WOS:000324597200036
J	Collart, C; Allen, GE; Bradshaw, CR; Smith, JC; Zegerman, P				Collart, Clara; Allen, George E.; Bradshaw, Charles R.; Smith, James C.; Zegerman, Philip			Titration of Four Replication Factors Is Essential for the Xenopus laevis Midblastula Transition	SCIENCE			English	Article							MAJOR DEVELOPMENTAL TRANSITION; INITIATION; DEGRADATION; EMBRYOS; KINASE; ONSET	The rapid, reductive early divisions of many metazoan embryos are followed by the midblastula transition (MBT), during which the cell cycle elongates and zygotic transcription begins. It has been proposed that the increasing nuclear to cytoplasmic (N/C) ratio is critical for controlling the events of the MBT. We show that four DNA replication factors-Cut5, RecQ4, Treslin, and Drf1-are limiting for replication initiation at increasing N/C ratios in vitro and in vivo in Xenopus laevis. The levels of these factors regulate multiple events of the MBT, including the slowing of the cell cycle, the onset of zygotic transcription, and the developmental activation of the kinase Chk1. This work provides a mechanism for how the N/C ratio controls the MBT and shows that the regulation of replication initiation is fundamental for normal embryogenesis.	[Collart, Clara; Allen, George E.; Bradshaw, Charles R.; Zegerman, Philip] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Collart, Clara; Smith, James C.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Zegerman, Philip] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; MRC National Institute for Medical Research; University of Cambridge	Zegerman, P (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol, Cambridge CB2 1QN, England.	p.zegerman@gurdon.cam.ac.uk		Bradshaw, Charles/0000-0002-3528-458X; Zegerman, Philip/0000-0002-5707-1083; Smith, Jim/0000-0003-2413-9392	AICR [10-0908]; Wellcome Trust [092096]; UK Medical Research Council [U117597140]; CRUK [C6946/A14492]; MRC [MC_U117597140] Funding Source: UKRI; Medical Research Council [MC_U117597140] Funding Source: researchfish; Worldwide Cancer Research [10-0908] Funding Source: researchfish	AICR; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	We are grateful to T. Takahashi, J. Walter, V. Costanzo, J. Diffley, H. Takisawa, and R. Laskey for reagents. DNA combing analysis was performed with assistance from V. Gaggioli. We are grateful to J. Pines, R. Laskey, and members of the Zegerman group for critical reading of this manuscript and S. Di Talia for discussions. P.Z. is funded by AICR 10-0908. J.C.S. and C.C. were supported by the Wellcome Trust and by the UK Medical Research Council (programme no. U117597140). All authors acknowledge the core support provided by CRUK C6946/A14492 and the Wellcome Trust 092096.	BLUMENTH.AB, 1973, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/SQB.1974.038.01.024; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Hartley RS, 1997, DEV BIOL, V188, P312, DOI 10.1006/dbio.1997.8647; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Mantiero D, 2011, EMBO J, V30, P4805, DOI 10.1038/emboj.2011.404; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; McCleland ML, 2009, J CELL BIOL, V187, P7, DOI 10.1083/jcb.200906191; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; WOODLAND HR, 1972, BIOCHEM J, V127, P597, DOI 10.1042/bj1270597	26	143	145	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					893	896		10.1126/science.1241530	http://dx.doi.org/10.1126/science.1241530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23907533	Green Accepted			2022-12-28	WOS:000323370600044
J	Garrott, RA; Oli, MK				Garrott, Robert A.; Oli, Madan K.			A Critical Crossroad for BLM's Wild Horse Program	SCIENCE			English	Editorial Material									[Garrott, Robert A.] Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA; [Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	Montana State University System; Montana State University Bozeman; State University System of Florida; University of Florida	Garrott, RA (corresponding author), Montana State Univ, Dept Ecol, Fish & Wildlife Ecol & Management Program, Bozeman, MT 59717 USA.	rgarrott@montana.edu						[Anonymous], 2013, AUSTRALIAN; BLM, 2011, CAR AM WILD HORS BUR; Csurhes S., 2009, PEST ANIMAL RISK ASS; GAO, 1990, RECD90110 GAO; National Research Council (NRC), 1991, WILD HORS POP FIELD; National Research Council (NRC), 2013, EST ADJ APPR MAN LEV, P195; NRC, 1980, WILD FREE ROAM HORS; NRC, 1982, WILD FREE ROAM HORS; U.S. General Accounting Office, 2008, GAO0977; Walters C., 1986, ADAPTIVE MANAGEMENT	10	37	37	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					847	848		10.1126/science.1240280	http://dx.doi.org/10.1126/science.1240280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MY	23970685				2022-12-28	WOS:000323370600025
J	Olumi, AF; Kaufman, DS; Zietman, A; Harisinghani, MG; Wu, CL				Olumi, Aria F.; Kaufman, Donald S.; Zietman, Anthony; Harisinghani, Mukesh G.; Wu, Chin-Lee			Case 25-2013: A 71-Year-Old Man with Hematuria and a Mass in the Bladder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSTATIC DUCT ADENOCARCINOMA; RADICAL PROSTATECTOMY; ENDOMETRIOID FEATURES; CARCINOMA; UTRICLE		[Olumi, Aria F.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Kaufman, Donald S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zietman, Anthony] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Harisinghani, Mukesh G.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Wu, Chin-Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Olumi, Aria F.] Harvard Univ, Sch Med, Dept Urol, Boston, MA USA; [Kaufman, Donald S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Zietman, Anthony] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Harisinghani, Mukesh G.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Wu, Chin-Lee] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Olumi, AF (corresponding author), Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA.		Harisinghani, Mukesh/D-7590-2011					BOSTWICK DG, 1985, AM J SURG PATHOL, V9, P595, DOI 10.1097/00000478-198508000-00004; Brinker DA, 1999, AM J SURG PATHOL, V23, P1471, DOI 10.1097/00000478-199912000-00004; CHRISTENSEN WN, 1991, CANCER, V67, P2118, DOI 10.1002/1097-0142(19910415)67:8<2118::AID-CNCR2820670818>3.0.CO;2-G; Eade TN, 2007, CANCER-AM CANCER SOC, V109, P2011, DOI 10.1002/cncr.22644; EPSTEIN JI, 1986, CANCER, V57, P111, DOI 10.1002/1097-0142(19860101)57:1<111::AID-CNCR2820570123>3.0.CO;2-N; Igdem S, 2010, ONKOLOGIE, V33, P169, DOI 10.1159/000288710; MELICOW MM, 1967, CANCER, V20, P1715, DOI 10.1002/1097-0142(196710)20:10<1715::AID-CNCR2820201022>3.0.CO;2-E; Millar EKA, 1996, HISTOPATHOLOGY, V29, P11, DOI 10.1046/j.1365-2559.1996.d01-483.x; Morgan TM, 2010, J UROLOGY, V184, P2303, DOI 10.1016/j.juro.2010.08.017; Tavora F, 2008, AM J SURG PATHOL, V32, P1060, DOI 10.1097/PAS.0b013e318160edaf; Tu WH, 2008, NAT CLIN PRACT UROL, V5, P55, DOI 10.1038/ncpuro0994; YOUNG BW, 1973, CANCER, V32, P1293, DOI 10.1002/1097-0142(197312)32:6<1293::AID-CNCR2820320601>3.0.CO;2-Q	12	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					660	667		10.1056/NEJMcpc1209278	http://dx.doi.org/10.1056/NEJMcpc1209278			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944304				2022-12-28	WOS:000326354500013
J	Stergachis, AB; Neph, S; Reynolds, A; Humbert, R; Miller, B; Paige, SL; Vernot, B; Cheng, JB; Thurman, RE; Sandstrom, R; Haugen, E; Heimfeld, S; Murry, CE; Akey, JM; Stamatoyannopoulos, JA				Stergachis, Andrew B.; Neph, Shane; Reynolds, Alex; Humbert, Richard; Miller, Brady; Paige, Sharon L.; Vernot, Benjamin; Cheng, Jeffrey B.; Thurman, Robert E.; Sandstrom, Richard; Haugen, Eric; Heimfeld, Shelly; Murry, Charles E.; Akey, Joshua M.; Stamatoyannopoulos, John A.			Developmental Fate and Cellular Maturity Encoded in Human Regulatory DNA Landscapes	CELL			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; HYPERSENSITIVE SITES; EPIGENETIC MEMORY; IN-VIVO; CHROMATIN; TRANSITIONS; PATTERNS; LINEAGE; CANCER	Cellular-state information between generations of developing cells may be propagated via regulatory regions. We report consistent patterns of gain and loss of DNase I-hypersensitive sites (DHSs) as cells progress from embryonic stem cells (ESCs) to terminal fates. DHS patterns alone convey rich information about cell fate and lineage relationships distinct from information conveyed by gene expression. Developing cells share a proportion of their DHS landscapes with ESCs; that proportion decreases continuously in each cell type as differentiation progresses, providing a quantitative benchmark of developmental maturity. Developmentally stable DHSs densely encode binding sites for transcription factors involved in autoregulatory feedback circuits. In contrast to normal cells, cancer cells extensively reactivate silenced ESC DHSs and those from developmental programs external to the cell lineage from which the malignancy derives. Our results point to changes in regulatory DNA landscapes as quantitative indicators of cell-fate transitions, lineage relationships, and dysfunction.	[Stergachis, Andrew B.; Neph, Shane; Reynolds, Alex; Humbert, Richard; Miller, Brady; Vernot, Benjamin; Thurman, Robert E.; Sandstrom, Richard; Haugen, Eric; Akey, Joshua M.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA; [Paige, Sharon L.; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Paige, Sharon L.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Miller, Brady] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [Heimfeld, Shelly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Cheng, Jeffrey B.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA.	jstam@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Akey, Joshua/0000-0002-4411-1330; Sandstrom, Richard/0000-0002-3356-1547; Haugen, Eric/0000-0001-7444-8981	NIH [U54HG004592, U54HG007010, U01ES017156, P30DK056465, P01GM081719, U01HL100405, P01HL094374, R01HL084642]; NIDDK [FDK095678A]; NHLBI [F30HL095343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, R01HL084642, P01HL094374, F30HL095343] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678, P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619, T32GM007266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants U54HG004592, U54HG007010, and U01ES017156 to J.A.S.; NIH grant P30DK056465 to S. H.; and NIH grants P01GM081719, U01HL100405, P01HL094374, and R01HL084642 to C. E. M. We thank many colleagues, particularly Joseph Costello (UCSF), for contributing cells for DNase I mapping and expression profiling. A. B. S. was supported by grant FDK095678A from NIDDK. S. L. P. was supported by NHLBI grant F30HL095343. We thank Rae Senarighi (UW) for expert assistance with graphic design. All data from this study are available through the ENCODE data repository at UCSC (http://www.encodeproject.org) and the Roadmap Epigenomics data repository at NCBI (http://www.ncbi.nlm.nih.gov/epigenomics). All data from this study are free to use and are not subject to consortium embargo dates.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Alon U., 2006, INTRO SYSTEMS BIOL D; Baer v., 1828, ENTWICKLUNGSGESCHICH; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Beard J, 1902, LANCET, V1, P1758; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cohen J., 1963, LIVING EMBRYOS INTRO; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBOULE D, 1994, DEVELOPMENT, P135; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Harvey W, 1651, EXERCITATIONES GENER; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hirszfeld L., 1932, Z IMMUNITATSFORSCH, V75, P209; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Liao WP, 2009, GENESIS, V47, P476, DOI 10.1002/dvg.20520; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Morgan TH, 1901, AM NAT, V35, P949, DOI 10.1086/278049; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Passeron T, 2009, J CLIN INVEST, V119, P954, DOI 10.1172/JCI34015; Patten B. M., 1920, EARLY EMBRYOLOGY CHI; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; PERSSON H, 1984, SCIENCE, V225, P718, DOI 10.1126/science.6463648; PTASHNE M, 1980, CELL, V19, P1, DOI 10.1016/0092-8674(80)90383-9; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Raff R. A., 1996, SHAPE LIFE GENES DEV; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; TATARINOV Iu S, 1964, Vopr Med Khim, V10, P90; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Waddington C.H., 1940, ORG GENES; Waddington C H, 1957, STRATEGY GENES DISCU; Waddington C. H., 1939, INTRO MODERN GENETIC; Waddington CH, 1935, NATURE, V135, P606, DOI 10.1038/135606a0; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	55	231	240	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					888	903		10.1016/j.cell.2013.07.020	http://dx.doi.org/10.1016/j.cell.2013.07.020			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953118	Green Accepted, Bronze			2022-12-28	WOS:000323202500018
J	Thedieck, K; Holzwarth, B; Prentzell, MT; Boehlke, C; Klasener, K; Ruf, S; Sonntag, AG; Maerz, L; Grellscheid, SN; Kremmer, E; Nitschke, R; Kuehn, EW; Jonker, JW; Groen, AK; Reth, M; Hall, MN; Baumeister, R				Thedieck, Kathrin; Holzwarth, Birgit; Prentzell, Mirja Tamara; Boehlke, Christopher; Klaesener, Kathrin; Ruf, Stefanie; Sonntag, Annika Gwendolin; Maerz, Lars; Grellscheid, Sushma-Nagaraja; Kremmer, Elisabeth; Nitschke, Roland; Kuehn, E. Wolfgang; Jonker, Johan W.; Groen, Albert K.; Reth, Michael; Hall, Michael N.; Baumeister, Ralf			Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells	CELL			English	Article							MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; HYDROGEN-PEROXIDE; COMPLEX 1; SIGNALING PATHWAY; RAPAMYCIN; PROTEIN; ACTIVATION; INITIATION; KINASE	Mammalian target of rapamycin complex 1 (mTORC1) controls growth and survival in response to metabolic cues. Oxidative stress affects mTORC1 via inhibitory and stimulatory inputs. Whereas downregulation of TSC1-TSC2 activates mTORC1 upon oxidative stress, the molecular mechanism of mTORC1 inhibition remains unknown. Here, we identify astrin as an essential negative mTORC1 regulator in the cellular stress response. Upon stress, astrin inhibits mTORC1 association and recruits the mTORC1 component raptor to stress granules (SGs), thereby preventing mTORC1-hyperactivation-induced apoptosis. In turn, balanced mTORC1 activity enables expression of stress factors. By identifying astrin as a direct molecular link between mTORC1, SG assembly, and the stress response, we establish a unifying model of mTORC1 inhibition and activation upon stress. Importantly, we show that in cancer cells, apoptosis suppression during stress depends on astrin. Being frequently upregulated in tumors, astrin is a potential clinically relevant target to sensitize tumors to apoptosis.	[Thedieck, Kathrin; Holzwarth, Birgit; Prentzell, Mirja Tamara; Klaesener, Kathrin; Ruf, Stefanie; Sonntag, Annika Gwendolin; Maerz, Lars; Nitschke, Roland; Reth, Michael; Baumeister, Ralf] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Thedieck, Kathrin; Klaesener, Kathrin; Ruf, Stefanie; Nitschke, Roland; Kuehn, E. Wolfgang; Reth, Michael; Baumeister, Ralf] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Thedieck, Kathrin; Nitschke, Roland; Baumeister, Ralf] Univ Freiburg, Ctr Syst Biol ZBSA, D-79104 Freiburg, Germany; [Prentzell, Mirja Tamara] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Ruf, Stefanie] Univ Freiburg, Res Training Grp RTG 1104, D-79104 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ Ctr Biochem & Mol Cell Res, D-79104 Freiburg, Germany; [Thedieck, Kathrin; Boehlke, Christopher; Kuehn, E. Wolfgang] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Klaesener, Kathrin; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Grellscheid, Sushma-Nagaraja] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Kremmer, Elisabeth] Inst Mol Immunol, Helmholtz Zentrum Munchen, D-81377 Munich, Germany; [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Jonker, Johan W.; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Durham University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Basel; University of Groningen	Thedieck, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	k.thedieck@umcg.nl	Nitschke, Roland/F-9525-2010; Boehlke, Christopher/AAZ-6627-2021; Jonker, Johan W./ABE-6853-2020	Nitschke, Roland/0000-0002-9397-8475; Boehlke, Christopher/0000-0002-6985-0201; Jonker, Johan W./0000-0002-3919-5437; Klasener, Kathrin/0000-0002-5969-2553; Prentzell, Mirja Tamara/0000-0002-9659-9825; Thedieck, Kathrin/0000-0002-9069-2930; Hall, Michael N/0000-0002-2998-0757	EC 6th FP NoE LifeSpan [LSHG-CT-2007-036894]; Schlieben-Lange-Programm; Excellence Initiative of the German Research Foundation [EXC 294, GSC-4]; Excellence Initiative of the German Research Foundation (Spemann Graduate School); DFG Research Training Group RTG [1104]; DFG [KU 1504, CRC746, CRC850]; BMBF Gerontosys II-NephAge [031 5896A]; Freiburg Institute for Advanced Studies, FRIAS; Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Addison Wheeler Fellowship; European Research Council [IRG-277169]; Human Frontier Science Program [CDA00013/2011-C]; Netherlands Organization for Scientific Research (VIDI) [016.126.338]; Dutch Digestive Foundation [WO 11-67]; Dutch Diabetes Foundation [2012.00.1537]	EC 6th FP NoE LifeSpan; Schlieben-Lange-Programm; Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); Excellence Initiative of the German Research Foundation (Spemann Graduate School); DFG Research Training Group RTG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); BMBF Gerontosys II-NephAge(Federal Ministry of Education & Research (BMBF)); Freiburg Institute for Advanced Studies, FRIAS(Fonds de la Recherche Scientifique - FNRS); Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik; Addison Wheeler Fellowship; European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Netherlands Organization for Scientific Research (VIDI)(Netherlands Organization for Scientific Research (NWO)); Dutch Digestive Foundation; Dutch Diabetes Foundation	We thank Daryl P. Shanley (Newcastle University, UK) and Anna Johann for helpful discussions and critical reading of the manuscript. We thank Jerry Pelletier, McGill University, Montreal, Quebec, Canada for kindly providing hippuristanol. We thank our reviewers for excellent feedback and helpful experimental suggestions. Special thanks go to the staff of the Life Imaging Center (LIC) in the Center for Systems Biology, Albert-Ludwigs-University Freiburg for excellent confocal and widefield microscopy resources and the support in image analysis. This study was supported in part by the EC 6th FP NoE LifeSpan (LSHG-CT-2007-036894, to K. T. and R. B.), the Schlieben-Lange-Programm (K. T.), the Excellence Initiative of the German Research Foundation (EXC 294 to K. T., R. B., M. R., E. W. K., and R.N.; GSC-4, Spemann Graduate School to M. T. P.), the DFG Research Training Group RTG 1104 (S. R.), DFG grant KU 1504 (E. W. K.), BMBF Gerontosys II-NephAge (031 5896A) (K. T. and R. B.), the DFG grants CRC746 (M. R. and R. B.) and CRC850 (R. B.), the Freiburg Institute for Advanced Studies, FRIAS (K. T.), and the Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik (K. T.). SNG is supported by an Addison Wheeler Fellowship. J.W.J. is supported by grants from the European Research Council (IRG-277169), Human Frontier Science Program (CDA00013/2011-C), the Netherlands Organization for Scientific Research (VIDI grant 016.126.338), the Dutch Digestive Foundation (grant WO 11-67), and the Dutch Diabetes Foundation (grant 2012.00.1537). A part of this work is the basis for a pending European patent application, filed on January 11, 2013 (Application no. EP13151022.4).	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Buechler S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-243; Chang MS, 2001, BIOCHEM BIOPH RES CO, V287, P116, DOI 10.1006/bbrc.2001.5554; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Dennis MD, 2013, J BIOL CHEM, V288, P10, DOI 10.1074/jbc.M112.402461; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Fournier MJ, 2013, MOL CELL BIOL, V33, P2285, DOI 10.1128/MCB.01517-12; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; Halim VA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003664; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang CS, 2002, CANCER RES, V62, P5689; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Li M, 2010, CELL SIGNAL, V22, P1469, DOI 10.1016/j.cellsig.2010.05.015; Luo XA, 2011, RNA BIOL, V8, P14, DOI 10.4161/rna.8.1.13483; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Pour NK, 2011, BIOCHEMISTRY-US, V50, P6942, DOI 10.1021/bi200711v; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Rubsamen D, 2012, RNA, V18, P1910, DOI 10.1261/rna.033019.112; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shao XP, 2001, MOL REPROD DEV, V59, P410, DOI 10.1002/mrd.1047; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sonntag AG, 2012, FEBS J, V279, P3314, DOI 10.1111/j.1742-4658.2012.08582.x; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Talarek N, 2010, MOL CELL, V38, P345, DOI 10.1016/j.molcel.2010.02.039; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014	66	180	189	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					859	874		10.1016/j.cell.2013.07.031	http://dx.doi.org/10.1016/j.cell.2013.07.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953116	Bronze			2022-12-28	WOS:000323202500016
J	Chiu, HY; Lin, SJ				Chiu, Hsien-Yi; Lin, Sung-Jan			A Painful Bulge in the Left Flank	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ABDOMINAL-WALL PSEUDOHERNIA; HERPES-ZOSTER; PARESIS		[Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Hsin Chu Branch, Hsinchu, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei, Taiwan; [Lin, Sung-Jan] Natl Taiwan Univ, Coll Engn, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Lin, SJ (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan South Rd, Taipei 100, Taiwan.	drsjlin@ntu.edu.tw		Chiu, Hsien-Yi/0000-0002-0493-9707; Lin, Sung-Jan/0000-0003-1325-3464				Cioni R, 1994, Electromyogr Clin Neurophysiol, V34, P125; Dobrev H, 2008, CLIN EXP DERMATOL, V33, P677, DOI 10.1111/j.1365-2230.2007.02657.x; ECONOMOU PG, 1984, JAMA-J AM MED ASSOC, V252, P1012, DOI 10.1001/jama.252.8.1012; Giuliani A, 2006, ACTA DERM-VENEREOL, V86, P73, DOI 10.1080/0001550510010042886; GREENBERG J, 1970, J AMER MED ASSOC, V212, P322, DOI 10.1001/jama.1970.03170150076025; Mancuso M, 2006, ARCH NEUROL-CHICAGO, V63, P1327, DOI 10.1001/archneur.63.9.1327; Oliveira Pedro Dantas, 2006, Hernia, V10, P364, DOI 10.1007/s10029-006-0102-6; Tashiro S, 2010, ARCH PHYS MED REHAB, V91, P321, DOI 10.1016/j.apmr.2009.10.011; THOMAS JE, 1972, NEUROLOGY, V22, P459, DOI 10.1212/WNL.22.5.459	9	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					639	640		10.1001/jama.2013.116866	http://dx.doi.org/10.1001/jama.2013.116866			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942683				2022-12-28	WOS:000323058400020
J	DeCamp, M; Koenig, TW; Chisolm, MS				DeCamp, Matthew; Koenig, Thomas W.; Chisolm, Margaret S.			Social Media and Physicians' Online Identity Crisis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EDUCATION		[DeCamp, Matthew] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [DeCamp, Matthew] Johns Hopkins Univ, Div Gen Internal Med, Baltimore, MD 21205 USA; [Koenig, Thomas W.; Chisolm, Margaret S.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	DeCamp, M (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	mdecamp1@jhmi.edu	DeCamp, Matthew/N-6028-2014; Koenig, Thomas/ABD-2278-2020; Chisolm, Margaret/C-3255-2008	Koenig, Thomas/0000-0002-1472-4638; DeCamp, Matthew/0000-0002-9371-8729; Chisolm, Margaret/0000-0001-7424-919X	NHLBI NIH HHS [5T32HL007180-38, T32 HL007180] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007180] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cheston CC, 2013, ACAD MED, V88, P893, DOI 10.1097/ACM.0b013e31828ffc23; Chretien KC, 2013, CIRCULATION, V127, P1413, DOI 10.1161/CIRCULATIONAHA.112.128017; Costello CynthiaY., 2005, PROFESSIONAL IDENTIT; Farnan JM, 2013, ANN INTERN MED, V158, P620, DOI 10.7326/0003-4819-158-8-201304160-00100; Jarvis-Selinger S, 2012, ACAD MED, V87, P1185, DOI 10.1097/ACM.0b013e3182604968; Ryan M., 2012, GUIDING PRINCIPLES P; Vayena E, 2012, AM J PUBLIC HEALTH, V102, P2225, DOI 10.2105/AJPH.2012.300813	7	63	63	3	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					581	582		10.1001/jama.2013.8238	http://dx.doi.org/10.1001/jama.2013.8238			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942675	Green Accepted			2022-12-28	WOS:000323058400010
J	Lutz, JF; Ouchi, M; Liu, DR; Sawamoto, M				Lutz, Jean-Francois; Ouchi, Makoto; Liu, David R.; Sawamoto, Mitsuo			Sequence-Controlled Polymers	SCIENCE			English	Review							OPENING METATHESIS POLYMERIZATION; TRANSFER RADICAL POLYMERIZATION; DNA-TEMPLATED POLYMERIZATION; DEFINED SYNTHETIC-POLYMERS; N-SUBSTITUTED MALEIMIDES; NUCLEIC-ACID ALDEHYDES; BLOCK-COPOLYMERS; CONJUGATED POLYMERS; PEPTIDE-SYNTHESIS; VINYL COPOLYMERS	Sequence-controlled polymers are macromolecules in which monomer units of different chemical nature are arranged in an ordered fashion. The most prominent examples are biological and have been studied and used primarily by molecular biologists and biochemists. However, recent progress in protein-and DNA-based nanotechnologies has shown the relevance of sequence-controlled polymers to nonbiological applications, including data storage, nanoelectronics, and catalysis. In addition, synthetic polymer chemistry has provided interesting routes for preparing nonnatural sequence-controlled polymers. Although these synthetic macromolecules do not yet compare in functional scope with their natural counterparts, they open up opportunities for controlling the structure, self-assembly, and macroscopic properties of polymer materials.	[Lutz, Jean-Francois] CNRS, Inst Charles Sadron, Precis Macromol Chem Grp, UPR22, F-67034 Strasbourg 2, France; [Ouchi, Makoto; Sawamoto, Mitsuo] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University; Harvard University; Harvard University; Howard Hughes Medical Institute	Lutz, JF (corresponding author), CNRS, Inst Charles Sadron, Precis Macromol Chem Grp, UPR22, 23 Rue Loess,Boite Postale 84047, F-67034 Strasbourg 2, France.	jflutz@unistra.fr	Liu, David R./HCH-3132-2022; Sawamoto, Mitsuo/AAH-3955-2020; Ouchi, Makoto/A-8372-2013; Lutz, Jean-François/C-3264-2009	Ouchi, Makoto/0000-0003-4540-7827; Lutz, Jean-François/0000-0002-3893-2458	European Research Council [258593]; CNRS; University of Strasbourg; International Center for Frontier Research in Chemistry (FRC, Strasbourg); excellence network Chimie des Systemes Complexes (LabEx CSC); Ministry of Education, Science, Sports, and Culture (MEXT) [18GS0209, A 24245026, A 23685024]; Howard Hughes Medical Institute; National Institute of General Medical Sciences, NIH [R01GM065865]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; International Center for Frontier Research in Chemistry (FRC, Strasbourg); excellence network Chimie des Systemes Complexes (LabEx CSC); Ministry of Education, Science, Sports, and Culture (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank D. A. Tirrell for his helpful comments and suggestion. J.F.L. thanks the European Research Council (Project SEQUENCES, grant agreement no. 258593), the CNRS, the University of Strasbourg, the International Center for Frontier Research in Chemistry (FRC, Strasbourg), and the excellence network Chimie des Systemes Complexes (LabEx CSC) for financial support. M. S. and M.O. thank the Ministry of Education, Science, Sports, and Culture (MEXT) through a grant-in-aid for financial support [Creative Science Research (18GS0209), Grant-in-Aid for Scientific Research (A 24245026), and Grant-in-Aid for Young Scientists (A 23685024)]. D. R. L. is grateful for support from the Howard Hughes Medical Institute and National Institute of General Medical Sciences, NIH, R01GM065865.	Aitken BS, 2012, MACROMOLECULES, V45, P681, DOI 10.1021/ma202304s; Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533; Atallah P, 2013, MACROMOLECULES, V46, P4735, DOI 10.1021/ma400067b; Badi N, 2009, CHEM SOC REV, V38, P3383, DOI 10.1039/b806413j; Bancroft C, 2001, SCIENCE, V293, P1763; Baradel N, 2013, ANGEW CHEM INT EDIT, V52, P2335, DOI 10.1002/anie.201209052; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; Bazzi HS, 2003, MACROMOLECULES, V36, P7899, DOI 10.1021/ma034683p; Berda E. B., 2012, POLYM SCI COMPREHENS, P195; Berthet MA, 2010, MACROMOLECULES, V43, P44, DOI 10.1021/ma902075q; Bielawski CW, 2007, PROG POLYM SCI, V32, P1, DOI 10.1016/j.progpolymsci.2006.08.006; Borner HG, 2009, PROG POLYM SCI, V34, P811, DOI 10.1016/j.progpolymsci.2009.05.001; BOHLER C, 1995, NATURE, V376, P578, DOI 10.1038/376578a0; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; Brudno Y, 2009, CHEM BIOL, V16, P265, DOI 10.1016/j.chembiol.2009.02.004; Chan-Seng D, 2012, ANGEW CHEM INT EDIT, V51, P12254, DOI 10.1002/anie.201206371; Chen CL, 2011, J AM CHEM SOC, V133, P5214, DOI 10.1021/ja200595f; Chen W, 2013, J AM CHEM SOC, V135, P4438, DOI 10.1021/ja312507z; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; DUVIGNEAUD V, 1954, J AM CHEM SOC, V76, P3115, DOI 10.1021/ja01641a004; Eckhardt D, 2005, CHEM COMMUN, P2814, DOI 10.1039/b503275j; Frauenrath H, 2008, CHEM-EUR J, V14, P2942, DOI 10.1002/chem.200701325; Hao ZH, 2013, MACROMOL RAPID COMM, V34, P411, DOI 10.1002/marc.201200685; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hartmann L, 2009, ADV MATER, V21, P3425, DOI 10.1002/adma.200801884; Hartmann L, 2008, CHEM-EUR J, V14, P2025, DOI 10.1002/chem.200701223; Hartmann L, 2011, MACROMOL CHEM PHYS, V212, P8, DOI 10.1002/macp.201000479; Hibi Y, 2011, ANGEW CHEM INT EDIT, V50, P7434, DOI 10.1002/anie.201103007; Hibi Y, 2011, POLYM CHEM-UK, V2, P341, DOI 10.1039/c0py00252f; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Houshyar S, 2012, POLYM CHEM-UK, V3, P1879, DOI 10.1039/c2py00529h; Ida S, 2010, J AM CHEM SOC, V132, P14748, DOI 10.1021/ja1070575; Ida S, 2009, J AM CHEM SOC, V131, P10808, DOI 10.1021/ja9031314; INAKI Y, 1986, J POLYM SCI POL CHEM, V24, P3249, DOI 10.1002/pola.1986.080241209; Ishihara Y, 2007, CHEM-EUR J, V13, P4560, DOI 10.1002/chem.200601423; Kiick KL, 2000, ANGEW CHEM INT EDIT, V39, P2148, DOI 10.1002/1521-3773(20000616)39:12<2148::AID-ANIE2148>3.0.CO;2-7; Kleiner RE, 2008, J AM CHEM SOC, V130, P4646, DOI 10.1021/ja0753997; Kool ET, 2002, ACCOUNTS CHEM RES, V35, P936, DOI 10.1021/ar000183u; Kramer JW, 2009, J AM CHEM SOC, V131, P16042, DOI 10.1021/ja9075327; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Leibfarth FA, 2013, ANGEW CHEM INT EDIT, V52, P199, DOI 10.1002/anie.201206476; Lewandowski B, 2013, SCIENCE, V339, P189, DOI 10.1126/science.1229753; Li J, 2012, J AM CHEM SOC, V134, P16352, DOI 10.1021/ja306866w; Li J, 2011, J AM CHEM SOC, V133, P6910, DOI 10.1021/ja200895s; LI T, 1994, NATURE, V369, P218, DOI 10.1038/369218a0; Li ZY, 2002, J AM CHEM SOC, V124, P746, DOI 10.1021/ja017319j; Lo PK, 2009, J AM CHEM SOC, V131, P4182, DOI 10.1021/ja809613n; Lutz JF, 2011, MACROMOL RAPID COMM, V32, P127, DOI 10.1002/marc.201000664; Lutz JF, 2010, POLYM CHEM-UK, V1, P55, DOI 10.1039/b9py00329k; Malyshev DA, 2012, P NATL ACAD SCI USA, V109, P12005, DOI 10.1073/pnas.1205176109; Matyjaszewski K, 2011, SCIENCE, V333, P1104, DOI 10.1126/science.1209660; MCGRATH KP, 1992, J AM CHEM SOC, V114, P727, DOI 10.1021/ja00028a048; McHale R, 2012, NAT CHEM, V4, P491, DOI [10.1038/NCHEM.1331, 10.1038/nchem.1331]; McKee ML, 2010, ANGEW CHEM INT EDIT, V49, P7948, DOI 10.1002/anie.201002721; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Milnes PJ, 2012, CHEM COMMUN, V48, P5614, DOI 10.1039/c2cc31975f; MINODA M, 1990, MACROMOLECULES, V23, P4889, DOI 10.1021/ma00225a001; Murnen HK, 2013, SOFT MATTER, V9, P90, DOI 10.1039/c2sm26849c; Murnen HK, 2012, MACROMOLECULES, V45, P5229, DOI 10.1021/ma300707t; Natalello A, 2011, MACROMOL RAPID COMM, V32, P233, DOI 10.1002/marc.201000482; Niu J, 2013, NAT CHEM, V5, P282, DOI [10.1038/NCHEM.1577, 10.1038/nchem.1577]; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Norris BN, 2013, MACROMOLECULES, V46, P1384, DOI 10.1021/ma400123r; Norris BN, 2010, ORG LETT, V12, P5514, DOI 10.1021/ol102398y; ORGEL LE, 1992, NATURE, V358, P203, DOI 10.1038/358203a0; Ouchi M, 2011, NAT CHEM, V3, P917, DOI [10.1038/NCHEM.1175, 10.1038/nchem.1175]; Ouchi M, 2009, CHEM REV, V109, P4963, DOI 10.1021/cr900234b; Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Pfeifer S, 2007, J AM CHEM SOC, V129, P9542, DOI 10.1021/ja0717616; Pfeifer S, 2009, J AM CHEM SOC, V131, P9195, DOI 10.1021/ja903635y; Pfeifer S, 2008, CHEM-EUR J, V14, P10949, DOI 10.1002/chem.200801237; PICCIRILLI JA, 1990, NATURE, V343, P33, DOI 10.1038/343033a0; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Rojas G, 2009, J AM CHEM SOC, V131, P17376, DOI 10.1021/ja907521p; Rosales AM, 2012, MACROMOLECULES, V45, P6027, DOI 10.1021/ma300625b; Rosenbaum DM, 2003, J AM CHEM SOC, V125, P13924, DOI 10.1021/ja038058b; Rzaev ZMO, 2000, PROG POLYM SCI, V25, P163, DOI 10.1016/S0079-6700(99)00027-1; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Satoh K, 2007, CHEM COMMUN, P1260, DOI 10.1039/b616598b; Satoh K, 2010, J AM CHEM SOC, V132, P10003, DOI 10.1021/ja1042353; Satoh K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1004; Schmidt BVKJ, 2011, NAT CHEM, V3, P234, DOI [10.1038/nchem.964, 10.1038/NCHEM.964]; Schnitzler T, 2012, ACCOUNTS CHEM RES, V45, P1419, DOI 10.1021/ar200211a; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; SIEVERS D, 1994, NATURE, V369, P221, DOI 10.1038/369221a0; Smith JA, 2000, MACROMOLECULES, V33, P3781, DOI 10.1021/ma9920792; Spijker HJ, 2007, MACROMOLECULES, V40, P12, DOI 10.1021/ma061808s; SZWARC M, 1956, NATURE, V178, P1168, DOI 10.1038/1781168a0; Terashima T, 2011, J AM CHEM SOC, V133, P4742, DOI 10.1021/ja2004494; Tong XM, 2011, CHEM COMMUN, V47, P1455, DOI 10.1039/c0cc04807k; van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Weiss J, 2012, POLYM CHEM-UK, V3, P352, DOI 10.1039/c1py00422k; Yu TB, 2009, ANGEW CHEM INT EDIT, V48, P1097, DOI 10.1002/anie.200805009; Zamfir M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2151; Zhang JH, 2012, ACS MACRO LETT, V1, P1383, DOI 10.1021/mz300535r; ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076	98	900	909	48	1362	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					628	+	1238149	10.1126/science.1238149	http://dx.doi.org/10.1126/science.1238149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929982				2022-12-28	WOS:000322884800029
J	Maisak, MS; Haag, J; Ammer, G; Serbe, E; Meier, M; Leonhardt, A; Schilling, T; Bahl, A; Rubin, GM; Nern, A; Dickson, BJ; Reiff, DF; Hopp, E; Borst, A				Maisak, Matthew S.; Haag, Juergen; Ammer, Georg; Serbe, Etienne; Meier, Matthias; Leonhardt, Aljoscha; Schilling, Tabea; Bahl, Armin; Rubin, Gerald M.; Nern, Aljoscha; Dickson, Barry J.; Reiff, Dierk F.; Hopp, Elisabeth; Borst, Alexander			A directional tuning map of Drosophila elementary motion detectors	NATURE			English	Article							VISUAL INTERNEURONS; OPTIC LOBE; DETECTION CIRCUITS; LOBULA PLATE; FLY; MELANOGASTER; PATHWAYS; MEDULLA; VISION; SELECTIVITY	The extraction of directional motion information from changing retinal images is one of the earliest and most important processing steps in any visual system. In the fly optic lobe, two parallel processing streams have been anatomically described, leading from two first-order interneurons, L1 and L2, via T4 and T5 cells onto large, wide-field motion-sensitive interneurons of the lobula plate(1). Therefore, T4 and T5 cells are thought to have a pivotal role in motion processing; however, owing to their small size, it is difficult to obtain electrical recordings of T4 and T5 cells, leaving their visual response properties largely unknown. We circumvent this problem by means of optical recording from these cells in Drosophila, using the genetically encoded calcium indicator GCaMP5 (ref. 2). Here we find that specific subpopulations of T4 and T5 cells are directionally tuned to one of the four cardinal directions; that is, front-to-back, back-to-front, upwards and downwards. Depending on their preferred direction, T4 and T5 cells terminate in specific sublayers of the lobula plate. T4 and T5 functionally segregate with respect to contrast polarity: whereas T4 cells selectively respond to moving brightness increments (ON edges), T5 cells only respond to moving brightness decrements (OFF edges). When the output from T4 or T5 cells is blocked, the responses of postsynaptic lobula plate neurons to moving ON (T4 block) or OFF edges (T5 block) are selectively compromised. The same effects are seen in turning responses of tethered walking flies. Thus, starting with L1 and L2, the visual input is split into separate ON and OFF pathways, and motion along all four cardinal directions is computed separately within each pathway. The output of these eight different motion detectors is then sorted such that ON (T4) and OFF (T5) motion detectors with the same directional tuning converge in the same layer of the lobula plate, jointly providing the input to downstream circuits and motion-driven behaviours.	[Maisak, Matthew S.; Haag, Juergen; Ammer, Georg; Serbe, Etienne; Meier, Matthias; Leonhardt, Aljoscha; Schilling, Tabea; Bahl, Armin; Reiff, Dierk F.; Hopp, Elisabeth; Borst, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Rubin, Gerald M.; Nern, Aljoscha] Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Dickson, Barry J.] Inst Mol Pathol, A-1030 Vienna, Austria	Max Planck Society; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Borst, A (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	borst@neuro.mpg.de	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Bahl, Armin/0000-0001-7591-5860; Meier, Matthias/0000-0003-3608-4384; Rubin, Gerald/0000-0001-8762-8703; Serbe-Kamp, Etienne/0000-0002-7097-6274	Deutsche Forschungsgemeinschaft [SFB 870]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank L. Looger, J. Simpson, V. Jayaraman and the Janelia GECI team for making and providing us with the GCaMP5 flies before publication; J. Plett for designing and engineering the LED arena; C. Theile, W. Essbauer and M. Sauter for fly work; and A. Mauss, F. Gabbiani and T. Bonhoeffer for critically reading the manuscript. This work was in part supported by the Deutsche Forschungsgemeinschaft (SFB 870). M. S. M., G. A., E. S., M. M., A. L., A. Ba and A. Bo are members of the Graduate School of Systemic Neurosciences.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Douglass JK, 1996, J NEUROSCI, V16, P4551; EGELHAAF M, 1995, J NEUROPHYSIOL, V73, P2540, DOI 10.1152/jn.1995.73.6.2540; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franceschini N., 1989, P360; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2013, J NEUROSCI, V33, P902, DOI 10.1523/JNEUROSCI.3374-12.2013; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reichardt W, 1961, SENS COMMUN, P303; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Sanchez D, 1915, CONTRIBUCION CONOCIM; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Single S, 1997, J NEUROSCI, V17, P6023; STRAUSFELD NJ, 1991, VISUAL NEUROSCI, V7, P13, DOI 10.1017/S0952523800010919; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757	34	206	206	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					212	+		10.1038/nature12320	http://dx.doi.org/10.1038/nature12320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925246				2022-12-28	WOS:000322825500036
J	LeardMann, CA; Powell, TM; Smith, TC; Bell, MR; Smith, B; Boyko, EJ; Hooper, TI; Gackstetter, GD; Ghamsary, M; Hoge, CW				LeardMann, Cynthia A.; Powell, Teresa M.; Smith, Tyler C.; Bell, Michael R.; Smith, Besa; Boyko, Edward J.; Hooper, Tomoko I.; Gackstetter, Gary D.; Ghamsary, Mark; Hoge, Charles W.			Risk Factors Associated With Suicide in Current and Former US Military Personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NATIONAL-DEATH-INDEX; MILLENNIUM COHORT; SERVICE MEMBERS; PRIMARY-CARE; VITAL STATUS; FOLLOW-UP; PRIME-MD; HEALTH; POPULATION	IMPORTANCE Beginning in 2005, the incidence of suicide deaths in the US military began to sharply increase. Unique stressors, such as combat deployments, have been assumed to underlie the increasing incidence. Previous military suicide studies, however, have relied on case series and cross-sectional investigations and have not linked data during service with postservice periods. OBJECTIVE To prospectively identify and quantify risk factors associated with suicide in current and former US military personnel including demographic, military, mental health, behavioral, and deployment characteristics. DESIGN, SETTING, AND PARTICIPANTS Prospective longitudinal study with accrual and assessment of participants in 2001, 2004, and 2007. Questionnaire data were linked with the National Death Index and the Department of Defense Medical Mortality Registry through December 31, 2008. Participants were current and former US military personnel from all service branches, including active and Reserve/National Guard, who were included in the Millennium Cohort Study (N = 151 560). MAIN OUTCOMES AND MEASURES Death by suicide captured by the National Death Index and the Department of Defense Medical Mortality Registry. RESULTS Through the end of 2008, findings were 83 suicides in 707 493 person-years of follow-up (11.73/100 000 person-years [95% CI, 9.21-14.26]). In Cox models adjusted for age and sex, factors significantly associated with increased risk of suicide included male sex, depression, manic-depressive disorder, heavy or binge drinking, and alcohol-related problems. None of the deployment-related factors (combat experience, cumulative days deployed, or number of deployments) were associated with increased suicide risk in any of the models. In multivariable Cox models, individuals with increased risk for suicide were men (hazard ratio [HR], 2.14; 95% CI, 1.17-3.92; P = .01; attributable risk [AR], 3.5 cases/10 000 persons), and those with depression (HR, 1.96; 95% CI, 1.05-3.64; P = .03; AR, 6.9/10 000 persons), manic-depressive disorder (HR, 4.35; 95% CI, 1.56-12.09; P = .005; AR, 35.6/10 000 persons), or alcohol-related problems (HR, 2.56; 95% CI, 1.56-4.18; P < .001; AR, 7.7/10 000 persons). A nested, matched case-control analysis using 20: 1 control participants per case confirmed these findings. CONCLUSIONS AND RELEVANCE In this sample of current and former military personnel observed July 1, 2001-December 31, 2008, suicide risk was independently associated with male sex and mental disorders but not with military-specific variables. These findings may inform approaches to mitigating suicide risk in this population.	[LeardMann, Cynthia A.; Powell, Teresa M.; Smith, Tyler C.; Smith, Besa] Naval Hlth Res Ctr, Dept Deployment Hlth Res, San Diego, CA 92106 USA; [Smith, Tyler C.] Natl Univ, Sch Hlth & Human Serv, San Diego, CA USA; [Smith, Besa] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Bell, Michael R.; Hooper, Tomoko I.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Boyko, Edward J.] Vet Affairs Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Gackstetter, Gary D.] Analyt Serv Inc, Arlington, VA USA; [Ghamsary, Mark] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA; [Hoge, Charles W.] Walter Reed Army Inst Res, Silver Spring, MD USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); University of California System; University of California San Diego; Uniformed Services University of the Health Sciences - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Loma Linda University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	LeardMann, CA (corresponding author), Naval Hlth Res Ctr, Dept Deployment Hlth Res, 140 Sylvester Rd, San Diego, CA 92106 USA.	cynthia.leardmann@med.navy.mil	Boyko, Edward J/G-2484-2017	Boyko, Edward J/0000-0002-3695-192X	Department of Defense [12-53, 60002]; Military Operational Medicine Research Program of the US Army Medical Research and Materiel Command, Fort Detrick, Maryland; VA Puget Sound Health Care System	Department of Defense(United States Department of Defense); Military Operational Medicine Research Program of the US Army Medical Research and Materiel Command, Fort Detrick, Maryland; VA Puget Sound Health Care System(US Department of Veterans Affairs)	This work represents report 12-53, supported by the Department of Defense, under work unit no. 60002. The Millennium Cohort Study is funded through the Military Operational Medicine Research Program of the US Army Medical Research and Materiel Command, Fort Detrick, Maryland. Dr Boyko's effort in this project was supported by VA Puget Sound Health Care System.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2011, WAR PREVENTING SUICI; [Anonymous], 2012, MSMR, V19, P11; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P7; Black SA, 2011, MIL PSYCHOL, V23, P433, DOI 10.1080/08995605.2011.590409; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Carr JR, 2004, SUICIDE LIFE-THREAT, V34, P233, DOI 10.1521/suli.34.3.233.42785; Cavanagh JTO, 1999, PSYCHOL MED, V29, P1141, DOI 10.1017/S0033291799001038; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Criqui MH, 1998, NOVART FDN SYMP, V216, P159; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P902, DOI 10.1097/01.ALC.0000164544.45746.A7; FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426; Gardner JW, 2000, MIL MED, V165, P57, DOI 10.1093/milmed/165.suppl_2.57; Goldberg IJ, 2001, CIRCULATION, V103, P472; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hoge CW, 2012, JAMA-J AM MED ASSOC, V308, P671, DOI 10.1001/jama.2012.9955; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hooper TI, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-15; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kazis LE, 1999, AM J MED QUAL, V14, P28, DOI 10.1177/106286069901400105; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; Littman AJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-99; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; PHILLIPS DP, 1993, SUICIDE LIFE-THREAT, V23, P307; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Smith TC, 2007, ANN EPIDEMIOL, V17, P525, DOI 10.1016/j.annepidem.2006.12.002; Smith TC, 2009, J OCCUP ENVIRON MED, V51, P1193, DOI 10.1097/JOM.0b013e3181b73146; SPEECHLEY M, 1991, CAN J PUBLIC HEALTH, V82, P38; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Tarabay J., NATL PUBLIC RADIO; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers F.W., 1993, ANN CONV INT SOC TRA; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270	38	261	266	1	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					496	506		10.1001/jama.2013.65164	http://dx.doi.org/10.1001/jama.2013.65164			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	196OZ	23925620				2022-12-28	WOS:000322786400022
J	Naaktgeboren, CA; De Groot, JAH; van Smeden, M; Moons, KGM; Reitsma, JB				Naaktgeboren, Christiana A.; De Groot, Joris A. H.; van Smeden, Maarten; Moons, Karel G. M.; Reitsma, Johannes B.			Evaluating Diagnostic Accuracy in the Face of Multiple Reference Standards	ANNALS OF INTERNAL MEDICINE			English	Article							CONGENITAL HEART-DEFECTS; SCREENING-TEST; PULSE OXIMETRY; BIAS; VERIFICATION; IMPUTATION; WOMEN	A universal challenge in studies that quantify the accuracy of diagnostic tests is establishing whether each participant has the disease of interest. Ideally, the same preferred reference standard would be used for all participants; however, for practical or ethical reasons, alternative reference standards that are often less accurate are frequently used instead. The use of different reference standards across participants in a single study is known as differential verification. Differential verification can cause severely biased accuracy estimates of the test or model being studied. Many variations of differential verification exist, but not all introduce the same risk of bias. A risk-of-bias assessment requires detailed information about which participants receive which reference standards and an estimate of the accuracy of the alternative reference standard. This article classifies types of differential verification and explores how they can lead to bias. It also provides guidance on how to report results and assess the risk of bias when differential verification occurs and highlights potential ways to correct for the bias.	[Naaktgeboren, Christiana A.; De Groot, Joris A. H.; van Smeden, Maarten; Moons, Karel G. M.; Reitsma, Johannes B.] Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Naaktgeboren, CA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.		van Smeden, Maarten/Y-7034-2019	van Smeden, Maarten/0000-0002-5529-1541; Reitsma, Johannes/0000-0003-4026-4345; de Groot, Joris/0000-0002-4846-5697	Netherlands Organization for Scientific Research [918.10.615]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Financial Support: By the Netherlands Organization for Scientific Research (project 918.10.615).	Alonzo TA, 2011, STAT MED, V30, P1852, DOI 10.1002/sim.4232; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; Buller HR, 2009, ANN INTERN MED, V150, P229, DOI 10.7326/0003-4819-150-4-200902170-00003; de Groot JAH, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4770; de Groot JAH, 2011, EPIDEMIOLOGY, V22, P234, DOI 10.1097/EDE.0b013e318207fc5c; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Ewer AK, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16020; Gaffikin L, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-36; Gupta A, 2011, CLIN INFECT DIS, V53, DOI 10.1093/cid/cir605; Harel O, 2006, STAT MED, V25, P3769, DOI 10.1002/sim.2494; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; Knottnerus JA., 2003, THE EVIDENCE BASE OF; Lehman CD, 2012, AM J ROENTGENOL, V199, P1169, DOI 10.2214/AJR.12.8842; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Little R.J.A., 2002, STAT ANAL MISSING DA; Lord SJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4684; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutjes AW, 2007, HEALTH TECHNOL ASSES, V11, pix; Sonke GS, 2009, J CLIN EPIDEMIOL, V62, P58, DOI 10.1016/j.jclinepi.2008.02.005; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Walter SD, 2012, STAT MED, V31, P1129, DOI 10.1002/sim.4444; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zuithoff NPA, 2009, FAM PRACT, V26, P241, DOI 10.1093/fampra/cmp036	26	28	28	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					195	+		10.7326/0003-4819-159-3-201308060-00009	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201RD	23922065				2022-12-28	WOS:000323159800005
J	Chescheir, NC				Chescheir, Nancy C.			Preterm birth in multiple pregnancy: a glimmer of hope?	LANCET			English	Editorial Material							SHORT CERVIX; PREVENTION		Univ N Carolina, Sch Med, Chapel Hill, NC 27517 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Chescheir, NC (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27517 USA.	cheschei@med.unc.edu		Chescheir, Nancy/0000-0002-0205-5051				Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001; Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53; Berghella V, 2012, OBSTET GYNECOL SURV, V67, P653, DOI 10.1097/OGX.0b013e318270d5b2; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Liem S, 2013, LANCET; Likis FE, COMP EFFECTIVENESS R; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; WHO, 2012, PRET BIRTH	9	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1314	1315		10.1016/S0140-6736(13)61540-8	http://dx.doi.org/10.1016/S0140-6736(13)61540-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23924879				2022-12-28	WOS:000325975700006
J	Lo, B; Ott, C				Lo, Bernard; Ott, Chelsea			What Is the Enemy in CME, Conflicts of Interest or Bias?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lo, Bernard; Ott, Chelsea] Greenwall Fdn, New York, NY 10170 USA		Lo, B (corresponding author), Greenwall Fdn, 420 Lexington Ave,Ste 2500, New York, NY 10170 USA.	bernardlo@greenwall.org						Accreditation Council for Continuing Medical Education, ACCME 2011 ANNUAL RE; Ellison JA, 2009, AM J MED, V122, P875, DOI 10.1016/j.amjmed.2009.02.026; Goldfarb E, 2012, J CONTIN EDUC HEALTH, V32, P205, DOI 10.1002/chp.21146; Institute of Medicine, CONFLICT OF INTEREST; Kahneman D., 2011, THINKING FAST AND SL; Kesselheim AS, 2012, NEW ENGL J MED, V367, P1119, DOI 10.1056/NEJMsa1202397; Loewenstein G, 2011, AM ECON REV, V101, P423, DOI 10.1257/aer.101.3.423	7	40	41	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1019	1020		10.1001/jama.2013.221227	http://dx.doi.org/10.1001/jama.2013.221227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	23959071				2022-12-28	WOS:000324133400013
J	Wesemann, DR; Portuguese, AJ; Meyers, RM; Gallagher, MP; Cluff-Jones, K; Magee, JM; Panchakshari, RA; Rodig, SJ; Kepler, TB; Alt, FW				Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Rodig, Scott J.; Kepler, Thomas B.; Alt, Frederick W.			Microbial colonization influences early B-lineage development in the gut lamina propria	NATURE			English	Article							ANTIBODY REPERTOIRE DEVELOPMENT; CELL DEVELOPMENT; RAG EXPRESSION; RECOMBINATION; IMMUNIZATION; TOLERANCE; GENES; MOUSE; FETAL; MICE	The RAG1/RAG2 endonuclease (RAG) initiates the V(D)J recombination reaction that assembles immunoglobulin heavy (IgH) and light (IgL) chain variable region exons from germline gene segments to generate primary antibody repertoires(1). IgH V(D)J assembly occurs in progenitor (pro-) B cells followed by that of IgL in precursor (pre-) B cells. Expression of IgH mu and IgL (Ig kappa or Ig lambda) chains generates IgM, which is expressed on immature B cells as the B-cell antigen-binding receptor (BCR). Rag expression can continue in immature B cells(2), allowing continued Ig kappa V(D)J recombination that replaces the initial V kappa J kappa exon with one that generates a new specificity(3-5). This 'receptor editing' process, which can also lead to Ig lambda V(D)J recombination and expression(3,6,7), provides a mechanism whereby antigen encounter at the Rag-expressing immature B-cell stage helps shape pre-immune BCR repertoires. As the major site of postnatal B-cell development, the bone marrow is the principal location of primary immunoglobulin repertoire diversification in mice. Here we report that early B-cell development also occurs within the mouse intestinal lamina propria (LP), where the associated V(D)J recombination/receptor editing processes modulate primary LP immunoglobulin repertoires. At weanling age in normally housed mice, the LP contains a population of Rag-expressing B-lineage cells that harbour intermediates indicative of ongoing V(D)J recombination and which contain cells with pro-B, pre-B and editing phenotypes. Consistent with LP-specific receptor editing, Rag-expressing LP B-lineage cells have similar V-H repertoires, but significantly different V kappa repertoires, compared to those of Rag2-expressing bone marrow counterparts. Moreover, colonization of germ-free mice leads to an increased ratio of Ig lambda-expressing versus Ig kappa-expressing B cells specifically in the LP. We conclude that B-cell development occurs in the intestinal mucosa, where it is regulated by extracellular signals from commensal microbes that influence gut immunoglobulin repertoires.	[Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Childrens Hosp Boston, Dept Med, Boston, MA 02115 USA; [Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wesemann, Duane R.; Portuguese, Andrew J.; Meyers, Robin M.; Gallagher, Michael P.; Cluff-Jones, Kendra; Magee, Jennifer M.; Panchakshari, Rohit A.; Alt, Frederick W.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Wesemann, Duane R.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Boston University	Alt, FW (corresponding author), Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA.	dwesemann@research.bwh.harvard.edu; alt@enders.tch.harvard.edu	Portuguese, Andrew Jay/AAX-4103-2020; Rodig, Scott/Y-3889-2019	Portuguese, Andrew Jay/0000-0003-1010-4578; Meyers, Robin/0000-0002-1802-7231; Wesemann, Duane/0000-0002-6690-944X	National Institutes of Health [AI020047, AI89972, HHSN272201000053C]; Lymphoma and Leukemia SCOR [7009-12]; American Academy of Allergy Asthma and Immunology; CSL-Behring; Career Award for Medical Scientists from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089972, R01AI020047, R37AI020047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma and Leukemia SCOR; American Academy of Allergy Asthma and Immunology; CSL-Behring; Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI020047 (to F. W. A.) and AI89972 (to D. R. W.), Lymphoma and Leukemia SCOR 7009-12 (to F. W. A.), and National Institutes of Health research contract HHSN272201000053C (to T. B. K.). D. R. W. was also supported by an award from the American Academy of Allergy Asthma and Immunology and CSL-Behring and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Butler JE, 2002, J IMMUNOL, V169, P6822, DOI 10.4049/jimmunol.169.12.6822; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Golby S, 2002, J LEUKOCYTE BIOL, V72, P279; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Jenne CN, 2006, DEV COMP IMMUNOL, V30, P165, DOI 10.1016/j.dci.2005.06.009; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Lanning D, 2000, IMMUNOL REV, V175, P214, DOI 10.1034/j.1600-065X.2000.017516.x; Lanning DK, 2005, TRENDS IMMUNOL, V26, P419, DOI 10.1016/j.it.2005.06.001; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nagaoka H, 2000, CURR OPIN IMMUNOL, V12, P187, DOI 10.1016/S0952-7915(99)00070-9; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; RAFF MC, 1976, NATURE, V259, P224, DOI 10.1038/259224a0; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	30	175	205	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465								10.1038/nature12496	http://dx.doi.org/10.1038/nature12496			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8YC	23965619	Green Submitted, Green Accepted			2022-12-28	WOS:000339424700001
J	Mertz, D; Kim, TH; Johnstone, J; Lam, PP; Science, M; Kuster, SP; Fadel, SA; Tran, D; Fernandez, E; Bhatnagar, N; Loeb, M				Mertz, Dominik; Kim, Tae Hyong; Johnstone, Jennie; Lam, Po-Po; Science, Michelle; Kuster, Stefan P.; Fadel, Shaza A.; Tran, Dat; Fernandez, Eduardo; Bhatnagar, Neera; Loeb, Mark			Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							A(H1N1) VIRUS; A H1N1; CHILDREN; QUALITY; RATIO; WOMEN; 1ST	Objective To evaluate risk factors for severe outcomes in patients with seasonal and pandemic influenza. Design Systematic review. Study selection Observational studies reporting on risk factor-outcome combinations of interest in participants with influenza. Outcomes included death, ventilator support, admission to hospital, admission to an intensive care unit, pneumonia, and composite outcomes. Data sources Medline, Embase, CINAHL, Global Health, and the Cochrane Central Register of Controlled Trials to March 2011. Risk of bias assessment Newcastle-Ottawa scale to assess the risk of bias. GRADE framework to evaluate the quality of evidence. Results 63 537 articles were identified of which 234 with a total of 610 782 participants met the inclusion criteria. The evidence supporting risk factors for severe outcomes of influenza ranged from being limited to absent. This was particularly relevant for the relative lack of data for non-2009 H1N1 pandemics and for seasonal influenza studies. Limitations in the published literature included lack of power and lack of adjustment for confounders was widespread: adjusted risk estimates were provided for only 5% of risk factor-outcome comparisons in 39 of 260 (15%) studies. The level of evidence was low for "any risk factor" (odds ratio for mortality 2.77, 95% confidence interval 1.90 to 4.05 for pandemic influenza and 2.04, 1.74 to 2.39 for seasonal influenza), obesity (2.74, 1.56 to 4.80 and 30.1, 1.74 to 2.39), cardiovascular diseases (2.92, 1.76 to 4.86 and 1.97, 1.06 to 3.67), and neuromuscular disease (2.68, 1.91 to 3.75 and 3.21, 1.84 to 5.58). The level of evidence was very low for all other risk factors. Some well accepted risk factors such as pregnancy and belonging to an ethnic minority group could not be identified as risk factors. In contrast, women who were less than four weeks post partum had a significantly increased risk of death from pandemic influenza (4.43, 1.24 to 15.81). Conclusion The level of evidence to support risk factors for influenza related complications is low and some well accepted risk factors, including pregnancy and ethnicity, could not be confirmed as risks. Rigorous and adequately powered studies are needed.	[Mertz, Dominik] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Mertz, Dominik; Kim, Tae Hyong; Johnstone, Jennie; Fernandez, Eduardo; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Lam, Po-Po] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Lam, Po-Po; Fadel, Shaza A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Science, Michelle; Tran, Dat] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Kuster, Stefan P.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Kuster, Stefan P.] Univ Zurich, Zurich, Switzerland; [Bhatnagar, Neera] McMaster Univ, Hlth Sci Lib, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Zurich; University Zurich Hospital; University of Zurich; McMaster University; McMaster University; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, MDCL 3203,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	loebm@mcmaster.ca	Kim, Tae Hyong/L-7336-2015; Kuster, Stefan/T-7388-2019	Kim, Tae Hyong/0000-0003-2920-9038; Kuster, Stefan/0000-0002-0525-6529; Fadel, Shaza/0000-0002-2336-6254	WHO	WHO(World Health Organization)	This systematic review was funded by WHO as part of an ongoing process of reviewing and revising current WHO recommendations. The protocol for the review was discussed with WHO and its suggestions were incorporated into the protocol.	[Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P301; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bender JM, 2009, PEDIATR EMERG CARE, V25, P369, DOI 10.1097/PEC.0b013e3181a792a9; Buda S, 2010, BUNDESGESUNDHEITSBLA, V53, P1223, DOI 10.1007/s00103-010-1158-0; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Center for Disease Control and Prevention, 2012, PEOPL HIGH RISK DEV; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dawood FS, 2010, PEDIATR INFECT DIS J, V29, P585, DOI 10.1097/INF.0b013e3181d411c5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fell DB, 2013, PREGNANCY OUTCOMES A; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; McMillan M, 2013, INFLUENZA VACCINATIO; Michiels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060348; Neupane B, 2010, J CLIN EPIDEMIOL, V63, P926, DOI 10.1016/j.jclinepi.2009.11.006; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Perneger TV, 2008, CONTEMP CLIN TRIALS, V29, P762, DOI 10.1016/j.cct.2008.06.002; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Stein M, 2010, ARCH PEDIAT ADOL MED, V164, P1015, DOI 10.1001/archpediatrics.2010.195; Thorlund K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025491; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; World Health Organization, 2009, FACT SHEET INFL; Xi XM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-256; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	37	361	373	2	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2013	347								f5061	10.1136/bmj.f5061	http://dx.doi.org/10.1136/bmj.f5061			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207TC	23974637	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000323625800002
J	Akhtar, W; de Jong, J; Pindyurin, AV; Pagie, L; Meuleman, W; de Ridder, J; Berns, A; Wessels, LFA; van Lohuizen, M; van Steensel, B				Akhtar, Waseem; de Jong, Johann; Pindyurin, Alexey V.; Pagie, Ludo; Meuleman, Wouter; de Ridder, Jeroen; Berns, Anton; Wessels, Lodewyk F. A.; van Lohuizen, Maarten; van Steensel, Bas			Chromatin Position Effects Assayed by Thousands of Reporters Integrated in Parallel	CELL			English	Article							NUCLEAR LAMINA INTERACTIONS; GENE-EXPRESSION; DOMAIN ORGANIZATION; ENHANCER TRAP; GENOME; CELL; PIGGYBAC; STATE; ARCHITECTURE; PLURIPOTENT	Reporter genes integrated into the genome are a powerful tool to reveal effects of regulatory elements and local chromatin context on gene expression. However, so far such reporter assays have been of low throughput. Here, we describe a multiplexing approach for the parallel monitoring of transcriptional activity of thousands of randomly integrated reporters. More than 27,000 distinct reporter integrations in mouse embryonic stem cells, obtained with two differentpromoters, show similar to 1,000-fold variation in expression levels. Data analysis indicates that lamina-associated domains act as attenuators of transcription, likely by reducing access of transcription factors to binding sites. Furthermore, chromatin compaction is predictive of reporter activity. We also found evidence for crosstalk between neighboring genes and estimate that enhancers can influence gene expression on average over similar to 20 kb. The multiplexed reporter assay is highly flexible in design and can be modified to query a wide range of aspects of gene regulation.	[Akhtar, Waseem; Berns, Anton; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Akhtar, Waseem; Pindyurin, Alexey V.; Pagie, Ludo; Meuleman, Wouter; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [de Jong, Johann; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Meuleman, Wouter; de Ridder, Jeroen; Wessels, Lodewyk F. A.] Delft Univ Technol, Delft Bioinformat Lab, NL-2628 CD Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology	Wessels, LFA (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	l.wessels@nki.nl; m.v.lohuizen@nki.nl; b.v.steensel@nki.nl	Pindyurin, Alexey/G-4167-2014	Pindyurin, Alexey/0000-0001-6959-0641; de Ridder, Jeroen/0000-0002-0828-3477; de Jong, Johann/0000-0002-2097-0915; Meuleman, Wouter/0000-0002-1196-5401	Netherlands Consortium for Systems Biology; EURYI; NWO-ALW VICI; ERC [293662]	Netherlands Consortium for Systems Biology; EURYI(European Science Foundation (ESF)); NWO-ALW VICI(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	We thank the NKI Genomics Core Facility for sequencing support, Guillaume Filion for insightful suggestions, Mario Amendola for providing the reference plasmid for IR copy number quantification, and members of our laboratories for helpful discussions and critical reading of the manuscript. This work was supported by the Netherlands Consortium for Systems Biology (L. F. A. W., M. v. L., B. v. S.) and EURYI, NWO-ALW VICI and ERC Advanced grant 293662 (B.v.S.).	Babenko VN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-318; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Chen M, 2013, CELL REP, V3, P128, DOI 10.1016/j.celrep.2012.12.003; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De S, 2009, GENOME RES, V19, P785, DOI 10.1101/gr.086165.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobzhansky T, 1936, BIOL REV CAMB PHILOS, V11, P364, DOI 10.1111/j.1469-185X.1936.tb00911.x; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hezroni H, 2011, J BIOL CHEM, V286, P35977, DOI 10.1074/jbc.M111.266254; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Montavon T, 2012, TRENDS CELL BIOL, V22, P347, DOI 10.1016/j.tcb.2012.04.003; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; OCHMAN H, 1988, GENETICS, V120, P621; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Southall Tony D., 2007, Briefings in Functional Genomics & Proteomics, V6, P133, DOI 10.1093/bfgp/elm013; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; WEBER F, 1984, CELL, V36, P983, DOI 10.1016/0092-8674(84)90048-5; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	53	200	210	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					914	927		10.1016/j.cell.2013.07.018	http://dx.doi.org/10.1016/j.cell.2013.07.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953119	Bronze			2022-12-28	WOS:000323202500020
J	Goldie, SJ; Sargeant, HW; Medjoub, K; Rust, P; Anderson, W				Goldie, Stephen J.; Sargeant, Harry W.; Medjoub, Karima; Rust, Philippa; Anderson, William			A footballer's finger injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HAND; FRACTURES; PHALANGES		[Goldie, Stephen J.; Sargeant, Harry W.; Medjoub, Karima; Anderson, William] Royal Hosp Sick Children, Dept Plast Surg, Edinburgh EH9 1LF, Midlothian, Scotland; [Goldie, Stephen J.; Sargeant, Harry W.; Medjoub, Karima; Rust, Philippa; Anderson, William] St Johns Hosp, Dept Plast Surg, Livingston, Scotland		Goldie, SJ (corresponding author), Royal Hosp Sick Children, Dept Plast Surg, Edinburgh EH9 1LF, Midlothian, Scotland.	Stephen_goldie@hotmail.com						Al-Qattan MM, 2001, J HAND SURG-BRIT EUR, V26, P201, DOI 10.1054/jhsb.2000.0549; BARTON NJ, 1979, HAND, V11, P134, DOI 10.1016/S0072-968X(79)80025-X; Mahabir RC, 2001, PEDIATR EMERG CARE, V17, P153, DOI 10.1097/00006565-200106000-00001; Papadonikolakis A, 2006, HAND CLIN, V22, P11, DOI 10.1016/j.hcl.2005.10.001; Seymour N, 1966, J Bone Joint Surg Br, V48, P347; Vadivelu R, 2006, J PEDIATR ORTHOPED, V26, P29, DOI 10.1097/01.bpo.0000189970.37037.59; Yeh PC, 2009, TECH ORTHOP, V24, P150, DOI 10.1097/BTO.0b013e3181b58eb2	7	0	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2013	347								f5069	10.1136/bmj.f5069	http://dx.doi.org/10.1136/bmj.f5069			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203ZD	23950197				2022-12-28	WOS:000323332700003
J	Moore, W				Moore, Wendy			PAST CARING Bringing chemistry out of the kitchen	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Borgias A., 1993, WOMEN IN CHEMISTRY A, P314; Duveen Denis I., 1953, CHYMIA, V4, P13, DOI DOI 10.2307/27757161	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2013	347								f5008	10.1136/bmj.f5008	http://dx.doi.org/10.1136/bmj.f5008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203XY	23943755				2022-12-28	WOS:000323329300022
J	Zardawi, I; Siriweera, E				Zardawi, Ibrahim; Siriweera, Eranga			Pellets in the Appendix	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zardawi, Ibrahim; Siriweera, Eranga] Royal Darwin Hosp, Darwin, NT, Australia		Zardawi, I (corresponding author), Royal Darwin Hosp, Darwin, NT, Australia.	ibrahim.zardawi@newcastle.edu.au							0	2	2	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6								10.1056/NEJMicm1214754	http://dx.doi.org/10.1056/NEJMicm1214754			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924027				2022-12-28	WOS:000322842000001
J	Hawkes, N				Hawkes, Nigel			Use of beta blockers during surgery may have caused 10 000 deaths in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bouri S, 2013, HEART; Huston L, 2013, FORBES           JUL	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2013	347								f4914	10.1136/bmj.f4914	http://dx.doi.org/10.1136/bmj.f4914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CN	23918611				2022-12-28	WOS:000323118400004
J	Loder, E				Loder, Elizabeth			Sharing data from clinical trials: where we are and what lies ahead	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE MORPHOGENETIC PROTEIN-2; METAANALYSIS; FUSION					eloder@bmj.com						Alltrials. net, ALL TRIALS REG ALL R; [Anonymous], 2013, SHAR CLIN RES DAT WO, P9; Carragee EJ, 2011, SPINE J, V11, P463, DOI 10.1016/j.spinee.2011.06.001; Carroll J, 2013, FIERCEBIOTECH; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; European AIDS Treatment Group, 2013, BIG PHARM MOB PAT BA; European Medicines Agency, PUBL ACC CLIN TRIAL; European Medicines Agency, DRAFT POL 70 PUBL AC; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; GlaxoSmithKline, DAT TRANSP; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7888; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Groves T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1252; Kimmelman J, 2010, SCI PROGR; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Liberati A, 2004, BMJ-BRIT MED J, V328, P531, DOI 10.1136/bmj.328.7438.531; National Institutes of Health, 2003, FIN NIH STAT SHAR RE; O'Dowd A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2639; Pharmalive, 2013, PHARM AD DAT SHAR PL; Sample I., 2013, GUARDIAN; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; UK Health Research Authority, UK HLTH RES AUTH NAT; Wellcome Trust, SHAR RES DAT IMPR PU	24	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4794	10.1136/bmj.f4794	http://dx.doi.org/10.1136/bmj.f4794			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900826				2022-12-28	WOS:000322821500022
J	Ferraro, PM; Taylor, EN; Eisner, BH; Gambaro, G; Rimm, EB; Mukamal, KJ; Curhan, GC				Ferraro, Pietro Manuel; Taylor, Eric N.; Eisner, Brian H.; Gambaro, Giovanni; Rimm, Eric B.; Mukamal, Kenneth J.; Curhan, Gary C.			History of Kidney Stones and the Risk of Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC SYNDROME; DIETARY CALCIUM; BLOOD-PRESSURE; HYPERTENSION; NEPHROLITHIASIS; POPULATION; OSTEOPONTIN; PREVALENCE; HEALTH; REPRODUCIBILITY	IMPORTANCE Kidney stone disease is common and may be associated with an increased risk of coronary heart disease (CHD). Previous studies of the association between kidney stones and CHD have often not controlled for important risk factors, and the results have been inconsistent. OBJECTIVE To examine the association between a history of kidney stones and the risk of CHD in 3 large prospective cohorts. DESIGN, SETTING, AND PARTICIPANTS A prospective study of 45 748 men and 196 357 women in the United States without a history of CHD at baseline who were participants in the Health Professionals Follow-up Study (HPFS) (45 748 men aged 40-75 years; follow-up from 1986 to 2010), Nurses' Health Study I (NHS I) (90 235 women aged 30-55 years; follow-up from 1992 to 2010), and Nurses' Health Study II (NHS II) (106 122 women aged 25-42 years; follow-up from 1991 to 2009). The diagnoses of kidney stones and CHD were updated biennially during follow-up. MAIN OUTCOMES AND MEASURES Coronary heart disease was defined as fatal or nonfatal myocardial infarction (MI) or coronary revascularization. The outcome was identified by biennial questionnaires and confirmed through review of medical records. RESULTS Of a total of 242 105 participants, 19 678 reported a history of kidney stones. After up to 24 years of follow-up in men and 18 years in women, 16 838 incident cases of CHD occurred. After adjusting for potential confounders, among women, those with a reported history of kidney stones had an increased risk of CHD than those without a history of kidney stones in NHS I (incidence rate [IR], 754 vs 514 per 100 000 person-years; multivariable hazard ratio [HR], 1.18 [95% CI, 1.08-1.28]) and NHS II (IR, 144 vs 55 per 100 000 person-years; multivariable HR, 1.48 [95% CI, 1.23-1.78]). There was no significant association in men (IR, 1355 vs 1022 per 100 000 person-years; multivariable HR, 1.06 [95% CI, 0.99-1.13]). Similar results were found when analyzing the individual end points (fatal and nonfatal MI and revascularization). CONCLUSIONS AND RELEVANCE Among the 2 cohorts of women, a history of kidney stones was associated with a modest but statistically significantly increased risk of CHD; there was no significant association in a separate cohort of men. Further research is needed to determine whether the association is sex-specific.	[Ferraro, Pietro Manuel; Gambaro, Giovanni] Columbus Gemelli Hosp, Dept Internal Med & Med Specialties, Div Nephrol, Renal Program, Rome, Italy; [Ferraro, Pietro Manuel; Taylor, Eric N.; Rimm, Eric B.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Eisner, Brian H.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Ferraro, PM (corresponding author), Univ Cattolica Sacro Cuore, Dept Internal Med & Med Specialties, Via G Moscati 31, I-00168 Rome, Italy.	manuel.ferraro@channing.harvard.edu	Ferraro, Manuel/H-1517-2012; Mukamal, Kenneth/GVR-7978-2022	Ferraro, Manuel/0000-0002-1379-022X; Gambaro, Giovanni/0000-0001-5733-2370	National Institutes of Health [DK91417, DK70756, CA087969, CA50385, CA055075, HL034594, HL35464]; NATIONAL CANCER INSTITUTE [R01CA050385, P01CA055075, UM1CA176726, UM1CA167552, P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK091417, P01DK070756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK91417, DK70756, CA087969, CA50385, CA055075, HL034594, and HL35464 from the National Institutes of Health.	Alexander RT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5287; Ando R, 2011, INT J UROL, V18, P131, DOI 10.1111/j.1442-2042.2010.02690.x; Aydin H, 2011, UROL RES, V39, P451, DOI 10.1007/s00240-011-0383-9; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; CAPPUCCIO FP, 1990, BRIT MED J, V300, P1234, DOI 10.1136/bmj.300.6734.1234; Centers for Disease Control and Prevention, 2008, NATL VITAL STAT REPO, V59; Chung SD, 2011, J UROLOGY, V186, P1888, DOI 10.1016/j.juro.2011.07.011; CIRILLO M, 1988, J HYPERTENS, V6, pS485, DOI 10.1097/00004872-198812040-00153; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Domingos F, 2011, NEPHROL DIAL TRANSPL, V26, P864, DOI 10.1093/ndt/gfq501; ELMFELDT D, 1976, J CHRON DIS, V29, P221, DOI 10.1016/0021-9681(76)90076-X; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gillen DL, 2005, AM J KIDNEY DIS, V46, P263, DOI 10.1053/j.ajkd.2005.04.030; Hamano S, 2005, INT J UROL, V12, P859, DOI 10.1111/j.1442-2042.2005.01160.x; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Jeong IG, 2011, AM J KIDNEY DIS, V58, P383, DOI 10.1053/j.ajkd.2011.03.021; Kleinman JG, 2004, NEPHRON PHYSIOL, V98, P43, DOI DOI 10.1159/000080263; LJUNGHALL S, 1976, ACTA MED SCAND, V199, P481; Madore F, 1998, AM J KIDNEY DIS, V32, P802, DOI 10.1016/S0272-6386(98)70136-2; MCCARRON DA, 1984, SCIENCE, V226, P386, DOI 10.1126/science.226.4673.386; Ohmori R, 2003, ATHEROSCLEROSIS, V170, P333, DOI 10.1016/S0021-9150(03)00298-3; Reilly RF, 2010, CLIN J AM SOC NEPHRO, V5, P1893, DOI 10.2215/CJN.04670510; Reiner AP, 2011, J UROLOGY, V185, P920, DOI 10.1016/j.juro.2010.10.086; Rendina D, 2009, NEPHROL DIAL TRANSPL, V24, P900, DOI 10.1093/ndt/gfn548; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Rule AD, 2010, J AM SOC NEPHROL, V21, P1641, DOI 10.1681/ASN.2010030253; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stoller ML, 2004, J UROLOGY, V171, P1920, DOI 10.1097/01.ju.0000120291.90839.49; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Taylor EN, 2009, J AM SOC NEPHROL, V20, P2253, DOI 10.1681/ASN.2009030276; US Renal Data System, USRDS 2010 ANN DAT R; Wang L, 2012, AM J CARDIOVASC DRUG, V12, P105, DOI 10.2165/11595400-000000000-00000; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; West B, 2008, AM J KIDNEY DIS, V51, P741, DOI 10.1053/j.ajkd.2007.12.030; WESTLUND K, 1973, AM J EPIDEMIOL, V97, P167, DOI 10.1093/oxfordjournals.aje.a121497; Yasui T, 1999, UROL RES, V27, P225, DOI 10.1007/s002400050114	42	139	147	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					408	415		10.1001/jama.2013.8780	http://dx.doi.org/10.1001/jama.2013.8780			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917291	Bronze, Green Accepted			2022-12-28	WOS:000322121500018
J	Macfarlane, RJ; Jones, MR; Lee, B; Auyeung, E; Mirkin, CA				Macfarlane, Robert J.; Jones, Matthew R.; Lee, Byeongdu; Auyeung, Evelyn; Mirkin, Chad A.			Topotactic Interconversion of Nanoparticle Superlattices	SCIENCE			English	Article							DNA; BINARY; SHAPE	The directed assembly of nanoparticle building blocks is a promising method for generating sophisticated three-dimensional materials by design. In this work, we have used DNA linkers to synthesize nanoparticle superlattices that have greater complexity than simple binary systems using the process of topotactic intercalation-the insertion of a third nanoparticle component at predetermined sites within a preformed binary lattice. Five distinct crystals were synthesized with this methodology, three of which have no equivalent in atomic or molecular crystals, demonstrating a general approach for assembling highly ordered ternary nanoparticle superlattices whose structures can be predicted before their synthesis. Additionally, the intercalation process was demonstrated to be completely reversible; the inserted nanoparticles could be expelled into solution by raising the temperature, and the ternary superlattice could be recovered by cooling.	[Macfarlane, Robert J.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Macfarlane, Robert J.; Jones, Matthew R.; Auyeung, Evelyn; Mirkin, Chad A.] Int Inst Nanotechnol, Evanston, IL 60208 USA; [Jones, Matthew R.; Auyeung, Evelyn; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Lee, Byeongdu] Argonne Natl Lab, Xray Sci Div, Adv Photon Source, Argonne, IL 60439 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010	Mirkin, Chad/0000-0002-6634-7627; Jones, Matthew/0000-0002-9289-291X	Air Force Office of Scientific Research [FA9550-11-1-0275, FA9550-12-1-0280, FA9550-09-1-0294]; Defense Advanced Research Projects Agency [HR0011-13-2-0002]; NSF-Materials Research Science and Engineering Center (MRSEC) [DMR-0520513]; Non-equilibrium Energy Research Center, an Energy Frontier Research Center; Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; NSF; Department of Defense; E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NSF-Nanoscale Science and Engineering Center; NSF-MRSEC; Keck Foundation; NU; NU Office for Research; Division Of Materials Research [1121262] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF-Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); Non-equilibrium Energy Research Center, an Energy Frontier Research Center; Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences; NSF(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF-Nanoscale Science and Engineering Center(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); NU; NU Office for Research; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank M. Kanatzidis for helpful discussions regarding the ternary crystal structures synthesized and their corresponding atomic analogs. This material is based on work supported by Air Force Office of Scientific Research awards FA9550-11-1-0275, FA9550-12-1-0280, and FA9550-09-1-0294; Defense Advanced Research Projects Agency award HR0011-13-2-0002; NSF-Materials Research Science and Engineering Center (MRSEC) program DMR-0520513; and the Non-equilibrium Energy Research Center, an Energy Frontier Research Center funded by Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences award DE-SC0000989. M.R.J. acknowledges a Graduate Research Fellowship from NSF; E. A. acknowledges the Department of Defense for a National Defense Science and Engineering Graduate Fellowship. Portions of this work were carried out at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) beamline located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E. I. DuPont de Nemours & Co., Dow Chemical Company, and the state of Illinois. Use of the APS was supported by the U.S. DOE, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. The TEM work was carried out in the Electron Probe Instrumentation Center facility of the Northwestern University (NU) Atomic and Nanoscale Characterization Experimental Center, which is supported by NSF-Nanoscale Science and Engineering Center, NSF-MRSEC, Keck Foundation, the state of Illinois, and NU. Ultrathin sectioning was carried out at the NU Biological Imaging Facility, supported by the NU Office for Research.	Auyeung E, 2012, ADV MATER, V24, P5181, DOI 10.1002/adma.201202069; Auyeung E, 2012, NAT NANOTECHNOL, V7, P24, DOI [10.1038/nnano.2011.222, 10.1038/NNANO.2011.222]; Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Cutler JI, 2012, J AM CHEM SOC, V134, P1376, DOI 10.1021/ja209351u; Dong AG, 2011, NANO LETT, V11, P1804, DOI 10.1021/nl200468p; Ellis BL, 2010, CHEM MATER, V22, P691, DOI 10.1021/cm902696j; Evers WH, 2009, ANGEW CHEM INT EDIT, V48, P9655, DOI 10.1002/anie.200904821; Jones MR, 2013, ANGEW CHEM INT EDIT, V52, P2886, DOI 10.1002/anie.201209504; Jones MR, 2011, J AM CHEM SOC, V133, P18865, DOI 10.1021/ja206777k; Jones MR, 2011, CHEM REV, V111, P3736, DOI 10.1021/cr1004452; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kim Y, 2013, J AM CHEM SOC, V135, P10342, DOI 10.1021/ja405988r; Knorowski C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215501; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Macfarlane RJ, 2010, ANGEW CHEM INT EDIT, V49, P4589, DOI 10.1002/anie.201000633; Macfarlane RJ, 2009, P NATL ACAD SCI USA, V106, P10493, DOI 10.1073/pnas.0900630106; Maye MM, 2010, NAT NANOTECHNOL, V5, P116, DOI [10.1038/NNANO.2009.378, 10.1038/nnano.2009.378]; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Mladek BM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268301; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Pryce IM, 2010, NANO LETT, V10, P4222, DOI 10.1021/nl102684x; Rao CNR, 1998, TRANSITION METAL OXI; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Ye XC, 2011, J AM CHEM SOC, V133, P2613, DOI 10.1021/ja108708v; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/NMAT3647, 10.1038/nmat3647]	33	115	118	6	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1222	1225		10.1126/science.1241402	http://dx.doi.org/10.1126/science.1241402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23970559				2022-12-28	WOS:000324248800038
J	Straub, M; Sigman, DM; Ren, HJ; Martinez-Garcia, A; Meckler, AN; Hain, MP; Haug, GH				Straub, Marietta; Sigman, Daniel M.; Ren, Haojia; Martinez-Garcia, Alfredo; Meckler, A. Nele; Hain, Mathis P.; Haug, Gerald H.			Changes in North Atlantic nitrogen fixation controlled by ocean circulation	NATURE			English	Article							AFRICAN HUMID PERIOD; ISOTOPIC COMPOSITION; ARABIAN SEA; CLIMATE; NITRATE; DENITRIFICATION; TERMINATION; PHOSPHORUS; RESPONSES; LATITUDE	In the ocean, the chemical forms of nitrogen that are readily available for biological use (known collectively as 'fixed' nitrogen) fuel the global phytoplankton productivity that exports carbon to the deep ocean(1-3). Accordingly, variation in the oceanic fixed nitrogen reservoir has been proposed as a cause of glacial-interglacial changes in atmospheric carbon dioxide concentration(2,3). Marine nitrogen fixation, which produces most of the ocean's fixed nitrogen, is thought to be affected by multiple factors, including ocean temperature(4) and the availability of iron(2,3,5) and phosphorus(6). Here we reconstruct changes in North Atlantic nitrogen fixation over the past 160,000 years from the shell-bound nitrogen isotope ratio (N-15/N-14) of planktonic foraminifera in Caribbean Sea sediments. The observed changes cannot be explained by reconstructed changes in temperature, the supply of (iron-bearing) dust or water column denitrification. We identify a strong, roughly 23,000-year cycle in nitrogen fixation and suggest that it is a response to orbitally driven changes in equatorial Atlantic upwelling(7), which imports 'excess' phosphorus (phosphorus in stoichiometric excess of fixed nitrogen) into the tropical North Atlantic surface(5,6). In addition, we find that nitrogen fixation was reduced during glacial stages 6 and 4, when North Atlantic Deep Water had shoaled to become glacial North Atlantic intermediate water(8), which isolated the Atlantic thermocline from excess phosphorus-rich mid-depth waters that today enter from the Southern Ocean. Although modern studies have yielded diverse views of the controls on nitrogen fixation(1,2,4,5), our palaeobiogeochemical data suggest that excess phosphorus is the master variable in the North Atlantic Ocean and indicate that the variations in its supply over the most recent glacial cycle were dominated by the response of regional ocean circulation to the orbital cycles.	[Straub, Marietta; Martinez-Garcia, Alfredo; Meckler, A. Nele; Haug, Gerald H.] ETH, Inst Geol, Dept Earth Sci, CH-8092 Zurich, Switzerland; [Sigman, Daniel M.; Hain, Mathis P.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ren, Haojia] Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; Columbia University	Straub, M (corresponding author), ETH, Inst Geol, Dept Earth Sci, CH-8092 Zurich, Switzerland.	marietta.straub@alumni.ethz.ch	Sigman, Daniel M/A-2649-2008; Meckler, Anna Nele/AAC-2490-2020; Martínez-García, Alfredo/A-6244-2010; Hain, Mathis P/I-5252-2012	Sigman, Daniel M/0000-0002-7923-1973; Meckler, Anna Nele/0000-0002-7225-8276; Martínez-García, Alfredo/0000-0002-7206-5079; Hain, Mathis P/0000-0002-8478-1857; REN, HAO-JIA/0000-0002-1769-4243; Straub, Marietta/0000-0002-1156-4085	SNF [200021-131886/1]; US NSF [OCE-1060947]; Grand Challenges Program of Princeton University; NSF; DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; Division Of Ocean Sciences [1060947] Funding Source: National Science Foundation	SNF; US NSF(National Science Foundation (NSF)); Grand Challenges Program of Princeton University; NSF(National Science Foundation (NSF)); DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank M. A. Weigand, S. Oleynik and S. Bishop for technical assistance and U. Rohl and V. Lukies for X-ray fluorescence scanning support. Funding was from SNF grant 200021-131886/1, US NSF grant OCE-1060947 and the Grand Challenges Program of Princeton University. This research used samples provided by the ODP, which is sponsored by the NSF and participating countries under the management of the Joint Oceanographic Institutions. X-ray fluorescence scanning was supported by the DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam.	Adkins J, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001200; ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Brandes JA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001856; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHRISTENSEN JP, 1994, CONT SHELF RES, V14, P547, DOI 10.1016/0278-4343(94)90103-1; Coles VJ, 2007, BIOGEOSCIENCES, V4, P455, DOI 10.5194/bg-4-455-2007; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DEMENOCAL PB, 1993, PALEOCEANOGRAPHY, V8, P209, DOI 10.1029/93PA02688; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Garcia H. E., 2010, WORLD OCEAN ATLAS 20, V4, P398; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Harris SE, 1999, QUATERNARY RES, V51, P14, DOI 10.1006/qres.1998.2008; Holz C, 2004, SEDIMENTOLOGY, V51, P1145, DOI 10.1111/j.1365-3091.2004.00665.x; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Jia GD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050021; Knapp AN, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003107; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Marchitto TM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001323; Marchitto TM, 1998, NATURE, V393, P557, DOI 10.1038/31197; MATTHEWSON AP, 1995, PALEOCEANOGRAPHY, V10, P677, DOI 10.1029/94PA03348; Meckler AN, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002156; MOLFINO B, 1990, SCIENCE, V249, P766, DOI 10.1126/science.249.4970.766; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Mora G, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001132; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; POKRAS EM, 1987, NATURE, V326, P486, DOI 10.1038/326486a0; Ren H, 2009, SCIENCE, V323, P244, DOI 10.1126/science.1165787; Ren HJ, 2012, LIMNOL OCEANOGR, V57, P1011, DOI 10.4319/lo.2012.57.4.1011; Ren HJ, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB004020; Sarnthein M., 1989, Proceedings of the Ocean Drilling Program Scientific Results, V108, P167, DOI 10.2973/odp.proc.sr.108.159.1989; Schlitzer R., 2012, OCEAN DATA VIEW; Schmidt MW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC000957; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Subramaniam A, 2013, GEOPHYS RES LETT, V40, P1766, DOI 10.1002/grl.50250; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Tjallingii R., 2006, THESIS U BREMEN; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Yu JM, 2010, EARTH PLANET SC LETT, V293, P114, DOI 10.1016/j.epsl.2010.02.029	45	59	59	8	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					200	+		10.1038/nature12397	http://dx.doi.org/10.1038/nature12397			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23965620				2022-12-28	WOS:000324244900036
J	Field, JK; Oudkerk, M; Pedersen, JH; Duffy, SW				Field, John K.; Oudkerk, Matthijs; Pedersen, Jesper Holst; Duffy, Stephen W.			Prospects for population screening and diagnosis of lung cancer	LANCET			English	Article							RISK PREDICTION MODEL; THORACOSCOPIC LOBECTOMY; SELECTION CRITERIA; PULMONARY NODULES; INDIVIDUAL RISK; HEAVY SMOKERS; SPIRAL CT; TOMOGRAPHY; TRIAL; MORTALITY	Deaths from lung cancer exceed those from any other type of malignancy, with 1.5 million deaths in 2010. Prevention and smoking cessation are still the main methods to reduce the death toll. The US National Lung Screening Trial, which compared CT screening with chest radiograph, yielded a mortality advantage of 20% to participants in the CT group. International debate is ongoing about whether sufficient evidence exists to implement CT screening programmes. When questions about effectiveness and cost-effectiveness have been answered, which will await publication of the largest European trial, NELSON, and pooled analysis of European CT screening trials, we discuss the main topics that will need consideration. These unresolved issues are risk prediction models to identify patients for CT screening; radiological protocols that use volumetric analysis for indeterminate nodules; options for surgical resection of CT-identified nodules; screening interval; and duration of screening. We suggest that a demonstration project of biennial screening over a 4-year period should be undertaken.	[Field, John K.] Univ Liverpool, Canc Res Ctr, Dept Mol & Clin Canc Med, Roy Castle Lung Canc Res Programme, Liverpool L3 9TA, Merseyside, England; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging, Groningen, Netherlands; [Pedersen, Jesper Holst] Univ Copenhagen, Rigshosp, Dept Cardiothorac Surg, DK-2100 Copenhagen, Denmark; [Duffy, Stephen W.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	University of Liverpool; University of Groningen; Rigshospitalet; University of Copenhagen; University of London; Queen Mary University London	Field, JK (corresponding author), Univ Liverpool, Canc Res Ctr, Dept Mol & Clin Canc Med, Roy Castle Lung Canc Res Programme, Roy Castle Bldg,200 London Rd, Liverpool L3 9TA, Merseyside, England.	j.k.field@liv.ac.uk	Field, John K./AAD-5674-2020	Field, John K./0000-0003-3951-6365; Oudkerk, Matthijs/0000-0003-2800-4110	National Institute for Health Research [09/61/01, 07/82/01] Funding Source: researchfish; Department of Health [09/61/01, 07/82/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ambrogi MC, 2011, J THORAC ONCOL, V6, P2044, DOI 10.1097/JTO.0b013e31822d538d; American Lung Association, 2012, PROV GUID LUNG CANC; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Bankier AA, 2012, RADIOLOGY, V265, P4, DOI 10.1148/radiol.12121145; Becker N, 2012, J CANCER RES CLIN, V138, P1475, DOI 10.1007/s00432-012-1228-9; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Cassidy A, 2006, INT J ONCOL, V28, P1295; Chang B, 2013, CHEST, V143, P172, DOI 10.1378/chest.11-2501; Chien CR, 2008, INT J CANCER, V122, P2594, DOI 10.1002/ijc.23413; Etzel CJ, 2008, CANCER PREV RES, V1, P255, DOI 10.1158/1940-6207.CAPR-08-0082; Field J, J SURG ONCO IN PRESS; Field J, 2013, AM ASS CANC RES ANN; Field JK, 2012, J THORAC ONCOL, V7, P10, DOI 10.1097/JTO.0b013e31823c58ab; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Hansen HJ, 2012, ANN CARDIOTHORAC SUR, V1, P70, DOI 10.3978/j.issn.2225-319X.2012.04.15; Hassanein M, 2012, CANCER PREV RES, V5, P992, DOI 10.1158/1940-6207.CAPR-11-0441; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Heuvelmans MA, 2013, EUR RADIOL, V23, P1836, DOI 10.1007/s00330-013-2799-9; Hoggart C, 2012, CANCER PREV RES, V5, P834, DOI 10.1158/1940-6207.CAPR-11-0237; Horeweg N, 2013, AM J RESP CRIT CARE, V187, P848, DOI 10.1164/rccm.201209-1651OC; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Infante M, 2008, LUNG CANCER, V59, P355, DOI 10.1016/j.lungcan.2007.08.040; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Lam S, 2008, EARLY DETECTION LUNG; Lim E, 2010, THORAX, V65, P1, DOI 10.1136/thx.2010.145938; Lim HJ, 2013, CHEST, V144, P1291, DOI 10.1378/chest.12-2987; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID; Office for National Statistics, 2011, CANC SURV ENGL PAT D; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Paul S, 2010, J THORAC CARDIOV SUR, V139, P366, DOI 10.1016/j.jtcvs.2009.08.026; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Peres J, 2013, J NATL CANCER I, V105, P1, DOI 10.1093/jnci/djs631; Petersen RH, 2012, J THORAC ONCOL, V7, P1026, DOI 10.1097/JTO.0b013e31824fe942; Peto R, 1996, BRIT MED BULL, V52, P12, DOI 10.1093/oxfordjournals.bmb.a011519; Pyenson BS, 2012, HEALTH AFFAIR, V31, P770, DOI 10.1377/hlthaff.2011.0814; Raji OY, 2012, ANN INTERN MED, V157, P242, DOI 10.7326/0003-4819-157-4-201208210-00004; Raji OY, 2010, CANCER PREV RES, V3, P664, DOI 10.1158/1940-6207.CAPR-09-0141; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Santarpia M, 2011, EXPERT REV RESP MED, V5, P413, DOI [10.1586/ers.11.27, 10.1586/ERS.11.27]; Senan S, 2013, LANCET ONCOL, V14, pE270, DOI 10.1016/S1470-2045(12)70592-2; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Spitz MR, 2013, J THORAC ONCOL, V8, P391, DOI 10.1097/JTO.0b013e318283da29; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Vallieres E, 2012, THORAX, V67, P1097, DOI 10.1136/thoraxjnl-2011-201043; van Baardwijk A, 2012, RADIOTHER ONCOL, V105, P145, DOI 10.1016/j.radonc.2012.09.008; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; van't Westeinde SC, 2011, CANCER J, V17, P3, DOI 10.1097/PPO.0b013e3182099319; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009; Xie XQ, 2013, EUR RADIOL, V23, P139, DOI 10.1007/s00330-012-2570-7; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	68	107	115	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					732	741		10.1016/S0140-6736(13)61614-1	http://dx.doi.org/10.1016/S0140-6736(13)61614-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23972816				2022-12-28	WOS:000323542400031
J	Motzer, RJ; Hutson, TE; Cella, D; Reeves, J; Hawkins, R; Guo, J; Nathan, P; Staehler, M; de Souza, P; Merchan, JR; Boleti, E; Fife, K; Jin, J; Jones, R; Uemura, H; De Giorgi, U; Harmenberg, U; Wang, JW; Sternberg, CN; Deen, K; McCann, L; Hackshaw, MD; Crescenzo, R; Pandite, LN; Choueiri, TK				Motzer, Robert J.; Hutson, Thomas E.; Cella, David; Reeves, James; Hawkins, Robert; Guo, Jun; Nathan, Paul; Staehler, Michael; de Souza, Paul; Merchan, Jaime R.; Boleti, Ekaterini; Fife, Kate; Jin, Jie; Jones, Robert; Uemura, Hirotsugu; De Giorgi, Ugo; Harmenberg, Ulrika; Wang, Jinwan; Sternberg, Cora N.; Deen, Keith; McCann, Lauren; Hackshaw, Michelle D.; Crescenzo, Rocco; Pandite, Lini N.; Choueiri, Toni K.			Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FUNCTIONAL ASSESSMENT; THERAPY; FATIGUE	BACKGROUND Pazopanib and sunitinib provided a progression-free survival benefit, as compared with placebo or interferon, in previous phase 3 studies involving patients with metastatic renal-cell carcinoma. This phase 3, randomized trial compared the efficacy and safety of pazopanib and sunitinib as first-line therapy. METHODS We randomly assigned 1110 patients with clear-cell, metastatic renal-cell carcinoma, in a 1:1 ratio, to receive a continuous dose of pazopanib (800 mg once daily; 557 patients) or sunitinib in 6-week cycles (50 mg once daily for 4 weeks, followed by 2 weeks without treatment; 553 patients). The primary end point was progression-free survival as assessed by independent review, and the study was powered to show the noninferiority of pazopanib versus sunitinib. Secondary end points included overall survival, safety, and quality of life. RESULTS Pazopanib was noninferior to sunitinib with respect to progression-free survival (hazard ratio for progression of disease or death from any cause, 1.05; 95% confidence interval [CI], 0.90 to 1.22), meeting the predefined noninferiority margin (upper bound of the 95% confidence interval, <1.25). Overall survival was similar (hazard ratio for death with pazopanib, 0.91; 95% CI, 0.76 to 1.08). Patients treated with sunitinib, as compared with those treated with pazopanib, had a higher incidence of fatigue (63% vs. 55%), the hand-foot syndrome (50% vs. 29%), and thrombocytopenia (78% vs. 41%); patients treated with pazopanib had a higher incidence of increased levels of alanine aminotransferase (60%, vs. 43% with sunitinib). The mean change from baseline in 11 of 14 health-related quality-of-life domains, particularly those related to fatigue or soreness in the mouth, throat, hands, or feet, during the first 6 months of treatment favored pazopanib (P<0.05 for all 11 comparisons). CONCLUSIONS Pazopanib and sunitinib have similar efficacy, but the safety and quality-of-life profiles favor pazopanib.	[Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Hutson, Thomas E.] Baylor Sammons Canc Center Texas Oncol, Dallas, TX USA; [Cella, David] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Reeves, James] Florida Canc Specialists, Ft Myers, FL USA; [Hawkins, Robert] Univ Manchester, Manchester, Lancs, England; [Hawkins, Robert] Natl Hlth Serv Fdn Trust, Christie Hosp, Manchester, Lancs, England; [Nathan, Paul] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England; [Boleti, Ekaterini] Royal Free Hosp, Dept Oncol, London NW3 2QG, England; [Fife, Kate] Addenbrookes Hosp, Ctr Oncol, Cambridge, England; [Jones, Robert] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Guo, Jun] Peking Univ, Renal Canc & Melanoma Unit, Canc Hosp, Beijing 100871, Peoples R China; [Jin, Jie] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Wang, Jinwan] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Wang, Jinwan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Staehler, Michael] Univ Munich, Interdisciplinary Ctr Renal Tumors, Dept Urol, Munich, Germany; [de Souza, Paul] Univ Western Sydney, Canc Res Grp, Sch Med, Mol Med Res Grp, Sydney, NSW, Australia; [Merchan, Jaime R.] Univ Miami, Sylvester Canc Ctr, Miami, FL USA; [Uemura, Hirotsugu] Kinki Univ, Dept Urol, Fac Med, Osaka, Japan; [De Giorgi, Ugo] Ist Sci Romagnolo Studio & Cura Tumori, Ist Ricovero & Cura Carattere Sci, Meldola, Italy; [Sternberg, Cora N.] San Camillo Hosp, Dept Med Oncol, Rome, Italy; [Sternberg, Cora N.] Forlanini Hosp, Dept Med Oncol, Rome, Italy; [Harmenberg, Ulrika] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Deen, Keith; McCann, Lauren; Hackshaw, Michelle D.; Crescenzo, Rocco; Pandite, Lini N.] GlaxoSmithKline, Collegeville, PA USA; [Choueiri, Toni K.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dana Farber Harvard Canc Ctr, Kidney Canc Program, Boston, MA 02115 USA; [Choueiri, Toni K.] Harvard Univ, Sch Med, Boston, MA USA	Memorial Sloan Kettering Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Florida Cancer Specialists; University of Manchester; Christie NHS Foundation Trust; Christie Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Glasgow; Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Munich; Western Sydney University; University of Miami; Kindai University (Kinki University); IRCCS Meldola (IRST); Azienda Ospedaliera San Camillo-Forlanini; Karolinska Institutet; Karolinska University Hospital; GlaxoSmithKline; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Motzer, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Genitourinary Oncol Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA.	motzerr@mskcc.org	Choueiri, Toni/K-5238-2019; Fife, Kate/ABB-4336-2020; Hutson, Thomas/AAS-9639-2020; Staehler, Michael/AGY-6799-2022; de Souza, Paul/P-5069-2019	Choueiri, Toni/0000-0002-9201-3217; Hutson, Thomas/0000-0002-4529-4212; Staehler, Michael/0000-0002-4574-6522; Nathan, Paul/0000-0002-2327-3250; Jones, Robert/0000-0002-2904-6980; Motzer, Robert/0000-0001-6925-2327	GlaxoSmithKline Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	GlaxoSmithKline Pharmaceuticals(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by GlaxoSmithKline Pharmaceuticals.	Benedict A, 2008, EUR SOC MED ONC C; Cella D, 2002, J PAIN SYMPTOM MANAG, V24, P547, DOI 10.1016/S0885-3924(02)00529-8; Cella D, 2004, ANN ONCOL, V15, P979, DOI 10.1093/annonc/mdh235; Cella D, 2012, EUR SOC MED ONC C; Cohen J., 1988, ANN C BRIT ED RES AS; Diaz, 1999, Cancer Control, V6, P571; Escudier B, 2012, ANN ONCOL, V23, P65, DOI 10.1093/annonc/mds227; Escudier B, 2012, ANN M AM SOC CLIN ON; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Karnofsky D. A., 1949, EVALUATION CHEMOTHER, P196; Kumar R, 2009, BRIT J CANCER, V101, P1717, DOI 10.1038/sj.bjc.6605366; McCann L, 2010, J CLIN ONCOL, V28; Mohamed AF, 2011, PHARMACOECONOMICS, V29, P977, DOI 10.2165/11593370-000000000-00000; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2012, J CLIN ONCOL, V30, P1371, DOI 10.1200/JCO.2011.36.4133; Motzer RJ, 2009, J NATL COMPR CANC NE, V7, P618, DOI 10.6004/jnccn.2009.0043; National Cancer Institute Cancer Therapy Evaluation Program, COMM TERM CRIT ADV E; Rao D, 2009, J PAIN SYMPTOM MANAG, V38, P291, DOI 10.1016/j.jpainsymman.2008.08.013; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Trask PC, 2008, VALUE HEALTH, V11, P669, DOI 10.1111/j.1524-4733.2007.00310.x; Wong Michael K, 2012, J Med Econ, V15, P1139, DOI 10.3111/13696998.2012.708689	22	1328	1366	2	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					722	731		10.1056/NEJMoa1303989	http://dx.doi.org/10.1056/NEJMoa1303989			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964934	Green Published			2022-12-28	WOS:000323349300009
J	Reaves, ML; Young, BD; Hosios, AM; Xu, YF; Rabinowitz, JD				Reaves, Marshall Louis; Young, Brian D.; Hosios, Aaron M.; Xu, Yi-Fan; Rabinowitz, Joshua D.			Pyrimidine homeostasis is accomplished by directed overflow metabolism	NATURE			English	Article							COLI ASPARTATE TRANSCARBAMOYLASE; ESCHERICHIA-COLI; UMP KINASE; INHIBITION; BIOSYNTHESIS; QUANTITATION; SYNTHETASE; MECHANISM; EVOLUTION; NITROGEN	Cellular metabolism converts available nutrients into usable energy and biomass precursors. The process is regulated to facilitate efficient nutrient use and metabolic homeostasis. Feedback inhibition of the first committed step of a pathway by its final product is a classical means of controlling biosynthesis(1-4). In a canonical example, the first committed enzyme in the pyrimidine pathway in Escherichia coli is allosterically inhibited by cytidine triphosphate(1,4,5). The physiological consequences of disrupting this regulation, however, have not been previously explored. Here we identify an alternative regulatory strategy that enables precise control of pyrimidine pathway end-product levels, even in the presence of dysregulated biosynthetic flux. The mechanism involves cooperative feedback regulation of the near-terminal pathway enzyme uridine monophosphate kinase(6). Such feedback leads to build-up of the pathway intermediate uridine monophosphate, which is in turn degraded by a conserved phosphatase, here termed UmpH, with previously unknown physiological function(7,8). Such directed overflow metabolism allows homeostasis of uridine triphosphate and cytidine triphosphate levels at the expense of uracil excretion and slower growth during energy limitation. Disruption of the directed overflow regulatory mechanism impairs growth in pyrimidine-rich environments. Thus, pyrimidine homeostasis involves dual regulatory strategies, with classical feedback inhibition enhancing metabolic efficiency and directed overflow metabolism ensuring end-product homeostasis.	[Reaves, Marshall Louis; Young, Brian D.; Hosios, Aaron M.; Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Reaves, Marshall Louis; Young, Brian D.; Hosios, Aaron M.; Rabinowitz, Joshua D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu	xu, yifan/GWZ-7154-2022; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	National Science foundation (NSF) [MCB-0643859]; NSF CDI [CBET-0941143]; DOE-AFOSR [DE-SC0002077/FA9550-09-1-0580]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097382] Funding Source: NIH RePORTER	National Science foundation (NSF)(National Science Foundation (NSF)); NSF CDI(National Science Foundation (NSF)); DOE-AFOSR; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.L.R. was supported by an National Science foundation (NSF) Graduate Research Fellowship. J.D.R. was supported by NSF CDI Award CBET-0941143 and CAREER Award MCB-0643859, and DOE-AFOSR Award DE-SC0002077/FA9550-09-1-0580, and an American Heart Association Scientist Development Grant.	ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3164, DOI 10.1021/bi00874a013; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bucurenci N, 1998, J BACTERIOL, V180, P473, DOI 10.1128/JB.180.3.473-477.1998; Clasquin M. F., 2012, CURR PROTOC BIOINFOR, V14, P1411; CRABTREE B, 1987, BIOCHEM J, V247, P113, DOI 10.1042/bj2470113; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; Fell D., 1997, UNDERSTANDING CONTRO; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; GERHART JC, 1962, J BIOL CHEM, V237, P891; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; HOFMEYR JHS, 1991, EUR J BIOCHEM, V200, P223, DOI 10.1111/j.1432-1033.1991.tb21071.x; KACSER H, 1995, BIOCHEM SOC T, V23, P341, DOI 10.1042/bst0230341; Kantrowitz ER, 2012, ARCH BIOCHEM BIOPHYS, V519, P81, DOI 10.1016/j.abb.2011.10.024; KELL DB, 1986, FEMS MICROBIOL LETT, V39, P305, DOI 10.1016/0378-1097(86)90020-0; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Lu WY, 2006, J AM SOC MASS SPECTR, V17, P37, DOI 10.1016/j.jasms.2005.09.001; Meyer P, 2008, J BIOL CHEM, V283, P36011, DOI 10.1074/jbc.M802614200; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Peterson AW, 2012, BIOCHEMISTRY-US, V51, P4776, DOI 10.1021/bi3006219; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; SAVAGEAU MA, 1975, J MOL EVOL, V5, P199, DOI 10.1007/BF01741242; Silhavy T. J., 1984, EXPT GENE FUSIONS; SMALL JR, 1993, EUR J BIOCHEM, V213, P613, DOI 10.1111/j.1432-1033.1993.tb17801.x; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; UMBARGER HE, 1956, SCIENCE, V123, P848, DOI 10.1126/science.123.3202.848; WILD JR, 1989, P NATL ACAD SCI USA, V86, P46, DOI 10.1073/pnas.86.1.46; YATES RA, 1956, J BIOL CHEM, V221, P757	43	67	68	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					237	+		10.1038/nature12445	http://dx.doi.org/10.1038/nature12445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23903661	Green Submitted, Green Accepted			2022-12-28	WOS:000322825500041
J	Foa, EB; Yusko, DA; McLean, CP; Suvak, MK; Bux, DA; Oslin, D; O'Brien, CP; Imms, P; Riggs, DS; Volpicelli, J				Foa, Edna B.; Yusko, David A.; McLean, Carmen P.; Suvak, Michael K.; Bux, Donald A., Jr.; Oslin, David; O'Brien, Charles P.; Imms, Patricia; Riggs, David S.; Volpicelli, Joseph			Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE; BEHAVIORAL INTERVENTIONS; RELIABILITY; EFFICACY; VALIDITY; ABUSE; WOMEN	IMPORTANCE Alcohol dependence comorbid with posttraumatic stress disorder (PTSD) has been found to be resistant to treatment. In addition, there is a concern that prolonged exposure therapy for PTSD may exacerbate alcohol use. OBJECTIVE To compare the efficacy of an evidence-based treatment for alcohol dependence (naltrexone) plus an evidence-based treatment for PTSD (prolonged exposure therapy), their combination, and supportive counseling. DESIGN, SETTING, AND PARTICIPANTS A single-blind, randomized clinical trial of 165 participants with PTSD and alcohol dependence conducted at the University of Pennsylvania and the Philadelphia Veterans Administration. Participant enrollment began on February 8, 2001, and ended on June 25, 2009. Data collection was completed on August 12, 2010. INTERVENTIONS Participants were randomly assigned to (1) prolonged exposure therapy plus naltrexone (100 mg/d), (2) prolonged exposure therapy plus pill placebo, (3) supportive counseling plus naltrexone (100 mg/d), or (4) supportive counseling plus pill placebo. Prolonged exposure therapy was composed of 12 weekly 90-minute sessions followed by 6 biweekly sessions. All participants received supportive counseling. MAIN OUTCOMES AND MEASURES The Timeline Follow-Back Interview and the PTSD Symptom Severity Interview were used to assess the percentage of days drinking alcohol and PTSD severity, respectively, and the Penn Alcohol Craving Scale was used to assess alcohol craving. Independent evaluations occurred prior to treatment (week 0), at post-treatment (week 24), and at 6 months after treatment discontinuation (week 52). RESULTS Participants in all 4 treatment groups had large reductions in the percentage of days drinking (mean change, -63.9% [95% CI, -73.6% to -54.2%] for prolonged exposure therapy plus naltrexone; -63.9% [95% CI, -73.9% to -53.8%] for prolonged exposure therapy plus placebo; -69.9% [95% CI, -78.7% to -61.2%] for supportive counseling plus naltrexone; and -61.0% [95% CI, -68.9% to -53.0%] for supportive counseling plus placebo). However, those who received naltrexone had lower percentages of days drinking than those who received placebo (mean difference, 7.93%; P = .008). There was also a reduction in PTSD symptoms in all 4 groups, but the main effect of prolonged exposure therapy was not statistically significant. Six months after the end of treatment, participants in all 4 groups had increases in percentage of days drinking. However, those in the prolonged exposure therapy plus naltrexone group had the smallest increases. CONCLUSIONS AND RELEVANCE In this study of patients with alcohol dependence and PTSD, naltrexone treatment resulted in a decrease in the percentage of days drinking. Prolonged exposure therapy was not associated with an exacerbation of alcohol use disorder.	[Foa, Edna B.; Yusko, David A.; McLean, Carmen P.; O'Brien, Charles P.; Imms, Patricia] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Suvak, Michael K.] Suffolk Univ, Dept Psychol, Boston, MA 02114 USA; [Bux, Donald A., Jr.] Montefiore Med Ctr, Dept Psychiat, Bronx, NY 10467 USA; [Oslin, David] Vet Adm, VISN Mental Illness Res Educ & Clin Ctr 4, Philadelphia, PA USA; [Riggs, David S.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Volpicelli, Joseph] Inst Addict Med, Plymouth Meeting, PA USA; [Volpicelli, Joseph] Temple Univ, Dept Psychiat, Philadelphia, PA 19122 USA	University of Pennsylvania; Suffolk University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Uniformed Services University of the Health Sciences - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Foa, EB (corresponding author), Univ Penn, Dept Psychiat, 3535 Market St,6th Floor, Philadelphia, PA 19104 USA.	foa@mail.med.upenn.edu		McLean, Carmen/0000-0003-4322-9318; Volpicelli, Joseph/0000-0003-2455-7770	National Institute on Alcohol Abuse and Alcoholism [RO1 AA012428]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012428] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grant RO1 AA012428 from the National Institute on Alcohol Abuse and Alcoholism (primary investigator: Edna B. Foa, PhD).	[Anonymous], 1994, DIAGNOSTIC AND STATI; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Berg BJ, 1996, DRUG SAFETY, V15, P274, DOI 10.2165/00002018-199615040-00005; Brady KT, 2005, ALCOHOL CLIN EXP RES, V29, P395, DOI 10.1097/01.ALC.0000156129.98265.57; Cahill S, 2009, EFFECTIVE TREATMENTS, P139; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Drapkin ML, 2011, J SUBST ABUSE TREAT, V41, P186, DOI 10.1016/j.jsat.2011.02.012; Flannery BA, 1999, ALCOHOL CLIN EXP RES, V23, P1289, DOI 10.1097/00000374-199908000-00001; Foa E., 2007, PROLONGED EXPOSURE T; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Foa EB, 2002, BIOL PSYCHIAT, V52, P987, DOI 10.1016/S0006-3223(02)01552-4; Foa Edna B, 2010, Ment Health Subst Use, V3, P131; Hien DA, 2004, AM J PSYCHIAT, V161, P1426, DOI 10.1176/appi.ajp.161.8.1426; Hien DA, 2009, J CONSULT CLIN PSYCH, V77, P607, DOI 10.1037/a0016227; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kranzler HR, 2001, ALCOHOL CLIN EXP RES, V25, P1335, DOI 10.1097/00000374-200109000-00014; McGovern MP, 2009, ADDICT BEHAV, V34, P892, DOI 10.1016/j.addbeh.2009.03.009; Miller W.R., 1991, PREPARING PEOPLE CHA; Muthem LK, 2007, MPLUS USERS GUIDE; Muthen LK, 2002, STRUCT EQU MODELING, V9, P599, DOI 10.1207/S15328007SEM0904_8; Nacasch N, 2011, J CLIN PSYCHIAT, V72, P1174, DOI 10.4088/JCP.09m05682blu; Ouimette PC, 1997, PSYCHOL ADDICT BEHAV, V11, P34, DOI 10.1037/0893-164X.11.1.34; Petrakis IL, 2006, SCHIZOPHRENIA BULL, V32, P644, DOI 10.1093/schbul/sbl010; Powers MB, 2012, J ANXIETY DISORD, V26, P617, DOI 10.1016/j.janxdis.2012.02.013; Raudenbush S., 2005, HLM 6 HIERARCHICAL L; Riggs DS, 2003, ADDICT BEHAV, V28, P1717, DOI 10.1016/j.addbeh.2003.08.044; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Siddiqui O, 2009, J BIOPHARM STAT, V19, P227, DOI 10.1080/10543400802609797; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; SOLOMON SD, 1992, JAMA-J AM MED ASSOC, V268, P633, DOI 10.1001/jama.268.5.633; Starosta Aron N, 2006, J Psychiatr Pract, V12, P80, DOI 10.1097/00131746-200603000-00003; Tidey JW, 2008, ALCOHOL CLIN EXP RES, V32, P58, DOI 10.1111/j.1530-0277.2007.00545.x; van Dam D, 2012, CLIN PSYCHOL REV, V32, P202, DOI 10.1016/j.cpr.2012.01.004; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876	37	143	148	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					488	495		10.1001/jama.2013.8268	http://dx.doi.org/10.1001/jama.2013.8268			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925619				2022-12-28	WOS:000322786400021
J	Altizer, S; Ostfeld, RS; Johnson, PTJ; Kutz, S; Harvell, CD				Altizer, Sonia; Ostfeld, Richard S.; Johnson, Pieter T. J.; Kutz, Susan; Harvell, C. Drew			Climate Change and Infectious Diseases: From Evidence to a Predictive Framework	SCIENCE			English	Review							CHANGE IMPACTS; OSTERTAGIA-GRUEHNERI; GLOBAL CLIMATE; TEMPERATURE; PARASITE; ECOLOGY; MALARIA; MARINE; CONSEQUENCES; RESISTANCE	Scientists have long predicted large-scale responses of infectious diseases to climate change, giving rise to a polarizing debate, especially concerning human pathogens for which socioeconomic drivers and control measures can limit the detection of climate-mediated changes. Climate change has already increased the occurrence of diseases in some natural and agricultural systems, but in many cases, outcomes depend on the form of climate change and details of the host-pathogen system. In this review, we highlight research progress and gaps that have emerged during the past decade and develop a predictive framework that integrates knowledge from ecophysiology and community ecology with modeling approaches. Future work must continue to anticipate and monitor pathogen biodiversity and disease trends in natural ecosystems and identify opportunities to mitigate the impacts of climate-driven disease emergence.	[Altizer, Sonia] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Johnson, Pieter T. J.] Univ Colorado, Boulder, CO 80309 USA; [Kutz, Susan] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB T2N 4Z6, Canada; [Kutz, Susan] Canadian Cooperat Wildlife Hlth Ctr, Calgary, AB T2N 4Z6, Canada; [Harvell, C. Drew] Cornell Univ, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; Cary Institute of Ecosystem Studies; University of Colorado System; University of Colorado Boulder; University of Calgary; Cornell University	Altizer, S (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	saltizer@uga.edu		Ostfeld, Richard/0000-0002-3707-9301; JOHNSON, PIETER/0000-0002-7997-5390; kutz, susan/0000-0003-2352-8687	NSF [DEB-0643831, IOS-1121529]; David and Lucile Packard Foundation; NSF Research Coordination Network grant on the Ecology of Infectious Marine Diseases; NSF Ecology and Evolution of Infectious Diseases grant [OCE-1215977]; Atkinson Center for a Sustainable Future at Cornell University	NSF(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF Research Coordination Network grant on the Ecology of Infectious Marine Diseases; NSF Ecology and Evolution of Infectious Diseases grant; Atkinson Center for a Sustainable Future at Cornell University	This work was supported in part by an NSF grant (DEB-0643831) to S. A., a Fellowship from the David and Lucile Packard Foundation and NSF grant (IOS-1121529) to P.T.J.J., an NSF Research Coordination Network grant on the Ecology of Infectious Marine Diseases, NSF Ecology and Evolution of Infectious Diseases grant (OCE-1215977) to C. D. H., and by the Atkinson Center for a Sustainable Future at Cornell University. S. K. thanks the Natural Sciences and Engineering Council of Canada, the Nasivvik Centre for Inuit Health; the governments of the Northwest Territories, Nunavut, and Yukon; and the government of Canada International Polar Year Program.	Adamo SA, 2011, J EXP BIOL, V214, P1997, DOI 10.1242/jeb.056531; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; Beeden R, 2012, ENVIRON MANAGE, V49, P1, DOI 10.1007/s00267-011-9770-9; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown VL, 2012, BIOL LETTERS, V8, P1036, DOI 10.1098/rsbl.2012.0635; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Burge CA, 2013, MICROB ECOL, V65, P869, DOI 10.1007/s00248-013-0190-7; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Fernandez-Triana J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023719; Ford SE, 2012, J MAR RES, V70, P205, DOI 10.1357/002224012802851922; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Garrett KA, 2013, AGR FOREST METEOROL, V170, P216, DOI 10.1016/j.agrformet.2012.04.018; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hoar BM, 2012, PARASITOLOGY, V139, P1339, DOI 10.1017/S0031182012000601; Hoar BM, 2012, PARASITOLOGY, V139, P1093, DOI 10.1017/S003118201200042X; Hobbelen PHF, 2013, THEOR ECOL-NETH, V6, P31, DOI 10.1007/s12080-011-0154-9; Hoberg EP, 2010, REV SCI TECH OIE, V29, P255, DOI 10.20506/rst.29.2.1972; Hoverman J. T., 2013, CLIMATE VULNERABILIT, VA, P61; Howard Elizabeth, 2010, Psyche (Cambridge), V2010, P1; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Hughes JE, 2002, ESTUARIES, V25, P235, DOI 10.1007/BF02691311; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; Ibelings BW, 2011, FRESHWATER BIOL, V56, P754, DOI 10.1111/j.1365-2427.2010.02565.x; Intergovernmental Panel on Climate Change, 2007, SUMM POL CLIM CHANG; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson PTJ, 2012, P NATL ACAD SCI USA, V109, P9006, DOI 10.1073/pnas.1201790109; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008; Laaksonen S, 2010, ECOHEALTH, V7, P7, DOI 10.1007/s10393-010-0308-z; Lafferty KD, 2009, ECOLOGY, V90, P932, DOI 10.1890/08-1767.1; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Maynard JA, 2011, CORAL REEFS, V30, P485, DOI 10.1007/s00338-010-0708-0; McMichael AJ, 2012, P NATL ACAD SCI USA, V109, P4730, DOI 10.1073/pnas.1120177109; Meakin S., 2009, ASSESSING IMPACTS CL; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Molnar PK, 2013, ECOL LETT, V16, P9, DOI 10.1111/ele.12022; Morgan ER, 2004, TRENDS ECOL EVOL, V19, P181, DOI 10.1016/j.tree.2004.01.011; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Murdock CC, 2012, P ROY SOC B-BIOL SCI, V279, P3357, DOI 10.1098/rspb.2012.0638; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Paull SH, 2012, GLOBAL CHANGE BIOL, V18, P3558, DOI 10.1111/gcb.12018; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Powell EN, 2012, J MAR RES, V70, P309, DOI 10.1357/002224012802851896; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rogers CS, 2012, CORAL REEFS, V31, P807, DOI 10.1007/s00338-012-0898-8; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Rohr JR, 2011, TRENDS ECOL EVOL, V26, P270, DOI 10.1016/j.tree.2011.03.002; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	73	679	696	31	900	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					514	519		10.1126/science.1239401	http://dx.doi.org/10.1126/science.1239401			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908230				2022-12-28	WOS:000322586700044
J	Sarkies, P; Miska, EA				Sarkies, Peter; Miska, Eric A.			Is There Social RNA?	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; EPIGENETIC MEMORY; C. ELEGANS; GERMLINE; MICRORNA; NEMATODE; POTENT; PIRNAS		[Sarkies, Peter] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Sarkies, P (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.	e.miska@gurdon.cam.ac.uk		Sarkies, Peter/0000-0003-0279-6199; Miska, Eric/0000-0002-4450-576X	Cancer Research UK [11832] Funding Source: Medline; Wellcome Trust [092096] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Brosnan CA, 2011, CURR OPIN PLANT BIOL, V14, P580, DOI 10.1016/j.pbi.2011.07.011; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Dieterich C, 2009, TRENDS GENET, V25, P203, DOI 10.1016/j.tig.2009.03.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Jose AM, 2011, NAT STRUCT MOL BIOL, V18, P1183, DOI 10.1038/nsmb.2134; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; Maule AG, 2011, TRENDS PARASITOL, V27, P505, DOI 10.1016/j.pt.2011.07.004; McEwan DL, 2012, MOL CELL, V47, P746, DOI 10.1016/j.molcel.2012.07.014; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Selkirk ME, 2012, PARASITOLOGY, V139, P605, DOI 10.1017/S0031182011002332; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yao B, 2012, EMBO REP, V13, P1102, DOI 10.1038/embor.2012.160; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhuang JJ, 2012, PARASITOLOGY, V139, P560, DOI 10.1017/S0031182011001788	25	39	42	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					467	468		10.1126/science.1243175	http://dx.doi.org/10.1126/science.1243175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	193UJ	23908213				2022-12-28	WOS:000322586700027
J	Garza Ocanas, L; Mifuji, RM				Garza Ocanas, Lourdes; Masaharu Mifuji, Roque			Cutaneous Loxoscelism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garza Ocanas, Lourdes; Masaharu Mifuji, Roque] Autonomous Univ Nuevo Leon, Sch Med, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Garza Ocanas, L (corresponding author), Autonomous Univ Nuevo Leon, Sch Med, Monterrey, Nuevo Leon, Mexico.	logarza@live.com.mx							0	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					E6	E6		10.1056/NEJMicm1212607	http://dx.doi.org/10.1056/NEJMicm1212607			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902513				2022-12-28	WOS:000322547400001
J	Jonas, K; Liu, J; Chien, P; Laub, MT				Jonas, Kristina; Liu, Jing; Chien, Peter; Laub, Michael T.			Proteotoxic Stress Induces a Cell-Cycle Arrest by Stimulating Lon to Degrade the Replication Initiator DnaA	CELL			English	Article							HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; CHROMOSOME-REPLICATION; PROTEIN; ROLES; EXPRESSION; SIGMA(32); ION; TRANSCRIPTION; RECOGNITION	The decision to initiate DNA replication is a critical step in the cell cycle of all organisms. Cells often delay replication in the face of stressful conditions, but the underlying mechanisms remain incompletely defined. Here, we demonstrate in Caulobacter crescentus that proteotoxic stress induces a cell-cycle arrest by triggering the degradation of DnaA, the conserved replication initiator. A depletion of available Hsp70 chaperone, DnaK, either through genetic manipulation or heat shock, induces synthesis of the Lon protease, which can directly degrade DnaA. Unexpectedly, we find that unfolded proteins, which accumulate following a loss of DnaK, also allosterically activate Lon to degrade DnaA, thereby ensuring a cell-cycle arrest. Our work reveals a mechanism for regulating DNA replication under adverse growth conditions. Additionally, our data indicate that unfolded proteins can actively and directly alter substrate recognition by cellular proteases.	[Jonas, Kristina; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Liu, Jing; Chien, Peter] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA; [Liu, Jing; Chien, Peter] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Laub, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	laub@mit.edu	Jonas, Kristina/K-4513-2015	Jonas, Kristina/0000-0002-1469-4424; Laub, Michael/0000-0002-8288-7607	National Institutes of Health grant [5R01GM082899, R00GM084157]; German Research Foundation (DFG) [JO 925/1-1]; University of Massachusetts as part of the Chemistry-Biology Interface Training Program [T32 GM08515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM084157, R01GM082899, T32GM008515] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Massachusetts as part of the Chemistry-Biology Interface Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Modell for help analyzing Illumina data and members of the Laub lab and R.T. Sauer for critical discussion and comments on the manuscript. We acknowledge S. Gomes, R.T. Sauer, G.T. Marczynski, C. Aakre, N. Hickey, and D. Curran for reagents. M.T L. is an Early Career Scientist at the Howard Hughes Medical Institute. This work was supported by a National Institutes of Health grant (5R01GM082899) to M.T.L., a National Institutes of Health grant (R00GM084157) to P.C., and a research fellowship (JO 925/1-1) from the German Research Foundation (DFG) to K.J. J.L. was supported in part by a Fellowship from the University of Massachusetts as part of the Chemistry-Biology Interface Training Program (T32 GM08515).	Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; AVEDISSIAN M, 1995, J BACTERIOL, V177, P3479, DOI 10.1128/jb.177.12.3479-3484.1995; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bruel N, 2012, J BIOL CHEM, V287, P44435, DOI 10.1074/jbc.M112.418525; CHARETTE MF, 1981, P NATL ACAD SCI-BIOL, V78, P4728, DOI 10.1073/pnas.78.8.4728; Collier J, 2009, J BACTERIOL, V191, P5706, DOI 10.1128/JB.00525-09; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; da Silva ACA, 2003, MOL MICROBIOL, V49, P541, DOI 10.1046/j.1365-2958.2003.03581.x; Fernandez-Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026028; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; Gorbatyuk B, 2005, MOL MICROBIOL, V55, P1233, DOI 10.1111/j.1365-2958.2004.04459.x; Gorbatyuk B, 2001, MOL MICROBIOL, V40, P485, DOI 10.1046/j.1365-2958.2001.02404.x; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Gur E, 2009, P NATL ACAD SCI USA, V106, P18503, DOI 10.1073/pnas.0910392106; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Ishida T, 2004, J BIOL CHEM, V279, P45546, DOI 10.1074/jbc.M402762200; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Jonas K, 2011, CURR BIOL, V21, P1092, DOI 10.1016/j.cub.2011.05.040; Jubete Y, 1996, J BIOL CHEM, V271, P30798, DOI 10.1074/jbc.271.48.30798; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2010, BIOCHEM CELL BIOL, V88, P49, DOI [10.1139/o09-154, 10.1139/O09-154]; KAWASAKI Y, 1990, MOL GEN GENET, V220, P277; Leonard AC, 2011, ANNU REV MICROBIOL, V65, P19, DOI 10.1146/annurev-micro-090110-102934; Marczynski GT, 1999, J BACTERIOL, V181, P1984, DOI 10.1128/JB.181.7.1984-1993.1999; Merrikh H, 2011, MOL MICROBIOL, V82, P434, DOI 10.1111/j.1365-2958.2011.07821.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; PHILLIPS TA, 1984, J BACTERIOL, V159, P283, DOI 10.1128/JB.159.1.283-287.1984; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; ROWLEY A, 1993, MOL CELL BIOL, V13, P1034, DOI 10.1128/MCB.13.2.1034; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Taylor JA, 2011, MOL MICROBIOL, V82, P312, DOI 10.1111/j.1365-2958.2011.07785.x; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; Tsokos CG, 2012, CURR OPIN MICROBIOL, V15, P744, DOI 10.1016/j.mib.2012.10.011; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Zawilak-Pawlik A, 2007, MOL MICROBIOL, V65, P979, DOI 10.1111/j.1365-2958.2007.05853.x; ZYLICZ M, 1993, PHILOS T ROY SOC B, V339, P271, DOI 10.1098/rstb.1993.0025	44	105	108	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					623	636		10.1016/j.cell.2013.06.034	http://dx.doi.org/10.1016/j.cell.2013.06.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911325	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000322629900015
J	Patil, CK; McCarroll, SA				Patil, Christopher K.; McCarroll, Steven A.			Of Rats and Men	CELL			English	Editorial Material									[Patil, Christopher K.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu		McCarroll, Steven/0000-0002-6954-8184				Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; James MR, 1997, TRENDS GENET, V13, P171, DOI 10.1016/S0168-9525(97)01130-X; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252	7	3	3	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					481	483		10.1016/j.cell.2013.07.022	http://dx.doi.org/10.1016/j.cell.2013.07.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911315	Bronze			2022-12-28	WOS:000322629900003
J	Smith, JM				Smith, Jeanette M.			Mosquito Nets John Singer Sargent	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					350	357		10.1001/jama.2013.5224	http://dx.doi.org/10.1001/jama.2013.5224			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917267				2022-12-28	WOS:000322121500001
J	Daneman, N				Daneman, Nick			A probiotic trial: tipping the balance of evidence?	LANCET			English	Editorial Material							ANTIBIOTIC-ASSOCIATED DIARRHEA; CLOSTRIDIUM-DIFFICILE; METAANALYSES; PREVENTION		[Daneman, Nick] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Infect Dis & Clin Epidemiol, Toronto, ON, Canada; [Daneman, Nick] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Daneman, N (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Infect Dis & Clin Epidemiol, Toronto, ON, Canada.	nick.daneman@sunnybrook.ca						Allen SJ, 2013, LANCET; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Kamdeu Fansi Alvine Adrienne, 2012, J Med Econ, V15, P53, DOI 10.3111/13696998.2011.629015; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0	11	8	8	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1228	1230		10.1016/S0140-6736(13)61571-8	http://dx.doi.org/10.1016/S0140-6736(13)61571-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23932218	hybrid			2022-12-28	WOS:000325756400007
J	Nakaki, F; Hayashi, K; Ohta, H; Kurimoto, K; Yabuta, Y; Saitou, M				Nakaki, Fumio; Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Yabuta, Yukihiro; Saitou, Mitinori			Induction of mouse germ-cell fate by transcription factors in vitro	NATURE			English	Article							GROUND-STATE; SPECIFICATION; EXPRESSION; DYNAMICS; LINEAGE; TRANSPLANTATION; PRDM14; BLIMP1; MICE	The germ-cell lineage ensures the continuity of life through the generation of male and female gametes, which unite to form a totipotent zygote. We have previously demonstrated that, by using cytokines, embryonic stem cells and induced pluripotent stem cells can be induced into epiblast-like cells (EpiLCs) and then into primordial germcell (PGC)-like cells with the capacity for both spermatogenesis and oogenesis(1,2), creating an opportunity for understanding and regulating mammalian germ-cell development in both sexes in vitro. Here we show that, without cytokines, simultaneous overexpression of three transcription factors, Blimp1 (also known as Prdm1), Prdm14 and Tfap2c (also known as AP2c), directs EpiLCs, but not embryonic stem cells, swiftly and efficiently into a PGC state. Notably, Prdm14 alone, but not Blimp1 or Tfap2c, suffices for the induction of the PGC state in EpiLCs. The transcription-factor-induced PGC state, irrespective of the transcription factors used, reconstitutes key transcriptome and epigenetic reprogramming in PGCs, but bypasses a mesodermal program that accompanies PGC or PGC-like-cell specification by cytokines including bone morphogenetic protein 4. Notably, the transcription-factor-induced PGC-like cells contribute to spermatogenesis and fertile offspring. Our findings provide a new insight into the transcriptional logic for PGC specification, and create a foundation for the transcription-factor-based reconstitution and regulation of mammalian gametogenesis.	[Nakaki, Fumio; Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Yabuta, Yukihiro; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, Kyoto 6068507, Japan; [Hayashi, Katsuhiko] JST, PRESTO, Sakyo Ku, Kyoto 6068501, Japan; [Ohta, Hiroshi; Kurimoto, Kazuki; Yabuta, Yukihiro; Saitou, Mitinori] JST, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyoto University	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp	Nakaki, Fumio/B-8284-2015	Nakaki, Fumio/0000-0003-4332-7735	Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST/ERATO; Takeda Science Foundation; Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research [24681039] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST/ERATO; Takeda Science Foundation(Takeda Science Foundation (TSF)); Academia for Repro-regenerative Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Bradley, A. Smith, G. Guo, H. Niwa and G. Nagamatsu for providing plasmids. We are grateful to the Center for Anatomical Studies (Graduate School of Medicine, Kyoto University) for performing the histological analyses. We thank M. Yamaji for advice and T. Mori for encouragement. F.N. is a Japan Society for the Promotion of Science (JSPS) Research Fellow. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by JST-CREST/ERATO; by the Takeda Science Foundation; and by the Academia for Repro-regenerative Medicine.	Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; R Development Core Team, 2012, R LANG ENV STAT COMP; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M., 2012, COLD SPRING HARB PER, V4, P223; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	203	212	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					222	+		10.1038/nature12417	http://dx.doi.org/10.1038/nature12417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23913270	Green Submitted			2022-12-28	WOS:000324244900041
J	Chokshi, DA; Stine, NW				Chokshi, Dave A.; Stine, Nicholas W.			Reconsidering the Politics of Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION; DISEASE		[Chokshi, Dave A.] Dept Vet Affairs, Washington, DC 20006 USA; [Stine, Nicholas W.] New York City Hlth & Hosp Corp, New York, NY USA; [Stine, Nicholas W.] NYU, Sch Med, New York, NY USA	New York University	Chokshi, DA (corresponding author), Dept Vet Affairs, 810 Vermont Ave NW, Washington, DC 20006 USA.	dave.chokshi@alumni.duke.edu		Stine, Nicholas/0000-0001-8811-259X; Chokshi, Dave/0000-0001-7467-4591				Chokshi DA, 2012, NEW ENGL J MED, V367, P295, DOI 10.1056/NEJMp1206268; Colgrove JK., 2011, EPIDEMIC CITY POLITI; Dowell D, 2012, LANCET, V380, P1787, DOI 10.1016/S0140-6736(12)60733-8; Frieden TR, 2013, NEW ENGL J MED, V368, P1857, DOI 10.1056/NEJMp1303819; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609	6	6	7	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1025	1026		10.1001/jama.2013.110872	http://dx.doi.org/10.1001/jama.2013.110872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	23975269				2022-12-28	WOS:000324133400016
J	Kesselheim, AS; Green, MD; Avorn, J				Kesselheim, Aaron S.; Green, Michael D.; Avorn, Jerry			Who Is Now Responsible for Discovering and Warning About Adverse Effects of Generic Drugs?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kesselheim, Aaron S.; Avorn, Jerry] Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Sch Med,Dept Med, Boston, MA 02120 USA; [Green, Michael D.] Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wake Forest University	Kesselheim, AS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Sch Med,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; AHRQ HHS [K08HS18465-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		HATCH OG, COMMUNICATION; Keelan J, 2011, AM J PUBLIC HEALTH, V101, P2016, DOI 10.2105/AJPH.2011.300198; Kesselheim AS, 2012, NEW ENGL J MED, V367, P1679, DOI 10.1056/NEJMp1208781; US Food and Drug Administration, 2013, SUPPLEMENTAL APPLICA	4	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1023	1024		10.1001/jama.2013.228349	http://dx.doi.org/10.1001/jama.2013.228349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	23922000				2022-12-28	WOS:000324133400015
J	Hong, JL; Meier, CR; Sandler, RS; Jick, SS; Sturmer, T				Hong, Jin-Liern; Meier, Christoph R.; Sandler, Robert S.; Jick, Susan S.; Stuermer, Til			Risk of colorectal cancer after initiation of orlistat: matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ABERRANT CRYPT FOCI; WEIGHT CHANGE; COLON-CANCER; METAANALYSIS; ADULTS	Objective To examine the risk of colorectal cancer after orlistat initiation in the UK population. Design Retrospective matched cohort study. Setting Data from the UK Clinical Practice Research Datalink from September 1998 to December 2008. Participants 33 625 adults aged 18 years or over who started treatment with orlistat; each orlistat initiator was matched to up to five non-initiators (n=160 347) on age, sex, body mass index, and calendar time. Main outcome measures Associations between orlistat initiation and the risk of colorectal cancer, assessed by calculating hazard ratios with propensity score adjusted Cox proportional hazard models. Results Of 193 972 patients with a median age of 47 (interquartile range 37-57) years, 77% were women and approximately 90% were obese (body mass index >= 30). Orlistat initiators were more likely to have a previous history of diabetes or hypertension and to receive prescriptions for anti-diabetes drugs, statins, and aspirin compared with non-initiators. In the intention to treat analysis, 57 colorectal cancer events were identified among orlistat initiators and 246 among non-initiators, with median follow-up times of 2.96 and 2.86 years, respectively. The calculated incidence rate of colorectal cancer per 100 000 person years was 53 (95% confidence interval 41 to 69) for orlistat initiators and 50 (44 to 57) for non-initiators. Orlistat initiation was not associated with a higher risk of colorectal cancer (adjusted hazard ratio 1.11, 95% confidence interval 0.84 to 1.47). Findings were robust in the as treated analyses and in patients who were aged 50 years or over, were morbidly obese, or had a history of diabetes. Conclusions This study found no evidence of an increased risk of colorectal cancer after the initiation of orlistat. It is limited by the relatively short follow-up time, and the possibility of adverse effects of long term orlistat use on risk of colorectal cancer cannot be excluded.	[Hong, Jin-Liern; Sandler, Robert S.; Stuermer, Til] Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Meier, Christoph R.] Univ Basel, Dept Pharmaceut Sci, Div Clin Pharm & Epidemiol, Basel Pharmacoepidemiol Unit, Basel, Switzerland; [Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland; [Meier, Christoph R.; Jick, Susan S.] Boston Univ, Sch Publ Hlth, Boston Collaborat Drug Surveillance Program, Boston, MA 02421 USA; [Sandler, Robert S.] Univ N Carolina, UNC Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Basel; University of Basel; Boston University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hong, JL (corresponding author), Univ N Carolina, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, CB 7435, Chapel Hill, NC 27599 USA.	jlhongtw@email.unc.edu	Stürmer, Til/AAB-5459-2022	Jick, Susan/0000-0002-2215-1067	Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina at Chapel Hill; National Institute of Aging at the National Institutes of Health [R01 AG023178]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178] Funding Source: NIH RePORTER	Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina at Chapel Hill; National Institute of Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by the population research award from the Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina at Chapel Hill and R01 AG023178 from the National Institute of Aging at the National Institutes of Health. The funding agencies had no role in the design of the study; in the analysis and interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication.	[Anonymous], 2006, ORLISTAT ZENICAL PRE; Bassett JK, 2010, CANCER EPIDEM BIOMAR, V19, P2978, DOI 10.1158/1055-9965.EPI-10-0543; Birks S, 2012, OBES REV, V13, P868, DOI 10.1111/j.1467-789X.2012.01010.x; Evaluate, 2011, ANT AG TOP 3 MARK PR; Garcia SB, 2006, CANCER LETT, V240, P221, DOI 10.1016/j.canlet.2005.09.011; Gupta AK, 2007, CLIN GASTROENTEROL H, V5, P526, DOI 10.1016/j.cgh.2007.02.014; Hutton B, 2004, AM J CLIN NUTR, V80, P1461, DOI 10.1093/ajcn/80.6.1461; Jacob S, 2009, DIABETES OBES METAB, V11, P361, DOI 10.1111/j.1463-1326.2008.00970.x; Johansson K, 2010, OBES REV, V11, P777, DOI 10.1111/j.1467-789X.2009.00693.x; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moore LL, 2004, INT J OBESITY, V28, P559, DOI 10.1038/sj.ijo.0802606; Mutch MG, 2009, CLIN GASTROENTEROL H, V7, P568, DOI 10.1016/j.cgh.2009.01.016; Nairooz S, EGYPT J HISTOL, V33, P635; O'Meara S, 2004, Obes Rev, V5, P51, DOI 10.1111/j.1467-789X.2004.00125.x; Rapp K, 2008, ANN ONCOL, V19, P641, DOI 10.1093/annonc/mdm549; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155	19	15	15	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2013	347								f5039	10.1136/bmj.f5039	http://dx.doi.org/10.1136/bmj.f5039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211BW	23982291	Green Published, hybrid			2022-12-28	WOS:000323880100001
J	Begin, P; Leclerc, G				Begin, Philippe; Leclerc, Georgette			Familial Primary Cryofibrinogenemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Begin, Philippe] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada; [Leclerc, Georgette] Chicoutimi Hlth Ctr, Saguenay, PQ, Canada	Universite de Montreal	Begin, P (corresponding author), Univ Montreal, Ctr Hosp, Montreal, PQ, Canada.	philippe.begin@umontreal.ca	Bégin, Philippe/AAU-9126-2021						0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					E10	E10		10.1056/NEJMicm1300987	http://dx.doi.org/10.1056/NEJMicm1300987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964955				2022-12-28	WOS:000323349300001
J	Jarman, B				Jarman, Brian			Quality of care and patient safety in the UK: the way forward after Mid Staffordshire	LANCET			English	Editorial Material							MORTALITY		Univ London Imperial Coll Sci Technol & Med, Fac Med, Dr Foster Unit, London EC4Y 8BN, England	Imperial College London	Jarman, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dr Foster Unit, London EC4Y 8BN, England.	b.jarman@imperial.ac.uk						Aylin P, 2004, BRIT MED J, V329, P825, DOI 10.1136/bmj.329.7470.825; Bottle A, 2008, HEALTH SERV RES, V43, P10, DOI 10.1111/j.1475-6773.2007.00742.x; Bottle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7116; Bristol Royal Infirmary Inquiry, 2001, CM5207; Care Quality Commission, 2013, CONS CHANG WAY WE IN; Department of Health, 2000, ORG MEM; Donnelly L, 2013, TELEGRAPH, DOI 10340209/Cameron-extends-fund-for-cancer-drugs.html; Dr Foster Intelligence, FOST APR 2007 GOOD H; Hammond P., 2013, TIMES; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman B., 2013, B JARMAN GUEST EDITO; Keogh B, 2013, REV QUALITY CARE TRE; Martin N., 2007, TELEGRAPH; Monitor, 2013, ASS SUST; OECD, 2013, JOINT M CHEM COMM WO; Robb E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1234; Robert Francis QC., 2010, COMMUNICATION; The Mid Staffordshire NHS Foundation Trust, 2013, PUBL INQ CHAIR R FRA; The National Advisory Group on the Safety of Patients in England, 2013, PROMISE LEARN COMMIT	19	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					573	575		10.1016/S0140-6736(13)61726-2	http://dx.doi.org/10.1016/S0140-6736(13)61726-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	205DV	23953373				2022-12-28	WOS:000323422800004
J	Carpenter, S; Aiello, D; Atianand, MK; Ricci, EP; Gandhi, P; Hall, LL; Byron, M; Monks, B; Henry-Bezy, M; Lawrence, JB; O'Neill, LAJ; Moore, MJ; Caffrey, DR; Fitzgerald, KA				Carpenter, Susan; Aiello, Daniel; Atianand, Maninjay K.; Ricci, Emiliano P.; Gandhi, Pallavi; Hall, Lisa L.; Byron, Meg; Monks, Brian; Henry-Bezy, Meabh; Lawrence, Jeanne B.; O'Neill, Luke A. J.; Moore, Melissa J.; Caffrey, Daniel R.; Fitzgerald, Katherine A.			A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes	SCIENCE			English	Article							IN-VIVO; EXPRESSION; REVEALS; GENOME; CELLS; A/B; TRANSCRIPTOMES; OSTEOPONTIN; TRANSLATION; RESOLUTION	An inducible program of inflammatory gene expression is central to antimicrobial defenses. This response is controlled by a collaboration involving signal-dependent activation of transcription factors, transcriptional co-regulators, and chromatin-modifying factors. We have identified a long noncoding RNA (lncRNA) that acts as a key regulator of this inflammatory response. Pattern recognition receptors such as the Toll-like receptors induce the expression of numerous lncRNAs. One of these, lincRNA-Cox2, mediates both the activation and repression of distinct classes of immune genes. Transcriptional repression of target genes is dependent on interactions of lincRNA-Cox2 with heterogeneous nuclear ribonucleoprotein A/B and A2/B1. Collectively, these studies unveil a central role of lincRNA-Cox2 as a broad-acting regulatory component of the circuit that controls the inflammatory response.	[Carpenter, Susan; Aiello, Daniel; Atianand, Maninjay K.; Gandhi, Pallavi; Monks, Brian; Henry-Bezy, Meabh; Caffrey, Daniel R.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Carpenter, Susan; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Ricci, Emiliano P.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Hall, Lisa L.; Byron, Meg; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Trinity College Dublin; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Caffrey, DR (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	daniel.caffrey@umassmed.edu; kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Ricci, Emiliano/G-7619-2012; Monks, Brian/B-8362-2015; Atianand, Maninjay/AAF-7823-2019	Ricci, Emiliano/0000-0002-9789-5837; Monks, Brian/0000-0003-4008-3093; Atianand, Maninjay/0000-0003-4135-2515; O'Neill, Luke/0000-0002-4333-2748; Lawrence, Jeanne/0000-0001-6572-3128; Fitzgerald, Kate/0000-0003-3175-609X	Ireland Health Research Board/Marie Curie Fellowship [MCPD/2010/04]; NIH [AI067497, GM053234]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497, R01AI067497, R56AI067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234] Funding Source: NIH RePORTER	Ireland Health Research Board/Marie Curie Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Singh for advice on RNA-seq, A. J. Crawford for help with quantification of RNA FISH, and K. Jeffrey, L. Stuart, N. Silverman, D. Golenbock, and E. Lien for critical reading of this manuscript. The data presented in this paper are tabulated in the main paper and in the supplementary materials. All RNA-seq data are available for download from NCBI Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE40978. Supported by Ireland Health Research Board/Marie Curie Fellowship MCPD/2010/04 (S. C.) and by NIH grants AI067497 (K.A.F.) and GM053234 (J.B.L.).	Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Dreyfuss G, 1996, CELL, V85, P963, DOI 10.1016/S0092-8674(00)81298-2; Gao CJ, 2005, J IMMUNOL, V175, P523, DOI 10.4049/jimmunol.175.1.523; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Peng XX, 2010, MBIO, V1, DOI 10.1128/mBio.00206-10; Raju CS, 2008, MOL BIOL CELL, V19, P3008, DOI 10.1091/mbc.E07-10-1083; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803	28	691	754	4	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					789	792		10.1126/science.1240925	http://dx.doi.org/10.1126/science.1240925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23907535	Green Submitted, Green Accepted			2022-12-28	WOS:000323122200049
J	Shneider, MM; Buth, SA; Ho, BT; Basler, M; Mekalanos, JJ; Leiman, PG				Shneider, Mikhail M.; Buth, Sergey A.; Ho, Brian T.; Basler, Marek; Mekalanos, John J.; Leiman, Petr G.			PAAR-repeat proteins sharpen and diversify the type VI secretion system spike	NATURE			English	Article							BACTERIOPHAGE-T4 BASEPLATE; 3-DIMENSIONAL STRUCTURE; VIBRIO-CHOLERAE; IDENTIFICATION; COMPETITION; EXPRESSION; APPARATUS; SOFTWARE; HOMOLOGY; SERVER	The bacterial type VI secretion system (T6SS) is a large multicomponent, dynamic macromolecular machine that has an important role in the ecology of many Gram-negative bacteria. T6SS is responsible for translocation of a wide range of toxic effector molecules, allowing predatory cells to kill both prokaryotic as well as eukaryotic prey cells(1-5). The T6SS organelle is functionally analogous to contractile tails of bacteriophages and is thought to attack cells by initially penetrating them with a trimeric protein complex called the VgrG spike(6,7). Neither the exact protein composition of the T6SS organelle nor the mechanisms of effector selection and delivery are known. Here we report that proteins from the PAAR (proline-alanine-alanine-arginine) repeat superfamily form a sharp conical extension on the VgrG spike, which is further involved in attaching effector domains to the spike. The crystal structures of two PAAR-repeat proteins bound to VgrG-like partners show that these proteins sharpen the tip of the T6SS spike complex. We demonstrate that PAAR proteins are essential for T6SS-mediated secretion and target cell killing by Vibrio cholerae and Acinetobacter baylyi. Our results indicate a new model of the T6SS organelle in which the VgrG-PAAR spike complex is decorated with multiple effectors that are delivered simultaneously into target cells in a single contraction-driven translocation event.	[Shneider, Mikhail M.; Buth, Sergey A.; Leiman, Petr G.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Shneider, Mikhail M.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow 117997, Russia; [Ho, Brian T.; Basler, Marek; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Harvard University; Harvard Medical School	Leiman, PG (corresponding author), Ecole Polytech Fed Lausanne, BSP 415, CH-1015 Lausanne, Switzerland.	john_mekalanos@hms.harvard.edu; petr.leiman@epfl.ch	Shneider, Mikhail/AAL-6817-2020; Basler, Marek/A-3559-2012; Leiman, Petr G/E-5120-2010; Buth, Sergey A./F-9794-2017; Buth, Sergey/P-1690-2019; Ho, Brian/M-1976-2019	Shneider, Mikhail/0000-0002-3768-3541; Basler, Marek/0000-0001-5414-2088; Leiman, Petr G/0000-0002-9091-0918; Buth, Sergey A./0000-0003-1922-0866; Buth, Sergey/0000-0003-1922-0866; Ho, Brian/0000-0003-4979-780X	Swiss National Science Foundation [31003A_127092]; EPFL; NIAID [AI-026289, AI-01845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, K08AI001845, R01AI018045, R37AI018045] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the entire staff of the Swiss Light Source PX beamlines and V. Olieric in particular for support related to crystallographic data collection. The project was made possible by the Swiss National Science Foundation (grant 31003A_127092) and EPFL funding to P. G. L., and grants AI-026289 and AI-01845 from the NIAID to J.J.M.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; BEARDEN JA, 1967, REV MOD PHYS, V39, P78, DOI 10.1103/RevModPhys.39.78; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; KIKUCHI Y, 1975, J MOL BIOL, V99, P673, DOI 10.1016/S0022-2836(75)80179-3; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408	36	312	324	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					350	+		10.1038/nature12453	http://dx.doi.org/10.1038/nature12453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23925114	Green Accepted, Green Submitted			2022-12-28	WOS:000323112400036
J	Lavery, MPJ; Speirits, FC; Barnett, SM; Padgett, MJ				Lavery, Martin P. J.; Speirits, Fiona C.; Barnett, Stephen M.; Padgett, Miles J.			Detection of a Spinning Object Using Light's Orbital Angular Momentum	SCIENCE			English	Article							ROTATIONAL FREQUENCY-SHIFT; DOPPLER-SHIFT; BEAM	The linear Doppler shift is widely used to infer the velocity of approaching objects, but this shift does not detect rotation. By analyzing the orbital angular momentum of the light scattered from a spinning object, we observed a frequency shift proportional to product of the rotation frequency of the object and the orbital angular momentum of the light. This rotational frequency shift was still present when the angular momentum vector was parallel to the observation direction. The multiplicative enhancement of the frequency shift may have applications for the remote detection of rotating bodies in both terrestrial and astronomical settings.	[Lavery, Martin P. J.; Padgett, Miles J.] Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland; [Speirits, Fiona C.; Barnett, Stephen M.] Univ Strathclyde, Dept Phys, SUPA, Glasgow G4 ONG, Lanark, Scotland	University of Glasgow; University of Strathclyde	Lavery, MPJ (corresponding author), Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland.	martin.lavery@glasgow.ac.uk	Lavery, Martin/H-2265-2015; Padgett, Miles J/B-7625-2008	Padgett, Miles J/0000-0001-6643-0618; Speirits, Fiona/0000-0002-6460-5231; Lavery, Martin/0000-0001-6419-421X; Barnett, Stephen/0000-0003-0733-4524	UK Engineering and Physical Sciences Research Council; Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office [W911NF-10-1-0395]; EPSRC [EP/I012451/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I012451/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by the UK Engineering and Physical Sciences Research Council and by the Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office award W911NF-10-1-0395. S. M. B. and M.J.P. thank the Royal Society and Wolfson Foundation.	ALLEN L, 1994, OPT COMMUN, V112, P141, DOI 10.1016/0030-4018(94)00484-6; ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; ASAKURA T, 1981, APPL PHYS, V25, P179, DOI 10.1007/BF00902971; Barnett SM, 2006, J MOD OPTIC, V53, P613, DOI 10.1080/09500340500186156; Barreiro S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113601; Belmonte A, 2011, OPT LETT, V36, P4437, DOI 10.1364/OL.36.004437; BialynickiBirula I, 1997, PHYS REV LETT, V78, P2539, DOI 10.1103/PhysRevLett.78.2539; Courtial J, 1998, PHYS REV LETT, V81, P4828, DOI 10.1103/PhysRevLett.81.4828; Courtial J, 1998, PHYS REV LETT, V80, P3217, DOI 10.1103/PhysRevLett.80.3217; Fickler R, 2012, SCIENCE, V338, P640, DOI 10.1126/science.1227193; Franke-Arnold S, 2007, OPT EXPRESS, V15, P8619, DOI 10.1364/OE.15.008619; Furhapter S, 2005, OPT EXPRESS, V13, P689, DOI 10.1364/OPEX.13.000689; GARETZ BA, 1981, J OPT SOC AM, V71, P609, DOI 10.1364/JOSA.71.000609; Harwit M, 2003, ASTROPHYS J, V597, P1266, DOI 10.1086/378623; Lavery MPJ, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/6/064006; Leach J, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/055; Leach J, 2006, OPT EXPRESS, V14, P11919, DOI 10.1364/OE.14.011919; MEYNART R, 1983, APPL OPTICS, V22, P535, DOI 10.1364/AO.22.000535; Padgett MJ, 2004, J OPT A-PURE APPL OP, V6, pS263, DOI 10.1088/1464-4258/6/5/024; Swartzlander GA, 2008, OPT EXPRESS, V16, P10200, DOI 10.1364/OE.16.010200; Tamburini F, 2011, NAT PHYS, V7, P195, DOI [10.1038/nphys1907, 10.1038/NPHYS1907]; Torner L, 2005, OPT EXPRESS, V13, P873, DOI 10.1364/OPEX.13.000873; Vasnetsov MV, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/046; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161	24	586	628	38	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					537	540		10.1126/science.1239936	http://dx.doi.org/10.1126/science.1239936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908234	Green Accepted			2022-12-28	WOS:000322586700050
J	Marrucci, L				Marrucci, Lorenzo			Spinning the Doppler Effect	SCIENCE			English	Editorial Material							LIGHT; BEAM		Univ Naples Federico II, Dipartimento Fis, I-80126 Naples, Italy	University of Naples Federico II	Marrucci, L (corresponding author), Univ Naples Federico II, Dipartimento Fis, Via Cintia, I-80126 Naples, Italy.	lorenzo.marrucci@unina.it	Marrucci, Lorenzo/A-4331-2012	Marrucci, Lorenzo/0000-0002-1154-8966				Ambrosio A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1996; ASAKURA T, 1981, APPL PHYS, V25, P179, DOI 10.1007/BF00902971; Bialynicki B. I., 2012, THE ANGULAR MOMENTUM; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Courtial J, 1998, PHYS REV LETT, V81, P4828, DOI 10.1103/PhysRevLett.81.4828; D'Ambrosio V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1951; Lavery MPJ, 2013, SCIENCE, V341, P537, DOI 10.1126/science.1239936; Padgett M, 2011, NAT PHOTONICS, V5, P343, DOI [10.1038/nphoton.2011.81, 10.1038/NPHOTON.2011.81]; Tamburini F, 2011, NAT PHYS, V7, P195, DOI [10.1038/nphys1907, 10.1038/NPHYS1907]; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161	10	18	20	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					464	465		10.1126/science.1242097	http://dx.doi.org/10.1126/science.1242097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908211				2022-12-28	WOS:000322586700025
J	Hirabayashi, S; Baranski, TJ; Cagan, RL				Hirabayashi, Susumu; Baranski, Thomas J.; Cagan, Ross L.			Transformed Drosophila Cells Evade Diet-Mediated Insulin Resistance through Wingless Signaling	CELL			English	Article							DIABETES-MELLITUS; CANCER-PATIENTS; MORTALITY; OBESITY; COHORT; ACTIVATION; APOPTOSIS; GROWTH; RISK; RAS	The risk of specific cancers increases in patients with metabolic dysfunction, including obesity and diabetes. Here, we use Drosophila as a model to explore the effects of diet on tumor progression. Feeding Drosophila a diet high in carbohydrates was previously demonstrated to direct metabolic dysfunction, including hyperglycemia, hyperinsulinemia, and insulin resistance. We demonstrate that high dietary sugar also converts Ras/Src-transformed tissue from localized growths to aggressive tumors with emergent metastases. Whereas most tissues displayed insulin resistance, Ras/Src tumors retained insulin pathway sensitivity, increased the ability to import glucose, and resisted apoptosis. High dietary sugar increased canonical Wingless/Wnt pathway activity, which upregulated insulin receptor gene expression to promote insulin sensitivity. The result is a feed-forward circuit that amplified diet-mediated malignant phenotypes within Ras/Src-transformed tumors. By targeting multiple steps in this circuit with rationally applied drug combinations, we demonstrate the potential of combinatorial drug intervention to treat diet-enhanced malignant tumors.	[Hirabayashi, Susumu; Cagan, Ross L.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Baranski, Thomas J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Icahn School of Medicine at Mount Sinai; Washington University (WUSTL)	Cagan, RL (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Annenberg 25-40,1 Gustave L Levy Pl,Box 1020, New York, NY 10029 USA.	ross.cagan@mssm.edu	Cagan, Ross Leigh/AAV-9528-2021; Tsai, Yu-Chen/B-5852-2008	Cagan, Ross/0000-0001-5297-450X	National Cancer Institute [R01 CA170495, R01 CA109730, R21 DK069940]; NATIONAL CANCER INSTITUTE [R01CA170495, R01CA109730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069940] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Diaz, J. Na, J. Pendse, L. P. Musselman, J. Fink, M. Vidal, and current and former Baranski and Cagan lab members for helpful discussions; C.Y. Nien for writing MATLAB scripts for quantitation; Y. Tomer and D. LeRoith for manuscript comments; and A. O'Reilly, M. Simon, D. Bilder, G. Halder, H. Steller, M. Krasnow, A. Dar, and K. Shokat for reagents. We also thank the Bloomington Stock Center, the Vienna Drosophila RNAi Center, and the Developmental Studies Hybridoma Bank for fly strains and antibodies. This research was supported by the National Cancer Institute (grants R01 CA170495 and R01 CA109730 to S.H. and R.L.C. and grant R21 DK069940 to R.L.C. and T.J.B.). R.L.C. and T.J.B. are cofounders of Medros, which uses fly models of human disease for drug development.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Anderson DC, 2005, ANN PHARMACOTHER, V39, P102, DOI 10.1345/aph.1E081; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Donadon Valter, 2009, Expert Rev Gastroenterol Hepatol, V3, P465, DOI 10.1586/egh.09.41; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Maehle BO, 2004, APMIS, V112, P349, DOI 10.1111/j.1600-0463.2004.apm1120605.x; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shields DJ, 2011, ONCOGENE, V30, P2123, DOI 10.1038/onc.2010.589; Singh R, 2013, CELL METAB, V17, P197, DOI 10.1016/j.cmet.2013.01.009; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	37	84	85	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					664	675		10.1016/j.cell.2013.06.030	http://dx.doi.org/10.1016/j.cell.2013.06.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911328	Bronze, Green Accepted			2022-12-28	WOS:000322629900018
J	Allen, SJ; Wareham, K; Wang, DL; Bradley, C; Hutchings, H; Harris, W; Dhar, A; Brown, H; Foden, A; Gravenor, MB; Mack, D				Allen, Stephen J.; Wareham, Kathie; Wang, Duolao; Bradley, Caroline; Hutchings, Hayley; Harris, Wyn; Dhar, Anjan; Brown, Helga; Foden, Alwyn; Gravenor, Michael B.; Mack, Dietrich			Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial	LANCET			English	Article							METAANALYSIS; PROBIOTICS; EPIDEMIOLOGY; MICROBIOTA; INFECTION; DISEASE; HEALTH; SCALE; TIME; RISK	Background Antibiotic-associated diarrhoea (AAD) occurs most frequently in older (>= 65 years) inpatients exposed to broad-spectrum antibiotics. When caused by Clostridium difficile, AAD can result in life-threatening illness. Although underlying disease mechanisms are not well understood, microbial preparations have been assessed in the prevention of AAD. However, studies have been mostly small single-centre trials with varying quality, providing insufficient data to reliably assess effectiveness. We aimed to do a pragmatic efficacy trial in older inpatients who would be representative of those admitted to National Health Service (NHS) and similar secondary care institutions and to recruit a sufficient number of patients to generate a definitive result. Methods We did a multicentre, randomised, double-blind, placebo-controlled, pragmatic, efficacy trial of inpatients aged 65 years and older and exposed to one or more oral or parenteral antibiotics. A computer-generated randomisation scheme was used to allocate participants (in a 1: 1 ratio) to receive either a multistrain preparation of lactobacilli and bifidobacteria, with a total of 6 x 10 1 organisms, one per day for 21 days, or an identical placebo. Patients, study staff, and specimen and data analysts were masked to assignment. The primary outcomes were occurrence of AAD within 8 weeks and C difficile diarrhoea (CDD) within 12 weeks of recruitment. Analysis was by modified intention-to-treat. This trial is registered, number ISRCTN70017204. Findings Of 17 420 patients screened, 1493 were randomly assigned to the microbial preparation group and 1488 to the placebo group. 1470 and 1471, respectively, were included in the analyses of the primary endpoints. AAD (including CDD) occurred in 159 (10.8%) participants in the microbial preparation group and 153 (10.4%) participants in the placebo group (relative risk [RR] 1.04; 95% CI 0.84-1.28; p=0.71). CDD was an uncommon cause of AAD and occurred in 12 (0.8%) participants in the microbial preparation group and 17 (1.2%) participants in the placebo group (RR 0.71; 95% CI 0.34-1.47; p=0.35). 578 (19.7%) participants had one or more serious adverse event; the frequency of serious adverse events was much the same in the two study groups and none was attributed to participation in the trial. Interpretation We identified no evidence that a multistrain preparation of lactobacilli and bifidobacteria was effective in prevention of AAD or CDD. An improved understanding of the pathophysiology of AAD is needed to guide future studies.	[Allen, Stephen J.; Hutchings, Hayley; Gravenor, Michael B.; Mack, Dietrich] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Wareham, Kathie] Morriston Hosp, Clin Res Unit, Swansea, W Glam, Wales; [Wang, Duolao] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Bradley, Caroline] Cty Durham & Darlington Fdn Trust, Darlington Mem Hosp, Dept Pharm, Darlington, Durham, England; [Harris, Wyn] Singleton Hosp, Swansea SA2 8QA, W Glam, Wales; [Dhar, Anjan] Darlington Mem Hosp, Dept Gastroenterol, Durham, England; [Dhar, Anjan] Bishop Auckland Hosp, Dept Gastroenterol, Durham, England; [Brown, Helga] Univ Hosp North Durham, Dept Geriatr, Durham, England; [Foden, Alwyn] Darlington Mem Hosp, Darlington, Durham, England; [Mack, Dietrich] Inst Med Diagnost GmbH, Bioscientia Lab Ingelheim, Ingelheim, Germany	Swansea University; Morriston Hospital; University of London; London School of Hygiene & Tropical Medicine; Singleton Hospital	Allen, SJ (corresponding author), Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales.	s.j.allen@swansea.ac.uk	Hutchings, Hayley A/C-9944-2013	Hutchings, Hayley Anne/0000-0003-4155-1741; Allen, Stephen/0000-0001-6675-249X	Health Technology Assessment programme; National Institute for Health Research, UK; National Institute for Health Research [06/39/02] Funding Source: researchfish	Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research, UK(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Health Technology Assessment programme; National Institute for Health Research, UK.	Allen SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-108; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Badger VO, 2012, JPEN-PARENTER ENTER, V36, P645, DOI 10.1177/0148607112446703; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Beausoleil M, 2007, CAN J GASTROENTEROL, V21, P732, DOI 10.1155/2007/720205; Beniwal RS, 2003, DIGEST DIS SCI, V48, P2077, DOI 10.1023/A:1026155328638; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2012, BRIT NATL FORMULARY; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cremonini Filippo, 2013, Evid Based Med, V18, P71, DOI 10.1136/eb-2012-100863; FAO/WHO, 2001, HLTH NUTR PROP PROB, V85; Gandek B., 2002, USERS MANUAL SF12 V2; Health Protection Agency, 2012, RES MAND CLOSTR DIFF; Hempel Susanne, 2011, Evid Rep Technol Assess (Full Rep), P1; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; ICH Secretariat, 2011, MEDDRA TERM SEL POIN; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Johnston BC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub3; Kanerva M, 2013, J HOSP INFECT, V83, P127, DOI 10.1016/j.jhin.2012.09.021; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; McFarland LV, 1998, DIGEST DIS, V16, P292, DOI 10.1159/000016879; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; McFarland LV, 2007, BMJ-BRIT MED J, V335, P54, DOI 10.1136/bmj.39255.829120.47; Office for National Statistics, 2011, OFF NAT STAT STAT B; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Public Health Wales, 2012, ALL WAL COMM CLOSTR; Ritchie ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034938; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; Stevens V, 2011, CLIN INFECT DIS, V53, P42, DOI 10.1093/cid/cir301; Stockenhuber A., 2008, GUT, V57, pA20; Thielman NM, 2002, DIGEST DIS SCI, V47, P1421, DOI 10.1023/A:1015867626766; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; *UK DEP HLTH, 2008, CLOSTR DIFF INF DEAL; Videlock EJ, 2012, ALIMENT PHARM THER, V35, P1355, DOI 10.1111/j.1365-2036.2012.05104.x; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Weiss K, 2007, INT J ANTIMICROB AG, V30, P309, DOI 10.1016/j.ijantimicag.2007.05.020	40	211	230	2	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1249	1257		10.1016/S0140-6736(13)61218-0	http://dx.doi.org/10.1016/S0140-6736(13)61218-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23932219	hybrid, Green Accepted			2022-12-28	WOS:000325756400028
J	Vanholme, R; Cesarino, I; Rataj, K; Xiao, YG; Sundin, L; Goeminne, G; Kim, H; Cross, J; Morreel, K; Araujo, P; Welsh, L; Haustraete, J; McClellan, C; Vanholme, B; Ralph, J; Simpson, GG; Halpin, C; Boerjan, W				Vanholme, Ruben; Cesarino, Igor; Rataj, Katarzyna; Xiao, Yuguo; Sundin, Lisa; Goeminne, Geert; Kim, Hoon; Cross, Joanna; Morreel, Kris; Araujo, Pedro; Welsh, Lydia; Haustraete, Jurgen; McClellan, Christopher; Vanholme, Bartel; Ralph, John; Simpson, Gordon G.; Halpin, Claire; Boerjan, Wout			Caffeoyl Shikimate Esterase (CSE) Is an Enzyme in the Lignin Biosynthetic Pathway in Arabidopsis	SCIENCE			English	Article							SECONDARY CELL-WALL; PHENYLPROPANOID METABOLISM; MONOLIGNOL BIOSYNTHESIS; TRANSCRIPTION FACTORS; DEPOSITION; THALIANA; 3'-HYDROXYLASE; PHENOTYPE; GROWTH; ACID	Lignin is a major component of plant secondary cell walls. Here we describe caffeoyl shikimate esterase (CSE) as an enzyme central to the lignin biosynthetic pathway. Arabidopsis thaliana cse mutants deposit less lignin than do wild-type plants, and the remaining lignin is enriched in p-hydroxyphenyl units. Phenolic metabolite profiling identified accumulation of the lignin pathway intermediate caffeoyl shikimate in cse mutants as compared to caffeoyl shikimate levels in the wild type, suggesting caffeoyl shikimate as a substrate for CSE. Accordingly, recombinant CSE hydrolyzed caffeoyl shikimate into caffeate. Associated with the changes in lignin, the conversion of cellulose to glucose in cse mutants increased up to fourfold as compared to that in the wild type upon saccharification without pretreatment. Collectively, these data necessitate the revision of currently accepted models of the lignin biosynthetic pathway.	[Vanholme, Ruben; Cesarino, Igor; Sundin, Lisa; Goeminne, Geert; Cross, Joanna; Morreel, Kris; Araujo, Pedro; Vanholme, Bartel; Boerjan, Wout] VIB Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Vanholme, Ruben; Cesarino, Igor; Sundin, Lisa; Goeminne, Geert; Cross, Joanna; Morreel, Kris; Araujo, Pedro; Vanholme, Bartel; Boerjan, Wout] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Rataj, Katarzyna; Xiao, Yuguo; Welsh, Lydia; McClellan, Christopher; Simpson, Gordon G.; Halpin, Claire] James Hutton Inst, Univ Dundee, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland; [Kim, Hoon; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53726 USA; [Kim, Hoon; Ralph, John] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI 53726 USA; [Kim, Hoon; Ralph, John] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Wisconsin Energy Inst, Madison, WI 53726 USA; [Haustraete, Jurgen] Univ Ghent, VIB, Dept Mol Biomed Res, Prot Serv Facil, B-9052 Ghent, Belgium; [Simpson, Gordon G.] James Hutton Inst, Dundee DD2 5DA, Scotland	Flanders Institute for Biotechnology (VIB); Ghent University; James Hutton Institute; University of Dundee; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Flanders Institute for Biotechnology (VIB); Ghent University; James Hutton Institute	Halpin, C (corresponding author), James Hutton Inst, Univ Dundee, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland.	c.halpin@dundee.ac.uk; wout.boerjan@psb.vib-ugent.be	Boerjan, Wout/Y-4158-2019; Araujo, Pedro/P-9688-2016; Kim, Hoon/E-8245-2013; Ralph, John/C-3161-2009; Vanholme, Ruben/AAA-7996-2022; Cesarino, Igor/N-5887-2014; Xiao, Yuguo/ABD-8421-2020	Boerjan, Wout/0000-0003-1495-510X; Araujo, Pedro/0000-0002-3205-5749; Kim, Hoon/0000-0001-7425-7464; Ralph, John/0000-0002-6093-4521; Cesarino, Igor/0000-0002-6789-2432; Xiao, Yuguo/0000-0002-0747-5856; Welsh, Lydia/0000-0003-1606-0852; McClellan, Christopher/0000-0002-4393-4079; Halpin, Claire/0000-0002-1808-8130	European Commission [211982, 270089]; Stanford University's Global Climate and Energy Project; Hercules program of Ghent University for the Synapt Q-Tof [AUGE/014]; Bijzonder Onderzoeksfonds-Zware Apparatuur of Ghent University [174PZA05]; Ghent University [01MRB510W]; Research Foundation-Flanders; Agency for Innovation by Science and Technology (IWT); CAPES-Brazil [201660/2010-5]; CNPq-Brazil [201998/2011-4]; U.S. Department of Energy's Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; Scottish Government; Science Advisory Board of the NSF [DBI-0922391]; BBSRC [BB/G016232/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016232/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Stanford University's Global Climate and Energy Project; Hercules program of Ghent University for the Synapt Q-Tof; Bijzonder Onderzoeksfonds-Zware Apparatuur of Ghent University; Ghent University(Ghent University); Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); U.S. Department of Energy's Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); Scottish Government; Science Advisory Board of the NSF; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank A. Bleys for help in preparing the manuscript and K. Graham for technical support. We gratefully acknowledge funding through the European Commission's Directorate-General for Research within the 7th Framework Program (FP7/2007-2013) under grant agreements 211982 (RENEWALL) and 270089 (MULTIBIOPRO); Stanford University's Global Climate and Energy Project (Towards New Degradable Lignin Types, Novel Mutants Optimized for Lignin, Growth and Biofuel Production via Re-Mutagenesis, and Efficient Biomass Conversion: Delineating the Best Lignin Monomer-Substitutes); the Hercules program of Ghent University for the Synapt Q-Tof (grant AUGE/014); the Bijzonder Onderzoeksfonds-Zware Apparatuur of Ghent University for the Fourier transform ion cyclotron resonance mass spectrometer (174PZA05); and the Multidisciplinary Research Partnership Biotechnology for a Sustainable Economy (01MRB510W) of Ghent University. R. V. is indebted to the Research Foundation-Flanders for a postdoctoral fellowship and L. S., I. C., and P. A. to the Agency for Innovation by Science and Technology (IWT), CAPES-Brazil (grant 201660/2010-5), and the CNPq-Brazil sandwich Ph.D. (grant 201998/2011-4), respectively, for predoctoral fellowships. J.R. and H. K. were funded in part by the U.S. Department of Energy's Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). G. G. S. was partially funded by the Scottish Government. W. B. is on the Science Advisory Board of the NSF-funded project Regulation and Modeling of Lignin Biosynthesis, DBI-0922391. A patent application, "Modified plants" PCT/GB2013/051206, on the modification of CSE expression to improve processes that require carbohydrate extraction, has been filed jointly by the University of Dundee and the Flanders Institute for Biotechnology (VIB).	Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Chen HC, 2011, P NATL ACAD SCI USA, V108, P21253, DOI 10.1073/pnas.1116416109; Coleman HD, 2008, P NATL ACAD SCI USA, V105, P4501, DOI 10.1073/pnas.0706537105; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Franke R, 2002, PLANT J, V30, P47, DOI 10.1046/j.1365-313X.2002.01267.x; Freudenberg K., 1968, MOL BIOL BIOCH BIOPH, V2, P1; Gao W, 2010, PLANT J, V62, P989, DOI 10.1111/j.1365-313X.2010.04209.x; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Humphreys JM, 2002, CURR OPIN PLANT BIOL, V5, P224, DOI 10.1016/S1369-5266(02)00257-1; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Nilsson R, 2010, MOL CELL PROTEOMICS, V9, P368, DOI 10.1074/mcp.M900289-MCP200; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Van Acker R., 2013, BIOTECHNOLOGY BIOFUE; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y	27	309	321	14	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1103	1106		10.1126/science.1241602	http://dx.doi.org/10.1126/science.1241602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	23950498	Green Published			2022-12-28	WOS:000323933100042
J	Main, DCJ				Main, David C. J.			PERSONAL VIEW Communication in difficult situations: what would a friend say?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE		Univ Bristol, Bristol BS40 5DU, Avon, England	University of Bristol	Main, DCJ (corresponding author), Univ Bristol, Langford House, Bristol BS40 5DU, Avon, England.	d.c.j.main@bristol.ac.uk						Albury W R, 2001, Med Humanit, V27, P35, DOI 10.1136/mh.27.1.35; British Medical Association, DONT TAK IT PERS; Charles C, 1999, BRIT MED J, V319, P780, DOI 10.1136/bmj.319.7212.780; General Medical Council, 2006, GOOD MED PRACT; Little P, 2001, BMJ-BRIT MED J, V322, P468, DOI 10.1136/bmj.322.7284.468; Pilnick A, 2011, SOC SCI MED, V72, P1374, DOI 10.1016/j.socscimed.2011.02.033; Platonova EA, 2008, MED CARE RES REV, V65, P696, DOI 10.1177/1077558708322863	7	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2013	347								f5037	10.1136/bmj.f5037	http://dx.doi.org/10.1136/bmj.f5037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	207TC	23974636				2022-12-28	WOS:000323625800001
J	Yoshida-Moriguchi, T; Willer, T; Anderson, ME; Venzke, D; Whyte, T; Muntoni, F; Lee, H; Nelson, SF; Yu, LP; Campbell, KP				Yoshida-Moriguchi, Takako; Willer, Tobias; Anderson, Mary E.; Venzke, David; Whyte, Tamieka; Muntoni, Francesco; Lee, Hane; Nelson, Stanley F.; Yu, Liping; Campbell, Kevin P.			SGK196 Is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function	SCIENCE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG SYNDROME; ALPHA-DYSTROGLYCAN; LAMININ-BINDING; MUTATIONS; ISPD	Phosphorylated O-mannosyl trisaccharide [N-acetylgalactosamine-beta 3-N-acetylglucosamine-beta 4-(phosphate-6-)mannose] is required for dystroglycan to bind laminin-G domain-containing extracellular proteins with high affinity in muscle and brain. However, the enzymes that produce this structure have not been fully elucidated. We found that glycosyltransferase-like domain-containing 2 (GTDC2) is a protein O-linked mannose beta 1,4-N-acetylglucosaminyltransferase whose product could be extended by beta 1,3-N-acetylgalactosaminyltransferase2 (B3GALNT2) to form the O-mannosyl trisaccharide. Furthermore, we identified SGK196 as an atypical kinase that phosphorylated the 6-position of O-mannose, specifically after the mannose had been modified by both GTDC2 and B3GALNT2. These findings suggest how mutations in GTDC2, B3GALNT2, and SGK196 disrupt dystroglycan receptor function and lead to congenital muscular dystrophy.	[Yoshida-Moriguchi, Takako; Willer, Tobias; Anderson, Mary E.; Venzke, David; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst,Dept Neurol, Dept Mol Physiol & Biophys,Dept Internal Med, Iowa City, IA 52242 USA; [Whyte, Tamieka; Muntoni, Francesco] Inst Child Hlth, Div Neurosci, Dubowitz Neuromuscular Ctr, London, England; [Whyte, Tamieka; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Yu, Liping] Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Nucl Magnet Resonance Facil, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst,Dept Neurol, Dept Mol Physiol & Biophys,Dept Internal Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Yu, Liping/0000-0003-3536-6427; Campbell, Kevin/0000-0003-2066-5889; Venzke, David/0000-0001-8180-9562	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; Muscular Dystrophy Campaign; Great Ormond Street Hospital Children Charity; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Great Ormond Street Hospital Children Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all members of the Campbell laboratory, C. M. Brenner, and C. M. Blaumueller for fruitful discussions; Y. Hara for making an adenovirus vector; H. van Bokhoven for providing patient cells; J. R. Levy for helping imaging studies; H. Nguyen for graphical arts; and the University of Iowa Proteomics Facility and Gene Transfer Vector Core for their services. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center grant (1U54NS053672, K.P.C.), the Muscular Dystrophy Campaign, and the Great Ormond Street Hospital Children Charity (F.M.). K.P.C. is an Investigator of the Howard Hughes Medical Institute. The data are included in the paper and the supplementary materials.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Chiba A, 1997, J BIOL CHEM, V272, P2156; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	16	144	152	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					896	899		10.1126/science.1239951	http://dx.doi.org/10.1126/science.1239951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23929950	Green Accepted			2022-12-28	WOS:000323370600045
J	Park, JH; Coy, JM; Kasirga, TS; Huang, CM; Fei, ZY; Hunter, S; Cobden, DH				Park, Jae Hyung; Coy, Jim M.; Kasirga, T. Serkan; Huang, Chunming; Fei, Zaiyao; Hunter, Scott; Cobden, David H.			Measurement of a solid-state triple point at the metal-insulator transition in VO2	NATURE			English	Article							VANADIUM DIOXIDE; PHASE-TRANSITION; ORGANIZATION; DOMAINS; STRESS	First-order phase transitions in solids are notoriously challenging to study. The combination of change in unit cell shape, long range of elastic distortion and flow of latent heat leads to large energy barriers resulting in domain structure, hysteresis and cracking. The situation is worse near a triple point, where more than two phases are involved. The well-known metal-insulator transition in vanadium dioxide(1), a popular candidate for ultrafast optical and electrical switching applications, is a case in point. Even though VO2 is one of the simplest strongly correlated materials, experimental difficulties posed by the first-order nature of the metal-insulator transition as well as the involvement of at least two competing insulating phases have led to persistent controversy about its nature(1-4). Here we show that studying single-crystal VO2 nanobeams(5-16) in a purpose-built nanomechanical strain apparatus allows investigation of this prototypical phase transition with unprecedented control and precision. Our results include the striking finding that the triple point of the metallic phase and two insulating phases is at the transition temperature, T-tr = T-c, which we determine to be 65.0 +/- 0.1 degrees C. The findings have profound implications for the mechanism of the metal-insulator transition in VO2, but they also demonstrate the importance of this approach for mastering phase transitions in many other strongly correlated materials, such as manganites(17) and iron-based superconductors(18).	[Park, Jae Hyung; Coy, Jim M.; Kasirga, T. Serkan; Huang, Chunming; Fei, Zaiyao; Hunter, Scott; Cobden, David H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Cobden, DH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	cobden@uw.edu	Kasirga, Talip Serkan/P-4641-2019	Kasirga, Talip Serkan/0000-0003-3510-5059; Fei, Zaiyao/0000-0002-5433-2778	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0002197]	US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	We thank B. Spivak, A. Levanyuk and J. Wei for discussions. The silicon chips were patterned at the University of Washington Microfabrication Facility and the Nanofabrication Facility at the University of California, Santa Barbara. This work was supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, award DE-SC0002197.	Atkin JM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.020101; BECKER MF, 1994, APPL PHYS LETT, V65, P1507, DOI 10.1063/1.112974; BERGLUND CN, 1969, PHYS REV, V185, P1022, DOI 10.1103/PhysRev.185.1022; Biermann S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026404; Cao J, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.241101; Cao J, 2010, NANO LETT, V10, P2667, DOI 10.1021/nl101457k; Cao J, 2009, NAT NANOTECHNOL, V4, P732, DOI [10.1038/nnano.2009.266, 10.1038/NNANO.2009.266]; Eyert V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016401; Guo H, 2011, NANO LETT, V11, P3207, DOI 10.1021/nl201460v; Hilton DJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226401; Jeong J, 2013, SCIENCE, V339, P1402, DOI 10.1126/science.1230512; Jones AC, 2010, NANO LETT, V10, P1574, DOI 10.1021/nl903765h; Kasirga TS, 2012, NAT NANOTECHNOL, V7, P723, DOI [10.1038/nnano.2012.176, 10.1038/NNANO.2012.176]; KUCHARCZYK D, 1979, J APPL CRYSTALLOGR, V12, P370, DOI 10.1107/S0021889879012711; Kubler C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116401; MAREZIO M, 1972, PHYS REV B-SOLID ST, V5, P2541, DOI 10.1103/PhysRevB.5.2541; Nakano M, 2012, NATURE, V487, P459, DOI 10.1038/nature11296; Podzorov V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.140406; POUGET JP, 1975, PHYS REV LETT, V35, P873, DOI 10.1103/PhysRevLett.35.873; Qazilbash MM, 2007, SCIENCE, V318, P1750, DOI 10.1126/science.1150124; RICE TM, 1994, PHYS REV LETT, V73, P3042, DOI 10.1103/PhysRevLett.73.3042; Sohn JI, 2009, NANO LETT, V9, P3392, DOI 10.1021/nl900841k; Tselev A, 2010, NANO LETT, V10, P4409, DOI 10.1021/nl1020443; Tselev A, 2010, NANO LETT, V10, P2003, DOI 10.1021/nl1008794; Wei J, 2012, NAT NANOTECHNOL, V7, P357, DOI [10.1038/NNANO.2012.70, 10.1038/nnano.2012.70]; Wei J, 2009, NAT NANOTECHNOL, V4, P420, DOI [10.1038/nnano.2009.141, 10.1038/NNANO.2009.141]; Wu JQ, 2006, NANO LETT, V6, P2313, DOI 10.1021/nl061831r; Zhang SX, 2009, NANO LETT, V9, P4527, DOI 10.1021/nl9028973; ZYLBERSZTEJN A, 1975, PHYS REV B, V11, P4383, DOI 10.1103/PhysRevB.11.4383	30	330	336	21	513	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					431	434		10.1038/nature12425	http://dx.doi.org/10.1038/nature12425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969461	Green Submitted			2022-12-28	WOS:000323316100029
J	Pauly, MV; Leive, AA				Pauly, Mark V.; Leive, Adam A.			The Unanticipated Consequences of Postponing the Employer Mandate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">The Obama administration's delay in implementing the employer mandate affects other provisions of the ACA, particularly subsidies for purchasing insurance, and creates distorted incentives that may leave the government paying significantly more than planned. <p id="p003">The Obama administration's decision to postpone implementation of the employer mandate is the latest in a series of delays and alterations of the Affordable Care Act (ACA). But postponing the mandate which requires larger employers to offer lower-income workers health insurance coverage similar to that available in the new insurance exchanges, on equal and affordable financial terms may create large ripple effects. The good news is that as compared with instituting the mandate as planned, postponing it should barely increase the number of uninsured Americans after ACA implementation. But it affects other provisions, particularly the individual subsidies for ...	[Pauly, Mark V.; Leive, Adam A.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	University of Pennsylvania	Pauly, MV (corresponding author), Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA.							Congressional Budget Office, 2013, EFF HLTH INS FED BUD; Gruber J, 2008, J HEALTH ECON, V27, P201, DOI 10.1016/j.jhealeco.2007.11.004; Pauly M., 1999, HLTH BEN WORK EC POL; SUMMERS LH, 1989, AM ECON REV, V79, P177	4	2	2	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					691	693		10.1056/NEJMp1308934	http://dx.doi.org/10.1056/NEJMp1308934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	204FA	23902383	Green Published			2022-12-28	WOS:000323349300003
J	Curzen, N; Gurbel, PA; Myat, A; Bhatt, DL; Redwood, SR				Curzen, Nicholas; Gurbel, Paul A.; Myat, Aung; Bhatt, Deepak L.; Redwood, Simon R.			What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?	LANCET			English	Article							ELEVATION MYOCARDIAL-INFARCTION; INTRAVENOUS BOLUS ABCIXIMAB; GLYCOPROTEIN IIB/IIIA INHIBITOR; DRUG-ELUTING STENTS; BARE-METAL STENTS; THROMBUS ASPIRATION; PRIMARY ANGIOPLASTY; DOUBLE-BLIND; ANTIPLATELET THERAPY; PLATELET INHIBITION	Acute ST-segment elevation myocardial infarction (STEMI) is a dynamic, thrombus-driven event. As understanding of its pathophysiology has improved, the central role of platelets in initiation and orchestration of this process has become clear. Key components of STEMI include formation of occlusive thrombus, mediation and ultimately amplification of the local vascular inflammatory response resulting in increased vasoreactivity, oedema formation, and microvascular obstruction. Activation, degranulation, and aggregation of platelets are the platforms from which these components develop. Therefore, prompt, potent, and predictable antithrombotic therapy is needed to optimise clinical outcomes after primary percutaneous coronary intervention. We review present pharmacological and mechanical adjunctive therapies for reperfusion and ask what is the optimum combination when primary percutaneous coronary intervention is used as the mode of revascularisation in patients with STEMI.	[Curzen, Nicholas] Univ Hosp Southampton NHS Fdn Trust, Wessex Cardiothorac Unit, Southampton SO16 6YD, Hants, England; [Gurbel, Paul A.] Sinai Hosp, Sinai Ctr Thrombosis Res, Cardiac Catheterisat Lab, Baltimore, MD 21215 USA; [Myat, Aung; Redwood, Simon R.] Kings Coll London, London BHF Ctr Res Excellence, St Thomas Hosp, Rayne Inst,Cardiovasc Div, London, England; [Bhatt, Deepak L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, VA Boston Healthcare Syst, Boston, MA 02115 USA	University of Southampton; University Hospital Southampton NHS Foundation Trust; Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Curzen, N (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England.	nick.curzen@uhs.nhs.uk	curzen, nick/AAD-8161-2020	Curzen, Nick/0000-0001-9651-7829	Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; British Heart Foundation [FS/11/70/28917]	Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; British Heart Foundation(British Heart Foundation)	AM is supported by the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust, in partnership with King's College London and King's College Hospital NHS Foundation Trust. AM acknowledges financial support from the British Heart Foundation via a Clinical Research Training Fellowship (grant number FS/11/70/28917). We thank Udaya Tantry (Sinai Center for Thrombosis Research, Baltimore, MD, USA) for providing us with the image for figure 1.	Agrawal K, 2013, NAT REV CARDIOL, V10, P121, DOI 10.1038/nrcardio.2012.199; Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; [Anonymous], 1988, LANCET, V2, P349; Antoniucci D, 2003, J AM COLL CARDIOL, V42, P1879, DOI 10.1016/j.jacc.2003.07.017; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bavry AA, 2008, EUR HEART J, V29, P2989, DOI 10.1093/eurheartj/ehn421; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bhatt DL, 2012, LANCET, V380, P1453, DOI 10.1016/S0140-6736(12)61021-6; Bhatt DL, 2009, NAT REV CARDIOL, V6, P737, DOI 10.1038/nrcardio.2009.192; Bhatt DL, 2009, NEW ENGL J MED, V361, P940, DOI 10.1056/NEJMp0806848; Burzotta F, 2008, INT J CARDIOL, V123, P313, DOI 10.1016/j.ijcard.2006.12.018; Burzotta F, 2009, EUR HEART J, V30, P2193, DOI 10.1093/eurheartj/ehp348; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Curzen N, 2012, HEART, V98, P1617, DOI 10.1136/heartjnl-2012-302299; Dangas GD, 2011, J AM COLL CARDIOL, V57, P2309, DOI 10.1016/j.jacc.2011.01.038; De Carlo M, 2012, JACC-CARDIOVASC INTE, V5, P1223, DOI 10.1016/j.jcin.2012.08.013; De Luca G, 2011, J THROMB HAEMOST, V9, P2361, DOI 10.1111/j.1538-7836.2011.04513.x; De Luca G, 2005, AM HEART J, V150, P557, DOI 10.1016/j.ahj.2004.10.044; De Luca G, 2008, EUR HEART J, V29, P3002, DOI 10.1093/eurheartj/ehn389; Dziewierz A, 2013, J THROMB THROMBOLYS, V36, P240, DOI 10.1007/s11239-012-0826-3; Eitel I, 2013, J AM COLL CARDIOL, V61, P1447, DOI 10.1016/j.jacc.2013.01.048; Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816; Frobert O, 2010, AM HEART J, V160, P1042, DOI 10.1016/j.ahj.2010.08.040; Gurbel PA, 2012, CIRCULATION, V125, P1276, DOI 10.1161/CIRCULATIONAHA.111.031195; Gurbel PA, 2010, CIRCULATION, V121, P739, DOI 10.1161/CIR.0b013e3181d40dc9; Ikari Y, 2008, JACC-CARDIOVASC INTE, V1, P424, DOI 10.1016/j.jcin.2008.06.004; Jang JS, 2012, J AM COLL CARDIOL, V60, pB145, DOI 10.1016/j.jacc.2012.08.533; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Koutouzis M, 2011, HEART, V97, P1484, DOI 10.1136/hrt.2011.224709; Kramer MCA, 2008, CIRCULATION, V118, P1810, DOI 10.1161/CIRCULATIONAHA.108.780734; Kubica J, 2012, CARDIOL J, V19, P230, DOI 10.5603/CJ.2012.0044; Kumbhani DJ, 2013, J AM COLL CARDIOL, V62, P1409, DOI 10.1016/j.jacc.2013.04.025; Ludman PF, BCIS AUDIT RETURNS A; Mehilli J, 2009, CIRCULATION, V119, P1933, DOI 10.1161/CIRCULATIONAHA.108.818617; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Migliorini A, 2010, J AM COLL CARDIOL, V56, P1298, DOI 10.1016/j.jacc.2010.06.011; Mongeon FP, 2010, CIRC-CARDIOVASC INTE, V3, P6, DOI 10.1161/CIRCINTERVENTIONS.109.904037; Montalescot G, 2013, AM HEART J, V165, P515, DOI 10.1016/j.ahj.2012.12.015; Montalescot G, 2011, LANCET, V378, P693, DOI 10.1016/S0140-6736(11)60876-3; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Myat A, 2010, OXFORD TXB INTERVENT, P419; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Onuma Y, 2013, EUR HEART J, V34, P1050, DOI 10.1093/eurheartj/ehs456; Owan TE, 2012, CATHETER CARDIO INTE, V80, P1173, DOI 10.1002/ccd.24306; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sambu N, 2011, BRIT J CLIN PHARMACO, V72, P683, DOI 10.1111/j.1365-2125.2011.03955.x; Sardella G, 2010, AM J CARDIOL, V106, P624, DOI 10.1016/j.amjcard.2010.04.014; Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017; Silvain J, 2011, J AM COLL CARDIOL, V57, P1359, DOI 10.1016/j.jacc.2010.09.077; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; Tamhane UU, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-10; Thiele H, 2008, CIRCULATION, V118, P49, DOI 10.1161/CIRCULATIONAHA.107.747642; Thiele H, 2012, LANCET, V379, P923, DOI 10.1016/S0140-6736(11)61872-2; van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519	73	20	21	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					633	643		10.1016/S0140-6736(13)61453-1	http://dx.doi.org/10.1016/S0140-6736(13)61453-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953387				2022-12-28	WOS:000323422800027
J	Luthi, M				Luethi, Martin			Gauging Greenland's Subglacial Water	SCIENCE			English	Editorial Material							FREE-SURFACE FLOW; DRAINAGE; FLOTATION; EVOLUTION; MODEL		ETH, Lab Hydraul Hydrol & Glaciol VAW, CH-8093 Zurich, Switzerland	ETH Zurich	Luthi, M (corresponding author), ETH, Lab Hydraul Hydrol & Glaciol VAW, CH-8093 Zurich, Switzerland.	luethi@vaw.baug.ethz.ch	Lüthi, Martin/AAA-3668-2021	Lüthi, Martin/0000-0003-4419-8496				Bartholomew I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002220; Chandler DM, 2013, NAT GEOSCI, V6, P195, DOI 10.1038/ngeo1737; Clarke GKC, 2005, ANNU REV EARTH PL SC, V33, P247, DOI 10.1146/annurev.earth.33.092203.122621; Cowton T, 2013, J GEOPHYS RES-EARTH, V118, P29, DOI 10.1029/2012JF002540; Faillettaz J, 2012, NAT HAZARD EARTH SYS, V12, P2977, DOI 10.5194/nhess-12-2977-2012; Hewitt IJ, 2012, J FLUID MECH, V702, P157, DOI 10.1017/jfm.2012.166; Meierbachtol T, 2013, SCIENCE, V341, P777, DOI 10.1126/science.1235905; Schoof C, 2012, J FLUID MECH, V702, P126, DOI 10.1017/jfm.2012.165; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618	9	1	1	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					721	722		10.1126/science.1242672	http://dx.doi.org/10.1126/science.1242672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950518				2022-12-28	WOS:000323122200026
J	Millien, VO; Lu, W; Shaw, J; Yuan, XY; Mak, G; Roberts, L; Song, LZ; Knight, JM; Creighton, CJ; Luong, A; Kheradmand, F; Corry, DB				Millien, Valentine Ongeri; Lu, Wen; Shaw, Joanne; Yuan, Xiaoyi; Mak, Garbo; Roberts, Luz; Song, Li-Zhen; Knight, J. Morgan; Creighton, Chad J.; Luong, Amber; Kheradmand, Farrah; Corry, David B.			Cleavage of Fibrinogen by Proteinases Elicits Allergic Responses Through Toll-Like Receptor 4	SCIENCE			English	Article							CELLS; ANTIGEN; INTERLEUKIN-4; ACTIVATION; DEFENSE; ASTHMA; FUNGI; IL-4	Proteinases and the innate immune receptor Toll-like receptor 4 (TLR4) are essential for expression of allergic inflammation and diseases such as asthma. A mechanism that links these inflammatory mediators is essential for explaining the fundamental basis of allergic disease but has been elusive. Here, we demonstrate that TLR4 is activated by airway proteinase activity to initiate both allergic airway disease and antifungal immunity. These outcomes were induced by proteinase cleavage of the clotting protein fibrinogen, yielding fibrinogen cleavage products that acted as TLR4 ligands on airway epithelial cells and macrophages. Thus, allergic airway inflammation represents an antifungal defensive strategy that is driven by fibrinogen cleavage and TLR4 activation. These findings clarify the molecular basis of allergic disease and suggest new therapeutic strategies.	[Millien, Valentine Ongeri; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Lu, Wen; Yuan, Xiaoyi; Knight, J. Morgan; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shaw, Joanne; Mak, Garbo; Roberts, Luz; Song, Li-Zhen; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Luong, Amber] Univ Texas Hlth Sci Ctr Houston, Dept Otorhinolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Kheradmand, Farrah; Corry, David B.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Kheradmand, F (corresponding author), Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA.	farrahk@bcm.edu; dcorry@bcm.edu	Lu, Wen/C-6543-2019		NIH [HL75243, AI057696, AI070973, CA125123, T32GM088129, R25GM56929]; C.N. and Mary V. Papadopoulos Charitable Fund from the Biology of Inflammation Center; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL075243, R01HL095382, R01HL117181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057696, U19AI070973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129, R25GM056929] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C.N. and Mary V. Papadopoulos Charitable Fund from the Biology of Inflammation Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The data presented in this paper are tabulated in the main paper and in the supplementary materials. Microarray data are available through the National Center for Biotechnology Information Gene Expression Omnibus, accession number GSE48609. We thank Y. Qian, T. Bird, and Y. Zhang for excellent technical assistance. Funding was provided by NIH grants HL75243, AI057696, and AI070973 (to D. B. C.); CA125123 (to C.J.C.); and T32GM088129 and R25GM56929 (to V.O.M.) and the C.N. and Mary V. Papadopoulos Charitable Fund from the Biology of Inflammation Center.	Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Clarke AH, 1999, INT ARCH ALLERGY IMM, V120, P126, DOI 10.1159/000024230; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; FINKELMAN FD, 1988, J IMMUNOL, V141, P2335; GAY NJ, 1992, BIOCHIM BIOPHYS ACTA, V1132, P290, DOI 10.1016/0167-4781(92)90163-T; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179; Jozefowski S, 2012, INFLAMM RES, V61, P113, DOI 10.1007/s00011-011-0395-5; Kelada SNP, 2011, AM J RESP CELL MOL, V45, P817, DOI 10.1165/rcmb.2010-0315OC; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Lim KC, 1999, AM J TROP MED HYG, V60, P487, DOI 10.4269/ajtmh.1999.60.487; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Singh M, 2010, J ALLERGY CLIN IMMUN, V125, P1369, DOI 10.1016/j.jaci.2010.02.035; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Tomee JFC, 1997, J INFECT DIS, V176, P740, DOI 10.1086/514098; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Woods CM, 2011, AM J RHINOL ALLERGY, V25, P236, DOI 10.2500/ajra.2011.25.3631	26	154	161	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					792	796		10.1126/science.1240342	http://dx.doi.org/10.1126/science.1240342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950537	Green Accepted			2022-12-28	WOS:000323122200050
J	Wichterle, H; Gifford, D; Mazzoni, E				Wichterle, Hynek; Gifford, David; Mazzoni, Esteban			Mapping Neuronal Diversity One Cell at a Time	SCIENCE			English	Editorial Material							GABAERGIC INTERNEURONS; NERVOUS-SYSTEM; CLASSIFICATION; NOMENCLATURE; SINGLE; ATLAS		[Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Pathol & Cell Bi, New York, NY 10032 USA; [Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Neurol, New York, NY 10032 USA; [Wichterle, Hynek] Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Neurosci, New York, NY 10032 USA; [Gifford, David] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Mazzoni, Esteban] NYU, Dept Biol, New York, NY 10003 USA	Columbia University; Columbia University; Columbia University; Massachusetts Institute of Technology (MIT); New York University	Wichterle, H (corresponding author), Columbia Univ, Med Ctr, Columbia Stem Cell Initiat, Ctr Motor Neuron Biol & Dis,Dept Pathol & Cell Bi, 630 168 St, New York, NY 10032 USA.	hw350@columbia.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078097, P01NS055923] Funding Source: NIH RePORTER; NINDS NIH HHS [P01NS055923, R01NS078097] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Gerber GK, 2007, PLOS COMPUT BIOL, V3, P1426, DOI 10.1371/journal.pcbi.0030148; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HALL DH, 1991, J NEUROSCI, V11, P1; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46	17	28	28	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					726	727		10.1126/science.1235884	http://dx.doi.org/10.1126/science.1235884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950522				2022-12-28	WOS:000323122200030
J	Palmer, J; Mullan, Z				Palmer, Joanna; Mullan, Zoe			Highlights 2013: health through the lens	LANCET			English	Editorial Material									[Palmer, Joanna] The Lancet, London NW1 7BY, England; Lancet Global Hlth, London, England		Palmer, J (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					492	492		10.1016/S0140-6736(13)61679-7	http://dx.doi.org/10.1016/S0140-6736(13)61679-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23931913				2022-12-28	WOS:000323162400011
J	Kadanoff, LP				Kadanoff, Leo P.			Kenneth Geddes Wilson (1936-2013) OBITUARY	NATURE			English	Biographical-Item									[Kadanoff, Leo P.] Perimeter Inst, Waterloo, ON, Canada; [Kadanoff, Leo P.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	Perimeter Institute for Theoretical Physics; University of Chicago	Kadanoff, LP (corresponding author), Perimeter Inst, Waterloo, ON, Canada.	leop@uchicago.edu							0	1	1	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					30	30		10.1038/500030a	http://dx.doi.org/10.1038/500030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23903743	Bronze			2022-12-28	WOS:000322514800017
J	Kucsko, G; Maurer, PC; Yao, NY; Kubo, M; Noh, HJ; Lo, PK; Park, H; Lukin, MD				Kucsko, G.; Maurer, P. C.; Yao, N. Y.; Kubo, M.; Noh, H. J.; Lo, P. K.; Park, H.; Lukin, M. D.			Nanometre-scale thermometry in a living cell	NATURE			English	Article							TEMPERATURE; CANCER; THERMOGENESIS; FLUORESCENCE; TISSUE; SPACE; SPINS; TIME	Sensitive probing of temperature variations on nanometre scales is an outstanding challenge in many areas of modern science and technology(1). In particular, a thermometer capable of subdegree temperature resolution over a large range of temperatures as well as integration within a living system could provide a powerful new tool in many areas of biological, physical and chemical research. Possibilities range from the temperature-induced control of gene expression(2-5) and tumour metabolism(6) to the cell-selective treatment of disease(7,8) and the study of heat dissipation in integrated circuits(1). By combining local light-induced heat sources with sensitive nanoscale thermometry, it may also be possible to engineer biological processes at the subcellular level(2-5). Here we demonstrate a new approach to nanoscale thermometry that uses coherent manipulation of the electronic spin associated with nitrogen-vacancy colour centres in diamond. Our technique makes it possible to detect temperature variations as small as 1.8 mK (a sensitivity of 9 mK Hz(-1/2)) in an ultrapure bulk diamond sample. Using nitrogen-vacancy centres in diamond nanocrystals (nanodiamonds), we directly measure the local thermal environment on length scales as short as 200 nanometres. Finally, by introducing both nanodiamonds and gold nanoparticles into a single human embryonic fibroblast, we demonstrate temperature-gradient control and mapping at the subcellular level, enabling unique potential applications in life sciences.	[Kucsko, G.; Maurer, P. C.; Yao, N. Y.; Park, H.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kubo, M.; Park, H.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Noh, H. J.; Park, H.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Noh, H. J.; Park, H.] Harvard Univ, Cambridge, MA 02142 USA; [Lo, P. K.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; City University of Hong Kong	Park, H (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	hongkun_park@harvard.edu; lukin@physics.harvard.edu	Park, Hongkun/R-9842-2019; lo, pik Kwan peggy/D-3196-2012; Yao, Norman/A-3929-2009	Park, Hongkun/0000-0001-9576-8829; Yao, Norman/0000-0003-0194-7266; Lo, Pik Kwan/0000-0001-5255-1718; Kucsko, Georg/0000-0002-4189-3154	NSF; Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUASAR programme); Army Research Office (MURI programme); Packard Foundation; NIH [5DP1OD003893-03]; NHGRI [1P50HG006193-01]; Swiss National Science Foundation [PBSKP2_143918]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA035083] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003893] Funding Source: NIH RePORTER; Division Of Physics [1125846] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUASAR programme)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office (MURI programme); Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank R. Walsworth, V. Denic, C. Latta, L. Jiang, A. Gorshkov, P. Cappellaro, A. Sushkov and I. Lovchinsky for discussions and help with experiments. This work was supported by the NSF, the Center for Ultracold Atoms, the Defense Advanced Research Projects Agency (QUASAR programme), the Army Research Office (MURI programme), the Packard Foundation, NIH Pioneer Awards (5DP1OD003893-03), the NHGRI (1P50HG006193-01) and the Swiss National Science Foundation (PBSKP2_143918) (P.C.M.).	Acosta VM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070801; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Chen XD, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3652910; Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hodges JS, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032118; Jin CY, 2011, NANO LETT, V11, P4818, DOI 10.1021/nl2026585; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kim SH, 2006, J MICROMECH MICROENG, V16, P526, DOI 10.1088/0960-1317/16/3/007; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Majumdar A, 1999, ANNU REV MATER SCI, V29, P505, DOI 10.1146/annurev.matsci.29.1.505; Maurer PC, 2010, NAT PHYS, V6, P912, DOI [10.1038/NPHYS1774, 10.1038/nphys1774]; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Toyli DM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031001; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Vetrone F, 2010, ACS NANO, V4, P3254, DOI 10.1021/nn100244a; Vreugdenburg TD, 2013, BREAST CANCER RES TR, V137, P665, DOI 10.1007/s10549-012-2393-x; Wee TL, 2007, J PHYS CHEM A, V111, P9379, DOI 10.1021/jp073938o; Xu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049021; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Yue Y., 2012, NANO REV	30	1138	1169	35	781	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					54	U71		10.1038/nature12373	http://dx.doi.org/10.1038/nature12373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23903748	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000322514800026
J	Murray, CJL; Lopez, AD				Murray, Christopher J. L.; Lopez, Alan D.			Measuring the Global Burden of Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYSTEMATIC ANALYSIS; LIFE EXPECTANCY; ECONOMIC COST; 187 COUNTRIES; RISK-FACTORS; 21 REGIONS; DISABILITY; MORTALITY; HEALTH; INJURY	The burden that disease places on societies around the world is complex and changing as communicable diseases are replaced by noncommunicable diseases. This article summarizes these changes and the current burden. It is difficult to deliver effective and high-quality care to patients without knowing their diagnoses; likewise, for health systems to be effective, it is necessary to understand the key challenges in efforts to improve population health and how these challenges are changing. Before the early 1990s, there was no comprehensive and internally consistent source of information on the global burden of diseases, injuries, and risk factors. To close this gap, the World Bank and the World Health Organization launched the Global Burden of Disease (GBD) Study in 1991.(1) Although assessments of selected diseases, injuries, and risk factors in selected populations ...	[Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic 3053, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Melbourne	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010	Lopez, Alan D/0000-0001-5818-6512				[Anonymous], 2012, EVALUATION; Coyte PC, 1998, ARTHRIT CARE RES, V11, P315, DOI 10.1002/art.1790110503; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Friedman C, 2004, J OCCUP ENVIRON MED, V46, P3, DOI 10.1097/01.jom.0000105915.59342.9a; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Hsairi M, 2003, Sante Publique, V15, P25; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Preston SH, 2007, INT J EPIDEMIOL, V36, P484, DOI 10.1093/ije/dym075; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; SALOMON JA, 2013, LANCET, V381, P628; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871; UNAIDS, 2010, GLOB REP UNAIDS REP; UNICEF, 2012, BUILD FUT WOM CHILDR; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; World Bank, 1993, WORLD DEV REP 1993 I; World Health Organization, 2000, WORLD HLTH REP 2000; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002; Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188	35	1093	1195	11	155	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					448	457		10.1056/NEJMra1201534	http://dx.doi.org/10.1056/NEJMra1201534			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902484	Bronze			2022-12-28	WOS:000322547400011
J	Vallurupalli, M				Vallurupalli, Mounica			Mourning on Morning Rounds	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEATH-ROUNDS; RESIDENTS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Vallurupalli, M (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Hough CL, 2005, J CRIT CARE, V20, P20, DOI 10.1016/j.jcrc.2004.09.006; Jackson VA, 2005, ACAD MED, V80, P648, DOI 10.1097/00001888-200507000-00007; Khot S, 2011, ARCH NEUROL-CHICAGO, V68, P1395, DOI 10.1001/archneurol.2011.618	3	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					404	405		10.1056/NEJMp1300969	http://dx.doi.org/10.1056/NEJMp1300969			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23902480				2022-12-28	WOS:000322547400005
J	Caroli, A; Perico, N; Perna, A; Antiga, L; Brambilla, P; Pisani, A; Visciano, B; Imbriaco, M; Messa, P; Cerutti, R; Dugo, M; Cancian, L; Buongiorno, E; De Pascalis, A; Gaspari, F; Carrara, F; Rubis, N; Prandini, S; Remuzzi, A; Remuzzi, G; Ruggenenti, P				Caroli, Anna; Perico, Norberto; Perna, Annalisa; Antiga, Luca; Brambilla, Paolo; Pisani, Antonio; Visciano, Bianca; Imbriaco, Massimo; Messa, Piergiorgio; Cerutti, Roberta; Dugo, Mauro; Cancian, Luca; Buongiorno, Erasmo; De Pascalis, Antonio; Gaspari, Flavio; Carrara, Fabiola; Rubis, Nadia; Prandini, Silvia; Remuzzi, Andrea; Remuzzi, Giuseppe; Ruggenenti, Piero		ALADIN Study Grp	Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial	LANCET			English	Article							LONG-ACTING SOMATOSTATIN; RENAL-FUNCTION; LIVER-DISEASE; PROGRESSION; VOLUME; INHIBITION; OCTREOTIDE; RECEPTORS; TOLVAPTAN; CHILDREN	Background Autosomal dominant polycystic kidney disease slowly progresses to end-stage renal disease and has no effective therapy. A pilot study suggested that the somatostatin analogue octreotide longacting release (LAR) could be nephroprotective in this context. We aimed to assess the effect of 3 years of octreotide-LAR treatment on kidney and cyst growth and renal function decline in participants with this disorder. Methods We did an academic, multicentre, randomised, single-blind, placebo-controlled, parallel-group trial in five hospitals in Italy. Adult (>18 years) patients with estimated glomerular filtration rate (GFR) of 40 mL/min per 1.73 m(2) or higher were randomly assigned (central allocation by phone with a computerised list, 1:1 ratio, stratified by centre, block size four and eight) to 3 year treatment with two 20 mg intramuscular injections of octreotide-LAR (n=40) or 0.9% sodium chloride solution (n=39) every 28 days. Study physicians and nurses were aware of the allocated group; participants and outcome assessors were masked to allocation. The primary endpoint was change in total kidney volume (TKV), measured by MRI, at 1 year and 3 year follow-up. Analyses were by modified intention to treat. This study is registered with ClinicalTrials.gov, NCT00309283. Findings Recruitment was between April 27, 2006, and May 12, 2008. 38 patients in the octreotide-LAR group and 37 patients in the placebo group had evaluable MRI scans at 1 year follow-up, at this timepoint, mean TKV increased significantly less in the octreotide-LAR group (46.2 mL, SE 18.2) compared with the placebo group (143.7 mL, 26.0; p=0.032). 35 patients in each group had evaluable MRI scans at 3 year follow-up, at this timepoint, mean TKV increase in the octreotide-LAR group (220.1 mL, 49.1) was numerically smaller than in the placebo group (454.3 mL, 80.8), but the difference was not significant (p=0.25). 37 (92.5%) participants in the octreotide-LAR group and 32 (82.1%) in the placebo group had at least one adverse event (p=0.16). Participants with serious adverse events were similarly distributed in the two treatment groups. However, four cases of cholelithiasis or acute cholecystitis occurred in the octreotide-LAR group and were probably treatment-related. Interpretation These findings provide the background for large randomised controlled trials to test the protective effect of somatostatin analogues against renal function loss and progression to end-stage kidney disease.	[Caroli, Anna; Perico, Norberto; Perna, Annalisa; Antiga, Luca; Gaspari, Flavio; Carrara, Fabiola; Rubis, Nadia; Prandini, Silvia; Remuzzi, Andrea; Remuzzi, Giuseppe; Ruggenenti, Piero] IRCCS Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis, I-24126 Bergamo, Italy; [Brambilla, Paolo] Azienda Osped Papa Giovanni XXIII, Radiol Unit, Bergamo, Italy; [Pisani, Antonio; Visciano, Bianca] Univ Naples Federico II, Cattedra Nefrol, Naples, Italy; [Imbriaco, Massimo] Univ Naples Federico II, Unita Radiol, Naples, Italy; [Messa, Piergiorgio; Cerutti, Roberta] Osped Maggiore Policlin IRCCS Milano, Unita Nefrol & Dialisi, Milan, Italy; [Dugo, Mauro] Osped Ca Foncello, Unita Nefrol & Dialisi, Treviso, Italy; [Cancian, Luca] Osped Ca Foncello, Unita Radiol, Treviso, Italy; [Buongiorno, Erasmo; De Pascalis, Antonio] Osped V Fazzi, Unita Nefrol & Dialisi, Lecce, Italy; [Remuzzi, Giuseppe; Ruggenenti, Piero] Azienda Osped Papa Giovanni XXIII, Unit Nephrol & Dialysis, Bergamo, Italy; [Remuzzi, Andrea] Univ Bergamo, Dept Ind Engn, Bergamo, Italy; [Antiga, Luca] Orobix Srl, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Naples Federico II; University of Naples Federico II; IRCCS Ca Granda Ospedale Maggiore Policlinico; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; ASST Papa Giovanni XXIII; University of Bergamo	Remuzzi, G (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Sci & Technol Pk,Kilometro Rosso Via Stezzano 87, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Perico, Norberto/ABH-3222-2020; Caroli, Anna/AAA-6454-2020; De Pascalis, Antonio/ABA-8988-2020; Cerutti, Roberta/Z-5807-2019; Ene-Iordache, Bogdan/C-6824-2018; Carrara, Fabiola/ABF-4666-2020; Perna, Annalisa/AAC-1323-2020; Rubis, Nadia/ABF-4293-2020; Prandini, Silvi/ABG-7735-2020; Remuzzi, Andrea/F-2409-2015; Remuzzi, Giuseppe/V-9766-2017	Perico, Norberto/0000-0002-3147-4327; Caroli, Anna/0000-0002-4130-4663; De Pascalis, Antonio/0000-0003-1685-7263; Ene-Iordache, Bogdan/0000-0002-4011-9343; Carrara, Fabiola/0000-0002-5799-9535; Perna, Annalisa/0000-0002-9257-0283; Prandini, Silvi/0000-0001-9337-9512; Imbriaco, Massimo/0000-0001-5262-5430; Cerutti, Roberta/0000-0002-3570-4070; PISANI, Antonio/0000-0003-0241-8323; Trillini, Matias/0000-0003-1859-1729; Remuzzi, Andrea/0000-0002-4301-8927; Remuzzi, Giuseppe/0000-0002-6194-3446	Polycystic Kidney Disease Foundation	Polycystic Kidney Disease Foundation	Funding Polycystic Kidney Disease Foundation.	ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; BIGGWITHER GW, 1992, BRIT MED J, V304, P1611, DOI 10.1136/bmj.304.6842.1611; BROUHARD BH, 1987, J PEDIATR-US, V110, P729, DOI 10.1016/S0022-3476(87)80011-2; Caroli A, 2010, CLIN J AM SOC NEPHRO, V5, P783, DOI 10.2215/CJN.05380709; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; De Leo V, 2001, FERTIL STERIL, V75, P632, DOI 10.1016/S0015-0282(00)01738-6; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; GINES A, 1992, GASTROENTEROLOGY, V103, P1868, DOI 10.1016/0016-5085(92)91446-B; Giustina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036411; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Grantham JJ, 2003, KIDNEY INT, V64, P1157, DOI 10.1046/j.1523-1755.2003.00242.x; Grantham JJ, 1997, KIDNEY INT, pS93; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Helal I, 2011, CLIN J AM SOC NEPHRO, V6, P2439, DOI 10.2215/CJN.01010211; Hogan MC, 2012, NEPHROL DIAL TRANSPL, V27, P3532, DOI 10.1093/ndt/gfs152; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Irazabal MV, 2011, KIDNEY INT, V80, P295, DOI 10.1038/ki.2011.119; Koenig JA, 1997, BRIT J PHARMACOL, V120, P52, DOI 10.1038/sj.bjp.0700859; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Miniero R, 2012, J PEDIAT HEMATOL ONC, V34, P407, DOI 10.1097/MPH.0b013e318253f082; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; REUBI JC, 1993, J CLIN ENDOCR METAB, V77, P1323, DOI 10.1210/jc.77.5.1323; Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Ruggenenti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032533; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Silva P, 1991, B MT DESERT ISL BIOL, V40, P25; Sullivan LP, 1998, J AM SOC NEPHROL, V9, P903; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; US Food and Drug Administration, 2013, SAMSC TOLV DRUG WARN; Van Keimpema L, 2009, GASTROENTEROLOGY, V137, P1661, DOI 10.1053/j.gastro.2009.07.052; VORA J, 1987, J CLIN ENDOCR METAB, V64, P975, DOI 10.1210/jcem-64-5-975; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491	37	176	183	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1485	1495		10.1016/S0140-6736(13)61407-5	http://dx.doi.org/10.1016/S0140-6736(13)61407-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	23972263				2022-12-28	WOS:000326622500026
J	Barnett, AH; Huisman, H; Jones, R; von Eynatten, M; Patel, S; Woerle, HJ				Barnett, Anthony H.; Huisman, Holger; Jones, Russell; von Eynatten, Maximilian; Patel, Sanjay; Woerle, Hans-Juergen			Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							ELDERLY-PATIENTS; CLINICAL-PRACTICE; GLYCEMIC CONTROL; WORKING PARTY; PEOPLE EDWPOP; ADD-ON; HYPOGLYCEMIA; MELLITUS; METFORMIN; EFFICACY	Background A substantial proportion of patients with type 2 diabetes are elderly (>= 65 years) but this group has been largely excluded from clinical studies of glucose-lowering drugs. We aimed to assess the effectiveness of linagliptin, a dipeptidyl peptidase-4 inhibitor, in elderly patients with type 2 diabetes. Methods In this randomised, double-blind, parallel-group, multinational phase 3 study, patients aged 70 years or older with type 2 diabetes, glycated haemoglobin A(1c) (HbA(1c)) of 7.0% or more, receiving metformin, sulfonylureas, or basal insulin, or combinations of these drugs, were randomised (by computer-generated randomisation sequence, concealed with a voice-response system, stratified by HbA(1c) level [<8.5% vs >= 8.5%] and insulin use [yes vs no], block size four) in a 2: 1 ratio to once-daily oral treatment with linagliptin 5 mg or matching placebo for 24 weeks. Investigators and participants were masked to assignment throughout the study. The primary endpoint was change in HbA(1c) from baseline to week 24. This trial is registered with ClinicalTrials.gov, number NCT01084005. Findings 241 community-living outpatients were randomised (162 linagliptin, 79 placebo). Mean age was 74.9 years (SD 4.3). Mean HbA(1c) was 7.8% (SD 0.8). At week 24, placebo-adjusted mean change in HbA(1c) with linagliptin was -0.64% (95% CI -0.81 to -0.48, p<0.0001). Overall safety and tolerability were much the same between the linagliptin and placebo groups; 75.9% of patients in both groups had an adverse event (linagliptin n=123, placebo n=60). No deaths occurred. Serious adverse events occurred in 8.6% (14) of patients in the linagliptin group and 6.3% (five) patients in the placebo group; none were deemed related to study drug. Hypoglycaemia was the most common adverse event in both groups, but did not differ between groups (24.1% [39] in the linagliptin group, 16.5% [13] in the placebo group; odds ratio 1.58, 95% CI 0.78-3.78, p=0.2083). Interpretation In elderly patients with type 2 diabetes linagliptin was efficacious in lowering glucose with a safety profile similar to placebo. These findings could inform treatment decisions for achieving individualised glycaemic goals with minimal risk in this important population of patients.	[Barnett, Anthony H.] Heart England NHS Fdn Trust, Ctr Diabet, Birmingham B9 5SS, W Midlands, England; [Barnett, Anthony H.] Univ Birmingham, Birmingham, W Midlands, England; [Huisman, Holger] Boehringer Ingelheim GmbH & Co KG, Alkmaar, Netherlands; [Jones, Russell; Patel, Sanjay] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England; [von Eynatten, Maximilian; Woerle, Hans-Juergen] Boehringer Ingelheim KG, Ingelheim, Germany	Heart of England NHS Foundation Trust; University of Birmingham; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Barnett, AH (corresponding author), Heart England NHS Fdn Trust, Ctr Diabet, Birmingham B9 5SS, W Midlands, England.	anthony.barnett@heartofengland.nhs.uk	Woerle, Hans/ABE-1013-2021		Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Boehringer Ingelheim.	Barzilai N, 2011, CURR MED RES OPIN, V27, P1049, DOI 10.1185/03007995.2011.568059; Bron M, 2012, POSTGRAD MED, V124, P124, DOI 10.3810/pgm.2012.01.2525; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Cerreta F, 2012, NEW ENGL J MED, V367, P1972, DOI 10.1056/NEJMp1209034; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Del Prato S, 2011, DIABETES OBES METAB, V13, P258, DOI 10.1111/j.1463-1326.2010.01350.x; Fravel MA, 2011, AM J HEALTH-SYST PH, V68, P500, DOI 10.2146/ajhp080085; Gallwitz B, 2013, INT J CLIN PRACT, V67, P317, DOI 10.1111/ijcp.12101; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; Gomis R, 2011, DIABETES OBES METAB, V13, P653, DOI 10.1111/j.1463-1326.2011.01391.x; Graefe-Mody U, 2012, CLIN PHARMACOKINET, V51, P411, DOI 10.2165/11630900-000000000-00000; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Herrera AP, 2010, AM J PUBLIC HEALTH, V100, pS105, DOI 10.2105/AJPH.2009.162982; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holstein A, 2010, EXPERT OPIN DRUG SAF, V9, P675, DOI 10.1517/14740338.2010.492777; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369; Kawamori R, 2012, DIABETES OBES METAB, V14, P348, DOI 10.1111/j.1463-1326.2011.01545.x; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Lakey WC, 2013, DIABETOLOGIA, V56, P1226, DOI 10.1007/s00125-013-2890-4; Luchsinger JA, 2012, J ALZHEIMERS DIS, V30, pS185, DOI 10.3233/JAD-2012-111433; MENEILLY GS, 1994, J CLIN ENDOCR METAB, V78, P1341, DOI 10.1210/jc.78.6.1341; Owens DR, 2011, DIABETIC MED, V28, P1352, DOI 10.1111/j.1464-5491.2011.03387.x; Patel S, 2011, DIABETOLOGIA, V54, pS339; Rosenstock J, 2013, DIABETES OBES METAB, V15, P906, DOI 10.1111/dom.12102; Rosenstock J, 2013, DIABETES VASC DIS RE, V10, P289, DOI 10.1177/1479164112475102; Schejter YD, 2012, J AM MED DIR ASSOC, V13, P234, DOI 10.1016/j.jamda.2010.07.014; Schweizer A, 2009, DIABETES OBES METAB, V11, P804, DOI 10.1111/j.1463-1326.2009.01051.x; Schweizer Anja, 2012, Diabetes Ther, V3, P8, DOI 10.1007/s13300-012-0008-5; Simeone JC, 2012, ANN PHARMACOTHER, V46, P157, DOI 10.1345/aph.1Q352; Sinclair A, 2012, J AM MED DIR ASSOC, V13, P497, DOI 10.1016/j.jamda.2012.04.012; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Strain WD, 2013, LANCET, V382, P409, DOI 10.1016/S0140-6736(13)60995-2; Taskinen MR, 2011, DIABETES OBES METAB, V13, P65, DOI 10.1111/j.1463-1326.2010.01326.x; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	35	125	134	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1413	1423		10.1016/S0140-6736(13)61500-7	http://dx.doi.org/10.1016/S0140-6736(13)61500-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	23948125				2022-12-28	WOS:000326237500026
J	Lam, TTY; Wang, J; Shen, YY; Zhou, BP; Duan, L; Cheung, CL; Ma, C; Lycett, SJ; Leung, CYH; Chen, XC; Li, LF; Hong, WS; Chai, YJ; Zhou, LL; Liang, HY; Ou, ZH; Liu, YM; Farooqui, A; Kelvin, DJ; Poon, LLM; Smith, DK; Pybus, OG; Leung, GM; Shu, YL; Webster, RG; Webby, RJ; Peiris, JSM; Rambaut, A; Zhu, HC; Guan, Y				Lam, Tommy Tsan-Yuk; Wang, Jia; Shen, Yongyi; Zhou, Boping; Duan, Lian; Cheung, Chung-Lam; Ma, Chi; Lycett, Samantha J.; Leung, Connie Yin-Hung; Chen, Xinchun; Li, Lifeng; Hong, Wenshan; Chai, Yujuan; Zhou, Linlin; Liang, Huyi; Ou, Zhihua; Liu, Yongmei; Farooqui, Amber; Kelvin, David J.; Poon, Leo L. M.; Smith, David K.; Pybus, Oliver G.; Leung, Gabriel M.; Shu, Yuelong; Webster, Robert G.; Webby, Richard J.; Peiris, Joseph S. M.; Rambaut, Andrew; Zhu, Huachen; Guan, Yi			The genesis and source of the H7N9 influenza viruses causing human infections in China	NATURE			English	Article							PHYLOGENETIC ANALYSIS; RECEPTOR-BINDING; SOUTHERN CHINA; ESTABLISHMENT; TRANSMISSION; SEQUENCES; ACCURACY; MODELS; ORIGIN; DUCKS	A novel H7N9 influenza A virus first detected in March 2013 has since caused more than 130 human infections in China, resulting in 40 deaths(1,2). Preliminary analyses suggest that the virus is a reassortant of H7, N9 and H9N2 avian influenza viruses, and carries some amino acids associated with mammalian receptor binding, raising concerns of a new pandemic(1,3,4). However, neither the source populations of the H7N9 outbreak lineage nor the conditions for its genesis are fully known(5). Using a combination of active surveillance, screening of virus archives, and evolutionary analyses, here we show that H7 viruses probably transferred from domestic duck to chicken populations in China on at least two independent occasions. We show that the H7 viruses subsequently reassorted with enzootic H9N2 viruses to generate the H7N9 outbreak lineage, and a related previously unrecognized H7N7 lineage. The H7N9 outbreak lineage has spread over a large geographic region and is prevalent in chickens at live poultry markets, which are thought to be the immediate source of human infections. Whether the H7N9 outbreak lineage has, or will, become enzootic in China and neighbouring regions requires further investigation. The discovery here of a related H7N7 influenza virus in chickens that has the ability to infect mammals experimentally, suggests that H7 viruses may pose threats beyond the current outbreak. The continuing prevalence of H7 viruses in poultry could lead to the generation of highly pathogenic variants and further sporadic human infections, with a continued risk of the virus acquiring human-to-human transmissibility.	[Lam, Tommy Tsan-Yuk; Wang, Jia; Shen, Yongyi; Ma, Chi; Li, Lifeng; Hong, Wenshan; Liang, Huyi; Ou, Zhihua; Liu, Yongmei; Smith, David K.; Leung, Gabriel M.; Zhu, Huachen; Guan, Yi] Shantou Univ, Coll Med, Joint Influenza Res Ctr SUMC HKU, Shantou 515041, Peoples R China; [Lam, Tommy Tsan-Yuk; Zhou, Boping; Duan, Lian; Chen, Xinchun; Li, Lifeng; Chai, Yujuan; Liang, Huyi; Ou, Zhihua; Poon, Leo L. M.; Peiris, Joseph S. M.; Zhu, Huachen; Guan, Yi] Shenzhen Third Peoples Hosp, HKU Shenzhen Branch, State Key Lab Emerging Infect Dis, Shenzhen 518112, Peoples R China; [Lam, Tommy Tsan-Yuk; Wang, Jia; Shen, Yongyi; Duan, Lian; Cheung, Chung-Lam; Ma, Chi; Leung, Connie Yin-Hung; Li, Lifeng; Chai, Yujuan; Zhou, Linlin; Liang, Huyi; Ou, Zhihua; Liu, Yongmei; Poon, Leo L. M.; Smith, David K.; Leung, Gabriel M.; Peiris, Joseph S. M.; Zhu, Huachen; Guan, Yi] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Shen, Yongyi] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China; [Lycett, Samantha J.; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Farooqui, Amber; Kelvin, David J.] Shantou Univ, Coll Med, Joint Vaccine Res Ctr SUMC UHN, Shantou 515041, Peoples R China; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA; [Shu, Yuelong] Natl Hlth & Family Planning Commiss, Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Beijing 102206, Peoples R China; [Webster, Robert G.; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Shantou University; University of Hong Kong; Xiamen University; University of Edinburgh; Shantou University; University of Oxford; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Zhu, HC (corresponding author), Shantou Univ, Coll Med, Joint Influenza Res Ctr SUMC HKU, Shantou 515041, Peoples R China.	zhuhch@hku.hk; yguan@hku.hk	Lycett, Samantha/F-9598-2013; Webby, Richard J/N-5657-2018; Shen, Yongyi/GWU-8031-2022; Pybus, Oliver G/B-2640-2012; Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020; Zhu, Huachen/A-8252-2017; Ou, Zhihua/AAX-1882-2020; Rambaut, Andrew/B-2481-2009; Cheung, Yiu Man/T-2708-2019; Lam, Tsan Yuk/D-4837-2012	Lycett, Samantha/0000-0003-3159-596X; Pybus, Oliver G/0000-0002-8797-2667; Poon, Leo Lit Man/0000-0002-9101-7953; Zhu, Huachen/0000-0003-2711-0501; Ou, Zhihua/0000-0002-1479-9007; Rambaut, Andrew/0000-0003-4337-3707; Farooqui, Amber/0000-0002-6031-9561; Guan, Yi/0000-0001-6057-9243; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Leung, Gabriel/0000-0002-2503-6283; Lam, Tsan Yuk/0000-0002-9769-1527; Leung, Connie YH/0000-0003-1102-4684; Smith, David/0000-0003-3608-0586; Shen, Yongyi/0000-0001-7660-5522	National Institutes of Health (National Institute of Allergy and Infectious Diseases) [HSN266200700005C]; Li Ka Shing Foundation; University Grants Committee of the Hong Kong SAR [AoE/M-12/06]; Shenzhen Peacock Plan High-End Talents Program [KQTD201203]; University Development Fund (HKU); Innovation and Technology Commission of the Hong Kong Government; Newton International Fellowship of the Royal Society; US Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project [GHN-A-OO-09-00010-00]; European Union [278433-PREDEMICS]; ERC [260864]; Wellcome Trust [092807]; Biotechnology and Biological Sciences Research Council [BB/E009670/1] Funding Source: researchfish; BBSRC [BB/E009670/1] Funding Source: UKRI	National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Li Ka Shing Foundation; University Grants Committee of the Hong Kong SAR; Shenzhen Peacock Plan High-End Talents Program; University Development Fund (HKU); Innovation and Technology Commission of the Hong Kong Government; Newton International Fellowship of the Royal Society; US Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project(United States Agency for International Development (USAID)); European Union(European Commission); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank our colleagues from the Joint Influenza Research Centre (SUMC/HKU) and the State Key Laboratory of Emerging Infectious Diseases for their technical assistance. This study was supported by the National Institutes of Health (National Institute of Allergy and Infectious Diseases contract HSN266200700005C), Li Ka Shing Foundation, the Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR (grant AoE/M-12/06), Shenzhen Peacock Plan High-End Talents Program (KQTD201203), the University Development Fund (HKU) and the Innovation and Technology Commission of the Hong Kong Government. T.T.-Y.L. was supported in part by a Newton International Fellowship of the Royal Society. Metabiota's involvement was supported by the US Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project, under the terms of Cooperative Agreement Number GHN-A-OO-09-00010-00. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no. 278433-PREDEMICS, ERC Grant agreement no. 260864 and the Wellcome Trust (grant 092807) to A. R. and S.J.L.	Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Cheung CL, 2007, J VIROL, V81, P10402, DOI 10.1128/JVI.01157-07; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duan LA, 2011, INFLUENZA OTHER RESP, V5, P65; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Huang K, 2012, J VIROL, V86, P6075, DOI 10.1128/JVI.06389-11; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lam TTY, 2013, INFECT GENET EVOL, V18, P367, DOI 10.1016/j.meegid.2013.03.015; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shortridge KF, 2000, VET MICROBIOL, V74, P141, DOI 10.1016/S0378-1135(00)00174-7; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; World Health Organization, 2013, NUMB CONF HUM CAS AV; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	28	336	370	5	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					241	+		10.1038/nature12515	http://dx.doi.org/10.1038/nature12515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	23965623	Green Accepted			2022-12-28	WOS:000325436100052
J	Qi, L; Qi, QB; Prudente, S; Mendonca, C; Andreozzi, F; di Pietro, N; Sturma, M; Novelli, V; Mannino, GC; Formoso, G; Gervino, EV; Hauser, TH; Muehlschlegel, JD; Niewczas, MA; Krolewski, AS; Biolo, G; Pandolfi, A; Rimm, E; Sesti, G; Trischitta, V; Hu, F; Doria, A				Qi, Lu; Qi, Qibin; Prudente, Sabrina; Mendonca, Christine; Andreozzi, Francesco; di Pietro, Natalia; Sturma, Mariella; Novelli, Valeria; Mannino, Gaia Chiara; Formoso, Gloria; Gervino, Ernest V.; Hauser, Thomas H.; Muehlschlegel, Jochen D.; Niewczas, Monika A.; Krolewski, Andrzej S.; Biolo, Gianni; Pandolfi, Assunta; Rimm, Eric; Sesti, Giorgio; Trischitta, Vincenzo; Hu, Frank; Doria, Alessandro			Association Between a Genetic Variant Related to Glutamic Acid Metabolism and Coronary Heart Disease in Individuals With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; GLUCAGON-LIKE PEPTIDE-1; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; RISK; SUSCEPTIBILITY; METAANALYSIS; GLUTATHIONE; PREVENTION; LOCUS	IMPORTANCE Diabetes is associated with an elevated risk of coronary heart disease (CHD). Previous studies have suggested that the genetic factors predisposing to excess cardiovascular risk may be different in diabetic and nondiabetic individuals. OBJECTIVE To identify genetic determinants of CHD that are specific to patients with diabetes. DESIGN, SETTING, AND PARTICIPANTS We studied 5 independent sets of CHD cases and CHD-negative controls from the Nurses' Health Study (enrolled in 1976 and followed up through 2008), Health Professionals Follow-up Study (enrolled in 1986 and followed up through 2008), Joslin Heart Study (enrolled in 2001-2008), Gargano Heart Study (enrolled in 2001-2008), and Catanzaro Study (enrolled in 2004-2010). Included were a total of 1517 CHD cases and 2671 CHD-negative controls, all with type 2 diabetes. Results in diabetic patients were compared with those in 737 nondiabetic CHD cases and 1637 nondiabetic CHD-negative controls from the Nurses' Health Study and Health Professionals Follow-up Study cohorts. Exposures included 2 543 016 common genetic variants occurring throughout the genome. MAIN OUTCOMES AND MEASURES Coronary heart disease-defined as fatal or nonfatal myocardial infarction, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, or angiographic evidence of significant stenosis of the coronary arteries. RESULTS A variant on chromosome 1q25 (rs10911021) was consistently associated with CHD risk among diabetic participants, with risk allele frequencies of 0.733 in cases vs 0.679 in controls (odds ratio, 1.36 [95% CI, 1.22-1.51]; P = 2 x 10(-8)). No association between this variant and CHD was detected among nondiabetic participants, with risk allele frequencies of 0.697 in cases vs 0.696 in controls (odds ratio, 0.99 [95% CI, 0.87-1.13]; P = .89), consistent with a significant gene x diabetes interaction on CHD risk (P = 2 x 10(-4)). Compared with protective allele homozygotes, rs10911021 risk allele homozygotes were characterized by a 32% decrease in the expression of the neighboring glutamate-ammonia ligase (GLUL) gene in human endothelial cells (P = .0048). A decreased ratio between plasma levels of gamma-glutamyl cycle intermediates pyroglutamic and glutamic acid was also shown in risk allele homozygotes (P = .029). CONCLUSION AND RELEVANCE A single-nucleotide polymorphism (rs10911021) was identified that was significantly associated with CHD among persons with diabetes but not in those without diabetes and was functionally related to glutamic acid metabolism, suggesting a mechanistic link.	[Qi, Lu; Qi, Qibin; Rimm, Eric; Hu, Frank] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Rimm, Eric; Hu, Frank] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Qi, Lu; Rimm, Eric; Hu, Frank] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Prudente, Sabrina; Trischitta, Vincenzo] IRCSS Casa Sollievo Sofferenza Mendel Lab, San Giovanni Rotondo, Italy; [Mendonca, Christine; Novelli, Valeria; Mannino, Gaia Chiara; Niewczas, Monika A.; Krolewski, Andrzej S.; Doria, Alessandro] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Andreozzi, Francesco; Mannino, Gaia Chiara; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [di Pietro, Natalia; Pandolfi, Assunta] Univ G DAnnunzio, Dept Expt & Clin Sci, Aging Res Ctr, G dAnnunzio Univ Fdn, Chieti, Italy; [Sturma, Mariella; Biolo, Gianni] Univ Trieste, Dept Med Surg & Hlth Sci, I-34127 Trieste, Italy; [Novelli, Valeria; Gervino, Ernest V.; Hauser, Thomas H.; Muehlschlegel, Jochen D.; Niewczas, Monika A.; Krolewski, Andrzej S.; Doria, Alessandro] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Formoso, Gloria] Univ G DAnnunzio, Dept Med & Aging Sci, Aging Res Ctr, G dAnnunzio Univ Fdn, Chieti, Italy; [Gervino, Ernest V.; Hauser, Thomas H.] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Muehlschlegel, Jochen D.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Trischitta, Vincenzo] IRCSS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Harvard University; Joslin Diabetes Center, Inc.; Magna Graecia University of Catanzaro; G d'Annunzio University of Chieti-Pescara; University of Trieste; Harvard University; Harvard Medical School; G d'Annunzio University of Chieti-Pescara; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome	Qi, L (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	nhlqi@channing.harvard.edu; alessandro.doria@joslin.harvard.edu	Prudente, Sabrina/H-2886-2016; pandolfi, assunta/K-4595-2016; Muehlschlegel, Danny/A-2993-2011; Di Pietro, Natalia/K-1604-2016; Mannino, Gaia C/K-1580-2016; Trischitta, Vincenzo/K-1487-2016; Biolo, Gianni/AAB-4983-2022; Sesti, Giorgio/B-1509-2012; Doria, Alessandro/H-9157-2018; Andreozzi, Francesco/J-4073-2018	Prudente, Sabrina/0000-0001-9220-8981; pandolfi, assunta/0000-0003-4135-7631; Di Pietro, Natalia/0000-0001-9720-2116; Mannino, Gaia C/0000-0002-6341-4572; Trischitta, Vincenzo/0000-0003-1174-127X; Doria, Alessandro/0000-0002-3830-4304; novelli, valeria/0000-0002-4859-0826; Sesti, Giorgio/0000-0002-1618-7688; BIOLO, GIANNI/0000-0002-6397-1598; Muehlschlegel, Jochen/0000-0002-6209-7253; Andreozzi, Francesco/0000-0001-9375-1513	National Institutes of Health [HL071981, DK091718, HL073168, DK046200, DK36836]; American Heart Association Scientist Development Award [0730094N]; Italian Ministry of Health ("Ricerca Corrente"); Fondazione Roma ("Sostegno alla ricerca scientifica biomedica"); National Institutes of Health Research Facilities Improvement Program from the National Center for Research Resources [RR10600-01, CA62528-01, RR14514-01]; NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014514, C06RR010600] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168, R01HL118266, R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK091718, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Award(American Heart Association); Italian Ministry of Health ("Ricerca Corrente")(Ministry of Health, Italy); Fondazione Roma ("Sostegno alla ricerca scientifica biomedica")(Fondazione Roma); National Institutes of Health Research Facilities Improvement Program from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants HL071981, DK091718, HL073168, DK046200 (Boston Obesity Nutrition Research Center), and DK36836 (Genetics Core of the Diabetes Research Center at the Joslin Diabetes Center) from the National Institutes of Health, an American Heart Association Scientist Development Award (0730094N), a grant from the Italian Ministry of Health ("Ricerca Corrente 2011 e 2012"), and a grant from Fondazione Roma ("Sostegno alla ricerca scientifica biomedica 2008"). A portion of this work was conducted in a facility constructed with support from the National Institutes of Health Research Facilities Improvement Program (RR10600-01, CA62528-01, RR14514-01) from the National Center for Research Resources.	Assimes TL, 2010, J AM COLL CARDIOL, V56, P1552, DOI 10.1016/j.jacc.2010.06.022; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bacci S, 2005, DIABETES, V54, P3021, DOI 10.2337/diabetes.54.10.3021; Biolo G, 2008, AM J CLIN NUTR, V88, P950, DOI 10.1093/ajcn/88.4.950; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doria A, 2008, JAMA-J AM MED ASSOC, V300, P2389, DOI 10.1001/jama.2008.649; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; GORFIEN S, 1993, EXP CELL RES, V206, P291, DOI 10.1006/excr.1993.1149; Greenfield JR, 2009, AM J CLIN NUTR, V89, P106, DOI 10.3945/ajcn.2008.26362; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; International Diabetes Federation, IDF DIAB; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1951; Lauzier B, 2013, J MOL CELL CARDIOL, V55, P92, DOI 10.1016/j.yjmcc.2012.11.008; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lomivorotov VV, 2011, HEART SURG FORUM, V14, pE384, DOI 10.1532/HSF98.20111074; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MEISTER A, 1976, ANNU REV BIOCHEM, V45, P559, DOI 10.1146/annurev.bi.45.070176.003015; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Newsholme Philip, 2012, Clin Biochem Rev, V33, P35; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Polonsky KS, 2012, NEW ENGL J MED, V367, P1332, DOI 10.1056/NEJMra1110560; Qi L, 2011, J AM COLL CARDIOL, V58, P2675, DOI 10.1016/j.jacc.2011.08.054; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2013, DIABETES CARE, V36, P737, DOI 10.2337/dc12-0852; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Samocha-Bonet D, 2011, J NUTR, V141, P1233, DOI 10.3945/jn.111.139824; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sharma R, 2011, ATHEROSCLEROSIS, V216, P157, DOI 10.1016/j.atherosclerosis.2011.01.022; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith NL, 2010, CIRC-CARDIOVASC GENE, V3, P256, DOI 10.1161/CIRCGENETICS.109.895763; Sufit A, 2012, JPEN-PARENTER ENTER, V36, P556, DOI 10.1177/0148607112448823; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; von Schacky C, 2000, AM J CLIN NUTR, V71, p224S, DOI 10.1093/ajcn/71.1.224s; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; YOSHIDA K, 1995, DIABETOLOGIA, V38, P201, DOI 10.1007/s001250050271	51	91	93	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					821	828		10.1001/jama.2013.276305	http://dx.doi.org/10.1001/jama.2013.276305			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982368	Green Accepted, Bronze			2022-12-28	WOS:000323561400022
J	Rodriguez-Lado, L; Sun, GF; Berg, M; Zhang, Q; Xue, HB; Zheng, QM; Johnson, CA				Rodriguez-Lado, Luis; Sun, Guifan; Berg, Michael; Zhang, Qiang; Xue, Hanbin; Zheng, Quanmei; Johnson, C. Annette			Groundwater Arsenic Contamination Throughout China	SCIENCE			English	Article							DRINKING-WATER; DATONG BASIN; AQUIFERS; MOBILIZATION; HISTORY; PLAIN; COAL	Arsenic-contaminated groundwater used for drinking in China is a health threat that was first recognized in the 1960s. However, because of the sheer size of the country, millions of groundwater wells remain to be tested in order to determine the magnitude of the problem. We developed a statistical risk model that classifies safe and unsafe areas with respect to geogenic arsenic contamination in China, using the threshold of 10 micrograms per liter, the World Health Organization guideline and current Chinese standard for drinking water. We estimate that 19.6 million people are at risk of being affected by the consumption of arsenic-contaminated groundwater. Although the results must be confirmed with additional field measurements, our risk model identifies numerous arsenic-affected areas and highlights the potential magnitude of this health threat in China.	[Rodriguez-Lado, Luis; Berg, Michael; Xue, Hanbin; Johnson, C. Annette] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Sun, Guifan; Zhang, Qiang; Zheng, Quanmei] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang 110001, Peoples R China	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); China Medical University	Johnson, CA (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.	annette.johnson@eawag.ch	Berg, Michael/C-3738-2012; Rodríguez-Lado, Luis/O-8563-2016	Berg, Michael/0000-0002-7342-4061; Rodríguez-Lado, Luis/0000-0002-0090-2405	Swiss State Secretariat for Education and Research [IZLCZ2 123971]; National Science and Technology Pillar Program of China [2006BAI06B04]; Chinese Academy of Sciences; Xunta de Galicia (Spain)	Swiss State Secretariat for Education and Research; National Science and Technology Pillar Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Xunta de Galicia (Spain)(Xunta de Galicia)	Supported by the Sino-Swiss Science and Technology Cooperation Program of the Swiss State Secretariat for Education and Research (project IZLCZ2 123971), the National Science and Technology Pillar Program of China during the 11th Five-Year Plan Period (contract grant no. 2006BAI06B04), and the External Cooperation Program of the Chinese Academy of Sciences. We thank G.-B. Jiang and J. Shi of the Research Center for Eco-Environmental Sciences, Beijing, for support and data collection in the initial phase of the project. L.R.-L. also acknowledges the Isidro Parga Pondal research program from the Xunta de Galicia (Spain) for current financial support. Additional data are available at www.eawag.ch/repository/remarc.	Amini M, 2008, ENVIRON SCI TECHNOL, V42, P3669, DOI 10.1021/es702859e; Bian JM, 2012, J GEOCHEM EXPLOR, V112, P347, DOI 10.1016/j.gexplo.2011.10.003; Currell M, 2011, APPL GEOCHEM, V26, P540, DOI 10.1016/j.apgeochem.2011.01.012; Deng YM, 2009, APPL GEOCHEM, V24, P587, DOI 10.1016/j.apgeochem.2008.12.018; Dochartaigh B. E. O., 2006, GROUNDWATER DEGRADAT; Edmunds WM, 2006, APPL GEOCHEM, V21, P2148, DOI 10.1016/j.apgeochem.2006.07.016; Guo HM, 2005, J GEOCHEM EXPLOR, V87, P109, DOI 10.1016/j.gexplo.2005.08.002; Guo HM, 2010, CHEM GEOL, V270, P117, DOI 10.1016/j.chemgeo.2009.11.010; Guo JX, 2007, J ENVIRON SCI HEAL A, V42, P1853, DOI 10.1080/10934520701566918; Hagiwara H, 2011, APPL GEOCHEM, V26, P380, DOI 10.1016/j.apgeochem.2010.12.011; Han SB, 2010, GEOCHIM COSMOCHIM AC, V74, pA378; Jin Yinlong, 2003, Wei Sheng Yan Jiu, V32, P519; Lado LR, 2008, APPL GEOCHEM, V23, P3010, DOI 10.1016/j.apgeochem.2008.06.028; Lee JJ, 2009, ENVIRON SCI TECHNOL, V43, P6662, DOI 10.1021/es900540s; Li SH, 2012, SCI TOTAL ENVIRON, V421, P31, DOI 10.1016/j.scitotenv.2011.02.040; Liu J, 2002, ENVIRON HEALTH PERSP, V110, P119, DOI 10.1289/ehp.02110119; Mead MN, 2005, ENVIRON HEALTH PERSP, V113, pA378, DOI 10.1289/ehp.113-a378; Qiu J, 2011, SCIENCE, V334, P745, DOI 10.1126/science.334.6057.745; Smedley PL, 2003, APPL GEOCHEM, V18, P1453, DOI 10.1016/S0883-2927(03)00062-3; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Sun GF, 2004, TOXICOL APPL PHARM, V198, P268, DOI 10.1016/j.taap.2003.10.017; Sun GF, 2001, ARSENIC EXPOSURE AND HEALTH EFFECTS IV, P79; Sun GF, 2011, KAOHSIUNG J MED SCI, V27, P377, DOI 10.1016/j.kjms.2011.05.004; TSENG WP, 1968, J NATL CANCER I, V40, P453; Winkel L, 2008, NAT GEOSCI, V1, P536, DOI 10.1038/ngeo254; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Xia YJ, 2004, TOXICOLOGY, V198, P25, DOI 10.1016/j.tox.2004.01.016; Xie XJ, 2013, CHEMOSPHERE, V90, P1878, DOI 10.1016/j.chemosphere.2012.10.012; Yu GQ, 2007, ENVIRON HEALTH PERSP, V115, P636, DOI 10.1289/ehp.9268; Zhang LH, 2007, PROC MONOGR ENG WATE, P1299	30	602	679	128	1225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					866	868		10.1126/science.1237484	http://dx.doi.org/10.1126/science.1237484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970694	Green Accepted			2022-12-28	WOS:000323370600036
J	Kohler, HR; Triebskorn, R				Koehler, Heinz-R.; Triebskorn, Rita			Wildlife Ecotoxicology of Pesticides: Can We Track Effects to the Population Level and Beyond?	SCIENCE			English	Review							DECREASES FORAGING SUCCESS; ENVIRONMENTAL CHEMICALS; CHIRONOMUS-RIPARIUS; TRANSGENIC CROPS; RISK-ASSESSMENT; EXPOSURE; INSECTICIDES; HERBICIDE; IMPACT; IMMUNOTOXICITY	During the past 50 years, the human population has more than doubled and global agricultural production has similarly risen. However, the productive arable area has increased by just 10%; thus the increased use of pesticides has been a consequence of the demands of human population growth, and its impact has reached global significance. Although we often know a pesticide's mode of action in the target species, we still largely do not understand the full impact of unintended side effects on wildlife, particularly at higher levels of biological organization: populations, communities, and ecosystems. In these times of regional and global species declines, we are challenged with the task of causally linking knowledge about the molecular actions of pesticides to their possible interference with biological processes, in order to develop reliable predictions about the consequences of pesticide use, and misuse, in a rapidly changing world.	[Koehler, Heinz-R.; Triebskorn, Rita] Univ Tubingen, Inst Evolut & Ecol, D-72072 Tubingen, Germany; [Triebskorn, Rita] Transfer Ctr Ecotoxicol & Ecophysiol, D-72108 Rottenburg, Germany	Eberhard Karls University of Tubingen	Kohler, HR (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Konrad Adenauer Str 20, D-72072 Tubingen, Germany.	heinz-r.koehler@uni-tuebingen.de	Köhler, Heinz-R./AAL-1350-2021					Adams S. M., 2002, BIOL INDICATORS AQUA; Amano T, 2011, ECOL LETT, V14, P1263, DOI 10.1111/j.1461-0248.2011.01699.x; Bandouchova H, 2011, NEUROENDOCRINOL LETT, V32, P77; Barnett EA, 2007, PEST MANAG SCI, V63, P1051, DOI 10.1002/ps.1444; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bernanke J, 2009, REV ENVIRON CONTAM T, V198, P1, DOI 10.1007/978-0-387-09647-6_1; Berny P, 2007, J VET PHARMACOL THER, V30, P93, DOI 10.1111/j.1365-2885.2007.00836.x; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bright J.A., 2008, 28 RSPB CTR CONS SCI; Brodman R, 2010, J HERPETOL, V44, P69, DOI 10.1670/08-320.1; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; Bruhl CA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01135; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cahill JF, 2008, ECOLOGY, V89, P1791, DOI 10.1890/07-0719.1; Clark BW, 2005, J AGR FOOD CHEM, V53, P4643, DOI 10.1021/jf040442k; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Committee on Ecological Risk Assessment Under FIFRA and ESA; Board on Environmental Studies and Toxicology Division on Earth and Life Studies; National Research Council, 2013, ASS RISKS END THREAT; Crain DA, 1998, ANIM REPROD SCI, V53, P77, DOI 10.1016/S0378-4320(98)00128-6; Cresswell JE, 2012, SCIENCE, V337, DOI 10.1126/science.1224618; de Snoo GR, 1999, PESTIC SCI, V55, P47, DOI 10.1002/(SICI)1096-9063(199901)55:1&lt;47::AID-PS859&gt;3.0.CO;2-#; DeLorenzo ME, 2001, ENVIRON TOXICOL CHEM, V20, P84, DOI [10.1897/1551-5028(2001)020&lt;0084:TOPTAM&gt;2.0.CO;2, 10.1002/etc.5620200108]; Devine GJ, 2007, AGR HUM VALUES, V24, P281, DOI 10.1007/s10460-007-9067-z; Egea-Serrano A, 2012, ECOL EVOL, V2, P1382, DOI 10.1002/ece3.249; Engelman CA, 2012, ECOL MODEL, V224, P90, DOI 10.1016/j.ecolmodel.2011.10.017; Farooqui T, 2013, NEUROCHEM INT, V62, P122, DOI 10.1016/j.neuint.2012.09.020; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Fleischli MA, 2004, ARCH ENVIRON CON TOX, V46, P542, DOI 10.1007/s00244-003-3065-y; FREEMARK K, 1995, AGR ECOSYST ENVIRON, V52, P67, DOI 10.1016/0167-8809(94)00534-L; FRY DM, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432528; Galloway T, 2003, ECOTOXICOLOGY, V12, P345, DOI 10.1023/A:1022579416322; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Gawade L, 2013, FOOD CHEM TOXICOL, V51, P61, DOI 10.1016/j.fct.2012.09.009; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Hamlin HJ, 2010, SYST BIOL REPROD MED, V56, P113, DOI 10.3109/19396360903244598; Hanazato T, 1998, ENVIRON POLLUT, V101, P361, DOI 10.1016/S0269-7491(98)00053-0; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Hayes TB, 2010, P NATL ACAD SCI USA, V107, P4612, DOI 10.1073/pnas.0909519107; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; KENDALL MD, 1992, SCI TOTAL ENVIRON, V115, P133, DOI 10.1016/0048-9697(92)90038-T; Kiesecker JM, 2011, ECOL RES, V26, P897, DOI 10.1007/s11284-010-0702-6; Koprivnikar J, 2012, J WILDLIFE DIS, V48, P925, DOI 10.7589/2011-09-258; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Langer-Jaesrich M, 2010, ECOTOXICOLOGY, V19, P1294, DOI 10.1007/s10646-010-0516-x; Lew S, 2013, ARCH ENVIRON CON TOX, V64, P399, DOI 10.1007/s00244-012-9852-6; Lew S, 2009, FRESEN ENVIRON BULL, V18, P1390; Lin PC, 2013, BASIC CLIN PHARMACOL, V112, P282, DOI 10.1111/bcpt.12027; Macneale KH, 2010, FRONT ECOL ENVIRON, V8, P475, DOI 10.1890/090142; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Manosa S, 2001, ENVIRON MONIT ASSESS, V71, P187, DOI 10.1023/A:1017545932219; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; McKinlay R, 2008, ENVIRON INT, V34, P168, DOI 10.1016/j.envint.2007.07.013; Muller R, 2012, ECOL EVOL, V2, P196, DOI 10.1002/ece3.71; Muir D, 1999, SCI TOTAL ENVIRON, V230, P83, DOI 10.1016/S0048-9697(99)00037-6; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006; Oelmann Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003869; OKA IN, 1976, SCIENCE, V193, P239, DOI 10.1126/science.193.4249.239; Parepa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2632; Paskova V, 2011, REV ENVIRON CONTAM T, V211, P25, DOI 10.1007/978-1-4419-8011-3_2; Pesce S, 2011, REV ENVIRON CONTAM T, V214, P87, DOI 10.1007/978-1-4614-0668-6_5; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; PIZL V, 1985, PEDOBIOLOGIA, V28, P399; Rattner BA, 2009, ECOTOXICOLOGY, V18, P773, DOI 10.1007/s10646-009-0354-x; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Rodrigues ARS, 2013, BIOL CONTROL, V64, P217, DOI 10.1016/j.biocontrol.2012.11.018; Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Sayyed AH, 2010, PESTIC BIOCHEM PHYS, V98, P325, DOI 10.1016/j.pestbp.2010.07.004; Scholz NL, 2012, BIOSCIENCE, V62, P428, DOI 10.1525/bio.2012.62.4.13; Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Stark JD, 2012, ACS SYM SER, V1111, P259; Starner K., 2011, 248 CAL ENV PROT AG; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Story P, 2001, WILDLIFE RES, V28, P179, DOI 10.1071/WR99060; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Triebskorn R, 2003, HUM ECOL RISK ASSESS, V9, P171, DOI 10.1080/713609858; TROTTER DM, 1991, CRIT REV ENV CONTR, V21, P137, DOI 10.1080/10643389109388412; Turusov V, 2002, ENVIRON HEALTH PERSP, V110, P125, DOI 10.1289/ehp.02110125; Van Wijngaarden RPA, 2005, ECOTOXICOLOGY, V14, P355, DOI 10.1007/s10646-004-6371-x; Walker CH, 2003, ECOTOXICOLOGY, V12, P307, DOI 10.1023/A:1022523331343; Wennergren U, 2000, ECOL APPL, V10, P295, DOI 10.1890/1051-0761(2000)010[0295:MLTEOP]2.0.CO;2; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P125	88	466	482	19	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					759	765		10.1126/science.1237591	http://dx.doi.org/10.1126/science.1237591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950533				2022-12-28	WOS:000323122200040
J	Kleiner, RE; Kapoor, TM				Kleiner, Ralph E.; Kapoor, Tarun M.			Bumping Up Kinase Activity with an ATP-Derived Neo-Substrate	CELL			English	Editorial Material							PARKINSONS-DISEASE; MITOCHONDRIA	Pharmacologic agents capable of increasing kinase function would be useful for treating diseases associated with reduced kinase activity, such as inherited forms of Parkinson's disease. In this issue, Hertz et al. report an innovative approach for activating the Parkinson's-associated kinase PINK1 in cells with an ATP-derived neo-substrate.	[Kleiner, Ralph E.; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA	Rockefeller University	Kleiner, RE (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA.	rkleiner@rockefeller.edu; kapoor@rockefeller.edu						Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Simpson GL, 2009, CURR OPIN DRUG DISC, V12, P585; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x	10	2	2	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					716	718		10.1016/j.cell.2013.07.043	http://dx.doi.org/10.1016/j.cell.2013.07.043			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953104	Bronze			2022-12-28	WOS:000323202500002
J	Steffen, L; Salathe, Y; Oppliger, M; Kurpiers, P; Baur, M; Lang, C; Eichler, C; Puebla-Hellmann, G; Fedorov, A; Wallraff, A				Steffen, L.; Salathe, Y.; Oppliger, M.; Kurpiers, P.; Baur, M.; Lang, C.; Eichler, C.; Puebla-Hellmann, G.; Fedorov, A.; Wallraff, A.			Deterministic quantum teleportation with feed-forward in a solid state system	NATURE			English	Article							ENTANGLEMENT; COMPUTATION; INFORMATION; QUBITS	Engineered macroscopic quantum systems based on superconducting electronic circuits are attractive for experimentally exploring diverse questions in quantum information science(1-3). At the current state of the art, quantum bits (qubits) are fabricated, initialized, controlled, read out and coupled to each other in simple circuits. This enables the realization of basic logic gates(4), the creation of complex entangled states(5,6) and the demonstration of algorithms(7) or error correction(8). Using different variants of low-noise parametric amplifiers(9), dispersive quantum non-demolition single-shot readout of single-qubit states with high fidelity has enabled continuous(10) and discrete(11) feedback control of single qubits. Here we realize full deterministic quantum teleportation with feed-forward in a chip-based superconducting circuit architecture(12-14). We use a set of two parametric amplifiers for both joint two-qubit and individual qubit single-shot readout, combined with flexible real-time digital electronics. Our device uses a crossed quantum bus technology that allows us to create complex networks with arbitrary connecting topology in a planar architecture. The deterministic teleportation process succeeds with order unit probability for any input state, as we prepare maximally entangled two-qubit states as a resource and distinguish all Bell states in a single two-qubit measurement with high efficiency and high fidelity. We teleport quantum states between two macroscopic systems separated by 6 mm at a rate of 10(4) s(-1), exceeding other reported implementations. The low transmission loss of superconducting waveguides is likely to enable the range of this and other schemes to be extended to significantly larger distances, enabling tests of non-locality and the realization of elements for quantum communication at microwave frequencies. The demonstrated feed-forward may also find application in error correction schemes.	[Steffen, L.; Salathe, Y.; Oppliger, M.; Kurpiers, P.; Baur, M.; Lang, C.; Eichler, C.; Puebla-Hellmann, G.; Fedorov, A.; Wallraff, A.] ETH, Dept Phys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Steffen, L (corresponding author), ETH, Dept Phys, CH-8093 Zurich, Switzerland.	lsteffen@phys.ethz.ch; andreas.wallraff@phys.ethz.ch	Fedorov, Arkady/F-4764-2012; Wallraff, Andreas J/C-2130-2009; Fedorov, Arkady/AAW-6070-2021; Eichler, Christopher/AAU-1816-2020	Fedorov, Arkady/0000-0002-9815-0968; Wallraff, Andreas J/0000-0002-3476-4485; Fedorov, Arkady/0000-0002-9815-0968; 	Eidgenossische Technische Hochschule Zurich (ETH Zurich); EU Integrated Project SOLID; EU Integrated Project SCALEQIT; Swiss National Science Foundation's National Centre of Competence in Research 'Quantum Science Technology'	Eidgenossische Technische Hochschule Zurich (ETH Zurich); EU Integrated Project SOLID; EU Integrated Project SCALEQIT; Swiss National Science Foundation's National Centre of Competence in Research 'Quantum Science Technology'	We thank A. Blais, F. Marquardt, S. Filipp and R. Renner for discussion and feedback; and J. Heinsoo, L. Heinzle, A. Landig, Y. Liu, F. Luthi and T. Menke for technical contributions to the experimental work. This work was supported financially by Eidgenossische Technische Hochschule Zurich (ETH Zurich), the EU Integrated Projects SOLID and SCALEQIT, and the Swiss National Science Foundation's National Centre of Competence in Research 'Quantum Science & Technology'.	Baur M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.040502; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Campagne-Ibarcq P, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021008; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Chow JM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.090502; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Eichler C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.113601; Eichler C, 2013, ARXIV13056583; Filipp S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200402; Fink JM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.083601; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Gambetta JM, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012308; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Goppl M, 2008, J APPL PHYS, V104, DOI 10.1063/1.3010859; Helmer F, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/50007; Houck AA, 2012, NAT PHYS, V8, P292, DOI [10.1038/nphys2251, 10.1038/NPHYS2251]; Johnson JE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.050506; Kim YH, 2001, PHYS REV LETT, V86, P1370, DOI 10.1103/PhysRevLett.86.1370; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Mariantoni M, 2011, SCIENCE, V334, P61, DOI 10.1126/science.1208517; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Motzoi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.110501; Murch KW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183602; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Nolleke C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140403; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.050507; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Strauch FW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167005; van Enk SJ, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052318; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851	46	164	167	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					319	+		10.1038/nature12422	http://dx.doi.org/10.1038/nature12422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23955231	Green Submitted			2022-12-28	WOS:000323112400029
J	Spence, D				Spence, Des			Charging patients fees is bad medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Borland S, 2013, DAILY MAIL; Kahn JG, 2005, HEALTH AFFAIR, V24, P1629, DOI 10.1377/hlthaff.24.6.1629	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2013	347								f5007	10.1136/bmj.f5007	http://dx.doi.org/10.1136/bmj.f5007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203WU	23940292				2022-12-28	WOS:000323326000004
J	Bobrow, M				Bobrow, Martin			Balancing privacy with public benefit	NATURE			English	Editorial Material									Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Bobrow, M (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	mb238@cam.ac.uk							0	10	10	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					123	123		10.1038/500123a	http://dx.doi.org/10.1038/500123a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197CH	23925206	Bronze			2022-12-28	WOS:000322825500003
J	Chan, CH; Morrow, JK; Li, CF; Gao, Y; Jin, GX; Moten, A; Stagg, LJ; Ladbury, JE; Cai, Z; Xu, DZ; Logothetis, CJ; Hung, MC; Zhang, SX; Lin, HK				Chan, Chia-Hsin; Morrow, John Kenneth; Li, Chien-Feng; Gao, Yuan; Jin, Guoxiang; Moten, Asad; Stagg, Loren J.; Ladbury, John E.; Cai, Zhen; Xu, Dazhi; Logothetis, Christopher J.; Hung, Mien-Chie; Zhang, Shuxing; Lin, Hui-Kuan			Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression	CELL			English	Article							TUMOR-INITIATING CELLS; DOWN-REGULATION; DEGRADATION; EXPRESSION; PROTEIN; AKT; PROLIFERATION; INHIBITOR; DISCOVERY; APOPTOSIS	Skp2 E3 ligase is overexpressed in numerous human cancers and plays a critical role in cell-cycle progression, senescence, metabolism, cancer progression, and metastasis. In the present study, we identified a specific Skp2 inhibitor using high-throughput in silico screening of large and diverse chemical libraries. This Skp2 inhibitor selectively suppresses Skp2 E3 ligase activity, but not activity of other SCF complexes. It also phenocopies the effects observed upon genetic Skp2 deficiency, such as suppressing survival and Akt-mediated glycolysis and triggering p53-independent cellular senescence. Strikingly, we discovered a critical function of Skp2 in positively regulating cancer stem cell populations and self-renewal ability through genetic and pharmacological approaches. Notably, Skp2 inhibitor exhibits potent antitumor activities in multiple animal models and cooperates with chemotherapeutic agents to reduce cancer cell survival. Our study thus provides pharmacological evidence that Skp2 is a promising target for restricting cancer stem cell and cancer progression.	[Chan, Chia-Hsin; Gao, Yuan; Jin, Guoxiang; Moten, Asad; Cai, Zhen; Xu, Dazhi; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Morrow, John Kenneth; Zhang, Shuxing] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Stagg, Loren J.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Logothetis, Christopher J.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Morrow, John Kenneth; Gao, Yuan; Hung, Mien-Chie; Zhang, Shuxing; Lin, Hui-Kuan] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Li, Chien-Feng] Chi Mei Fdn Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Li, Chien-Feng] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan; [Moten, Asad] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chi Mei Hospital; National Health Research Institutes - Taiwan; Harvard University; China Medical University Taiwan; China Medical University Taiwan	Zhang, SX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	shuzhang@mdanderson.org; hklin@mdanderson.org	Chan, Chia-Hsin/AAT-7782-2020; Zhang, Shuxing/F-9942-2014; Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Chan, Chia-Hsin/0000-0001-8506-7500; Li, Chien-Feng/0000-0002-9527-7576; Morrow, John/0000-0002-7190-0466; Ladbury, John/0000-0002-6328-7200	MDACC support grant [CA016672]; MDACC Trust Scholar Award; MDACC Prostate SPORE development award [P50 CA140388]; National Institutes of Health grants; American Cancer Society [IRG-08-061-01]; MDACC Prostate SPORE career award; MDACC-UT Austin CTT-TI3D grants; MDACC Breast SPORE career development award; Susan G. Komen Foundation postdoctoral fellowship award [PDF12230504]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA140388, R01CA149321, R01CA136787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079588] Funding Source: NIH RePORTER	MDACC support grant; MDACC Trust Scholar Award; MDACC Prostate SPORE development award; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); MDACC Prostate SPORE career award; MDACC-UT Austin CTT-TI3D grants; MDACC Breast SPORE career development award; Susan G. Komen Foundation postdoctoral fellowship award(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. B.A. Schulman for reagents and Dr. David Hawke at the Proteomics Facility of the University of Texas MD Anderson Cancer Center (MDACC) for the support of LC-MS/MS analysis. The pharmacokinetic analysis was supported in part by MDACC support grant CA016672, with special thanks to the Pharmacology and Analytical Facility. This work was supported by the MDACC Trust Scholar Award, the MDACC Prostate SPORE development award (P50 CA140388), National Institutes of Health grants (to H.K.L.), grant IRG-08-061-01 from the American Cancer Society, MDACC Prostate SPORE career award, MDACC-UT Austin CTT-TI3D grants (to S.Z.), and MDACC Breast SPORE career development award and Susan G. Komen Foundation postdoctoral fellowship award (PDF12230504, to C.H.C.).	Ahad AM, 2011, BIOORGAN MED CHEM, V19, P2046, DOI 10.1016/j.bmc.2011.01.049; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chan CH, 2011, J MOL MED, V89, P857, DOI 10.1007/s00109-011-0766-y; Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Du-Cuny L, 2009, BIOORGAN MED CHEM, V17, P6983, DOI 10.1016/j.bmc.2009.08.022; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koch U, 2010, SEMIN CANCER BIOL, V20, P116, DOI 10.1016/j.semcancer.2010.02.003; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Rajan P, 2008, STEM CELL REV, V4, P211, DOI 10.1007/s12015-008-9037-x; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Yadav VR, 2012, J BIOL CHEM, V287, P245, DOI 10.1074/jbc.M111.274613; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yokoi S, 2003, CANCER SCI, V94, P344, DOI 10.1111/j.1349-7006.2003.tb01444.x; Zhang SX, 2007, J COMPUT AID MOL DES, V21, P97, DOI 10.1007/s10822-007-9102-6; Zhang SX, 2011, METHODS MOL BIOL, V716, P23, DOI 10.1007/978-1-61779-012-6_2; Zhang Shuxing, 2009, Int J Bioinform Res Appl, V5, P269, DOI 10.1504/IJBRA.2009.026419; Zhang SX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-126; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	36	270	286	5	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					556	568		10.1016/j.cell.2013.06.048	http://dx.doi.org/10.1016/j.cell.2013.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911321	Bronze, Green Accepted			2022-12-28	WOS:000322629900010
J	Pinkney, TD; Calvert, M; Bartlett, DC; Gheorghe, A; Redman, V; Dowswell, G; Hawkins, W; Mak, T; Youssef, H; Richardson, C; Hornby, S; Magill, L; Haslop, R; Wilson, S; Morton, D				Pinkney, Thomas D.; Calvert, Melanie; Bartlett, David C.; Gheorghe, Adrian; Redman, Val; Dowswell, George; Hawkins, William; Mak, Tony; Youssef, Haney; Richardson, Caroline; Hornby, Steven; Magill, Laura; Haslop, Richard; Wilson, Sue; Morton, Dion		West Midlands Res Collaborative; ROSSINI Trial Investigators	Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE-ASSOCIATED INFECTION; COLORECTAL SURGERY; INCISION SITES; HEALTH; PREVENTION; REDUCE; SURVEILLANCE; DISCHARGE; EUROQOL; RATES	Objective To determine the clinical effectiveness of wound edge protection devices in reducing surgical site infection after abdominal surgery. Design Multicentre observer blinded randomised controlled trial. Participants Patients undergoing laparotomy at 21 UK hospitals. Interventions Standard care or the use of a wound edge protection device during surgery. Main outcome measures Surgical site infection within 30 days of surgery, assessed by blinded clinicians at seven and 30 days and by patient's self report for the intervening period. Secondary outcomes included quality of life, duration of stay in hospital, and the effect of characteristics of the patient and operation on the efficacy of the device. Results 760 patients were enrolled with 382 patients assigned to the device group and 378 to the control group. Six patients in the device group and five in the control group did not undergo laparotomy. Fourteen patients, seven in each group, were lost to follow-up. A total of 184 patients experienced surgical site infection within 30 days of surgery, 91/369 (24.7%) in the device group and 93/366 (25.4%) in the control group (odds ratio 0.97, 95% confidence interval 0.69 to 1.36; P=0.85). This lack of benefit was consistent across wound assessments performed by clinicians and those reported by patients and across all secondary outcomes. In the secondary analyses no subgroup could be identified in which there was evidence of clinical benefit associated with use of the device. Conclusions Wound edge protection devices do not reduce the rate of surgical site infection in patients undergoing laparotomy, and therefore their routine use for this role cannot be recommended.	[Pinkney, Thomas D.; Calvert, Melanie; Bartlett, David C.; Dowswell, George; Hawkins, William; Mak, Tony; Youssef, Haney; Richardson, Caroline; Hornby, Steven; Magill, Laura; Wilson, Sue; Morton, Dion] Old Queen Elizabeth Hosp, West Midlands Res Collaborat, Birmingham, W Midlands, England; [Pinkney, Thomas D.; Morton, Dion] Univ Birmingham, Acad Dept Surg, Birmingham, W Midlands, England; [Calvert, Melanie; Gheorghe, Adrian; Redman, Val; Dowswell, George; Haslop, Richard; Wilson, Sue] Univ Birmingham, Birmingham, W Midlands, England; [Magill, Laura; Morton, Dion] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Pinkney, TD (corresponding author), Old Queen Elizabeth Hosp, West Midlands Res Collaborat, Birmingham, W Midlands, England.	thomas.pinkney@uhb.nhs.uk	Bonney, Glenn Kunnath/U-2111-2017; Lythgoe, Mark/AAX-9895-2020; Calvert, Melanie/F-7055-2011; Pinkney, Thomas/HGA-4022-2022; Futaba, Kaori/M-1323-2018; Lund, Jonathan/K-6631-2019; Bach, Simon P/X-5328-2018; MITTAPALLI, DEVENDER/D-8144-2018	Bonney, Glenn Kunnath/0000-0002-9034-3255; Lythgoe, Mark/0000-0002-8952-7639; Calvert, Melanie/0000-0002-1856-837X; Pinkney, Thomas/0000-0001-7320-6673; Futaba, Kaori/0000-0002-7358-5439; Lund, Jonathan/0000-0001-5195-2181; Bach, Simon P/0000-0001-8412-7241; Tierney, Gillian/0000-0001-8222-0258; Elsey, Elizabeth/0000-0003-0099-145X; Daniels, Ian/0000-0002-9114-0812; MITTAPALLI, DEVENDER/0000-0002-4932-1572; Magill, Laura/0000-0003-2498-8407; Bartlett, David/0000-0001-8564-9420; Bashir, Gareth/0000-0002-8519-8612; Adedeji, Olufunso/0000-0003-2571-3413; Humes, David/0000-0002-7071-4098; Hardman, John/0000-0002-6591-5119	NIHR [PB-PG-1208-18234]; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: researchfish; National Institute for Health Research [PB-PG-1208-18234] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by NIHR; Research for Patient Benefit programme (PB-PG-1208-18234). Wound edge protection devices were provided free of charge by 3M (Bracknell, UK), who also hosted the online e-learning module and quiz. Representatives from 3M did not sit on the trial management group and had no input in trial design, data collection, data analysis, or manuscript synthesis.	[Anonymous], SURV SURG SIT INF EN; Barie PS, 2012, ANN SURG, V255, P1030, DOI 10.1097/SLA.0b013e3182574dd3; Blumetti J, 2007, SURGERY, V142, P704, DOI 10.1016/j.surg.2007.05.012; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bruce J, 2001, Health Technol Assess, V5, P1; Cheng KP, 2012, COLORECTAL DIS, V14, pE346, DOI 10.1111/j.1463-1318.2012.02943.x; Coello R, 2005, J HOSP INFECT, V60, P93, DOI 10.1016/j.jhin.2004.10.019; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Edwards JP, 2012, ANN SURG, V256, P53, DOI 10.1097/SLA.0b013e3182570372; FERRAZ EM, 1995, AM J INFECT CONTROL, V23, P290, DOI 10.1016/0196-6553(95)90059-4; Gheorghe A, 2012, ANN SURG, V255, P1017, DOI 10.1097/SLA.0b013e31823e7411; Health Protection Agency, 2011, SURV SURG SIT INF NH; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Horiuchi T, 2007, J TRAUMA, V62, P212, DOI 10.1097/01.ta.0000196704.78785.ae; Horiuchi T, 2010, SURG INFECT, V11, P501, DOI 10.1089/sur.2009.072; Howard DPJ, 2010, COLORECTAL DIS, V12, P423, DOI 10.1111/j.1463-1318.2009.01817.x; Lee P, 2009, ARCH SURG-CHICAGO, V144, P872, DOI 10.1001/archsurg.2009.151; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Miransky J, 2001, DIS COLON RECTUM, V44, P1100, DOI 10.1007/BF02234629; NYSTROM PO, 1984, DIS COLON RECTUM, V27, P451, DOI 10.1007/BF02555535; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Petherick ES, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-170; Pinkney TD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-217; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; REDMOND HP, 1994, BRIT J SURG, V81, P1811; Reid K, 2010, DIS COLON RECTUM, V53, P1374, DOI 10.1007/DCR.0b013e3181ed3f7e; Serra-Aracil X, 2011, ARCH SURG-CHICAGO, V146, P606, DOI 10.1001/archsurg.2011.90; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Song F, 1998, BRIT J SURG, V85, P1232; Sookhai S, 1999, LANCET, V353, P1585, DOI 10.1016/S0140-6736(99)00950-2; Tanner J, 2009, J HOSP INFECT, V72, P243, DOI 10.1016/j.jhin.2009.03.021; Theodoridis TD, 2011, CLIN EXP OBSTET GYN, V38, P57; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE	33	148	150	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2013	347								f4305	10.1136/bmj.f4305	http://dx.doi.org/10.1136/bmj.f4305			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BI	23903454	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000322822200001
J	Busby, JN; Panjikar, S; Landsberg, MJ; Hurst, MRH; Lott, JS				Busby, Jason N.; Panjikar, Santosh; Landsberg, Michael J.; Hurst, Mark R. H.; Lott, J. Shaun			The BC component of ABC toxins is an RHS-repeat-containing protein encapsulation device	NATURE			English	Article							BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FAMILY; SYSTEM; ACQUISITION; TENEURINS; ELEMENTS; COMPLEX	The ABC toxin complexes produced by certain bacteria are of interest owing to their potent insecticidal activity(1,2) and potential role in human disease(3). These complexes comprise at least three proteins (A, B and C), which must assemble to be fully toxic(4). The carboxyterminal region of the C protein is the main cytotoxic component(5), and is poorly conserved between different toxin complexes. A general model of action has been proposed, in which the toxin complex binds to the cell surface via the A protein, is endocytosed, and subsequently forms a pH-triggered channel, allowing the translocation of C into the cytoplasm, where it can cause cytoskeletal disruption in both insect and mammalian cells(5). Toxin complexes have been visualized using single-particle electron microscopy(6,7), but no high-resolution structures of the components are available, and the role of the B protein in the mechanism of toxicity remains unknown. Here we report the three-dimensional structure of the complex formed between the B and C proteins, determined to 2.5 angstrom by X-ray crystallography. These proteins assemble to form an unprecedented, large hollow structure that encapsulates and sequesters the cytotoxic, C-terminal region of the C protein like the shell of an egg. The shell is decorated on one end by a beta-propeller domain, which mediates attachment of the B-C heterodimer to the A protein in the native complex. The structure reveals how C auto-proteolyses when folded in complex with B. The C protein is the first example, to our knowledge, of a structure that contains rearrangement hotspot (RHS) repeats(8), and illustrates a marked structural architecture that is probably conserved across both this widely distributed bacterial protein family and the related eukaryotic tyrosine-aspartate (YD)-repeat-containing protein family, which includes the teneurins(9). The structure provides the first clues about the function of these protein repeat families, and suggests a generic mechanism for protein encapsulation and delivery.	[Busby, Jason N.; Lott, J. Shaun] Univ Auckland, Sch Biol Sci, AgRes Struct Biol Lab, Auckland 1142, New Zealand; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic 3168, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Landsberg, Michael J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Hurst, Mark R. H.] AgResearch, Lincoln Res Ctr, Innovat Farming Syst, Christchurch 8140, New Zealand	University of Auckland; Monash University; University of Queensland; AgResearch - New Zealand	Lott, JS (corresponding author), Univ Auckland, Sch Biol Sci, AgRes Struct Biol Lab, Auckland 1142, New Zealand.	mark.hurst@agresearch.co.nz; s.lott@auckland.ac.nz	Panjikar, Santosh/D-2709-2012; Hurst, Mark/J-7309-2013; Landsberg, Michael/A-3363-2011; Busby, Jason/D-9607-2013	Panjikar, Santosh/0000-0001-7429-3879; Landsberg, Michael/0000-0002-2464-990X; Busby, Jason/0000-0002-9805-9224; Lott, Shaun/0000-0003-3660-452X; Hurst, Mark/0000-0001-5826-5253	New Zealand Foundation for Research, Science and Technology [C10X0804]	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	We are grateful to M. Sullivan, R. Kingston, T. Baker and many other members of the Structural Biology section at the University of Auckland for discussions, to V. Arcus for initial enthusiasm, and to B. Hankamer for provision of laboratory space at the University of Queensland and for mentorship. This work was supported by the New Zealand Foundation for Research, Science and Technology contract C10X0804, awarded to M. R. H. H. We would like to thank all beamline staff at the MX1, MX2 and SAXS/WAXS beamlines at the Australian Synchrotron for their support, and to the New Zealand Synchrotron Group Ltd for synchrotron access arrangements.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Buetow L, 2001, NAT STRUCT BIOL, V8, P584, DOI 10.1038/89610; Busby JN, 2012, J MOL BIOL, V415, P359, DOI 10.1016/j.jmb.2011.11.018; Chand D, 2013, MOL CELL NEUROSCI, V52, P38, DOI 10.1016/j.mcn.2012.09.006; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; ffrench-Constant RH, 2006, NAT BIOTECHNOL, V24, P660, DOI 10.1038/nbt0606-660; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gatsogiannis C, 2013, NATURE, V495, P520, DOI 10.1038/nature11987; HILL CW, 1994, MOL MICROBIOL, V12, P865, DOI 10.1111/j.1365-2958.1994.tb01074.x; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hurst MRH, 2011, J BACTERIOL, V193, P1966, DOI 10.1128/JB.01044-10; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Landsberg MJ, 2011, P NATL ACAD SCI USA, V108, P20544, DOI 10.1073/pnas.1111155108; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Minet AD, 1999, J CELL SCI, V112, P2019; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro VB, 2007, CELL MICROBIOL, V9, P2372, DOI 10.1111/j.1462-5822.2007.00966.x; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	35	95	104	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					547	+		10.1038/nature12465	http://dx.doi.org/10.1038/nature12465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23913273				2022-12-28	WOS:000324826300058
J	Dorner, M; Horwitz, JA; Donovan, BM; Labitt, RN; Budell, WC; Friling, T; Vogt, A; Catanese, MT; Satoh, T; Kawai, T; Akira, S; Law, M; Rice, CM; Ploss, A				Dorner, Marcus; Horwitz, Joshua A.; Donovan, Bridget M.; Labitt, Rachael N.; Budell, William C.; Friling, Tamar; Vogt, Alexander; Catanese, Maria Teresa; Satoh, Takashi; Kawai, Taro; Akira, Shizuo; Law, Mansun; Rice, Charles M.; Ploss, Alexander			Completion of the entire hepatitis C virus life cycle in genetically humanized mice	NATURE			English	Article							B TYPE-I; TARGETED DISRUPTION; CYCLOPHILIN-A; RNA; INFECTION; CELLS; REPLICATION; EXPRESSION; RECEPTOR; ENTRY	More than 130 million people worldwide chronically infected with hepatitis C virus (HCV) are at risk of developing severe liver disease. Antiviral treatments are only partially effective against HCV infection, and a vaccine is not available. Development of more efficient therapies has been hampered by the lack of a small animal model. Building on the observation that CD81 and occludin (OCLN) comprise the minimal set of human factors required to render mouse cells permissive to HCV entry(1), we previously showed that transient expression of these two human genes is sufficient to allow viral uptake into fully immunocompetent inbred mice(2). Here we demonstrate that transgenic mice stably expressing human CD81 and OCLN also support HCV entry, but innate and adaptive immune responses restrict HCV infection in vivo. Blunting antiviral immunity in genetically humanized mice infected with HCV results in measurable viraemia over several weeks. In mice lacking the essential cellular cofactor cyclophilin A (CypA), HCV RNA replication is markedly diminished, providing genetic evidence that this process is faithfully recapitulated. Using a cell-based fluorescent reporter activated by the NS3-4A protease we visualize HCV infection in single hepatocytes in vivo. Persistently infected mice produce de novo infectious particles, which can be inhibited with directly acting antiviral drug treatment, thereby providing evidence for the completion of the entire HCV life cycle in inbred mice. This genetically humanized mouse model opens new opportunities to dissect genetically HCV infection in vivo and provides an important preclinical platform for testing and prioritizing drug candidates and may also have utility for evaluating vaccine efficacy.	[Dorner, Marcus; Horwitz, Joshua A.; Donovan, Bridget M.; Labitt, Rachael N.; Budell, William C.; Friling, Tamar; Vogt, Alexander; Catanese, Maria Teresa; Rice, Charles M.; Ploss, Alexander] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA; [Satoh, Takashi; Kawai, Taro; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Rockefeller University; Osaka University; Scripps Research Institute	Ploss, A (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ricec@rockefeller.edu; aploss@princeton.edu	Ploss, Alexander/ABG-2330-2020; Akira, Shizuo/C-3134-2009	Ploss, Alexander/0000-0001-9322-7252; Dorner, Marcus/0000-0003-0321-4226; Kawai, Taro/0000-0001-7510-4662; Law, Mansun/0000-0002-8934-9756; Vogt, Alexander/0000-0002-9917-112X	National Institute of Diabetes and Digestive and Kidney Diseases [RC1DK087193]; National Institute for Allergy and Infectious Disease [R01AI072613, R01AI099284]; National Cancer Institute [R01CA057973]; The Starr Foundation; Greenberg Medical Research Institute; Richard Salomon Family Foundation; Ronald A. Shellow, M. D. Memorial Fund; MGM Mirage Voice Foundation; German Research Foundation (Deutsche Forschungsgesellschaft); The Rockefeller University Women & Science Fellowship; Infectious Disease Society of America; American Liver Foundation; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072613, R01AI079031, R01AI099284, R01AI107301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087193] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23689030] Funding Source: KAKEN	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Starr Foundation; Greenberg Medical Research Institute; Richard Salomon Family Foundation; Ronald A. Shellow, M. D. Memorial Fund; MGM Mirage Voice Foundation; German Research Foundation (Deutsche Forschungsgesellschaft)(German Research Foundation (DFG)); The Rockefeller University Women & Science Fellowship; Infectious Disease Society of America; American Liver Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Sable, E. Castillo, B. Flatley, S. Shirley, A. Webson and E. Giang for laboratory support. A. North and the Rockefeller University Bioimaging Core Facility, S. Mazel and the Rockefeller University Flowcytometry Core Facility, C. Yang and the Gene Targeting Center and R. Tolwani and the staff of the Comparative Bioscience Center provided technical support. This study was supported in part by award number RC1DK087193 (to C. M. R. and A. P.) from the National Institute of Diabetes and Digestive and Kidney Diseases, R01AI072613, R01AI099284 (to C. M. R.), R01AI079031 (to M. L.) from the National Institute for Allergy and Infectious Disease, R01CA057973(to C. M. R.) from the National Cancer Institute, The Starr Foundation, the Greenberg Medical Research Institute, the Richard Salomon Family Foundation, the Ronald A. Shellow, M. D. Memorial Fund, the MGM Mirage Voice Foundation, Gregory F. Lloyd Memorial contributions, and anonymous donors. M. D. was supported by a postdoctoral fellowship from the German Research Foundation (Deutsche Forschungsgesellschaft). M. T. C. is a recipient of The Rockefeller University Women & Science Fellowship. A. P. is a recipient of the Astella Young Investigator Award from the Infectious Disease Society of America and a Liver Scholar Award from the American Liver Foundation. The funding sources were not involved in the study design, collection, analysis and interpretation of data or in the writing of the report.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horwitz JA, 2013, VIROLOGY, V439, P23, DOI [10.1016/j.virol.2013.01.019, 10.1016/j.virol.201]; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	41	172	180	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					237	+		10.1038/nature12427	http://dx.doi.org/10.1038/nature12427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23903655	Green Submitted, Green Accepted			2022-12-28	WOS:000324244900044
J	Rosell, R; Bivona, TG; Karachaliou, N				Rosell, Rafael; Bivona, Trever G.; Karachaliou, Niki			Genetics and biomarkers in personalisation of lung cancer treatment	LANCET			English	Article							GROWTH-FACTOR RECEPTOR; EGFR T790M MUTATION; INDUCED APOPTOSIS; ACQUIRED-RESISTANCE; THERAPEUTIC TARGET; PI3K INHIBITORS; MEK INHIBITION; KINASE; PATHWAY; ACTIVATION	Non-small-cell lung cancer is often diagnosed at the metastatic stage, with median survival of just 1 year. The identification of driver mutations in the epidermal growth factor receptor (EGFR) as the primary oncogenic event in a subset of lung adenocarcinomas led to a model of targeted treatment and genetic profiling of the disease. EGFR tyrosine kinase inhibitors confer remission in 60% of patients, but responses are short-lived. The pre-existing EGFR Thr790Met mutation could be a subclonal driver responsible for these transient responses. Overexpression of AXL and reduced MED12 function are hallmarks of resistance to tyrosine kinase inhibitors in EGFR-mutant non-small-cell lung cancer. Crosstalk between signalling pathways is another mechanism of resistance; therefore, identification of the molecular components involved could lead to the development of combination therapies cotargeting these molecules instead of EGFR tyrosine kinase inhibitor monotherapy. Additionally, novel biomarkers could be identified through deep sequencing analysis of serial rebiopsies before and during treatment.	[Rosell, Rafael] Catalan Inst Oncol Badalona, Badalona, Spain; [Rosell, Rafael; Karachaliou, Niki] Pangaea Biotech, Breakthrough Canc Res Unit, Barcelona, Spain; [Rosell, Rafael; Bivona, Trever G.; Karachaliou, Niki] Canc Therapeut Innovat Grp, New York, NY USA; [Bivona, Trever G.] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Karachaliou, Niki] Quiron Dexeus Univ Hosp, Barcelona, Spain	Catalan Institute of Oncology; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rosell, R (corresponding author), Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Med Oncol Serv, Ctra Canyet S-N, Badalona 08916, Barcelona, Spain.	rrosell@iconcologia.net			LaCaixa Foundation; Redes Tematicas de Investigacion en Cancer [RD12/0036/0072]; NIH Director's New Innovator Award; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; American Lung Association; National Lung Cancer Partnership; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; Wendell and Eddi Van Auken; California Institute for Quantitative Biosciences	LaCaixa Foundation(La Caixa Foundation); Redes Tematicas de Investigacion en Cancer; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Lung Association; National Lung Cancer Partnership; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; Wendell and Eddi Van Auken; California Institute for Quantitative Biosciences	Work in RR's laboratory is supported by a grant from LaCaixa Foundation and by a grant from Redes Tematicas de Investigacion en Cancer (RD12/0036/0072). TGB acknowledges research funding support from the following sources: NIH Director's New Innovator Award, Howard Hughes Medical Institute, Doris Duke Charitable Foundation, American Lung Association, National Lung Cancer Partnership, Sidney Kimmel Foundation for Cancer Research, Searle Scholars Program, Wendell and Eddi Van Auken, and California Institute for Quantitative Biosciences. The funding agencies had no role in the drafting of the report or in the decision to publish.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Ammoun S, 2014, ONCOGENE, V33, P336, DOI 10.1038/onc.2012.587; Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Bernards R, 2012, CELL, V151, P465, DOI 10.1016/j.cell.2012.10.014; Bivona T, 2013, J CLIN ONCOL S, V31; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Blakely CM, 2012, CANCER DISCOV, V2, P872, DOI 10.1158/2159-8290.CD-12-0387; Buettner R, 2013, J CLIN ONCOL, V31, P1858, DOI 10.1200/JCO.2012.45.9867; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; CULLEN MH, 1988, BRIT J CANCER, V58, P359, DOI 10.1038/bjc.1988.219; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Drilon A, 2012, LANCET ONCOL, V13, pE418, DOI 10.1016/S1470-2045(12)70291-7; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Fujita Y, 2012, J THORAC ONCOL, V7, P1640, DOI 10.1097/JTO.0b013e3182653d7f; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; He L, 2013, CANCER DISCOV, V3, P324, DOI 10.1158/2159-8290.CD-12-0417; Hegde GV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004438; Heist Rebecca S, 2012, Cancer Cell, V21, DOI 10.1016/j.ccr.2012.03.007; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Konishi J, 2010, ONCOGENE, V29, P589, DOI 10.1038/onc.2009.366; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lam YWF, 2014, OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH, P95, DOI 10.1155/2013/641089; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Little AS, 2013, ONCOGENE, V32, P1207, DOI 10.1038/onc.2012.160; Littlepage LE, 2012, CANCER DISCOV, V2, P638, DOI 10.1158/2159-8290.CD-12-0093; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Nieminen AI, 2013, P NATL ACAD SCI USA, V110, pE1839, DOI 10.1073/pnas.1208530110; Paccez JD, 2013, ONCOGENE, V32, P689, DOI 10.1038/onc.2012.89; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pullamsetti SS, 2013, ONCOGENE, V32, P1121, DOI 10.1038/onc.2012.136; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; Rosell R, 2012, ESMO C VIENN AUSTR S; Rosell R., 2012, MOL BASED DECISION M, P137; Rosell R., 2012, MOL BASED DECISION M, P75; Rosell R, 2013, NEW ENGL J MED, V368, P1551, DOI 10.1056/NEJMcibr1214549; Rosell R, 2012, LANCET ONCOL, V13, P971, DOI 10.1016/S1470-2045(12)70369-8; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Serizawa M, 2013, J THORAC ONCOL, V8, P259, DOI 10.1097/JTO.0b013e318279e942; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Sos ML, 2012, ONCOGENE, V31, P4811, DOI 10.1038/onc.2011.640; Spoerke JM, 2012, CLIN CANCER RES, V18, P6771, DOI 10.1158/1078-0432.CCR-12-2347; Stern HM, 2010, CLIN CANCER RES, V16, P1587, DOI 10.1158/1078-0432.CCR-09-3108; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Tabara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041017; Tanizaki J, 2011, ONCOGENE, V30, P4097, DOI 10.1038/onc.2011.111; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Xargay-Torrent S, 2011, CLIN CANCER RES, V17, P3956, DOI 10.1158/1078-0432.CCR-10-3412; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; Yang X, 2012, P NATL ACAD SCI USA, V109, pE2813, DOI 10.1073/pnas.1204311109; Zander T, 2012, J CLIN ONCOL S, V30; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	96	220	239	2	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					720	731		10.1016/S0140-6736(13)61715-8	http://dx.doi.org/10.1016/S0140-6736(13)61715-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23972815				2022-12-28	WOS:000323542400030
J	Ahima, RS; Lazar, MA				Ahima, Rexford S.; Lazar, Mitchell A.			The Health Risk of Obesity-Better Metrics Imperative	SCIENCE			English	Editorial Material							BODY-MASS INDEX; NORMAL-WEIGHT; MORTALITY; ASSOCIATION; DISEASE; METAANALYSIS; POPULATION; FITNESS; PARADOX; COHORT		[Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ahima, RS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	ahima@mail.med.upenn.edu; lazar@mail.med.upenn.edu	Ahima, Rexford/W-1394-2019; Lazar, Mitchell A/AAF-3738-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01-DK-049210] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P2085, DOI 10.1001/jama.2012.14669; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Hughes V, 2013, NATURE, V497, P428, DOI 10.1038/497428a; Kokkinos P, 2012, DIABETES CARE, V35, P1021, DOI 10.2337/dc11-2407; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lee SH, 2011, CLIN ENDOCRINOL, V75, P475, DOI 10.1111/j.1365-2265.2011.04085.x; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Tseng CH, 2013, ATHEROSCLEROSIS, V226, P186, DOI 10.1016/j.atherosclerosis.2012.09.004; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	18	225	235	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					856	858		10.1126/science.1241244	http://dx.doi.org/10.1126/science.1241244			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MY	23970691				2022-12-28	WOS:000323370600031
J	Hurst, MD; Mudd, SM; Attal, M; Hilley, G				Hurst, Martin D.; Mudd, Simon M.; Attal, Mikael; Hilley, George			Hillslopes Record the Growth and Decay of Landscapes	SCIENCE			English	Article							CARRIZO PLAIN; DENUDATION; CALIFORNIA; SCARPS; UPLIFT	Earth's surface archives the combined history of tectonics and erosion, which tend to roughen landscapes, and sediment transport and deposition, which smooth them. We analyzed hillslope morphology in the tectonically active Dragon's Back Pressure Ridge in California, United States, to assess whether tectonic uplift history can be reconstructed using measurable attributes of hillslope features within landscapes. Hilltop curvature and hillslope relief mirror measured rates of vertical displacement caused by tectonic forcing, and their relationships are consistent with those expected when idealizing hillslope transport as a nonlinear diffusion process. Hilltop curvature lags behind relief in its response to changing erosion rates, allowing growing landscapes to be distinguished from decaying landscapes. Numerical modeling demonstrates that hillslope morphology may be used to infer changes in tectonic rates.	[Hurst, Martin D.; Mudd, Simon M.; Attal, Mikael] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Hurst, Martin D.] British Geol Survey, Nottingham NG12 5GG, England; [Hilley, George] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA	University of Edinburgh; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Stanford University	Hurst, MD (corresponding author), Univ Edinburgh, Sch Geosci, Drummond St, Edinburgh EH8 9XP, Midlothian, Scotland.	mhurst@bgs.ac.uk	Mudd, Simon M/F-8521-2010; Attal, Mikael/H-8127-2013	Mudd, Simon M/0000-0002-1357-8501; Attal, Mikael/0000-0001-8639-6090; Hurst, Martin/0000-0002-9822-076X	National Environmental Research Council [NE/G524128/1]; Carnegie Trust for the Universities of Scotland;  [NE/H001174/1]; Natural Environment Research Council [NE/H001174/1, bgs05002] Funding Source: researchfish; NERC [bgs05002, NE/H001174/1] Funding Source: UKRI	National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Carnegie Trust for the Universities of Scotland; ; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a National Environmental Research Council grant (NE/G524128/1) awarded to M.D.H. and by grant NE/H001174/1 and a grant from the Carnegie Trust for the Universities of Scotland to S.M.M.. Thanks to J. Roering, D. Lague, and M. Ellis for helpful discussions. Three anonymous reviewers provided comments that greatly improved the manuscript. Data are available in either the supplementary materials or at the Community Surface Dynamics Modeling System (http://csdms.colorado.edu/wiki/Main_Page).]	ANDREWS DJ, 1987, J GEOPHYS RES-SOLID, V92, P12857, DOI 10.1029/JB092iB12p12857; Arrowsmith JR, 1998, J GEOPHYS RES-SOL EA, V103, P10141, DOI 10.1029/98JB00505; Binnie SA, 2007, GEOLOGY, V35, P743, DOI 10.1130/G23641A.1; DiBiase RA, 2012, EARTH SURF PROC LAND, V37, P855, DOI 10.1002/esp.3205; DiBiase RA, 2010, EARTH PLANET SC LETT, V289, P134, DOI 10.1016/j.epsl.2009.10.036; Hilley GE, 2008, GEOLOGY, V36, P367, DOI 10.1130/G24517A.1; Hurst MD, 2013, J GEOPHYS RES-EARTH, V118, P832, DOI 10.1002/jgrf.20049; Hurst MD, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002057; Mudd SM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000516; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; Roering JJ, 2007, EARTH PLANET SC LETT, V264, P245, DOI 10.1016/j.epsl.2007.09.035; Whittaker AC, 2012, LITHOSPHERE-US, V4, P160, DOI 10.1130/RF.L003.1	12	50	52	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					868	871		10.1126/science.1241791	http://dx.doi.org/10.1126/science.1241791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970695	Green Accepted			2022-12-28	WOS:000323370600037
J	McCann, KL; Baserga, SJ				McCann, Kathleen L.; Baserga, Susan J.			Mysterious Ribosomopathies	SCIENCE			English	Editorial Material							TRANSLATION; P53		[McCann, Kathleen L.; Baserga, Susan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	McCann, KL (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	susan.baserga@yale.edu		McCann, Kathleen/0000-0002-7144-4851	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM052581, R01GM052581] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29 GM052581, GM 52581, R01 GM052581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Boultwood Jacqueline, 2012, Adv Biol Regul, V52, P196; Burwick N, 2011, SEMIN HEMATOL, V48, P136, DOI 10.1053/j.seminhematol.2011.01.002; Freed EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002892; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Raiser D. M., 2013, LEUKEMIA LYMPHOMA, V1; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579	13	84	85	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					849	850		10.1126/science.1244156	http://dx.doi.org/10.1126/science.1244156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970686	Green Accepted			2022-12-28	WOS:000323370600026
J	Verma, IM				Verma, Inder M.			Gene Therapy That Works	SCIENCE			English	Editorial Material							ACTIVATION; DISEASE		Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.	verma@salk.edu						Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Biasco L, 2012, MOL THER, V20, P709, DOI 10.1038/mt.2011.289; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boelens JJ, 2006, J INHERIT METAB DIS, V29, P413, DOI 10.1007/s10545-005-0258-8; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137	13	35	37	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					853	855		10.1126/science.1242551	http://dx.doi.org/10.1126/science.1242551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970689				2022-12-28	WOS:000323370600029
J	Gelfand, M				Gelfand, Mikhail			What is to be done about Russian science?	NATURE			English	Editorial Material									[Gelfand, Mikhail] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Gelfand, Mikhail] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 117901, Russia	Lomonosov Moscow State University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Gelfand, M (corresponding author), Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia.	mikhail.gelfand@gmail.com	Gelfand, Mikhail S/F-3425-2012	Gelfand, Mikhail/0000-0003-4181-0846					0	2	2	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					379	379		10.1038/500379a	http://dx.doi.org/10.1038/500379a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	203TJ	23969425	Bronze			2022-12-28	WOS:000323316100004
J	Wolfe, SM				Wolfe, Sidney M.			When EMA and FDA decisions conflict: differences in patients or in regulation?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC USA.	Swolfe@citizen.org						Agency EM, 2013, REF MARK AUTH QSIV P; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5291; Colman E, 2010, ADV COMM M PHENT TOP, P4; European Medicines Agency, 2013, WITHDR MARK AUTH APP; FDA, NDA 22529 LORC HYDR, P76; FDA, 2012, CLIN BRIEF DOC END M, P94; FDA, 2012, FDA APPR WEIGHT MAN; FDA Center for Drug Evaluation and Research, 2012, END MET DRUGS ADV CO, p[328, 354]; FDA Center for Drug Evaluation and Research, APPL 022529ORIG1S000, P6; Food and Drug Administration, 2012, MED TARG LONG TERM W; Palatini P, 2009, PROG CARDIOVASC DIS, V52, P1, DOI 10.1016/j.pcad.2009.06.001; Williams G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c824	12	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 22	2013	347								f5140	10.1136/bmj.f5140	http://dx.doi.org/10.1136/bmj.f5140			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207ST	23970394				2022-12-28	WOS:000323624800001
J	Spence, D				Spence, Des			FROM THE FRONTLINE The BMA and its staff's private health cover	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Davies M, 2013, PULSE           0415; Lipworth L, 2007, ANN PLAS SURG, V59, P119, DOI 10.1097/SAP.0b013e318052ac50; McCartney M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2311; Spence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f418; Tims A, 2011, OBSERVER	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2013	347								f5199	10.1136/bmj.f5199	http://dx.doi.org/10.1136/bmj.f5199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SO	23965256				2022-12-28	WOS:000323624300013
J	Tellez, LA; Medina, S; Han, WF; Ferreira, JG; Licona-Limon, P; Ren, XY; Lam, TT; Schwartz, GJ; de Araujo, IE				Tellez, Luis A.; Medina, Sara; Han, Wenfei; Ferreira, Jozelia G.; Licona-Limon, Paula; Ren, Xueying; Lam, TuKiet T.; Schwartz, Gary J.; de Araujo, Ivan E.			A Gut Lipid Messenger Links Excess Dietary Fat to Dopamine Deficiency	SCIENCE			English	Article							BRAIN DOPAMINE; DRUG-ADDICTION; FOOD REWARD; OBESITY; MECHANISMS; RAT; ANANDAMIDE; RELEASE; SEEKING; ABSENCE	Excessive intake of dietary fats leads to diminished brain dopaminergic function. It has been proposed that dopamine deficiency exacerbates obesity by provoking compensatory overfeeding as one way to restore reward sensitivity. However, the physiological mechanisms linking prolonged high-fat intake to dopamine deficiency remain elusive. We show that administering oleoylethanolamine, a gastrointestinal lipid messenger whose synthesis is suppressed after prolonged high-fat exposure, is sufficient to restore gut-stimulated dopamine release in high-fat-fed mice. Administering oleoylethanolamine to high-fat-fed mice also eliminated motivation deficits during flavorless intragastric feeding and increased oral intake of low-fat emulsions. Our findings suggest that high-fat-induced gastrointestinal dysfunctions play a key role in dopamine deficiency and that restoring gut-generated lipid signaling may increase the reward value of less palatable, yet healthier, foods.	[Tellez, Luis A.; Medina, Sara; Han, Wenfei; Ferreira, Jozelia G.; Ren, Xueying; de Araujo, Ivan E.] John B Pierce Lab, New Haven, CT 06519 USA; [Tellez, Luis A.; Han, Wenfei; Ferreira, Jozelia G.; Ren, Xueying; de Araujo, Ivan E.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA; [Han, Wenfei] Tongji Univ, Sch Stomatol, Shanghai 200072, Peoples R China; [Licona-Limon, Paula] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Lam, TuKiet T.] Yale Univ, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06511 USA; [Schwartz, Gary J.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Tongji University; Yale University; Yale University; Yeshiva University; Albert Einstein College of Medicine	de Araujo, IE (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.	iaraujo@jbpierce.org	Ren, Xueying/AAA-9464-2020; Ferreira, Jozelia/C-5724-2015; Ren, Xueying/ABF-8967-2021	Ferreira, Jozelia/0000-0003-0097-3104; Ren, Xueying/0000-0002-6503-0425; Tellez, Luis A/0000-0002-3101-5817; De Araujo, Ivan/0000-0003-3081-3339	Yale Clinical and Translational Science Award [UL1RR024139]; NIH [DC009997, DK085579, DK020541, DK026687]; Ajinomoto USA; Instituto de Ciencia y Tecnologia del Distrito Federal (Mexico) [BI10-164]; China Scholarship Council (CSC) [201206260072]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P60DK020541, R01DK085579, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009997] Funding Source: NIH RePORTER	Yale Clinical and Translational Science Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto USA; Instituto de Ciencia y Tecnologia del Distrito Federal (Mexico); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Freire, M. LoPresti, and T. Abbott for surgical procedures, gut sample preparation, and MS data analysis respectively; Yale Clinical and Translational Science Award (UL1RR024139) for the 4000 QTRAP (AB Sciex) liquid chromatography (LC)-tandem mass spectrometry; and PerkinElmer for the Flexar ultra-high performance LC. I.E.d.A. is funded by NIH grants DC009997 and DK085579 and Ajinomoto USA. G.J.S. is funded by NIH grants DK020541 and DK026687. L. A. T. was supported by Instituto de Ciencia y Tecnologia del Distrito Federal (Mexico) BI10-164. W. H. was supported by China Scholarship Council (CSC) 201206260072.	Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berthoud HR, 2012, P NUTR SOC, V71, P478, DOI 10.1017/S0029665112000602; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; de Araujo IE, 2012, PHYSIOL BEHAV, V106, P394, DOI 10.1016/j.physbeh.2012.02.026; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Di Marzo V, 2004, BIOORGAN MED CHEM, V12, P5161, DOI 10.1016/j.bmc.2004.07.026; Diep TA, 2011, FASEB J, V25, P765, DOI 10.1096/fj.10-166595; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Ferreira JG, 2012, J PHYSIOL-LONDON, V590, P953, DOI 10.1113/jphysiol.2011.218289; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; McCutcheon JE, 2012, SYNAPSE, V66, P346, DOI 10.1002/syn.21519; Murray JE, 2012, NEUROPSYCHOPHARMACOL, V37, P2456, DOI 10.1038/npp.2012.104; Proulx K, 2005, AM J PHYSIOL-REG I, V289, pR729, DOI 10.1152/ajpregu.00029.2005; REED DR, 1990, APPETITE, V14, P219, DOI 10.1016/0195-6663(90)90089-Q; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Sotak BN, 2005, BRAIN RES, V1061, P88, DOI 10.1016/j.brainres.2005.08.053; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65	29	189	192	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					800	802		10.1126/science.1239275	http://dx.doi.org/10.1126/science.1239275			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950538				2022-12-28	WOS:000323122200052
J	Hirschtick, RE				Hirschtick, Robert E.			Scared of Worms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hirschtick, RE (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	rober@northwestern.edu						Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285	2	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					583	584		10.1001/jama.2013.167500	http://dx.doi.org/10.1001/jama.2013.167500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942676				2022-12-28	WOS:000323058400011
J	Muchnik, L; Aral, S; Taylor, SJ				Muchnik, Lev; Aral, Sinan; Taylor, Sean J.			Social Influence Bias: A Randomized Experiment	SCIENCE			English	Article							WORD-OF-MOUTH; NETWORKS; CONTAGION; EMERGENCE; REVIEWS	Our society is increasingly relying on the digitized, aggregated opinions of others to make decisions. We therefore designed and analyzed a large-scale randomized experiment on a social news aggregation Web site to investigate whether knowledge of such aggregates distorts decision-making. Prior ratings created significant bias in individual rating behavior, and positive and negative social influences created asymmetric herding effects. Whereas negative social influence inspired users to correct manipulated ratings, positive social influence increased the likelihood of positive ratings by 32% and created accumulating positive herding that increased final ratings by 25% on average. This positive herding was topic-dependent and affected by whether individuals were viewing the opinions of friends or enemies. A mixture of changing opinion and greater turnout under both manipulations together with a natural tendency to up-vote on the site combined to create the herding effects. Such findings will help interpret collective judgment accurately and avoid social influence bias in collective intelligence in the future.	[Muchnik, Lev] Hebrew Univ Jerusalem, Sch Business Adm, IL-91905 Jerusalem, Israel; [Aral, Sinan] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA; [Taylor, Sean J.] NYU, Stern Sch Business, New York, NY 10012 USA	Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); New York University	Aral, S (corresponding author), MIT, Alfred P Sloan Sch Management, 100 Main St, Cambridge, MA 02142 USA.	sinana@mit.edu		Aral, Sinan/0000-0002-2762-058X; Muchnik, Lev/0000-0002-5011-8336	Microsoft Research faculty fellowship; NSF Career Award [0953832]	Microsoft Research faculty fellowship(Microsoft); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank D. Eckles and D. Watts for invaluable discussions. This work was supported by a Microsoft Research faculty fellowship (S. A.) and by NSF Career Award 0953832 (S. A.). The research was approved by the New York University institutional review board. There are legal obstacles to making the data available and revealing the name of the Web site, but code is available upon request. All of the user data that we analyzed is publically available, except the treatment assignment and the random identifier that links a deidentified user to a vote, and therefore does not contain any other information that cannot be obtained by crawling the Web site. The randomized testing that the Web site performed is covered by the Web site's terms of service. Opt-in permissions were granted by the users when they registered for the Web site. No data on nonregistered users was collected.	Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2011, IEEE INTELL SYST, V26, P91, DOI 10.1109/MIS.2011.89; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Aral S, 2011, MARKET SCI, V30, P217, DOI 10.1287/mksc.1100.0596; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Archak N, 2011, MANAGE SCI, V57, P1485, DOI 10.1287/mnsc.1110.1370; Bakshy E, 2009, 10TH ACM CONFERENCE ON ELECTRONIC COMMERCE - EC 2009, P325; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Cabral L., 2004, W10363 NAT BUR EC RE; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345; Danescu-Niculescu-Mizil C., 2009, WWW, P141, DOI [10.1145/1526709.1526729, DOI 10.1145/1526709.1526729]; Dellarocas C, 2003, MANAGE SCI, V49, P1407, DOI 10.1287/mnsc.49.10.1407.17308; Hidalgo CA, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/4/052; Hirshleifer D., 1995, NEW EC HUMAN BEHAV, P188; Janis IL, 1982, GROUPTHINK PSYCHOL S; Leskovec J, 2006, LECT NOTES ARTIF INT, V3918, P380; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Merton R., 2006, SOCIAL THEORY SOCIAL; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pope DG, 2009, J HEALTH ECON, V28, P1154, DOI 10.1016/j.jhealeco.2009.08.006; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SIMON HA, 1955, BIOMETRIKA, V42, P425; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Wu F, 2008, LECT NOTES COMPUT SC, V5385, P334	29	424	438	21	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					647	651		10.1126/science.1240466	http://dx.doi.org/10.1126/science.1240466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197XC	23929980				2022-12-28	WOS:000322884800036
J	Ayles, H; Muyoyeta, M; Du Toit, E; Schaap, A; Floyd, S; Simwinga, M; Shanaube, K; Chishinga, N; Bond, V; Dunbar, R; De Haas, P; James, A; Gey van Pittius, NC; Claassens, M; Fielding, K; Fenty, J; Sismanidis, C; Hayes, RJ; Beyers, N; Godfrey-Faussett, P				Ayles, Helen; Muyoyeta, Monde; Du Toit, Elizabeth; Schaap, Ab; Floyd, Sian; Simwinga, Musonda; Shanaube, Kwame; Chishinga, Nathaniel; Bond, Virginia; Dunbar, Rory; De Haas, Petra; James, Anelet; Gey van Pittius, Nico C.; Claassens, Mareli; Fielding, Katherine; Fenty, Justin; Sismanidis, Charalampos; Hayes, Richard J.; Beyers, Nulda; Godfrey-Faussett, Peter		ZAMSTAR Team	Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial	LANCET			English	Article							HIGH HIV PREVALENCE; INFECTIOUS TUBERCULOSIS; TB; DISEASE; ZAMBIA; HARARE; RISK	Background Southern Africa has had an unprecedented increase in the burden of tuberculosis, driven by the HIV epidemic. The Zambia, South Africa Tuberculosis and AIDS Reduction (ZAMSTAR) trial examined two public health interventions that aimed to reduce the burden of tuberculosis by facilitating either rapid sputum diagnosis or integrating tuberculosis and HIV services within the community. Methods ZAMSTAR was a community-randomised trial done in Zambia and the Western Cape province of South Africa. Two interventions, community-level enhanced tuberculosis case-fi nding (ECF) and household level tuberculosis-HIV care, were implemented between Aug 1, 2006, and July 31, 2009, and assessed in a 2x2 factorial design between Jan 9, 2010, and Dec 6, 2010. All communities had a strengthened tuberculosis-HIV programme implemented in participating health-care centres. 24 communities, selected according to population size and tuberculosis notifi cation rate, were randomly allocated to one of four study groups using a randomisation schedule stratifi ed by country and baseline prevalence of tuberculous infection: group 1 strengthened tuberculosis-HIV programme at the clinic alone; group 2, clinic plus ECF; group 3, clinic plus household intervention; and group 4, clinic plus ECF and household interventions. The primary outcome was the prevalence of culture-confi rmed pulmonary tuberculosis in adults (>= 18 years), defi ned as Mycobacterium tuberculosis isolated from one respiratory sample, measured 4 years after the start of interventions in a survey of 4000 randomly selected adults in each community in 2010. The secondary outcome was the incidence of tuberculous infection, measured using tuberculin skin testing in a cohort of schoolchildren, a median of 4 years after a baseline survey done before the start of interventions. This trial is registered, number ISRCTN36729271. Findings Prevalence of tuberculosis was evaluated in 64 463 individuals randomly selected from the 24 communities; 894 individuals had active tuberculosis. Averaging over the 24 communities, the geometric mean of tuberculosis prevalence was 832 per 100 000 population. The adjusted prevalence ratio for the comparison of ECF versus non-ECF intervention groups was 1.09 (95% CI 0.86-1.40) and of household versus non-household intervention groups was 0.82 (0.64-1.04). The incidence of tuberculous infection was measured in a cohort of 8809 children, followed up for a median of 4 years; the adjusted rate ratio for ECF versus non-ECF groups was 1.36 (95% CI 0.59-3.14) and for household versus non-household groups was 0.45 (0.20-1.05). Interpretation Although neither intervention led to a statistically signifi cant reduction in tuberculosis, two independent indicators of burden provide some evidence of a reduction in tuberculosis among communities receiving the household intervention. By contrast the ECF intervention had no eff ect on either outcome.	[Ayles, Helen; De Haas, Petra; Godfrey-Faussett, Peter] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Schaap, Ab; Floyd, Sian; Fielding, Katherine; Fenty, Justin; Sismanidis, Charalampos; Hayes, Richard J.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England; [Bond, Virginia] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England; [Ayles, Helen; Muyoyeta, Monde; Schaap, Ab; Simwinga, Musonda; Shanaube, Kwame; Chishinga, Nathaniel; Bond, Virginia] Univ Zambia, ZAMBART Project, Lusaka, Zambia; [Du Toit, Elizabeth; Dunbar, Rory; James, Anelet; Claassens, Mareli; Beyers, Nulda] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa; [Gey van Pittius, Nico C.] Univ Stellenbosch, Fac Med & Hlth Sci, Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Zambia; Stellenbosch University; Stellenbosch University	Ayles, H (corresponding author), ZAMBART Project, POB 50697, Lusaka, Zambia.	helen@zambart.org.zm	van Pittius, Nicolaas C Gey/D-3434-2015; Trajman, Anete/C-7679-2016; Claassens, Mareli/Y-3544-2019	van Pittius, Nicolaas C Gey/0000-0002-8807-4105; Trajman, Anete/0000-0002-4000-4984; Claassens, Mareli/0000-0002-5927-284X; Fielding, Katherine/0000-0002-6524-3754; Shanaube, Kwame/0000-0001-7899-0890; Ayles, Helen/0000-0003-4108-2842; Hayes, Richard/0000-0002-1729-9892	Bill & Melinda Gates Foundation; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Bill & Melinda Gates Foundation.	[Anonymous], 2011, GLOB TUB CONTR 2011; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Ayles H, 2012, 19 C RETR OPP INF 5; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544; Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Feachem RGA, 2004, TROP MED INT HEALTH, V9, P1139, DOI 10.1111/j.1365-3156.2004.01343.x; Flores G, 2005, PEDIATRICS, V116, P1433, DOI 10.1542/peds.2005-0786; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hayes RJ, 2009, INTERD STAT, P3; Health Systems Trust, CAP TOWN TB CONTR PR; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Miller AC, 2010, INT J TUBERC LUNG D, V14, P720; Partnership ST, 2006, GLOB PLAN STOP TB 20; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Sismanidis C, 2008, CLIN TRIALS, V5, P316, DOI 10.1177/1740774508094747; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2012, WHO POL COLL TB HIV	32	145	145	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1183	1194		10.1016/S0140-6736(13)61131-9	http://dx.doi.org/10.1016/S0140-6736(13)61131-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	23915882				2022-12-28	WOS:000325209100023
J	Haitin, Y; Carlson, AE; Zagotta, WN				Haitin, Yoni; Carlson, Anne E.; Zagotta, William N.			The structural mechanism of KCNH-channel regulation by the eag domain	NATURE			English	Article							LONG-QT SYNDROME; HERG POTASSIUM CHANNELS; AMINO-TERMINAL DOMAIN; HUMAN-ETHER; MUTATIONS; DROSOPHILA; DEACTIVATION; PHYSIOLOGY; BINDING; REGION	The KCNH voltage-dependent potassium channels (ether-a-go-go, EAG; EAG-related gene, ERG; EAG-like channels, ELK) are important regulators of cellular excitability(1-3) and have key roles in diseases such as cardiac long QT syndrome type 2 (LQT2)(4), epilepsy(5), schizophrenia(6) and cancer(7). The intracellular domains of KCNH channels are structurally distinct from other voltage-gated channels. The amino-terminal region contains an eag domain, which is composed of a Per-Arnt-Sim (PAS) domain and aPAS-cap domain(8), whereas the carboxy-terminal region contains a cyclic nucleotide-binding homology domain (CNBHD), which is connected to the pore through a C-linker domain. Many disease-causing mutations localize to these specialized intracellular domains, which underlie the unique gating and regulation of KCNH channels(9). It has been suggested that the eag domain may regulate the channel by interacting with either the S4-S5 linker or the CNBHD8,10. Here we present a 2 angstrom resolution crystal structure of the eag domain-CNBHD complex of themouse EAG1 (also known as KCNH1) channel. It displays extensive interactions between the eag domain and the CNBHD, indicating that the regulatory mechanism of the eag domain primarily involves the CNBHD. Notably, the structure reveals that a number of LQT2 mutations at homologous positions in human ERG, in addition to cancer-associated mutations in EAG channels, localize to the eag domain-CNBHD interface. Furthermore, mutations at the interface produced marked effects on channel gating, demonstrating the important physiological role of the eag domain-CNBHD interaction. Our structure of the eag domain-CNBHD complex of mouse EAG1 provides unique insights into the physiological and pathophysiological mechanisms of KCNH channels.	[Haitin, Yoni; Carlson, Anne E.; Zagotta, William N.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	zagotta@uw.edu	Haitin, Yoni/AAQ-4571-2021; Carlson, Anne/I-9495-2019	Haitin, Yoni/0000-0002-1648-6792; Carlson, Anne/0000-0003-2724-1325	National Institutes of Health (NIH) [R01 EY010329]; International Human Frontier Science Program Organization (HFSPO) [LT-001025/2011]; NIH [F32 HL095241]; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Cunnington and S. Camp for technical assistance. We thank the beamline staff at the Advanced Light Source (ALS). We also thank G. Flynn, J. Bankston, M. Puljung and S. Gordon for helpful discussions and critical reading of the manuscript. This work was supported by the National Institutes of Health (NIH) grant R01 EY010329 (W.N.Z.), The International Human Frontier Science Program Organization (HFSPO) long-term postdoctoral fellowship LT-001025/2011 (Y.H.), and NIH grant F32 HL095241 (A.E.C.). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	38	80	83	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					444	+		10.1038/nature12487	http://dx.doi.org/10.1038/nature12487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23975098	Green Accepted			2022-12-28	WOS:000324545700051
J	Hatzivassiliou, G; Haling, JR; Chen, HF; Song, K; Price, S; Heald, R; Hewitt, JFM; Zak, M; Peck, A; Orr, C; Merchant, M; Hoeflich, KP; Chan, J; Luoh, SM; Anderson, DJ; Ludlam, MJC; Wiesmann, C; Ultsch, M; Friedman, LS; Malek, S; Belvin, M				Hatzivassiliou, Georgia; Haling, Jacob R.; Chen, Huifen; Song, Kyung; Price, Steve; Heald, Robert; Hewitt, Joanne F. M.; Zak, Mark; Peck, Ariana; Orr, Christine; Merchant, Mark; Hoeflich, Klaus P.; Chan, Jocelyn; Luoh, Shiuh-Ming; Anderson, Daniel J.; Ludlam, Mary J. C.; Wiesmann, Christian; Ultsch, Mark; Friedman, Lori S.; Malek, Shiva; Belvin, Marcia			Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers	NATURE			English	Article							WILD-TYPE; KINASE ACTIVATION; C-RAF; B-RAF; MUTATIONS; PATHWAYS; PI3K	KRAS and BRAF activating mutations drive tumorigenesis through constitutive activation of the MAPK pathway. As these tumours represent an area of high unmet medical need, multiple allosteric MEK inhibitors, which inhibit MAPK signalling in both genotypes, are being tested in clinical trials. Impressive single-agent activity in BRAF-mutant melanoma has been observed; however, efficacy has been far less robust in KRAS-mutant disease(1). Here we show that, owing to distinct mechanisms regulating MEK activation in KRAS-versus BRAF-driven tumours(2,3), different mechanisms of inhibition are required for optimal antitumour activity in each genotype. Structural and functional analysis illustrates that MEK inhibitors with superior efficacy in KRAS-driven tumours (GDC-0623 and G-573, the former currently in phase I clinical trials) form a strong hydrogen-bond interaction with S212 in MEK that is critical for blocking MEK feedback phosphorylation by wild-type RAF. Conversely, potent inhibition of active, phosphorylated MEK is required for strong inhibition of the MAPK pathway in BRAF-mutant tumours, resulting in superior efficacy in this genotype with GDC-0973 (also known as cobimetinib), a MEK inhibitor currently in phase III clinical trials. Our study highlights that differences in the activation state of MEK in KRAS-mutant tumours versus BRAF-mutant tumours can be exploited through the design of inhibitors that uniquely target these distinct activation states of MEK. These inhibitors are currently being evaluated in clinical trials to determine whether improvements in therapeutic index within KRAS versus BRAF preclinical models translate to improved clinical responses in patients.	[Hatzivassiliou, Georgia; Song, Kyung; Orr, Christine; Merchant, Mark; Hoeflich, Klaus P.; Chan, Jocelyn; Luoh, Shiuh-Ming; Friedman, Lori S.; Belvin, Marcia] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Haling, Jacob R.; Peck, Ariana; Malek, Shiva] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Chen, Huifen; Zak, Mark] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Price, Steve; Heald, Robert; Hewitt, Joanne F. M.] Argenta, Harlow CM19 5TR, Essex, England; [Anderson, Daniel J.; Ludlam, Mary J. C.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Wiesmann, Christian; Ultsch, Mark] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Belvin, M (corresponding author), Genentech Inc, Dept Translat Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	hatzivassiliou.georgia@gene.com; belvin.marcia@gene.com		Wiesmann, Christian/0000-0002-4092-9880; Malek, Shiva/0000-0002-9526-7968; Anderson, Daniel/0000-0002-3249-2439; Merchant, Mark/0000-0003-0690-8581; Peck, Ariana/0000-0002-5940-3897	Department of Energy; National Institutes of Health; National Institute of General Medical Sciences; National Center for Research Resources	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would like to acknowledge the Genentech IVCC group, IVP dosing group, as well as B. Liu and I. Yen and for technical support. SSRL is supported by the Department of Energy, the National Institutes of Health, the National Institute of General Medical Sciences and the National Center for Research Resources.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Chapman MS, 2011, EXPERT OPIN INV DRUG, V20, P209, DOI 10.1517/13543784.2011.548803; Choo EF, 2010, XENOBIOTICA, V40, P751, DOI 10.3109/00498254.2010.514365; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Friday BB, 2008, CANCER RES, V68, P6145, DOI 10.1158/0008-5472.CAN-08-1430; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Gopalbhai K, 2003, J BIOL CHEM, V278, P8118, DOI 10.1074/jbc.M211870200; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heald RA, 2012, J MED CHEM, V55, P4594, DOI 10.1021/jm2017094; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Resing KA, 1998, BIOCHEMISTRY-US, V37, P463, DOI 10.1021/bi971750x; Rice KD, 2012, ACS MED CHEM LETT, V3, P416, DOI 10.1021/ml300049d; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Rosen L, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-4716; Sheth PR, 2011, BIOCHEMISTRY-US, V50, P7964, DOI 10.1021/bi200542r; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498	29	209	218	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					232	236		10.1038/nature12441	http://dx.doi.org/10.1038/nature12441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23934108				2022-12-28	WOS:000324244900043
J	Howe, MW; Tierney, PL; Sandberg, SG; Phillips, PEM; Graybiel, AM				Howe, Mark W.; Tierney, Patrick L.; Sandberg, Stefan G.; Phillips, Paul E. M.; Graybiel, Ann M.			Prolonged dopamine signalling in striatum signals proximity and value of distant rewards	NATURE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; NEURONS; PREDICTION; NAVIGATION; DEPLETION	Predictions about future rewarding events have a powerful influence on behaviour. The phasic spike activity of dopamine-containing neurons, and corresponding dopamine transients in the striatum, are thought to underlie these predictions, encoding positive and negative reward prediction errors(1-5). However, many behaviours are directed towards distant goals, for which transient signals may fail to provide sustained drive. Here we report an extended mode of reward-predictive dopamine signalling in the striatum that emerged as rats moved towards distant goals. These dopamine signals, which were detected with fast-scan cyclic voltammetry (FSCV), gradually increased or-in rare instances-decreased as the animals navigated mazes to reach remote rewards, rather than having phasic or steady tonic profiles. These dopamine increases (ramps) scaled flexibly with both the distance and size of the rewards. During learning, these dopamine signals showed spatial preferences for goals in different locations and readily changed in magnitude to reflect changing values of the distant rewards. Such prolonged dopamine signalling could provide sustained motivational drive, a control mechanism that may be important for normal behaviour and that can be impaired in a range of neurologic and neuropsychiatric disorders.	[Howe, Mark W.; Tierney, Patrick L.; Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Howe, Mark W.; Tierney, Patrick L.; Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Graybiel, AM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	graybiel@mit.edu	Phillips, Paul/E-7813-2013; Phillips, Paul E. M./A-4463-2008	Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026; Graybiel, Ann/0000-0002-4326-7720	US National Institutes of Health (NIH) [R01 MH060379]; National Parkinson Foundation; CHDI Foundation [A-5552]; Stanley H. and Sheila G. Sydney Fund; Mark Gorenberg fellowship; NIH [R01 DA027858, R01 MH079292]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060379, R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027858] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Parkinson Foundation; CHDI Foundation; Stanley H. and Sheila G. Sydney Fund; Mark Gorenberg fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Telian, L. Li, T. Lechina, S. Ng-Evans and N. Hollon for help, and M. J. Kim, K. S. Smith, T. J. Sejnowski, L. G. Gibb and Y. Kubota for their comments. This work was supported by US National Institutes of Health (NIH) grant R01 MH060379 (A. M. G.), National Parkinson Foundation (A. M. G.), CHDI Foundation grant A-5552, the Stanley H. and Sheila G. Sydney Fund (A. M. G.), a Mark Gorenberg fellowship (M. W. H.), and NIH grants R01 DA027858 and R01 MH079292 (P.E.M.P.).	Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Braun AA, 2012, NEUROBIOL LEARN MEM, V97, P402, DOI 10.1016/j.nlm.2012.03.004; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Day JJ, 2010, BIOL PSYCHIAT, V68, P306, DOI 10.1016/j.biopsych.2010.03.026; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Gan JO, 2010, NAT NEUROSCI, V13, P25, DOI 10.1038/nn.2460; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Keithley RB, 2009, TRAC-TREND ANAL CHEM, V28, P1127, DOI 10.1016/j.trac.2009.07.002; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wang LP, 2011, NEURON, V72, P1055, DOI 10.1016/j.neuron.2011.10.019; WHISHAW IQ, 1985, BEHAV BRAIN RES, V18, P11, DOI 10.1016/0166-4328(85)90165-2; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	28	295	296	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					575	+		10.1038/nature12475	http://dx.doi.org/10.1038/nature12475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23913271	Green Submitted, Green Accepted			2022-12-28	WOS:000323625900034
J	Sitas, F; Egger, S; Bradshaw, D; Groenewald, P; Laubscher, R; Kielkowski, D; Peto, R				Sitas, Freddy; Egger, Sam; Bradshaw, Debbie; Groenewald, Pam; Laubscher, Ria; Kielkowski, Danuta; Peto, Richard			Differences among the coloured, white, black, and other South African populations in smoking-attributed mortality at ages 35-74 years: a case-control study of 481 640 deaths	LANCET			English	Article							LUNG-CANCER RISK; HEALTH; TRENDS; AMERICANS	Background The full eventual effects of current smoking patterns cannot yet be seen in Africa. In South Africa, however, men and women in the coloured (mixed black and white ancestry) population have smoked for many decades. We assess mortality from smoking in the coloured, white, and black (African) population groups. Methods In this case-control study, 481 640 South African notifications of death at ages 35-74 years between 1999 and 2007 yielded information about age, sex, population group, education, smoking 5 years ago (yes or no), and underlying disease. Cases were deaths from diseases expected to be affected by smoking; controls were deaths from selected other diseases, excluding only HIV, cirrhosis, unknown causes, external causes, and mental disorders. Disease-specific case-control comparisons yielded smoking-associated relative risks (RRs; diluted by combining some ex-smokers with the never-smokers). These RRs, when combined with national mortality rates, yielded smoking-attributed mortality rates. Summation yielded RRs and smoking-attributed numbers for overall mortality. Findings In the coloured population, smoking prevalence was high in both sexes and smokers had about 50% higher overall mortality than did otherwise similar non-smokers or ex-smokers (men, RR 1.55, 95% CI 1.43-1.67; women, 1.49, 1.38-1.60). RRs were similar in the white population (men, 1.37, 1.29-1.46; women, 1.51, 1.40-1.62), but lower among Africans (men, 1.17, 1.15-1.19; women, 1.16, 1.13-1.20). If these associations are largely causal, smoking-attributed proportions for overall male deaths at ages 35-74 years were 27% (5608/20 767) in the coloured, 14% (3913/28 951) in the white, and 8% (20 398/264 011) in the African population. For female deaths, these proportions were 17% (2728/15 593) in the coloured, 12% (2084/17 899) in the white, and 2% (4038/205 623) in the African population. Because national mortality rates were also substantially higher in the coloured than in the white population, the hazards from smoking in the coloured population were more than double those in the white population. Interpretation The highest smoking-attributed mortality rates were in the coloured population and the lowest were in Africans. The substantial hazards already seen among coloured South Africans suggest growing hazards in all populations in Africa where young adults now smoke.	[Sitas, Freddy; Egger, Sam] NSW Canc Council, Canc Res Div, Woolloomooloo, NSW, Australia; [Sitas, Freddy] Univ Sydney, Sch Populat Hlth, Sydney, NSW 2006, Australia; [Sitas, Freddy] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Bradshaw, Debbie; Groenewald, Pam; Laubscher, Ria] South African Med Res Council, Burden Dis Res Unit, ZA-7505 Tygerberg, South Africa; [Kielkowski, Danuta] Natl Hlth Lab Serv, Johannesburg, South Africa; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England	Cancer Council New South Wales; University of Sydney; University of New South Wales Sydney; South African Medical Research Council; National Health Laboratory Service; University of Oxford; University of Oxford	Bradshaw, D (corresponding author), South African Med Res Council, Burden Dis Res Unit, ZA-7505 Tygerberg, South Africa.	debbie.bradshaw@mrc.ac.za		Sitas, Freddy/0000-0001-9679-1481; Egger, Sam/0000-0003-1808-6909	South African Medical Research Council; UK Medical Research Council; Cancer Research UK; British Heart Foundation; New South Wales Cancer Council; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); New South Wales Cancer Council(Cancer Council New South Wales); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	South African Medical Research Council, UK Medical Research Council, Cancer Research UK, British Heart Foundation, New South Wales Cancer Council.	Amos CI, 2010, J NATL CANCER I, V102, P1199, DOI 10.1093/jnci/djq232; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Bradshaw D, 2003, INITIAL BURDEN DIS E; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Dorrington R. E., 2001, IMPACT HIV AIDS ADUL; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073; Groenewald P, 2007, SAMJ S AFR MED J, V97, P674; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; IARC, 2007, IARC HDB CANC PREV, V11, P15; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Mechanic LE, 2007, CANCER EPIDEM BIOMAR, V16, P214, DOI 10.1158/1055-9965.EPI-06-0790; Norman R., 2006, REVISED BURDEN DIS E; Peer N, 2009, SAMJ S AFR MED J, V99, P744; PETO R, 1992, BRIT MED J, V305, P829, DOI 10.1136/bmj.305.6857.829-b; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Reddy P, 1996, S AFR MED J, V86, P1389; SCHOUTEN LJ, 1994, J EPIDEMIOL COMMUN H, V48, P596, DOI 10.1136/jech.48.6.596; SHISANA O, 2005, S AFRICAN NATL HIV P; Sitas F, 2004, TOB CONTROL, V13, P396, DOI 10.1136/tc.2004.007682; Sitas F, 2009, MED J AUSTRALIA, V191, P166, DOI 10.5694/j.1326-5377.2009.tb02730.x; Statistics South Africa, 2010, MORT CAUS DEATH S AF; Statistics South Africa, MID POP EST 2011; Statistics South Africa, 2006, STAT S AFR PUBL; Steyn K, 2002, J CARDIOVASC RISK, V9, P161, DOI 10.1097/00043798-200206000-00005; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; van Walbeek C, 2002, SAMJ S AFR MED J, V92, P468; VANDERBURGH C, 1979, S AFR MED J, V55, P975; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 1992, ICD10 INT CLASS DIS	33	32	35	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					685	693		10.1016/S0140-6736(13)61610-4	http://dx.doi.org/10.1016/S0140-6736(13)61610-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23972813				2022-12-28	WOS:000323542400026
J	Cavanna, AE; Seri, S				Cavanna, Andrea E.; Seri, Stefano			Tourette's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EUROPEAN CLINICAL GUIDELINES; BEHAVIOR-THERAPY; PREVALENCE; CHILDREN; STIMULATION; DISORDERS; SPECTRUM; QUALITY; LIFE; TICS		[Cavanna, Andrea E.] Birmingham & Solihull Mental Hlth NHS Fdn Trust, Dept Neuropsychiat, Birmingham, W Midlands, England; [Cavanna, Andrea E.] Univ Birmingham, Birmingham, W Midlands, England; [Cavanna, Andrea E.] Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Cavanna, Andrea E.] UCL, London, England; [Cavanna, Andrea E.; Seri, Stefano] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Birmingham; University of London; University College London; University of London; University College London; Aston University	Cavanna, AE (corresponding author), Barberry Natl Ctr Mental Hlth, Dept Neuropsychiat, Birmingham B15 2FG, W Midlands, England.	a.cavanna@ion.ucl.ac.uk						Ali F, 2013, NEUROPSYCHIATRY-LOND, V3, P321, DOI 10.2217/NPY.13.25; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bloch MH, 2009, J AM ACAD CHILD PSY, V48, P884, DOI 10.1097/CHI.0b013e3181b26e9f; Cath DC, 2011, EUR CHILD ADOLES PSY, V20, P155, DOI 10.1007/s00787-011-0164-6; Cavanna AE, 2008, NEUROLOGY, V71, P1410, DOI 10.1212/01.wnl.0000327890.02893.61; Cavanna AE, 2007, ACTA NEUROL SCAND, V116, P385, DOI 10.1111/j.1600-0404.2007.00879.x; Cavanna AE, 2013, NEUROSCI BIOBEHAV R, V37, P1008, DOI 10.1016/j.neubiorev.2012.10.011; Cavanna AE, 2012, EUR J PAEDIATR NEURO, V16, P310, DOI 10.1016/j.ejpn.2012.01.010; Cavanna AE, 2011, J NEUROL NEUROSUR PS, V82, P1320, DOI 10.1136/jnnp.2010.225029; Crossley E, PSYCHIAT RE IN PRESS; Eddy CM, 2011, J NEUROL, V258, P291, DOI 10.1007/s00415-010-5754-6; Eddy CM, 2013, BEHAV NEUROL, V27, P15, DOI [10.3233/BEN-120298, 10.1155/2013/417516]; Felling RJ, 2011, J NEUROSCI, V31, P12387, DOI 10.1523/JNEUROSCI.0150-11.2011; Frank M, 2013, BEHAV NEUROL, V27, P105, DOI [10.3233/BEN-120309, 10.1155/2013/134863]; Freeman RD, 2000, DEV MED CHILD NEUROL, V42, P436, DOI 10.1017/S0012162200000839; Gilles de la Tourette G., 1885, ARCH NEUROL-CHICAGO, V9, P158; Gilles de la Tourette G, 1885, ARCH NEUROL-CHICAGO, V9, P158; Hassan N, 2012, FUNCT NEUROL, V27, P23; Jankovic J, 2006, J NEUROPSYCH CLIN N, V18, P86, DOI 10.1176/appi.neuropsych.18.1.86; Khalifa Najah, 2005, Acta Paediatr, V94, P1608, DOI 10.1080/08035250510043879; Madhusudan N, 2013, BASAL GANGLIA, V3, P77, DOI 10.1016/j.baga.2013.03.001; Muller-Vahl KR, 2011, EUR CHILD ADOLES PSY, V20, P209, DOI 10.1007/s00787-011-0166-4; Piacentini J, 2010, JAMA-J AM MED ASSOC, V303, P1929, DOI 10.1001/jama.2010.607; Piedad JCP, 2012, NEUROSURGERY, V71, P173, DOI 10.1227/NEU.0b013e3182535a00; Robertson MM, 2006, J PSYCHOSOM RES, V61, P349, DOI 10.1016/j.jpsychores.2006.07.019; Robertson MM, 2009, J PSYCHOSOM RES, V67, P475, DOI 10.1016/j.jpsychores.2009.07.010; Roessner V, 2011, EUR CHILD ADOLES PSY, V20, P173, DOI 10.1007/s00787-011-0163-7; Scharf JM, 2012, J AM ACAD CHILD PSY, V51, P192, DOI 10.1016/j.jaac.2011.11.004; Stern JS, 2005, POSTGRAD MED J, V81, P12, DOI 10.1136/pgmj.2004.023614; Thomas R, 2013, J NEURAL TRANSM, V120, P689, DOI 10.1007/s00702-013-0979-z; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Verdellen C, 2011, EUR CHILD ADOLES PSY, V20, P197, DOI 10.1007/s00787-011-0167-3; Waldon K, 2013, BEHAV NEUROL, V26, P265, DOI [10.3233/BEN-2012-120269, 10.1155/2013/626410]; Wilhelm S, 2012, ARCH GEN PSYCHIAT, V69, P795, DOI 10.1001/archgenpsychiatry.2011.1528; Worbe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012959; Wright A, 2012, J NEUROPSYCH CLIN N, V24, P16, DOI 10.1176/appi.neuropsych.10010013	36	49	50	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f4964	10.1136/bmj.f4964	http://dx.doi.org/10.1136/bmj.f4964			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SC	23963548	Green Accepted			2022-12-28	WOS:000323623100003
J	Windecker, S; Bax, JJ; Myat, A; Stone, GW; Marber, MS				Windecker, Stephan; Bax, Jeroen J.; Myat, Aung; Stone, Gregg W.; Marber, Michael S.			Future treatment strategies in ST-segment elevation myocardial infarction	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HOSPITAL CARDIAC-ARREST; LEFT-VENTRICULAR FUNCTION; CHEST COMPRESSION DEVICE; BONE-MARROW-CELLS; REPERFUSION INJURY; BARE-METAL; INTRACORONARY INJECTION; THROMBOLYTIC THERAPY; MAGNETIC-RESONANCE	Over the past five decades, management of acute ST-segment elevation myocardial infarction (STEMI) has evolved substantially. Current treatment encompasses a systematic chain of network activation, antithrombotic drugs, and rapid instigation of mechanical reperfusion, although pharmacoinvasive strategies remain relevant. Secondary prevention with drugs and lifestyle modifications completes the contemporary management package. Despite a tangible improvement in outcomes, STEMI remains a frequent cause of morbidity and mortality, justifying the quest to find new therapeutic avenues. Ways to reduce delays in doing coronary angioplasty after STEMI onset include early recognition of symptoms by patients and prehospital diagnosis by paramedics so that the emergency room can be bypassed in favour of direct admission to the catheterisation laboratory. Mechanical reperfusion can be optimised by improvements to stent design, whereas visualisation of infarct size has been improved by developments in cardiac MRI. Novel treatments to modulate the inflammatory component of atherosclerosis and the vulnerable plaque include use of bioresorbable vascular scaffolds and anti-proliferative drugs. Translational efforts to improve patients' outcomes after STEMI in relation to cardioprotection, cardiac remodelling, and regeneration are also being realised.	[Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Bax, Jeroen J.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Myat, Aung; Marber, Michael S.] Kings Coll London, British Heart Fdn Ctr Res Excellence, St Thomas Hosp, Rayne Inst,Cardiovasc Div, London, England; [Stone, Gregg W.] New York Presbyterian Hosp, Ctr Intervent Vasc Therapy, New York, NY USA; [Stone, Gregg W.] New York Presbyterian Hosp, Cardiovasc Res Fdn, New York, NY USA; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA	University of Bern; University Hospital of Bern; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); NewYork-Presbyterian Hospital; Columbia University	Windecker, S (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	marber, michael/AAW-7916-2021	Marber, Michael/0000-0002-3463-7128	Swiss National Science Foundation [SNF 33CM30_140336/1, SNF 32003B_146442/1]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; British Heart Foundation [FS/11/70/28917]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; British Heart Foundation(British Heart Foundation)	SW acknowledges research support from the Swiss National Science Foundation (SNF 33CM30_140336/1 and SNF 32003B_146442/1). MSM and AM are supported by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust, in partnership with King's College London and King's College Hospital NHS Foundation Trust. AM also acknowledges financial support from the British Heart Foundation via a Clinical Research Training Fellowship (FS/11/70/28917).	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Braunwald E, 2006, J AM COLL CARDIOL, V47, pC101, DOI 10.1016/j.jacc.2005.10.072; Brugaletta S, 2012, ATHEROSCLEROSIS, V221, P106, DOI 10.1016/j.atherosclerosis.2011.12.008; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Chung ES, 2010, CIRC-HEART FAIL, V3, P650, DOI 10.1161/CIRCHEARTFAILURE.110.945881; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Fraccarollo D, 2008, HYPERTENSION, V51, P905, DOI 10.1161/HYPERTENSIONAHA.107.100941; Fraccarollo D, 2012, CARDIOVASC RES, V94, P293, DOI 10.1093/cvr/cvs109; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Friedrich MG, 2008, J AM COLL CARDIOL, V51, P1581, DOI 10.1016/j.jacc.2008.01.019; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Hallstrom A, 2006, JAMA-J AM MED ASSOC, V295, P2620, DOI 10.1001/jama.295.22.2620; Hattori K, 2012, JACC-CARDIOVASC IMAG, V5, P169, DOI 10.1016/j.jcmg.2011.11.012; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hazinski MF, 2010, CIRCULATION, V122, P8250, DOI 10.1161/CIRCULATIONAHA.110.970897; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449; Hopenfeld B, 2009, J ELECTROCARDIOL, V42, P481, DOI 10.1016/j.jelectrocard.2009.06.017; Huber K, 2013, AM HEART J, V165, P123, DOI 10.1016/j.ahj.2012.10.032; Huikuri HV, 2008, EUR HEART J, V29, P2723, DOI 10.1093/eurheartj/ehn436; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kaul P, 2012, AM J CARDIOL, V110, P1555, DOI 10.1016/j.amjcard.2012.07.020; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kern KB, 2012, JACC-CARDIOVASC INTE, V5, P597, DOI 10.1016/j.jcin.2012.01.017; Kern KB, 2012, CURR OPIN CRIT CARE, V18, P246, DOI 10.1097/MCC.0b013e32835180d6; Kim HW, 2009, J AM COLL CARDIOL, V55, P1, DOI 10.1016/j.jacc.2009.06.059; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Lurie KG, 2005, ACAD EMERG MED, V12, P79, DOI 10.1197/j.aem.2004.11.010; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Mercola M, 2012, NATURE, V492, P360, DOI 10.1038/nature11763; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P390, DOI 10.1016/j.jacc.2010.05.066; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Nichol G, 2010, CIRCULATION, V121, P709, DOI 10.1161/CIR.0b013e3181cdb7db; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Ong MEH, 2006, JAMA-J AM MED ASSOC, V295, P2629, DOI 10.1001/jama.295.22.2629; Onuma Y, 2011, CIRCULATION, V123, P779, DOI 10.1161/CIRCULATIONAHA.110.971606; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; REIMER KA, 1979, LAB INVEST, V40, P633; Roncalli J, 2011, EUR HEART J, V32, P1748, DOI 10.1093/eurheartj/ehq455; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Serruys PW, 2012, EUR HEART J, V33, P16, DOI 10.1093/eurheartj/ehr384; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Strauer BE, 2001, DEUT MED WOCHENSCHR, V126, P932, DOI 10.1055/s-2001-16579-1; Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takarada S, 2009, ATHEROSCLEROSIS, V202, P491, DOI 10.1016/j.atherosclerosis.2008.05.014; Tang TY, 2009, J AM COLL CARDIOL, V53, P2039, DOI 10.1016/j.jacc.2009.03.018; Tawakol A, 2013, J AM COLL CARDIOL, V62, P909, DOI 10.1016/j.jacc.2013.04.066; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Ting HH, 2008, CIRCULATION, V118, P1066, DOI 10.1161/CIRCULATIONAHA.108.190402; Ting HH, 2008, ARCH INTERN MED, V168, P959, DOI 10.1001/archinte.168.9.959; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Van de Hoef TP, 2012, J INTERV CARDIOL, V25, P549, DOI 10.1111/j.1540-8183.2012.00768.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	89	52	57	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					644	657		10.1016/S0140-6736(13)61452-X	http://dx.doi.org/10.1016/S0140-6736(13)61452-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953388				2022-12-28	WOS:000323422800028
J	Scornik, H				Scornik, Hugo			In the Shadows	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Conyers Pediat, Conyers, GA USA		Scornik, H (corresponding author), Conyers Pediat, Conyers, GA USA.							Goodwyn W., 2013, CONSTRUCTION BOOMING	1	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					598	598		10.1056/NEJMp1305614	http://dx.doi.org/10.1056/NEJMp1305614			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944297				2022-12-28	WOS:000326354500004
J	Tang, JCY; Szikra, T; Kozorovitskiy, Y; Teixiera, M; Sabatini, BL; Roska, B; Cepko, CL				Tang, Jonathan C. Y.; Szikra, Tamas; Kozorovitskiy, Yevgenia; Teixiera, Miguel; Sabatini, Bernardo L.; Roska, Botond; Cepko, Constance L.			A Nanobody-Based System Using Fluorescent Proteins as Scaffolds for Cell-Specific Gene Manipulation	CELL			English	Article							RNA INTERFERENCE; NERVOUS-SYSTEM; BIPOLAR CELLS; IN-VIVO; EXPRESSION; TRANSCRIPTION; OTX2; RECOMBINASE; ACTIVATION; DISSECTION	Fluorescent proteins are commonly used to label cells across organisms, but the unmodified forms cannot control biological activities. Using GFP-binding proteins derived from Camelid antibodies, we co-opted GFP as a scaffold for inducing formation of biologically active complexes, developing a library of hybrid transcription factors that control gene expression only in the presence of GFP or its derivatives. The modular design allows for variation in key properties such as DNA specificity, transcriptional potency, and drug dependency. Production of GFP controlled cell-specific gene expression and facilitated functional perturbations in the mouse retina and brain. Further, retrofitting existing transgenic GFP mouse and zebrafish lines for GFP-dependent transcription enabled applications such as optogenetic probing of neural circuits. This work establishes GFP as a multifunctional scaffold and opens the door to selective manipulation of diverse GFP-labeled cells across transgenic lines. This approach may also be extended to exploit other intracellular products as cell-specific scaffolds in multicellular organisms.	[Tang, Jonathan C. Y.; Kozorovitskiy, Yevgenia; Sabatini, Bernardo L.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tang, Jonathan C. Y.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tang, Jonathan C. Y.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Kozorovitskiy, Yevgenia; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Szikra, Tamas; Teixiera, Miguel; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Teixiera, Miguel] Univ Basel, CH-4003 Basel, Switzerland	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Friedrich Miescher Institute for Biomedical Research; University of Basel	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu	Roska, Botond/AAD-7268-2021; Kozorovitskiy, Yevgenia/GOP-1185-2022	Kozorovitskiy, Yevgenia/0000-0002-3710-1484	Leonard and Isabelle Goldenson Research Fellowship; European Research Council; Swiss-Hungarian grant; TREATRUSH grant from the European Union; SEEBETTER grant from the European Union; OPTONEURO grant from the European Union; Howard Hughes Medical Institute	Leonard and Isabelle Goldenson Research Fellowship; European Research Council(European Research Council (ERC)European Commission); Swiss-Hungarian grant; TREATRUSH grant from the European Union; SEEBETTER grant from the European Union; OPTONEURO grant from the European Union; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Matt Harris and Katrin Henke for assistance with zebrafish injections; Mark Emerson for discussions of Otx2 experiment; Quentin Gilly of Perrimon lab for access to microplate reader; James deMelo for help with mouse transfer; Tim Cherry for contributing to illustrations; and Kailun Jiang, Jonathan Coleman, Susan Dymecki, Jacob Hodgson, Douglas Allan, Andreas Mayer, Jesse Gray, Michael Springer, Kevin Struhl, Ben Huang, and members of the Cepko/Tabin/Dymecki lab for comments. We are grateful to Heinrich Leonhardt and Ulrich Rothbauer for advice and GBP reagents. We thank Liqun Luo, David Bartel, Gerald Rubin, Benjamin White, Dominic Esposito, Warner Greene, and Matija Peterlin for plasmids from Addgene, Robert Margolskee for Tg(GUS8.4GFP) line, and Leonard Zon for Tg(Ubi-GFP) line. Y.K. was supported by the Leonard and Isabelle Goldenson Research Fellowship. B. R. was supported by a European Research Council grant, a Swiss-Hungarian grant, and TREATRUSH, SEEBETTER, and OPTONEURO grants from the European Union. C. L. C. and B. L. S. were supported by the Howard Hughes Medical Institute.	Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chang AL, 2012, CURR OPIN BIOTECH, V23, P679, DOI 10.1016/j.copbio.2012.01.005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Emerson MM, 2011, DEV BIOL, V360, P241, DOI 10.1016/j.ydbio.2011.09.012; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Hsu PD, 2012, ACS CHEM NEUROSCI, V3, P603, DOI 10.1021/cn300089k; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Samson M, 2009, DEV DYNAM, V238, P3218, DOI 10.1002/dvdy.22138; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054146; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Wickersham IR, 2012, CURR OPIN NEUROBIOL, V22, P121, DOI 10.1016/j.conb.2011.12.001; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	55	82	83	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					928	939		10.1016/j.cell.2013.07.021	http://dx.doi.org/10.1016/j.cell.2013.07.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953120	Bronze, Green Accepted			2022-12-28	WOS:000323202500021
J	Smith, JM				Smith, Jeanette M.			Chicken in Sunrise Georgia O'Keeffe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					564	565		10.1001/jama.2013.5249	http://dx.doi.org/10.1001/jama.2013.5249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942662				2022-12-28	WOS:000323058400001
J	Kutsuna, S; Hayakawa, K				Kutsuna, Satoshi; Hayakawa, Kayoko			Rubella Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kutsuna, Satoshi; Hayakawa, Kayoko] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Kutsuna, S (corresponding author), Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan.	sonare.since1192@gmail.com	Hayakawa, Kayoko/GNW-2394-2022	Hayakawa, Kayoko/0000-0002-5480-4405; Kutsuna, Satoshi/0000-0002-6929-8955					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					558	558		10.1056/NEJMicm1303608	http://dx.doi.org/10.1056/NEJMicm1303608			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924006				2022-12-28	WOS:000322842000012
J	Zhou, CF; Wu, SY; Martin, T; Luo, ZX				Zhou, Chang-Fu; Wu, Shaoyuan; Martin, Thomas; Luo, Zhe-Xi			A Jurassic mammaliaform and the earliest mammalian evolutionary adaptations	NATURE			English	Article							ALLOTHERIAN MAMMALS; NORTHEASTERN CHINA; MIDDLE-EAR; TEETH; DIVERSIFICATION; EUTRICONODONT	The earliest evolution of mammals and origins of mammalian features can be traced to the mammaliaforms of the Triassic and Jurassic periods that are extinct relatives to living mammals. Here we describe a new fossil from the Middle Jurassic that has a mandibular middle ear, a gradational transition of thoracolumbar vertebrae and primitive ankle features, but highly derived molars with a high crown and multiple roots that are partially fused. The upper molars have longitudinal cusp rows that occlude alternately with those of the lower molars. This specialization for masticating plants indicates that herbivory evolved among mammaliaforms, before the rise of crown mammals. The new species shares the distinctive dental features of the eleutherodontid clade, previously represented only by isolated teeth despite its extensive geographic distribution during the Jurassic. This eleutherodontid was terrestrial and had ambulatory gaits, analogous to extant terrestrial mammals such as armadillos or rock hyrax. Its fur corroborates that mammalian integument had originated well before the common ancestor of living mammals.	[Zhou, Chang-Fu; Wu, Shaoyuan] Shenyang Normal Univ, Paleontol Museum Liaoning, Shenyang 110034, Liaoning, Peoples R China; [Martin, Thomas; Luo, Zhe-Xi] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Shenyang Normal University; University of Bonn; University of Chicago	Luo, ZX (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Nussallee 8, D-53115 Bonn, Germany.	zxluo@uchicago.edu	Luo, Zhe-XI/AAU-2263-2021	Zhou, Chang-Fu/0000-0002-3744-7573	Key Lab for Paleobiological Evolution of Northeastern Asia, Ministry of Land Resources of China; Shenyang Normal University and Paleontological Museum of Liaoning; Deutsche Forschungsmeinschaft (DFG); Alexander von Humboldt-Foundation; National Science Foundation; University of Chicago	Key Lab for Paleobiological Evolution of Northeastern Asia, Ministry of Land Resources of China; Shenyang Normal University and Paleontological Museum of Liaoning; Deutsche Forschungsmeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); University of Chicago(University of Chicago)	We thank G. Sun for proposing this research, and for his encouragement and support throughout; O. Dulfer for preparation of the fossil; P. Goddertz and K. Jager for their CT scanning and virtual reconstructions; G. Oleschinski for SEM photography; and A. Isch for graphics support. We benefited from discussion with K. C. Beard, W. A. Clemens, M. R. Dawson, D. Y. Hu, W. v. Koenigswald, G. Sun and J.R. Wible. J. R. Wible and M. R. Dawson helped to improve the manuscript. Support was from the Key Lab for Paleobiological Evolution of Northeastern Asia, Ministry of Land Resources of China, and Shenyang Normal University and Paleontological Museum of Liaoning (C.Z. and S. W.), Deutsche Forschungsmeinschaft (DFG) (T. M.), Alexander von Humboldt-Foundation, National Science Foundation and the University of Chicago (Z.-X.L.). This is publication no. 60 from DFG Research Unit 771, Universitat Bonn.	Averianov A O, 2011, Dokl Biol Sci, V437, P103, DOI 10.1134/S0012496611020074; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Clemens W.A., 1980, Zitteliana, V5, P51; Crompton A.W., 1972, B BRIT MUS NAT HIST, V21, P29; Hahn G., 1989, Geologica et Palaeontologica, V23, P205; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Hu Y., 2006, THESIS CITY U NEW YO; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; JENKINS FA, 1983, SCIENCE, V220, P712, DOI 10.1126/science.220.4598.712; Jenkins Jr F. A., 1971, PEABODY MUS NAT HIST, V36, P1; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Ji Q, 1999, NATURE, V398, P326; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KRAUSE DW, 1982, PALEOBIOLOGY, V8, P265, DOI 10.1017/S0094837300006989; Lazzari V, 2010, J MAMM EVOL, V17, P177, DOI 10.1007/s10914-010-9139-5; Lessertisseur J., 1967, TRAITE ZOOLOGIE, P709; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Liu YQ, 2012, PALAEOGEOGR PALAEOCL, V323, P1, DOI 10.1016/j.palaeo.2012.01.017; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Peng N, 2012, ACTA GEOL SIN-ENGL, V86, P1326, DOI 10.1111/1755-6724.12003; Rougier Guillermo W., 1996, American Museum Novitates, V3187, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; SIGOGNEAU-RUSSELL D, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P137; Szalay F. S., 1994, EVOLUTIONARY HIST MA; von Koenigswald W, 2011, PALAEONTOGR ABT A, V294, P63	40	124	133	0	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					163	167		10.1038/nature12429	http://dx.doi.org/10.1038/nature12429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925238				2022-12-28	WOS:000322825500026
J	Harjutsalo, V; Sund, R; Knip, M; Groop, PH				Harjutsalo, Valma; Sund, Reijo; Knip, Mikael; Groop, Per-Henrik			Incidence of Type 1 Diabetes in Finland	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Harjutsalo, Valma] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Sund, Reijo] Natl Inst Hlth & Welf, Serv Syst Res Unit, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Groop, Per-Henrik] Folkhalsan Inst Genet, Biomedicum Helsinki, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki	Harjutsalo, V (corresponding author), Folkhalsan Inst Genet, Haartmaninkatu 8,POB 63, FIN-00014 Helsinki, Finland.	valma.harjutsalo@helsinki.fi	Knip, Mikael/AAL-3773-2020; Harjutsalo, Valma/AAL-6588-2021; Sund, Reijo/N-5471-2016	Harjutsalo, Valma/0000-0003-3568-9779; Sund, Reijo/0000-0002-6268-8117; Knip, Mikael/0000-0003-0474-0033				Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Forlenza GP, 2011, CURR OPIN ENDOCRINOL, V18, P248, DOI 10.1097/MED.0b013e32834872ce; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; HULKKO T, 2010, INFECT DIS FINLAND; Kaikkonen R., 2012, HLTH WELL BEING INEQ; Knip M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007690	6	165	170	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					427	428		10.1001/jama.2013.8399	http://dx.doi.org/10.1001/jama.2013.8399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917294	Bronze			2022-12-28	WOS:000322121500021
J	Eatough, RP; Falcke, H; Karuppusamy, R; Lee, KJ; Champion, DJ; Keane, EF; Desvignes, G; Schnitzeler, DHFM; Spitler, LG; Kramer, M; Klein, B; Bassa, C; Bower, GC; Brunthaler, A; Cognard, I; Deller, AT; Demorest, PB; Freire, PCC; Kraus, A; Lyne, AG; Noutsos, A; Stappers, B; Wex, N				Eatough, R. P.; Falcke, H.; Karuppusamy, R.; Lee, K. J.; Champion, D. J.; Keane, E. F.; Desvignes, G.; Schnitzeler, D. H. F. M.; Spitler, L. G.; Kramer, M.; Klein, B.; Bassa, C.; Bower, G. C.; Brunthaler, A.; Cognard, I.; Deller, A. T.; Demorest, P. B.; Freire, P. C. C.; Kraus, A.; Lyne, A. G.; Noutsos, A.; Stappers, B.; Wex, N.			A strong magnetic field around the supermassive black hole at the centre of the Galaxy	NATURE			English	Article							SAGITTARIUS-A-ASTERISK; GALACTIC-CENTER; LINEAR-POLARIZATION; FARADAY-ROTATION; CENTRAL PARSEC; ACCRETION; RADIO; DISCOVERY; EMISSION; DISKS	Earth's nearest candidate supermassive black hole lies at the centre of the Milky Way(1). Its electromagnetic emission is thought to be powered by radiatively inefficient accretion of gas from its environment(2), which is a standard mode of energy supply for most galactic nuclei. X-ray measurements have already resolved a tenuous hot gas component from which the black hole can be fed(3). The magnetization of the gas, however, which is a crucial parameter determining the structure of the accretion flow, remains unknown. Strong magnetic fields can influence the dynamics of accretion, remove angular momentum from the infalling gas(4), expel matter through relativistic jets(5) and lead to synchrotron emission such as that previously observed(6-8). Here we report multi-frequency radio measurements of a newly discovered pulsar close to the Galactic Centre(9-12) and show that the pulsar's unusually large Faraday rotation (the rotation of the plane of polarization of the emission in the presence of an external magnetic field) indicates that there is a dynamically important magnetic field near the black hole. If this field is accreted down to the event horizon it provides enough magnetic flux to explain the observed emission-from radio to X-ray wavelengths-from the black hole.	[Eatough, R. P.; Falcke, H.; Karuppusamy, R.; Lee, K. J.; Champion, D. J.; Desvignes, G.; Schnitzeler, D. H. F. M.; Spitler, L. G.; Kramer, M.; Klein, B.; Brunthaler, A.; Freire, P. C. C.; Kraus, A.; Noutsos, A.; Wex, N.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Falcke, H.] Radboud Univ Nijmegen, Dept Astrophys, Inst Math Astrophys & Particle Phys, NL-6500 GL Nijmegen, Netherlands; [Falcke, H.; Deller, A. T.] ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Keane, E. F.; Kramer, M.; Bassa, C.; Lyne, A. G.; Stappers, B.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Klein, B.] Bonn Rhein Sieg Univ Appl Sci, D-53757 St Augustin, Germany; [Bower, G. C.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Cognard, I.] Univ Orleans, CNRS, LPC2E, F-45071 Orleans, France; [Cognard, I.] Nancay Paris Observ, F-18330 Nancay, France; [Demorest, P. B.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA	Max Planck Society; Radboud University Nijmegen; University of Manchester; Jodrell Bank Centre for Astrophysics; Hochschule Bonn Rhein Sieg; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; National Radio Astronomy Observatory (NRAO)	Eatough, RP (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	reatough@mpifr-bonn.mpg.de	Bower, Geoffrey/ABC-8386-2020; Freire, Paulo/ABE-8926-2021	Bower, Geoffrey/0000-0003-4056-9982; Freire, Paulo/0000-0003-1307-9435; Bassa, Cees/0000-0002-1429-9010; Eatough, Ralph/0000-0001-6196-4135; Spitler, Laura G/0000-0002-3775-8291; Deller, Adam/0000-0001-9434-3837; Champion, David/0000-0003-1361-7723; Cognard, Ismael/0000-0002-1775-9692; Noutsos, Aristeidis/0000-0002-4151-3860; Brunthaler, Andreas/0000-0003-4468-761X; Keane, Evan/0000-0002-4553-655X; Kramer, Michael/0000-0002-4175-2271; Karuppusamy, Ramesh/0000-0002-5307-2919	European Research Council for the ERC Starting Grant BEACON [279702]; ERC Advanced Grant LEAP [227947]; Advanced Grant of the European Research Council under the European Union's Seventh Framework Programme [227610]; Region Centre in France; Science and Technology Facilities Council [ST/J001562/1] Funding Source: researchfish; STFC [ST/J001562/1] Funding Source: UKRI	European Research Council for the ERC Starting Grant BEACON(European Research Council (ERC)); ERC Advanced Grant LEAP; Advanced Grant of the European Research Council under the European Union's Seventh Framework Programme; Region Centre in France(Region Centre-Val de Loire); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We wish to thank D. D. Xu., P. Lazarus and L. Guillemot for discussions. We also thank O. Wucknitz and R. Beck for reading the manuscript. R. K., L. G. S. and P. C. C. F. gratefully acknowledge financial support from the European Research Council for the ERC Starting Grant BEACON under contract no. 279702. K.J.L. was funded by ERC Advanced Grant LEAP under contract no. 227947. H. F. acknowledges funding from an Advanced Grant of the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 227610. This work was based on observations with the 100-m telescope of the MPIfR (Max-Planck-Institut fur Radioastronomie) at Effelsberg. The Nancay radio telescope is part of the Paris Observatory, associated with the Centre National de la Recherche Scientifique (CNRS), and partly supported by the Region Centre in France. The National Radio Astronomy Observatory (NRAO) is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc.	Baganoff FK, 2003, ASTROPHYS J, V591, P891, DOI 10.1086/375145; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Beckwith K, 2008, ASTROPHYS J, V678, P1180, DOI 10.1086/533492; Bower GC, 2005, ASTROPHYS J, V618, pL29, DOI 10.1086/427498; Bower GC, 1999, ASTROPHYS J, V521, P582, DOI 10.1086/307592; Brentjens MA, 2005, ASTRON ASTROPHYS, V441, P1217, DOI 10.1051/0004-6361:20052990; Cordes J. M., 2002, PREPRINT; Dexter J, 2010, ASTROPHYS J, V717, P1092, DOI 10.1088/0004-637X/717/2/1092; Eatough R., 2013, ASTRONOMERS TELEGRAM, V5040, P1; Eatough R. P., 2013, NEUTRON STARS PULSAR, P382; Falcke H, 2000, ASTRON ASTROPHYS, V362, P113; FALCKE H, 1993, ASTRON ASTROPHYS, V278, pL1; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Kennea JA, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L24; Law CJ, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/36; Lazarus P, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/97; Lazio TJW, 1998, ASTROPHYS J, V505, P715, DOI 10.1086/306174; Lee K. J., 2013, ASTRON TELEGR, V5064, P1; Liu K, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/1; Macquart JP, 2006, ASTROPHYS J, V646, pL111, DOI 10.1086/506932; Marrone DP, 2007, ASTROPHYS J, V654, pL57, DOI 10.1086/510850; Mori K, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L23; Moscibrodzka M, 2009, ASTROPHYS J, V706, P497, DOI 10.1088/0004-637X/706/1/497; Muno MP, 2004, ASTROPHYS J, V613, P326, DOI 10.1086/422865; NARAYAN R, 1994, ASTROPHYS J, V428, pL13, DOI 10.1086/187381; PLANTE RL, 1995, ASTROPHYS J, V445, pL113, DOI 10.1086/187902; Rea N, 2013, ASTRON TELEGRAM, V5032, P1; Shannon R. M., 2013, PREPRINT; Wharton RS, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/108; Zhao JH, 2010, ASTROPHYS J, V723, P1097, DOI 10.1088/0004-637X/723/2/1097	30	275	277	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					391	394		10.1038/nature12499	http://dx.doi.org/10.1038/nature12499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23945588	Green Submitted			2022-12-28	WOS:000324545700039
J	Iwamoto, H; Yagi, N				Iwamoto, H.; Yagi, N.			The Molecular Trigger for High-Speed Wing Beats in a Bee	SCIENCE			English	Article							X-RAY-DIFFRACTION; STRETCH-ACTIVATION; FLIGHT-MUSCLE; MYOSIN-FILAMENTS; CROSS-BRIDGES; INSECT; ACTIN; DROSOPHILA; SKELETAL; EXTENSIBILITY	The high-frequency wing beat of higher-order insects is driven by self-sustained oscillations of constantly activated flight muscles. However, whether its underlying mechanism is based on flight muscle-specific features or on preexisting contractile functions is unknown. Here, we recorded X-ray diffraction movies, at a rate of 5000 frames/second, simultaneously from the two antagonistic flight muscles of bumblebees during wing beat. Signals that occurred at the right timing for triggering each wing-beat stroke were resolved in both muscles. The signals likely reflect stretch-induced myosin deformation, which would also enhance force in vertebrate muscles. The results suggest that insects use a refined preexisting force-enhancing mechanism for high-frequency wing beat, rather than developing a novel mechanism.	[Iwamoto, H.; Yagi, N.] Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Res & Utilizat Div, Sayo, Hyogo 6795198, Japan	Japan Synchrotron Radiation Research Institute	Iwamoto, H (corresponding author), Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Res & Utilizat Div, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	iwamoto@spring8.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23612009]; CREST, Japan Science and Technology Agency, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	We thank Photron, Inc., for the use of the demonstration model of the CMOS camera. Performed under approval of SPring-8 (Proposal 2012A1839). Supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, 23612009 (H.I.) and partly by CREST, Japan Science and Technology Agency, Japan (N.Y.). H.I. and N.Y. planned and performed experiments, analyzed data, and wrote the paper. Data have been deposited in the Dryad Repository (accession: doi: 10.5061/dryad.bt51g).	ABBOTT RH, 1977, J PHYSIOL-LONDON, V266, P13, DOI 10.1113/jphysiol.1977.sp011754; Agianian B, 2004, EMBO J, V23, P772, DOI 10.1038/sj.emboj.7600097; Bekyarova TI, 2008, P NATL ACAD SCI USA, V105, P10372, DOI 10.1073/pnas.0709877105; Bullard B, 2011, J MUSCLE RES CELL M, V32, P303, DOI 10.1007/s10974-011-9278-1; Dickinson M, 2005, NATURE, V433, P330, DOI 10.1038/nature03230; HILL AV, 1949, PROC R SOC SER B-BIO, V136, P399, DOI 10.1098/rspb.1949.0033; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Irving TC, 2000, BIOPHYS J, V78, P2511, DOI 10.1016/S0006-3495(00)76796-8; Iwamoto H, 2003, BIOPHYS J, V85, P2492, DOI 10.1016/S0006-3495(03)74672-4; IWAMOTO H, 1995, BIOPHYS J, V68, P243, DOI 10.1016/S0006-3495(95)80180-3; Iwamoto H, 2007, P R SOC B, V274, P2297, DOI 10.1098/rspb.2007.0607; Iwamoto H, 2011, BIOPHYS J, V100, P11; Iwamoto H, 2010, BIOPHYS J, V99, P184, DOI 10.1016/j.bpj.2010.04.009; Iwamoto H, 2009, J MOL BIOL, V390, P99, DOI 10.1016/j.jmb.2009.05.002; Josephson RK, 2000, J EXP BIOL, V203, P2713; Linari M, 2004, BIOPHYS J, V87, P1101, DOI 10.1529/biophysj.103.037374; Perz-Edwards RJ, 2011, P NATL ACAD SCI USA, V108, P120, DOI 10.1073/pnas.1014599107; PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035; Stelzer JE, 2006, J GEN PHYSIOL, V128, P461, DOI 10.1085/jgp.200609634; Swank DM, 2012, METHODS, V56, P69, DOI 10.1016/j.ymeth.2011.10.015; THORSON J, 1983, J PHYSIOL-LONDON, V343, P59, DOI 10.1113/jphysiol.1983.sp014881; Tregear RT, 1998, BIOPHYS J, V74, P1439, DOI 10.1016/S0006-3495(98)77856-7; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Wu SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039422; Wu SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012643	25	19	19	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1243	1246		10.1126/science.1237266	http://dx.doi.org/10.1126/science.1237266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23970560				2022-12-28	WOS:000324248800044
J	Whittier, SK; Hengge, AC; Loria, JP				Whittier, Sean K.; Hengge, Alvan C.; Loria, J. Patrick			Conformational Motions Regulate Phosphoryl Transfer in Related Protein Tyrosine Phosphatases	SCIENCE			English	Article							TRIOSEPHOSPHATE ISOMERASE; DIHYDROFOLATE-REDUCTASE; CHEMICAL-EXCHANGE; ENZYME CATALYSIS; LOOP DYNAMICS; STATE; 1B	Many studies have implicated a role for conformational motions during the catalytic cycle, acting to optimize the binding pocket or facilitate product release, but a more intimate role in the chemical reaction has not been described. We address this by monitoring active-site loop motion in two protein tyrosine phosphatases (PTPs) using nuclear magnetic resonance spectroscopy. The PTPs, YopH and PTP1B, have very different catalytic rates; however, we find in both that the active-site loop closes to its catalytically competent position at rates that mirror the phosphotyrosine cleavage kinetics. This loop contains the catalytic acid, suggesting that loop closure occurs concomitantly with the protonation of the leaving group tyrosine and explains the different kinetics of two otherwise chemically and mechanistically indistinguishable enzymes.	[Whittier, Sean K.; Loria, J. Patrick] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hengge, Alvan C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Loria, J. Patrick] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Utah System of Higher Education; Utah State University; Yale University	Loria, JP (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	patrick.loria@yale.edu	Hengge, Alvan/C-8667-2011	Hengge, Alvan/0000-0002-5696-2087	 [NIH-T32GM008283];  [NIH-GM47297];  [NSF-MCB1121372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047297, T32GM008283, R29GM047297] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hoch, D. Korzhnev, M. Maciejewski, and G. Armstrong for access to their high-field NMR instruments and G. Khirich for running Monte Carlo simulations. S.K.W., A.C.H., and J.PL. acknowledge support from grants NIH-T32GM008283, NIH-GM47297, and NSF-MCB1121372.	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Antoniou D, 2012, J PHYS CHEM LETT, V3, P3538, DOI 10.1021/jz301670s; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Brandao TAS, 2010, J BIOL CHEM, V285, P15874, DOI 10.1074/jbc.M109.066951; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; BURKE TR, 1994, BIOCHEM BIOPH RES CO, V204, P129, DOI 10.1006/bbrc.1994.2435; Desamero R, 2003, BIOCHEMISTRY-US, V42, P2941, DOI 10.1021/bi026994i; Eichmuller C, 2005, J BIOMOL NMR, V32, P281, DOI 10.1007/s10858-005-0658-y; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; HENGGE AC, 1995, BIOCHEMISTRY-US, V34, P13982, DOI 10.1021/bi00043a003; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hu X, 2006, BIOPHYS J, V91, P948, DOI 10.1529/biophysj.105.080259; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Juszczak LJ, 1997, BIOCHEMISTRY-US, V36, P2227, DOI 10.1021/bi9622130; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; Liu SJ, 2008, J AM CHEM SOC, V130, P17075, DOI 10.1021/ja8068177; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Pedersen AK, 2004, ACTA CRYSTALLOGR D, V60, P1527, DOI 10.1107/S0907444904015094; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Silva RG, 2011, P NATL ACAD SCI USA, V108, P18661, DOI 10.1073/pnas.1114900108; Wang CY, 2003, J AM CHEM SOC, V125, P8968, DOI 10.1021/ja035139z; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1995, J BIOL CHEM, V270, P11199, DOI 10.1074/jbc.270.19.11199; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4	30	115	115	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					899	903		10.1126/science.1241735	http://dx.doi.org/10.1126/science.1241735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970698	Green Accepted			2022-12-28	WOS:000323370600046
J	Klein, R				Klein, Rudolf			ESSAY The NHS in the age of anxiety: rhetoric and reality-an essay by Rudolf Klein	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Bath, Bath BA2 7AY, Avon, England	University of Bath	Klein, R (corresponding author), Univ Bath, Bath BA2 7AY, Avon, England.	rudolfklein30@gmail.com						Appleby J., 2013, IS HLTH SOCIAL CARE; Black N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2066; Comptroller and Auditor General, 2013, MAN TRANS REF HLTH S; Department of Health, NHS OUTC FRAM 2013 2; Department of Health, 2012, MAND MAND GOV NHS CO; Ford J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4422; Francis R., 2013, REP MIDST NHS FDN TR; Klein R, 2012, THINKING RATIONING; Le Grand J, 1998, LEARNING NHS INTERNA; MARMOR T, 2004, FADS MED CARE MANAGE; Mays N, 2011, UNDERSTANDING NEW LA; National Advisory Group on the Safety of Patients in England, 2013, PROM LEARN A COMM AC; NHS Choices, 2013, KEOGH MORT REV; NHS England, 2013, NHS BEL PEOPL NHS CA	14	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2013	347								f5104	10.1136/bmj.f5104	http://dx.doi.org/10.1136/bmj.f5104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SO	23965509				2022-12-28	WOS:000323624300010
J	Mansoor, AM; Mansoor, SE				Mansoor, Andre M.; Mansoor, Steven E.			Quincke's Pulse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mansoor, Andre M.; Mansoor, Steven E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Mansoor, AM (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	mansooan@ohsu.edu							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					E8	E8		10.1056/NEJMicm1215624	http://dx.doi.org/10.1056/NEJMicm1215624			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944324				2022-12-28	WOS:000326354500001
J	Tiengo, A; Esposito, P; Mereghetti, S; Turolla, R; Nobili, L; Gastaldello, F; Gotz, D; Israel, GL; Rea, N; Stella, L; Zane, S; Bignami, GF				Tiengo, Andrea; Esposito, Paolo; Mereghetti, Sandro; Turolla, Roberto; Nobili, Luciano; Gastaldello, Fabio; Goetz, Diego; Israel, Gian Luca; Rea, Nanda; Stella, Luigi; Zane, Silvia; Bignami, Giovanni F.			A variable absorption feature in the X-ray spectrum of a magnetar	NATURE			English	Article							SOFT GAMMA-REPEATERS; ISOLATED NEUTRON-STARS; SGR 0418+5729; RADIATIVE MECHANISM; GIANT FLARE; SPIN-DOWN; FIELD; ATMOSPHERES; EMISSION; PULSARS	Soft-gamma-ray repeaters (SGRs) and anomalous X-ray pulsars (AXPs) are slowly rotating, isolated neutron stars that sporadically undergo episodes of long-term flux enhancement (outbursts) generally accompanied by the emission of short bursts of hard X-rays(1,2). This behaviour can be understood in the magnetar model(3-5), according to which these sources are mainly powered by their own magnetic energy. This is supported by the fact that the magnetic fields inferred from several observed properties(6-8) of SGRs and AXPs are greater than-or at the high end of the range of-those of radio pulsars. In the peculiar case of SGR 0418+5729, a weak dipole magnetic moment is derived from its timing parameters(9), whereas a strong field has been proposed to reside in the stellar interior(10,11) and in multipole components on the surface(12). Here we show that the X-ray spectrum of SGR 0418+5729 has an absorption line, the properties of which depend strongly on the star's rotational phase. This line is interpreted as a proton cyclotron feature and its energy implies a magnetic field ranging from 2x10(14) gauss to more than 10(15) gauss.	[Tiengo, Andrea; Bignami, Giovanni F.] Ist Univ Super, I-27100 Pavia, Italy; [Tiengo, Andrea; Esposito, Paolo; Mereghetti, Sandro; Gastaldello, Fabio; Bignami, Giovanni F.] Ist Astrofis Spaziale & Fis Cosm Milano, INAF, I-20133 Milan, Italy; [Tiengo, Andrea] Ist Nazl Fis Nucl, Sez Pavia, I-27100 Pavia, Italy; [Turolla, Roberto; Nobili, Luciano] Univ Padua, Dipartimento Fis & Astron, I-35131 Padua, Italy; [Turolla, Roberto; Zane, Silvia] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Goetz, Diego] AIM CEA Irfu Serv Astrophys, F-91191 Gif Sur Yvette, France; [Israel, Gian Luca; Stella, Luigi] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; [Rea, Nanda] Inst Ciencies Espai IEEC CSIC, E-08193 Barcelona, Spain	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University of London; University College London; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC)	Tiengo, A (corresponding author), Ist Univ Super, Piazza Vittoria 15, I-27100 Pavia, Italy.	andrea.tiengo@iusspavia.it	Esposito, Paolo/ABE-6389-2020; Rea, Nanda/I-2853-2015; Gastaldello, Fabio/N-4226-2015; Esposito, Paolo/Q-2639-2019	Esposito, Paolo/0000-0003-4849-5092; Rea, Nanda/0000-0003-2177-6388; Gastaldello, Fabio/0000-0002-9112-0184; Esposito, Paolo/0000-0003-4849-5092; Bignami, Giovanni/0000-0001-9582-2450; TUROLLA, ROBERTO/0000-0002-5825-8149; MEREGHETTI, SANDRO/0000-0003-3259-7801; Zane, Silvia/0000-0001-5326-880X; Israel, GianLuca/0000-0001-5480-6438; Stella, Luigi/0000-0002-0018-1687; Tiengo, Andrea/0000-0002-6038-1090	INAF through a PRIN; ASI [I/032/10/0]; STFC [ST/H00260X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H00260X/1] Funding Source: researchfish	INAF through a PRIN; ASI(Agenzia Spaziale Italiana (ASI)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank G. Goggi and C. Paizis for discussions. This work is based on data and software provided by the ESA XMM-Newton Science Archive (XSA) and the NASA/GSFC High Energy Astrophysics Science Archive Research Center (HEASARC). We acknowledge partial funding from INAF through a PRIN 2010 grant and ASI through contract I/032/10/0.	Beloborodov AM, 2007, ASTROPHYS J, V657, P967, DOI 10.1086/508917; Bignami GF, 2003, NATURE, V423, P725, DOI 10.1038/nature01703; Esposito P, 2010, MON NOT R ASTRON SOC, V405, P1787, DOI 10.1111/j.1365-2966.2010.16551.x; Gelfand JD, 2005, ASTROPHYS J, V634, pL89, DOI 10.1086/498643; Gotthelf EV, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/1/58; Guver T, 2011, MON NOT R ASTRON SOC, V418, P2773, DOI 10.1111/j.1365-2966.2011.19677.x; Haberl F, 2006, ASTRON ASTROPHYS, V451, pL17, DOI 10.1051/0004-6361:20065093; Heindl W.A., 2004, AIP C SER, V714, P323; Kargaltsev O, 2012, SCIENCE, V337, P946, DOI 10.1126/science.1221378; Kouveliotou C, 1998, NATURE, V393, P235, DOI 10.1038/30410; MAKISHIMA K, 1990, PUBL ASTRON SOC JPN, V42, P295; Masada Y, 2010, PUBL ASTRON SOC JPN, V62, P1093, DOI 10.1093/pasj/62.4.1093; Medin Z, 2008, MON NOT R ASTRON SOC, V383, P161, DOI 10.1111/j.1365-2966.2007.12518.x; Mereghetti S, 2008, ASTRON ASTROPHYS REV, V15, P225, DOI [10.1007/s00159-008-0011-z, 10.1007/s00159-008-0011-Z]; Mori K, 2007, MON NOT R ASTRON SOC, V377, P905, DOI 10.1111/j.1365-2966.2007.11663.x; Potekhin AY, 1998, J PHYS B-AT MOL OPT, V31, P49, DOI 10.1088/0953-4075/31/1/008; Rea N, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/65; Rea N, 2010, SCIENCE, V330, P944, DOI 10.1126/science.1196088; Rea N., 2011, ASTROPHYSICS SPACE S, P247; Thompson C, 2001, ASTROPHYS J, V561, P980, DOI 10.1086/323256; Thompson C, 2002, ASTROPHYS J, V574, P332, DOI 10.1086/340586; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; THOMPSON C, 1995, MON NOT R ASTRON SOC, V275, P255, DOI 10.1093/mnras/275.2.255; Truemper J., 1978, APJ, V219, pL105, DOI [10.1086/182617, DOI 10.1086/182617]; Turolla R, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/105; Turolla R, 2009, ASTROPHYS SPACE SC L, V357, P141; van der Horst AJ, 2010, ASTROPHYS J LETT, V711, pL1, DOI 10.1088/2041-8205/711/1/L1; van Kerkwijk MH, 2007, ASTROPHYS SPACE SCI, V308, P191, DOI 10.1007/s10509-007-9343-9; Vietri M, 2007, ASTROPHYS J, V661, P1089, DOI 10.1086/517506	29	126	126	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					312	314		10.1038/nature12386	http://dx.doi.org/10.1038/nature12386			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23955229	Green Submitted, Green Published			2022-12-28	WOS:000323112400027
J	Yan, J; Enge, M; Whitington, T; Dave, K; Liu, JP; Sur, I; Schmierer, B; Jolma, A; Kivioja, T; Taipale, M; Taipale, J				Yan, Jian; Enge, Martin; Whitington, Thomas; Dave, Kashyap; Liu, Jianping; Sur, Inderpreet; Schmierer, Bernhard; Jolma, Arttu; Kivioja, Teemu; Taipale, Minna; Taipale, Jussi			Transcription Factor Binding in Human Cells Occurs in Dense Clusters Formed around Cohesin Anchor Sites	CELL			English	Article							GENE-EXPRESSION; HUMAN GENOME; NUCLEOSOME ORGANIZATION; HISTONE ACETYLATION; CHROMATIN-STRUCTURE; MITOTIC CHROMATIN; COLORECTAL-CANCER; EUKARYOTIC GENOME; DNA-REPLICATION; SNP RS6983267	During cell division, transcription factors (TFs) are removed from chromatin twice, during DNA synthesis and during condensation of chromosomes. How TFs can efficiently find their sites following these stages has been unclear. Here, we have analyzed the binding pattern of expressed TFs in human colorectal cancer cells. We find that binding of TFs is highly clustered and that the clusters are enriched in binding motifs for several major TF classes. Strikingly, almost all clusters are formed around cohesin, and loss of cohesin decreases both DNA accessibility and binding of TFs to clusters. We show that cohesin remains bound in S phase, holding the nascent sister chromatids together at the TF cluster sites. Furthermore, cohesin remains bound to the cluster sites when TFs are evicted in early M phase. These results suggest that cohesin-binding functions as a cellular memory that promotes re-establishment of TF clusters after DNA replication and chromatin condensation.	[Yan, Jian; Enge, Martin; Whitington, Thomas; Dave, Kashyap; Liu, Jianping; Sur, Inderpreet; Schmierer, Bernhard; Jolma, Arttu; Kivioja, Teemu; Taipale, Minna; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Sci Life Lab, S-14183 Stockholm, Sweden; [Kivioja, Teemu] Univ Helsinki, Dept Comp Sci, Helsinki 00014, Finland; [Kivioja, Teemu; Taipale, Minna; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland	Karolinska Institutet; University of Helsinki; University of Helsinki	Taipale, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Sci Life Lab, S-14183 Stockholm, Sweden.	jussi.taipale@ki.se	Dave, Kashyap/D-3290-2014; Jolma, Arttu/AAK-9649-2021; Yan, Jian/B-2631-2018; Schmierer, Bernhard/P-4208-2019; Enge, Martin/GYQ-5073-2022	Dave, Kashyap/0000-0003-0332-8362; Yan, Jian/0000-0002-1267-2870; Schmierer, Bernhard/0000-0002-9082-7022; Jolma, Arttu/0000-0002-2543-7490; Taipale, Minna/0000-0002-1905-2551; Enge, Martin/0000-0001-8748-8931; Sur, Inderpreet Kaur/0000-0001-5787-1040; Liu, Jianping/0000-0002-7336-3895	EU FP7 project SYSCOL; Goran Gustafssons stiftelse; Knut and Alice Wallenberg Foundation; Vetenskapsradet; Cancerfonden; Center for Biosciences; Academy of Finland Center of Excellence in Cancer Genetics	EU FP7 project SYSCOL; Goran Gustafssons stiftelse; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vetenskapsradet(Swedish Research Council); Cancerfonden(Swedish Cancer Society); Center for Biosciences; Academy of Finland Center of Excellence in Cancer Genetics	We thank R. Nurmi, S. Miettinen, S. Augsten, L. Hu, and A. Zetterlund for technical assistance. This work was supported by the EU FP7 project SYSCOL, Goran Gustafssons stiftelse, Knut and Alice Wallenberg Foundation, Vetenskapsradet, Cancerfonden, the Center for Biosciences and the Academy of Finland Center of Excellence in Cancer Genetics.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BODE J, 1980, EUR J BIOCHEM, V110, P143, DOI 10.1111/j.1432-1033.1980.tb04849.x; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; OLIVA R, 1987, J BIOL CHEM, V262, P17016; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Rollins RA, 1999, GENETICS, V152, P577; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Whitington T, 2009, NUCLEIC ACIDS RES, V37, P14, DOI 10.1093/nar/gkn866; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	44	235	239	0	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					801	813		10.1016/j.cell.2013.07.034	http://dx.doi.org/10.1016/j.cell.2013.07.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953112	Bronze			2022-12-28	WOS:000323202500012
J	Zeuzem, S; Soriano, V; Asselah, T; Bronowicki, JP; Lohse, AW; Mullhaupt, B; Schuchmann, M; Bourliere, M; Buti, M; Roberts, SK; Gane, EJ; Stern, JO; Vinisko, R; Kukolj, MAG; Gallivan, JP; Bocher, WO; Mensa, FJ				Zeuzem, Stefan; Soriano, Vincent; Asselah, Tarik; Bronowicki, Jean-Pierre; Lohse, Ansgar W.; Muellhaupt, Beat; Schuchmann, Marcus; Bourliere, Marc; Buti, Maria; Roberts, Stuart K.; Gane, Ed J.; Stern, Jerry O.; Vinisko, Richard; Kukolj, M. A. George; Gallivan, John-Paul; Boecher, Wulf-Otto; Mensa, Federico J.			Faldaprevir and Deleobuvir for HCV Genotype 1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERFERON-FREE REGIMEN; PROTEASE INHIBITOR; ANTIVIRAL AGENTS; RIBAVIRIN; COMBINATION; BOCEPREVIR; TELAPREVIR; RESISTANCE; ABT-450/R; ALPHA-2A	BackgroundInterferon-free regimens would be a major advance in the treatment of patients with chronic hepatitis C virus (HCV) infection. MethodsIn this phase 2b, randomized, open-label trial of faldaprevir (a protease inhibitor) and deleobuvir (a nonnucleoside polymerase inhibitor), we randomly assigned 362 previously untreated patients with HCV genotype 1 infection to one of five groups: faldaprevir at a dose of 120 mg once daily and deleobuvir at a dose of 600 mg three times daily, plus ribavirin, for 16, 28, or 40 weeks (TID16W, TID28W, or TID40W, respectively); faldaprevir at a dose of 120 mg once daily and deleobuvir at a dose of 600 mg twice daily, plus ribavirin, for 28 weeks (BID28W); or faldaprevir at a dose of 120 mg once daily and deleobuvir at a dose of 600 mg three times daily, without ribavirin, for 28 weeks (TID28W-NR). The primary end point was a sustained virologic response 12 weeks after the completion of therapy. ResultsThe primary end point was met in 59% of patients in the TID16W group, 59% of patients in the TID28W group, 52% of patients in the TID40W group, 69% of patients in the BID28W group, and 39% of patients in the TID28W-NR group. The sustained virologic response 12 weeks after the completion of therapy did not differ significantly according to treatment duration or dosage among ribavirin-containing regimens. This response was significantly higher with TID28W than with TID28W-NR (P=0.03). Rates of a sustained virologic response 12 weeks after the completion of therapy were 56 to 85% among patients with genotype 1b infection versus 11 to 47% among patients with genotype 1a infection and 58 to 84% among patients with IL28B CC versus 33 to 64% with non-CC genotypes. Rash, photosensitivity, nausea, vomiting, and diarrhea were the most common adverse events. ConclusionsThe rate of a sustained virologic response 12 weeks after the completion of therapy was 52 to 69% among patients who received interferon-free treatment with faldaprevir in combination with deleobuvir plus ribavirin. (Funded by Boehringer Ingelheim; SOUND-C2 ClinicalTrials.gov number, NCT01132313.) In this phase 2b study, an interferon-free regimen consisting of the combination of a protease inhibitor (faldaprevir), a nonnucleoside polymerase inhibitor (deleobuvir), and ribavirin was effective for the treatment of chronic hepatitis C virus infection. The introduction of the direct-acting antiviral agents telaprevir and boceprevir (nonstructural protein 3/4A [NS3/4A] protease inhibitors) was a major advance in the management of chronic infection with hepatitis C virus (HCV) genotype 1, the most prevalent and difficult-to-cure genotype.(1) However, these drugs are used in combination with pegylated interferon alfa and ribavirin, which are associated with a high rate of side effects and discontinuation.(2) In addition, many patients cannot receive pegylated interferon because of contraindications.(3) Host genetic factors are known to influence the response to treatment with pegylated interferon and ribavirin in patients infected with HCV genotype 1. Single-nucleotide polymorphisms ...	[Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, D-60590 Frankfurt, Germany; [Lohse, Ansgar W.] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Schuchmann, Marcus] Univ Hosp Mainz, Mainz, Germany; [Bronowicki, Jean-Pierre; Boecher, Wulf-Otto] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany; [Soriano, Vincent] Hosp Carlos III, Dept Infect Dis, Madrid, Spain; [Asselah, Tarik] Univ Paris 07, Beaujon Hosp, AP HP, INSERM,U773,CRB3, Clichy, France; [Bronowicki, Jean-Pierre] Ctr Hosp Univ Nancy, INSERM, U954, Vandoeuvre Les Nancy, France; [Bronowicki, Jean-Pierre] Univ Lorraine, Vandoeuvre Les Nancy, France; [Bourliere, Marc] Hop St Joseph, Marseille, France; [Muellhaupt, Beat] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Buti, Maria] Hosp Univ Vall dHebron, Ciberehd Inst Carlos 3, Barcelona, Spain; [Roberts, Stuart K.] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Gane, Ed J.] Auckland Clin Studies, Auckland, New Zealand; [Stern, Jerry O.; Vinisko, Richard; Mensa, Federico J.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; Boehringer Ingelheim Pharmaceut Inc, Laval, PQ, Canada	Goethe University Frankfurt; University of Hamburg; University Medical Center Hamburg-Eppendorf; University Hospital Mainz; Boehringer Ingelheim; Hospital Carlos III; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; University of Zurich; University Zurich Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; Florey Institute of Neuroscience & Mental Health; Boehringer Ingelheim; Boehringer Ingelheim	Zeuzem, S (corresponding author), Goethe Univ Frankfurt, Med Ctr, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeuzem@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Soriano, Vicente/O-5730-2018; Mullhaupt, Beat/O-3744-2016	Soriano, Vicente/0000-0002-4624-5199; Buti Ferret, Maria/0000-0002-0732-3078; Mullhaupt, Beat/0000-0002-9020-8192	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Supported by Boehringer Ingelheim.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Beaulieu PL, 2012, J HEPATOL, V56, pS321, DOI 10.1016/S0168-8278(12)60834-4; Di Bisceglie AM, 2011, J HEPATOL, V54, pS540, DOI 10.1016/S0168-8278(11)61365-2; Florian J, 2011, HEPATOLOGY, V54, p1444A; Gane EJ, 2012, J HEPATOL, V56, pS555, DOI 10.1016/S0168-8278(12)61423-8; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Koch GG, 1990, STAT METHODOLOGY PHA, P414; Kramer JR, 2012, J HEPATOL, V56, P320, DOI 10.1016/j.jhep.2011.05.032; Larrey D, 2009, HEPATOLOGY, V50, p267A; Lawitz E, 2012, J HEPATOL, V56, pS7, DOI 10.1016/S0168-8278(12)60027-0; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Ogawa E, 2012, J GASTROEN HEPATOL, V27, P1233, DOI 10.1111/j.1440-1746.2011.06965.x; Poordad F, 2012, J HEPATOL, V56, pS549, DOI 10.1016/S0168-8278(12)61410-X; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reesink HW, 2010, GASTROENTEROLOGY, V138, P913, DOI 10.1053/j.gastro.2009.10.033; Sane R, 2011, J HEPATOL, V54, pS488, DOI 10.1016/S0168-8278(11)61238-5; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sulkowski M, 2012, J HEPATOL, V56, pS560; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	29	191	193	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					630	639		10.1056/NEJMoa1213557	http://dx.doi.org/10.1056/NEJMoa1213557			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944300	Green Accepted			2022-12-28	WOS:000326354500009
J	Spechler, SJ				Spechler, Stuart Jon			Barrett Esophagus and Risk of Esophageal Cancer A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GASTROESOPHAGEAL-REFLUX DISEASE; PROTON PUMP INHIBITORS; ENDOSCOPIC SURVEILLANCE; RADIOFREQUENCY ABLATION; NEOPLASTIC PROGRESSION; INTESTINAL METAPLASIA; GRADE DYSPLASIA; GASTRIC CARDIA; ADENOCARCINOMA; THERAPY	IMPORTANCE Barrett esophagus, a complication of gastroesophageal reflux disease (GERD), predisposes patients to esophageal adenocarcinoma, a tumor that has increased in incidence more than 7-fold over the past several decades. Controversy exists regarding the issues of endoscopic screening and surveillance for Barrett esophagus, treatment for the underlying GERD, and the role of endoscopic eradication therapy. OBJECTIVES To review current concepts on the pathogenesis, diagnosis, and treatment of Barrett esophagus; to discuss the importance of dysplasia and the role of endoscopic eradication therapy for its treatment; and to review current management guidelines. EVIDENCE REVIEW MEDLINE and the Cochrane Library were searched from 1984 to April 2013. Additional citations were obtained by reviewing references from selected research and review articles. FINDINGS Risk factors for cancer in Barrett esophagus include chronic GERD, hiatal hernia, advanced age, male sex, white race, cigarette smoking, and obesity with an intra-abdominal body fat distribution. The annual risk of esophageal cancer is approximately 0.25% for patients without dysplasia and 6% for patients with high-grade dysplasia. High-quality studies have found no significant differences in cancer incidence for patients with Barrett esophagus whose GERD is treated medically or surgically. Endoscopic eradication therapy with radiofrequency ablation significantly reduces the frequency of progression to cancer for patients with high-grade dysplasia. CONCLUSIONS AND RELEVANCE Endoscopic screening is recommended for patients with multiple risk factors for cancer in Barrett esophagus. For patients with Barrett esophagus without dysplasia, endoscopic surveillance at intervals of 3 to 5 years is recommended, and GERD is treated much as it is for patients without Barrett esophagus. Endoscopic eradication therapy is the treatment of choice for high-grade dysplasia and is an option for low-grade dysplasia. Endoscopic eradication therapy is not recommended for the general population of patients with nondysplastic Barrett esophagus.	[Spechler, Stuart Jon] VA North Texas Healthcare Syst, Dallas, TX USA; [Spechler, Stuart Jon] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Spechler, SJ (corresponding author), Dallas VA Med Ctr 111B1, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	sjspechler@aol.com			BARRX Medical	BARRX Medical	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Spechler reports consulting for Torax Medical, Ironwood Pharmaceuticals, and Takeda and research support from BARRX Medical.	Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Bulsiewicz WJ, 2013, CLIN GASTROENTEROL H, V11, P636, DOI 10.1016/j.cgh.2012.10.028; Burke ZD, 2012, CURR OPIN GENET DEV, V22, P494, DOI 10.1016/j.gde.2012.08.001; Buttar NS, 2002, GASTROENTEROLOGY, V122, P1101, DOI 10.1053/gast.2002.32371; Chang EY, 2007, ANN SURG, V246, P11, DOI 10.1097/01.sla.0000261459.10565.e9; Coleman HG, 2011, EUR J EPIDEMIOL, V26, P739, DOI 10.1007/s10654-011-9596-z; Cook MB, 2012, GASTROENTEROLOGY, V142, P744, DOI 10.1053/j.gastro.2011.12.049; Corey KE, 2003, AM J GASTROENTEROL, V98, P2390, DOI 10.1016/j.amjgastroenterol.2003.08.008; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Crockett SD, 2009, CLIN GASTROENTEROL H, V7, P613, DOI 10.1016/j.cgh.2009.02.024; Curvers WL, 2010, AM J GASTROENTEROL, V105, P1523, DOI 10.1038/ajg.2010.171; de Jager CPC, 2012, ALIMENT PHARM THER, V36, P941, DOI 10.1111/apt.12069; Desai TK, 2012, GUT, V61, P970, DOI 10.1136/gutjnl-2011-300730; Deshpande A, 2013, J GASTROEN HEPATOL, V28, P235, DOI 10.1111/jgh.12065; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; Dunbar KB, 2012, AM J GASTROENTEROL, V107, P850, DOI 10.1038/ajg.2012.78; Dunn SP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004564; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; El-Serag HB, 2006, GASTROINTEST ENDOSC, V64, P671, DOI 10.1016/j.gie.2006.03.010; El-Serag HB, 2014, GUT, V63, P220, DOI 10.1136/gutjnl-2012-304189; El-Serag HB, 2011, GASTROENTEROLOGY, V140, P386, DOI 10.1053/j.gastro.2010.12.019; El-Serag HB, 2004, AM J GASTROENTEROL, V99, P1877, DOI 10.1111/j.1572-0241.2004.30228.x; Evans JA, 2012, GASTROINTEST ENDOSC, V76, P1087, DOI 10.1016/j.gie.2012.08.004; Fischbach LA, 2012, HELICOBACTER, V17, P163, DOI 10.1111/j.1523-5378.2011.00931.x; Fleischer DE, 2010, DIGEST DIS SCI, V55, P1918, DOI 10.1007/s10620-010-1218-1; Fraser LA, 2013, OSTEOPOROSIS INT, V24, P1161, DOI 10.1007/s00198-012-2112-9; Gray NA, 2011, AM J GASTROENTEROL, V106, P1899, DOI 10.1038/ajg.2011.255; Haigh CR, 2003, GASTROENTEROLOGY, V124, P615, DOI 10.1053/gast.2003.50091; Hillman LC, 2004, MED J AUSTRALIA, V180, P387, DOI 10.5694/j.1326-5377.2004.tb05991.x; Huo XF, 2011, AM J PHYSIOL-GASTR L, V301, pG278, DOI 10.1152/ajpgi.00092.2011; Hur C, 2004, J NATL CANCER I, V96, P316, DOI 10.1093/jnci/djh039; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Iijima K, 2002, GASTROENTEROLOGY, V122, P1248, DOI 10.1053/gast.2002.32963; Inadomi JM, 2003, ANN INTERN MED, V138, P176, DOI 10.7326/0003-4819-138-3-200302040-00009; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; Johnson DA, 2013, CLIN GASTROENTEROL H, V11, P458, DOI 10.1016/j.cgh.2012.11.031; Kastelein F, 2013, CLIN GASTROENTEROL H, V11, P382, DOI 10.1016/j.cgh.2012.11.014; Kastelein F, 2011, GASTROENTEROLOGY, V141, P2000, DOI 10.1053/j.gastro.2011.08.036; Katz D, 1998, AM J GASTROENTEROL, V93, P536; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Keszthelyi D, 2010, ALIMENT PHARM THER, V32, P1124, DOI 10.1111/j.1365-2036.2010.04453.x; Kuipers EJ, 2006, BASIC CLIN PHARMACOL, V99, P187, DOI 10.1111/j.1742-7843.2006.pto_478.x; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; LAMBERTS R, 1993, GASTROENTEROLOGY, V104, P1356, DOI 10.1016/0016-5085(93)90344-C; Leers JM, 2011, ANN SURG, V253, P271, DOI 10.1097/SLA.0b013e3181fbad42; Lo WK, 2013, CLIN GASTROENTEROL H, V11, P483, DOI 10.1016/j.cgh.2012.12.011; Merwat SN, 2009, AM J GASTROENTEROL, V104, P1897, DOI 10.1038/ajg.2009.87; Namasivayam V, 2010, CLIN GASTROENTEROL H, V8, P743, DOI 10.1016/j.cgh.2010.05.030; Naylor Gregory, 2003, Can J Gastroenterol, V17 Suppl B, p13B; Oberg S, 2005, ANN SURG, V242, P49, DOI 10.1097/01.sla.0000167864.46462.9f; Ouatu-Lascar R, 1999, GASTROENTEROLOGY, V117, P327, DOI 10.1053/gast.1999.0029900327; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; Pechz O, 2008, GUT, V57, P1200, DOI 10.1136/gut.2007.142539; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Quasdorff M, 2011, ANN INTERN MED, V155, P405, DOI 10.7326/0003-4819-155-6-201109200-00022; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Rice TW, 2011, J THORAC CARDIOV SUR, V141, P875, DOI 10.1016/j.jtcvs.2010.12.022; Richter JE, 2013, CLIN GASTROENTEROL H, V11, P465, DOI 10.1016/j.cgh.2012.12.006; Riddell RH, 2009, AM J GASTROENTEROL, V104, P2588, DOI 10.1038/ajg.2009.390; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rubenstein JH, 2008, GASTROINTEST ENDOSC, V68, P849, DOI 10.1016/j.gie.2008.02.062; Sarosi G, 2008, DIS ESOPHAGUS, V21, P43, DOI 10.1111/j.1442-2050.2007.00744.x; Sarzynski E, 2011, DIGEST DIS SCI, V56, P2349, DOI 10.1007/s10620-011-1589-y; Shaheen NJ, 2012, ANN INTERN MED, V157, P808, DOI 10.7326/0003-4819-157-11-201212040-00008; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6; Shaheen NJ, 2005, AM J GASTROENTEROL, V100, P577, DOI 10.1111/j.1572-0241.2005.41422.x; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 1998, AM J GASTROENTEROL, V93, P1033; Sierra F, 2007, ALIMENT PHARM THER, V26, P545, DOI 10.1111/j.1365-2036.2007.03407.x; Sikkema M, 2011, AM J GASTROENTEROL, V106, P1231, DOI 10.1038/ajg.2011.153; Society for Surgery of the Alimentary Tract, SSAT PAT CAR GUID MA; Sonnenberg A, 2002, ALIMENT PHARM THERAP, V16, P41, DOI 10.1046/j.1365-2036.2002.01146.x; Souza RF, 2000, CANCER RES, V60, P5767; Souza RF, 2005, CA-CANCER J CLIN, V55, P334, DOI 10.3322/canjclin.55.6.334; Spechler SJ, 2005, AM J GASTROENTEROL, V100, P927, DOI 10.1111/j.1572-0241.2005.41201.x; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; SPECHLER SJ, 1994, LANCET, V344, P1533, DOI 10.1016/S0140-6736(94)90349-2; Spechler SJ, 2007, NAT CLIN PRACT GASTR, V4, P470, DOI 10.1038/ncpgasthep0876; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; Spechler SJ, 2012, CLIN GASTROENTEROL H, V10, P1237, DOI 10.1016/j.cgh.2012.08.015; Tejani MA, 2012, CURR TREAT OPTION ON, V13, P390, DOI 10.1007/s11864-012-0193-5; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Tran T, 2005, AM J GASTROENTEROL, V100, P1002, DOI 10.1111/j.1572-0241.2005.41007.x; Vaccaro BJ, 2011, DIGEST DIS SCI, V56, P1996, DOI 10.1007/s10620-011-1680-4; vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5; Wang A, 2009, DIGEST DIS SCI, V54, P964, DOI 10.1007/s10620-009-0742-3; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Wani S, 2011, CLIN GASTROENTEROL H, V9, P220, DOI 10.1016/j.cgh.2010.11.008; Williams C, 2006, ALIMENT PHARM THER, V23, P3, DOI 10.1111/j.1365-2036.2006.02707.x; Winberg H, 2012, SCAND J GASTROENTERO, V47, P397, DOI 10.3109/00365521.2012.667145; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569; Zhang HY, 2009, CANCER RES, V69, P9083, DOI 10.1158/0008-5472.CAN-09-2518; Zhou C, 2012, GASTROINTEST ENDOSC, V76, P32, DOI 10.1016/j.gie.2012.02.003; Zhu H, 2006, J MED MICROBIOL, V55, P1265, DOI 10.1099/jmm.0.46611-0	103	166	171	5	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					627	636		10.1001/jama.2013.226450	http://dx.doi.org/10.1001/jama.2013.226450			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942681				2022-12-28	WOS:000323058400018
J	Reynolds, RM; Allan, KM; Raja, EA; Bhattacharya, S; McNeill, G; Hannaford, PC; Sarwar, N; Lee, AJ; Bhattacharya, S; Norman, JE				Reynolds, Rebecca M.; Allan, Keith M.; Raja, Edwin A.; Bhattacharya, Sohinee; McNeill, Geraldine; Hannaford, Philip C.; Sarwar, Nadeem; Lee, Amanda J.; Bhattacharya, Siladitya; Norman, Jane E.			Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; WEIGHT-GAIN; INSULIN-RESISTANCE; RISK-FACTORS; ADIPOSITY; BIRTH; COHORT; MEN; ASSOCIATIONS	Objectives To determine whether maternal obesity during pregnancy is associated with increased mortality from cardiovascular events in adult offspring. Design Record linkage cohort analysis. Setting Birth records from the Aberdeen Maternity and Neonatal databank linked to the General Register of Deaths, Scotland, and the Scottish Morbidity Record systems. Population 37 709 people with birth records from 1950 to present day. Main outcome measures Death and hospital admissions for cardiovascular events up to 1 January 2012 in offspring aged 34-61. Maternal body mass index (BMI) was calculated from height and weight measured at the first antenatal visit. The effect of maternal obesity on outcomes in offspring was tested with time to event analysis with Cox proportional hazard regression to compare outcomes in offspring of mothers in underweight, overweight, or obese categories of BMI compared with offspring of women with normal BMI. Results All cause mortality was increased in offspring of obese mothers (BMI >30) compared with mothers with normal BMI after adjustment for maternal age at delivery, socioeconomic status, sex of offspring, current age, birth weight, gestation at delivery, and gestation at measurement of BMI (hazard ratio 1.35, 95% confidence interval 1.17 to 1.55). In adjusted models, offspring of obese mothers also had an increased risk of hospital admission for a cardiovascular event (1.29, 1.06 to 1.57) compared with offspring of mothers with normal BMI. The offspring of overweight mothers also had a higher risk of adverse outcomes. Conclusions Maternal obesity is associated with an increased risk of premature death in adult offspring. As one in five women in the United Kingdom is obese at antenatal booking, strategies to optimise weight before pregnancy are urgently required.	[Reynolds, Rebecca M.] Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH14 6TJ, Midlothian, Scotland; [Allan, Keith M.; Raja, Edwin A.; Bhattacharya, Sohinee; McNeill, Geraldine; Hannaford, Philip C.; Sarwar, Nadeem; Lee, Amanda J.; Bhattacharya, Siladitya] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Norman, Jane E.] Univ Edinburgh, Queens Med Res Inst, Med Res Council Ctr Reprod Hlth, Tommys Ctr Fetal & Maternal Hlth, Edinburgh EH14 6TJ, Midlothian, Scotland	University of Edinburgh; University of Aberdeen; University of Edinburgh	Reynolds, RM (corresponding author), Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH14 6TJ, Midlothian, Scotland.	R.Reynolds@ed.ac.uk	Reynolds, Rebecca M/C-3044-2008	Reynolds, Rebecca M/0000-0001-6226-8270; McNeill, Geraldine/0000-0003-0373-650X; Bhattacharya, Sohinee/0000-0002-2358-5860; Norman, Jane/0000-0001-6031-6953; Bhattacharya, Siladitya/0000-0002-4588-356X	chief scientist office, Scotland; Chest, Heart and Stroke, Scotland; Tommy's and the British Heart Foundation; MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: researchfish; Chief Scientist Office [CZB/4/582, CZG/2/478] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09/01PhD] Funding Source: researchfish	chief scientist office, Scotland; Chest, Heart and Stroke, Scotland; Tommy's and the British Heart Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; The Sir Jules Thorn Charitable Trust	This work was supported by grants from the chief scientist office, Scotland, and Chest, Heart and Stroke, Scotland. We also acknowledge support from Tommy's and the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Dupout WD, 2008, STAT MODELLING BIOME; Fattah C, 2009, EUR J OBSTET GYN R B, V144, P32, DOI 10.1016/j.ejogrb.2009.01.015; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010; Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048; LASKARZEWSKI P, 1980, AM J CLIN NUTR, V33, P2350, DOI 10.1093/ajcn/33.11.2350; Lawlor DA, 2011, AM J CLIN NUTR, V94, P142, DOI 10.3945/ajcn.110.009324; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Reynolds RM, 2001, J CLIN ENDOCR METAB, V86, P245, DOI 10.1210/jc.86.1.245; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854	27	327	331	2	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2013	347								f4539	10.1136/bmj.f4539	http://dx.doi.org/10.1136/bmj.f4539			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203XY	23943697	Green Published, hybrid			2022-12-28	WOS:000323329300003
J	Murray, CJL				Murray, Christopher J. L.			GBD 2013: open call for collaborators	LANCET			English	Editorial Material									Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					491	492		10.1016/S0140-6736(13)61692-X	http://dx.doi.org/10.1016/S0140-6736(13)61692-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23931912				2022-12-28	WOS:000323162400010
J	Colbert, JA				Colbert, James A.			Experiments in Continuity Rethinking Residency Training in Ambulatory Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERNAL-MEDICINE		[Colbert, James A.] Newton Wellesley Hosp, Dept Med, Newton, MA USA; [Colbert, James A.] Brigham & Womens Hosp, Div Med Commun, Boston, MA 02115 USA	Newton Wellesley Hospital; Harvard University; Brigham & Women's Hospital	Colbert, JA (corresponding author), Newton Wellesley Hosp, Dept Med, Newton, MA USA.							Bodenheimer T, 2011, NEW ENGL J MED, V365, P5, DOI 10.1056/NEJMp1104942; Chang A, 2013, J GEN INTERN MED, V28, P801, DOI 10.1007/s11606-012-2193-3; Meyers FJ, 2007, ACAD MED, V82, P1211, DOI 10.1097/ACM.0b013e318159d010; Mladenovic J, 2008, J GEN INTERN MED, V23, P914, DOI 10.1007/s11606-008-0511-6; Warm EJ, 2008, J GEN INTERN MED, V23, P921, DOI 10.1007/s11606-008-0588-y	5	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					504	505		10.1056/NEJMp1301604	http://dx.doi.org/10.1056/NEJMp1301604			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197HX	23924001				2022-12-28	WOS:000322842000005
J	Tol, WA; Barbui, C; van Ommeren, M				Tol, Wietse A.; Barbui, Corrado; van Ommeren, Mark			Management of Acute Stress, PTSD, and Bereavement WHO Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tol, Wietse A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Barbui, Corrado] Univ Verona, WHO, Collaborating Ctr Res & Training Mental Hlth & Se, Sect Psychiat,Dept Publ Hlth & Community Med, I-37100 Verona, Italy; [van Ommeren, Mark] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva 27, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Verona; World Health Organization; World Health Organization	van Ommeren, M (corresponding author), WHO, Dept Mental Hlth & Subst Abuse, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	vanommerenm@who.int						Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Bass JK, 2013, NEW ENGL J MED, V368, P2182, DOI 10.1056/NEJMoa1211853; Benedek DM, GUIDELINEWATCH MARCH; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Maercker A, 2013, LANCET, V381, P1683, DOI 10.1016/S0140-6736(12)62191-6; World Health Organization, MHGAP INTERVENTION G; World Health Organization, GUIDELINES FOR THE M; World Health Organization, WHO HANDBOOK FOR GUI; World Health Organization and United Nations High Commissioner for Refugees, ASSESSMENT AND MANAG	9	82	84	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					477	478		10.1001/jama.2013.166723	http://dx.doi.org/10.1001/jama.2013.166723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925613				2022-12-28	WOS:000322786400015
J	Steventon, A; Tunkel, S; Blunt, I; Bardsley, M				Steventon, Adam; Tunkel, Sarah; Blunt, Ian; Bardsley, Martin			Effect of telephone health coaching (Birmingham OwnHealth) on hospital use and associated costs: cohort study with matched controls	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROPENSITY-SCORE; CORONARY-ANGIOGRAPHY; MEDICAL LITERATURE; CRITICAL-APPRAISAL; CARE; PEOPLE; INTERVENTION; MORTALITY; ADMISSION; SERVICE	Objectives To test the effect of a telephone health coaching service (Birmingham OwnHealth) on hospital use and associated costs. Design Analysis of person level administrative data. Difference-in-difference analysis was done relative to matched controls. Setting Community based intervention operating in a large English city with industry. Participants 2698 patients recruited from local general practices before 2009 with heart failure, coronary heart disease, diabetes, or chronic obstructive pulmonary disease; and a history of inpatient or outpatient hospital use. These individuals were matched on a 1:1 basis to control patients from similar areas of England with respect to demographics, diagnoses of health conditions, previous hospital use, and a predictive risk score. Intervention Telephone health coaching involved a personalised care plan and a series of outbound calls usually scheduled monthly. Median length of time enrolled on the service was 25.5 months. Control participants received usual healthcare in their areas, which did not include telephone health coaching. Main outcome measures Number of emergency hospital admissions per head over 12 months after enrolment. Secondary metrics calculated over 12 months were: hospital bed days, elective hospital admissions, outpatient attendances, and secondary care costs. Results In relation to diagnoses of health conditions and other baseline variables, matched controls and intervention patients were similar before the date of enrolment. After this point, emergency admissions increased more quickly among intervention participants than matched controls (difference 0.05 admissions per head, 95% confidence interval 0.00 to 0.09, P=0.046). Outpatient attendances also increased more quickly in the intervention group (difference 0.37 attendances per head, 0.16 to 0.58, P<0.001), as did secondary care costs (difference 175 pound per head, 22 pound to 328 pound, P=0.025). Checks showed that we were unlikely to have missed reductions in emergency admissions because of unobserved differences between intervention and matched control groups. Conclusions The Birmingham OwnHealth telephone health coaching intervention did not lead to the expected reductions in hospital admissions or secondary care costs over 12 months, and could have led to increases.	[Steventon, Adam; Blunt, Ian; Bardsley, Martin] Nuffield Trust, London W1G 7LP, England; [Tunkel, Sarah] Ernst & Young, London SE1 2AF, England		Steventon, A (corresponding author), Nuffield Trust, London W1G 7LP, England.	adam.steventon@nuffieldtrust.org.uk			Department of Health in England	Department of Health in England	This study was funded by the Department of Health in England, which reviewed the study protocol as part of the application for funding and agreed to publication. The views expressed are those of the authors and not of the Department of Health and does not constitute any form of assurance, legal opinion or advice. The organisations at which the authors are based shall have no liability to any third party in respect to the contents of this article.	Alkema GE, 2007, HEALTH SERV RES, V42, P1632, DOI 10.1111/j.1475-6773.2006.00668.x; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2008, STAT MED, V27, P2066, DOI 10.1002/sim.3243; Azarmina P, 2007, J TELEMED TELECARE, V13, pS3; Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Birmingham East and North NHS NHS Direct and Pfizer Health Solutions, 2007, OWNHEALTH BIRM SUCC; Communities and Local Government, 2008, ENGLISH INDICES DEPR; Direct NHS, 2011, CHIEF EX REP AG IT 6; Fouche Eveline, 2009, RAMZI ADAM; Govan L, 2011, DIABETES CARE, V34, P1992, DOI 10.2337/dc10-2099; Gravelle H, 2006, BMJ; Groenwold RHH, 2009, J CLIN EPIDEMIOL, V62, P22, DOI 10.1016/j.jclinepi.2008.02.011; Hansen BB, 2008, BIOMETRIKA, V95, P481, DOI 10.1093/biomet/asn004; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hutchison AJ, 2011, J TELEMED TELECARE, V17, P451, DOI 10.1258/jtt.2011.110513; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Information Centre for health and social care, 2012, QUAL OUTC FRAM ACH P; Jordan RE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-707; Kim SE, 2013, HEALTH SERV RES, V48, P1730, DOI 10.1111/1475-6773.12060; Lin WC, 2012, MED CARE, V50, P91, DOI 10.1097/MLR.0b013e31822dcedf; Lucas FL, 2008, CIRCULATION, V118, P2797, DOI 10.1161/CIRCULATIONAHA.108.789446; McLean S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d120; Motheral Brenda R, 2011, Am J Manag Care, V17, pe10; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Office for National Statistics, NAT STAT 2001 AR CLA; Richards SH, 2003, HEALTH SOC CARE COMM, V11, P510, DOI 10.1046/j.1365-2524.2003.00457.x; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Steventon Adam, 2012, BMJ, V344, pe3874, DOI 10.1136/bmj.e3874; Steventon A, 2012, HEALTH SERV RES, V47, P1679, DOI 10.1111/j.1475-6773.2011.01367.x; Subramanian U, 2004, TELEMED J E-HEALTH, V10, P155, DOI 10.1089/1530562041641345; The Health and Social Care information Centre, 2012, HOSP EP STAT; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; Wennberg JE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f549; West SG, 2008, AM J PUBLIC HEALTH, V98, P1359, DOI 10.2105/AJPH.2007.124446	41	26	27	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2013	347								f4585	10.1136/bmj.f4585	http://dx.doi.org/10.1136/bmj.f4585			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201CT	23920348	hybrid, Green Published			2022-12-28	WOS:000323119000001
J	Francalacci, P; Morelli, L; Angius, A; Berutti, R; Reinier, F; Atzeni, R; Pilu, R; Busonero, F; Maschio, A; Zara, I; Sanna, D; Useli, A; Urru, MF; Marcelli, M; Cusano, R; Oppo, M; Zoledziewska, M; Pitzalis, M; Deidda, F; Porcu, E; Poddie, F; Kang, HM; Lyons, R; Tarrier, B; Gresham, JB; Li, BS; Tofanelli, S; Alonso, S; Dei, M; Lai, S; Mulas, A; Whalen, MB; Uzzau, S; Jones, C; Schlessinger, D; Abecasis, GR; Sanna, S; Sidore, C; Cucca, F				Francalacci, Paolo; Morelli, Laura; Angius, Andrea; Berutti, Riccardo; Reinier, Frederic; Atzeni, Rossano; Pilu, Rosella; Busonero, Fabio; Maschio, Andrea; Zara, Ilenia; Sanna, Daria; Useli, Antonella; Urru, Maria Francesca; Marcelli, Marco; Cusano, Roberto; Oppo, Manuela; Zoledziewska, Magdalena; Pitzalis, Maristella; Deidda, Francesca; Porcu, Eleonora; Poddie, Fausto; Kang, Hyun Min; Lyons, Robert; Tarrier, Brendan; Gresham, Jennifer Bragg; Li, Bingshan; Tofanelli, Sergio; Alonso, Santos; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Whalen, Michael B.; Uzzau, Sergio; Jones, Chris; Schlessinger, David; Abecasis, Gonalo R.; Sanna, Serena; Sidore, Carlo; Cucca, Francesco			Low-Pass DNA Sequencing of 1200 Sardinians Reconstructs European Y-Chromosome Phylogeny	SCIENCE			English	Article							HUMAN-EVOLUTION; MODERN HUMANS; AFRICA; ORIGIN; LEGACY; TREE; ROOT	Genetic variation within the male-specific portion of the Y chromosome (MSY) can clarify the origins of contemporary populations, but previous studies were hampered by partial genetic information. Population sequencing of 1204 Sardinian males identified 11,763 MSY single-nucleotide polymorphisms, 6751 of which have not previously been observed. We constructed a MSY phylogenetic tree containing all main haplogroups found in Europe, along with many Sardinian-specific lineage clusters within each haplogroup. The tree was calibrated with archaeological data from the initial expansion of the Sardinian population similar to 7700 years ago. The ages of nodes highlight different genetic strata in Sardinia and reveal the presumptive timing of coalescence with other human populations. We calculate a putative age for coalescence of similar to 180,000 to 200,000 years ago, which is consistent with previous mitochondrial DNA-based estimates.	[Francalacci, Paolo; Morelli, Laura; Sanna, Daria; Useli, Antonella] Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy; [Angius, Andrea; Pilu, Rosella; Busonero, Fabio; Maschio, Andrea; Zoledziewska, Magdalena; Pitzalis, Maristella; Deidda, Francesca; Porcu, Eleonora; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Whalen, Michael B.; Sanna, Serena; Sidore, Carlo; Cucca, Francesco] CNR, IRGB, Monserrato, Italy; [Angius, Andrea; Berutti, Riccardo; Reinier, Frederic; Atzeni, Rossano; Zara, Ilenia; Urru, Maria Francesca; Marcelli, Marco; Cusano, Roberto; Oppo, Manuela; Jones, Chris] Ctr Adv Studies Res & Dev Sardinia CRS4, Pula, Italy; [Berutti, Riccardo; Zoledziewska, Magdalena; Pitzalis, Maristella; Deidda, Francesca; Porcu, Eleonora; Poddie, Fausto; Uzzau, Sergio; Sidore, Carlo; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Busonero, Fabio; Maschio, Andrea; Porcu, Eleonora; Kang, Hyun Min; Abecasis, Gonalo R.; Sidore, Carlo] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Lyons, Robert; Tarrier, Brendan; Gresham, Jennifer Bragg] Univ Michigan, DNA Sequencing Core, Ann Arbor, MI 48109 USA; [Li, Bingshan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37235 USA; [Tofanelli, Sergio] Univ Pisa, Dipartimento Biol, I-56126 Pisa, Italy; [Alonso, Santos] Univ Pais Vasco Euskal Herriko Unibertsitatea, Dept Genet Antropol Fis & Fisiol Anim, Bilbao 48080, Spain; [Uzzau, Sergio] Porto Conte Ric, I-07041 Sassari, Italy; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA	University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; University of Pisa; University of Basque Country; Porto Conte Ricerche; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Francalacci, P (corresponding author), Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy.	pfrancalacci@uniss.it; fcucca@uniss.it	sanna, serena/H-3009-2019; Mulas, Antonella/B-4231-2015; Alonso, Santos/L-8316-2014; Dei, Mariano/AAY-3870-2020; Uzzau, Sergio/F-3233-2015; Lai, Sandra/AAY-4176-2020; Maschio, Andrea/AAX-8185-2020; Sidore, Carlo/AAV-7967-2020; Angius, Andrea/P-9549-2015; Deidda, Francesca/P-1541-2018; marcelli, marco/AGR-6853-2022	sanna, serena/0000-0002-3768-1749; Alonso, Santos/0000-0003-0221-4048; Uzzau, Sergio/0000-0001-6246-2794; Sidore, Carlo/0000-0001-7504-7477; Angius, Andrea/0000-0003-2596-6461; Deidda, Francesca/0000-0003-3447-7440; Pitzalis, Maristella/0000-0003-4975-6987; CUCCA, Francesco/0000-0002-7414-1995; Cusano, Roberto/0000-0001-5543-7881; Mulas, Antonella/0000-0002-6856-1483; TOFANELLI, Sergio/0000-0002-7399-9308; WHALEN, MICHAELBERNARD/0000-0001-7300-8511; FRANCALACCI, Paolo/0000-0001-7912-162X; Atzeni, Rossano/0000-0003-0020-0013; Zoledziewska, Magdalena/0000-0002-3033-6133; Poddie, Fausto PierAngelo/0000-0003-2893-9549; maschio, andrea/0000-0002-4238-9144; Angius, Andrea/0000-0001-9372-1162; LAI, SANDRA/0000-0003-4198-9989; Dei, Mariano/0000-0002-7404-508X	NIH from the National Institute of Aging [NO1-AG-1-2109]; Sardinian Autonomous Region [7/2009, cRP3-154, cRP2-597]; Fondazione Banco di Sardegna; Basque Government [G. I. C. IT-542-10]; National Human Genome Research Institute [HG005581, HG005552, HG006513, HG007022]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005581, U01HG006513, R01HG007022, RC2HG005552] Funding Source: NIH RePORTER	NIH from the National Institute of Aging; Sardinian Autonomous Region(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Basque Government(Basque Government); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by NIH contract NO1-AG-1-2109 from the National Institute of Aging to the IRGB institute; by Sardinian Autonomous Region (L. R. no. 7/2009) grants cRP3-154 to F. C. and cRP2-597 to P. F.; by Fondazione Banco di Sardegna grants to P. F. and L. M.; by Basque Government grant G. I. C. IT-542-10 to S. A.; and by National Human Genome Research Institute grants HG005581, HG005552, HG006513, and HG007022 to G. R. A. We are grateful to all the Sardinian donors for providing blood samples. We also thank the 1000 Genomes Project consortium for making available their sequencing data, in compliance with the Fort Lauderdale principles. We thank H. Skaletsky for detailed information about sequence blocks on the Y chromosome; M. Uda and R. Nagaraja for useful comments; C. Calo, D. Luiselli, and C. de la Rua for providing some non-Sardinian samples; E. Garau, M. Rendeli, A. Moravetti, and B. Wilkens for the archaeological background; and the CRS4 HPC group for their IT support, in particular L. Leoni and C. Podda. Genotype data have been deposited at the European Genome-phenome Archive (EGA, www.ebi.ac.uk/ega/), which is hosted by the European Bioinformatics Institute, under accession number EGAS00001000532.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Gibbons A, 2012, SCIENCE, V338, P189, DOI 10.1126/science.338.6104.189; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lilliu G., 1982, LA CIVILTA NURAGICA; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tykot RH., 1994, RADIOCARBON DATING I, P115; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112	18	98	101	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					565	569		10.1126/science.1237947	http://dx.doi.org/10.1126/science.1237947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908240	Green Accepted			2022-12-28	WOS:000322586700058
J	Kappeler, PM				Kappeler, Peter M.			Why Male Mammals Are Monogamous	SCIENCE			English	Editorial Material							MATING SYSTEMS; SEXUAL SELECTION; SOCIAL MONOGAMY; EVOLUTION		[Kappeler, Peter M.] Univ Gottingen, German Primate Ctr DPZ, Behav Ecol & Sociobiol Unit, D-37077 Gottingen, Germany; [Kappeler, Peter M.] Univ Gottingen, Dept Sociobiol Anthropol, D-37077 Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Gottingen	Kappeler, PM (corresponding author), Univ Gottingen, German Primate Ctr DPZ, Behav Ecol & Sociobiol Unit, D-37077 Gottingen, Germany.	pkappel@gwdg.de						Clutton-Brock T, 2012, EVOL ANTHROPOL, V21, P136, DOI 10.1002/evan.21316; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Dobson FS, 2010, BEHAV ECOL, V21, P747, DOI 10.1093/beheco/arq048; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P14069, DOI 10.1073/pnas.1201718109; GUBERNICK DJ, 1994, INFANTICIDE PARENTAL, P427; Henrich J, 2012, PHILOS T R SOC B, V367, P657, DOI 10.1098/rstb.2011.0290; IMS RA, 1988, NATURE, V335, P541, DOI 10.1038/335541a0; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Komers PE, 1997, P ROY SOC B-BIOL SCI, V264, P1261, DOI 10.1098/rspb.1997.0174; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213	15	6	6	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					469	470		10.1126/science.1242001	http://dx.doi.org/10.1126/science.1242001			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908214				2022-12-28	WOS:000322586700028
J	Anand, P; Brown, JD; Lin, CY; Qi, J; Zhang, RL; Artero, PC; Alaiti, MA; Bullard, J; Alazem, K; Margulies, KB; Cappola, TP; Lemieux, M; Plutzky, J; Bradner, JE; Haldar, SM				Anand, Priti; Brown, Jonathan D.; Lin, Charles Y.; Qi, Jun; Zhang, Rongli; Artero, Pedro Calderon; Alaiti, M. Amer; Bullard, Jace; Alazem, Kareem; Margulies, Kenneth B.; Cappola, Thomas P.; Lemieux, Madeleine; Plutzky, Jorge; Bradner, James E.; Haldar, Saptarsi M.			BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure	CELL			English	Article							ELONGATION-FACTOR-B; P-TEFB; SELECTIVE-INHIBITION; CARDIAC DYSFUNCTION; GENE-EXPRESSION; BRD4; HYPERTROPHY; STRESS; GROWTH; PHOSPHORYLATION	Heart failure (HF) is driven by the interplay between regulatory transcription factors and dynamic alterations in chromatin structure. Pathologic gene trans-activation in HF is associated with recruitment of histone acetyl-transferases and local chromatin hyperacetylation. We therefore assessed the role of acetyl-lysine reader proteins, or bromodomains, in HF. Using a chemical genetic approach, we establish a central role for BET family bromodomain proteins in gene control during HF pathogenesis. BET inhibition potently suppresses cardiomyocyte hypertrophy in vitro and pathologic cardiac remodeling in vivo. Integrative transcriptional and epigenomic analyses reveal that BET proteins function mechanistically as pause-release factors critical to expression of genes that are central to HF pathogenesis and relevant to the pathobiology of failing human hearts. This study implicates epigenetic readers as essential effectors of transcriptional pause release during HF pathogenesis and identifies BET coactivator proteins as therapeutic targets in the heart.	[Anand, Priti; Zhang, Rongli; Artero, Pedro Calderon; Alaiti, M. Amer; Bullard, Jace; Alazem, Kareem; Haldar, Saptarsi M.] Case Western Reserve Univ, Case Cardiovasc Res Inst, Dept Med, Sch Med, Cleveland, OH 44106 USA; [Anand, Priti; Zhang, Rongli; Artero, Pedro Calderon; Alaiti, M. Amer; Bullard, Jace; Alazem, Kareem; Haldar, Saptarsi M.] Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Brown, Jonathan D.; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA; [Lin, Charles Y.; Qi, Jun; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Margulies, Kenneth B.; Cappola, Thomas P.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Lemieux, Madeleine] Bioinfo, Plantagenet, ON K0B 1L0, Canada; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School	Bradner, JE (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	james_bradner@dfci.harvard.edu; saptarsi.haldar@case.edu	Plutzky, Jorge/V-3410-2019	Lemieux, Madeleine/0000-0001-6355-8691	Individual Biomedical Research Award from The Hartwell Foundation; Visconsi Research Scholars Fund [NIH-K08 CA128972]; Burroughs-Wellcome Fund; Damon-Runyon Cancer Research Foundation; Richard and Susan Smith Family Foundation; Next Generation Award; U.S. Department of Defense [NIH-T32 HL105338, NIH-R01 HL105993, NIH-K08 HL105678];  [NIH-R01 DK093821];  [NIH-K08 HL086614]; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, K08HL105678, R01HL105993, K08HL086614, T32HL105338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093821] Funding Source: NIH RePORTER	Individual Biomedical Research Award from The Hartwell Foundation; Visconsi Research Scholars Fund; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Damon-Runyon Cancer Research Foundation; Richard and Susan Smith Family Foundation; Next Generation Award; U.S. Department of Defense(United States Department of Defense); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to R. Young and P. Rahl for stimulating discussions; M. Berkeley and the late E. Fox (DFCI Microarray Core) for assistance with microarray experiments; Avery Whitlock for illustrations; and Tom Volkert, Jennifer Love, and Sumeet Gupta at the Whitehead Genome Core for assistance with genome sequencing. This research was supported by an NIH-R01 DK093821 and NIH-K08 HL086614, Individual Biomedical Research Award from The Hartwell Foundation, and the Visconsi Research Scholars Fund (S.M.H.); NIH-K08 CA128972, the Burroughs-Wellcome Fund, the Damon-Runyon Cancer Research Foundation, the Richard and Susan Smith Family Foundation, and the Next Generation Award (J.E.B.); U.S. Department of Defense (C.Y.L.); NIH-T32 HL105338 (M.A.A.); NIH-R01 HL105993 (K.B. M. and T.P.C); and NIH-K08 HL105678 (J.D.B.). Dr. Bradner is the scientific founder of Tensha Therapeutics, which is clinically translating drug-like derivatives of the JQ1 chemical probe of BET bromodomains used in this study, as cancer therapeutics. As such, the Dana-Farber Cancer Institute and Dr. Bradner have been granted minority equity in Tensha.	Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Bousette N, 2010, P NATL ACAD SCI USA, V107, P18481, DOI 10.1073/pnas.1013555107; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Espinoza-Derout J, 2009, CIRC RES, V104, P1347, DOI 10.1161/CIRCRESAHA.108.191726; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maier HJ, 2012, P NATL ACAD SCI USA, V109, P11794, DOI 10.1073/pnas.1116584109; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Patel MC, 2013, MOL CELL BIOL, V33, P2497, DOI 10.1128/MCB.01180-12; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Sayed D, 2013, J BIOL CHEM, V288, P2546, DOI 10.1074/jbc.M112.429449; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yoshikawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052522; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhao MM, 2004, PHYSIOL GENOMICS, V19, P93, DOI 10.1152/physiolgenomics.00040.2004; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	265	282	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					569	582		10.1016/j.cell.2013.07.013	http://dx.doi.org/10.1016/j.cell.2013.07.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911322	Green Accepted, Bronze			2022-12-28	WOS:000322629900011
J	Nisen, P; Rockhold, F				Nisen, Perry; Rockhold, Frank			Access to Patient-Level Data from GlaxoSmithKline Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								GlaxoSmithKline is providing access to patient-level clinical trial data under a new policy. This article reviews the data-access plan. Efforts are under way to increase the transparency of clinical trial data. Among the efforts are those being undertaken at GlaxoSmithKline, where we have recently made a commitment to provide access to deidentified patient-level data. We are taking this step because it is the right thing to do, both scientifically and for society, and it is in line with our company's commitment to transparency in clinical trial reporting. As of May 2013, investigators are able to request access to deidentified patient-level data from a subset of GlaxoSmithKline-sponsored clinical trials. We expect that research teams requesting data will have sufficient statistical ...	[Nisen, Perry; Rockhold, Frank] GlaxoSmithKline, Res & Dev, King Of Prussia, PA USA	GlaxoSmithKline	Nisen, P (corresponding author), GlaxoSmithKline, Res & Dev, King Of Prussia, PA USA.		Rockhold, Frank W./C-7078-2019	Rockhold, Frank W./0000-0003-3732-4765					0	100	100	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					475	478		10.1056/NEJMsr1302541	http://dx.doi.org/10.1056/NEJMsr1302541			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902490	Green Published			2022-12-28	WOS:000322547400018
J	Tepper, RG; Ashraf, J; Kaletsky, R; Kleemann, G; Murphy, CT; Bussemaker, HJ				Tepper, Ronald G.; Ashraf, Jasmine; Kaletsky, Rachel; Kleemann, Gunnar; Murphy, Coleen T.; Bussemaker, Harmen J.			PQM-1 Complements DAF-16 as a Key Transcriptional Regulator of DAF-2-Mediated Development and Longevity	CELL			English	Article							LIFE-SPAN; ELEGANS; TARGETS; STRESS; LONG; PROTEIN; IDENTIFICATION; EXPRESSION; GENES	Reduced insulin/IGF-1-like signaling (IIS) extends C. elegans lifespan by upregulating stress response (class I) and downregulating other (class II) genes through a mechanism that depends on the conserved transcription factor DAF-16/FOXO. By integrating genome-wide mRNA expression responsiveness to DAF-16 with genome-wide in vivo binding data for a compendium of transcription factors, we discovered that PQM-1 is the elusive transcriptional activator that directly controls development (class II) genes by binding to the DAF-16-associated element (DAE). DAF-16 directly regulates class I genes only, through the DAF-16-binding element (DBE). Loss of PQM-1 suppresses daf-2 longevity and further slows development. Surprisingly, the nuclear localization of PQM-1 and DAF-16 is controlled by IIS in opposite ways and was also found to be mutually antagonistic. We observe progressive loss of nuclear PQM-1 with age, explaining declining expression of PQM-1 targets. Together, our data suggest an elegant mechanism for balancing stress response and development.	[Tepper, Ronald G.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ashraf, Jasmine; Kaletsky, Rachel; Kleemann, Gunnar; Murphy, Coleen T.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Ashraf, Jasmine; Kaletsky, Rachel; Kleemann, Gunnar; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bussemaker, Harmen J.] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	Columbia University; Princeton University; Princeton University; Columbia University	Murphy, CT (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu; hjb2004@columbia.edu		Kaletsky, Rachel/0000-0002-7176-9154; Murphy, Coleen/0000-0002-8257-984X	NIH [R01HG003008, U54CA121852, P50GM071508, DP2OD004402, R01AG034446]; John Simon Guggenheim Foundation Fellowship; Glenn and Keck Foundations; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034446] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Simon Guggenheim Foundation Fellowship; Glenn and Keck Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the C. elegans Genetics Center, I. Hope, and S. Kim for strains; X.-J. Lu for implementing the REDUCE suite; M. Huynen for help with the phylogenetic analysis of the PQM-1 protein sequence; and M. Chalfie, I. Greenwald, O. Hobert, and members of the Bussemaker and Murphy laboratories, and the anonymous reviewers for valuable suggestions. This work was supported by NIH grants R01HG003008, U54CA121852, and P50GM071508, as well as a John Simon Guggenheim Foundation Fellowship to H.J.B., and by NIH Innovator award DP2OD004402 and R01AG034446 and grants from the Glenn and Keck Foundations to C.T.M. R.G.T. and H.J.B. performed all computational analyses; C.T.M. designed all C. elegans experiments; R.K. and J.A. performed DAE promoter binding experiments; G.K. and J.A. performed dauer recovery experiment; J.A. performed all remaining experiments; and R.G.T., H.J.B., and C.T.M. wrote the manuscript.	Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Boorsma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003112; BRENNER S, 1974, GENETICS, V77, P71; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2006, NAT GENET, V38, P397, DOI 10.1038/ng0406-397; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Siggs OM, 2012, CELL CYCLE, V11, P3358, DOI 10.4161/cc.21277; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Tonsaker T, 2012, MECH AGEING DEV, V133, P50, DOI 10.1016/j.mad.2011.09.006; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013	39	170	178	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					676	690		10.1016/j.cell.2013.07.006	http://dx.doi.org/10.1016/j.cell.2013.07.006			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911329	Green Accepted, Bronze			2022-12-28	WOS:000322629900019
J	McCartney, M				McCartney, Margaret			Patient information leaflets: "a stupid system"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Askari A, 2012, JRSM Short Rep, V3, P35, DOI 10.1258/shorts.2012.011163; Coulter A, 1998, BMJ-BRIT MED J, V317, P225, DOI 10.1136/bmj.317.7153.225; Grewal P, 2013, HERNIA; Guy's and St Thomas' NHS Foundation Trust, 2012, OUR PAT INF LEAFL; Shergill Iqbal, 2010, BMC Res Notes, V3, P27, DOI 10.1186/1756-0500-3-27; Smith H, 1998, BRIT MED J, V317, P264, DOI 10.1136/bmj.317.7153.264	6	19	19	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4748	10.1136/bmj.f4748	http://dx.doi.org/10.1136/bmj.f4748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900316				2022-12-28	WOS:000322821500016
J	Ross, LF; Rothstein, MA; Clayton, EW				Ross, Lainie Friedman; Rothstein, Mark A.; Clayton, Ellen Wright			Mandatory Extended Searches in All Genome Sequencing "Incidental Findings," Patient Autonomy, and Shared Decision Making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Ross, Lainie Friedman] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Rothstein, Mark A.] Univ Louisville, Sch Med, Inst Bioeth Hlth Policy & Law, Louisville, KY 40292 USA; [Clayton, Ellen Wright] Vanderbilt Univ, Ctr Biomed Eth & Soc, Nashville, TN 37235 USA	University of Chicago; University of Louisville; Vanderbilt University	Ross, LF (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 6082, Chicago, IL 60637 USA.	lross@uchicago.edu		Clayton, Ellen/0000-0002-0308-4110	NHGRI NIH HHS [1R21HG00612-01] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], INCIDENTAL FINDINGS; [Anonymous], POLICY STATEMENT POI; Green R. C., ACMG RECOMMENDATIONS; Grosse SD, 2006, PEDIATRICS, V117, P923, DOI 10.1542/peds.2005-0553; Krier JB, CURRENT PROTOCOLS HU; Ross LF, 2012, J INHERIT METAB DIS, V35, P627, DOI 10.1007/s10545-011-9435-0; Timmermans S, 2010, J HEALTH SOC BEHAV, V51, P408, DOI 10.1177/0022146510386794; US Preventive Services Task Force, DRAFT RECOMMENDATION	8	71	72	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					367	368		10.1001/jama.2013.41700	http://dx.doi.org/10.1001/jama.2013.41700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917281				2022-12-28	WOS:000322121500008
J	Jordan, AS; McSharry, DG; Malhotra, A				Jordan, Amy S.; McSharry, David G.; Malhotra, Atul			Adult obstructive sleep apnoea	LANCET			English	Article							POSITIVE AIRWAY PRESSURE; MANDIBULAR ADVANCEMENT SPLINT; EXPIRATORY LUNG-VOLUME; ORAL APPLIANCE; OBESE-PATIENTS; WEIGHT-LOSS; SYSTEMIC HYPERTENSION; DAYTIME SLEEPINESS; CONTROLLED-TRIAL; MUSCLE-ACTIVITY	Obstructive sleep apnoea is an increasingly common disorder of repeated upper airway collapse during sleep, leading to oxygen desaturation and disrupted sleep. Features include snoring, witnessed apnoeas, and sleepiness. Pathogenesis varies; predisposing factors include small upper airway lumen, unstable respiratory control, low arousal threshold, small lung volume, and dysfunctional upper airway dilator muscles. Risk factors include obesity, male sex, age, menopause, fluid retention, adenotonsillar hypertrophy, and smoking. Obstructive sleep apnoea causes sleepiness, road traffic accidents, and probably systemic hypertension. It has also been linked to myocardial infarction, congestive heart failure, stroke, and diabetes mellitus though not definitively. Continuous positive airway pressure is the treatment of choice, with adherence of 60-70%. Bi-level positive airway pressure or adaptive servo-ventilation can be used for patients who are intolerant to continuous positive airway pressure. Other treatments include dental devices, surgery, and weight loss.	[Jordan, Amy S.] Univ Melbourne, Melbourne, Vic, Australia; [Jordan, Amy S.] Inst Breathing & Sleep, Melbourne, Vic, Australia; [McSharry, David G.; Malhotra, Atul] Brigham & Womens Hosp, Boston, MA 02115 USA; [McSharry, David G.; Malhotra, Atul] Harvard Univ, Sch Med, Boston, MA USA; [Malhotra, Atul] Univ Calif San Diego, San Diego, CA 92103 USA	University of Melbourne; Institute for Breathing & Sleep (IBAS); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Jordan, AS (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia.	ajordan@unimelb.edu.au	Jordan, Amy/I-5626-2019	Jordan, Amy/0000-0001-8561-9766	Australian Research Council; NHMRC Australia; Apnex Medical; Philips; Sleep Group Solutions; Pfizer; Apnicure; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085188, R01HL090897, K24HL093218] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); Apnex Medical; Philips; Sleep Group Solutions; Pfizer(Pfizer); Apnicure; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	AM has received consulting and research income from Philips, Sleep Group Solutions, Pfizer, Apnex Medical, and Apnicure but has relinquished all outside personal income since May, 2012. DGM has received funding from the American Heart Association. ASJ is funded by the Australian Research Council and NHMRC Australia. Before 2010, she received consulting income from Apnex Medical.	Almeida FR, 2013, SLEEP BREATH, V17, P659, DOI 10.1007/s11325-012-0739-6; Aronsohn RS, 2010, AM J RESP CRIT CARE, V181, P507, DOI 10.1164/rccm.200909-1423OC; Awad KM, 2012, AM J MED, V125, P485, DOI 10.1016/j.amjmed.2011.11.025; Ayas NT, 2006, ARCH INTERN MED, V166, P977, DOI 10.1001/archinte.166.9.977; Ayas NT, 2004, SLEEP, V27, P249, DOI 10.1093/sleep/27.2.249; BADR MS, 1995, J APPL PHYSIOL, V78, P1806, DOI 10.1152/jappl.1995.78.5.1806; BALLARD RD, 1990, J APPL PHYSIOL, V68, P2034, DOI 10.1152/jappl.1990.68.5.2034; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; BEGLE RL, 1990, AM REV RESPIR DIS, V141, P854, DOI 10.1164/ajrccm/141.4_Pt_1.854; Brooks D, 1997, J CLIN INVEST, V99, P106, DOI 10.1172/JCI119120; Cano-Pumarega I, 2011, AM J RESP CRIT CARE, V184, P1299, DOI 10.1164/rccm.201101-0130OC; Chervin RD, 2000, CHEST, V118, P372, DOI 10.1378/chest.118.2.372; Chi L, 2011, EUR RESPIR J, V38, P348, DOI 10.1183/09031936.00119210; Chin CH, 2012, J APPL PHYSIOL, V112, P403, DOI 10.1152/japplphysiol.00021.2011; Cistulli PA, 2005, EXPERT REV MED DEVIC, V2, P749, DOI 10.1586/17434440.2.6.749; Craig SE, 2012, THORAX, V67, P1090, DOI 10.1136/thoraxjnl-2012-202178; Dai YMN, 2010, CIRCULATION, V121, P1598, DOI 10.1161/CIRCULATIONAHA.109.902452; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Deane SA, 2009, SLEEP, V32, P648, DOI 10.1093/sleep/32.5.648; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Eastwood PR, 2011, SLEEP, V34, P1479, DOI 10.5665/sleep.1380; Eckert DJ, 2007, CHEST, V131, P595, DOI 10.1378/chest.06.2287; Eckert DJ, 2011, J APPL PHYSIOL, V111, P1644, DOI 10.1152/japplphysiol.00653.2011; Eckert DJ, 2011, CLIN SCI, V120, P505, DOI 10.1042/CS20100588; Edwards BA, 2012, J PHYSIOL-LONDON, V590, P1199, DOI 10.1113/jphysiol.2011.223925; Edwards BA, 2010, SEMIN RESP CRIT CARE, V31, P618, DOI 10.1055/s-0030-1265902; Eikermann M, 2007, CHEST, V131, P1702, DOI 10.1378/chest.06-2653; Engleman HM, 1996, CHEST, V109, P1470, DOI 10.1378/chest.109.6.1470; Ferguson KA, 1996, CHEST, V109, P1269, DOI 10.1378/chest.109.5.1269; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Foster GE, 2010, HYPERTENSION, V56, P369, DOI 10.1161/HYPERTENSIONAHA.110.152108; Friberg D, 1998, AM J RESP CRIT CARE, V157, P586, DOI 10.1164/ajrccm.157.2.96-06049; Gotsopoulos H, 2002, AM J RESP CRIT CARE, V166, P743, DOI 10.1164/rccm.200203-208OC; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Grigg-Damberger MM, 2012, J CLIN SLEEP MED, V8, P323, DOI 10.5664/jcsm.1928; Guimaraes KC, 2009, AM J RESP CRIT CARE, V179, P962, DOI 10.1164/rccm.200806-981OC; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hanly PJ, 2001, NEW ENGL J MED, V344, P102, DOI 10.1056/NEJM200101113440204; Heinzer RC, 2008, EUR RESPIR J, V31, P1308, DOI 10.1183/09031936.00067607; Heinzer RC, 2005, AM J RESP CRIT CARE, V172, P114, DOI 10.1164/rccm.200404-552OC; Holley AB, 2011, CHEST, V140, P1511, DOI 10.1378/chest.10-2851; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; Hoyos CM, 2012, THORAX, V67, P1081, DOI 10.1136/thoraxjnl-2011-201420; Ip MSM, 2001, CHEST, V119, P62, DOI 10.1378/chest.119.1.62; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-20; Itzhaki S, 2007, CHEST, V131, P740, DOI 10.1378/chest.06-0965; Javaheri S, 2009, J CLIN SLEEP MED, V5, P205; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; Jobin V, 2007, J APPL PHYSIOL, V102, P1587, DOI 10.1152/japplphysiol.00439.2006; Jordan AS, 2009, SLEEP, V32, P361, DOI 10.1093/sleep/32.3.361; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kezirian EJ, 2012, OTOLARYNG HEAD NECK, V147, P964, DOI 10.1177/0194599812453000; Kezirian EJ, 2010, LARYNGOSCOPE, V120, P1481, DOI 10.1002/lary.20946; Kezirian EJ, 2010, ARCH OTOLARYNGOL, V136, P393, DOI 10.1001/archoto.2010.26; Kimoff J, 2001, AM J RESP CRIT CARE, V164, P250; Kingshott RN, 2001, AM J RESP CRIT CARE, V163, P918, DOI 10.1164/ajrccm.163.4.2005036; Kirkness JP, 2008, J APPL PHYSIOL, V104, P1618, DOI 10.1152/japplphysiol.00045.2008; Kirkness JP, 2011, SLEEP, V34, P459, DOI 10.1093/sleep/34.4.459; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Kohler M, 2010, THORAX, V65, P829, DOI 10.1136/thx.2010.135848; Kuna ST, 2011, AM J RESP CRIT CARE, V183, P1238, DOI 10.1164/rccm.201011-1770OC; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Lettieri CJ, 2008, J CLIN SLEEP MED, V4, P333; Lindberg E, 2012, CHEST, V142, P935, DOI 10.1378/chest.11-1844; Malhotra A, 2008, THORAX, V63, P925, DOI 10.1136/thx.2007.086835; Malhotra A, 2002, AM J RESP CRIT CARE, V166, P1388, DOI 10.1164/rccm.2112072; Malhotra A, 2006, AM J MED, V119, pe9, DOI DOI 10.1016/J.AMJMED.2005.01.077; Malhotra A, 2008, J CLIN SLEEP MED, V4, P406; Malhotra A, 2009, PROG CARDIOVASC DIS, V51, P279, DOI 10.1016/j.pcad.2008.10.004; Marcus CL, 2000, SLEEP, V23, pS140; Marien H, 2008, J CLIN SLEEP MED, V4, P339; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Masa JF, 2011, AM J RESP CRIT CARE, V184, P964, DOI 10.1164/rccm.201103-0428OC; McSharry D, 2012, RESP PHYSIOL NEUROBI, V183, P59, DOI 10.1016/j.resp.2012.05.024; MEZZANOTTE WS, 1992, J CLIN INVEST, V89, P1571, DOI 10.1172/JCI115751; Montesi SB, 2012, J CLIN SLEEP MED, V8, P587, DOI 10.5664/jcsm.2170; Montesi SB, 2012, CHEST, V142, P239, DOI 10.1378/chest.11-2322; Morgenthaler TI, 2007, SLEEP, V30, P468, DOI 10.1093/sleep/30.4.468; Mostafiz W, 2011, CHEST, V139, P1331, DOI 10.1378/chest.10-2224; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; Oksenberg A, 2001, EUR RESPIR J, V18, P340, DOI 10.1183/09031936.01.00038101; Owens RL, 2012, J APPL PHYSIOL, V113, P691, DOI 10.1152/japplphysiol.00091.2012; Owens RL, 2010, J APPL PHYSIOL, V108, P445, DOI 10.1152/japplphysiol.00755.2009; Pack AI, 2001, AM J RESP CRIT CARE, V164, P1675, DOI 10.1164/ajrccm.164.9.2103032; Parati G, 2012, J HYPERTENS, V30, P633, DOI 10.1097/HJH.0b013e328350e53b; Patil S, 2004, AM J RESP CRIT CARE, V169, pA435; Pepin JL, 2009, EUR RESPIR J, V33, P1062, DOI 10.1183/09031936.00016808; Pepin JL, 2010, AM J RESP CRIT CARE, V182, P954, DOI 10.1164/rccm.200912-1803OC; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pillar F, 2000, AM J RESP CRIT CARE, V162, P1627, DOI 10.1164/ajrccm.162.5.2003131; PILLAR G, 1994, CHEST, V106, P1702, DOI 10.1378/chest.106.6.1702; Platt AB, 2010, CHEST, V137, P102, DOI 10.1378/chest.09-0842; Powell ED, 2012, J CLIN SLEEP MED, V8, P43, DOI 10.5664/jcsm.1658; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Punjabi NM, 2009, AM J RESP CRIT CARE, V179, P235, DOI 10.1164/rccm.200809-1392OC; Redenius R, 2008, J CLIN SLEEP MED, V4, P205; Redolfi S, 2011, AM J RESP CRIT CARE, V184, P1062, DOI 10.1164/rccm.201102-0350OC; REEVESHOCHE MK, 1995, AM J RESP CRIT CARE, V151, P443, DOI 10.1164/ajrccm.151.2.7842204; Rosen CL, 2012, SLEEP, V35, P757, DOI 10.5665/sleep.1870; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Saboisky Julian P, 2012, Front Neurol, V3, P95, DOI 10.3389/fneur.2012.00095; Saboisky JP, 2009, EXPERT OPIN THER TAR, V13, P795, DOI 10.1517/14728220903005608; Schwab RJ, 2003, AM J RESP CRIT CARE, V168, P522, DOI 10.1164/rccm.200208-866OC; Schwartz AR, 2012, AM J RESP CRIT CARE, V185, P420, DOI 10.1164/rccm.201109-1614OC; Sforza E, 2011, EUR RESPIR J, V37, P1137, DOI 10.1183/09031936.00043210; Sharma SK, 2011, NEW ENGL J MED, V365, P2277, DOI 10.1056/NEJMoa1103944; Sharma SK, 2010, INDIAN J MED RES, V131, P171; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Sivam S, 2012, EUR RESPIR J, V40, P913, DOI 10.1183/09031936.00177011; SMITH PL, 1985, ANN INTERN MED, V103, P850, DOI 10.7326/0003-4819-103-6-850; Squier SB, 2010, J APPL PHYSIOL, V109, P977, DOI 10.1152/japplphysiol.00080.2010; Stadler DL, 2010, J APPL PHYSIOL, V109, P1027, DOI 10.1152/japplphysiol.01397.2009; Stamatakis K, 2008, SLEEP, V31, P1018; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Strohl KP, 2012, COMPR PHYSIOL, V2, P1853, DOI 10.1002/cphy.c110053; Sugerman HJ, 1992, AM J CLIN NUTR; SULLIVAN CE, 1981, LANCET, V1, P862; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Van de Heyning PH, 2012, LARYNGOSCOPE, V122, P1626, DOI 10.1002/lary.23301; VANDEGRAAFF WB, 1988, J APPL PHYSIOL, V65, P2124, DOI 10.1152/jappl.1988.65.5.2124; Vennelle M, 2010, SLEEP, V33, P267, DOI 10.1093/sleep/33.2.267; Weaver EM, 2010, SLEEP MED REV, V14, P283, DOI 10.1016/j.smrv.2010.05.001; Weaver EM, 2004, OTOLARYNG HEAD NECK, V130, P659, DOI 10.1016/j.otohns.2003.12.012; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; Weinstock TG, 2012, SLEEP, V35, P617, DOI 10.5665/sleep.1816; Wellman A, 2004, AM J RESP CRIT CARE, V170, P1225, DOI 10.1164/rccm.200404-510OC; Whittle AT, 1999, THORAX, V54, P323, DOI 10.1136/thx.54.4.323; Yim-Yeh S, 2011, OBESITY, V19, P17, DOI 10.1038/oby.2010.116; Yim-Yeh S, 2010, SLEEP, V33, P1177, DOI 10.1093/sleep/33.9.1177; Younes M, 2001, AM J RESP CRIT CARE, V163, P1181, DOI 10.1164/ajrccm.163.5.2007013; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	139	692	730	16	178	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					736	747		10.1016/S0140-6736(13)60734-5	http://dx.doi.org/10.1016/S0140-6736(13)60734-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	23910433	Green Accepted, Green Submitted			2022-12-28	WOS:000331653300035
J	Tedeschi, A; Wutz, G; Huet, S; Jaritz, M; Wuensche, A; Schirghuber, E; Davidson, IF; Tang, W; Cisneros, DA; Bhaskara, V; Nishiyama, T; Vaziri, A; Wutz, A; Ellenberg, J; Peters, JM				Tedeschi, Antonio; Wutz, Gordana; Huet, Sebastien; Jaritz, Markus; Wuensche, Annelie; Schirghuber, Erika; Davidson, Iain Finley; Tang, Wen; Cisneros, David A.; Bhaskara, Venugopal; Nishiyama, Tomoko; Vaziri, Alipasha; Wutz, Anton; Ellenberg, Jan; Peters, Jan-Michael			Wapl is an essential regulator of chromatin structure and chromosome segregation	NATURE			English	Article							BUDDING YEAST; IN-VIVO; COHESIN; PROTEIN; SEPARASE; ANAPHASE; ORGANIZATION; INTERPHASE; EXPRESSION; PROPHASE	Mammalian genomes contain several billion base pairs of DNA that are packaged in chromatin fibres. At selected gene loci, cohesin complexes have been proposed to arrange these fibres into higher-order structures(1-7), but how important this function is for determining overall chromosome architecture and how the process is regulated are not well understood. Using conditional mutagenesis in the mouse, here we show that depletion of the cohesin-associated protein Wapl(8,9) stably locks cohesin on DNA, leads to clustering of cohesin in axial structures, and causes chromatin condensation in interphase chromosomes. These findings reveal that the stability of cohesin-DNA interactions is an important determinant of chromatin structure, and indicate that cohesin has an architectural role in interphase chromosome territories. Furthermore, we show that regulation of cohesin-DNA interactions by Wapl is important for embryonic development, expression of genes such as c-myc (also known as Myc), and cell cycle progression. In mitosis, Wapl-mediated release of cohesin from DNA is essential for proper chromosome segregation and protects cohesin from cleavage by the protease separase, thus enabling mitotic exit in the presence of functional cohesin complexes.	[Tedeschi, Antonio; Wutz, Gordana; Jaritz, Markus; Schirghuber, Erika; Davidson, Iain Finley; Tang, Wen; Cisneros, David A.; Bhaskara, Venugopal; Nishiyama, Tomoko; Vaziri, Alipasha; Wutz, Anton; Peters, Jan-Michael] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Huet, Sebastien; Wuensche, Annelie; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Huet, Sebastien] Inst Genet & Dev Rennes, CNRS, UMR 6290, F-35043 Rennes, France; [Huet, Sebastien] Univ Europeenne Bretagne, Univ Rennes 1, Struct Federat Rech Biosit, Fac Med, F-35043 Rennes, France; [Cisneros, David A.; Vaziri, Alipasha] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Cisneros, David A.; Vaziri, Alipasha] Univ Vienna, Res Platform Quantum Phenomena& Nanoscale Biol Sy, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bretagne Occidentale; Universite de Rennes; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna	Peters, JM (corresponding author), Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	jan-michael.peters@imp.ac.at	Cisneros, David A./B-1141-2012; Ellenberg, Jan/I-4688-2014	Cisneros, David A./0000-0001-9919-0075; Ellenberg, Jan/0000-0001-5909-701X; Tedeschi, Antonio/0000-0001-7276-4550; Bhaskara, Venugopal/0000-0002-8807-3292; Jaritz, Markus/0000-0002-9326-2047	European Molecular Biology Organization (EMBO); Japanese Society for the Promotion of Science (JSPS); Agence National de la Recherche [JCJC-SVSE2-2011]; European Union [FP7-PEOPLE-2011-CIG]; MFPL VIPS Program (BMWF); MFPL VIPS Program (City of Vienna); Vienna Science and Technology Fund (WWTF) [VRG10-11]; Research Platform Quantum Phenomena and Nanoscale Biological Systems (QuNaBioS); Boehringer Ingelheim; Austrian Science Fund (FWF) [SFB F34, Z196-B20]; Austrian Research Promotion Agency (FFG, Laura Bassi Center for Optimized Structural Studies); Vienna Science and Technology Fund [WWTF LS09-13]; European Community [241548 (MitoSys)]; Grants-in-Aid for Scientific Research [25711002] Funding Source: KAKEN	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agence National de la Recherche(French National Research Agency (ANR)); European Union(European Commission); MFPL VIPS Program (BMWF); MFPL VIPS Program (City of Vienna); Vienna Science and Technology Fund (WWTF); Research Platform Quantum Phenomena and Nanoscale Biological Systems (QuNaBioS); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG, Laura Bassi Center for Optimized Structural Studies); Vienna Science and Technology Fund; European Community(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We dedicate this paper to the memory of B. Peters, who performed the first experiments on Wapl in our laboratory. We are grateful to K. Aumayr, O. F.-Capetillo, T. Hoffmann, M. E. Idarraga-Amado, S. Kueng, T. Kulcsar, M. Leeb, P. Pasierbek, D. Santamaria, G. Schmauss, A. Souabni, H. Tkadletz, K. Wendt and members of the Peters laboratory for discussions and assistance, J. Hutchins for suggesting the term vermicelli, K. Nasmyth for the separase mouse model, and M. Barbacid, T. Cremer, T. Hirano, T. Jenuwein, M. Malumbres and J. Zuber for reagents. T.N. was supported by the European Molecular Biology Organization (EMBO) and the Japanese Society for the Promotion of Science (JSPS). S. H. was supported by funds from the Agence National de la Recherche (JCJC-SVSE2-2011, ChromaTranscript project) and the European Union (FP7-PEOPLE-2011-CIG, ChromaTranscript project). D. A. C. was supported by MFPL VIPS Program (BMWF and City of Vienna). A. V. acknowledges financial support by the Vienna Science and Technology Fund (WWTF) project VRG10-11, the Research Platform Quantum Phenomena and Nanoscale Biological Systems (QuNaBioS) and by Boehringer Ingelheim. Research in the laboratory of J.-M.P. is supported by Boehringer Ingelheim, the Austrian Science Fund (FWF special research program SFB F34 'Chromosome Dynamics', and Wittgenstein award Z196-B20), the Austrian Research Promotion Agency (FFG, Laura Bassi Center for Optimized Structural Studies), the Vienna Science and Technology Fund (WWTF LS09-13), and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 241548 (MitoSys).	Bugler B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-29; Buheitel J, 2013, EMBO J, V32, P666, DOI 10.1038/emboj.2013.7; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; DeMare L. E., 2013, GENOME RES; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Seitan VC, 2012, CURR OPIN GENET DEV, V22, P93, DOI 10.1016/j.gde.2011.11.003; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Verni F, 2000, GENETICS, V154, P1693; Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	45	190	191	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					564	+		10.1038/nature12471	http://dx.doi.org/10.1038/nature12471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23975099	Green Accepted			2022-12-28	WOS:000324826300062
J	Lee, SM; Donaldson, GP; Mikulski, Z; Boyajian, S; Ley, K; Mazmanian, SK				Lee, S. Melanie; Donaldson, Gregory P.; Mikulski, Zbigniew; Boyajian, Silva; Ley, Klaus; Mazmanian, Sarkis K.			Bacterial colonization factors control specificity and stability of the gut microbiota	NATURE			English	Article							BACTEROIDES-THETAIOTAOMICRON; INTESTINAL MICROBIOTA; COMMENSAL; DIVERSITY; DISEASE; SYMBIOSIS; SYSTEM; MODEL; FLORA	Mammals harbour a complex gut microbiome, comprising bacteria that confer immunological, metabolic and neurological benefits(1). Despite advances in sequence-based microbial profiling and myriad studies defining microbiome composition during health and disease, little is known about the molecular processes used by symbiotic bacteria to stably colonize the gastrointestinal tract. We sought to define how mammals assemble and maintain the Bacteroides, one of the most numerically prominent genera of the human microbiome. Here we find that, whereas the gut normally contains hundreds of bacterial species(2,3), germ-free mice mono-associated with a single Bacteroides species are resistant to colonization by the same, but not different, species. To identify bacterial mechanisms for species-specific saturable colonization, we devised an in vivo genetic screen and discovered a unique class of polysaccharide utilization loci that is conserved among intestinal Bacteroides. We named this genetic locus the commensal colonization factors (ccf). Deletion of the ccf genes in the model symbiont, Bacteroides fragilis, results in colonization defects in mice and reduced horizontal transmission. The ccf genes of B. fragilis are upregulated during gut colonization, preferentially at the colonic surface. When we visualize microbial biogeography within the colon, B. fragilis penetrates the colonic mucus and resides deep within crypt channels, whereas ccf mutants are defective in crypt association. Notably, the CCF system is required for B. fragilis colonization following microbiome disruption with Citrobacter rodentium infection or antibiotic treatment, suggesting that the niche within colonic crypts represents a reservoir for bacteria to maintain long-term colonization. These findings reveal that intestinal Bacteroides have evolved species-specific physical interactions with the host that mediate stable and resilient gut colonization, and the CCF system represents a novel molecular mechanism for symbiosis.	[Lee, S. Melanie; Donaldson, Gregory P.; Boyajian, Silva; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Mikulski, Zbigniew; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA	California Institute of Technology; La Jolla Institute for Immunology	Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	sarkis@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021; Mikulski, Zbigniew/AAB-4447-2020	Mazmanian, Sarkis/0000-0003-2713-1513; Mikulski, Zbigniew/0000-0002-1918-9216; Donaldson, Gregory/0000-0002-8551-374X	National Institutes of Health [GM099535, DK078938]; Crohn's and Colitis Foundation of America;  [GM007616]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, P01DK091222, R56DK078938, R21DK083633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099535, T32GM007616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Thron and S. McBride for the maintenance of germ-free animals, J. Selicha for assisting with the experimental procedures and G. Chodaczek for help with confocal and two-photon microscopy. We are grateful to E. C. Martens and members of the Mazmanian laboratory for critical review of the manuscript. S. M. L. and G. P. D. were supported by a pre-doctoral training grant (GM007616). This work was supported by grants from the National Institutes of Health (GM099535 and DK078938) and the Crohn's and Colitis Foundation of America to S.K.M.	Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kawada M, 2008, LAB INVEST, V88, P883, DOI 10.1038/labinvest.2008.47; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	27	348	358	6	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					426	+		10.1038/nature12447	http://dx.doi.org/10.1038/nature12447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23955152	Green Accepted			2022-12-28	WOS:000324545700047
J	Delgoffe, GM; Woo, SR; Turnis, ME; Gravano, DM; Guy, C; Overacre, AE; Bettini, ML; Vogel, P; Finkelstein, D; Bonnevier, J; Workman, CJ; Vignali, DAA				Delgoffe, Greg M.; Woo, Seng-Ryong; Turnis, Meghan E.; Gravano, David M.; Guy, Cliff; Overacre, Abigail E.; Bettini, Matthew L.; Vogel, Peter; Finkelstein, David; Bonnevier, Jody; Workman, Creg J.; Vignali, Dario A. A.			Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; TRANSCRIPTION FACTOR FOXP3; BREAST-CANCER CELLS; IN-VIVO; NEUROPILIN-1; EXPRESSION; AKT; DIFFERENTIATION; ACTIVATION; MARKER	Regulatory T cells (T-reg cells) have a crucial role in the immune system by preventing autoimmunity, limiting immunopathology, and maintaining immune homeostasis(1). However, they also represent a major barrier to effective anti-tumour immunity and sterilizing immunity to chronic viral infections(1). The transcription factor Foxp3 has a major role in the development and programming of T-reg cells(2,3). The relative stability of T-reg cells at inflammatory disease sites has been a highly contentious subject(4-6). There is considerable interest in identifying pathways that control the stability of T-reg cells as many immune-mediated diseases are characterized by either exacerbated or limited T-reg-cell function. Here we show that the immune-cell-expressed ligand semaphorin-4a (Sema4a) and the T-reg-cell-expressed receptor neuropilin-1 (Nrp1) interact both in vitro, to potentiate T-reg-cell function and survival, and in vivo, at inflammatory sites. Using mice with a T-reg-cell-restricted deletion of Nrp1, we show that Nrp1 is dispensable for suppression of autoimmunity and maintenance of immune homeostasis, but is required by T-reg cells to limit anti-tumour immune responses and to cure established inflammatory colitis. Sema4a ligation of Nrp1 restrained Akt phosphorylation cellularly and at the immunologic synapse by phosphatase and tensin homologue (PTEN), which increased nuclear localization of the transcription factor Foxo3a. The Nrp1-induced transcriptome promoted T-reg-cell stability by enhancing quiescence and survival factors while inhibiting programs that promote differentiation. Importantly, this Nrp1-dependent molecular program is evident in intra-tumoral T-reg cells. Our data support a model in which T-reg-cell stability can be subverted in certain inflammatory sites, but is maintained by a Sema4a-Nrp1 axis, highlighting this pathway as a potential therapeutic target that could limit T-reg-cell-mediated tumour-induced tolerance without inducing autoimmunity.	[Delgoffe, Greg M.; Woo, Seng-Ryong; Turnis, Meghan E.; Gravano, David M.; Guy, Cliff; Overacre, Abigail E.; Bettini, Matthew L.; Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Overacre, Abigail E.] Univ Tennessee, Hlth Sci Ctr, Integrated Biomed Sci Program, Memphis, TN 38163 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Bonnevier, Jody] R&D Syst Inc, Minneapolis, MN 55413 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Vignali, DAA (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vignali.lab@stjude.org	Vogel, Peter/N-2490-2018; Delgoffe, Greg M./HCH-2805-2022	Vogel, Peter/0000-0002-7535-0545; Delgoffe, Greg M./0000-0002-2957-8135; Overacre, Abigail/0000-0003-4027-3487	National Institutes of Health [R01 AI091977, AI039480, F32 AI098383]; NCI Comprehensive Cancer Center Support CORE grant [CA21765]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI098383, T32AI007610, R29AI039480, R01AI039480, R01AI091977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Comprehensive Cancer Center Support CORE grant; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank E. J. Wherry and H. Chi for advice; A. Rudensky, D. Cheresh, K. Yang, T. Geiger and H. Chi for mice; D. R. Green for plasmids; and B. Triplett, M. Howard and M. McKenna at St Louis Cord Blood Bank for cord blood samples. The authors also thank K. Forbes and A. McKenna for maintenance, breeding and genotyping of mouse colonies; A. Castellaw for preparation of human cord blood samples; K. M. Vignali for assistance with cloning; A. Herrada for generating Nrp1-IgG1; A. L. Szymczak-Workman for assistance with histological analysis; S. Morgan, G. Lennon and R. Cross of the St Jude Immunology Flow Lab for cell sorting; the staff of the Shared Animal Resource Center at St Jude Children's Research Hospital for the animal husbandry; the Hartwell Center for Biotechnology and Bioinformatics at St Jude Children's Research Hospital for Affymetrix microarray analysis; the Veterinary Pathology Core for histological preparation; and the Immunology Department at St Jude Children's Research Hospital for helpful discussions. This work was supported by the National Institutes of Health (R01 AI091977 and AI039480 to D. A. A. V.; F32 AI098383 to G. M. D.), NCI Comprehensive Cancer Center Support CORE grant (CA21765, to D. A. A. V.) and ALSAC (to D.A.A.V.).	Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Demoulin S, 2013, J LEUKOCYTE BIOL, V93, P343, DOI 10.1189/jlb.0812397; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kerdiles YM, 2011, IMMUNITY, V34, P135, DOI 10.1016/j.immuni.2011.01.008; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Milpied P, 2009, EUR J IMMUNOL, V39, P1466, DOI 10.1002/eji.200839040; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Piechnik A., 2013, INT J CANC; Qiao M, 2007, IMMUNOLOGY, V121, P146, DOI 10.1111/j.1365-2567.2007.02625.x; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sawant A, 2012, J IMMUNOL, V189, P4258, DOI 10.4049/jimmunol.1101855; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wilde S, 2012, J IMMUNOL, V189, P598, DOI 10.4049/jimmunol.1102165; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	31	365	390	6	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					252	+		10.1038/nature12428	http://dx.doi.org/10.1038/nature12428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23913274	Green Accepted			2022-12-28	WOS:000324244900047
J	Sabol, TJ; Hong, SLS; Pianta, RC; Burchinal, MR				Sabol, T. J.; Hong, S. L. Soliday; Pianta, R. C.; Burchinal, M. R.			Can Rating Pre-K Programs Predict Children's Learning?	SCIENCE			English	Editorial Material									[Sabol, T. J.] Northwestern Univ, Inst Policy Res, Evanston, IL 60208 USA; [Hong, S. L. Soliday; Burchinal, M. R.] Univ N Carolina, Frank Porter Graham Child Dev Inst, Chapel Hill, NC 27599 USA; [Pianta, R. C.] Univ Virginia, Ctr Adv Study Teaching & Learning, Charlottesville, VA 22904 USA	Northwestern University; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia	Sabol, TJ (corresponding author), Northwestern Univ, Inst Policy Res, Evanston, IL 60208 USA.	terri.sabol@northwestern.edu		Pianta, Robert/0000-0002-6280-8051; Sabol, Terri/0000-0003-1991-6564				Barnett WS, 2011, SCIENCE, V333, P975, DOI 10.1126/science.1204534; Camilli G, 2010, TEACH COLL REC, V112, P579; Early D. M., 2005, PREKINDERGARTEN 11 S; Gormley WT, 2008, SCIENCE, V320, P1723, DOI 10.1126/science.1156019; Harms T., 1998, EARLY CHILDHOOD ENV; Jacobson-Chernoff J., 2007, PRESCHOOL 1 FINDINGS; Pianta R. C., 2004, CLASSROOM ASSESSMENT; Pianta Robert C, 2009, Psychol Sci Public Interest, V10, P49, DOI 10.1177/1529100610381908; Raudenbush SW, 2004, J EDUC BEHAV STAT, V29, P121, DOI 10.3102/10769986029001121; Rothstein J, 2009, EDUC FINANC POLICY, V4, P537, DOI 10.1162/edfp.2009.4.4.537; Tout K, 2010, CHILD CARE QUALITY R; Zellman G.L., 2008, ASSESSING VALIDITY Q	12	108	108	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					845	846		10.1126/science.1233517	http://dx.doi.org/10.1126/science.1233517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MY	23970684				2022-12-28	WOS:000323370600024
J	Alexandrov, LB; Nik-Zainal, S; Wedge, DC; Aparicio, SAJR; Behjati, S; Biankin, AV; Bignell, GR; Bolli, N; Borg, A; Borresen-Dale, AL; Boyault, S; Burkhardt, B; Butler, AP; Caldas, C; Davies, HR; Desmedt, C; Eils, R; Eyfjord, JE; Foekens, JA; Greaves, M; Hosoda, F; Hutter, B; Ilicic, T; Imbeaud, S; Imielinsk, M; Jager, N; Jones, DTW; Jones, D; Knappskog, S; Kool, M; Lakhani, SR; Lopez-Otin, C; Martin, S; Munshi, NC; Nakamura, H; Northcott, PA; Pajic, M; Papaemmanuil, E; Paradiso, A; Pearson, JV; Puente, XS; Raine, K; Ramakrishna, M; Richardson, AL; Richter, J; Rosenstiel, P; Schlesner, M; Schumacher, TN; Span, PN; Teague, JW; Totoki, Y; Tutt, ANJ; Valdes-Mas, R; van Buuren, MM; van 't Veer, L; Vincent-Salomon, A; Waddell, N; Yates, LR; Zucman-Rossi, J; Futreal, PA; McDermott, U; Lichter, P; Meyerson, M; Grimmond, SM; Siebert, R; Campo, E; Shibata, T; Pfister, SM; Campbell, PJ; Stratton, MR				Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.; Aparicio, Samuel A. J. R.; Behjati, Sam; Biankin, Andrew V.; Bignell, Graham R.; Bolli, Niccolo; Borg, Ake; Borresen-Dale, Anne-Lise; Boyault, Sandrine; Burkhardt, Birgit; Butler, Adam P.; Caldas, Carlos; Davies, Helen R.; Desmedt, Christine; Eils, Roland; Eyfjord, Jorunn Erla; Foekens, John A.; Greaves, Mel; Hosoda, Fumie; Hutter, Barbara; Ilicic, Tomislav; Imbeaud, Sandrine; Imielinsk, Marcin; Jaeger, Natalie; Jones, David T. W.; Jones, David; Knappskog, Stian; Kool, Marcel; Lakhani, Sunil R.; Lopez-Otin, Carlos; Martin, Sancha; Munshi, Nikhil C.; Nakamura, Hiromi; Northcott, Paul A.; Pajic, Marina; Papaemmanuil, Elli; Paradiso, Angelo; Pearson, John V.; Puente, Xose S.; Raine, Keiran; Ramakrishna, Manasa; Richardson, Andrea L.; Richter, Julia; Rosenstiel, Philip; Schlesner, Matthias; Schumacher, Ton N.; Span, Paul N.; Teague, Jon W.; Totoki, Yasushi; Tutt, Andrew N. J.; Valdes-Mas, Rafael; van Buuren, Marit M.; van 't Veer, Laura; Vincent-Salomon, Anne; Waddell, Nicola; Yates, Lucy R.; Zucman-Rossi, Jessica; Futreal, P. Andrew; McDermott, Ultan; Lichter, Peter; Meyerson, Matthew; Grimmond, Sean M.; Siebert, Reiner; Campo, Elias; Shibata, Tatsuhiro; Pfister, Stefan M.; Campbell, Peter J.; Stratton, Michael R.		Australian Pancreatic Canc Genome; ICGC Breast Canc Consortium; ICGC MMML-Seq Consortium; ICGC PedBrain	Signatures of mutational processes in human cancer	NATURE			English	Article							RECURRENT MUTATIONS; SOMATIC MUTATIONS; GENETIC LANDSCAPE; FREQUENT MUTATION; DRIVER MUTATIONS; MISMATCH REPAIR; EXOME; REVEALS; ADENOCARCINOMA; INSTABILITY	All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, 'kataegis', is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.	[Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.; Behjati, Sam; Bignell, Graham R.; Bolli, Niccolo; Butler, Adam P.; Davies, Helen R.; Ilicic, Tomislav; Jones, David; Martin, Sancha; Papaemmanuil, Elli; Raine, Keiran; Ramakrishna, Manasa; Teague, Jon W.; Yates, Lucy R.; Futreal, P. Andrew; McDermott, Ultan; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; [Nik-Zainal, Serena] Addenbrookes Hosp NHS Trust, Dept Med Genet, Cambridge CB2 0QQ, England; [Aparicio, Samuel A. J. R.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Aparicio, Samuel A. J. R.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Ctr Translat & Appl Genom, Vancouver, BC V5Z 1L3, Canada; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge CB2 2XY, England; [Biankin, Andrew V.; Pajic, Marina] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland; [Biankin, Andrew V.] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G4 0SF, Lanark, Scotland; [Biankin, Andrew V.] Kinghorn Canc Ctr, Darlinghurst, NSW, Australia; [Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Biankin, Andrew V.] Univ New S Wales, South Western Sydney Clin Sch, Fac Med, Liverpool, NSW 2170, Australia; [Bolli, Niccolo; Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Bolli, Niccolo; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Borg, Ake] Lund Univ, Dept Oncol, SE-22185 Lund, Sweden; [Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Genet, Inst Canc Res, N-0310 Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0310 Oslo, Norway; [Boyault, Sandrine] Ctr Leon Berard, Plateforme Bioinformat Synergie Lyon Canc, F-69373 Lyon 08, France; [Burkhardt, Birgit] Univ Childrens Hosp, NHL BFM Study Ctr, D-48149 Munster, Germany; [Burkhardt, Birgit] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany; [Burkhardt, Birgit] Univ Childrens Hosp, NHL BFM Study Ctr, D-35392 Giessen, Germany; [Burkhardt, Birgit] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, D-35392 Giessen, Germany; [Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Desmedt, Christine] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab BCTL, B-1000 Brussels, Belgium; [Eils, Roland; Hutter, Barbara; Jaeger, Natalie; Schlesner, Matthias] German Canc Res Ctr, Dept Theoret Bioinformat B080, D-69120 Heidelberg, Germany; [Eyfjord, Jorunn Erla] Univ Iceland, Canc Res Lab, Fac Med, Biomed Ctr, IS-101 Reykjavik, Iceland; [Foekens, John A.] Erasmus MC Canc Inst, Dept Med Oncol, NL-3015 CE Rotterdam, Netherlands; [Greaves, Mel] Inst Canc Res, Dept Haematooncol, Sutton SM2 5NG, Surrey, England; [Hosoda, Fumie; Nakamura, Hiromi; Totoki, Yasushi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 1040045, Japan; [Imbeaud, Sandrine; Zucman-Rossi, Jessica] IUH, INSERM, UMR 674, F-75475 Paris, France; [Imbeaud, Sandrine; Zucman-Rossi, Jessica] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75006 Paris, France; [Imielinsk, Marcin; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, Sect Oncol, N-5020 Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Lakhani, Sunil R.] Univ Queensland, Royal Brisbane & Womens Hosp, Clin Res Ctr, Sch Med & Pathol Queensland, Brisbane, Qld 4029, Australia; [Lopez-Otin, Carlos; Puente, Xose S.; Valdes-Mas, Rafael] Univ Oviedo, IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Munshi, Nikhil C.] Harvard Univ, Sch Med, Jerome Lipper Multiple Myeloma Dis Ctr, Dana Farber Canc Inst, Boston, MA 02215 USA; [Munshi, Nikhil C.] Boston Vet Adm Healthcare Syst, West Roxbury, MA 02132 USA; [Paradiso, Angelo] Natl Canc Inst, Clin Expt Oncol Lab, I-70126 Bari, Italy; [Pearson, John V.; Waddell, Nicola; Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Richardson, Andrea L.; Meyerson, Matthew] Dana Farber Canc Inst, Boston, MA 02215 USA; [Richardson, Andrea L.; Meyerson, Matthew] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24118 Kiel, Germany; [Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24118 Kiel, Germany; [Schumacher, Ton N.; van Buuren, Marit M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6500 HB Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Tutt, Andrew N. J.] Kings Coll London, Sch Med, Breakthrough Breast Canc Res Unit, London SW3 6JB, England; [van 't Veer, Laura] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Vincent-Salomon, Anne] INSERM, U830, Dept Pathol, Inst Curie, F-75248 Paris 05, France; [Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Campo, Elias] Univ Barcelona, Unidad Hematopatol, Serv Anat Patol, Hosp Clin,IDIBAPS, E-08036 Barcelona, Spain; [Pfister, Stefan M.] Dept Pediat Hematol & Oncol, D-69120 Heidelberg, Germany	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of Cambridge; University of Glasgow; University of Glasgow; Garvan Institute of Medical Research; University of New South Wales Sydney; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Lund University; University of Oslo; University of Oslo; UNICANCER; Centre Leon Berard; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Institut Jules Bordet; Universite Libre de Bruxelles; Helmholtz Association; German Cancer Research Center (DKFZ); University of Iceland; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of London; Institute of Cancer Research - UK; National Cancer Center - Japan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bergen; University of Bergen; Haukeland University Hospital; Royal Brisbane & Women's Hospital; University of Queensland; University of Oviedo; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; IRCCS Istituto Tumori Bari Giovanni Paolo II; University of Queensland; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Kiel; University of Kiel; Netherlands Cancer Institute; Radboud University Nijmegen; Radboud University Nijmegen; University of London; King's College London; Netherlands Cancer Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Alexandrov, LB (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	mrs@sanger.ac.uk	Span, Paul/G-4710-2012; Schumacher, Ton/Y-2432-2019; López-Otín, Carlos/AAB-2106-2020; Bolli, Niccolo/D-4057-2011; Sweep, C.G.J./H-8096-2014; Puente, Xosé S./ADB-0672-2022; Pearson, John V/F-2249-2011; Desmedt, Christine/P-7438-2017; Munshi, Nikhil/ABE-2338-2021; Caldas, Carlos/U-7250-2019; Campo, Elias/AAC-5593-2019; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Kool, Marcel/H-2541-2013; Lakhani, Sunil R/I-1970-2018; Burkhardt, Birgit/AAS-9678-2021; Eils, Roland/B-6121-2009; Jones, David TW/G-9588-2013; Pfister, Stefan M/F-6860-2013; Valdés-Mas, Rafael/AAC-2879-2021; Bult, Peter/L-4236-2015; Stadler, Peter F. F/L-7857-2015; j, zucman-rossi/AAV-3594-2021; Hoffmann, Steve/E-1438-2013; Rosenstiel, Philip/A-5137-2009; Nik-Zainal, Serena/ABD-4437-2020; Klapper, Wolfram/S-6314-2016; Schlesner, Matthias/I-4030-2013; Wedge, David/AAC-4977-2021; Ammerpohl, Ole/G-2691-2010; Shibata, Tatsuhiro/ABA-8234-2020; Siebert, Reiner/A-8049-2010; Jones, David T. W./Z-1963-2019; zucman-rossi, Jessica/B-5098-2009; Northcott, Paul A/N-4022-2018; Pearson, John/AAT-4211-2020; Langenberger, David/AAF-3313-2020; paradiso, angelo V/J-9457-2018; Gill, Anthony/D-4215-2015; Waddell, Nicola/H-4929-2015; Hoell, Jessica/J-8136-2016; Shibata, Tatsuhiro/AAO-1278-2021; Alexandrov, Ludmil/AAS-1454-2021; Radlwimmer, Bernhard/I-3229-2013; Imbeaud, Sandrine/P-8780-2017; Langenberger, David/D-4155-2013	Span, Paul/0000-0002-1930-6638; Schumacher, Ton/0000-0003-0517-8804; López-Otín, Carlos/0000-0001-6964-1904; Bolli, Niccolo/0000-0002-1018-5139; Sweep, C.G.J./0000-0003-1103-3070; Puente, Xosé S./0000-0001-9525-1483; Pearson, John V/0000-0003-0904-4598; Desmedt, Christine/0000-0002-5223-5579; Caldas, Carlos/0000-0003-3547-1489; Campo, Elias/0000-0001-9850-9793; Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Lakhani, Sunil R/0000-0003-4067-2760; Burkhardt, Birgit/0000-0002-1151-829X; Eils, Roland/0000-0002-0034-4036; Jones, David TW/0000-0002-2036-5141; Pfister, Stefan M/0000-0002-5447-5322; Valdés-Mas, Rafael/0000-0002-0737-5425; Bult, Peter/0000-0001-6427-9889; Stadler, Peter F. F/0000-0002-5016-5191; j, zucman-rossi/0000-0002-5687-0334; Rosenstiel, Philip/0000-0002-9692-8828; Schlesner, Matthias/0000-0002-5896-4086; zucman-rossi, Jessica/0000-0002-5687-0334; Northcott, Paul A/0000-0002-1220-5252; Gill, Anthony/0000-0002-9447-1967; Waddell, Nicola/0000-0002-3950-2476; Hoell, Jessica/0000-0002-5532-9845; Alexandrov, Ludmil/0000-0003-3596-4515; Biankin, Andrew/0000-0002-0362-5597; Kuppers, Ralf/0000-0002-6691-7191; Aparicio, Samuel/0000-0002-0487-9599; Hutter, Barbara/0000-0002-9034-0329; Martin, Sancha/0000-0001-6213-5259; Radlwimmer, Bernhard/0000-0002-4553-7800; McDermott, Ultan/0000-0001-9032-4700; Meyerson, Matthew/0000-0002-9133-8108; Tutt, Andrew/0000-0001-8715-2901; Raine, Keiran/0000-0002-5634-1539; Jaeger, Natalie/0000-0002-9589-7580; Wedge, David/0000-0002-7572-3196; Yates, Lucy/0000-0003-4519-7794; Nik-Zainal, Serena/0000-0001-5054-1727; Knappskog, Stian/0000-0002-4153-1655; Pajic, Marina/0000-0002-3871-3829; Kreuz, Markus/0000-0002-0520-8391; Imbeaud, Sandrine/0000-0001-8439-6732; , Stephan/0000-0002-5928-9449; Claviez, Alexander/0000-0002-1561-5185; Langenberger, David/0000-0001-9424-9701	Wellcome Trust [098051]; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; Breast Cancer Now [KCL-Q1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Now	We would like to thank the Wellcome Trust for support (grant reference 098051) together with many other funding bodies and individuals (Supplementary Note 1).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koito A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00028; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Pfeifer GP, 2010, GENOME MED, V2, DOI 10.1186/gm175; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Tomita-Mitchell A, 2000, MUTAT RES-FUND MOL M, V450, P125, DOI 10.1016/S0027-5107(00)00020-8; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	64	5889	6024	28	661	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					415	+		10.1038/nature12477	http://dx.doi.org/10.1038/nature12477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23945592	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000323316100026
J	Sandborn, WJ; Feagan, BG; Rutgeerts, P; Hanauer, S; Colombel, JF; Sands, BE; Lukas, M; Fedorak, RN; Lee, S; Bressler, B; Fox, I; Rosario, M; Sankoh, S; Xu, J; Stephens, K; Milch, C; Parikh, A				Sandborn, William J.; Feagan, Brian G.; Rutgeerts, Paul; Hanauer, Stephen; Colombel, Jean-Frederic; Sands, Bruce E.; Lukas, Milan; Fedorak, Richard N.; Lee, Scott; Bressler, Brian; Fox, Irving; Rosario, Maria; Sankoh, Serap; Xu, Jing; Stephens, Kristin; Milch, Catherine; Parikh, Asit		GEMINI 2 Study Grp	Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CERTOLIZUMAB PEGOL; NATALIZUMAB; ANTIBODY; JC; ADALIMUMAB; INFLIXIMAB; PREVALENCE; RISK; BK	BACKGROUND The efficacy of vedolizumab, an alpha(4)beta(7) integrin antibody, in Crohn's disease is unknown. METHODS In an integrated study with separate induction and maintenance trials, we assessed intravenous vedolizumab therapy (300 mg) in adults with active Crohn's disease. In the induction trial, 368 patients were randomly assigned to receive vedolizumab or placebo at weeks 0 and 2 (cohort 1), and 747 patients received open-label vedolizumab at weeks 0 and 2 (cohort 2); disease status was assessed at week 6. In the maintenance trial, 461 patients who had had a response to vedolizumab were randomly assigned to receive placebo or vedolizumab every 8 or 4 weeks until week 52. RESULTS At week 6, a total of 14.5% of the patients in cohort 1 who received vedolizumab and 6.8% who received placebo were in clinical remission (i.e., had a score on the Crohn's Disease Activity Index [CDAI] of <= 150, with scores ranging from 0 to approximately 600 and higher scores indicating greater disease activity) (P = 0.02); a total of 31.4% and 25.7% of the patients, respectively, had a CDAI-100 response (>= 100-point decrease in the CDAI score) (P = 0.23). Among patients in cohorts 1 and 2 who had a response to induction therapy, 39.0% and 36.4% of those assigned to vedolizumab every 8 weeks and every 4 weeks, respectively, were in clinical remission at week 52, as compared with 21.6% assigned to placebo (P<0.001 and P = 0.004 for the two vedolizumab groups, respectively, vs. placebo). Antibodies against vedolizumab developed in 4.0% of the patients. Nasopharyngitis occurred more frequently, and headache and abdominal pain less frequently, in patients receiving vedolizumab than in patients receiving placebo. Vedolizumab, as compared with placebo, was associated with a higher rate of serious adverse events (24.4% vs. 15.3%), infections (44.1% vs. 40.2%), and serious infections (5.5% vs. 3.0%). CONCLUSIONS Vedolizumab-treated patients with active Crohn's disease were more likely than patients receiving placebo to have a remission, but not a CDAI-100 response, at week 6; patients with a response to induction therapy who continued to receive vedolizumab (rather than switching to placebo) were more likely to be in remission at week 52. Adverse events were more common with vedolizumab.	[Sandborn, William J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Feagan, Brian G.] Univ Western Ontario, Robarts Res Inst, Robarts Clin Trials, London, ON N6A 5K8, Canada; [Feagan, Brian G.] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; [Feagan, Brian G.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 5K8, Canada; [Fedorak, Richard N.] Univ Alberta, Edmonton, AB, Canada; [Bressler, Brian] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Rutgeerts, Paul] Katholieke Univ Leuven, Louvain, Belgium; [Rutgeerts, Paul] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Hanauer, Stephen] Univ Chicago, Chicago, IL 60637 USA; [Colombel, Jean-Frederic] Univ Lille Nord France, Ctr Hosp Reg Univ Lille, Dept Hepatogastroenterol, Lille, France; [Colombel, Jean-Frederic] Univ Lille Nord France, Ctr Hosp Reg Univ Lille, Ctr Invest Clin, Lille, France; [Colombel, Jean-Frederic; Sands, Bruce E.] Icahn Sch Med Mt Sinai, New York, NY USA; [Lukas, Milan] Gen Fac Hosp, Prague, Czech Republic; [Lee, Scott] Univ Washington, Seattle, WA 98195 USA; [Fox, Irving; Rosario, Maria; Sankoh, Serap; Xu, Jing; Stephens, Kristin; Milch, Catherine; Parikh, Asit] Millennium Pharmaceut Inc, Cambridge, MA USA	University of California System; University of California San Diego; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Alberta; University of British Columbia; KU Leuven; KU Leuven; University Hospital Leuven; University of Chicago; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Icahn School of Medicine at Mount Sinai; General University Hospital Prague; University of Washington; University of Washington Seattle; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wsandborn@ucsd.edu; bfeagan@robarts.ca	Feagan, Brian G/M-4283-2015; Loftus, Edward V/E-8304-2011; Desreumaux, Pierre F/R-6877-2018; Lukas, Milan/J-6382-2017; Snydman, David R/O-3889-2014; Pavli, Paul/GZL-0607-2022; Feagan, Brian/G-3292-2011; Calvet, Xavier/H-3288-2019; Gearry, Richard B/H-3959-2019; Andersen, Vibeke/I-7932-2012; Sands, Bruce/R-7887-2019; Leong, Rupert WL/J-7839-2012; Rogler, Gerhard/O-5308-2015; Sandborn, William/ABE-8342-2020	Loftus, Edward V/0000-0001-7199-6851; Desreumaux, Pierre F/0000-0002-6127-5281; Lukas, Milan/0000-0002-1463-3840; Snydman, David R/0000-0003-0119-3978; Calvet, Xavier/0000-0002-6278-9663; Gearry, Richard B/0000-0002-2298-5141; Andersen, Vibeke/0000-0002-0127-2863; Sands, Bruce/0000-0001-5762-5042; Leong, Rupert WL/0000-0001-5944-3488; Rogler, Gerhard/0000-0002-1733-9188; Stremmel, Wolfgang/0000-0002-8545-1753; Fedorak, Richard/0000-0002-7382-0080; Dryden, Gerald/0000-0001-9787-4537; Schwartz, David/0000-0002-7026-7099; Gasbarrini, Antonio/0000-0003-4863-6924; Calvet, Xavier/0000-0002-4413-4209; Ryan, Barbara/0000-0001-8400-9202	Millennium Pharmaceuticals [NCT00783692]	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Funded by Millennium Pharmaceuticals; GEMINI 2 ClinicalTrials.gov number, NCT00783692.	Baumgart DC, 2013, LANCET, V381, P204; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dignass AU, 2010, J CROHNS COLITIS, V4, P353, DOI 10.1016/j.crohns.2010.07.001; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Engels EA, 2005, INT J CANCER, V117, P1013, DOI 10.1002/ijc.21277; Feagan BG, 2009, CLIN GASTROENTEROL H, V7, P494; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Feagan BG, 2008, CLIN GASTROENTEROL H, V6, P1370, DOI 10.1016/j.cgh.2008.06.007; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; PADGETT BL, 1973, J INFECT DIS, V127, P467, DOI 10.1093/infdis/127.4.467; Parikh A, 2012, INFLAMM BOWEL DIS, V18, P1470, DOI 10.1002/ibd.21896; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; Pepio AM, 2010, 2010 ADV INFL BOW DI; Peyrin-Biroulet L, 2008, CLIN GASTROENTEROL H, V6, P644, DOI 10.1016/j.cgh.2008.03.014; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sandborn WJ, 2007, ANN INTERN MED, V146, P829, DOI 10.7326/0003-4819-146-12-200706190-00159; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sandborn WJ, 2003, AM J GASTROENTEROL, V98, P2372, DOI 10.1016/j.amjgastroenterol.2003.08.009; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Soler D, 2009, J PHARMACOL EXP THER, V330, P864, DOI 10.1124/jpet.109.153973; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Verbeeck J, 2008, GUT, V57, P1393, DOI 10.1136/gut.2007.145698; Weber T, 1997, J INFECT DIS, V176, P250, DOI 10.1086/514032; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	39	1267	1332	6	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					711	721		10.1056/NEJMoa1215739	http://dx.doi.org/10.1056/NEJMoa1215739			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964933	Green Published			2022-12-28	WOS:000323349300008
J	Blobel, GA; Hardison, RC				Blobel, Gerd A.; Hardison, Ross C.			A Cluster to Remember	CELL			English	Editorial Material							MITOTIC BOOKMARKING; GENE-EXPRESSION; COHESIN; BINDING	Based on a massive transcription factor location analysis within a single cell type, in this issue Yan et al. find that the great majority of occupancies occur within dense clusters of up to 100 factors that almost invariably contain cohesins. Retention of cohesins at cluster sites during mitosis raises the possibility that they contribute to transcriptional memory during the cell cycle.	[Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hardison, Ross C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hardison, RC (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	rch8@psu.edu	Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516	NHGRI NIH HHS [U54 HG006998, U54HG006998, RC2 HG005573] Funding Source: Medline; NIDDK NIH HHS [R01DK054937, R37 DK058044, R01 DK054937, R01DK065806, R37DK058044, R01 DK065806] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006998, RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054937, R37DK058044, R01DK065806] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dorsett D, 2013, CURR OPIN CELL BIOL, V25, P327, DOI 10.1016/j.ceb.2013.02.003; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003382; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48	10	0	0	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					718	720		10.1016/j.cell.2013.07.041	http://dx.doi.org/10.1016/j.cell.2013.07.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953105	Bronze, Green Accepted			2022-12-28	WOS:000323202500003
J	Takeda, S; Mizuta, T; Fuwa, M; van Loock, P; Furusawa, A				Takeda, Shuntaro; Mizuta, Takahiro; Fuwa, Maria; van Loock, Peter; Furusawa, Akira			Deterministic quantum teleportation of photonic quantum bits by a hybrid technique	NATURE			English	Article							PODOLSKY-ROSEN CHANNELS; EXPERIMENTAL REALIZATION; STATE; COMPUTATION; OPERATIONS; QUBITS	Quantum teleportation(1) allows for the transfer of arbitrary unknown quantum states from a sender to a spatially distant receiver, provided that the two parties share an entangled state and can communicate classically. It is the essence of many sophisticated protocols for quantum communication and computation(2-5). Photons are an optimal choice for carrying information in the form of 'flying qubits', but the teleportation of photonic quantum bits(6-11) (qubits) has been limited by experimental inefficiencies and restrictions. Main disadvantages include the fundamentally probabilistic nature of linear-optics Bell measurements(12), as well as the need either to destroy the teleported qubit or attenuate the input qubit when the detectors do not resolve photon numbers(13). Here we experimentally realize fully deterministic quantum teleportation of photonic qubits without post-selection. The key step is to make use of a hybrid technique involving continuous-variable teleportation(14-16) of a discrete-variable, photonic qubit. When the receiver's feedforward gain is optimally tuned, the continuous-variable teleporter acts as a pure loss channel(17,18), and the input dual-rail-encoded qubit, based on a single photon, represents a quantum error detection code against photon loss(19) and hence remains completely intact for most teleportation events. This allows for a faithful qubit transfer even with imperfect continuous-variable entangled states: for four qubits the overall transfer fidelities range from 0.79 to 0.82 and all of them exceed the classical limit of teleportation. Furthermore, even for a relatively low level of the entanglement, qubits are teleported much more efficiently than in previous experiments, albeit post-selectively (taking into account only the qubit subspaces), and with a fidelity comparable to the previously reported values.	[Takeda, Shuntaro; Mizuta, Takahiro; Fuwa, Maria; Furusawa, Akira] Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [van Loock, Peter] Johannes Gutenberg Univ Mainz, Inst Phys, D-55128 Mainz, Germany	University of Tokyo; Johannes Gutenberg University of Mainz	Furusawa, A (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	akiraf@ap.t.u-tokyo.ac.jp	Takeda, Shuntaro/A-3318-2015; Furusawa, Akira/P-5787-2014	Furusawa, Akira/0000-0002-6176-6742	PDIS; GIA; G-COE; APSA; FIRST; SCOPE programme; ASCR-JSPS; ALPS	PDIS; GIA; G-COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); APSA; FIRST; SCOPE programme; ASCR-JSPS; ALPS	This work was partly supported by PDIS, GIA, G-COE, APSA and FIRST, commissioned by MEXT (Japan); by the SCOPE programme commissioned by MIC (Japan); and by ASCR-JSPS. S. T. and M. F. acknowledge financial support from ALPS. We thank L. Mista Jr, H. Yonezawa and J. Kimble for comments.	BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bowen WP, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.032302; Braunstein SI, 1998, NATURE, V394, P840, DOI 10.1038/29674; Braunstein SL, 1998, PHYS REV LETT, V80, P869, DOI 10.1103/PhysRevLett.80.869; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Hofmann HF, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.040301; Ide T, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012313; Jia XJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250503; JOZSA R, 1994, J MOD OPTIC, V41, P2315, DOI 10.1080/09500349414552171; Kim YH, 2001, PHYS REV LETT, V86, P1370, DOI 10.1103/PhysRevLett.86.1370; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Lee N, 2011, SCIENCE, V332, P330, DOI 10.1126/science.1201034; Lutkenhaus N, 1999, PHYS REV A, V59, P3295, DOI 10.1103/PhysRevA.59.3295; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Mista L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012322; Nielsen M A, 2000, QUANTUM COMPUTATION, P380; Pan JW, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.777; Pan JW, 2003, NATURE, V421, P721, DOI 10.1038/nature01412; Polkinghorne RES, 1999, PHYS REV LETT, V83, P2095, DOI 10.1103/PhysRevLett.83.2095; Takeda S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.043803; VAIDMAN L, 1994, PHYS REV A, V49, P1473, DOI 10.1103/PhysRevA.49.1473; Yonezawa H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.110503; Zavatta A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.020502	30	162	166	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					315	318		10.1038/nature12366	http://dx.doi.org/10.1038/nature12366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23955230	Green Submitted			2022-12-28	WOS:000323112400028
J	Head, S				Head, Stephen			CARE OF THE DYING IN THE COMMUNITY New pharmacological models needed to care for dying patients at home	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Nottinghamshire Healthcare Trust, Edwinstowe Hlth Ctr, Mansfield NG21 9QS, England		Head, S (corresponding author), Nottinghamshire Healthcare Trust, Edwinstowe Hlth Ctr, Mansfield NG21 9QS, England.	shead@doctors.org.uk						Collis E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4085	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2013	347								f4882	10.1136/bmj.f4882	http://dx.doi.org/10.1136/bmj.f4882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203YP	23945357				2022-12-28	WOS:000323331100001
J	Jacob, JA				Jacob, Julie A.			ELECTRONIC HEALTH RECORDS Financial incentives are spurring growth of electronic health records	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												julieajacob215@gmail.com						Fleming NS, 2011, HEALTH AFFAIR, V30, P481, DOI 10.1377/hlthaff.2010.0768; Kennedy K., 2013, US TODAY	2	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2013	347								f4901	10.1136/bmj.f4901	http://dx.doi.org/10.1136/bmj.f4901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201DK	23935059				2022-12-28	WOS:000323120700003
J	Virtanen, M; Nyberg, ST; Batty, GD; Jokela, M; Heikkila, K; Fransson, EI; Alfredsson, L; Bjorner, JB; Borritz, M; Burr, H; Casini, A; Clays, E; De Bacquer, D; Dragano, N; Elovainio, M; Erbel, R; Ferrie, JE; Hamer, M; Jockel, KH; Kittel, F; Knutsson, A; Koskenvuo, M; Koskinen, A; Lunau, T; Madsen, IEH; Nielsen, ML; Nordin, M; Oksanen, T; Pahkin, K; Pejtersen, JH; Pentti, J; Rugulies, R; Salo, P; Shipley, MJ; Siegrist, J; Steptoe, A; Suominen, SB; Theorell, T; Toppinen-Tanner, S; Vaananen, A; Vahtera, J; Westerholm, PJM; Westerlund, H; Slopen, N; Kawachi, I; Singh-Manoux, A; Kivimaki, M				Virtanen, Marianna; Nyberg, Solja T.; Batty, G. David; Jokela, Markus; Heikkila, Katriina; Fransson, Eleonor I.; Alfredsson, Lars; Bjorner, Jakob B.; Borritz, Marianne; Burr, Hermann; Casini, Annalisa; Clays, Els; De Bacquer, Dirk; Dragano, Nico; Elovainio, Marko; Erbel, Raimund; Ferrie, Jane E.; Hamer, Mark; Joeckel, Karl-Heinz; Kittel, France; Knutsson, Anders; Koskenvuo, Markku; Koskinen, Aki; Lunau, Thorsten; Madsen, Ida E. H.; Nielsen, Martin L.; Nordin, Maria; Oksanen, Tuula; Pahkin, Krista; Pejtersen, Jan H.; Pentti, Jaana; Rugulies, Reiner; Salo, Paula; Shipley, Martin J.; Siegrist, Johannes; Steptoe, Andrew; Suominen, Sakari B.; Theorell, Tores; Toppinen-Tanner, Salla; Vaananen, Ari; Vahtera, Jussi; Westerholm, Peter J. M.; Westerlund, Hugo; Slopen, Natalie; Kawachi, Ichiro; Singh-Manoux, Archana; Kivimaki, Mika		IPD-Work Consortium	Perceived job insecurity as a risk factor for incident coronary heart disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EFFORT-REWARD IMBALANCE; HEALTH-RELATED BEHAVIORS; BRITISH CIVIL-SERVANTS; WORK-RELATED STRESS; OCCUPATIONAL-HEALTH; PSYCHOSOCIAL FACTORS; PRECARIOUS EMPLOYMENT; BASE-LINE; CARDIOVASCULAR-DISEASES; FLEXIBLE EMPLOYMENT	Objective To determine the association between self reported job insecurity and incident coronary heart disease. Design A meta-analysis combining individual level data from a collaborative consortium and published studies identified by a systematic review. Data sources We obtained individual level data from 13 cohort studies participating in the Individual-Participant-Data Meta-analysis in Working Populations Consortium. Four published prospective cohort studies were identified by searches of Medline (to August 2012) and Embase databases (to October 2012), supplemented by manual searches. Review methods Prospective cohort studies that reported risk estimates for clinically verified incident coronary heart disease by the level of self reported job insecurity. Two independent reviewers extracted published data. Summary estimates of association were obtained using random effects models. Results The literature search yielded four cohort studies. Together with 13 cohort studies with individual participant data, the meta-analysis comprised up to 174 438 participants with a mean follow-up of 9.7 years and 1892 incident cases of coronary heart disease. Age adjusted relative risk of high versus low job insecurity was 1.32 (95% confidence interval 1.09 to 1.59). The relative risk of job insecurity adjusted for sociodemographic and risk factors was 1.19 (1.00 to 1.42). There was no evidence of significant differences in this association by sex, age (<50 v >= 50 years), national unemployment rate, welfare regime, or job insecurity measure. Conclusions The modest association between perceived job insecurity and incident coronary heart disease is partly attributable to poorer socioeconomic circumstances and less favourable risk factor profiles among people with job insecurity.	[Virtanen, Marianna; Nyberg, Solja T.; Heikkila, Katriina; Koskinen, Aki; Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Toppinen-Tanner, Salla; Vaananen, Ari; Vahtera, Jussi; Kivimaki, Mika] Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland; [Batty, G. David; Ferrie, Jane E.; Hamer, Mark; Pahkin, Krista; Shipley, Martin J.; Steptoe, Andrew; Singh-Manoux, Archana; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Jokela, Markus; Kivimaki, Mika] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.; Theorell, Tores; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Alfredsson, Lars] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Bjorner, Jakob B.; Madsen, Ida E. H.] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Borritz, Marianne; Nielsen, Martin L.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Burr, Hermann] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany; [Casini, Annalisa; Kittel, France] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Clays, Els; De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Dragano, Nico; Lunau, Thorsten; Siegrist, Johannes] Univ Dusseldorf, Fac Med, Inst Med Sociol, D-40225 Dusseldorf, Germany; [Elovainio, Marko] Natl Inst Hlth & Welf, Helsinki, Finland; [Erbel, Raimund] Univ Duisburg Essen, West German Heart Ctr Essen, Dept Cardiol, Essen, Germany; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England; [Joeckel, Karl-Heinz] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Koskenvuo, Markku] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Nordin, Maria] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Pejtersen, Jan H.] Danish Natl Ctr Social Res, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Salo, Paula] Univ Turku, Dept Psychol, Turku, Finland; [Suominen, Sakari B.] Folkhalsan Res Ctr, Helsinki, Finland; [Suominen, Sakari B.; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, SF-20500 Turku, Finland; [Suominen, Sakari B.] Nord Sch Publ Hlth, Gothenburg, Sweden; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; Uppsala Univ, Uppsala, Sweden; [Slopen, Natalie; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Slopen, Natalie] Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA; [Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France	Finnish Institute of Occupational Health; University of London; University College London; University of Edinburgh; University of Helsinki; Jonkoping University; Karolinska Institutet; Stockholm University; Stockholm County Council; National Research Centre for the Working Environment; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Universite Libre de Bruxelles; Ghent University; Heinrich Heine University Dusseldorf; Finland National Institute for Health & Welfare; University of Duisburg Essen; University of Bristol; University of Duisburg Essen; Mid-Sweden University; University of Helsinki; Umea University; University of Copenhagen; University of Copenhagen; University of Turku; Folkhalsan Research Center; University of Turku; University of Turku; Uppsala University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Virtanen, M (corresponding author), Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland.	marianna.virtanen@ttl.fi	Nielsen, Martin Lindhardt/E-3071-2012; Casini, Annalisa/ABG-2250-2020; Rugulies, Reiner/E-8140-2010; Batty, GD/Y-4401-2018; Siegrist, Johannes/AAL-6814-2021; Oksanen, Tuula/AAK-5599-2021; Alfredsson, Lars/AAC-9007-2019; Pejtersen, Jan/AAP-2383-2020; Fransson, Eleonor I/J-7792-2013; Singh-Manoux, Archana/F-6804-2013; Ferrie, Jane/AAZ-2009-2020; Hamer, Mark/AAJ-6814-2021; Hamer, Mark/C-1602-2008; Salo, Paula/D-6649-2013; De Bacquer, Dirk/HGU-3191-2022; Steptoe, Andrew/Y-2440-2019; Kivimaki, Mika/B-3607-2012; Westerlund, Hugo/A-3049-2012; Vahtera, Jussi/J-3271-2013; Jokela, Markus/A-4669-2009	Nielsen, Martin Lindhardt/0000-0002-1523-0453; Casini, Annalisa/0000-0002-3539-4500; Rugulies, Reiner/0000-0002-7752-131X; Batty, GD/0000-0003-1822-5753; Siegrist, Johannes/0000-0002-7530-4178; Alfredsson, Lars/0000-0003-1688-6697; Fransson, Eleonor I/0000-0001-9042-4832; Singh-Manoux, Archana/0000-0002-1244-5037; Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Salo, Paula/0000-0002-0812-277X; Kivimaki, Mika/0000-0002-4699-5627; Westerlund, Hugo/0000-0002-8806-5698; Jokela, Markus/0000-0003-0117-0012; Heikkila, Katriina/0000-0001-6269-6881; Steptoe, Andrew/0000-0001-7808-4943; Suominen, Sakari B./0000-0001-6648-603X; Vahtera, Jussi/0000-0002-6036-061X; Burr, Hermann/0000-0002-3864-6347; Theorell, Tores/0000-0003-1956-7931; Elovainio, Marko/0000-0002-1401-1910; Clays, Els/0000-0002-1092-945X; Madsen, Ida/0000-0003-3635-3900; De Bacquer, Dirk/0000-0002-3202-7238	EU New OSH ERA Research Program; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund; Academy of Finland [132944, 258598]; BUPA Foundation [22094477]; British Heart Foundation [RG/13/2/30098, RG/10/005/28296] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI	EU New OSH ERA Research Program; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund; Academy of Finland(Academy of Finland); BUPA Foundation; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The IPD-Work Consortium is supported by the EU New OSH ERA Research Program (funded by the Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; German Social Accident Insurance, Germany; and Danish Work Environment Research Fund), Academy of Finland (grants 132944 and 258598), and BUPA Foundation (grant 22094477). Funding bodies for each participating cohort study are listed on their websites. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Alfredsson L, 2002, SCAND J WORK ENV HEA, V28, P238, DOI 10.5271/sjweh.671; [Anonymous], 2007, OECD EMPL OUTL, P105; Backe EM, 2012, INT ARCH OCC ENV HEA, V85, P67, DOI 10.1007/s00420-011-0643-6; Bartley M, 2005, J EPIDEMIOL COMMUN H, V59, P718, DOI 10.1136/jech.2004.032235; Bartley M, 2001, J EPIDEMIOL COMMUN H, V55, P776, DOI 10.1136/jech.55.11.776; Benach J, 2007, J EPIDEMIOL COMMUN H, V61, P276, DOI 10.1136/jech.2005.045237; Benach J, 2002, SCAND J WORK ENV HEA, V28, P191, DOI 10.5271/sjweh.664; Benach J, 2002, J EPIDEMIOL COMMUN H, V56, P405, DOI 10.1136/jech.56.6.405; Benach J, 2000, AM J PUBLIC HEALTH, V90, P1316, DOI 10.2105/AJPH.90.8.1316; Benach J, 2010, INT J HEALTH SERV, V40, P195, DOI 10.2190/HS.40.2.a; Borritz M, 2006, SCAND J PUBLIC HEALT, V34, P49, DOI 10.1080/14034940510032275; Cheng GHL, 2008, APPL PSYCHOL-INT REV, V57, P272, DOI 10.1111/j.1464-0597.2007.00312.x; COOPER CL, 1976, J OCCUP PSYCHOL, V49, P11, DOI 10.1111/j.2044-8325.1976.tb00325.x; Cornelissen T., 2007, FLEXIBILITY SECURITY; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; De Witte H., 1999, EUR J WORK ORGAN PSY, V8, P155, DOI [DOI 10.1080/135943299398302, https://doi.org/10.1080/135943299398302]; De Witte H, 2005, SA J IND PSYCHOL, V31, P1; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Ferrie J E, 1997, J Health Psychol, V2, P373, DOI 10.1177/135910539700200307; Ferrie JE, 2008, SCAND J WORK ENV HEA, P98; Ferrie JE, 2005, SOC SCI MED, V60, P1593, DOI 10.1016/j.socscimed.2004.08.006; Ferrie JE, 1999, WHO REG PUB, P59; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450; Ferrie JE, 2001, J ROY SOC MED, V94, P71, DOI 10.1177/014107680109400206; Feveile H, 2007, STAT TRANSIT, V8, P441; GREENHALGH L, 1984, ACAD MANAGE REV, V9, P438, DOI 10.2307/258284; Greenhalgh L., 2010, INT STUDIES MANAGEME, V40, P6, DOI [10.2753/IMO0020-8825400101, DOI 10.2753/IMO0020-8825400101]; Harma M, 2006, SCAND J WORK ENV HEA, V32, P413; Hartley J., 1991, JOBINSECURITY; HEANEY CA, 1994, SOC SCI MED, V38, P1431, DOI 10.1016/0277-9536(94)90281-X; Heikkila K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f165; Hjemdahl P, 2012, STRESS AND CARDIOVASCULAR DISEASE, P1, DOI 10.1007/978-1-84882-419-5; Hurrell JJ, 1998, AM J PUBLIC HEALTH, V88, P1012, DOI 10.2105/AJPH.88.7.1012; Isaksson K, 2000, HLTH EFFECTS NEW LAB; JENKINS CD, 1971, NEW ENGL J MED, V284, P244, DOI 10.1056/NEJM197102042840506; JENKINS CD, 1976, NEW ENGL J MED, V294, P987, DOI 10.1056/NEJM197604292941806; Kim IH, 2012, HEALTH POLICY, V104, P99, DOI 10.1016/j.healthpol.2011.11.002; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 1997, J APPL PSYCHOL, V82, P858, DOI 10.1037/0021-9010.82.6.858; Kivimaki M, 2013, ATHEROSCLEROSIS, DOI [10.1016/j.atherosclerosis.2012.12.027, DOI 10.1016/J.ATHER0SCLER0SIS.2012.12.027]; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Klandermans B., 1999, EUR J WORK ORGAN PSY, V8, P145, DOI [DOI 10.1080/135943299398294, 10.1080/135943299398294]; Kompier MAJ, 2006, SCAND J WORK ENV HEA, V32, P421, DOI 10.5271/sjweh.1048; Kopp M, 2006, J EPIDEMIOL COMMUN H, V60, P782, DOI 10.1136/jech.2005.042960; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; KRISTENSEN TS, 1989, SCAND J WORK ENV HEA, V15, P165, DOI 10.5271/sjweh.1864; Kristensen TS, 1999, SCAND J WORK ENV HEA, V25, P550, DOI 10.5271/sjweh.479; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Landsbergis PA, 2003, J OCCUP ENVIRON MED, V45, P61, DOI 10.1097/00043764-200301000-00014; Landsbergis Paul A., 2001, Work, V17, P191; Laszlo KD, 2010, SOC SCI MED, V70, P867, DOI 10.1016/j.socscimed.2009.11.022; Lavis JN, 2001, CAN J PUBLIC HEALTH, V92, P72, DOI 10.1007/BF03404849; Lee S, 2004, ANN EPIDEMIOL, V14, P24, DOI 10.1016/S1047-2797(03)00074-7; Low CA, 2010, PSYCHOSOM MED, V72, P842, DOI 10.1097/PSY.0b013e3181f6934f; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Marmot MG, 1999, WHO REG PUB, P1; Matthews KA, 2005, AM PSYCHOL, V60, P783, DOI 10.1037/0003-066X.60.8.783; Menendez M, 2007, SOC SCI MED, V64, P776, DOI 10.1016/j.socscimed.2006.10.035; Moynihan R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5183; Muntaner C, 2010, INT J HEALTH SERV, V40, P281, DOI 10.2190/HS.40.2.h; Nakao M, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-4; Netterstrom B, 2010, INT J OCCUP MED ENV, V23, P217, DOI 10.2478/v10001-010-0031-6; Nielsen ML, 2002, WORK STRESS, V16, P191, DOI 10.1080/02678370210164003; Nyberg ST, 2012, J INTERN MED, V272, P65, DOI 10.1111/j.1365-2796.2011.02482.x; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Pelfrene Edwin, 2003, Eur J Cardiovasc Prev Rehabil, V10, P345, DOI 10.1097/01.hjr.0000095048.46631.f0; Peltzer K, 2009, STRESS HEALTH, V25, P247, DOI 10.1002/smi.1244; Perlman F, 2009, AM J PUBLIC HEALTH, V99, P1818, DOI 10.2105/AJPH.2008.154815; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Peter R, 2000, INT ARCH OCC ENV HEA, V73, pS41, DOI 10.1007/PL00014625; Quinlan M, 2001, INT J HEALTH SERV, V31, P335, DOI 10.2190/607H-TTV0-QCN6-YLT4; Quinlan M, 2007, INT J LAW PSYCHIAT, V30, P385, DOI 10.1016/j.ijlp.2007.06.010; Quinlan M, 2009, INT J HEALTH SERV, V39, P1, DOI 10.2190/HS.39.1.a; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Rugulies R, 2010, J EPIDEMIOL COMMUN H, V64, P75, DOI 10.1136/jech.2008.078493; Sauter SL, 1999, IND HEALTH, V37, P199, DOI 10.2486/indhealth.37.199; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schnall P, 2000, OCCUP MED-STATE ART, V15, P1; Scott HK, 2004, INT J HEALTH SERV, V34, P143, DOI 10.2190/WAM3-MNN2-6UNF-FDEX; Siegrist J, 2005, PSYCHONEUROENDOCRINO, V30, P1033, DOI 10.1016/j.psyneuen.2005.03.017; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; SIEGRIST J, 1990, SOC SCI MED, V31, P1127, DOI 10.1016/0277-9536(90)90234-J; SIEGRIST J, 1986, SOC SCI MED, V22, P247, DOI 10.1016/0277-9536(86)90073-0; Siegrist J, 2010, INT J OCCUP MED ENV, V23, P279, DOI 10.2478/v10001-010-0013-8; Slopen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040512; Smith TW, 2002, J CONSULT CLIN PSYCH, V70, P548, DOI 10.1037//0022-006X.70.3.548; Sparks K, 2001, J OCCUP ORGAN PSYCH, V74, P489, DOI 10.1348/096317901167497; STANSFELD SA, 2002, STRESS HEART; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sverke M, 2002, APPL PSYCHOL-INT REV, V51, P23, DOI 10.1111/1464-0597.0077z; Sverke Magnus, 2002, J Occup Health Psychol, V7, P242, DOI 10.1037/1076-8998.7.3.242; Tompa Emile, 2007, Work, V28, P209; Triolo P K, 1989, AAOHN J, V37, P232; Tsutsumi A, 2004, SOC SCI MED, V59, P2335, DOI 10.1016/j.socscimed.2004.03.030; Vaananen A, 2009, PREV MED, V49, P142, DOI 10.1016/j.ypmed.2009.06.026; van Vegchel N, 2005, SOC SCI MED, V60, P1117, DOI 10.1016/j.socscimed.2004.06.043; Virtanen M, 2005, INT J EPIDEMIOL, V34, P610, DOI 10.1093/ije/dyi024; Virtanen M, 2003, OCCUP ENVIRON MED, V60, P948, DOI 10.1136/oem.60.12.948; XU WX, 2010, CIRCULATION, V122, pE185; Zapf D, 1996, J Occup Health Psychol, V1, P145, DOI 10.1037/1076-8998.1.2.145	105	141	143	2	50	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2013	347								f4746	10.1136/bmj.f4746	http://dx.doi.org/10.1136/bmj.f4746			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201DC	23929894	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000323119900001
J	Burd, CM				Burd, Christian M.			Doctors should listen to the whole patient: don't forget the stethoscope in neurological examination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CAROTID STENOSIS; DISEASE; BRUIT; RISK		North West London Hosp NHS Trust, Northwick Pk Hosp, Harrow HA1 3UJ, Middx, England	Imperial College London	Burd, CM (corresponding author), North West London Hosp NHS Trust, Northwick Pk Hosp, Harrow HA1 3UJ, Middx, England.	cburd66@gmail.com	Christian, Burd/AAD-3993-2021					Brown P, 1997, LANCET, V349, P533, DOI 10.1016/S0140-6736(97)80086-4; BROWN P, 1995, LANCET, V346, P306, DOI 10.1016/S0140-6736(95)92190-7; Jiwa M, 2012, J MED INTERNET RES, V14, P238, DOI 10.2196/jmir.1986; King A, 2013, STROKE, V44, P542, DOI 10.1161/STROKEAHA.112.673608; Ozawa T, 2011, CLIN AUTON RES, V21, P181, DOI 10.1007/s10286-010-0102-6; Pickett CA, 2010, STROKE, V41, P2295, DOI 10.1161/STROKEAHA.110.585554; Ratchford EV, 2009, NEUROL RES, V31, P748, DOI 10.1179/174313209X382458; Smith JH, 2009, NEUROLOGY, V73, pE81, DOI 10.1212/WNL.0b013e3181bd138d; Smith P E, 2008, Pract Neurol, V8, P195, DOI 10.1136/pn.2007.134031; Wityk RJ, 1996, SEMIN NEUROL, V16, P27, DOI 10.1055/s-2008-1040956	10	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2013	347								f4625	10.1136/bmj.f4625	http://dx.doi.org/10.1136/bmj.f4625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CN	23918609				2022-12-28	WOS:000323118400002
J	Blois, JL; Zarnetske, PL; Fitzpatrick, MC; Finnegan, S				Blois, Jessica L.; Zarnetske, Phoebe L.; Fitzpatrick, Matthew C.; Finnegan, Seth			Climate Change and the Past, Present, and Future of Biotic Interactions	SCIENCE			English	Review							NO-ANALOG COMMUNITIES; MASS EXTINCTION; ARCTIC VEGETATION; DISTRIBUTIONS; BIODIVERSITY; TEMPERATURE; DIVERSITY; RESPONSES; LAKE; LAST	Biotic interactions drive key ecological and evolutionary processes and mediate ecosystem responses to climate change. The direction, frequency, and intensity of biotic interactions can in turn be altered by climate change. Understanding the complex interplay between climate and biotic interactions is thus essential for fully anticipating how ecosystems will respond to the fast rates of current warming, which are unprecedented since the end of the last glacial period. We highlight episodes of climate change that have disrupted ecosystems and trophic interactions over time scales ranging from years to millennia by changing species' relative abundances and geographic ranges, causing extinctions, and creating transient and novel communities dominated by generalist species and interactions. These patterns emerge repeatedly across disparate temporal and spatial scales, suggesting the possibility of similar underlying processes. Based on these findings, we identify knowledge gaps and fruitful areas for research that will further our understanding of the effects of climate change on ecosystems.	[Blois, Jessica L.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Zarnetske, Phoebe L.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Fitzpatrick, Matthew C.] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 21532 USA; [Finnegan, Seth] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Merced; Yale University; University System of Maryland; University of Maryland Center for Environmental Science; University of California System; University of California Berkeley	Blois, JL (corresponding author), Univ Calif Merced, Sch Nat Sci, 5200 North Lake Rd, Merced, CA 95343 USA.	jblois@ucmerced.edu	Blois, Jessica/G-5893-2011; Fitzpatrick, Matthew/ABC-1930-2020; Zarnetske, Phoebe/V-3974-2019; Zarnetske, Phoebe/C-5484-2012; Fitzpatrick, Matt/F-7620-2010	Blois, Jessica/0000-0003-4048-177X; Fitzpatrick, Matthew/0000-0003-1911-8407; Zarnetske, Phoebe/0000-0001-6257-6951; Zarnetske, Phoebe/0000-0001-6257-6951; Fitzpatrick, Matt/0000-0003-1911-8407	NSF [EAR-0844223, DEB-1257033, DEB-1257164]; Yale Climate and Energy Institute, Yale University; National Oceanic and Atmospheric Administration Maryland Sea Grant [NA10OAR4170072 SA7528114DDD]; Division Of Environmental Biology [1257033, 1257508] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Yale Climate and Energy Institute, Yale University; National Oceanic and Atmospheric Administration Maryland Sea Grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank K. Amatangelo, D. Skelly, M. Urban, and two anonymous reviewers for comments that greatly improved the manuscript, and members of the Smithsonian's Evolution of Terrestrial Ecosystems Community Assembly and Disassembly working group and the National Evolutionary Synthesis Center's working group on determinants of extinction in ancient and modern seas for fruitful discussions. Funding for this project comes from NSF (grant EAR-0844223 to J.W., grant DEB-1257033 to J.L.B., and grant DEB-1257164 to M. C. F.) and the Yale Climate and Energy Institute, Yale University (P.L.Z.). Additional support was provided by National Oceanic and Atmospheric Administration Maryland Sea Grant grant NA10OAR4170072 SA7528114DDD to M. C. F. This is Paleobiology Database publication no. 180.	Adams JM, 2011, REV PALAEOBOT PALYNO, V164, P60, DOI 10.1016/j.revpalbo.2010.11.005; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Araujo MB, 2011, ECOGRAPHY, V34, P897, DOI 10.1111/j.1600-0587.2011.06919.x; Baiser B, 2012, GLOBAL ECOL BIOGEOGR, V21, P579, DOI 10.1111/j.1466-8238.2011.00705.x; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Blackburn TJ, 2013, SCIENCE, V340, P941, DOI 10.1126/science.1234204; Blois JL, 2013, ECOGRAPHY, V36, P460, DOI 10.1111/j.1600-0587.2012.07852.x; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Cody S, 2010, ECOGRAPHY, V33, P326, DOI 10.1111/j.1600-0587.2010.06327.x; Currano ED, 2010, ECOL MONOGR, V80, P547, DOI 10.1890/09-2138.1; Dalsgaard B, 2013, ECOGRAPHY, V36, P1331, DOI 10.1111/j.1600-0587.2013.00201.x; Domingo MS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2138; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Eronen JT, 2010, INTEGR ZOOL, V5, P88, DOI 10.1111/j.1749-4877.2010.00192.x; Finnegan S, 2012, P NATL ACAD SCI USA, V109, P6829, DOI 10.1073/pnas.1117039109; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; Fritz SA, 2013, TRENDS ECOL EVOL, V28, P509, DOI 10.1016/j.tree.2013.05.004; Giannini TC, 2013, ECOGRAPHY, V36, P649, DOI 10.1111/j.1600-0587.2012.07191.x; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Greene SE, 2012, EARTH-SCI REV, V113, P72, DOI 10.1016/j.earscirev.2012.03.009; Grimm EC, 2011, QUATERNARY SCI REV, V30, P2626, DOI 10.1016/j.quascirev.2011.05.015; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Harnik PG, 2012, TRENDS ECOL EVOL, V27, P608, DOI 10.1016/j.tree.2012.07.010; Hein CL, 2012, AMBIO, V41, P303, DOI 10.1007/s13280-012-0308-z; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hoekman D, 2011, OECOLOGIA, V165, P1073, DOI 10.1007/s00442-010-1802-2; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; Jablonski D, 2008, EVOLUTION, V62, P715, DOI 10.1111/j.1558-5646.2008.00317.x; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Kratina P, 2012, ECOLOGY, V93, P1421, DOI 10.1890/11-1595.1; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Matias L, 2012, FOREST ECOL MANAG, V282, P10, DOI 10.1016/j.foreco.2012.06.053; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Milazzo M, 2013, J ANIM ECOL, V82, P468, DOI 10.1111/j.1365-2656.2012.02034.x; Mokany K, 2012, GLOBAL CHANGE BIOL, V18, P3149, DOI 10.1111/j.1365-2486.2012.02760.x; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Norberg J, 2012, NAT CLIM CHANGE, V2, P747, DOI [10.1038/NCLIMATE1588, 10.1038/nclimate1588]; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Ordonez A, 2013, ECOL LETT, V16, P773, DOI 10.1111/ele.12110; Payne JL, 2012, ANNU REV EARTH PL SC, V40, P89, DOI 10.1146/annurev-earth-042711-105329; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Post E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2722; Prokoph A, 2008, EARTH-SCI REV, V87, P113, DOI 10.1016/j.earscirev.2007.12.003; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Rockwell RF, 2011, OIKOS, V120, P696, DOI 10.1111/j.1600-0706.2010.18837.x; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; SCHUBERT JK, 1995, PALAEOGEOGR PALAEOCL, V116, P1, DOI 10.1016/0031-0182(94)00093-N; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Schweizer MK, 2007, PALEOBIOLOGY, V33, P590, DOI 10.1666/05079.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Swann AL, 2010, P NATL ACAD SCI USA, V107, P1295, DOI 10.1073/pnas.0913846107; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Urban MC, 2013, ANN NY ACAD SCI, V1297, P44, DOI 10.1111/nyas.12184; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795; Walther GR, 2007, GLOBAL ECOL BIOGEOGR, V16, P801, DOI 10.1111/j.1466-8238.2007.00328.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8; Woodburne MO, 2009, P NATL ACAD SCI USA, V106, P13399, DOI 10.1073/pnas.0906802106; Yeakel JD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0239; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zarnetske PL, 2012, SCIENCE, V336, P1516, DOI 10.1126/science.1222732	89	497	511	45	894	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					499	504		10.1126/science.1237184	http://dx.doi.org/10.1126/science.1237184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908227				2022-12-28	WOS:000322586700041
J	Little, P; Stuart, B; Francis, N; Douglas, E; Tonkin-Crine, S; Anthierens, S; Cals, JWL; Melbye, H; Santer, M; Moore, M; Coenen, S; Butler, C; Hood, K; Kelly, M; Godycki-Cwirko, M; Mierzecki, A; Torres, A; Llor, C; Davies, M; Mullee, M; O'Reilly, G; van der Velden, A; Geraghty, AWA; Goossens, H; Verheij, T; Yardley, L				Little, Paul; Stuart, Beth; Francis, Nick; Douglas, Elaine; Tonkin-Crine, Sarah; Anthierens, Sibyl; Cals, Jochen W. L.; Melbye, Hasse; Santer, Miriam; Moore, Michael; Coenen, Samuel; Butler, Chris; Hood, Kerenza; Kelly, Mark; Godycki-Cwirko, Maciek; Mierzecki, Artur; Torres, Antoni; Llor, Carl; Davies, Melanie; Mullee, Mark; O'Reilly, Gilly; van der Velden, Alike; Geraghty, Adam W. A.; Goossens, Herman; Verheij, Theo; Yardley, Lucy		GRACE Consortium	Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial	LANCET			English	Article							C-REACTIVE PROTEIN; PRIMARY-CARE; ACUTE COUGH; GENERAL-PRACTICE; INTERVENTION; STRATEGIES; PNEUMONIA; COUNTRIES; DATABASE; COHORT	Background High-volume prescribing of antibiotics in primary care is a major driver of antibiotic resistance. Education of physicians and patients can lower prescribing levels, but it frequently relies on highly trained staff. We assessed whether internet-based training methods could alter prescribing practices in multiple health-care systems. Methods After a baseline audit in October to December, 2010, primary-care practices in six European countries were cluster randomised to usual care, training in the use of a C-reactive protein (CRP) test at point of care, in enhanced communication skills, or in both CRP and enhanced communication. Patients were recruited from February to May, 2011. This trial is registered, number ISRCTN99871214. Results The baseline audit, done in 259 practices, provided data for 6771 patients with lower-respiratory-tract infections (3742 [55.3%]) and upper-respiratory-tract infections (1416 [20.9%]), of whom 5355 (79.1%) were prescribed antibiotics. After randomisation, 246 practices were included and 4264 patients were recruited. The antibiotic prescribing rate was lower with CRP training than without (33% vs 48%, adjusted risk ratio 0.54, 95% CI 0.42-0.69) and with enhanced-communication training than without (36% vs 45%, 0.69, 0.54-0.87). The combined intervention was associated with the greatest reduction in prescribing rate (CRP risk ratio 0.53, 95% CI 0.36-0.74, p< 0.0001; enhanced communication 0.68, 0.50-0.89, p=0.003; combined 0.38, 0.25-0.55, p< 0.0001). Interpretation Internet training achieved important reductions in antibiotic prescribing for respiratory-tract infections across language and cultural boundaries.	[Little, Paul; Stuart, Beth; Tonkin-Crine, Sarah; Santer, Miriam; Moore, Michael; Mullee, Mark; O'Reilly, Gilly; Geraghty, Adam W. A.] Univ Southampton, Primary Care & Populat Sci Div, Southampton, Hants, England; [Douglas, Elaine; Yardley, Lucy] Univ Med Ctr Utrecht, CAHP, Fac Social & Human Sci, Utrecht, Netherlands; [van der Velden, Alike; Verheij, Theo] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Francis, Nick; Butler, Chris] Cardiff Univ, Sch Med, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Hood, Kerenza; Kelly, Mark] Cardiff Univ, Sch Med, South East Wales Trials Unit, Cardiff CF10 3AX, S Glam, Wales; [Godycki-Cwirko, Maciek] Med Univ Lodz, Dept Family & Community Med, Lodz, Poland; [Mierzecki, Artur] Pomeranian Med Univ, Independent Lab Family Physician Educ, Szczecin, Poland; [Davies, Melanie] Ely, Ely Bridge Surg, Cardiff, S Glam, Wales; [Torres, Antoni] August Pi & Sunyer Univ Barcelona Ciber Enfermeda, Barcelona Insitut Invest Biomed, Hosp Clin, Pneumol Dept,Clin Inst Thorax, Barcelona, Spain; [Torres, Antoni] Univ Antwerp, Ctr Gen Practice, B-2020 Antwerp, Belgium; [Goossens, Herman] Univ Antwerp, Lab Med Microbiol, B-2020 Antwerp, Belgium; [Anthierens, Sibyl] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, B-2020 Antwerp, Belgium; [Anthierens, Sibyl] Univ Antwerp, Dept Microbiol, B-2020 Antwerp, Belgium; [Llor, Carl] Univ Rovira & Virgili, E-43007 Tarragona, Spain; [Llor, Carl] Spanish Soc Family Med, Barcelona, Spain; [Cals, Jochen W. L.] Maastricht Univ, CAPHRI, Maastricht, Netherlands; [Melbye, Hasse] Univ Tromso, Gen Practice Res Unit, Tromso, Norway	University of Southampton; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Cardiff University; Cardiff University; Medical University Lodz; Pomeranian Medical University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; Universitat Rovira i Virgili; Maastricht University; UiT The Arctic University of Tromso	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Primary Care & Populat Sci Div, Southampton SO16 5ST, Hants, England.	p.little@soton.ac.uk	Tonkin-Crine, Sarah/Q-1198-2016; Torres, Antoni/H-6128-2017; Moore, Michael/C-3447-2011; Kelson, Mark J/E-6753-2016; Coenen, Samuel JA/A-6410-2011; Mierzecki, Artur M./A-8012-2015; Francis, Nick/B-7413-2009; Hood, Kerenza/C-2528-2008; Cals, Jochen WL/A-1262-2007	Tonkin-Crine, Sarah/0000-0003-4470-1151; Torres, Antoni/0000-0002-8643-2167; Moore, Michael/0000-0002-5127-4509; Kelson, Mark J/0000-0001-7744-3780; Coenen, Samuel JA/0000-0002-1238-8052; Francis, Nick/0000-0001-8939-7312; Hood, Kerenza/0000-0002-5268-8631; Cals, Jochen WL/0000-0001-9550-5674; Anthierens, Sibyl/0000-0003-4762-1907; Moragas Moreno, Ana/0000-0002-1307-0943; Geraghty, Adam/0000-0001-7984-8351; Butler, Christopher/0000-0002-0102-3453; Llor, Carl/0000-0001-6644-717X; Stuart, Beth/0000-0001-5432-7437; Douglas, Elaine/0000-0001-8540-1126; Melbye, Hasse/0000-0002-9773-3141; Santer, Miriam/0000-0001-7264-5260; Coast, Joanna/0000-0002-3537-5166; Adriaenssens, Niels/0000-0002-7957-1177; Touboul, Pierre-Jean/0000-0002-8872-9917; Little, Paul/0000-0003-3664-1873; Yardley, Lucy/0000-0002-3853-883X	European Commission Framework Programme 6, National Institute for Health Research, Research Foundation Flanders; Economic and Social Research Council [ES/F029624/1] Funding Source: researchfish; National Institute for Health Research [PDF-2009-02-45] Funding Source: researchfish; ESRC [ES/F029624/1] Funding Source: UKRI	European Commission Framework Programme 6, National Institute for Health Research, Research Foundation Flanders; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	European Commission Framework Programme 6, National Institute for Health Research, Research Foundation Flanders.	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; Akkerman AE, 2004, J ANTIMICROB CHEMOTH, V54, P1116, DOI 10.1093/jac/dkh480; Anthierens S, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-101; Arnold SR, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003539.PUB2; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Butler CC, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.d8173, 10.1136/bmj.e682]; Cals JWL, 2013, ANN FAM MED, V11, P157, DOI 10.1370/afm.1477; Cals JWL, 2010, ANN FAM MED, V8, P124, DOI 10.1370/afm.1090; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Coenen S, 2004, J ANTIMICROB CHEMOTH, V54, P661, DOI 10.1093/jac/dkh374; Falk G, 2009, FAM PRACT, V26, P10, DOI 10.1093/fampra/cmn095; Francis NA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2885; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Kroening-Roche JC, 2012, J EMERG MED, V43, P221, DOI 10.1016/j.jemermed.2011.06.143; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Smith S, 2007, COCHRANE DB SYST REV, V8; Smith SM, 2004, COCHRANE DB SYST REV, V4; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; Welschen I, 2004, BRIT MED J, V329, P431, DOI 10.1136/bmj.38182.591238.EB; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	27	261	261	1	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1175	1182		10.1016/S0140-6736(13)60994-0	http://dx.doi.org/10.1016/S0140-6736(13)60994-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	23915885	Green Published			2022-12-28	WOS:000325209100022
J	Nguyen, KD; Fentress, SJ; Qiu, YF; Yun, KR; Cox, JS; Chawla, A				Nguyen, Khoa D.; Fentress, Sarah J.; Qiu, Yifu; Yun, Karen; Cox, Jeffery S.; Chawla, Ajay			Circadian Gene Bmal1 Regulates Diurnal Oscillations of Ly6C(hi) Inflammatory Monocytes	SCIENCE			English	Article							IMMUNE DEFENSE; INNATE; CLOCK; RECRUITMENT; RHYTHMS; ROLES; MACROPHAGES; METABOLISM; INFECTION; SUBSETS	Circadian clocks have evolved to regulate physiologic and behavioral rhythms in anticipation of changes in the environment. Although the molecular clock is present in innate immune cells, its role in monocyte homeostasis remains unknown. Here, we report that Ly6C(hi) inflammatory monocytes exhibit diurnal variation, which controls their trafficking to sites of inflammation. This cyclic pattern of trafficking confers protection against Listeria monocytogenes and is regulated by the repressive activity of the circadian gene Bmal1. Accordingly, myeloid cell-specific deletion of Bmal1 induces expression of monocyte-attracting chemokines and disrupts rhythmic cycling of Ly6C(hi) monocytes, predisposing mice to development of pathologies associated with acute and chronic inflammation. These findings have unveiled a critical role for BMAL1 in controlling the diurnal rhythms in Ly6C(hi) monocyte numbers.	[Nguyen, Khoa D.; Qiu, Yifu; Yun, Karen; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Nguyen, Khoa D.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA; [Fentress, Sarah J.; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu		Nguyen, Khoa/0000-0002-6720-2470; Qiu, Yifu/0000-0001-5645-3189	NIH [HL076746, DK094641, DP1AR064158, PO1AI063302, T32AI007334]; Larry L. Hillblom Foundation Network; Diabetes Family Fund [University of California, San Francisco (UCSF)]; Stanford Graduate fellowship; American Heart Association (AHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation Network; Diabetes Family Fund [University of California, San Francisco (UCSF)]; Stanford Graduate fellowship(Stanford University); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Chawla laboratory and A. Loh for comments on the manuscript. The data presented in this paper are tabulated in the main paper and in the supplementary materials. The authors' work was supported by NIH grants HL076746 and DK094641, a Larry L. Hillblom Foundation Network grant, the Diabetes Family Fund [University of California, San Francisco (UCSF)], and an NIH Director's Pioneer Award (DP1AR064158) to A.C. and NIH grant PO1AI063302 to J.S.C. K.D.N. was supported by Stanford Graduate and American Heart Association (AHA) Predoctoral fellowships, Y.Q. by an AHA Postdoctoral Fellowship, and S.J.F. by an NIH Training Grant (T32AI007334). All animal care and procedures were performed in accordance with Stanford University's Administrative Panel on Laboratory Animal Care and UCSF's Institutional Animal Care and Use Committee guidelines. The authors declare that they have no competing financial interests.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; MARTIN RJ, 1993, AM REV RESPIR DIS, V147, pS25, DOI 10.1164/ajrccm/147.6_Pt_2.S25; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x; Sahar Saurabh, 2013, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-642-25950-0_2; Saini C, 2011, COLD SH Q B, V76, P39, DOI 10.1101/sqb.2011.76.010918; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Serbina NV, 2012, ADV IMMUNOL, V113, P119, DOI 10.1016/B978-0-12-394590-7.00003-8; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; SHACKELFORD PG, 1973, SCIENCE, V182, P285, DOI 10.1126/science.182.4109.285; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	36	388	401	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1483	1488		10.1126/science.1240636	http://dx.doi.org/10.1126/science.1240636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	23970558	Green Accepted			2022-12-28	WOS:000324894600042
J	Uzureau, P; Uzureau, S; Lecordier, L; Fontaine, F; Tebabi, P; Homble, F; Grelard, A; Zhendre, V; Nolan, DP; Lins, L; Crowet, JM; Pays, A; Felu, C; Poelvoorde, P; Vanhollebeke, B; Moestrup, SK; Lyngso, J; Pedersen, JS; Mottram, JC; Dufourc, EJ; Perez-Morga, D; Pays, E				Uzureau, Pierrick; Uzureau, Sophie; Lecordier, Laurence; Fontaine, Frederic; Tebabi, Patricia; Homble, Fabrice; Grelard, Axelle; Zhendre, Vanessa; Nolan, Derek P.; Lins, Laurence; Crowet, Jean-Marc; Pays, Annette; Felu, Cecile; Poelvoorde, Philippe; Vanhollebeke, Benoit; Moestrup, Soren K.; Lyngso, Jeppe; Pedersen, Jan Skov; Mottram, Jeremy C.; Dufourc, Erick J.; Perez-Morga, David; Pays, Etienne			Mechanism of Trypanosoma brucei gambiense resistance to human serum	NATURE			English	Article							BLOOD-STREAM FORMS; HAPTOGLOBIN-HEMOGLOBIN RECEPTOR; LYTIC FACTOR; TRYPANOLYTIC FACTOR; EXPRESSION; GENE; DIFFERENTIATION; GLYCOPROTEIN; AGGREGATION; MEMBRANES	The African parasite Trypanosoma brucei gambiense accounts for 97% of human sleeping sickness cases(1). T. b. gambiense resists the specific human innate immunity acting against several other tsetsefly-transmitted trypanosome species such as T. b. brucei, the causative agent of nagana disease in cattle. Human immunity to some African trypanosomes is due to two serum complexes designated trypanolytic factors (TLF-1 and -2), which both contain haptoglobin-related protein (HPR) and apolipoprotein LI (APOL1)(2-4). Whereas HPR association with haemoglobin (Hb) allows TLF-1 binding and uptake via the trypanosome receptor TbHpHbR (ref. 5), TLF-2 enters trypanosomes independently of TbHpHbR (refs 4, 5). APOL1 kills trypanosomes after insertion into endosomal/lysosomal membranes(2,6,7). Here we report that T. b. gambiense resists TLFs via a hydrophobic beta-sheet of the T. b. gambiense-specific glycoprotein (TgsGP)(8), which prevents APOL1 toxicity and induces stiffening of membranes upon interaction with lipids. Two additional features contribute to resistance to TLFs: reduction of sensitivity to APOL1 requiring cysteine protease activity, and TbHpHbR inactivation due to a L210S substitution. According to such a multifactorial defence mechanism, transgenic expression of T. b. brucei TbHpHbR in T. b. gambiense did not cause parasite lysis in normal human serum. However, these transgenic parasites were killed in hypohaptoglobinaemic serum, after high TLF-1 uptake in the absence of haptoglobin (Hp) that competes for Hb and receptor binding. TbHpHbR inactivation preventing high APOL1 loading in hypohaptoglobinaemic serum may have evolved because of the overlapping endemic area of T. b. gambiense infection and malaria, the main cause of haemolysis-induced hypohaptoglobinaemia in western and central Africa(9).	[Uzureau, Pierrick; Uzureau, Sophie; Lecordier, Laurence; Fontaine, Frederic; Tebabi, Patricia; Pays, Annette; Felu, Cecile; Poelvoorde, Philippe; Vanhollebeke, Benoit] Univ Libre Bruxelles ULB, IBMM, Lab Mol Parasitol, B-6041 Gosselies, Belgium; [Homble, Fabrice] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Grelard, Axelle; Zhendre, Vanessa; Dufourc, Erick J.] Univ Bordeaux, Inst Polytech Bordeaux, Inst Chem & Biol Membranes & Nanoobjects, CNRS,UMR 5248, F-33600 Pessac, France; [Nolan, Derek P.] Trinity Coll Dublin, Sch Biochem & Immunol, Mol Parasitol Grp, Dublin 2, Ireland; [Lins, Laurence; Crowet, Jean-Marc] Univ Liege, Ctr Numer Mol Biophys, B-5030 Gembloux, Belgium; [Moestrup, Soren K.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark; [Lyngso, Jeppe; Pedersen, Jan Skov] Univ Aarhus, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus, Denmark; [Lyngso, Jeppe; Pedersen, Jan Skov] Univ Aarhus, Dept Chem, DK-8000 Aarhus, Denmark; [Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Perez-Morga, David] Univ Libre Bruxelles, Ctr Microscopy & Mol Imaging CMMI, B-6041 Gosselies, Belgium; [Perez-Morga, David; Pays, Etienne] Univ Libre Bruxelles, Mol Parasitol Lab, IBMM, B-6041 Gosselies, Belgium; [Pays, Etienne] Univ Libre Bruxelles, Walloon Excellence Life Sci & Biotechnol WELBIO, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Trinity College Dublin; University of Liege; Aarhus University; Aarhus University; Aarhus University; University of Glasgow; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Pays, E (corresponding author), Univ Libre Bruxelles, Walloon Excellence Life Sci & Biotechnol WELBIO, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	Pedersen, Jan Skov/A-8346-2008; Lyngsø, Jeppe/N-4163-2018; LINS, LAURENCE/Y-1661-2019; DUFOURC, Erick Joel/AAA-4992-2020; Moestrup, Søren Kragh/A-1403-2014; Moestrup, Søren Kragh/AAD-1735-2019; Homble, Fabrice/AAH-3780-2020; crowet, jean-marc/E-3989-2012	Pedersen, Jan Skov/0000-0002-7768-0206; Lyngsø, Jeppe/0000-0002-6301-1300; LINS, LAURENCE/0000-0001-7772-6748; DUFOURC, Erick Joel/0000-0002-8221-9326; Moestrup, Søren Kragh/0000-0003-3862-2107; Homble, Fabrice/0000-0001-6031-136X; Vanhollebeke, Benoit/0000-0002-0353-365X; GRELARD, Axelle/0000-0002-6708-2253; Nolan, Derek/0000-0002-3742-4304; Perez-Morga, David/0000-0002-7168-1865; crowet, jean-marc/0000-0002-9252-2396; Mottram, Jeremy/0000-0001-5574-3766; Uzureau, sophie/0000-0002-6444-2815	Belgian Fund for Scientific Research; Walloon WELBIO excellence programme; Interuniversity Attraction Poles Programme-Belgian Science Policy; ERC [233312 TROJA]; European Regional Development Fund; Walloon Region; TGIR-RMN-THC Fr3050 (French high-field NMR network); Welcome Trust; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish	Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Walloon WELBIO excellence programme(WELBIO); Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office); ERC(European Research Council (ERC)European Commission); European Regional Development Fund(European Commission); Walloon Region; TGIR-RMN-THC Fr3050 (French high-field NMR network); Welcome Trust(Wellcome Trust); Lundbeck Foundation(Lundbeckfonden)	We thank M. Prevost for advice, C. Giroud and T. Baltz for help with T. b. gambiense culture adaptation, D. Horn for the gift of pTMF plasmid and E. Dupont for technical assistance. This work was supported by the Belgian Fund for Scientific Research, the Walloon WELBIO excellence programme, the Interuniversity Attraction Poles Programme-Belgian Science Policy, and the ERC grant 233312 TROJA. The CMMI is supported by the European Regional Development Fund and the Walloon Region. Financial support from the TGIR-RMN-THC Fr3050 (French high-field NMR network) and the Welcome Trust is also acknowledged.	BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Bussler H, 1998, J BIOL CHEM, V273, P32582, DOI 10.1074/jbc.273.49.32582; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; DeJesus E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003317; Devaux S, 2007, MOL BIOL CELL, V18, P1293, DOI 10.1091/mbc.E06-09-0841; DOULIEZ JP, 1994, J CHIM PHYS PCB, V91, P874, DOI 10.1051/jcp/1994910874; Felu C, 2007, AM J TROP MED HYG, V76, P922, DOI 10.4269/ajtmh.2007.76.922; FOLCH J, 1957, J BIOL CHEM, V226, P497; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gibson W, 2007, INT J PARASITOL, V37, P829, DOI 10.1016/j.ijpara.2007.03.002; Gibson W, 2010, INFECT GENET EVOL, V10, P453, DOI 10.1016/j.meegid.2010.03.005; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Harrington JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044384; Higgins MK, 2013, P NATL ACAD SCI USA, V110, P1905, DOI 10.1073/pnas.1214943110; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Kieft R, 2010, P NATL ACAD SCI USA, V107, P16137, DOI 10.1073/pnas.1007074107; Klose A, 2006, ANAL BIOCHEM, V353, P57, DOI 10.1016/j.ab.2006.01.037; Lecordier L, 2007, MOL MICROBIOL, V64, P1164, DOI 10.1111/j.1365-2958.2007.05725.x; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Nolan DP, 2000, EUR J BIOCHEM, V267, P4601, DOI 10.1046/j.1432-1327.2000.01476.x; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Raper J, 1999, INFECT IMMUN, V67, P1910; Raper J, 1996, J EXP MED, V183, P1023, DOI 10.1084/jem.183.3.1023; ROUGEMONT A, 1988, LANCET, V2, P709; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 2012, MOL MICROBIOL, V84, P225, DOI 10.1111/j.1365-2958.2012.08013.x; Sani MA, 2008, FEBS J, V275, P561, DOI 10.1111/j.1742-4658.2007.06222.x; Santos CC, 2007, MOL MICROBIOL, V66, P991, DOI 10.1111/j.1365-2958.2007.05970.x; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; SOMMER JM, 1993, FEBS LETT, V316, P53, DOI 10.1016/0014-5793(93)81735-I; Symula RE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001728; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2010, EUKARYOT CELL, V9, P1272, DOI 10.1128/EC.00076-10; Vanhollebeke B, 2010, MOL MICROBIOL, V76, P806, DOI 10.1111/j.1365-2958.2010.07156.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	47	109	109	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					430	+		10.1038/nature12516	http://dx.doi.org/10.1038/nature12516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23965626				2022-12-28	WOS:000324545700048
J	Bindman, AB; Blum, JD; Kronick, R				Bindman, Andrew B.; Blum, Jonathan D.; Kronick, Richard			Medicare Payment for Chronic Care Delivered in a Patient-Centered Medical Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bindman, Andrew B.; Kronick, Richard] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94118 USA; [Blum, Jonathan D.] US Dept HHS, Ctr Medicare Serv, Washington, DC 20201 USA; [Blum, Jonathan D.] US Dept HHS, Ctr Medicaid Serv, Washington, DC 20201 USA	University of California System; University of California San Francisco; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Bindman, AB (corresponding author), Univ Calif San Francisco, Dept Med, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.	abindman@medsfgh.ucsf.edu						American Academy of Family Physicians (AAFP) American Academy of Pediatrics (AAP) American College of Physicians (ACP) American Osteopathic Association (AOA), 2007, JOINT PRINCIPLES OF; [Anonymous], RECOMMENDATIONS RELA; Centers for Medicare and Medicaid Services, 2012, CHRONIC CONDITIONS A; Centers for Medicare and Medicaid Services, INNOVATION MODELS; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886	5	9	9	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1125	1126		10.1001/jama.2013.276525	http://dx.doi.org/10.1001/jama.2013.276525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23929029	Green Submitted			2022-12-28	WOS:000324500300015
J	Murphy, G; Lisnevskaia, L; Isenberg, D				Murphy, Grainne; Lisnevskaia, Larissa; Isenberg, David			Autoimmune Rheumatic Diseases 2 Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment	LANCET			English	Article							STEM-CELL TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; COMPLEMENTARITY-DETERMINING REGION-1; PROTEASOME INHIBITOR BORTEZOMIB; PRIMARY SJOGRENS-SYNDROME; PLACEBO-CONTROLLED TRIAL; TERM-FOLLOW-UP; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; MYCOPHENOLATE-MOFETIL	Increased understanding of the molecular mechanisms underlying the pathogenenesis of autoimmune rheumatic diseases has led to targeted biological treatments that modulate various aspects of the immune response. These new treatments, together with more judicious use of other immunosuppressive drugs, have resulted in marked improvements in morbidity and mortality. Although belimumab, an agent that inhibits B-cell survival, is the first drug to be approved by the US Food and Drug Administration for the treatment of systemic lupus erythematosus in 50 years, many other immunological targets are under investigation. We discuss the recent advances in the biological treatment of autoimmune rheumatic diseases, with a particular focus on systemic lupus erythematosus.	[Murphy, Grainne; Isenberg, David] Univ Coll London Hosp, Ctr Rheumatol, Dept Med, London WC1E 6JF, England; [Lisnevskaia, Larissa] Oshawa Clin, Oshawa, ON, Canada	University College London Hospitals NHS Foundation Trust; University of London; University College London	Isenberg, D (corresponding author), Univ Coll London Hosp, Ctr Rheumatol, Rayne Bldg, London WC1E 6JF, England.	d.isenberg@ucl.ac.uk		Isenberg, David/0000-0001-9514-2455				Al-Musawi ZS, 2011, ARCH IRAN MED, V14, P66, DOI 011141/AIM.0016; Alarcon-Segovia D, 2003, ARTHRITIS RHEUM, V48, P442, DOI 10.1002/art.10763; Alsanafi S, 2011, JCR-J CLIN RHEUMATOL, V17, P142, DOI 10.1097/RHU.0b013e318214f30c; Amato AA, 2011, ANN NEUROL, V70, P427, DOI 10.1002/ana.22477; Appel GB, 2009, J AM SOC NEPHROL, V20, P1103, DOI 10.1681/ASN.2008101028; Arabshahi B, 2012, J PEDIATR-US, V160, P520, DOI 10.1016/j.jpeds.2011.11.057; Aringer M, 2004, ARTHRITIS RHEUM-US, V50, P3161, DOI 10.1002/art.20576; Aringer M, 2009, RHEUMATOLOGY, V48, P1451, DOI 10.1093/rheumatology/kep270; Bang SY, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/565039; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bertsias GK, 2012, ANN RHEUM DIS, V71, P1771, DOI 10.1136/annrheumdis-2012-201940; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Burness CB, 2011, DRUGS, V71, P2435, DOI 10.2165/11208440-000000000-00000; Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; Chen H, 2011, RHEUMATOLOGY, V50, P1640, DOI 10.1093/rheumatology/ker176; Condon MB, 2013, ANN RHEUM DIS, V72, P1280, DOI 10.1136/annrheumdis-2012-202844; Daikh DI, 2001, J IMMUNOL, V166, P2913, DOI 10.4049/jimmunol.166.5.2913; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Diaz-Lagares C, 2012, AUTOIMMUN REV, V11, P357; Dorner T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1942; Efthimiou P, 2011, INT J RHEUM DIS, V14, pE3, DOI 10.1111/j.1756-185X.2010.01592.x; Eilat E, 2001, P NATL ACAD SCI USA, V98, P1148, DOI 10.1073/pnas.98.3.1148; Ezeonyeji AN, 2012, RHEUMATOLOGY, V51, P476, DOI 10.1093/rheumatology/ker337; Fernandez-Nebro A, 2012, LUPUS, V21, P1063, DOI 10.1177/0961203312446627; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Gillis JZ, 2007, ARTHRIT RHEUM-ARTHR, V57, P538, DOI 10.1002/art.22629; Ginzler EM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3738; Ginzler EM, 2005, NEW ENGL J MED, V353, P2219, DOI 10.1056/NEJMoa043731; Gladman DD, 2003, J RHEUMATOL, V30, P1955; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hiepe F, 2012, ANN RHEUM DIS, V71, DOI 10.1136/annrheumdis-2011-201230.34; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Horowitz DM, 2009, EXPERT OPIN PHARMACO, V10, P1501, DOI 10.1517/14656560902946419; Houssiau FA, 2010, ANN RHEUM DIS, V69, P61, DOI 10.1136/ard.2008.102533; Houssiau FA, 2010, ANN RHEUM DIS, V69, P2083, DOI 10.1136/ard.2010.131995; Illei GG, 2006, ARTHRITIS RHEUM, V54, P4043; INGHIRAMI G, 1988, CLIN EXP RHEUMATOL, V6, P269; Isenberg D, 2010, RHEUMATOLOGY, V49, P128, DOI 10.1093/rheumatology/kep346; Jayne D, 2004, LUPUS, V13, P168, DOI 10.1191/0961203304lu525oa; Langford CA, 2012, ARTHRITIS RHEUM-US, V64, pS707; Li EK, 2009, RHEUMATOLOGY, V48, P892, DOI 10.1093/rheumatology/kep124; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; MALIDE D, 1995, HUM PATHOL, V26, P558, DOI 10.1016/0046-8177(95)90253-8; McBride JM, GENENTECHS RONTALIZU; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Mekinian A, 2012, ANN RHEUM DIS, V71, P84, DOI 10.1136/annrheumdis-2011-200086; Melander C, 2009, CLIN J AM SOC NEPHRO, V4, P579, DOI 10.2215/CJN.04030808; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Murata H, 2002, ARTHRITIS RHEUM, V46, P2141, DOI 10.1002/art.10432; Murray E, 2010, CLIN RHEUMATOL, V29, P707, DOI 10.1007/s10067-010-1387-5; Narazaki M, 2011, RHEUMATOLOGY, V50, P1344, DOI 10.1093/rheumatology/ker152; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Oddis CV, 2013, ARTHRITIS RHEUM-US, V65, P314, DOI 10.1002/art.37754; Oyama Y, 2007, BONE MARROW TRANSPL, V40, P549, DOI 10.1038/sj.bmt.1705782; Pena-Rossi C, 2009, LUPUS, V18, P547, DOI 10.1177/0961203309102803; Pepper R, 2009, NEPHROL DIAL TRANSPL, V24, P3717, DOI 10.1093/ndt/gfp336; Podolskaya A, 2008, ARCH DIS CHILD, V93, P401, DOI 10.1136/adc.2007.126276; Pottier V, 2011, LUPUS, V20, P656, DOI 10.1177/0961203310386276; Ramos-Casals M, 2007, MEDICINE, V86, P242, DOI 10.1097/MD.0b013e3181441a68; Rapoport MJ, 2005, CLIN IMMUNOL, V117, P262, DOI 10.1016/j.clim.2005.09.003; Ripley BJM, 2005, ANN RHEUM DIS, V64, P849, DOI 10.1136/ard.2004.022681; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Salvador FB, 2012, CLIN EXP RHEUMATOL, V30, P979; Shirota Y, 2005, ARTHRITIS RHEUM-US, V52, pS697; Silva F, 2011, ARTHRITIS RHEUM-US, V63, P2495, DOI 10.1002/art.30394; Sthoeger ZM, 2009, J AUTOIMMUN, V33, P77, DOI 10.1016/j.jaut.2009.03.009; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; StudnickaBenke A, 1996, BRIT J RHEUMATOL, V35, P1067; Tayal V, 2011, JCR-J CLIN RHEUMATOL, V17, P79, DOI 10.1097/RHU.0b013e31820e715c; Taylor PC, 2011, ANN RHEUM DIS, V70, P2119, DOI 10.1136/ard.2011.151522; Tew GW, 2010, LUPUS, V19, P146, DOI 10.1177/0961203309350752; Todd DJ, 2007, INT J CLIN PRACT, V61, P494, DOI 10.1111/j.1742-1241.2007.01289.x; Traczewski P, 2011, BRIT J CLIN PHARMACO, V71, P175, DOI 10.1111/j.1365-2125.2010.03767.x; Tsai CY, 2000, NEPHRON, V85, P207, DOI 10.1159/000045663; Urowitz MB, 1997, J RHEUMATOL, V24, P1061; US National Library of Medicine, STUD EV OCR PAT NEPH; US National Library of Medicine, STUD SAF MDX 1342 CO; US National Library of Medicine, AB CYCL COMB THER LU; van Laar JM, 2005, ANN RHEUM DIS, V64, P1515, DOI 10.1136/ard.2005.043240; Wallace DJ, 2010, EULAR 2010; Wallace DJ, 2007, DUBOIS LUPUS ERYTHEM, P1152; Wofsy D, 2012, ARTHRITIS RHEUM-US, V64, P3660, DOI 10.1002/art.34624; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; YTTERBERG SR, 1982, ARTHRITIS RHEUM, V25, P401, DOI 10.1002/art.1780250407	91	83	89	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					809	818		10.1016/S0140-6736(13)60889-2	http://dx.doi.org/10.1016/S0140-6736(13)60889-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23972423				2022-12-28	WOS:000324239200031
J	Boyle, P				Boyle, Paul			A UK View on the US Attack on Social Sciences	SCIENCE			English	Editorial Material									[Boyle, Paul] UK Econ & Social Res Council ESRC, Swindon SN2 1UJ, Wilts, England; [Boyle, Paul] Sci Europe, B-1040 Brussels, Belgium	UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC)	Boyle, P (corresponding author), UK Econ & Social Res Council ESRC, Swindon SN2 1UJ, Wilts, England.	ESRC.CEO@esrc.ac.uk						Calvert J, 2009, EMBO REP, V10, P201, DOI 10.1038/embor.2009.15; Economic and Social Research Council, 2013, ESRC CEL IMP PRIZ; H. M. Government Cabinet Office, 2012, APPL BEHAV INSIGHTS; H. M. Government Cabinet Office, 2013, WHAT WORKS EV CTR SO; Mann R., 2012, COMMUNICATION   1130; National Research Council and Institute of Medicine, 2013, US HLTH INT PERSP SH	6	4	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					719	719		10.1126/science.1242563	http://dx.doi.org/10.1126/science.1242563			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201DZ	23950516				2022-12-28	WOS:000323122200024
J	Meierbachtol, T; Harper, J; Humphrey, N				Meierbachtol, T.; Harper, J.; Humphrey, N.			Basal Drainage System Response to Increasing Surface Melt on the Greenland Ice Sheet	SCIENCE			English	Article							SUBGLACIAL DRAINAGE; WEST GREENLAND; WATER-LEVEL; FAST-FLOW; ACCELERATION; TEMPERATURE; MECHANISMS; EVOLUTION; VELOCITY; ISBRAE	Surface meltwater reaching the bed of the Greenland ice sheet imparts a fundamental control on basal motion. Sliding speed depends on ice/bed coupling, dictated by the configuration and pressure of the hydrologic drainage system. In situ observations in a four-site transect containing 23 boreholes drilled to Greenland's bed reveal basal water pressures unfavorable to water-draining conduit development extending inland beneath deep ice. This finding is supported by numerical analysis based on realistic ice sheet geometry. Slow meltback of ice walls limits conduit growth, inhibiting their capacity to transport increased discharge. Key aspects of current conceptual models for Greenland basal hydrology, derived primarily from the study of mountain glaciers, appear to be limited to a portion of the ablation zone near the ice sheet margin.	[Meierbachtol, T.; Harper, J.] Univ Montana, Dept Geosci, Missoula, MT 59812 USA; [Humphrey, N.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA	University of Montana System; University of Montana; University of Wyoming	Meierbachtol, T (corresponding author), Univ Montana, Dept Geosci, 32 Campus Dr, Missoula, MT 59812 USA.	toby.meierbachtol@umontana.edu		humphrey, neil/0000-0002-5175-2080; Harper, Joel/0000-0002-2151-8509	SKB-Posiva-NWMO through the Greenland Analogue Project; NSF (Office of Polar Programs-Arctic Natural Sciences) [0909495]; Division Of Polar Programs [0909503] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0909495] Funding Source: National Science Foundation	SKB-Posiva-NWMO through the Greenland Analogue Project; NSF (Office of Polar Programs-Arctic Natural Sciences)(National Science Foundation (NSF)); Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank J. Johnson for his thoughtful review and comments that improved this manuscript. Many thanks to all those who provided field assistance. This work is funded by SKB-Posiva-NWMO through the Greenland Analogue Project and NSF (Office of Polar Programs-Arctic Natural Sciences grant no. 0909495).	Allen C, 2010, ICEBRIDGE MCORDS L2; Alley RB, 1996, HYDROL PROCESS, V10, P649; Bartholomaus TC, 2008, NAT GEOSCI, V1, P33, DOI 10.1038/ngeo.2007.52; Bartholomew I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002220; Bartholomew I, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047063; Bartholomew I, 2010, NAT GEOSCI, V3, P408, DOI 10.1038/NGEO863; Chandler DM, 2013, NAT GEOSCI, V6, P195, DOI 10.1038/ngeo1737; Hoffman MJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001934; HUBBARD BP, 1995, J GLACIOL, V41, P572, DOI 10.3189/S0022143000034894; IKEN A, 1986, J GLACIOL, V32, P101, DOI 10.3189/S0022143000006936; IKEN A, 1993, J GLACIOL, V39, P15, DOI 10.3189/S0022143000015689; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; KAMB B, 1987, J GEOPHYS RES-SOLID, V92, P9083, DOI 10.1029/JB092iB09p09083; Luthi M, 2002, J GLACIOL, V48, P369, DOI 10.3189/172756502781831322; McGrath D, 2011, J GLACIOL, V57, P954, DOI 10.3189/002214311798043735; Mote TL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031976; Palmer S, 2011, EARTH PLANET SC LETT, V302, P423, DOI 10.1016/j.epsl.2010.12.037; Ru┬thlisberger H., 1972, J GLACIOL, V11, P177, DOI [10.3189/S0022143000022188, DOI 10.1017/S0022143000022188]; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Shepherd A., 2009, GEOPHYS RES LETT, V36, P2; Sole AJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001948; Sundal AV, 2011, NATURE, V469, P522, DOI 10.1038/nature09740; Tedesco M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028466; Thomsen H. H., 1991, RAPP GRONL GEOL UNDE, V152, P36; Thomsen HH., 1991, REPORT GEOLOGICAL SU, V152, P80; van As D, 2012, CRYOSPHERE, V6, P199, DOI 10.5194/tc-6-199-2012; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	28	117	117	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					777	779		10.1126/science.1235905	http://dx.doi.org/10.1126/science.1235905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950535				2022-12-28	WOS:000323122200045
J	Llordes, A; Garcia, G; Gazquez, J; Milliron, DJ				Llordes, Anna; Garcia, Guillermo; Gazquez, Jaume; Milliron, Delia J.			Tunable near-infrared and visible-light transmittance in nanocrystal-in-glass composites	NATURE			English	Article							OPTICAL-PROPERTIES; AMORPHOUS OXIDE; RAMAN-SPECTRA; NANOCOMPOSITE; CHEMISTRY; ION	Amorphous metal oxides are useful in optical(1,2), electronic(3-5) and electrochemical devices(6,7). The bonding arrangement within these glasses largely determines their properties, yet it remains a challenge to manipulate their structures in a controlled manner. Recently, we developed synthetic protocols for incorporating nanocrystals that are covalently bonded into amorphous materials(8,9). This 'nanocrystal-in-glass' approach not only combines two functional components in one material, but also the covalent link enables us to manipulate the glass structure to change its properties. Here we illustrate the power of this approach by introducing tin-doped indium oxide nanocrystals into niobium oxide glass (NbOx), and realize a new amorphous structure as a consequence of linking it to the nanocrystals. The resulting material demonstrates a previously unrealized optical switching behaviour that will enable the dynamic control of solar radiation transmittance through windows. These transparent films can block near-infrared and visible light selectively and independently by varying the applied electrochemical voltage over a range of 2.5 volts. We also show that the reconstructed NbOx glass has superior properties-its optical contrast is enhanced fivefold and it has excellent electrochemical stability, with 96 per cent of charge capacity retained after 2,000 cycles.	[Llordes, Anna; Garcia, Guillermo; Milliron, Delia J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Gazquez, Jaume] ICMAB CSIC, Inst Ciencia Mat Barcelona, Bellaterra 08193, Catalonia, Spain	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB)	Milliron, DJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	dmilliron@lbl.gov	Milliron, Delia J/D-6002-2012; Llordes, Anna/H-2370-2015; Gazquez, Jaume/C-5334-2012	Llordes, Anna/0000-0003-4169-9156; Gazquez, Jaume/0000-0002-2561-328X	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy (DOE) [DE-AC02-05CH11231]; DOE Early Career Research Program; Consejo Superior de Investigaciones Cientificas, CSIC, JAE; DOE-BES, Materials Sciences and Engineering Division; ORNL's Shared Research Equipment (ShaRE) User Program; DOE-BES	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy (DOE)(United States Department of Energy (DOE)); DOE Early Career Research Program(United States Department of Energy (DOE)); Consejo Superior de Investigaciones Cientificas, CSIC, JAE; DOE-BES, Materials Sciences and Engineering Division; ORNL's Shared Research Equipment (ShaRE) User Program; DOE-BES(United States Department of Energy (DOE))	We thank S. Raoux and J. L. Jordan-Sweet as well as S. Mannsfeld and M. Toney for assistance in synchrotron XRD measurements at the National Synchrotron Light Source (Brookhaven National Laboratory) and Stanford Synchrotron Radiation Lightsource (SSRL); and R. Zuckermann, P. J. Schuck, R. J. Mendelsberg, and especially M. Salmeron and O. Yaghi for critical reading of the manuscript. This work was performed at the Molecular Foundry, Lawrence Berkeley National Laboratory, and was supported by the Office of Science, Office of Basic Energy Sciences, of the US Department of Energy (DOE) under contract number DE-AC02-05CH11231. D. J. M. and G. G. were supported by a DOE Early Career Research Program grant under the same contract, and J. G. was supported by Consejo Superior de Investigaciones Cientificas, CSIC, JAE. Scanning transmission electron microscopy images were taken at Oak Ridge National Laboratory (ORNL), supported by DOE-BES, Materials Sciences and Engineering Division, and by ORNL's Shared Research Equipment (ShaRE) User Program, which is also sponsored by DOE-BES. XRD data shown in the manuscript was acquired at SSRL, beamline 11-3.	Arhammar C, 2011, P NATL ACAD SCI USA, V108, P6355, DOI 10.1073/pnas.1019698108; Buonsanti R, 2012, NANO LETT, V12, P3872, DOI 10.1021/nl302206s; Choi SI, 2008, CHEM MATER, V20, P2609, DOI 10.1021/cm703706m; Dong AG, 2011, J AM CHEM SOC, V133, P998, DOI 10.1021/ja108948z; Dong WY, 2007, J AM CHEM SOC, V129, P13894, DOI 10.1021/ja073804o; Falcao EL, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134204; Garcia G, 2013, ADV OPT MATER, V1, P215, DOI 10.1002/adom.201200051; Garcia G, 2011, NANO LETT, V11, P4415, DOI 10.1021/nl202597n; Granqvist C.G., 2002, HDB INORGANIC ELECTR; Idota Y, 1997, SCIENCE, V276, P1395, DOI 10.1126/science.276.5317.1395; JEHNG JM, 1991, CHEM MATER, V3, P100, DOI 10.1021/cm00013a025; KIM SH, 1995, J AM CERAM SOC, V78, P1061, DOI 10.1111/j.1151-2916.1995.tb08437.x; Kim YH, 2012, NATURE, V489, P128, DOI 10.1038/nature11434; LEHN JM, 1985, SCIENCE, V227, P849, DOI 10.1126/science.227.4689.849; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Li SY, 2010, J APPL PHYS, V108, DOI 10.1063/1.3487980; LINES ME, 1991, J APPL PHYS, V69, P6876, DOI 10.1063/1.347677; Llordes A, 2011, J MATER CHEM, V21, P11631, DOI 10.1039/c1jm10514k; Mattarelli M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.094204; MCCONNELL AA, 1976, SPECTROCHIM ACTA A, V32, P1067, DOI 10.1016/0584-8539(76)80291-7; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Rosario AV, 2005, J SOLID STATE ELECTR, V9, P665, DOI 10.1007/s10008-004-0637-3; Rosen EL, 2012, ANGEW CHEM INT EDIT, V51, P684, DOI 10.1002/anie.201105996; Rosenflanz A, 2004, NATURE, V430, P761, DOI 10.1038/nature02729; Rosseinsky D., 2007, ELECTROCHROMISM ELEC; Sakamoto A, 2010, INT J APPL GLASS SCI, V1, P237, DOI 10.1111/j.2041-1294.2010.00027.x; Schirmeisen A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225901; Shelby JE, 2005, INTRODUCTION TO GLASS SCIENCE AND TECHNOLOGY, P1; Tangirala R, 2010, ANGEW CHEM INT EDIT, V49, P2878, DOI 10.1002/anie.200906642; Villa EM, 2008, ANGEW CHEM INT EDIT, V47, P4844, DOI 10.1002/anie.200801125; Wang RY, 2012, ADV MATER, V24, P99, DOI 10.1002/adma.201102623; Zhou HS, 2005, ANGEW CHEM INT EDIT, V44, P797, DOI 10.1002/anie.200460937	32	586	603	48	685	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					323	+		10.1038/nature12398	http://dx.doi.org/10.1038/nature12398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23955232	Green Published			2022-12-28	WOS:000323112400030
J	Tingley, MW; Estes, LD; Wilcove, DS				Tingley, Morgan W.; Estes, Lyndon D.; Wilcove, David S.			Climate change must not blow conservation off course	NATURE			English	Editorial Material							SHIFTS		[Tingley, Morgan W.; Estes, Lyndon D.; Wilcove, David S.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Wilcove, David S.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Tingley, MW (corresponding author), Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA.	mtingley@princeton.edu; lestes@princeton.edu; dwilcove@princeton.edu	Tingley, Morgan W/F-8519-2011	Tingley, Morgan W/0000-0002-1477-2218; Wilcove, David S./0000-0002-1354-0503				Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Game ET, 2011, GLOBAL CHANGE BIOL, V17, P3150, DOI 10.1111/j.1365-2486.2011.02457.x; Hagerman S, 2010, GLOBAL ENVIRON CHANG, V20, P192, DOI 10.1016/j.gloenvcha.2009.10.005; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x	9	29	29	0	71	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					271	272		10.1038/500271a	http://dx.doi.org/10.1038/500271a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AF	23955216	Bronze			2022-12-28	WOS:000323112400009
J	Berman, F; Cerf, V				Berman, Francine; Cerf, Vint			Who Will Pay for Public Access to Research Data?	SCIENCE			English	Editorial Material									[Berman, Francine] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Cerf, Vint] Google, Reston, VA 20190 USA	Rensselaer Polytechnic Institute; Google Incorporated	Berman, F (corresponding author), Rensselaer Polytech Inst, Troy, NY 12180 USA.	bermaf@rpi.edu						Alzheimer, ADNI OV; [Anonymous], 2013, NY TIMES, pA24; BRTF-SDPA, 2010, SUST EC DIG PLAN FIN; Holdren JP, PUBLIC ACCESS MEMORA; Lenssen P., GOOGLE STOPS RES DAT; Monastersky R, 2013, NATURE, V495, P430, DOI 10.1038/495430a; Reichman J., 2003, LAW CONTEMP PROBL, V66, P314; Reichman JH, 2012, MINN LAW REV, V96, P1362; [No title captured]	9	29	29	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					616	617		10.1126/science.1241625	http://dx.doi.org/10.1126/science.1241625			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197XC	23929969				2022-12-28	WOS:000322884800022
J	Martin, MJ; Bishof, M; Swallows, MD; Zhang, X; Benko, C; von-Stecher, J; Gorshkov, AV; Rey, AM; Ye, J				Martin, M. J.; Bishof, M.; Swallows, M. D.; Zhang, X.; Benko, C.; von-Stecher, J.; Gorshkov, A. V.; Rey, A. M.; Ye, Jun			A Quantum Many-Body Spin System in an Optical Lattice Clock	SCIENCE			English	Article							ULTRACOLD ATOMS; GAS; ENTANGLEMENT; SIMULATION; LIMIT	Strongly interacting quantum many-body systems arise in many areas of physics, but their complexity generally precludes exact solutions to their dynamics. We explored a strongly interacting two-level system formed by the clock states in Sr-87 as a laboratory for the study of quantum many-body effects. Our collective spin measurements reveal signatures of the development of many-body correlations during the dynamical evolution. We derived a many-body Hamiltonian that describes the experimental observation of atomic spin coherence decay, density-dependent frequency shifts, severely distorted lineshapes, and correlated spin noise. These investigations open the door to further explorations of quantum many-body effects and entanglement through use of highly coherent and precisely controlled optical lattice clocks.	[Martin, M. J.; Bishof, M.; Swallows, M. D.; Zhang, X.; Benko, C.; von-Stecher, J.; Rey, A. M.; Ye, Jun] NIST, JILA, Boulder, CO 80309 USA; [Martin, M. J.; Bishof, M.; Swallows, M. D.; Zhang, X.; Benko, C.; von-Stecher, J.; Rey, A. M.; Ye, Jun] Univ Colorado, Boulder, CO 80309 USA; [Martin, M. J.; Bishof, M.; Swallows, M. D.; Zhang, X.; Benko, C.; von-Stecher, J.; Rey, A. M.; Ye, Jun] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Gorshkov, A. V.] CALTECH, IQIM, Pasadena, CA 91125 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; California Institute of Technology	Martin, MJ (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	mjmartin@caltech.edu; arey@jilau1.colorado.edu; ye@jila.colorado.edu	Gorshkov, Alexey V/A-9848-2008; Ye, Jun/C-3312-2011; Benko, Craig/L-2678-2015; Martin, Michael/AAV-6857-2021	Gorshkov, Alexey V/0000-0003-0509-3421; Ye, Jun/0000-0003-0076-2112; Martin, Michael/0000-0002-6022-217X	National Institute of Standards and Technology, Defense Advanced Research Projects Agency Optical Lattice Emulator Program; National Defense Science and Engineering Graduate fellowship program; NSF IQIM; Lee A. DuBridge Foundation; Gordon and Betty Moore Foundation	National Institute of Standards and Technology, Defense Advanced Research Projects Agency Optical Lattice Emulator Program; National Defense Science and Engineering Graduate fellowship program; NSF IQIM; Lee A. DuBridge Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank S. Blatt, J. Thomsen, W. Zhang, T. Nicholson, J. Williams, B. Bloom, and S. Campbell for technical help and A. D. Ludlow, K. R. A. Hazzard, M. Foss-Feig, A. J. Daley, and J. K. Thompson for discussions. The work is supported by the National Institute of Standards and Technology, Defense Advanced Research Projects Agency Optical Lattice Emulator Program administered by Army Research Office, NSF, and Air Force Office of Scientific Research. M. B. acknowledges support from the National Defense Science and Engineering Graduate fellowship program. A. V. G. acknowledges support from NSF IQIM, the Lee A. DuBridge Foundation, and the Gordon and Betty Moore Foundation.	Bishof M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052716; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Campbell GK, 2009, SCIENCE, V324, P360, DOI 10.1126/science.1169724; Cazalilla MA, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103033; Chotia A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.080405; de Miranda MHG, 2011, NAT PHYS, V7, P502, DOI [10.1038/NPHYS1939, 10.1038/nphys1939]; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Gibble K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.113202; Gorshkov AV, 2010, NAT PHYS, V6, P289, DOI 10.1038/NPHYS1535; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Jo GB, 2009, SCIENCE, V325, P1521, DOI 10.1126/science.1177112; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Lemke ND, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.103902; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Lucke B, 2011, SCIENCE, V334, P773, DOI 10.1126/science.1208798; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Rey AM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.260402; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Sorensen A, 2001, NATURE, V409, P63, DOI 10.1038/35051038; Wu CJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.186402; Yu ZH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010801	28	128	129	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					632	636		10.1126/science.1236929	http://dx.doi.org/10.1126/science.1236929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929976	Green Accepted, Green Submitted			2022-12-28	WOS:000322884800032
J	Park, JM; Hu, JH; Milshteyn, A; Zhang, PW; Moore, CG; Park, S; Datko, MC; Domingo, RD; Reyes, CM; Wang, XDJ; Etzkorn, FA; Xiao, B; Szumlinski, KK; Kern, D; Linden, DJ; Worley, PF				Park, Joo Min; Hu, Jia-Hua; Milshteyn, Aleksandr; Zhang, Ping-Wu; Moore, Chester G.; Park, Sungjin; Datko, Michael C.; Domingo, Racquel D.; Reyes, Cindy M.; Wang, Xiaodong J.; Etzkorn, Felicia A.; Xiao, Bo; Szumlinski, Karen K.; Kern, Dorothee; Linden, David J.; Worley, Paul F.			A Prolyl-Isomerase Mediates Dopamine-Dependent Plasticity and Cocaine Motor Sensitization	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; POTENTIATION; ACTIVATION; PROTEIN; HOMER; ISOMERIZATION; SPECTROSCOPY; CYCLOPHILIN; RESPONSES	Synaptic plasticity induced by cocaine and other drugs underlies addiction. Here we elucidate molecular events at synapses that cause this plasticity and the resulting behavioral response to cocaine in mice. In response to D1-dopamine-receptor signaling that is induced by drug administration, the glutamate-receptor protein metabotropic glutamate receptor 5 (mGluR5) is phosphorylated by microtubule-associated protein kinase (MAPK), which we show potentiates Pin1-mediated prolyl-isomerization of mGluR5 in instances where the product of an activity-dependent gene, Homer1a, is present to enable Pin1-mGluR5 interaction. These biochemical events potentiate N-methyl-D-aspartate receptor (NMDAR)-mediated currents that underlie synaptic plasticity and cocaine-evoked motor sensitization as tested in mice with relevant mutations. The findings elucidate how a coincidence of signals from the nucleus and the synapse can render mGluR5 accessible to activation with consequences for drug-induced dopamine responses and point to depotentiation at corticostriatal synapses as a possible therapeutic target for treating addiction.	[Park, Joo Min; Hu, Jia-Hua; Zhang, Ping-Wu; Moore, Chester G.; Park, Sungjin; Xiao, Bo; Linden, David J.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Milshteyn, Aleksandr; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02452 USA; [Datko, Michael C.; Domingo, Racquel D.; Reyes, Cindy M.; Szumlinski, Karen K.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Datko, Michael C.; Domingo, Racquel D.; Reyes, Cindy M.; Szumlinski, Karen K.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Wang, Xiaodong J.; Etzkorn, Felicia A.] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA; [Park, Joo Min] Jeju Natl Univ, Dept Physiol, Sch Med, Cheju 690756, South Korea	Johns Hopkins University; Johns Hopkins University; Brandeis University; Howard Hughes Medical Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Virginia Polytechnic Institute & State University; Jeju National University	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	Datko, Michael/AAP-1465-2021; Szumlinski, Karen K./J-9617-2015	Szumlinski, Karen K./0000-0003-1078-1077; Etzkorn, Felicia A./0000-0001-5850-3661; Domingo-Gonzalez, Racquel/0000-0002-7494-0439; Xiao, Bo/0000-0002-6161-9478	NIH [DA011742, DA010309, MH084020, MH51106, NS050274, CA110940]; Howard Hughes Medical Institute; Office of Basic Energy Sciences, Catalysis Science Program; U.S. Department of Energy [DE-FG02-05ER15699]; NATIONAL CANCER INSTITUTE [R01CA110940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R29MH051106, P50MH084020, R01MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309, R37DA010309, R01DA011742] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Basic Energy Sciences, Catalysis Science Program; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	J.-H.H. performed biochemical studies that provided the basis for structural studies performed by A.M., and electrophysiological studies performed by J.M.P. Grm5<SUP>AA/AA</SUP> and Grm5<SUP>R/R</SUP> KI mice were generated by P.-W.Z. and B.X. We thank Anthony R. Means of Duke University for Pin1<SUP>-/-</SUP> mice. This work was supported by NIH grants DA011742 (P.F.W.), DA010309 (P.F.W.), MH084020 (P.F.W. and D.J.L.), MH51106 (D.J.L.), NS050274 (P.F.W.), and CA110940 (F.A.E.) and in part by the Howard Hughes Medical Institute (D.K.), the Office of Basic Energy Sciences, Catalysis Science Program, and U.S. Department of Energy, award DE-FG02-05ER15699 (D.K.).	Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Atchison FW, 2003, DEVELOPMENT, V130, P3579, DOI 10.1242/dev.00584; Bird MK, 2010, INT J NEUROPSYCHOPH, V13, P133, DOI 10.1017/S1461145709990162; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bosco DA, 2010, J MOL BIOL, V403, P723, DOI 10.1016/j.jmb.2010.08.001; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Cornish JL, 2001, J ADDICT DIS, V20, P43, DOI 10.1300/J069v20n03_05; Cozzoli DK, 2009, J NEUROSCI, V29, P8655, DOI 10.1523/JNEUROSCI.5900-08.2009; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gass JT, 2009, BIOL PSYCHIAT, V65, P717, DOI 10.1016/j.biopsych.2008.11.001; Ghasemzadeh MB, 2009, SYNAPSE, V63, P42, DOI 10.1002/syn.20577; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kenny PJ, 2005, PSYCHOPHARMACOLOGY, V179, P247, DOI 10.1007/s00213-004-2069-2; Knackstedt LA, 2010, J NEUROSCI, V30, P7984, DOI 10.1523/JNEUROSCI.1244-10.2010; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Namanja AT, 2010, J AM CHEM SOC, V132, P5607, DOI 10.1021/ja9096779; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Orlando LR, 2009, J NEUROCHEM, V110, P557, DOI 10.1111/j.1471-4159.2009.06139.x; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Pickens CL, 2011, TRENDS NEUROSCI, V34, P411, DOI 10.1016/j.tins.2011.06.001; Pisani A, 2001, NEUROSCIENCE, V106, P579, DOI 10.1016/S0306-4522(01)00297-4; Pisani A, 1997, BRIT J PHARMACOL, V120, P1007, DOI 10.1038/sj.bjp.0700999; Platt DM, 2008, PSYCHOPHARMACOLOGY, V200, P167, DOI 10.1007/s00213-008-1191-y; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shim S, 2009, NEURON, V64, P471, DOI 10.1016/j.neuron.2009.09.025; Szumlinski KK, 2007, PSYCHOPHARMACOLOGY, V190, P415, DOI 10.1007/s00213-006-0641-7; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Wang XDJ, 2004, J AM CHEM SOC, V126, P15533, DOI 10.1021/ja046396m; Wang XS, 2013, ADDICT BIOL, V18, P40, DOI 10.1111/j.1369-1600.2011.00432.x; Yin HH, 2007, EUR J NEUROSCI, V25, P3226, DOI 10.1111/j.1460-9568.2007.05606.x; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	41	49	49	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					637	650		10.1016/j.cell.2013.07.001	http://dx.doi.org/10.1016/j.cell.2013.07.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911326	Green Accepted, Bronze			2022-12-28	WOS:000322629900016
J	O'Connell, T; Rasanathan, K; Chopra, M				O'Connell, Thomas; Rasanathan, Kumanan; Chopra, Mickey			What does universal health coverage mean?	LANCET			English	Editorial Material							CHILD SURVIVAL; EQUITY; NUTRITION; CARE		[O'Connell, Thomas; Rasanathan, Kumanan; Chopra, Mickey] UNICEF, Hlth Sect, New York, NY 10007 USA	UNICEF	O'Connell, T (corresponding author), UNICEF, Hlth Sect, 3 United Nations Plaza, New York, NY 10007 USA.	toconnell@unicef.org	O'Connell, Thomas S./AAZ-1965-2020	O'Connell, Thomas S./0000-0002-6003-008X				Bloom G, 2008, SOC SCI MED, V66, P2076, DOI 10.1016/j.socscimed.2008.01.034; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Frenz P, 2010, GLOB S HLTH SYST RES; Gwatkin DR, 2011, LANCET, V377, P2160, DOI 10.1016/S0140-6736(10)62058-2; Kenya National Commission on Human Rights, 2009, FOR HOM DIL CIT NO K; Kingston LN, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-11; Kirby M, 1999, Health Hum Rights, V4, P6, DOI 10.2307/4065166; Kutzin J, 2012, B WORLD HEALTH ORGAN, V90, P867, DOI 10.2471/BLT.12.113654; Lang T, 2009, EUR J PUBLIC HEALTH, V19, P133, DOI 10.1093/eurpub/ckp025; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; O'Connell T., 2012, NAT HLTH INS AS AFR; Ooms G, 2013, B WORLD HEALTH ORGAN, V91, P2, DOI 10.2471/BLT.12.115808; Ozgediz D, 2009, WORLD J SURG, V33, P1, DOI 10.1007/s00268-008-9799-y; Rasanathan Kumanan, 2010, Health Hum Rights, V12, P49; United Nations Children's Fund (UNICEF), 2010, PROGR CHILDR ACH MDG; United Nations General Assembly, 2012, 67 UN GEN ASS NEW YO; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; World Health Assembly, 2005, 58 WORLD HLTH ASS GE	22	97	98	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					277	279		10.1016/S0140-6736(13)60955-1	http://dx.doi.org/10.1016/S0140-6736(13)60955-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	23953765				2022-12-28	WOS:000330027500037
J	Kuhlman, SJ; Olivas, ND; Tring, E; Ikrar, T; Xu, XM; Trachtenberg, JT				Kuhlman, Sandra J.; Olivas, Nicholas D.; Tring, Elaine; Ikrar, Taruna; Xu, Xiangmin; Trachtenberg, Joshua T.			A disinhibitory microcircuit initiates critical-period plasticity in the visual cortex	NATURE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; REMOTE-CONTROL; RESPONSES; ORGANIZATION; INHIBITION; MECHANISMS; RESOLUTION; AMBLYOPIA; NEOCORTEX; NETWORK	Early sensory experience instructs the maturation of neural circuitry in the cortex(1,2). This has been studied extensively in the primary visual cortex, in which loss of vision to one eye permanently degrades cortical responsiveness to that eye(3,4), a phenomenon known as ocular dominance plasticity (ODP). Cortical inhibition mediates this process(4-6), but the precise role of specific classes of inhibitory neurons in ODP is controversial. Here we report that evoked firing rates of binocular excitatory neurons in the primary visual cortex immediately drop by half when vision is restricted to one eye, but gradually return to normal over the following twenty-four hours, despite the fact that vision remains restricted to one eye. This restoration of binocular-like excitatory firing rates after monocular deprivation results from a rapid, although transient, reduction in the firing rates of fast-spiking, parvalbumin-positive (PV) interneurons, which in turn can be attributed to a decrease in local excitatory circuit input onto PV interneurons. This reduction in PV-cell-evoked responses after monocular lid suture is restricted to the critical period for ODP and appears to be necessary for subsequent shifts in excitatory ODP. Pharmacologically enhancing inhibition at the time of sight deprivation blocks ODP and, conversely, pharmacogenetic reduction of PV cell firing rates can extend the critical period for ODP. These findings define the microcircuit changes initiating competitive plasticity during critical periods of cortical development. Moreover, they show that the restoration of evoked firing rates of layer 2/3 pyramidal neurons by PV-specific disinhibition is a key step in the progression of ODP.	[Kuhlman, Sandra J.; Tring, Elaine; Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90048 USA; [Olivas, Nicholas D.; Ikrar, Taruna; Xu, Xiangmin] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Xu, Xiangmin] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine	Xu, XM (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	xiangmix@uci.edu; joshua.trachtenberg@gmail.com	Core, Vector/CAF-4832-2022; Ikrar, Taruna/I-3357-2014; Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282	US National Eye Institute [EY016052]; US National Institute of Neurological Disorders and Stroke [NS078434]; NARSAD; NATIONAL EYE INSTITUTE [R01EY023871, R01EY016052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023700] Funding Source: NIH RePORTER	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Smith, W. Thompson, K. Miller and M. P. Stryker for comments on earlier versions of this manuscript, Y. Shi for help with software, Z. Nenadic for analytical suggestions, D. Ringach for help with GCaMP6 analysis and Z. J. Huang for useful discussions. This work was funded by grants from the US National Eye Institute (EY016052) to J. T. T., and the US National Institute of Neurological Disorders and Stroke (NS078434) and a NARSAD Young Investigator Grant to X.X.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Antonini A, 1999, J NEUROSCI, V19, P4388; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; de Villers-Sidani E, 2011, PROG BRAIN RES, V191, P119, DOI 10.1016/B978-0-444-53752-2.00009-6; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dong SY, 2010, MOL BIOSYST, V6, P1376, DOI 10.1039/c002568m; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gdalyahu A, 2012, NEURON, V75, P121, DOI 10.1016/j.neuron.2012.04.035; Gordon JA, 1996, J NEUROSCI, V16, P3274; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holmes JM, 2011, ARCH OPHTHALMOL-CHIC, V129, P1451, DOI 10.1001/archophthalmol.2011.179; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Jiang B, 2005, BRAIN RES REV, V50, P126, DOI 10.1016/j.brainresrev.2005.05.007; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kanonidou Evgenia, 2011, International Ophthalmology, V31, P249, DOI 10.1007/s10792-011-9434-z; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Kuhlman SJ, 2011, NAT NEUROSCI, V14, P1121, DOI 10.1038/nn.2890; Lambo ME, 2013, J NEUROSCI, V33, P8810, DOI 10.1523/JNEUROSCI.4502-12.2013; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shi YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015517; Shih F., 2009, IMAGE PROCESSING MAT; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Webber Ann L, 2005, Clin Exp Optom, V88, P365; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu XM, 2010, J NEUROPHYSIOL, V103, P2301, DOI 10.1152/jn.00992.2009; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	46	250	252	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					543	+		10.1038/nature12485	http://dx.doi.org/10.1038/nature12485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23975100	Green Accepted, Green Submitted			2022-12-28	WOS:000324826300057
J	Ni, LN; Bronk, P; Chang, EC; Lowell, AM; Flam, JO; Panzano, VC; Theobald, DL; Griffith, LC; Garrity, PA				Ni, Lina; Bronk, Peter; Chang, Elaine C.; Lowell, April M.; Flam, Juliette O.; Panzano, Vincent C.; Theobald, Douglas L.; Griffith, Leslie C.; Garrity, Paul A.			A gustatory receptor paralogue controls rapid warmth avoidance in Drosophila	NATURE			English	Article							NEURAL CIRCUITS; HEAT-SENSOR; TEMPERATURE; CHANNEL; TRPA1; NEURONS; MELANOGASTER; EXPRESSION; TASTE; ARCHITECTURE	Behavioural responses to temperature are critical for survival, and animals from insects to humans show strong preferences for specific temperatures(1,2). Preferred temperature selection promotes avoidance of adverse thermal environments in the short term and maintenance of optimal body temperatures over the long term(1,2), but its molecular and cellular basis is largely unknown. Recent studies have generated conflicting views of thermal preference in Drosophila, attributing importance to either internal(3) or peripheral(4) warmth sensors. Here we reconcile these views by showing that thermal preference is not a singular response, but involves multiple systems relevant in different contexts. We found previously that the transient receptor potential channel TRPA1 acts internally to control the slowly developing preference response of flies exposed to a shallow thermal gradient(3). We now find that the rapid response of flies exposed to a steep warmth gradient does not require TRPA1; rather, the gustatory receptor GR28B(D) drives this behaviour through peripheral thermosensors. Gustatory receptors are a large gene family, widely studied in insect gustation and olfaction, and are implicated in host-seeking by insect disease vectors(5-7), but have not previously been implicated in thermosensation. At the molecular level, GR28B(D) misexpression confers thermosensitivity upon diverse cell types, suggesting that it is a warmth sensor. These data reveal a new type of thermosensory molecule and uncover a functional distinction between peripheral and internal warmth sensors in this tiny ectotherm reminiscent of thermoregulatory systems in larger, endothermic animals(2). The use of multiple, distinct molecules to respond to a given temperature, as observed here, may facilitate independent tuning of an animal's distinct thermosensory responses.	[Ni, Lina; Bronk, Peter; Chang, Elaine C.; Lowell, April M.; Flam, Juliette O.; Panzano, Vincent C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Ni, Lina; Bronk, Peter; Chang, Elaine C.; Lowell, April M.; Flam, Juliette O.; Panzano, Vincent C.; Griffith, Leslie C.; Garrity, Paul A.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Theobald, Douglas L.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University	Garrity, PA (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA.	pgarrity@brandeis.edu	Theobald, Douglas L/F-3514-2013	Theobald, Douglas L/0000-0002-2695-8343; Garrity, Paul/0000-0002-8274-6564; Griffith, Leslie/0000-0003-3164-9876	National Institute of Mental Health (NIMH) [EUREKA R01 MH094721]; National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS044232]; National Science Foundation [IOS-1025307]; National Institute of General Medical Sciences (NIGMS) [R01 GM054408]; NIMH [R01 MH067284]; NIGMS [R01 GM094468]; NINDS National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094468, R01GM096053, P01GM103770, T32GM007122, R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284, R01MH094721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Garrity laboratory, C. B. Chien, L. Huang, R. Huey, E. Marder and G. Turrigiano for comments, H. Amrein, Y. Jan, C. Montell, C. Zuker and Bloomington Stock Center for strains, N. Donelson, M. Klein, A. Samuel, T. Lauer, P. Taneja, S. Nelson, Y. Yu, H. Bell, P. Sengupta, F. Baier and L. Vosshall for assistance. Supported by grants from National Institute of Mental Health (NIMH) (EUREKA R01 MH094721), National Institute of Neurological Disorders and Stroke (NINDS) (PO1 NS044232) and National Science Foundation (IOS-1025307) to P. A. G., National Institute of General Medical Sciences (NIGMS) (R01 GM054408) and NIMH (R01 MH067284) to L. C. G., NIGMS (R01 GM094468) to D. L. T. and NINDS National Research Service Award to V.C.P.	Bernstein JG, 2012, CURR OPIN NEUROBIOL, V22, P61, DOI 10.1016/j.conb.2011.10.023; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Flouris AD, 2011, EUR J APPL PHYSIOL, V111, P1, DOI 10.1007/s00421-010-1602-8; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Gingl E, 2005, J NEUROPHYSIOL, V94, P176, DOI 10.1152/jn.01164.2004; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Redelings BD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-40; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Silbering AF, 2010, EMBO REP, V11, P173, DOI 10.1038/embor.2010.8; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	31	135	139	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					580	+		10.1038/nature12390	http://dx.doi.org/10.1038/nature12390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23925112	Green Accepted			2022-12-28	WOS:000323625900035
J	Ravichandran, B				Ravichandran, Balaji			MEDICINE AND THE MEDIA Smoke screen: Indian film and television's anti-tobacco obsession	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												balaji.ravichandran@mod-langs.ox.ac.uk						[Anonymous], 2009, INDIAN EXPRESS; [Anonymous], 2012, ZEE NEWS        0216; Arora M, 2012, TOB CONTROL, V21, P482, DOI 10.1136/tc.2011.043539; Bhaumik S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2608; Dhar A, 2011, HINDU           1111; Mudur G, 2007, BRIT MED J, V335, P366, DOI 10.1136/bmj.39314.582917.DB; National Drug Dependence Treatment Center (NDDTC), ALC WEB IND REG LEG; Phartiyal S, 2013, REUTERS INDIA   0530; SHARMA R, 2001, BMJ-BRIT MED J, V323, P1149; Sinha K., 2012, TIMES INDIA; Verma S, 2012, DAILY MAIL INDI 0502	11	3	3	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2013	347								f5258	10.1136/bmj.f5258	http://dx.doi.org/10.1136/bmj.f5258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207TC	23974640				2022-12-28	WOS:000323625800007
J	Seymour, PA; Serup, P				Seymour, Philip A.; Serup, Palle			Bulking Up on Beta Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSULIN-RESISTANCE	<p id="p002">Finding a way to boost the numbers of pancreatic insulin-secreting beta cells is a major goal of diabetes research. A step toward this goal is the recent identification of a hormone secreted by the liver and by white fat that induces the beta cell to proliferate. <p id="p003">Current diabetes therapies provide suboptimal glycemic control, fueling efforts to develop strategies to restore the functional mass of insulin-secreting beta cells in the pancreases of patients with diabetes. This feat can be accomplished either by halting or slowing the death of beta cells or by increasing their proliferation. The adaptive proliferation of adult beta cells is possible in response to increased insulin resistance (e.g., during pregnancy(1) or as a consequence of inhibiting insulin signaling in the liver(2)), but the proliferative response is modest. <p id="p004">Now, Yi et al.(3) describe a hormone that increases beta-cell proliferation by a factor far greater ...	[Seymour, Philip A.; Serup, Palle] Univ Copenhagen, Danish Stem Cell Ctr, Copenhagen, Denmark	University of Copenhagen	Seymour, PA (corresponding author), Univ Copenhagen, Danish Stem Cell Ctr, Copenhagen, Denmark.		Serup, Palle/A-7407-2011	Serup, Palle/0000-0002-0858-590X; Seymour, Philip/0000-0001-5782-6020	Novo Nordisk Foundation Section for Basic Stem Cell Biology [Serup Group NNF] Funding Source: researchfish	Novo Nordisk Foundation Section for Basic Stem Cell Biology		Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008	5	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					777	779		10.1056/NEJMcibr1307038	http://dx.doi.org/10.1056/NEJMcibr1307038			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964941				2022-12-28	WOS:000323349300016
J	Fahami, R				Fahami, Radia			10-MINUTE CONSULTATION Abnormal vaginal discharge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									East Pk Rd Practice, Leicester LE5 5FD, Leics, England		Fahami, R (corresponding author), East Pk Rd Practice, Leicester LE5 5FD, Leics, England.	r.fahami@gmail.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2013	347								f4975	10.1136/bmj.f4975	http://dx.doi.org/10.1136/bmj.f4975			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203XY	23943752				2022-12-28	WOS:000323329300019
J	Roukos, V; Voss, TC; Schmidt, CK; Lee, S; Wangsa, D; Misteli, T				Roukos, Vassilis; Voss, Ty C.; Schmidt, Christine K.; Lee, Seungtaek; Wangsa, Darawalee; Misteli, Tom			Spatial Dynamics of Chromosome Translocations in Living Cells	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; DNA-PKCS; MOBILITY; RECOMBINATION; REPAIR	Chromosome translocations are a hallmark of cancer cells. We have developed an experimental system to visualize the formation of translocations in living cells and apply it to characterize the spatial and dynamic properties of translocation formation. We demonstrate that translocations form within hours of the occurrence of double-strand breaks (DSBs) and that their formation is cell cycle-independent. Translocations form preferentially between prepositioned genome elements, and perturbation of key factors of the DNA repair machinery uncouples DSB pairing from translocation formation. These observations generate a spatiotemporal framework for the formation of translocations in living cells.	[Roukos, Vassilis; Schmidt, Christine K.; Misteli, Tom] NCI, Bethesda, MD 20892 USA; [Voss, Ty C.] NCI, High Throughput Imaging Facil, Bethesda, MD 20892 USA; [Lee, Seungtaek] PerkinElmer Hlth Sci Inc, Waltham, MA 02451 USA; [Wangsa, Darawalee] NCI, Genet Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Roukos, Vassilis/K-6248-2012; Roukos, Vassilis/AAC-4827-2020; Schmidt, Christine/AAF-2625-2021	Schmidt, Christine/0000-0002-8363-7933; Roukos, Vassilis/0000-0002-5065-3937	National Institutes of Health (NIH), NCI, Center for Cancer Research; EMBO; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Tsukamoto, M. Jasin, E. Heard, D. Jullien, and M. Dundr for reagents; B. J. Taylor, S. Banerjee, J. Simone, and K. McKinnon for help with FACS experiments; T. Karpova (NCI Fluorescence Imaging Microscopy Facility) for help with microscopy; and T. Ried and K. Meaburn for expertise with SKY analysis and FISH. This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research, and by an EMBO long-term fellowship (C. K. S.). We dedicate this work to the memory of Dr. Michael Potter, NCI, a giant in the field of chromosome translocations.	Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Weinstock David M, 2007, Nat Cell Biol, V9, P978	16	195	201	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					660	664		10.1126/science.1237150	http://dx.doi.org/10.1126/science.1237150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929981	Green Accepted			2022-12-28	WOS:000322884800040
J	Bhatt, AS; Freeman, SS; Herrera, AF; Pedamallu, CS; Gevers, D; Duke, F; Jung, J; Michaud, M; Walker, BJ; Young, S; Earl, AM; Kostic, AD; Ojesina, AI; Hasserjian, R; Ballen, KK; Chen, YB; Hobbs, G; Antin, JH; Soiffer, RJ; Baden, LR; Garrett, WS; Hornick, JL; Marty, FM; Meyerson, M				Bhatt, Ami S.; Freeman, Samuel S.; Herrera, Alex F.; Pedamallu, Chandra Sekhar; Gevers, Dirk; Duke, Fujiko; Jung, Joonil; Michaud, Monia; Walker, Bruce J.; Young, Sarah; Earl, Ashlee M.; Kostic, Aleksander D.; Ojesina, Akinyemi I.; Hasserjian, Robert; Ballen, Karen K.; Chen, Yi-Bin; Hobbs, Gabriela; Antin, Joseph H.; Soiffer, Robert J.; Baden, Lindsey R.; Garrett, Wendy S.; Hornick, Jason L.; Marty, Francisco M.; Meyerson, Matthew			Sequence-Based Discovery of Bradyrhizobium enterica in Cord Colitis Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-SITU HYBRIDIZATION; BONE-MARROW; HEPATIC COMPLICATIONS; CELL; BLOOD; IDENTIFICATION; NITROIMIDAZOLES; METRONIDAZOLE; SEARCH; ADULTS	BACKGROUND Immunosuppression is associated with a variety of idiopathic clinical syndromes that may have infectious causes. It has been hypothesized that the cord colitis syndrome, a complication of umbilical-cord hematopoietic stem-cell transplantation, is infectious in origin. METHODS We performed shotgun DNA sequencing on four archived, paraffin-embedded endoscopic colon-biopsy specimens obtained from two patients with cord colitis. Computational subtraction of human and known microbial sequences and assembly of residual sequences into a bacterial draft genome were performed. We used polymerase-chain-reaction (PCR) assays and fluorescence in situ hybridization to determine whether the corresponding bacterium was present in additional patients and controls. RESULTS DNA sequencing of the biopsy specimens revealed more than 2.5 million sequencing reads that did not match known organisms. These sequences were computationally assembled into a 7.65-Mb draft genome showing a high degree of homology with genomes of bacteria in the bradyrhizobium genus. The corresponding newly discovered bacterium was provisionally named Bradyrhizobium enterica. PCR identified B. enterica nucleotide sequences in biopsy specimens from all three additional patients with cord colitis whose samples were tested, whereas B. enterica sequences were absent in samples obtained from healthy controls and patients with colon cancer or graft-versus-host disease. CONCLUSIONS We assembled a novel bacterial draft genome from the direct sequencing of tissue specimens from patients with cord colitis. Association of these sequences with cord colitis suggests that B. enterica may be an opportunistic human pathogen.	[Bhatt, Ami S.; Herrera, Alex F.; Pedamallu, Chandra Sekhar; Duke, Fujiko; Kostic, Aleksander D.; Ojesina, Akinyemi I.; Antin, Joseph H.; Soiffer, Robert J.; Baden, Lindsey R.; Garrett, Wendy S.; Marty, Francisco M.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Michaud, Monia; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hasserjian, Robert; Ballen, Karen K.; Chen, Yi-Bin] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Baden, Lindsey R.; Marty, Francisco M.] Brigham & Womens Hosp, Dept Internal Med, Div Infect Dis, Boston, MA 02115 USA; [Hornick, Jason L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bhatt, Ami S.; Freeman, Samuel S.; Pedamallu, Chandra Sekhar; Gevers, Dirk; Duke, Fujiko; Jung, Joonil; Walker, Bruce J.; Young, Sarah; Earl, Ashlee M.; Kostic, Aleksander D.; Ojesina, Akinyemi I.; Garrett, Wendy S.; Meyerson, Matthew] Broad Inst, Cambridge, MA USA; [Hobbs, Gabriela] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center	Meyerson, M (corresponding author), 450 Brookline Ave, Boston, MA 02215 USA.	matthew_meyerson@dfci.harvard.edu	Gevers, Dirk/C-1451-2009; Marty, Francisco M./H-7088-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Pedamallu, Chandra Sekhar/AAV-6723-2020	Marty, Francisco M./0000-0002-3708-8734; Bhatt, Ami/0000-0001-8099-2975; Earl, Ashlee/0000-0001-7857-9145; Garrett, Wendy/0000-0002-5092-0150; Kostic, Aleksandar/0000-0002-0837-4360; Hobbs, Gabriela/0000-0002-0199-9333; Freeman, Samuel/0000-0001-8285-0057; Meyerson, Matthew/0000-0002-9133-8108; Hornick, Jason/0000-0001-6475-8345; Ojesina, Akinyemi/0000-0003-0755-3639	National Cancer Institute; American Association for Cancer Research; American Society for Blood and Marrow Transplantation; Bladder Cancer Advocacy Network; Starr Cancer Consortium; National Cancer Institute [RC2CA148317]; NATIONAL CANCER INSTITUTE [RC2CA148317, R01CA183559, T32CA009172, R01CA154426] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Association for Cancer Research; American Society for Blood and Marrow Transplantation; Bladder Cancer Advocacy Network; Starr Cancer Consortium; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and others.; Supported by grants from the American Association for Cancer Research, the American Society for Blood and Marrow Transplantation, and the Bladder Cancer Advocacy Network (all to Dr. Bhatt); and by grants from the Starr Cancer Consortium and National Cancer Institute (RC2CA148317) (both to Dr. Meyerson).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Cid J, 2011, NEW ENGL J MED, V365, P2336, DOI 10.1056/NEJMc1111264; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; EDWARDS DI, 1986, BIOCHEM PHARMACOL, V35, P53, DOI 10.1016/0006-2952(86)90554-X; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; GOBER JW, 1989, APPL ENVIRON MICROB, V55, P1420, DOI 10.1128/AEM.55.6.1420-1425.1989; Herrera AF, 2011, NEW ENGL J MED, V365, P815, DOI 10.1056/NEJMoa1104959; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jjemba PK, 2002, CHEMOSPHERE, V46, P1019, DOI 10.1016/S0045-6535(01)00139-4; Kaneko T, 2002, DNA RES, V9, P225, DOI 10.1093/dnares/9.6.225; KELLEY BC, 1981, ARCH MICROBIOL, V129, P344, DOI 10.1007/BF00406459; Klein AK, 2001, BIOL BLOOD MARROW TR, V7, P454, DOI 10.1016/S1083-8791(01)80013-6; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P770, DOI 10.1016/0016-5085(86)91137-6; MCDONALD GB, 1986, GASTROENTEROLOGY, V90, P460, DOI 10.1016/0016-5085(86)90949-2; MULLER M, 1986, BIOCHEM PHARMACOL, V35, P37, DOI 10.1016/0006-2952(86)90552-6; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Schulenburg A, 2004, ANN HEMATOL, V83, P101, DOI 10.1007/s00277-003-0756-4; Swidsinski A, 2006, INFLAMM BOWEL DIS, V12, P824, DOI 10.1097/00054725-200608000-00018; Swidsinski A, 2005, WORLD J GASTROENTERO, V11, P1131, DOI 10.3748/wjg.v11.i8.1131; Tanaka Y, 2001, J INFECT DIS, V183, P359, DOI 10.1086/318091; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; van Kraaij MGJ, 2000, BONE MARROW TRANSPL, V26, P299, DOI 10.1038/sj.bmt.1702484; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	36	86	91	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					517	528		10.1056/NEJMoa1211115	http://dx.doi.org/10.1056/NEJMoa1211115			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924002	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000322842000008
J	Elster, EA; Butler, FK; Rasmussen, TE				Elster, Eric A.; Butler, Frank K.; Rasmussen, Todd E.			Implications of Combat Casualty Care for Mass Casualty Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; DEATH		[Elster, Eric A.; Rasmussen, Todd E.] Uniformed Serv Univ Hlth Sci, Norman M Rich Dept Surg, Bethesda, MD 20814 USA; [Elster, Eric A.] Naval Med Res Ctr, Silver Spring, MD USA; [Butler, Frank K.; Rasmussen, Todd E.] US Army Inst Surg Res, Joint Base San Antonio, Ft Sam Houston, TX USA	Uniformed Services University of the Health Sciences - USA; Naval Medical Research Center (NMRC); United States Department of Defense; United States Army	Elster, EA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	eric.elster@usuhs.edu	Elster, Eric/ABG-6091-2021; Rasmussen, Todd/Y-2122-2019	Rasmussen, Todd/0000-0003-1120-4116; Elster, Eric/0000-0002-0981-2748				Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Mabry RL, 2012, J TRAUMA ACUTE CARE, V73, pS32, DOI 10.1097/TA.0b013e3182606001; Morrison JJ, 2013, ANN SURG, V257, P330, DOI 10.1097/SLA.0b013e31827eefcf; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Propper BW, 2009, ANN SURG, V250, P311, DOI 10.1097/SLA.0b013e3181ae34a2; Timbie JW, 2012, AHRQ PUBLICATION 12, V12-E006-EF	9	40	40	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					475	476		10.1001/jama.2013.167481	http://dx.doi.org/10.1001/jama.2013.167481			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925612				2022-12-28	WOS:000322786400014
J	Cao, C; Li, N; Li, X; Liu, L				Cao, Cong; Li, Ning; Li, Xia; Liu, Li			Reforming China's S&T System	SCIENCE			English	Editorial Material							PUBLISH; PERISH		[Cao, Cong] Univ Nottingham, Nottingham NG8 1BB, England; [Cao, Cong] Dalian Univ Technol, Dalian 116024, Peoples R China; [Li, Ning] Univ Guam, Mangilao, GU 96923 USA; [Li, Ning] Chinese Acad Sci, Inst Policy & Management, Beijing 100190, Peoples R China; [Li, Xia] Shanghai Jiao Tong Univ, Shanghai 200240, Peoples R China; [Liu, Li] Tsinghua Univ, Beijing 100084, Peoples R China	University of Nottingham; Dalian University of Technology; University of Guam; Chinese Academy of Sciences; CAS Institutes of Science & Development; Shanghai Jiao Tong University; Tsinghua University	Cao, C (corresponding author), Univ Nottingham, Nottingham NG8 1BB, England.	cong.cao@nottingham.ac.uk	Cao, Cong/U-1847-2019	Li, Ning/0000-0002-2699-4563; Cao, Cong/0000-0002-3407-7837				Alberts B, 2013, SCIENCE, V340, P787, DOI 10.1126/science.1240319; [Anonymous], 2008, OECD REV INN POL CHI; Benner M, 2012, SCI PUBL POLICY, V39, P258, DOI 10.1093/scipol/scs006; Cao Cong, 2004, CHINA INT J, V2, P262; Ding YM, 2001, SCIENCE, V291, P1477; Ghafele R., 2012, POLICY RES WORKING S, V6143; Hu Jintao, COMMUNICATION; Hu Jintao, 18 NAT C COMM PART C; *IDRC, 1997, DEC REF SCI TECHN PO; International Evaluation Committee, 2011, INT EV FUND MAN NAT; Lieberthal Kenneth, 1988, POLICY MAKING CHINA; Ministry of Housing and Urban Rural Development, 2012, COD DES URB ROAD ENG, P4; Nature, 2006, NATURE, V441, P785; Neal Homer A., 2008, SPUTNIK US SCI POLIC, P25; Qiu J, 2010, NATURE, V463, P142, DOI 10.1038/463142a; Rao Yi, 2004, NATURE S, V432, pA12; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916; Xue L, 1997, J ENG TECHNOL MANAGE, V14, P67, DOI 10.1016/S0923-4748(97)00002-7	18	61	67	2	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					460	462		10.1126/science.1234206	http://dx.doi.org/10.1126/science.1234206			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	193UJ	23908209				2022-12-28	WOS:000322586700023
J	Norris, RD; Turner, SK; Hull, PM; Ridgwell, A				Norris, R. D.; Turner, S. Kirtland; Hull, P. M.; Ridgwell, A.			Marine Ecosystem Responses to Cenozoic Global Change	SCIENCE			English	Review							EOCENE THERMAL MAXIMUM; CLIMATE-CHANGE; CARBON-DIOXIDE; PACIFIC-OCEAN; DEEP-SEA; EVOLUTION; PRODUCTIVITY; TEMPERATURE; GREENHOUSE; RECORD	The future impacts of anthropogenic global change on marine ecosystems are highly uncertain, but insights can be gained from past intervals of high atmospheric carbon dioxide partial pressure. The long-term geological record reveals an early Cenozoic warm climate that supported smaller polar ecosystems, few coral-algal reefs, expanded shallow-water platforms, longer food chains with less energy for top predators, and a less oxygenated ocean than today. The closest analogs for our likely future are climate transients, 10,000 to 200,000 years in duration, that occurred during the long early Cenozoic interval of elevated warmth. Although the future ocean will begin to resemble the past greenhouse world, it will retain elements of the present "icehouse" world long into the future. Changing temperatures and ocean acidification, together with rising sea level and shifts in ocean productivity, will keep marine ecosystems in a state of continuous change for 100,000 years.	[Norris, R. D.; Turner, S. Kirtland] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Hull, P. M.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Ridgwell, A.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; Yale University; University of Bristol	Norris, RD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	rnorris@ucsd.edu	Ridgwell, Andy/AAD-9487-2021	Ridgwell, Andy/0000-0003-2333-0128; Kirtland Turner, Sandra/0000-0002-3606-5071	NERC [NE/H023852/1] Funding Source: UKRI; Natural Environment Research Council [NE/H023852/1] Funding Source: researchfish; Office Of Internatl Science &Engineering [1159100] Funding Source: National Science Foundation	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))		Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Backman J, 2009, CENT EUR J GEOSCI, V1, P157, DOI 10.2478/v10085-009-0015-6; Bains S, 2000, NATURE, V407, P171, DOI 10.1038/35025035; Bains S, 1999, SCIENCE, V285, P724, DOI 10.1126/science.285.5428.724; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; Berger WH, 2007, DEEP-SEA RES PT II, V54, P2399, DOI 10.1016/j.dsr2.2007.07.024; BERGER WH, 1968, J MAR RES, V26, P134; Boersma A, 1989, PALEOCEANOGRAPHY, V4, P271, DOI 10.1029/PA004i003p00271; Bowen GJ, 2010, NAT GEOSCI, V3, P866, DOI 10.1038/NGEO1014; Bown P, 2009, MAR MICROPALEONTOL, V71, P60, DOI 10.1016/j.marmicro.2009.01.005; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; Cao L, 2009, BIOGEOSCIENCES, V6, P375, DOI 10.5194/bg-6-375-2009; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Cowman PF, 2009, MOL PHYLOGENET EVOL, V52, P621, DOI 10.1016/j.ympev.2009.05.015; Coxall HK, 2007, PALEOBIOLOGY, V33, P495, DOI 10.1666/06034.1; Cramer BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007255; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dunkley Jones T, 2010, PHILOS T R SOC A, V368, P2395, DOI 10.1098/rsta.2010.0053; Edgar KM, 2013, GEOLOGY, V41, P15, DOI 10.1130/G33388.1; Faul KL, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001916; Foster LC, 2013, P NATL ACAD SCI USA, V110, P9273, DOI 10.1073/pnas.1300579110; Fulton TL, 2010, P ROY SOC B-BIOL SCI, V277, P1065, DOI 10.1098/rspb.2009.1783; Gibbs SJ, 2012, BIOGEOSCIENCES, V9, P4679, DOI 10.5194/bg-9-4679-2012; Gibbs SJ, 2013, NAT GEOSCI, V6, P218, DOI 10.1038/ngeo1719; Gibbs SJ, 2006, GEOLOGY, V34, P233, DOI 10.1130/G22381.1; Graham MH, 2003, TRENDS ECOL EVOL, V18, P33, DOI 10.1016/S0169-5347(02)00006-X; Gussone N, 2004, EARTH PLANET SC LETT, V227, P201, DOI 10.1016/j.epsl.2004.09.004; Hallock P, 2005, SEDIMENT GEOL, V175, P19, DOI 10.1016/j.sedgeo.2004.12.027; Haywood AM, 2011, PHILOS T R SOC A, V369, P933, DOI 10.1098/rsta.2010.0317; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Hilting AK, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001458; Hollis CJ, 2012, EARTH PLANET SC LETT, V349, P53, DOI 10.1016/j.epsl.2012.06.024; Hollis CJ, 2009, GEOLOGY, V37, P99, DOI 10.1130/G25200A.1; Houben AJP, 2013, SCIENCE, V340, P341, DOI 10.1126/science.1223646; Hull PM, 2011, EARTH PLANET SC LETT, V301, P98, DOI 10.1016/j.epsl.2010.10.031; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Kaiho K, 1998, GEOLOGY, V26, P491, DOI 10.1130/0091-7613(1998)026<0491:GCFODS>2.3.CO;2; Keller G, 2009, PALAEOGEOGR PALAEOCL, V284, P47, DOI 10.1016/j.palaeo.2009.08.029; Kelly DC, 2012, MAR GEOL, V303, P75, DOI 10.1016/j.margeo.2012.02.003; Kelly DC, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001163; Kirwan ML, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036050; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Langer MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054443; Leon-Rodriguez L, 2010, PALAEOGEOGR PALAEOCL, V298, P409, DOI 10.1016/j.palaeo.2010.10.029; Li L, 2011, EARTH PLANET SC LETT, V309, P10, DOI 10.1016/j.epsl.2011.04.016; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lyle AO, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001230; Lyle M, 2008, REV GEOPHYS, V46, DOI 10.1029/2005RG000190; Marx FG, 2011, J MAMM EVOL, V18, P77, DOI 10.1007/s10914-010-9148-4; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Norris RD, 2012, EVOL ECOL, V26, P393, DOI 10.1007/s10682-011-9488-4; Palike H, 2012, NATURE, V488, P609, DOI 10.1038/nature11360; Pagani M, 2006, NATURE, V442, P671, DOI 10.1038/nature05043; Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; Payros A, 2010, SEDIMENT GEOL, V228, P184, DOI 10.1016/j.sedgeo.2010.04.010; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pereira SL, 2008, MOL PHYLOGENET EVOL, V46, P430, DOI 10.1016/j.ympev.2007.11.020; Perrin C, 2010, SPEC PUBL INT ASS SE, V42, P17; Polovina JJ, 2012, DEEP-SEA RES PT II, V77-80, P82, DOI 10.1016/j.dsr2.2012.04.006; Pross J, 2012, NATURE, V488, P73, DOI 10.1038/nature11300; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P87, DOI 10.5194/bg-4-87-2007; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Ridgwell A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001372; Robinson SA, 2011, GEOLOGY, V39, P51, DOI 10.1130/G31422.1; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Rohling EJ, 2010, EARTH PLANET SC LETT, V291, P97, DOI 10.1016/j.epsl.2009.12.054; Salamy KA, 1999, PALAEOGEOGR PALAEOCL, V145, P61, DOI 10.1016/S0031-0182(98)00093-5; Santini F., 2013, ITAL J ZOOL, V80, P1; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Siddall M, 2010, J QUATERNARY SCI, V25, P19, DOI 10.1002/jqs.1270; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Sommer U, 2002, HYDROBIOLOGIA, V484, P11, DOI 10.1023/A:1021340601986; Speijer RP, 2012, AUSTRIAN J EARTH SCI, V105, P6; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Steinke S, 2010, PALAEOGEOGR PALAEOCL, V289, P33, DOI 10.1016/j.palaeo.2010.02.007; Stoll HM, 2007, EARTH PLANET SC LETT, V258, P192, DOI 10.1016/j.epsl.2007.03.037; Takayanagi H, 2012, GEODIVERSITAS, V34, P189, DOI 10.5252/g2012n1a11; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Wilson Moyra E. J., 1998, P165; Winguth AME, 2012, GEOLOGY, V40, P263, DOI 10.1130/G32529.1; Yamaguchi T, 2012, PALAEOGEOGR PALAEOCL, V346, P130, DOI 10.1016/j.palaeo.2012.06.004; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zamagni J, 2012, PALAEOGEOGR PALAEOCL, V317, P48, DOI 10.1016/j.palaeo.2011.12.010	102	103	105	23	461	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					492	498		10.1126/science.1240543	http://dx.doi.org/10.1126/science.1240543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908226				2022-12-28	WOS:000322586700040
J	Loy, CT; Schofield, PR; Turner, AM; Kwok, JBJ				Loy, Clement T.; Schofield, Peter R.; Turner, Anne M.; Kwok, John B. J.			Genetics of dementia	LANCET			English	Review							FAMILIAL ALZHEIMERS-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HEXANUCLEOTIDE REPEAT EXPANSION; PRECURSOR PROTEIN GENES; HUNTINGTONS-DISEASE; PRION DISEASE; TRINUCLEOTIDE REPEAT; MOLECULAR DIAGNOSIS; MISSENSE MUTATIONS	25% of all people aged 55 years and older have a family history of dementia. For most, the family history is due to genetically complex disease, where many genetic variations of small effect interact to increase risk of dementia. The lifetime risk of dementia for these families is about 20%, compared with 10% in the general population. A small proportion of families have an autosomal dominant family history of early-onset dementia, which is often due to mendelian disease, caused by a mutation in one of the dementia genes. Each family member has a 50% chance of inheriting the mutation, which confers a lifetime dementia risk of over 95%. In this Review, we focus on the evidence for, and the approach to, genetic testing in Alzheimer's disease (APP, PSEN1, and PSEN2 genes), frontotemporal dementia (MAPT, GRN, C9ORF72, and other genes), and other familial dementias. We conclude by discussing the practical aspects of genetic counselling.	[Loy, Clement T.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Loy, Clement T.; Schofield, Peter R.; Kwok, John B. J.] Neurosci Res Australia, Randwick, NSW 2031, Australia; [Loy, Clement T.] Westmead Hosp, Huntington Dis Serv, Westmead, NSW 2145, Australia; [Schofield, Peter R.; Kwok, John B. J.] Univ New S Wales, Kensington, NSW 2033, Australia; [Turner, Anne M.] Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW, Australia	University of Sydney; Neuroscience Research Australia; University of Sydney; University of New South Wales Sydney	Kwok, JBJ (corresponding author), Neurosci Res Australia, Barker St, Randwick, NSW 2031, Australia.	j.kwok@neura.edu.au	; Schofield, Peter/C-9669-2011	Kwok, John/0000-0001-9574-6195; Schofield, Peter/0000-0003-2967-9662	National Health and Medical Research Council (NHMRC); NHMRC [510218]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	CTL was supported by a National Health and Medical Research Council (NHMRC) Translating Research into Practice Fellowship. JBJK was supported by the NHMRC Project Grant No. 510218. NHMRC had no role in the writing of the manuscript or the decision to submit it for publication. We thank Glenda Halliday and Michael Hornberger for the images in figure 3, and Elizabeth McCusker and Sally-Anne Duke for their comments on the manuscript.	Adib-Samii P, 2010, STROKE, V41, P630, DOI 10.1161/STROKEAHA.109.568402; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Alzheimer's Association, 2013, SEARCH ALZH CAUS RIS; Alzheimer's Disease International, 2009, WORLD ALZHEIMER REPO; Alzheimer's Society, SUPP FAM ALZH DIS; Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; BARBER R, 1995, J NEUROL NEUROSUR PS, V59, P61, DOI 10.1136/jnnp.59.1.61; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bennett J, 2011, SEMIN LIVER DIS, V31, P233, DOI 10.1055/s-0031-1286054; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Blair IP, 2010, J NEUROL NEUROSUR PS, V81, P639, DOI 10.1136/jnnp.2009.194399; Bonifati V, 2008, CURR NEUROL NEUROSCI, V8, P187, DOI 10.1007/s11910-008-0030-1; Borroni B, 2010, REJUV RES, V13, P509, DOI 10.1089/rej.2010.1017; Boxer AL, 2007, NEUROLOGY, V69, P283, DOI 10.1212/01.wnl.0000265815.38958.b6; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Chen-Plotkin AS, 2011, ARCH NEUROL-CHICAGO, V68, P488, DOI 10.1001/archneurol.2011.53; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Cohn-Hokke PE, 2012, AM J MED GENET B, V159B, P628, DOI 10.1002/ajmg.b.32080; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M., 2012, ALZHEIMER DIS FRONTO; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Di Rocco M, 2004, AM J MED GENET B, V129B, P85, DOI 10.1002/ajmg.b.30029; Dobson-Stone C, 2012, NEUROLOGY, V79, P995, DOI 10.1212/WNL.0b013e3182684634; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gadjusek DC, 1972, AM J HUM GENET, V24, pS1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Godbolt AK, 2004, ARCH NEUROL-CHICAGO, V61, P1743, DOI 10.1001/archneur.61.11.1743; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goldman JS, 2011, NEUROLOGY, V76, P475, DOI 10.1212/WNL.0b013e31820a0d13; Goldman JS, 2011, GENET MED, V13, P597, DOI 10.1097/GIM.0b013e31821d69b8; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.009; Guerreiro RJ, 2010, NEUROBIOL AGING, V31, P725, DOI 10.1016/j.neurobiolaging.2008.06.012; Halliday GM, 2005, ANN NEUROL, V57, P139, DOI 10.1002/ana.20366; Harding AJ, 2004, AM J MED GENET B, V128B, P118, DOI 10.1002/ajmg.b.30014; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; Henry ML, 2010, CURR OPIN NEUROL, V23, P633, DOI 10.1097/WCO.0b013e32833fb93e; Herve D, 2010, J GERIATR PSYCH NEUR, V23, P269, DOI 10.1177/0891988710383570; HGMIS, GEN DIS INF PRONT; Hodges JR, 2010, BRAIN, V133, P300, DOI 10.1093/brain/awp248; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20203; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kanazawa I, 1998, NEUROGENETICS, V2, P1, DOI 10.1007/s100480050046; Karlstrom H, 2008, J NEUROCHEM, V104, P573, DOI 10.1111/j.1471-4159.2007.05038.x; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Le Pira F, 2002, J NEUROL SCI, V201, P53, DOI 10.1016/S0022-510X(02)00194-6; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lifton RP, 2010, NEW ENGL J MED, V362, P1235, DOI 10.1056/NEJMe1001090; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Lleo A, 2002, ARCH NEUROL-CHICAGO, V59, P1759, DOI 10.1001/archneur.59.11.1759; Loy CT, 2010, BRAIN, V133, DOI 10.1093/brain/awq186; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; MACMILLAN JC, 1991, ANN NEUROL, V30, P411, DOI 10.1002/ana.410300314; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Maruff P, 1996, ANN NEUROL, V40, P421, DOI 10.1002/ana.410400311; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Menendez M, 2004, J ALZHEIMERS DIS, V6, P475; Merwick A, 2012, EPILEPSIA, V53, P81, DOI 10.1111/j.1528-1167.2012.03617.x; Montenegro G, 2011, ANN NEUROL, V69, P464, DOI 10.1002/ana.22235; Moscarillo TJ, 2007, COMMUNITY GENET, V10, P97, DOI 10.1159/000099087; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nervi A, 2011, ARCH NEUROL-CHICAGO, V68, P90, DOI 10.1001/archneurol.2010.319; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulson HL, 2011, SEMIN NEUROL, V31, P449, DOI 10.1055/s-0031-1299784; Pearson JP, 2011, J NEUROL, V258, P647, DOI 10.1007/s00415-010-5815-x; Perez-Poyato MS, 2011, CURR PHARM BIOTECHNO, V12, P897, DOI 1389-2010/11 $58.00+.00; Pericak-Vance MA, 2002, GENETIC BASIS COMMON, P818; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Racette BA, 1998, J NEUROL NEUROSUR PS, V65, P577, DOI 10.1136/jnnp.65.4.577; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Rascovsky K, 2007, ALZ DIS ASSOC DIS, V21, pS14, DOI 10.1097/WAD.0b013e31815c3445; Raux G, 2005, J MED GENET, V42, P793, DOI 10.1136/jmg.2005.033456; Razvi SSM, 2005, J NEUROL NEUROSUR PS, V76, P739, DOI 10.1136/jnnp.2004.051847; Reid WGJ, 2011, J NEUROL NEUROSUR PS, V82, P1033, DOI 10.1136/jnnp.2010.232678; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rockwood K, 1998, Int Psychogeriatr, V10, P53, DOI 10.1017/S1041610298005146; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rohrer JD, 2011, CURR OPIN NEUROL, V24, P542, DOI 10.1097/WCO.0b013e32834cd442; Roks G, 2000, BRAIN, V123, P2130, DOI 10.1093/brain/123.10.2130; Rossor MN, 2010, LANCET NEUROL, V9, P793, DOI 10.1016/S1474-4422(10)70159-9; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Ryan NS, 2010, BIOMARK MED, V4, P99, DOI 10.2217/BMM.09.92; Sajjadi SA, 2012, NEUROLOGY, V78, P1670, DOI 10.1212/WNL.0b013e3182574f79; Schneider SA, 2007, NAT CLIN PRACT NEURO, V3, P517, DOI 10.1038/ncpneuro0606; See TM, 2010, J GERIATR PSYCH NEUR, V23, P260, DOI 10.1177/0891988710383574; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Seniow J, 2002, MOVEMENT DISORD, V17, P1077, DOI 10.1002/mds.10195; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Snowden JS, 2011, ACTA NEUROPATHOL, V122, P99, DOI 10.1007/s00401-011-0816-0; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541; Tanahashi H, 1996, NEUROSCI LETT, V218, P139, DOI 10.1016/S0304-3940(96)13138-4; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Teare MD, 2005, LANCET, V366, P1036, DOI 10.1016/S0140-6736(05)67382-5; University of Washington, 2012, GEN; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; Van Rij MC, 2012, EUR J HUM GENET, V20, P368, DOI 10.1038/ejhg.2011.202; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Velakoulis D, 2009, BRIT J PSYCHIAT, V194, P298, DOI 10.1192/bjp.bp.108.057034; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Ward ME, 2011, J MOL NEUROSCI, V45, P574, DOI 10.1007/s12031-011-9622-3; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; WENT L, 1994, J MED GENET, V31, P555; Whitwell JL, 2012, NAT REV NEUROL, V8, P131, DOI 10.1038/nrneurol.2012.7; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]; Zekanowski C, 2003, EXP NEUROL, V184, P991, DOI 10.1016/S0014-4886(03)00384-4	143	182	196	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					828	840		10.1016/S0140-6736(13)60630-3	http://dx.doi.org/10.1016/S0140-6736(13)60630-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	23927914				2022-12-28	WOS:000332398700030
J	Ermolaeva, MA; Segref, A; Dakhovnik, A; Ou, HL; Schneider, JI; Utermohlen, O; Hoppe, T; Schumacher, B				Ermolaeva, Maria A.; Segref, Alexandra; Dakhovnik, Alexander; Ou, Hui-Ling; Schneider, Jennifer I.; Utermoehlen, Olaf; Hoppe, Thorsten; Schumacher, Bjoern			DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; PATHWAY; ACTIVATION; EVOLUTION; INFECTION; APOPTOSIS; DAF-16	DNA damage responses have been well characterized with regard to their cell-autonomous checkpoint functions leading to cell cycle arrest, senescence and apoptosis(1). In contrast, systemic responses to tissue-specific genome instability remain poorly understood. In adult Caenorhabditis elegans worms germ cells undergo mitotic and meiotic cell divisions, whereas somatic tissues are entirely post-mitotic. Consequently, DNA damage checkpoints function specifically in the germ line(2), whereas somatic tissues in adult C. elegans are highly radio-resistant(3). Some DNA repair systems such as global-genome nucleotide excision repair (GG-NER) remove lesions specifically in germ cells(4). Here we investigated how genome instability in germ cells affects somatic tissues in C. elegans. We show that exogenous and endogenous DNA damage in germ cells evokes elevated resistance to heat and oxidative stress. The somatic stress resistance is mediated by the ERK MAP kinase MPK-1 in germ cells that triggers the induction of putative secreted peptides associated with innate immunity. The innate immune response leads to activation of the ubiquitin-proteasome system (UPS) in somatic tissues, which confers enhanced proteostasis and systemic stress resistance. We propose that elevated systemic stress resistance promotes endurance of somatic tissues to allow delay of progeny production when germ cells are genomically compromised.	[Ermolaeva, Maria A.; Segref, Alexandra; Dakhovnik, Alexander; Ou, Hui-Ling; Schneider, Jennifer I.; Hoppe, Thorsten; Schumacher, Bjoern] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Utermoehlen, Olaf] Univ Cologne, Med Ctr, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Utermoehlen, Olaf] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Schumacher, Bjoern] Univ Cologne, D-50937 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schumacher, B (corresponding author), Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Zulpicher Str 47A, D-50674 Cologne, Germany.	bjoern.schumacher@uni-koeln.de	Hoppe, Thorsten/AAC-7880-2020; Schumacher, Björn/I-4829-2013	Schumacher, Björn/0000-0001-6097-5238; Segref, Alexandra/0000-0001-8095-4469; Hoppe, Thorsten/0000-0002-4734-9352	US National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; Mitani laboratory; Deutsche Forschungsgemeinschaft (DFG) [SFB 670-TP4]; EC Network of Excellence RUBICON [LSHC-CT-2005-018683]; DFG [CECAD, FOR885, SFB635, KFO286, HO2541/4-1, SFB 829, KFO 286]; European Research Council [260383]; Marie Curie [FP7 ITN CodeAge 316354, aDDRess 316390, MARRIAGE 316964, ERG239330]; German-Israeli Foundation [GIF 2213-1935.13/2008, 1104-68.11/2010]; Deutsche Krebshilfe [109453]; BMBF (SyBaCol); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitani laboratory; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EC Network of Excellence RUBICON; DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Marie Curie(European Commission); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF (SyBaCol)(Federal Ministry of Education & Research (BMBF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Torres for technical support, P. Frommolt for advice on statistics, and A. Williams for comments on the manuscript. C. elegans strains were kindly provided by the CGC (funded by the US National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440)), and the Mitani laboratory. We thank D. Kim, F. Ausubel and V. Jantsch for strains and reagents. M. A. E. received the European Molecular Biology Organization (EMBO) long-term fellowship, A. D. received the IGS-DHD fellowship, and H.-L.O. received the CECAD fellowship. O.U. acknowledges funding from the Deutsche Forschungsgemeinschaft (DFG) (SFB 670-TP4), and T. H. from the EC Network of Excellence RUBICON (LSHC-CT-2005-018683), DFG (CECAD, FOR885, SFB635, KFO286 and HO2541/4-1). B. S. acknowledges funding from the DFG (CECAD, SFB 829 and KFO 286), European Research Council (starting grant 260383), Marie Curie (FP7 ITN CodeAge 316354, aDDRess 316390, MARRIAGE 316964 and ERG239330), German-Israeli Foundation (GIF 2213-1935.13/2008 and 1104-68.11/2010), Deutsche Krebshilfe (109453) and BMBF (SyBaCol).	Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; BRENNER S, 1974, GENETICS, V77, P71; Bush KT, 1997, J BIOL CHEM, V272, P9086; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Greiss S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-334; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iizuka M., 2009, WORLD J GASTROENTERO, V11, P1272; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; JOHNSON TE, 1988, J GERONTOL, V43, pB137, DOI 10.1093/geronj/43.5.B137; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rutkowski R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002238; Segref A, 2011, GENETICS, V187, P1235, DOI 10.1534/genetics.111.126797; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Thomas JH, 2006, GENETICS, V172, P2269, DOI 10.1534/genetics.105.052746; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Yamawaki TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000468	34	145	146	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					416	+		10.1038/nature12452	http://dx.doi.org/10.1038/nature12452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23975097	Green Accepted			2022-12-28	WOS:000324545700045
J	Zhou, WJ; Geng, ZH; Spence, JR; Geng, JG				Zhou, Wei-Jie; Geng, Zhen H.; Spence, Jason R.; Geng, Jian-Guo			Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection	NATURE			English	Article							IN-VITRO; R-SPONDIN1; CANCER; GROWTH; COLON; MICE	Cancer research has been rightly and successfully focused on prevention, early detection, and identification of specific molecular targets that distinguish the malignant cells from the neighbouring benign cells(1). However, reducing lethal tissue injury caused by intensive chemoradiotherapy during treatment of late-stage metastatic cancers remains a key clinical challenge. Here we tested whether the induction of adult stem cells could repair chemoradiation-induced tissue injury and prolong overall survival in mice. We found that intestinal stem cells (ISCs)(2) expressed Slit2 and its single-span transmembrane cell-surface receptor roundabout 1 (Robo1)(3,4). Partial genetic deletion of Robo1 decreased ISC numbers and caused villus hypotrophy, whereas a Slit2 transgene increased ISC numbers and triggered villus hypertrophy. During lethal dosages of chemoradiation, administering a short pulse of R-spondin 1 (Rspo1; a Wnt agonist)(5-14) plus Slit2 reduced ISC loss, mitigated gut impairment and protected animals from death, without concomitantly decreasing tumour sensitivity to chemotherapy. Therefore Rspo1 and Slit2 may act as therapeutic adjuvants to enhance host tolerance to aggressive chemoradiotherapy for eradicating metastatic cancers.	[Zhou, Wei-Jie; Geng, Zhen H.; Geng, Jian-Guo] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Geng, JG (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	jgeng@umich.edu		Zhou, Weijie/0000-0002-0021-9454	National Institutes of Health [CA126897]; NATIONAL CANCER INSTITUTE [R01CA126897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK091415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Ma for generating recombinant proteins, M. H. Geng for technical assistance, X. Yang for helping with the in situ hybridization and J. Connett for critical reading of the manuscript. This work was supported by a grant from the National Institutes of Health (CA126897 to J.-G.G.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Booth C, 1999, EXP CELL RES, V249, P359, DOI 10.1006/excr.1999.4483; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Duan LP, 2004, J LIPID RES, V45, P1312, DOI 10.1194/jlr.M400030-JLR200; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; MARTIN DS, 1982, CANCER RES, V42, P3964; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Phutthaphadoong S, 2010, ONCOL REP, V23, P53, DOI 10.3892/or_00000605; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Solanas G, 2011, EXP CELL RES, V317, P2695, DOI 10.1016/j.yexcr.2011.07.019; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416; Ye BQ, 2010, J IMMUNOL, V185, P6294, DOI 10.4049/jimmunol.1001648; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17	30	99	107	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					107	+		10.1038/nature12416	http://dx.doi.org/10.1038/nature12416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23903657	Green Accepted			2022-12-28	WOS:000323888300041
J	Santiago, J; Henzler, C; Hothorn, M				Santiago, Julia; Henzler, Christine; Hothorn, Michael			Molecular Mechanism for Plant Steroid Receptor Activation by Somatic Embryogenesis Co-Receptor Kinases	SCIENCE			English	Article							EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; PERCEPTION; BRASSINOSTEROIDS; COMPLEX; BRI1/BAK1; FLAGELLIN; BINDING; BAK1; BRI1	Brassinosteroids, which control plant growth and development, are sensed by the leucine-rich repeat (LRR) domain of the membrane receptor kinase BRASSINOSTEROID INSENSITIVE 1 (BRI1), but it is unknown how steroid binding at the cell surface activates the cytoplasmic kinase domain of the receptor. A family of somatic embryogenesis receptor kinases (SERKs) has been genetically implicated in mediating early brassinosteroid signaling events. We found a direct and steroid-dependent interaction between the BRI1 and SERK1 LRR domains by analysis of their complex crystal structure at 3.3 angstrom resolution. We show that the SERK1 LRR domain is involved in steroid sensing and, through receptor-co-receptor heteromerization, in the activation of the BRI1 signaling pathway. Our work reveals how known missense mutations in BRI1 and in SERKs modulate brassinosteroid signaling and the targeting mechanism of BRI1 receptor antagonists.	[Santiago, Julia; Henzler, Christine; Hothorn, Michael] Max Planck Gesell, Friedrich Miescher Lab, Struct Plant Biol Lab, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Hothorn, M (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Struct Plant Biol Lab, Spemannstr 39, D-72076 Tubingen, Germany.	mhothorn@tuebingen.mpg.de		Hothorn, Michael/0000-0002-3597-5698; Santiago, Julia/0000-0002-5765-6495	Max Planck Society; Federation of European Biochemical Societies long-term fellowship; International Human Frontier Science Program Organization Career Development Award	Max Planck Society(Max Planck Society); Federation of European Biochemical Societies long-term fellowship; International Human Frontier Science Program Organization Career Development Award(Human Frontier Science Program)	We thank Y. Jaillais and M. Jinek for comments on the manuscript, J. Martinez for help with data collection, A. Pauluhn for providing beam time and staff members of beamline PXII (Swiss Light Source, Villigen, Switzerland), Y. Jaillais for bri1<INF>sud1</INF> and GABI_13E10 transgenic lines, and M. Blazquez for bes1-1D. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 4LSA (bri1<INF>sud1</INF>), 4LSC (SERK1), and 4LSX (bri1<INF>sud1</INF>-BL-SERK1). Supported by the Max Planck Society, a Federation of European Biochemical Societies long-term fellowship (J.S.), and an International Human Frontier Science Program Organization Career Development Award (M.H.). M.H. and Joanne Chory (Salk Institute) are inventors on a patent application filed by the Salk Institute for Biological Studies entitled "Structure of the Brassinosteroid Receptor BRI1, and Modulation of BRI1 Signaling" (patent 20130007910).	Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Back TG, 2003, J PLANT GROWTH REGUL, V22, P350, DOI 10.1007/s00344-003-0057-0; Back TG, 2002, PHYTOCHEMISTRY, V59, P627, DOI 10.1016/S0031-9422(02)00019-5; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Muto T, 2013, BIOORGAN MED CHEM, V21, P4413, DOI 10.1016/j.bmc.2013.04.048; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597	31	231	246	6	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					889	892		10.1126/science.1242468	http://dx.doi.org/10.1126/science.1242468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23929946				2022-12-28	WOS:000323370600043
J	Boumil, MM; Curfman, GD				Boumil, Marcia M.; Curfman, Gregory D.			On Access and Accountability - Two Supreme Court Rulings on Generic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">In June, the U.S. Supreme Court issued two rulings regarding the marketing of generic drugs. The decisions have mixed implications for consumers, but given the size and growth rate of the industry, their impact can be expected to be substantial. <p id="p003">In June, the U.S. Supreme Court issued two rulings regarding the marketing of generic drugs that may alter the pharmaceutical business landscape. First, in Federal Trade Commission v. Actavis, the Court confronted the law governing a controversial pharmaceutical marketing practice known as reverse payment agreements, or pay for delay.(1) This practice occurs when a generic drug company identifies a vulnerable patent held by a brand-name drug manufacturer and seeks approval from the Food and Drug Administration (FDA) for a generic version before the patent expires, provoking a lawsuit for infringement. The two companies then forge a settlement whereby the brand-name ...	[Boumil, Marcia M.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Boumil, MM (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.								0	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					696	697		10.1056/NEJMp1308368	http://dx.doi.org/10.1056/NEJMp1308368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	204FA	23923990				2022-12-28	WOS:000323349300005
J	Farkas, RH; Unger, EF; Temple, R				Farkas, Ronald H.; Unger, Ellis F.; Temple, Robert			Zolpidem and Driving Impairment - Identifying Persons at Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Farkas, Ronald H.; Unger, Ellis F.; Temple, Robert] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Farkas, RH (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], FDA REQUIRES LOWER R; Colten HR, 2006, SLEEP DISORDERS SLEE	2	78	78	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					689	691		10.1056/NEJMp1307972	http://dx.doi.org/10.1056/NEJMp1307972			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23923991				2022-12-28	WOS:000323349300002
J	Mousavi, SAR; Chauvin, A; Pascaud, F; Kellenberger, S; Farmer, EE				Mousavi, Seyed A. R.; Chauvin, Adeline; Pascaud, Francois; Kellenberger, Stephan; Farmer, Edward E.			GLUTAMATE RECEPTOR-LIKE genes mediate leaf-to-leaf wound signalling	NATURE			English	Article							JASMONIC ACID; ATPASE ACTIVITY; ARABIDOPSIS; DEFENSE; PLANTS; ACCUMULATION; POTENTIALS; EXPRESSION; INDUCTION; RESPONSES	Wounded leaves communicate their damage status to one another through a poorly understood process of long-distance signalling. This stimulates the distal production of jasmonates, potent regulators of defence responses. Using non-invasive electrodes we mapped surface potential changes in Arabidopsis thaliana after wounding leaf eight and found that membrane depolarizations correlated with jasmonate signalling domains in undamaged leaves. Furthermore, current injection elicited jasmonoyl-isoleucine accumulation, resulting in a transcriptome enriched in RNAs encoding key jasmonate signalling regulators. From among 34 screened membrane protein mutant lines, mutations in several clade 3 GLUTAMATE RECEPTOR-LIKE genes (GLRs 3.2, 3.3 and 3.6) attenuated wound-induced surface potential changes. Jasmonate-response gene expression in leaves distal to wounds was reduced in a glr3.3 glr3.6 double mutant. This work provides a genetic basis for investigating mechanisms of long-distance wound signalling in plants and indicates that plant genes related to those important for synaptic activity in animals function in organ-to-organ wound signalling.	[Mousavi, Seyed A. R.; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Chauvin, Adeline] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland; [Pascaud, Francois; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne; University of Geneva; University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Farmer, Edward E/H-1635-2011; mousavi, seyyed amin ayatollahi/Q-8504-2016	mousavi, seyyed amin ayatollahi/0000-0002-5367-483X; Mousavi, Seyed Ali Reza/0000-0002-2948-1771; Kellenberger, Stephan/0000-0003-1755-6198	Faculty of Biology and Medicine Interdisciplinary grant; Swiss NSF [3100A0-122441, 31003A-138235]	Faculty of Biology and Medicine Interdisciplinary grant; Swiss NSF(Swiss National Science Foundation (SNSF))	Supported by a Faculty of Biology and Medicine Interdisciplinary grant (to S.K. and E.E.F.) and Swiss NSF grants 3100A0-122441 and 31003A-138235 (to E.E.F.). We thank I. Acosta, D. Gasperini, S. Stolz and A. Chetelat and other Farmer lab members for critical comments and/or technical help, M. Blanchard for help with electrophysiology, and the Lausanne Genomic Technologies Facility and M. Shakhsi-Niaei for help with transcriptome analyses. We thank Y. Lee and F. Mauch for rbohD seeds, P. Schweizer and P. Reymond for insect larvae, J.-L. Wolfender for analytics support, and R. Benton, C. Fankhauser, N. Geldner, C. Hardtke and Y. Poirier for valuable comments.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berberich T., 2008, HDB PLANT FUNCTIONAL, P113; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Brux A, 2008, PLANT CELL, V20, P1088, DOI 10.1105/tpc.108.058362; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Carpaneto A, 2007, PLANT PHYSIOL, V143, P487, DOI 10.1104/pp.106.090928; Chauvin A, 2013, NEW PHYTOL, V197, P566, DOI 10.1111/nph.12029; Chiu JC, 2002, MOL BIOL EVOL, V19, P1066, DOI 10.1093/oxfordjournals.molbev.a004165; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dengler NG, 2006, CAN J BOT, V84, P1660, DOI 10.1139/B06-126; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Favre P, 2007, PHYSIOL PLANTARUM, V131, P263, DOI 10.1111/j.1399-3054.2007.00954.x; Fisahn J, 2004, PLANT CELL PHYSIOL, V45, P456, DOI 10.1093/pcp/pch054; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Herde O, 1996, PLANT PHYSIOL, V112, P853, DOI 10.1104/pp.112.2.853; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kang S, 2006, MOL CELLS, V21, P418; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Kramell R, 1997, CHROMATOGRAPHIA, V45, P104, DOI 10.1007/BF02505545; Krol E, 2010, J BIOL CHEM, V285, P13471, DOI 10.1074/jbc.M109.097394; Kwaaitaal M, 2011, BIOCHEM J, V440, P355, DOI 10.1042/BJ20111112; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; MINORSKY PV, 1989, PLANT CELL ENVIRON, V12, P119, DOI 10.1111/j.1365-3040.1989.tb01924.x; Mueller MJ, 2006, PLANT J, V45, P472, DOI 10.1111/j.1365-313X.2005.02614.x; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Schaller A, 2001, PLANTA, V212, P431, DOI 10.1007/s004250000413; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stahlberg R, 2006, COMMUNICATION IN PLANTS: NEURONAL ASPECTS OF PLANT LIFE, P291; STAHLBERG R, 1994, PLANT CELL ENVIRON, V17, P1143, DOI 10.1111/j.1365-3040.1994.tb02012.x; Stephens NR, 2008, PLANT PHYSIOL, V146, P529, DOI 10.1104/pp.107.108134; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; vanWees S, 2008, COLD SPRING HARB PRO; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Walters D. R., 2011, PLANT DEFENSE; WILDON DC, 1992, NATURE, V360, P62, DOI 10.1038/360062a0; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zimmermann MR, 2009, PLANT PHYSIOL, V149, P1593, DOI 10.1104/pp.108.133884	54	441	459	17	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					422	+		10.1038/nature12478	http://dx.doi.org/10.1038/nature12478			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969459	Green Accepted, Green Submitted			2022-12-28	WOS:000323316100027
J	Palmsten, K; Hernandez-Diaz, S; Huybrechts, KF; Williams, PL; Michels, KB; Achtyes, ED; Mogun, H; Setoguchi, S				Palmsten, Kristin; Hernandez-Diaz, Sonia; Huybrechts, Krista F.; Williams, Paige L.; Michels, Karin B.; Achtyes, Eric D.; Mogun, Helen; Setoguchi, Soko			Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; MATERNAL OBESITY; OUTCOMES; DEPRESSION; PREGNANCY; PROFILE; ASSOCIATION; DULOXETINE; MORTALITY; SELECTION	Objective To determine whether use of serotonin or non-serotonin reuptake inhibitors near to delivery is associated with postpartum hemorrhage. Design Cohort study. Setting 2000-07 nationwide Medicaid data (Medicaid Analytic eXtract). Population 106 000 pregnant women aged 12-55 with a diagnosis of mood or anxiety disorder. Women were categorized into four mutually exclusive exposure groups according to pharmacy dispensing data: current (delivery date), recent (1-30 days before delivery date), past (1-5 months before delivery date), and no exposure (reference group). Main outcome measures Risk of postpartum hemorrhage by timing of exposure and by serotonin or non-serotonin reuptake inhibitors, classes of antidepressant, and antidepressant types. Relative risks and 95% confidence intervals adjusted for delivery year, risk factors for postpartum hemorrhage, indicators of severity of mood/anxiety disorder, other indications for antidepressants, and other drugs. High dimensional propensity score (hdPS) methods were used to empirically identify and adjust for additional factors. Results 12 710 (12%) women had current exposure to serotonin reuptake inhibitor monotherapy, and 1495 (1.4%) women had current exposure to non-serotonin reuptake inhibitor monotherapy. The risk of postpartum hemorrhage was 2.8% among women with mood/anxiety disorders but no exposure to antidepressants, 4.0% in the current users of serotonin reuptake inhibitors, 3.8% in the current users of non-serotonin reuptake inhibitors, 3.2% in the recent users of serotonin reuptake inhibitors, 3.1% in the recent users of non-serotonin reuptake inhibitors, 2.5% in the past users of serotonin reuptake inhibitors, and 3.4% in the past users of non-serotonin reuptake inhibitors. Compared with no exposure, women with current exposure to serotonin reuptake inhibitors had a 1.47-fold increased risk of postpartum hemorrhage (95% confidence interval 1.33 to 1.62) and women with current non-serotonin reuptake inhibitor exposure had a 1.39-fold increased risk (1.07 to 1.81). Results were similar with hdPS adjustment. Women with current exposure to serotonin reuptake inhibitors had an adjusted excess risk of 1.26% (0.90% to 1.62%), with a number needed to harm of 80, and for women with current exposure to non-serotonin reuptake inhibitors the excess risk was 1.03% (0.07% to 1.99%), with a number needed to harm of 97. For exposure to serotonin reuptake inhibitors the relative risk was 1.19 (1.03 to 1.38) for recent exposure and 0.93 (0.82 to 1.06) for past exposure; for non-serotonin reuptake inhibitors the figures were 1.17 (0.80 to 1.70) and 1.26 (1.00 to 1.59), respectively. Current exposure to selective serotonin reuptake inhibitor monotherapy was also associated with postpartum hemorrhage (1.42, 1.27 to 1.57), as was current serotonin norepinephrine (noradrenaline) reuptake inhibitor (1.90, 1.37 to 2.63) and tricyclic monotherapy (1.77, 0.90 to 3.47). All types of selective serotonin reuptake inhibitors available for analysis and venlafaxine, a serotonin norepinephrine reuptake inhibitor, were significantly associated with postpartum hemorrhage. Conclusions Exposure to serotonin and non-serotonin reuptake inhibitors, including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and tricyclics, close to the time of delivery was associated with a 1.4 to 1.9-fold increased risk for postpartum hemorrhage. While potential confounding by unmeasured factors cannot be ruled out, these findings suggest that patients treated with antidepressants during late pregnancy are more likely to experience postpartum hemorrhage.	[Palmsten, Kristin; Hernandez-Diaz, Sonia; Michels, Karin B.; Setoguchi, Soko] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Huybrechts, Krista F.; Mogun, Helen] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Huybrechts, Krista F.; Mogun, Helen] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Williams, Paige L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Sch Med,Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Michels, Karin B.] Univ Freiburg, Med Ctr, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [Achtyes, Eric D.] Michigan State Univ, Coll Human Med, Div Psychiat & Behav Med, Grand Rapids, MI 49503 USA; [Setoguchi, Soko] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Freiburg; Michigan State University; Michigan State University College of Human Medicine; Duke University	Palmsten, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	kkp762@mail.harvard.edu	Achtyes, Eric/M-6024-2016; Achtyes, Eric/AAA-6372-2020	Achtyes, Eric/0000-0001-8939-1535; 	Agency for Healthcare Research and Quality (AHRQ) [R01HS018533]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [T32HD060454]; AHRQ [K02-HS017731]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017731, R01HS018533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Agency for Healthcare Research and Quality (AHRQ) (grant R01HS018533 to SH-D). KP was supported by training grant T32HD060454 in reproductive, perinatal, and pediatric epidemiology from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. SS was supported by a mid-career development award grant K02-HS017731 from the AHRQ. The AHRQ had no role in the study design and the collection, analysis, and interpretation of data and writing of the article and the decision to submit it for publication. Research was conducted independently of the sponsor and funders.	American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P1039; Ananth CV, 2011, AM J EPIDEMIOL, V174, P99, DOI 10.1093/aje/kwr045; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; Baskett T F, 2005, J Obstet Gynaecol, V25, P7, DOI 10.1080/01674820400023408; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Castro VM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000544; Clark SM, 2011, OBSTET GYN CLIN N AM, V38, P297, DOI 10.1016/j.ogc.2011.02.017; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Cordeaux Y, 2009, J PHARMACOL EXP THER, V328, P682, DOI 10.1124/jpet.108.143040; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2006, BASIC CLIN PHARMACOL, V98, P304, DOI 10.1111/j.1742-7843.2006.pto_303.x; de Abajo FJ, 2011, DRUG AGING, V28, P345, DOI 10.2165/11589340-000000000-00000; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Fyfe EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-112; Garcia G, MATERNAL CHILD HLTH; Gilbert TT, 2003, OBSTET GYNECOL, V102, P897, DOI 10.1016/S0029-7844(03)00767-1; Guirgis R. R., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P149; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2; Kuo F, 2004, BIOORG MED CHEM LETT, V14, P3481, DOI 10.1016/j.bmcl.2004.04.066; Lee YC, 2012, J CLIN PSYCHOPHARM, V32, P518, DOI 10.1097/JCP.0b013e31825ccd5a; Magann EF, 2005, SOUTH MED J, V98, P419, DOI 10.1097/01.SMJ.0000152760.34443.86; Marchant S, 2006, PAEDIATR PERINAT EP, V20, P392, DOI 10.1111/j.1365-3016.2006.00743.x; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Nonacs R, 2003, PSYCHIAT CLIN N AM, V26, P547, DOI 10.1016/S0193-953X(03)00046-7; O'Donnell JF., 2011, GOODMAN GILMANS PHAR; Owens MJ, 2001, BIOL PSYCHIAT, V50, P345, DOI 10.1016/S0006-3223(01)01145-3; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Palmsten K, 2013, EPIDEMIOLOGY, V24, P682, DOI 10.1097/EDE.0b013e31829e0aaa; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Rassen JA, 2012, PHARMACOEPIDEMIOLOGY; Rassen JA, 2011, AM J EPIDEMIOL, V173, P1404, DOI 10.1093/aje/kwr001; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Romano PS, 2005, OBSTET GYNECOL, V106, P717, DOI 10.1097/01.AOG.0000179552.36108.6d; Salkeld E, 2008, J CLIN PSYCHOPHARM, V28, P230, DOI 10.1097/JCP.0b013e318166c52e; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Thase ME, 2005, J CLIN PSYCHOPHARM, V25, P132, DOI 10.1097/01.jcp.0000155815.44338.95; Thase ME, 1998, J CLIN PSYCHIAT, V59, P502, DOI 10.4088/JCP.v59n1002; The National Health and Nutrition Examination Survey (NHANES), 2005, AN REP GUID; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Walker AM, 1991, EPIDEMIOLOGY RESOURC; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; West SL, 2000, J CLIN EPIDEMIOL, V53, P823, DOI 10.1016/S0895-4356(99)00237-1; Zou GY, 2011, STAT METHODS MED RES	60	65	68	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2013	347								f4877	10.1136/bmj.f4877	http://dx.doi.org/10.1136/bmj.f4877			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	207SO	23965506	Green Published, hybrid			2022-12-28	WOS:000323624300004
J	Sharif, A				Sharif, Adnan			Prioritising existing donors to receive organs would boost donation from ethnic minorities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LAW; ALLOCATION; ATTITUDES; ISRAEL		Queen Elizabeth Hosp, Renal Inst Birmingham, Dept Nephrol & Transplantat, Birmingham B15 2WB, W Midlands, England	University of Birmingham	Sharif, A (corresponding author), Queen Elizabeth Hosp, Renal Inst Birmingham, Dept Nephrol & Transplantat, Birmingham B15 2WB, W Midlands, England.	adnan.sharif@uhb.nhs.uk		Sharif, Adnan/0000-0002-7586-9136				Department of Health, 2008, ORG TRANSPL REP ORG; Department of Health, 2012, NBTA REP BLACK AS MI; Lavee J, 2013, AM J TRANSPLANT, V13, P780, DOI 10.1111/ajt.12001; Lavee J, 2012, CURR OPIN CRIT CARE, V18, P707, DOI 10.1097/MCC.0b013e328357a2e2; Lavee J, 2010, LANCET, V375, P1131, DOI 10.1016/S0140-6736(09)61795-5; Morgan M, 2008, SOC SCI MED, V66, P147, DOI 10.1016/j.socscimed.2007.08.012; Morgan M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-266; NHS Blood and Transplant, ACT REP 2011 2012; NHS Blood and Transplant, REL PERSP ORG DON; Sharif A, 2011, TRANSPLANTATION, V92, P1108, DOI 10.1097/TP.0b013e318231ea17	10	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f5036	10.1136/bmj.f5036	http://dx.doi.org/10.1136/bmj.f5036			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SC	23963108				2022-12-28	WOS:000323623100006
J	Hovius, JWR; de Wever, B; Sohne, M; Brouwer, MC; Coumou, J; Wagemakers, A; Oei, A; Knol, H; Narasimhan, S; Hodiamont, CJ; Jahfari, S; Pals, ST; Horlings, HM; Fikrig, E; Sprong, H; van Oers, MHJ				Hovius, Joppe W. R.; de Wever, Bob; Sohne, Maaike; Brouwer, Matthijs C.; Coumou, Jeroen; Wagemakers, Alex; Oei, Anneke; Knol, Henrike; Narasimhan, Sukanya; Hodiamont, Caspar J.; Jahfari, Setareh; Pals, Steven T.; Horlings, Hugo M.; Fikrig, Erol; Sprong, Hein; van Oers, Marinus H. J.			A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe	LANCET			English	Editorial Material									[Hovius, Joppe W. R.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [de Wever, Bob; Oei, Anneke; Hodiamont, Caspar J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sohne, Maaike; van Oers, Marinus H. J.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands; [Brouwer, Matthijs C.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Coumou, Jeroen; Wagemakers, Alex] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Pals, Steven T.; Horlings, Hugo M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Narasimhan, Sukanya; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Div Infect Dis, New Haven, CT 06510 USA; [Jahfari, Setareh; Sprong, Hein] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Yale University; Netherlands National Institute for Public Health & the Environment	Hovius, JWR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	lyme@amc.uva.nl	Hovius, Joppe/GZL-6894-2022	Hovius, Joppe/0000-0003-0066-2437; Pals, Steven/0000-0002-1419-0939; Sprong, Hein/0000-0002-0218-4320; Wagemakers, Alex/0000-0001-9632-7830; Brouwer, Matthijs/0000-0001-7775-7843	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049200] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI049200] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Geller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051914; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Subramanian G, 2012, TICKS TICK-BORNE DIS, V3, P405, DOI 10.1016/j.ttbdis.2012.10.001	6	185	190	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					658	658		10.1016/S0140-6736(13)61644-X	http://dx.doi.org/10.1016/S0140-6736(13)61644-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953389	Green Accepted			2022-12-28	WOS:000323422800029
J	Thielmann, M; Kottenberg, E; Kleinbongard, P; Wendt, D; Gedik, N; Pasa, S; Price, V; Tsagakis, K; Neuhauser, M; Peters, J; Jakob, H; Heusch, G				Thielmann, Matthias; Kottenberg, Eva; Kleinbongard, Petra; Wendt, Daniel; Gedik, Nilguen; Pasa, Susanne; Price, Vivien; Tsagakis, Konstantinos; Neuhaeuser, Markus; Peters, Juergen; Jakob, Heinz; Heusch, Gerd			Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial	LANCET			English	Article							REDUCES MYOCARDIAL INJURY; GRAFT-SURGERY; VALVE-REPLACEMENT; CARDIAC-SURGERY; HEART; INFARCTION; ANGIOPLASTY; TRANSLATION; ISOFLURANE; PROTECTION	Background Remote ischaemic preconditioning has been associated with reduced risk of myocardial injury after coronary artery bypass graft (CABG) surgery. We investigated the safety and efficacy of this procedure. Methods Eligible patients were those scheduled to undergo elective isolated first-time CABG surgery under cold crystalloid cardioplegia and cardiopulmonary bypass at the West-German Heart Centre, Essen, Germany, between April, 2008, and October, 2012. Patients were prospectively randomised to receive remote ischaemic preconditioning (three cycles of 5 min ischaemia and 5 min reperfusion in the left upper arm after induction of anaesthesia) or no ischaemic preconditioning (control). The primary endpoint was myocardial injury, as reflected by the geometric mean area under the curve (AUC) for perioperative concentrations of cardiac troponin I (cTnI) in serum in the first 72 h after CABG. Mortality was the main safety endpoint. Analysis was done in intention-to-treat and per-protocol populations. This trial is registered with ClinicalTrials.gov, number NCT01406678. Findings 329 patients were enrolled. Baseline characteristics and perioperative data did not differ between groups. cTnI AUC was 266 ng/mL over 72 h (95% CI 237-298) in the remote ischaemic preconditioning group and 321 ng/mL (287-360) in the control group. In the intention-to-treat population, the ratio of remote ischaemic preconditioning to control for cTnI AUC was 0.83 (95% CI 0.70-0.97, p=0.022). cTnI release remained lower in the per-protocol analysis (0.79, 0.66-0.94, p=0.001). All-cause mortality was assessed over 1.54 (SD 1.22) years and was lower with remote ischaemic preconditioning than without (ratio 0.27, 95% CI 0.08-0.98, p=0.046). Interpretation Remote ischaemic preconditioning provided perioperative myocardial protection and improved the prognosis of patients undergoing elective CABG surgery.	[Thielmann, Matthias; Wendt, Daniel; Pasa, Susanne; Price, Vivien; Tsagakis, Konstantinos; Jakob, Heinz] Univ Klinikum Essen, Dept Thorac & Cardiovasc Surg, D-45122 Essen, Germany; [Kottenberg, Eva; Peters, Juergen] Univ Klinikum Essen, Klin Anasthesiol & Intens Med, D-45122 Essen, Germany; [Kleinbongard, Petra; Gedik, Nilguen; Heusch, Gerd] Univ Klinikum Essen, Inst Pathophysiol, D-45122 Essen, Germany; [Neuhaeuser, Markus] Koblenz Univ Appl Sci, Dept Math & Technol, Remagen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Heusch, G (corresponding author), Univ Klinikum Essen, Inst Pathophysiol, Hufelandstr 55, D-45122 Essen, Germany.	gerd.heusch@uk-essen.de	Heusch, Gerd/ABE-6675-2020	Price, Vivien/0000-0003-3573-5106	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	Funding German Research Foundation.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Candilio L, 2013, J CARDIOVASC MED, V14, P193, DOI 10.2459/JCM.0b013e328359dd7b; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Hoole S, 2012, CIRCULATION, V126; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Jensen RV, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0285-1; Karuppasamy P, 2011, BASIC RES CARDIOL, V106, P511, DOI 10.1007/s00395-011-0185-9; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Kottenberg E, 2014, J THORAC CARDIOV SUR, V147, P376, DOI 10.1016/j.jtcvs.2013.01.005; Li L, 2010, J SURG RES, V164, pE21, DOI 10.1016/j.jss.2010.06.016; Lucchinetti E, 2012, ANESTHESIOLOGY, V116, P296, DOI 10.1097/ALN.0b013e318242349a; Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Sloth AD, 2012, J AM COLL CARDIOL, V60, pB20, DOI 10.1016/j.jacc.2012.08.074; Thielmann M, 2005, EUR HEART J, V26, P2440, DOI 10.1093/eurheartj/ehi437; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Wu QP, 2011, CIRC J, V75, P1885, DOI 10.1253/circj.CJ-10-1130; Xie JJ, 2012, HEART, V98, P384, DOI 10.1136/heartjnl-2011-300860; Young PJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0256-6; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9	30	349	369	0	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					597	604		10.1016/S0140-6736(13)61450-6	http://dx.doi.org/10.1016/S0140-6736(13)61450-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953384				2022-12-28	WOS:000323422800023
J	Erdik, M				Erdik, Mustafa			Earthquake Risk in Turkey	SCIENCE			English	Editorial Material							ISTANBUL; SCENARIO		[Erdik, Mustafa] Bogazici Univ, Dept Earthquake Engn, Kandilli Observ, TR-34684 Istanbul, Turkey; [Erdik, Mustafa] Bogazici Univ, Earthquake Engn Res Inst, TR-34684 Istanbul, Turkey	Bogazici University; Bogazici University	Erdik, M (corresponding author), Bogazici Univ, Dept Earthquake Engn, Kandilli Observ, TR-34684 Istanbul, Turkey.	erdik@boun.edu.tr						[Anonymous], 2003, EARTHQ MAST IST IST; [Anonymous], 1998, CAHIERS CTR EUROPEEN; Bal IE, 2008, J EARTHQ ENG, V12, P12, DOI 10.1080/13632460802013388; Demircioglu M. B., 2011, 201107 PEER U CAL BE; Dilley M, 2005, DISAST RISK MANAGE, P1; Griffiths JHP, 2007, EARTHQ SPECTRA, V23, P63, DOI 10.1193/1.2424988; Parsons T, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002667; Strasser FO, 2008, J EARTHQ ENG, V12, P246, DOI 10.1080/13632460802014188	8	8	8	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					724	725		10.1126/science.1238945	http://dx.doi.org/10.1126/science.1238945			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950520				2022-12-28	WOS:000323122200028
J	Wassersug, RJ				Wassersug, Richard J.			PERSONAL VIEW Consent forms for clinical trials are too aggressive	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Wassersug, RJ (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.	richard.wassersug@ubc.ca							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2013	347								f4879	10.1136/bmj.f4879	http://dx.doi.org/10.1136/bmj.f4879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203XY	23943746				2022-12-28	WOS:000323329300012
J	Dalziel, SR; Thompson, JMD; Macias, CG; Fernandes, RM; Johnson, DW; Waisman, Y; Cheng, N; Acworth, J; Chamberlain, JM; Osmond, MH; Plint, A; Valerio, P; Black, KJL; Fitzpatrick, E; Newton, AS; Kuppermann, N; Klassen, TP				Dalziel, Stuart R.; Thompson, John M. D.; Macias, Charles G.; Fernandes, Ricardo M.; Johnson, David W.; Waisman, Yehezkel; Cheng, Nicholas; Acworth, Jason; Chamberlain, James M.; Osmond, Martin H.; Plint, Amy; Valerio, Paolo; Black, Karen J. L.; Fitzpatrick, Eleanor; Newton, Amanda S.; Kuppermann, Nathan; Klassen, Terry P.		Pediat Emergency Res Networks PERN	Predictors of severe H1N1 infection in children presenting within Pediatric Emergency Research Networks (PERN): retrospective case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLUENZA-A H1N1; PANDEMIC H1N1; SEASONAL INFLUENZA; VIRUS-INFECTION; UNITED-STATES; HOSPITALIZED-PATIENTS; A(H1N1) INFECTION; INTENSIVE-CARE; MEDICINE; CALIFORNIA	Objective To identify historical and clinical findings at emergency department presentation associated with severe H1N1 outcome in children presenting with influenza-like illness. Design Multicentre retrospective case-control study. Setting 79 emergency departments of hospitals associated with the Pediatric Emergency Research Networks in 12 countries. Participants 265 children (<16 years), presenting between 16 April and 31 December 2009, who fulfilled Centers for Disease Control and Prevention criteria for influenza-like illness and developed severe outcomes from laboratory confirmed H1N1 infection. For each case, two controls presenting with influenza-like illness but without severe outcomes were included: one random control and one age matched control. Main outcome measures Severe outcomes included death or admission to intensive care for assisted ventilation, inotropic support, or both. Multivariable conditional logistic regression was used to compare cases and controls, with effect sizes measured as adjusted odds ratios. Results 151 (57%) of the 265 cases were male, the median age was 6 (interquartile range 2.3-10.0) years, and 27 (10%) died. Six factors were associated with severe outcomes in children presenting with influenza-like illness: history of chronic lung disease (odds ratio 10.3, 95% confidence interval 1.5 to 69.8), history of cerebral palsy/developmental delay (10.2, 2.0 to 51.4), signs of chest retractions (9.6, 3.2 to 29.0), signs of dehydration (8.8, 1.6 to 49.3), requirement for oxygen (5.8, 2.0 to 16.2), and tachycardia relative to age). Conclusion These independent risk factors may alert clinicians to children at risk of severe outcomes when presenting with influenza-like illness during future pandemics.	[Dalziel, Stuart R.] Starship Childrens Hosp, Auckland, New Zealand; [Dalziel, Stuart R.; Thompson, John M. D.] Univ Auckland, Auckland 1, New Zealand; [Macias, Charles G.] Baylor Coll Med, Houston, TX 77030 USA; [Macias, Charles G.] Texas Childrens Hosp, Houston, TX 77030 USA; [Fernandes, Ricardo M.] Hosp Santa Maria, Dept Pediat, Lisbon, Portugal; [Fernandes, Ricardo M.] Inst Mol Med, Fac Med, Lab Clin Pharmacol & Therapeut, Lisbon, Portugal; [Johnson, David W.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Waisman, Yehezkel] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Cheng, Nicholas] Childrens Hosp Westmead, Sydney, NSW, Australia; [Acworth, Jason] Royal Childrens Hosp, Brisbane, Qld, Australia; [Chamberlain, James M.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Osmond, Martin H.; Plint, Amy] Univ Ottawa, Ottawa, ON, Canada; [Osmond, Martin H.; Plint, Amy] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Valerio, Paolo] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Black, Karen J. L.; Fitzpatrick, Eleanor] IWK Hlth Ctr, Halifax, NS, Canada; [Newton, Amanda S.] Univ Alberta, Edmonton, AB, Canada; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Klassen, Terry P.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada	Starship Children's Hospital; University of Auckland; Baylor College of Medicine; Baylor College of Medicine; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Alberta Childrens Hospital; University of Calgary; University of Sydney; Royal Children's Hospital Brisbane; Children's National Health System; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Onze Lieve Vrouwe Gasthuis Hospital; Dalhousie University; University of Alberta; University of California System; University of California Davis; University of California System; University of California Davis; University of Manitoba	Dalziel, SR (corresponding author), Starship Childrens Hosp, Auckland, New Zealand.	sdalziel@adhb.govt.nz	Ong, Gene/W-3154-2019; Acworth, Jason/B-1339-2011; Thompson, Graham/Y-4180-2019; Jouvet, Philippe A/H-3293-2018; Fernandes, Ricardo M/C-7501-2015; Mintegi, Santiago/G-8252-2011; Benito, Javier/G-9198-2011; Rodrigues, Fernanda/AAW-4615-2021; Hendrickson, Marissa/ABA-7225-2021; Plint, Amy/AAE-2250-2020	Ong, Gene/0000-0002-9879-0594; Acworth, Jason/0000-0002-6602-3155; Thompson, Graham/0000-0002-6781-4186; Jouvet, Philippe A/0000-0001-5684-3398; Fernandes, Ricardo M/0000-0002-7253-6475; Mintegi, Santiago/0000-0002-2342-8881; Benito, Javier/0000-0003-1548-7408; Van de Voorde, Patrick/0000-0001-9053-0475; Klassen, Terry/0000-0002-5309-7091; Hendrickson, Marissa/0000-0002-1545-0982; Lyttle, Mark/0000-0002-8634-7210; Osmond, Martin/0000-0001-8275-8381	HRSA/MCHB/EMSC [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, U03MC22685]; Health Research Council of New Zealand; Logan Campbell Trust, Auckland, New Zealand; CureKids, New Zealand	HRSA/MCHB/EMSC(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Health Research Council of New Zealand(Health Research Council of New Zealand); Logan Campbell Trust, Auckland, New Zealand; CureKids, New Zealand	PECARN is supported by HRSA/MCHB/EMSC through the following cooperative agreements: U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, and U03MC22685. SRD is supported by the Health Research Council of New Zealand. JMDT received funding from the Logan Campbell Trust, Auckland, New Zealand, to attend an investigator meeting with time funded by CureKids, New Zealand. Investigators' time was funded by their host institutions. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagdure D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015173; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Bryant PA, 2010, PEDIATR INFECT DIS J, V29, P694, DOI 10.1097/INF.0b013e3181de4b9c; Calitri C, 2010, EUR J PEDIATR, V169, P1511, DOI 10.1007/s00431-010-1255-y; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Chamberlain JM, 2005, PEDIATRICS, V115, P388, DOI 10.1542/peds.2004-0586; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Fanella ST, 2011, INFECT CONT HOSP EP, V32, P435, DOI 10.1086/659401; Farias JA, 2010, INTENS CARE MED, V36, P1015, DOI 10.1007/s00134-010-1853-1; Fuhrman C, 2011, EPIDEMIOL INFECT, V139, P1202, DOI 10.1017/S0950268810002414; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Herberg JA, 2011, PEDIATR INFECT DIS J, V30, P438, DOI 10.1097/INF.0b013e3182040c90; Hiba V, 2011, J ANTIMICROB CHEMOTH, V66, P1150, DOI 10.1093/jac/dkr089; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Klassen TP, 2010, PEDIATR EMERG CARE, V26, P541, DOI 10.1097/PEC.0b013e3181e5bec1; Kumar S, 2010, PEDIATR INFECT DIS J, V29, P591, DOI 10.1097/INF.0b013e3181d73e32; Launay E, 2011, INT J INFECT DIS, V15, pE122, DOI 10.1016/j.ijid.2010.08.006; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Libster R, 2010, NEW ENGL J MED, V363, P2472, DOI 10.1056/NEJMc1008806; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Lockman JL, 2010, PEDIATR CRIT CARE ME, V11, P173, DOI 10.1097/PCC.0b013e3181ccedae; Louie JK, 2010, ARCH PEDIAT ADOL MED, V164, P1023, DOI 10.1001/archpediatrics.2010.203; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Ostovar GA, 2011, CLIN PEDIATR, V50, P348, DOI 10.1177/0009922810390512; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Stein M, 2010, ARCH PEDIAT ADOL MED, V164, P1015, DOI 10.1001/archpediatrics.2010.195; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Yung M, 2011, PEDIATRICS, V127, pE156, DOI 10.1542/peds.2010-0801	33	29	32	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2013	347								f4836	10.1136/bmj.f4836	http://dx.doi.org/10.1136/bmj.f4836			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203WU	23940290	Green Published, hybrid			2022-12-28	WOS:000323326000002
J	Adey, A; Burton, JN; Kitzman, JO; Hiatt, JB; Lewis, AP; Martin, BK; Qiu, RL; Lee, C; Shendure, J				Adey, Andrew; Burton, Joshua N.; Kitzman, Jacob O.; Hiatt, Joseph B.; Lewis, Alexandra P.; Martin, Beth K.; Qiu, Ruolan; Lee, Choli; Shendure, Jay			The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line	NATURE			English	Article							SEQUENCE; DNA; CONTAMINATION; INTEGRATION; FRAMEWORK; BREAST	The HeLa cell line was established in 1951 from cervical cancer cells taken from a patient, Henrietta Lacks. This was the first successful attempt to immortalize human-derived cells in vitro(1). The robust growth and unrestricted distribution of HeLa cells resulted in its broad adoption-both intentionally and through widespread cross-contamination(2)-and for the past 60 years it has served a role analogous to that of a model organism(3). The cumulative impact of the HeLa cell line on research is demonstrated by its occurrence in more than 74,000 PubMed abstracts (approximately 0.3%). The genomic architecture of HeLa remains largely unexplored beyond its karyotype(4), partly because like many cancers, its extensive aneuploidy renders such analyses challenging. We carried out haplotype-resolved whole-genome sequencing(5) of the HeLa CCL-2 strain, examined point-and indel-mutation variations, mapped copy-number variations and loss of heterozygosity regions, and phased variants across full chromosome arms. We also investigated variation and copy-number profiles for HeLa S3 and eight additional strains. We find that HeLa is relatively stable in terms of point variation, with few new mutations accumulating after early passaging. Haplotype resolution facilitated reconstruction of an amplified, highly rearranged region of chromosome 8q24.21 at which integration of the human papilloma virus type 18 (HPV-18) genome occurred and that is likely to be the event that initiated tumorigenesis. We combined these maps with RNA-seq(6) and ENCODE Project(7) data sets to phase the HeLa epigenome. This revealed strong, haplotype-specific activation of the proto-oncogene MYC by the integrated HPV-18 genome approximately 500 kilobases upstream, and enabled global analyses of the relationship between gene dosage and expression. These data provide an extensively phased, high-quality reference genome for past and future experiments relying on HeLa, and demonstrate the value of haplotype resolution for characterizing cancer genomes and epigenomes.	[Adey, Andrew; Burton, Joshua N.; Kitzman, Jacob O.; Hiatt, Joseph B.; Lewis, Alexandra P.; Martin, Beth K.; Qiu, Ruolan; Lee, Choli; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA.	acadey@uw.edu; shendure@uw.edu	Shendure, Jay/AAU-3684-2021	Kitzman, Jacob/0000-0002-6145-882X; Shendure, Jay/0000-0002-1516-1865; Martin, Beth/0000-0002-9661-014X; Burton, Joshua/0000-0003-2817-7353	National Genome Research Institute (NHGRI) [HG006283]; National Cancer Institute [CA160080]; National Science Foundation [DGE-0718124]; NHGRI [T32HG000035]; National Institute of Aging [AG039173]; NATIONAL CANCER INSTITUTE [R21CA160080] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039173] Funding Source: NIH RePORTER	National Genome Research Institute (NHGRI); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The genome sequence described in this paper was derived from a HeLa cell line. Henrietta Lacks, and the HeLa cell line that was established from her tumour cells in 1951, have made significant contributions to scientific progress and advances in human health. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. We also thank M. Kircher, M. Snyder, A. Kumar and R. Patwardhan as well as other members of the Shendure laboratory for advice and suggestions. We thank the Stamatoyannopoulos and Malik laboratories for cell aliquots. Our work was supported by a gift from the Washington Research Foundation; grant HG006283 from the National Genome Research Institute (NHGRI, to J.S.); grant CA160080 from the National Cancer Institute (to J.S.); a graduate research fellowship DGE-0718124 from the National Science Foundation (to A. A. and J.K.); grant T32HG000035 from the NHGRI (to J.N.B.); and grant AG039173 from the National Institute of Aging (to J.B.H.). J.S. is the Lowell Milken Prostate Cancer Foundation Young Investigator. J.S. is a member of the scientific advisory board or serves as a consultant for Ariosa Diagnostics, Stratos Genomics, Good Start Genetics, and Adaptive Biotechnologies.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2013, CANC GEN PROJ; Bouallaga I, 2000, EMBO REP, V1, P422, DOI 10.1093/embo-reports/kvd091; Corver WE, 2008, CANCER RES, V68, P10333, DOI 10.1158/0008-5472.CAN-08-2665; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; GARTLER SM, 1968, NATURE, V217, P750, DOI 10.1038/217750a0; GEY GO, 1952, CANCER RES, V12, P264; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; LAZO PA, 1989, CANCER RES, V49, P4305; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macville M, 1999, CANCER RES, V59, P141; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; NELSONREES WA, 1981, SCIENCE, V212, P446, DOI 10.1126/science.6451928; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Peter M, 2006, ONCOGENE, V25, P5985, DOI 10.1038/sj.onc.1209625; PUCK TT, 1955, P NATL ACAD SCI USA, V41, P432, DOI 10.1073/pnas.41.7.432; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rosty C, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-15; Skloot R., 2011, IMMORTAL LIFE HENRIE; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Wistuba II, 1997, CANCER RES, V57, P3154	42	231	246	5	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					207	+		10.1038/nature12064	http://dx.doi.org/10.1038/nature12064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925245	Green Accepted			2022-12-28	WOS:000322825500035
J	Vander Lugt, MT; Braun, TM; Hanash, S; Ritz, J; Ho, VT; Antin, JH; Zhang, Q; Wong, CH; Wang, H; Chin, A; Gomez, A; Harris, AC; Levine, JE; Choi, SW; Couriel, D; Reddy, P; Ferrara, JLM; Paczesny, S				Vander Lugt, Mark T.; Braun, Thomas M.; Hanash, Samir; Ritz, Jerome; Ho, Vincent T.; Antin, Joseph H.; Zhang, Qing; Wong, Chee-Hong; Wang, Hong; Chin, Alice; Gomez, Aurelie; Harris, Andrew C.; Levine, John E.; Choi, Sung W.; Couriel, Daniel; Reddy, Pavan; Ferrara, James L. M.; Paczesny, Sophie			ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE GVHD; CLINICAL-TRIALS; T-CELLS; EXPRESSION; SURVIVAL; PROTEIN; IL-33; BIOMARKER; BLOOD; SERUM	BACKGROUND No plasma biomarkers are associated with the response of acute graft-versus-host disease (GVHD) to therapy after allogeneic hematopoietic stem-cell transplantation. METHODS We compared 12 biomarkers in plasma obtained a median of 16 days after therapy initiation from 10 patients with a complete response by day 28 after therapy initiation and in plasma obtained from 10 patients with progressive GVHD during therapy. The lead biomarker, suppression of tumorigenicity 2 (ST2), was measured at the beginning of treatment for GVHD in plasma from 381 patients and during the first month after transplantation in three independent sets totaling 673 patients to determine the association of this biomarker with treatment-resistant GVHD and 6-month mortality after treatment or transplantation. RESULTS Of the 12 markers, ST2 had the most significant association with resistance to GVHD therapy and subsequent death without relapse. As compared with patients with low ST2 values at therapy initiation, patients with high ST2 values were 2.3 times as likely to have treatment-resistant GVHD (95% confidence interval [CI], 1.5 to 3.6) and 3.7 times as likely to die within 6 months after therapy (95% CI, 2.3 to 5.9). Patients with low ST2 values had lower mortality without relapse than patients with high ST2 values, regardless of the GVHD grade (11% vs. 31% among patients with grade I or II GVHD and 14% vs. 67% among patients with grade III or IV GVHD, P<0.001 for both comparisons). Plasma ST2 values at day 14 after transplantation were associated with 6-month mortality without relapse, regardless of the intensity of the conditioning regimen. CONCLUSIONS ST2 levels measured at the initiation of therapy for GVHD and during the first month after transplantation improved risk stratification for treatment-resistant GVHD and death without relapse after transplantation.	[Vander Lugt, Mark T.; Gomez, Aurelie; Harris, Andrew C.; Levine, John E.; Choi, Sung W.; Ferrara, James L. M.; Paczesny, Sophie] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Braun, Thomas M.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Couriel, Daniel; Reddy, Pavan; Ferrara, James L. M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hanash, Samir; Zhang, Qing; Wong, Chee-Hong; Wang, Hong; Chin, Alice; Paczesny, Sophie] Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, Seattle, WA 98104 USA; [Ritz, Jerome; Ho, Vincent T.; Antin, Joseph H.] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Harvard University; Dana-Farber Cancer Institute	Paczesny, S (corresponding author), Indiana Univ, Bone Marrow & Stem Cell Transplantat Program, Melvin & Bren Simon Canc Ctr, 1044 W Walnut St,Rm 425, Indianapolis, IN 46202 USA.	sophpacz@iu.edu	Harris, Andrew C./L-5499-2019; Paczesny, Sophie/AAR-5119-2021; Paczesny, Sophie/I-4682-2019; Ritz, Jerome/C-7929-2009	Paczesny, Sophie/0000-0001-5571-2775; Ritz, Jerome/0000-0001-5526-4669; Levine, John/0000-0002-9133-0800; Reddy, Pavan/0000-0001-7264-8429; Harris, Andrew/0000-0002-4538-8817; Levine, John/0000-0002-5611-7828	National Institutes of Health [RC1HL101102, R01CA168814, P01-CA039542, T32-HL007622]; M.J. Murdock Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA082709, P01CA039542, R01CA183560, R01CA168814, R01CA183559] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007622, RC1HL101102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.J. Murdock Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health.; Supported by grants (RC1HL101102, R01CA168814, P01-CA039542, and T32-HL007622) from the National Institutes of Health. The linear trap quadrupole-Fourier-transform mass spectrometer used in this work was funded in part by the M.J. Murdock Charitable Trust.	Bacigalupo A, 2007, BRIT J HAEMATOL, V137, P87, DOI 10.1111/j.1365-2141.2007.06533.x; Cragg L, 2000, BIOL BLOOD MARROW TR, V6, P441, DOI 10.1016/S1083-8791(00)70036-X; De Gruttola VG, 2001, CONTROL CLIN TRIALS, V22, P485, DOI 10.1016/S0197-2456(01)00153-2; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P474, DOI 10.1006/bbrc.1997.6810; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Levine JE, 2012, BLOOD, V119, P3854, DOI 10.1182/blood-2012-01-403063; Levine JE, 2010, BIOL BLOOD MARROW TR, V16, P1693, DOI 10.1016/j.bbmt.2010.05.019; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; MacMillan ML, 2012, BRIT J HAEMATOL, V157, P732, DOI 10.1111/j.1365-2141.2012.09114.x; MacMillan ML, 2010, BLOOD, V115, P5412, DOI 10.1182/blood-2009-12-258442; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P387, DOI 10.1053/bbmt.2002.v8.pm12171485; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Paczesny S, 2013, BLOOD, V121, P585, DOI 10.1182/blood-2012-08-355990; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Robin M, 2009, TRANSPLANTATION, V88, P1131, DOI 10.1097/TP.0b013e3181bc2583; ROSSLER U, 1995, DEV BIOL, V168, P86, DOI 10.1006/dbio.1995.1063; Saliba RM, 2012, BONE MARROW TRANSPL, V47, P125, DOI 10.1038/bmt.2011.41; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Weisdorf D, 2012, BIOL BLOOD MARROW TR, V18, P1727, DOI 10.1016/j.bbmt.2012.06.014; Westin JR., 2011, ADV HEMATOL, V2011; Xhaard A, 2012, BIOL BLOOD MARROW TR, V18, P406, DOI 10.1016/j.bbmt.2011.06.012; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yanagisawa K, 1997, J BIOCHEM-TOKYO, V121, P95	38	258	261	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					529	539		10.1056/NEJMoa1213299	http://dx.doi.org/10.1056/NEJMoa1213299			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924003	Green Accepted, Bronze			2022-12-28	WOS:000322842000009
J	Gatta, L; Vakil, N; Vaira, D; Scarpignato, C				Gatta, Luigi; Vakil, Nimish; Vaira, Dino; Scarpignato, Carmelo			Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CLINICAL-TRIAL; STANDARD TRIPLE THERAPY; 1ST LINE TREATMENT; CONCOMITANT THERAPY; ANTIMICROBIAL RESISTANCE; QUADRUPLE THERAPY; RISK-FACTORS; OPEN-LABEL; QUALITY; EFFICACY	Objective To do a systematic review and meta-analysis of studies comparing sequential therapy for eradication of Helicobacter pylori with pre-existing and new therapies, thus providing a glimpse of eradication success worldwide. Design Systematic review and meta-analysis. Data sources Medline, Embase, and Cochrane Central Register of Controlled Trials up to May 2013; abstract books of major European, American, and Asian gastroenterological meetings. Study selection Randomised controlled trials in previously untreated adults, in which sequential therapy was compared with a pre-existing or new therapy. Results 46 randomised controlled trials were reviewed and analysed. 5666 patients were randomised to sequential therapy and 7866 to other (established and new) treatments. The overall eradication rate of sequential therapy was 84.3% (95% confidence interval 82.1% to 86.4%). Sequential therapy was superior to seven day triple therapy (relative risk 1.21, 95% confidence interval 1.17 to 1.25; I-2=29.3%; number needed to treat 6, 95% confidence interval 5% to 7%), marginally superior to 10 day triple therapy (1.11, 1.04 to 1.19; I-2=67.2%; NNT 10, 7 to 15), but not superior to 14 day triple therapy (1.00, 0.94 to 1.06; I-2=54.3%), bismuth based therapy (1.01, 0.95 to 1.06; I-2=21.1%), and non-bismuth based therapy (0.99, 0.94 to 1.05; I-2=52.3%). Data on eradication according to pre-treatment antimicrobial susceptibility testing were available in eight studies, and sequential therapy was able to eradicate 72.8% (61.6% to 82.8%) of the strains resistant to clarithromycin. Conclusions Eradication rates with pre-existing and new therapies for H pylori are suboptimal. Regional monitoring of resistance rates should help to guide treatment, and new agents for treatment need to be developed.	[Gatta, Luigi] Versilia Hosp, Gastroenterol & Endoscopy Unit, Lido Di Camaiore, Italy; [Gatta, Luigi; Scarpignato, Carmelo] Univ Parma, Dept Clin & Expt Med, I-43125 Parma, Italy; [Vakil, Nimish] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Vaira, Dino] Univ Bologna, Dept Med & Surg Sci, I-40126 Bologna, Italy	Ospedale Versilia; University of Parma; University Hospital of Parma; University of Wisconsin System; University of Wisconsin Madison; University of Bologna	Gatta, L (corresponding author), Univ Parma, Dept Clin & Expt Med, Clin Pharmacol & Digest Pathophysiol Unit, I-43125 Parma, Italy.	gattalg@gmail.com	Scarpignato, Carmelo/ABC-1745-2021; Gatta, Luigi/S-6795-2016	Scarpignato, Carmelo/0000-0001-5645-857X; Gatta, Luigi/0000-0001-5789-3813	Pfizer; Janssen-Cilag; Sidem; AstraZeneca; Takeda; Ironwood; Otsuka	Pfizer(Pfizer); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sidem; AstraZeneca(AstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd); Ironwood; Otsuka(Otsuka Pharmaceutical)	All authors have completed the ICMJE uniform disclosure form at www. icmje. org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; CS has received consulting fees for advisory committees or review panels from Pfizer, Janssen-Cilag, and Sidem and for speaking and teaching from AstraZeneca; NV has received consulting fees for speaking and teaching from AstraZeneca, Takeda, Ironwood, and Otsuka and has ownership interest (stock shareholder) in Meridian Diagnostics and Orexo; no other relationships or activities that could appear to have influenced the submitted work.	Aminian Keyvan, 2010, Trop Gastroenterol, V31, P303; Ang TL, 2013, GASTROENTEROLOGY, V144, pS53; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Choi HS, 2012, WORLD J GASTROENTERO, V18, P2377, DOI 10.3748/wjg.v18.i19.2377; Choi Woo Hyuk, 2008, Korean J Gastroenterol, V51, P280; Chung JW, 2012, J GASTROEN HEPATOL, V27, P1675, DOI 10.1111/j.1440-1746.2012.07249.x; De Francesco V, 2004, DIGEST LIVER DIS, V36, P322, DOI 10.1016/j.dld.2003.12.015; De Francesco V, 2004, ALIMENT PHARM THER, V19, P407, DOI 10.1046/j.1365-2036.2004.01818.x; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Duck WM, 2004, EMERG INFECT DIS, V10, P1088, DOI 10.3201/eid1006.030744; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; Fakheri H, 2012, HELICOBACTER, V17, P43, DOI 10.1111/j.1523-5378.2011.00896.x; Federico A, 2012, GASTROENTEROLOGY, V143, P55, DOI 10.1053/j.gastro.2012.03.043; Focareta R, 2003, DIG LIVER DIS S4, V35, pS33; Franceschi F, 2012, GASTROENTEROLOGY, V142, pS487; Galla L, 2011, GASTROENTEROLOGY, V140, pS148; Gao XZ, 2010, WORLD J GASTROENTERO, V16, P4357, DOI 10.3748/wjg.v16.i34.4357; Gatta L, 2012, LANCET, V379, P407, DOI 10.1016/S0140-6736(12)60181-0; Gatta L, 2009, AM J GASTROENTEROL, V104, P3069, DOI 10.1038/ajg.2009.555; Gisbert JP, 2012, CLIN EXP GASTROENTER, V5, P23, DOI 10.2147/CEG.S25419; Gisbert JP, 2010, J CLIN GASTROENTEROL, V44, P313, DOI 10.1097/MCG.0b013e3181c8a1a3; GLUPCZYNSKI Y, 1992, EUR J CLIN MICROBIOL, V11, P777; Glupczynski Y, 2001, EUR J CLIN MICROBIOL, V20, P820, DOI 10.1007/s100960100611; Graham DY, 2007, HELICOBACTER, V12, P275, DOI 10.1111/j.1523-5378.2007.00518.x; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Graham DY, 2013, CLIN GASTROENTEROL H; Graham PL, 2012, J CLIN EPIDEMIOL, V65, P503, DOI 10.1016/j.jclinepi.2011.09.012; Greenberg ER, 2011, LANCET, V378, P507, DOI 10.1016/S0140-6736(11)60825-8; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harmandar FA, 2012, GUT, V61, pA443; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hu SQ, 2009, SHI JIE HUA REN XIAO, V17, P1693; Huang YK, 2012, J DIGEST DIS, V13, P232, DOI 10.1111/j.1751-2980.2012.00575.x; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Javid G, 2013, INDIAN J GASTROENTER, V32, P190, DOI 10.1007/s12664-013-0304-7; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kalapothakos P, 2012, GUT, V61, pA444; Kim YS, 2011, ALIMENT PHARM THER, V34, P1098, DOI 10.1111/j.1365-2036.2011.04843.x; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lahbabi M, 2012, CLIN RES HEPATOL GAS; Liang Z, 2010, CHIN J GASTROENTEROL, V15, P483; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liou JM, 2012, LANCET, V6736, P61579; Liu SHK, 2013, GASTROENTEROLOGY, V144, pS54; Luther J, 2010, AM J GASTROENTEROL, V105, P65, DOI 10.1038/ajg.2009.508; Ma ChunXi, 2008, Academic Journal of Second Military Medical University, V29, P908; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Malfertheiner P, 1997, EUR J GASTROEN HEPAT, V9, P1; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Malfertheiner P, 2011, LANCET, V377, P905, DOI 10.1016/S0140-6736(11)60020-2; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; McNicholl AG, 2013, GUT; Megraud F, 1997, GUT, V41, pS1; Megraud F, 2012, GASTROENTEROLOGY, V142, pS146; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Molina-Infante J, 2010, ALIMENT PHARM THER, V31, P1077, DOI 10.1111/j.1365-2036.2010.04274.x; Oh HS, 2012, J GASTROEN HEPATOL, V27, P504, DOI 10.1111/j.1440-1746.2011.06922.x; Paoluzi OA, 2010, J CLIN GASTROENTEROL, V44, P261, DOI 10.1097/MCG.0b013e3181acebef; Park HG, 2012, ALIMENT PHARM THER, V35, P56, DOI 10.1111/j.1365-2036.2011.04902.x; Park S, 2009, GASTROENTEROLOGY, V136, pA339; Qian J, 2012, HELICOBACTER, V17, P478, DOI 10.1111/j.1523-5378.2012.00993.x; Romano M, 2010, GUT, V59, P1465, DOI 10.1136/gut.2010.215350; Sardarian H, 2013, HELICOBACTER, V18, P129, DOI 10.1111/hel.12017; Scaccianoce G, 2006, CAN J GASTROENTEROL, V20, P113, DOI 10.1155/2006/258768; Schulz KF, 2002, ANN INTERN MED, V136, P254, DOI 10.7326/0003-4819-136-3-200202050-00022; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Seddik H, 2013, EUR J CLIN PHARM; Singh M, 2012, GUT, V61, pA212; Song Y, 2010, CHIN J GASTROENTEROL, V15, P240; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; Vakil N, 2006, AM J GASTROENTEROL, V101, P497, DOI 10.1111/j.1572-0241.2006.00454.x; Wu DC, 2010, CLIN GASTROENTEROL H, V8, P36, DOI 10.1016/j.cgh.2009.09.030; Wu GL, 2011, WORLD CHIN J DIG, V19, P3100; Wu HY, 2008, GUT, V57, pA330; Yep-Gamarra V, 2013, GASTROENTEROLOGY, V144, pS333; Zhao QX, 2009, WORLD CHIN J DIG, V17, P3666, DOI DOI 10.3969/J.ISSN.1009-3079.2009.35.021; Zullo A, 2005, ALIMENT PHARM THERAP, V21, P1419, DOI 10.1111/j.1365-2036.2005.02519.x; Zullo A, 2003, ALIMENT PHARM THER, V17, P719, DOI 10.1046/j.1365-2036.2003.01461.x; Zullo A, 2000, ALIMENT PHARM THER, V14, P715; Zullo A, 2013, CLIN RES HEPATOL GAS	84	184	191	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2013	347								f4587	10.1136/bmj.f4587	http://dx.doi.org/10.1136/bmj.f4587			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CY	23926315	hybrid, Green Published			2022-12-28	WOS:000323119500009
J	Roeb, M; Sattler, C				Roeb, Martin; Sattler, Christian			Isothermal Water Splitting	SCIENCE			English	Editorial Material							EFFICIENCY; CYCLES		[Roeb, Martin; Sattler, Christian] German Aerosp Ctr DLR, Inst Solar Res, D-51147 Cologne, Germany	Helmholtz Association; German Aerospace Centre (DLR)	Roeb, M (corresponding author), German Aerosp Ctr DLR, Inst Solar Res, D-51147 Cologne, Germany.	martin.roeb@dlr.de	Sattler, Christian/A-7860-2012	Sattler, Christian/0000-0002-4314-1124; Roeb, Martin/0000-0002-9813-5135				Chueh WC, 2010, SCIENCE, V330, P1797, DOI 10.1126/science.1197834; Diver R.B., 2006, P ISEC 2006 ASME INT; Ermanoski I, 2013, J SOL ENERG-T ASME, V135, DOI 10.1115/1.4023356; Furler P, 2012, ENERG FUEL, V26, P7051, DOI 10.1021/ef3013757; Gokon N, 2011, INT J HYDROGEN ENERG, V36, P4757, DOI 10.1016/j.ijhydene.2011.01.076; Kaneko H., 2009, P ASME 3 INT C EN SU; Lapp J, 2012, ENERGY, V37, P591, DOI 10.1016/j.energy.2011.10.045; Muhich CL, 2013, SCIENCE, V341, P540, DOI 10.1126/science.1239454; Neises M, 2012, SOL ENERGY, V86, P3040, DOI 10.1016/j.solener.2012.07.012; Roeb M, 2011, SOL ENERGY, V85, P634, DOI 10.1016/j.solener.2010.04.014; Siegel NP, 2013, IND ENG CHEM RES, V52, P3276, DOI 10.1021/ie400193q	11	27	27	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					470	471		10.1126/science.1241311	http://dx.doi.org/10.1126/science.1241311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908215				2022-12-28	WOS:000322586700029
J	Futier, E; Constantin, JM; Paugam-Burtz, C; Pascal, J; Eurin, M; Neuschwander, A; Marret, E; Beaussier, M; Gutton, C; Lefrant, JY; Allaouchiche, B; Verzilli, D; Leone, M; De Jong, A; Bazin, JE; Pereira, B; Jaber, S				Futier, Emmanuel; Constantin, Jean-Michel; Paugam-Burtz, Catherine; Pascal, Julien; Eurin, Mathilde; Neuschwander, Arthur; Marret, Emmanuel; Beaussier, Marc; Gutton, Christophe; Lefrant, Jean-Yves; Allaouchiche, Bernard; Verzilli, Daniel; Leone, Marc; De Jong, Audrey; Bazin, Jean-Etienne; Pereira, Bruno; Jaber, Samir		IMPROVE Study Grp	A Trial of Intraoperative Low-Tidal-Volume Ventilation in Abdominal Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; POSTOPERATIVE PULMONARY COMPLICATIONS; MULTIFACTORIAL RISK INDEX; MECHANICAL VENTILATION; INFLAMMATORY RESPONSES; PROTECTIVE-VENTILATION; RECRUITMENT MANEUVERS; GENERAL-ANESTHESIA; ORGAN DYSFUNCTION; LUNG INJURY	Background Lung-protective ventilation with the use of low tidal volumes and positive end-expiratory pressure is considered best practice in the care of many critically ill patients. However, its role in anesthetized patients undergoing major surgery is not known. Methods In this multicenter, double-blind, parallel-group trial, we randomly assigned 400 adults at intermediate to high risk of pulmonary complications after major abdominal surgery to either nonprotective mechanical ventilation or a strategy of lung-protective ventilation. The primary outcome was a composite of major pulmonary and extrapulmonary complications occurring within the first 7 days after surgery. Results The two intervention groups had similar characteristics at baseline. In the intention-to-treat analysis, the primary outcome occurred in 21 of 200 patients (10.5%) assigned to lung-protective ventilation, as compared with 55 of 200 (27.5%) assigned to nonprotective ventilation (relative risk, 0.40; 95% confidence interval [CI], 0.24 to 0.68; P=0.001). Over the 7-day postoperative period, 10 patients (5.0%) assigned to lung-protective ventilation required noninvasive ventilation or intubation for acute respiratory failure, as compared with 34 (17.0%) assigned to nonprotective ventilation (relative risk, 0.29; 95% CI, 0.14 to 0.61; P=0.001). The length of the hospital stay was shorter among patients receiving lung-protective ventilation than among those receiving nonprotective ventilation (mean difference, -2.45 days; 95% CI, -4.17 to -0.72; P=0.006). Conclusions As compared with a practice of nonprotective mechanical ventilation, the use of a lung-protective ventilation strategy in intermediate-risk and high-risk patients undergoing major abdominal surgery was associated with improved clinical outcomes and reduced health care utilization.	[Futier, Emmanuel; Constantin, Jean-Michel; Pascal, Julien; Bazin, Jean-Etienne] Hop Estaing, Dept Anesthesie & Reanimat, Clermont Ferrand, France; [Futier, Emmanuel; Constantin, Jean-Michel] Univ Clermont Ferrand 2, Retinoids Reprod & Dev Dis Unit, Equipe Accueil 7281, Clermont Ferrand, France; [Pereira, Bruno] Ctr Hosp Univ CHU Clermont Ferrand, Direct Rech Clin, Biostat Unit, Clermont Ferrand, France; [Paugam-Burtz, Catherine; Eurin, Mathilde; Neuschwander, Arthur] Hop Univ Paris Nord Val de Seine, Hop Beaujon, AP HP, Dept Anesthesie & Reanimat, Paris, France; [Paugam-Burtz, Catherine; Eurin, Mathilde; Neuschwander, Arthur] Univ Paris Diderot, Paris, France; [Marret, Emmanuel] Hop Tenon, Dept Anesthesie & Reanimat, F-75970 Paris, France; [Beaussier, Marc; Gutton, Christophe] Hop St Antoine, AP HP, Dept Anesthesie & Reanimat, F-75571 Paris, France; [Lefrant, Jean-Yves] CHU Nimes, Sect Anesthesie, Nimes, France; [Lefrant, Jean-Yves] CHU Nimes, Dept Anestheie & Reanimat, Nimes, France; [Allaouchiche, Bernard] Hop Edouard Herriot, Dept Anesthesie & Reanimat, CHU Lyon, Lyon, France; [Verzilli, Daniel; De Jong, Audrey; Jaber, Samir] Hop St Eloi, Dept Anesthesie & Reanimat B, CHU Montpellier, Montpellier, France; [Verzilli, Daniel; De Jong, Audrey; Jaber, Samir] INSERM, U1046, Montpellier, France; [Verzilli, Daniel; De Jong, Audrey; Jaber, Samir] Univ Montpellier I, Montpellier, France; [Leone, Marc] Hop Nord Marseille, Assistance Publ Hop Marseille, Dept Anesthesie & Reanimat, Marseille, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; CHU Lyon; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Jaber, S (corresponding author), DAR B, 80 Ave Augustin Fliche, F-34295 Montpellier, France.	s-jaber@chu-montpellier.fr	Leone, Marc/P-4835-2016; De Jong, Audrey/N-6406-2018; De Jong, Audrey/AAA-8553-2020	Leone, Marc/0000-0002-3097-758X; De Jong, Audrey/0000-0002-3413-2752; Paugam-Burtz, Catherine/0000-0002-8168-7152; Pereira, Bruno/0000-0003-3778-7161	General Electric Medical Systems; Fresenius Kabi; Fisher and Paykel Healthcare; Baxter; Drager; Hospal; Merck Sharp Dohme; LFB Biomedicaments; Bird; Astute Medical; Astellas; Novartis; Drager France; Maquet France; Fisher; Paykel Healthcare; Abbott; Philips; Pfizer	General Electric Medical Systems(General Electric); Fresenius Kabi; Fisher and Paykel Healthcare; Baxter; Drager; Hospal; Merck Sharp Dohme(Merck & Company); LFB Biomedicaments; Bird; Astute Medical; Astellas(Astellas Pharmaceuticals); Novartis(Novartis); Drager France; Maquet France; Fisher; Paykel Healthcare; Abbott(Abbott Laboratories); Philips; Pfizer(Pfizer)	Dr. Futier reports receiving consulting fees from General Electric Medical Systems, lecture fees from Fresenius Kabi, and reimbursement of travel expenses from Fisher and Paykel Healthcare. Dr Constantin reports receiving consulting fees from Baxter, Fresenius Kabi, Drager, and General Electric Medical Systems, payment for expert testimony from Baxter, Drager, and Fresenius Kabi, lecture fees from General Electric Medical Systems, Drager, Fresenius Kabi, Baxter, Hospal, Merck Sharp & Dohme, and LFB Biomedicaments, payment for the development of educational presentations from Drager, General Electric Medical Systems, Baxter, and Fresenius Kabi, and reimbursement of travel expenses from Bird, Astute Medical, Astellas, Fresenius Kabi, Baxter, and Hospal. Dr. Paugam-Burtz reports receiving consulting fees from Fresenius Kabi, lecture fees and reimbursement of travel expenses from Astellas, and payment for the development of educational presentations from LFB Biomedicaments and Merck Sharp & Dohme. Dr. Allaouchiche reports receiving consulting fees from Fresenius Kabi and lecture fees from Novartis and Astellas. Dr. Leone reports receiving consulting fees from LFB Biomedicaments and lecture fees from Fresenius Kabi and Novartis. Dr. Jaber reports receiving consulting fees from Drager France and Maquet France, lecture fees from Fisher and Paykel Healthcare, Abbott, and Philips, and reimbursement of travel expenses from Pfizer. No other potential conflict of interest relevant to this article was reported.	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; BENDIXEN HH, 1963, NEW ENGL J MED, V269, P991, DOI 10.1056/NEJM196311072691901; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Bouadma L, 2007, CRIT CARE MED, V35, P2601, DOI 10.1097/01.CCM.0000286398.78243.CE; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Futier E, 2011, ANESTHESIOLOGY, V114, P1354, DOI 10.1097/ALN.0b013e31821811ba; Hess DR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.014; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hong CM, 2010, ANESTH ANALG, V110, P1652, DOI 10.1213/ANE.0b013e3181cfc416; Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jaber S, 2012, ANAESTHESIA, V67, P999, DOI 10.1111/j.1365-2044.2012.07218.x; Jaber S, 2010, ANESTHESIOLOGY, V112, P453, DOI 10.1097/ALN.0b013e3181c5e5f2; Keenan SP, 2011, CAN MED ASSOC J, V183, pE195, DOI 10.1503/cmaj.100071; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Lawrence VA, 1996, CHEST, V110, P744, DOI 10.1378/chest.110.3.744; Lellouche F, 2012, ANESTHESIOLOGY, V116, P1072, DOI 10.1097/ALN.0b013e3182522df5; Lim SC, 2004, CRIT CARE MED, V32, P2378, DOI 10.1097/01.CCM.0000147444.58070.72; Mascia L, 2010, JAMA-J AM MED ASSOC, V304, P2620, DOI 10.1001/jama.2010.1796; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Popping DM, 2008, ARCH SURG-CHICAGO, V143, P990, DOI 10.1001/archsurg.143.10.990; Putensen C, 2009, ANN INTERN MED, V151, P897, DOI 10.7326/0003-4819-151-12-200912150-00021; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Severgnini P, 2013, ANESTHESIOLOGY; Shander A, 2011, CRIT CARE MED, V39, P2163, DOI 10.1097/CCM.0b013e31821f0522; Thompson JS, 2003, ARCH SURG-CHICAGO, V138, P596, DOI 10.1001/archsurg.138.6.596; Treschan TA, 2012, BRIT J ANAESTH, V109, P263, DOI 10.1093/bja/aes140; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wrigge H, 2004, ANESTH ANALG, V98, P775; Wrigge H, 2005, INTENS CARE MED, V31, P1379, DOI 10.1007/s00134-005-2767-1; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	812	870	7	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					428	437		10.1056/NEJMoa1301082	http://dx.doi.org/10.1056/NEJMoa1301082			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902482	Bronze			2022-12-28	WOS:000322547400009
J	Qiu, J; Wenz, LS; Zerbes, RM; Oeljeklaus, S; Bohnert, M; Stroud, DA; Wirth, C; Ellenrieder, L; Thornton, N; Kutik, S; Wiese, S; Schulze-Specking, A; Zufall, N; Chacinska, A; Guiard, B; Hunte, C; Warscheid, B; van der Laan, M; Pfanner, N; Wiedemann, N; Becker, T				Qiu, Jian; Wenz, Lena-Sophie; Zerbes, Ralf M.; Oeljeklaus, Silke; Bohnert, Maria; Stroud, David A.; Wirth, Christophe; Ellenrieder, Lars; Thornton, Nicolas; Kutik, Stephan; Wiese, Sebastian; Schulze-Specking, Agnes; Zufall, Nicole; Chacinska, Agnieszka; Guiard, Bernard; Hunte, Carola; Warscheid, Bettina; van der Laan, Martin; Pfanner, Nikolaus; Wiedemann, Nils; Becker, Thomas			Coupling of Mitochondrial Import and Export Translocases by Receptor-Mediated Supercomplex Formation	CELL			English	Article							BETA-BARREL PROTEINS; OUTER-MEMBRANE; EVOLUTIONARY CONSERVATION; BIOGENESIS; CHANNEL; COMPLEX; TOM40; BACTERIA; PATHWAY; DOMAIN	The mitochondrial outer membrane harbors two protein translocases that are essential for cell viability: the translocase of the outer mitochondrial membrane (TOM) and the sorting and assembly machinery (SAM). The precursors of beta-barrel proteins use both translocases-TOM for import to the intermembrane space and SAM for export into the outer membrane. It is unknown if the translocases cooperate and where the beta-barrel of newly imported proteins is formed. We established a position-specific assay for monitoring beta-barrel formation in vivo and in organello and demonstrated that the beta-barrel was formed and membrane inserted while the precursor was bound to SAM. beta-barrel formation was inhibited by SAM mutants and, unexpectedly, by mutants of the central import receptor, Tom22. We show that the cytosolic domain of Tom22 links TOM and SAM into a supercomplex, facilitating precursor transfer on the intermembrane space side. Our study reveals receptor-mediated coupling of import and export translocases as a means of precursor channeling.	[Qiu, Jian; Wenz, Lena-Sophie; Zerbes, Ralf M.; Bohnert, Maria; Stroud, David A.; Wirth, Christophe; Ellenrieder, Lars; Thornton, Nicolas; Kutik, Stephan; Schulze-Specking, Agnes; Zufall, Nicole; Hunte, Carola; van der Laan, Martin; Pfanner, Nikolaus; Wiedemann, Nils; Becker, Thomas] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Qiu, Jian] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Qiu, Jian; Wenz, Lena-Sophie; Zerbes, Ralf M.; Ellenrieder, Lars] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Bohnert, Maria; Kutik, Stephan; Wiese, Sebastian; Hunte, Carola; Warscheid, Bettina; van der Laan, Martin; Pfanner, Nikolaus; Wiedemann, Nils; Becker, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Wiese, Sebastian; Warscheid, Bettina] Univ Freiburg, Fak Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Chacinska, Agnieszka] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; nils.wiedemann@biochemie.uni-freiburg.de	Hunte, Carola/E-4071-2015; Stroud, David A/B-4929-2016; Becker, Thomas/AAS-9404-2020; Qiu, Jian/ABD-2260-2020; Stroud, David Arthur/HGB-4331-2022; Bohnert, Maria/AAB-7704-2019; Pfanner, Nikolaus/AAV-7878-2021	Hunte, Carola/0000-0002-0826-3986; Stroud, David A/0000-0002-2048-3383; Qiu, Jian/0000-0001-7873-0722; Stroud, David Arthur/0000-0002-2048-3383; van der Laan, Martin/0000-0003-0789-9912; Chacinska, Agnieszka/0000-0002-2832-2568; Warscheid, Bettina/0000-0001-5096-1975; Bohnert, Maria/0000-0002-8154-555X; Wiedemann, Nils/0000-0001-8305-6728; Wirth, Christophe/0000-0001-8864-6508	Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	We thank Drs. C. Meisinger and R. Ieva for discussion. This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School), Landesforschungspreis Baden-Wurttemberg, and Bundesministerium fur Bildung und Forschung.	Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; Becker T, 2009, CURR OPIN CELL BIOL, V21, P484, DOI 10.1016/j.ceb.2009.04.002; Bohnert M, 2012, MOL BIOL CELL, V23, P3948, DOI 10.1091/mbc.E12-04-0295; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Klein A, 2012, J CELL BIOL, V199, P599, DOI 10.1083/jcb.201207161; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Shiota T, 2012, MOL BIOL CELL, V23, P3936, DOI 10.1091/mbc.E12-03-0202; Stroud DA, 2011, MOL BIOL CELL, V22, P2823, DOI 10.1091/mbc.E11-02-0148; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200	31	91	91	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					596	608		10.1016/j.cell.2013.06.033	http://dx.doi.org/10.1016/j.cell.2013.06.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911324	Bronze			2022-12-28	WOS:000322629900013
J	Sinclair, A; Morley, J				Sinclair, Alan; Morley, John			Frailty and diabetes	LANCET			English	Editorial Material							OLDER-PEOPLE EDWPOP; WORKING PARTY; MELLITUS; ADULTS		[Sinclair, Alan] Univ Bedfordshire, Inst Diabet Older People, Luton LU2 8LE, Beds, England; [Morley, John] St Louis Univ, Sch Med, Div Geriatr Med & Endocrinol, St Louis, MO USA	University of Bedfordshire; Saint Louis University	Sinclair, A (corresponding author), Univ Bedfordshire, Inst Diabet Older People, Luton LU2 8LE, Beds, England.	sinclair.5@btinternet.com	Morley, John Edward/K-1570-2019					Barnett AH, 2013, LANCET; Chen LK, 2010, AGEING RES REV, V9, pS18, DOI 10.1016/j.arr.2010.08.008; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Mohandas A, 2011, POPUL HEALTH MANAG, V14, P277, DOI 10.1089/pop.2010.0066; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Sinclair AJ, 2000, J ROY COLL PHYS LOND, V34, P240; Sinclair A, 2012, J AM MED DIR ASSOC, V13, P497, DOI 10.1016/j.jamda.2012.04.012; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Speight J, 2013, DIABETIC MED, V30, P74, DOI 10.1111/j.1464-5491.2012.03748.x; Strain WD, 2013, LANCET, V382, P409, DOI 10.1016/S0140-6736(13)60995-2	13	27	27	1	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1386	1387		10.1016/S0140-6736(13)61676-1	http://dx.doi.org/10.1016/S0140-6736(13)61676-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242JW	23948126				2022-12-28	WOS:000326237500006
J	Getahun, H; Raviglione, M				Getahun, Haileyesus; Raviglione, Mario			Household tuberculosis interventions-how confident are we?	LANCET			English	Editorial Material							SOUTH-AFRICA; ZAMSTAR		[Getahun, Haileyesus; Raviglione, Mario] WHO, Global TB Programme, CH-1211 Geneva, Switzerland	World Health Organization	Getahun, H (corresponding author), WHO, Global TB Programme, CH-1211 Geneva, Switzerland.	getahunh@who.int	Getahun, Haileyesus/ABC-5181-2020					Ayles H, 2013, LANCET; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dixon P, 2003, CAN J EXP PSYCHOL, V57, P189, DOI 10.1037/h0087425; Martinson N, 2013, 20 C RETR OPP INF AT; Sismanidis C, 2008, CLIN TRIALS, V5, P316, DOI 10.1177/1740774508094747; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World Health Organization, 2013, SYST SCREEN ACT TUB	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1157	1159		10.1016/S0140-6736(13)61568-8	http://dx.doi.org/10.1016/S0140-6736(13)61568-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SL	23915880				2022-12-28	WOS:000325209100007
J	Johnston, SE; Gratten, J; Berenos, C; Pilkington, JG; Clutton-Brock, TH; Pemberton, JM; Slate, J				Johnston, Susan E.; Gratten, Jacob; Berenos, Camillo; Pilkington, Jill G.; Clutton-Brock, Tim H.; Pemberton, Josephine M.; Slate, Jon			Life history trade-offs at a single locus maintain sexually selected genetic variation	NATURE			English	Article							ANTAGONISTIC SELECTION; POPULATION; WEAPONRY; FITNESS; POLYMORPHISM; ASSOCIATION; RESISTANCE; REVEALS; CAPTURE	Sexual selection, through intra-male competition or female choice, is assumed to be a source of strong and sustained directional selection in the wild(1,2). In the presence of such strong directional selection, alleles enhancing a particular trait are predicted to become fixed within a population, leading to a decrease in the underlying genetic variation(3). However, there is often considerable genetic variation underlying sexually selected traits in wild populations, and consequently, this phenomenon has become a long-discussed issue in the field of evolutionary biology(1,4,5). In wild Soay sheep, large horns confer an advantage in strong intra-sexual competition, yet males show an inherited polymorphism for horn type and have substantial genetic variation in their horn size(6). Here we show that most genetic variation in this trait is maintained by a trade-off between natural and sexual selection at a single gene, relaxin-like receptor 2 (RXFP2). We found that an allele conferring larger horns, Ho+, is associated with higher reproductive success, whereas a smaller horn allele, Ho-P, confers increased survival, resulting in a net effect of overdominance (that is, heterozygote advantage) for fitness at RXFP2. The nature of this trade-off is simple relative to commonly proposed explanations for the maintenance of sexually selected traits, such as genic capture(7,8) ('good genes') and sexually antagonistic selection(5,9). Our results demonstrate that by identifying the genetic architecture of trait variation, we can determine the principal mechanisms maintaining genetic variation in traits under strong selection and explain apparently counter-evolutionary observations.	[Johnston, Susan E.; Gratten, Jacob; Slate, Jon] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Johnston, Susan E.; Berenos, Camillo; Pilkington, Jill G.; Pemberton, Josephine M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Gratten, Jacob] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Clutton-Brock, Tim H.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Sheffield; University of Edinburgh; University of Queensland; University of Cambridge	Johnston, SE (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	Susan.Johnston@ed.ac.uk; j.slate@shef.ac.uk	Gratten, Jacob/G-1485-2011; Slate, Jon/D-2925-2012; Pemberton, Josephine M/F-3100-2010	Gratten, Jacob/0000-0003-1293-409X; Slate, Jon/0000-0003-3356-5123; Johnston, Susan/0000-0002-5623-8902	Natural Environment Research Council (NERC); NERC; European Research Council (ERC); Biotechnology and Biological Sciences Research Council CASE studentship; NERC [NE/G004854/1] Funding Source: UKRI; Natural Environment Research Council [NE/G004854/1, NE/B504314/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the numerous Soay sheep project members and volunteers for collection of data and samples; M. Robinson, J. Hadfield, D. Childs and D. Nussey for statistical advice and discussions; J. McEwan, N. Pickering and J. Kijas for SNP information; D. Beraldi, E. Brown and P. Ellis for laboratory assistance; L. Evenden, J. Gibson and L. Murphy at the Wellcome Trust Clinical Research Facility Genetics Core for genome-wide SNP genotypes; I. Stevenson for database development; G. Prior and A. Ozgul for images; National Trust for Scotland and Scottish Natural Heritage for permission to work on St Kilda; and QinetiQ and Eurest for logistical support. The Soay sheep project is funded by the Natural Environment Research Council (NERC). SNP genotyping was funded by NERC and the European Research Council (ERC). S. E. J. was funded by a Biotechnology and Biological Sciences Research Council CASE studentship.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Andersson Malte, 1994; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Chenoweth SF, 2010, ANNU REV ECOL EVOL S, V41, P81, DOI 10.1146/annurev-ecolsys-102209-144657; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Connallon T, 2012, GENETICS, V190, P1477, DOI 10.1534/genetics.111.137117; Dominik S, 2012, ANIM GENET, V43, P468, DOI 10.1111/j.1365-2052.2011.02271.x; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Falconer DS, 1996, INTRO QUANTITATIVE G; Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Gratten J, 2012, MOL ECOL, V21, P2977, DOI 10.1111/j.1365-294X.2012.05536.x; GREAVES JH, 1977, GENET RES, V30, P257, DOI 10.1017/S0016672300017663; Grubb P., 1974, P195; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hayward AD, 2011, J EVOLUTION BIOL, V24, P1664, DOI 10.1111/j.1420-9101.2011.02300.x; Hedrick P.W., 2011, GENETICS POPULATIONS; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Slate J, 2010, TRENDS GENET, V26, P275, DOI 10.1016/j.tig.2010.03.005; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stevenson IR, 2004, SOAY SHEEP: DYNAMICS AND SELECTION IN AN ISLAND POPULATION, P243; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029	34	191	199	4	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					93	+		10.1038/nature12489	http://dx.doi.org/10.1038/nature12489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23965625				2022-12-28	WOS:000325106000037
J	Hirano, M; Guo, P; McCurley, N; Schorpp, M; Das, S; Boehm, T; Cooper, MD				Hirano, Masayuki; Guo, Peng; McCurley, Nathanael; Schorpp, Michael; Das, Sabyasachi; Boehm, Thomas; Cooper, Max D.			Evolutionary implications of a third lymphocyte lineage in lampreys	NATURE			English	Article							GAMMA-DELTA; ADAPTIVE IMMUNITY; T-CELLS; RECEPTOR; ANTIGEN	Jawed vertebrates (gnathostomes) and jawless vertebrates (cyclostomes) have different adaptive immune systems(1,2). Gnathostomes use T- and B-cell antigen receptors belonging to the immunoglobulin superfamily(3,4). Cyclostomes, the lampreys and hagfish, instead use leucine-rich repeat proteins to construct variable lymphocyte receptors (VLRs), two types of which, VLRA and VLRB, are reciprocally expressed by lymphocytes resembling gnathostome T and B cells(5-7). Here we define another lineage of T-cell-like lymphocytes that express the recently identified VLRC receptors(8,9). Both VLRC+ and VLRA(+) lymphocytes express orthologues of genes that gnathostome gamma delta and alpha beta T cells use for their differentiation, undergo VLRC and VLRA assembly and repertoire diversification in the 'thymoid' gill region, and express their VLRs solely as cell-surface proteins. Our findings suggest that the genetic programmes for two primordial T-cell lineages and a prototypic B-cell lineage were already present in the last common vertebrate ancestor approximately 500 million years ago. We propose that functional specialization of distinct T-cell-like lineages was an ancient feature of a primordial immune system.	[Hirano, Masayuki; Guo, Peng; McCurley, Nathanael; Das, Sabyasachi; Cooper, Max D.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Hirano, Masayuki; Guo, Peng; McCurley, Nathanael; Das, Sabyasachi; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Schorpp, Michael; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Emory University; Emory University; Max Planck Society	Cooper, MD (corresponding author), Emory Univ, Emory Vaccine Ctr, 1462 Clifton Rd North East, Atlanta, GA 30322 USA.	max.cooper@emory.edu		Das, Sabyasachi/0000-0002-9116-9623	National Institutes of Health [R01AI072435, R01GM100151]; Georgia Research Alliance; Max Planck Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. L. Turnbough Jr for providing B. anthracis exosporium, H. Yi for help with electron microscopy, S. A. Durham and R. E. Karaffa II for help with cell sorting, S. Holland for help with gene orthology analysis, Q. Han for help with cloning, and B. R. Herrin, M. Kasahara and Y. Sutoh for suggestions and discussion. M. H., P. G., N.M., S. D. and M. D. C. are supported by National Institutes of Health grants (R01AI072435 and R01GM100151) and the Georgia Research Alliance; M. S. and T. B. are supported by the Max Planck Society.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Das S, 2013, P NATL ACAD SCI USA, V110, P6043, DOI 10.1073/pnas.1302500110; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Kasamatsu J, 2010, P NATL ACAD SCI USA, V107, P14304, DOI 10.1073/pnas.1001910107; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; NAKAJIMA S, 1995, J IMMUNOL, V155, P1117; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Wesch D, 2011, CELL MOL LIFE SCI, V68, P2357, DOI 10.1007/s00018-011-0699-1; Wilson KC, 2004, GROWTH FACTORS, V22, P97, DOI 10.1080/08977190410001704679	21	156	159	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					435	+		10.1038/nature12467	http://dx.doi.org/10.1038/nature12467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23934109	Green Accepted			2022-12-28	WOS:000324545700049
J	Graven, HD; Keeling, RF; Piper, SC; Patra, PK; Stephens, BB; Wofsy, SC; Welp, LR; Sweeney, C; Tans, PP; Kelley, JJ; Daube, BC; Kort, EA; Santoni, GW; Bent, JD				Graven, H. D.; Keeling, R. F.; Piper, S. C.; Patra, P. K.; Stephens, B. B.; Wofsy, S. C.; Welp, L. R.; Sweeney, C.; Tans, P. P.; Kelley, J. J.; Daube, B. C.; Kort, E. A.; Santoni, G. W.; Bent, J. D.			Enhanced Seasonal Exchange of CO2 by Northern Ecosystems Since 1960	SCIENCE			English	Article							ATMOSPHERIC CO2; AMPLITUDE INCREASE; CARBON-DIOXIDE; PLANT-GROWTH; MAUNA-LOA; VEGETATION; CLIMATE; TRENDS; ALASKA; BALANCE	Seasonal variations of atmospheric carbon dioxide (CO2) in the Northern Hemisphere have increased since the 1950s, but sparse observations have prevented a clear assessment of the patterns of long-term change and the underlying mechanisms. We compare recent aircraft-based observations of CO2 above the North Pacific and Arctic Oceans to earlier data from 1958 to 1961 and find that the seasonal amplitude at altitudes of 3 to 6 km increased by 50% for 45 degrees to 90 degrees N but by less than 25% for 10 degrees to 45 degrees N. An increase of 30 to 60% in the seasonal exchange of CO2 by northern extratropical land ecosystems, focused on boreal forests, is implicated, substantially more than simulated by current land ecosystem models. The observations appear to signal large ecological changes in northern forests and a major shift in the global carbon cycle.	[Graven, H. D.; Keeling, R. F.; Piper, S. C.; Welp, L. R.; Bent, J. D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Patra, P. K.] Res Inst Global Change, Yokohama, Kanagawa, Japan; [Stephens, B. B.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Wofsy, S. C.; Daube, B. C.; Santoni, G. W.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Sweeney, C.; Tans, P. P.] NOAA, Boulder, CO USA; [Kelley, J. J.] Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA; [Kort, E. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); National Center Atmospheric Research (NCAR) - USA; Harvard University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Graven, HD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	hgraven@ucsd.edu	Kort, Eric A/F-9942-2012; Sweeney, Colm/AAE-9291-2019; Stephens, Britton B/B-7962-2008; Tans, Pieter/AAG-8273-2019; Patra, Prabir/B-5206-2009	Kort, Eric A/0000-0003-4940-7541; Stephens, Britton B/0000-0002-1966-6182; Tans, Pieter/0000-0002-9883-0787; Patra, Prabir/0000-0001-5700-9389; Sweeney, Colm/0000-0002-4517-0797; Graven, Heather/0000-0003-3934-2502; Welp, Lisa/0000-0001-7125-0478	DOE [DE-SC0005090]; NSF [ATM-0628575, ATM-0628519, ATM-0628388, ATM-0628452, ATM-1036399]; National Center for Atmospheric Research (NCAR); NASA [NNX11AF36G]; U.S. Navy/Office of Naval Research [N00014-67-A-0103-0007]; NSF; Ministry of Education, Culture, Sports, Science and Technology Green Network of Excellence program; Environmental Protection Agency's Science to Achieve Results program	DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Center for Atmospheric Research (NCAR)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA(National Aeronautics & Space Administration (NASA)); U.S. Navy/Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology Green Network of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environmental Protection Agency's Science to Achieve Results program	The Scripps CO<INF>2</INF> Program is supported by DOE grant DE-SC0005090. HIPPO was supported by NSF grants ATM-0628575, ATM-0628519, ATM-0628388, ATM-0628452, and ATM-1036399, and by the National Center for Atmospheric Research (NCAR). Recovery and updating of early aircraft, MLO, and BRW data was supported by NSF grant ATM-1036399. L. R. W. was supported by NASA award NNX11AF36G. Early observations at BRW were funded by U.S. Navy/Office of Naval Research contract N00014-67-A-0103-0007. Online access to all observational data is summarized in section SM10 of the supplementary materials. NCAR is supported by the NSF. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of NOAA, NSF, DOE or NASA. We thank the HIPPO science team and the crew and support staff at the NCAR Research Aviation Facility. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups for producing and making available their model output. Support of the CMIP data sets is provided by the Office of Science, U.S. Department of Energy. C. Roedenbeck provided assistance with the TM3 model. P. K. P. is partially supported by the Ministry of Education, Culture, Sports, Science and Technology Green Network of Excellence program. G. W. S. acknowledges support from the NSF Graduate Research Fellowship Program and the Environmental Protection Agency's Science to Achieve Results program.	BACASTOW RB, 1985, J GEOPHYS RES-ATMOS, V90, P10529, DOI 10.1029/JD090iD06p10529; BISCHOF W, 1966, TELLUS, V18, P155; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; FRA, 2010, GLOB FOR RES ASS 201; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Gurney KR, 2011, TELLUS B, V63, P328, DOI 10.1111/j.1600-0889.2011.00534.x; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Heimann M, 1989, ASPECTS CLIMATE VARI, V55, P277; HOUGHTON RA, 1987, J GEOPHYS RES-ATMOS, V92, P4223, DOI 10.1029/JD092iD04p04223; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Kasischke ES, 2010, CAN J FOREST RES, V40, P1313, DOI 10.1139/X10-098; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; KEELING CD, 1968, J GEOPHYS RES, V73, P4511, DOI 10.1029/JB073i014p04511; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Keeling CD, 2011, TELLUS B, V63, P1, DOI 10.1111/j.1600-0889.2010.00507.x; Keeling R.F., 2009, ATMOSPHERIC CO2 RECO; Kelley J. J., 1969, ANAL CARBON DIOXIDE; Kohlmaier GH, 1989, TELLUS B, V41, P487, DOI 10.1111/j.1600-0889.1989.tb00137.x; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Patra PK, 2011, ATMOS CHEM PHYS, V11, P4163, DOI [10.5194/acp-11-4163-2011, 10.5194/acp-11-12813-2011]; PEARMAN GI, 1981, J GEOPHYS RES-OCEANS, V86, P9839, DOI 10.1029/JC086iC10p09839; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Rodenbeck C, 2003, TELLUS B, V55, P488, DOI 10.1034/j.1600-0889.2003.00033.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schaefer K, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001960; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thoning KW, 2012, ATMOSPHERIC CARBON D; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Verbyla D, 2008, GLOBAL ECOL BIOGEOGR, V17, P547, DOI 10.1111/j.1466-8238.2008.00396.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welp LR, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000126; Wofsy SC, 2011, PHILOS T R SOC A, V369, P2073, DOI 10.1098/rsta.2010.0313; Zimov SA, 1996, CLIMATIC CHANGE, V33, P111, DOI 10.1007/BF00140516; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973	44	260	263	12	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1085	1089		10.1126/science.1239207	http://dx.doi.org/10.1126/science.1239207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	23929948				2022-12-28	WOS:000323933100037
J	Chiu, IM; Heesters, BA; Ghasemlou, N; Von Hehn, CA; Zhao, F; Tran, J; Wainger, B; Strominger, A; Muralidharan, S; Horswill, AR; Wardenburg, JB; Hwang, SW; Carroll, MC; Woolf, CJ				Chiu, Isaac M.; Heesters, Balthasar A.; Ghasemlou, Nader; Von Hehn, Christian A.; Zhao, Fan; Tran, Johnathan; Wainger, Brian; Strominger, Amanda; Muralidharan, Sriya; Horswill, Alexander R.; Wardenburg, Juliane Bubeck; Hwang, Sun Wook; Carroll, Michael C.; Woolf, Clifford J.			Bacteria activate sensory neurons that modulate pain and inflammation	NATURE			English	Article							FORMYL-PEPTIDE RECEPTORS; STAPHYLOCOCCUS-AUREUS; ALPHA-HEMOLYSIN; T-CELLS; IMMUNITY; USA300; MICE; IDENTIFICATION; PATHOGENESIS; NOCICEPTORS	Nociceptor sensory neurons are specialized to detect potentially damaging stimuli, protecting the organism by initiating the sensation of pain and eliciting defensive behaviours. Bacterial infections produce pain by unknown molecular mechanisms, although they are presumed to be secondary to immune activation. Here we demonstrate that bacteria directly activate nociceptors, and that the immune response mediated through TLR2, MyD88, T cells, B cells, and neutrophils and monocytes is not necessary for Staphylococcus aureus-induced pain in mice. Mechanical and thermal hyperalgesia in mice is correlated with live bacterial load rather than tissue swelling or immune activation. Bacteria induce calcium flux and action potentials in nociceptor neurons, in part via bacterial N-formylated peptides and the pore-forming toxin alpha-haemolysin, through distinct mechanisms. Specific ablation of Nav1.8-lineage neurons, which include nociceptors, abrogated pain during bacterial infection, but concurrently increased local immune infiltration and lymphadenopathy of the draining lymph node. Thus, bacterial pathogens produce pain by directly activating sensory neurons that modulate inflammation, an unsuspected role for the nervous systemin host-pathogen interactions.	[Chiu, Isaac M.; Ghasemlou, Nader; Von Hehn, Christian A.; Tran, Johnathan; Wainger, Brian; Strominger, Amanda; Muralidharan, Sriya; Hwang, Sun Wook; Woolf, Clifford J.] Boston Childrens Hosp, Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Chiu, Isaac M.; Ghasemlou, Nader; Von Hehn, Christian A.; Tran, Johnathan; Wainger, Brian; Strominger, Amanda; Muralidharan, Sriya; Hwang, Sun Wook; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Heesters, Balthasar A.; Carroll, Michael C.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Heesters, Balthasar A.; Carroll, Michael C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Heesters, Balthasar A.] Univ Med Ctr, NL-3584 CX Utrecht, Netherlands; [Zhao, Fan] Brandeis Univ, Dept Chem, Quantitat Biol Program, Waltham, MA 02454 USA; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Wardenburg, Juliane Bubeck] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Wardenburg, Juliane Bubeck] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Hwang, Sun Wook] Korea Univ, Grad Sch Med, Seoul 136705, South Korea	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Brandeis University; University of Iowa; University of Chicago; University of Chicago; Korea University; Korea University Medicine (KU Medicine)	Woolf, CJ (corresponding author), Boston Childrens Hosp, Kirby Neurobiol Ctr, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Wainger, Brian/L-7553-2017; Heesters, Balthasar/ABA-7594-2021; Ghasemlou, Nader/AAB-5673-2022; Woolf, Clifford/A-9784-2010; Chiu, Isaac/R-3803-2016; Zhao, Fan/A-3686-2012	Heesters, Balthasar/0000-0002-2909-8481; Ghasemlou, Nader/0000-0002-1696-7342; Chiu, Isaac/0000-0002-0723-4841; Hwang, Sun Wook/0000-0001-8460-7480; Zhao, Fan/0000-0002-6103-5608	NIH [PO1AI078897, 5RO1AI039246, R37NS039518, 5P01NS072040, 5F32NS076297]; FACS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039246, P01AI078897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039518, F32NS076297, P01NS072040, R37NS039518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FACS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Barrett, V. Wang, N. Andrews, C. Melin, Y. Wang, K. Duong, E. Cobos del Moral, O. Babanyi and G. Bryman for technical help. We thank Y.-C. Cheng and R. Becker for technical advice; J. Sprague and A. Yekkirala for developing whole-well imaging; I. Inoshima for recombinant alpha HL; R. Malley, J. Steen and Q. Ma for discussions; J. Chiu for moral support; S. Liberles, B. Xu and V. Kuchroo for mentoring. This work was supported by NIH PO1AI078897, 5RO1AI039246 (M. C. C.), R37NS039518, 5P01NS072040 (C. J. W.), 5F32NS076297 (I. M. C.), FACS, and microarrays at Boston Children's Hospital IDDRC facilities (NIH-P30-HD018655).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Harzenetter MD, 2007, J IMMUNOL, V179, P607, DOI 10.4049/jimmunol.179.1.607; Hill DR, 2002, ORG LETT, V4, P111, DOI 10.1021/ol016976d; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Lang R, 2011, NEUROPEPTIDES, V45, P1, DOI 10.1016/j.npep.2010.10.005; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morgan M, 2011, INJURY, V42, pS11, DOI 10.1016/S0020-1383(11)70127-9; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Pinter E, 2006, PHARMACOL THERAPEUT, V112, P440, DOI 10.1016/j.pharmthera.2006.04.010; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rittner HL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000362; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; WEIHE E, 1991, INT J NEUROSCI, V59, P1; White R J, 2009, J Wound Care, V18, P245; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Zhang XC, 2011, PAIN, V152, P140, DOI 10.1016/j.pain.2010.10.002	53	490	500	9	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					52	+		10.1038/nature12479	http://dx.doi.org/10.1038/nature12479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23965627	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000323888300030
J	Tanvir, NR; Levan, AJ; Fruchter, AS; Hjorth, J; Hounsell, RA; Wiersema, K; Tunnicliffe, RL				Tanvir, N. R.; Levan, A. J.; Fruchter, A. S.; Hjorth, J.; Hounsell, R. A.; Wiersema, K.; Tunnicliffe, R. L.			A 'kilonova' associated with the short-duration gamma-ray burst GRB130603B	NATURE			English	Article							NEUTRON-STAR; R-PROCESS; NUCLEOSYNTHESIS; MERGERS	Short-duration gamma-ray bursts are intense flashes of cosmic gamma-rays, lasting less than about two seconds, whose origin is unclear(1,2). The favoured hypothesis is that they are produced by a relativistic jet created by the merger of two compact stellar objects (specifically two neutron stars or a neutron star and a black hole). This is supported by indirect evidence such as the properties of their host galaxies(3), but unambiguous confirmation of the model is still lacking. Mergers of this kind are also expected to create significant quantities of neutron-rich radioactive species(4,5), whose decay should result in a faint transient, known as a 'kilonova', in the days following the burst(6-8). Indeed, it is speculated that this mechanism may be the predominant source of stable r-process elements in the Universe(5,9). Recent calculations suggest that much of the kilonova energy should appear in the near-infrared spectral range, because of the high optical opacity created by these heavy r-process elements(10-13). Here we report optical and near-infrared observations that provide strong evidence for such an event accompanying the short-duration gamma-ray burst GRB130603B. If this, the simplest interpretation of the data, is correct, then it confirms that compact-object mergers are the progenitors of short-duration gamma-ray bursts and the sites of significant production of r-process elements. It also suggests that kilonovae offer an alternative, unbeamed electromagnetic signature of the most promising sources for direct detection of gravitational waves.	[Tanvir, N. R.; Wiersema, K.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Levan, A. J.; Tunnicliffe, R. L.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Fruchter, A. S.; Hounsell, R. A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Hjorth, J.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark	University of Leicester; University of Warwick; Space Telescope Science Institute; University of Copenhagen; Niels Bohr Institute	Tanvir, NR (corresponding author), Univ Leicester, Dept Phys & Astron, Univ Rd, Leicester LE1 7RH, Leics, England.	nrt3@le.ac.uk	Hjorth, Jens/M-5787-2014; Levan, Andrew/F-6179-2014	Hjorth, Jens/0000-0002-4571-2306; Levan, Andrew/0000-0001-7821-9369	Danish National Research Foundation;  [GO/DD 13497]; STFC [ST/K001000/1, ST/I001719/1, PP/E002064/1, ST/F007159/1, ST/L001306/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F007159/1, PP/E002064/1, ST/I001719/1, ST/L001306/1, ST/K001000/1] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was based partly on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the US National Science Foundation on behalf of the Gemini partnership: the National Science Foundation (United States), the National Research Council (Canada), CONICYT (Chile), the Australian Research Council (Australia), the Ministerio da Ciencia e Tecnologia (Brazil) and SECYT (Argentina). This work was also partly based on observations made using ESO telescopes at the Paranal Observatory. The UKIRT is operated by the Joint Astronomy Centre on behalf of the UK Science and Technology Facilities Council. The UKIRT/WFCAM data used here were pipeline-processed by the Cambridge Astronomical Survey Unit. The HST data were obtained under programme GO/DD 13497. We thank the Space Telescope Science Institute director for approving Director's Discretionary Time observations, and staff, particularly D. Taylor, for expediting them. The Dark Cosmology Centre is funded by the Danish National Research Foundation. This work made use of data supplied by the UK Swift Science Data Centre at the University of Leicester. We acknowledge discussions with A. de Ugarte Postigo and D. Watson.	Aasi J., 2013, LIVING REV REL UNPUB; Abadie J, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/17/173001; Barnes J., 2013, ASTROPHYS J UNPUB; Barthelmy S. D., 2013, GCN CIRC, V14741; Berger E., 2013, ASTROPHYS J UNPUB; Cucchiara A., 2013, ASTROPHYS J UNPUB; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; Fong W, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/56; Fong W, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/189; Freiburghaus C, 1999, ASTROPHYS J, V525, pL121, DOI 10.1086/312343; Golenetskii S., 2013, GCN CIRC; Goriely S, 2011, ASTROPHYS J LETT, V738, DOI 10.1088/2041-8205/738/2/L32; Granot J, 2002, ASTROPHYS J, V568, P820, DOI 10.1086/338966; Grossman D., 2013, MON NOT R ASTR UNPUB; Hjorth J, 2005, ASTROPHYS J, V630, pL117, DOI 10.1086/491733; Hjorth J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0275; Kasen D., 2013, ASTROPHYS J UNPUB; KOUVELIOTOU C, 1993, ASTROPHYS J, V413, pL101, DOI 10.1086/186969; Lee WH, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/1/017; Levan A. J., 2013, GCN CIRC, V14455; Li LX, 1998, ASTROPHYS J, V507, pL59, DOI 10.1086/311680; Melandri A., 2013, GCN CIRC, V14735; Metzger BD, 2010, MON NOT R ASTRON SOC, V406, P2650, DOI 10.1111/j.1365-2966.2010.16864.x; Nakar E, 2007, PHYS REP, V442, P166, DOI 10.1016/j.physrep.2007.02.005; Rosswog S, 2005, ASTROPHYS J, V634, P1202, DOI 10.1086/497062; Rosswog S, 1999, ASTRON ASTROPHYS, V341, P499; Rowlinson A, 2010, MON NOT R ASTRON SOC, V408, P383, DOI 10.1111/j.1365-2966.2010.17115.x; Tanaka M., 2013, ASTROPHYS J IN PRESS; Thoene C. C., 2013, 14744 GCN, V14744	29	499	508	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					547	549		10.1038/nature12505	http://dx.doi.org/10.1038/nature12505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23912055	Green Submitted			2022-12-28	WOS:000323625900027
J	Bombard, Y; Robson, M; Offit, K				Bombard, Yvonne; Robson, Mark; Offit, Kenneth			Revealing the Incidentalome When Targeting the Tumor Genome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT AUTONOMY; RISKS; DUTY; WARN		[Bombard, Yvonne; Robson, Mark; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, New York, NY 10021 USA; [Bombard, Yvonne] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Bombard, Yvonne] Yale Univ, Dept Epidemiol & Publ Hlth, Sch Publ Hlth, New Haven, CT 06520 USA; [Robson, Mark] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Offit, Kenneth] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program,Dept Med, New York, NY USA; [Offit, Kenneth] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, 222 E 70th St, New York, NY 10021 USA.	offitk@mskcc.org		Robson, Mark/0000-0002-3109-1692	CIHR Funding Source: Medline; NCATS NIH HHS [UL1 TR000457] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bombard Y, 2013, EUR J HUM GENET; Bombard Y, 2012, AM J BIOETHICS, V12, P12, DOI 10.1080/15265161.2012.699157; Goddard KAB, 2013, GENET MED, V15, P721, DOI 10.1038/gim.2013.37; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Pasche B, 2011, JAMA-J AM MED ASSOC, V305, P1596, DOI 10.1001/jama.2011.484; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700	8	47	47	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					795	796		10.1001/jama.2013.276573	http://dx.doi.org/10.1001/jama.2013.276573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982363	Green Accepted			2022-12-28	WOS:000323561400015
J	Roehr, B				Roehr, Bob			RURAL HEALTHCARE What healthcare reform means for rural America	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Andrada ER, 2013, CRIT CARE MED; [Anonymous], 2012, AMERICAS HEALTH RANK; Posner C, 2013, THE COUNTIES THAT NE	3	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2013	347								f5093	10.1136/bmj.f5093	http://dx.doi.org/10.1136/bmj.f5093			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211BW	23982211				2022-12-28	WOS:000323880100007
J	Nielsen, OH; Ainsworth, MA				Nielsen, Ole Haagen; Ainsworth, Mark Andrew			Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE CROHNS-DISEASE; CERTOLIZUMAB PEGOL; ULCERATIVE-COLITIS; FACTOR-ALPHA; MONOCLONAL-ANTIBODY; MAINTENANCE THERAPY; DOSE INTENSIFICATION; BIOLOGIC THERAPIES; INFUSION REACTIONS; COLORECTAL-CANCER	A 35-year-old man presents with an exacerbation of Crohn's ileocolitis. He received a diagnosis of Crohn's disease 8 years ago and has been treated on three previous occasions with prednisone. Because of a recurrent need for glucocorticoids, treatment with azathioprine (150 mg per day) was started 1 year ago. He now reports abdominal pain in the right lower quadrant, which developed 1 week ago, with an increase in stool frequency to eight to nine stools per day. Laboratory tests show a hemoglobin concentration of 10.7 g per deciliter and a C-reactive protein level of 21 mg per liter. Magnetic resonance enterography shows inflammation localized to the distal ileum and colon. The patient is referred to a gastroenterologist. An ileocolonoscopy reveals patchy erythema and ulcerations near the hepatic flexure as well as similar lesions in the terminal ileum. Biopsy specimens obtained during colonoscopy show acute and chronic granulomatous inflammation, and the gastroenterologist recommends treatment with a tumor necrosis factor (TNF) inhibitor.	[Nielsen, Ole Haagen; Ainsworth, Mark Andrew] Univ Copenhagen, Herlev Hosp, Fac Hlth & Med Sci, Dept Gastroenterol,Med Sect, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Nielsen, OH (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Gastroenterol D112M, 75 Herlev Ringvej, DK-2730 Herlev, Denmark.	ohn@dadlnet.dk	Ainsworth, Mark Andrew/AAO-6988-2020; Ainsworth, Mark Andrew/CAA-2707-2022; Nielsen, Ole Haagen/AAK-2482-2021	Ainsworth, Mark Andrew/0000-0002-4899-1048; Ainsworth, Mark Andrew/0000-0002-4899-1048; Nielsen, Ole Haagen/0000-0003-4612-8635				Aguas M, 2012, WORLD J GASTROENTERO, V18, P4391, DOI 10.3748/wjg.v18.i32.4391; Akobeng AK, 2005, COCHRANE DB SYST REV, V1; Allez M, 2009, ALIMENT PHARM THER, V31, P92, DOI 10.1111/j.1365-2036.2009.04130.x; Biancone L, 2007, NAT CLIN PRACT GASTR, V4, P78, DOI 10.1038/ncpgasthep0695; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; Bonafede MMK, 2012, ADV THER, V29, P234, DOI 10.1007/s12325-012-0007-y; Bridges CB, 2013, ANN INTERN MED, V158, P191, DOI 10.7326/0003-4819-158-3-201302050-00584; Campi P, 2007, CURR OPIN ALLERGY CL, V7, P393, DOI 10.1097/ACI.0b013e3282ef96df; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Chevaux JB, 2010, INFLAMM BOWEL DIS, V16, P916, DOI 10.1002/ibd.21147; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Dignass AU, 2010, J CROHNS COLITIS, V4, P353, DOI 10.1016/j.crohns.2010.07.001; Feagan BG, 2011, ALIMENT PHARM THER, V33, P541, DOI 10.1111/j.1365-2036.2010.04568.x; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Ghabril M, 2013, CLIN GASTROENTEROL H, V11, P558, DOI 10.1016/j.cgh.2012.12.025; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; GORDON M, 2011, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD008414.PUB2; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hoivik ML, 2013, GUT, V62, P368, DOI 10.1136/gutjnl-2012-302311; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Jess T, 2005, AM J GASTROENTEROL, V100, P2724, DOI 10.1111/j.1572-0241.2005.00287.x; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Katz L, 2012, INFLAMM BOWEL DIS, V18, P2026, DOI 10.1002/ibd.22902; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kiss LS, 2011, ALIMENT PHARM THER, V34, P911, DOI 10.1111/j.1365-2036.2011.04827.x; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P500, DOI 10.1038/ajg.2010.52; Kotlyar DS, 2011, CLIN GASTROENTEROL H, V9, P36, DOI 10.1016/j.cgh.2010.09.016; Lee LYW, 2012, EUR J GASTROEN HEPAT, V24, P1078, DOI 10.1097/MEG.0b013e32835558cf; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1409, DOI 10.1038/ajg.2012.218; Lichtenstein GR, 2010, CLIN GASTROENTEROL H, V8, P600, DOI 10.1016/j.cgh.2010.01.014; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Lim W, 2010, COCHRANE DB SYST REV, V12; Long MD, 2012, GASTROENTEROLOGY, V143, P390, DOI 10.1053/j.gastro.2012.05.004; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; Lozeron P, 2009, ARCH NEUROL-CHICAGO, V66, P490, DOI 10.1001/archneurol.2009.11; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marehbian J, 2009, AM J GASTROENTEROL, V104, P2524, DOI 10.1038/ajg.2009.322; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Nielsen OH, 2013, J CLIN PHARMACOL, V53, P575, DOI 10.1002/jcph.2; Ordas I, 2012, CLIN PHARMACOL THER, V91, P635, DOI 10.1038/clpt.2011.328; Ordas I, 2011, GUT, V60, P1754, DOI 10.1136/gutjnl-2011-300934; Paltiel M, 2008, ARCH DERMATOL, V144, P1190, DOI 10.1001/archderm.144.9.1190; Panccione R, 2011, GASTROENTEROLOGY, V140, pS134; Papa A, 2009, AM J GASTROENTEROL, V104, P1575, DOI 10.1038/ajg.2009.162; Peyrin-Biroulet L, 2008, CLIN GASTROENTEROL H, V6, P644, DOI 10.1016/j.cgh.2008.03.014; Peyrin-Biroulet L, 2011, INFLAMM BOWEL DIS, V17, P471, DOI 10.1002/ibd.21417; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rutgeerts P, 2006, NEW ENGL J MED, V354, P2200; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2007, GUT, V56, P1232, DOI 10.1136/gut.2006.106781; Sandborn WJ, 2007, ANN INTERN MED, V146, P829, DOI 10.7326/0003-4819-146-12-200706190-00159; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2009, GASTROENTEROLOGY, V137, P1250, DOI 10.1053/j.gastro.2009.06.061; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Sandborn WJ, 2010, CLIN GASTROENTEROL H, V8, P688, DOI 10.1016/j.cgh.2010.04.021; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Sandborn WJ, 2013, GASTROENTEROLOGY; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Shah SB, 2008, REV GASTROENTEROL DI, V8, P159; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TARGOWNIK LE, 2013, AM J GASTROENTEROL, V108, P157; Taylor PC, 2010, CURR OPIN PHARMACOL, V10, P308, DOI 10.1016/j.coph.2010.01.005; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; Vermeire S, 2009, BEST PRACT RES CL GA, V23, P101, DOI 10.1016/j.bpg.2008.12.005; Yoshida K, 2012, INFLAMM BOWEL DIS, V18, P1617, DOI 10.1002/ibd.21928; Zhang J, 2012, JAMA-J AM MED ASSOC, V308, P43, DOI 10.1001/jama.2012.7304	82	229	236	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					754	762		10.1056/NEJMct1209614	http://dx.doi.org/10.1056/NEJMct1209614			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964937				2022-12-28	WOS:000323349300012
J	Owen, SF; Tuncdemir, SN; Bader, PL; Tirko, NN; Fishell, G; Tsien, RW				Owen, Scott F.; Tuncdemir, Sebnem N.; Bader, Patrick L.; Tirko, Natasha N.; Fishell, Gord; Tsien, Richard W.			Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons	NATURE			English	Article							RAT HIPPOCAMPUS; FEEDFORWARD INHIBITION; PYRAMIDAL NEURONS; SYNAPTIC DEPRESSION; AUTISM; NOREPINEPHRINE; MOTHERHOOD; ACTIVATION; EXCITATION; FREQUENCY	Neuromodulatory control by oxytocin is essential to a wide range of social(1,2), parental(3) and stress-related behaviours(4). Autism spectrum disorders (ASD) are associated with deficiencies in oxytocin levels(5) and with genetic alterations of the oxytocin receptor (OXTR)(6). Thirty years ago, Muhlethaler et al.(7) found that oxytocin increases the firing of inhibitory hippocampal neurons, but it remains unclear how elevated inhibition could account for the ability of oxytocin to improve information processing in the brain. Here we describe in mammalian hippocampus a simple yet powerful mechanism by which oxytocin enhances cortical information transfer while simultaneously lowering background activity, thus greatly improving the signal-to-noise ratio. Increased fast-spiking interneuron activity not only suppresses spontaneous pyramidal cell firing, but also enhances the fidelity of spike transmission and sharpens spike timing. Use-dependent depression at the fast-spiking interneuron-pyramidal cell synapse is both necessary and sufficient for the enhanced spike throughput. We show the generality of this novel circuit mechanism by activation of fast-spiking interneurons with cholecystokinin or channelrhodopsin-2. This provides insight into how a diffusely delivered neuromodulator can improve the performance of neural circuitry that requires synapse specificity and millisecond precision.	[Owen, Scott F.; Bader, Patrick L.; Tsien, Richard W.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Tuncdemir, Sebnem N.; Bader, Patrick L.; Tirko, Natasha N.; Fishell, Gord; Tsien, Richard W.] NYU, Inst Neurosci, New York, NY 10016 USA	Stanford University; New York University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	richard.tsien@nyumc.org		Owen, Scott/0000-0001-6294-7513; Fishell, Gordon/0000-0002-9640-9278; Tuncdemir, Sebnem/0000-0003-0573-0179	Burnett Family Fund; Mosbacher Fund; Mathers Foundation; National Institute of Mental Health [MH064070, MH071739]; National Institute of Neurological Disorders and Stroke [NS024067]; Simons Foundation [95395]; NDSEG fellowship; NIMH-NRSA fellowship [F31MH084430]; SNSF; SFGBM fellowship [PASMP3_140063/1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH071739, R56MH064070, R01MH064070, F31MH084430, R01MH071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067, R01NS074785] Funding Source: NIH RePORTER	Burnett Family Fund; Mosbacher Fund; Mathers Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; NDSEG fellowship; NIMH-NRSA fellowship; SNSF(Swiss National Science Foundation (SNSF)); SFGBM fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Foldy for generous assistance with techniques for interneuron recording and classification, and thank Y. Li, M. Tadross, A. Mitra, D. Poburko, L. Prolo, J. Huguenard, S. Hestrin, D. Madison, L. Luo, K. Pelkey and K. Deisseroth for discussion and comments. This work was supported by the Burnett Family Fund, the Mosbacher Fund, and the Mathers Foundation, as well as grants from the National Institute of Mental Health (MH064070, MH071739), the National Institute of Neurological Disorders and Stroke (NS024067) and the Simons Foundation (95395). S.F.O. is supported by an NDSEG fellowship and by an NIMH-NRSA fellowship (F31MH084430). P.L.B. is supported by an SNSF and SFGBM fellowship (PASMP3_140063/1).	Alberi S, 1997, EUR J NEUROSCI, V9, P2605, DOI 10.1111/j.1460-9568.1997.tb01690.x; Anagnostou E, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-16; Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bergles DE, 1996, J NEUROSCI, V16, P572; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Hao J, 2009, P NATL ACAD SCI USA, V106, P21906, DOI 10.1073/pnas.0912022106; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Kuo SP, 2011, NEURON, V71, P306, DOI 10.1016/j.neuron.2011.05.039; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; MUHLETHALER M, 1984, BRAIN RES, V308, P97, DOI 10.1016/0006-8993(84)90921-1; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SEGAL M, 1976, BRAIN RES, V107, P513, DOI 10.1016/0006-8993(76)90141-4; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Zaninetti M, 2000, EUR J NEUROSCI, V12, P3975, DOI 10.1046/j.1460-9568.2000.00290.x	36	226	230	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					458	+		10.1038/nature12330	http://dx.doi.org/10.1038/nature12330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23913275	Green Accepted			2022-12-28	WOS:000323316100035
J	Cochat, P; Rumsby, G				Cochat, Pierre; Rumsby, Gill			Primary Hyperoxaluria	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ALANINE-GLYOXYLATE AMINOTRANSFERASE; GENOTYPE-PHENOTYPE CORRELATION; CALCIUM-OXALATE UROLITHIASIS; SHOCK-WAVE LITHOTRIPSY; STAGE RENAL-DISEASE; 4-HYDROXY-2-OXOGLUTARATE ALDOLASE; KIDNEY-TRANSPLANTATION; LIVER-TRANSPLANTATION; MUTATION ANALYSIS; URINARY OXALATE	The primary hyperoxalurias are a group of autosomal recessive disorders of endogenous oxalate overproduction. This review discusses the major biochemical, genetic, and therapeutic advances that have led to a better understanding of the disease. The primary hyperoxalurias are a group of autosomal recessive disorders involving the overproduction of oxalate. Although the initial recognition of the disease is attributed to Lepoutre, who reported it in 1925,(1) the elucidation of the underlying biochemical abnormalities occurred many years later. This review discusses the major biochemical, genetic, and therapeutic advances that have led to a better understanding of primary hyperoxaluria. Oxalate, a dicarboxylic acid (HOOC-COOH), is a highly insoluble end product of metabolism in humans. It is excreted almost entirely by the kidney, particularly in the form of its calcium salt, and has a tendency to crystallize in ...	[Cochat, Pierre] Hosp Civils Lyon, Ctr Reference Malad Renales Rares Nephrogones, Lyon, France; [Cochat, Pierre] Hosp Civils Lyon, Ctr Rech Sci, UMR 5305, Lyon, France; [Cochat, Pierre] Univ Lyon 1, F-69365 Lyon, France; [Rumsby, Gill] Univ Coll London Hosp, London, England	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University College London Hospitals NHS Foundation Trust; University of London; University College London	Cochat, P (corresponding author), Hop Femme Mere Enfants, Serv Nephrol Rhumatol Dermatol Pediat, 59 Blvd Pinel, F-69677 Bron, France.	pierre.cochat@chu-lyon.fr			Lucane Pharma; Advicenne Pharma; Raptor Pharmaceutical; Novartis; Pfizer; Fresenius Medical Care; Amgen; Baxter; Merck Serono; Astellas; Sandoz	Lucane Pharma; Advicenne Pharma; Raptor Pharmaceutical; Novartis(Novartis); Pfizer(Pfizer); Fresenius Medical Care; Amgen(Amgen); Baxter; Merck Serono(Merck & Company); Astellas(Astellas Pharmaceuticals); Sandoz(Novartis)	Dr. Cochat reports receiving consulting fees from Lucane Pharma and Advicenne Pharma, providing expert testimony for Centre d'Investigation Clinique-Robert-Debre, and receiving support for travel expenses through his institution from Raptor Pharmaceutical, Novartis, Pfizer, Fresenius Medical Care, Amgen, Baxter, Merck Serono, Astellas, and Sandoz. No other potential conflict of interest relevant to this article was reported.	Al-Abadi E, 2013, PEDIATR NEPHROL, V28, P1085, DOI 10.1007/s00467-013-2424-9; Bacchetta J, 2010, PEDIATR NEPHROL, V25, P1081, DOI 10.1007/s00467-010-1453-x; Baker PRS, 2004, AM J PHYSIOL-CELL PH, V287, pC1359, DOI 10.1152/ajpcell.00238.2004; Bakshi NA, 2012, BLOOD, V120, P8, DOI 10.1182/blood-2011-12-400192; BARRATT TM, 1991, ARCH DIS CHILD, V66, P501, DOI 10.1136/adc.66.4.501; Beck BB, 2013, EUR J HUM GENET, V21, P162, DOI 10.1038/ejhg.2012.139; Beck BB, 2013, EXPERT OPIN INV DRUG, V22, P117, DOI 10.1517/13543784.2013.741587; Beck BB, 2012, NEPHROL DIAL TRANSPL, V27, P2984, DOI 10.1093/ndt/gfr776; Behnam JI, 2006, BIOCHEM J, V394, P409, DOI 10.1042/BJ20051397; Belostotsky R, 2012, J MOL MED, V90, P1497, DOI 10.1007/s00109-012-0930-z; Belostotsky R, 2010, AM J HUM GENET, V87, P392, DOI 10.1016/j.ajhg.2010.07.023; Bergstralh EJ, 2010, AM J TRANSPLANT, V10, P2493, DOI 10.1111/j.1600-6143.2010.03271.x; Blomgren PM, 1997, ANAT REC, V249, P341, DOI 10.1002/(SICI)1097-0185(199711)249:3<341::AID-AR4>3.0.CO;2-X; COCHAT P, 1995, NEPHROL DIAL TRANSPL, V10, P3, DOI 10.1093/ndt/10.supp8.3; Cochat P, 2013, PEDIAT NEPHROL; Cochat P, 2012, NEPHROL DIAL TRANSPL, V27, P1729, DOI 10.1093/ndt/gfs078; Cregeen DP, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9200; Daudon M, 1998, J NEPHROL, V11, P51; Daudon M, 2008, NEW ENGL J MED, V359, P100, DOI 10.1056/NEJMc0800990; Dietzen DJ, 1997, CLIN CHEM, V43, P1315; Fargue S, 2013, BBA-MOL BASIS DIS, V1832, P1776, DOI 10.1016/j.bbadis.2013.04.010; Fargue S, 2013, J BIOL CHEM, V288, P2475, DOI 10.1074/jbc.M112.432617; Fargue S, 2009, KIDNEY INT, V76, P767, DOI 10.1038/ki.2009.237; Frishberg Y, 2005, AM J NEPHROL, V25, P269, DOI 10.1159/000086357; Guha C, 2005, AM J NEPHROL, V25, P161, DOI 10.1159/000085408; Harambat J, 2012, CLIN J AM SOC NEPHRO, V7, P458, DOI 10.2215/CJN.07430711; Harambat J, 2010, KIDNEY INT, V77, P443, DOI 10.1038/ki.2009.435; Hatch M, 2011, AM J PHYSIOL-GASTR L, V300, pG461, DOI 10.1152/ajpgi.00434.2010; Hoppe B, 1998, KIDNEY INT, V54, P921, DOI 10.1046/j.1523-1755.1998.00066.x; Hoppe B, 1999, KIDNEY INT, V56, P268, DOI 10.1046/j.1523-1755.1999.00546.x; Hoppe B, 2012, NAT REV NEPHROL, V8, P467, DOI 10.1038/nrneph.2012.113; Hoppe B, 2011, NEPHROL DIAL TRANSPL, V26, P3609, DOI 10.1093/ndt/gfr107; Hopper ED, 2008, J BIOL CHEM, V283, P30493, DOI 10.1074/jbc.M803525200; Illies F, 2006, KIDNEY INT, V70, P1642, DOI 10.1038/sj.ki.5001806; Jamieson NV, 1998, J NEPHROL, V11, P36; Jiang JL, 2008, TRANSPLANTATION, V85, P1253, DOI 10.1097/TP.0b013e31816de49e; Kamoun A, 1996, PEDIATR NEPHROL, V10, P479, DOI 10.1007/s004670050143; Kemper MJ, 1998, J NEPHROL, V11, P46; Knight J, 2012, AM J PHYSIOL-RENAL, V302, pF688, DOI 10.1152/ajprenal.00473.2011; Lepoutre C, 1925, J UROLOGY, V20, P424; Lieske JC, 2005, AM J NEPHROL, V25, P290, DOI 10.1159/000086360; Lorenzo V, 2006, KIDNEY INT, V70, P1115, DOI 10.1038/sj.ki.5001758; Malla I, 2009, PEDIATR TRANSPLANT, V13, P782, DOI 10.1111/j.1399-3046.2008.01049.x; Marangella M, 2004, UROL INT, V72, P6, DOI 10.1159/000076583; Mbarek IB, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-25; Milliner DS, 2005, AM J NEPHROL, V25, P154, DOI 10.1159/000085407; Milliner DS, 2001, KIDNEY INT, V59, P31, DOI 10.1046/j.1523-1755.2001.00462.x; Monico CG, 2011, CLIN J AM SOC NEPHRO, V6, P2289, DOI 10.2215/CJN.02760311; Monico CG, 2005, KIDNEY INT, V67, P1704, DOI 10.1111/j.1523-1755.2005.00267.x; Mookadam F, 2010, CIRC J, V74, P2403, DOI 10.1253/circj.CJ-10-0107; Mor E, 2013, LIVER TRANSPLANT, V19, P646, DOI 10.1002/lt.23642; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Pais VM, 2005, UROL RES, V33, P390, DOI 10.1007/s00240-005-0483-5; Punjabi OS, 2011, J AAPOS, V15, P214, DOI 10.1016/j.jaapos.2010.12.015; Riedel TJ, 2012, BBA-MOL BASIS DIS, V1822, P1544, DOI 10.1016/j.bbadis.2012.06.014; Riedel TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026021; Rumsby G, 2005, UROL RES, V33, P318, DOI 10.1007/s00240-005-0494-2; Rumsby G, 1998, J NEPHROL, V11, P13; Rumsby G, 2001, NEPHROL DIAL TRANSPL, V16, P1697, DOI 10.1093/ndt/16.8.1697; Sahin G, 2005, CLIN NEPHROL, V63, P402; Salido EC, 2006, P NATL ACAD SCI USA, V103, P18249, DOI 10.1073/pnas.0607218103; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Sikora P, 2008, KIDNEY INT, V73, P1181, DOI 10.1038/ki.2008.63; Straub M, 2010, PEDIATR NEPHROL, V25, P1239, DOI 10.1007/s00467-009-1394-4; van der Hoeven SM, 2012, NEPHROL DIAL TRANSPL, V27, P3855, DOI 10.1093/ndt/gfs320; van Woerden CS, 2004, KIDNEY INT, V66, P746, DOI 10.1111/j.1523-1755.2004.00796.x; van Woerden CS, 2003, NEPHROL DIAL TRANSPL, V18, P273, DOI 10.1093/ndt/18.2.273; Williams EL, 2012, NEPHROL DIAL TRANSPL, V27, P3191, DOI 10.1093/ndt/gfs039; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; WILLIAMS HE, 1968, J LAB CLIN MED, V71, P495; Zhang XX, 2001, ACTA CRYSTALLOGR D, V57, P1936, DOI 10.1107/S0907444901017334	71	288	314	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					649	658		10.1056/NEJMra1301564	http://dx.doi.org/10.1056/NEJMra1301564			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944302				2022-12-28	WOS:000326354500011
J	Ferner, R				Ferner, Robin			A bee in the bonnet about honey and healing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Bayram NA, 2012, J EMERG MED, V43, pE389, DOI 10.1016/j.jemermed.2011.02.021; Dat AD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008762.pub2; Dumville JC, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD009110.PUB3; Dumville JC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009111.pub3; Dumville JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009099.pub2; Gamgee JS., 1861, BRIT MED J, V1, P211; Gamgee JS., 1857, BRIT MED J; Jull AB, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005083.pub3; Kapadia HM, 2002, J ROY SOC MED, V95, P96, DOI 10.1258/jrsm.95.2.96; Nelson EA, 2007, COCHRANE DB SYST REV, V1; Smith MEB, 2013, ANN INTERN MED, V159, P39, DOI 10.7326/0003-4819-159-1-201307020-00007; Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2; Vermeulen H, 2004, COCHRANE DB SYST REV, V2, pCD003554; Vermeulen H, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005486.PUB.2	14	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2013	347								f5015	10.1136/bmj.f5015	http://dx.doi.org/10.1136/bmj.f5015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203ZD	23950196				2022-12-28	WOS:000323332700002
J	Ip, H; Schomberg, LEE; Ahmed, L				Ip, Hugh; Schomberg, Lucy Ellen Eyre; Ahmed, Liju			Pleural effusions in a patient with tuberculosis on dialysis	LANCET			English	Editorial Material							CHYLOTHORAX		[Ip, Hugh; Schomberg, Lucy Ellen Eyre; Ahmed, Liju] NHS Fdn Trust, St Thomas Hosp, Dept Resp Med, London, England	Guy's & St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust	Ip, H (corresponding author), St Thomas Hosp, Dept Resp Med, London SE1 7EH, England.	hughip@gmail.com	Ahmed, Liju/I-6286-2018	Ahmed, Liju/0000-0001-7722-8829; Ip, Hugh/0000-0001-7423-5054	Department of Health [1793] Funding Source: Medline; National Institute for Health Research [ACF-2012-17-007] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ananthan VS, 2012, LUNG INDIA, V29, P166, DOI 10.4103/0970-2113.95332; Huggins JT, 2010, SEMIN RESP CRIT CARE, V31, P743, DOI 10.1055/s-0030-1269834; Karapolat S, 2008, SURG TODAY, V38, P938, DOI 10.1007/s00595-007-3739-6; McGrath EE, 2010, RESP MED, V104, P1, DOI 10.1016/j.rmed.2009.08.010; VENNERA MC, 1983, THORAX, V38, P694, DOI 10.1136/thx.38.9.694	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					570	570		10.1016/S0140-6736(13)61643-8	http://dx.doi.org/10.1016/S0140-6736(13)61643-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201SD	23931925				2022-12-28	WOS:000323162400035
J	Rickman, C; Bickmore, WA				Rickman, Colin; Bickmore, Wendy A.			Flashing a Light on the Spatial Organization of Transcription	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; FACTORIES; DYNAMICS; GENE		[Rickman, Colin] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland; [Rickman, Colin; Bickmore, Wendy A.] Edinburgh Super Resolut Imaging Consortium, Edinburgh, Midlothian, Scotland; [Bickmore, Wendy A.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Heriot Watt University; University of Edinburgh	Rickman, C (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland.	wendy.bickmore@igmm.ed.ac.uk	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735; Rickman, Colin/0000-0001-8938-524X	Medical Research Council [MC_PC_U127527202] Funding Source: researchfish; Medical Research Council [MR/K01563X/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MR/K01563X/1, MC_PC_U127527202] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cisse II, 2013, SCIENCE, V341, P664, DOI 10.1126/science.1239053; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Iborra FJ, 1996, J CELL SCI, V109, P1427; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; McEvoy AL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-106; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017	9	3	3	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					621	622		10.1126/science.1242889	http://dx.doi.org/10.1126/science.1242889			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929972				2022-12-28	WOS:000322884800025
J	Simons, M; Eichmann, A				Simons, Michael; Eichmann, Anne			Lymphatics Are in My Veins	SCIENCE			English	Editorial Material							VASCULATURE; PROX1; DIFFERENTIATION; MATURATION; VESSELS		[Simons, Michael; Eichmann, Anne] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Eichmann, Anne] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Eichmann, Anne] Coll France, Ctr Interdisciplinary Res Biol, Inserm 1050, F-75231 Paris, France	Yale University; Yale University; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Simons, M (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06510 USA.	michael.simons@yale.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111504] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL111504] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; [Anonymous], 2013, YAL N AM VASC BIOL O; Chen CY, 2012, J CLIN INVEST, V122, P2006, DOI 10.1172/JCI57513; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Deng Y, 2013, J CLIN INVEST, V123, P1202, DOI 10.1172/JCI63034; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Koltowska K, 2013, DEVELOPMENT, V140, P1857, DOI 10.1242/dev.089565; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Murtomaki A, 2013, DEVELOPMENT, V140, P2365, DOI 10.1242/dev.083865; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232	19	12	12	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					622	624		10.1126/science.1243452	http://dx.doi.org/10.1126/science.1243452			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929973	Green Accepted			2022-12-28	WOS:000322884800026
J	Lebwohl, B; Granath, F; Ekbom, A; Smedby, KE; Murray, JA; Neugut, AI; Green, PHR; Ludvigsson, JF				Lebwohl, Benjamin; Granath, Fredrik; Ekbom, Anders; Smedby, Karin E.; Murray, Joseph A.; Neugut, Alfred I.; Green, Peter H. R.; Ludvigsson, Jonas F.			Mucosal Healing and Risk for Lymphoproliferative Malignancy in Celiac Disease A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							GLUTEN-FREE DIET; T-CELL LYMPHOMA; SMALL-INTESTINAL HISTOPATHOLOGY; HISTOLOGICAL FOLLOW-UP; NON-HODGKIN-LYMPHOMA; VILLOUS ATROPHY; MORTALITY; RECOVERY; PREVALENCE; SPRUE	Background: Celiac disease (CD) is associated with an increased risk for lymphoproliferative malignancy (LPM). Whether this risk is affected by the results of follow-up intestinal biopsy, performed to document mucosal healing, is unknown. Objective: To examine the association between mucosal healing in CD and subsequent LPM. Design: Population-based cohort study. Setting: 28 pathology departments in Sweden. Patients: 7625 patients with CD who had follow-up biopsy after initial diagnosis. Measurements: The risk for LPM was compared with that of the general population by using expected rates. The rate of LPM in patients with persistent villous atrophy was compared with that of those with mucosal healing by using Cox regression. Results: Among 7625 patients with CD and follow-up biopsy, 3308 (43%) had persistent villous atrophy. The overall risk for LPM was higher than that in the general population (standardized incidence ratio [SIR], 2.81 [95% CI, 2.10 to 3.67]) and was greater among patients with persistent villous atrophy (SIR, 3.78 [CI, 2.71 to 5.12]) than among those with mucosal healing (SIR, 1.50 [CI, 0.77 to 2.62]). Persistent villous atrophy compared with mucosal healing was associated with an increased risk for LPM (hazard ratio [HR], 2.26 [CI, 1.18 to 4.34]). The risk for T-cell lymphoma was increased (HR, 3.51 [CI, 0.75 to 16.34]) but not for B-cell lymphoma (HR, 0.97 [CI, 0.21 to 4.49]). Limitation: No data on dietary adherence. Conclusion: Increased risk for LPM in CD is associated with the follow-up biopsy results, with a higher risk among patients with persistent villous atrophy. Follow-up biopsy may effectively stratify patients with CD by risk for subsequent LPM.	Columbia Univ, Coll Phys & Surg, New York, NY USA; Karolinska Univ Hosp, Stockholm, Sweden; Karolinska Inst, Stockholm, Sweden; Mayo Clin, Coll Med, Rochester, MN USA; Orebro Univ Hosp, SE-70185 Orebro, Sweden	Columbia University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Mayo Clinic; Orebro University	Ludvigsson, JF (corresponding author), Orebro Univ Hosp, Dept Pediat, SE-70185 Orebro, Sweden.	jonasludvigsson@yahoo.com	Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602	National Institutes of Health; American-Scandinavian Foundation; Celiac Sprue Association; Orebro University Hospital; Karolinska Institutet; Swedish Society of Medicine; Swedish Research Council; Swedish Celiac Society; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071003, R56DK071003, R01DK057892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American-Scandinavian Foundation; Celiac Sprue Association; Orebro University Hospital; Karolinska Institutet(Karolinska Institutet); Swedish Society of Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Celiac Society; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Primary Funding Source: National Institutes of Health, The American-Scandinavian Foundation, Celiac Sprue Association, Orebro University Hospital, Karolinska Institutet, Swedish Society of Medicine, Swedish Research Council, and Swedish Celiac Society.	Askling J, 2002, GASTROENTEROLOGY, V123, P1428, DOI 10.1053/gast.2002.36585; Bardella MT, 2007, HISTOPATHOLOGY, V50, P465, DOI 10.1111/j.1365-2559.2007.02621.x; Biagi F, 2004, NUTR REV, V62, P360, DOI [10.1301/nr.2004.sept.360-363, 10.1111/j.1753-4887.2004.tb00062.x]; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Catassi C, 2002, JAMA-J AM MED ASSOC, V287, P1413, DOI 10.1001/jama.287.11.1413; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Ciacci C, 2002, DIGESTION, V66, P178, DOI 10.1159/000066757; Ciclitira PJ, 2001, GASTROENTEROLOGY, V120, P1526, DOI 10.1053/gast.2001.24056; Collin P, 2004, GASTROINTEST ENDOSC, V59, P158, DOI 10.1016/S0016-5107(03)01311-7; Elfstrom P, 2011, JNCI-J NATL CANCER I, V103, P436, DOI 10.1093/jnci/djq564; Gao Y, 2009, GASTROENTEROLOGY, V136, P91, DOI 10.1053/j.gastro.2008.09.031; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Hutchinson JM, 2010, QJM-INT J MED, V103, P511, DOI 10.1093/qjmed/hcq076; Kaukinen K, 2007, ALIMENT PHARM THER, V25, P1237, DOI 10.1111/j.1365-2036.2007.03311.x; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Leffler D, 2011, JAMA-J AM MED ASSOC, V306, P1582, DOI [10.1001/jama.2011.1312, 10.1001/jama.306.14.1582]; Leffler DA, 2009, CLIN GASTROENTEROL H, V7, P530, DOI 10.1016/j.cgh.2008.12.032; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Olen O, 2011, DIGEST LIVER DIS, V43, P862, DOI 10.1016/j.dld.2011.07.012; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sharaiha RZ, 2012, CANCER-AM CANCER SOC, V118, P3786, DOI 10.1002/cncr.26700; Smedby KE, 2005, GUT, V54, P54, DOI 10.1136/gut.2003.032094; Tuire I, 2012, AM J GASTROENTEROL, V107, P1563, DOI 10.1038/ajg.2012.220; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C	33	155	157	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					169	+		10.7326/0003-4819-159-3-201308060-00006	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201RD	23922062	Green Accepted			2022-12-28	WOS:000323159800002
J	Bollrath, J; Powrie, F				Bollrath, Julia; Powrie, Fiona			Feed Your T-regs More Fiber	SCIENCE			English	Editorial Material							PROMOTES; CELLS		[Bollrath, Julia; Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Expt Med Div NDM, Oxford OX3 9DU, England	University of Oxford	Bollrath, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Translat Gastroenterol Unit, Expt Med Div NDM, Oxford OX3 9DU, England.	fiona.powrie@path.ox.ac.uk			Biotechnology and Biological Sciences Research Council [BB/I005609/1] Funding Source: researchfish; Wellcome Trust [095688] Funding Source: Medline; BBSRC [BB/I005609/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kim S, 2012, ARCH PHARM RES, V35, P1505, DOI 10.1007/s12272-012-0900-6; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	11	39	42	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					463	464		10.1126/science.1242674	http://dx.doi.org/10.1126/science.1242674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908210				2022-12-28	WOS:000322586700024
J	Poznik, GD; Henn, BM; Yee, MC; Sliwerska, E; Euskirchen, GM; Lin, AA; Snyder, M; Quintana-Murci, L; Kidd, JM; Underhill, PA; Bustamante, CD				Poznik, G. David; Henn, Brenna M.; Yee, Muh-Ching; Sliwerska, Elzbieta; Euskirchen, Ghia M.; Lin, Alice A.; Snyder, Michael; Quintana-Murci, Lluis; Kidd, Jeffrey M.; Underhill, Peter A.; Bustamante, Carlos D.			Sequencing Y Chromosomes Resolves Discrepancy in Time to Common Ancestor of Males Versus Females	SCIENCE			English	Article							MITOCHONDRIAL-DNA; MODERN HUMANS; TREE; DEPENDENCY; AMERICANS; EVOLUTION; ORIGINS; AFRICA	The Y chromosome and the mitochondrial genome have been used to estimate when the common patrilineal and matrilineal ancestors of humans lived. We sequenced the genomes of 69 males from nine populations, including two in which we find basal branches of the Y-chromosome tree. We identify ancient phylogenetic structure within African haplogroups and resolve a long-standing ambiguity deep within the tree. Applying equivalent methodologies to the Y chromosome and the mitochondrial genome, we estimate the time to the most recent common ancestor (T-MRCA) of the Y chromosome to be 120 to 156 thousand years and the mitochondrial genome T-MRCA to be 99 to 148 thousand years. Our findings suggest that, contrary to previous claims, male lineages do not coalesce significantly more recently than female lineages.	[Poznik, G. David] Stanford Univ, Sch Med, Program Biomed Informat, Stanford, CA 94305 USA; [Poznik, G. David] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Henn, Brenna M.; Yee, Muh-Ching; Euskirchen, Ghia M.; Snyder, Michael; Kidd, Jeffrey M.; Underhill, Peter A.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Sliwerska, Elzbieta; Kidd, Jeffrey M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Sliwerska, Elzbieta; Kidd, Jeffrey M.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lin, Alice A.] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Quintana-Murci, Lluis] Inst Pasteur, Unit Human Evolutionary Genet, F-75015 Paris, France; [Quintana-Murci, Lluis] CNRS, URA3012, F-75015 Paris, France	Stanford University; Stanford University; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	cdbustam@stanford.edu	Quintana-Murci, Lluis/AAB-7468-2022	Kidd, Jeffrey/0000-0002-9631-1465; Quintana-Murci, Lluis/0000-0003-2429-6320; Snyder, Michael/0000-0003-0784-7987; Bustamante, Carlos D./0000-0002-4187-7920	National Library of Medicine training grant [LM-07033]; NSF [DGE-1147470]; NIH [3R01HG003229, DP5OD009154]; Institut Pasteur; CNRS; Foundation Simone et Cino del Duca Research Grant; Ancestry.com; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009154] Funding Source: NIH RePORTER	National Library of Medicine training grant; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Foundation Simone et Cino del Duca Research Grant; Ancestry.com; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank O. Cornejo, S. Gravel, D. Siegmund, and E. Tsang for helpful discussions; M. Sikora and H. Costa for mapping reads from Gabonese samples; and H. Cann for assistance with HGDP samples. This work was supported by National Library of Medicine training grant LM-07033 and NSF graduate research fellowship DGE-1147470 (G. D. P.); NIH grant 3R01HG003229 (B. M. H. and C. D. B.); NIH grant DP5OD009154 (J.M.K. and E. S.); and Institut Pasteur, a CNRS Maladies Infectieuses Emergentes Grant, and a Foundation Simone et Cino del Duca Research Grant (L. Q. M.). P. A. U. consulted for, P. A. U. and B. M. H. have stock in, and C. D. B. is on the advisory board of a project at 23andMe. C. D. B. is on the scientific advisory boards of Personalis, Inc.; InVitae (formerly Locus Development, Inc.); and Ancestry.com. M. S. is a scientific advisory member and founder of Personalis, a scientific advisory member for Genapsys Former, and a consultant for Illumina and Beckman Coulter Society for American Medical Pathology. B. M. H. formerly had a paid consulting relationship with Ancestry.com. Variants have been deposited to dbSNP (ss825679106-825690384). Individual level genetic data are available, through a data access agreement to respect the privacy of the participants for transfer of genetic data, by contacting C.D.B.	CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tang H, 2002, GENETICS, V161, P447; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	23	142	146	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					562	565		10.1126/science.1237619	http://dx.doi.org/10.1126/science.1237619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908239	Green Submitted, Green Accepted			2022-12-28	WOS:000322586700057
J	Fowkes, FGR; Rudan, D; Rudan, I; Aboyans, V; Denenberg, JO; McDermott, MM; Norman, PE; Sampson, UKA; Williams, LJ; Mensah, GA; Criqui, MH				Fowkes, F. Gerald R.; Rudan, Diana; Rudan, Igor; Aboyans, Victor; Denenberg, Julie O.; McDermott, Mary M.; Norman, Paul E.; Sampson, Uchechukwe K. A.; Williams, Linda J.; Mensah, George A.; Criqui, Michael H.			Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis	LANCET			English	Article							ANKLE-BRACHIAL INDEX; NUTRITION EXAMINATION SURVEY; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; NATIONAL-HEALTH; INTERMITTENT CLAUDICATION; POPULATION; MORTALITY; ATHEROSCLEROSIS; ASSOCIATION	Background Lower extremity peripheral artery disease is the third leading cause of atherosclerotic cardiovascular morbidity, following coronary artery disease and stroke. This study provides the first comparison of the prevalence of peripheral artery disease between high-income countries (HIC) and low-income or middle-income countries (LMIC), establishes the primary risk factors for peripheral artery disease in these settings, and estimates the number of people living with peripheral artery disease regionally and globally. Methods We did a systematic review of the literature on the prevalence of peripheral artery disease in which we searched for community-based studies since 1997 that defined peripheral artery disease as an ankle brachial index (ABI) lower than or equal to 0.90. We used epidemiological modelling to defi ne age-specific and sex-specific prevalence rates in HIC and in LMIC and combined them with UN population numbers for 2000 and 2010 to estimate the global prevalence of peripheral artery disease. Within a subset of studies, we did meta-analyses of odds ratios (ORs) associated with 15 putative risk factors for peripheral artery disease to estimate their effect size in HIC and LMIC. We then used the risk factors to predict peripheral artery disease numbers in eight WHO regions (three HIC and five LMIC). Findings 34 studies satisfied the inclusion criteria, 22 from HIC and 12 from LMIC, including 112 027 participants, of which 9347 had peripheral artery disease. Sex-specific prevalence rates increased with age and were broadly similar in HIC and LMIC and in men and women. The prevalence in HIC at age 45-49 years was 5.28% (95% CI 3.38-8.17%) in women and 5.41% (3.41-8.49%) in men, and at age 85-89 years, it was 18.38% (11.16-28.76%) in women and 18.83% (12.03-28.25%) in men. Prevalence in men was lower in LMIC than in HIC (2.89% [2.04-4.07%] at 45-49 years and 14.94% [9.58-22.56%] at 85-89 years). In LMIC, rates were higher in women than in men, especially at younger ages (6.31% [4.86-8.15%] of women aged 45-49 years). Smoking was an important risk factor in both HIC and LMIC, with meta-OR for current smoking of 2.72 (95% CI 2.39-3.09) in HIC and 1.42 (1.25-1.62) in LMIC, followed by diabetes (1.88 [1.66-2.14] vs 1.47 [1.29-1.68]), hypertension (1.55 [1.42-1.71] vs 1.36 [1.24-1.50]), and hypercholesterolaemia (1.19 [1.07-1.33] vs 1.14 [1.03-1.25]). Globally, 202 million people were living with peripheral artery disease in 2010, 69.7% of them in LMIC, including 54.8 million in southeast Asia and 45.9 million in the western Pacific Region. During the preceding decade the number of individuals with peripheral artery disease increased by 28.7% in LMIC and 13.1% in HIC. Interpretation In the 21st century, peripheral artery disease has become a global problem. Governments, non-governmental organisations, and the private sector in LMIC need to address the social and economic consequences, and assess the best strategies for optimum treatment and prevention of this disease.	[Fowkes, F. Gerald R.; Rudan, Diana; Rudan, Igor; Williams, Linda J.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Diana] Univ Hosp Dubrava, Zagreb, Croatia; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Aboyans, Victor] INSERM, U1094, Limoges, France; [Denenberg, Julie O.; Criqui, Michael H.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch, Dept Med & Prevent Med, Chicago, IL 60611 USA; [Norman, Paul E.] Univ Western Australia, Sch Surg, Fremantle, WA, Australia; [Sampson, Uchechukwe K. A.] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN USA; [Mensah, George A.] NHLBI, Immediate Off Director, NIH, Bethesda, MD 20892 USA	University of Edinburgh; CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California San Diego; Northwestern University; Feinberg School of Medicine; University of Western Australia; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Fowkes, FGR (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	gerry.fowkes@ed.ac.uk	Aboyans, Victor/AAN-8308-2020; Tóth-Vajna, Gergely/O-6660-2017; Rudan, Igor/I-1467-2012	Tóth-Vajna, Gergely/0000-0003-1975-8260; Rudan, Igor/0000-0001-6993-6884; Mensah, George/0000-0002-0387-5326; Aboyans, Victor/0000-0002-0322-9818	Peripheral Arterial Disease Research Coalition (Europe)	Peripheral Arterial Disease Research Coalition (Europe)	Peripheral Arterial Disease Research Coalition (Europe).	Aboyans V, 2007, J VASC SURG, V45, P319, DOI 10.1016/j.jvs.2006.10.032; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; An W, 2010, CIRCULATION, V122, pE43; [Anonymous], 2011, LANCET, V377, P527, DOI 10.1016/S0140-6736(11)60182-7; Blanes JI, 2009, INT ANGIOL, V28, P20; Buitron-Granados LV, 2004, ANGIOLOGY, V55, P43, DOI 10.1177/000331970405500107; Carbayo JA, 2007, NUTR METAB CARDIOVAS, V17, P41, DOI 10.1016/j.numecd.2005.08.009; Chuang SY, 2005, INT J CARDIOL, V98, P99, DOI 10.1016/j.ijcard.2004.01.019; Criqui MH, 2005, CIRCULATION, V112, P2703, DOI 10.1161/CIRCULATIONAHA.105.546507; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dumville JC, 2004, BRIT J GEN PRACT, V54, P826; Eldrup N, 2006, EUR HEART J, V27, P316, DOI 10.1093/eurheartj/ehi644; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2006, EUR J CARDIOV PREV R, V13, P964, DOI 10.1097/01.hjr.0000201511.28590.9f; Fowler B, 2002, AUST NZ J PUBL HEAL, V26, P219, DOI 10.1111/j.1467-842X.2002.tb00677.x; Fujiwara T, 2004, ATHEROSCLEROSIS, V177, P83, DOI 10.1016/j.atherosclerosis.2004.05.028; Garofolo L, 2007, EUR J VASC ENDOVASC, V34, P23, DOI 10.1016/j.ejvs.2007.02.008; General Assembly United Nations New York Sept 19-20 2011, GEN ASS UN NEW YORK; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Guerchet M, 2012, EUR J VASC ENDOVASC, V44, P164, DOI 10.1016/j.ejvs.2012.05.019; He Y, 2006, J VASC SURG, V44, P333, DOI 10.1016/j.jvs.2006.03.032; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hozawa A, 2004, HYPERTENS RES, V27, P955, DOI 10.1291/hypres.27.955; Institute of Medicine, 2010, PROM CARD HLTH DEV W; KANNEL WB, 1970, CIRCULATION, V41, P875, DOI 10.1161/01.CIR.41.5.875; Kim JY, 2010, J KOREAN SURG SOC, V78, P305, DOI 10.4174/jkss.2010.78.5.305; Kroger K, 2006, EUR J EPIDEMIOL, V21, P279, DOI 10.1007/s10654-006-0015-9; Kweon SS, 2005, J KOREAN MED SCI, V20, P373, DOI 10.3346/jkms.2005.20.3.373; Lee YH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-94; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Makdisse M, 2007, ARQ BRAS CARDIOL, V88, P630, DOI 10.1590/S0066-782X2007000600002; Makdisse M, 2008, ARQ BRAS CARDIOL, V91, P370; McDermott MM, 2007, J AM COLL CARDIOL, V50, P974, DOI 10.1016/j.jacc.2007.05.030; McDermott MM, 2000, CIRCULATION, V101, P1007, DOI 10.1161/01.CIR.101.9.1007; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Murabito JM, 2002, AM HEART J, V143, P961, DOI 10.1067/mhj.2002.122871; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; Ohnishi H, 2010, J ATHEROSCLER THROMB, V17, P751, DOI 10.5551/jat.3731; Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207; Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Premalatha G, 2000, DIABETES CARE, V23, P1295, DOI 10.2337/diacare.23.9.1295; Ramos R, 2009, EUR J VASC ENDOVASC, V38, P305, DOI 10.1016/j.ejvs.2009.04.013; Rooks RN, 2002, J GERONTOL B-PSYCHOL, V57, pS247, DOI 10.1093/geronb/57.4.S247; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Sinning CR, 2010, EUR HEART J, V31, P499; SMITH GD, 1990, CIRCULATION, V82, P1925, DOI 10.1161/01.CIR.82.6.1925; Sritara P, 2007, ANGIOLOGY, V58, P572, DOI 10.1177/0003319707303652; Stoffers HEJH, 1996, INT J EPIDEMIOL, V25, P282, DOI 10.1093/ije/25.2.282; Stoffers HEJH, 1996, J CLIN EPIDEMIOL, V49, P1401, DOI 10.1016/S0895-4356(96)00275-2; Subramaniam T, 2011, VASC MED, V16, P87, DOI 10.1177/1358863X11400781; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38; United Nations, 2011, WORLD POP PROSP 2010; United Nations Department of Environmental and Social Affairs, WORLD POP PROSP 2010; Vock DM, 2011, B WORLD HEALTH ORGAN, V89, P112, DOI 10.2471/BLT.09.073577; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang Yong, 2009, Zhonghua Xin Xue Guan Bing Za Zhi, V37, P1127; WHO, HLTH STAT HLTH INF S; Woo J, 2006, ATHEROSCLEROSIS, V186, P360, DOI 10.1016/j.atherosclerosis.2005.07.022; World Bank, DAT COUNTR LEND GROU; World Health Organization, GLOB HLTH OBS DAT RE; Xu DC, 2010, VASC MED, V15, P361, DOI 10.1177/1358863X10378376; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	71	1870	1971	11	151	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1329	1340		10.1016/S0140-6736(13)61249-0	http://dx.doi.org/10.1016/S0140-6736(13)61249-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23915883				2022-12-28	WOS:000325975700023
J	van Weel, C				van Weel, Chris			Primary-care research to inform policy and implementation	LANCET			English	Editorial Material									[van Weel, Chris] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6500 HB Nijmegen, Netherlands; [van Weel, Chris] Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia	Radboud University Nijmegen; Australian National University	van Weel, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, POB 9101, NL-6500 HB Nijmegen, Netherlands.	c.vanweel@elg.umcn.nl	van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701				Gillies JCM, 2009, BRIT J GEN PRACT, V59, P356, DOI 10.3399/bjgp09X420626; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Little P, 2013, LANCET	3	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1156	1157		10.1016/S0140-6736(13)61445-2	http://dx.doi.org/10.1016/S0140-6736(13)61445-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SL	23915881				2022-12-28	WOS:000325209100006
J	Ridker, PM; Wilson, PWF				Ridker, Paul M.; Wilson, Peter W. F.			A Trial-Based Approach to Statin Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPY; RISK; CHOLESTEROL		[Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Wilson, Peter W. F.] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA; [Wilson, Peter W. F.] Atlanta Vet Adm Med Ctr, Atlanta, GA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org	Wilson, Peter W.F./J-2455-2016	Venkatasubramanian, Siddharth/0000-0002-5860-0768				Gibbons GH, 2013, CIRCULATION, V128, P1713, DOI 10.1161/CIRCULATIONAHA.113.004587; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2012, CIRC-CARDIOVASC QUAL, V5, P592, DOI 10.1161/CIRCOUTCOMES.112.966556	7	44	45	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1123	1124		10.1001/jama.2013.276529	http://dx.doi.org/10.1001/jama.2013.276529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23942579				2022-12-28	WOS:000324500300014
J	Magny, EG; Pueyo, JI; Pearl, FMG; Cespedes, MA; Niven, JE; Bishop, SA; Couso, JP				Magny, Emile G.; Pueyo, Jose Ignacio; Pearl, Frances M. G.; Cespedes, Miguel Angel; Niven, Jeremy E.; Bishop, Sarah A.; Couso, Juan Pablo			Conserved Regulation of Cardiac Calcium Uptake by Peptides Encoded in Small Open Reading Frames	SCIENCE			English	Article							SARCOPLASMIC-RETICULUM; SARCOLIPIN; PHOSPHOLAMBAN; DROSOPHILA; TRANSPORT; CONTRACTILITY; SHAVENBABY; REVEALS; SERCA	Small open reading frames (smORFs) are short DNA sequences that are able to encode small peptides of less than 100 amino acids. Study of these elements has been neglected despite thousands existing in our genomes. We and others previously showed that peptides as short as 11 amino acids are translated and provide essential functions during insect development. Here, we describe two peptides of less than 30 amino acids regulating calcium transport, and hence influencing regular muscle contraction, in the Drosophila heart. These peptides seem conserved for more than 550 million years in a range of species from flies to humans, in which they have been implicated in cardiac pathologies. Such conservation suggests that the mechanisms for heart regulation are ancient and that smORFs may be a fundamental genome component that should be studied systematically.	[Magny, Emile G.; Pueyo, Jose Ignacio; Pearl, Frances M. G.; Cespedes, Miguel Angel; Niven, Jeremy E.; Bishop, Sarah A.; Couso, Juan Pablo] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Pearl, Frances M. G.] Inst Canc Res, Div Canc Therapeut, Sutton SM2 5NG, Surrey, England	University of Sussex; University of London; Institute of Cancer Research - UK	Couso, JP (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	j.p.couso@sussex.ac.uk	Couso, Juan Pablo/ABH-5860-2020	Pearl, Frances/0000-0002-8210-4393; Pueyo, Jose Ignacio/0000-0002-4255-1850; Magny, Emile/0000-0001-7553-7097	Conacyt; Daphne Jackson Fellowship; UK Medical Research Council; Royal Society University Fellowship; Wellcome Trust Fellowship [087516]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Daphne Jackson Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society University Fellowship(Royal Society of London); Wellcome Trust Fellowship(Wellcome Trust)	We thank Rose Phillips, Roger Phillips, and J. Thorpe for technical support; M. Ramaswami for the antibody to Ca-P60A; and F. Casares, M. Baylies, I. Galindo, C. Alonso, and laboratory members for manuscript comments. E. M. was supported by Conacyt, F. P. was supported by a Daphne Jackson Fellowship and the UK Medical Research Council, and J.N. was supported by a Royal Society University Fellowship. Otherwise, this work was funded by a Wellcome Trust Fellowship (ref 087516) awarded to J. P. C. The GenBank accession number for Drosophila Scl sequences is NR_001662.	Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Ladoukakis E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r118; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Pueyo JI, 2011, DEV BIOL, V355, P183, DOI 10.1016/j.ydbio.2011.03.033; Razzaq R. I., 2001, GENE DEV, V15, P22; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8	18	226	246	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1116	1120		10.1126/science.1238802	http://dx.doi.org/10.1126/science.1238802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	23970561				2022-12-28	WOS:000323933100046
J	Feudtner, C; Schreiner, M; Lantos, JD				Feudtner, Chris; Schreiner, Mark; Lantos, John D.			Risks (and Benefits) in Comparative Effectiveness Research Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Feudtner, Chris] Childrens Hosp Philadelphia, Dept Med Eth, Philadelphia, PA 19104 USA; [Schreiner, Mark] Childrens Hosp Philadelphia, Committees Prot Human Subjects, Philadelphia, PA 19104 USA; [Lantos, John D.] Childrens Mercy Hosp, Childrens Mercy Bioeth Ctr, Kansas City, MO 64108 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Mercy Hospital	Feudtner, C (corresponding author), Childrens Hosp Philadelphia, Dept Med Eth, Philadelphia, PA 19104 USA.		Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434; Schreiner, Mark/0000-0002-0062-1232				Department of Health and Human Services, 2013, FED REGISTER, V78, P38343; Feudtner C, 2008, ARCH PEDIAT ADOL MED, V162, P854, DOI 10.1001/archpedi.162.9.854; Kass N, 2012, JAMA-J AM MED ASSOC, V307, P1589, DOI 10.1001/jama.2012.491; Schreiner MS, 2013, JAMA PEDIATR, V167, P603, DOI 10.1001/jamapediatrics.2013.152; Vist G. E., 2008, COCHRANE DATABASE SY, V3	5	22	22	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					892	894		10.1056/NEJMp1309322	http://dx.doi.org/10.1056/NEJMp1309322			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211KV	23964898				2022-12-28	WOS:000323906900003
J	Mewton, N; Ovize, M				Mewton, Nathan; Ovize, Michel			Remote preconditioning and all-cause mortality	LANCET			English	Editorial Material							MYOCARDIAL INJURY; REPERFUSION; ISCHEMIA; SURGERY		[Mewton, Nathan] Univ Lyon 1, CIC Lyon, INSERM, CarMeN,U1060, F-69365 Lyon, France; [Ovize, Michel] Hosp Civils Lyon, Hop Louis Pradel, Serv Explorat Fonct Cardiovasc, F-69394 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Ovize, M (corresponding author), Hosp Civils Lyon, Hop Louis Pradel, Serv Explorat Fonct Cardiovasc, F-69394 Lyon, France.	michel.ovize@chu-lyon.fr	Ovize, michel/AAL-9247-2020					Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2012, CLIN RES CARDIOL, V101, P339, DOI 10.1007/s00392-011-0397-x; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Meybohm P, 2012, EUR HEART J, V33, P1423; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Przyklenk K, CIRC RES IN PRESS; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	14	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					579	580		10.1016/S0140-6736(13)61607-4	http://dx.doi.org/10.1016/S0140-6736(13)61607-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	205DV	23953375				2022-12-28	WOS:000323422800006
J	Gerlach, C; Thiriot, A; von Andrian, UH				Gerlach, Carmen; Thiriot, Aude; von Andrian, Ulrich H.			Of Origins and Pedigrees: Lineage Tracing of Dendritic Cells	CELL			English	Editorial Material							EXPRESSION; DEFINES; ZBTB46	Understanding the ontogeny of distinct hematopoietic cell types remains a challenge. In this issue, Schraml et al. contribute to unraveling the complexity of a central component of the mononuclear phagocyte system by using a new in vivo approach to trace the progeny of common dendritic cell precursors.	[Gerlach, Carmen; Thiriot, Aude; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA.	uva@hms.harvard.edu		Gerlach, Carmen/0000-0001-7889-2393				Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839	10	1	1	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					720	722		10.1016/j.cell.2013.07.044	http://dx.doi.org/10.1016/j.cell.2013.07.044			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953106	Bronze			2022-12-28	WOS:000323202500004
J	Ha, T				Ha, Taekjip			Single-Molecule Approaches Embrace Molecular Cohorts	CELL			English	Review							UVRD HELICASE; STRANDED-DNA; PROTEINS; MECHANISM; PATHWAYS; EXCHANGE; REVEAL	Enormous mechanistic insight has been gained by studying the behavior of single molecules. The same approaches used to study proteins in isolation are now being leveraged to examine the changes in functional behavior that emerge when single molecules have company.	[Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Inst Genom Biol, Urbana, IL 61801 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Ha, T (corresponding author), Univ Illinois, Howard Hughes Med Inst, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	National Science Foundation [0822613, 0646550]; National Institutes of Health [GM065367, AI083025, RR025341]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in our laboratory was funded by the National Science Foundation (0822613 and 0646550) and by the National Institutes of Health (GM065367, AI083025, and RR025341). I would like to thank A. van Oijen and M. Williams for stimulating discussion and C. Thibodeuax for proofreading the manuscript. I apologize for not being able to cite all relevant literature due to space constraints.	Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Comstock MJ, 2011, NAT METHODS, V8, P335, DOI 10.1038/NMETH.1574; Graham JS, 2011, NUCLEIC ACIDS RES, V39, P2249, DOI 10.1093/nar/gkq1140; Joshi CP, 2012, P NATL ACAD SCI USA, V109, P15121, DOI 10.1073/pnas.1208508109; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Lee KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2882; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108; McCauley MJ, 2013, NUCLEIC ACIDS RES, V41, P167, DOI 10.1093/nar/gks1031; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yokota H, 2013, BIOPHYS J, V104, P924, DOI 10.1016/j.bpj.2013.01.014; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	16	24	25	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					723	726		10.1016/j.cell.2013.07.012	http://dx.doi.org/10.1016/j.cell.2013.07.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953107	Green Accepted, Bronze			2022-12-28	WOS:000323202500005
J	Abe-Ouchi, A; Saito, F; Kawamura, K; Raymo, ME; Okuno, J; Takahashi, K; Blatter, H				Abe-Ouchi, Ayako; Saito, Fuyuki; Kawamura, Kenji; Raymo, Maureen E.; Okuno, Jun'ichi; Takahashi, Kunio; Blatter, Heinz			Insolation-driven 100,000-year glacial cycles and hysteresis of ice-sheet volume	NATURE			English	Article							CARBON-DIOXIDE; CLIMATE; MODEL; SYSTEM; SIMULATIONS; TEMPERATURE; GROWTH; PHASE	The growth and reduction of Northern Hemisphere ice sheets over the past million years is dominated by an approximately 100,000-year periodicity and a sawtooth pattern(1,2) (gradual growth and fast termination). Milankovitch theory proposes that summer insolation at high northern latitudes drives the glacial cycles(3), and statistical tests have demonstrated that the glacial cycles are indeed linked to eccentricity, obliquity and precession cycles(4,5). Yet insolation alone cannot explain the strong 100,000-year cycle, suggesting that internal climatic feedbacks may also be at work(4-7). Earlier conceptual models, for example, showed that glacial terminations are associated with the build-up of Northern Hemisphere 'excess ice'(5,8-10), but the physical mechanisms underpinning the 100,000-year cycle remain unclear. Here we show, using comprehensive climate and ice-sheet models, that insolation and internal feedbacks between the climate, the ice sheets and the lithosphere-asthenosphere system explain the 100,000-year periodicity. The responses of equilibrium states of ice sheets to summer insolation show hysteresis(11-13), with the shape and position of the hysteresis loop playing a key part in determining the periodicities of glacial cycles. The hysteresis loop of the North American ice sheet is such that after inception of the ice sheet, its mass balance remains mostly positive through several precession cycles, whose amplitudes decrease towards an eccentricity minimum. The larger the ice sheet grows and extends towards lower latitudes, the smaller is the insolation required to make the mass balance negative. Therefore, once a large ice sheet is established, a moderate increase in insolation is sufficient to trigger a negative mass balance, leading to an almost complete retreat of the ice sheet within several thousand years. This fast retreat is governed mainly by rapid ablation due to the lowered surface elevation resulting from delayed isostatic rebound(14-16), which is the lithosphere-asthenosphere response. Carbon dioxide is involved, but is not determinative, in the evolution of the 100,000-year glacial cycles.	[Abe-Ouchi, Ayako; Okuno, Jun'ichi; Blatter, Heinz] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Abe-Ouchi, Ayako; Saito, Fuyuki; Okuno, Jun'ichi; Takahashi, Kunio] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokohama, Kanagawa 2360001, Japan; [Abe-Ouchi, Ayako; Kawamura, Kenji; Okuno, Jun'ichi] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Kawamura, Kenji] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Raymo, Maureen E.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Blatter, Heinz] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Columbia University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Abe-Ouchi, A (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan.	abeouchi@aori.u-tokyo.ac.jp	Raymo, Maureen E/A-1270-2012; Abe-Ouchi, Ayako/M-6359-2013; SAITO, Fuyuki/B-8776-2013; Kawamura, Kenji/C-7660-2011	Abe-Ouchi, Ayako/0000-0003-1745-5952; Kawamura, Kenji/0000-0003-1163-700X; SAITO, Fuyuki/0000-0001-5935-9614	JSPS KAKENHI [25241005, 22101005, 21671001]; MEXT, Japan; Ministry of the Environment, Japan [S-10]; Grants-in-Aid for Scientific Research [22221002, 22101005, 21671001] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Discussions with numerous people including M. Kimoto, J. Hargreaves, M. Yoshimori, J. Annan, F.-F. Jin and W.-L. Chan contributed to this work. M. Ichino and T. Segawa provided technical support. We thank the MIROC group for continuous development and support of the MIROC GCM. The numerical experiments were carried out on the NIES supercomputer system (NEC SX-8R/128M16) and the JAMSTEC Earth Simulator. This research was supported by JSPS KAKENHI grants 25241005, 22101005 and 21671001, the Global COE Program grant "From the Earth to 'Earths'", MEXT, Japan, and the Environment Research and Technology Development Fund (S-10) of the Ministry of the Environment, Japan.	Abe-Ouchi A, 2007, CLIM PAST, V3, P423, DOI 10.5194/cp-3-423-2007; ABE-OUCHI A, 1993, ANN GLACIOL-SER, V18, P203, DOI 10.1017/S0260305500011514; Berger A, 1998, CLIM DYNAM, V14, P615, DOI 10.1007/s003820050245; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Calov R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024518; Calov R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016078; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Claussen M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026111; Crucifix M, 2001, EARTH PLANET SC LETT, V184, P623, DOI 10.1016/S0012-821X(00)00361-7; Deblonde G, 1992, PALAEOGEOGR PALAEOCL, V98, P37, DOI 10.1016/0031-0182(92)90255-4; Ganopolski A, 2011, CLIM PAST, V7, P1415, DOI 10.5194/cp-7-1415-2011; Ganopolski A, 2009, QUATERNARY SCI REV, V28, P3361, DOI 10.1016/j.quascirev.2009.09.019; Gregoire LJ, 2012, NATURE, V487, P219, DOI 10.1038/nature11257; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Huybers P, 2011, NATURE, V480, P229, DOI 10.1038/nature10626; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kurahashi-Nakamura T, 2010, CLIM DYNAM, V35, P713, DOI 10.1007/s00382-009-0609-5; Laske G., 1997, EOS T AM GEOPHYSICAL, V78, pF483; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lisiecki LE, 2010, NAT GEOSCI, V3, P349, DOI 10.1038/NGEO828; Marshall SJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015192; Milankovitch M., 1941, KANON ERDBESTRAHLUNG; OERLEMANS J, 1980, NATURE, V287, P430, DOI 10.1038/287430a0; Okada Y., 2008, THESIS U TOKYO; Okuno J, 2001, EARTH PLANETS SPACE, V53, P1121, DOI 10.1186/BF03352408; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; Paillard D, 2004, EARTH PLANET SC LETT, V227, P263, DOI 10.1016/j.epsl.2004.08.023; Parrenin F, 2003, EARTH PLANET SC LETT, V214, P243, DOI 10.1016/S0012-821X(03)00363-7; PELTIER WR, 1995, J GEOPHYS RES-ATMOS, V100, P14269, DOI 10.1029/95JD00015; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; POLLARD D, 1982, NATURE, V296, P334, DOI 10.1038/296334a0; POLLARD D., 1984, MILANKOVITCH CLIMA 2, P541; Pollard D, 2010, CLIMATIC CHANGE, V100, P173, DOI 10.1007/s10584-010-9830-9; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; REEH N, 1991, POLARFORSCHUNG, V0059; SALTZMAN B, 1984, J ATMOS SCI, V41, P3380, DOI 10.1175/1520-0469(1984)041<3380:TLQGAT>2.0.CO;2; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Tziperman E, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001241	42	227	234	2	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					190	+		10.1038/nature12374	http://dx.doi.org/10.1038/nature12374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925242	Green Published			2022-12-28	WOS:000322825500031
J	Prokopenko, MG; Hirst, MB; De Brabandere, L; Lawrence, DJP; Berelson, WM; Granger, J; Chang, BX; Dawson, S; Crane, EJ; Chong, L; Thamdrup, B; Townsend-Small, A; Sigman, DM				Prokopenko, M. G.; Hirst, M. B.; De Brabandere, L.; Lawrence, D. J. P.; Berelson, W. M.; Granger, J.; Chang, B. X.; Dawson, S.; Crane, E. J., III; Chong, L.; Thamdrup, B.; Townsend-Small, A.; Sigman, D. M.			Nitrogen losses in anoxicmarine sediments driven by Thioploca-anammox bacterial consortia	NATURE			English	Article							CONTINENTAL-MARGIN; METHANE OXIDATION; SULFUR BACTERIA; NORTH PACIFIC; FRESH-WATER; MARINE; DENITRIFICATION; NITRATE; DIAGENESIS; CARBON	Ninety per cent of marine organic matter burial occurs in continental margin sediments, where a substantial fraction of organic carbon escapes oxidation and enters long-term geologic storage within sedimentary rocks. In such environments, microbial metabolism is limited by the diffusive supply of electron acceptors. One strategy to optimize energy yields in a resource-limited habitat is symbiotic metabolite exchange among microbial associations(1,2). Thermodynamic and geochemical considerations indicate that microbial cometabolisms are likely to play a critical part in sedimentary organic carbon cycling(3-5). Yet only one association, between methanotrophic archaea and sulphate-reducing bacteria, has been demonstrated in marine sedimentsin situ(6,7), and little is known of the role of microbial symbiotic interactions in other sedimentary biogeochemical cycles(8). Here we report in situ molecular and incubation-based evidence for a novel symbiotic consortium between two chemolithotrophic bacteria-anaerobic ammonium-oxidizing (anammox) bacteria and the nitrate-sequestering sulphur-oxidizing Thioploca species-in anoxic sediments of the Soledad basin at the Mexican Pacific margin. A mass balance of benthic solute fluxes and the corresponding nitrogen isotope composition of nitrate and ammonium fluxes indicate that anammox bacteria rely on Thioploca species for the supply of metabolic substrates and account for about 57 +/- 21 per cent of the total benthic N-2 production. We show that Thioploca-anammox symbiosis intensifies benthic fixed nitrogen losses in anoxic sediments, bypassing diffusion-imposed limitations by efficiently coupling the carbon, nitrogen and sulphur cycles.	[Prokopenko, M. G.] Pomona Coll, Dept Geol, Claremont, CA 91711 USA; [Prokopenko, M. G.; Berelson, W. M.; Chong, L.] Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Hirst, M. B.; Dawson, S.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [De Brabandere, L.; Thamdrup, B.] Univ Southern Denmark, Dept Biol, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; [Lawrence, D. J. P.; Crane, E. J., III] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Granger, J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Chang, B. X.; Sigman, D. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Townsend-Small, A.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA	Claremont Colleges; Pomona College; University of Southern California; University of California System; University of California Davis; University of Southern Denmark; Claremont Colleges; Pomona College; University of Connecticut; Princeton University; University System of Ohio; University of Cincinnati	Prokopenko, MG (corresponding author), Pomona Coll, Dept Geol, Claremont, CA 91711 USA.	prokopen@usc.edu	Sigman, Daniel M/A-2649-2008; De Brabandere, Loreto C/A-8134-2014; Thamdrup, Bo/F-3889-2016	Sigman, Daniel M/0000-0002-7923-1973; Thamdrup, Bo/0000-0002-1221-7077; Crane, Edward/0000-0002-9910-9502; Dawson, Scott/0000-0002-0843-1759; Lawrence, Daniel/0000-0002-2181-9352	NSF OCE [OCE-0727123]	NSF OCE(National Science Foundation (NSF))	This work was supported by NSF OCE grant number OCE-0727123 to W. M. B. and D. M. S. We thank the captain and crew of the RV New Horizon, as well as the members of the at-sea and shore-based science party, N. Rollins, T. Riedel, S. Loyd and H. Gron Jensen for their assistance during the cruise. We thank P. Rafter for delta<SUP>15</SUP>N measurements of bottom water NO<INF>3</INF><SUP>-</SUP>. We thank M. Schmid and G. Kuenen for discussions. We are grateful to D. Valentine for suggestions that improved the manuscript.	Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Berelson WM, 1996, J MAR RES, V54, P731, DOI 10.1357/0022240963213673; Berelson WM, 2005, GEOCHIM COSMOCHIM AC, V69, P4611, DOI 10.1016/j.gca.2005.05.011; Bernhard J.M., 2004, SULFUR BIOGEOCHEMIST, V379, P35; Bernhard JM, 2012, ISME J, V6, P951, DOI 10.1038/ismej.2011.171; BIEBL H, 1978, ARCH MICROBIOL, V117, P9, DOI 10.1007/BF00689344; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Chong LS, 2012, MAR CHEM, V128, P13, DOI 10.1016/j.marchem.2011.10.007; Christensen JP, 1987, GLOBAL BIOGEOCHEM CY, V1, P97, DOI 10.1029/GB001i002p00097; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Devol AH, 1997, CONT SHELF RES, V17, P1029, DOI 10.1016/S0278-4343(97)00003-4; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; Foster RA, 2006, ENVIRON MICROBIOL, V8, P1913, DOI 10.1111/j.1462-2920.2006.01068.x; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hartnett HE, 2003, GEOCHIM COSMOCHIM AC, V67, P247, DOI 10.1016/S0016-7037(02)01076-1; Hirsch MD, 2011, MICROB ECOL, V61, P264, DOI 10.1007/s00248-010-9743-1; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Hogslund S, 2009, ISME J, V3, P647, DOI 10.1038/ismej.2009.17; Jayakumar A, 2009, MICROB ECOL, V58, P350, DOI 10.1007/s00248-009-9487-y; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Jorgensen BB, 1999, FEMS MICROBIOL ECOL, V28, P301, DOI 10.1016/S0168-6496(98)00122-6; Kojima H, 2003, APPL ENVIRON MICROB, V69, P390, DOI 10.1128/AEM.69.1.390-398.2003; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Orphan VJ, 2011, ENV MICROBIOL REP, V3, P16; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Penton CR, 2006, APPL ENVIRON MICROB, V72, P6829, DOI 10.1128/AEM.01254-06; Prokopenko MG, 2011, GEOCHIM COSMOCHIM AC, V75, P7180, DOI 10.1016/j.gca.2011.09.023; Prokopenko MG, 2006, EARTH PLANET SC LETT, V242, P186, DOI 10.1016/j.epsl.2005.11.044; RISGAARDPETERSEN N, 1995, SOIL SCI SOC AM J, V59, P1077, DOI 10.2136/sssaj1995.03615995005900040018x; Salman V, 2011, SYST APPL MICROBIOL, V34, P243, DOI 10.1016/j.syapm.2011.02.001; SCHINK B, 2006, PROKARYOTES, V2, P309; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Teske A, 1996, SYST APPL MICROBIOL, V18, P517; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; van Geen A, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003192; Wang GZ, 2010, GEOCHIM COSMOCHIM AC, V74, P3938, DOI 10.1016/j.gca.2010.03.034; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x	43	73	79	8	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					194	+		10.1038/nature12365	http://dx.doi.org/10.1038/nature12365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925243				2022-12-28	WOS:000322825500032
J	Safavi-Naeini, AH; Groblacher, S; Hill, JT; Chan, J; Aspelmeyer, M; Painter, O				Safavi-Naeini, Amir H.; Groeblacher, Simon; Hill, Jeff T.; Chan, Jasper; Aspelmeyer, Markus; Painter, Oskar			Squeezed light from a silicon micromechanical resonator	NATURE			English	Article							QUANTUM-NOISE REDUCTION; RADIATION-PRESSURE; OPTICAL CAVITY; GROUND-STATE; INTERFEROMETER; MICROMIRROR; OSCILLATOR	Monitoring a mechanical object's motion, even with the gentle touch of light, fundamentally alters its dynamics. The experimental manifestation of this basic principle of quantum mechanics, its link to the quantum nature of light and the extension of quantum measurement to the macroscopic realm have all received extensive attention over the past half-century(1,2). The use of squeezed light, with quantum fluctuations below that of the vacuum field, was proposed nearly three decades ago(3) as a means of reducing the optical read-out noise in precision force measurements. Conversely, it has also been proposed that a continuous measurement of a mirror's position with light may itself give rise to squeezed light(4,5). Such squeezed-light generation has recently been demonstrated in a system of ultracold gas-phase atoms(6) whose centre-of-mass motion is analogous to the motion of a mirror. Here we describe the continuous position measurement of a solid-state, optomechanical system fabricated from a silicon microchip and comprising a micromechanical resonator coupled to a nanophotonic cavity. Laser light sent into the cavity is used to measure the fluctuations in the position of the mechanical resonator at a measurement rate comparable to its resonance frequency and greater than its thermal decoherence rate. Despite the mechanical resonator's highly excited thermal state (10(4) phonons), we observe, through homodyne detection, squeezing of the reflected light's fluctuation spectrum at a level 4.5 +/- 0.2 per cent below that of vacuum noise over a bandwidth of a few megahertz around the mechanical resonance frequency of 28 megahertz. With further device improvements, on-chip squeezing at significant levels should be possible, making such integrated microscale devices well suited for precision metrology applications.	[Safavi-Naeini, Amir H.; Groeblacher, Simon; Hill, Jeff T.; Chan, Jasper; Painter, Oskar] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [Safavi-Naeini, Amir H.; Groeblacher, Simon; Hill, Jeff T.; Chan, Jasper; Painter, Oskar] CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA 91125 USA; [Safavi-Naeini, Amir H.; Groeblacher, Simon; Hill, Jeff T.; Painter, Oskar] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Aspelmeyer, Markus] Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol, A-1090 Vienna, Austria; [Painter, Oskar] Max Planck Inst Sci Light, D-91058 Erlangen, Germany	California Institute of Technology; California Institute of Technology; California Institute of Technology; University of Vienna; Max Planck Society	Painter, O (corresponding author), CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA.	opainter@caltech.edu	Hill, Jeffrey T/A-5027-2013; Aspelmeyer, Markus/C-4098-2017; Groeblacher, Simon/O-2455-2014	Hill, Jeffrey T/0000-0001-6330-2354; Aspelmeyer, Markus/0000-0003-4499-7335; Groeblacher, Simon/0000-0003-3932-7820; Safavi-Naeini, Amir H./0000-0001-6176-1274; Painter, Oskar/0000-0002-1581-9209	DARPA/MTO ORCHID from the AFOSR; Institute for Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation; Vienna Science and Technology Fund WWTF; European Commission through IP SIQS; European Commission through iQUOEMS; European Research Council; NSERC; European Commission through a Marie Curie Fellowship	DARPA/MTO ORCHID from the AFOSR; Institute for Quantum Information and Matter, an NSF Physics Frontiers Center(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Vienna Science and Technology Fund WWTF; European Commission through IP SIQS; European Commission through iQUOEMS; European Research Council(European Research Council (ERC)European Commission); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Commission through a Marie Curie Fellowship	We would like to thank K. Hammerer and A. A. Clerk for discussions. This work was supported by the DARPA/MTO ORCHID programme through a grant from the AFOSR; the Institute for Quantum Information and Matter, an NSF Physics Frontiers Center with support of the Gordon and Betty Moore Foundation; the Vienna Science and Technology Fund WWTF; the European Commission, through IP SIQS and iQUOEMS; and the European Research Council. A.H.S.-N. and J.C. gratefully acknowledge support from NSERC. S.G. acknowledges support from the European Commission through a Marie Curie Fellowship.	Abadie J, 2011, NAT PHYS, V7, P962, DOI [10.1038/NPHYS2083, 10.1038/nphys2083]; Abbott B, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073032; Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Braginsky V. B., 1995, QUANTUM MEASUREMENTS; Brooks DWC, 2012, NATURE, V488, P476, DOI 10.1038/nature11325; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; CAVES CM, 1980, PHYS REV LETT, V45, P75, DOI 10.1103/PhysRevLett.45.75; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Corbitt T, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.021802; Eichenfield M, 2009, NATURE, V459, P550, DOI 10.1038/nature08061; FABRE C, 1994, PHYS REV A, V49, P1337, DOI 10.1103/PhysRevA.49.1337; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Hoff UB, 2013, OPT LETT, V38, P1413, DOI 10.1364/OL.38.001413; HOLLENHORST JN, 1979, PHYS REV D, V19, P1669, DOI 10.1103/PhysRevD.19.1669; Liu YT, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.122002; MANCINI S, 1994, PHYS REV A, V49, P4055, DOI 10.1103/PhysRevA.49.4055; Mehmet M, 2011, OPT EXPRESS, V19, P25763, DOI 10.1364/OE.19.025763; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; SHELBY RM, 1986, PHYS REV LETT, V57, P691, DOI 10.1103/PhysRevLett.57.691; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Taylor MA, 2013, NAT PHOTONICS, V7, P229, DOI [10.1038/nphoton.2012.346, 10.1038/NPHOTON.2012.346]; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787; WALLS DF, 1983, NATURE, V306, P141, DOI 10.1038/306141a0; WU LA, 1986, PHYS REV LETT, V57, P2520, DOI 10.1103/PhysRevLett.57.2520; YUEN HP, 1976, PHYS REV A, V13, P2226, DOI 10.1103/PhysRevA.13.2226	30	398	400	7	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					185	189		10.1038/nature12307	http://dx.doi.org/10.1038/nature12307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925241	Green Accepted			2022-12-28	WOS:000322825500030
J	Cole, TB				Cole, Thomas B.			Alone in Green Antonio Henrique Amaral	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					462	463		10.1001/jama.2013.5236	http://dx.doi.org/10.1001/jama.2013.5236			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925598				2022-12-28	WOS:000322786400001
J	Adair, R; Wholey, DR; Christianson, J; White, KM; Britt, H; Lee, SN				Adair, Richard; Wholey, Douglas R.; Christianson, Jon; White, Katie M.; Britt, Heather; Lee, Suhna			Improving Chronic Disease Care by Adding Laypersons to the Primary Care Team A Parallel Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL HOME; HEALTH-CARE; BLOOD-PRESSURE; GUIDED CARE; MANAGEMENT; PERFORMANCE; SUPPORT; MODEL; INTERVENTIONS; ASSISTANTS	Background: Improving the quality and efficiency of chronic disease care is an important goal. Objective: To test whether patients with chronic disease working with lay "care guides" would achieve more evidence-based goals than those receiving usual care. Design: Parallel-group randomized trial, stratified by clinic and conducted from July 2010 to April 2012. Patients were assigned in a 2: 1 ratio to a care guide or usual care. Patients, providers, and persons assessing outcomes were not blinded to treatment assignment. (ClinicalTrials.gov: NCT01156974) Setting: 6 primary care clinics in Minnesota. Patients: Adults with hypertension, diabetes, or heart failure. Intervention: 2135 patients were given disease-specific information about standard care goals and asked to work toward goals for 1 year, with or without the help of a care guide. Care guides were 12 laypersons who received brief training about these diseases and behavior change. Measurements: The primary end point for each patient was change in percentage of goals met 1 year after enrollment. Results: The percentage of goals met increased in both the care guide and usual care groups (changes from baseline, 10.0% and 3.9%, respectively). Patients with care guides achieved more goals than usual care patients (82.6% vs. 79.1%; odds ratio, 1.31 [95% CI, 1.16 to 1.47]; P < 0.001); reduced unmet goals by 30.1% compared with 12.6% for usual care patients; and improved more than usual care patients in meeting several individual goals, including not using tobacco. Estimated cost was $286 per patient per year. Limitations: Providers' usual care may have been influenced by contact with care guides. Last available data in the electronic health record were used to assess end points. Conclusion: Adding care guides to the primary care team can improve care for some patients with chronic disease at low cost.	Allina Hlth, Minneapolis, MN 55407 USA; Univ Minnesota, Minneapolis, MN 55455 USA	Allina Health System; University of Minnesota System; University of Minnesota Twin Cities	Adair, R (corresponding author), Care of Radel K, Allina Hlth, 2925 Chicago Ave, Minneapolis, MN 55407 USA.	kimberly.radel@allina.com		White, Katie/0000-0002-7662-3867	Robina Foundation	Robina Foundation	Financial Support: By the Robina Foundation.	Adair R, 2012, J AMBUL CARE MANAG, V35, P27, DOI 10.1097/JAC.0b013e31823b0fbe; Allen JK, 2011, CIRC-CARDIOVASC QUAL, V4, P595, DOI 10.1161/CIRCOUTCOMES.111.961573; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Banerjee D, 2010, ARCH INTERN MED, V170, P1399, DOI 10.1001/archinternmed.2010.270; Bazinsky KR, 2012, JAMA-J AM MED ASSOC, V307, P1261, DOI 10.1001/jama.2012.364; Berry-Millett R, 2009, SYNTH PROJ RES SYNTH; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2007, ANN FAM MED, V5, P457, DOI 10.1370/afm.731; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Brownstein JN, 2011, J AMBUL CARE MANAG, V34, P210, DOI 10.1097/JAC.0b013e31821c645d; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P2595, DOI 10.1001/jama.2012.6382; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clark CE, 2011, DIABETIC MED, V28, P250, DOI 10.1111/j.1464-5491.2010.03204.x; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Fifield J, 2012, J GEN INTERN MED; Gabbay RA, 2011, JT COMM J QUAL PATIE, V37, P265, DOI 10.1016/S1553-7250(11)37034-1; Garson A, 2012, HEALTH AFFAIR, V31, P1016, DOI 10.1377/hlthaff.2011.0859; Gensichen J, 2009, ANN INTERN MED, V151, P369, DOI 10.7326/0003-4819-151-6-200909150-00001; Ghorob A, 2012, NEW ENGL J MED, V366, P1955, DOI 10.1056/NEJMp1202775; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007; Hiss RG, 2007, DIABETES EDUCATOR, V33, P493, DOI 10.1177/0145721707301349; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Kerr EA, 2012, ARCH INTERN MED, V172, P938, DOI 10.1001/archinternmed.2012.2253; Lin WC, 2012, MED CARE, V50, P91, DOI 10.1097/MLR.0b013e31822dcedf; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; McCall N, 2011, NEW ENGL J MED, V365, P1704, DOI 10.1056/NEJMsa1011785; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nelson K, 2010, HEALTH AFFAIR, V29, P963, DOI 10.1377/hlthaff.2010.0129; Nocon RS, 2012, JAMA-J AM MED ASSOC, V308, P60, DOI 10.1001/jama.2012.7048; Noordman J, 2012, PATIENT EDUC COUNS, V89, P227, DOI 10.1016/j.pec.2012.07.006; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Powell AA, 2012, J GEN INTERN MED, V27, P405, DOI 10.1007/s11606-011-1906-3; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Rittenhouse DR, 2011, HEALTH AFFAIR, V30, P1575, DOI 10.1377/hlthaff.2010.1210; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Rosenthal EL, 2010, HEALTH AFFAIR, V29, P1338, DOI 10.1377/hlthaff.2010.0081; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Sevin C, 2009, J AMBUL CARE MANAG, V32, P24, DOI 10.1097/01.JAC.0000343121.07844.e0; Stellefson M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120180; Sutherland D, 2009, J CLIN NURS, V18, P2978, DOI 10.1111/j.1365-2702.2009.02900.x; Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Turner BJ, 2012, J GEN INTERN MED, V27, P1258, DOI 10.1007/s11606-012-2095-4; Wagner EH, 2002, BMJ-BRIT MED J, V325, P913, DOI 10.1136/bmj.325.7370.913; Wolff JL, 2010, GERONTOLOGIST, V50, P459, DOI 10.1093/geront/gnp124	47	28	28	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					176	+		10.7326/0003-4819-159-3-201308060-00007	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201RD	23922063				2022-12-28	WOS:000323159800003
J	Sokol, DK				Sokol, Daniel K.			Waking up to the effects of fatigue in doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Kings Coll London, London, England; [Sokol, Daniel K.] 12 Kings Bench Walk, London, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London, England.	daniel.sokol@talk21.com						Gander P, 2007, OCCUP ENVIRON MED, V64, P733, DOI 10.1136/oem.2006.030916; Murrow G, 2012, IMPACT WORKING TIME; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Sullenberger CB, 2009, HIGHEST DUTY; Worrall M, 2009, DO REDUCED DOCTORS W	5	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2013	347								f4906	10.1136/bmj.f4906	http://dx.doi.org/10.1136/bmj.f4906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CN	23918610				2022-12-28	WOS:000323118400003
J	Rickels, R; Shilatifard, A				Rickels, Ryan; Shilatifard, Ali			A Histone Modifier's Ill-Gotten Copy Gains	CELL			English	Editorial Material							REPLICATION		[Rickels, Ryan; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Shilatifard, A (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	ash@stowers.org			NATIONAL CANCER INSTITUTE [R01CA150265] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA150265] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Black JC, 2013, CELL, V154, P541, DOI 10.1016/j.cell.2013.06.051; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Hiratani L, 2009, CURR OPIN GENET DEV, V19, P142, DOI 10.1016/j.gde.2009.02.002; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Pope BD, 2013, CELL, V152, P1390, DOI 10.1016/j.cell.2013.02.038; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Smith E, 2007, GENE DEV, V21, P1141, DOI 10.1101/gad.1559407; Smith E, 2013, GENE DEV, V27, P1079, DOI 10.1101/gad.215137.113	10	1	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					477	479		10.1016/j.cell.2013.07.010	http://dx.doi.org/10.1016/j.cell.2013.07.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911314	Bronze			2022-12-28	WOS:000322629900001
J	Greaves, D; Coggle, S; Pollard, C; Aliyu, SH; Moore, EM				Greaves, Daniel; Coggle, Sian; Pollard, Christopher; Aliyu, Sani H.; Moore, Elinor M.			Strongyloides stercoralis infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PARENTERAL IVERMECTIN; HYPERINFECTION; ALBENDAZOLE; SINGLE; AREA; THIABENDAZOLE; EOSINOPHILIA; POPULATION; MANAGEMENT; DIAGNOSIS		[Greaves, Daniel; Coggle, Sian; Moore, Elinor M.] Addenbrookes Hosp, Dept Infect Dis, Cambridge CB2 0QQ, England; [Pollard, Christopher] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Aliyu, Sani H.] Addenbrookes Hosp, Dept Microbiol, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Greaves, D (corresponding author), Addenbrookes Hosp, Dept Infect Dis, Cambridge CB2 0QQ, England.	greaves@doctors.org.uk		Pollard, Christopher/0000-0002-1868-272X				Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Biggs BA, 2009, AM J TROP MED HYG, V80, P788, DOI 10.4269/ajtmh.2009.80.788; Boulware DR, 2008, NEW ENGL J MED, V358, P2839; Chiodini PL, 2000, LANCET, V355, P43, DOI 10.1016/S0140-6736(99)02744-0; DATRY A, 1994, T ROY SOC TROP MED H, V88, P344, DOI 10.1016/0035-9203(94)90110-4; Dulley FL, 2009, BONE MARROW TRANSPL, V43, P741, DOI 10.1038/bmt.2008.383; GANN PH, 1994, J INFECT DIS, V169, P1076, DOI 10.1093/infdis/169.5.1076; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Ghosh K, 2007, T ROY SOC TROP MED H, V101, P1163, DOI 10.1016/j.trstmh.2007.05.021; Gonzalez A, 2010, T ROY SOC TROP MED H, V104, P613, DOI 10.1016/j.trstmh.2010.06.001; Gotuzzo E, 1999, AM J TROP MED HYG, V60, P146, DOI 10.4269/ajtmh.1999.60.146; Greaves D, 2012, BRIT J HAEMATOL, V158, P2, DOI 10.1111/j.1365-2141.2012.09183.x; GYORKOS TW, 1990, AM J EPIDEMIOL, V132, P257, DOI 10.1093/oxfordjournals.aje.a115655; Hamilton KW, 2011, TRANSPLANTATION, V91, P1019, DOI 10.1097/TP.0b013e3182115b7b; HM Government, HOM OFF IMM STAT JAN; HM Government. Foreign and Commonwealth Office, 2013, TRAV ADV COUNTR THAI; Igual-Adell R, 2004, EXPERT OPIN PHARMACO, V5, P2615, DOI 10.1517/14656566.5.12.2615; JONES CA, 1954, AM J CLIN PATHOL, V24, P1154; Keiser PB, 2004, CLIN MICROBIOL REV, V17, P208, DOI 10.1128/CMR.17.1.208-217.2004; KOBAYASHI J, 1994, DIAGN MICR INFEC DIS, V18, P19, DOI 10.1016/0732-8893(94)90129-5; Lichtenberger P, 2009, TRANSPL INFECT DIS, V11, P137, DOI 10.1111/j.1399-3062.2008.00358.x; Loutfy MR, 2002, AM J TROP MED HYG, V66, P749, DOI 10.4269/ajtmh.2002.66.749; Marti H, 1996, AM J TROP MED HYG, V55, P477, DOI 10.4269/ajtmh.1996.55.477; Mejia R, 2012, CURR OPIN INFECT DIS, V25, P458, DOI 10.1097/QCO.0b013e3283551dbd; Nontasut Ponganant, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P442; Nuesch R, 2005, J TRAVEL MED, V12, P80; Posey DL, 2007, CLIN INFECT DIS, V45, P1310, DOI 10.1086/522529; Prendki V, 2011, EMERG INFECT DIS, V17, P931, DOI 10.3201/eid1705.100490; Roxby AC, 2009, CLIN INFECT DIS, V49, P1411, DOI 10.1086/630201; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Sims H, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2670; SORVILLO F, 1983, BRIT J VENER DIS, V59, P342; Suputtamongkol Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001044; Terashima Angelica, 2002, International Journal of Infectious Diseases, V6, P28, DOI 10.1016/S1201-9712(02)90132-3; Valerio L, 2013, T ROY SOC TROP MED H, V107, P465, DOI 10.1093/trstmh/trt053; van Doorn HR, 2007, J CLIN MICROBIOL, V45, P438, DOI 10.1128/JCM.01735-06; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; World Health Organization, 2013, NEGL TROP DIS STRONG; WURTZ R, 1994, AM J TROP MED HYG, V51, P339, DOI 10.4269/ajtmh.1994.51.339; Zaha Osamu, 2004, Journal of Infection and Chemotherapy, V10, P348, DOI 10.1007/s10156-004-0345-z; Zeehaida M, 2011, TROP BIOMED, V28, P188	41	111	114	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4610	10.1136/bmj.f4610	http://dx.doi.org/10.1136/bmj.f4610			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900531				2022-12-28	WOS:000322821500005
J	Vora, NM; Basavaraju, SV; Feldman, KA; Paddock, CD; Orciari, L; Gitterman, S; Griese, S; Wallace, RM; Said, M; Blau, DM; Selvaggi, G; Velasco-Villa, A; Ritter, J; Yager, P; Kresch, A; Niezgoda, M; Blanton, J; Stosor, V; Falta, EM; Lyon, GM; Zembower, T; Kuzmina, N; Rohatgi, PK; Recuenco, S; Zaki, S; Damon, I; Franka, R; Kuehnert, MJ				Vora, Neil M.; Basavaraju, Sridhar V.; Feldman, Katherine A.; Paddock, Christopher D.; Orciari, Lillian; Gitterman, Steven; Griese, Stephanie; Wallace, Ryan M.; Said, Maria; Blau, Dianna M.; Selvaggi, Gennaro; Velasco-Villa, Andres; Ritter, Jana; Yager, Pamela; Kresch, Agnes; Niezgoda, Mike; Blanton, Jesse; Stosor, Valentina; Falta, Edward M.; Lyon, G. Marshall, III; Zembower, Teresa; Kuzmina, Natalia; Rohatgi, Prashant K.; Recuenco, Sergio; Zaki, Sherif; Damon, Inger; Franka, Richard; Kuehnert, Matthew J.		Transplant-Associated Rabies Virus	Raccoon Rabies Virus Variant Transmission Through Solid Organ Transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; ADVISORY-COMMITTEE; IMMUNE-RESPONSE; BAT RABIES; ENCEPHALITIS; VACCINATION; DONOR; RECOMMENDATIONS; MANAGEMENT; DEATHS	IMPORTANCE The rabies virus causes a fatal encephalitis and can be transmitted through tissue or organ transplantation. In February 2013, a kidney recipient with no reported exposures to potentially rabid animals died from rabies 18 months after transplantation. OBJECTIVES To investigate whether organ transplantation was the source of rabies virus exposure in the kidney recipient, and to evaluate for and prevent rabies in other transplant recipients from the same donor. DESIGN Organ donor and all transplant recipient medical records were reviewed. Laboratory tests to detect rabies virus-specific binding antibodies, rabies virus neutralizing antibodies, and rabies virus antigens were conducted on available specimens, including serum, cerebrospinal fluid, and tissues from the donor and the recipients. Viral ribonucleic acid was extracted from tissues and amplified for nucleoprotein gene sequencing for phylogenetic comparisons. MAIN OUTCOMES AND MEASURES Determination of whether the donor died from undiagnosed rabies and whether other organ recipients developed rabies. RESULTS In retrospect, the donor's clinical presentation (which began with vomiting and upper extremity paresthesias and progressed to fever, seizures, dysphagia, autonomic dysfunction, and brain death) was consistent with rabies. Rabies virus antigen was detected in archived autopsy brain tissue collected from the donor. The rabies viruses infecting the donor and the deceased kidney recipient were consistent with the raccoon rabies virus variant and were more than 99.9% identical across the entire N gene (1349/1350 nucleotides), thus confirming organ transplantation as the route of transmission. The 3 other organ recipients remained asymptomatic, with rabies virus neutralizing antibodies detected in their serum after completion of postexposure prophylaxis (range, 0.3-40.8 IU/mL). CONCLUSIONS AND RELEVANCE Unlike the 2 previous clusters of rabies virus transmission through solid organ transplantation, there was a long incubation period in the recipient who developed rabies, and survival of 3 other recipients without pretransplant rabies vaccination. Rabies should be considered in patients with acute progressive encephalitis of unexplained etiology, especially for potential organ donors. A standard evaluation of potential donors who meet screening criteria for infectious encephalitis should be considered, and risks and benefits for recipients of organs from these donors should be evaluated.	[Vora, Neil M.; Orciari, Lillian; Wallace, Ryan M.; Velasco-Villa, Andres; Yager, Pamela; Niezgoda, Mike; Blanton, Jesse; Kuzmina, Natalia; Recuenco, Sergio; Damon, Inger; Franka, Richard] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Vora, Neil M.; Griese, Stephanie; Wallace, Ryan M.; Said, Maria] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Basavaraju, Sridhar V.; Kuehnert, Matthew J.] Ctr Dis Control & Prevent, Off Blood Organ & Other Tissue Safety, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Feldman, Katherine A.; Said, Maria] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Paddock, Christopher D.; Blau, Dianna M.; Ritter, Jana; Zaki, Sherif] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Gitterman, Steven; Kresch, Agnes; Rohatgi, Prashant K.] Vet Affairs Med Ctr, Washington, DC 20422 USA; [Gitterman, Steven; Kresch, Agnes; Rohatgi, Prashant K.] George Washington Univ, Sch Med, Washington, DC USA; [Griese, Stephanie] North Carolina Div Publ Hlth, Raleigh, NC USA; [Selvaggi, Gennaro] Univ Miami, Miller Sch Med, Miami Transplant Inst, Miami, FL 33136 USA; [Stosor, Valentina; Zembower, Teresa] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Falta, Edward M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lyon, G. Marshall, III] Emory Univ, Sch Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); George Washington University; University of Miami; Northwestern University; Feinberg School of Medicine; Walter Reed National Military Medical Center; Emory University	Kuehnert, MJ (corresponding author), Ctr Dis Control & Prevent, Off Blood Organ & Other Tissue Safety, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd NE,MS A07, Atlanta, GA 30333 USA.	mgk8@cdc.gov	Selvaggi, Gennaro/GSN-9593-2022; Kuzmina, Natalia/AAY-8589-2020; Vora, Neil Manhar/AAJ-7269-2021	Selvaggi, Gennaro/0000-0003-4675-7095; Kuzmina, Natalia/0000-0001-6650-9369; Vora, Neil Manhar/0000-0002-4989-3108; Velasco-Villa, Andres/0000-0003-1538-9373; Blanton, Jesse/0000-0002-2634-355X; Feldman, Katherine/0000-0003-4653-8802; Recuenco-Cabrera, Sergio/0000-0002-8446-7411	Centers for Disease Control and Prevention (CDC); Maryland Department of Health and Mental Hygiene; North Carolina Division of Public Health; Florida Department of Health	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Maryland Department of Health and Mental Hygiene; North Carolina Division of Public Health; Florida Department of Health	This investigation was supported by the Centers for Disease Control and Prevention (CDC), Maryland Department of Health and Mental Hygiene, North Carolina Division of Public Health, and Florida Department of Health and funded as part of routine infectious disease outbreak investigation activities.	Barry A., 2008, Morbidity and Mortality Weekly Report, V57, P799; Blanton JD, 2012, JAVMA-J AM VET MED A, V241, P712, DOI 10.2460/javma.241.6.712; Burton EC, 2005, ARCH NEUROL-CHICAGO, V62, P873, DOI 10.1001/archneur.62.6.873; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1102; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1165; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1182; Christenson J. C., 2007, Morbidity and Mortality Weekly Report, V56, P361; Cramer CH, 2008, PEDIATR TRANSPLANT, V12, P874, DOI 10.1111/j.1399-3046.2008.00936.x; Eckerle I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056974; ENRIGHT JB, 1970, CAN J MICROBIOL, V16, P667, DOI 10.1139/m70-115; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Gibbons RV, 2002, ANN EMERG MED, V39, P528, DOI 10.1067/mem.2002.121521; Glaser C, 2009, CLIN INFECT DIS, V49, P1848, DOI 10.1086/648420; Hamir AN, 1996, VET REC, V138, P114, DOI 10.1136/vr.138.5.114; HAMIR AN, 1995, VET REC, V136, P295, DOI 10.1136/vr.136.12.295; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Holzmann-Pazgal G., 2010, Morbidity and Mortality Weekly Report, V59, P185; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; KAPLAN MM, 1975, J IMMUNOL, V114, P1761; Khetsuriani N, 2007, EPIDEMIOL INFECT, V135, P583, DOI 10.1017/S0950268806007163; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Liao PH, 2012, PATHOL INT, V62, P619, DOI 10.1111/j.1440-1827.2012.02846.x; Maier T, 2010, CLIN INFECT DIS, V50, P1112, DOI 10.1086/651267; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nett RJ, 2012, TRANSPL INFECT DIS, V14, P268, DOI 10.1111/j.1399-3062.2012.00743.x; Niezgoda M, 1998, AM J VET RES, V59, P1629; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; Organ Procurement and Transplantation Network, GUID REC CENTR NERV; Petersen B, 2013, NONFLAVIVIRUS ENCEPH; Rodriguez-Romo R, 2011, TRANSPL INFECT DIS, V13, P492, DOI 10.1111/j.1399-3062.2011.00665.x; Rupprecht Charles E., 2010, Morbidity and Mortality Weekly Report, V59, P1; Sattler AC, 2009, VACCINE, V27, P7187, DOI 10.1016/j.vaccine.2009.09.035; Seem DL, 2013, PUBLIC HEALTH REP, V128, P247, DOI 10.1177/003335491312800403; Slate D, 2005, VIRUS RES, V111, P68, DOI 10.1016/j.virusres.2005.03.012; Slate D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000549; Srinivasan A, 2005, NEW ENGL J MED, V352, P1103, DOI 10.1056/NEJMoa043018; Standard Nucleotide BLAST, STAND NUCL BLAST; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Vetter JM, 2011, CORNEA, V30, P241, DOI 10.1097/ICO.0b013e3181e4572a; Willoughby RE, 2005, NEW ENGL J MED, V352, P2508, DOI 10.1056/NEJMoa050382	42	68	71	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					398	407		10.1001/jama.2013.7986	http://dx.doi.org/10.1001/jama.2013.7986			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917290	Green Accepted, Bronze			2022-12-28	WOS:000322121500017
J	Ward, LM; Rauch, F				Ward, Leanne M.; Rauch, Frank			Oral bisphosphonates for paediatric osteogenesis imperfecta?	LANCET			English	Editorial Material							INTRAVENOUS PAMIDRONATE; CHILDREN; ADOLESCENTS; ALENDRONATE		[Ward, Leanne M.] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Rauch, Frank] Shriners Hosp Children, Montreal, PQ, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; McGill University	Ward, LM (corresponding author), Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada.	lward@cheo.on.ca	Ward, Leanne Marie/AAF-8482-2020; Rauch, Frank/D-1554-2009	Ward, Leanne Marie/0000-0003-1557-9185; Rauch, Frank/0000-0002-6261-0360				Ben Amor IM, 2013, J BONE MINER RES, V28, P2001, DOI 10.1002/jbmr.1942; Bishop N, 2013, LANCET; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gatti D, 2005, J BONE MINER RES, V20, P758, DOI 10.1359/JBMR.041232; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Monti E, 2010, THER CLIN RISK MANAG, V6, P367, DOI 10.2147/TCRM.S5932; Rauch F, 2002, J CLIN INVEST, V110, P1293, DOI 10.1172/JCI200215952; Rauch F, 2009, J BONE MINER RES, V24, P1282, DOI [10.1359/JBMR.090213, 10.1359/jbmr.090213]; Sakkers R, 2004, LANCET, V363, P1427, DOI 10.1016/S0140-6736(04)16101-1; Seikaly MG, 2005, J PEDIATR ORTHOPED, V25, P786, DOI 10.1097/01.bpo.0000176162.78980.ed; Shapiro JR, 2003, CALCIFIED TISSUE INT, V72, P103, DOI 10.1007/s00223-001-1055-5; Ward LM, 2011, J CLIN ENDOCR METAB, V96, P355, DOI 10.1210/jc.2010-0636; Ward LM, 2005, J CLIN ENDOCR METAB, V90, P4051, DOI 10.1210/jc.2004-2054	13	9	9	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1388	1389		10.1016/S0140-6736(13)61531-7	http://dx.doi.org/10.1016/S0140-6736(13)61531-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	23927912				2022-12-28	WOS:000326237500007
J	Elder, A; Chi, J; Ozdalga, E; Kugler, J; Verghese, A				Elder, Andrew; Chi, Jeff; Ozdalga, Errol; Kugler, John; Verghese, Abraham			The Road Back to the Bedside	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICAL-EXAMINATION; CLINICAL SKILLS		[Elder, Andrew] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Chi, Jeff; Ozdalga, Errol; Kugler, John; Verghese, Abraham] Stanford Univ, Sch Med, Program Bedside Med, Stanford, CA 94305 USA	University of Edinburgh; Stanford University	Verghese, A (corresponding author), 300 Pasteur Dr,S102, Stanford, CA 94305 USA.			Elder, Andrew/0000-0003-3229-9601				Elder A, 2011, CLIN MED, V11, P231, DOI 10.7861/clinmedicine.11-3-231; Fred HL, 2005, TEX HEART I J, V32, P255; Fromme HB, 2009, MT SINAI J MED, V76, P365, DOI 10.1002/msj.20123; Holmboe ES, 2004, ACAD MED, V79, P16, DOI 10.1097/00001888-200401000-00006; Reilly BM, 2003, LANCET, V362, P1100, DOI 10.1016/S0140-6736(03)14464-9; Sharma Sandeep, 2011, Perm J, V15, P23; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461; Wass V, 2001, LANCET, V357, P945, DOI 10.1016/S0140-6736(00)04221-5; Willett LL, 2007, AM J MED SCI, V333, P74, DOI 10.1097/00000441-200702000-00002; Wipf JE, 1999, ARCH INTERN MED, V159, P1082, DOI 10.1001/archinte.159.10.1082	10	38	39	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					799	800		10.1001/jama.2013.227195	http://dx.doi.org/10.1001/jama.2013.227195			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982364				2022-12-28	WOS:000323561400017
J	Katz, SJ; Morrow, M				Katz, Steven J.; Morrow, Monica			Contralateral Prophylactic Mastectomy for Breast Cancer Addressing Peace of Mind	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES		[Katz, Steven J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Katz, Steven J.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Morrow, Monica] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; Memorial Sloan Kettering Cancer Center	Katz, SJ (corresponding author), Univ Michigan, Dept Med, 2800 Plymouth Rd,North Campus Res Complex,Bldg 16, Ann Arbor, MI 48109 USA.	skatz@umich.edu	KATZ, STEVEN/ABH-8886-2020		NATIONAL CANCER INSTITUTE [P01CA163233] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA163233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bedrosian I, 2010, JNCI-J NATL CANCER I, V102, P401, DOI 10.1093/jnci/djq018; Cemal Y, 2013, PLAST RECONSTR SURG, V131, p320E, DOI 10.1097/PRS.0b013e31827cf576; Houssami N, 2013, ANN SURG, V257, P249, DOI 10.1097/SLA.0b013e31827a8d17; Katz SJ, CANCER, DOI [10.1002/cncr.28260, DOI 10.1002/CNCR.28260]; Nichols HB, 2011, J CLIN ONCOL, V29, P1564, DOI 10.1200/JCO.2010.32.7395; Tuttle TM, 2009, J CLIN ONCOL, V27, P1362, DOI 10.1200/JCO.2008.20.1681	6	63	63	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					793	794		10.1001/jama.2013.101055	http://dx.doi.org/10.1001/jama.2013.101055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23907558				2022-12-28	WOS:000323561400014
J	Osinusi, A; Meissner, EG; Lee, YJ; Bon, D; Heytens, L; Nelson, A; Sneller, M; Kohli, A; Barrett, L; Proschan, M; Herrmann, E; Shivakumar, B; Gu, WJ; Kwan, R; Teferi, G; Talwani, R; Silk, R; Kotb, C; Wroblewski, S; Fishbein, D; Dewar, R; Highbarger, H; Zhang, X; Kleiner, D; Wood, BJ; Chavez, J; Symonds, WT; Subramanian, M; McHutchison, J; Polis, MA; Fauci, AS; Masur, H; Kottilil, S				Osinusi, Anuoluwapo; Meissner, Eric G.; Lee, Yu-Jin; Bon, Dimitra; Heytens, Laura; Nelson, Amy; Sneller, Michael; Kohli, Anita; Barrett, Lisa; Proschan, Michael; Herrmann, Eva; Shivakumar, Bhavana; Gu, Wenjuan; Kwan, Richard; Teferi, Geb; Talwani, Rohit; Silk, Rachel; Kotb, Colleen; Wroblewski, Susan; Fishbein, Dawn; Dewar, Robin; Highbarger, Helene; Zhang, Xiao; Kleiner, David; Wood, Brad J.; Chavez, Jose; Symonds, William T.; Subramanian, Mani; McHutchison, John; Polis, Michael A.; Fauci, Anthony S.; Masur, Henry; Kottilil, Shyamasundaran			Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLUS RIBAVIRIN; UNITED-STATES; VIRUS-INFECTION; TELAPREVIR; INTERFERON-ALPHA-2B; COMBINATION; PREVALENCE; BOCEPREVIR; THERAPY; PLACEBO	IMPORTANCE The efficacy of directly acting antiviral agents in interferon-free regimens for the treatment of chronic hepatitis C infections needs to be evaluated in different populations. OBJECTIVE To determine the efficacy and safety of sofosbuvir with weight-based or low-dose ribavirin among a population with unfavorable treatment characteristics. DESIGN, SETTING, AND PATIENTS Single-center, randomized, 2-part, open-label phase 2 study involving 60 treatment-naive patients with hepatitis C virus (HCV) genotype 1 enrolled at the National Institutes of Health (October 2011-April 2012). INTERVENTIONS In the study's first part, 10 participants with early to moderate liver fibrosis were treated with 400 mg/d of sofosbuvir and weight-based ribavirin for 24 weeks. In the second part, 50 participants with all stages of liver fibrosis were randomized 1: 1 to receive 400 mg of sofosbuvir with either weight-based or low-dose 600 mg/d of ribavirin for 24 weeks. MAIN OUTCOMES AND MEASURES The primary study end point was the proportion of participants with undetectable HCV viral load 24 weeks after treatment completion (sustained virologic response of 24 weeks [SVR24]). RESULTS In the first part of the study, 9 participants (90%; 95% CI, 55%-100%) achieved SVR24. In the second part, 7 participants (28%) in the weight-based group and 10 (40%) in the low-dose group relapsed after treatment completion leading to SVR24 rates of 68%(95% CI, 46%-85%) in the weight-based group and 48%(95% CI, 28%-69%; P = .20) in the low-dose group. Twenty individuals participated in a pharmacokinetic-viral kinetic substudy, which demonstrated a slower loss rate of infectious virus in relapsers than in participants who achieved SVR (clearance, 3.57/d vs 5.60/d; P = .009). The most frequent adverse events were headache, anemia, fatigue, and nausea. There were 7 grade 3 events including anemia, neutropenia, nausea, hypophosphatemia, and cholelithiasis or pancreatitis. No one discontinued treatment due to adverse events. CONCLUSION AND RELEVANCE In a population of patients with a high prevalence of unfavorable traditional predictors of treatment response, a 24-week regimen of sofosbuvir and weight-based or low-dose ribavirin resulted in SVR24 rates of 68% and 48%, respectively.	[Osinusi, Anuoluwapo; Meissner, Eric G.; Lee, Yu-Jin; Nelson, Amy; Sneller, Michael; Kohli, Anita; Barrett, Lisa; Shivakumar, Bhavana; Wroblewski, Susan; Zhang, Xiao; Polis, Michael A.; Fauci, Anthony S.; Kottilil, Shyamasundaran] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Osinusi, Anuoluwapo; Silk, Rachel; Kotb, Colleen] Sci Applicat Int Corp SAIC Frederick Inc, Clin Res Directorate, Clin Monitoring Res Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Bon, Dimitra; Herrmann, Eva] Goethe Univ Frankfurt, Inst Biostat & Math Modeling, D-60054 Frankfurt, Germany; [Heytens, Laura; Kwan, Richard; Masur, Henry] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Proschan, Michael] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Gu, Wenjuan; Dewar, Robin; Highbarger, Helene] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Frederick, MD USA; [Teferi, Geb; Chavez, Jose] Unity Hlth Care Inc, Washington, DC USA; [Talwani, Rohit] Univ Maryland, Dept Infect Dis, Baltimore, MD 21201 USA; [Fishbein, Dawn] MedStar Washington Hosp Ctr, Dept Infect Dis, Washington, DC USA; [Kleiner, David] NCI, Dept Pathol, Bethesda, MD 20892 USA; [Wood, Brad J.] NIH, Ctr Intervent Oncol Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Wood, Brad J.] NCI, Bethesda, MD 20892 USA; [Symonds, William T.; Subramanian, Mani; McHutchison, John] Gilead Sci Inc, Foster City, CA 94404 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University System of Maryland; University of Maryland Baltimore; MedStar Washington Hospital Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gilead Sciences	Kottilil, S (corresponding author), NIAID, Immunopathogenesis Sect, Immunoregulat Lab, NIH, Bldg 10,Room 11N204, Bethesda, MD 20892 USA.	skottilil@niaid.nih.gov	Talwani, Rohit/B-8234-2019; Wood, Bradford J/M-7995-2017; Kottilil, Shyam/ABF-7605-2021; Kleiner, David E/N-2770-2013	Wood, Bradford J/0000-0002-4297-0051; Kleiner, David E/0000-0003-3442-4453; Lee, Yu-Jin/0000-0001-7050-9185; Polis, Michael/0000-0002-9151-2268; Nelson, Amy/0000-0001-9028-1894	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases; German Research Foundation by the clinical research unit KFO 129; NATIONAL CANCER INSTITUTE [ZICBC010687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL040015, ZIACL009010] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation by the clinical research unit KFO 129; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This project was funded in whole by grant HHSN261200800001E from the National Cancer Institute, National Institutes of Health. This research was supported in part by the National Institute of Allergy and Infectious Diseases and by the German Research Foundation by the clinical research unit KFO 129. Pharmasset Pharmaceuticals and subsequently Gilead Sciences provided sofosbuvir and scientific advice.	Ali S, 2008, ANTIMICROB AGENTS CH, V52, P4356, DOI 10.1128/AAC.00444-08; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bodenheimer HC, 1997, HEPATOLOGY, V26, P473, DOI 10.1002/hep.510260231; Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657; DIBISCEGLIE AM, 1995, ANN INTERN MED, V123, P897, DOI 10.7326/0003-4819-123-12-199512150-00001; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Neukam K, 2013, J INFECTION, V67, P59, DOI 10.1016/j.jinf.2013.03.010; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013	23	240	245	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					804	811		10.1001/jama.2013.109309	http://dx.doi.org/10.1001/jama.2013.109309			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982366	Bronze, Green Accepted			2022-12-28	WOS:000323561400020
J	Feagan, BG; Rutgeerts, P; Sands, BE; Hanauer, S; Colombel, JF; Sandborn, WJ; Van Assche, G; Axler, J; Kim, HJ; Danese, S; Fox, I; Milch, C; Sankoh, S; Wyant, T; Xu, J; Parikh, A				Feagan, Brian G.; Rutgeerts, Paul; Sands, Bruce E.; Hanauer, Stephen; Colombel, Jean-Frederic; Sandborn, William J.; Van Assche, Gert; Axler, Jeffrey; Kim, Hyo-Jong; Danese, Silvio; Fox, Irving; Milch, Catherine; Sankoh, Serap; Wyant, Tim; Xu, Jing; Parikh, Asit		GEMINI 1Study Grp	Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL-ADHESION MOLECULE-1; JC VIRUS; INTEGRIN; NATALIZUMAB; ANTIBODY; ALPHA(4)BETA(7); PREVALENCE; ANTAGONISM; INFLIXIMAB; EXPRESSION	BACKGROUND Gut-selective blockade of lymphocyte trafficking by vedolizumab may constitute effective treatment for ulcerative colitis. METHODS We conducted two integrated randomized, double-blind, placebo-controlled trials of vedolizumab in patients with active disease. In the trial of induction therapy, 374 patients (cohort 1) received vedolizumab (at a dose of 300 mg) or placebo intravenously at weeks 0 and 2, and 521 patients (cohort 2) received open-label vedolizumab at weeks 0 and 2, with disease evaluation at week 6. In the trial of maintenance therapy, patients in either cohort who had a response to vedolizumab at week 6 were randomly assigned to continue receiving vedolizumab every 8 or 4 weeks or to switch to placebo for up to 52 weeks. A response was defined as a reduction in the Mayo Clinic score (range, 0 to 12, with higher scores indicating more active disease) of at least 3 points and a decrease of at least 30% from baseline, with an accompanying decrease in the rectal bleeding subscore of at least 1 point or an absolute rectal bleeding subscore of 0 or 1. RESULTS Response rates at week 6 were 47.1% and 25.5% among patients in the vedolizumab group and placebo group, respectively (difference with adjustment for stratification factors, 21.7 percentage points; 95% confidence interval [CI], 11.6 to 31.7; P<0.001). At week 52, 41.8% of patients who continued to receive vedolizumab every 8 weeks and 44.8% of patients who continued to receive vedolizumab every 4 weeks were in clinical remission (Mayo Clinic score 2 and no subscore >1), as compared with 15.9% of patients who switched to placebo (adjusted difference, 26.1 percentage points for vedolizumab every 8 weeks vs. placebo [95% CI, 14.9 to 37.2; P<0.001] and 29.1 percentage points for vedolizumab every 4 weeks vs. placebo [95% CI, 17.9 to 40.4; P<0.001]). The frequency of adverse events was similar in the vedolizumab and placebo groups. CONCLUSIONS Vedolizumab was more effective than placebo as induction and maintenance therapy for ulcerative colitis.	[Feagan, Brian G.] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5K8, Canada; [Feagan, Brian G.] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; [Feagan, Brian G.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 5K8, Canada; [Rutgeerts, Paul; Van Assche, Gert] Katholieke Univ Leuven, Louvain, Belgium; [Rutgeerts, Paul; Van Assche, Gert] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Sands, Bruce E.; Colombel, Jean-Frederic] Icahn Sch Med Mt Sinai, New York, NY USA; [Hanauer, Stephen] Univ Chicago, Chicago, IL 60637 USA; [Colombel, Jean-Frederic] Univ Lille Nord France, Dept Hepatogastroenterol, Lille, France; [Colombel, Jean-Frederic] Univ Lille Nord France, Ctr Hosp Reg Univ Lille, Ctr Invest Clin, Lille, France; [Sandborn, William J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Axler, Jeffrey] Univ Toronto, Toronto Digest Dis Associates, Toronto, ON, Canada; [Axler, Jeffrey] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Kim, Hyo-Jong] Kyung Hee Univ Hosp, Seoul, South Korea; [Danese, Silvio] Ist Clin Humanitas, Milan, Italy; [Fox, Irving; Milch, Catherine; Sankoh, Serap; Wyant, Tim; Xu, Jing; Parikh, Asit] Millennium Pharmaceut Inc, Cambridge, MA USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); KU Leuven; KU Leuven; University Hospital Leuven; Icahn School of Medicine at Mount Sinai; University of Chicago; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of California System; University of California San Diego; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Kyung Hee University; Kyung Hee University Hospital; IRCCS Humanitas Research Hospital; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Feagan, BG (corresponding author), Univ Western Ontario, Robarts Res Inst, 100 Perth Dr, London, ON N6A 5K8, Canada.	bfeagan@robarts.ca	Feagan, Brian G/M-4283-2015; Desreumaux, Pierre F/R-6877-2018; Danese, Silvio/ABH-9571-2020; Rogler, Gerhard/O-5308-2015; Snydman, David R/O-3889-2014; Sands, Bruce/R-7887-2019; Loftus, Edward V/E-8304-2011; Feagan, Brian/G-3292-2011; Pavli, Paul/GZL-0607-2022; Andersen, Vibeke/I-7932-2012; Lukas, Milan/J-6382-2017; Sandborn, William/ABE-8342-2020; Leong, Rupert WL/J-7839-2012; Radford-Smith, Graham L/G-5749-2017	Desreumaux, Pierre F/0000-0002-6127-5281; Danese, Silvio/0000-0001-7341-1351; Rogler, Gerhard/0000-0002-1733-9188; Snydman, David R/0000-0003-0119-3978; Sands, Bruce/0000-0001-5762-5042; Loftus, Edward V/0000-0001-7199-6851; Andersen, Vibeke/0000-0002-0127-2863; Lukas, Milan/0000-0002-1463-3840; Leong, Rupert WL/0000-0001-5944-3488; Radford-Smith, Graham L/0000-0002-2047-6239; Schwartz, David/0000-0002-7026-7099; Ryan, Barbara/0000-0001-8400-9202; Dryden, Gerald/0000-0001-9787-4537	Millennium Pharmaceuticals	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Funded by Millennium Pharmaceuticals; GEMINI 1 ClinicalTrials.gov number, NCT00783718.	Arihiro S, 2002, PATHOL INT, V52, P367, DOI 10.1046/j.1440-1827.2002.01365.x; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Briskin M, 1997, AM J PATHOL, V151, P97; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Engels EA, 2005, INT J CANCER, V117, P1013, DOI 10.1002/ijc.21277; ERLE DJ, 1994, J IMMUNOL, V153, P517; Feagan BG, 2005, NEW ENGL J MED, V352, P2499, DOI 10.1056/NEJMoa042982; Fedyk ER, 2012, INFLAMM BOWEL DIS, V18, P2107, DOI 10.1002/ibd.22940; Haanstra KG, 2013, J IMMUNOL, V190, P1961, DOI 10.4049/jimmunol.1202490; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Milch C., 2011, ECCO INFLAMM BOWEL D, V60, pA407; PADGETT BL, 1973, J INFECT DIS, V127, P467, DOI 10.1093/infdis/127.4.467; Pepio AM, 2010, 2010 ADV INFL BOS DI; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Schwab N, 2012, NEUROLOGY, V78, P458, DOI 10.1212/WNL.0b013e3182478d4b; Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901; Soler D, 2009, J PHARMACOL EXP THER, V330, P864, DOI 10.1124/jpet.109.153973; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0; Sutherland L, 2000, COCHRANE DB SYST REV, V2; SUTHERLAND L, 2000, COCHRANE DB SYST REV, V2, P544; Tysabri, 2012, TYS; Verbeeck J, 2008, GUT, V57, P1393, DOI 10.1136/gut.2007.145698; Weber T, 1997, J INFECT DIS, V176, P250, DOI 10.1086/514032	35	1436	1499	7	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					699	710		10.1056/NEJMoa1215734	http://dx.doi.org/10.1056/NEJMoa1215734			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964932				2022-12-28	WOS:000323349300007
J	Roberts, RG; Sutikna, T				Roberts, Richard G.; Sutikna, Thomas			Michael John Morwood (1950-2013) OBITUARY	NATURE			English	Biographical-Item									[Roberts, Richard G.; Sutikna, Thomas] Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Sutikna, Thomas] Pusat Arkeol Nas, Jakarta, Indonesia	University of Wollongong	Roberts, RG (corresponding author), Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	rgrob@uow.edu.au; thomasutikna@yahoo.com	Roberts, Richard Graham/B-8245-2013; Sutikna, Thomas/C-4709-2018	Roberts, Richard Graham/0000-0002-0128-4119; Sutikna, Thomas/0000-0002-9742-4226				MORWOOD MJ, PUBLICATION LIST	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					401	401		10.1038/500401a	http://dx.doi.org/10.1038/500401a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969451	Bronze			2022-12-28	WOS:000323316100018
J	Richards, DA; Hill, JJ; Gask, L; Lovell, K; Chew-Graham, C; Bower, P; Cape, J; Pilling, S; Araya, R; Kessler, D; Bland, JM; Green, C; Gilbody, S; Lewis, G; Manning, C; Hughes-Morley, A; Barkham, M				Richards, David A.; Hill, Jacqueline J.; Gask, Linda; Lovell, Karina; Chew-Graham, Carolyn; Bower, Peter; Cape, John; Pilling, Stephen; Araya, Ricardo; Kessler, David; Bland, J. Martin; Green, Colin; Gilbody, Simon; Lewis, Glyn; Manning, Chris; Hughes-Morley, Adwoa; Barkham, Michael			Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BEHAVIORAL ACTIVATION; ANXIETY; INTERVENTION; METAANALYSIS; MANAGEMENT; COMMUNITY; EFFICACY; DISORDER; THERAPY	Objective To compare the clinical effectiveness of collaborative care with usual care in the management of patients with moderate to severe depression. Design Cluster randomised controlled trial. Setting 51 primary care practices in three primary care districts in the United Kingdom. Participants 581 adults aged 18 years and older who met ICD-10 (international classification of diseases, 10th revision) criteria for a depressive episode on the revised Clinical Interview Schedule. We excluded acutely suicidal patients and those with psychosis, or with type I or type II bipolar disorder; patients whose low mood was associated with bereavement or whose primary presenting problem was alcohol or drug abuse; and patients receiving psychological treatment for their depression by specialist mental health services. We identified potentially eligible participants by searching computerised case records in general practices for patients with depression. Interventions Collaborative care, including depression education, drug management, behavioural activation, relapse prevention, and primary care liaison, was delivered by care managers. Collaborative care involved six to 12 contacts with participants over 14 weeks, supervised by mental health specialists. Usual care was family doctors' standard clinical practice. Main outcome measures Depression symptoms (patient health questionnaire 9; PHQ-9), anxiety (generalised anxiety disorder 7; GAD-7), and quality of life (short form 36 questionnaire; SF-36) at four and 12 months; satisfaction with service quality (client satisfaction questionnaire; CSQ-8) at four months. Results 276 participants were allocated to collaborative care and 305 allocated to usual care. At four months, mean depression score was 11.1 (standard deviation 7.3) for the collaborative care group and 12.7 (6.8) for the usual care group. After adjustment for baseline depression, mean depression score was 1.33 PHQ-9 points lower (95% confidence interval 0.35 to 2.31, P=0.009) in participants receiving collaborative care than in those receiving usual care at four months, and 1.36 points lower (0.07 to 2.64, P=0.04) at 12 months. Quality of mental health but not physical health was significantly better for collaborative care than for usual care at four months, but not 12 months. Anxiety did not differ between groups. Participants receiving collaborative care were significantly more satisfied with treatment than those receiving usual care. The number needed to treat for one patient to drop below the accepted diagnostic threshold for depression on the PHQ-9 was 8.4 immediately after treatment, and 6.5 at 12 months. Conclusions Collaborative care has persistent positive effects up to 12 months after initiation of the intervention and is preferred by patients over usual care.	[Richards, David A.; Green, Colin] Univ Exeter, Sch Med, Inst Hlth Res, Exeter EX1 2LU, Devon, England; [Hill, Jacqueline J.] Univ Exeter, Sch Psychol, Exeter EX1 2LU, Devon, England; [Gask, Linda; Hughes-Morley, Adwoa] Univ Manchester, Inst Populat Hlth, Manchester Acad Hlth Sci Ctr, Ctr Primary Care, Manchester, Lancs, England; [Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Chew-Graham, Carolyn] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Bower, Peter] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Populat Hlth, NIHR Sch Primary Care Res,Ctr Primary Care, Manchester, Lancs, England; [Cape, John; Pilling, Stephen] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Araya, Ricardo; Kessler, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Gilbody, Simon] Univ York, Dept Hlth Sci, Mental Hlth Res Grp, York YO10 5DD, N Yorkshire, England; [Gilbody, Simon] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Lewis, Glyn] UCL, Mental Hlth Sci Unit, London, England; [Manning, Chris] Upstream Healthcare, Teddington, Middx, England; [Barkham, Michael] Univ Sheffield, Dept Psychol, Ctr Psychol Serv Res, Sheffield S10 2TN, S Yorkshire, England	University of Exeter; University of Exeter; University of Manchester; University of Manchester; Keele University; University of Manchester; University of London; University College London; University of Bristol; University of York - UK; University of York - UK; University of Hull; University of York - UK; University of London; University College London; University of Sheffield	Richards, DA (corresponding author), Univ Exeter, Sch Med, Inst Hlth Res, Exeter EX1 2LU, Devon, England.	d.a.richards@exeter.ac.uk	John, Cape/B-9039-2009; Araya, Ricardo/S-3144-2019; Kessler, david/ABB-6489-2021; Bower, Peter/A-1508-2011; Lewis, Glyn/E-9944-2012; Lovell, Karina S E/E-6410-2012; Gilbody, Simon/AAY-3720-2021; Richards, David/B-4807-2009	John, Cape/0000-0003-3108-7228; Araya, Ricardo/0000-0002-0420-5148; Bower, Peter/0000-0001-9558-3349; Lewis, Glyn/0000-0001-5205-8245; Lovell, Karina S E/0000-0001-8821-895X; Gilbody, Simon/0000-0002-8236-6983; Parker, Adwoa/0000-0002-2880-3935; Richards, David/0000-0002-8821-5027; Barkham, Michael/0000-0003-1687-6376	UK Medical Research Council (MRC) [G0701013]; MRC [G0701013, G0401181] Funding Source: UKRI; Medical Research Council [G0401181, G0701013] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10203] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This report is independent research funded by the UK Medical Research Council (MRC; reference G0701013), managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership.	[Anonymous], 2012, NATURE, V489, P473; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Beck AT, 1987, COGNITIVE THERAPY DE; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Cape J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-38; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; Department for Communities and Local Government, 2008, ENGL IND MULT DEPR 2; Department of Health, 2012, IAPT 3 YEAR REP 1 MI; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Ekers D, 2008, PSYCHOL MED, V38, P611, DOI 10.1017/S0033291707001614; Ekers D, 2011, BRIT J PSYCHIAT, V198, P66, DOI 10.1192/bjp.bp.110.079111; Elliott R, 1993, HDB EFFECTIVE PSYCHO, P455; Evans S. J. W., 1990, MINIM MINIMISATION P; Gask L, 2005, SOC SCI MED, V61, P1785, DOI 10.1016/j.socscimed.2005.03.038; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gunn J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-88; Irvin JE, 1999, J CONSULT CLIN PSYCH, V67, P563, DOI 10.1037/0022-006X.67.4.563; Killaspy H, 2006, BMJ-BRIT MED J, V332, P815, DOI 10.1136/bmj.38773.518322.7C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Meltzer H, 1995, OPCS SURVEYS PSYCHIA; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; National Institute for Health and Clinical Excellence, 2009, DEPR AD CHRON PHYS H; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Richards DA, 2008, PSYCHOL MED, V38, P279, DOI 10.1017/S0033291707001365; Richards DA, 2006, GEN HOSP PSYCHIAT, V28, P296, DOI 10.1016/j.genhosppsych.2006.03.005; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Simpson Angela, 2008, Ment Health Fam Med, V5, P95; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Ware JE, 1993, SF36 HLTH SURVEY MAN; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	128	129	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2013	347								f4913	10.1136/bmj.f4913	http://dx.doi.org/10.1136/bmj.f4913			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	207RR	23959152	Green Published, hybrid			2022-12-28	WOS:000323621900001
J	Fenner, K; Canonica, S; Wackett, LP; Elsner, M				Fenner, Kathrin; Canonica, Silvio; Wackett, Lawrence P.; Elsner, Martin			Evaluating Pesticide Degradation in the Environment: Blind Spots and Emerging Opportunities	SCIENCE			English	Review							ORGANIC-MATTER; SURFACE-WATER; FATE; ATRAZINE; OXIDATION; BIODEGRADATION; METOLACHLOR; METABOLITES; MECHANISMS; HERBICIDES	The benefits of global pesticide use come at the cost of their widespread occurrence in the environment. An array of abiotic and biotic transformations effectively removes pesticides from the environment, but may give rise to potentially hazardous transformation products. Despite a large body of pesticide degradation data from regulatory testing and decades of pesticide research, it remains difficult to anticipate the extent and pathways of pesticide degradation under specific field conditions. Here, we review the major scientific challenges in doing so and discuss emerging opportunities to identify pesticide degradation processes in the field.	[Fenner, Kathrin; Canonica, Silvio] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Fenner, Kathrin] ETH, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland; [Wackett, Lawrence P.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Elsner, Martin] Helmholtz Zentrum Munchen, Inst Groundwater Ecol, D-85764 Neuherberg, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Minnesota System; University of Minnesota Twin Cities; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Fenner, K (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland.	kathrin.fenner@eawag.ch	Elsner, Martin/J-4637-2012	Elsner, Martin/0000-0003-4746-9052	U.S. NSF [1237754]	U.S. NSF(National Science Foundation (NSF))	We thank R. Schwarzenbach, K. Lanz, and C. Stamm for helpful comments on the manuscript and the Swiss National Science Foundation (SNSF), Eawag, the Federal Office for the Environment (FOEN), the German National Science Foundation (DFG, SPP-1315), the Helmholtz Association, and the U.S. NSF (Partnerships for Innovation grant 1237754) for continuous support of our work.	[Anonymous], 2012, FAOSTAT; Atkinson R, 1999, WATER AIR SOIL POLL, V115, P219, DOI 10.1023/A:1005286313693; Barrett KA, 2005, ENVIRON SCI TECHNOL, V39, P9223, DOI 10.1021/es051342d; Bartel H., 2010, WASSERWIRTSCHAFT D 1; Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004; Boxall ABA, 2004, ENVIRON SCI TECHNOL, V38, p368A, DOI 10.1021/es040624v; Burrows HD, 2002, J PHOTOCH PHOTOBIO B, V67, P71, DOI 10.1016/S1011-1344(02)00277-4; Buser HR, 1998, ENVIRON SCI TECHNOL, V32, P626, DOI 10.1021/es970652w; Buttiglieri G, 2009, WATER RES, V43, P2865, DOI 10.1016/j.watres.2009.03.035; Canonica S, 2003, ENVIRON TOXICOL CHEM, V22, P1743, DOI 10.1897/01-237; Canonica S, 2008, PHOTOCH PHOTOBIO SCI, V7, P547, DOI 10.1039/b719982a; Choi MK, 2009, J MICROBIOL BIOTECHN, V19, P1679, DOI 10.4014/jmb.0905.05057; Choung CB, 2011, ARCH ENVIRON CON TOX, V60, P417, DOI 10.1007/s00244-010-9560-z; Copley SD, 2009, NAT CHEM BIOL, V5, P560, DOI 10.1038/nchembio.197; Cupples AM, 2007, SOIL BIOL BIOCHEM, V39, P232, DOI 10.1016/j.soilbio.2006.07.011; De Laurentiis E, 2012, ENVIRON SCI TECHNOL, V46, P8164, DOI 10.1021/es3015887; de Souza ML, 1998, J BACTERIOL, V180, P1951, DOI 10.1128/JB.180.7.1951-1954.1998; Devers M, 2008, ENVIRON MICROBIOL, V10, P676, DOI 10.1111/j.1462-2920.2007.01490.x; Dieter HH, 2010, REGUL TOXICOL PHARM, V56, P121, DOI 10.1016/j.yrtph.2009.07.012; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; Gerecke AC, 2001, ENVIRON SCI TECHNOL, V35, P3915, DOI 10.1021/es010103x; Gilliom R.J., 2006, QUALITY OUR NATIONS; Halladja S, 2009, PHOTOCH PHOTOBIO SCI, V8, P1066, DOI 10.1039/b901306g; Hofstetter TB, 2011, TRAC-TREND ANAL CHEM, V30, P618, DOI 10.1016/j.trac.2010.10.012; Hoigne J., 1990, AQUATIC CHEM KINETIC, P43; Huntscha S, 2008, ENVIRON SCI TECHNOL, V42, P5507, DOI 10.1021/es800395c; Janniche GS, 2012, J CONTAM HYDROL, V140, P45, DOI 10.1016/j.jconhyd.2012.08.008; Jin MQ, 2010, J ENVIRON SCI-CHINA, V22, P290, DOI 10.1016/S1001-0742(09)60107-8; Jochimsen B, 2011, P NATL ACAD SCI USA, V108, P11393, DOI 10.1073/pnas.1104922108; Kern S, 2009, ENVIRON SCI TECHNOL, V43, P7039, DOI 10.1021/es901979h; Kilchmann S., 2009, ERGEBNISSE GRUNDWASS; Kurt-Karakus PB, 2011, ENVIRON TOXICOL CHEM, V30, P1539, DOI 10.1002/etc.545; Laffin B, 2010, TOXICOLOGY, V267, P39, DOI 10.1016/j.tox.2009.10.003; Loch AR, 2002, ENVIRON SCI TECHNOL, V36, P4065, DOI 10.1021/es0206285; Malaguerra F, 2012, SCI TOTAL ENVIRON, V414, P433, DOI 10.1016/j.scitotenv.2011.09.071; Milosevic N, 2013, WATER RES, V47, P637, DOI 10.1016/j.watres.2012.10.029; Monard C, 2013, BIODEGRADATION, V24, P203, DOI 10.1007/s10532-012-9574-5; Muir DCG, 2004, ENVIRON TOXICOL CHEM, V23, P2421, DOI 10.1897/03-457; NIST, 2019, NDRL NIST SOL KIN DA; Padhye LP, 2013, WATER RES, V47, P725, DOI 10.1016/j.watres.2012.10.043; Pesce S, 2010, AQUAT TOXICOL, V99, P492, DOI 10.1016/j.aquatox.2010.06.006; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Reemtsma T, 2013, J CHROMATOGR A, V1271, P95, DOI 10.1016/j.chroma.2012.11.023; Regulation (EC) No 2009/1107 of the European Parliament and of the Council of 21, 2009, OJ L, V309, P1, DOI DOI 10.3000/17252555.L_2009.309.ENG; Schmidt CK, 2008, ENVIRON SCI TECHNOL, V42, P6340, DOI 10.1021/es7030467; Schreglmann K, 2013, ANAL BIOANAL CHEM, V405, P2857, DOI 10.1007/s00216-012-6616-0; Seffernick JL, 2007, J BACTERIOL, V189, P6989, DOI 10.1128/JB.00630-07; U.S. Environmental Protection Agency (U.S. EPA), 2011, PEST IND SAL US; Wackett LP, 2002, APPL MICROBIOL BIOT, V58, P39, DOI 10.1007/s00253-001-0862-y; Xu JC, 2001, ENVIRON TOXICOL CHEM, V20, P2717, DOI [10.1002/etc.5620201210, 10.1897/1551-5028(2001)020&lt;2717:FOAAAI&gt;2.0.CO;2]; Zeng T, 2013, ENVIRON SCI TECHNOL, V47, P6735, DOI 10.1021/es3030808; Zeng T, 2012, ENVIRON SCI TECHNOL, V46, P3177, DOI 10.1021/es203584d	52	626	645	99	1077	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					752	758		10.1126/science.1236281	http://dx.doi.org/10.1126/science.1236281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950532				2022-12-28	WOS:000323122200039
J	Nelson, WA; Bjornstad, ON; Yamanaka, T				Nelson, William A.; Bjornstad, Ottar N.; Yamanaka, Takehiko			Recurrent Insect Outbreaks Caused by Temperature-Driven Changes in System Stability	SCIENCE			English	Article							LIFE-CYCLES; FOOD-WEB; DYNAMICS; POPULATIONS; PREY; SIZE; TRANSITIONS; HERBIVORES; ENRICHMENT; MODELS	Insects often undergo regular outbreaks in population density but identifying the causal mechanism for such outbreaks in any particular species has proven difficult. Here, we show that outbreak cycles in the tea tortrix Adoxophyes honmai can be explained by temperature-driven changes in system stability. Wavelet analysis of a 51-year time series spanning more than 200 outbreaks reveals a threshold in outbreak amplitude each spring when temperature exceeds 15 degrees C and a secession of outbreaks each fall as temperature decreases. This is in close agreement with our independently parameterized mathematical model that predicts the system crosses a Hopf bifurcation from stability to sustained cycles as temperature increases. These results suggest that temperature can alter system stability and provide an explanation for generation cycles in multivoltine insects.	[Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Yamanaka, Takehiko] Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, Tsukuba, Ibaraki 3058604, Japan	Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute for Agro-Environmental Sciences (NIAES) Japan	Nelson, WA (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	nelsonw@queensu.ca	Nelson, William A/D-1405-2013	Yamanaka, Takehiko/0000-0003-2888-1076	Natural Sciences and Engineering Research Council Discovery grants; U.S. Department of Agricultures National Research Initiative	Natural Sciences and Engineering Research Council Discovery grants; U.S. Department of Agricultures National Research Initiative(United States Department of Agriculture (USDA))	We thank K. Uchimura for access to up-to-date light-catch data. W.A.N. was supported by Natural Sciences and Engineering Research Council Discovery grants. O.N.B. received support from the U.S. Department of Agricultures National Research Initiative. Raw time-series data are provided in Dryad (doi:10.5061/dryad.n11d4).	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Becks L, 2008, ECOLOGY, V89, P3222, DOI 10.1890/07-1988.1; Binzer A, 2012, PHILOS T R SOC B, V367, P2935, DOI 10.1098/rstb.2012.0230; Carmona R., 1998, PRACTICAL TIME FREQU, V9; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Danks HV, 1987, INSECT DORMANCY ECOL; Forster J, 2011, AM NAT, V178, P668, DOI 10.1086/662174; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GURNEY WSC, 1994, THEOR POPUL BIOL, V46, P319, DOI 10.1006/tpbi.1994.1030; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Massie TM, 2010, P NATL ACAD SCI USA, V107, P4236, DOI 10.1073/pnas.0908725107; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; O'Connor MI, 2011, AM NAT, V178, P626, DOI 10.1086/662171; Ohlberger J, 2011, AM NAT, V177, P211, DOI 10.1086/657925; Powell JA, 2000, B MATH BIOL, V62, P977, DOI 10.1006/bulm.2000.0192; RINALDI S, 1993, B MATH BIOL, V55, P15, DOI 10.1007/BF02460293; ROFF D, 1983, DIAPAUSE LIFE CYCLE, P253; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; Tamaki Y., 1991, TORTRICID PESTS THEI, P541; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAYLOR F, 1981, AM NAT, V117, P1, DOI 10.1086/283683; Taylor RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2714; Vasseur DA, 2005, AM NAT, V166, P184, DOI 10.1086/431285; Yamanaka T, 2012, AM NAT, V179, P95, DOI 10.1086/663201	30	72	74	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					796	799		10.1126/science.1238477	http://dx.doi.org/10.1126/science.1238477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23907532				2022-12-28	WOS:000323122200051
J	Yuan, CX; Ji, Q; Meng, QJ; Tabrum, AR; Luo, ZX				Yuan, Chong-Xi; Ji, Qiang; Meng, Qing-Jin; Tabrum, Alan R.; Luo, Zhe-Xi			Earliest Evolution of Multituberculate Mammals Revealed by a New Jurassic Fossil	SCIENCE			English	Article							INTRINSIC HAND PROPORTIONS; ALLOTHERIAN MAMMALS; LOCOMOTOR BEHAVIOR; ADAPTATIONS; MARSUPIALS; CHINA	Multituberculates were successful herbivorous mammals and were more diverse and numerically abundant than any other mammal groups in Mesozoic ecosystems. The clade also developed diverse locomotor adaptations in the Cretaceous and Paleogene. We report a new fossil skeleton from the Late Jurassic of China that belongs to the basalmost multituberculate family. Dental features of this new Jurassic multituberculate show omnivorous adaptation, and its well-preserved skeleton sheds light on ancestral skeletal features of all multituberculates, especially the highly mobile joints of the ankle, crucial for later evolutionary success of multituberculates in the Cretaceous and Paleogene.	[Yuan, Chong-Xi; Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Meng, Qing-Jin] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Tabrum, Alan R.] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; [Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Chinese Academy of Geological Sciences; University of Chicago	Luo, ZX (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	zxluo@uchicago.edu	Luo, Zhe-XI/AAU-2263-2021; Meng, Q./GSI-6185-2022		Ministry of Land Resources; Ministry of Science and Technology of China; Scientific Commission of Beijing; Beijing Museum of Natural History; NSF; Carnegie Museum; University of Chicago	Ministry of Land Resources; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Scientific Commission of Beijing; Beijing Museum of Natural History; NSF(National Science Foundation (NSF)); Carnegie Museum; University of Chicago(University of Chicago)	We thank Z. Zeng, D. Liu, X. Xia (BMNH), M. A. Klingler, and A. M. Isch for assistance for research and graphics, and J. R. Wible and M. R. Dawson for improving the manuscript. Authors benefited from discussion with R. L. Cifelli, W. A. Clemens, M. R. Dawson, G. Hahn, J. A. Hopson, Y.-Q. Liu, T. Martin, P. C. Sereno, and J. R. Wible. Support was received from Ministry of Land Resources and Ministry of Science and Technology of China 973 Project Funding (C.-X.Y. and Q. J.), Scientific Commission of Beijing and Beijing Museum of Natural History (Q.-J.M.), NSF, Carnegie Museum, and University of Chicago (Z.-X.L.).	Badiola A, 2011, CRETACEOUS RES, V32, P45, DOI 10.1016/j.cretres.2010.10.003; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; Chen M, 2013, J MAMM EVOL, V20, P159, DOI 10.1007/s10914-012-9199-9; Cifelli RL, 2013, CAN J EARTH SCI, V50, P315, DOI 10.1139/e2012-051; Greenwald N. S., 1988, J VERTEBR PALEONTOL, V8, P265; Hahn Gerhard, 1998, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V28, P39; Hahn Gerhard, 2000, P97; JENKINS FA, 1983, SCIENCE, V220, P712, DOI 10.1126/science.220.4598.712; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Kielan-Jaworowska Z, 2001, PALAEONTOLOGY, V44, P389, DOI 10.1111/1475-4983.00185; Kielan-Jaworowska Z., 1994, POSTCRANIAL ANATOMY, V36; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Kusuhashi N, 2009, J VERTEBR PALEONTOL, V29, P1264, DOI 10.1671/039.029.0433; Liu YQ, 2012, PALAEOGEOGR PALAEOCL, V323, P1, DOI 10.1016/j.palaeo.2012.01.017; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; ROSE KD, 2006, BEGINNING AGE MAMMAL; ROUGIER GW, 1997, AM MUS NOVIT, P1; Sereno Paul C., 2006, P315; Szalay F. S., 1994, EVOLUTIONARY HIST MA; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Weisbecker V, 2006, J MORPHOL, V267, P1469, DOI 10.1002/jmor.10495; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880	30	79	88	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					779	783		10.1126/science.1237970	http://dx.doi.org/10.1126/science.1237970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950536				2022-12-28	WOS:000323122200046
J	Coyle, SM; Flores, J; Lim, WA				Coyle, Scott M.; Flores, Jonathan; Lim, Wendell A.			Exploitation of Latent Allostery Enables the Evolution of New Modes of MAP Kinase Regulation	CELL			English	Article							CATALYTIC PROMISCUITY; PROTEIN; SUPERFAMILY; BINDING; OUTPUT; SITES	Allosteric interactions provide precise spatiotemporal control over signaling proteins, but how allosteric activators and their targets coevolve is poorly understood. Here, we trace the evolution of two allosteric activator motifs within the yeast scaffold protein Ste5 that specifically target the mating MAP kinase Fus3. One activator (Ste5-VWA) provides pathway insulation and dates to the divergence of Fus3 from its paralog, Kss1; a second activator (Ste5-FBD) that tunes mating behavior is, in contrast, not conserved in most lineages. Surprisingly, both Ste5 activator motifs could regulate MAP kinases that diverged from Fus3 prior to the emergence of Ste5, suggesting that Ste5 activators arose by exploiting latent regulatory features already present in the MAPK ancestor. The magnitude of this latent allosteric potential drifts widely among pre-Ste5 MAP kinases, providing a pool of hidden phenotypic diversity that, when revealed by new activators, could lead to functional divergence and to the evolution of distinct signaling behaviors.	[Coyle, Scott M.; Flores, Jonathan; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Coyle, Scott M.] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA; [Lim, Wendell A.] UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu			National Science Foundation; NIH [RO1 GM55040, PN2 EY016546, P50 6M081879]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, P50GM081879, T32GM007810] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.M.C. is supported by a National Science Foundation Graduate Research Fellowship. This work was supported by NIH grants RO1 GM55040, PN2 EY016546, and P50 6M081879 (to W. A. L.), and the Howard Hughes Medical Institute (to W. A. L.). We thank R. Almeida, P. Dumesic, J. Fraser, R. Gordley, A. Johnson, I. Nocadel, L. Pack, S. Peisajovich, T. Sorrels, J. Walter, A. Weeks, P. Wei, E. Woods, and J. Zalatan for helpful discussions. S. Rajan, S. S. Sidhu, T. Sorrels, and J. Zalatan provided strains and reagents.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Baker CR, 2012, CELL, V151, P80, DOI 10.1016/j.cell.2012.08.018; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Booth LN, 2010, NATURE, V468, P959, DOI 10.1038/nature09560; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Ringia EAT, 2004, BIOCHEMISTRY-US, V43, P224, DOI 10.1021/bi035815+; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Wise EL, 2005, BIOCHEMISTRY-US, V44, P1816, DOI 10.1021/bi0478143; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	34	37	37	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					875	887		10.1016/j.cell.2013.07.019	http://dx.doi.org/10.1016/j.cell.2013.07.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953117	Green Accepted, Bronze			2022-12-28	WOS:000323202500017
J	You, CH; Okano, H; Hui, S; Zhang, ZG; Kim, M; Gunderson, CW; Wang, YP; Lenz, P; Yan, DL; Hwa, T				You, Conghui; Okano, Hiroyuki; Hui, Sheng; Zhang, Zhongge; Kim, Minsu; Gunderson, Carl W.; Wang, Yi-Ping; Lenz, Peter; Yan, Dalai; Hwa, Terence			Coordination of bacterial proteome with metabolism by cyclic AMP signalling	NATURE			English	Article							LAC OPERON EXPRESSION; ESCHERICHIA-COLI; CATABOLITE REPRESSION; ADENYLATE-CYCLASE; PHOSPHOTRANSFERASE SYSTEM; TRANSIENT REPRESSION; BETA-GALACTOSIDASE; GENE-EXPRESSION; GROWTH; GLUCOSE	The cyclic AMP (cAMP)-dependent catabolite repression effect in Escherichia coli is among the most intensely studied regulatory processes in biology. However, the physiological function(s) of cAMP signalling and its molecular triggers remain elusive. Here we use a quantitative physiological approach to show that cAMP signalling tightly coordinates the expression of catabolic proteins with biosynthetic and ribosomal proteins, in accordance with the cellular metabolic needs during exponential growth. The expression of carbon catabolic genes increased linearly with decreasing growth rates upon limitation of carbon influx, but decreased linearly with decreasing growth rate upon limitation of nitrogen or sulphur influx. In contrast, the expression of biosynthetic genes showed the opposite linear growth-rate dependence as the catabolic genes. A coarse-grained mathematical model provides a quantitative framework for understanding and predicting gene expression responses to catabolic and anabolic limitations. A scheme of integral feedback control featuring the inhibition of cAMP signalling by metabolic precursors is proposed and validated. These results reveal a key physiological role of cAMP-dependent catabolite repression: to ensure that proteomic resources are spent on distinct metabolic sectors as needed in different nutrient environments. Our findings underscore the power of quantitative physiology in unravelling the underlying functions of complex molecular signalling networks.	[You, Conghui; Okano, Hiroyuki; Hui, Sheng; Kim, Minsu; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [You, Conghui; Okano, Hiroyuki; Zhang, Zhongge; Gunderson, Carl W.; Hwa, Terence] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [Hui, Sheng; Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Wang, Yi-Ping] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Lenz, Peter] Univ Marburg, Dept Phys, D-35032 Marburg, Germany; [Lenz, Peter] Univ Marburg, Ctr Synthet Microbiol, D-35032 Marburg, Germany; [Yan, Dalai] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Peking University; Philipps University Marburg; Philipps University Marburg; Indiana University System; Indiana University Bloomington	Hwa, T (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	hwa@ucsd.edu	Hwa, Terry/GOJ-9904-2022; Hwa, Terence/J-4012-2013; Lenz, Peter/L-5980-2013	Hwa, Terence/0000-0003-1837-6842; Hui, Sheng/0000-0002-4226-6806; Lenz, Peter/0000-0001-7705-3950; Wang, Yiping/0000-0002-1995-8521	Human Frontiers in Science Program [RGP0022]; NSF [PHY1058793]; NSF through the Center for Theoretical Biological Physics [PHY0822283]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095903] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1058793] Funding Source: National Science Foundation	Human Frontiers in Science Program(Human Frontier Science Program); NSF(National Science Foundation (NSF)); NSF through the Center for Theoretical Biological Physics(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to R. Bender, A. Danchin, P. Geiduschek, J. Ingraham, S. Kustu, W. F. Loomis, A. Narang, J. Rabinowitz, M. H. Saier and members of the Hwa laboratory for valuable comments. This work was supported by the Human Frontiers in Science Program (RGP0022), and by the NSF to T.H. (PHY1058793) and through the Center for Theoretical Biological Physics (PHY0822283).	BENDER RA, 1977, J BACTERIOL, V132, P100, DOI 10.1128/JB.132.1.100-105.1977; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; CLARK DJ, 1964, BIOCHIM BIOPHYS ACTA, V92, P85, DOI 10.1016/0926-6569(64)90272-X; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/nchembio.685, 10.1038/NCHEMBIO.685]; Epps HMR, 1942, BIOCHEM J, V36, P619, DOI 10.1042/bj0360619; EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300; Goyal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000802; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; HARWOOD JP, 1975, J BIOL CHEM, V250, P4656; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hogema BM, 1997, MOL MICROBIOL, V24, P857, DOI 10.1046/j.1365-2958.1997.3991761.x; Inada T, 1996, GENES CELLS, V1, P293, DOI 10.1046/j.1365-2443.1996.24025.x; Kim M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.46; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Kuo JT, 2003, FEBS LETT, V553, P397, DOI 10.1016/S0014-5793(03)01071-8; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leigh J.R., 2004, CONTROL THEORY; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Maaloe O., 1979, BIOL REGUL DEV, P487; MAGASANIK B, 1961, COLD SPRING HARB SYM, V26, P249, DOI 10.1101/SQB.1961.026.01.031; MAKMAN RS, 1965, J BIOL CHEM, V240, P1309; MANDELSTAM J, 1962, BIOCHEM J, V82, P489, DOI 10.1042/bj0820489; MCFALL E, 1962, BIOCHIM BIOPHYS ACTA, V55, P900; MONOD J, 1947, GROWTH, V11, P223; Narang A, 2007, J THEOR BIOL, V244, P326, DOI 10.1016/j.jtbi.2006.08.007; NEIDHARDT FC, 1957, J BACTERIOL, V73, P260, DOI 10.1128/JB.73.2.260-263.1957; OKADA T, 1981, J BACTERIOL, V146, P1030, DOI 10.1128/JB.146.3.1030-1037.1981; PERLMAN RL, 1969, NATURE, V223, P810, DOI 10.1038/223810a0; PETERKOFSKY A, 1979, P NATL ACAD SCI USA, V76, P1099, DOI 10.1073/pnas.76.3.1099; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; SAIER MH, 1976, J BIOL CHEM, V251, P883; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Scott M, 2011, CURR OPIN BIOTECH, V22, P559, DOI 10.1016/j.copbio.2011.04.014; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; SILVERSTONE AE, 1970, P NATL ACAD SCI USA, V66, P773, DOI 10.1073/pnas.66.3.773; TYLER B, 1970, J BACTERIOL, V102, P411, DOI 10.1128/JB.102.2.411-422.1970; ULLMANN A, 1976, P NATL ACAD SCI USA, V73, P3476, DOI 10.1073/pnas.73.10.3476; WANNER BL, 1978, J BACTERIOL, V136, P947, DOI 10.1128/JB.136.3.947-954.1978; Yan DL, 2011, APPL ENVIRON MICROB, V77, P6763, DOI 10.1128/AEM.05257-11; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	48	238	245	12	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					301	306		10.1038/nature12446	http://dx.doi.org/10.1038/nature12446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23925119	Green Accepted			2022-12-28	WOS:000323112400025
J	Chestnov, O; Mendis, S; Bettcher, D				Chestnov, Oleg; Mendis, Shanthi; Bettcher, Douglas			A milestone in the response to non-communicable diseases	LANCET			English	Editorial Material									[Chestnov, Oleg; Mendis, Shanthi; Bettcher, Douglas] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Mendis, S (corresponding author), WHO, CH-1211 Geneva, Switzerland.	mendiss@who.int	Mendis, Shanthi/GLT-0465-2022	mendis, shanthi/0000-0002-8959-5738				[Anonymous], 2013, FOLL UP POL DECL HIG; [Anonymous], UN GEN ASS 66 SESS P; Organization WH, 2009, GLOB HLTH RISKS MORT; WHO, 2011, SCAL ACT NONC DIS MU; WHO, 2010, GLOB STAT REP NONC D	5	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					481	482		10.1016/S0140-6736(13)61457-9	http://dx.doi.org/10.1016/S0140-6736(13)61457-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23931911				2022-12-28	WOS:000323162400004
J	Carter, JB; Barnes, JA; Niell, BL; Nardi, V				Carter, Joi B.; Barnes, Jeffrey A.; Niell, Bethany L.; Nardi, Valentina			Case 24-2013: A 53-Year-Old Woman with Erythroderma, Pruritus, and Lymphadenopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL LYMPHOMA		[Carter, Joi B.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Barnes, Jeffrey A.] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Niell, Bethany L.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Nardi, Valentina] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Carter, Joi B.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Barnes, Jeffrey A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Niell, Bethany L.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Nardi, Valentina] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Carter, JB (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.				Harvard Medical School Department of Continuing Medical Education; Massachusetts General Hospital, Department of Pathology; Beth Israel Deaconess Medical Center, Department of Pathology; Brigham and Women's Hospital, Department of Pathology	Harvard Medical School Department of Continuing Medical Education; Massachusetts General Hospital, Department of Pathology; Beth Israel Deaconess Medical Center, Department of Pathology; Brigham and Women's Hospital, Department of Pathology	This case was discussed at the postgraduate course Dermatopathology Update, with course directors Drs. Lyn M. Duncan, Mai P. Hoang, Martin C. Mihm, Jr., George F. Murphy, and Steven R. Tahan, and was sponsored by the Harvard Medical School Department of Continuing Medical Education and Massachusetts General Hospital, Department of Pathology; Beth Israel Deaconess Medical Center, Department of Pathology; and Brigham and Women's Hospital, Department of Pathology.	[Anonymous], 2007, N ENGL J MED, V357, P2496; Bain BJ, 2008, WHO CLASSIFICATION T, P51; Bernengo MG, 2007, HAEMATOLOGICA, V92, P784, DOI 10.3324/haematol.11127; Duvic M, 2010, J CLIN ONCOL, V28, P2365, DOI 10.1200/JCO.2009.25.8301; Lee CH, 2007, INT J DERMATOL, V46, P1198, DOI 10.1111/j.1365-4632.2007.03190.x; Olsen E, 2008, BLOOD, V111, P4830; Olsen EA, 2011, J AM ACAD DERMATOL, V64, P352, DOI 10.1016/j.jaad.2010.08.037; Ralfkiaer E, 2008, SEZARY SYNDROME; Vonderheid EC, 2006, J CUTAN PATHOL, V33, P27, DOI 10.1111/j.0303-6987.2006.00541.x	9	3	3	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					559	569		10.1056/NEJMcpc1201415	http://dx.doi.org/10.1056/NEJMcpc1201415			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924007				2022-12-28	WOS:000322842000013
J	Liu, Z; Guan, DB; Crawford-Brown, D; Zhang, Q; He, KB; Liu, JG				Liu, Zhu; Guan, Dabo; Crawford-Brown, Douglas; Zhang, Qiang; He, Kebin; Liu, Jianguo			A low-carbon road map for China	NATURE			English	Editorial Material									[Liu, Zhu] Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA; [Liu, Zhu] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Guan, Dabo] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Crawford-Brown, Douglas] Univ Cambridge, Cambridge Ctr Climate Change Mitigat Res, Cambridge CB2 1TN, England; [Zhang, Qiang] Tsinghua Univ, Beijing 100084, Peoples R China; [He, Kebin] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China; [Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA	Harvard University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Leeds; University of Cambridge; Tsinghua University; Tsinghua University; Michigan State University	Liu, Z (corresponding author), Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA.	d.guan@leeds.ac.uk	He, Kebin/ABF-5224-2020; Guan, Dabo/Y-2406-2019; Liu, Zhu/A-4634-2013; Zhang, Qiang/D-9034-2012; Liu, Jianguo/G-5211-2015; Guan, Dabo/K-5534-2017	Guan, Dabo/0000-0003-3773-3403; Liu, Zhu/0000-0002-8968-7050; Liu, Jianguo/0000-0001-6344-0087; Guan, Dabo/0000-0003-3773-3403				Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Liang S, 2013, BIORESOURCE TECHNOL, V131, P139, DOI 10.1016/j.biortech.2012.12.008; Liu Z, 2012, ENERG POLICY, V49, P751, DOI 10.1016/j.enpol.2012.07.016; Liu Z, 2012, ENERGY, V45, P1059, DOI 10.1016/j.energy.2012.06.007; Liu Z, 2012, ENERGY, V37, P245, DOI 10.1016/j.energy.2011.11.040; McElroy MB, 2009, SCIENCE, V325, P1378, DOI 10.1126/science.1175706; National Bureau of Statistics of China, 2012, CHIN STAT YB 2012; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pauliuk S, 2012, ENVIRON SCI TECHNOL, V46, P148, DOI 10.1021/es201904c; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332	10	290	313	15	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					143	145		10.1038/500143a	http://dx.doi.org/10.1038/500143a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197CH	23925225				2022-12-28	WOS:000322825500012
J	Takemura, S; Bharioke, A; Lu, ZY; Nern, A; Vitaladevuni, S; Rivlin, PK; Katz, WT; Olbris, DJ; Plaza, SM; Winston, P; Zhao, T; Horne, JA; Fetter, RD; Takemura, S; Blazek, K; Chang, LA; Ogundeyi, O; Saunders, MA; Shapiro, V; Sigmund, C; Rubin, GM; Scheffer, LK; Meinertzhagen, IA; Chklovskii, DB				Takemura, Shin-ya; Bharioke, Arjun; Lu, Zhiyuan; Nern, Aljoscha; Vitaladevuni, Shiv; Rivlin, Patricia K.; Katz, William T.; Olbris, Donald J.; Plaza, Stephen M.; Winston, Philip; Zhao, Ting; Horne, Jane Anne; Fetter, Richard D.; Takemura, Satoko; Blazek, Katerina; Chang, Lei-Ann; Ogundeyi, Omotara; Saunders, Mathew A.; Shapiro, Victor; Sigmund, Christopher; Rubin, Gerald M.; Scheffer, Louis K.; Meinertzhagen, Ian A.; Chklovskii, Dmitri B.			A visual motion detection circuit suggested by Drosophila connectomics	NATURE			English	Article							OPTIC LOBE; SENSITIVE PATHWAYS; SELECTIVE UNITS; MOVEMENT; FLY; MELANOGASTER; CELLS; INTERNEURONS; MEDULLA; SIGNALS	Animal behaviour arises from computations in neuronal circuits, but our understanding of these computations has been frustrated by the lack of detailed synaptic connection maps, or connectomes. For example, despite intensive investigations over half a century, the neuronal implementation of local motion detection in the insect visual system remains elusive. Here we develop a semi-automated pipeline using electron microscopy to reconstruct a connectome, containing 379 neurons and 8,637 chemical synaptic contacts, within the Drosophila optic medulla. By matching reconstructed neurons to examples from light microscopy, we assigned neurons to cell types and assembled a connectome of the repeating module of the medulla. Within this module, we identified cell types constituting a motion detection circuit, and showed that the connections onto individual motion-sensitive neurons in this circuit were consistent with their direction selectivity. Our results identify cellular targets for future functional investigations, and demonstrate that connectomes can provide key insights into neuronal computations.	[Takemura, Shin-ya; Bharioke, Arjun; Lu, Zhiyuan; Nern, Aljoscha; Vitaladevuni, Shiv; Rivlin, Patricia K.; Katz, William T.; Olbris, Donald J.; Plaza, Stephen M.; Winston, Philip; Zhao, Ting; Fetter, Richard D.; Takemura, Satoko; Blazek, Katerina; Chang, Lei-Ann; Ogundeyi, Omotara; Saunders, Mathew A.; Shapiro, Victor; Sigmund, Christopher; Rubin, Gerald M.; Scheffer, Louis K.; Meinertzhagen, Ian A.; Chklovskii, Dmitri B.] HHMI, Ashburn, VA 20147 USA; [Lu, Zhiyuan; Horne, Jane Anne; Meinertzhagen, Ian A.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS B3H 4R2, Canada	Howard Hughes Medical Institute; Dalhousie University	Chklovskii, DB (corresponding author), HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	iam@dal.ca; mitya@janelia.hhmi.org	Bharioke, Arjun/AAL-3302-2021; Zhao, Ting/C-9500-2014	Bharioke, Arjun/0000-0003-3012-1412; Katz, William/0000-0002-9417-6212; Meinertzhagen, Ian/0000-0002-6578-4526; Takemura, Shin-ya/0000-0003-2400-6426; Rubin, Gerald/0000-0001-8762-8703	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ASHMORE JF, 1980, NATURE, V288, P84, DOI 10.1038/288084a0; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BAUSENWEIN B, 1992, CELL TISSUE RES, V270, P25, DOI 10.1007/BF00381876; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; Campos-Ortega J. A., 1972, INFORMATION PROCESSI, V1972, P31, DOI 10.1007/978-3-642-65477-0_5; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Dollar P., 2006, P IEEE COMP SOC C CO, V2, P1964, DOI DOI 10.1109/CVPR.2006.298; Douglass JK, 1996, J NEUROSCI, V16, P4551; Douglass JK, 2003, MICROSC RES TECHNIQ, V62, P132, DOI 10.1002/jemt.10367; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Heisenberg M., 1984, VISION DROSOPHILA GE; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kirschfeld K., 1972, INFORM PROCESSING VI, P61; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; Meinertzhagen Ian A., 1993, P1363; MIZUNAMI M, 1990, BIOL CYBERN, V64, P1, DOI 10.1007/BF00203624; Mohanta PP, 2002, INT C PATT RECOG, P664, DOI 10.1109/ICPR.2002.1044838; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Reichardt W, 1961, SENS COMMUN, P303; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rivera-Alba M, 2011, CURR BIOL, V21, P2000, DOI 10.1016/j.cub.2011.10.022; Sato M., 2000, 8 PAC C COMP GRAPH A; Scheffer L. K., 2013, PREPRINT; Schnell B, 2012, J COMP PHYSIOL A, V198, P389, DOI 10.1007/s00359-012-0716-3; SCHULING FH, 1989, J COMP PHYSIOL A, V165, P179, DOI 10.1007/BF00619192; Soille P., 2003, MORPHOLOGICAL IMAGE, P316; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; SRINIVASAN MV, 1980, J COMP PHYSIOL, V140, P1, DOI 10.1007/BF00613743; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; STRAUSFELD NJ, 1991, VISUAL NEUROSCI, V7, P13, DOI 10.1017/S0952523800010919; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Van Eck NJ, 2007, STUD CLASS DATA ANAL, P299; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vitaladevuni S., 2008, WORKSH MICR IM APPL; VITALADEVUNI SN, 2010, IEEE COMP SOC C COMP; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	59	413	417	5	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					175	+		10.1038/nature12450	http://dx.doi.org/10.1038/nature12450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925240	Green Accepted			2022-12-28	WOS:000322825500028
J	Zheng, XT; Bi, SD; Wang, XL; Meng, J				Zheng, Xiaoting; Bi, Shundong; Wang, Xiaoli; Meng, Jin			A new arboreal haramiyid shows the diversity of crown mammals in the Jurassic period	NATURE			English	Article							ALLOTHERIAN MAMMALS; DIVERSIFICATION; EVOLUTION; ORIGINS; TEETH; TAIL	A major unsolved problem in mammalian evolution is the origin of Allotheria, including Multituberculata and Haramiyida(1-5). Multituberculates are the most diverse and best known Mesozoic era mammals and ecologically resemble rodents, but haramiyids are known mainly from isolated teeth, hampering our search for their phylogenetic relationships. Here we report a new haramiyid from the Jurassic period of China, which is, to our knowledge the largest reported so far. It has a novel dentition, a mandible resembling advanced multituberculates and postcranial features adapted for arboreal life. Our phylogenetic analysis places Haramiyida within crown Mammalia, suggesting the origin of crown Mammalia in the Late Triassic period and diversification in the Jurassic, which contrasts other estimated divergence times of crown Mammalia(6-8). The new haramiyid reveals additional mammalian features of the group, helps to identify other haramiyids represented by isolated teeth, and shows again that, regardless of various phylogenetic scenarios, a complex pattern of evolution involving many convergences and/or reversals existed in Mesozoic mammals. [GRAPHICS] .	[Zheng, Xiaoting; Wang, Xiaoli] Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Shandong, Peoples R China; [Zheng, Xiaoting; Wang, Xiaoli] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Bi, Shundong; Meng, Jin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China; [Bi, Shundong] Indiana Univ Penn, Dept Biol, Indiana, PA 15705 USA; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; American Museum of Natural History (AMNH)	Bi, SD (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China.	bishundong@ivpp.ac.cn; jmeng@amnh.org	Xiaoli, Wang/H-1079-2014		National Basic Research Program of China 973 Program [2012CB821906]; National Natural Science Foundation of China [41172016, 41128002]; Hundred Talents Programs of the Chinese Academy of Sciences	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Programs of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank C. Zhao for illustrations, J. R. Wible for access to comparative specimens, W. Zhang for scanning electron microscope photography and T. Qiao for help with PAUP analyses. This work was supported by the National Basic Research Program of China 973 Program 2012CB821906, National Natural Science Foundation of China 41172016 and 41128002, and the Hundred Talents Programs of the Chinese Academy of Sciences.	Averianov A O, 2011, Dokl Biol Sci, V437, P103, DOI 10.1134/S0012496611020074; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Butler PM, 2000, ACTA PALAEONTOL POL, V45, P317; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; CROMPTON AW, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P55; Dagosto M, 1996, J HUM EVOL, V30, P29, DOI 10.1006/jhev.1996.0003; Hahn G., 1989, Geologica et Palaeontologica, V23, P205; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Jenkins FA, 1997, NATURE, V385, P715, DOI 10.1038/385715a0; Kermack KA, 1998, ACTA PALAEONTOL POL, V43, P581; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Lemelin P, 1999, J ZOOL, V247, P165, DOI 10.1017/S0952836999002046; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Martin Thomas, 2010, Palaeobiodiversity Palaeoenvironments, V90, P295, DOI 10.1007/s12549-010-0030-4; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Napier J. R., 1993, HANDS; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P681, DOI 10.1016/B978-0-444-59425-9.00025-1; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Schmitt D, 2005, AM J PHYS ANTHROPOL, V126, P435, DOI 10.1002/ajpa.20075; SIGOGNEAU-RUSSELL D, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P137; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sullivan C., J VERTEBR P IN PRESS; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Youlatos D, 2003, J ZOOL, V259, P423, DOI 10.1017/S0952836903003431	30	89	98	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					199	202		10.1038/nature12353	http://dx.doi.org/10.1038/nature12353			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925244				2022-12-28	WOS:000322825500033
J	Manley, GT; Maas, AIR				Manley, Geoffrey T.; Maas, Andrew I. R.			Traumatic Brain Injury An International Knowledge-Based Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94110 USA; [Maas, Andrew I. R.] Univ Antwerp, Dept Neurosurg, B-2020 Antwerp, Belgium	University of California System; University of California San Francisco; University of Antwerp	Manley, GT (corresponding author), Univ Calif San Francisco, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu						[Anonymous], INJURY PREVENTION AN; [Anonymous], BRAIN RESEARCH THROU; [Anonymous], J NEUROTRAUMA, DOI DOI 10.1089/NEU.2013.2970; [Anonymous], NINDS COMMON DATA EL; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	9	84	85	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					473	474		10.1001/jama.2013.169158	http://dx.doi.org/10.1001/jama.2013.169158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925611				2022-12-28	WOS:000322786400013
J	Smit, P; Brewer, J				Smit, Peter; Brewer, Jeffrey			Foreign Body in Right Side of Chest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BULLET		[Smit, Peter] SUNY Buffalo, Buffalo, NY 14215 USA; [Brewer, Jeffrey] Erie Cty Med Ctr & Labs, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Smit, P (corresponding author), SUNY Buffalo, Dept Surg, 462 Grider St, Buffalo, NY 14215 USA.	pjsmit@buffalo.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM099607] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM099607] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews CM, 2010, MIL MED, V175, P72, DOI 10.7205/MILMED-D-09-00068; FULGINITI J, 1993, CHEST, V103, P626, DOI 10.1378/chest.103.2.626; LIMPER AH, 1990, ANN INTERN MED, V112, P604, DOI 10.7326/0003-4819-112-8-604; Miller KR, 2011, INJURY, V42, P441, DOI 10.1016/j.injury.2010.08.006; O'Connor JV, 2006, AM SURGEON, V72, P345; Swanson K L, 2001, Chest Surg Clin N Am, V11, P861	6	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					529	530		10.1001/jama.2013.169720	http://dx.doi.org/10.1001/jama.2013.169720			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925623	Green Accepted			2022-12-28	WOS:000322786400025
J	Currie, GP; Small, I; Douglas, G				Currie, Graeme P.; Small, Iain; Douglas, Graham			Long acting beta(2) agonists in adult asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADD-ON THERAPY; INHALED CORTICOSTEROIDS; DOUBLE-BLIND; SALMETEROL; FORMOTEROL; EXACERBATIONS; METAANALYSIS; FLUTICASONE; BUDESONIDE; SAFETY		[Currie, Graeme P.; Douglas, Graham] Aberdeen Royal Infirm, Resp Unit, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Currie, GP (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen AB25 2ZN, Scotland.	Graeme.currie@nhs.net						Barnes PJ, 2007, BRIT MED J, V335, P513, DOI 10.1136/bmj.39273.537778.AD; Bateman E, 2008, ANN INTERN MED, V149, P33, DOI 10.7326/0003-4819-149-1-200807010-00229; Beasley R, 2013, THORAX, V68, P119, DOI 10.1136/thoraxjnl-2012-202483; Beasley R, 2010, LANCET, V376, P750, DOI 10.1016/S0140-6736(10)61158-0; Bjermer L, 2003, BMJ-BRIT MED J, V327, P891, DOI 10.1136/bmj.327.7420.891; British Thoracic Society Scottish Intercollegiate Guidelines Network, BRIT GUID MAN ASTHM; Canadian Agency for Drugs and Technologies in Health (CADTH), 2009, LONG ACT BETA2 AG IN; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Currie GP, 2005, CHEST, V128, P2954, DOI 10.1378/chest.128.4.2954; Currie GP, 2003, QJM-INT J MED, V96, P435, DOI 10.1093/qjmed/hcg071; Ducharme FM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003137.pub4; Ducharme FM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005535.pub2; FDA Drug Safety Communication, NEW WARN US GAD BAS, DOI 12031841/http://www.fda.gov/Drugs/DrugSafety/ucm223966.htm.; Holt S, 2001, BRIT MED J, V323, P253, DOI 10.1136/bmj.323.7307.253; Ilowite J, 2004, ANN ALLERG ASTHMA IM, V92, P641, DOI 10.1016/S1081-1206(10)61430-5; Jackson CM, 2004, DRUG SAFETY, V27, P243, DOI 10.2165/00002018-200427040-00003; Jaeschke R, 2008, AM J RESP CRIT CARE, V178, P1009, DOI 10.1164/rccm.200804-494OC; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; Medicine and Healthcare products Regulatory Agency (MHRA), 2010, LONG ACT BETA2 AG RE; Morales DR, 2013, THORAX, V68, P192, DOI 10.1136/thoraxjnl-2012-202071; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Institute for Health and Clinical Excellence, 2008, CORT TREATM CHRON AS; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Papi A, 2013, LANCET RESP MED, V1, P23, DOI 10.1016/S2213-2600(13)70012-2; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sears MR, 2009, EUR RESPIR J, V33, P21, DOI 10.1183/09031936.00145006; Sears MR, 2013, THORAX, V68, P195, DOI 10.1136/thoraxjnl-2012-202414; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Wilson ECF, 2010, PHARMACOECONOMICS, V28, P597, DOI 10.2165/11537550-000000000-00000	31	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2013	347								f4662	10.1136/bmj.f4662	http://dx.doi.org/10.1136/bmj.f4662			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CT	23920253				2022-12-28	WOS:000323119000002
J	Specks, U; Merkel, PA; Seo, P; Spiera, R; Langford, CA; Hoffman, GS; Kallenberg, CGM; Clair, EWS; Fessler, BJ; Ding, L; Viviano, L; Tchao, NK; Phippard, DJ; Asare, AL; Lim, N; Ikle, D; Jepson, B; Brunetta, P; Allen, NB; Fervenza, FC; Geetha, D; Keogh, K; Kissin, EY; Monach, PA; Peikert, T; Stegeman, C; Ytterberg, SR; Mueller, M; Sejismundo, LP; Mieras, K; Stone, JH				Specks, Ulrich; Merkel, Peter A.; Seo, Philip; Spiera, Robert; Langford, Carol A.; Hoffman, Gary S.; Kallenberg, Cees G. M.; Clair, E. William St.; Fessler, Barri J.; Ding, Linna; Viviano, Lisa; Tchao, Nadia K.; Phippard, Deborah J.; Asare, Adam L.; Lim, Noha; Ikle, David; Jepson, Brett; Brunetta, Paul; Allen, Nancy B.; Fervenza, Fernando C.; Geetha, Duvuru; Keogh, Karina; Kissin, Eugene Y.; Monach, Paul A.; Peikert, Tobias; Stegeman, Coen; Ytterberg, Steven R.; Mueller, Mark; Sejismundo, Lourdes P.; Mieras, Kathleen; Stone, John H.		RAVE-ITN Res Grp	Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; CYCLOPHOSPHAMIDE; RITUXIMAB; MAINTENANCE; ACTIVATION; PROTEINASE-3; LYMPHOCYTES; SPECIFICITY	Background The 18-month efficacy of a single course of rituximab as compared with conventional immunosuppression with cyclophosphamide followed by azathioprine in patients with severe (organ-threatening) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is unknown. Methods In a multicenter, randomized, double-blind, double-dummy, noninferiority trial, we compared rituximab (375 mg per square meter of body-surface area administered once a week for 4 weeks) followed by placebo with cyclophosphamide administered for 3 to 6 months followed by azathioprine for 12 to 15 months. The primary outcome measure was complete remission of disease by 6 months, with the remission maintained through 18 months. Results A total of 197 patients were enrolled. As reported previously, 64% of the patients in the rituximab group, as compared with 53% of the patients in the cyclophosphamide-azathioprine group, had a complete remission by 6 months. At 12 and 18 months, 48% and 39%, respectively, of the patients in the rituximab group had maintained the complete remissions, as compared with 39% and 33%, respectively, in the comparison group. Rituximab met the prespecified criteria for noninferiority (P<0.001, with a noninferiority margin of 20%). There was no significant difference between the groups in any efficacy measure, including the duration of complete remission and the frequency or severity of relapses. Among the 101 patients who had relapsing disease at baseline, rituximab was superior to conventional immunosuppression at 6 months (P=0.01) and at 12 months (P=0.009) but not at 18 months (P=0.06), at which time most patients in the rituximab group had reconstituted B cells. There was no significant between-group difference in adverse events. Conclusions In patients with severe ANCA-associated vasculitis, a single course of rituximab was as effective as continuous conventional immunosuppressive therapy for the induction and maintenance of remissions over the course of 18 months. (Funded by the National Institute of Allergy and Infectious Diseases and others; RAVE ClinicalTrials.gov number, .)	[Specks, Ulrich; Fervenza, Fernando C.; Keogh, Karina; Peikert, Tobias; Ytterberg, Steven R.; Mieras, Kathleen] Mayo Clin Fdn, Rochester, MN USA; [Merkel, Peter A.; Kissin, Eugene Y.; Monach, Paul A.] Boston Univ, Med Ctr, Boston, MA USA; [Stone, John H.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Seo, Philip; Geetha, Duvuru; Sejismundo, Lourdes P.] Johns Hopkins Univ, Baltimore, MD USA; [Ding, Linna; Viviano, Lisa; Mueller, Mark] NIAID, Bethesda, MD 20892 USA; [Tchao, Nadia K.; Phippard, Deborah J.; Asare, Adam L.; Lim, Noha] Immune Tolerance Network, Bethesda, MD USA; [Spiera, Robert] Hosp Special Surg, New York, NY 10021 USA; [Langford, Carol A.; Hoffman, Gary S.] Cleveland Clin Fdn, Cleveland, OH USA; [Kallenberg, Cees G. M.; Stegeman, Coen] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Clair, E. William St.; Allen, Nancy B.] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Ikle, David; Jepson, Brett] Rho, Chapel Hill, NC USA; [Fessler, Barri J.] Univ Alabama Birmingham, Birmingham, AL USA; [Brunetta, Paul] Genentech Inc, San Francisco, CA USA	Mayo Clinic; Boston University; Harvard University; Massachusetts General Hospital; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Immune Tolerance Network; Cleveland Clinic Foundation; University of Groningen; Duke University; Rho; University of Alabama System; University of Alabama Birmingham; Roche Holding; Genentech	Stone, JH (corresponding author), Massachusetts Gen Hosp, Rheumatol Unit, 55 Fruit St, Boston, MA 02114 USA.	jhstone@partners.org	Ikle, David/AAK-7541-2020; Fervenza, Fernando/AAK-2400-2020; Farina, Giuseppina/B-1800-2019; Spiera, Robert/W-7479-2019; Lim, Noha/ABA-2509-2020	Ikle, David/0000-0003-0091-5246; Farina, Giuseppina/0000-0002-3948-6920; Seo, Philip/0000-0003-3435-6737; Asare, Adam/0000-0002-9299-3518; Carey, John/0000-0001-7292-2328; Stegeman, Coen/0000-0002-0224-0927; Monach, Paul/0000-0003-4937-0515; Kissin, Eugene/0000-0002-7748-3384	NIH [N01-AI-15416, ITN021AI]; National Institute of Allergy and Infectious Diseases; Juvenile Diabetes Research Foundation; Genentech; Biogen Idec; National Center for Research Resources (NCRR) [UL1 RR024150-01, UL1 RR025005, UL1 RR025771, NIH M01 RR00533]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K24 AR049185, K23 AR052820, K24 AR02224]; Arthritis Foundation Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025005, UL1RR025771, UL1RR024150, M01RR000533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002224, K23AR052820, K24AR049185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Genentech(Roche HoldingGenentech); Biogen Idec(Biogen); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was performed as a project of the Immune Tolerance Network (NIH contract N01-AI-15416; protocol number ITN021AI), an international clinical research consortium head-quartered at the University of California, San Francisco.; Supported by the National Institute of Allergy and Infectious Diseases, the Juvenile Diabetes Research Foundation, Genentech, and Biogen Idec. At the Mayo Clinic, the trial was supported by a Clinical and Translational Science Award (CTSA) grant (UL1 RR024150-01) from the National Center for Research Resources (NCRR). At Johns Hopkins, the trial was supported by a CTSA grant (UL1 RR025005) from the NCRR and by grants (K24 AR049185, to Dr. Stone; and K23 AR052820, to Dr. Seo) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). At Boston University, the trial was supported by CTSA grants (UL1 RR025771 and NIH M01 RR00533) from the NCRR and a grant (K24 AR02224) from the NIAMS (all to Dr. Merkel) and an Arthritis Foundation Investigator Award (to Dr. Monach).	Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CUPPS TR, 1982, J IMMUNOL, V128, P2453; Damoiseaux J, 2009, ANN RHEUM DIS, V68, P228, DOI 10.1136/ard.2007.086579; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Exley AR, 1997, ARTHRITIS RHEUM, V40, P371, DOI 10.1002/art.1780400222; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; Franssen C, 1998, J INTERN MED, V244, P209; Hiemstra TF, 2010, JAMA-J AM MED ASSOC, V304, P2381, DOI 10.1001/jama.2010.1658; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Holle JU, 2011, ARTHRITIS RHEUM-US, V63, P257, DOI 10.1002/art.27763; HURD ER, 1975, ARTHRITIS RHEUM-US, V18, P67, DOI 10.1002/art.1780180113; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Langford CA, 1999, ARTHRITIS RHEUM, V42, P2666; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Little MA, 2010, ANN RHEUM DIS, V69, P1036, DOI 10.1136/ard.2009.109389; Nachman PH, 1996, J AM SOC NEPHROL, V7, P33; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Smith RM, 2012, ARTHRITIS RHEUM-US, V64, P3760, DOI 10.1002/art.34583; Specks U, 2001, ARTHRITIS RHEUM, V44, P2836, DOI 10.1002/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W; Specks UMP., 2011, OPEN ARTHRITIS J, V4, P1, DOI [10.2174/1876539401104010001, DOI 10.2174/1876539401104010001]; STEVENSON HC, 1980, IMMUNOLOGY, V39, P391; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Walsh M, 2012, ARTHRITIS RHEUM-US, V64, P542, DOI 10.1002/art.33361; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; ZHU LP, 1987, J CLIN INVEST, V79, P1082, DOI 10.1172/JCI112922	33	460	491	3	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					417	427		10.1056/NEJMoa1213277	http://dx.doi.org/10.1056/NEJMoa1213277			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902481	Green Accepted, Bronze			2022-12-28	WOS:000322547400008
J	Sugarman, J				Sugarman, Jeremy			HIV Cure Research: Expanding the Ethical Considerations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIALS		[Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sugarman, J (corresponding author), Johns Hopkins Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	jsugarman@jhu.edu		Sugarman, Jeremy/0000-0001-7022-8332	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068619, U01AI068619, P30AI094189] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI094189, UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Henderson GE, 2006, SOC SCI MED, V62, P239, DOI 10.1016/j.socscimed.2005.05.022; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Lo B, 2013, CURR OPIN HIV AIDS, V8, P243, DOI 10.1097/COH.0b013e32835ea1c5; McNeil DG, 2013, NY TIMES, pA10; Pollack A., 2013, NY TIMES; Ryan B., 2013, MISLEADING NEWS REPO; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; Woodsong C, 2005, AM J PUBLIC HEALTH, V95, P412, DOI 10.2105/AJPH.2004.041624	10	26	26	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					490	U104		10.7326/00030003-4819-159-7-201310010-00694	http://dx.doi.org/10.7326/00030003-4819-159-7-201310010-00694			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234FQ	23938938				2022-12-28	WOS:000325628000007
J	Ross, JM; Stewart, JB; Hagstrom, E; Brene, S; Mourier, A; Coppotelli, G; Freyer, C; Lagouge, M; Hoffer, BJ; Olson, L; Larsson, NG				Ross, Jaime M.; Stewart, James B.; Hagstrom, Erik; Brene, Stefan; Mourier, Arnaud; Coppotelli, Giuseppe; Freyer, Christoph; Lagouge, Marie; Hoffer, Barry J.; Olson, Lars; Larsson, Nils-Goran			Germline mitochondrial DNA mutations aggravate ageing and can impair brain development	NATURE			English	Article							PURIFYING SELECTION; MTDNA; HETEROPLASMY; FREQUENCY; DELETIONS; REVEALS; TISSUES	Ageing is due to an accumulation of various types of damage(1,2), and mitochondrial dysfunction has long been considered to be important in this process(3-8). There is substantial sequence variation in mammalian mitochondrial DNA (mtDNA)(9), and the high mutation rate is counteracted by different mechanisms that decrease maternal transmission of mutated mtDNA(10-13). Despite these protective mechanisms(14), it is becoming increasingly clear that lowlevel mtDNA heteroplasmy is quite common and often inherited in humans(15,16). We designed a series of mouse mutants to investigate the extent to which inherited mtDNA mutations can contribute to ageing. Here we report that maternally transmitted mtDNA mutations can induce mild ageing phenotypes in mice with a wild-type nuclear genome. Furthermore, maternally transmittedmtDNAmutations lead to anticipation of reduced fertility in mice that are heterozygous for themtDNAmutator allele (PolgAwt/mut) and aggravate premature ageing phenotypes inmtDNAmutatormice (PolgAmut/mut). Unexpectedly, a combination of maternally transmitted and somatic mtDNA mutations also leads to stochastic brain malformations. Our findings show that a pre-existing mutation load will not only allow somatic mutagenesis to create a critically high total mtDNA mutation load sooner but will also increase clonal expansionofmtDNA mutations(17) to enhance the normally occurring mosaic respiratory chain deficiency in ageing tissues(18,19). Our findings suggest that maternally transmitted mtDNA mutations may have a similar role in aggravating aspects of normal human ageing.	[Ross, Jaime M.; Coppotelli, Giuseppe; Olson, Lars] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Stewart, James B.; Mourier, Arnaud; Freyer, Christoph; Lagouge, Marie] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Hagstrom, Erik; Freyer, Christoph; Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, S-17177 Stockholm, Sweden; [Brene, Stefan] Karolinska Inst, KERIC, Dept Neurobiol Care Sci & Soc, S-17176 Stockholm, Sweden; [Hoffer, Barry J.] Univ Hosp, Case Western Reserve Med Ctr, Dept Neurosurg, Cleveland, OH 44106 USA	Karolinska Institutet; Max Planck Society; Karolinska Institutet; Karolinska Institutet; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Olson, L (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	lars.olson@ki.se; larsson@age.mpg.de	Larsson, Nils-Göran/GVS-5578-2022; MOURIER, Arnaud/F-9657-2019; Stewart, James B/C-9633-2011; MOURIER, Arnaud/I-8117-2012	Larsson, Nils-Göran/0000-0001-5100-996X; MOURIER, Arnaud/0000-0002-5413-611X; Stewart, James B/0000-0002-2902-4968; MOURIER, Arnaud/0000-0002-5413-611X; Freyer, Christoph/0000-0003-0418-1673	ERC [268897, 322744]; Swedish Research Council [K2011-62X-21870-01-6, K2012-62X-03185-42-4]; Swedish Brain Foundation; Swedish Brain Power; Swedish Parkinson Foundation; Karolinska Distinguished Professor Award; Swedish Alzheimer Foundation; National Institutes of Health [AG04418, NS070825]; National Institute on Drug Abuse; National Institutes of Health/Karolinska Institutet Graduate Partnerships Program; Swedish Society for Medical Research; United Mitochondrial Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Swedish Brain Power; Swedish Parkinson Foundation; Karolinska Distinguished Professor Award; Swedish Alzheimer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health/Karolinska Institutet Graduate Partnerships Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Society for Medical Research; United Mitochondrial Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by ERC Advanced Investigator grants (268897 to N.-G. L. and 322744 to L.O.), the Swedish Research Council (K2011-62X-21870-01-6 to N.-G. L. and K2012-62X-03185-42-4 to L.O.), the Swedish Brain Foundation (N.-G. L. and J.M.R.), Swedish Brain Power (L.O. and J.M.R.), the Swedish Parkinson Foundation (N.-G. L.), the Karolinska Distinguished Professor Award (L.O.), the Swedish Alzheimer Foundation (L.O.) the National Institutes of Health (AG04418 to L.O. and NS070825 to B.J.H.), the National Institute on Drug Abuse (J.M.R.), the National Institutes of Health/Karolinska Institutet Graduate Partnerships Program (J.M.R.) and the Swedish Society for Medical Research (G. C.). J.B.S. acknowledges support from the United Mitochondrial Disease Foundation.	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; ERNSTER L, 1955, EXP CELL RES, V9, P348, DOI 10.1016/0014-4827(55)90108-7; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Freyer C, 2012, NAT GENET, V44, P1282, DOI 10.1038/ng.2427; Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hancock DK, 2005, GENOMICS, V86, P446, DOI 10.1016/j.ygeno.2005.06.006; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161	33	187	191	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					412	+		10.1038/nature12474	http://dx.doi.org/10.1038/nature12474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23965628	Green Accepted			2022-12-28	WOS:000324545700044
J	Li, S; Zhang, L; Yao, Q; Li, L; Dong, N; Rong, J; Gao, WQ; Ding, XJ; Sun, LM; Chen, X; Chen, S; Shao, F				Li, Shan; Zhang, Li; Yao, Qing; Li, Lin; Dong, Na; Rong, Jie; Gao, Wenqing; Ding, Xiaojun; Sun, Liming; Chen, Xing; Chen, She; Shao, Feng			Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains	NATURE			English	Article							NECROSIS-FACTOR RECEPTOR; BACTERIAL EFFECTOR; PROTEIN; TRADD; SUPERFAMILY; NLEB; COLONIZATION; INHIBITION; PATHWAYS	The tumour necrosis factor (TNF) family is crucial for immune homeostasis, cell death and inflammation. These cytokines are recognized by members of the TNF receptor (TNFR) family of death receptors, including TNFR1 and TNFR2, and FAS and TNF-related apoptosis-inducing ligand (TRAIL) receptors(1). Death receptor signalling requires death-domain-mediated homotypic/heterotypic interactions between the receptor and its downstream adaptors, including TNFR1-associated death domain protein (TRADD) and FAS-associated death domain protein (FADD)(2). Here we discover that death domains in several proteins, including TRADD, FADD, RIPK1 and TNFR1, were directly inactivated by NleB, an entero-pathogenic Escherichia coli (EPEC) type III secretion system effector known to inhibit host nuclear factor-kappa B (NF-kappa B) signalling(3,4). NleB contained an unprecedented N-acetylglucosamine (GlcNAc) transferase activity that specifically modified a conserved arginine in these death domains (Arg 235 in the TRADD death domain). NleB GlcNAcylation (the addition of GlcNAc onto a protein side chain) of death domains blocked homotypic/heterotypic death domain interactions and assembly of the oligomeric TNFR1 complex, thereby disrupting TNF signalling in EPEC-infected cells, including NF-kappa B signalling, apoptosis and necroptosis. Type-III-delivered NleB also blocked FAS ligand and TRAIL-induced cell death by preventing formation of a FADD-mediated death-inducing signalling complex (DISC). The arginine GlcNAc transferase activity of NleB was required for bacterial colonization in the mouse model of EPEC infection. The mechanism of action of NleB represents a new model by which bacteria counteract host defences, and also a previously unappreciated post-translational modification.	[Li, Shan; Yao, Qing] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Li, Shan; Zhang, Li; Yao, Qing; Li, Lin; Dong, Na; Gao, Wenqing; Ding, Xiaojun; Sun, Liming; Chen, She; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Li] Chinese Acad Med Sci, Grad Sch, Beijing 100730, Peoples R China; [Zhang, Li] Beijing Union Med Coll, Beijing 100730, Peoples R China; [Rong, Jie; Chen, Xing] Peking Univ, Coll Chem & Mol Engn, Dept Biol Chem, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Peking University	Chen, S (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	chenshe@nibs.ac.cn; shaofeng@nibs.ac.cn	Chen, Xing/C-1914-2015; Yao, Qing/AAE-1680-2020	Sun, Liming/0000-0002-0136-5605; Li, Shan/0000-0001-8646-3193; Chen, Xing/0000-0002-3058-7370	Howard Hughes Medical Institute; National Basic Research Program of China 973 Programs [2010CB835400, 2012CB518700, 2010CB835204]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Basic Research Program of China 973 Programs(National Basic Research Program of China)	We thank I. Rosenshine for providing nleBE deletion EPEC strains, H. Wu for the TNFR1/2 plasmid, K. Iwai for LUBAC antibodies, H. Sakurai for the p-TAK1 antibody, Z. Yang for yeast two-hybrid screen, L. Feng for synthesizing Ac<INF>4</INF>GlcNAc-d<INF>3</INF>, M. Dong for accessing the ETD instrument and X. Liu for assistance with mass spectrometry data analyses. We also thank members of the Shao laboratory for discussions and technical assistance. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F. S. This work was also supported by the National Basic Research Program of China 973 Programs 2010CB835400 and 2012CB518700 to F. S. and 2010CB835204 to S.C.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2010, BBA-GEN SUBJECTS, V1800, P134, DOI 10.1016/j.bbagen.2009.07.022; Chen NJ, 2008, P NATL ACAD SCI USA, V105, P12429, DOI 10.1073/pnas.0806585105; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HORTON D, 1967, J ORG CHEM, V32, P1073, DOI 10.1021/jo01279a048; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Misyurina O, 2010, CAN J MICROBIOL, V56, P739, DOI [10.1139/W10-059, 10.1139/w10-059]; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Ruchaud-Sparagano MH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002414; SINGH DG, 1995, FEBS LETT, V376, P61, DOI 10.1016/0014-5793(95)01247-6; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yan DP, 2012, NAT IMMUNOL, V13, P1063, DOI 10.1038/ni.2417; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	38	194	211	1	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					242	+		10.1038/nature12436	http://dx.doi.org/10.1038/nature12436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23955153				2022-12-28	WOS:000324244900045
J	Takahashi, Y; Sipp, D; Enomoto, H				Takahashi, Yoshiko; Sipp, Douglas; Enomoto, Hideki			Tissue Interactions in Neural Crest Cell Development and Disease	SCIENCE			English	Review							ENTERIC NERVOUS-SYSTEM; DEVELOPING SYMPATHETIC NEURONS; STEM-CELL; SCHWANN-CELLS; GLIAL-CELLS; ADULT SKIN; NEUROBLASTOMA; NEUROGENESIS; MELANOCYTES; TRANSITION	The neural crest is a transient population of migratory cells in the embryo that gives rise to a wide variety of different cell types, including those of the peripheral nervous system. Dysfunction of neural crest cells (NCCs) is associated with multiple diseases, such as neuroblastoma and Hirschsprung disease. Recent studies have identified NCC behaviors during their migration and differentiation, with implications for their contributions to development and disease. Here, we describe how interactions between cells of the neural crest and lineages such as the vascular system, as well as those involving environmental signals and microbial pathogens, are critically important in determining the roles played by these cells.	[Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Takahashi, Yoshiko] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Sipp, Douglas; Enomoto, Hideki] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Enomoto, Hideki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; Kobe University	Takahashi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yotayota@develop.zool.kyoto-u.ac.jp; enomotoh@med.kobe-u.ac.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882; Dupin E, 2003, P NATL ACAD SCI USA, V100, P5229, DOI 10.1073/pnas.0831229100; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kaltschmidt B, 2012, STEM CELL REV REP, V8, P658, DOI 10.1007/s12015-011-9340-9; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Le Douarin NM, 2012, CURR OPIN GENET DEV, V22, P381, DOI 10.1016/j.gde.2012.06.001; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Le Douarin NM, 1999, NEURAL CREST, V2; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Nagashimada M, 2012, J CLIN INVEST, V122, P3145, DOI 10.1172/JCI63401; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; O'Donnell AM, 2010, PEDIATR SURG INT, V26, P1065, DOI 10.1007/s00383-010-2692-4; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Saito D, 2012, SCIENCE, V336, P1578, DOI 10.1126/science.1222369; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; van Noesel MM, 2012, LANCET ONCOL, V13, P229, DOI 10.1016/S1470-2045(12)70012-8; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053	30	85	87	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					860	863		10.1126/science.1230717	http://dx.doi.org/10.1126/science.1230717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970693				2022-12-28	WOS:000323370600033
J	Kamel, F				Kamel, Freya			Paths from Pesticides to Parkinson's	SCIENCE			English	Editorial Material							DISEASE; EXPOSURE; RISK; SERUM		NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kamel, F (corresponding author), NIEHS, Epidemiol Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	kamel@niehs.nih.gov		Kamel, Freya/0000-0001-5052-6615	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044007] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baldi I, 2003, NEUROEPIDEMIOLOGY, V22, P305, DOI 10.1159/000071194; Cannon JR, 2013, NEUROBIOL DIS, V57, P38, DOI 10.1016/j.nbd.2012.06.025; Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717; Hayden KM, 2010, NEUROLOGY, V74, P1524, DOI 10.1212/WNL.0b013e3181dd4423; Kamel F, 2012, NEUROTOXICOLOGY, V33, P457, DOI 10.1016/j.neuro.2012.04.001; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Richardson JR, 2009, ARCH NEUROL-CHICAGO, V66, P870, DOI 10.1001/archneurol.2009.89; Taetzsch T, 2013, J BIOCHEM MOL TOXIC, V27, P137, DOI 10.1002/jbt.21464; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	18	91	94	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					722	723		10.1126/science.1243619	http://dx.doi.org/10.1126/science.1243619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950519	Green Published			2022-12-28	WOS:000323122200027
J	Lease, RO; Ehlers, TA				Lease, Richard O.; Ehlers, Todd A.			Incision into the Eastern Andean Plateau During Pliocene Cooling	SCIENCE			English	Article							CANYON INCISION; CLIMATE; STRATIGRAPHY; MECHANISMS; ALTIPLANO; HISTORY; UPLIFT; PERU; GEOCHRONOLOGY; GLACIATION	Canyon incision into mountain topography is commonly used as a proxy for surface uplift driven by tectonic or geodynamic processes, but climatic changes can also instigate incision. The similar to 1250-kilometer (km)-long eastern margin of the Andean Plateau hosts a series of 1.5- to 2.5-km-deep canyons that cross major deformation zones. Using (U-Th)/He thermochronology, we document a transition from Miocene faulting to Pliocene canyon incision across the northeastern plateau margin. Regionally, widespread Pliocene incision into the eastern plateau margin is concurrent with a shift in global climate from early Pliocene warmth to late Pliocene cooling. Enhanced moisture transport onto the Andean Plateau driven by sea surface temperature changes during cooling is the likely pacemaker for canyon incision.	[Lease, Richard O.; Ehlers, Todd A.] Univ Tubingen, Dept Geosci, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen	Lease, RO (corresponding author), US Geol Survey, Anchorage, AK 99508 USA.	rlease@usgs.gov	Ehlers, Todd A/A-9582-2012	Ehlers, Todd A/0000-0001-9436-0303; Lease, Richard/0000-0003-2582-8966	NSF Continental Dynamics program [EAR-0907817]; Directorate For Geosciences [0907817] Funding Source: National Science Foundation	NSF Continental Dynamics program(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank E. Enkelmann and P. Reiners for laboratory assistance, N. Eichelberger for field assistance, and the NSF Continental Dynamics program for support (EAR-0907817 to T.A.E.). The data reported in this paper are available in the supplementary materials.	Aalto R, 2003, NATURE, V425, P493, DOI 10.1038/nature02002; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Barnes JB, 2012, GEOLOGY, V40, P1135, DOI 10.1130/G33229.1; Beck SL, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000124; Bookhagen B, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P223; Bradley RS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016546; Carlotto V., 2006, B SOC GEOLOGICA PERU, V101, P91; CHEILLETZ A, 1992, TECTONOPHYSICS, V205, P307, DOI 10.1016/0040-1951(92)90433-7; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; CLAPPERTON CM, 1979, NATURE, V277, P375, DOI 10.1038/277375a0; Ehlers TA, 2009, EARTH PLANET SC LETT, V281, P238, DOI 10.1016/j.epsl.2009.02.026; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; Fritz SC, 2007, QUATERNARY RES, V68, P410, DOI 10.1016/j.yqres.2007.07.008; Garreaud R, 2003, PALAEOGEOGR PALAEOCL, V194, P5, DOI 10.1016/S0031-0182(03)00269-4; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Gaupp R, 1999, PALAEOGEOGR PALAEOCL, V151, P79, DOI 10.1016/S0031-0182(99)00017-6; Gotberg N, 2010, GEOL SOC AM BULL, V122, P727, DOI 10.1130/B26477.1; Hoke GD, 2007, TECTONICS, V26, DOI 10.1029/2006TC002082; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Horton BK, 2005, TECTONICS, V24, DOI 10.1029/2003TC001619; KENNAN L, 1997, GEOL SOC SPEC PUBL, V120, P307, DOI DOI 10.1144/GSL.SP.1997.120.01.20; Ketcham RA, 2005, REV MINERAL GEOCHEM, V58, P275, DOI 10.2138/rmg.2005.58.11; Klein AG, 1999, QUATERNARY SCI REV, V18, P63, DOI 10.1016/S0277-3791(98)00095-X; KONTAK DJ, 1990, J S AM EARTH SCI, V3, P231, DOI 10.1016/0895-9811(90)90005-L; McQuarrie N, 2008, TECTONICS, V27, DOI 10.1029/2006TC002054; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Placzek C, 2006, GEOL SOC AM BULL, V118, P515, DOI 10.1130/B25770.1; Placzek CJ, 2013, EARTH PLANET SC LETT, V363, P97, DOI 10.1016/j.epsl.2012.12.017; Poulsen CJ, 2010, SCIENCE, V328, P490, DOI 10.1126/science.1185078; Reiners PW, 2006, ANNU REV EARTH PL SC, V34, P419, DOI 10.1146/annurev.earth.34.031405.125202; Schildgen TF, 2007, GEOLOGY, V35, P523, DOI 10.1130/G23532A.1; Schildgen TF, 2010, EARTH PLANET SC LETT, V293, P377, DOI 10.1016/j.epsl.2010.03.009; Thompson LG, 2013, SCIENCE, V340, P945, DOI 10.1126/science.1234210; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1984, SCIENCE, V226, P50, DOI 10.1126/science.226.4670.50; Zeilinger G, 2007, TERRA NOVA, V19, P373, DOI 10.1111/j.1365-3121.2007.00762.x	38	44	48	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					774	776		10.1126/science.1239132	http://dx.doi.org/10.1126/science.1239132			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950534				2022-12-28	WOS:000323122200044
J	Schraml, BU; van Blijswijk, J; Zelenay, S; Whitney, PG; Filby, A; Acton, SE; Rogers, NC; Moncaut, N; Carvajal, JJ; Sousa, CRE				Schraml, Barbara U.; van Blijswijk, Janneke; Zelenay, Santiago; Whitney, Paul G.; Filby, Andrew; Acton, Sophie E.; Rogers, Neil C.; Moncaut, Natalia; Carvajal, Jaime J.; Reis e Sousa, Caetano			Genetic Tracing via DNGR-1 Expression History Defines Dendritic Cells as a Hematopoietic Lineage	CELL			English	Article							TRANSCRIPTION FACTOR ZDC; MACROPHAGES; MONOCYTES; DIFFERENTIATION; IDENTIFICATION; PROGENITORS; ACTIVATION; PRECURSORS; REGULATOR; RECEPTOR	Mononuclear phagocytes are classified as macrophages or dendritic cells (DCs) based on cell morphology, phenotype, or select functional properties. However, these attributes are not absolute and often overlap, leading to difficulties in cell-type identification. To circumvent this issue, we describe a mouse model to define DCs based on their ontogenetic descendence from a committed precursor. We show that precursors of mouse conventional DCs, but not other leukocytes, are marked by expression of DNGR-1. Genetic tracing of DNGR-1 expression history specifically marks cells traditionally ascribed to the DC lineage, and this restriction is maintained after inflammation. Notably, in some tissues, cells previously thought to be monocytes/macrophages are in fact descendants from DC precursors. These studies provide an in vivo model for fate mapping of DCs, distinguishing them from other leukocyte lineages, and thus help to unravel the functional complexity of the mononuclear phagocyte system.	[Schraml, Barbara U.; van Blijswijk, Janneke; Zelenay, Santiago; Whitney, Paul G.; Acton, Sophie E.; Rogers, Neil C.; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3LY, England; [Filby, Andrew] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Flow Cytometry Lab, London WC2A 3LY, England; [Acton, Sophie E.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Moncaut, Natalia; Carvajal, Jaime J.] Inst Canc Res, Chester Beatty Labs, Div Canc Biol, London SW3 6JB, England; [Carvajal, Jaime J.] CSIC UPO JA, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain	Cancer Research UK; Cancer Research UK; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Sousa, CRE (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@cancer.org.uk	Acton, Sophie/G-9784-2012; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021; Carvajal, Jaime J/O-3681-2014	Acton, Sophie/0000-0003-2704-716X; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Carvajal, Jaime J/0000-0002-7277-0317; Rogers, Neil/0000-0001-8977-7585; Whitney, Paul/0000-0003-3836-7601; Schraml, Barbara/0000-0002-5801-0151; Zelenay, Santiago/0000-0002-6865-3978	Cancer Research UK; European Research Council (ERC) [AdG-2010-268670]; EMBO long-term fellowship; Boehringer Ingelheim Fonds; Overseas Biomedical Fellowship from the NHMRC of Australia; Henry Wellcome Fellowship [WT089009MA]; Cancer Research UK [15689] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council (ERC)(European Research Council (ERC)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Overseas Biomedical Fellowship from the NHMRC of Australia; Henry Wellcome Fellowship; Cancer Research UK(Cancer Research UK)	We thank Frederic Geissmann and members of the Immunobiology Laboratory for helpful discussions and suggestions. C. R. S. is funded by Cancer Research UK, a prize from Fondation Bettencourt-Schueller, and a grant from the European Research Council (ERC Advanced Researcher Grant AdG-2010-268670). B. U. S. was supported by an EMBO long-term fellowship, J.v.B. was supported by Boehringer Ingelheim Fonds, P. G. W. was supported by an Overseas Biomedical Fellowship from the NHMRC of Australia, and S. E. A. was supported by a Henry Wellcome Fellowship (WT089009MA). We thank CRUK Transgenic Services for generation of genetically modified mice and the Biological Resources staff for animal care and assistance with mouse experiments. We thank Yasmine Belkaid and John Grainger for their help with the isolation of intestinal lamina propria cells.	Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Filby A, 2012, CYTOM PART A, V81A, P637, DOI 10.1002/cyto.a.22091; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Milling S, 2010, IMMUNOL REV, V234, P259, DOI 10.1111/j.0105-2896.2009.00866.x; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	52	204	208	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					843	858		10.1016/j.cell.2013.07.014	http://dx.doi.org/10.1016/j.cell.2013.07.014			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953115	Bronze			2022-12-28	WOS:000323202500015
J	Dhaliwal, G; Detsky, AS				Dhaliwal, Gurpreet; Detsky, Allan S.			The Evolution of the Master Diagnostician	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, Med Serv, San Francisco, CA USA; [Detsky, Allan S.] Univ Toronto, Dept Med, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Christmas C, 2008, MAYO CLIN PROC, V83, P989, DOI 10.4065/83.9.989; Ely JW, 2011, ACAD MED, V86, P307, DOI 10.1097/ACM.0b013e31820824cd; Goldberg C, 2012, AM J MED, V125, P1047, DOI 10.1016/j.amjmed.2012.04.003; Kahneman D., 2011, THINKING FAST SLOW; Klein G.A., 2017, SOURCES POWER PEOPLE; Mylopoulos M, 2012, ACAD MED, V87, P1413, DOI 10.1097/ACM.0b013e31826735fc; Schiff GD, 2008, AM J MED, V121, P38, DOI 10.1016/j.amjmed.2008.02.004; Walsh PC, 2008, CAN J UROL, V15, P4230	9	16	16	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					579	580		10.1001/jama.2013.7572	http://dx.doi.org/10.1001/jama.2013.7572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942674				2022-12-28	WOS:000323058400009
J	Hedman, MM; Gosmeyer, CM; Nicholson, PD; Sotin, C; Brown, RH; Clark, RN; Baines, KH; Buratti, BJ; Showalter, MR				Hedman, M. M.; Gosmeyer, C. M.; Nicholson, P. D.; Sotin, C.; Brown, R. H.; Clark, R. N.; Baines, K. H.; Buratti, B. J.; Showalter, M. R.			An observed correlation between plume activity and tidal stresses on Enceladus	NATURE			English	Article							WATER RESERVOIR; CASSINI ISS; SOUTH-POLE; E-RING; SPECTROMETER; ERUPTIONS; ORIGIN; VIMS; MASS	Saturn's moon Enceladus emits a plume of water vapour and micrometre-sized ice particles from a series of warm fissures located near its south pole(1-10). This geological activity could be powered or controlled by variations in the tidal stresses experienced by Enceladus as it moves around its slightly eccentric orbit. The specific mechanisms by which these varying stresses are converted into heat, however, are still being debated(11-16). Furthermore, it has proved difficult to find a clear correlation between the predicted tidal forces and measured temporal variations in the plume's gas content(17-19) or the particle flux from individual sources(20,21). Here we report that the plume's horizontally integrated brightness is several times greater when Enceladus is near the point in its eccentric orbit where it is furthest from Saturn (apocentre) than it is when near the point of closest approach to the planet (pericentre). More material therefore seems to be escaping from beneath Enceladus' surface at times when geophysical models predict its fissures should be under tension(12,15,16) and therefore may be wider open.	[Hedman, M. M.; Nicholson, P. D.] Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; [Gosmeyer, C. M.] Indiana Univ, Dept Astron, Bloomington, IN 47405 USA; [Sotin, C.; Baines, K. H.; Buratti, B. J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Brown, R. H.] Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Clark, R. N.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [Showalter, M. R.] SETI Inst, Mountain View, CA 94043 USA	Cornell University; Indiana University System; Indiana University Bloomington; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; United States Department of the Interior; United States Geological Survey	Hedman, MM (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.	mmhedman@astro.cornell.edu		Hedman, Matthew/0000-0002-8592-0812	VIMS team; Cassini project; NASA [NNX12AC29G]; Cornell University	VIMS team; Cassini project; NASA(National Aeronautics & Space Administration (NASA)); Cornell University	We acknowledge the support of the VIMS team, the Cassini project and NASA. This work was supported in part by NASA grant NNX12AC29G. The work of C.M.G. on this project was made possible by the Research Experience for Undergraduates programme at Cornell University.	Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Hansen CJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047415; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hedman MM, 2009, ASTROPHYS J, V693, P1749, DOI 10.1088/0004-637X/693/2/1749; Hurford TA, 2007, NATURE, V447, P292, DOI 10.1038/nature05821; Hurford TA, 2012, ICARUS, V220, P896, DOI 10.1016/j.icarus.2012.06.022; Hurford TA, 2009, ICARUS, V203, P541, DOI 10.1016/j.icarus.2009.04.025; Ingersoll AP, 2011, ICARUS, V216, P492, DOI 10.1016/j.icarus.2011.09.018; Meyer J, 2007, ICARUS, V188, P535, DOI 10.1016/j.icarus.2007.03.001; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; Porco C., 2011, AGU FALL M; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Postberg F, 2008, ICARUS, V193, P438, DOI 10.1016/j.icarus.2007.09.001; Postberg F, 2011, NATURE, V474, P620, DOI 10.1038/nature10175; Saur J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035811; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; Smith HT, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015184; Smith-Konter B, 2008, ICARUS, V198, P435, DOI 10.1016/j.icarus.2008.07.005; Spencer JR, 2009, SATURN FROM CASSINI-HUYGENS, P683, DOI 10.1007/978-1-4020-9217-6_21; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tobie G, 2008, ICARUS, V196, P642, DOI 10.1016/j.icarus.2008.03.008; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	23	105	107	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					182	184		10.1038/nature12371	http://dx.doi.org/10.1038/nature12371			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23903658				2022-12-28	WOS:000322825500029
J	Kerlin, MP; Tokar, JL				Kerlin, Meeta Prasad; Tokar, Jeffrey L.			Acute Gastrointestinal Bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Alain BBN, 2008, CHIN J TRAUMATOL, V11, P114; Arisawa T, 2007, INT J MOL MED, V20, P373; Banerjee S, 2010, GASTROINTEST ENDOSC, V71, P663, DOI 10.1016/j.gie.2009.11.026; Baradarian R, 2004, AM J GASTROENTEROL, V99, P619, DOI 10.1111/j.1572-0241.2004.04073.x; Bari K, 2012, WORLD J GASTROENTERO, V18, P1166, DOI 10.3748/wjg.v18.i11.1166; Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; Barkun AN, 2008, GASTROINTEST ENDOSC, V67, P1064, DOI 10.1016/j.gie.2008.02.040; Barkun AN, 2012, AM J GASTROENTEROL, V107, P507, DOI 10.1038/ajg.2011.474; Barkun AN, 2010, GASTROINTEST ENDOSC, V72, P1138, DOI 10.1016/j.gie.2010.08.011; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Barkun AN, 2009, GASTROINTEST ENDOSC, V69, P786, DOI 10.1016/j.gie.2008.05.031; Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Boonpongmanee S, 2004, GASTROINTEST ENDOSC, V59, P788, DOI 10.1016/S0016-5107(04)00181-6; Cappell MS, 2008, MED CLIN N AM, V92, P491, DOI 10.1016/j.mcna.2008.01.005; Chen GC, 2007, AM J EMERG MED, V25, P774, DOI 10.1016/j.ajem.2006.12.024; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Das A, 2004, GASTROINTEST ENDOSC, V60, P85, DOI 10.1016/S0016-5107(04)01291-X; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Enestvedt BK, 2008, GASTROINTEST ENDOSC, V67, P422, DOI 10.1016/j.gie.2007.09.024; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Gralnek IM, 2008, NEW ENGL J MED, V359, P928, DOI 10.1056/NEJMra0706113; Hearnshaw SA, 2010, GUT, V59, P1022, DOI 10.1136/gut.2008.174599; Hreinsson JP, 2013, SCAND J GASTROENTERO, V48, P439, DOI 10.3109/00365521.2012.763174; Huang ES, 2011, GASTROINTEST ENDOSC, V74, P971, DOI 10.1016/j.gie.2011.04.045; Hwang JH, 2012, GASTROINTEST ENDOSC, V75, P1132, DOI 10.1016/j.gie.2012.02.033; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Kanwal F, 2010, AM J GASTROENTEROL, V105, P1710, DOI 10.1038/ajg.2010.180; Kurata JH, 1997, J CLIN GASTROENTEROL, V24, P2, DOI 10.1097/00004836-199701000-00002; LAINE L, 1995, ANN INTERN MED, V123, P280, DOI 10.7326/0003-4819-123-4-199508150-00007; Laine L, 2012, AM J GASTROENTEROL, V107, P361; Laine L, 2012, AM J GASTROENTEROL, V107, P345, DOI 10.1038/ajg.2011.480; Laine L, 2009, CLIN GASTROENTEROL H, V7, P33, DOI 10.1016/j.cgh.2008.08.016; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Lau JYW, 1998, ENDOSCOPY, V30, P513, DOI 10.1055/s-2007-1001336; Leontiadis GI, 2007, MAYO CLIN PROC, V82, P286; Lim CH, 2011, ENDOSCOPY, V43, P1018, DOI 10.1055/s-0030-1256742; Lin HJ, 1996, J CLIN GASTROENTEROL, V22, P267, DOI 10.1097/00004836-199606000-00005; LONGSTRETH GF, 1995, AM J GASTROENTEROL, V90, P206; Malaty HM, 2000, ARCH INTERN MED, V160, P105, DOI 10.1001/archinte.160.1.105; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Masaoka T, 2007, J GASTROEN HEPATOL, V22, P1404, DOI 10.1111/j.1440-1746.2006.04762.x; MCCOLL KEL, 1993, GUT, V34, P762, DOI 10.1136/gut.34.6.762; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; Okazaki H, 2009, J GASTROENTEROL, V44, P550, DOI 10.1007/s00535-009-0039-5; Pasha SF, 2012, TECH GASTROINTEST EN, V14, P100, DOI 10.1016/j.tgie.2012.02.001; Pennazio M, 2012, TECH GASTROINTEST EN, V14, P94, DOI 10.1016/j.tgie.2012.01.004; Razzaghi A, 2012, J CLIN GASTROENTEROL, V46, P482, DOI 10.1097/MCG.0b013e31823d33e3; Rockall TA, 1996, LANCET, V347, P1138, DOI 10.1016/S0140-6736(96)90607-8; Rondonotti E, 2013, DIGEST LIVER DIS, V45, P179, DOI 10.1016/j.dld.2012.07.012; Saltzman JR, 2011, GASTROINTEST ENDOSC, V74, P1215, DOI 10.1016/j.gie.2011.06.024; Sarin N, 2009, CAN J GASTROENTEROL, V23, P489, DOI 10.1155/2009/604639; Shingina A, 2011, ALIMENT PHARM THER, V33, P1010, DOI 10.1111/j.1365-2036.2011.04618.x; Sreedharan A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005415.pub3; Srirajaskanthan R, 2010, INT J CLIN PRACT, V64, P868, DOI 10.1111/j.1742-1241.2009.02267.x; Stanley AJ, 2009, LANCET, V373, P42, DOI 10.1016/S0140-6736(08)61769-9; Stanley AJ, 2012, WORLD J GASTROENTERO, V18, P2739, DOI 10.3748/wjg.v18.i22.2739; Stollman N, 2004, LANCET, V363, P631, DOI 10.1016/S0140-6736(04)15597-9; Strate LL, 2005, GASTROENTEROL CLIN N, V34, P643, DOI 10.1016/j.gtc.2005.08.007; Strate LL, 2005, AM J GASTROENTEROL, V100, P1821, DOI 10.1111/j.1572-0241.2005.41755.x; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Sung JJY, 2009, ANN INTERN MED, V150, P455, DOI 10.7326/0003-4819-150-7-200904070-00105; Tai CM, 2007, AM J EMERG MED, V25, P273, DOI 10.1016/j.ajem.2006.07.014; Talamini G, 1997, DIGESTION, V58, P211, DOI 10.1159/000201446; Targownik LE, 2007, CAN J GASTROENTEROL, V21, P425, DOI 10.1155/2007/636032; Targownik LE, 2006, CLIN GASTROENTEROL H, V4, P1459, DOI 10.1016/j.cgh.2006.08.018; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wolf AT, 2007, AM J GASTROENTEROL, V102, P290, DOI 10.1111/j.1572-0241.2006.00969.x; YAVORSKI RT, 1995, AM J GASTROENTEROL, V90, P568; Zuccaro G, 1998, AM J GASTROENTEROL, V93, P1202; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8	71	6	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					ITC1	ITC216		10.7326/0003-4819-159-3-201308060-01002	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-01002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NQ	23922080				2022-12-28	WOS:000209756100001
J	Kulkarni, K; Lakhani, N; Cope, A; McGrath, D				Kulkarni, Kunal; Lakhani, Neeta; Cope, Alexandra; McGrath, Daniel			A growing abdominal problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE SIGMOID VOLVULUS; COLON; RESECTION		[Kulkarni, Kunal] Nuffield Orthopaed Ctr, Oxford OX3 7LD, England; [Lakhani, Neeta] Leicester Royal Infirm, Leicester, Leics, England; [Cope, Alexandra; McGrath, Daniel] Royal Berkshire Hosp, Dept Gen Surg, Reading RG1 5AN, Berks, England	Nuffield Orthopaedic Centre; University of Leicester; Royal Berkshire Hospital	Kulkarni, K (corresponding author), Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.	kunalkulkarni@doctors.org.uk	Kulkarni, Kunal/GYI-9096-2022	Kulkarni, Kunal/0000-0002-9405-0273; Cope, Alexandra/0000-0001-7315-8720				Akcan A, 2007, AM J SURG, V193, P421, DOI 10.1016/j.amjsurg.2006.08.077; [Anonymous], SIGM VOLV; [Anonymous], LARG BOW OBSTR; Atamanalp SS, 2013, TECH COLOPROCTOL; BAGARANI M, 1993, DIS COLON RECTUM, V36, P186, DOI 10.1007/BF02051177; Brussgaard C, 1947, SURGERY, V22, P466; Choi D, 1998, J ROY COLL SURG EDIN, V43, P64; Dite P, 2003, DIGEST DIS, V21, P63, DOI 10.1159/000071341; General Medical Council, 2013, LEARNING; Katsikogiannis Nikolaos, 2012, Case Rep Gastroenterol, V6, P293, DOI 10.1159/000339216; KHOURY GA, 1977, BRIT J SURG, V64, P587, DOI 10.1002/bjs.1800640817; Kuzu MA, 2002, DIS COLON RECTUM, V45, P1085, DOI 10.1007/s10350-004-6364-0; Lal Sunil K, 2006, Gastrointest Endosc Clin N Am, V16, P175, DOI 10.1016/j.giec.2006.01.010; Nawaz Khan A, MEDSCAPE; Raveenthiran V, 2010, COLORECTAL DIS, V12, pE1, DOI 10.1111/j.1463-1318.2010.02262.x; Reilly PMJ, 1992, CURRENT SURG THERAPY, P170; SROUJIEH AS, 1992, DIS COLON RECTUM, V35, P64, DOI 10.1007/BF02053341; Tan KK, 2010, WORLD J SURG, V34, P1943, DOI 10.1007/s00268-010-0563-8; UK Department of Health Social Services and Public Safety, 2004, FORM 4 AD WHO AR UN	19	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2013	347								f4547	10.1136/bmj.f4547	http://dx.doi.org/10.1136/bmj.f4547			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CN	23918608				2022-12-28	WOS:000323118400001
J	Fiorillo, CD				Fiorillo, Christopher D.			Two Dimensions of Value: Dopamine Neurons Represent Reward But Not Aversiveness	SCIENCE			English	Article							ROSTROMEDIAL TEGMENTAL NUCLEUS; LATERAL HABENULA; STIMULI; RESPONSES; SIGNALS; DIFFERENCE; PREDICTION; PUNISHMENT; ACTIVATION; AVOIDANCE	Whereas reward (appetitiveness) and aversiveness (punishment) have been distinguished as two discrete dimensions within psychology and behavior, physiological and computational models of their neural representation have treated them as opposite sides of a single continuous dimension of "value." Here, I show that although dopamine neurons of the primate ventral midbrain are activated by evidence for reward and suppressed by evidence against reward, they are insensitive to aversiveness. This indicates that reward and aversiveness are represented independently as two dimensions, even by neurons that are closely related to motor function. Because theory and experiment support the existence of opponent neural representations for value, the present results imply four types of value-sensitive neurons corresponding to reward-ON (dopamine), reward-OFF, aversive-ON, and aversive-OFF.	Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Fiorillo, CD (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, 291 Daehak Ro,Bldg 611, Taejon 305701, South Korea.	fiorillo@kaist.ac.kr	Fiorillo, Christopher Dante/C-1718-2011	Fiorillo, Christopher/0000-0002-7232-9505	Basic Science Research Program [2012R1A1A2006996]; World Class University (WCU) program of the National Research Foundation of Korea (NRF) [R32-2008-000-10218-0]; Ministry of Education, Science and Technology; Howard Hughes Medical Institute	Basic Science Research Program; World Class University (WCU) program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	I thank W. T. Newsome for advice and helpful discussions, J. R. Brown for excellent technical assistance, and W. A. Phillips, J. R. Wickens, and M. R. Song for constructive comments on the manuscript. Research was supported by grants from the Basic Science Research Program (2012R1A1A2006996) and World Class University (WCU) program (R32-2008-000-10218-0) of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, and a grant to W. T. Newsome from the Howard Hughes Medical Institute.	Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Fiorillo CD, 2011, NEUROSCIENCE, V197, P162, DOI 10.1016/j.neuroscience.2011.09.037; Fiorillo CD, 2013, J NEUROSCI, V33, P4710, DOI 10.1523/JNEUROSCI.3883-12.2013; Fiorillo CD, 2013, J NEUROSCI, V33, P4693, DOI 10.1523/JNEUROSCI.3886-12.2013; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Moutoussis M, 2008, NETWORK-COMP NEURAL, V19, P137, DOI 10.1080/09548980802192784; Oleson EB, 2012, J NEUROSCI, V32, P14804, DOI 10.1523/JNEUROSCI.3087-12.2012; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Ravel S, 2003, J NEUROSCI, V23, P8489; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Skinner B. F., 1969, CONTINGENCIES OF REI; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tobler PN, 2003, J NEUROSCI, V23, P10402; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047	26	127	127	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					546	549		10.1126/science.1238699	http://dx.doi.org/10.1126/science.1238699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908236				2022-12-28	WOS:000322586700053
J	White, NJ; Pukrittayakamee, S; Hien, TT; Faiz, MA; Mokuolu, OA; Dondorp, AM				White, Nicholas J.; Pukrittayakamee, Sasithon; Tran Tinh Hien; Faiz, M. Abul; Mokuolu, Olugbenga A.; Dondorp, Arjen M.			Malaria	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; HUMAN CEREBRAL MALARIA; VON-WILLEBRAND-FACTOR; ACUTE-RENAL-FAILURE; VIVAX MALARIA; AFRICAN CHILDREN; ARTEMETHER-LUMEFANTRINE; PYRONARIDINE-ARTESUNATE; INFECTED ERYTHROCYTES; INTRACRANIAL-PRESSURE	Although global morbidity and mortality have decreased substantially, malaria, a parasite infection of red blood cells, still kills roughly 2000 people per day, most of whom are children in Africa. Two factors largely account for these decreases; increased deployment of insecticide-treated bednets and increased availability of highly effective artemisinin combination treatments. In large trials, parenteral artesunate (an artemisinin derivative) reduced severe malaria mortality by 22.5% in Africa and 34.7% in Asia compared with quinine, whereas adjunctive interventions have been uniformly unsuccessful. Rapid tests have been an important addition to microscopy for malaria diagnosis. Chemopreventive strategies have been increasingly deployed in Africa, notably intermittent sulfadoxine-pyrimethamine treatment in pregnancy, and monthly amodiaquine-sulfadoxine-pyrimethamine during the rainy season months in children aged between 3 months and 5 years across the sub-Sahel. Enthusiasm for malaria elimination has resurfaced. This ambitious but laudable goal faces many challenges, including the worldwide economic downturn, difficulties in elimination of vivax malaria, development of pyrethroid resistance in some anopheline mosquitoes, and the emergence of artemisinin resistance in Plasmodium falciparum in southeast Asia. We review the epidemiology, clinical features, pathology, prevention, and treatment of malaria.	[White, Nicholas J.; Pukrittayakamee, Sasithon; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [White, Nicholas J.; Dondorp, Arjen M.] Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Tran Tinh Hien] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Faiz, M. Abul] Dev Care Fdn, Dept Med, Dhaka, Bangladesh; [Mokuolu, Olugbenga A.] Univ Ilorin, Teaching Hosp, Ilorin, Nigeria	Mahidol University; University of Oxford; University of Oxford; University of Ilorin	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	nickw@tropmedres.ac	Richie, Thomas L/A-8028-2011; White, Nicholas J/I-4629-2012; Torero, Rebeca/C-1703-2012	White, Nicholas/0000-0002-1897-1978	Wellcome Trust as part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme	Wellcome Trust as part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme(Wellcome Trust)	NJW and AMD are supported by the Wellcome Trust as part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Aneck-Hahn NH, 2007, J ANDROL, V28, P423, DOI 10.2164/jandrol.106.001701; [Anonymous], 2012, MALARIA J, V11, pe424; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Ayimba E, 2011, CLIN EXP IMMUNOL, V166, P218, DOI 10.1111/j.1365-2249.2011.04474.x; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Birbeck GL, 2010, LANCET NEUROL, V9, P1173, DOI 10.1016/S1474-4422(10)70270-2; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Chalwe V, 2009, EMERG INFECT DIS, V15, P749, DOI 10.3201/eid1505.081009; Chen LH, 2006, JAMA-J AM MED ASSOC, V296, P2234, DOI 10.1001/jama.296.18.2234; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Cooke BM, 2000, PARASITOL TODAY, V16, P416, DOI 10.1016/S0169-4758(00)01753-1; Cordery DV, 2009, ADV EXP MED BIOL, V653, P175; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; Dasari P, 2011, BLOOD, V118, P4946, DOI 10.1182/blood-2011-05-353920; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; de Mast Q, 2009, AM J TROP MED HYG, V80, P492, DOI 10.4269/ajtmh.2009.80.492; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2002, T ROY SOC TROP MED H, V96, P282, DOI 10.1016/S0035-9203(02)90100-8; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Faiz MA, 2005, LANCET, V366, P717; Falade C, 2007, TROP MED INT HEALTH, V12, P1279, DOI 10.1111/j.1365-3156.2007.01931.x; Farnert A, 2010, TRENDS PARASITOL, V26, P465, DOI 10.1016/j.pt.2010.06.003; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Godfray HCJ, 2013, J ANIM ECOL, V82, P15, DOI 10.1111/1365-2656.12003; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Hanson J, 2012, J INFECT DIS, V206, P571, DOI 10.1093/infdis/jis400; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hanson JP, 2013, CRIT CARE MED, V41, P972, DOI 10.1097/CCM.0b013e31827466d2; Hendriksen ICE, 2013, CLIN PHARMACOL THER, V93, P443, DOI 10.1038/clpt.2013.26; Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297; Hendriksen ICE, 2012, CLIN INFECT DIS, V55, P1144, DOI 10.1093/cid/cis590; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Jarvis JN, 2006, CLIN INFECT DIS, V42, P1719, DOI 10.1086/504329; Kantele A, 2011, CLIN INFECT DIS, V52, P1356, DOI 10.1093/cid/cir180; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kreeftmeijer-Vegter AR, 2012, MALARIA J, V11, pe102; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Lampah DA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001032; LOOAREESUWAN S, 1987, NEW ENGL J MED, V317, P675, DOI 10.1056/NEJM198709103171105; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Manning L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029203; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Maude RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027273; Maude RJ, 2009, T ROY SOC TROP MED H, V103, P665, DOI 10.1016/j.trstmh.2009.03.001; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Medana IM, 2007, J INFECT DIS, V195, P921, DOI 10.1086/512089; Medana IM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-267; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mohanty S, 2011, CLIN INFECT DIS, V53, P349, DOI 10.1093/cid/cir405; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; NEWTON CRJC, 1991, LANCET, V337, P573, DOI 10.1016/0140-6736(91)91638-B; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Nguansangiam S, 2007, TROP MED INT HEALTH, V12, P1037, DOI 10.1111/j.1365-3156.2007.01881.x; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Phu NH, 2002, NEW ENGL J MED, V347, P895, DOI 10.1056/NEJMoa020074; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Potchen MJ, 2012, AM J NEURORADIOL, V33, P1740, DOI 10.3174/ajnr.A3035; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Rueangweerayut R, 2012, NEW ENGL J MED, V366, P1298, DOI 10.1056/NEJMoa1007125; Sarda V, 2009, INFECT IMMUN, V77, P3130, DOI 10.1128/IAI.00122-09; Schlagenhauf P, 2012, CLIN INFECT DIS, V54, pe124, DOI 10.1093/cid/cis215; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Shaikh S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-144; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suwanarusk R, 2004, J INFECT DIS, V189, P190, DOI 10.1086/380468; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TRANG TTM, 1992, CLIN INFECT DIS, V15, P874, DOI 10.1093/clind/15.5.874; Tshefu AK, 2010, LANCET, V375, P1457, DOI 10.1016/S0140-6736(10)60322-4; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; von Seidlein L, 2012, CLIN INFECT DIS, V54, P1080, DOI 10.1093/cid/cis034; WALLER D, 1991, T ROY SOC TROP MED H, V85, P362, DOI 10.1016/0035-9203(91)90291-6; WARRELL DA, 1986, AM J TROP MED HYG, V35, P882, DOI 10.4269/ajtmh.1986.35.882; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116; White NJ, 2013, LANCET INFECT DIS, V13, P175, DOI 10.1016/S1473-3099(12)70198-6; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, POLICY RECOMMENDATIO; WHO, 2010, GUID TREATM MAL, V2nd; WHO Global Malaria Programme, SINGL DOS PRIM GAM P; Williams TN, 2012, LANCET INFECT DIS, V12, P427, DOI 10.1016/S1473-3099(12)70067-1; World Health Organization, 2018, MAL RAP DIAGN TEST P; World Health Organization, 2004, GLOB STRAT FRAM INT; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641	143	667	690	8	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					723	735		10.1016/S0140-6736(13)60024-0	http://dx.doi.org/10.1016/S0140-6736(13)60024-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	23953767				2022-12-28	WOS:000331653300034
J	Corti, D; Bianchi, S; Vanzetta, F; Minola, A; Perez, L; Agatic, G; Guarino, B; Silacci, C; Marcandalli, J; Marsland, BJ; Piralla, A; Percivalle, E; Sallusto, F; Baldanti, F; Lanzavecchia, A				Corti, Davide; Bianchi, Siro; Vanzetta, Fabrizia; Minola, Andrea; Perez, Laurent; Agatic, Gloria; Guarino, Barbara; Silacci, Chiara; Marcandalli, Jessica; Marsland, Benjamin J.; Piralla, Antonio; Percivalle, Elena; Sallusto, Federica; Baldanti, Fausto; Lanzavecchia, Antonio			Cross-neutralization of four paramyxoviruses by a human monoclonal antibody	NATURE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MEMORY B-CELLS; HUMAN METAPNEUMOVIRUS; FUSION PROTEIN; F-GLYCOPROTEIN; IN-VITRO; INFECTION; GENERATION; PREFUSION; INFANTS	Broadly neutralizing antibodies reactive against most and even all variants of the same viral species have been described for influenza and HIV-1 (ref. 1). However, whether a neutralizing antibody could have the breadth of range to target different viral species was unknown. Human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV) are common pathogens that cause severe disease in premature newborns, hospitalized children(2,3) and immune-compromised patients(2,4,5), and play a role in asthma exacerbations(6). Although antisera generated against either HRSV or HMPV are not cross-neutralizing(7), we speculated that, because of the repeated exposure to these viruses, cross-neutralizing antibodies may be selected in some individuals. Here we describe a human monoclonal antibody (MPE8) that potently cross-neutralizes HRSV and HMPV as well as two animal paramyxoviruses: bovine RSV (BRSV) and pneumonia virus of mice (PVM). In its germline configuration, MPE8 is HRSV-specific and its breadth is achieved by somatic mutations in the light chain variable region. MPE8 did not result in the selection of viral escape mutants that evaded antibody targeting and showed potent prophylactic efficacy in animal models of HRSV and HMPV infection, as well as prophylactic and therapeutic efficacy in the more relevant model of lethal PVM infection. The core epitope of MPE8 was mapped on two highly conserved anti-parallel beta-strands on the pre-fusion viral F protein, which are rearranged in the post-fusion F protein conformation. Twenty-six out of the thirty HRSV-specific neutralizing antibodies isolated were also found to be specific for the pre-fusion F protein. Taken together, these results indicate that MPE8 might be used for the prophylaxis and therapy of severe HRSV and HMPV infections and identify the pre-fusion F protein as a candidate HRSV vaccine.	[Corti, Davide; Bianchi, Siro; Vanzetta, Fabrizia; Agatic, Gloria; Guarino, Barbara] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Corti, Davide; Minola, Andrea; Perez, Laurent; Silacci, Chiara; Marcandalli, Jessica; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Marsland, Benjamin J.] Univ Lausanne, Serv Pneumol, CHUV, CH-1011 Lausanne, Switzerland; [Piralla, Antonio; Percivalle, Elena; Baldanti, Fausto] IRCCS, Policlin San Matteo, I-27100 Pavia, Italy; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Fondazione San Matteo; University of Pavia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	davide.corti@humabs.ch; lanzavecchia@irb.usi.ch	Perez, Laurent/ABA-4145-2021; Piralla, Antonio/K-4756-2018; Baldanti, Fausto/J-4924-2018; percivalle, elena/K-7994-2016	Perez, Laurent/0000-0002-8860-7928; Piralla, Antonio/0000-0002-6062-2579; Baldanti, Fausto/0000-0002-3358-8969; percivalle, elena/0000-0002-3355-1410; Bianchi, Siro/0000-0002-5100-8905; Zatta, Fabrizia/0000-0003-4945-8058; Guarino, Barbara/0000-0003-3759-3252; Corti, Davide/0000-0002-5797-1364	European Research Council [250348 IMMUNExplore]; Swiss National Science Foundation [141254]; Helmut Horten Foundation	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Helmut Horten Foundation	We would like to thank M. Nussenzweig and H. Wardemann for providing reagents for antibody cloning and expression, I. Capua, B. Zecchin and L. Selli for experiments involving BRSV and R. Wepf for electron microscopy. This work was supported by the European Research Council (grant no. 250348 IMMUNExplore) and the Swiss National Science Foundation (grant no. 141254). A. L. is supported by the Helmut Horten Foundation.	Adams O, 2010, CLIN INFECT DIS, V51, P185, DOI 10.1086/653534; [Anonymous], 2013, FIELDS VIROLOGY; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Bonville CA, 2004, J VIROL, V78, P7984, DOI 10.1128/JVI.78.15.7984-7989.2004; Calder LJ, 2000, VIROLOGY, V271, P122, DOI 10.1006/viro.2000.0279; Connolly SA, 2006, P NATL ACAD SCI USA, V103, P17903, DOI 10.1073/pnas.0608678103; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; de Fontbrune FS, 2007, CLIN INFECT DIS, V45, P1019, DOI 10.1086/521912; Domachowske Joseph B, 2004, Pediatr Infect Dis J, V23, pS228, DOI 10.1097/01.inf.0000144672.81955.a4; Durbin JE, 2002, J IMMUNOL, V168, P2944, DOI 10.4049/jimmunol.168.6.2944; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; GROOTHUIS JR, 1995, PEDIATRICS, V95, P463; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Shah JN, 2011, BLOOD, V117, P2755, DOI 10.1182/blood-2010-08-263400; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Ulbrandt ND, 2006, J VIROL, V80, P7799, DOI 10.1128/JVI.00318-06; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wyde PR, 2003, ANTIVIR RES, V60, P51, DOI 10.1016/S0166-3542(03)00153-0; Zhao XD, 2004, VIROLOGY, V318, P608, DOI 10.1016/j.virol.2003.10.018; Zhu Q, 2012, J INFECT DIS, V205, P635, DOI 10.1093/infdis/jir790	35	175	199	2	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					439	+		10.1038/nature12442	http://dx.doi.org/10.1038/nature12442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23955151				2022-12-28	WOS:000324545700050
J	Aragona, M; Panciera, T; Manfrin, A; Giulitti, S; Michielin, F; Elvassore, N; Dupont, S; Piccolo, S				Aragona, Mariaceleste; Panciera, Tito; Manfrin, Andrea; Giulitti, Stefano; Michielin, Federica; Elvassore, Nicola; Dupont, Sirio; Piccolo, Stefano			A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors	CELL			English	Article							HIPPO SIGNALING-PATHWAY; CELL CONTACT INHIBITION; TISSUE ARCHITECTURE; YAP PATHWAY; F-ACTIN; CANCER; PROLIFERATION; TAZ; TRANSDUCTION; INACTIVATION	Key cellular decisions, such as proliferation or growth arrest, typically occur at spatially defined locations within tissues. Loss of this spatial control is a hallmark of many diseases, including cancer. Yet, how these patterns are established is incompletely understood. Here, we report that physical and architectural features of a multicellular sheet inform cells about their proliferative capacity through mechanical regulation of YAP and TAZ, known mediators of Hippo signaling and organ growth. YAP/TAZ activity is confined to cells exposed to mechanical stresses, such as stretching, location at edges/curvatures contouring an epithelial sheet, or stiffness of the surrounding extracellular matrix. We identify the F-actin-capping/severing proteins Cofilin, CapZ, and Gelsolin as essential gatekeepers that limit YAP/TAZ activity in cells experiencing low mechanical stresses, including contact inhibition of proliferation. We propose that mechanical forces are overarching regulators of YAP/TAZ in multicellular contexts, setting responsiveness to Hippo, WNT, and GPCR signaling.	[Aragona, Mariaceleste; Panciera, Tito; Manfrin, Andrea; Dupont, Sirio; Piccolo, Stefano] Univ Padua, Sch Med, Dept Mol Med, I-35131 Padua, Italy; [Giulitti, Stefano; Michielin, Federica; Elvassore, Nicola] Univ Padua, Dept Ind Engn DII, I-35131 Padua, Italy	University of Padua; University of Padua	Dupont, S (corresponding author), Univ Padua, Sch Med, Dept Mol Med, Viale Colombo 3, I-35131 Padua, Italy.	dupont@bio.unipd.it; piccolo@bio.unipd.it	Dupont, Sirio/AAP-8133-2021; Manfrin, Andrea/AAC-1066-2020; Aragona, Mariaceleste/AAB-7307-2021	Manfrin, Andrea/0000-0002-1519-6582; Aragona, Mariaceleste/0000-0002-2239-3541; Panciera, Tito/0000-0002-9272-5716; PICCOLO, STEFANO/0000-0002-2037-0004; MICHIELIN, FEDERICA/0000-0003-2065-6851; Dupont, Sirio/0000-0002-6869-1966	AIRC-PI; PRIN-Miur; University of Padua; AIRC Special Program Molecular Clinical Oncology; HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur	AIRC-PI(Fondazione AIRC per la ricerca sul cancro); PRIN-Miur(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Padua; AIRC Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro); HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur	We thank Michelangelo Cordenonsi, Francesca Zanconato, Elena Enzo, and Oliver Wessely for thoughtful discussion. This work is supported by AIRC-PI, PRIN-Miur and by a University of Padua grant to S. D. and by AIRC Special Program Molecular Clinical Oncology "5 per mille," HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S.P.	Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Guo CL, 2012, P NATL ACAD SCI USA, V109, P5576, DOI 10.1073/pnas.1114781109; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Luni C, 2013, BIOPHYS J, V104, P934, DOI 10.1016/j.bpj.2012.12.049; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Rohn JL, 2011, J CELL BIOL, V194, P789, DOI 10.1083/jcb.201103168; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	37	990	1008	20	262	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1047	1059		10.1016/j.cell.2013.07.042	http://dx.doi.org/10.1016/j.cell.2013.07.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23954413	Bronze, Green Submitted			2022-12-28	WOS:000323767300018
J	Jorgensen, L; McKerrall, SJ; Kuttruff, CA; Ungeheuer, F; Felding, J; Baran, PS				Jorgensen, Lars; McKerrall, Steven J.; Kuttruff, Christian A.; Ungeheuer, Felix; Felding, Jakob; Baran, Phil S.			14-Step Synthesis of (+)-Ingenol from (+)-3-Carene	SCIENCE			English	Article							DRUG DISCOVERY; INGENOL; EUPHORBIACEAE; OXIDATIONS; ECONOMY; ACCESS; PLANTS	Ingenol is a diterpenoid with unique architecture and has derivatives possessing important anticancer activity, including the recently Food and Drug Administration-approved Picato, a first-in-class drug for the treatment of the precancerous skin condition actinic keratosis. Currently, that compound is sourced inefficiently from Euphorbia peplus. Here, we detail an efficient, highly stereocontrolled synthesis of (+)-ingenol proceeding in only 14 steps from inexpensive (+)-3-carene and using a two-phase design. This synthesis will allow for the creation of fully synthetic analogs of bioactive ingenanes to address pharmacological limitations and provides a strategic blueprint for chemical production. These results validate two-phase terpene total synthesis as not only an academic curiosity but also a viable alternative to isolation or bioengineering for the efficient preparation of polyoxygenated terpenoids at the limits of chemical complexity.	[Jorgensen, Lars; McKerrall, Steven J.; Kuttruff, Christian A.; Ungeheuer, Felix; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Felding, Jakob] LEO Pharma AS, External Discovery, DK-2750 Ballerup, Denmark	Scripps Research Institute; LEO Pharma	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Kuttruff, Christian/ABC-4160-2020; Ungeheuer, Felix/C-4520-2017	Ungeheuer, Felix/0000-0001-6159-1228; McKerrall, Steven/0000-0002-2966-5810	LEO Pharma; Carlsberg Foundation; Danish Council for Independent Research (Technology and Production Sciences); Alexander von Humboldt Foundation	LEO Pharma(LEO Pharma); Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Financial support for this work was provided by LEO Pharma. The Carlsberg Foundation and the Danish Council for Independent Research (Technology and Production Sciences) provided postdoctoral fellowships for L.J., and the Alexander von Humboldt Foundation provided a postdoctoral fellowship for C.A.K. We are grateful to A. Rheingold and C. E. Moore (University of California, San Diego) for x-ray crystallographic analysis and G. Siuzdak (the Scripps Research Institute) for mass spectrometry assistance. We thank H. Bladh (LEO Pharma) for valuable discussions and LEO Pharma for generous donations of natural 20-deoxyingenol and ingenol. Metrical parameters for the structures of compounds 14, 20, and 21 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-943074, 943076, and 943075, respectively. A provisional patent application has been filed and is available under patent application no. U.S. 61/829,861.	Alder RW, 1996, CHEM REV, V96, P2097, DOI 10.1021/cr940246k; [Anonymous], 2012, EUR MED AG EMA PUBL; Appendino G, 1999, EUR J ORG CHEM, V1999, P3413; Appendino G, 1999, J NAT PROD, V62, P76, DOI 10.1021/np980218n; Brummond KM, 2002, ORG LETT, V4, P1931, DOI 10.1021/ol025955w; Burns NZ, 2009, ANGEW CHEM INT EDIT, V48, P2854, DOI 10.1002/anie.200806086; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Epstein OL, 2005, ANGEW CHEM INT EDIT, V44, P121, DOI 10.1002/anie.200461807; Fujiwara M, 1996, ANTIMICROB AGENTS CH, V40, P271, DOI 10.1128/AAC.40.1.271; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; HASLER CM, 1992, CANCER RES, V52, P202; HECKER E, 1968, CANCER RES, V28, P2338; Hohmann J, 2000, PLANTA MED, V66, P291, DOI 10.1055/s-2000-8568; Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kirby J, 2010, PHYTOCHEMISTRY, V71, P1466, DOI 10.1016/j.phytochem.2010.06.001; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Konegawa T, 1997, SYNLETT, P1297; Kuwajima I, 2005, CHEM REV, V105, P4661, DOI 10.1021/cr040636z; Liang XF, 2012, SYNLETT, P2647, DOI 10.1055/s-0032-1317415; Mountford P. G., 2010, GREEN CHEM PHARM IND, P145, DOI DOI 10.1002/9783527629688.CH7; Nakamura A, 2013, SYNTHESIS-STUTTGART, V45, P1421, DOI 10.1055/s-0033-1338426; Nickel A, 2004, J AM CHEM SOC, V126, P16300, DOI 10.1021/ja044123l; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Schmidt R. J., 1987, J LINN SOC BOT, V94, P221; SHIBUYA K, 1994, SYNTHETIC COMMUN, V24, P2923, DOI 10.1080/00397919408010614; Siller G, 2010, AUSTRALAS J DERMATOL, V51, P99, DOI 10.1111/j.1440-0960.2010.00626.x; Tanino K, 2003, J AM CHEM SOC, V125, P1498, DOI 10.1021/ja029226n; U.S. Food and Drug Administration, 2013, 2012 NOV NEW DRUGS S; Vasas A, 2012, EUR J ORG CHEM, V2012, P5115, DOI 10.1002/ejoc.201200733; Watanabe K, 2004, J ORG CHEM, V69, P7802, DOI 10.1021/jo048833l; Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; Winkler JD, 2002, J AM CHEM SOC, V124, P9726, DOI 10.1021/ja026600a; ZECHEIST.K, 1970, TETRAHEDRON LETT, P4075; Zhu CY, 2012, J AM CHEM SOC, V134, P13577, DOI 10.1021/ja3061479	37	217	220	18	362	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					878	882		10.1126/science.1241606	http://dx.doi.org/10.1126/science.1241606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23907534				2022-12-28	WOS:000323370600040
J	Kalinin, SV; Spaldin, NA				Kalinin, Sergei V.; Spaldin, Nicola A.			Functional Ion Defects in Transition Metal Oxides	SCIENCE			English	Editorial Material							CHEMICAL EXPANSION		[Kalinin, Sergei V.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Spaldin, Nicola A.] ETH, CH-8093 Zurich, Switzerland	United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kalinin, SV (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.	sergei2@ornl.gov; nicola.spaldin@mat.ethz.ch	Kalinin, Sergei V/GQP-1812-2022; Kalinin, Sergei V/I-9096-2012; Spaldin, Nicola A/A-1017-2010	Kalinin, Sergei V/0000-0001-5354-6152; Kalinin, Sergei V/0000-0001-5354-6152; Spaldin, Nicola A/0000-0003-0709-9499				Bagotsky V. S., 2009, FUEL CELLS PROBLEMS; Chen XY, 2005, CHEM MATER, V17, P4537, DOI 10.1021/cm050905h; Eliseev EA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.085416; Fuchigami K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.066104; Gertner J., 2013, IDEA FACTORY BELL LA; Grande T, 2012, CHEM MATER, V24, P338, DOI 10.1021/cm2030608; Jesse S, 2012, MRS BULL, V37, P651, DOI 10.1557/mrs.2012.144; Jiang W, 2011, J APPL PHYS, V110, DOI 10.1063/1.3622623; Kim YM, 2012, NAT MATER, V11, P888, DOI [10.1038/NMAT3393, 10.1038/nmat3393]; Kumar A, 2011, NAT CHEM, V3, P707, DOI [10.1038/NCHEM.1112, 10.1038/nchem.1112]; Palcut M, 2007, J PHYS CHEM C, V111, P813, DOI 10.1021/jp0642746; Patrakeev MV, 2003, J SOLID STATE CHEM, V172, P219, DOI 10.1016/S0022-4596(03)00040-9; Poccia N, 2011, NAT MATER, V10, P733, DOI [10.1038/NMAT3088, 10.1038/nmat3088]; Spaldin NA, 2005, SCIENCE, V309, P391, DOI 10.1126/science.1113357; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Yi HT, 2011, ADV MATER, V23, P3403, DOI 10.1002/adma.201100805	17	191	191	5	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					858	859		10.1126/science.1243098	http://dx.doi.org/10.1126/science.1243098			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970692				2022-12-28	WOS:000323370600032
J	Zhu, HJ; Tromp, J				Zhu, Hejun; Tromp, Jeroen			Mapping Tectonic Deformation in the Crust and Upper Mantle Beneath Europe and the North Atlantic Ocean	SCIENCE			English	Article							AZIMUTHAL ANISOTROPY; SEISMIC ANISOTROPY; PLATE BOUNDARY; TOMOGRAPHY; INVERSION; COMPLEX; MODEL	We constructed a three-dimensional azimuthally anisotropic model of Europe and the North Atlantic Ocean based on adjoint seismic tomography. Several features are well correlated with historical tectonic events in this region, such as extension along the North Atlantic Ridge, trench retreat in the Mediterranean, and counterclockwise rotation of the Anatolian Plate. Beneath northeastern Europe, the direction of the fast anisotropic axis follows trends of ancient rift systems older than 350 million years, suggesting "frozen-in" anisotropy related to the formation of the craton. Local anisotropic strength profiles identify the brittle-ductile transitions in lithospheric strength. In continental regions, these profiles also identify the lower crust, characterized by ductile flow. The observed anisotropic fabric is generally consistent with the current surface strain rate measured by geodetic surveys.	[Zhu, Hejun; Tromp, Jeroen] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Tromp, Jeroen] Princeton Univ, Program Appl & Computat Math, Princeton, NJ 08544 USA	Princeton University; Princeton University	Zhu, HJ (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	hejunzhu@princeton.edu	ZHu, Hejun/C-1933-2018; Tromp, Jeroen/B-6185-2015	ZHu, Hejun/0000-0002-7452-075X; Tromp, Jeroen/0000-0002-2742-8299	NSF [1063057, 1112906]	NSF(National Science Foundation (NSF))	This research is supported by NSF grants 1063057 and 1112906. The observed seismic waveforms used in this study were collected from the Incorporated Research Institutions for Seismology (www.iris.edu), Observations and Research Facilities for European Seismology (www.orfeus-eu.org), and the Kandilli Observatory (www.koeri.boun.edu.tr). The open-source spectral-element software package SPECFEM3D_GLOBE and the seismic measurement software package FLEXWIN used in this study are freely available for download via the Computational Infrastructure for Geodynamics (www.geodynamics.org).	Artemieva IM, 2006, GEOL SOC MEM, V32, P11, DOI 10.1144/GSL.MEM.2006.032.01.02; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Debayle E, 2005, NATURE, V433, P509, DOI 10.1038/nature03247; Ekstrom G, 1998, NATURE, V394, P168, DOI 10.1038/28148; Endrun B, 2011, NAT GEOSCI, V4, P203, DOI 10.1038/NGEO1065; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Goes S, 1999, SCIENCE, V286, P1928, DOI 10.1126/science.286.5446.1928; Gung YC, 2003, NATURE, V422, P707, DOI 10.1038/nature01559; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Komatitsch D, 1999, GEOPHYS J INT, V139, P806, DOI 10.1046/j.1365-246x.1999.00967.x; Kreemer C, 2003, GEOPHYS J INT, V154, P8, DOI 10.1046/j.1365-246X.2003.01917.x; Kustowski B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005169; Lin FC, 2011, NAT GEOSCI, V4, P55, DOI 10.1038/NGEO1036; Marone F, 2007, NATURE, V447, P198, DOI 10.1038/nature05742; Molinari I, 2011, GEOPHYS J INT, V185, P352, DOI 10.1111/j.1365-246X.2011.04940.x; MONTAGNER JP, 1986, J GEOPHYS RES-SOLID, V91, P511, DOI 10.1029/JB091iB01p00511; Park J, 2002, SCIENCE, V296, P485, DOI 10.1126/science.1067319; Schivardi R, 2011, GEOPHYS J INT, V185, P469, DOI 10.1111/j.1365-246X.2011.04953.x; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Simons FJ, 2002, GEOPHYS J INT, V151, P738, DOI 10.1046/j.1365-246X.2002.01787.x; SMITH ML, 1973, J GEOPHYS RES, V78, P3321, DOI 10.1029/JB078i017p03321; Tape C, 2009, SCIENCE, V325, P988, DOI 10.1126/science.1175298; TARANTOLA A, 1984, GEOPHYSICS, V49, P1259, DOI 10.1190/1.1441754; Tromp J, 2005, GEOPHYS J INT, V160, P195, DOI [10.1111/j.1365-246X.2004.02453.x, 10.1111/J.1365-246X.2004.02453.X]; VINNIK LP, 1992, GEOPHYS J INT, V111, P433, DOI 10.1111/j.1365-246X.1992.tb02102.x; Wortel MJR, 2000, SCIENCE, V290, P1910, DOI 10.1126/science.290.5498.1910; Yuan HY, 2010, NATURE, V466, P1063, DOI 10.1038/nature09332; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0; Zhu HJ, 2012, NAT GEOSCI, V5, P493, DOI 10.1038/ngeo1501; ZIELHUIS A, 1994, SCIENCE, V265, P79, DOI 10.1126/science.265.5168.79	30	54	55	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					871	875		10.1126/science.1241335	http://dx.doi.org/10.1126/science.1241335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23929947				2022-12-28	WOS:000323370600038
J	Davis, M; Tachtatzis, PM				Davis, Mike; Tachtatzis, Phaedra Maria			From haemochromatosis to liver transplant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tachtatzis, Phaedra Maria] St James Univ Hosp, Liver Transplant Unit, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Tachtatzis, PM (corresponding author), St James Univ Hosp, Liver Transplant Unit, Leeds LS9 7TF, W Yorkshire, England.	phaedratachtatzis@me.com		Davis, Michael/0000-0002-0984-4758					0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f4423	10.1136/bmj.f4423	http://dx.doi.org/10.1136/bmj.f4423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SC	23963547	Bronze			2022-12-28	WOS:000323623100001
J	Wood, G				Wood, Greg			I blew the whistle on the government's disability assessments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dr.greg.wood.wca@gmail.com							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f5009	10.1136/bmj.f5009	http://dx.doi.org/10.1136/bmj.f5009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SC	23963107				2022-12-28	WOS:000323623100005
J	Elias, WJ; Huss, D; Voss, T; Loomba, J; Khaled, M; Zadicario, E; Frysinger, RC; Sperling, SA; Wylie, S; Monteith, SJ; Druzgal, J; Shah, BB; Harrison, M; Wintermark, M				Elias, W. Jeffrey; Huss, Diane; Voss, Tiffini; Loomba, Johanna; Khaled, Mohamad; Zadicario, Eyal; Frysinger, Robert C.; Sperling, Scott A.; Wylie, Scott; Monteith, Stephen J.; Druzgal, Jason; Shah, Binit B.; Harrison, Madaline; Wintermark, Max			A Pilot Study of Focused Ultrasound Thalamotomy for Essential Tremor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA-KNIFE THALAMOTOMY; QUALITY STANDARDS SUBCOMMITTEE; DEEP BRAIN-STIMULATION; THALAMIC-STIMULATION; AMERICAN-ACADEMY; PHASED-ARRAY; OF-LIFE; SURGERY; SKULL; DISABILITY	BackgroundRecent advances have enabled delivery of high-intensity focused ultrasound through the intact human cranium with magnetic resonance imaging (MRI) guidance. This preliminary study investigates the use of transcranial MRI-guided focused ultrasound thalamotomy for the treatment of essential tremor. MethodsFrom February 2011 through December 2011, in an open-label, uncontrolled study, we used transcranial MRI-guided focused ultrasound to target the unilateral ventral intermediate nucleus of the thalamus in 15 patients with severe, medication-refractory essential tremor. We recorded all safety data and measured the effectiveness of tremor suppression using the Clinical Rating Scale for Tremor to calculate the total score (ranging from 0 to 160), hand subscore (primary outcome, ranging from 0 to 32), and disability subscore (ranging from 0 to 32), with higher scores indicating worse tremor. We assessed the patients' perceptions of treatment efficacy with the Quality of Life in Essential Tremor Questionnaire (ranging from 0 to 100%, with higher scores indicating greater perceived disability). ResultsThermal ablation of the thalamic target occurred in all patients. Adverse effects of the procedure included transient sensory, cerebellar, motor, and speech abnormalities, with persistent paresthesias in four patients. Scores for hand tremor improved from 20.4 at baseline to 5.2 at 12 months (P=0.001). Total tremor scores improved from 54.9 to 24.3 (P=0.001). Disability scores improved from 18.2 to 2.8 (P=0.001). Quality-of-life scores improved from 37% to 11% (P=0.001). ConclusionsIn this pilot study, essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy. Large, randomized, controlled trials will be required to assess the procedure's efficacy and safety. (Funded by the Focused Ultrasound Surgery Foundation; ClinicalTrials.gov number, NCT01304758.) In an uncontrolled, open-label pilot study, essential tremor improved in 15 patients treated with MRI-guided focused ultrasound thalamotomy. Adverse effects included persistent paresthesias in four patients. The study was too small to assess the safety of this procedure. Essential tremor, the most common movement disorder, with a prevalence as high as 4%, is characterized by a rhythmic oscillation of agonist and antagonist muscle groups, typically between 8 and 12 Hz.(1) The cause of this disorder remains unknown, although there is often a familial component with a link to a particular polymorphism in the gene encoding leucine-rich repeat and immunoglobulin domain-containing protein 1 (LINGO1). Although essential tremor is not medically dangerous, it is progressive and disabling in the home and workplace.(2) The degree of tremor does not always correlate with the severity of disability,(3) and patients with ...	[Elias, W. Jeffrey; Loomba, Johanna; Khaled, Mohamad; Frysinger, Robert C.; Monteith, Stephen J.] Univ Virginia, Hlth Sci Ctr, Dept Neurosurg, Charlottesville, VA 22908 USA; [Huss, Diane] Univ Virginia, Hlth Sci Ctr, Dept Phys Therapy, Charlottesville, VA 22908 USA; [Voss, Tiffini; Sperling, Scott A.; Wylie, Scott; Shah, Binit B.; Harrison, Madaline] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22908 USA; [Druzgal, Jason; Wintermark, Max] Univ Virginia, Hlth Sci Ctr, Dept Neuroradiol, Charlottesville, VA 22908 USA; [Zadicario, Eyal] InSightec, Haifa, Israel	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Elias, WJ (corresponding author), Univ Virginia, Dept Neurosurg, Box 800212, Charlottesville, VA 22908 USA.	wje4r@virginia.edu		Druzgal, Jason/0000-0001-7240-9487; Wintermark, Max/0000-0002-6726-3951; Sperling, Scott/0000-0001-7454-0534	Focused Ultrasound Surgery Foundation	Focused Ultrasound Surgery Foundation	Supported by the Focused Ultrasound Surgery Foundation.	Anderson VC, 2009, NEUROSCI LETT, V462, P166, DOI 10.1016/j.neulet.2009.07.003; Aubry JF, 2003, J ACOUST SOC AM, V113, P84, DOI 10.1121/1.1529663; Clement GT, 2000, PHYS MED BIOL, V45, P1071, DOI 10.1088/0031-9155/45/4/319; Clement GT, 2002, PHYS MED BIOL, V47, P1219, DOI 10.1088/0031-9155/47/8/301; CLINE HE, 1993, MAGNET RESON MED, V30, P98, DOI 10.1002/mrm.1910300115; DEPOORTER J, 1995, MAGNET RESON MED, V33, P74, DOI 10.1002/mrm.1910330111; Diaz NL, 2010, PARKINSONISM RELAT D, V16, P604, DOI 10.1016/j.parkreldis.2010.07.011; FRY WJ, 1954, J NEUROSURG, V11, P471, DOI 10.3171/jns.1954.11.5.0471; Heroux ME, 2006, ARCH PHYS MED REHAB, V87, P661, DOI 10.1016/j.apmr.2006.01.017; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 1998, ULTRASOUND MED BIOL, V24, P275, DOI 10.1016/S0301-5629(97)00269-X; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Jeanmonod D, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.10.FOCUS11248; KOLLER W, 1986, NEUROLOGY, V36, P1001, DOI 10.1212/WNL.36.7.1001; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; Kooshkabadi A, 2013, J NEUROSURG, V118, P713, DOI 10.3171/2013.1.JNS121111; Lim SY, 2010, ARCH NEUROL-CHICAGO, V67, P584, DOI 10.1001/archneurol.2010.69; Lorenz D, 2006, MOVEMENT DISORD, V21, P1114, DOI 10.1002/mds.20884; Louis ED, 1998, MOVEMENT DISORD, V13, P5, DOI 10.1002/mds.870130105; Louis ED, 2001, MOVEMENT DISORD, V16, P914, DOI 10.1002/mds.1184; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; McDannold N, 2004, MAGN RESON MED, V51, P913, DOI 10.1002/mrm.20060; McDannold N, 2010, NEUROSURGERY, V66, P323, DOI 10.1227/01.NEU.0000360379.95800.2F; MEYERS R, 1959, J NEUROSURG, V16, P32, DOI 10.3171/jns.1959.16.1.0032; NELSON E, 1959, J NEUROPATH EXP NEUR, V18, P489, DOI 10.1097/00005072-195910000-00001; Pahwa R, 2001, MOVEMENT DISORD, V16, P140, DOI 10.1002/1531-8257(200101)16:1<140::AID-MDS1025>3.0.CO;2-T; REUBEN DB, 1990, J AM GERIATR SOC, V38, P1105, DOI 10.1111/j.1532-5415.1990.tb01373.x; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Schneier FR, 2001, J CLIN PSYCHIAT, V62, P367, DOI 10.4088/JCP.v62n0511; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Sun J, 1999, J ACOUST SOC AM, V105, P2519, DOI 10.1121/1.426863; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Troster AI, 2005, PARKINSONISM RELAT D, V11, P367, DOI 10.1016/j.parkreldis.2005.05.009; Woods SP, 2008, COGN BEHAV NEUROL, V21, P28, DOI 10.1097/WNN.0b013e3181684414; Young RF, 2010, J NEUROSURG, V112, P1311, DOI 10.3171/2009.10.JNS09332; Zesiewicz TA, 2011, NEUROLOGY, V77, P1752, DOI 10.1212/WNL.0b013e318236f0fd; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	39	462	479	9	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					640	648		10.1056/NEJMoa1300962	http://dx.doi.org/10.1056/NEJMoa1300962			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944301				2022-12-28	WOS:000326354500010
J	Kamerow, D				Kamerow, Douglas			How to decrease overtreatment in cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Brownlee S., 2007, OVERTREATED WHY TOO; Esserman L, 2013, JAMA; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Kamerow D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6544; Preventing Overdiagnosis, PREV OV C 10 12 SEPT; US Preventive Services Task Force, AHRQ PUBL, V13-05196-EF-3; 2002, BMJ, V324, P859	7	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2013	347								f5071	10.1136/bmj.f5071	http://dx.doi.org/10.1136/bmj.f5071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203YP	23945466				2022-12-28	WOS:000323331100012
J	Spiegelhalter, D				Spiegelhalter, David			Have there been 13 000 needless deaths at 14 NHS trusts?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Spiegelhalter, D (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	d.spiegelhalter@statslab.cam.ac.uk						BBC News, 2013, BBC NEWS; Donnelly L, 2013, TELEGRAPH, DOI 10340209/Cameron-extends-fund-for-cancer-drugs.html; Francis R, 2010, INDEPENDENT INQUIRY, VI; Health and Social Care Information Centre, 2013, SUMM HOSP LEV MORT I; Health and Social Care Information Centre, 2012, SUMM HOSP LEV MORT I; Keogh B., 2013, BASILDON THURROCK NH; Keogh B, 2013, REV QUALITY CARE TRE; Triggle N., 2013, BBC NEWS; Walker S., 2013, OURNHS          0724	9	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2013	347								f4893	10.1136/bmj.f4893	http://dx.doi.org/10.1136/bmj.f4893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CY	23924510				2022-12-28	WOS:000323119500013
J	Martin, J; Sanfilippo, F; Bradlow, W; Sabharwal, NK				Martin, Judy; Sanfilippo, Filippo; Bradlow, William; Sabharwal, Nikant K.			Severe vasospastic angina complicated by multiple pulseless electrical activity arrests	LANCET			English	Editorial Material							SPASM		[Martin, Judy; Sanfilippo, Filippo; Bradlow, William; Sabharwal, Nikant K.] John Radcliffe Hosp, Oxford Heart Ctr, Oxford OX3 9DU, England	University of Oxford	Sabharwal, NK (corresponding author), John Radcliffe Hosp, Dept Cardiol, Headley Way, Oxford OX3 9DU, England.	nikant.sabharwal@ouh.nhs.uk	Sanfilippo, Filippo/N-7045-2017	Sanfilippo, Filippo/0000-0001-5144-0776				Gaikwad NJ, 2010, CRIT CARE RESUSC, V12, P269; Matsue Y, 2012, J AM COLL CARDIOL, V60, P908, DOI 10.1016/j.jacc.2012.03.070; MYERBURG RJ, 1992, NEW ENGL J MED, V326, P1451, DOI 10.1056/NEJM199205283262202; Takagi Y, 2011, CIRC-ARRHYTHMIA ELEC, V4, P295, DOI 10.1161/CIRCEP.110.959809	4	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2013	382	9890					478	478		10.1016/S0140-6736(13)61096-X	http://dx.doi.org/10.1016/S0140-6736(13)61096-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MX	23911380				2022-12-28	WOS:000322638500038
J	McNutt, M				McNutt, Marcia			Climate Change Impacts	SCIENCE			English	Editorial Material														McNutt, Marcia/0000-0003-0117-7716					0	65	71	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					435	435		10.1126/science.1243256	http://dx.doi.org/10.1126/science.1243256			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	193UJ	23908191				2022-12-28	WOS:000322586700001
J	Muhich, CL; Evanko, BW; Weston, KC; Lichty, P; Liang, XH; Martinek, J; Musgrave, CB; Weimer, AW				Muhich, Christopher L.; Evanko, Brian W.; Weston, Kayla C.; Lichty, Paul; Liang, Xinhua; Martinek, Janna; Musgrave, Charles B.; Weimer, Alan W.			Efficient Generation of H-2 by Splitting Water with an Isothermal Redox Cycle	SCIENCE			English	Article							ATOMIC LAYER DEPOSITION; HYDROGEN-PRODUCTION; SOLAR HYDROGEN; 2-STEP; FERRITES; SYSTEM; CO2	Solar thermal water-splitting (STWS) cycles have long been recognized as a desirable means of generating hydrogen gas (H-2) from water and sunlight. Two-step, metal oxide-based STWS cycles generate H-2 by sequential high-temperature reduction and water reoxidation of a metal oxide. The temperature swings between reduction and oxidation steps long thought necessary for STWS have stifled STWS's overall efficiency because of thermal and time losses that occur during the frequent heating and cooling of the metal oxide. We show that these temperature swings are unnecessary and that isothermal water splitting (ITWS) at 1350 degrees C using the "hercynite cycle" exhibits H-2 production capacity >3 and >12 times that of hercynite and ceria, respectively, per mass of active material when reduced at 1350 degrees C and reoxidized at 1000 degrees C.	[Muhich, Christopher L.; Evanko, Brian W.; Weston, Kayla C.; Lichty, Paul; Liang, Xinhua; Martinek, Janna; Musgrave, Charles B.; Weimer, Alan W.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA; [Musgrave, Charles B.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Musgrave, CB (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.	charles.musgrave@colorado.edu; alan.weimer@colorado.edu	MUSGRAVE, CHARLES B/Y-2966-2018; Weimer, Alan/GOJ-7967-2022	Weimer, Alan/0000-0002-2471-349X; Muhich, Christopher/0000-0003-3089-559X	NSF [CBET 0966201]; U.S. Department of Energy Fuel Cell Technologies Office through the Solar Thermochemical Hydrogen (STCH) directive	NSF(National Science Foundation (NSF)); U.S. Department of Energy Fuel Cell Technologies Office through the Solar Thermochemical Hydrogen (STCH) directive(United States Department of Energy (DOE))	Supported by NSF grant CBET 0966201 and by the U.S. Department of Energy Fuel Cell Technologies Office through the Solar Thermochemical Hydrogen (STCH) directive. We thank V. Aston, A. Sagastegui, and C. Herradon. Data used in this study will be made freely available upon request.	Allendorf MD, 2008, ENERG FUEL, V22, P4115, DOI 10.1021/ef8005004; Arifin D, 2012, ENERG ENVIRON SCI, V5, P9438, DOI 10.1039/c2ee22090c; Barreto L, 2003, INT J HYDROGEN ENERG, V28, P267, DOI 10.1016/S0360-3199(02)00074-5; Chueh WC, 2010, SCIENCE, V330, P1797, DOI 10.1126/science.1197834; FLETCHER EA, 1977, SCIENCE, V197, P1050, DOI 10.1126/science.197.4308.1050; Fletcher EA, 2001, J SOL ENERG-T ASME, V123, P63, DOI 10.1115/1.1349552; Kodama T, 2008, SOL ENERGY, V82, P73, DOI 10.1016/j.solener.2007.03.005; Kodama T, 2005, SOL ENERGY, V78, P623, DOI 10.1016/j.solener.2004.04.008; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Liang XH, 2012, MICROPOR MESOPOR MAT, V149, P106, DOI 10.1016/j.micromeso.2011.08.025; Lichty P, 2012, INT J HYDROGEN ENERG, V37, P16888, DOI 10.1016/j.ijhydene.2012.08.004; Meredig B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245119; NAKAMURA T, 1977, SOL ENERGY, V19, P467, DOI 10.1016/0038-092X(77)90102-5; Ogden JM, 1999, ANNU REV ENERG ENV, V24, P227, DOI 10.1146/annurev.energy.24.1.227; Perkins C, 2004, INT J HYDROGEN ENERG, V29, P1587, DOI 10.1016/j.ijhydene.2004.02.019; Perkins C, 2009, AICHE J, V55, P286, DOI 10.1002/aic.11810; Scheffe JR, 2013, ENERG ENVIRON SCI, V6, P963, DOI 10.1039/c3ee23568h; Scheffe JR, 2011, CHEM MATER, V23, P2030, DOI 10.1021/cm103622e; Scheffe JR, 2010, INT J HYDROGEN ENERG, V35, P3333, DOI 10.1016/j.ijhydene.2010.01.140; Steinfeld A, 2005, SOL ENERGY, V78, P603, DOI 10.1016/j.solener.2003.12.012; Steinfeld A, 1999, SOL ENERGY, V65, P43, DOI 10.1016/S0038-092X(98)00092-9; TAMAURA Y, 1995, ENERGY, V20, P325, DOI 10.1016/0360-5442(94)00099-O; Wang Z, 2012, INT J HYDROGEN ENERG, V37, P16287, DOI 10.1016/j.ijhydene.2012.03.057	23	251	254	14	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					540	542		10.1126/science.1239454	http://dx.doi.org/10.1126/science.1239454			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908235				2022-12-28	WOS:000322586700051
J	Dua, A; Manadan, A				Dua, Anisha; Manadan, Augustine			Heerfordt's Syndrome, or Uveoparotid Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 32-year-old woman presented with a 6-week history of swelling of both parotid glands, dry eyes, and dry mouth. She reported having difficulty moving the right side of her face, and she felt tingling in the right side of her tongue. A 32-year-old woman presented with a 6-week history of swelling of both parotid glands, dry eyes, and dry mouth. She reported having difficulty moving the right side of her face, and she felt tingling in the right side of her tongue. Physical examination revealed enlargement of both parotid glands, which were firm and nontender, submandibular enlargement, and enlargement of lacrimal glands (Panel A). She did not have a fever, and there was no uveitis. She could not completely close her right eye, was unable to purse her lips, and was unable to smile on the right side of her face. ...	[Dua, Anisha] West Penn Allegheny Hlth Syst, Pittsburgh, PA USA; [Manadan, Augustine] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Dua, A (corresponding author), West Penn Allegheny Hlth Syst, Pittsburgh, PA USA.			Manadan, Augustine/0000-0001-6200-5139					0	14	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					458	458		10.1056/NEJMicm1303454	http://dx.doi.org/10.1056/NEJMicm1303454			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902485				2022-12-28	WOS:000322547400012
J	Klitzman, R; Appelbaum, PS; Chung, W				Klitzman, Robert; Appelbaum, Paul S.; Chung, Wendy			Return of Secondary Genomic Findings vs Patient Autonomy Implications for Medical Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Klitzman, Robert] Columbia Univ, Masters Bioeth Program, New York, NY 10032 USA; [Klitzman, Robert; Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY 10032 USA; [Chung, Wendy] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Chung, Wendy] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Klitzman, R (corresponding author), Columbia Univ, Div Psychiat Law & Eth, 1051 Riverside Dr,Unit 15, New York, NY 10032 USA.	rlk2@columbia.edu	Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042	NHGRI NIH HHS [P20 HG005535, R01 HG006600, P50 HG007257, P20 HG005535-02, R21 HG006596] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007257, R01HG006600, P20HG005535, R21HG006596] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Green R, 2013, ACMG RECOMMENDATIONS; Green R. C., ACMG RECOMMENDATIONS; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119	7	62	63	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					369	370		10.1001/jama.2013.41709	http://dx.doi.org/10.1001/jama.2013.41709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917282	Green Accepted			2022-12-28	WOS:000322121500009
J	Simon, NM				Simon, Naomi M.			Treating Complicated Grief	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BEREAVEMENT-RELATED DEPRESSION; DUAL PROCESS MODEL; QUALITY-OF-LIFE; DIAGNOSTIC-CRITERIA; TRAUMATIC GRIEF; POST-LOSS; PREVALENCE; SYMPTOMS; NORTRIPTYLINE; DISORDER	IMPORTANCE The death of a loved one is one of life's greatest, universal stressors to which most bereaved individuals successfully adapt without clinical intervention. For a minority of bereaved individuals, grief is complicated by superimposed problems and healing does not occur. The resulting syndrome of complicated grief causes substantial distress and functional impairment even years after a loss, yet knowing when and how to intervene can be a challenge. OBJECTIVE To discuss the differential diagnosis, risk factors for and management of complicated grief based on available evidence and clinical observations. EVIDENCE REVIEW MEDLINE was searched from January 1990 to October 2012. Additional citations were procured from references of select research and review articles. Available treatment studies targeting complicated grief were included. RESULTS A strong research literature led to inclusion of complicated grief in the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (termed persistent complex bereavement disorder as a subtype of other specified trauma and stressor-related disorders), although it is a condition for which more research is formally recommended, and there is still ongoing discussion about the optimal name and diagnostic criteria for the disorder. Reliable screening instruments are available, and the estimated prevalence rate is 7% of bereaved people. Randomized controlled data support the efficacy of a targeted psychotherapy including elements that foster resolution of complicating problems and facilitate the natural healing process. Preliminary studies suggest antidepressant medications may be helpful. CONCLUSION AND RELEVANCE Individuals with complicated grief have greater risk of adverse health outcomes, should be diagnosed and assessed for suicide risk and comorbid conditions such as depression and posttraumatic stress disorder, and should be considered for treatment.	[Simon, Naomi M.] Massachusetts Gen Hosp, Ctr Anxiety & Traumat Stress Disorders, Boston, MA 02114 USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Dept Psychiat, Complicated Grief Program, Boston, MA 02114 USA; [Simon, Naomi M.] Red Sox Fdn MGH Home Base Program, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Simon, NM (corresponding author), Massachusetts Gen Hosp, Ctr Anxiety & Traumat Stress Disorders, 1 Bowdoin Sq,6th Floor, Boston, MA 02114 USA.	nsimon@partners.org			National Institute for Mental Health [5R01MH085308]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085308] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Clinical Crossroads receives no external support. Dr Simon's work was supported in part by grant 5R01MH085308 from the National Institute for Mental Health.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ayers T, 2004, DEATH STUD, V28, P491, DOI 10.1080/07481180490461188; Ben Barnes J, 2012, J AFFECT DISORDERS, V136, P366, DOI 10.1016/j.jad.2011.11.022; Boelen PA, 2008, PSYCHIAT RES, V157, P311, DOI 10.1016/j.psychres.2007.05.013; Boelen PA, 2007, EUR ARCH PSY CLIN N, V257, P444, DOI 10.1007/s00406-007-0744-0; Boelen PA, 2007, J CONSULT CLIN PSYCH, V75, P277, DOI 10.1037/0022-006X.75.2.277; Boelen PA, 2012, J NERV MENT DIS, V200, P362, DOI 10.1097/NMD.0b013e31824cc60e; Bonanno GA, 2002, J PERS SOC PSYCHOL, V83, P1150, DOI 10.1037//0022-3514.83.5.1150; Bonanno GA, 2004, PSYCHOL AGING, V19, P260, DOI 10.1037/0882-7974.19.2.260; Bowlby J., 1980, ATTACHMENT LOSS, VIII; Bui E, 2013, DEPRESS ANXIETY, V30, P123, DOI 10.1002/da.22029; Bui Eric, 2012, Dialogues Clin Neurosci, V14, P149; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; Dyregrov K, 2003, DEATH STUD, V27, P143, DOI 10.1080/07481180302892; Fujisawa D, 2010, J AFFECT DISORDERS, V127, P352, DOI 10.1016/j.jad.2010.06.008; Galatzer-Levy IR, 2012, SOC SCI MED, V74, P1987, DOI 10.1016/j.socscimed.2012.02.022; Germain A, 2005, J TRAUMA STRESS, V18, P343, DOI 10.1002/jts.20035; Golden AMJ, 2010, PSYCHIAT RES, V178, P336, DOI 10.1016/j.psychres.2009.08.021; Gupta S, 2011, J ABNORM PSYCHOL, V120, P635, DOI 10.1037/a0023541; Hargrave PA, 2012, J TRAUMA STRESS, V25, P344, DOI 10.1002/jts.21703; Hensley PL, 2009, J AFFECT DISORDERS, V113, P142, DOI 10.1016/j.jad.2008.05.016; HOFER MA, 1984, PSYCHOSOM MED, V46, P183, DOI 10.1097/00006842-198405000-00001; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; Horowitz MJ, 1997, AM J PSYCHIAT, V154, P904; Hoyert DL, 2012, DEATHS PRELIMINARY D; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031209; Kersting A, 2011, J AFFECT DISORDERS, V131, P339, DOI 10.1016/j.jad.2010.11.032; Langner R, 2005, J PSYCHOSOM RES, V58, P235, DOI 10.1016/j.jpsychores.2004.09.012; Latham AE, 2004, SUICIDE LIFE-THREAT, V34, P350, DOI 10.1521/suli.34.4.350.53737; Maccallum F, 2011, DEPRESS ANXIETY, V28, P658, DOI 10.1002/da.20866; Maccallum F, 2011, J BEHAV THER EXP PSY, V42, P26, DOI 10.1016/j.jbtep.2010.08.006; Maciejewski PK, 2007, JAMA-J AM MED ASSOC, V297, P716, DOI 10.1001/jama.297.7.716; Mancini AD, 2012, CURR OPIN PSYCHIATR, V25, P46, DOI 10.1097/YCO.0b013e32834de48a; Mancini AD, 2009, J CLIN PSYCHOL, V65, P1127, DOI 10.1002/jclp.20601; Meert KL, 2011, J PALLIAT MED, V14, P207, DOI 10.1089/jpm.2010.0291; Mutabaruka J, 2012, STRESS HEALTH, V28, P289, DOI 10.1002/smi.1429; Neria Y, 2007, J TRAUMA STRESS, V20, P251, DOI 10.1002/jts.20223; Newson RS, 2011, J AFFECT DISORDERS, V132, P231, DOI 10.1016/j.jad.2011.02.021; PASTERNAK RE, 1991, J CLIN PSYCHIAT, V52, P307; Prigerson H, 2002, DEATH STUD, V26, P781, DOI 10.1080/07481180290106571; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Reynolds CF, 1999, AM J PSYCHIAT, V156, P202; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Shear K, 2007, EUR ARCH PSY CLIN N, V257, P453, DOI 10.1007/s00406-007-0745-z; Shear KM, 2006, PSYCHIAT SERV, V57, P1291, DOI 10.1176/appi.ps.57.9.1291; Shear MK, 2012, DEPRESS ANXIETY, V29, P461, DOI 10.1002/da.21963; Shear MK, 2011, DEPRESS ANXIETY, V28, P103, DOI 10.1002/da.20780; Shear MK, 2006, 46 ANN M NEW CLIN DR; Silverman GK, 2000, PSYCHOL MED, V30, P857, DOI 10.1017/S0033291799002524; Simon NM, 2008, PSYCHIAT RES, V159, P31, DOI 10.1016/j.psychres.2007.05.011; Simon NM, 2007, AM J PSYCHIAT, V164, P1760, DOI 10.1176/appi.ajp.2007.07050800; Simon NM, 2007, COMPR PSYCHIAT, V48, P395, DOI 10.1016/j.comppsych.2007.05.002; Simon NM, 2011, DEPRESS ANXIETY, V28, P118, DOI 10.1002/da.20775; Simon NM, 2012, DEPRESS ANXIETY, V29, P541, DOI 10.1002/da.21979; Simon NM, 2005, J CLIN PSYCHIAT, V66, P1105, DOI 10.4088/JCP.v66n0903; Stammel N, 2013, J AFFECT DISORDERS, V144, P87, DOI 10.1016/j.jad.2012.05.063; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Stroebe M, 2010, OMEGA-J DEATH DYING, V61, P273, DOI 10.2190/OM.61.4.b; Tal Young Ilanit, 2012, Dialogues Clin Neurosci, V14, P177; Wagner B, 2006, DEATH STUD, V30, P429, DOI 10.1080/07481180600614385; WEISSMAN MM, 2000, COMPREHENSIVE GUIDE; Wittouck C, 2011, CLIN PSYCHOL REV, V31, P69, DOI 10.1016/j.cpr.2010.09.005; Zisook S, 2010, J CLIN PSYCHIAT, V71, P1097, DOI 10.4088/JCP.10ac06391blu; Zygmont M, 1998, J CLIN PSYCHIAT, V59, P241, DOI 10.4088/JCP.v59n0507	66	96	98	9	88	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					416	423		10.1001/jama.2013.8614	http://dx.doi.org/10.1001/jama.2013.8614			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187LV	23917292	Green Accepted			2022-12-28	WOS:000322121500019
J	Ptashne, M				Ptashne, Mark			Francois Jacob (1920-2013)	CELL			English	Biographical-Item									Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Ptashne, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	m-ptashne@mskcc.org						JACOB F, PUBLICATION LIST	1	5	6	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1180	1182		10.1016/j.cell.2013.05.025	http://dx.doi.org/10.1016/j.cell.2013.05.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23901416	Bronze			2022-12-28	WOS:000319979200001
J	Bishop, N; Adami, S; Ahmed, SF; Anton, J; Arundel, P; Burren, CP; Devogelaer, JP; Hangartner, T; Hosszu, E; Lane, JM; Lorenc, R; Makitie, O; Munns, CF; Paredes, A; Pavlov, H; Plotkin, H; Raggio, CL; Reyes, ML; Schoenau, E; Semler, O; Sillence, DO; Steiner, RD				Bishop, Nick; Adami, Silvano; Ahmed, S. Faisal; Anton, Jordi; Arundel, Paul; Burren, Christine P.; Devogelaer, Jean-Pierre; Hangartner, Thomas; Eva Hosszu; Lane, Joseph M.; Lorenc, Roman; Makitie, Outi; Munns, Craig F.; Paredes, Ana; Pavlov, Helene; Plotkin, Horacio; Raggio, Cathleen L.; Loreto Reyes, Maria; Schoenau, Eckhard; Semler, Oliver; Sillence, David O.; Steiner, Robert D.			Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							INTRAVENOUS PAMIDRONATE TREATMENT; BISPHOSPHONATE; INFANTS	Background Children with osteogenesis imperfecta are often treated with intravenous bisphosphonates. We aimed to assess the safety and efficacy of risedronate, an orally administered third-generation bisphosphonate, in children with the disease. Methods In this multicentre, randomised, parallel, double-blind, placebo-controlled trial, children aged 4-15 years with osteogenesis imperfecta and increased fracture risk were randomly assigned by telephone randomisation system in a 2: 1 ratio to receive either daily risedronate (2.5 or 5 mg) or placebo for 1 year. Study treatment was masked from patients, investigators, and study centre personnel. Thereafter, all children received risedronate for 2 additional years in an open-label extension. The primary efficacy endpoint was percentage change in lumbar spine areal bone mineral density (BMD) at 1 year. The primary efficacy analysis was done by ANCOVA, with treatment, age group, and pooled centre as fixed effects, and baseline as covariate. Analyses were based on the intention-to-treat population, which included all patients who were randomly assigned and took at least one dose of assigned study treatment. The trial is registered with ClinicalTrials.gov, number NCT00106028. Findings Of 147 patients, 97 were randomly assigned to the risedronate group and 50 to the placebo group. Three patients from the risedronate group and one from the placebo group did not receive study treatment, leaving 94 and 49 in the intention-to-treat population, respectively. The mean increase in lumbar spine areal BMD after 1 year was 16.3% in the risedronate group and 7.6% in the placebo group (difference 8.7%, 95% CI 5.7-11.7; p<0.0001). After 1 year, clinical fractures had occurred in 29 (31%) of 94 patients in the risedronate group and 24 (49%) of 49 patients in the placebo group (p=0.0446). During years 2 and 3 (open-label phase), clinical fractures were reported in 46 (53%) of 87 patients in the group that had received risedronate since the start of the study, and 32 (65%) of 49 patients in the group that had been given placebo during the first year. Adverse event profiles were otherwise similar between the two groups, including frequencies of reported upper-gastrointestinal and selected musculoskeletal adverse events. Interpretation Oral risedronate increased areal BMD and reduced the risk of first and recurrent clinical fractures in children with osteogenesis imperfecta, and the drug was generally well tolerated. Risedronate should be regarded as a treatment option for children with osteogenesis imperfecta.	[Bishop, Nick; Arundel, Paul] Univ Sheffield, Dept Human Metab, Acad Unit Child Hlth, Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; [Adami, Silvano] Univ Verona, Rheumatol Rehabil Unit, I-37100 Verona, Italy; [Ahmed, S. Faisal] Univ Glasgow, Royal Hosp Sick Children, Glasgow, Lanark, Scotland; [Anton, Jordi] Univ Barcelona, Dept Paediat, Paediat Rheumatol Unit, Hosp St Joan de Deu, Barcelona, Spain; [Burren, Christine P.] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Dept Paediat Endocrinol & Diabet, Bristol, Avon, England; [Devogelaer, Jean-Pierre] Catholic Univ Louvain, SaintLuc Univ Hosp, B-1200 Brussels, Belgium; [Hangartner, Thomas] Wright State Univ, Biomed Imaging Lab, Dayton, OH 45435 USA; [Eva Hosszu] Semmelweis Univ, Endocrine Ward, Dept Paediat 2, H-1085 Budapest, Hungary; [Lane, Joseph M.] Hosp Special Surg, Dept Orthoped & Trauma, New York, NY 10021 USA; [Pavlov, Helene] Hosp Special Surg, Dept Radiol & Imaging, New York, NY 10021 USA; [Raggio, Cathleen L.] Hosp Special Surg, Dept Pediat Orthoped, New York, NY 10021 USA; [Lorenc, Roman] Childrens Mem Hlth Inst, Dept Biochem Radioimmunol & Expt Med, Warsaw, Poland; [Makitie, Outi] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Makitie, Outi] Univ Helsinki, Helsinki, Finland; [Munns, Craig F.] Sydney Childrens Hosp Network, Westmead, NSW, Australia; [Sillence, David O.] Sydney Childrens Hosp Network, Connect Tissue Dysplasia Serv, Westmead, NSW, Australia; [Paredes, Ana] Miami Childrens Hosp, Herbert Wertheim Coll Med, Miami, FL USA; [Plotkin, Horacio] Univ Nebraska, Med Ctr, Childrens Hosp, Omaha, NE USA; [Loreto Reyes, Maria] Pontificia Univ Catolica Chile, Santiago, Chile; [Schoenau, Eckhard; Semler, Oliver] Univ Cologne, Childrens Hosp, D-50931 Cologne, Germany; [Steiner, Robert D.] Marshfield Clin Res Fdn, Marshfield, WI USA	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Verona; University of Glasgow; University of Barcelona; Bristol Royal Hospital For Children; University of Bristol; Universite Catholique Louvain; University System of Ohio; Wright State University Dayton; Semmelweis University; Children's Memorial Health Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Nebraska System; University of Nebraska Medical Center; Pontificia Universidad Catolica de Chile; University of Cologne	Bishop, N (corresponding author), Univ Sheffield, Dept Human Metab, Acad Unit Child Hlth, Sheffield Childrens Hosp, Sheffield, S Yorkshire, England.		Burren, Christine/AAE-5845-2019; Rauch, Frank/D-1554-2009; Munns, Craig F/A-8719-2015; Anton, Jordi/A-9848-2017; Steiner, Robert D./AAJ-5756-2020; Hangartner, Thomas/AAG-4479-2020	Burren, Christine/0000-0002-3778-2945; Munns, Craig F/0000-0001-5898-5808; Anton, Jordi/0000-0002-8792-4219; Steiner, Robert D./0000-0003-4177-4590; Makitie, Outi/0000-0002-4547-001X; Semler, Oliver/0000-0003-0029-7556	Alliance for Better Bone Health (Warner Chilcott); Alliance for Better Bone Health (Sanofi)	Alliance for Better Bone Health (Warner Chilcott); Alliance for Better Bone Health (Sanofi)	Alliance for Better Bone Health (Warner Chilcott and Sanofi).	ANDERSEN PE, 1989, CLIN GENET, V36, P250; Arundel P, 2010, TOP BONE BIOL, V6, P215, DOI 10.1007/978-1-84882-822-3_13; Astrom E, 1998, ACTA PAEDIATR, V87, P64; Astrom E, 2007, ARCH DIS CHILD, V92, P332, DOI 10.1136/adc.2006.096552; Bembi B, 1997, J PEDIATR-US, V131, P622, DOI 10.1016/S0022-3476(97)70074-X; Bishop N, 2010, EARLY HUM DEV, V86, P743, DOI 10.1016/j.earlhumdev.2010.08.002; Bishop N, 2010, J BONE MINER RES, V25, P32, DOI 10.1359/jbmr.090712; Bishop N, 2009, ENDOCR DEV, V16, P157, DOI 10.1159/000223694; Bradbury LA, 2012, OSTEOPOROSIS INT, V23, P285, DOI 10.1007/s00198-011-1658-2; DiMeglio LA, 2004, BONE, V35, P1038, DOI 10.1016/j.bone.2004.07.003; Favus MJ, 2010, NEW ENGL J MED, V363, P2027, DOI 10.1056/NEJMct1004903; Gatti D, 2005, J BONE MINER RES, V20, P758, DOI 10.1359/JBMR.041232; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Glorieux FH, 2000, J PEDIATR ENDOCR MET, V13, P989; Greulich WW., 1959, CALIF MED, V91, P53; Jahn-Eirriermacher A, 2008, COMPUT STAT DATA AN, V52, P4989, DOI 10.1016/j.csda.2008.04.009; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kuurila K, 2000, EUR J PEDIATR, V159, P515, DOI 10.1007/s004310051322; Land C, 2006, BONE, V39, P901, DOI 10.1016/j.bone.2006.04.004; Letocha AD, 2005, J BONE MINER RES, V20, P977, DOI 10.1359/JBMR.050109; Phillipi CA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005088.pub2; Plotkin H, 2000, J CLIN ENDOCR METAB, V85, P1846, DOI 10.1210/jc.85.5.1846; Rauch F, 2009, J BONE MINER RES, V24, P1282, DOI [10.1359/JBMR.090213, 10.1359/jbmr.090213]; Sakkers R, 2004, LANCET, V363, P1427, DOI 10.1016/S0140-6736(04)16101-1; Seikaly MG, 2005, J PEDIATR ORTHOPED, V25, P786, DOI 10.1097/01.bpo.0000176162.78980.ed; Senthilnathan S, 2008, ARCH DIS CHILD, V93, P398, DOI 10.1136/adc.2007.125468; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Ward LM, 2011, J CLIN ENDOCR METAB, V96, P355, DOI 10.1210/jc.2010-0636	29	119	131	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 26	2013	382	9902					1424	1432		10.1016/S0140-6736(13)61091-0	http://dx.doi.org/10.1016/S0140-6736(13)61091-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242JW	23927913				2022-12-28	WOS:000326237500027
J	Richard, M; Schrauwen, EJA; de Graaf, M; Bestebroer, TM; Spronken, MIJ; van Boheemen, S; de Meulder, D; Lexmond, P; Linster, M; Herfst, S; Smith, DJ; van den Brand, JM; Burke, DF; Kuiken, T; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM				Richard, Mathilde; Schrauwen, Eefje J. A.; de Graaf, Miranda; Bestebroer, Theo M.; Spronken, Monique I. J.; van Boheemen, Sander; de Meulder, Dennis; Lexmond, Pascal; Linster, Martin; Herfst, Sander; Smith, Derek J.; van den Brand, Judith M.; Burke, David F.; Kuiken, Thijs; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.			Limited airborne transmission of H7N9 influenza A virus between ferrets	NATURE			English	Article							SINGLE AMINO-ACID; HUMAN INFECTIONS; POULTRY; ORIGIN; HEMAGGLUTININ; REPLICATION; ADAPTATION; GENERATION; DIVERSITY	Wild waterfowl form the main reservoir of influenza A viruses, from which transmission occurs directly or indirectly to various secondary hosts, including humans(1). Direct avian-to-human transmission has been observed for viruses of subtypes A(H5N1), A(H7N2), A(H7N3), A(H7N7), A(H9N2) and A(H10N7) upon human exposure to poultry(2-7), but a lack of sustained human-to-human transmission has prevented these viruses from causing new pandemics. Recently, avian A(H7N9) viruses were transmitted to humans, causing severe respiratory disease and deaths in China(8). Because transmission via respiratory droplets and aerosols (hereafter referred to as airborne transmission) is the main route for efficient transmission between humans, it is important to gain an insight into airborne transmission of the A(H7N9) virus. Here we show that although the A/Anhui/1/2013 A(H7N9) virus harbours determinants associated with human adaptation and transmissibility between mammals, its airborne transmissibility in ferrets is limited, and it is intermediate between that of typical human and avian influenza viruses. Multiple A(H7N9) virus genetic variants were transmitted. Upon ferret passage, variants with higher avian receptor binding, higher pH of fusion, and lower thermostability were selected, potentially resulting in reduced transmissibility. This A(H7N9) virus outbreak highlights the need for increased understanding of the determinants of efficient airborne transmission of avian influenza viruses between mammals.	[Richard, Mathilde; Schrauwen, Eefje J. A.; de Graaf, Miranda; Bestebroer, Theo M.; Spronken, Monique I. J.; van Boheemen, Sander; de Meulder, Dennis; Lexmond, Pascal; Linster, Martin; Herfst, Sander; van den Brand, Judith M.; Kuiken, Thijs; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Smith, Derek J.; Burke, David F.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014; de Graaf, Miranda/K-1262-2018; Linster, Martin/AAY-9088-2020; de Graaf, Miranda/AFM-6878-2022; Burke, David F/C-2091-2013; Richard, Mathilde/F-5461-2017	Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; de Graaf, Miranda/0000-0002-7831-0098; de Graaf, Miranda/0000-0002-7831-0098; Burke, David F/0000-0001-8830-3951; Richard, Mathilde/0000-0003-0240-9312; Kuiken, Thijs/0000-0001-5501-9049; Linster, Martin/0000-0003-2636-2512; Osterhaus, Albert/0000-0002-6074-1172; Herfst, Sander/0000-0001-9866-8903	NIAID-NIH [HHSN266200700010C]; EU program EMPERIE; EU program ANTIGONE	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EU program EMPERIE; EU program ANTIGONE	We thank P. van Run, S. van der Vliet and A. Reiners for technical assistance. We thank the Chinese CDC for providing the A/Anhui/1/2013 isolate and R. Webby for the synthetic construct of HA. This work was financed through NIAID-NIH contract HHSN266200700010C and EU FP7 programs EMPERIE and ANTIGONE.	[Anonymous], 2013, HUM INF INFL A H7N9; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; CALLEJA M, 2004, P UK E SCI ALL HANDS; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nishiura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055358; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; REED L. J., 1938, AMER JOUR HYG, V27, P493; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smith RE, 2007, BIOINFORMATICS, V23, P1099, DOI 10.1093/bioinformatics/btm073; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; van Riel D, 2010, AM J PATHOL, V177, P2185, DOI 10.2353/ajpath.2010.100401; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, AV INFL A H7N9 VIR; Wu H, 2013, N ENGL J MED; Xiong X., 2013, NATURE; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	37	156	165	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					560	+		10.1038/nature12476	http://dx.doi.org/10.1038/nature12476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23925116	Green Submitted, Green Accepted			2022-12-28	WOS:000324826300061
J	Dorr, JR; Yu, Y; Milanovic, M; Beuster, G; Zasada, C; Dabritz, JHM; Lisec, J; Lenze, D; Gerhardt, A; Schleicher, K; Kratzat, S; Purfurst, B; Walenta, S; Mueller-Klieser, W; Graler, M; Hummel, M; Keller, U; Buck, AK; Dorken, B; Willmitzer, L; Reimann, M; Kempa, S; Lee, S; Schmitt, CA				Doerr, Jan R.; Yu, Yong; Milanovic, Maja; Beuster, Gregor; Zasada, Christin; Daebritz, J. Henry M.; Lisec, Jan; Lenze, Dido; Gerhardt, Anne; Schleicher, Katharina; Kratzat, Susanne; Purfuerst, Bettina; Walenta, Stefan; Mueller-Klieser, Wolfgang; Graeler, Markus; Hummel, Michael; Keller, Ulrich; Buck, Andreas K.; Doerken, Bernd; Willmitzer, Lothar; Reimann, Maurice; Kempa, Stefan; Lee, Soyoung; Schmitt, Clemens A.			Synthetic lethal metabolic targeting of cellular senescence in cancer therapy	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; P53 TUMOR-SUPPRESSOR; NF-KAPPA-B; IN-VIVO; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; HUMAN-CELLS; AUTOPHAGY; HETEROCHROMATIN; LYMPHOMAGENESIS	Activated oncogenes and anticancer chemotherapy induce cellular senescence, a terminal growth arrest of viable cells characterized by S-phase entry-blocking histone 3 lysine 9 trimethylation (H3K9me3)(1,2). Although therapy-induced senescence (TIS) improves long-term outcomes(3), potentially harmful properties of senescent tumour cells make their quantitative elimination a therapeutic priority. Here we use the Em-myc transgenic mouse lymphoma model in which TIS depends on the H3K9 histone methyltransferase Suv39h1 to show the mechanism and therapeutic exploitation of senescence-related metabolic reprogramming in vitro and in vivo. After senescence-inducing chemotherapy, TIS-competent lymphomas but not TIS-incompetent Suv39h1(-) lymphomas show increased glucose utilization and much higher ATP production. We demonstrate that this is linked to massive proteotoxic stress, which is a consequence of the senescence-associated secretory phenotype (SASP) described previously(4-6). SASP-producing TIS cells exhibited endoplasmic reticulum stress, an unfolded protein response (UPR), and increased ubiquitination, thereby targeting toxic proteins for autophagy in an acutely energy-consuming fashion. Accordingly, TIS lymphomas, unlike senescence models that lack a strong SASP response, were more sensitive to blocking glucose utilization or autophagy, which led to their selective elimination through caspase-12-and caspase-3-mediated endoplasmic-reticulum-related apoptosis. Consequently, pharmacological targeting of these metabolic demands on TIS induction in vivo prompted tumour regression and improved treatment outcomes further. These findings unveil the hypercatabolic nature of TIS that is therapeutically exploitable by synthetic lethal metabolic targeting.	[Doerr, Jan R.; Milanovic, Maja; Daebritz, J. Henry M.; Lisec, Jan; Gerhardt, Anne; Schleicher, Katharina; Doerken, Bernd; Reimann, Maurice; Lee, Soyoung; Schmitt, Clemens A.] Charite, Mol Krebsforschungszentrum MKFZ, D-13353 Berlin, Germany; [Yu, Yong; Beuster, Gregor; Purfuerst, Bettina; Doerken, Bernd; Lee, Soyoung; Schmitt, Clemens A.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Zasada, Christin; Kempa, Stefan] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany; [Lisec, Jan] Deutsch Krebsforschungzentrum DKFZ, German Canc Consortium, D-69120 Heidelberg, Germany; [Lenze, Dido; Hummel, Michael] Charite, Dept Pathol, D-10117 Berlin, Germany; [Kratzat, Susanne; Keller, Ulrich] Tech Univ Munich, Dept Med 3, D-81675 Munich, Germany; [Walenta, Stefan; Mueller-Klieser, Wolfgang] Johannes Gutenberg Univ Mainz, Univ Med, Inst Physiol & Pathophysiol, D-55128 Mainz, Germany; [Graeler, Markus] Univ Klinikum Jena, Dept Anesthesiol & Intens Care Med, D-07747 Jena, Germany; [Graeler, Markus] Univ Klinikum Jena, Ctr Sepsis Control & Care CSCC, D-07747 Jena, Germany; [Buck, Andreas K.] Univ Klinikum Wurzburg, Dept Nucl Med, D-97080 Wurzburg, Germany; [Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Johannes Gutenberg University of Mainz; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Wurzburg; Max Planck Society	Schmitt, CA (corresponding author), Charite, Mol Krebsforschungszentrum MKFZ, Augustenburger Pl 1, D-13353 Berlin, Germany.	clemens.schmitt@charite.de	kempa, stefan/C-5213-2008; Lee, Soyoung/AHC-5032-2022; Gräler, Markus/ABH-1905-2021; Lee, Soyoung/T-6669-2019; 高, 雨莉/HGU-8187-2022; Schmitt, Clemens A/S-9479-2017	kempa, stefan/0000-0002-0696-9299; Lee, Soyoung/0000-0002-4614-2931; Gräler, Markus/0000-0001-6650-7849; Schmitt, Clemens A/0000-0002-4731-2226; Zasada, Christin/0000-0003-1547-8317; Dabritz, Jan Henry Matthias/0000-0002-7184-9656; Schleicher, Katharina/0000-0002-8819-7287; Hummel, Michael/0000-0001-6717-605X; Milanovic, Maja/0000-0003-1860-6003; Buck, Andreas/0000-0002-6447-0613; Lisec, Jan/0000-0003-1220-2286; Yu, Yong/0000-0003-1928-2514; Dorr, Jan Rafael/0000-0002-4927-6548	Boehringer Ingelheim Foundation; Deutsche Forschungsgemeinschaft [MK576/15-1, SFB 824, SFB/TRR 54]; Helmholtz Association (Helmholtz Alliance 'Preclinical Comprehensive Cancer Center') [HA-305]; Deutsche Krebshilfe [108789]; Excellence Initiative; German Cancer Consortium (GCC)	Boehringer Ingelheim Foundation(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association (Helmholtz Alliance 'Preclinical Comprehensive Cancer Center'); Deutsche Krebshilfe(Deutsche Krebshilfe); Excellence Initiative; German Cancer Consortium (GCC)	We thank the late A. Harris, T. Jacks, T. Jenuwein, P. A. Khavari, N. Mizushima, D. Peeper, and M. Vander Heiden for mice, cells and materials; the flow cytometry facility at the Berlin-Brandenburg Center for Regenerative Therapies; N. Burbach, J. Drager, A. Herrmann, K. Kirste, S. Masswig, B. Teichmann and S. Spiesicke-Wegener for technical assistance; and members of the Schmitt laboratory for discussions and editorial advice. This work was supported by a Ph.D. fellowship to J. R. D. from the Boehringer Ingelheim Foundation, and grants from the Deutsche Forschungsgemeinschaft to W.M.-K. (MK576/15-1), to U. K. and A. K. B. (SFB 824), to U. K., B. D., S. L. and C. A. S. (SFB/TRR 54), and to C. A. S. from the Helmholtz Association (Helmholtz Alliance 'Preclinical Comprehensive Cancer Center'; grant no. HA-305) and the Deutsche Krebshilfe (grant no. 108789). This interdisciplinary work was made possible by the structural framework of the inter-institutional cooperation between Charite and MDC (now represented by the Berlin Institute of Health (BIH)), the Berlin School of Integrative Oncology (BSIO) graduate program funded within the Excellence Initiative, and the German Cancer Consortium (GCC).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bode Constantin, 2012, Methods Mol Biol, V874, P33, DOI 10.1007/978-1-61779-800-9_3; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Giavalisco P, 2008, ANAL CHEM, V80, P9417, DOI 10.1021/ac8014627; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kempa S, 2009, J BASIC MICROB, V49, P82, DOI 10.1002/jobm.200800337; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lisec J, 2011, PLANT J, V68, P326, DOI 10.1111/j.1365-313X.2011.04689.x; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moskowitz CH, 2010, J CLIN ONCOL, V28, P1896, DOI 10.1200/JCO.2009.26.5942; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Reimer TA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-47; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Walenta S, 2000, CANCER RES, V60, P916; Warburg O., 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	46	333	353	4	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					421	+		10.1038/nature12437	http://dx.doi.org/10.1038/nature12437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23945590				2022-12-28	WOS:000324545700046
J	Humphrey, LL; Deffebach, M; Pappas, M; Baumann, C; Artis, K; Mitchell, JP; Zakher, B; Fu, RW; Slatore, CG				Humphrey, Linda L.; Deffebach, Mark; Pappas, Miranda; Baumann, Christina; Artis, Kathryn; Mitchell, Jennifer Priest; Zakher, Bernadette; Fu, Rongwei; Slatore, Christopher G.			Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U. S. Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							SMOKING-CESSATION; FOLLOW-UP; SPIRAL CT; RANDOMIZED FEASIBILITY; CUMULATIVE INCIDENCE; CHEST RADIOGRAPH; ITALUNG TRIAL; RISK; CELL; SURVIVAL	Background: Lung cancer is the leading cause of cancer-related death in the United States. Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection and treatment may be beneficial. Purpose: To update the 2004 review of screening for lung cancer for the U.S. Preventive Services Task Force, focusing on screening with low-dose computed tomography (LDCT). Data Sources: MEDLINE (2000 to 31 May 2013), the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the fourth quarter of 2012), Scopus, and reference lists. Study Selection: English-language randomized, controlled trials or cohort studies that evaluated LDCT screening for lung cancer. Data Extraction: One reviewer extracted study data about participants, design, analysis, follow-up, and results, and a second reviewer checked extractions. Two reviewers rated study quality using established criteria. Data Synthesis: Four trials reported results of LDCT screening among patients with smoking exposure. One large good-quality trial reported that screening was associated with significant reductions in lung cancer (20%) and all-cause (6.7%) mortality. Three small European trials showed no benefit of screening. Harms included radiation exposure, overdiagnosis, and a high rate of falsepositive findings that typically were resolved with further imaging. Smoking cessation was not affected. Incidental findings were common. Limitations: Three trials were underpowered and of insufficient duration to evaluate screening effectiveness. Overdiagnosis, an important harm of screening, is of uncertain magnitude. No studies reported results in women or minority populations. Conclusion: Strong evidence shows that LDCT screening can reduce lung cancer and all-cause mortality. The harms associated with screening must be balanced with the benefits.	Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA; Portland VA Med Ctr, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Humphrey, LL (corresponding author), Oregon Hlth & Sci Univ, Mailcode BICC, Pacific Northwest Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	linda.humphrey@va.gov		Slatore, Christopher/0000-0003-0958-8122	AHRQ [HHSA-290-2007-10057-IEPC3]; Portland Veterans Affairs Medical Center; Veterans Affairs Health Services Research and Development Career Development Award	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Portland Veterans Affairs Medical Center; Veterans Affairs Health Services Research and Development Career Development Award(US Department of Veterans Affairs)	By AHRQ under contract HHSA-290-2007-10057-IEPC3, task order 13, and the Portland Veterans Affairs Medical Center. Drs. Humphrey, Deffebach, and Slatore are supported by resources from the Portland Veterans Affairs Medical Center. Dr. Slatore is sponsored by a Veterans Affairs Health Services Research and Development Career Development Award.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Aggestrup LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000663; American Cancer Society, 2013, CANC FACTS FIG 2013; American Cancer Society, 2010, CANC FACTS FIG 2010; Anderson CM, 2009, CANCER EPIDEM BIOMAR, V18, P3476, DOI 10.1158/1055-9965.EPI-09-0176; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Ashraf H, 2009, THORAX, V64, P388, DOI 10.1136/thx.2008.102475; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Becker N, 2012, J CANCER RES CLIN, V138, P1475, DOI 10.1007/s00432-012-1228-9; Berg AO, 2004, ANN INTERN MED, V140, P738, DOI 10.7326/0003-4819-140-9-200405040-00014; Burns DM, 2000, CANCER, V89, P2506, DOI 10.1002/1097-0142(20001201)89:11+<2506::AID-CNCR33>3.3.CO;2-#; Byrne MM, 2008, MED DECIS MAKING, V28, P917, DOI 10.1177/0272989X08322013; CHAN CK, 1989, CHEST, V96, P291, DOI 10.1378/chest.96.2.291; Chang MY, 2007, J THORAC CARDIOV SUR, V134, P850, DOI 10.1016/j.jtcvs.2007.03.044; Christian C, 2006, LUNG CANCER, V54, P185, DOI 10.1016/j.lungcan.2006.08.003; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Cox LS, 2003, CANCER, V98, P2495, DOI 10.1002/cncr.11813; Croswell JM, 2010, ANN INTERN MED, V152, P505, DOI 10.7326/0003-4819-152-8-201004200-00007; Croswell JM, 2009, ANN FAM MED, V7, P212, DOI 10.1370/afm.942; DAVILA DG, 1993, MAYO CLIN PROC, V68, P170, DOI 10.1016/S0025-6196(12)60166-9; FLEHINGER BJ, 1993, CANCER, V72, P1573, DOI 10.1002/1097-0142(19930901)72:5<1573::AID-CNCR2820720514>3.0.CO;2-9; FONTHAM ETH, 1994, JAMA-J AM MED ASSOC, V271, P1752, DOI 10.1001/jama.271.22.1752; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Goodgame B, 2008, AM J CLIN ONCOL-CANC, V31, P22, DOI 10.1097/COC.0b013e3180ca77d1; Goya T, 2005, LUNG CANCER, V50, P227, DOI 10.1016/j.lungcan.2005.05.021; HALPERN MT, 1993, JNCI-J NATL CANCER I, V85, P457, DOI 10.1093/jnci/85.6.457; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Henschke CI, 2004, CLIN IMAG, V28, P317, DOI 10.1016/j.clinimag.2004.05.001; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Hocking WG, 2010, JNCI-J NATL CANCER I, V102, P722, DOI 10.1093/jnci/djq126; Hole DJ, 1996, BRIT MED J, V313, P711; Howlader N, 2011, SEER CANC STAT REV 1; Humphrey L, 2013, SCREENING LUNG CANC; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Infante M, 2008, LUNG CANCER, V59, P355, DOI 10.1016/j.lungcan.2007.08.040; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JETT JR, 1993, MAYO CLIN PROC, V68, P603, DOI 10.1016/S0025-6196(12)60376-0; Kaerlev L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-188; Kates M, 2011, CHEST, V139, P491, DOI 10.1378/chest.09-2547; Liu XG, 2011, LUNG CANCER, V73, P230, DOI 10.1016/j.lungcan.2010.11.012; MacRedmond R, 2006, THORAX, V61, P54, DOI 10.1136/thx.2004.037580; Maeda H, 2012, EUR J CARDIO-THORAC, V41, P357, DOI 10.1016/j.ejcts.2011.05.050; Maeda R, 2010, CHEST, V138, P357, DOI 10.1378/chest.09-3046; Marcus PM, 2006, J NATL CANCER I, V98, P748, DOI 10.1093/jnci/djj207; Mascalchi M, 2012, BRIT J RADIOL, V85, P1134, DOI 10.1259/bjr/20711289; Mascalchi M, 2006, AM J ROENTGENOL, V187, P421, DOI 10.2214/AJR.05.0088; McKenna RJ, 2006, ANN THORAC SURG, V81, P421, DOI 10.1016/j.athoracsur.2005.07.078; Menezes RJ, 2010, LUNG CANCER, V67, P177, DOI 10.1016/j.lungcan.2009.03.030; Naff JL, 2007, CHEST, V131, P1289, DOI 10.1378/chest.06-2687; Nelson H, 2009, 1005142EF1 AG HEALTH; Nesbitt JC, 1997, CANC MED; O'Connor GT, 2012, JAMA-J AM MED ASSOC, V307, P2434, DOI 10.1001/jama.2012.6096; Okada M, 2004, ANN THORAC SURG, V77, P1926, DOI 10.1016/j.athoracsur.2004.01.002; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; OSANN KE, 1991, CANCER RES, V51, P4893; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Pinsky PF, 2005, CANCER-AM CANCER SOC, V103, P157, DOI 10.1002/cncr.20746; Raji OY, 2012, ANN INTERN MED, V157, P242, DOI 10.7326/0003-4819-157-4-201208210-00004; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Shemesh J, 2006, CLIN IMAG, V30, P181, DOI 10.1016/j.clinimag.2005.11.002; Shirvani SM, 2012, INT J RADIAT ONCOL, V84, P1060, DOI 10.1016/j.ijrobp.2012.07.2354; Sinicrope PS, 2010, ACAD RADIOL, V17, P1012, DOI 10.1016/j.acra.2010.04.003; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; SOBUE T, 1992, CANCER, V69, P685, DOI 10.1002/1097-0142(19920201)69:3<685::AID-CNCR2820690315>3.0.CO;2-W; Strand TE, 2006, THORAX, V61, P710, DOI 10.1136/thx.2005.056481; Strauss G M, 1999, Surg Oncol Clin N Am, V8, P747; Styn MA, 2009, CANCER EPIDEM BIOMAR, V18, P3484, DOI 10.1158/1055-9965.EPI-09-0895; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Taylor KL, 2007, LUNG CANCER, V56, P125, DOI 10.1016/j.lungcan.2006.11.015; Tong LZ, 1996, CANCER, V78, P1004, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1004::AID-CNCR10>3.0.CO;2-6; Townsend CO, 2005, CANCER-AM CANCER SOC, V103, P2154, DOI 10.1002/cncr.21045; Toyoda Y, 2008, BRIT J CANCER, V98, P1602, DOI 10.1038/sj.bjc.6604351; TRICHOPOULOS D, 1992, JAMA-J AM MED ASSOC, V268, P1697, DOI 10.1001/jama.268.13.1697; Tsushima K, 2008, RESPIROLOGY, V13, P817, DOI 10.1111/j.1440-1843.2008.01379.x; van den Bergh KAM, 2011, EUR RESPIR J, V38, P154, DOI 10.1183/09031936.00123410; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; van den Bergh KAM, 2009, EUR RESPIR J, V34, P711, DOI 10.1183/09031936.00098908; van der Aalst CM, 2011, EUR RESPIR J, V37, P1466, DOI 10.1183/09031936.00035410; van der Aalst CM, 2010, THORAX, V65, P600, DOI 10.1136/thx.2009.133751; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; van't Westeinde SC, 2012, EUR J CARDIO-THORAC, V42, P420, DOI 10.1093/ejcts/ezs081; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2008, J THORAC CARDIOV SUR, V136, P611, DOI 10.1016/j.jtcvs.2008.02.082; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Wagnetz U, 2012, AM J ROENTGENOL, V198, P351, DOI 10.2214/AJR.11.6726; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Xu DM, 2006, LUNG CANCER, V54, P177, DOI 10.1016/j.lungcan.2006.08.006	100	375	390	3	47	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					411	+		10.7326/0003-4819-159-6-201309170-00690	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00690			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	23897166				2022-12-28	WOS:000325625900017
J	Beye, M; Schreck, S; Sorgenfrei, F; Trabant, C; Pontius, N; Schussler-Langeheine, C; Wurth, W; Fohlisch, A				Beye, M.; Schreck, S.; Sorgenfrei, F.; Trabant, C.; Pontius, N.; Schuessler-Langeheine, C.; Wurth, W.; Foehlisch, A.			Stimulated X-ray emission for materials science	NATURE			English	Article							ELECTRONIC-STRUCTURE; SCATTERING; OPERATION; LASER	Resonant inelastic X-ray scattering and X-ray emission spectroscopy can be used to probe the energy and dispersion of the elementary low-energy excitations that govern functionality in matter: vibronic, charge, spin and orbital excitations(1-7). A key drawback of resonant inelastic X-ray scattering has been the need for high photon densities to compensate for fluorescence yields of less than a per cent for soft X-rays(8). Sample damage from the dominant non-radiative decays thus limits the materials to which such techniques can be applied and the spectral resolution that can be obtained. A means of improving the yield is therefore highly desirable. Here we demonstrate stimulated X-ray emission for crystalline silicon at photon densities that are easily achievable with free-electron lasers(9). The stimulated radiative decay of core excited species at the expense of non-radiative processes reduces sample damage and permits narrow-bandwidth detection in the directed beam of stimulated radiation. We deduce how stimulated X-ray emission can be enhanced by several orders of magnitude to provide, with high yield and reduced sample damage, a superior probe for low-energy excitations and their dispersion in matter. This is the first step to bringing nonlinear X-ray physics in the condensed phase from theory(10-16) to application.	[Beye, M.; Schreck, S.; Sorgenfrei, F.; Trabant, C.; Pontius, N.; Schuessler-Langeheine, C.; Foehlisch, A.] Helmholtz Zentrum Berlin Mat & Energie GmbH, Inst Methods & Instrumentat Synchrotron Radiat Re, D-12489 Berlin, Germany; [Schreck, S.; Trabant, C.; Foehlisch, A.] Univ Potsdam, Fak Phys & Astron, D-14476 Potsdam, Germany; [Sorgenfrei, F.; Wurth, W.] Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; [Sorgenfrei, F.; Wurth, W.] Ctr Free Electron Laser Sci, D-22761 Hamburg, Germany; [Trabant, C.] Univ Cologne, Inst Phys 2, D-50937 Cologne, Germany	Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Potsdam; University of Wurzburg; University of Hamburg; University of Cologne	Beye, M (corresponding author), Helmholtz Zentrum Berlin Mat & Energie GmbH, Inst Methods & Instrumentat Synchrotron Radiat Re, Albert Einstein Str 15, D-12489 Berlin, Germany.	martin.beye@helmholtz-berlin.de	Schüßler-Langeheine, Christian/C-3186-2008; Beye, Martin/F-1165-2011; Pontius, Niko/I-1804-2013	Schüßler-Langeheine, Christian/0000-0002-4553-9726; Beye, Martin/0000-0002-3924-2993; Pontius, Niko/0000-0002-5658-1751; Sorgenfrei, Nomi Lucia Ada Nathalie/0000-0001-9179-8895; Alexander, Fohlisch/0000-0003-4126-8233	VolkswagenStiftung; German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft [05K10PK2]	VolkswagenStiftung(Volkswagen); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank N. Rohringer, A. Scherz and J. Stohr for discussions. We acknowledge support from the FLASH staff. Financial support was given to M. B. by the VolkswagenStiftung. Further support was given by the German Federal Ministry of Education and Research through the priority programme FLASH: "Matter in the light of ultrashort and extremely intense X-ray pulses" and contract number 05K10PK2, and also by the Deutsche Forschungsgemeinschaft through the graduate school: "Physics with new advanced coherent radiation sources".	Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; Ament LJP, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.705; Biggs JD, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4706899; Di Mitri S, 2011, PROC SPIE, V8078, DOI 10.1117/12.886491; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Fruhling U, 2009, NAT PHOTONICS, V3, P523, DOI 10.1038/NPHOTON.2009.160; Glover TE, 2012, NATURE, V488, P603, DOI 10.1038/nature11340; Harbola U, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085108; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Hennies F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.193002; HRICOVINI K, 1993, PHYS REV LETT, V70, P1992, DOI 10.1103/PhysRevLett.70.1992; Kotani A, 2001, REV MOD PHYS, V73, P203, DOI 10.1103/RevModPhys.73.203; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P307, DOI 10.1063/1.555594; Kunnus K, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4772685; Le Tacon M, 2011, NAT PHYS, V7, P725, DOI [10.1038/nphys2041, 10.1038/NPHYS2041]; Martins M, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2364148; McNeil BWJ, 2010, NAT PHOTONICS, V4, P814, DOI 10.1038/nphoton.2010.239; Mukamel S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.235110; Nordgren J, 2000, J ELECTRON SPECTROSC, V110, pIX, DOI 10.1016/S0368-2048(00)00153-5; Patterson B, 2010, DOWN BEAT, V77, P10; Pietzsch A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.153004; Pile D, 2011, NAT PHOTONICS, V5, P456, DOI 10.1038/nphoton.2011.178; Rohringer N, 2012, NATURE, V481, P488, DOI 10.1038/nature10721; Salen P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153003; Schlappa J, 2012, NATURE, V485, P82, DOI 10.1038/nature10974; Schlappa J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.047401; Schweigert IV, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.012504; Sun YP, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.013812; Tanaka S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.043001; Tiedtke K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/023029; Wernet P, 2011, PHYS CHEM CHEM PHYS, V13, P16941, DOI 10.1039/c0cp02934c; YEH JJ, 1985, ATOM DATA NUCL DATA, V32, P1, DOI 10.1016/0092-640X(85)90016-6	33	87	87	1	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					191	+		10.1038/nature12449	http://dx.doi.org/10.1038/nature12449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23965622	Green Published			2022-12-28	WOS:000324244900034
J	Fuchs, VR				Fuchs, Victor R.			Current Challenges to Academic Health Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Fuchs, Victor R.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, SIEPR, 366 Galvez, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Bartlett J, 1950, FAMILIAR QUOTATIONS, P1128; Chen AH, 2013, NEW ENGL J MED, V368, P2450, DOI 10.1056/NEJMp1215594; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P1143, DOI 10.1001/jama.2012.292; ENTHOVEN AC, 1993, HEALTH AFFAIR, V12, P27, DOI 10.1377/hlthaff.12.3.27; Gawande A, 2011, NEW YORKER, P41	5	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1021	1022		10.1001/jama.2013.227197	http://dx.doi.org/10.1001/jama.2013.227197			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	23948811				2022-12-28	WOS:000324133400014
J	Moynihan, R				Moynihan, Ray			Science of overdiagnosis to be served up with a good dose of humility	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC KIDNEY-DISEASE		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Heath I, 2013, JAMA INTERN MED, V173, P956, DOI 10.1001/jamainternmed.2013.970; Kamerow D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5071; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; Tiefer L, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2809; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013	8	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f5157	10.1136/bmj.f5157	http://dx.doi.org/10.1136/bmj.f5157			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SC	23963561				2022-12-28	WOS:000323623100020
J	Apovian, CM; Aronne, LJ				Apovian, Caroline M.; Aronne, Louis J.			Zonisamide for Weight Reduction in Obese Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIETS	BACKGROUND Obese individuals who have failed to achieve adequate weight loss with lifestyle changes have limited nonsurgical therapeutic options. We evaluated the efficacy and tolerability of zonisamide, an antiepileptic drug, for enhancing weight loss in obese patients receiving diet and lifestyle guidance. METHODS This was a 1-year, randomized, double-blind, placebo-controlled trial conducted from January 9, 2006, through September 20, 2011, at Duke University Medical Center. A total of 225 obese (mean [SD] body mass index, 37.6 [4.9]) participants included 134 women (59.6%) and 91 men (40.4%) without diabetes mellitus. (Body mass index is calculated as weight in kilograms divided by height in meters squared.) Interventions were daily dosing with placebo (n = 74), 200 mg of zonisamide (n = 76), or 400 mg of zonisamide (n = 75), in addition to diet and lifestyle counseling by a dietitian for 1 year. Primary outcome was change in body weight at 1 year. RESULTS Of the 225 randomized patients, 218 (96.9%) provided 1-year follow-up assessments. Change in body weight was -4.0 kg (95% CI, -5.8 to -2.3 kg; least squares mean, -3.7%) for placebo, -4.4 kg (-6.1 to -2.6 kg; -3.9%; P=.79 vs placebo) for 200 mg of zonisamide, and -7.3 kg (-9.0 to -5.6 kg; -6.8%; P=.009 vs placebo) for 400 mg of zonisamide. In the categorical analysis, 23 (31.1%) assigned to placebo, 26 (34.2%; P=.72) assigned to 200 mg of zonisamide, and 41 (54.7%; P=.007) assigned to 400 mg of zonisamide achieved 5% or greater weight loss; for 10% or greater weight loss, the corresponding numbers were 6 (8.1%), 17 (22.4%; P=.02), and 24 (32.0%; P < .001). Gastrointestinal, nervous system, and psychiatric adverse events occurred at a higher incidence with zonisamide than with placebo. CONCLUSION Zonisamide at the daily dose of 400 mg moderately enhanced weight loss achieved with diet and lifestyle counseling but had a high incidence of adverse events.	[Apovian, Caroline M.] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Aronne, Louis J.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Boston University; Cornell University	Apovian, CM (corresponding author), Boston Med Ctr, 88 E Newton St,Robinson 4400, Boston, MA 02118 USA.	caroline.apovian@bmc.org	Aronne, Louis/ABC-8865-2020; Gadde, Kishore/N-1963-2017	Gadde, Kishore/0000-0002-1856-5574; Apovian, Caroline/0000-0002-8029-1922	MetaProteomics; Orexigen; Atkins Foundation; Amylin; Lilly; sanofi-aventis; Pfizer; Aspire Bariatrics; Amylin Pharmaceuticals; Arena Pharmaceuticals; Eisai; Ethicon Endo-Surgery; GlaxoSmithKline Consumer Healthcare; GI Dynamics; High Point Pharmaceuticals; Novo Nordisk; Orexigen Therapeutics; Takeda Pharmaceuticals; VIVUS; Weight Watchers; Zafgen	MetaProteomics; Orexigen; Atkins Foundation; Amylin; Lilly(Eli Lilly); sanofi-aventis(Sanofi-Aventis); Pfizer(Pfizer); Aspire Bariatrics; Amylin Pharmaceuticals(Bristol-Myers Squibb); Arena Pharmaceuticals; Eisai(Eisai Co Ltd); Ethicon Endo-Surgery; GlaxoSmithKline Consumer Healthcare(GlaxoSmithKline); GI Dynamics; High Point Pharmaceuticals; Novo Nordisk(Novo Nordisk); Orexigen Therapeutics; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); VIVUS; Weight Watchers; Zafgen	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Apovian reported having served on advisory boards for Allergan, Orexigen, Johnson and Johnson, Merck, Abbott, Arena, Amylin, sanofi-aventis, Zafgen; having received research grants from MetaProteomics, Orexigen, Atkins Foundation, Amylin, Lilly, sanofi-aventis, and Pfizer; and receiving royalties as the author of diet plan books. Dr Aronne reported having served as a consultant, speaker, or advisor for or having received research support from Aspire Bariatrics, Amylin Pharmaceuticals, Arena Pharmaceuticals, Eisai, Ethicon Endo-Surgery, GlaxoSmithKline Consumer Healthcare, GI Dynamics, High Point Pharmaceuticals, Novo Nordisk, Orexigen Therapeutics, Pfizer, Takeda Pharmaceuticals, VIVUS, Weight Watchers, and Zafgen; having an ownership interest in BMIQ, Myos Corporation, and Zafgen; and serving on the board of directors for Myos Corporation.	Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; De Simone G, 2008, CURR PHARM DESIGN, V14, P655, DOI 10.2174/138161208783877820; Gadde KM, 2012, ARCH INTERN MED, V172, P1557, DOI 10.1001/2013.jamainternmed.99; Gadde KM, 2003, JAMA-J AM MED ASSOC, V289, P1820, DOI 10.1001/jama.289.14.1820; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809	7	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					637	638		10.1001/jama.2013.101049	http://dx.doi.org/10.1001/jama.2013.101049			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942682				2022-12-28	WOS:000323058400019
J	Gabel, HW; Greenberg, ME				Gabel, Harrison W.; Greenberg, Michael E.			The Maturing Brain Methylome	SCIENCE			English	Editorial Material							DNA; 5-HYDROXYMETHYLCYTOSINE; MECP2; METHYLATION; CHROMATIN; GENOME		[Gabel, Harrison W.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gabel, HW (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu			NINDS NIH HHS [R01 NS048276] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	14	9	9	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					626	627		10.1126/science.1242671	http://dx.doi.org/10.1126/science.1242671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929975	Green Accepted			2022-12-28	WOS:000322884800028
J	Park, JH; Goldstein, AH; Timkovsky, J; Fares, S; Weber, R; Karlik, J; Holzinger, R				Park, J. -H.; Goldstein, A. H.; Timkovsky, J.; Fares, S.; Weber, R.; Karlik, J.; Holzinger, R.			Active Atmosphere-Ecosystem Exchange of the Vast Majority of Detected Volatile Organic Compounds	SCIENCE			English	Article							PROTON-TRANSFER-REACTION; AEROSOL; FOREST; EMISSION	Numerous volatile organic compounds (VOCs) exist in Earth's atmosphere, most of which originate from biogenic emissions. Despite VOCs' critical role in tropospheric chemistry, studies for evaluating their atmosphere-ecosystem exchange (emission and deposition) have been limited to a few dominant compounds owing to a lack of appropriate measurement techniques. Using a high-mass resolution proton transfer reaction-time of flight-mass spectrometer and an absolute value eddy-covariance method, we directly measured 186 organic ions with net deposition, and 494 that have bidirectional flux. This observation of active atmosphere-ecosystem exchange of the vast majority of detected VOCs poses a challenge to current emission, air quality, and global climate models, which do not account for this extremely large range of compounds. This observation also provides new insight for understanding the atmospheric VOC budget.	[Park, J. -H.; Goldstein, A. H.; Fares, S.; Weber, R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Park, J. -H.; Timkovsky, J.; Holzinger, R.] Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [Goldstein, A. H.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Fares, S.] Res Ctr Soil Plant Syst, Consiglio Ric & Sperimentaz Agr, Rome, Italy; [Karlik, J.] Univ Calif Cooperat Extens, Bakersfield, CA 93307 USA	University of California System; University of California Berkeley; Utrecht University; University of California System; University of California Berkeley; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of California System	Goldstein, AH (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ahg@berkeley.edu	Holzinger, Rupert/C-9160-2009; Goldstein, Allen H/A-6857-2011; Fares, Silvano/H-4322-2011; Park, Jeong-Hoo/I-2923-2013	Holzinger, Rupert/0000-0003-1902-1824; Goldstein, Allen H/0000-0003-4014-4896; Fares, Silvano/0000-0002-1990-0928; 	Netherlands Organization for Scientific Research (NWO) under the ALW-Middelgroot program [834.08.002]; California Air Resources Board [06-329]; Citrus Research Board; University of Utrecht	Netherlands Organization for Scientific Research (NWO) under the ALW-Middelgroot program(Netherlands Organization for Scientific Research (NWO)); California Air Resources Board; Citrus Research Board; University of Utrecht	This work was supported by the Netherlands Organization for Scientific Research (NWO) under the ALW-Middelgroot program (grant 834.08.002), the California Air Resources Board (Award 06-329), the Citrus Research Board, and the University of Utrecht short stay fellowship program. We thank the Gorden Ranch for hosting this study and for the assistance provided by the University of California Lindcove Research and Extension station.	Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Di Carlo P, 2004, SCIENCE, V304, P722, DOI 10.1126/science.1094392; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Holzinger R, 2005, ATMOS CHEM PHYS, V5, P67, DOI 10.5194/acp-5-67-2005; Holzinger R, 2010, ATMOS CHEM PHYS, V10, P10111, DOI 10.5194/acp-10-10111-2010; Jang MS, 2002, SCIENCE, V298, P814, DOI 10.1126/science.1075798; Jordan A, 2009, INT J MASS SPECTROM, V286, P122, DOI 10.1016/j.ijms.2009.07.005; Karl T, 2010, SCIENCE, V330, P816, DOI 10.1126/science.1192534; Kurpius MR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016785; Lee A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007050; Park JH, 2013, ATMOS CHEM PHYS, V13, P1439, DOI 10.5194/acp-13-1439-2013; Ruuskanen TM, 2011, ATMOS CHEM PHYS, V11, P611, DOI 10.5194/acp-11-611-2011	16	164	167	5	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					643	647		10.1126/science.1235053	http://dx.doi.org/10.1126/science.1235053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929979				2022-12-28	WOS:000322884800035
J	Hochman, ME; Chen, AY; Serota, M				Hochman, Michael E.; Chen, Alex Y.; Serota, Martin			Payer Agnosticism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hochman, Michael E.; Chen, Alex Y.; Serota, Martin] AltaMed Hlth Serv, Commerce, CA USA; [Chen, Alex Y.] Childrens Hosp, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Hochman, ME (corresponding author), AltaMed Hlth Serv, Commerce, CA USA.							Reinhardt UE, 2011, HEALTH AFFAIR, V30, P2125, DOI 10.1377/hlthaff.2011.0813; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	2	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					502	503		10.1056/NEJMp1303174	http://dx.doi.org/10.1056/NEJMp1303174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197HX	23924000				2022-12-28	WOS:000322842000004
J	Spence, D				Spence, Des			Bad medicine: atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK STRATIFICATION SCHEMES; STROKE; ANTICOAGULATION; WARFARIN					destwo@yahoo.co.uk						Bradley A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3719; British Heart Foundation, 2009, STROK STAT 2009; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Hart RG, 2009, STROKE, V40, P2607, DOI 10.1161/STROKEAHA.109.549428; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x	8	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2013	347								f4910	10.1136/bmj.f4910	http://dx.doi.org/10.1136/bmj.f4910			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CY	23924656				2022-12-28	WOS:000323119500014
J	Diffenbaugh, NS; Field, CB				Diffenbaugh, Noah S.; Field, Christopher B.			Changes in Ecologically Critical Terrestrial Climate Conditions	SCIENCE			English	Review							WINTER WARMING EVENTS; NO-ANALOG COMMUNITIES; WHITE SPRUCE; RANGE SHIFTS; IMPACTS; FUTURE; TEMPERATURE; DROUGHT; RESPONSES; HEAT	Terrestrial ecosystems have encountered substantial warming over the past century, with temperatures increasing about twice as rapidly over land as over the oceans. Here, we review the likelihood of continued changes in terrestrial climate, including analyses of the Coupled Model Intercomparison Project global climate model ensemble. Inertia toward continued emissions creates potential 21st-century global warming that is comparable in magnitude to that of the largest global changes in the past 65 million years but is orders of magnitude more rapid. The rate of warming implies a velocity of climate change and required range shifts of up to several kilometers per year, raising the prospect of daunting challenges for ecosystems, especially in the context of extensive land use and degradation, changes in frequency and severity of extreme events, and interactions with other stresses.	[Diffenbaugh, Noah S.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Diffenbaugh, Noah S.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Field, Christopher B.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA	Stanford University; Stanford University; Carnegie Institution for Science	Diffenbaugh, NS (corresponding author), Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA.	diffenbaugh@stanford.edu	Diffenbaugh, Noah S/I-5920-2014	Diffenbaugh, Noah S/0000-0002-8856-4964	NSF [0955283]; Carnegie Institution for Science	NSF(National Science Foundation (NSF)); Carnegie Institution for Science	We thank two anonymous reviewers for insightful and constructive comments on the manuscript. We acknowledge the World Climate Research Programme and the climate modeling groups for producing and making available their model output and the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison for coordinating support database development. Our work was supported by NSF grant 0955283 to N.S.D. and support from the Carnegie Institution for Science to C.B.F.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Alroy J, 2000, PALEOBIOLOGY, V26, P259, DOI 10.1666/0094-8373(2000)26[259:GCCANA]2.0.CO;2; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Boggs CL, 2012, ECOL LETT, V15, P502, DOI 10.1111/j.1461-0248.2012.01766.x; Bokhorst S, 2012, GLOBAL CHANGE BIOL, V18, P1152, DOI 10.1111/j.1365-2486.2011.02565.x; Bokhorst SF, 2009, J ECOL, V97, P1408, DOI 10.1111/j.1365-2745.2009.01554.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crutzen P, 2000, GLOBAL CHANGE NEWSLE, V41, P17; Davis SJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/011001; Davis SJ, 2010, SCIENCE, V329, P1330, DOI 10.1126/science.1188566; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dickinson R.E., 2007, CLIMATE CHANGE 2007; Diffenbaugh N.S., 2008, EOS T AM GEOPHYS UN, V89, P553, DOI DOI 10.1029/2008EO530001; Diffenbaugh Noah S, 2013, Nat Clim Chang, V3, P379; Diffenbaugh NS, 2013, SUSTAIN SCI, V8, P135, DOI 10.1007/s11625-012-0174-4; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Diffenbaugh NS, 2011, CLIMATIC CHANGE, V107, P615, DOI 10.1007/s10584-011-0112-y; Diffenbaugh NS, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044007; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Donat MG, 2013, J GEOPHYS RES-ATMOS, V118, P2098, DOI 10.1002/jgrd.50150; Field C. B., 2012, Managing the risks of extreme events and disasters to advance climate change adaptation. Special report of the Intergovernmental Panel on Climate Change; Fischlin A, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P211; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2005, P NATL ACAD SCI USA, V102, P10832, DOI 10.1073/pnas.0504755102; Fuller DO, 2004, CONSERV BIOL, V18, P249, DOI 10.1111/j.1523-1739.2004.00018.x; Gillett NP, 2011, NAT GEOSCI, V4, P83, DOI 10.1038/NGEO1047; Giorgi F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024288; Giorgi F, 2011, J CLIMATE, V24, P5309, DOI 10.1175/2011JCLI3979.1; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Harden JW, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051958; Hawkins E., 2010, CLIM DYN, DOI 10-1007/s00382-010-0810-6; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Humboldt Von A., 1807, ESSAY GEOGRAPHY PLAN, P274; IEA, 2012, WORLD EN OUTL 2012, P529; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jansen E., CLIMATE CHANGE 2007; Jones C, 2010, TELLUS B, V62, P682, DOI 10.1111/j.1600-0889.2010.00490.x; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kharin VV, 2013, CLIMATIC CHANGE, V119, P345, DOI 10.1007/s10584-013-0705-8; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Kunkel KE, 2013, B AM METEOROL SOC, V94, P499, DOI 10.1175/BAMS-D-11-00262.1; Kunreuther H, 2013, NAT CLIM CHANGE, V3, P447, DOI [10.1038/NCLIMATE1740, 10.1038/nclimate1740]; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2010, NAT GEOSCI, V3, P142, DOI 10.1038/ngeo813; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Metz B, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P1; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nakicenovic N, 2000, SPECIAL REPORT EMISS; Negron-Juarez RI, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043733; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Peterson TC, 2013, B AM METEOROL SOC, V94, P821, DOI 10.1175/BAMS-D-12-00066.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rogelj J., 2012, NATURE CLIM CHANGE, DOI 10.1038/NCLIMATE1385; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Rood SB, 2008, J HYDROL, V349, P397, DOI 10.1016/j.jhydrol.2007.11.012; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schlaepfer DR, 2012, GLOBAL CHANGE BIOL, V18, P1988, DOI 10.1111/j.1365-2486.2012.02642.x; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Shafer SL, 2001, ECOSYSTEMS, V4, P200, DOI 10.1007/s10021-001-0004-5; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tebaldi C, 2006, CLIMATIC CHANGE, V79, P185, DOI 10.1007/s10584-006-9051-4; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Toomey M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049041; Trapp RJ, 2007, P NATL ACAD SCI USA, V104, P19719, DOI 10.1073/pnas.0705494104; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vincent WF, 2009, POLAR SCI, V3, P171, DOI 10.1016/j.polar.2009.05.004; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westra S, 2013, J CLIMATE, V26, P3904, DOI 10.1175/JCLI-D-12-00502.1; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Wilmking M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023331; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	129	371	390	45	633	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					486	492		10.1126/science.1237123	http://dx.doi.org/10.1126/science.1237123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908225				2022-12-28	WOS:000322586700039
J	Green, RC; Lupski, JR; Biesecker, LG				Green, Robert C.; Lupski, James R.; Biesecker, Leslie G.			Reporting Genomic Sequencing Results to Ordering Clinicians Incidental, but Not Exceptional	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Green, Robert C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Green, RC (corresponding author), Harvard Univ, Sch Med, 41 Ave Louis Pasteur,EC Alumnae Bldg,Ste 301, Boston, MA 02115 USA.	rcgreen@genetics.med.harvard.edu	Biesecker, Leslie/AAG-2526-2021		NATIONAL CANCER INSTITUTE [R01CA154517] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006615, U54HG003273, ZIAHG200359, U54HG006542, R01HG003178, ZIAHG200387, R01HG002213, R01HG005092, UM1HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA154517, R01 CA154517] Funding Source: Medline; NHGRI NIH HHS [HG003178, HG005092, R01 HG002213, U54 HG003273, UM1 HG006542, R01 HG005092, U54 HG006542, HG006542, HG02213, R01 HG006615, R01 HG003178, HG006615] Funding Source: Medline; NINDS NIH HHS [NS058529, R01 NS058529] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American College of Genetics and Genomics, INC FIND CLIN GEN CL; Boone PM, 2013, GENET MED, V15, P45, DOI 10.1038/gim.2012.95; Garg A, 2008, FITZPATRICKS DERMATO, P25; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Green RC, 2013, GENOMIC PERSONALIZED, V2; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gunderman RB, 2006, ESSENTIAL RADIOLOGY, V2nd; Ladd S, 2008, MED RADIOL DIAGN IMA, P149, DOI 10.1007/978-3-540-49831-5_9; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156	9	60	63	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					365	366		10.1001/jama.2013.41703	http://dx.doi.org/10.1001/jama.2013.41703			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917280	Green Accepted			2022-12-28	WOS:000322121500007
J	Yang, LQ; Lin, CR; Jin, CY; Yang, JC; Tanasa, B; Li, WB; Merkurjev, D; Ohgi, KA; Meng, D; Zhang, J; Evans, CP; Rosenfeld, MG				Yang, Liuqing; Lin, Chunru; Jin, Chunyu; Yang, Joy C.; Tanasa, Bogdan; Li, Wenbo; Merkurjev, Daria; Ohgi, Kenneth A.; Meng, Da; Zhang, Jie; Evans, Christopher P.; Rosenfeld, Michael G.			lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs	NATURE			English	Article							LONG NONCODING RNA; PROSTATE-CANCER; CELL-GROWTH; EXPRESSION; TRANSCRIPTION; ENHANCERS; IDENTIFICATION; ACETYLATION; METHYLATION; MACROPHAGE	Although recent studies have indicated roles of long non-coding RNAs (lncRNAs) in physiological aspects of cell-type determination and tissue homeostasis(1), their potential involvement in regulated gene transcription programs remains rather poorly understood. The androgen receptor regulates a large repertoire of genes central to the identity and behaviour of prostate cancer cells(2), and functions in a ligand-independent fashion in many prostate cancers when they become hormone refractory after initial androgen deprivation therapy(3). Here we report that two lncRNAs highly overexpressed in aggressive prostate cancer, PRNCR1 (also known as PCAT8) and PCGEM1, bind successively to the androgen receptor and strongly enhance both ligand-dependent and ligand-independent androgen-receptor-mediated gene activation programs and proliferation in prostate cancer cells. Binding of PRNCR1 to the carboxy-terminally acetylated androgen receptor on enhancers and its association with DOT1L appear to be required for recruitment of the second lncRNA, PCGEM1, to the androgen receptor amino terminus that is methylated by DOT1L. Unexpectedly, recognition of specific protein marks by PCGEM1-recruited pygopus 2 PHD domain enhances selective looping of androgen-receptor-bound enhancers to target gene promoters in these cells. In 'resistant' prostate cancer cells, these overexpressed lncRNAs can interact with, and are required for, the robust activation of both truncated and full-length androgen receptor, causing ligand-independent activation of the androgen receptor transcriptional program and cell proliferation. Conditionally expressed short hairpin RNA targeting these lncRNAs in castration-resistant prostate cancer cell lines strongly suppressed tumour xenograft growth in vivo. Together, these results indicate that these overexpressed lncRNAs can potentially serve as a required component of castration-resistance in prostatic tumours.	[Yang, Liuqing; Lin, Chunru; Jin, Chunyu; Tanasa, Bogdan; Li, Wenbo; Merkurjev, Daria; Ohgi, Kenneth A.; Zhang, Jie; Rosenfeld, Michael G.] Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Yang, Liuqing; Lin, Chunru] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yang, Joy C.; Evans, Christopher P.] Univ Calif Davis, Sch Med, Dept Urol, Sacramento, CA 95817 USA; [Tanasa, Bogdan] Scripps Res Inst, Grad Program, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Merkurjev, Daria] Univ Calif San Diego, Dept Bioengn, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Meng, Da] Univ Calif San Diego, Dept Biol Sci, Neurosci Grad Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	lyang7@mdanderson.org; clin2@mdanderson.org; mrosenfeld@ucsd.edu	li, wenbo/GZM-8930-2022; Jin, Chunyu/A-4506-2016	Meng, Da/0000-0003-4451-4049	National Institutes of Health (NIH) [DK039949, DK18477, NS034934, CA173903]; Department of Defense [PC111467, SV2C-AACR-DT0812]; Prostate Cancer Foundation; NIH Pathway to Independence Award [1K99DK094981-01, 4R00CA166527-02]; US Army Medical Research and Material Command Era of Hope Postdoctoral award [W81XWH-08-1-0554]; Cancer Prevention Research Institute of Texas First-time Faculty Recruitment Award [R1218]; Cancer Research Institute Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA173903, R00CA166527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, T32DK007541, R00DK094981, R37DK039949, R01DK018477, K99DK094981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Prostate Cancer Foundation; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command Era of Hope Postdoctoral award; Cancer Prevention Research Institute of Texas First-time Faculty Recruitment Award; Cancer Research Institute Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to X. Dai for providing the PYGO2 shRNA and cDNA constructs and J. Hightower for assistance with figure presentation. This work was supported by National Institutes of Health (NIH) grants DK039949, DK18477, NS034934 and CA173903, Department of Defense grant and initially by a grant from Prostate Cancer Foundation to M.G.R.; by Department of Defense grant PC111467 and SV2C-AACR-DT0812 to C. D. E; by grants from the NIH Pathway to Independence Award (1K99DK094981-01) to C.-R.L.; by US Army Medical Research and Material Command Era of Hope Postdoctoral award (W81XWH-08-1-0554), NIH Pathway to Independence Award (4R00CA166527-02) and Cancer Prevention Research Institute of Texas First-time Faculty Recruitment Award (R1218) to L.-Q.Y.; C.-Y.J. is the recipient of a Cancer Research Institute Postdoctoral Fellowship. M. G. R. is an Investigator of the Howard Hughes Medical Institute.	Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Gu BN, 2009, J CELL BIOL, V185, P811, DOI 10.1083/jcb.200810133; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Petrovics G, 2004, ONCOGENE, V23, P605, DOI 10.1038/sj.onc.1207069; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sun AJ, 2010, INT J CANCER, V126, P764, DOI 10.1002/ijc.24778; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	30	502	547	6	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					598	+		10.1038/nature12451	http://dx.doi.org/10.1038/nature12451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23945587	Green Accepted, Green Submitted			2022-12-28	WOS:000323625900039
J	Stein, RS; Toda, S				Stein, Ross S.; Toda, Shinji			Megacity Megaquakes-Two Near Misses	SCIENCE			English	Editorial Material							EARTHQUAKE		[Stein, Ross S.] US Geol Survey, Menlo Pk, CA 94025 USA; [Toda, Shinji] Tohoku Univ, IRIDeS, Sendai, Miyagi 980, Japan	United States Department of the Interior; United States Geological Survey; Tohoku University	Stein, RS (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	rstein@usgs.gov; toda@irides.tohoku.ac.jp						[Anonymous], LOC EARTHQ JAP US JM; Berryman KR, 2012, SCIENCE, V336, P1690, DOI 10.1126/science.1218959; Boyd OS, 2012, B SEISMOL SOC AM, V102, P909, DOI 10.1785/0120110008; Field E. H., 2011, 2011 FALL M 5 9 DEC; Holzer TL, 2013, EARTHQ SPECTRA, V29, P155, DOI 10.1193/1.4000106; Jordan TH, 2011, ANN GEOPHYS-ITALY, V54, P315, DOI 10.4401/ag-5350; Kagan YY, 2000, GEOPHYS J INT, V143, P438, DOI 10.1046/j.1365-246X.2000.01267.x; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; Rhoades DA, 2009, B SEISMOL SOC AM, V99, P636, DOI 10.1785/0120080063; Shearer PM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008957; Toda S, 2013, GEOPHYS RES LETT, V40, P2562, DOI 10.1002/grl.50524	11	13	13	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					850	852		10.1126/science.1238944	http://dx.doi.org/10.1126/science.1238944			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970687				2022-12-28	WOS:000323370600027
J	Rao, A; Chow, PCY; Gelinas, S; Schlenker, CW; Li, CZ; Yip, HL; Jen, AKY; Ginger, DS; Friend, RH				Rao, Akshay; Chow, Philip C. Y.; Gelinas, Simon; Schlenker, Cody W.; Li, Chang-Zhi; Yip, Hin-Lap; Jen, Alex K. -Y.; Ginger, David S.; Friend, Richard H.			The role of spin in the kinetic control of recombination in organic photovoltaics	NATURE			English	Article							HETEROJUNCTION SOLAR-CELLS; CHARGE-TRANSFER EXCITONS; OPEN-CIRCUIT VOLTAGE; EFFICIENCY; ENERGY; MORPHOLOGY; SEPARATION; ADDITIVES; POLYMERS; GEMINATE	In biological complexes, cascade structures promote the spatial separation of photogenerated electrons and holes, preventing their recombination(1). In contrast, the photogenerated excitons in organic photovoltaic cells are dissociated at a single donor-acceptor heterojunction formed within a de-mixed blend of the donor and acceptor semiconductors(2). The nanoscale morphology and high charge densities give a high rate of electron-hole encounters, which should in principle result in the formation of spin-triplet excitons, as in organic light-emitting diodes(3). Although organic photovoltaic cells would have poor quantum efficiencies if every encounter led to recombination, state-of-the-art examples nevertheless demonstrate near-unity quantum efficiency(4). Here we show that this suppression of recombination arises through the interplay between spin, energetics and delocalization of electronic excitations in organic semiconductors. We use time-resolved spectroscopy to study a series of model high-efficiency polymer-fullerene systems in which the lowest-energy molecular triplet exciton (T-1) for the polymer is lower in energy than the intermolecular charge transfer state. We observe the formation of T-1 states following bimolecular recombination, indicating that encounters of spin-uncorrelated electrons and holes generate charge transfer states with both spin-singlet ((CT)-C-1) and spin-triplet ((CT)-C-3) characters. We show that the formation of triplet excitons can be the main loss mechanism in organic photovoltaic cells. But we also find that, even when energetically favoured, the relaxation of (CT)-C-3 states to T-1 states can be strongly suppressed by wavefunction delocalization, allowing for the dissociation of (CT)-C-3 states back to free charges, thereby reducing recombination and enhancing device performance. Our results point towards new design rules both for photo-conversion systems, enabling the suppression of electron-hole recombination, and for organic light-emitting diodes, avoiding the formation of triplet excitons and enhancing fluorescence efficiency.	[Rao, Akshay; Chow, Philip C. Y.; Gelinas, Simon; Friend, Richard H.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Schlenker, Cody W.; Jen, Alex K. -Y.; Ginger, David S.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Li, Chang-Zhi; Yip, Hin-Lap; Jen, Alex K. -Y.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	University of Cambridge; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Friend, RH (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	rhf10@cam.ac.uk	Li, Chang-Zhi/ABA-9963-2020; Li, Chang-Zhi/AAE-9270-2019; Ginger, David S/C-4866-2011; Yip, Hin-Lap/A-3637-2012; Chow, Philip/X-5936-2019; JEN, Alex/E-5957-2012	Ginger, David S/0000-0002-9759-5447; Yip, Hin-Lap/0000-0002-5750-9751; Chow, Philip/0000-0002-2373-503X; JEN, Alex/0000-0002-9219-7749; Friend, Richard Henry/0000-0001-6565-6308; Rao, Akshay/0000-0003-0320-2962; Li, Chang-Zhi/0000-0003-1968-2032; Rao, Akshay/0000-0003-4261-0766	Corpus Christi College, Cambridge; Fonds Quebecois de Recherche sur la Nature et les Technologies; EPSRC; Winton Programme for the Physics of Sustainability; National Science Foundation [DMR-1215753]; Office of Naval Research [N00014-11-1-0300]; Engineering and Physical Sciences Research Council [EP/G060738/1] Funding Source: researchfish; EPSRC [EP/G060738/1] Funding Source: UKRI	Corpus Christi College, Cambridge; Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Winton Programme for the Physics of Sustainability; National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank N. Greenham for discussions. A.R. thanks Corpus Christi College, Cambridge for a Research Fellowship. S.G. thanks Fonds Quebecois de Recherche sur la Nature et les Technologies for funding. This work is supported by the EPSRC and the Winton Programme for the Physics of Sustainability. C.W.S. was supported by the National Science Foundation (DMR-1215753). D.S.G., C.-Z.L., H.-L.Y. and A.K.-Y.J. acknowledge support from the Office of Naval Research (N00014-11-1-0300). Some of the work was done at the UW NanoTech User Facility, a member of the NSF National Nanotechnology Infrastructure Network. We thank J. Richards and D. Pozzo for performing grazing-incidence small-angle X-ray scattering measurements, S. Williams for transmission electron microscopy and G. Shao for help with atomic force microscopy measurements.	Bakulin AA, 2012, SCIENCE, V335, P1340, DOI 10.1126/science.1217745; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; Blankenship R. E., 2001, MOL MECH PHOTOSYNTHE; Cirmi G, 2007, OPT LETT, V32, P2396, DOI 10.1364/OL.32.002396; Credgington D, 2011, ADV FUNCT MATER, V21, P2744, DOI 10.1002/adfm.201100225; Deibel C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3005593; Di Nuzzo D, 2010, ADV MATER, V22, P4321, DOI 10.1002/adma.201001452; Etzold F, 2012, J AM CHEM SOC, V134, P10569, DOI 10.1021/ja303154g; Gelinas S, 2011, J PHYS CHEM C, V115, P7114, DOI 10.1021/jp200466y; Hammond MR, 2011, ACS NANO, V5, P8248, DOI 10.1021/nn202951e; Hilczer M, 2010, J PHYS CHEM C, V114, P6808, DOI 10.1021/jp912262h; Hodgkiss JM, 2012, ADV FUNCT MATER, V22, P1567, DOI 10.1002/adfm.201102433; Hoke ET, 2012, ADV ENERGY MATER, V2, P1351, DOI 10.1002/aenm.201200169; Hu B, 2009, ADV MATER, V21, P1500, DOI 10.1002/adma.200802386; Jamieson FC, 2012, CHEM SCI, V3, P485, DOI 10.1039/c1sc00674f; Koster LJA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2170424; Lou SJ, 2011, J AM CHEM SOC, V133, P20661, DOI 10.1021/ja2085564; Morteani AC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.247402; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Peet J, 2007, NAT MATER, V6, P497, DOI 10.1038/nmat1928; Scharber MC, 2011, ENERG ENVIRON SCI, V4, P5077, DOI 10.1039/c1ee02181h; Schlenker CW, 2012, J AM CHEM SOC, V134, P19661, DOI 10.1021/ja306110b; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Soon YW, 2011, CHEM SCI, V2, P1111, DOI 10.1039/c0sc00606h; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Vandewal K, 2009, NAT MATER, V8, P904, DOI [10.1038/NMAT2548, 10.1038/nmat2548]; Veldman D, 2009, ADV FUNCT MATER, V19, P1939, DOI 10.1002/adfm.200900090; Wallikewitz BH, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045209; Zhang Y, 2011, CHEM MATER, V23, P2289, DOI 10.1021/cm200316s; Zhao GJ, 2010, ADV MATER, V22, P4355, DOI 10.1002/adma.201001339	30	396	397	14	663	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					435	+		10.1038/nature12339	http://dx.doi.org/10.1038/nature12339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23925118	Green Accepted			2022-12-28	WOS:000323316100030
J	Fritsch, R; Downward, J				Fritsch, Ralph; Downward, Julian			SnapShot: Class I PI3K Isoform Signaling	CELL			English	Editorial Material							RECEPTOR; ACTIVATION; P110-BETA; CANCER; RAS		[Fritsch, Ralph] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [Downward, Julian] Inst Canc Res, Div Canc Biol, Lung Canc Grp, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	Fritsch, R (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.		Fritsch, Ralph/Q-8836-2019	Downward, Julian/0000-0002-2331-4729; Fritsch, Ralph/0000-0001-9639-3213	Cancer Research UK [15680] Funding Source: researchfish; Worldwide Cancer Research [13-0142] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Worldwide Cancer Research		Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290	8	22	24	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					940	+	940.e1	10.1016/j.cell.2013.07.045	http://dx.doi.org/10.1016/j.cell.2013.07.045			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953121	Bronze			2022-12-28	WOS:000323202500022
J	Hertz, NT; Berthet, A; Sos, ML; Thorn, KS; Burlingame, AL; Nakamura, K; Shokat, KM				Hertz, Nicholas T.; Berthet, Amandine; Sos, Martin L.; Thorn, Kurt S.; Burlingame, Al L.; Nakamura, Ken; Shokat, Kevan M.			A Neo-Substrate that Amplifies Catalytic Activity of Parkinson's-Disease-Related Kinase PINK1	CELL			English	Article							PROTEIN-KINASE; ENZYMATIC SYNTHESIS; TYROSINE KINASE; MITOCHONDRIAL FISSION; OXIDATIVE STRESS; CELLS; MUTATIONS; APOPTOSIS; NUCLEOTIDES; SPECIFICITY	Mitochondria have long been implicated in the pathogenesis of Parkinson's disease (PD). Mutations in the mitochondrial kinase PINK1 that reduce kinase activity are associated with mitochondrial defects and result in an autosomal-recessive form of early-onset PD. Therapeutic approaches for enhancing the activity of PINK1 have not been considered because no allosteric regulatory sites for PINK1 are known. Here, we show that an alternative strategy, a neo-substrate approach involving the ATP analog kinetin triphosphate (KTP), can be used to increase the activity of both PD-related mutant PINK1(G309D) and PINK1(WT). Moreover, we show that application of the KTP precursor kinetin to cells results in biologically significant increases in PINK1 activity, manifest as higher levels of Parkin recruitment to depolarized mitochondria, reduced mitochondrial motility in axons, and lower levels of apoptosis. Discovery of neo-substrates for kinases could provide a heretofore-unappreciated modality for regulating kinase activity.	[Hertz, Nicholas T.; Sos, Martin L.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hertz, Nicholas T.; Sos, Martin L.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Hertz, Nicholas T.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Grad Programs Neurosci & Biomed Sci, San Francisco, CA 94158 USA; [Burlingame, Al L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Berthet, Amandine; Nakamura, Ken] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	kevan.shokat@ucsf.edu	Sos, Martin L/I-1852-2014	Thorn, Kurt/0000-0001-9310-288X; Nakamura, Ken/0000-0002-9192-182X; Hertz, Nicholas/0000-0002-6527-6898	Genentech; Michael J. Fox Foundation; Burroughs-Wellcome Medical Scientist Fund Career Award; National Institute of Neurological Disorders and Stroke [1KO8NS062954-01A1, P30NS069496]; Prostate Cancer Foundation (PCF); NIH [NCRR RR015804, NCRR RR001614];  [RO1 EB001987]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069496, K08NS062954] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Michael J. Fox Foundation; Burroughs-Wellcome Medical Scientist Fund Career Award(Burroughs Wellcome Fund); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Prostate Cancer Foundation (PCF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Laura Lavery for providing recombinantly expressed TRAP1, Michael Lopez for synthesis of 9-methyl-kinetin, Xiaoxi Zhuang (University of Chicago) for C57BL/6 background PINK1<SUP>-/-</SUP> mice, and Valerie Ohman for excellent administrative assistance. We thank Zachary A. Knight, Robert H. Edwards, and Daniel de Roulet, Jr. for critical reading of the manuscript. N.T.H. was supported by a Genentech predoctoral grant. K. M. S. was supported by RO1 EB001987, and early work was supported by the Michael J. Fox Foundation. K.N. and A. B. were supported by a Burroughs-Wellcome Medical Scientist Fund Career Award and grant awards 1KO8NS062954-01A1 and P30NS069496 from the National Institute of Neurological Disorders and Stroke. M. L. S. is supported by a Young Investigator Award from the Prostate Cancer Foundation (PCF) and is a fellow of the International Association for the Study of Lung Cancer (IASLC). Mass spectrometry was made possible by NIH grants NCRR RR015804 and NCRR RR001614. Imaging data were collected at the Nikon Imaging Center at QB3/UCSF. N.T.H. and K. M. S. are inventors on a patent application related to kinetin and PINK1. UCSF has licensed the patent application to Mitokinin LLC. N.T.H. and K. M. S. are cofounders and members of Mitokinin LLC.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Cardona F, 2011, HUM MUTAT, V32, P369, DOI 10.1002/humu.21444; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ferrando IM, 2012, MOL CELL PROTEOMICS, V11, P355, DOI 10.1074/mcp.M111.015750; FERRER A, 1985, BIOCHEM BIOPH RES CO, V132, P497, DOI 10.1016/0006-291X(85)91161-1; Gao YJ, 2011, PROTEIN CELL, V2, P99, DOI 10.1007/s13238-011-1021-6; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heinis C, 2006, ACS CHEM BIOL, V1, P575, DOI 10.1021/cb6003146; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Ishii Y, 2003, BBA-MOL CELL RES, V1643, P11, DOI 10.1016/j.bbamcr.2003.08.004; Ishii Y, 2002, CELL GROWTH DIFFER, V13, P19; Kissil JL, 1997, ONCOGENE, V15, P403, DOI 10.1038/sj.onc.1201172; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klinkenberg M, 2010, NEUROSCIENCE, V166, P422, DOI 10.1016/j.neuroscience.2009.12.068; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; KORNBERG A, 1955, J BIOL CHEM, V215, P417; Krishnan P, 2002, J BIOL CHEM, V277, P5453, DOI 10.1074/jbc.M109025200; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LIEBERMAN I, 1955, J BIOL CHEM, V215, P429; LIEBERMAN I, 1955, J BIOL CHEM, V215, P403; Liu Y, 1998, BIOORGAN MED CHEM, V6, P1219, DOI 10.1016/S0968-0896(98)00099-6; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Merrick KA, 2011, MOL CELL, V42, P624, DOI 10.1016/j.molcel.2011.03.031; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; PARKIN DW, 1984, J BIOL CHEM, V259, P9411; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Ray AS, 2004, BIOCHEM PHARMACOL, V68, P1825, DOI 10.1016/j.bcp.2004.07.010; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shetty RS, 2011, HUM MOL GENET, V20, P4093, DOI 10.1093/hmg/ddr333; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Ultanir SK, 2012, NEURON, V73, P1127, DOI 10.1016/j.neuron.2012.01.019; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vela JE, 2007, J CHROMATOGR B, V848, P335, DOI 10.1016/j.jchromb.2006.10.063; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wei LY, 2010, BIOORG MED CHEM LETT, V20, P3897, DOI 10.1016/j.bmcl.2010.05.019; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhou ZR, 2012, BIOCHEM J, V441, P143, DOI 10.1042/BJ20110699	64	182	189	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					737	747		10.1016/j.cell.2013.07.030	http://dx.doi.org/10.1016/j.cell.2013.07.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953109	Bronze, Green Accepted			2022-12-28	WOS:000323202500007
J	Bel, EH				Bel, Elisabeth H.			Mild Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED CORTICOSTEROIDS; SEVERE EXACERBATIONS; LUNG-FUNCTION; HIGH-RISK; CHILDHOOD; CHILDREN; THERAPY; ASSOCIATION; ANTAGONISTS; BUDESONIDE	A 20-year-old college student with a history of asthma and allergic rhinitis, which were diagnosed in childhood, presents with cough and tightness of the chest that interfere with his sleep three or four times per month. He requires albuterol two or three times per week. He enjoys playing tennis but generally wheezes after a match. Last year, during the pollen season, he sought treatment in an emergency department for acute asthma but was not admitted to the hospital. His forced expiratory volume in 1 second (FEV1) is 93% of the predicted value. How should this case be evaluated and managed?	Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Bel, EH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.h.bel@amc.uva.nl			GlaxoSmithKline; Novartis; Chiesi	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Chiesi(Chiesi Pharmaceuticals Inc)	Dr. Bel reports receiving consulting and lecture fees from GlaxoSmithKline and grants to her institution from Novartis, GlaxoSmithKline and Chiesi. No other potential conflict of interest relevant to this article was reported.	Abramson MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001186.pub2; [Anonymous], TRENDS ASTHM MORB MO; [Anonymous], 2007, 3 EXP PAN NAT ASTHM; Barnes ML, 2007, ALLERGY, V62, P73, DOI 10.1111/j.1398-9995.2006.01263.x; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V102, P531, DOI 10.1016/S0091-6749(98)70268-4; Bateman ED, 2008, PULM PHARMACOL THER, V21, P264, DOI 10.1016/j.pupt.2007.05.002; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Boulet LP, 2011, EXPERT REV RESP MED, V5, P377, DOI [10.1586/ERS.11.34, 10.1586/ers.11.34]; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Cazzoletti L, 2007, J ALLERGY CLIN IMMUN, V120, P1360, DOI 10.1016/j.jaci.2007.09.019; Chauhan BF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009611.pub2; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; Crocker DD, 2011, AM J PREV MED, V41, pS5, DOI [10.1016/j.amepre.2011.05.012, 10.1016/j.amepre.2011.04.011]; Drazen JM, 1996, NEW ENGL J MED, V335, P841, DOI 10.1056/NEJM199609193351202; Drazen JM, 1999, NEW ENGL J MED, V340, P663; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Ducharme FM, 2011, COCHRANE DB SYST REV, V5; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Gibson PG, 2004, THORAX, V59, P94, DOI 10.1136/thorax.2003.011858; Gotzsche PC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001187.pub3; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; Hanania NA, 2009, NEW ENGL J MED, V360, P1487, DOI 10.1056/NEJMoa0806290; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jia CE, 2013, J ALLERGY CLIN IMMUN, V131, P695, DOI 10.1016/j.jaci.2012.08.023; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mitchell EA, 2012, THORAX, V67, P941, DOI 10.1136/thoraxjnl-2011-200901; O'Byrne PM, 2010, AM J RESP CRIT CARE, V182, P983, DOI 10.1164/ajrccm.182.7.983a; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Peters SP, 2007, NEW ENGL J MED, V357, P728; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Petsky HL, 2012, THORAX, V67, P199, DOI 10.1136/thx.2010.135574; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reed CE, 2006, J ALLERGY CLIN IMMUN, V118, P543, DOI 10.1016/j.jaci.2006.06.020; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Taylor DR, 2008, EUR RESPIR J, V32, P545, DOI 10.1183/09031936.00155307; Thomas M, 2012, PRIM CARE RESP J, V21, P8, DOI 10.4104/pcrj.2012.00022; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204	50	25	25	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					549	557		10.1056/NEJMcp1214826	http://dx.doi.org/10.1056/NEJMcp1214826			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924005				2022-12-28	WOS:000322842000011
J	Crosby, SS				Crosby, Sondra S.			Primary Care Management of Non-English-Speaking Refugees Who Have Experienced Trauma A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTTRAUMATIC-STRESS-DISORDER; INTERNALLY DISPLACED PERSONS; MENTAL-HEALTH; TORTURE SURVIVORS; PERSISTENT PAIN; IMMIGRANT; SEQUELAE; VIOLENCE; PATIENT; SOMALI	IMPORTANCE Refugees are a vulnerable class of immigrants who have fled their countries, typically following war, violence, or natural disaster, and who have frequently experienced trauma. In primary care, engaging refugees to develop a positive therapeutic relationship is challenging. Relative to care of other primary care patients, there are important differences in symptom evaluation and developing treatment plans. OBJECTIVES To discuss the importance of and methods for obtaining refugee trauma histories, to recognize the psychological and physical manifestations of trauma characteristic of refugees, and to explore how cultural differences and limited English proficiency affect the refugee patient-clinician relationship and how to best use interpreters. EVIDENCE REVIEW MEDLINE and the Cochrane Library were searched from 1984 to 2012. Additional citations were obtained from lists of references from select research and review articles on this topic. FINDINGS Engagement with a refugee patient who has experienced trauma requires an understanding of the trauma history and the trauma-related symptoms. Mental health symptoms and chronic pain are commonly experienced by refugee patients. Successful treatment requires a multidisciplinary approach that is culturally acceptable to the refugee. CONCLUSIONS AND RELEVANCE Refugee patients frequently have experienced trauma requiring a directed history and physical examination, facilitated by an interpreter if necessary. Intervention should be sensitive to the refugee's cultural mores.	[Crosby, Sondra S.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Crosby, Sondra S.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University; Boston University	Crosby, SS (corresponding author), Boston Med Ctr, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	scrosby@bu.edu		Crosby, Sondra/0000-0002-1672-5407				Amnesty International, AMNESTY INTERNATIONA; Amnesty International, MASS RAPE TIME FOR R; Amowitz LL, 2002, JAMA-J AM MED ASSOC, V287, P513, DOI 10.1001/jama.287.4.513; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Campagna AM, 2013, MAYO CLIN PROC, V88, P31, DOI 10.1016/j.mayocp.2012.07.027; Carinci AJ, 2010, CURR PAIN HEADACHE R, V14, P73, DOI 10.1007/s11916-010-0101-2; Carlsson JM, 2006, J NERV MENT DIS, V194, P725, DOI 10.1097/01.nmd.0000243079.52138.b7; Carroll J, 2007, PATIENT EDUC COUNS, V66, P337, DOI 10.1016/j.pec.2007.01.008; CHEUNG P, 1993, AUST NZ J PSYCHIAT, V27, P422, DOI 10.3109/00048679309075798; Crosby SS, 2007, GEN HOSP PSYCHIAT, V29, P169, DOI 10.1016/j.genhosppsych.2006.11.003; Crosby SS, 2010, LARYNGOSCOPE, V120, P414, DOI 10.1002/lary.20731; Danielsen L, 1992, TORTURE SUPPL 1, P27; Danneskiold-Samsoe B, 1992, TORTURE SUPPL 1, P33; Donovan P, 2002, LANCET, V360, pS17, DOI 10.1016/S0140-6736(02)11804-6; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Grigg-Saito D, 2010, AM J PUBLIC HEALTH, V100, P2026, DOI 10.2105/AJPH.2009.177030; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Jaranson JM, 2004, AM J PUBLIC HEALTH, V94, P591, DOI 10.2105/AJPH.94.4.591; Jerlang P, 1992, TORTURE SUPPL 1, P38; Julher M, 1992, TORTURE SUPPL 1, P25; Kaiser Commission on Medicaid and the Uninsured, 2001, CARING FOR IMMIGRANT; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Keatley E, 2013, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0b013e3182776a70, DOI 10.1097/HTR.OB013E3182776A70]; Keygnaert I, 2012, CULT HEALTH SEX, V14, P505, DOI 10.1080/13691058.2012.671961; Kreps GL, 2008, PATIENT EDUC COUNS, V71, P328, DOI 10.1016/j.pec.2008.03.001; Lauderdale DS, 2006, MED CARE, V44, P914, DOI 10.1097/01.mlr.0000220829.87073.f7; Liedl A, 2011, PAIN MED, V12, P234, DOI 10.1111/j.1526-4637.2010.01040.x; Longacre McKenna, 2012, Torture, V22, P38; Massachusetts Department of Public Health, REFUGEE AND IMMIGRAN; Miles SH, 2008, BMJ-BRIT MED J, V337, pa1088; Minnesota Department of Public Health, REFUGEE HEALTH PROVI; Modvig J, 2004, BROKEN SPIRITS THE T, P42; Mollica R, 2006, HEALING INVISIBLEWOU; Mollica RF, 1991, PSYCHOL ASSESSMENT, V3, P2; Mollica RF, 2014, INT J SOC PSYCHIATR, V60, P6, DOI 10.1177/0020764012471597; Mollica Richard F, 2011, Torture, V21, P8; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Moreno A, 2002, SPINAL CORD, V40, P213, DOI 10.1038/sj.sc.3101284; Moreno A, 2001, JAMA-J AM MED ASSOC, V285, P1215, DOI 10.1001/jama.285.9.1215; Moreno A, 2000, JAMA-J AM MED ASSOC, V284, P538, DOI 10.1001/jama.284.5.538; Murray KE, 2010, AM J ORTHOPSYCHIAT, V80, P576, DOI 10.1111/j.1939-0025.2010.01062.x; Ngo-Metzger Q, 2003, J GEN INTERN MED, V18, P44, DOI 10.1046/j.1525-1497.2003.20205.x; Nour NM, 2004, OBSTET GYNECOL SURV, V59, P272, DOI 10.1097/01.OGX.0000118939.19371.AF; Office of Refugee Resettlement, ORR YEAR IN REVIEW 2; Office of Refugee Resettlement, SERVICES FOR SURVIVO; Office of the United Nations High Commissioner on Human Rights, THE ISTANBUL PROTOCO; Padhye Subhash, 2008, Cancer Ther, V6, P495; Physicians for Human Rights, 2009, NOWHERE TO TURN FAIL; Physicians for Human Rights, EXAMINING ASYLUM SEE; Piwowarczyk L, 2000, JAMA-J AM MED ASSOC, V284, P539, DOI 10.1001/jama.284.5.539; Piwowarczyk L, 2008, INT ENCY PUBLIC HLTH, V6, P341, DOI DOI 10.1016/B978-012373960-5.00397-X; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; Rabbe A, 1992, TORTURE SUPPL 1, P36; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Rasmussen OV, 1992, TORTURE SUPPL 1, P41; Refugee Health Technical Assistance Center, UPCOMINGWEBINARS; Shannon Patricia, 2012, Ment Health Fam Med, V9, P47; Simpson J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1361; Sjolund BH, 2009, J REHABIL MED, V41, P689, DOI 10.2340/16501977-0426; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Swiss S, 1998, JAMA-J AM MED ASSOC, V279, P625, DOI 10.1001/jama.279.8.625; United Nations General Assembly, SEXUAL AND GENDER BA; United Nations General Assembly, CONVENTION AGAINST T; United Nations High Commissioner for Refugees, CONVENTION AND PROTO; United Nations High Commissioner for Refugees, YEAR CRIS UNHCR GLOB; United Nations High Commissioner for Refugees (UNHCR), WHAT IS A REFUGEE; US Department of State, HUMAN RIGHTS REPORTS; Walker PF, 2007, IMMIGRANT MEDICINE; WESTERMEYER J, 1989, PSYCHOSOMATICS, V30, P34, DOI 10.1016/S0033-3182(89)72315-X; Westermeyer JJ, 2010, PSYCHIAT SERV, V61, P1132, DOI 10.1176/ps.2010.61.11.1132; Williams ACD, 2010, J PAIN SYMPTOM MANAG, V40, P715, DOI 10.1016/j.jpainsymman.2010.02.018; Williams ME, 2011, J IMMIGR MINOR HEALT, V13, P780, DOI 10.1007/s10903-010-9417-6; Wolfe L, 2013, ATLANTIC; World Health Organization, FEMALE GENITAL MUTIL	75	68	68	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					519	528		10.1001/jama.2013.8788	http://dx.doi.org/10.1001/jama.2013.8788			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	196OZ	23925622				2022-12-28	WOS:000322786400024
J	Stoltzfus, RJ; Rasmussen, KM				Stoltzfus, Rebecca J.; Rasmussen, Kathleen M.			The dangers of being born too small or too soon	LANCET			English	Editorial Material							GROWTH		[Stoltzfus, Rebecca J.; Rasmussen, Kathleen M.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Stoltzfus, RJ (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	rjs62@cornell.edu						Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Caulfield L E, 1991, Paediatr Perinat Epidemiol, V5, P263, DOI 10.1111/j.1365-3016.1991.tb00709.x; Chantry CJ, 2011, PEDIATRICS, V127, pE171, DOI 10.1542/peds.2009-2663; Heidkamp RA, 2011, EVALUATION OF AN INF; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Neufeld LM, 2004, INT J GYNECOL OBSTET, V84, P220, DOI 10.1016/S0020-7292(03)00335-7; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Ruel MT, 2001, NESTLE NUTR WORKS SE, V47, P123; Vik T, 1997, ACTA OBSTET GYN SCAN, V76, P76	10	8	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					380	381		10.1016/S0140-6736(13)61567-6	http://dx.doi.org/10.1016/S0140-6736(13)61567-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23911366				2022-12-28	WOS:000322638500011
J	Moellering, RE; Cravatt, BF				Moellering, Raymond E.; Cravatt, Benjamin F.			Functional Lysine Modification by an Intrinsically Reactive Primary Glycolytic Metabolite	SCIENCE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHORYLATION; ACTIVATION; COMPLEXES; PROTEIN; CELLS; SITE; KEY	The posttranslational modification of proteins and their regulation by metabolites represent conserved mechanisms in biology. At the confluence of these two processes, we report that the primary glycolytic intermediate 1,3-bisphosphoglycerate (1,3-BPG) reacts with select lysine residues in proteins to form 3-phosphoglyceryl-lysine (pgK). This reaction, which does not require enzyme catalysis, but rather exploits the electrophilicity of 1,3-BPG, was found by proteomic profiling to be enriched on diverse classes of proteins and prominently in or around the active sites of glycolytic enzymes. pgK modifications inhibit glycolytic enzymes and, in cells exposed to high glucose, accumulate on these enzymes to create a potential feedback mechanism that contributes to the buildup and redirection of glycolytic intermediates to alternate biosynthetic pathways.	[Moellering, Raymond E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Moellering, RE (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	rmoeller@scripps.edu; cravatt@scripps.edu		Moellering, Raymond/0000-0002-2043-7838	NIH [CA087660]; Damon Runyon Cancer Research Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R37CA087660, R01CA087660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Dix and S. Niessen for assistance with mass spectrometry, C. Wang for support and advice on the use of CIMAGE software, and G. Simon for helpful discussions. Supported by the NIH (CA087660), the Damon Runyon Cancer Research Foundation (R.E.M. is a Howard Hughes Medical Institute Postdoctoral Fellow), and the Skaggs Institute for Chemical Biology.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; DEMOSS JA, 1956, P NATL ACAD SCI USA, V42, P325, DOI 10.1073/pnas.42.6.325; Fueger BJ, 2006, J NUCL MED, V47, P999; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; ROSA R, 1978, J CLIN INVEST, V62, P907, DOI 10.1172/JCI109218; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Sims PA, 2003, BIOCHEMISTRY-US, V42, P8298, DOI 10.1021/bi0346345; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Walsh C., 2006, POSTTRANSLATIONAL MO; Wang TN, 2012, J AM CHEM SOC, V134, P8958, DOI 10.1021/ja301994d; Yego ECK, 2010, J BIOL CHEM, V285, P3181, DOI 10.1074/jbc.M109.083907; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	25	134	143	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					549	553		10.1126/science.1238327	http://dx.doi.org/10.1126/science.1238327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908237	Green Accepted			2022-12-28	WOS:000322586700054
J	Hansen, BMS; Kalirai, JS; Anderson, J; Dotter, A; Richer, HB; Rich, RM; Shara, MM; Fahlman, GG; Hurley, JR; King, IR; Reitzel, D; Stetson, PB				Hansen, B. M. S.; Kalirai, J. S.; Anderson, J.; Dotter, A.; Richer, H. B.; Rich, R. M.; Shara, M. M.; Fahlman, G. G.; Hurley, J. R.; King, I. R.; Reitzel, D.; Stetson, P. B.			An age difference of two billion years between a metal-rich and a metal-poor globular cluster	NATURE			English	Article							DWARF COOLING SEQUENCE; ACS SURVEY; GALAXY; HALO; DISK; ABUNDANCES; EVOLUTION; STARS	Globular clusters trace the formation history of the spheroidal components of our Galaxy and other galaxies(1), which represent the bulk of star formation over the history of the Universe(2). The clusters exhibit a range of metallicities (abundances of elements heavier than helium), with metal-poor clusters dominating the stellar halo of the Galaxy, and higher-metallicity clusters found within the inner Galaxy, associated with the stellar bulge, or the thick disk(3,4). Age differences between these clusters can indicate the sequence in which the components of the Galaxy formed, and in particular which clusters were formed outside the Galaxy and were later engulfed along with their original host galaxies, and which were formed within it. Here we report an absolute age of 9.9 +/- 0.7 billion years (at 95 per cent confidence) for the metal-rich globular cluster 47 Tucanae, determined by modelling the properties of the cluster's white-dwarf cooling sequence. This is about two billion years younger than has been inferred for the metal-poor cluster NGC 6397 from the same models, and provides quantitative evidence that metal-rich clusters like 47 Tucanae formed later than metal-poor halo clusters like NGC 6397.	[Hansen, B. M. S.; Rich, R. M.; Reitzel, D.] Univ Calif Los Angeles, Div Astron, Los Angeles, CA 90095 USA; [Kalirai, J. S.; Anderson, J.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Kalirai, J. S.] Johns Hopkins Univ, Ctr Astrophys Sci, Baltimore, MD 21218 USA; [Dotter, A.] Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Richer, H. B.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Shara, M. M.] Amer Museum Nat Hist, Dept Astrophys, New York, NY 10024 USA; [Fahlman, G. G.; Stetson, P. B.] NRC Herzberg, Victoria, BC V9E 2E7, Canada; [Hurley, J. R.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [King, I. R.] Univ Washington, Dept Astron, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; Space Telescope Science Institute; Johns Hopkins University; Australian National University; University of British Columbia; American Museum of Natural History (AMNH); National Research Council Canada; Swinburne University of Technology; University of Washington; University of Washington Seattle	Hansen, BMS (corresponding author), Univ Calif Los Angeles, Div Astron, Los Angeles, CA 90095 USA.	hansen@astro.ucla.edu		Hurley, Jarrod/0000-0003-2694-0415	NASA through Space Telescope Science Institute [GO-11677]; NASA [NAS 5-26555]; Natural Science and Engineering Research Council of Canada	NASA through Space Telescope Science Institute(Space Telescope Science Institute); NASA(National Aeronautics & Space Administration (NASA)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support for the programme GO-11677 was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. This work is supported in part by the Natural Science and Engineering Research Council of Canada.	Bedin LR, 2009, ASTROPHYS J, V697, P965, DOI 10.1088/0004-637X/697/2/965; Brodie JP, 2006, ANNU REV ASTRON ASTR, V44, P193, DOI 10.1146/annurev.astro.44.051905.092441; Carretta E, 2009, ASTRON ASTROPHYS, V508, P695, DOI 10.1051/0004-6361/200913003; De Angeli F, 2005, ASTRON J, V130, P116, DOI 10.1086/430723; Dotter A, 2007, ASTRON J, V134, P376, DOI 10.1086/517915; Dotter A, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/74; Fukugita M, 1998, ASTROPHYS J, V503, P518, DOI 10.1086/306025; Garcia-Berro E, 2010, NATURE, V465, P194, DOI 10.1038/nature09045; Gratton RG, 2003, ASTRON ASTROPHYS, V408, P529, DOI 10.1051/0004-6361:20031003; Hansen BMS, 2002, ASTROPHYS J, V574, pL155, DOI 10.1086/342528; Hansen BMS, 2004, ASTROPHYS J SUPPL S, V155, P551, DOI 10.1086/424832; Koch A, 2008, ASTRON J, V135, P1551, DOI 10.1088/0004-6256/135/4/1551; Marin-Franch A, 2009, ASTROPHYS J, V694, P1498, DOI 10.1088/0004-637X/694/2/1498; McWilliam A, 2008, ASTROPHYS J, V684, P326, DOI 10.1086/589957; Milone AP, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/58; MINNITI D, 1995, ASTRON J, V109, P1663, DOI 10.1086/117393; Muratov AL, 2010, ASTROPHYS J, V718, P1266, DOI 10.1088/0004-637X/718/2/1266; Paxton B, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/3; Rosenberg A, 1999, ASTRON J, V118, P2306, DOI 10.1086/301089; Salaris M, 2007, ASTRON ASTROPHYS, V476, P243, DOI 10.1051/0004-6361:20078445; Salaris M, 2002, ASTRON ASTROPHYS, V388, P492, DOI 10.1051/0004-6361:20020554; Salaris M, 1998, ASTRON ASTROPHYS, V335, P943; Shapiro KL, 2010, MON NOT R ASTRON SOC, V403, pL36, DOI 10.1111/j.1745-3933.2010.00810.x; Thompson IB, 2010, ASTRON J, V139, P329, DOI 10.1088/0004-6256/139/2/329; Tonini C, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/39; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500; VandenBerg DA, 2000, ASTROPHYS J SUPPL S, V129, P315, DOI 10.1086/313404; Wright EL, 2006, PUBL ASTRON SOC PAC, V118, P1711, DOI 10.1086/510102	30	99	101	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					51	53		10.1038/nature12334	http://dx.doi.org/10.1038/nature12334			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23903747	Green Submitted			2022-12-28	WOS:000322514800025
J	Stefflova, K; Thybert, D; Wilson, MD; Streeter, I; Aleksic, J; Karagianni, P; Brazma, A; Adams, DJ; Talianidis, I; Marioni, JC; Flicek, P; Odom, DT				Stefflova, Klara; Thybert, David; Wilson, Michael D.; Streeter, Ian; Aleksic, Jelena; Karagianni, Panagiota; Brazma, Alvis; Adams, David J.; Talianidis, Iannis; Marioni, John C.; Flicek, Paul; Odom, Duncan T.			Cooperativity and Rapid Evolution of Cobound Transcription Factors in Closely Related Mammals	CELL			English	Article							CHROMATIN ACCESSIBILITY; FACTOR-BINDING; TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; CHIP-SEQ; DROSOPHILA; GENOME; OCCUPANCY; ENHANCERS; DYNAMICS	To mechanistically characterize the microevolutionary processes active in altering transcription factor (TF) binding among closely related mammals, we compared the genome-wide binding of three tissue-specific TFs that control liver gene expression in six rodents. Despite an overall fast turnover of TF binding locations between species, we identified thousands of TF regions of highly constrained TF binding intensity. Although individual mutations in bound sequence motifs can influence TF binding, most binding differences occur in the absence of nearby sequence variations. Instead, combinatorial binding was found to be significant for genetic and evolutionary stability; cobound TFs tend to disappear in concert and were sensitive to genetic knockout of partner TFs. The large, qualitative differences in genomic regions bound between closely related mammals, when contrasted with the smaller, quantitative TF binding differences among Drosophila species, illustrate how genome structure and population genetics together shape regulatory evolution.	[Stefflova, Klara; Odom, Duncan T.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Thybert, David; Streeter, Ian; Brazma, Alvis; Marioni, John C.; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Wilson, Michael D.] Univ Toronto, Hosp Sick Children SickKids, Genet & Genome Biol Program, Toronto, ON M5G 1L7, Canada; [Wilson, Michael D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Aleksic, Jelena] Univ Cambridge, Dept Genet, Cambridge CB1 3QA, England; [Aleksic, Jelena] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Karagianni, Panagiota; Talianidis, Iannis] Biomed Sci Res Ctr Alexander Fleming, Vari 16672, Greece; [Adams, David J.; Flicek, Paul; Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Cambridge; University of Cambridge; Alexander Fleming Biomedical Sciences Research Center; Wellcome Trust Sanger Institute	Flicek, P (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	flicek@ebi.ac.uk; duncan.odom@cruk.cam.ac.uk	Wilson, Michael D/K-6294-2014; Talianidis, Iannis/F-7556-2016	Wilson, Michael D/0000-0002-4015-3066; Talianidis, Iannis/0000-0002-1209-3609; Streeter, Ian/0000-0003-4024-3552; Flicek, Paul/0000-0002-3897-7955; Barsi, Klara/0000-0001-9338-0468; Thybert, David/0000-0001-7806-7318; Brazma, Alvis/0000-0001-5988-7409; Adams, David/0000-0001-9490-0306; Marioni, John/0000-0001-9092-0852; Odom, Duncan/0000-0001-6201-5599	European Molecular Biology Laboratory; Cancer Research UK; Wellcome Trust [WT095908, WT098051]; Marie Curie Reintegration Award; European Research Council; EMBO Young Investigator Programme; European Community [244356]; European Community Reintegration Fellowship; Cancer Research UK [13031, 15603] Funding Source: researchfish	European Molecular Biology Laboratory; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Reintegration Award; European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); European Community(European Commission); European Community Reintegration Fellowship; Cancer Research UK(Cancer Research UK)	We thank the CRUK-CI Genomics and Bioinformatics Cores for technical assistance, the EBI's systems team for management of computational resources, and the thoughtful anonymous peer reviewers. This research was supported by the European Molecular Biology Laboratory (A.B., J.C.M., and P.F.), Cancer Research UK (K.S., M.D.W., D.J.A., and D.T.O.), the Wellcome Trust (WT095908 to D.T. and P.F.) and (WT098051 to P.F., D.J.A., and D.T.O.), Marie Curie Reintegration Award (K.S.), and the European Research Council and EMBO Young Investigator Programme (D.T.O.). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2010-2014) under grant agreement 244356 (NextGen) and for a Reintegration Fellowship (K.S.).	Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Boj SF, 2009, DIABETES, V58, P1245, DOI 10.2337/db08-0812; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Gonzalez J, 2012, METHODS MOL BIOL, V855, P361, DOI 10.1007/978-1-61779-582-4_13; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; He BZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002053; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Lin MF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000067; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Ludwig MG, 2000, J BIOL CHEM, V275, P39981, DOI 10.1074/jbc.M007529200; Lynch M, 2007, ORIGINS GENOME ARCHI; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Piano F, 1999, GENETICS, V152, P605; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	48	102	103	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					530	540		10.1016/j.cell.2013.07.007	http://dx.doi.org/10.1016/j.cell.2013.07.007			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911320	Green Published, hybrid			2022-12-28	WOS:000322629900008
J	Leichsenring, M; Maes, J; Mossner, R; Driever, W; Onichtchouk, D				Leichsenring, Manuel; Maes, Julia; Moessner, Rebecca; Driever, Wolfgang; Onichtchouk, Daria			Pou5f1 Transcription Factor Controls Zygotic Gene Activation In Vertebrates	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; REGULATORY NETWORK; ENDODERM FORMATION; ZEBRAFISH; EXPRESSION; DROSOPHILA; PLURIPOTENCY; TRANSITION; EVOLUTION; REGIONS	The development of multicellular animals is initially controlled by maternal gene products deposited in the oocyte. During the maternal-to-zygotic transition, transcription of zygotic genes commences, and developmental control starts to be regulated by zygotic gene products. In Drosophila, the transcription factor Zelda specifically binds to promoters of the earliest zygotic genes and primes them for activation. It is unknown whether a similar regulation exists in other animals. We found that zebrafish Pou5f1, a homolog of the mammalian pluripotency transcription factor Oct4, occupies SOX-POU binding sites before the onset of zygotic transcription and activates the earliest zygotic genes. Our data position Pou5f1 and SOX-POU sites at the center of the zygotic gene activation network of vertebrates and provide a link between zygotic gene activation and pluripotency control.	[Leichsenring, Manuel; Maes, Julia; Moessner, Rebecca; Driever, Wolfgang; Onichtchouk, Daria] Univ Freiburg, Fac Biol, Inst Biol 1, Dev Biol Unit, D-79085 Freiburg, Germany; [Driever, Wolfgang; Onichtchouk, Daria] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79085 Freiburg, Germany	University of Freiburg; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 1, Dev Biol Unit, D-79085 Freiburg, Germany.	driever@biologie.uni-freiburg.de; daria.onichtchouk@biologie.uni-freiburg.de	Onichtchouk, Daria/E-1741-2012	Onichtchouk, Daria/0000-0001-6497-1445; Driever, Wolfgang/0000-0002-9551-9141	Deutsche Forschungsgemeinschaft [DFG-EXC294, DFG-SFB592]; Bundesministerium fur Bildung und Forschung [BMBF-0313921FRISYS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank S. Shvartsman for scientific discussion; S. Arnold, G. Pyrowolakis, V. Taylor, A. Fuchs, S. Eckerle, and M. Fernandes for comments; B. Wendik and J. Paddeken for participating in initial stages of this work; Y. Kamachi for Sox3/19a/19b antibody; L. Yampolsky for help with statistics; and S. Gotter for fish care. Supported by Deutsche Forschungsgemeinschaft grants DFG-EXC294 and DFG-SFB592 (W. D. and D.O.) and Bundesministerium fur Bildung und Forschung grant BMBF-0313921FRISYS (W. D.). Microarray and ChIP-Seq data GEO (www.ncbi.nlm.nih.gov/geo) accession numbers: CHIP-seq data, GSE39780; microarray data, GSE41107, GSE17655, and GSE17656.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Belting HG, 2001, DEVELOPMENT, V128, P4165; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Fernandez-Tresguerres B, 2010, P NATL ACAD SCI USA, V107, P19955, DOI 10.1073/pnas.1010708107; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; KANE DA, 1993, DEVELOPMENT, V119, P447; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Papatsenko I, 2010, BIOINFORMATICS, V26, P2731, DOI 10.1093/bioinformatics/btq513; Reim G, 2004, DEV CELL, V6, P91, DOI 10.1016/S1534-5807(03)00396-4; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Satija R, 2012, GENOME RES, V22, P656, DOI 10.1101/gr.130682.111; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003	29	142	148	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1005	1009		10.1126/science.1242527	http://dx.doi.org/10.1126/science.1242527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23950494				2022-12-28	WOS:000323652300044
J	Myerson, AS; Trout, BL				Myerson, Allan S.; Trout, Bernhardt L.			Nucleation from Solution	SCIENCE			English	Editorial Material							NONCLASSICAL NUCLEATION; CRYSTALS; SURFACE		[Myerson, Allan S.; Trout, Bernhardt L.] MIT, Dept Chem Engn, Cambridge, MA 02130 USA	Massachusetts Institute of Technology (MIT)	Myerson, AS (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave,E19-502, Cambridge, MA 02130 USA.	myerson@mit.edu; trout@mit.edu						Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Dawkins Richard, 1976, SELFISH GENE; Diao Y, 2011, NAT MATER, V10, P867, DOI [10.1038/nmat3117, 10.1038/NMAT3117]; E WN, 2010, ANNU REV PHYS CHEM, V61, P391, DOI 10.1146/annurev.physchem.040808.090412; Erdemir D, 2009, ACCOUNTS CHEM RES, V42, P621, DOI 10.1021/ar800217x; Garetz BA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.175501; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Giberti F, 2013, J CHEM THEORY COMPUT, V9, P2526, DOI 10.1021/ct4002027; Lechner W, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651367; Raiteri P, 2010, J AM CHEM SOC, V132, P17623, DOI 10.1021/ja108508k; Santiso EE, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3548889; Sear RP, 2012, INT MATER REV, V57, P328, DOI 10.1179/1743280411Y.0000000015; TENWOLDE PR, 1995, PHYS REV LETT, V75, P2714, DOI 10.1103/PhysRevLett.75.2714; Vekilov PG, 2010, CRYST GROWTH DES, V10, P5007, DOI 10.1021/cg1011633; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915	15	138	143	4	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					855	856		10.1126/science.1243022	http://dx.doi.org/10.1126/science.1243022			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970690				2022-12-28	WOS:000323370600030
J	Reimer, LJ; Thomsen, EK; Tisch, DJ; Henry-Halldin, CN; Zimmerman, PA; Baea, ME; Dagoro, H; Susapu, M; Hetzel, MW; Bockarie, MJ; Michael, E; Siba, PM; Kazura, JW				Reimer, Lisa J.; Thomsen, Edward K.; Tisch, Daniel J.; Henry-Halldin, Cara N.; Zimmerman, Peter A.; Baea, Manasseh E.; Dagoro, Henry; Susapu, Melinda; Hetzel, Manuel W.; Bockarie, Moses J.; Michael, Edwin; Siba, Peter M.; Kazura, James W.			Insecticidal Bed Nets and Filariasis Transmission in Papua New Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELIMINATE LYMPHATIC FILARIASIS; WUCHERERIA-BANCROFTI INFECTION; GLOBAL PROGRAM; VECTOR-CONTROL; END-POINTS; MALARIA; DISEASE; IMPACT; PREVALENCE; IVERMECTIN	BACKGROUND Global efforts to eliminate lymphatic filariasis are based on the annual mass administration of antifilarial drugs to reduce the microfilaria reservoir available to the mosquito vector. Insecticide-treated bed nets are being widely used in areas in which filariasis and malaria are coendemic. METHODS We studied five villages in which five annual mass administrations of antifilarial drugs, which were completed in 1998, reduced the transmission of Wuchereria bancrofti, one of the nematodes that cause lymphatic filariasis. A total of 21,899 anopheles mosquitoes were collected for 26 months before and 11 to 36 months after bed nets treated with long-lasting insecticide were distributed in 2009. We evaluated the status of filarial infection and the presence of W. bancrofti DNA in anopheline mosquitoes before and after the introduction of insecticide-treated bed nets. We then used a model of population dynamics to estimate the probabilities of transmission cessation. RESULTS Village-specific rates of bites from anopheline mosquitoes ranged from 6.4 to 61.3 bites per person per day before the bed-net distribution and from 1.1 to 9.4 bites for 11 months after distribution (P<0.001). During the same period, the rate of detection of W. bancrofti in anopheline mosquitoes decreased from 1.8% to 0.4% (P=0.005), and the rate of detection of filarial DNA decreased from 19.4% to 14.9% (P=0.13). The annual transmission potential was 5 to 325 infective larvae inoculated per person per year before the bed-net distribution and 0 after the distribution. Among all five villages with a prevalence of microfilariae of 2 to 38%, the probability of transmission cessation increased from less than 1.0% before the bed-net distribution to a range of 4.9 to 95% in the 11 months after distribution. CONCLUSIONS Vector control with insecticide-treated bed nets is a valuable tool for W. bancrofti elimination in areas in which anopheline mosquitoes transmit the parasite.	[Reimer, Lisa J.; Thomsen, Edward K.; Baea, Manasseh E.; Dagoro, Henry; Hetzel, Manuel W.; Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Reimer, Lisa J.; Thomsen, Edward K.; Baea, Manasseh E.; Dagoro, Henry; Hetzel, Manuel W.; Siba, Peter M.] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Susapu, Melinda] Papua New Guinea Dept Hlth, Port Moresby, Papua N Guinea; [Reimer, Lisa J.; Thomsen, Edward K.; Tisch, Daniel J.; Henry-Halldin, Cara N.; Zimmerman, Peter A.; Kazura, James W.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Reimer, Lisa J.; Thomsen, Edward K.; Susapu, Melinda; Bockarie, Moses J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hetzel, Manuel W.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Michael, Edwin] Univ Notre Dame, South Bend, IN USA	PNG Institute Of Medical Research; PNG Institute Of Medical Research; Case Western Reserve University; Liverpool School of Tropical Medicine; University of Liverpool; University of Queensland; University of Notre Dame	Kazura, JW (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Sch Med, 2109 Adelbert Rd,Suite 431, Cleveland, OH 44106 USA.	jxk14@case.edu; jxk14@case.edu	Bockarie, Moses/AAV-4578-2020; Tisch, Daniel/Q-5044-2019; Thomsen, Edward/AAH-3299-2020; Bockarie, Moses/AAW-3130-2021; Michael, Edwin/D-3388-2014	Thomsen, Edward/0000-0003-1136-6430; Reimer, Lisa/0000-0002-9711-4981; Hetzel, Manuel W./0000-0002-5285-3254; Zimmerman, Peter/0000-0002-5349-4513; Halldin, Cara/0000-0002-8050-8407	U.S. Public Health Service; National Institutes of Health [U19 AI065717]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097262, U19AI089686, U19AI065717] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the U.S. Public Health Service and a grant (U19 AI065717) from the National Institutes of Health.	Alexander NDE, 2001, T ROY SOC TROP MED H, V95, P277, DOI 10.1016/S0035-9203(01)90233-0; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P361; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P121; [Anonymous], 2007, NAT STRAT PLAN ACT P; Backhouse T. C., 1934, Transactions of the Royal Society of Tropical Medicine and Hygiene, V27, P365, DOI 10.1016/S0035-9203(34)90052-3; BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478; Belkin J.N., 1962, MOSQUITOES S PACIFIC, VI and II; Bockarie MJ, 1998, LANCET, V351, P162, DOI 10.1016/S0140-6736(97)07081-5; Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; Bockarie MJ, 2002, MED VET ENTOMOL, V16, P116, DOI 10.1046/j.0269-283x.2002.00352.x; Bockarie MJ, 2009, ANNU REV ENTOMOL, V54, P469, DOI 10.1146/annurev.ento.54.110807.090626; Brockarie M, 1996, AM J TROP MED HYG, V54, P577, DOI 10.4269/ajtmh.1996.54.577; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; Farid HA, 2007, AM J TROP MED HYG, V77, P593, DOI 10.4269/ajtmh.2007.77.593; Gambhir M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-22; Gambhir M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002874; Gass K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001479; Gyapong M, 1996, SOC SCI MED, V43, P235, DOI 10.1016/0277-9536(95)00365-7; Henry-Halldin CN, 2011, AM J TROP MED HYG, V84, P166, DOI 10.4269/ajtmh.2011.10-0438; Kazura JW, 2005, REPORT SCI WORKING G, P58; Kyelem D, 2008, AM J TROP MED HYG, V79, P480; Maxwell CA, 1999, B WORLD HEALTH ORGAN, V77, P138; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; NELSON G S, 1958, Bull World Health Organ, V19, P204; NELSON G. S., 1959, JOUR HEL MINTHOL, V33, P233, DOI 10.1017/S0022149X00033484; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Pedersen EM, 2002, ANN TROP MED PARASIT, V96, pS91, DOI 10.1179/000349802125002437; Prasittisuk C, 2002, ANN TROP MED PARASIT, V96, pS133, DOI 10.1179/000349802125002482; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; Sunish IP, 2007, B WORLD HEALTH ORGAN, V85, P138, DOI 10.2471/BLT.06.029389; Sunish IP, 2003, TROP MED INT HEALTH, V8, P316, DOI 10.1046/j.1365-3156.2003.01033.x; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; van den Berg H, 2013, LANCET INFECT DIS, V13, P89, DOI 10.1016/S1473-3099(12)70148-2; WEBBER RH, 1979, T ROY SOC TROP MED H, V73, P722, DOI 10.1016/0035-9203(79)90031-2; Yamey G, 2000, BRIT MED J, V320, P269, DOI 10.1136/bmj.320.7230.269	40	62	63	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					745	753		10.1056/NEJMoa1207594	http://dx.doi.org/10.1056/NEJMoa1207594			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964936	Green Accepted			2022-12-28	WOS:000323349300011
J	Binder, A; Ellis, S				Binder, Allan; Ellis, Spencer			RATIONAL TESTING When to order an antinuclear antibody test	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE; AUTOANTIBODIES; GUIDELINES		[Binder, Allan; Ellis, Spencer] East & North Hertfordshire NHS Trust, Lister Hosp, Stevenage SG1 4AB, Herts, England	Lister Hospital	Binder, A (corresponding author), East & North Hertfordshire NHS Trust, Lister Hosp, Stevenage SG1 4AB, Herts, England.	allan.binder@nhs.net						BARADA FA, 1981, ARTHRITIS RHEUM, V24, P1236, DOI 10.1002/art.1780241003; CERVERA R, 1993, MEDICINE, V72, P113, DOI 10.1097/00005792-199303000-00005; CLEGG DO, 1991, J RHEUMATOL, V18, P1340; Fernando MMA, 2005, ANN RHEUM DIS, V64, P524, DOI 10.1136/ard.2003.015248; Habash-Bseiso DE, 2005, CLIN MED RES, V3, P190, DOI 10.3121/cmr.3.3.190; Hoffman IEA, 2004, ANN RHEUM DIS, V63, P1155, DOI 10.1136/ard.2003.013417; Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71; Ramos-Casals M, 2004, LUPUS, V13, P777, DOI 10.1191/0961203304lu1080oa; Satoh M, 2009, MOD RHEUMATOL, V19, P219, DOI 10.1007/s10165-009-0155-3; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tan EM, 1999, ARTHRITIS RHEUM, V42, P455, DOI 10.1002/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505	14	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2013	347								f5060	10.1136/bmj.f5060	http://dx.doi.org/10.1136/bmj.f5060			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SO	23965507				2022-12-28	WOS:000323624300009
J	West, R; May, S; West, M; Croghan, E; McEwen, A				West, Robert; May, Sylvia; West, Matthew; Croghan, Emma; McEwen, Andy			Performance of English stop smoking services in first 10 years: analysis of service monitoring data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CESSATION INTERVENTIONS; HEALTH-PROFESSIONALS; GUIDELINES; ABSTINENCE	Objectives To analyse the performance of the English Stop Smoking Services from 2001/02 to 2010/11. Design Analysis of national service monitoring data. Setting England. Participants Smokers recorded as having been treated by English stop smoking services between April 2001 and March 2011. Main outcome measures Annual figures for the number of quit dates set (throughput), the percentage of these that led to biochemically verified abstinence after four weeks (four week quit rate), and the "impact" in terms of the number of four week quitters beyond those who it is estimated would have stopped with only a prescription for smoking cessation treatment; characteristics of smokers being treated, medication used, and mode of delivery (for example, one to one, group based); variability across local services in throughput, four week quit rates, and impact for 2010/11. Results Throughput rose from 227 335 in 2001/02 to 787 527 (8% of all smokers) in 2010/11. The percentage of four week quitters declined slightly from 35% to 34%. Impact rose from 22 933 four week quitters created in 2001/02 to 72 411 in 2010/11 (corresponding to an estimated 21 723 12 month quitters). The services were successful in reaching disadvantaged smokers; 54% (n=425 684) were in receipt of free prescriptions in 2010/11. Substantial variation existed across local services in throughput, success rates, and impact. Conclusions The English stop smoking services have had an increasing impact in helping smokers to stop in their first 10 years of operation and have successfully reached disadvantaged groups. However, performance across local services has varied considerably.	[West, Robert; McEwen, Andy] UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, London WC1E 6BT, England; [West, Robert; May, Sylvia; West, Matthew; McEwen, Andy] NCSCT, London W1J 7BU, England; [Croghan, Emma] North 51 Ltd, Publ Hlth Serv, Nottingham, England; [Croghan, Emma] North 51 Ltd, Lifestyle Serv, Nottingham, England	Cancer Research UK; University of London; University College London	West, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, Mortimer St, London WC1E 6BT, England.	robert.west@ucl.ac.uk	West, Robert/B-5414-2009; West, Robert/B-5414-2009	West, Robert/0000-0002-0291-5760; West, Robert/0000-0001-6398-0921	Department of Health [DOH T336/BSS/M, 49945]; Cancer Research UK; Cancer Research UK [14135] Funding Source: researchfish	Department of Health; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This paper was part of the work of the National Centre for Smoking Cessation and Training that was funded by the Department of Health (DOH T336/BSS/M award number 49945). RW is a member of the UK Centre for Tobacco Control Studies, and RW and AMcE are funded by Cancer Research UK. The study sponsor had no role in the study design; the collection, analysis, and interpretation of data; the writing of the article; or the decision to submit it for publication. The researchers are independent from the funder.	Brose LS, 2013, ADDICT BEHAV, V38, P2529, DOI 10.1016/j.addbeh.2013.04.006; Brose LS, 2011, THORAX, V66, P924, DOI 10.1136/thoraxjnl-2011-200251; Department of Health, 2013, LOC STOP SMOK SERV K; Department of Health, 1999, SMOK KILLS WHIT PAP; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Health and Social Care Information Centre, 2011, STAT NHS STOP SMOK S; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; McIlvar M, 2012, DEV INDEPENDENT AUDI; Michie S, 2011, ANN BEHAV MED, V41, P59, DOI 10.1007/s12160-010-9235-z; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; Pine-Abata H, 2013, ADDICTION, V108, P1476, DOI 10.1111/add.12172; Pine-Abata H, 2013, ADDICTION, V108, P1470, DOI 10.1111/add.12158; Raw M, 1998, THORAX, V53, pS1, DOI 10.1136/thx.53.2008.S1; Stapleton JA, 2012, NICOTINE TOB RES, V14, P463, DOI 10.1093/ntr/ntr236; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub4; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub2; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	19	70	70	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f4921	10.1136/bmj.f4921	http://dx.doi.org/10.1136/bmj.f4921			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	207SC	23963106	hybrid, Green Published			2022-12-28	WOS:000323623100002
J	Hassan, AS; Gouws, P				Hassan, Ali S.; Gouws, Pieter			PICTURE QUIZ Visual field constriction in a 42 year old woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OPTIC-NERVE HEAD; DISC DRUSEN; BURIED DRUSEN; DEFECTS; EYES		[Hassan, Ali S.; Gouws, Pieter] Conquest Hosp, Dept Ophthalmol, Hastings TN37 7RD, E Sussex, England		Hassan, AS (corresponding author), Conquest Hosp, Dept Ophthalmol, Hastings TN37 7RD, E Sussex, England.	alishassan@doctors.org.uk	Gouws, Pieter/GXM-5533-2022	Gouws, Pieter/0000-0001-9558-929X				American Academy of Ophthalmology, 2007, OPTIC DISC DRUSEN, P129; BECK RW, 1985, ARCH OPHTHALMOL-CHIC, V103, P1155; CARTER JE, 1989, J CLIN NEURO-OPHTHAL, V9, P273; CHERN S, 1991, ANN OPHTHALMOL, V23, P66; COHEN DN, 1971, ARCH OPHTHALMOL-CHIC, V85, P224; Delas B, 2012, CLIN OPHTHALMOL, V6, P225, DOI 10.2147/OPTH.S22991; FORD CS, 1983, SOUTHERN MED J, V76, P1060, DOI 10.1097/00007611-198308000-00038; FRIEDMAN AH, 1975, BRIT J OPHTHALMOL, V59, P413, DOI 10.1136/bjo.59.8.413; HARRIS MJ, 1981, AM J OPHTHALMOL, V92, P70, DOI 10.1016/S0002-9394(14)75910-0; Kurz-Levin MM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1045; Lansche RK, 1975, ARCH OPHTHALMOL-CHIC, V59, P413; Lee AG, 2005, AM J OPHTHALMOL, V139, P1062, DOI 10.1016/j.ajo.2005.01.020; LORENTZEN S, 1961, ACTA OPHTHALMOL, V39, P626; LORENTZEN SE, 1966, ACTA OPHTHALMOL    S, P1; MULLIE MA, 1985, CAN J OPHTHALMOL, V20, P114; NEWMAN NJ, 1989, AM J OPHTHALMOL, V107, P236, DOI 10.1016/0002-9394(89)90305-X; Purvin V, 2004, ARCH OPHTHALMOL-CHIC, V122, P48, DOI 10.1001/archopht.122.1.48; Tan DKL, 2013, CLIN OPHTHALMOL, V7, P795, DOI 10.2147/OPTH.S42233; TSO MOM, 1981, OPHTHALMOLOGY, V88, P1066; Wilkins JM, 2004, J NEURO-OPHTHALMOL, V24, P125, DOI 10.1097/00041327-200406000-00006; You QS, 2009, ACTA OPHTHALMOL, V87, P227, DOI 10.1111/j.1755-3768.2008.01211.x	21	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2013	347								f4927	10.1136/bmj.f4927	http://dx.doi.org/10.1136/bmj.f4927			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207RR	23959153				2022-12-28	WOS:000323621900002
J	Thompson, IM; Goodman, PJ; Tangen, CM; Parnes, HL; Minasian, LM; Godley, PA; Lucia, MS; Ford, LG				Thompson, Ian M., Jr.; Goodman, Phyllis J.; Tangen, Catherine M.; Parnes, Howard L.; Minasian, Lori M.; Godley, Paul A.; Lucia, M. Scott; Ford, Leslie G.			Long-Term Survival of Participants in the Prostate Cancer Prevention Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							5-ALPHA-REDUCTASE INHIBITORS; FOLLOW-UP; FINASTERIDE; SENSITIVITY	BackgroundIn the Prostate Cancer Prevention Trial (PCPT), finasteride significantly reduced the risk of prostate cancer but was associated with an increased risk of high-grade disease. With up to 18 years of follow-up, we analyzed rates of survival among all study participants and among those with prostate cancer. MethodsWe collected data on the incidence of prostate cancer among PCPT participants for an additional year after our first report was published in 2003 and searched the Social Security Death Index to assess survival status through October 31, 2011. ResultsAmong 18,880 eligible men who underwent randomization, prostate cancer was diagnosed in 989 of 9423 (10.5%) in the finasteride group and 1412 of 9457 (14.9%) in the placebo group (relative risk in the finasteride group, 0.70; 95% confidence interval [CI], 0.65 to 0.76; P<0.001). Of the men who were evaluated, 333 (3.5%) in the finasteride group and 286 (3.0%) in the placebo group had high-grade cancer (Gleason score, 7 to 10) (relative risk, 1.17; 95% CI, 1.00 to 1.37; P=0.05). Of the men who died, 2538 were in the finasteride group and 2496 were in the placebo group, for 15-year survival rates of 78.0% and 78.2%, respectively. The unadjusted hazard ratio for death in the finasteride group was 1.02 (95% CI, 0.97 to 1.08; P=0.46). Ten-year survival rates were 83.0% in the finasteride group and 80.9% in the placebo group for men with low-grade prostate cancer and 73.0% and 73.6%, respectively, for those with high-grade prostate cancer. ConclusionsFinasteride reduced the risk of prostate cancer by about one third. High-grade prostate cancer was more common in the finasteride group than in the placebo group, but after 18 years of follow-up, there was no significant between-group difference in the rates of overall survival or survival after the diagnosis of prostate cancer. (Funded by the National Cancer Institute.) The use of finasteride to prevent prostate cancer reduced the risk of low-grade tumors by 43%, as compared with placebo. High-grade tumors were more common in the finasteride group, but long-term follow-up did not show a significant between-group difference in survival. With the advent of prostate-specific antigen (PSA) testing in the late 1980s, the rate of diagnosis of prostate cancer rose dramatically. Currently, a man in the United States has a 16.5% lifetime risk of receiving a diagnosis of prostate cancer.(1) The timing and magnitude of the 44% reduction in prostate-cancer mortality after the widespread adoption of PSA testing suggest that both screening and treatment improvements have contributed to this decline.(2) Unfortunately, treatments for prostate cancer (radiation and surgery) are associated with a substantial risk of side effects, including sexual, urinary, and bowel complications, that can dramatically affect quality of life. ...	[Thompson, Ian M., Jr.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Goodman, Phyllis J.; Tangen, Catherine M.] SW Oncol Grp, Ctr Stat, Seattle, WA USA; [Goodman, Phyllis J.; Tangen, Catherine M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Parnes, Howard L.; Minasian, Lori M.; Ford, Leslie G.] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Godley, Paul A.] Univ N Carolina, Sch Med, Div Hematol Oncol, Sch Publ Hlth, Chapel Hill, NC USA; [Godley, Paul A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lucia, M. Scott] Univ Colorado, Denver Sch Med, Dept Pathol, Denver, CO 80202 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Southwest Oncology Group; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Thompson, IM (corresponding author), Canc Therapy & Res Ctr S Texas, Suite U627,7979 Wurzbach Rd, San Antonio, TX 78229 USA.	thompsoni@uthscsa.edu			Public Health Service grant from Division of Cancer Prevention, National Cancer Institute [CA37429]; Ferring; Amgen; Eli Lilly; NATIONAL CANCER INSTITUTE [UM1CA182883, U10CA037429, U01CA086402, P30CA054174] Funding Source: NIH RePORTER	Public Health Service grant from Division of Cancer Prevention, National Cancer Institute; Ferring(Ferring Pharmaceuticals); Amgen(Amgen); Eli Lilly(Eli Lilly); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Public Health Service grant (CA37429) from the Division of Cancer Prevention, National Cancer Institute. Dr. Thompson reports receiving consulting fees from Ferring and being a named inventor on patent applications filed by his institution for a penile-prosthesis design for the management of erectile dysfunction and for a lab-on-a-chip procedure for point-of-service identification of biomarkers for prostate-cancer detection; and Dr. Tangen, receiving consulting fees from Amgen and Eli Lilly. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2012, NY TIMES; Cuzick J, 2010, CANCER PREV RES, V3, P689, DOI 10.1158/1940-6207.CAPR-10-0096; Etzioni R, 2012, CANCER-AM CANCER SOC, V118, P5955, DOI 10.1002/cncr.27594; FDA, 2011, FDA DRUG SAF COMM 5; Hamilton RJ, 2010, CANCER EPIDEM BIOMAR, V19, P2164, DOI 10.1158/1055-9965.EPI-10-0082; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Lucia MS, 2007, JNCI-J NATL CANCER I, V99, P1375, DOI 10.1093/jnci/djm117; Manecksha RP, 2012, SCI WORLD J, DOI 10.1100/2012/650858; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; OLLENDORF D, 2009, MANAGEMENT OPTIONS L; Quinn J, 2008, WEST J EMERG MED, V9, P6; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroder FH, 2012, NEW ENGL J MED, V366, P2137; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Theoret MR, 2011, NEW ENGL J MED, V365, P97, DOI 10.1056/NEJMp1106783; Thompson IM, 2007, J UROLOGY, V177, P1749, DOI 10.1016/j.juro.2007.01.071; Thompson IM, 2006, J NATL CANCER I, V98, P1128, DOI 10.1093/jnci/djj307; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Winn D., COULD REC CHANG AV D	21	183	187	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					603	610		10.1056/NEJMoa1215932	http://dx.doi.org/10.1056/NEJMoa1215932			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944298	Green Published, Green Accepted			2022-12-28	WOS:000326354500006
J	Peterson, PN; Greiner, MA; Qualls, LG; Al-Khatib, SM; Curtis, JP; Fonarow, GC; Hammill, SC; Heidenreich, PA; Hammill, BG; Piccini, JP; Hernandez, AF; Curtis, LH; Masoudi, FA				Peterson, Pamela N.; Greiner, Melissa A.; Qualls, Laura G.; Al-Khatib, Sana M.; Curtis, Jeptha P.; Fonarow, Gregg C.; Hammill, Stephen C.; Heidenreich, Paul A.; Hammill, Bradley G.; Piccini, Jonathan P.; Hernandez, Adrian F.; Curtis, Lesley H.; Masoudi, Frederick A.			QRS Duration, Bundle-Branch Block Morphology, and Outcomes Among Older Patients With Heart Failure Receiving Cardiac Resynchronization Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; DEVICE-BASED THERAPY; RHYTHM ABNORMALITIES; AMERICAN-COLLEGE; 2008 GUIDELINES; MORTALITY; DYSFUNCTION; UPDATE; IMPACT	IMPORTANCE The benefits of cardiac resynchronization therapy (CRT) in clinical trials were greater among patients with left bundle-branch block (LBBB) or longer QRS duration. OBJECTIVE To measure associations between QRS duration and morphology and outcomes among patients receiving a CRT defibrillator (CRT-D) in clinical practice. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of Medicare beneficiaries in the National Cardiovascular Data Registry's ICD Registry between 2006 and 2009 who underwent CRT-D implantation. Patients were stratified according to whether they were admitted for CRT-D implantation or for another reason, then categorized as having either LBBB or no LBBB and QRS duration of either 150 ms or greater or 120 to 149 ms. MAIN OUTCOMES AND MEASURES All-cause mortality; all-cause, cardiovascular, and heart failure readmission; and complications. Patients underwent follow-up for up to 3 years, with follow-up through December 2011. RESULTS Among 24 169 patients admitted for CRT-D implantation, 1-year and 3-year mortality rates were 9.2% and 25.9%, respectively. All-cause readmission rates were 10.2% at 30 days and 43.3% at 1 year. The unadjusted rate and adjusted risk of both 3-year mortality and of 1-year all-cause readmission were lowest among patients with LBBB and QRS duration of 150 ms or greater. There were no observed associations with complications. [GRAPHICS] . CONCLUSIONS AND RELEVANCE Among fee-for-service Medicare beneficiaries undergoing CRT-D implantation in clinical practice, LBBB and QRS duration of 150 ms or greater, compared with LBBB and QRS duration less than 150 ms or no LBBB regardless of QRS duration, was associated with lower risk of all-cause mortality and of all-cause, cardiovascular, and heart failure readmissions.	[Peterson, Pamela N.] Denver Hlth Med Ctr, Denver, CO 80204 USA; [Peterson, Pamela N.; Masoudi, Frederick A.] Univ Colorado Denver, Aurora, CO USA; [Peterson, Pamela N.; Masoudi, Frederick A.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Greiner, Melissa A.; Qualls, Laura G.; Al-Khatib, Sana M.; Hammill, Bradley G.; Piccini, Jonathan P.; Hernandez, Adrian F.; Curtis, Lesley H.] Duke Clin Res Inst, Durham, NC USA; [Al-Khatib, Sana M.; Piccini, Jonathan P.; Hernandez, Adrian F.; Curtis, Lesley H.] Duke Univ, Dept Med, Sch Med, Durham, NC 27706 USA; [Curtis, Jeptha P.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Dept Med, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90024 USA; [Hammill, Stephen C.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Heidenreich, Paul A.] VA Palo Alto Healthcare Syst, Palo Alto, CA USA	Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Duke University; Duke University; Yale University; University of California System; University of California Los Angeles; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Peterson, PN (corresponding author), Denver Hlth Med Ctr, Dept Med, Div Cardiol, 777 Bannock St,MC 0960, Denver, CO 80204 USA.	pamela.peterson@ucdenver.edu	Fonarow, Gregg C/D-5988-2014; Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016; Masoudi, Frederick/Q-7467-2019	Fonarow, Gregg C/0000-0002-3192-8093; Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616; 	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA29020050032I]; AHRQ [K08 HS019814-01]; American College of Cardiology Foundation; American College of Cardiology Foundation's National Cardiovascular Data Registry	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Cardiology Foundation(General Electric); American College of Cardiology Foundation's National Cardiovascular Data Registry	This study was funded under contract number HHSA29020050032I (Duke University Developing Evidence to Inform Decisions about Effectiveness [DEcIDE] Center) from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, as part of the DEcIDE program. Dr Peterson was supported by grant K08 HS019814-01 from the AHRQ. Dr Masoudi has a contract with the American College of Cardiology Foundation. This research was also supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry. The ICD Registry is an initiative of the American College of Cardiology Foundation and the Heart Rhythm Society.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Adelstein EC, 2009, AM J CARDIOL, V103, P238, DOI 10.1016/j.amjcard.2008.08.069; Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264; Bilchick KC, 2010, CIRCULATION, V122, P2022, DOI 10.1161/CIRCULATIONAHA.110.956011; Birnie DH, 2006, CURR OPIN CARDIOL, V21, P20, DOI 10.1097/01.hco.0000198983.93755.99; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Dupont M, 2012, J AM COLL CARDIOL, V60, P592, DOI 10.1016/j.jacc.2012.03.059; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Hammill SC, 2007, HEART RHYTHM, V4, P1260, DOI 10.1016/j.hrthm.2007.07.021; Harrell FE, 2001, REGRESSION MODELING, P53; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Rickard J, 2010, PACE, V33, P590, DOI 10.1111/j.1540-8159.2009.02649.x; Sipahi I, 2011, ARCH INTERN MED, V171, P1454, DOI 10.1001/archinternmed.2011.247; Tracy, 2013, CIRCULATION, V127, pE357, DOI 10.1161/CIR.0b013e318283168f; Tracy CM, 2012, CIRCULATION, V126, P1784, DOI 10.1161/CIR.0b013e3182618569; Wokhlu A, 2009, HEART RHYTHM, V6, P1439, DOI 10.1016/j.hrthm.2009.07.009	22	67	68	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					617	626		10.1001/jama.2013.8641	http://dx.doi.org/10.1001/jama.2013.8641			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942680	Bronze			2022-12-28	WOS:000323058400017
J	Suri, RM; Vanoverschelde, JL; Grigioni, F; Schaff, HV; Tribouilloy, C; Avierinos, JF; Barbieri, A; Pasquet, A; Huebner, M; Rusinaru, D; Russo, A; Michelena, HI; Enriquez-Sarano, M				Suri, Rakesh M.; Vanoverschelde, Jean-Louis; Grigioni, Francesco; Schaff, Hartzell V.; Tribouilloy, Christophe; Avierinos, Jean-Francois; Barbieri, Andrea; Pasquet, Agnes; Huebner, Marianne; Rusinaru, Dan; Russo, Antonio; Michelena, Hector I.; Enriquez-Sarano, Maurice			Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; EARLY-SURGERY; HEART; MULTICENTER; GUIDELINES; PROLAPSE; SOCIETY; DISEASE; REPAIR	IMPORTANCE The optimal management of severe mitral valve regurgitation in patients without class I triggers (heart failure symptoms or left ventricular dysfunction) remains controversial in part due to the poorly defined long-term consequences of current management strategies. In the absence of clinical trial data, analysis of large multicenter registries is critical. OBJECTIVE To ascertain the comparative effectiveness of initial medical management (nonsurgical observation) vs early mitral valve surgery following the diagnosis of mitral regurgitation due to flail leaflets. DESIGN, SETTING, AND PARTICIPANTS The Mitral Regurgitation International Database (MIDA) registry includes 2097 consecutive patients with flail mitral valve regurgitation (1980-2004) receiving routine cardiac care from 6 tertiary centers (France, Italy, Belgium, and the United States). Mean follow-up was 10.3 years and was 98% complete. Of 1021 patients with mitral regurgitation without the American College of Cardiology (ACC) and the American Heart Association (AHA) guideline class I triggers, 575 patients were initially medically managed and 446 underwent mitral valve surgery within 3 months following detection. MAIN OUTCOMES AND MEASURES Association between treatment strategy and survival, heart failure, and new-onset atrial fibrillation. RESULTS There was no significant difference in early mortality (1.1% for early surgery vs 0.5% for medical management, P=.28) and new-onset heart failure rates (0.9% for early surgery vs 0.9% for medical management, P=.96) between treatment strategies at 3 months. In contrast, long-term survival rates were higher for patients with early surgery (86% vs 69% at 10 years, P < .001), which was confirmed in adjusted models (hazard ratio [HR], 0.55 [95% CI, 0.41-0.72], P < .001), a propensity-matched cohort (32 variables; HR, 0.52 [95% CI, 0.35-0.79], P=.002), and an inverse probability-weighted analysis (HR, 0.66 [95% CI, 0.52-0.83], P < .001), associated with a 5-year reduction in mortality of 52.6%(P < .001). Similar results were observed in relative reduction in mortality following early surgery in the subset with class II triggers (59.3 after 5 years, P=.002). Long-term heart failure risk was also lower with early surgery (7% vs 23% at 10 years, P < .001), which was confirmed in risk-adjusted models (HR, 0.29 [95% CI, 0.19-0.43], P < .001), a propensity-matched cohort (HR, 0.44 [95% CI, 0.26-0.76], P=.003), and in the inverse probability-weighted analysis (HR, 0.51 [95% CI, 0.36-0.72], P < .001). Reduction in late-onset atrial fibrillation was not observed (HR, 0.85 [95% CI, 0.64-1.13], P=.26). CONCLUSION AND RELEVANCE Among registry patients with mitral valve regurgitation due to flail mitral leaflets, performance of early mitral surgery compared with initial medical management was associated with greater long-term survival and a lower risk of heart failure, with no difference in new-onset atrial fibrillation.	[Suri, Rakesh M.; Schaff, Hartzell V.; Huebner, Marianne; Michelena, Hector I.; Enriquez-Sarano, Maurice] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Vanoverschelde, Jean-Louis; Pasquet, Agnes] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Grigioni, Francesco; Russo, Antonio] Univ Bologna, Bologna, Italy; [Tribouilloy, Christophe; Rusinaru, Dan] Univ Hosp, INSERM, ERI 12, Amiens, France; [Avierinos, Jean-Francois] Aix Marseille Univ, Marseille, France; [Barbieri, Andrea] Univ Modena, I-41100 Modena, Italy; [Huebner, Marianne] Michigan State Univ, E Lansing, MI 48824 USA	Mayo Clinic; Universite Catholique Louvain; University of Bologna; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; UDICE-French Research Universities; Aix-Marseille Universite; Universita di Modena e Reggio Emilia; Michigan State University	Suri, RM (corresponding author), Mayo Clin, Div Cardiovasc Surg, 200 1st St SW, Rochester, MN 55905 USA.	suri.rakesh@mayo.edu	Barbieri, Andrea/ABB-3006-2020; Grigioni, Francesco/AAL-3603-2020; Huebner, Marianne/AAA-6882-2020	Schaff, Hartzell/0000-0003-0994-027X; Huebner, Marianne/0000-0002-9694-9231; GRIGIONI, FRANCESCO/0000-0002-4767-7073; Vanoverschelde, Jean-Louis/0000-0002-8133-8913; Barbieri, Andrea/0000-0002-7189-9602; Enriquez-Sarano, Maurice/0000-0003-0910-5450; Avierinos, Jean Francois/0000-0002-3775-8371	Edwards Lifesciences; Sorin Group; St Jude Medical; Abbott Vascular	Edwards Lifesciences; Sorin Group; St Jude Medical(St. Jude Medical); Abbott Vascular(Abbott Laboratories)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Suri reports receiving grant funding from Edwards Lifesciences, Sorin Group, and St Jude Medical and support for travel and accommodations from Sorin Group and serving on the eligibility committee for the Abbot COAPT trial. Dr Grigioni reports receiving payment for lectures from Edwards Lifesciences. Dr Enriquez-Sarano reports serving as a board member for Valtech and receiving grant funding from Abbott Vascular.	Agricola E, 2003, J AM SOC ECHOCARDIOG, V16, P61, DOI 10.1067/mje.2003.23; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Concato J, 2010, J INVEST MED, V58, P764, DOI 10.231/JIM.0b013e3181e3d2af; Enriquez-Sarano M, 2005, NEW ENGL J MED, V352, P875, DOI 10.1056/NEJMoa041451; Enriquez-Sarano M, 2010, CIRCULATION, V121, P804, DOI 10.1161/CIRCULATIONAHA.109.868083; Gammie JS, 2007, CIRCULATION, V115, P881, DOI 10.1161/CIRCULATIONAHA.106.634436; Gillam LD, 2010, CIRCULATION, V121, P813, DOI 10.1161/CIRCULATIONAHA.109.868109; Gillinov AM, 2010, ANN THORAC SURG, V90, P481, DOI 10.1016/j.athoracsur.2010.03.101; Grigioni F, 2008, JACC-CARDIOVASC IMAG, V1, P133, DOI 10.1016/j.jcmg.2007.12.005; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Hlatky MA, 2012, J AM COLL CARDIOL, V60, P569, DOI 10.1016/j.jacc.2011.12.057; Kang DH, 2009, CIRCULATION, V119, P797, DOI 10.1161/CIRCULATIONAHA.108.802314; Ling LH, 1997, CIRCULATION, V96, P1819, DOI 10.1161/01.CIR.96.6.1819; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Montant P, 2009, J THORAC CARDIOV SUR, V138, P1339, DOI 10.1016/j.jtcvs.2009.03.046; R Development Core Team, 2012, R LANG ENV STAT COMP; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosenhek R, 2006, CIRCULATION, V113, P2238, DOI 10.1161/CIRCULATIONAHA.105.599175; Rosenhek R, 2011, SEMIN THORAC CARDIOV, V23, P203, DOI 10.1053/j.semtcvs.2011.09.002; Suri RM, 2011, J THORAC CARDIOV SUR, V142, P970, DOI 10.1016/j.jtcvs.2011.07.027; Tietge WJ, 2012, NETH HEART J, V20, P94, DOI 10.1007/s12471-012-0249-y; Tribouilloy C, 2009, J AM COLL CARDIOL, V54, P1961, DOI 10.1016/j.jacc.2009.06.047; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428	23	242	242	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					609	616		10.1001/jama.2013.8643	http://dx.doi.org/10.1001/jama.2013.8643			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942679	Green Submitted, Bronze			2022-12-28	WOS:000323058400016
J	Kitchener, HC; Denton, K; Soldan, K; Crosbie, EJ				Kitchener, Henry C.; Denton, Karin; Soldan, Kate; Crosbie, Emma J.			Developing role of HPV in cervical cancer prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HUMAN-PAPILLOMAVIRUS VACCINATION; NEOPLASIA GRADE 3; INTRAEPITHELIAL NEOPLASIA; COST-EFFECTIVENESS; RANDOMIZED-TRIAL; YOUNG-WOMEN; FOLLOW-UP; CYTOLOGY; RISK; MANAGEMENT		[Kitchener, Henry C.; Crosbie, Emma J.] Univ Manchester, St Marys Hosp, Inst Canc Sci, Manchester M13 9WL, Lancs, England; [Denton, Karin] Publ Hlth England, South West Qual Assurance Reference Ctr, Bristol, Avon, England; [Soldan, Kate] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London, England	University of Manchester; Public Health England; Public Health England	Kitchener, HC (corresponding author), Univ Manchester, St Marys Hosp, Inst Canc Sci, Manchester M13 9WL, Lancs, England.	Henry.kitchener@manchester.ac.uk		Crosbie, Emma/0000-0003-0284-8630; Soldan, Kate/0000-0002-0361-3174	Department of Health [NIHR-CS-012-009] Funding Source: Medline; National Institute for Health Research [NIHR-CS-012-009] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2010, CLIN PRACT GUID ASS; Anttila A, 2009, EUR J CANCER, V45, P2685, DOI 10.1016/j.ejca.2009.07.017; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Barken SS, 2012, INT J CANCER, V130, P2438, DOI 10.1002/ijc.26248; BC Cancer Agency, 2011, CERV CANC SCREEN PRO; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Cancer Research UK, 2010, CERV CANC MORT STAT; Castanon A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5174; Chesson HW, 2008, EMERG INFECT DIS, V14, P244, DOI 10.3201/eid1402.070499; Cox JT, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.020; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Gardasil, 2013, INF GARD; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GlaxoSmithKline, 2013, CERV PROD OV; Harper DM, 2009, EXPERT REV VACCINES, V8, P1663, DOI [10.1586/erv.09.123, 10.1586/ERV.09.123]; Jensen KE, 2012, CANCER EPIDEM BIOMAR, V21, P1949, DOI 10.1158/1055-9965.EPI-12-0663; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kelly RS, 2011, BRIT J CANCER, V105, P983, DOI 10.1038/bjc.2011.326; Kitchener HC, 2008, BJOG-INT J OBSTET GY, V115, P1001, DOI 10.1111/j.1471-0528.2008.01748.x; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kitchener HC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13510; Kitchener HC, 2011, EUR J CANCER, V47, P864, DOI 10.1016/j.ejca.2011.01.008; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Leinonen MK, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7789; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sasieni P, 2003, BRIT J CANCER, V89, P88, DOI 10.1038/sj.bjc.6600974; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; Waller J, 2007, SEX TRANSM INFECT, V83, P155, DOI 10.1136/sti.2006.023333; White J, 2010, ANN HPV VACCINE COVE; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	48	24	27	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2013	347								f4781	10.1136/bmj.f4781	http://dx.doi.org/10.1136/bmj.f4781			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CY	23926316				2022-12-28	WOS:000323119500011
J	Gulsuner, S; Walsh, T; Watts, AC; Lee, MK; Thornton, AM; Casadei, S; Rippey, C; Shahin, H; Nimgaonkar, VL; Go, RCP; Savage, RM; Swerdlow, NR; Gur, RE; Braff, DL; King, MC; McClellan, JM				Gulsuner, Suleyman; Walsh, Tom; Watts, Amanda C.; Lee, Ming K.; Thornton, Anne M.; Casadei, Silvia; Rippey, Caitlin; Shahin, Hashem; Nimgaonkar, Vishwajit L.; Go, Rodney C. P.; Savage, Robert M.; Swerdlow, Neal R.; Gur, Raquel E.; Braff, David L.; King, Mary-Claire; McClellan, Jon M.		COGS; PAARTNERS Study Grp	Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network	CELL			English	Article							GENE; DIFFERENTIATION; HETEROGENEITY; DYSFUNCTION; INTEGRATION; ASSOCIATION; DISORDERS; PARADIGM; VARIANTS; PATHWAYS	Genes disrupted in schizophrenia may be revealed by de novo mutations in affected persons from otherwise healthy families. Furthermore, during normal brain development, genes are expressed in patterns specific to developmental stage and neuroanatomical structure. We identified de novo mutations in persons with schizophrenia and then mapped the responsible genes onto transcriptome profiles of normal human brain tissues from age 13 weeks gestation to adulthood. In the dorsolateral and ventrolateral prefrontal cortex during fetal development, genes harboring damaging de novo mutations in schizophrenia formed a network significantly enriched for transcriptional coexpression and protein interaction. The 50 genes in the network function in neuronal migration, synaptic transmission, signaling, transcriptional regulation, and transport. These results suggest that disruptions of fetal prefrontal cortical neurogenesis are critical to the pathophysiology of schizophrenia. These results also support the feasibility of integrating genomic and transcriptome analyses to map critical neurodevelopmental processes in time and space in the brain.	[Gulsuner, Suleyman; Walsh, Tom; Watts, Amanda C.; Lee, Ming K.; Thornton, Anne M.; Casadei, Silvia; Rippey, Caitlin; Shahin, Hashem; King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Gulsuner, Suleyman; Walsh, Tom; Watts, Amanda C.; Lee, Ming K.; Thornton, Anne M.; Casadei, Silvia; Rippey, Caitlin; Shahin, Hashem; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [McClellan, Jon M.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Shahin, Hashem] Bethlehem Univ, Dept Biol, Bethlehem, Israel; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA; [Go, Rodney C. P.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Savage, Robert M.; PAARTNERS Study Grp] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Swerdlow, Neal R.; Braff, David L.; COGS] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Gur, Raquel E.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; University of Pennsylvania	King, MC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	mcking@uw.edu	Gulsuner, Suleyman/AAF-2098-2020; Greenwood, Tiffany/F-6356-2012; Tsuang, Debby/L-7234-2016; Swerdlow, Neal/AAU-4912-2020; Gur, Ruben/K-1999-2019	Gulsuner, Suleyman/0000-0002-3897-1238; Greenwood, Tiffany/0000-0002-6080-6503; Tsuang, Debby/0000-0002-4716-1894; Gur, Ruben/0000-0002-9657-1996; King, Mary-Claire/0000-0001-9426-1743; Lazzeroni, Laura/0000-0002-1846-6920; Walsh, Tom/0000-0002-8875-0310	NARSAD; NIMH [R01MH083989, R01MH083849, R01MH083756, R01MH084071, R03TW008696]; FOGARTY INTERNATIONAL CENTER [R03TW008696] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA157744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083849, R01MH084071, R01MH083989, R01MH093533, U01MH096844, R01MH086135, R01MH083756] Funding Source: NIH RePORTER	NARSAD(NARSAD); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Jim Watson for advice and support throughout the project. This work was supported by a gift from Steve and Connie Lieber, by NARSAD grants to M.-C.K. and to T.W., and by NIMH grants R01MH083989, R01MH083849, R01MH083756, R01MH084071, and R03TW008696. Grants supporting the collection of clinical material for the NIMH repository are indicated in the Supplemental Information.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Choi KH, 2010, EUR J PHARMACOL, V626, P123, DOI 10.1016/j.ejphar.2009.09.035; Costa E, 2007, EPIGENETICS-US, V2, P29; Duchrow Michael, 1995, Archivum Immunologiae et Therapiae Experimentalis, V43, P117; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Gaisler-Salomon I, 2012, HIPPOCAMPUS, V22, P1027, DOI 10.1002/hipo.22014; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Glascher J, 2012, P NATL ACAD SCI USA, V109, P14681, DOI 10.1073/pnas.1206608109; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Insel TR, 2009, ARCH GEN PSYCHIAT, V66, P128, DOI 10.1001/archgenpsychiatry.2008.540; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kalkstein S, 2010, CURR TOP BEHAV NEURO, V4, P373, DOI 10.1007/7854_2010_42; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Martin C, 2007, NEUROENDOCRINOLOGY, V85, P257, DOI 10.1159/000103557; Masana M, 2012, CURR TOP MED CHEM, V12, P2357, DOI 10.2174/156802612805289872; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pacary E, 2007, MOL CELL NEUROSCI, V35, P409, DOI 10.1016/j.mcn.2007.04.002; Patten BA, 2006, J NEUROSCI, V26, P3102, DOI 10.1523/JNEUROSCI.4829-05.2006; Press W., 2008, GLOBAL BURDEN DIS; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Shyu, 1992, STAT MODELS; Simons CJP, 2013, SCHIZOPHRENIA BULL, V39, P848, DOI 10.1093/schbul/sbs067; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Talley EM, 1999, J NEUROSCI, V19, P1895; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Uslaner JM, 2012, NEUROPHARMACOLOGY, V62, P1413, DOI 10.1016/j.neuropharm.2010.11.015; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yunker AMR, 2003, NEUROSCIENCE, V117, P321, DOI 10.1016/S0306-4522(02)00936-3; Zhang CW, 2012, J NEUROSCI, V32, P12589, DOI 10.1523/JNEUROSCI.6518-11.2012	69	382	388	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					518	529		10.1016/j.cell.2013.06.049	http://dx.doi.org/10.1016/j.cell.2013.06.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911319	Bronze, Green Accepted			2022-12-28	WOS:000322629900007
J	Dyer, O				Dyer, Owen			The growth of medical marijuana	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												owen_dyer@hotmail.com						Anderson D. M., 2011, MED MARIJUANA LAWS T; [Anonymous], CANN READ GLOB ISS L; [Anonymous], 2013, MAR ITS LEG NOW WHAT; [Anonymous], 2012 AR YOUTH SURV; Grinspoon L, 2005, HIST CANNABIS MED DR; Harper S, 2012, ANN EPIDEMIOL, V22, P207, DOI 10.1016/j.annepidem.2011.12.002; Joy JE, 1999, MARIJUANA MED ASSESS; Korn P, 2010, PORTLAND TRIBUN 0414; Lynne-Landsman SD, 2013, AM J PUBLIC HEALTH, V103, P1500, DOI 10.2105/AJPH.2012.301117	9	4	4	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2013	347								f4755	10.1136/bmj.f4755	http://dx.doi.org/10.1136/bmj.f4755			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BI	23903247				2022-12-28	WOS:000322822200008
J	Caley, M				Caley, Michael			Remember Barbara Starfield: primary care is the health system's bedrock	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCOME INEQUALITY; MORTALITY; STATES		Publ Hlth Warwickshire, Gen Practice & Publ Hlth, Warwick CV34 4TH, England		Caley, M (corresponding author), Publ Hlth Warwickshire, Gen Practice & Publ Hlth, Warwick CV34 4TH, England.	mikecaley@doctors.org.uk						CASANOVA C, 1995, INT J HEALTH SERV, V25, P283, DOI 10.2190/PCF7-ALX9-6CN3-7X9G; Centre for Workforce Intelligence, 2013, GP IN DEPTH REV PREL; Charlesworth A, 2013, ANATOMY HLTH SPENDIN; Department of Health, 2013, CONS GP CONTR 2013 1; Health and Social Care Information Centre, 2013, NHS HOSP COMM HLTH S; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Shi L, 2004, J EPIDEMIOL COMMUN H, V58, P374, DOI 10.1136/jech.2003.013078; Shi LY, 1999, J FAM PRACTICE, V48, P275; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Stafford N, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4265; Starfield B, 2005, HEALTH AFFAIR, V24, pW97, DOI 10.1377/hlthaff.W5.97; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	13	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4627	10.1136/bmj.f4627	http://dx.doi.org/10.1136/bmj.f4627			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197BE	23900532				2022-12-28	WOS:000322821500006
J	King, ICC; Brierley, NA; Erdinger, K				King, Ian C. C.; Brierley, Neil A.; Erdinger, Kajetan			A midline neck lump in a child	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[King, Ian C. C.; Brierley, Neil A.; Erdinger, Kajetan] James Cook Univ Hosp, Dept Plast & Reconstruct Surg, Middlesbrough TS4 3BW, Cleveland, England	James Cook University Hospital	King, ICC (corresponding author), James Cook Univ Hosp, Dept Plast & Reconstruct Surg, Middlesbrough TS4 3BW, Cleveland, England.	ianccking@doctors.org.uk		/0000-0002-8853-7480				Allard RH, 1983, HEAD NECK SURG, V5, P134; Edwards RM, 2013, PEDIAT RADIOL; Fallat ME, 2005, PRINCIPLES PRACTICE, P863; Foley David S, 2006, Semin Pediatr Surg, V15, P70, DOI 10.1053/j.sempedsurg.2006.02.003; Heshmati HM, 1997, MAYO CLIN PROC, V72, P315, DOI 10.4065/72.4.315; Hirshoren N, 2009, OTOLARYNG HEAD NECK, V140, P338, DOI 10.1016/j.otohns.2008.12.002; Hussain K, 2013, EUR ARCH OTORHINOLAR; LiVolsi VA, 1974, CANCER, V34, P1305; Mondin V, 2008, AURIS NASUS LARYNX, V35, P11, DOI 10.1016/j.anl.2007.06.001; Roback S A, 1994, Semin Pediatr Surg, V3, P142; Tharmabala M, 2013, INT J SURG CASE REP, V4, P58, DOI 10.1016/j.ijscr.2012.10.003	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4447	10.1136/bmj.f4447	http://dx.doi.org/10.1136/bmj.f4447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900812				2022-12-28	WOS:000322821500002
J	Moynihan, R; Glassock, R; Doust, J				Moynihan, Ray; Glassock, Richard; Doust, Jenny			Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; POPULATION; PREVALENCE; MORTALITY; ALBUMINURIA; ASSOCIATION; QUALITY; HEALTH; IMPACT		[Moynihan, Ray; Doust, Jenny] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Glassock, Richard] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Bond University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Moynihan, R (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	raymoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020; Doust, Jenny/AGI-8773-2022	Doust, Jenny/0000-0002-4024-9308				[Anonymous], 2002, KIDN DIS OUTC QUAL I; [Anonymous], 2012, BMJ; [Anonymous], 2013, KIDNEY INT S, V3; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crinson I, 2010, BRIT J GEN PRACT, V60, P403, DOI 10.3399/bjgp10X502100; De Boer IH., 2012, JAMA-J AM MED ASSOC, V308, P1; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Drawz PE, 2012, AM HEART J, V164, P925, DOI 10.1016/j.ahj.2012.09.003; Eriksen BO, 2007, KIDNEY INT, V72, P1242, DOI 10.1038/sj.ki.5002472; Fink HA, 2012, COMP EFFECTIVENESS R; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Glassock RJ, 2010, CURR HYPERTENS REP, V12, P364, DOI 10.1007/s11906-010-0133-3; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hoy WE, 1998, KIDNEY INT, V54, P1296, DOI 10.1046/j.1523-1755.1998.00099.x; Kidney Health Australia, 2012, CHRON KIDN DIS MAN G; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Moyer VA, 2012, ANN INTERN MED, V157, P567, DOI 10.7326/0003-4819-157-8-201210160-00533; National Institute for Health and Care Excellence, CHRON KIDN DIS EARL; National Institute for Health and Care Excellence, QUAL OUTC FRAM; National Kidney Foundation, CHRON KIDN DIS; National Kidney Foundation, 2012, CHRON KIDN DIS; National Kidney Foundation/, 2012, KDIGO GUID CKD CLASS; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS17; Nissenson AR, 2001, AM J KIDNEY DIS, V37, P1177, DOI 10.1053/ajkd.2001.24520; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; O'Hare AM, 2013, JAMA-J AM MED ASSOC, V309, P1343, DOI 10.1001/jama.2013.1328; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Phillips LA, 2009, QJM-INT J MED, V102, P415, DOI 10.1093/qjmed/hcp030; Pickering Thomas G, 2006, J Clin Hypertens (Greenwich), V8, P57, DOI 10.1111/j.1524-6175.2005.05121.x; Rutkowski M, 2009, AM J KIDNEY DIS, V53, pS86, DOI 10.1053/j.ajkd.2008.07.052; Samal L, 2013, CLIN J AM SOC NEPHRO, V8, P131, DOI 10.2215/CJN.12681211; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Spence D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3188; Weiner DE, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.05.054; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Winearls CG, 2010, NEFROLOGIA, V30, P493, DOI 10.3265/Nefrologia.pre2010.Jul.10501; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013	42	97	100	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4298	10.1136/bmj.f4298	http://dx.doi.org/10.1136/bmj.f4298			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900313				2022-12-28	WOS:000322821500001
J	Tilburt, JC; Wynia, MK; Sheeler, RD; Thorsteinsdottir, B; James, KM; Egginton, JS; Liebow, M; Hurst, S; Danis, M; Goold, SD				Tilburt, Jon C.; Wynia, Matthew K.; Sheeler, Robert D.; Thorsteinsdottir, Bjorg; James, Katherine M.; Egginton, Jason S.; Liebow, Mark; Hurst, Samia; Danis, Marion; Goold, Susan Dorr			Views of US Physicians About Controlling Health Care Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-SURVEY; ATTITUDES; MEDICINE	IMPORTANCE Physicians' views about health care costs are germane to pending policy reforms. OBJECTIVE To assess physicians' attitudes toward and perceived role in addressing health care costs. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional survey mailed in 2012 to 3897 US physicians randomly selected from the AMA Masterfile. MAIN OUTCOMES AND MEASURES Enthusiasm for 17 cost-containment strategies and agreement with an 11-measure cost-consciousness scale. RESULTS A total of 2556 physicians responded (response rate = 65%). Most believed that trial lawyers (60%), health insurance companies (59%), hospitals and health systems (56%), pharmaceutical and device manufacturers (56%), and patients (52%) have a "major responsibility" for reducing health care costs, whereas only 36% reported that practicing physicians have "major responsibility." Most were "very enthusiastic" for "promoting continuity of care" (75%), "expanding access to quality and safety data" (51%), and "limiting access to expensive treatments with little net benefit" (51%) as a means of reducing health care costs. Few expressed enthusiasm for "eliminating fee-for-service payment models" (7%). Most physicians reported being "aware of the costs of the tests/treatments [they] recommend" (76%), agreed they should adhere to clinical guidelines that discourage the use of marginally beneficial care (79%), and agreed that they "should be solely devoted to individual patients' best interests, even if that is expensive" (78%) and that "doctors need to take a more prominent role in limiting use of unnecessary tests" (89%). Most (85%) disagreed that they "should sometimes deny beneficial but costly services to certain patients because resources should go to other patients that need them more." In multivariable logistic regression models testing associations with enthusiasm for key cost-containment strategies, having a salary plus bonus or salary-only compensation type was independently associated with enthusiasm for "eliminating fee for service" (salary plus bonus: odds ratio [OR], 3.3, 99% CI, 1.8-6.1; salary only: OR, 4.3, 99% CI, 2.2-8.5). In multivariable linear regression models, group or government practice setting (beta = 0.87, 95% CI, 0.29 to 1.45, P = .004; and beta = 0.99, 95% CI, 0.20 to 1.79, P = .01, respectively) and having a salary plus bonus compensation type (beta = 0.82; 95% CI, 0.32 to 1.33; P = .002) were positively associated with cost-consciousness. Finding the "uncertainty involved in patient care disconcerting" was negatively associated with cost-consciousness (beta = -1.95; 95% CI, -2.71 to -1.18; P < .001). CONCLUSION AND RELEVANCE In this survey about health care cost containment, US physicians reported having some responsibility to address health care costs in their practice and expressed general agreement about several quality initiatives to reduce cost but reported less enthusiasm for cost containment involving changes in payment models.	[Tilburt, Jon C.; Liebow, Mark] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [Tilburt, Jon C.; Thorsteinsdottir, Bjorg; James, Katherine M.] Mayo Clin, Biomed Eth Program, Rochester, MN 55905 USA; [Tilburt, Jon C.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Tilburt, Jon C.] Mayo Clin, Healthcare Delivery Res Program, Ctr Sci Healthcare Delivery, Rochester, MN 55905 USA; [Tilburt, Jon C.; Egginton, Jason S.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA; [Wynia, Matthew K.] Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; [Sheeler, Robert D.] Mayo Clin, Dept Family Med, Rochester, MN 55905 USA; [Thorsteinsdottir, Bjorg] Mayo Clin, Div Primary Care Internal Med, Rochester, MN 55905 USA; [Hurst, Samia] Univ Geneva, Inst Biomed Eth, CH-1211 Geneva 4, Switzerland; [Danis, Marion] NIH, Dept Bioeth, Bethesda, MD 20892 USA; [Goold, Susan Dorr] Univ Michigan, Med Ctr, Dept Gen Internal Med, Ann Arbor, MI USA; [Wynia, Matthew K.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; American Medical Association; Mayo Clinic; Mayo Clinic; University of Geneva; National Institutes of Health (NIH) - USA; University of Michigan System; University of Michigan; University of Chicago	Tilburt, JC (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	tilburt.jon@mayo.edu	Wynia, Matthew/T-2210-2019; Hurst, Samia A./A-9661-2008; Goold, Susan Dorr/N-6930-2014	Hurst, Samia A./0000-0002-1980-5226; Goold, Susan Dorr/0000-0002-0258-9774	Greenwall Foundation; Mayo Clinic Program in Professionalism and Ethics; Mayo Clinic Foundation; Swiss National Science Foundation [PP00P3_123340]; CLINICAL CENTER [ZIACL010518] Funding Source: NIH RePORTER	Greenwall Foundation; Mayo Clinic Program in Professionalism and Ethics; Mayo Clinic Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CLINICAL CENTER	Dr Tilburt's research was funded by the Faculty Scholars Program of the Greenwall Foundation, Mayo Clinic Program in Professionalism and Ethics, and an Early Career Development Award from the Mayo Clinic Foundation. Dr Hurst is funded by a grant from the Swiss National Science Foundation (PP00P3_123340).	ABIM Foundation, MEDICAL PROFESSIONAL; ABIM Foundation, CHOOSING WISELY; American Association for Public Opinion Research (AAPOR), 2016, STAND DEF FIN DISP C; American College of Physicians, HIGH VALUE CARE; American Medical Association, OPINIONE 9 0652 PHYS; Antiel RM, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0907876; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Council on Ethical and Judicial Affairs, PHYSICIAN STEWARDSHI; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Ginsburg ME, 2000, WESTERN J MED, V173, P390, DOI 10.1136/ewjm.173.6.390; GOOLD SD, 1994, J GEN INTERN MED, V9, P544, DOI 10.1007/BF02599278; Gruen RL, 2006, JAMA-J AM MED ASSOC, V296, P2467, DOI 10.1001/jama.296.20.2467; Hurst SA, 2005, ARCH INTERN MED, V165, P639, DOI 10.1001/archinte.165.6.639; Hurst SA, 2006, J GEN INTERN MED, V21, P1138, DOI 10.1111/j.1525-1497.2006.00551.x; Joint Commission, TWO LEADING HEALTH C; Kocher R, 2010, ANN INTERN MED, V153, P536, DOI 10.7326/0003-4819-153-8-201010190-00274; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Schroeder SA, 2013, NEW ENGL J MED, V368, P2029, DOI 10.1056/NEJMsb1302322; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	23	178	179	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					380	388		10.1001/jama.2013.8278	http://dx.doi.org/10.1001/jama.2013.8278			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187LV	23917288	Bronze, Green Accepted			2022-12-28	WOS:000322121500015
J	Steinberg, MB; Delnevo, CD				Steinberg, Michael B.; Delnevo, Cristine D.			Increasing the "Smoking Age": The Right Thing to Do	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							YOUTH ACCESS; UNITED-STATES; YOUNG-ADULTS; TOBACCO		Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; Sch Publ Hlth, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Steinberg, MB (corresponding author), Rutgers Robert Wood Johnson Med Sch, Div Gen Internal Med, 125 Paterson St,Suite 2304, New Brunswick, NJ 08903 USA.	michael.steinberg@rutgers.edu	Delnevo, Cristine D/D-5002-2015	Delnevo, Cristine D/0000-0001-9597-4307	NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA072720] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad S, 2005, HEALTH POLICY, V75, P74, DOI 10.1016/j.healthpol.2005.02.004; Ahmad S, 2007, HEALTH POLICY, V80, P378, DOI 10.1016/j.healthpol.2006.04.001; [Anonymous], 2012, NEW YORK CIT DEP HLT; DiFranza JR, 2001, TOB CONTROL, V10, P323, DOI 10.1136/tc.10.4.323; Fidler JA, 2010, ADDICTION, V105, P1984, DOI 10.1111/j.1360-0443.2010.03039.x; Hammond D, 2005, TOB CONTROL, V14, P181, DOI 10.1136/tc.2004.009621; Lightwood J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047145; Ling PM, 2002, AM J PUBLIC HEALTH, V92, P908, DOI 10.2105/AJPH.92.6.908; Sundh M, 2007, EUR J PUBLIC HEALTH, V17, P171, DOI 10.1093/eurpub/ckl109; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO	10	9	9	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					558	+		10.7326/0003-4819-159-8-201310150-00695	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00695			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	249BH	23975346	Green Accepted			2022-12-28	WOS:000326751200019
J	Hinkley, N; Sherman, JA; Phillips, NB; Schioppo, M; Lemke, ND; Beloy, K; Pizzocaro, M; Oates, CW; Ludlow, AD				Hinkley, N.; Sherman, J. A.; Phillips, N. B.; Schioppo, M.; Lemke, N. D.; Beloy, K.; Pizzocaro, M.; Oates, C. W.; Ludlow, A. D.			An Atomic Clock with 10(-18) Instability	SCIENCE			English	Article							OPTICAL CLOCKS; FREQUENCY STABILITY; METROLOGY; TIME; STANDARDS; NOISE	Atomic clocks have been instrumental in science and technology, leading to innovations such as global positioning, advanced communications, and tests of fundamental constant variation. Timekeeping precision at 1 part in 10(18) enables new timing applications in relativistic geodesy, enhanced Earth- and space-based navigation and telescopy, and new tests of physics beyond the standard model. Here, we describe the development and operation of two optical lattice clocks, both using spin-polarized, ultracold atomic ytterbium. A measurement comparing these systems demonstrates an unprecedented atomic clock instability of 1.6 x 10(-18) after only 7 hours of averaging.	[Hinkley, N.; Sherman, J. A.; Phillips, N. B.; Schioppo, M.; Lemke, N. D.; Beloy, K.; Pizzocaro, M.; Oates, C. W.; Ludlow, A. D.] NIST, Boulder, CO 80305 USA; [Hinkley, N.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Pizzocaro, M.] Inst Nazl Ric Metrol, I-10135 Turin, Italy; [Pizzocaro, M.] Politecn Torino, I-10125 Turin, Italy	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; Istituto Nazionale di Ricerca Metrologica (INRIM); Polytechnic University of Turin	Ludlow, AD (corresponding author), NIST, 325 Broadway, Boulder, CO 80305 USA.	ludlow@boulder.nist.gov	Pizzocaro, Marco/V-8136-2017; Lemke, Nathan D/L-9059-2013; Sherman, Jeffrey A/G-3006-2011	Lemke, Nathan D/0000-0003-4165-0715; PIZZOCARO, Marco/0000-0003-2353-362X; Schioppo, Marco/0000-0002-0197-2763	Defense Advanced Research Projects Agency Quantum Assisted Sensing and Readout program; NASA Fundamental Physics; NIST	Defense Advanced Research Projects Agency Quantum Assisted Sensing and Readout program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NASA Fundamental Physics; NIST(National Institute of Standards & Technology (NIST) - USA)	We thank the Defense Advanced Research Projects Agency Quantum Assisted Sensing and Readout program, NASA Fundamental Physics, and NIST for financial support; D. Hume for experimental assistance; and T. Fortier and S. Diddams for femtosecond optical frequency comb measurements.	Bauch A, 2003, MEAS SCI TECHNOL, V14, P1159, DOI 10.1088/0957-0233/14/8/301; Blatt S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.140801; Chiba T, 2011, PROG THEOR PHYS, V126, P993, DOI 10.1143/PTP.126.993; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Cole GD, 2013, NAT PHOTONICS, V7, P644, DOI [10.1038/NPHOTON.2013.174, 10.1038/nphoton.2013.174]; Dick G. J., 1990, NASA C PUBLICATION, V3116, P487; Diddams SA, 2004, SCIENCE, V306, P1318, DOI 10.1126/science.1102330; Greenhall CA, 1999, IEEE T ULTRASON FERR, V46, P1183, DOI 10.1109/58.796124; Guena J, 2012, IEEE T ULTRASON FERR, V59, P391, DOI 10.1109/TUFFC.2012.2208; ITANO WM, 1993, PHYS REV A, V47, P3554, DOI 10.1103/PhysRevA.47.3554; Jiang YY, 2011, NAT PHOTONICS, V5, P158, DOI [10.1038/nphoton.2010.313, 10.1038/NPHOTON.2010.313]; Katori H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.173005; Kessler T, 2012, NAT PHOTONICS, V6, P687, DOI [10.1038/NPHOTON.2012.217, 10.1038/nphoton.2012.217]; Kleppner D, 2006, PHYS TODAY, V59, P10, DOI 10.1063/1.2195297; Le Targat R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3109; Lemke ND, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.103902; Lemke ND, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.063001; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Levine J, 1999, REV SCI INSTRUM, V70, P2567, DOI 10.1063/1.1149844; Parker TE, 2010, METROLOGIA, V47, P1, DOI 10.1088/0026-1394/47/1/001; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Santarelli G, 1998, IEEE T ULTRASON FERR, V45, P887, DOI 10.1109/58.710548; Schiller S, 2007, NUCL PHYS B-PROC SUP, V166, P300, DOI 10.1016/j.nuclphysbps.2006.12.032; Schiller S, 2009, EXP ASTRON, V23, P573, DOI 10.1007/s10686-008-9126-5; Sherman JA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153002; Westergaard PG, 2010, IEEE T ULTRASON FERR, V57, P623, DOI 10.1109/TUFFC.2010.1457; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259	29	585	617	16	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2013	341	6151					1215	1218		10.1126/science.1240420	http://dx.doi.org/10.1126/science.1240420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23970562	Green Submitted			2022-12-28	WOS:000324248800036
J	Kaproth, BM; Marone, C				Kaproth, Bryan M.; Marone, C.			Slow Earthquakes, Preseismic Velocity Changes, and the Origin of Slow Frictional Stick-Slip	SCIENCE			English	Article							NUCLEATION; MECHANISM; EVOLUTION; STRENGTH; FAULTS; PHASE	Earthquakes normally occur as frictional stick-slip instabilities, resulting in catastrophic failure and seismic rupture. Tectonic faults also fail in slow earthquakes with rupture durations of months or more, yet their origin is poorly understood. Here, we present laboratory observations of repetitive, slow stick-slip in serpentinite fault zones and mechanical evidence for their origin. We document a transition from unstable to stable frictional behavior with increasing slip velocity, providing a mechanism to limit the speed of slow earthquakes. We also document reduction of P-wave speed within the active shear zone before stick-slip events. If similar mechanisms operate in nature, our results suggest that higher-resolution studies of elastic properties in tectonic fault zones may aid in the search for reliable earthquake precursors.	[Kaproth, Bryan M.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Penn State Univ, Energy Inst, Ctr Geomech Geofluids & Geohazards, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kaproth, BM (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.				NSF [OCE-0648331, EAR-0746192, EAR-0950517]; Directorate For Geosciences [1045825] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank B. Carpenter, M. Scuderi, J. Leeman, M. Ikari, and S. Swavely for assistance in the laboratory and S. Haines and D. Moore for their help with x-ray diffraction interpretation. This work was supported by NSF grants OCE-0648331, EAR-0746192, and EAR-0950517. Data are available in the supplementary materials.	Ben-David O, 2010, NATURE, V463, P76, DOI 10.1038/nature08676; Bouchon M, 2013, NAT GEOSCI, V6, P299, DOI [10.1038/ngeo1770, 10.1038/NGEO1770]; Brantut N, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007876; DIETERICH JH, 1994, PURE APPL GEOPHYS, V143, P283, DOI 10.1007/BF00874332; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; ELLSWORTH WL, 1995, SCIENCE, V268, P851, DOI 10.1126/science.268.5212.851; Fortin J, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004005; Ghosh A, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009249; GODDARD JD, 1990, P ROY SOC LOND A MAT, V430, P105, DOI 10.1098/rspa.1990.0083; Haines SH, 2013, J STRUCT GEOL, V51, P206, DOI 10.1016/j.jsg.2013.01.002; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Ikari MJ, 2013, NAT GEOSCI, V6, P468, DOI [10.1038/NGEO1818, 10.1038/ngeo1818]; Ikari MJ, 2011, GEOLOGY, V39, P83, DOI 10.1130/G31416.1; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Knuth M. W., 2013, GRANUL MATTER; Kohli AH, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007833; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Moore DE, 1997, J GEOPHYS RES-SOL EA, V102, P14787, DOI 10.1029/97JB00995; Niu FL, 2008, NATURE, V454, P204, DOI 10.1038/nature07111; Peng ZG, 2010, NAT GEOSCI, V3, P599, DOI 10.1038/NGEO940; REINEN LA, 1994, PURE APPL GEOPHYS, V143, P317, DOI 10.1007/BF00874334; Rivet D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047151; Roy M, 1996, J GEOPHYS RES-SOL EA, V101, P13919, DOI 10.1029/96JB00529; Rubin AM, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005642; SACKS IS, 1978, NATURE, V275, P599, DOI 10.1038/275599a0; SCHOLZ C, 1972, J GEOPHYS RES, V77, P6392, DOI 10.1029/JB077i032p06392; Scholz C.H., 2002, MECH EARTHQUAKES FAU, P81; Schubnel A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031076; Schubnel A, 2011, EARTH PLANET SC LETT, V308, P424, DOI 10.1016/j.epsl.2011.06.013; Voisin C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033356	30	107	107	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1229	1232		10.1126/science.1239577	http://dx.doi.org/10.1126/science.1239577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23950495				2022-12-28	WOS:000324248800040
J	Allen, AS; Berkovic, SF; Cossette, P; Delanty, N; Dlugos, D; Eichler, EE; Epstein, MP; Glauser, T; Goldstein, DB; Han, YJ; Heinzen, EL; Hitomi, Y; Howell, KB; Johnson, MR; Kuzniecky, R; Lowenstein, DH; Lu, YF; Madou, MRZ; Marson, AG; Mefford, HC; Nieh, SE; O'Brien, TJ; Ottman, R; Petrovski, S; Poduri, A; Ruzzo, EK; Scheffer, IE; Sherr, EH; Yuskaitis, CJ; Abou-Khalil, B; Alldredge, BK; Bautista, JF; Berkovic, SF; Boro, A; Cascino, GD; Consalvo, D; Crumrine, P; Devinsky, O; Dlugos, D; Epstein, MP; Fiol, M; Fountain, NB; French, J; Friedman, D; Geller, EB; Glauser, T; Glynn, S; Haut, SR; Hayward, J; Helmers, SL; Joshi, S; Kanner, A; Kirsch, HE; Knowlton, RC; Kossoff, E; Kuperman, R; Kuzniecky, R; Lowenstein, DH; McGuire, SM; Motika, PV; Novotny, EJ; Ottman, R; Paolicchi, JM; Parent, JM; Park, K; Poduri, A; Scheffer, IE; Shellhaas, RA; Sherr, EH; Shih, JJ; Singh, R; Sirven, J; Smith, MC; Sullivan, J; Thio, LL; Venkat, A; Vining, EPG; Von Allmen, GK; Weisenberg, JL; Widdess-Walsh, P; Winawer, MR				Allen, Andrew S.; Berkovic, Samuel F.; Cossette, Patrick; Delanty, Norman; Dlugos, Dennis; Eichler, Evan E.; Epstein, Michael P.; Glauser, Tracy; Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Hitomi, Yuki; Howell, Katherine B.; Johnson, Michael R.; Kuzniecky, Ruben; Lowenstein, Daniel H.; Lu, Yi-Fan; Madou, Maura R. Z.; Marson, Anthony G.; Mefford, Heather C.; Nieh, Sahar Esmaeeli; O'Brien, Terence J.; Ottman, Ruth; Petrovski, Slave; Poduri, Annapurna; Ruzzo, Elizabeth K.; Scheffer, Ingrid E.; Sherr, Elliott H.; Yuskaitis, Christopher J.; Abou-Khalil, Bassel; Alldredge, Brian K.; Bautista, Jocelyn F.; Berkovic, Samuel F.; Boro, Alex; Cascino, Gregory D.; Consalvo, Damian; Crumrine, Patricia; Devinsky, Orrin; Dlugos, Dennis; Epstein, Michael P.; Fiol, Miguel; Fountain, Nathan B.; French, Jacqueline; Friedman, Daniel; Geller, Eric B.; Glauser, Tracy; Glynn, Simon; Haut, Sheryl R.; Hayward, Jean; Helmers, Sandra L.; Joshi, Sucheta; Kanner, Andres; Kirsch, Heidi E.; Knowlton, Robert C.; Kossoff, Erich; Kuperman, Rachel; Kuzniecky, Ruben; Lowenstein, Daniel H.; McGuire, Shannon M.; Motika, Paul V.; Novotny, Edward J.; Ottman, Ruth; Paolicchi, Juliann M.; Parent, Jack M.; Park, Kristen; Poduri, Annapurna; Scheffer, Ingrid E.; Shellhaas, Renee A.; Sherr, Elliott H.; Shih, Jerry J.; Singh, Rani; Sirven, Joseph; Smith, Michael C.; Sullivan, Joseph; Thio, Liu Lin; Venkat, Anu; Vining, Eileen P. G.; Von Allmen, Gretchen K.; Weisenberg, Judith L.; Widdess-Walsh, Peter; Winawer, Melodie R.			De novo mutations in epileptic encephalopathies	NATURE			English	Article							EPILEPSIES; DISEASE	Epileptic encephalopathies are a devastating group of severe childhood epilepsy disorders for which the cause is often unknown(1). Here we report a screen for de novo mutations in patients with two classical epileptic encephalopathies: infantile spasms (n = 149) and Lennox-Gastaut syndrome (n = 115). We sequenced the exomes of 264 probands, and their parents, and confirmed 329 de novo mutations. A likelihood analysis showed a significant excess of de novo mutations in the similar to 4,000 genes that are the most intolerant to functional genetic variation in the human population (P = 2.9 x 10(-3)). Among these are GABRB3, with de novo mutations in four patients, and ALG13, with the same de novo mutation in two patients; both genes show clear statistical evidence of association with epileptic encephalopathy. Given the relevant site-specific mutation rates, the probabilities of these outcomes occurring by chance are P = 4.1 x 10(-10) and P = 7.8 x 10(-12), respectively. Other genes with de novo mutations in this cohort include CACNA1A, CHD2, FLNA, GABRA1, GRIN1, GRIN2B, HNRNPU, IQSEC2, MTOR and NEDD4L. Finally, we show that the de novo mutations observed are enriched in specific gene sets including genes regulated by the fragile X protein (P < 10(-8)), as has been reported previously for autism spectrum disorders(2).	[Allen, Andrew S.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Duke Clin Res Inst, Durham, NC 27710 USA; [Allen, Andrew S.] Duke Univ, Med Ctr, Ctr Human Genome Variat, Durham, NC 27710 USA; [Berkovic, Samuel F.; Petrovski, Slave] Univ Melbourne Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Cossette, Patrick] Univ Montreal, CHUM Hop Notre Dame Montre, Montreal, PQ H2L 4M1, Canada; [Cossette, Patrick] CHUM Res Ctr, Montreal, PQ H2L 4M1, Canada; [Delanty, Norman] Royal Coll Surg, Dublin 9, Ireland; [Delanty, Norman] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Dlugos, Dennis; Venkat, Anu] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Neurol & Pediat, Philadelphia, PA 19104 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Gen Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Epstein, Michael P.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Glauser, Tracy] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Goldstein, David B.; Han, Yujun; Heinzen, Erin L.; Hitomi, Yuki; Lu, Yi-Fan; Petrovski, Slave; Ruzzo, Elizabeth K.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Howell, Katherine B.] Royal Childrens Hosp Melbourne, Dept Neurol, Parkville, Vic 3052, Australia; [Johnson, Michael R.] Ctr Clin Translat Div Brain Sci, London SW7 2AZ, England; [Kuzniecky, Ruben; French, Jacqueline; Friedman, Daniel] NYU, Sch Med, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Lowenstein, Daniel H.; Madou, Maura R. Z.; Kirsch, Heidi E.; Sullivan, Joseph] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Marson, Anthony G.] Univ Liverpool, Ctr Clin Sci, Dept Mol & Clin Pharmacol, Liverpool L9 7LJ, Merseyside, England; [Mefford, Heather C.] Univ Washington, Div Med Genet, Dept Pediat, Seattle, WA 98115 USA; [Nieh, Sahar Esmaeeli] Univ Calif San Francisco, San Francisco, CA 94143 USA; [O'Brien, Terence J.; Petrovski, Slave] Royal Melbourne Hosp, Dept Med, Parkville, Vic 3146, Australia; [O'Brien, Terence J.; Petrovski, Slave] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3146, Australia; [Ottman, Ruth] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA; [Ottman, Ruth] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Ottman, Ruth] Columbia Univ, GH Sergievsky Ctr, New York, NY 10027 USA; [Ottman, Ruth] New York State Psychiat Inst & Hosp, Div Epidemiol, New York, NY 10032 USA; [Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Div Epilepsy & Clin Neurophysiol, Boston, MA 02115 USA; [Scheffer, Ingrid E.] Univ Melbourne Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Florey Inst, Parkville, Vic 3052, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Dept Pediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Sherr, Elliott H.] Univ Calif San Francisco, Pediat & Inst Human Genet, Dept Neurol, San Francisco, CA 94158 USA; [Yuskaitis, Christopher J.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Abou-Khalil, Bassel; Paolicchi, Juliann M.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Alldredge, Brian K.] Univ Calif San Francisco, Sch Med, UCSF Sch Pharm, Dept Clin Pharm,Dept Neurol, San Francisco, CA 94143 USA; [Bautista, Jocelyn F.] Cleveland Clin Neurol Inst, Cleveland Clin Lerner Coll Med & Epilepsy Ctr, Dept Neurol, Cleveland, OH 44195 USA; [Boro, Alex] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Neurol, Bronx, NY 10467 USA; [Cascino, Gregory D.] Mayo Clin, Div Epilepsy, Rochester, MN 55905 USA; [Consalvo, Damian] Ramos Meji Hosp, Div Neurol, Epilepsy Ctr, RA-1221 Buenos Aires, DF, Argentina; [Crumrine, Patricia] Univ Pittsburgh, UPMC, Med Epilepsy Program & EEG & Child Neurol, Childrens Hosp Pittsburgh,Sch Med, Pittsburgh, PA 15224 USA; [Devinsky, Orrin] NYU, Sch Med, St Barnabas Epilepsy Ctr, New York, NY 10016 USA; [Fiol, Miguel] Univ Minnesota, Sch Med, Epilepsy Care Ctr, Dept Neurol, Minneapolis, MN 55414 USA; [Fountain, Nathan B.] Univ Virginia, FE Dreifuss Comprehens Epilepsy Program, Charlottesville, VA 22908 USA; [Geller, Eric B.; Widdess-Walsh, Peter] St Barnabas Hosp, Div Neurol, Livingston, NJ 07039 USA; [Glynn, Simon] Univ Michigan Hlth Syst, Dept Neurol, Comprehens Epilepsy Program, Ann Arbor, MI 48109 USA; [Haut, Sheryl R.] Montefiore Med Ctr, Comprehens Epilepsy Ctr, Bronx, NY 10467 USA; [Hayward, Jean] Kaiser Permanente Grp, Oakland, CA 94618 USA; [Helmers, Sandra L.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Joshi, Sucheta] Univ Michigan, Ann Arbor, MI 48109 USA; [Kanner, Andres; Smith, Michael C.] Rush Univ, Med Ctr, Rush Epilepsy Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Kirsch, Heidi E.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Knowlton, Robert C.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Kossoff, Erich] Johns Hopkins Univ Hosp, Child Neurol Pediat Neurol Residency Program, Baltimore, MD 21287 USA; [Kuperman, Rachel] Childrens Hosp, Epilepsy Program, Oakland, CA 94609 USA; [Kuperman, Rachel] Res Ctr Oakland, Oakland, CA 94609 USA; [McGuire, Shannon M.] Childrens Hosp Epilepsy Ctr New Orleans, New Orleans, LA 70118 USA; [Motika, Paul V.] Oregon Hlth & Sci Univ, Comprehens Epilepsy Ctr, Portland, OR 97239 USA; [Novotny, Edward J.] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Neurol, Seattle, WA 98105 USA; [Novotny, Edward J.] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Pediat, Seattle, WA 98105 USA; [Paolicchi, Juliann M.] Weill Cornell Med Ctr, New York, NY 10065 USA; [Parent, Jack M.] Univ Michigan, Med Ctr, Dept Neurol & Neurosci, Grad Program, Ann Arbor, MI 49108 USA; [Parent, Jack M.] Ann Arbor Vet Adm Healthcare Syst, Ann Arbor, MI 48105 USA; [Park, Kristen] Univ Colorado, Childrens Hosp Colorado, Sch Med, Dept Neurol, Denver, CO 80045 USA; Univ Colorado, Childrens Hosp Colorado, Sch Med, Dept Pediat, Denver, CO 80045 USA; [Shellhaas, Renee A.] Univ Michigan, Ann Arbor, MI USA; [Shih, Jerry J.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Singh, Rani] Univ Michigan Hlth Syst, Div Pediat Neurol, Ann Arbor, MI 48109 USA; [Sirven, Joseph] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; [Thio, Liu Lin] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Vining, Eileen P. G.] Dept Neurol, Baltimore, MD 21287 USA; [Von Allmen, Gretchen K.] Univ Texas Houston, Sch Med, Div Child & Adolescent Neurol, Dept Pediat, Houston, TX 77030 USA; [Weisenberg, Judith L.] Washington Univ, Sch Med, Div Pediat Neurol, Dept Neurol, St Louis, MO 63110 USA; [Winawer, Melodie R.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Winawer, Melodie R.] Columbia Univ, GH Sergievsky Ctr, New York, NY 10032 USA	Duke University; Duke University; University of Melbourne; Universite de Montreal; Universite de Montreal; Royal College of Surgeons - Ireland; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Emory University; Cincinnati Children's Hospital Medical Center; Duke University; Royal Children's Hospital Melbourne; New York University; University of California System; University of California San Francisco; University of Liverpool; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Royal Melbourne Hospital; Royal Melbourne Hospital; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Harvard University; Boston Children's Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard Medical School; Vanderbilt University; University of California System; University of California San Francisco; Case Western Reserve University; Cleveland Clinic Foundation; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Mayo Clinic; Hospital Ramos Mejia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia; University of Michigan System; University of Michigan; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Kaiser Permanente; Emory University; University of Michigan System; University of Michigan; Rush University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins Medicine; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Children's Hospital of New Orleans; Oregon Health & Science University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Cornell University; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Michigan System; University of Michigan; Mayo Clinic; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic Phoenix; Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL); Columbia University; Columbia University	Allen, AS (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Duke Clin Res Inst, Durham, NC 27710 USA.		Ottman, Ruth/O-2371-2013; Resource Center, NINDS Human Genetics/AGF-2474-2022; O'Brien, Terence/AAU-5525-2021; Scheffer, Ingrid E/G-1668-2013; French, Jacqueline A/G-6795-2013; O'Brien, Terence/L-8102-2013; Thio, Liu Lin/A-4318-2008; Bautista, Jocelyn F./AAP-6901-2021; Hitomi, Yuki/V-8236-2019; Goldstein, David/AAY-8125-2020; Marson, Anthony/AAW-9776-2020; Novotny, Edward J./ABG-9577-2021; Ruzhnikov, Maura RZ/L-8859-2019; Shellhaas, Renee/H-6697-2019	Ottman, Ruth/0000-0001-7074-242X; Scheffer, Ingrid E/0000-0002-2311-2174; French, Jacqueline A/0000-0003-2242-8027; O'Brien, Terence/0000-0002-7198-8621; Thio, Liu Lin/0000-0002-9779-7903; Marson, Anthony/0000-0002-6861-8806; Ruzhnikov, Maura RZ/0000-0001-9610-1612; Shellhaas, Renee/0000-0002-3175-3908; Widdess-Walsh, Peter/0000-0003-4217-2575; Kirsch, Heidi/0000-0002-3144-2085; Park, Kristen/0000-0001-5527-3047; Buerki, Sarah Elisabeth/0000-0003-3054-1791; Petrovski, Slave/0000-0002-1527-961X; Delaney, Norman/0000-0002-3953-9842; Allen, Andrew/0000-0002-7232-2143; Cascino, Gregory/0000-0002-5380-2977; Novotny, Edward/0000-0001-9726-0447; Devinsky, Orrin/0000-0003-0044-4632; Berkovic, Samuel/0000-0003-4580-841X	National Institute of Neurological Disorders and Stroke [NS053998, NS077364, NS077274, NS077303, NS077276]; Richard Thalheimer Philanthropic Fund; ARRA [1RC2NS070342]; NIAID [R56AI098588]; Ellison Medical Foundation New Scholar award [AG-NS-0441-08]; SAID-Frederick, Inc. [M11-074]; Center for HIV/AIDS Vaccine Immunology ("CHAVI") from the National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1AIO67854]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI098588, U01AI067854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070342, U01NS077303, U01NS077274, U01NS053998, U01NS077276, U01NS077364] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Richard Thalheimer Philanthropic Fund; ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation New Scholar award(Lawrence Ellison Foundation); SAID-Frederick, Inc.; Center for HIV/AIDS Vaccine Immunology ("CHAVI") from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the patients, their families, clinical research coordinators and referring physicians for participating in the Epilepsy Phenome/Genome Project (EPGP) and providing the phenotype data and DNA samples used in this study. We thank the following professional and lay organizations for substantial assistance in publicizing EPGP and therefore enabling us to recruit participants effectively: AED Pregnancy Registry, American Epilepsy Society, Association of Child Neurology Nurses, California School Nurses Organization, Child Neurology Society, Citizens United for Research in Epilepsy, Dravet Syndrome Foundation, Epilepsy Alliance of Orange County, Epilepsy Foundation, Epilepsy Therapy Project, Finding a Cure for Epilepsy and Seizures, IDEA League, InfantileSpasms.com, Lennox-Gastaut Syndrome Foundation, PatientsLikeMe, People Against Childhood Epilepsy, PVNH Support & Awareness, and Seizures & Epilepsy Education. We thank the EPGP Administrative Core (C. Freyer, K. Schardein, R.N., M. S., R. Fahlstrom, M. P. H., S. Cristofaro, R.N., B.S.N. and K. McGovern), EPGP Bioinformatics Core (G. Nesbitt, K. McKenna, V. Mays), staff at the Coriell Institute - NINDS Genetics Repository (C. Tarn, A. Scutti), and members of the Duke Center for Human Genome Variation (B. Krueger, J. Bridgers, J. Keebler, H. Shin Kim, E. Campbell, K. Cronin, L. Hong and M. McCall) for their dedication and commitment to this work. We also thank S. Shinnar (Albert Einstein College of Medicine) and N. Risch (University of California, San Francisco) for valuable input into the creation of EPGP and Epi4K, and R. Stewart, K. Gwinn and R. Corriveau from the National Institute of Neurological Disorders and Stroke for their careful oversight and guidance of both EPGP and Epi4K. This work was supported by grants from the National Institute of Neurological Disorders and Stroke (The Epilepsy Phenome/Genome Project NS053998; Epi4K Project 1-Epileptic Encephalopathies NS077364; Epi4K-Administrative Core NS077274; Epi4K-Sequencing, Biostatistics and Bioinformatics Core NS077303 and Epi4K-Phenotyping and Clinical Informatics Core NS077276); Finding a Cure for Epilepsy and Seizures; and the Richard Thalheimer Philanthropic Fund. We would like to acknowledge the following individuals and groups for their contribution of control samples: J. Hoover-Fong, N. Sobreira and D. Valle; The MURDOCK Study Community Registry and Biorepository (D. Murdock); S. Sisodiya; D. Attix; O. Chiba-Falek; V. Shashi; P. Lugar; W. Lowe; S. Palmer; D. Marchuk; Z. Farfel, D. Lancet, E. Pras; Q. Zhao; D. Daskalakis; R. Brown; E. Holtzman; R. Gbadegesin; M. Winn; S. Kerns; and H. Oster. The collection of control samples was funded in part by ARRA 1RC2NS070342, NIAID R56AI098588, the Ellison Medical Foundation New Scholar award AG-NS-0441-08, an award from SAID-Frederick, Inc. (M11-074), and with federal funds by the Center for HIV/AIDS Vaccine Immunology ("CHAVI") under a grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (UO1AIO67854).	Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Hitomi Y., 2013, ANN NEUROL; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Karn CF, 2013, CLIN TRIALS, V10, P568, DOI 10.1177/1740774513484392; Kasperaviciute D, 2010, BRAIN, V133, P2136, DOI 10.1093/brain/awq130; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Mulley JC, 2011, EPILEPSIA, V52, P423, DOI 10.1111/j.1528-1167.2010.02932.x; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Otsuka M, 2010, EPILEPSIA, V51, P2449, DOI 10.1111/j.1528-1167.2010.02767.x; Petrovski S., 2013, PLOS GEN IN PRESS; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Tanaka M., 2012, JASPERS BASIC MECH E; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712	31	1033	1063	6	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					217	+		10.1038/nature12439	http://dx.doi.org/10.1038/nature12439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23934111	Green Accepted, Green Submitted			2022-12-28	WOS:000324244900040
J	D'Angelo, G; Uemura, T; Chuang, CC; Polishchuk, E; Santoro, M; Ohvo-Rekila, H; Sato, T; Di Tullio, G; Varriale, A; D'Auria, S; Daniele, T; Capuani, F; Johannes, L; Mattjus, P; Monti, M; Pucci, P; Williams, RL; Burke, JE; Platt, FM; Harada, A; De Matteis, MA				D'Angelo, Giovanni; Uemura, Takefumi; Chuang, Chia-Chen; Polishchuk, Elena; Santoro, Michele; Ohvo-Rekila, Henna; Sato, Takashi; Di Tullio, Giuseppe; Varriale, Antonio; D'Auria, Sabato; Daniele, Tiziana; Capuani, Fabrizio; Johannes, Ludger; Mattjus, Peter; Monti, Maria; Pucci, Piero; Williams, Roger L.; Burke, John E.; Platt, Frances M.; Harada, Akihiro; De Matteis, Maria Antonietta			Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi	NATURE			English	Article							GLYCOSPHINGOLIPID SYNTHESIS; GLUCOSYLCERAMIDE; TOXIN; BINDING; SURFACE; SPHINGOLIPIDS; 4-PHOSPHATE; PTDINS(4)P; PROTEINS; SYNTHASE	Newly synthesized proteins and lipids are transported across the Golgi complex via different mechanisms whose respective roles are not completely clear. We previously identified a non-vesicular intra-Golgi transport pathway for glucosylceramide (GlcCer)-the common precursor of the different series of glycosphingolipids-that is operated by the cytosolic GlcCer-transfer protein FAPP2 (also known as PLEKHA8) (ref. 1). However, the molecular determinants of the FAPP2-mediated transfer of GlcCer from the cis-Golgi to the trans-Golgi network, as well as the physiological relevance of maintaining two parallel transport pathways of GlcCer-vesicular and non-vesicular-through the Golgi, remain poorly defined. Here, using mouse and cell models, we clarify the molecular mechanisms underlying the intra-Golgi vectorial transfer of GlcCer by FAPP2 and show that GlcCer is channelled by vesicular and non-vesicular transport to two topologically distinct glycosylation tracks in the Golgi cisternae and the trans-Golgi network, respectively. Our results indicate that the transport modality across the Golgi complex is a key determinant for the glycosylation pattern of a cargo and establish a new paradigm for the branching of the glycosphingolipid synthetic pathway.	[D'Angelo, Giovanni; Polishchuk, Elena; Santoro, Michele; Capuani, Fabrizio; De Matteis, Maria Antonietta] Telethon Inst Genet & Med, I-80131 Naples, Italy; [D'Angelo, Giovanni; Varriale, Antonio; D'Auria, Sabato] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Uemura, Takefumi; Sato, Takashi; Harada, Akihiro] Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol & Cellular Biol, Lab Mol Traff, Gunma 3718512, Japan; [Chuang, Chia-Chen; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Ohvo-Rekila, Henna; Mattjus, Peter] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland; [Di Tullio, Giuseppe; Daniele, Tiziana] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; [Johannes, Ludger] Inst Curie, Ctr Rech, F-75248 Paris 05, France; [Johannes, Ludger] CNRS, UMR144, F-75248 Paris, France; [Monti, Maria; Pucci, Piero] Univ Naples Federico II, Dipartimento Sci Chim, I-80145 Naples, Italy; [Monti, Maria; Pucci, Piero] Univ Naples Federico II, CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Williams, Roger L.; Burke, John E.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Harada, Akihiro] Osaka Univ, Dept Cell Biol, Suita, Osaka 5650871, Japan	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Gunma University; University of Oxford; Abo Akademi University; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; MRC Laboratory Molecular Biology; Osaka University	De Matteis, MA (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	dematteis@tigem.it	Daniele, Tiziana/AAN-1916-2020; Johannes, Ludger/M-9778-2017; Varriale, Antonio/AAL-1439-2020; Johannes, Ludger/W-8593-2019; Capuani, Fabrizio/B-7829-2008; d'auria, sabato/C-3565-2015; Burke, John/H-3922-2019; Mattjus, Peter/ABE-3596-2021; Mattjus, Peter/AAQ-7531-2021; MONTI, Maria/J-2816-2018; De Matteis, Maria Antonietta/AHE-5161-2022	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Capuani, Fabrizio/0000-0003-2026-6335; d'auria, sabato/0000-0001-9320-494X; Burke, John/0000-0001-7904-9859; Mattjus, Peter/0000-0001-8991-5933; MONTI, Maria/0000-0002-7775-7154; De Matteis, Maria Antonietta/0000-0003-0053-3061; Daniele, Tiziana/0000-0002-6465-1078; Platt, Frances/0000-0001-7614-0403; DANGELO, GIOVANNI/0000-0001-5466-8709; Williams, Roger/0000-0001-7754-4207; PUCCI, Pietro/0000-0002-5885-1495; D'Angelo, Giovanni/0000-0002-0734-4127	Telethon [GSP08002, GGP06166]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 8623]; EU (FP7 Lipidomicnet); AIRC [MFAG 10585]; Academy of Finland; Sigrid Juselius Foundation; Study Abroad Scholarship from the Taiwan Ministry of Education; MRC [MC_U105184308] Funding Source: UKRI; British Heart Foundation [PG/11/109/29247] Funding Source: researchfish; Medical Research Council [MC_U105184308] Funding Source: researchfish	Telethon(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); EU (FP7 Lipidomicnet); AIRC(Fondazione AIRC per la ricerca sul cancro); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Study Abroad Scholarship from the Taiwan Ministry of Education; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Luini, C. Wilson and D. Priestman for discussions, A. Egorova for help with electron microscopy, G. Liebisch, A. Sigruener and G. Schmitz for lipidomic analysis. M. A. D. M. acknowledges the support of Telethon (GSP08002 and GGP06166), Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG 8623), and the EU (FP7 Lipidomicnet). G.D.'A. acknowledges the support of AIRC (MFAG 10585). P. M. acknowledges the support of Academy of Finland and Sigrid Juselius Foundation. C.-C. C. was funded by a Study Abroad Scholarship from the Taiwan Ministry of Education.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He J, 2011, J BIOL CHEM, V286, P18650, DOI 10.1074/jbc.M111.233015; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Mallard Frederic, 2003, Methods Mol Med, V73, P209; Moto YH, 2008, NEUROREPORT, V19, P621, DOI 10.1097/WNR.0b013e3282fb7d99; Muramatsu K, 2008, BIOCHEM BIOPH RES CO, V370, P419, DOI 10.1016/j.bbrc.2008.03.103; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; PIETRO ES, 2009, PLOS BIOL, V0007; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yan XG, 2004, MOL CELL PROTEOMICS, V3, P10, DOI 10.1074/mcp.R300010-MCP200; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200	30	104	108	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465								10.1038/nature12423	http://dx.doi.org/10.1038/nature12423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8YC	23913272				2022-12-28	WOS:000339424700002
J	Holmes, D				Holmes, David			Rafael Rosell: leading the long march against lung cancer	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 24	2013	382	9893					675	675		10.1016/S0140-6736(13)61763-8	http://dx.doi.org/10.1016/S0140-6736(13)61763-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23972801				2022-12-28	WOS:000323542400012
J	Madison, AS; Tebo, BM; Mucci, A; Sundby, B; Luther, GW				Madison, Andrew S.; Tebo, Bradley M.; Mucci, Alfonso; Sundby, Bjorn; Luther, George W., III			Abundant Porewater Mn(III) Is a Major Component of the Sedimentary Redox System	SCIENCE			English	Article							DISSOLVED REACTIVE MANGANESE; OXYGEN CONCENTRATIONS; MN(IV) REDUCTION; OXIDATION; DIAGENESIS; IRON; BIOTURBATION; ENVIRONMENT; COMPLEXES; PATHWAYS	Soluble manganese(III) [Mn(III)] can potentially serve as both oxidant and reductant in one-electron-transfer reactions with other redox species. In near-surface sediment porewater, it is often overlooked as a major component of Mn cycling. Applying a spectrophotometric kinetic method to hemipelagic sediments from the Laurentian Trough (Quebec, Canada), we found that soluble Mn(III), likely stabilized by organic or inorganic ligands, accounts for up to 90% of the total dissolved Mn pool. Vertical profiles of dissolved oxygen and dissolved and solid Mn suggest that soluble Mn(III) is primarily produced via oxidation of Mn(II) diffusing upwards from anoxic sediments with lesser contributions from biotic and abiotic reductive dissolution of MnO2. The conceptual model of the sedimentary redox cycle should therefore explicitly include dissolved Mn(III).	[Madison, Andrew S.; Luther, George W., III] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Tebo, Bradley M.] Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Beaverton, OR 97006 USA; [Mucci, Alfonso; Sundby, Bjorn] McGill Univ, GEOTOP, Montreal, PQ H3A 0E8, Canada; [Mucci, Alfonso; Sundby, Bjorn] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A 0E8, Canada; [Sundby, Bjorn] Univ Quebec, Inst Sci Rimouski, Rimouski, PQ G5L 3A1, Canada	University of Delaware; Oregon Health & Science University; McGill University; McGill University; University of Quebec	Madison, AS (corresponding author), Golder Associates Inc, 200 Century Pkwy,Suite C, Mt Laurel, NJ 08054 USA.	andrew_madison@golder.com	Luther, George/A-6384-2008; Tebo, Bradley M/A-8432-2017	Luther, George/0000-0002-0780-885X; Tebo, Bradley M/0000-0002-6301-4325; Mucci, Alfonso/0000-0001-9155-6319	Chemical Oceanography Division of the National Foundation [OCE-1155385, OCE-1031272, OCE-1031200, OCE-1154307]; Natural Sciences and Engineering Research Council of Canada (NSERC); Directorate For Geosciences [1155385] Funding Source: National Science Foundation; Division Of Ocean Sciences [1154307] Funding Source: National Science Foundation	Chemical Oceanography Division of the National Foundation(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by grants from the Chemical Oceanography Division of the National Foundation to G.W.L. (OCE-1155385 and OCE-1031272) and B.M.T. (OCE-1031200 and OCE-1154307), and from the Natural Sciences and Engineering Research Council of Canada (NSERC) through Discovery and Ship-time grants to A.M. and B.S. Raw data are presented in the supplementary materials.	ALLER RC, 1990, PHILOS T R SOC A, V331, P51, DOI 10.1098/rsta.1990.0056; Anschutz P, 2000, GEOCHIM COSMOCHIM AC, V64, P2751, DOI 10.1016/S0016-7037(00)00400-2; Boudreau BP, 1998, J MAR RES, V56, P1259, DOI 10.1357/002224098765093634; Clement BG, 2009, GEOCHIM COSMOCHIM AC, V73, P1878, DOI 10.1016/j.gca.2008.12.023; Dellwig O, 2012, J MARINE SYST, V90, P31, DOI 10.1016/j.jmarsys.2011.08.007; Duckworth OW, 2005, ENVIRON SCI TECHNOL, V39, P6037, DOI 10.1021/es050275k; EMERSON S, 1982, GEOCHIM COSMOCHIM AC, V46, P1073, DOI 10.1016/0016-7037(82)90060-6; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; Homoky WB, 2011, GEOCHIM COSMOCHIM AC, V75, P5032, DOI 10.1016/j.gca.2011.06.019; JOHNSON KS, 1992, SCIENCE, V257, P1242, DOI 10.1126/science.257.5074.1242; Katsev S, 2007, LIMNOL OCEANOGR, V52, P2555, DOI 10.4319/lo.2007.52.6.2555; Klewicki JK, 1998, ENVIRON SCI TECHNOL, V32, P2916, DOI 10.1021/es980308e; KOSTKA JE, 1995, GEOCHIM COSMOCHIM AC, V59, P885; LEWIS BL, 1991, DEEP-SEA RES, V38, pS773, DOI 10.1016/S0198-0149(10)80009-3; Lin H, 2012, GEOCHIM COSMOCHIM AC, V99, P179, DOI 10.1016/j.gca.2012.09.020; Luther GW, 2010, AQUAT GEOCHEM, V16, P395, DOI 10.1007/s10498-009-9082-3; Luther GW, 1997, GEOCHIM COSMOCHIM AC, V61, P4043, DOI 10.1016/S0016-7037(97)00239-1; LUTHER GW, 1992, MAR CHEM, V40, P81, DOI 10.1016/0304-4203(92)90049-G; Luther GW, 2005, GEOMICROBIOL J, V22, P195, DOI 10.1080/01490450590946022; Madison AS, 2011, TALANTA, V84, P374, DOI 10.1016/j.talanta.2011.01.025; Mulsow S, 1998, LIMNOL OCEANOGR, V43, P1; Neretin LN, 2003, MAR CHEM, V82, P125, DOI 10.1016/S0304-4203(03)00048-3; Parker DL, 2004, GEOCHIM COSMOCHIM AC, V68, P4809, DOI 10.1016/j.gca.2004.05.038; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Schippers A, 2005, GEOCHIM COSMOCHIM AC, V69, P2241, DOI 10.1016/j.gca.2004.10.016; Schnetger B, 2012, J MARINE SYST, V90, P23, DOI 10.1016/j.jmarsys.2011.08.006; SHAW TJ, 1990, GEOCHIM COSMOCHIM AC, V54, P1233, DOI 10.1016/0016-7037(90)90149-F; SUNDBY B, 1981, GEOCHIM COSMOCHIM AC, V45, P293, DOI 10.1016/0016-7037(81)90240-4; Taillefert M, 2000, ENVIRON SCI TECHNOL, V34, P2169, DOI 10.1021/es990120a; TEBO BM, 1991, DEEP-SEA RES, V38, pS883, DOI 10.1016/S0198-0149(10)80015-9; Trouwborst RE, 2006, SCIENCE, V313, P1955, DOI 10.1126/science.1132876; Yakushev E, 2009, MAR CHEM, V117, P59, DOI 10.1016/j.marchem.2009.09.007	32	173	182	13	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					875	878		10.1126/science.1241396	http://dx.doi.org/10.1126/science.1241396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970696				2022-12-28	WOS:000323370600039
J	Suweis, S; Simini, F; Banavar, JR; Maritan, A				Suweis, Samir; Simini, Filippo; Banavar, Jayanth R.; Maritan, Amos			Emergence of structural and dynamical properties of ecological mutualistic networks	NATURE			English	Article							NESTEDNESS ANALYSIS; STABILITY; ARCHITECTURE; EVOLUTION; BIODIVERSITY; COMMUNITIES; ECOSYSTEMS; DIVERSITY; SYSTEMS	Mutualistic networks are formed when the interactions between two classes of species are mutually beneficial. They are important examples of cooperation shaped by evolution. Mutualism between animals and plants has a key role in the organization of ecological communities(1-3). Such networks in ecology have generally evolved a nested architecture(4,5) independent of species composition and latitude(6,7); specialist species, with only few mutualistic links, tend to interact with a proper subset of the many mutualistic partners of any of the generalist species(1). Despite sustained efforts(5,8-10) to explain observed network structure on the basis of community-level stability or persistence, such correlative studies have reached minimal consensus(11-13). Here we show that nested interaction networks could emerge as a consequence of an optimization principle aimed at maximizing the species abundance in mutualistic communities. Using analytical and numerical approaches, we show that because of the mutualistic interactions, an increase in abundance of a given species results in a corresponding increase in the total number of individuals in the community, and also an increase in the nestedness of the interaction matrix. Indeed, the species abundances and the nestedness of the interaction matrix are correlated by a factor that depends on the strength of the mutualistic interactions. Nestedness and the observed spontaneous emergence of generalist and specialist species occur for several dynamical implementations of the variational principle under stationary conditions. Optimized networks, although remaining stable, tend to be less resilient than their counterparts with randomly assigned interactions. In particular, we show analytically that the abundance of the rarest species is linked directly to the resilience of the community. Our work provides a unifying framework for studying the emergent structural and dynamical properties of ecological mutualistic networks(2,5,10,14).	[Suweis, Samir; Maritan, Amos] Univ Padua, Ist Nazl Fis Nucl, Dipartimento Fis & Astron G Galilei, I-35131 Padua, Italy; [Suweis, Samir; Maritan, Amos] Univ Padua, Ist Nazl Fis Nucl, CNISM, I-35131 Padua, Italy; [Simini, Filippo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Simini, Filippo] Northeastern Univ, Dept Phys Biol & Comp Sci, Boston, MA 02115 USA; [Simini, Filippo] Budapest Univ Technol & Econ, Inst Phys, H-1111 Budapest, Hungary; [Banavar, Jayanth R.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Northeastern University; Northeastern University; Budapest University of Technology & Economics; University System of Maryland; University of Maryland College Park	Suweis, S (corresponding author), Univ Padua, Ist Nazl Fis Nucl, Dipartimento Fis & Astron G Galilei, Via Marzolo 8, I-35131 Padua, Italy.	suweis@pd.infn.it; amos.maritan@pd.infn.it		Suweis, Samir/0000-0002-1603-8375; Maritan, Amos/0000-0002-3535-7873	Cariparo foundation	Cariparo foundation(Fondazione Cariparo)	A.M. and S.S. acknowledge the Cariparo foundation for financial support. We thank S. Allesina, T. Cooke, J. Grilli and L. Mari for discussions and Studio 7 a.m. for graphics support.	Allesina S, 2012, NATURE, V487, P175, DOI 10.1038/487175a; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Campbell C, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021924; Douglas M. W., 2011, P R SOC B, V278, P2401; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2011, ECOL LETT, V14, P877, DOI 10.1111/j.1461-0248.2011.01649.x; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson AR, 2006, J ANIM ECOL, V75, P1239, DOI 10.1111/j.1365-2656.2006.01145.x; Twardochleb LA, 2012, ECOL APPL, V22, P1162, DOI 10.1890/11-0871.1; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Zhang F, 2011, ECOL LETT, V14, P797, DOI 10.1111/j.1461-0248.2011.01647.x	30	172	174	8	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					449	452		10.1038/nature12438	http://dx.doi.org/10.1038/nature12438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969462	Green Submitted			2022-12-28	WOS:000323316100033
J	Ziller, MJ; Gu, HC; Muller, F; Donaghey, J; Tsai, LTY; Kohlbacher, O; De Jager, PL; Rosen, ED; Bennett, DA; Bernstein, BE; Gnirke, A; Meissner, A				Ziller, Michael J.; Gu, Hongcang; Mueller, Fabian; Donaghey, Julie; Tsai, Linus T. -Y.; Kohlbacher, Oliver; De Jager, Philip L.; Rosen, Evan D.; Bennett, David A.; Bernstein, Bradley E.; Gnirke, Andreas; Meissner, Alexander			Charting a dynamic DNA methylation landscape of the human genome	NATURE			English	Article							MAMMALIAN DEVELOPMENT; CELLS; WIDE; METHYLOME; DISEASE; MOUSE; PLURIPOTENT; SELECTION; TRAITS; LOCI	DNA methylation is a defining feature of mammalian cellular identity and is essential for normal development(1,2). Most cell types, except germ cells and pre-implantation embryos(3-5), display relatively stable DNA methylation patterns, with 70-80% of all CpGs being methylated(6). Despite recent advances, we still have a limited understanding of when, where and how many CpGs participate in genomic regulation. Here we report the in-depth analysis of 42 whole-genome bisulphite sequencing data sets across 30 diverse human cell and tissue types. We observe dynamic regulation for only 21.8% of autosomal CpGs within a normal developmental context, most of which are distal to transcription start sites. These dynamic CpGs co-localize with gene regulatory elements, particularly enhancers and transcription-factor-binding sites, which allow identification of key lineage-specific regulators. In addition, differentially methylated regions (DMRs) often contain single nucleotide polymorphisms associated with cell-type-related diseases as determined by genome-wide association studies. The results also highlight the general inefficiency of whole-genome bisulphite sequencing, as 70-80% of the sequencing reads across these data sets provided little or no relevant information about CpG methylation. To demonstrate further the utility of our DMR set, we use it to classify unknown samples and identify representative signature regions that recapitulate major DNA methylation dynamics. In summary, although in theory every CpG can change its methylation state, our results suggest that only a fraction does so as part of coordinated regulatory programs. Therefore, our selected DMRs can serve as a starting point to guide new, more effective reduced representation approaches to capture the most informative fraction of CpGs, as well as further pinpoint putative regulatory elements.	[Ziller, Michael J.; Gu, Hongcang; Donaghey, Julie; De Jager, Philip L.; Rosen, Evan D.; Bernstein, Bradley E.; Gnirke, Andreas; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ziller, Michael J.; Donaghey, Julie; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ziller, Michael J.; Mueller, Fabian; Donaghey, Julie; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tsai, Linus T. -Y.; Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, D-72074 Tubingen, Germany; [Kohlbacher, Oliver] Univ Tubingen, Quantitat Biol Ctr, D-72074 Tubingen, Germany; [De Jager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Psychiat, Boston, MA 02115 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Rush University; Harvard University; Massachusetts General Hospital	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Kohlbacher, Oliver/AAF-3297-2021; Müller, Fabian/HGD-0719-2022; Kohlbacher, Oliver/B-7310-2008	Kohlbacher, Oliver/0000-0003-1739-4598; Müller, Fabian/0000-0001-5809-2321; Kohlbacher, Oliver/0000-0003-1739-4598; Gu, Hongcang/0000-0002-1439-7606; Tsai, Linus/0000-0002-0134-6949	National Institutes of Health (NIH) Roadmap Epigenomics Project [ES017690]; NIH [P30AG10161, R01AG17917, R01AG15819, R01AG36042, U01ES017155, P01GM099117]; Pew Charitable Trusts; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036042, R01AG015819, P30AG010161, R01AG017917] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Roadmap Epigenomics Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank K. Clement, P. Samavarchi-Tehrani, Z. Smith, M. Chan and R. Karnik for discussions and feedback. We would also like to thank F. Kelley, T. Durham, C. Epstein, N. Shoresh, G. Lauwers and the Massachusetts General Hospital tissue repository for assisting in sample and data management. E.D.R. is supported by the National Institutes of Health (NIH) Roadmap Epigenomics Project (ES017690). D.A.B. is supported by NIH grants P30AG10161, R01AG17917, R01AG15819 and R01AG36042. A.M. is supported by the Pew Charitable Trusts and is a New York Stem Cell Foundation, Robertson Investigator. This work was funded by NIH grants (U01ES017155 and P01GM099117) and The New York Stem Cell Foundation.	Bell CG, 2012, EPIGENETICS-US, V7, P1188, DOI 10.4161/epi.22127; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	30	860	888	6	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					477	481		10.1038/nature12433	http://dx.doi.org/10.1038/nature12433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23925113	Green Accepted, Green Submitted			2022-12-28	WOS:000323316100039
J	Hoeksma, J				Hoeksma, Jon			Turning doctors into coders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Ehlth Insider, London, England		Hoeksma, J (corresponding author), Ehlth Insider, London, England.	jon@e-health-media.com							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2013	347								f5142	10.1136/bmj.f5142	http://dx.doi.org/10.1136/bmj.f5142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207SC	23963559				2022-12-28	WOS:000323623100018
J	Gao, P; Ascano, M; Zillinger, T; Wang, WY; Dai, PH; Serganov, AA; Gaffney, BL; Shuman, S; Jones, RA; Deng, L; Hartmann, G; Barchet, W; Tuschl, T; Patel, DJ				Gao, Pu; Ascano, Manuel; Zillinger, Thomas; Wang, Weiyi; Dai, Peihong; Serganov, Artem A.; Gaffney, Barbara L.; Shuman, Stewart; Jones, Roger A.; Deng, Liang; Hartmann, Gunther; Barchet, Winfried; Tuschl, Thomas; Patel, Dinshaw J.			Structure-Function Analysis of STING Activation by c[G(2 ',5 ') pA(3 ',5 ')p] and Targeting by Antiviral DMXAA	CELL			English	Article							CYCLIC DI-GMP; CYTOSOLIC DNA; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; AMP SYNTHASE; 2ND-MESSENGER; DINUCLEOTIDE; STIMULATOR; MECHANISM; ADAPTER; SENSOR	Binding of dsDNA by cyclic GMP-AMP (cGAMP) synthase (cGAS) triggers formation of the metazoan second messenger c[G(2',5')pA(3',5')p], which binds the signaling protein STING with subsequent activation of the interferon (IFN) pathway. We show that human hSTING H232 adopts a "closed" conformation upon binding c[G(2',5') pA(3',5') p] and its linkage isomer c[G(2',5') pA(2',5') p], as does mouse mSting(R231) on binding c[G(2',5') pA(3',5') p], c[G(3',5') pA(3',5') p] and the antiviral agent DMXAA, leading to similar "closed" conformations. Comparing hSTING to mSting, 2',5'-linkage-containing cGAMP isomers were more specific triggers of the IFN pathway compared to the all-3',5'-linkage isomer. Guided by structural information, we identified a unique point mutation (S162A) placed within the cyclic-dinucleotide-binding site of hSTING that rendered it sensitive to the otherwise mouse-specific drug DMXAA, a conclusion validated by binding studies. Our structural and functional analysis highlights the unexpected versatility of STING in the recognition of natural and synthetic ligands within a small-molecule pocket created by the dimerization of STING.	[Gao, Pu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Wang, Weiyi; Dai, Peihong; Deng, Liang] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10065 USA; [Dai, Peihong; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Ascano, Manuel; Serganov, Artem A.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Zillinger, Thomas; Hartmann, Gunther; Barchet, Winfried] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Gaffney, Barbara L.; Jones, Roger A.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University; University of Bonn; Rutgers State University New Brunswick	Barchet, W (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	winfried.barchet@ukb.uni-bonn.de; ttuschl@mail.rockefeller.edu; pateld@mskcc.org	Wang, Weiyi/GZN-0408-2022; Hartmann, Gunther/P-7492-2017; Zillinger, Thomas/AAD-7320-2020; Deng, Liang/GXH-6710-2022; Ascano, Manuel/ABA-3586-2020; Jones, Roger A./GRY-0637-2022	Hartmann, Gunther/0000-0003-1021-2018; Zillinger, Thomas/0000-0002-0866-4835; Ascano, Manuel/0000-0002-9370-5493; Barchet, Winfried/0000-0002-6745-6606; Jones, Roger A./0000-0002-6835-6615	Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; HHMI; DFG [BA3544/1-1, SFB670, SFB704]; NIH [GM79760, R56AI095692, GM42498]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079760, R01GM042498] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; HHMI(Howard Hughes Medical Institute); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the synchrotron beam line staffs at the Brookhaven and Argonne National laboratories for their assistance and Kenneth Breslauer for discussions related to interpretation of ITC experiments. D.J.P is supported by grants from the Abby Rockefeller Mauze Trust and the Maloris and STARR Foundations. T. T. is supported by HHMI. W. B. and G. H. are members of the DFG Excellence Cluster ImmunoSensation. W. B. is supported by DFG grant BA3544/1-1, G. H. by SFB670, and W. B. and G. H. by SFB704. R.J. is supported by NIH grant GM79760, L. D. is supported by NIH grant R56AI095692 and S. S. is supported by NIH grant GM42498. The structural research was performed by P. G. under the supervision of D.J.P., the RT-PCR measurements involving transcriptional activation were performed by M. A. and A. A. S. under the supervision of T. T., the assays describing cGAMP stimulation of BMDM were performed by W. W. and P. D. under the supervision of L. D. and S. S., the cellular assays monitoring STING-dependent interferon induction were performed by T.Z. under the supervision of W. B. and G. H., and chemical synthesis of cGAMP linkage isomers was performed by B. L. G. under the supervision of R.A.J. All participants participated in the writing of the paper and agree with the contents.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Baguley BC, 2002, INT J RADIAT ONCOL, V54, P1503, DOI 10.1016/S0360-3016(02)03920-2; Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kim S., 2013, ACS CHEM BIOL; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	28	324	371	3	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					748	762		10.1016/j.cell.2013.07.023	http://dx.doi.org/10.1016/j.cell.2013.07.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23910378	Bronze, Green Accepted			2022-12-28	WOS:000323202500008
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC The curious case of 600 extra deaths a week	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2013	347								f5014	10.1136/bmj.f5014	http://dx.doi.org/10.1136/bmj.f5014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201DK	23935062				2022-12-28	WOS:000323120700012
J	Feder, G; Wathen, CN; MacMillan, HL				Feder, Gene; Wathen, C. Nadine; MacMillan, Harriet L.			An Evidence-Based Response to Intimate Partner Violence WHO Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED-CONTROLLED-TRIAL		[Feder, Gene] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England; [Wathen, C. Nadine] Western Univ, Fac Informat & Media Studies, London, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [MacMillan, Harriet L.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	University of Bristol; Western University (University of Western Ontario); McMaster University; McMaster University	Feder, G (corresponding author), Univ Bristol, Sch Social & Community Med, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, Avon, England.	gene.feder@bristol.ac.uk	MacMillan, Harriet/B-4530-2016	MacMillan, Harriet/0000-0002-1223-706X; Feder, Gene/0000-0002-7890-3926				Cohen JA, 2011, ARCH PEDIAT ADOL MED, V165, P16, DOI 10.1001/archpediatrics.2010.247; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Taft A, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD007007.PUB2; World Health Organization, RESPONDING TO INTIMA	8	32	33	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					479	480		10.1001/jama.2013.167453	http://dx.doi.org/10.1001/jama.2013.167453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925614				2022-12-28	WOS:000322786400016
J	Selvaraj, S				Selvaraj, Sakthivel			PERSONAL VIEW Africa could learn from India's burgeoning pharma sector	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India	Selvaraj, S (corresponding author), Publ Hlth Fdn India, New Delhi, India.	shakti@phfi.org	Selvaraj, Sakthivel/ABD-5873-2021; Selvaraj, Sakthivel/ABE-6897-2020	Selvaraj, Sakthivel/0000-0001-5940-1958				Centre for Monitoring Indian Economy, 2012, IND TRAD BAS DIR GEN; Emerging Market Information Services, 2012, PHARM SECT IND; Gopakumar KM, 2012, UNPACKING ISSUE COUN; Government of India, 2012, ANN REPORT; Government of India. Central Drugs Standards Control Organisation Directorate General Health Services Ministry of Health and Family Welfare, 2009, REP COUNTR SURV SPUR; Kaplan WA, 2005, LOCAL PRODUCTION PHA; Nakakeeto ON, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-6; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Selvaraj Sakthivel, 2013, HINDU           0407	9	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2013	347								f4235	10.1136/bmj.f4235	http://dx.doi.org/10.1136/bmj.f4235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BM	23913693				2022-12-28	WOS:000322822800001
J	De Bock, K; Georgiadou, M; Schoors, S; Kuchnio, A; Wong, BW; Cantelmo, AR; Quaegebeur, A; Ghesquiere, B; Cauwenberghs, S; Eelen, G; Phng, LK; Betz, I; Tembuyser, B; Brepoels, K; Welti, J; Geudens, I; Segura, I; Cruys, B; Bifari, F; Decimo, I; Blanco, R; Wyns, S; Vangindertael, J; Rocha, S; Collins, RT; Munck, S; Daelemans, D; Imamura, H; Devlieger, R; Rider, M; Van Veldhoven, PP; Schuit, F; Bartrons, R; Hofkens, J; Fraisl, P; Telang, S; DeBerardinis, RJ; Schoonjans, L; Vinckier, S; Chesney, J; Gerhardt, H; Dewerchin, M; Carmeliet, P				De Bock, Katrien; Georgiadou, Maria; Schoors, Sandra; Kuchnio, Anna; Wong, Brian W.; Cantelmo, Anna Rita; Quaegebeur, Annelies; Ghesquiere, Bart; Cauwenberghs, Sandra; Eelen, Guy; Phng, Li-Kun; Betz, Inge; Tembuyser, Bieke; Brepoels, Katleen; Welti, Jonathan; Geudens, Ilse; Segura, Inmaculada; Cruys, Bert; Bifari, Franscesco; Decimo, Ilaria; Blanco, Raquel; Wyns, Sabine; Vangindertael, Jeroen; Rocha, Susana; Collins, Russel T.; Munck, Sebastian; Daelemans, Dirk; Imamura, Hiromi; Devlieger, Roland; Rider, Mark; Van Veldhoven, Paul P.; Schuit, Frans; Bartrons, Ramon; Hofkens, Johan; Fraisl, Peter; Telang, Sucheta; DeBerardinis, Ralph J.; Schoonjans, Luc; Vinckier, Stefan; Chesney, Jason; Gerhardt, Holger; Dewerchin, Mieke; Carmeliet, Peter			Role of PFKFB3-Driven Glycolysis in Vessel Sprouting	CELL			English	Article							CORONARY ENDOTHELIAL-CELLS; AEROBIC GLYCOLYSIS; CANCER; 6-PHOSPHOFRUCTO-2-KINASE; METABOLISM; ENERGY; REQUIRES; MODEL; NOTCH	Vessel sprouting by migrating tip and proliferating stalk endothelial cells (ECs) is controlled by genetic signals (such as Notch), but it is unknown whether metabolism also regulates this process. Here, we show that ECs relied on glycolysis rather than on oxidative phosphorylation for ATP production and that loss of the glycolytic activator PFKFB3 in ECs impaired vessel formation. Mechanistically, PFKFB3 not only regulated EC proliferation but also controlled the formation of filopodia/lamellipodia and directional migration, in part by compartmentalizing with F-actin in motile protrusions. Mosaic in vitro and in vivo sprouting assays further revealed that PFKFB3 overexpression overruled the pro-stalk activity of Notch, whereas PFKFB3 deficiency impaired tip cell formation upon Notch blockade, implying that glycolysis regulates vessel branching.	[De Bock, Katrien; Georgiadou, Maria; Schoors, Sandra; Kuchnio, Anna; Wong, Brian W.; Cantelmo, Anna Rita; Quaegebeur, Annelies; Ghesquiere, Bart; Cauwenberghs, Sandra; Eelen, Guy; Betz, Inge; Tembuyser, Bieke; Brepoels, Katleen; Welti, Jonathan; Segura, Inmaculada; Cruys, Bert; Bifari, Franscesco; Decimo, Ilaria; Wyns, Sabine; Fraisl, Peter; Schoonjans, Luc; Vinckier, Stefan; Dewerchin, Mieke; Carmeliet, Peter] Univ Louvain, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Dept Oncol, B-3000 Louvain, Belgium; [Phng, Li-Kun; Geudens, Ilse; Gerhardt, Holger] Univ Louvain, Vesalius Res Ctr, Vasc Patterning Lab, Dept Oncol, B-3000 Louvain, Belgium; [Vangindertael, Jeroen; Rocha, Susana; Hofkens, Johan] Univ Louvain, Mol Imaging & Photon Lab, B-3000 Louvain, Belgium; [Munck, Sebastian] Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Daelemans, Dirk] Univ Louvain, Rega Inst, Lab Virol & Chemotherapy, B-3000 Louvain, Belgium; [Devlieger, Roland] Univ Louvain, Dept Gynaecol & Obstet, B-3000 Louvain, Belgium; [Van Veldhoven, Paul P.] Univ Louvain, Lab Lipid Biochem & Prot Interact, B-3000 Louvain, Belgium; [Schuit, Frans] Univ Louvain, Gene Express Unit, B-3000 Louvain, Belgium; [Fraisl, Peter] Univ Louvain, Vesalius Res Ctr, Dept Oncol, Lab Cell Proliferat, B-3000 Louvain, Belgium; [De Bock, Katrien; Georgiadou, Maria; Schoors, Sandra; Kuchnio, Anna; Wong, Brian W.; Cantelmo, Anna Rita; Quaegebeur, Annelies; Ghesquiere, Bart; Cauwenberghs, Sandra; Eelen, Guy; Betz, Inge; Tembuyser, Bieke; Brepoels, Katleen; Welti, Jonathan; Segura, Inmaculada; Cruys, Bert; Bifari, Franscesco; Decimo, Ilaria; Wyns, Sabine; Fraisl, Peter; Schoonjans, Luc; Vinckier, Stefan; Dewerchin, Mieke; Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Phng, Li-Kun; Geudens, Ilse; Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, B-3000 Louvain, Belgium; [Munck, Sebastian] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Fraisl, Peter] VIB, Vesalius Res Ctr, Lab Cell Proliferat, B-3000 Louvain, Belgium; [Blanco, Raquel; Collins, Russel T.; Gerhardt, Holger] Canc Res UK, London Res Inst, Vasc Biol Lab, London WC2A 3LY, England; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Rider, Mark] Univ Louvain, De Duve Inst, Hormone & Prot Phosphorylat Res Lab, B-1200 Brussels, Belgium; [Bartrons, Ramon] Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, Barcelona 08907, Spain; [Telang, Sucheta; Chesney, Jason] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Cancer Research UK; Kyoto University; Kyoto University; Universite Catholique Louvain; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Louisville; University of Texas System; University of Texas Southwestern Medical Center Dallas	Carmeliet, P (corresponding author), Univ Louvain, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Dept Oncol, B-3000 Louvain, Belgium.	peter.carmeliet@vib-kuleuven.be	Imamura, Hiromi/AAD-5109-2019; , Van Veldhoven Paul/U-6359-2019; Carmeliet, Peter/AAQ-5140-2020; Hofkens, Johan/AAL-4204-2020; Rocha, Susana/AAH-8343-2020; Georgiadou, Maria/AAL-3136-2021; De Bock, Katrien/L-2273-2013; Phng, Li-Kun/L-7346-2013; Segura, Inmaculada/AAA-7958-2020; Bifari, Francesco/M-3430-2014; Devlieger, Roland/AAS-9181-2020; Hofkens, Johan/AAP-9255-2020; Cantelmo, Anna Rita/G-6766-2018; Georgiadou, Maria/J-6924-2013; Wong, Brian/B-6168-2009; Gerhardt, Holger/G-4610-2011; Rocha, Susana/O-7622-2016; Daelemans, Dirk/P-7923-2017; Ghesquiere, Bart/HGU-8736-2022; Decimo, Ilaria/AAL-9917-2021; Segura, Inmaculada/D-2878-2013; Hofkens, Johan/D-4284-2017	Imamura, Hiromi/0000-0002-1896-0443; , Van Veldhoven Paul/0000-0002-4478-2564; Carmeliet, Peter/0000-0001-7961-1821; Rocha, Susana/0000-0003-1258-9396; Georgiadou, Maria/0000-0003-0948-6337; De Bock, Katrien/0000-0001-8232-4663; Segura, Inmaculada/0000-0003-1849-5569; Bifari, Francesco/0000-0003-2028-3012; Devlieger, Roland/0000-0001-7837-4684; Cantelmo, Anna Rita/0000-0002-2748-264X; Georgiadou, Maria/0000-0002-3744-9755; Wong, Brian/0000-0001-8447-3064; Gerhardt, Holger/0000-0002-3030-0384; Rocha, Susana/0000-0003-1258-9396; Daelemans, Dirk/0000-0001-7092-1153; Ghesquiere, Bart/0000-0003-1547-1705; Decimo, Ilaria/0000-0002-6627-1263; Quaegebeur, Annelies/0000-0001-5357-9341; Welti, Jonathan/0000-0002-9433-8138; Bartrons, Ramon/0000-0001-9349-5847; Hofkens, Johan/0000-0002-9101-0567; Collins, Russell T/0000-0002-1847-4517; Munck, Sebastian/0000-0002-5182-5358	FWO; Emmanuel Vanderschueren fellows of the VLK; Fondazione Umberto Veronesi; FWO and Marie Curie Foundation; Federal Government of Belgium [IUAP7/03]; Flemish Government (Methusalem funding); Concerted Research Activities Belgium [GOA2006/11]; FWO [G.0652.08, G.0692.09, G.0532.10, G.0817.11, 1.5.202.10.N.00]; Foundation Leducq Transatlantic Network (ARTEMIS); ERC (advanced research grant) [EU-ERC269073]; Cancer Research UK; Lister Institute of Preventive Medicine; ARTEMIS; ERC [311719]; HFSP fellowship;  [8,088,385]; NATIONAL CANCER INSTITUTE [R01CA149438] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24657101] Funding Source: KAKEN	FWO(FWO); Emmanuel Vanderschueren fellows of the VLK; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); FWO and Marie Curie Foundation; Federal Government of Belgium; Flemish Government (Methusalem funding); Concerted Research Activities Belgium; FWO(FWO); Foundation Leducq Transatlantic Network (ARTEMIS); ERC (advanced research grant); Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; ARTEMIS(European Commission); ERC(European Research Council (ERC)European Commission); HFSP fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. Adams for VE-cadherin(PAC)-Cre<SUP>ERT2</SUP> mice and L. Notebaert for help with the figures. K.D.B., B.G., and I.S. are postdoctoral fellows of the FWO. M.G. and S.S. received funding as Emmanuel Vanderschueren fellows of the VLK. A.R.C. is funded by Fondazione Umberto Veronesi. B.W.W. received funding from the FWO and Marie Curie Foundation. A.K. and A.Q. are PhD FWO fellows. S.S. and B.C. are funded by the IWT. P.C. is supported by the Federal Government of Belgium (grant IUAP7/03), the Flemish Government (Methusalem funding), Concerted Research Activities Belgium (grant GOA2006/11), the FWO (grants G.0652.08, G.0692.09, G.0532.10, G.0817.11, and 1.5.202.10.N.00), the Foundation Leducq Transatlantic Network (ARTEMIS), and the ERC (advanced research grant EU-ERC269073). H.G. receives support from Cancer Research UK, the Lister Institute of Preventive Medicine, ARTEMIS, and the ERC (starting grant REshape 311719). L.K.P. and R.B. are supported by HFSP fellowships. P.C. is an inventor on patent applications claiming subject matter related to the results described in this paper. R.J.D. is a member of the scientific advisory board of Peleton Therapeutics. J.C. and S.T. are coinventors of U.S. patent 8,088,385 (PFKFB3 inhibitors for the treatment of proliferative cancer).	ALHABORI M, 1995, INT J BIOCHEM CELL B, V27, P123, DOI 10.1016/1357-2725(94)00079-Q; Bando H, 2005, CLIN CANCER RES, V11, P5784, DOI 10.1158/1078-0432.CCR-05-0149; BAQUER NZ, 1975, J EMBRYOL EXP MORPH, V33, P853; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Buchwald P, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-20; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DOBRINA A, 1983, BIOCHIM BIOPHYS ACTA, V762, P295, DOI 10.1016/0167-4889(83)90084-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fantin A, 2013, NAT PROTOC, V8, P418, DOI 10.1038/nprot.2013.015; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Goidts V, 2012, ONCOGENE, V31, P3235, DOI 10.1038/onc.2011.490; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Groschner LN, 2012, PFLUG ARCH EUR J PHY, V464, P63, DOI 10.1007/s00424-012-1085-z; Harjes U, 2012, BRIT J CANCER, V107, P1207, DOI 10.1038/bjc.2012.398; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hereng TH, 2011, HUM REPROD, V26, P3249, DOI 10.1093/humrep/der317; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; LAING RA, 1992, INVEST OPHTH VIS SCI, V33, P3315; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LEIGHTON B, 1987, FEBS LETT, V225, P93, DOI 10.1016/0014-5793(87)81137-7; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MERTENS S, 1990, AM J PHYSIOL, V258, pH689, DOI 10.1152/ajpheart.1990.258.3.H689; Pavlova GA, 2010, J COMP PHYSIOL A, V196, P241, DOI 10.1007/s00359-010-0509-5; Peters K, 2009, CELL PHYSIOL BIOCHEM, V24, P483, DOI 10.1159/000257490; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; SPOLARICS Z, 1991, AM J PHYSIOL, V261, pG185, DOI 10.1152/ajpgi.1991.261.2.G185; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wojtas K, 1997, MOL BIOL CELL, V8, P1665, DOI 10.1091/mbc.8.9.1665; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	40	807	814	12	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					651	663		10.1016/j.cell.2013.06.037	http://dx.doi.org/10.1016/j.cell.2013.06.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911327	Bronze			2022-12-28	WOS:000322629900017
J	Masood, E				Masood, Ehsan			Pakistan must seize the chance to revive its science	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Masood, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	news@researchresearch.com							0	1	1	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					7	7		10.1038/500007a	http://dx.doi.org/10.1038/500007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	192VK	23903716	Bronze			2022-12-28	WOS:000322514800003
J	Narlikar, GJ; Sundaramoorthy, R; Owen-Hughes, T				Narlikar, Geeta J.; Sundaramoorthy, Ramasubramanian; Owen-Hughes, Tom			Mechanisms and Functions of ATP-Dependent Chromatin-Remodeling Enzymes	CELL			English	Review							DNA-BINDING DOMAIN; NUCLEOSOME ORGANIZATION; CRYSTAL-STRUCTURE; SWI2/SNF2 ATPASE; CONCERTED ACTION; HISTONE H2AZ; CHD1; SWI/SNF; COMPLEX; ISWI		[Narlikar, Geeta J.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Sundaramoorthy, Ramasubramanian; Owen-Hughes, Tom] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of California System; University of California San Francisco; University of Dundee	Narlikar, GJ (corresponding author), Univ Calif San Francisco, Genentech Hall 600,16th St, San Francisco, CA 94158 USA.	geeta.narlikar@ucsf.edu; t.a.owenhughes@dundee.ac.uk		Owen-Hughes, Tom/0000-0002-0618-8185	Wellcome Trust Senior Fellowship [095062]; MRC grant [G1100021]; Medical Research Council [G1100021] Funding Source: researchfish; Wellcome Trust [095062/Z/10/Z] Funding Source: researchfish; MRC [G1100021] Funding Source: UKRI	Wellcome Trust Senior Fellowship(Wellcome Trust); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	T.O.-H. was funded by Wellcome Trust Senior Fellowship 095062, and R.S. was funded by MRC grant G1100021. We thank members of the G.J.N. and T.O.-H. labs for discussion and suggestions.	Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Blossey R, 2008, HFSP J, V2, P167, DOI 10.2976/1.2909080; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Burd CJ, 2013, MOL CELL ENDOCRINOL, V380, P25, DOI 10.1016/j.mce.2013.03.020; Chatterjee N, 2011, NUCLEIC ACIDS RES, V39, P8378, DOI 10.1093/nar/gkr535; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Durand-Dubief M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002974; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Eapen VV, 2012, MOL CELL BIOL, V32, P4727, DOI 10.1128/MCB.00566-12; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Erdel F, 2011, FEBS J, V278, P3608, DOI 10.1111/j.1742-4658.2011.08282.x; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hauk G, 2011, CURR OPIN STRUC BIOL, V21, P719, DOI 10.1016/j.sbi.2011.09.003; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Hennig BP, 2012, EMBO REP, V13, P997, DOI 10.1038/embor.2012.146; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Hota SK, 2013, NAT STRUCT MOL BIOL, V20, P222, DOI 10.1038/nsmb.2486; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lorch Y, 2011, NAT STRUCT MOL BIOL, V18, P881, DOI 10.1038/nsmb.2072; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; McKnight JN, 2011, MOL CELL BIOL, V31, P4746, DOI 10.1128/MCB.05735-11; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Patel A, 2013, NUCLEIC ACIDS RES, V41, P1637, DOI 10.1093/nar/gks1440; Pointner J, 2012, EMBO J, V31, P4388, DOI 10.1038/emboj.2012.289; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Sharma A, 2011, J BIOL CHEM, V286, P42099, DOI 10.1074/jbc.C111.294462; Shim YS, 2012, EMBO J, V31, P4375, DOI 10.1038/emboj.2012.267; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Skiniotis G, 2007, J BIOL CHEM, V282, P20804, DOI 10.1074/jbc.C700081200; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Soutourina J, 2006, MOL CELL BIOL, V26, P4920, DOI 10.1128/MCB.00415-06; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tan S, 2011, CURR OPIN STRUC BIOL, V21, P128, DOI 10.1016/j.sbi.2010.11.006; Tang LL, 2010, PROG BIOPHYS MOL BIO, V102, P122, DOI 10.1016/j.pbiomolbio.2010.05.001; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Ulyanova NP, 2005, MOL CELL BIOL, V25, P11156, DOI 10.1128/MCB.25.24.11156-11170.2005; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	91	403	407	4	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					490	503		10.1016/j.cell.2013.07.011	http://dx.doi.org/10.1016/j.cell.2013.07.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911317	hybrid, Green Published			2022-12-28	WOS:000322629900005
J	Wong, JJL; Ritchie, W; Ebner, OA; Selbach, M; Wong, JWH; Huang, YZ; Gao, DD; Pinello, N; Gonzalez, M; Baidya, K; Thoeng, A; Khoo, TL; Bailey, CG; Holst, J; Rasko, JEJ				Wong, Justin J-L; Ritchie, William; Ebner, Olivia A.; Selbach, Matthias; Wong, Jason W. H.; Huang, Yizhou; Gao, Dadi; Pinello, Natalia; Gonzalez, Maria; Baidya, Kinsha; Thoeng, Annora; Khoo, Teh-Liane; Bailey, Charles G.; Holst, Jeff; Rasko, John E. J.			Orchestrated Intron Retention Regulates Normal Granulocyte Differentiation	CELL			English	Article							MESSENGER-RNA DECAY; LAMIN B1; GENE-EXPRESSION; TRANSCRIPTION FACTORS; NUCLEAR-ENVELOPE; SURVEILLANCE; QUANTIFICATION; ABSENCE	Intron retention (IR) is widely recognized as a consequence of mis-splicing that leads to failed excision of intronic sequences from pre-messenger RNAs. Our bioinformatic analyses of transcriptomic and proteomic data of normal white blood cell differentiation reveal IR as a physiological mechanism of gene expression control. IR regulates the expression of 86 functionally related genes, including those that determine the nuclear shape that is unique to granulocytes. Retention of introns in specific genes is associated with downregulation of splicing factors and higher GC content. IR, conserved between human and mouse, led to reduced mRNA and protein levels by triggering the nonsense-mediated decay (NMD) pathway. In contrast to the prevalent view that NMDis limited to mRNAs encoding aberrant proteins, our data establish that IR coupled with NMD is a conserved mechanism in normal granulopoiesis. Physiological IR may provide an energetically favorable level of dynamic gene expression control prior to sustained gene translation.	[Wong, Justin J-L; Ritchie, William; Gao, Dadi; Pinello, Natalia; Gonzalez, Maria; Baidya, Kinsha; Thoeng, Annora; Khoo, Teh-Liane; Bailey, Charles G.; Holst, Jeff; Rasko, John E. J.] Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW 2050, Australia; [Ritchie, William; Gao, Dadi] Centenary Inst, Bioinformat Lab, Camperdown, NSW 2050, Australia; [Holst, Jeff] Centenary Inst, Origins Canc Lab, Camperdown, NSW 2050, Australia; [Wong, Justin J-L; Ritchie, William; Gao, Dadi; Pinello, Natalia; Gonzalez, Maria; Baidya, Kinsha; Thoeng, Annora; Khoo, Teh-Liane; Bailey, Charles G.; Holst, Jeff; Rasko, John E. J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Ebner, Olivia A.; Selbach, Matthias] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Wong, Jason W. H.; Huang, Yizhou] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Wong, Jason W. H.; Huang, Yizhou] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia	University of Sydney; Centenary Institute; University of Sydney; Centenary Institute; University of Sydney; Centenary Institute; University of Sydney; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Rasko, JEJ (corresponding author), Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW 2050, Australia.	j.rasko@centenary.org.au	Huang, Yizhou/Q-5862-2019; Gao, Dadi/AAW-4359-2020; Huang, Yizhou/AAR-5842-2021; Wong, Jason/A-9466-2008; Holst, Jeff/H-7634-2012; Wong, Justin/AAE-7986-2020	Gao, Dadi/0000-0002-3638-8479; Huang, Yizhou/0000-0002-7003-3110; Wong, Jason/0000-0003-2953-7728; Holst, Jeff/0000-0002-0377-9318; Wong, Justin/0000-0002-7038-5079; Pinello Gini, Natalia/0000-0003-3514-6627; Gonzalez, Maria/0000-0001-8798-7212; Bailey, Charles/0000-0002-4725-7829; rasko, John/0000-0003-2975-807X	Cancer Council NSW; Rebecca L Cooper Medical Research Foundation; National Health and Medical Research Council [571156]; Cancer Institute of NSW; National Breast Cancer Foundation; Tour de Cure; Cure the Future; anonymous foundation; National Breast Cancer Foundation [ECF-12-05] Funding Source: researchfish	Cancer Council NSW(Cancer Council New South Wales); Rebecca L Cooper Medical Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of NSW; National Breast Cancer Foundation; Tour de Cure; Cure the Future; anonymous foundation; National Breast Cancer Foundation	We thank Rob Middleton for computer support; Rob Solomon, Steven Allen, Frank Kao, Suat Dervish, and Shi-Hong Yang for FACS; Qian Wang, Jessica Vanslambrouck, Kristina Jahn, Delfine Cheng, and Adrian Smith for microscopy; and Geneworks for next-generation sequencing. This study was supported by Cancer Council NSW (J.E.J.R., W.R. and J.H.), Rebecca L Cooper Medical Research Foundation (J.E.J.R. and J.H.), National Health and Medical Research Council (W.R.; 571156), Cancer Institute of NSW (W.R. and J.W.H.W), National Breast Cancer Foundation (J.H.), Tour de Cure (C.G.B. and J.E.J.R), Cure the Future (J.J.-L.W. and J.E.J.R.) and an anonymous foundation (J.E.J.R.).	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Bell TJ, 2010, P NATL ACAD SCI USA, V107, P21152, DOI 10.1073/pnas.1015264107; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Bicknell AA, 2012, BIOESSAYS, V34, P1025, DOI 10.1002/bies.201200073; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Ji JY, 2007, J BIOL CHEM, V282, P20015, DOI 10.1074/jbc.M611094200; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kanehisa M., 2012, BIOINFORMATICS, V40, pD109; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lee G, 1999, WINTROBES CLIN HEMAT; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Malhas A, 2010, CELL CYCLE, V9, P531, DOI 10.4161/cc.9.3.10511; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Olins AL, 2008, EUR J CELL BIOL, V87, P279, DOI 10.1016/j.ejcb.2008.02.007; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; PADGETT RA, 1983, CELL, V35, P101, DOI 10.1016/0092-8674(83)90212-X; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shao W, 2012, MOL CELL BIOL, V32, P470, DOI 10.1128/MCB.06234-11; Shi J, 2008, MOL CELL BIOL, V28, P883, DOI 10.1128/MCB.01345-07; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	60	288	297	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					583	595		10.1016/j.cell.2013.06.052	http://dx.doi.org/10.1016/j.cell.2013.06.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911323	Bronze			2022-12-28	WOS:000322629900012
J	Hurren, ET				Hurren, Elizabeth T.			The art of medicine The dangerous dead: dissecting the criminal corpse	LANCET			English	Editorial Material									Univ Leicester, Sch Hist Studies, Med Humanities Res Ctr, Leicester LE1 7RH, Leics, England	University of Leicester	Hurren, ET (corresponding author), Univ Leicester, Sch Hist Studies, Med Humanities Res Ctr, Leicester LE1 7RH, Leics, England.	eh140@le.ac.uk		Hurren, Elizabeth/0000-0002-2691-3081	Wellcome Trust [095904] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Buncle John, 1756, CONTAINING VARIOUS O, VII; Buncle John, 1756, CONTAINING VARIOUS O, V1; Hurren ET, 2012, DYING FOR VICTORIAN MEDICINE: ENGLISH ANATOMY AND ITS TRADE IN THE DEAD POOR, C. 1834-1929, P1	3	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 27	2013	382	9889					302	303		10.1016/S0140-6736(13)61626-8	http://dx.doi.org/10.1016/S0140-6736(13)61626-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FT	23901413	Green Accepted			2022-12-28	WOS:000322544900014
J	Hirsch, AT; Duval, S				Hirsch, Alan T.; Duval, Sue			The global pandemic of peripheral artery disease	LANCET			English	Editorial Material							LOWER-EXTREMITY; HOSPITALIZATION; AMPUTATION; RATES		[Hirsch, Alan T.] Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hirsch, AT (corresponding author), Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	hirsc005@umn.edu	Duval, Susan/AAI-1874-2020	Duval, Sue/0000-0003-1025-8665				Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Fowkes FGR, 2013, LANCET; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Hirsch AT, 2006, CIRCULATION, V113, P1474, DOI 10.1161/CIRCULATIONAHA.106.173994; International Campaign to Ban Landmines, 2012, LANDMINE MONITOR 201; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, UNAIDS REPORT ON THE; Krueger CA, 2012, J TRAUMA ACUTE CARE, V73, pS438, DOI 10.1097/TA.0b013e318275469c; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Li YF, 2012, DIABETES CARE, V35, P273, DOI 10.2337/dc11-1360; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahoney EM, 2010, CIRC-CARDIOVASC QUAL, V3, P642, DOI 10.1161/CIRCOUTCOMES.109.930735; Moxey PW, 2011, DIABETIC MED, V28, P1144, DOI 10.1111/j.1464-5491.2011.03279.x; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Peacock JM, 2011, PREV CHRONIC DIS, V8	14	92	100	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1312	1314		10.1016/S0140-6736(13)61576-7	http://dx.doi.org/10.1016/S0140-6736(13)61576-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23915884				2022-12-28	WOS:000325975700005
J	Sanjuan-Pla, A; Macaulay, IC; Jensen, CT; Woll, PS; Luis, TC; Mead, A; Moore, S; Carella, C; Matsuoka, S; Jones, TB; Chowdhury, O; Stenson, L; Lutteropp, M; Green, JCA; Facchini, R; Boukarabila, H; Grover, A; Gambardella, A; Thongjuea, S; Carrelha, J; Tarrant, P; Atkinson, D; Clark, SA; Nerlov, C; Jacobsen, SEW				Sanjuan-Pla, Alejandra; Macaulay, Iain C.; Jensen, Christina T.; Woll, Petter S.; Luis, Tiago C.; Mead, Adam; Moore, Susan; Carella, Cintia; Matsuoka, Sahoko; Jones, Tiphaine Bouriez; Chowdhury, Onima; Stenson, Laura; Lutteropp, Michael; Green, Joanna C. A.; Facchini, Raffaella; Boukarabila, Hanane; Grover, Amit; Gambardella, Adriana; Thongjuea, Supat; Carrelha, Joana; Tarrant, Paul; Atkinson, Deborah; Clark, Sally-Ann; Nerlov, Claus; Jacobsen, Sten Eirik W.			Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy	NATURE			English	Article							SELF-RENEWAL; IN-VIVO; DIFFERENTIATION; THROMBOPOIETIN; RECONSTITUTION; HETEROGENEITY; PROGENITORS; GENERATION	The blood system is maintained by a small pool of haematopoietic stem cells (HSCs), which are required and sufficient for replenishing all human blood cell lineages at millions of cells per second throughout life. Megakaryocytes in the bone marrow are responsible for the continuous production of platelets in the blood, crucial for preventing bleeding-a common and life-threatening side effect of many cancer therapies-and major efforts are focused at identifying the most suitable cellular and molecular targets to enhance platelet production after bone marrow transplantation or chemotherapy(1). Although it has become clear that distinct HSC subsets exist that are stably biased towards the generation of lymphoid or myeloid blood cells(2-4), we are yet to learn whether other types of lineage-biased HSC exist or understand their inter-relationships and how differently lineage-biased HSCs are generated and maintained. The functional relevance of notable phenotypic and molecular similarities between megakaryocytes and bone marrow cells with an HSC cell-surface phenotype(5-8) remains unclear. Here we identify and prospectively isolate a molecularly and functionally distinct mouse HSC subset primed for platelet-specific gene expression, with enhanced propensity for short-and long-term reconstitution of platelets. Maintenance of platelet-biased HSCs crucially depends on thrombopoietin, the primary extrinsic regulator of platelet development(9). Platelet-primed HSCs also frequently have a long-term myeloid lineage bias, can self-renew and give rise to lymphoid-biased HSCs. These findings show that HSC subtypes can be organized into a cellular hierarchy, with platelet-primed HSCs at the apex. They also demonstrate that molecular and functional priming for platelet development initiates already in a distinct HSC population. The identification of a platelet-primed HSC population should enable the rational design of therapies enhancing platelet output.	[Sanjuan-Pla, Alejandra; Moore, Susan; Nerlov, Claus] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 16UU, Midlothian, Scotland; [Sanjuan-Pla, Alejandra; Moore, Susan; Nerlov, Claus] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH9 16UU, Midlothian, Scotland; [Sanjuan-Pla, Alejandra; Moore, Susan; Carella, Cintia; Nerlov, Claus] EMBL Mouse Biol Program, I-00015 Monterotondo, Italy; [Macaulay, Iain C.; Jensen, Christina T.; Woll, Petter S.; Luis, Tiago C.; Mead, Adam; Matsuoka, Sahoko; Jones, Tiphaine Bouriez; Chowdhury, Onima; Stenson, Laura; Lutteropp, Michael; Green, Joanna C. A.; Facchini, Raffaella; Boukarabila, Hanane; Grover, Amit; Gambardella, Adriana; Thongjuea, Supat; Carrelha, Joana; Tarrant, Paul; Atkinson, Deborah; Clark, Sally-Ann; Nerlov, Claus; Jacobsen, Sten Eirik W.] Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Macaulay, Iain C.; Jensen, Christina T.; Woll, Petter S.; Luis, Tiago C.; Mead, Adam; Matsuoka, Sahoko; Jones, Tiphaine Bouriez; Chowdhury, Onima; Stenson, Laura; Lutteropp, Michael; Green, Joanna C. A.; Facchini, Raffaella; Boukarabila, Hanane; Carrelha, Joana; Tarrant, Paul; Atkinson, Deborah; Clark, Sally-Ann; Jacobsen, Sten Eirik W.] Univ Oxford, Weatherall Inst Mol Med, Haematopoiet Stem Cell Biol Lab, Oxford OX3 9DS, England	University of Edinburgh; University of Edinburgh; European Molecular Biology Laboratory (EMBL); University of Oxford; University of Oxford	Jacobsen, SEW (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England.	claus.nerlov@imm.ox.ac.uk; sten.jacobsen@imm.ox.ac.uk	Jacobsen, Sten Eirik W/D-3974-2018; Sanjuan-Pla, Alejandra/GRX-9588-2022; Mead, Adam/A-8796-2012; carella, Cintia/K-3227-2018	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Sanjuan-Pla, Alejandra/0000-0002-0170-5542; Mead, Adam/0000-0001-8522-1002; carella, Cintia/0000-0001-9557-3300; Carrelha, Joana/0000-0002-0324-2617; Facchini, Raffaella/0000-0002-6026-6893; Woll, Petter S./0000-0002-2340-2526; Cunha Luis, Tiago/0000-0002-6305-1257; Thongjuea, Supat/0000-0002-9129-4694; Macaulay, Iain/0000-0002-6761-757X	Medical Research Council, UK [H4RPLK0]; MRC; European Commission; Association for International Cancer Research; Spanish Ministry of Education and Science; Medical Research Council [G84/6443, G0900892, G0700711B, G0801073, MC_UU_12009/7, MC_PC_12020, G0501838, G0701761, MC_UU_12009/5] Funding Source: researchfish; MRC [MC_UU_12009/7, G0501838, G0801073, G0900892, G84/6443, MC_UU_12009/5, MC_PC_12020, G0701761] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Association for International Cancer Research; Spanish Ministry of Education and Science(Spanish Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Biomedical Services at Oxford University, B. Wu and H. Ferry for technical assistance, and M. Jose Fernandez Nestosa, S. Luc and N. Buza-Vidas for discussions and experimental contributions. This work was supported by the Medical Research Council, UK Grant H4RPLK0 (to S.E.W.J.) and an MRC Program Grant and Strategic Award (to C. N.), by the European Commission FP7 CardioCell (to C. N.) and EuroSyStem (to S.E.W.J.) projects, and by the Association for International Cancer Research (to C. N.). A. S.-P. was supported by a postdoctoral BEOI fellowship from the Spanish Ministry of Education and Science.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Moreira Pedro N., 2006, V349, P151; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Nash RA, 1996, ONCOLOGIST, V1, P371; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Shimazu T, 2012, BLOOD, V119, P4889, DOI 10.1182/blood-2011-10-388736; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	28	363	374	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					232	+		10.1038/nature12495	http://dx.doi.org/10.1038/nature12495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	23934107				2022-12-28	WOS:000325436100050
J	Sonati, T; Reimann, RR; Falsig, J; Baral, PK; O'Connor, T; Hornemann, S; Yaganoglu, S; Li, B; Herrmann, US; Wieland, B; Swayampakula, M; Rahman, MH; Das, D; Kav, N; Riek, R; Liberski, PP; James, MNG; Aguzzi, A				Sonati, Tiziana; Reimann, Regina R.; Falsig, Jeppe; Baral, Pravas Kumar; O'Connor, Tracy; Hornemann, Simone; Yaganoglu, Sine; Li, Bei; Herrmann, Uli S.; Wieland, Barbara; Swayampakula, Mridula; Rahman, Muhammad Hafizur; Das, Dipankar; Kav, Nat; Riek, Roland; Liberski, Pawel P.; James, Michael N. G.; Aguzzi, Adriano			The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein	NATURE			English	Article							PRP KNOCKOUT MICE; MACROMOLECULAR CRYSTALLOGRAPHY; MOUSE MODEL; NMR; DISEASE; SCRAPIE; DOMAIN; NEURODEGENERATION; SUSCEPTIBILITY; INFECTION	Prion infections cause lethal neurodegeneration. This process requires the cellular prion protein (PrPC; ref. 1), which contains a globular domain hinged to a long amino-proximal flexible tail(2). Here we describe rapid neurotoxicity in mice and cerebellar organotypic cultured slices exposed to ligands targeting the alpha 1 and alpha 3 helices of the PrPC globular domain. Ligands included seven distinct monoclonal antibodies(3), monovalent Fab(1) fragments and recombinant single-chain variable fragment miniantibodies. Similar to prion infections(4-6), the toxicity of globular domain ligands required neuronal PrPC, was exacerbated by PrPC overexpression, was associated with calpain activation and was antagonized by calpain inhibitors. Neurodegeneration was accompanied by a burst of reactive oxygen species, and was suppressed by antioxidants. Furthermore, genetic ablation of the superoxide-producing enzyme NOX2 (also known as CYBB) protected mice from globular domain ligand toxicity. We also found that neurotoxicity was prevented by deletions of the octapeptide repeats within the flexible tail. These deletions did not appreciably compromise globular domain antibody binding, suggesting that the flexible tail is required to transmit toxic signals that originate from the globular domain and trigger oxidative stress and calpain activation. Supporting this view, various octapeptide ligands were not only innocuous to both cerebellar organotypic cultured slices and mice, but also prevented the toxicity of globular domain ligands while not interfering with their binding. We conclude that PrPC consists of two functionally distinct modules, with the globular domain and the flexible tail exerting regulatory and executive functions, respectively. Octapeptide ligands also prolonged the life of mice expressing the toxic PrPC mutant(7), PrP(Lambda 94-134), indicating that the flexible tail mediates toxicity in two distinct PrPC-related conditions. Flexible tail-mediated toxicity may conceivably play a role in further prion pathologies, such as familial Creutzfeldt-Jakob disease in humans bearing supernumerary octapeptides.	[Sonati, Tiziana; Reimann, Regina R.; Falsig, Jeppe; O'Connor, Tracy; Hornemann, Simone; Yaganoglu, Sine; Li, Bei; Herrmann, Uli S.; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Baral, Pravas Kumar; Wieland, Barbara; Swayampakula, Mridula; James, Michael N. G.] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Rahman, Muhammad Hafizur; Das, Dipankar; Kav, Nat] Univ Alberta, Dept Agr Food & Nutr Sci, Agr Forestry Ctr 410, Edmonton, AB T6G 2P5, Canada; [Riek, Roland] ETH Honggerberg, ETH Zurich, CH-8093 Zurich, Switzerland; [Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lab Electron Microscopy & Neuropathol, PL-92216 Lodz, Poland	University of Zurich; University Zurich Hospital; University of Alberta; University of Alberta; Swiss Federal Institutes of Technology Domain; ETH Zurich; Medical University Lodz	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	Adriano.Aguzzi@usz.ch	Reimann, Regina R./A-1195-2016	Reimann, Regina R./0000-0002-6396-4195; Herrmann, Uli Simon/0000-0002-1327-5199; James, Michael/0000-0002-5978-4562; Aguzzi, Adriano/0000-0002-0344-6708; Riek, Roland/0000-0002-6333-066X	European Research Council; European Union; Swiss National Foundation; Foundation Alliance BioSecure; Clinical Research Priority Program (KFSP) of the University of Zurich; Novartis Research Foundation; PrioNet Canada; Alberta Prion Research Institute (APRI); Polish Swiss Research [PSPB-062/2010]	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Foundation Alliance BioSecure; Clinical Research Priority Program (KFSP) of the University of Zurich; Novartis Research Foundation; PrioNet Canada; Alberta Prion Research Institute (APRI); Polish Swiss Research	We thank S. Izui, H. Monyer, D. Burton and G. Mallucci for reagents and mice, S. Schauer and the Functional Genomics Center Zurich for advice and help with affinity determinations, A. Steingotter, U. Ungethum, M. Polymenidou, A. Lau and A. Keller for input, R. Moos, B. Sikorska, C. Tiberi, P. Schwarz, A. Varol, K. Arroyo and M. Delic for technical help. A. A. is the recipient of an Advanced Grant of the European Research Council and is supported by grants from the European Union (PRIORITY, LUPAS and NEURINOX), the Swiss National Foundation, the Foundation Alliance BioSecure, the Clinical Research Priority Program (KFSP) of the University of Zurich, and the Novartis Research Foundation. J. F. is supported by a career development award of the University of Zurich. Research support from PrioNet Canada and Alberta Prion Research Institute (APRI) for the work conducted in the Canadian laboratories is gratefully acknowledged. P. P. L. and A. A. are supported by Polish Swiss Research grant nr PSPB-062/2010. This paper is dedicated to the memory of Dr Marek Fischer, who created the tga20 mouse line.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Aller MI, 2003, GENESIS, V36, P97, DOI 10.1002/gene.10204; Baral PK, 2011, ACTA CRYSTALLOGR F, V67, P1211, DOI 10.1107/S1744309111026273; Baudino L, 2007, BLOOD, V109, P5355, DOI 10.1182/blood-2006-11-059899; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Das D, 2005, PROTEIN EXPRES PURIF, V39, P199, DOI 10.1016/j.pep.2004.10.007; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faas H, 2010, NEUROIMAGE, V49, P2607, DOI 10.1016/j.neuroimage.2009.10.009; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fatokun AA, 2008, FRONT BIOSCI-LANDMRK, V13, P3288, DOI 10.2741/2926; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Gonzalez A, 2008, J APPL CRYSTALLOGR, V41, P176, DOI 10.1107/S0021889807057822; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Grunecker B, 2010, NMR BIOMED, V23, P913, DOI 10.1002/nbm.1508; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; Keller R., 2004, COMPUTER AIDED RESON, V1; Krasemann S, 1995, Brain Res Mol Brain Res, V34, P173; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mead S, 2006, BRAIN, V129, P2297, DOI 10.1093/brain/awl226; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riek R., 1998, THESIS ETH ZURICH; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vital C., 1999, Clinical and Experimental Pathology, V47, P153; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamaguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043540; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	55	150	151	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					102	+		10.1038/nature12402	http://dx.doi.org/10.1038/nature12402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23903654	Green Accepted			2022-12-28	WOS:000323888300040
J	Corcos, O; Cazals-Hatem, D; Durand, F; Kapel, N; Guinhut, M; Stefanescu, C; Treton, X; Bondjemah, V; Attar, A; Marmuse, JP; Bouhnik, Y; Joly, F				Corcos, Olivier; Cazals-Hatem, Dominique; Durand, Francois; Kapel, Nathalie; Guinhut, Marie; Stefanescu, Carmen; Treton, Xavier; Bondjemah, Vanessa; Attar, Alain; Marmuse, Jean-Pierre; Bouhnik, Yoram; Joly, Francisca			Intestinal failure after bariatric surgery	LANCET			English	Editorial Material							SHORT-BOWEL SYNDROME		[Corcos, Olivier; Guinhut, Marie; Stefanescu, Carmen; Treton, Xavier; Bondjemah, Vanessa; Attar, Alain; Bouhnik, Yoram; Joly, Francisca] Univ Paris 07, Beaujon Hosp Clichy, Dept Gastroenterol, F-92110 Clichy, France; [Cazals-Hatem, Dominique] Univ Paris 07, Beaujon Hosp Clichy, Dept Pathol, F-92110 Clichy, France; [Durand, Francois] Univ Paris 07, Beaujon Hosp Clichy, Dept Hepatol & Liver Transplantat, F-92110 Clichy, France; [Kapel, Nathalie] Univ Paris 05, Pitie Salpetriere Hosp, Dept Funct Coprol, Paris, France; [Marmuse, Jean-Pierre] Univ Paris 07, Bichat Hosp Paris, Dept Digest & Bariatr Surg, F-92110 Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Corcos, O (corresponding author), Univ Paris 07, Beaujon Hosp Clichy, Dept Gastroenterol Intestinal Failure & Intestina, 100 Blvd Gen Leclerc, F-92110 Clichy, France.	olivier.corcos@bjn.aphp.fr	ATTAR, Alain/AAK-3909-2020	Durand, Francois/0000-0002-0357-1090; treton, xavier/0000-0001-8123-9213; Corcos, Olivier/0000-0002-9034-7053				Joly F, 2009, GASTROENTEROLOGY, V136, P824, DOI 10.1053/j.gastro.2008.10.084; Messing B, 2006, GASTROENTEROLOGY, V130, pS43, DOI 10.1053/j.gastro.2005.09.064; O'Keefe SJD, 2006, CLIN GASTROENTEROL H, V4, P6, DOI 10.1016/j.cgh.2005.10.002; Tucci S, 2010, FEBS J, V277, P4699, DOI 10.1111/j.1742-4658.2010.07876.x	4	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 24	2013	382	9893					742	742		10.1016/S0140-6736(13)61214-3	http://dx.doi.org/10.1016/S0140-6736(13)61214-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23972817				2022-12-28	WOS:000323542400032
J	Michael, HA				Michael, Holly A.			An Arsenic Forecast for China	SCIENCE			English	Editorial Material							GROUNDWATER; BANGLADESH; HEALTH		[Michael, Holly A.] Univ Delaware, Dept Geol Sci, Newark, DE 19716 USA; [Michael, Holly A.] Univ Delaware, Dept Civil & Environm Engn, Newark, DE 19716 USA	University of Delaware; University of Delaware	Michael, HA (corresponding author), Univ Delaware, Dept Geol Sci, Newark, DE 19716 USA.	hmichael@udel.edu	Michael, Holly A/F-8447-2010	Michael, Holly A/0000-0003-1107-7698				Caldwell B. K., 2003, International Journal of Population Geography, V9, P23, DOI 10.1002/ijpg.271; Currell M, 2011, APPL GEOCHEM, V26, P540, DOI 10.1016/j.apgeochem.2011.01.012; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Flanagan SV, 2012, B WORLD HEALTH ORGAN, V90, P839, DOI 10.2471/BLT.11.101253; George CM, 2013, AM J TROP MED HYG, V89, P138, DOI 10.4269/ajtmh.12-0664; He J, 2013, J HYDROL, V492, P79, DOI 10.1016/j.jhydrol.2013.04.007; Johnston RB, 2007, J ENVIRON SCI HEAL A, V42, P1889, DOI 10.1080/10934520701567155; Kinniburgh D.G., 2001, WC0019 BGS, V2; Lan Z., 1997, J HYG RES, V26, P310; Li J, 2013, NATURE, V499, P14, DOI 10.1038/499015a; Ravenscroft P., 2009, ARSENIC POLLUTION GL; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Sun GF, 2011, KAOHSIUNG J MED SCI, V27, P377, DOI 10.1016/j.kjms.2011.05.004; Wang Lianfang, 1994, V27, P159; Yu GQ, 2007, ENVIRON HEALTH PERSP, V115, P636, DOI 10.1289/ehp.9268	15	62	67	11	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					852	853		10.1126/science.1242212	http://dx.doi.org/10.1126/science.1242212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970688				2022-12-28	WOS:000323370600028
J	Wallace, AF; Hedges, LO; Fernandez-Martinez, A; Raiteri, P; Gale, JD; Waychunas, GA; Whitelam, S; Banfield, JF; De Yoreo, JJ				Wallace, Adam F.; Hedges, Lester O.; Fernandez-Martinez, Alejandro; Raiteri, Paolo; Gale, Julian D.; Waychunas, Glenn A.; Whitelam, Stephen; Banfield, Jillian F.; De Yoreo, James J.			Microscopic Evidence for Liquid-Liquid Separation in Supersaturated CaCO3 Solutions	SCIENCE			English	Article							CALCIUM-CARBONATE; MOLECULAR-DYNAMICS; NUCLEATION; CLUSTERS; THERMODYNAMICS; GROWTH; WATER	Recent experimental observations of the onset of calcium carbonate (CaCO3) mineralization suggest the emergence of a population of clusters that are stable rather than unstable as predicted by classical nucleation theory. This study uses molecular dynamics simulations to probe the structure, dynamics, and energetics of hydrated CaCO3 clusters and lattice gas simulations to explore the behavior of cluster populations before nucleation. Our results predict formation of a dense liquid phase through liquid-liquid separation within the concentration range in which clusters are observed. Coalescence and solidification of nanoscale droplets results in formation of a solid phase, the structure of which is consistent with amorphous CaCO3. The presence of a liquid-liquid binodal enables a diverse set of experimental observations to be reconciled within the context of established phase-separation mechanisms.	[Wallace, Adam F.; Hedges, Lester O.; Fernandez-Martinez, Alejandro; Waychunas, Glenn A.; Banfield, Jillian F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Wallace, Adam F.; Hedges, Lester O.; Whitelam, Stephen; De Yoreo, James J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Wallace, Adam F.] Univ Delaware, Dept Geol Sci, Newark, DE 19716 USA; [Fernandez-Martinez, Alejandro] Univ Grenoble 1, CNRS, Inst Sci Terre ISTerre, F-38041 Grenoble, France; [Raiteri, Paolo; Gale, Julian D.] Curtin Univ, Dept Chem, Nanochem Res Inst, Perth, WA 6845, Australia; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [De Yoreo, James J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [De Yoreo, James J.] Pacific NW Natl Lab, Div Phys Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Delaware; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Curtin University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Wallace, AF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA.	afw@udel.edu; james.deyoreo@pnnl.gov	Gale, Julian D/B-7987-2009; Wallace, Adam/A-9976-2012; Gale, Julian D./AAC-3668-2019; Raiteri, Paolo/E-1465-2011; Fernandez-Martinez, Alejandro/B-4042-2010; Fernandez-Martinez, Alejandro/I-4101-2019	Gale, Julian D/0000-0001-9587-9457; Gale, Julian D./0000-0001-9587-9457; Raiteri, Paolo/0000-0003-0692-0505; Fernandez-Martinez, Alejandro/0000-0001-5073-9629; Fernandez-Martinez, Alejandro/0000-0001-5073-9629; Hedges, Lester/0000-0002-5624-0500; Banfield, Jill/0000-0001-8203-8771	Center for Nanoscale Control of Geologic CO2, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-05CH11231]; DOE [DE-AC02-06CH11357]; Office of Science of the DOE [DE-AC02-05CH1123]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; Australian Research Council [DP0986999]	Center for Nanoscale Control of Geologic CO2, an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Office of Science of the DOE(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); Australian Research Council(Australian Research Council)	This work was performed at the Lawrence Berkeley National Laboratory in support of the Center for Nanoscale Control of Geologic CO<INF>2</INF>, an Energy Frontier Research Center, and was carried out at the Molecular Foundry, a Scientific User Facility, both of which are funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under contract DE-AC02-05CH11231. Use of the Advanced Photon Source, an Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory, was supported by the DOE under contract DE-AC02-06CH11357. This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the DOE under contract DE-AC02-05CH1123 and the Lawrencium computational cluster resource provided by the IT Division at the Lawrence Berkeley National Laboratory (supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract DE-AC02-05CH11231). J.D.G. and P.R. thank the Australian Research Council for funding under grant DP0986999 and iVEC/National Computational Infrastructure for computing resources.	[Anonymous], 2012, FARADAY DISCUSS, V155, P139; Bewernitz MA, 2012, FARADAY DISCUSS, V159, P291, DOI 10.1039/c2fd20080e; BINDER K, 1974, PHYS REV B, V9, P2328, DOI 10.1103/PhysRevB.9.2328; CAHN JW, 1959, J CHEM PHYS, V31, P688, DOI 10.1063/1.1730447; Chaudhury S, 2012, J CHEM THEORY COMPUT, V8, P677, DOI 10.1021/ct200529b; Demichelis R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1604; Faatz M, 2004, ADV MATER, V16, P996, DOI 10.1002/adma.200306565; Gebauer D, 2011, NANO TODAY, V6, P564, DOI 10.1016/j.nantod.2011.10.005; Gebauer D, 2010, ANGEW CHEM INT EDIT, V49, P8889, DOI 10.1002/anie.201003220; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Goodwin AL, 2010, CHEM MATER, V22, P3197, DOI 10.1021/cm100294d; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Hu Q, 2012, FARADAY DISCUSS, V159, P509, DOI 10.1039/c2fd20124k; Kawska A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145677; Lin ST, 2010, J PHYS CHEM B, V114, P8191, DOI 10.1021/jp103120q; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Quigley D, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3530288; Raiteri P, 2010, J AM CHEM SOC, V132, P17623, DOI 10.1021/ja108508k; Rieger J, 2007, FARADAY DISCUSS, V136, P265, DOI 10.1039/b701450c; Sator N, 2003, PHYS REP, V376, P1, DOI 10.1016/S0370-1573(02)00583-5; SIGGIA ED, 1979, PHYS REV A, V20, P595, DOI 10.1103/PhysRevA.20.595; STAUFFER D, 1982, PHYS REV LETT, V49, P1299, DOI 10.1103/PhysRevLett.49.1299; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Tribello GA, 2009, J PHYS CHEM B, V113, P11680, DOI 10.1021/jp902606x; VICSEK T, 1984, PHYS REV LETT, V52, P1669, DOI 10.1103/PhysRevLett.52.1669; Wang JM, 2011, J COMPUT CHEM, V32, P3505, DOI 10.1002/jcc.21939; Wang XL, 2013, GEOCHIM COSMOCHIM AC, V103, P1, DOI 10.1016/j.gca.2012.10.044; Wolf SE, 2008, J AM CHEM SOC, V130, P12342, DOI 10.1021/ja800984y	29	345	349	41	570	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					885	889		10.1126/science.1230915	http://dx.doi.org/10.1126/science.1230915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23970697	Green Submitted			2022-12-28	WOS:000323370600042
J	Watts, G				Watts, Geoff			Keith Fox: the pursuit of GRACE, RITA, and other affairs of the heart Profile	LANCET			English	Biographical-Item																		FOX K, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 17	2013	382	9892					589	589		10.1016/S0140-6736(13)61733-X	http://dx.doi.org/10.1016/S0140-6736(13)61733-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953377	Bronze			2022-12-28	WOS:000323422800011
J	Bornholdt, ZA; Noda, T; Abelson, DM; Halfmann, P; Wood, MR; Kawaoka, Y; Saphire, EO				Bornholdt, Zachary A.; Noda, Takeshi; Abelson, Dafna M.; Halfmann, Peter; Wood, Malcolm R.; Kawaoka, Yoshihiro; Saphire, Erica Ollmann			Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle	CELL			English	Article							MATRIX PROTEIN VP40; OLIGOMERIZATION; MEMBRANE; ASSOCIATION	Proteins, particularly viral proteins, can be multifunctional, but the mechanisms behind multifunctionality are not fully understood. Here, we illustrate through multiple crystal structures, biochemistry, and cellular microscopy that VP40 rearranges into different structures, each with a distinct function required for the ebolavirus life cycle. A butterfly-shaped VP40 dimer traffics to the cellular membrane. Once there, electrostatic interactions trigger rearrangement of the polypeptide into a linear hexamer. These hexamers construct a multilayered, filamentous matrix structure that is critical for budding and resembles tomograms of authentic virions. A third structure of VP40, formed by a different rearrangement, is not involved in virus assembly but instead uniquely binds RNA to regulate viral transcription inside infected cells. These results provide a functional model for ebolavirus matrix assembly and the other roles of VP40 in the virus life cycle and demonstrate how a single wild-type, unmodified polypeptide can assemble into different structures for different functions.	[Bornholdt, Zachary A.; Abelson, Dafna M.; Saphire, Erica Ollmann] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wood, Malcolm R.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; [Halfmann, Peter; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Tokyo; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Saphire, EO (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	erica@scripps.edu	Halfmann, Peter/W-8084-2019	Abelson, Dafna/0000-0003-4627-6902; Saphire, Erica Ollmann/0000-0002-1206-7451; Bornholdt, Zachary/0000-0002-7557-9219	Burroughs Welcome Fund; Skaggs Institute of Chemical Biology; National Institute of Allergy and Infectious Disease [R43 AI1088843]; Region V "Great Lakes" Regional Center for Excellence (RCE) for Biodefense and Emerging Infectious Disease Research Program (National Institutes of Health) [U54 AI057153]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology;  [2T32AI007244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244, R43AI088843, U54AI057153] Funding Source: NIH RePORTER	Burroughs Welcome Fund(Burroughs Wellcome Fund); Skaggs Institute of Chemical Biology; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Region V "Great Lakes" Regional Center for Excellence (RCE) for Biodefense and Emerging Infectious Disease Research Program (National Institutes of Health); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the beamline scientists at APS 19-ID and GM/CA 23-ID, SSRL 12-2, and ALS 5.0.2, Dr. Jean-Philippe Julien for assistance with the SEC-MALS analysis, Christina Corbaci for the Graphical Abstract, and Drs. Glen Nemerow and B. V. V Prasad for helpful comments and suggestions. E.O.S. was supported by a Career Award in the Biomedical Sciences and an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Welcome Fund, as well as The Skaggs Institute of Chemical Biology and a National Institute of Allergy and Infectious Disease award (R43 AI1088843). Z.A.B. was supported by a grant (2T32AI007244) to the TSRI Department of Immunology and Microbial Science. Y.K. acknowledges membership within and support from the Region V "Great Lakes" Regional Center for Excellence (RCE) for Biodefense and Emerging Infectious Disease Research Program (National Institutes of Health award [U54 AI057153]). T.N. was supported by a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science and by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology. This is manuscript #21649 from The Scripps Research Institute.	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Dessen A, 2000, ACTA CRYSTALLOGR D, V56, P758, DOI 10.1107/S0907444900004388; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; Hoenen T, 2005, J VIROL, V79, P1898, DOI 10.1128/JVI.79.3.1898-1905.2005; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Kuhn JH, 2011, VIRUS TAXONOMY, P665; Money VA, 2009, P NATL ACAD SCI USA, V106, P4441, DOI 10.1073/pnas.0805740106; Nanbo A., 2013, SCI REP, V3, P1; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Wyatt PJ, 1998, J COLLOID INTERF SCI, V197, P9, DOI 10.1006/jcis.1997.5215; ZSCHORNIG O, 1993, BIOCHIM BIOPHYS ACTA, V1148, P1, DOI 10.1016/0005-2736(93)90153-Q	29	155	159	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					763	774		10.1016/j.cell.2013.07.015	http://dx.doi.org/10.1016/j.cell.2013.07.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953110	Bronze, Green Accepted			2022-12-28	WOS:000323202500009
J	Kirpalani, H; Millar, D; Lemyre, B; Yoder, BA; Chiu, A; Roberts, RS				Kirpalani, Haresh; Millar, David; Lemyre, Brigitte; Yoder, Bradley A.; Chiu, Aaron; Roberts, Robin S.		NIPPV Study Grp	A Trial Comparing Noninvasive Ventilation Strategies in Preterm Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; NASAL; EXTUBATION; NCPAP	BackgroundTo reduce the risk of bronchopulmonary dysplasia in extremely-low-birth-weight infants, clinicians attempt to minimize the use of endotracheal intubation by the early introduction of less invasive forms of positive airway pressure. MethodsWe randomly assigned 1009 infants with a birth weight of less than 1000 g and a gestational age of less than 30 weeks to one of two forms of noninvasive respiratory support nasal intermittent positive-pressure ventilation (IPPV) or nasal continuous positive airway pressure (CPAP) at the time of the first use of noninvasive respiratory support during the first 28 days of life. The primary outcome was death before 36 weeks of postmenstrual age or survival with bronchopulmonary dysplasia. ResultsOf the 497 infants assigned to nasal IPPV for whom adequate data were available, 191 died or survived with bronchopulmonary dysplasia (38.4%), as compared with 180 of 490 infants assigned to nasal CPAP (36.7%) (adjusted odds ratio, 1.09; 95% confidence interval, 0.83 to 1.43; P=0.56). The frequencies of air leaks and necrotizing enterocolitis, the duration of respiratory support, and the time to full feedings did not differ significantly between treatment groups. ConclusionsAmong extremely-low-birth-weight infants, the rate of survival to 36 weeks of postmenstrual age without bronchopulmonary dysplasia did not differ significantly after noninvasive respiratory support with nasal IPPV as compared with nasal CPAP. (Funded by the Canadian Institutes of Health Research; NIPPV ClinicalTrials.gov number, NCT00433212; Controlled-Trials.com number, ISRCTN15233270.) In a randomized trial involving extremely-low-birth-weight infants eligible for noninvasive ventilation, the survival rate without bronchopulmonary dysplasia after nasal intermittent positive-pressure ventilation was similar to the rate after nasal continuous positive airway pressure. In extremely-low-birth-weight infants, bronchopulmonary dysplasia remains a leading cause of early death,(1) a strong predictor of later neurologic impairment,(2) and a major reason for resource use(3) and rehospitalization during the first year of life.(4) Improvements in survival rates among such infants have led to rates of bronchopulmonary dysplasia of up to 60% at the lowest gestational ages.(1),(5),(6) Tracheal intubation and mechanical ventilation are associated with ventilator-induced lung injury and airway inflammation, leading to bronchopulmonary dysplasia.(7),(8) Prolonged duration of intubation and mechanical ventilation in extremely-low-birth-weight infants is associated with an increased risk of death or survival with neurologic ...	[Kirpalani, Haresh] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Kirpalani, Haresh; Roberts, Robin S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Lemyre, Brigitte] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Chiu, Aaron] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Millar, David] Royal Matern Hosp, Dept Neonatol, Belfast, Antrim, North Ireland; [Yoder, Bradley A.] Univ Utah, Sch Med, Dept Neonatol, Salt Lake City, UT USA; [Yoder, Bradley A.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McMaster University; University of Ottawa; University of Manitoba; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kirpalani, H (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	kirpalanih@email.chop.edu	Lemyre, Brigitte/I-2571-2019; Abubakar, Kabir M/AAC-9972-2020; Ranu, Sukhvinder/AAI-2753-2020; Chandrasekharan, Praveen/X-1729-2019; Dempsey, Eugene Michael/H-8051-2015	Lemyre, Brigitte/0000-0003-2743-0417; Ranu, Sukhvinder/0000-0001-9077-076X; Halliday, Henry/0000-0001-7978-4992; Jonsson, Baldvin/0000-0002-9812-732X; Miletin, Jan/0000-0003-0489-6054; Hubbard, Marie/0000-0003-0388-4983; Dempsey, Eugene Michael/0000-0002-6266-3462; McNamara, Patrick/0000-0001-7648-8872; Chandrasekharan, Praveen/0000-0001-8727-3017	Canadian Institutes of Health Research [MCT-80246]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research (MCT-80246).	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Chang HY, 2011, PEDIATR RES, V69, P84, DOI 10.1203/PDR.0b013e3181ff6770; Cui Yun-Pu, 2009, Zhonghua Er Ke Za Zhi, V47, P532; Davis PG, 2010, J PEDIATR-US, V156, P382, DOI 10.1016/j.jpeds.2009.09.069; Davis PG, 2001, COCHRANE DATABASE SY, V3; Dumpa V, 2012, J PERINATOL, V32, P438, DOI 10.1038/jp.2011.117; Dunn MS, 2011, PEDIATRICS, V128, pE1069, DOI 10.1542/peds.2010-3848; Finer NN, 2010, NEW ENGL J MED, V362, P2235; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; GARLAND JS, 1985, PEDIATRICS, V76, P406; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Greenough A, 2008, COCHRANE DATABASE SY, V1; GREGORY GA, 1971, NEW ENGL J MED, V284, P1333, DOI 10.1056/NEJM197106172842401; Jackson JK, 2003, PEDIATRICS, V111; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kiciman NM, 1998, PEDIATR PULM, V25, P175, DOI 10.1002/(SICI)1099-0496(199803)25:3<175::AID-PPUL7>3.0.CO;2-L; Kieran EA, 2011, ARCH DIS CHILD-FETAL, V96, pF156, DOI 10.1136/adc.2010.203190; Kirpalani H, 2006, J PEDIATR-US, V149, P301, DOI 10.1016/j.jpeds.2006.05.011; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; Lemyre B, 2002, COCHRANE DATABASE SY, V1; LESOUEF PN, 1983, J APPL PHYSIOL, V55, P359, DOI 10.1152/jappl.1983.55.2.359; LLEWELLYN MA, 1970, ARCH DIS CHILD, V45, P453, DOI 10.1136/adc.45.242.453; LOFTUS BC, 1994, LARYNGOSCOPE, V104, P1019; Meneses J, 2012, ARCH PEDIAT ADOL MED, V166, P372, DOI 10.1001/archpediatrics.2011.1142; Moretti C, 1999, EARLY HUM DEV, V56, P167, DOI 10.1016/S0378-3782(99)00046-8; Moretti C, 2008, PEDIATR INT, V50, P85, DOI 10.1111/j.1442-200X.2007.02525.x; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; O'Brien K, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-43; Owen L S, 2008, Arch Dis Child Fetal Neonatal Ed, V93, pF148; Owen LS, 2011, ARCH DIS CHILD-FETAL, V96, pF422, DOI 10.1136/adc.2010.205195; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Shinwell ES, 2007, ARCH DIS CHILD-FETAL, V92, pF30, DOI 10.1136/adc.2006.094474; Smith VC, 2004, J PEDIATR-US, V144, P799, DOI 10.1016/j.jpeds.2004.03.026; Stefanescu BM, 2003, PEDIATRICS, V112, P1031, DOI 10.1542/peds.112.5.1031; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stroustrup A, 2010, PEDIATRICS, V126, pE291, DOI 10.1542/peds.2009-3456; van Kaam A, 2011, NEONATOLOGY, V99, P338, DOI 10.1159/000326843; Walsh MC, 2005, J PEDIATR-US, V146, P798, DOI 10.1016/j.jpeds.2005.01.047; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Wright CJ, 2011, PEDIATRICS, V128, P111, DOI 10.1542/peds.2010-3875	40	144	161	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					611	620		10.1056/NEJMoa1214533	http://dx.doi.org/10.1056/NEJMoa1214533			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944299				2022-12-28	WOS:000326354500007
J	O'Leary, MA; Bloch, JI; Flynn, JJ; Gaudin, TJ; Giallombardo, A; Giannini, NP; Goldberg, SL; Kraatz, BP; Luo, ZX; Meng, J; Ni, XJ; Novacek, MJ; Perini, FA; Randall, Z; Rougier, GW; Sargis, EJ; Silcox, MT; Simmons, NB; Spaulding, M; Velazco, PM; Weksler, M; Wible, JR; Cirranello, AL				O'Leary, Maureen A.; Bloch, Jonathan I.; Flynn, John J.; Gaudin, Timothy J.; Giallombardo, Andres; Giannini, Norberto P.; Goldberg, Suzann L.; Kraatz, Brian P.; Luo, Zhe-Xi; Meng, Jin; Ni, Xijun; Novacek, Michael J.; Perini, Fernando A.; Randall, Zachary; Rougier, Guillermo W.; Sargis, Eric J.; Silcox, Mary T.; Simmons, Nancy B.; Spaulding, Michelle; Velazco, Paul M.; Weksler, Marcelo; Wible, John R.; Cirranello, Andrea L.			Response to Comment on "The Placental Mammal Ancestor and the Post-K-Pg Radiation of Placentals"	SCIENCE			English	Editorial Material							DIVERGENCE; ORIGINS		[O'Leary, Maureen A.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Bloch, Jonathan I.; Randall, Zachary] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Flynn, John J.; Giallombardo, Andres; Goldberg, Suzann L.; Kraatz, Brian P.; Meng, Jin; Ni, Xijun; Novacek, Michael J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Gaudin, Timothy J.] Univ Tennessee, Dept Biol & Environm Sci, Chattanooga, TN 37403 USA; [Giannini, Norberto P.; Simmons, Nancy B.; Velazco, Paul M.; Cirranello, Andrea L.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Kraatz, Brian P.] Western Univ Hlth Sci, Dept Anat, Pomona, CA 91766 USA; [Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Perini, Fernando A.] Univ Fed Minas Gerais, Dept Zool, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; [Rougier, Guillermo W.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Sargis, Eric J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Silcox, Mary T.] Univ Toronto, Dept Anthropol, Scarborough, ON M1C 1A4, Canada; [Spaulding, Michelle; Wible, John R.] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA 15206 USA; [Weksler, Marcelo] Univ Fed Estado Rio de Janeiro UNIRIO, Inst Biociencias, Dept Zool, BR-20290240 Rio De Janeiro, Brazil	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida; American Museum of Natural History (AMNH); University of Tennessee System; University of Tennessee at Chattanooga; American Museum of Natural History (AMNH); Western University of Health Sciences; University of Chicago; Universidade Federal de Minas Gerais; University of Louisville; Yale University; University of Toronto; University Toronto Scarborough; Universidade Federal do Estado do Rio de Janeiro	O'Leary, MA (corresponding author), SUNY Stony Brook, Dept Anat Sci, HSC T-8 040, Stony Brook, NY 11794 USA.	maureen.oleary@stonybrook.edu	Luo, Zhe-XI/AAU-2263-2021; Perini, Fernando/I-1452-2012; Velazco, Paúl/P-7283-2019; Weksler, Marcelo/A-7420-2010	Perini, Fernando/0000-0002-4336-9284; Velazco, Paúl/0000-0001-7195-7422; Weksler, Marcelo/0000-0001-8111-4779; Silcox, Mary/0000-0002-4174-9435; Giannini, Norberto/0000-0002-8402-0126; O'Leary, Maureen A./0000-0001-7837-5708; Bloch, Jonathan/0000-0003-1484-6931; Simmons, Nancy B./0000-0001-8807-7499				Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Davalos LM, 2012, BIOL REV, V87, P991, DOI 10.1111/j.1469-185X.2012.00240.x; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; McKenna MC, 1997, CLASSIFICATION MAMMA; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Sanjuan R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002685; Springer MS, 2013, SCIENCE, V341, DOI 10.1126/science.1238025; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Won YJ, 2005, P NATL ACAD SCI USA, V102, P6581, DOI 10.1073/pnas.0502127102	12	11	12	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146								10.1126/science.1238162	http://dx.doi.org/10.1126/science.1238162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929968	Green Submitted			2022-12-28	WOS:000322884800019
J	Springer, MS; Meredith, RW; Teeling, EC; Murphy, WJ				Springer, Mark S.; Meredith, Robert W.; Teeling, Emma C.; Murphy, William J.			Technical Comment on "The Placental Mammal Ancestor and the Post-K-Pg Radiation of Placentals"	SCIENCE			English	Editorial Material							PHYLOGENY		[Springer, Mark S.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Meredith, Robert W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA; [Teeling, Emma C.] Natl Univ Ireland Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 4, Ireland; [Murphy, William J.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	University of California System; University of California Riverside; Montclair State University; University College Dublin; Texas A&M University System; Texas A&M University College Station	Springer, MS (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	mark.springer@ucr.edu; wmurphy@cvm.tamu.edu		Teeling, Emma/0000-0002-3309-1346	Division Of Environmental Biology [0946430] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], 1861, ORIGIN SPECIES MEANS; Baker RH, 1998, MOL PHYLOGENET EVOL, V9, P427, DOI 10.1006/mpev.1998.0519; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Finarelli J, 2008, J MAMM EVOL, V15, P231, DOI 10.1007/s10914-008-9074-x; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Lefeuvre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019193; Losos JB, 2012, SCIENCE, V338, P1428, DOI 10.1126/science.1232455; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Wang XM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)483[0001:AAAACF]2.0.CO;2	13	47	48	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146								10.1126/science.1238025	http://dx.doi.org/10.1126/science.1238025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929967				2022-12-28	WOS:000322884800018
J	Helmstaedter, M; Briggman, KL; Turaga, SC; Jain, V; Seung, HS; Denk, W				Helmstaedter, Moritz; Briggman, Kevin L.; Turaga, Srinivas C.; Jain, Viren; Seung, H. Sebastian; Denk, Winfried			Connectomic reconstruction of the inner plexiform layer in the mouse retina	NATURE			English	Article							GANGLION-CELLS; BIPOLAR CELLS; DIRECTION-SELECTIVITY; ELECTRON-MICROSCOPY; AMACRINE CELLS; SYNAPTIC CONNECTIONS; RABBIT RETINA; MICROCIRCUITRY; CIRCUIT; MORPHOLOGIES	Comprehensive high-resolution structural maps are central to functional exploration and understanding in biology. For the nervous system, in which high resolution and large spatial extent are both needed, such maps are scarce as they challenge data acquisition and analysis capabilities. Here we present for the mouse inner plexiform layer-the main computational neuropil region in the mammalian retina-the dense reconstruction of 950 neurons and their mutual contacts. This was achieved by applying a combination of crowd-sourced manual annotation and machine-learning-based volume segmentation to serial block-face electron microscopy data. We characterize a new type of retinal bipolar interneuron and show that we can subdivide a known type based on connectivity. Circuit motifs that emerge from our data indicate a functional mechanism for a known cellular response in a ganglion cell that detects localized motion, and predict that another ganglion cell is motion sensitive.	[Helmstaedter, Moritz; Briggman, Kevin L.; Denk, Winfried] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Turaga, Srinivas C.; Jain, Viren; Seung, H. Sebastian] MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Max Planck Society; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Helmstaedter, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	mhelmstaedter@neuro.mpg.de		Turaga, Srinivas/0000-0003-3247-6487	Max-Planck Society; DFG; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003133] Funding Source: NIH RePORTER	Max-Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Diamond, T. Euler, R. Masland, M. Meister and J. Sanes for discussions, J. Kornfeld and F. Svara for programming and continually improving KNOSSOS, M. Muller and J. Tritthardt for programming and building instrumentation, C. Roome for IT support, and A. Borst, M. Fee, T. Gollisch and A. Karpova for comments on the manuscript. We especially thank F. Isensee for help with synapse identification. We thank P. Bastians, A. Biasotto, F. Drawitsch, H. Falk, A. Gable, M. Grohmann, A. Gabelein, J. Hanne, F. Isensee, H. Jakobi, M. Kotchourko, E. Moller, J. Pollmann, C. Rohrig, A. Rommerskirchen, L. Schreiber, C. Willburger, H. Wissler and J. Youm for reconstruction management and annotator training, and N. Abazova, S. Abele, O. Aderhold, C. Altburger, T. Amberger, K. Aninditha, A. Antunes, E. Atsiatorme, H. Augenstein, I. Bartsch, I. Barz, P. Bastians, J. Bauer, H. Bauersachs, R. Bay, J. Becker, M. Beez, S. Bender, M. Berberich, I. Bertlich, J. Bewersdorf, A. Biasotto, P. Biti, M. Bittmann, K. Bretzel, J. Briegel, E. Buckler, A. Buntjer, C. Burkhardt, S. Buhler, S. Daum, N. Demir, E. Demirel, S. Dettmer, M. Diemer, J. Dietrich, S. Dittrich, C. Domnick, F. Drawitsch, C. Eck, L. Ehm, S. Ehrhardt, T. Eliguezel, K. Ernst, O. Eryilmaz, F. Euler, H. Falk, K. Fischer, K. Foerster, R. Foitzik, A. Foltin, R. Foltin, S. Freiss, A. Gable, P. Gallandi, K. Garbe, A. Gebhardt, F. Gebhart, S. Gottwalt, A. Greis, M. Grohmann, A. Gromann, S. Grobner, E. Grun, M. Grun, K. Guo, A. Gabelein, K. Haase, J. Hammerich, J. Hanne, B. Hauber, M. Hensen, F. Hentzschel, M. Herberz, M. Heumannskamper, C. Hilbert, L. Hofmann, P. Hofmann, T. Hondrich, U. Hausler, M. Horeth, J. Hugle, F. Isensee, A. Ivanova, F. Jahnke, H. Jakobi, M. Joel, M. Jonczyk, A. Joschko, A. Junger, K. Kappler, S. Kaspar, C. Kehrel, J. Kern, K. Kessler, S. Khoury, M. Kiapes, M. Kirchberger, A. Klein, C. Klein, S. Klein, J. Kratzer, C. Kraut, P. Kremer, P. Kretzer, F. Kroller, D. Kruger, M. Kuderer, S. Kull, S. Kwakman, S. Laiouar, L. Lebelt, H. Lesch, R. Lichtenberger, J. Liermann, C. Lieven, J. Lin, B. Linser, S. Lorger, J. Lott, D. Luft, L. Lust, J. Loffler, C. Marschall, B. Martin, D. Maton, B. Mayer, S. Mayorca, de. Ituarte, M. Meleux, C. Meyer, M. Moll, T. Moll, L. Mroszewski, E. Moller, M. Muller, L. Munster, N. Nasresfahani, J. Nassal, M. Neuschwanger, C. Nguyen, J. Nguyen, N. Nitsche, S. Oberrauch, F. Obitz, D. Ollech, C. Orlik, T. Otolski, S. Oumohand, A. Palfi, J. Pesch, M. Pfarr, S. Pfarr, M. Pohrath, J. Pollmann, M. Prokscha, S. Putzke, E. Rachmad, M. Reichert, J. Reinhardt, M. Reitz, J. Remus, M. Richter, M. Richter, J. Ricken, N. Rieger, F. Rodriguez. Jahnke, A. Rommerskirchen, M. Roth, I. Rummer, J. Ratzer, C. Rohrig, J. Rother, V. Saratov, E. Sauter, T. Schackel, M. Schamberger, M. Scheller, J. Schied, M. Schiedeck, J. Schiele, K. Schleich, M. Schlosser, S. Schmidt, C. Schneeweis, K. Schramm, M. Schramm, L. Schreiber, D. Schwarz, A. Schurholz, L. Schutz, A. Seitz, C. Sellmann, E. Serger, J. Sieber, L. Silbermann, I. Sonntag, T. Speck, Y. Sohngen, T. Tannig, N. Tisch, V. Tran, J. Trendel, M. Uhrig, D. Vecsei, F. Viehweger, V. Viehweger, R. Vogel, A. Vogel, J. Volz, P. Weber, K. Wegmeyer, J. Wiederspohn, E. Wiegand, R. Wiggers, C. Willburger, H. Wissler, V. Wissdorf, S. Worner, J. Youm, A. Zegarra, J. Zeilfelder, F. Zickgraf and T. Ziegler for cell reconstruction. This work was supported by the Max-Planck Society and the DFG (Leibniz prize to W.D.). H.S.S. is grateful for support from the Gatsby Charitable Foundation.	AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; AMTHOR FR, 1984, BRAIN RES, V298, P187, DOI 10.1016/0006-8993(84)91167-3; Andres B, 2012, LECT NOTES COMPUT SC, V7574, P778, DOI 10.1007/978-3-642-33712-3_56; Asari H, 2012, NAT NEUROSCI, V15, P1581, DOI 10.1038/nn.3241; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Binding J, 2013, MICROSC MICROANAL, V19, P38, DOI 10.1017/S1431927612013852; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Calkins DJ, 2007, J NEUROSCI, V27, P2646, DOI 10.1523/JNEUROSCI.4739-06.2007; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Helmstaedter M, 2007, BRAIN RES REV, V55, P193, DOI 10.1016/j.brainresrev.2007.07.011; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Joo HR, 2011, VISUAL NEUROSCI, V28, P29, DOI 10.1017/S0952523810000374; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; KOLB H, 1981, VISION RES, V21, P1081, DOI 10.1016/0042-6989(81)90013-4; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Macneil MA, 1999, J COMP NEUROL, V413, P305; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; PETERS A, 1979, TRENDS NEUROSCI, V2, P183, DOI 10.1016/0166-2236(79)90074-2; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sivyer B, 2011, J COMP NEUROL, V519, P3128, DOI 10.1002/cne.22720; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; STEVENS JK, 1980, BRAIN RES REV, V2, P265, DOI 10.1016/0165-0173(80)90010-7; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Studer D, 2000, J MICROSC-OXFORD, V197, P94, DOI 10.1046/j.1365-2818.2000.00638.x; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Turaga S. C., 2009, P ADV NEUR INF PROC, V22, P1; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P1; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109; Zhou ZJ, 2008, J PHYSIOL-LONDON, V586, P4371, DOI 10.1113/jphysiol.2008.159020	51	595	606	10	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					168	+		10.1038/nature12346	http://dx.doi.org/10.1038/nature12346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23925239				2022-12-28	WOS:000322825500027
J	North, CS; Pfefferbaum, B				North, Carol S.; Pfefferbaum, Betty			Mental Health Response to Community Disasters A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; COGNITIVE-BEHAVIORAL THERAPY; CIVILIAN MISSISSIPPI SCALE; PSYCHIATRIC-DISORDERS; SCREENING INSTRUMENTS; TERRORIST ATTACKS; MOOD DISORDERS; VICTIMS SPEAK; SEPTEMBER 11	IMPORTANCE Exposure to a disaster is common, and one-third or more of individuals severely exposed may develop posttraumatic stress disorder or other disorders. A systematic approach to the delivery of timely and appropriate disaster mental health services may facilitate their integration into the emergency medical response. OBJECTIVE To review and summarize the evidence for how best to identify individuals in need of disaster mental health services and triage them to appropriate care. EVIDENCE REVIEW Search of the peer-reviewed English-language literature on disaster mental health response in PsycINFO, PubMed, Cochrane Database of Systematic Reviews, Academic Search Complete, and Google Scholar (inception to September 2012) and PILOTS (inception to February 2013), using a combination of subject headings and text words (Disasters, Natural Disasters, Mental Health, Mental Health Programs, Public Health Services, Mental Disorders, Mental Health Services, Community Mental Health Services, Emergency Services Psychiatric, Emotional Trauma, Triage, and Response). FINDINGS Unlike physical injuries, adverse mental health outcomes of disasters may not be apparent, and therefore a systematic approach to case identification and triage to appropriate interventions is required. Symptomatic individuals in postdisaster settings may experience new-onset disaster-related psychiatric disorders, exacerbations of preexisting psychopathology, and/or psychological distress. Descriptive disaster mental health studies have found that many (11%-38%) distressed individuals presenting for evaluation at shelters and family assistance centers have stress-related and adjustment disorders; bereavement, major depression, and substance use disorders were also observed, and up to 40% of distressed individuals had preexisting disorders. Individuals with more intense reactions to disaster stress were more likely to accept referral to mental health services than those with less intense reactions. Evidence-based treatments are available for patients with active psychiatric disorders, but psychosocial interventions such as psychological first aid, psychological debriefing, crisis counseling, and psychoeducation for individuals with distress have not been sufficiently evaluated to establish their benefit or harm in disaster settings. CONCLUSION AND RELEVANCE In postdisaster settings, a systematic framework of case identification, triage, and mental health interventions should be integrated into emergency medicine and trauma care responses.	[North, Carol S.] VA North Texas Hlth Care Syst, Dallas, TX USA; [North, Carol S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [North, Carol S.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Emergency Med, Dallas, TX 75390 USA; [Pfefferbaum, Betty] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Terrorism & Disaster Ctr,Dept Psychiat & Behav Sc, Oklahoma City, OK 73190 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma Health Sciences Center	North, CS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 6363 Forest Pk Rd,Ste 651, Dallas, TX 75390 USA.	carol.north@utsouthwestern.edu			Substance Abuse and Mental Health Services Administration [1 U79SM57278]; Terrorism and Disaster Center (TDC) at the University of Oklahoma Health Sciences Center	Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); Terrorism and Disaster Center (TDC) at the University of Oklahoma Health Sciences Center	Dr Pfefferbaum's work on this article was supported in part by a grant from the Substance Abuse and Mental Health Services Administration (1 U79SM57278), which established the Terrorism and Disaster Center (TDC) at the University of Oklahoma Health Sciences Center. The TDC is a partner in the National Child Traumatic Stress Network.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; American Red Cross, 2006, PSYCH 1 AID HELP OTH; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Basoglu M, 2007, PSYCHOL MED, V37, P203, DOI 10.1017/S0033291706009123; Bisson JI, 2009, EFFECTIVE TREATMENTS, P539; Born CT, 2007, J AM ACAD ORTHOP SUR, V15, P388, DOI 10.5435/00124635-200707000-00004; Bossini L, 2012, EXPERT OPIN PHARMACO, V13, P1707, DOI 10.1517/14656566.2012.699523; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Brymer M., 2006, PSYCHOL 1 AID FIELD, V2nd; Bui Eric, 2012, Dialogues Clin Neurosci, V14, P149; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; Challen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-542; Chiu S, 2011, ANN CLIN PSYCHIATRY, V23, P95; Chiu S, 2010, J AFFECT DISORDERS, V121, P212, DOI 10.1016/j.jad.2009.05.028; COCHRANE AL, 1971, BRIT MED BULL, V27, P3, DOI 10.1093/oxfordjournals.bmb.a070810; Compton MT, 2005, COMMUNITY MENT HLT J, V41, P647, DOI 10.1007/s10597-005-8846-5; Elal G, 2005, J TRAUMA STRESS, V18, P213, DOI 10.1002/jts.20030; Elrod CL, 2006, ANN AM ACAD POLIT SS, V604, P152, DOI 10.1177/0002716205285186; Everly G., 2006, BRIEF TREAT CRISIS I, V6, P130, DOI DOI 10.1093/BRIEF-TREATMENT/MHJ009; Everly George S Jr, 2006, Int J Emerg Ment Health, V8, P93; Foa EB, 2005, NEUROPSYCHOPHARMACOL, V30, P1806, DOI 10.1038/sj.npp.1300815; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; Friedman MJ, 2009, EFFECTIVE TREATMENTS, P563; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Green BL, 1998, PSYCHIAT CLIN NEUR S, V52, pS67, DOI DOI 10.1046/J.1440-1819.1998.0520S5S67.X; Guha-Sapir D, ANN DISASTER STAT RE; Hadorn DC, 1996, J CLIN EPIDEMIOL, V49, P749, DOI 10.1016/0895-4356(96)00019-4; Hall Molly J, 2003, Biosecur Bioterror, V1, P139, DOI 10.1089/153871303766275817; Hamblen JL, 2009, ADM POLICY MENT HLTH, V36, P206, DOI 10.1007/s10488-009-0213-3; Hensley PL, 2006, J AFFECT DISORDERS, V92, P117, DOI 10.1016/j.jad.2005.12.041; Herman D, 2002, J URBAN HEALTH, V79, P322, DOI 10.1093/jurban/79.3.322; Hollon SD, 2010, DEPRESS ANXIETY, V27, P891, DOI 10.1002/da.20741; Holtzheimer PE, 2012, HAND CLINIC, V106, P681, DOI 10.1016/B978-0-444-52002-9.00041-3; Inglesby TV, 2011, JAMA-J AM MED ASSOC, V306, P1372, DOI 10.1001/jama.2011.1359; Inkelas M, 2000, J TRAUMA STRESS, V13, P149, DOI 10.1023/A:1007733217042; Institute of Medicine, 2003, PREP PSYCH CONS TERR; Institute of Medicine, 2006, POSTTRAUMATIC STRESS; Ioachimescu OC, 2012, EXPERT OPIN PHARMACO, V13, P1243, DOI 10.1517/14656566.2012.683860; Jack K, 2002, J URBAN HEALTH, V79, P332, DOI 10.1093/jurban/79.3.332; Jakobsen JC, 2012, PSYCHOL MED, V42, P1343, DOI 10.1017/S0033291711002236; Jonas DE, 2013, PSYCHOLOGICAL PHARM; Kudler HS, 2009, EFFECTIVE TREATMENTS, P346; Levitt JT, 2007, BEHAV RES THER, V45, P1419, DOI 10.1016/j.brat.2007.01.004; Litz BT, 2009, EFFECTIVE TREATMENTS, P546; Lowrey W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-97; Najavits LM, 2007, GUIDE TREATMENTS WOR, P513; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 1996, J TRAUMA STRESS, V9, P285, DOI 10.1007/BF02110661; Norris FH, 2006, PSYCHIAT SERV, V57, P1328, DOI 10.1176/appi.ps.57.9.1328; Norris FH, 2009, ADM POLICY MENT HLTH, V36, P176, DOI 10.1007/s10488-009-0215-1; Norris FH, 2009, ADM POLICY MENT HLTH, V36, P159, DOI 10.1007/s10488-009-0218-y; North Carol S, 2008, Mo Med, V105, P62; North CS, 2008, PSYCHIAT ANN, V38, P104, DOI 10.3928/00485713-20080201-06; North Carol S, 2002, CNS Spectr, V7, P580; North CS, 2013, CAN J PSYCHIAT, V58, P125, DOI 10.1177/070674371305800301; North CS, 2012, AM J PUBLIC HEALTH, V102, pE40, DOI 10.2105/AJPH.2012.300689; North CS, 2011, DISASTER MED PUBLIC, V5, pS205, DOI 10.1001/dmp.2011.50; North CS, 2011, ARCH GEN PSYCHIAT, V68, P173, DOI 10.1001/archgenpsychiatry.2010.131; North CS, 2007, TEXTBOOK OF DISASTER PSYCHIATRY, P29, DOI 10.1017/CBO9780511544415.003; North CS, 2009, AM J PSYCHIAT, V166, P34, DOI 10.1176/appi.ajp.2008.08050644; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; North CS, 2004, PSYCHIAT CLIN N AM, V27, P589, DOI 10.1016/j.psc.2004.03.001; North CS, 2002, JAMA-J AM MED ASSOC, V288, P633, DOI 10.1001/jama.288.5.633; North CS, 2007, US PSYCHIAT, V2007, P35; Norwood AE, 2000, PSYCHIAT QUART, V71, P207, DOI 10.1023/A:1004678010161; Nucifora FC, 2011, DISASTER MED PUBLIC, V5, pS172, DOI 10.1001/dmp.2011.51; Nucifora F, 2007, DISASTER MED PUBLIC, V1, pS33, DOI 10.1097/DMP.0b013e31814b98ae; Pandya A, 2010, J PSYCHIATR PRACT, V16, P193, DOI 10.1097/01.pra.0000375717.77831.83; Pfefferbaum B, 2013, CAN J PSYCHIAT, V58, P135, DOI 10.1177/070674371305800303; Pfefferbaum B, 2012, DISASTER MED PUBLIC, V6, P60, DOI 10.1001/dmp.2012.1; Pfefferbaum Betty, 2002, CNS Spectr, V7, P575; Redwood-Campbell L, 2011, PREHOSP DISASTER MED, V26, P184, DOI 10.1017/S1049023X11006388; Regel S, 2007, OCCUP MED-OXFORD, V57, P411, DOI 10.1093/occmed/kqm071; Reyes G, 2004, PSYCHOTHERAPY, V41, P399, DOI 10.1037/0033-3204.41.4.399; Roberts NP, 2009, AM J PSYCHIAT, V166, P293, DOI 10.1176/appi.ajp.2008.08040590; Rose S, 2003, PSYCHOTHER PSYCHOSOM, V72, P176, DOI 10.1159/000070781; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; Ruggiero KJ, 2006, J TRAUMA STRESS, V19, P699, DOI 10.1002/jts.20141; Ruzek Josef I, 2004, Prehosp Disaster Med, V19, P46; Ruzek JI, 2008, PREHOSP DISASTER MED, V23, P397, DOI 10.1017/S1049023X00006130; Satcher D, 2007, JAMA-J AM MED ASSOC, V298, P2540, DOI 10.1001/jama.298.21.2540; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Shekelle PG, 1999, WESTERN J MED, V170, P348; Shelton RC, 2010, CNS DRUGS, V24, P131, DOI 10.2165/11530280-000000000-00000; Siegel CE, 2004, AM J PUBLIC HEALTH, V94, P582, DOI 10.2105/AJPH.94.4.582; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Silver SM., 2005, INT J STRESS MANAG, V12, P29, DOI [DOI 10.1037/1072-5245.12.1.29, 10.1037/1072-5245.12.1.29]; Simonsen LF, 2003, COMMUNITY BASED PSYC; Steel JL, 2011, INJURY, V42, P288, DOI 10.1016/j.injury.2010.11.045; Subbarao I, 2008, DISASTER MED PUBLIC, V2, P57, DOI 10.1097/DMP.0b013e31816564af; Suris A, 2013, ANN CLIN PSYCHIATRY, V25, P33; Suris A, 2011, J TRAUMA STRESS, V24, P605, DOI 10.1002/jts.20674; Thoma NC, 2012, AM J PSYCHIAT, V169, P22, DOI 10.1176/appi.ajp.2011.11030433; Thoresen S, 2010, SOC PSYCH PSYCH EPID, V45, P405, DOI 10.1007/s00127-009-0073-x; Timmreck TC, 2003, PLANNING PROGRAM DEV, P87; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tuma F, 2007, PSYCHIATRY, V70, P358, DOI 10.1521/psyc.2007.70.4.358; Ursano RJ, 2007, TEXTBOOK OF DISASTER PSYCHIATRY, P311, DOI 10.1017/CBO9780511544415.016; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Walsh F, 2007, FAM PROCESS, V46, P207, DOI 10.1111/j.1545-5300.2007.00205.x; Watson PJ, 2011, AM PSYCHOL, V66, P482, DOI 10.1037/a0024806; Wessely S, 2004, PSYCHIATRY, V67, P153, DOI 10.1521/psyc.67.2.153.35953; Wessely S, 2008, PSYCHIATRY, V71, P287, DOI 10.1521/psyc.2008.71.4.287; World Health Organisation (WHO), 2011, PSYCH 1 AID GUID FIE; Young BH, 2006, INTERVENTIONS FOLLOW, P135	110	299	308	8	109	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					507	518		10.1001/jama.2013.107799	http://dx.doi.org/10.1001/jama.2013.107799			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	196OZ	23925621				2022-12-28	WOS:000322786400023
J	Woodside, KJ				Woodside, Kenneth J.			A Handshake	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Hosp Case Med Ctr, Div Transplant & Hepatobiliary Surg, Dept Surg, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University Hospital	Woodside, KJ (corresponding author), Univ Hosp Case Med Ctr, Div Transplant & Hepatobiliary Surg, Dept Surg, Cleveland, OH USA.	woodside@umich.edu		Woodside, Kenneth/0000-0002-7495-3758					0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					481	481		10.1001/jama.2013.8353	http://dx.doi.org/10.1001/jama.2013.8353			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925615				2022-12-28	WOS:000322786400017
J	Moritz, C; Agudo, R				Moritz, Craig; Agudo, Rosa			The Future of Species Under Climate Change: Resilience or Decline?	SCIENCE			English	Review							RANGE SHIFTS; GLOBAL CLIMATE; GENETIC DIVERSITY; ECOLOGICAL RESPONSES; WILD BIRD; BIODIVERSITY; COMMUNITIES; IMPACTS; MARINE; MODELS	As climates change across already stressed ecosystems, there is no doubt that species will be affected, but to what extent and which will be most vulnerable remain uncertain. The fossil record suggests that most species persisted through past climate change, whereas forecasts of future impacts predict large-scale range reduction and extinction. Many species have altered range limits and phenotypes through 20th-century climate change, but responses are highly variable. The proximate causes of species decline relative to resilience remain largely obscure; however, recent examples of climate-associated species decline can help guide current management in parallel with ongoing research.	[Moritz, Craig; Agudo, Rosa] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Moritz, Craig; Agudo, Rosa] Australian Natl Univ, Ctr Biodivers Anal, Canberra, ACT 0200, Australia; [Moritz, Craig] CSIRO, Ecosyst Sci Div, Canberra, ACT 2601, Australia; [Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94710 USA	Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of California System; University of California Berkeley	Moritz, C (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia.	gekkojessie@gmail.com			National Science Foundation (the Australian Research Council); Gordon and Betty Moore Foundation; Spanish postdoctoral fellowship; Ramon Areces Foundation	National Science Foundation (the Australian Research Council); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Spanish postdoctoral fellowship; Ramon Areces Foundation	We thank all members of the Moritz lab for their helpful comments and suggestions. C.M.'s research relating to climate change effects has been supported by the National Science Foundation (the Australian Research Council) and the Gordon and Betty Moore Foundation. R. A. is funded by a Spanish postdoctoral fellowship financed by the Ramon Areces Foundation (www.fundacionareces.es/fundacionareces/).	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bell RC, 2010, MOL ECOL, V19, P2531, DOI 10.1111/j.1365-294X.2010.04676.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bernstein L., 2007, CONTRIBUTION OF WORK; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Coope G.R., 2004, ESS B, V2, P57; Cooper RA, 2006, GEOLOGY, V34, P241, DOI 10.1130/G22206.1; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Eastman LM, 2012, GLOBAL CHANGE BIOL, V18, P1499, DOI 10.1111/j.1365-2486.2012.02644.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gomulkiewicz R, 2009, AM NAT, V174, pE218, DOI 10.1086/645086; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Grayson DK, 2006, QUATERNARY SCI REV, V25, P2964, DOI 10.1016/j.quascirev.2006.03.004; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Lavergne S, 2006, GLOBAL CHANGE BIOL, V12, P1466, DOI 10.1111/j.1365-2486.2006.01183.x; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lenoir J, 2013, GLOBAL CHANGE BIOL, V19, P1470, DOI 10.1111/gcb.12129; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Lindsay DL, 2008, MOL ECOL, V17, P2122, DOI 10.1111/j.1365-294X.2008.03673.x; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; MacDonald GM, 2008, PROG PHYS GEOG, V32, P139, DOI 10.1177/0309133308094081; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Moritz C, 2012, PHILOS T R SOC B, V367, P1680, DOI 10.1098/rstb.2012.0018; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; Oza AU, 2012, MOL PHYLOGENET EVOL, V62, P407, DOI 10.1016/j.ympev.2011.10.010; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Reed TE, 2013, SCIENCE, V340, P488, DOI 10.1126/science.1232870; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rubidge EM, 2012, NAT CLIM CHANGE, V2, P285, DOI 10.1038/NCLIMATE1415; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Sears MW, 2011, INTEGR COMP BIOL, V51, P666, DOI 10.1093/icb/icr111; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Terry RC, 2011, GLOBAL CHANGE BIOL, V17, P3019, DOI 10.1111/j.1365-2486.2011.02438.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Willis KJ, 2011, ANNU REV ECOL EVOL S, V42, P267, DOI 10.1146/annurev-ecolsys-102209-144704; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Zarnetske PL, 2012, SCIENCE, V336, P1516, DOI 10.1126/science.1222732	108	439	454	45	761	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					504	508		10.1126/science.1237190	http://dx.doi.org/10.1126/science.1237190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908228				2022-12-28	WOS:000322586700042
J	Landon, BE; Roberts, DH				Landon, Bruce E.; Roberts, David H.			Reenvisioning Specialty Care and Payment Under Global Payment Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Div Gen Med, Boston, MA 02115 USA; [Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Div Primary Care, Boston, MA 02115 USA; [Roberts, David H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	landon@hcp.med.harvard.edu						Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Landon BE, 2012, NEW ENGL J MED, V366, P393, DOI 10.1056/NEJMp1112637; Medpac, 2013, REP C MED PAYM POL	3	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					371	372		10.1001/jama.2013.75247	http://dx.doi.org/10.1001/jama.2013.75247			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917283				2022-12-28	WOS:000322121500010
J	Hung, CL; Gurarie, V; Chin, C				Hung, Chen-Lung; Gurarie, Victor; Chin, Cheng			From Cosmology to Cold Atoms: Observation of Sakharov Oscillations in a Quenched Atomic Superfluid	SCIENCE			English	Article								Predicting the dynamics of many-body systems far from equilibrium is a challenging theoretical problem. A long-predicted phenomenon in hydrodynamic nonequilibrium systems is the occurrence of Sakharov oscillations, which manifest in the anisotropy of the cosmic microwave background and the large-scale correlations of galaxies. Here, we report the observation of Sakharov oscillations in the density fluctuations of a quenched atomic superfluid through a systematic study in both space and time domains and with tunable interaction strengths. Our work suggests a different approach to the study of nonequilibrium dynamics of quantum many-body systems and the exploration of their analogs in cosmology and astrophysics.	[Hung, Chen-Lung; Chin, Cheng] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Hung, Chen-Lung; Chin, Cheng] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Gurarie, Victor] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University of Chicago; University of Chicago; University of Colorado System; University of Colorado Boulder	Chin, C (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	cchin@uchicago.edu			NSF [PHY-1206095, PHY-1211914, DMR-1205303]; Army Research Office [W911NF0710576]; Defense Advanced Research Projects Agency OLE Program; Packard foundation; Division Of Materials Research [1205303] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Army Research Office; Defense Advanced Research Projects Agency OLE Program; Packard foundation(The David & Lucile Packard Foundation); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to L. Radzihovsky, W. Hu, and C.-L. Kuo for helpful discussions. We thank X. Zhang, L.-C. Ha, and S.-K. Tung for the laboratory support. C.-L.H. and C.C. are supported by NSF award PHY-1206095, Army Research Office grant W911NF0710576 with funds from the Defense Advanced Research Projects Agency OLE Program, and the Packard foundation. V.G. is supported by NSF awards PHY-1211914 and DMR-1205303. The data presented in this paper are available upon request sent to cchin@uchicago.edu.	BOND JR, 1984, ASTROPHYS J, V285, pL45, DOI 10.1086/184362; Cheneau M, 2012, NATURE, V481, P484, DOI 10.1038/nature10748; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Eisenstein DJ, 2008, PHYS TODAY, V61, P44, DOI 10.1063/1.2911177; Fedichev PO, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.033602; Grishchuk L. P., 2012, USP FIZ NAUK, V182, P222; Hu W, 2002, ANNU REV ASTRON ASTR, V40, P171, DOI 10.1146/annurev.astro.40.060401.093926; Hung CL, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/075019; Hung CL, 2011, NATURE, V470, P236, DOI 10.1038/nature09722; Imambekov A, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033604; Jaskula JC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.220401; Lahav O, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.240401; Larson D, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/16; Natu SS, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.053607; PEEBLES PJE, 1970, ASTROPHYS J, V162, P815, DOI 10.1086/150713; Pethick CJ, 2008, BOSE-EINSTEIN CONDENSATION IN DILUTE GASES, P1; Petrov DS, 2000, PHYS REV LETT, V84, P2551, DOI 10.1103/PhysRevLett.84.2551; Retzker A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.110402; Sakharov A. D., 1965, SOV PHYS JETP, V49, P345; SUNYAEV RA, 1970, ASTROPHYS SPACE SCI, V7, P3; Uhlmann M, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/248; UNRUH WG, 1981, PHYS REV LETT, V46, P1351, DOI 10.1103/PhysRevLett.46.1351; Yefsah T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.130401; Zeldovich YB, 1983, RELATIVISTIC ASTROPH, V2	26	108	109	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1213	1215		10.1126/science.1237557	http://dx.doi.org/10.1126/science.1237557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23907531	Green Submitted			2022-12-28	WOS:000324248800035
J	He, CC; Wei, YJ; Sun, K; Li, BH; Dong, XN; Zou, ZJ; Liu, Y; Kinch, LN; Khan, S; Sinha, S; Xavier, RJ; Grishin, NV; Xiao, GH; Eskelinen, EL; Scherer, PE; Whistler, JL; Levine, B				He, Congcong; Wei, Yongjie; Sun, Kai; Li, Binghua; Dong, Xiaonan; Zou, Zhongju; Liu, Yang; Kinch, Lisa N.; Khan, Shaheen; Sinha, Sangita; Xavier, Ramnik J.; Grishin, Nick V.; Xiao, Guanghua; Eskelinen, Eeva-Liisa; Scherer, Philipp E.; Whistler, Jennifer L.; Levine, Beth			Beclin 2 Functions in Autophagy, Degradation of G Protein-Coupled Receptors, and Metabolism	CELL			English	Article							MEMBRANE-TRAFFICKING; SORTING PROTEINS; LINKAGE; SYSTEM; CELLS; FAMILY; SCAN	The molecular mechanism of autophagy and its relationship to other lysosomal degradation pathways remain incompletely understood. Here, we identified a previously uncharacterized mammalian-specific protein, Beclin 2, which, like Beclin 1, functions in autophagy and interacts with class III PI3K complex components and Bcl-2. However, Beclin 2, but not Beclin 1, functions in an additional lysosomal degradation pathway. Beclin 2 is required for ligand-induced endolysosomal degradation of several G protein-coupled receptors (GPCRs) through its interaction with GASP1. Beclin 2 homozygous knockout mice have decreased embryonic viability, and heterozygous knockout mice have defective autophagy, increased levels of brain cannabinoid 1 receptor, elevated food intake, and obesity and insulin resistance. Our findings identify Beclin 2 as a converging regulator of autophagy and GPCR turnover and highlight the functional and mechanistic diversity of Beclin family members in autophagy, endolysosomal trafficking, and metabolism.	[He, Congcong; Wei, Yongjie; Zou, Zhongju; Kinch, Lisa N.; Grishin, Nick V.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [He, Congcong; Wei, Yongjie; Dong, Xiaonan; Zou, Zhongju; Liu, Yang; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Sun, Kai; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [He, Congcong; Wei, Yongjie; Sun, Kai; Li, Binghua; Dong, Xiaonan; Zou, Zhongju; Liu, Yang; Khan, Shaheen; Scherer, Philipp E.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Sinha, Sangita] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58102 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] MIT, Cambridge, MA 02142 USA; [Eskelinen, Eeva-Liisa] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FI-00014 Helsinki, Finland; [Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; North Dakota State University Fargo; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; Eskelinen, Eeva-Liisa/AAF-3496-2019	Scherer, Philipp E/0000-0003-0680-3392; Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Kinch, Lisa/0000-0003-3041-2615; Deldicque, Louise/0000-0003-3393-5278; Khan, Shaheen/0000-0002-1472-8129; Sun, Kai/0000-0002-4778-4549; Dong, Xiaonan/0000-0001-7967-2755	NIH [ROI CA109618, ROI GM094575, ROI DK55758, PO1 DK088761, ROI DA019958, ROI DK043351, K99 DK094980, R21 AI078198, P20 RR015566]; Welch Foundation [I-1505]; state of California for medical research on alcohol and substance abuse through the University of California, San Francisco; Academy of Finland; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK055758, K99DK094980, P01DK088761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103332, R01GM094575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); state of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Haley Harrington for assistance with manuscript preparation and the Electron Microscopy Unit of the Institute of Biotechnology, University of Helsinki, Finland for providing laboratory facilities. This work was supported by NIH awards ROI CA109618 (B. L.), ROI GM094575 (N. V. G.), ROI DK55758 (P. E. S.), PO1 DK088761 (P. E. S.), ROI DA019958 (J. L. W.), ROI DK043351 (R. J. X.), K99 DK094980 (C. H.), R21 AI078198 (S. S.), and P20 RR015566 (S. S.); a Welch Foundation Award I-1505 (N. V. G.); and funds provided by the state of California for medical research on alcohol and substance abuse through the University of California, San Francisco to J. L. W. E.-L. E. was supported by the Academy of Finland. The authors Y. W., K. S., and B. Li all contributed equally to this manuscript.	Abu-Helo A, 2010, PHARMACOL THERAPEUT, V126, P244, DOI 10.1016/j.pharmthera.2010.03.004; Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Bosse Y, 2004, J LIPID RES, V45, P419, DOI 10.1194/jlr.M300401-JLR200; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2008, DRUG DISCOV TODAY, V13, P1026, DOI 10.1016/j.drudis.2008.09.001; Dong CH, 2011, HUM GENET, V129, P209, DOI 10.1007/s00439-010-0916-2; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moser E, 2010, PHARMACOLOGY, V86, P22, DOI 10.1159/000314161; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schelling JR, 2008, DIABETES, V57, P235, DOI 10.2337/db07-0313; Shmulewitz D, 2006, P NATL ACAD SCI USA, V103, P3502, DOI 10.1073/pnas.0510156103; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Strappazzon F, 2011, EMBO J, V30, P1195, DOI 10.1038/emboj.2011.49; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Tschische P, 2010, TRAFFIC, V11, P660, DOI 10.1111/j.1600-0854.2010.1045.x; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhao LX, 2010, AUTOPHAGY, V6, P386, DOI 10.4161/auto.6.3.11289	31	113	128	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1085	1099		10.1016/j.cell.2013.07.035	http://dx.doi.org/10.1016/j.cell.2013.07.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23954414	Bronze, Green Accepted			2022-12-28	WOS:000323767300021
J	Seton, M; Wu, CC; Louissaint, A				Seton, Margaret; Wu, Carol C.; Louissaint, Abner, Jr.			Case 26-2013: A 46-Year-Old Woman with Muscle Pain and Swelling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE REGULATOR AIRE; POPULATION-BASED COHORT; RED-CELL APLASIA; MYASTHENIA-GRAVIS; INFLAMMATORY MYOPATHY; THYMOMA; DERMATOMYOSITIS; POLYMYOSITIS; CANCER; RISK	<p id="p002">A 46-year-old woman presented with pain and swelling in her arms and lower legs for 3 weeks. Examination showed swelling and tenderness of the left arm and tenderness in both calves. Chest imaging revealed a mediastinal mass. A diagnostic procedure was performed. <p id="p003">Presentation of Case <p id="p004">Dr. Luke A. Neilans (Medicine): A 46-year-old woman was seen in the emergency department at this hospital because of muscle pain and swelling in her arms and lower legs. <p id="p005">The patient had been well until approximately 3 weeks before admission, when a deep ache developed in her left triceps, in the absence of trauma. During the following weeks, the pain persisted, gradually spreading to both arms and both legs, and was exacerbated by movement; she began having difficulty rising from chairs and climbing stairs because of pain. Two weeks before admission, examination by her primary care physician ...	[Seton, Margaret] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wu, Carol C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Louissaint, Abner, Jr.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Seton, Margaret] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wu, Carol C.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Louissaint, Abner, Jr.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Seton, M (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.							Aarli JA, 1998, CURR OPIN NEUROL, V11, P233, DOI 10.1097/00019052-199806000-00007; Ago T, 1999, INTERNAL MED, V38, P155, DOI 10.2169/internalmedicine.38.155; Boehm T, 2006, TRENDS IMMUNOL, V27, P477, DOI 10.1016/j.it.2006.08.004; Buchbinder R, 2001, ANN INTERN MED, V134, P1087, DOI 10.7326/0003-4819-134-12-200106190-00008; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Dalakas Marinos C., 1995, Annals of Neurology, V37, pS74; FINE RM, 1993, INT J DERMATOL, V32, P22, DOI 10.1111/j.1365-4362.1993.tb00953.x; GEARY CG, 1975, BRIT J HAEMATOL, V29, P479, DOI 10.1111/j.1365-2141.1975.tb01845.x; Margaritora S, 2010, ANN THORAC SURG, V89, P245, DOI 10.1016/j.athoracsur.2009.08.074; Marx A, 2010, J THORAC ONCOL, V5, pS266, DOI 10.1097/JTO.0b013e3181f1f63f; Masuda M, 2000, AM J HEMATOL, V63, P102, DOI 10.1002/(SICI)1096-8652(200002)63:2<102::AID-AJH9>3.0.CO;2-P; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c; MONTES LF, 1972, J AMER MED ASSOC, V222, P1619, DOI 10.1001/jama.222.13.1619; Mygland A, 2000, ARCH NEUROL-CHICAGO, V57, P527, DOI 10.1001/archneur.57.4.527; Nagasawa K, 1999, INTERNAL MED, V38, P81, DOI 10.2169/internalmedicine.38.81; Oddis CV, 2011, RHEUMATOLOGY, P1439; RUNDLE LG, 1963, ARCH PATHOL, V75, P276; Shichijo K, 2005, ACTA NEUROPATHOL, V109, P539, DOI 10.1007/s00401-005-0990-z; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; Somnier FE, 2002, NEUROLOGY, V59, P92, DOI 10.1212/WNL.59.1.92; Stockton D, 2001, BRIT J CANCER, V85, P41, DOI 10.1054/bjoc.2001.1699; Strobel P, 2007, J PATHOL, V211, P563, DOI 10.1002/path.2141; Suzuki S, 2007, ARCH NEUROL-CHICAGO, V64, P1121, DOI 10.1001/archneur.64.8.1121; Travis WD., 2004, TRAVIS WB WHO CLASSI; Van de Warrenburg BPC, 2002, MUSCLE NERVE, V25, P293, DOI 10.1002/mus.10022; Welsh JS, 2000, JAMA-J AM MED ASSOC, V283, P1142, DOI 10.1001/jama.283.9.1142; 2007, N ENGL J MED, V356, P2185	27	8	9	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					764	773		10.1056/NEJMcpc1208152	http://dx.doi.org/10.1056/NEJMcpc1208152			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964939				2022-12-28	WOS:000323349300014
J	Swaminathan, RV; Feldman, DN				Swaminathan, Rajesh V.; Feldman, Dmitriy N.			TRILOGY ACS: prasugrel of benefit only after angiography?	LANCET			English	Editorial Material							ELEVATION MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; CLOPIDOGREL; ASPIRIN; PRETREATMENT; THERAPY		[Swaminathan, Rajesh V.; Feldman, Dmitriy N.] New York Presbyterian Hosp, Weill Cornell Med Coll, Div Cardiol, New York, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital	Feldman, DN (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Div Cardiol, New York, NY 10021 USA.	dnf9001@med.cornell.edu						Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; James SK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3527; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2013, LANCET, V382, P605, DOI 10.1016/S0140-6736(13)61451-8; Yusuf S, 2001, NEW ENGL J MED, V345, P494	11	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					580	582		10.1016/S0140-6736(13)61640-2	http://dx.doi.org/10.1016/S0140-6736(13)61640-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953376				2022-12-28	WOS:000323422800007
J	Lamberth, C; Jeanmart, S; Luksch, T; Plant, A				Lamberth, Clemens; Jeanmart, Stephane; Luksch, Torsten; Plant, Andrew			Current Challenges and Trends in the Discovery of Agrochemicals	SCIENCE			English	Review							SCYTALONE DEHYDRATASE INHIBITORS; RICE BLAST FUNGICIDES; CROP PROTECTION; DESIGN; PATHOGEN; POTENT	Crop protection chemistry has come a long way from its "alchemic" beginnings in the late 19th century to a high-tech science that supports the sustainable production of food, feed, and fiber for a rapidly growing population. Cutting-edge developments in the design and synthesis of agrochemicals help to tackle today's challenges of weed and pest resistance, higher regulatory safety margins, and higher cost of goods with the invention of selective, environmentally benign, low use rate, and cost-effective active ingredients.	[Lamberth, Clemens; Jeanmart, Stephane; Luksch, Torsten; Plant, Andrew] Syngenta Crop Protect AG, Res Chem, CH-4332 Stein, Switzerland	Syngenta	Lamberth, C (corresponding author), Syngenta Crop Protect AG, Res Chem, Schaffhauserstr 101, CH-4332 Stein, Switzerland.	clemens.lamberth@syngenta.com						Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; Basarab GS, 1999, BIOORG MED CHEM LETT, V9, P1613, DOI 10.1016/S0960-894X(99)00247-4; Basarab GS, 2002, BIOORGAN MED CHEM, V10, P4143, DOI 10.1016/S0968-0896(02)00272-9; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Beffa R., 2004, Pflanzenschutz-Nachrichten Bayer, V57, P46; Benardeau A, 2009, BIOORG MED CHEM LETT, V19, P2468, DOI 10.1016/j.bmcl.2009.03.036; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blaser HU, 2002, ADV SYNTH CATAL, V344, P17, DOI 10.1002/1615-4169(200201)344:1<17::AID-ADSC17>3.0.CO;2-8; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bretschneider T, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P1108; Brewster W. K., 2012, 244 ACS NAT M PHIL P; Cantrell CL, 2012, J NAT PROD, V75, P1231, DOI 10.1021/np300024u; Chan DMT, 2005, BORONIC ACIDS: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS AND MEDICINE, P205, DOI 10.1002/3527606548.ch5; Charette A. B., 2001, ORG REACT, P1; Clarke ED, 2003, CHIMIA, V57, P731, DOI 10.2533/000942903777678641; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; Dinges J., 2012, BIOACTIVE HETEROCYCL, P155; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Hanagan M. A., 2011, 242 AM CHEM SOC ACS; Hao GF, 2012, J AM CHEM SOC, V134, P11168, DOI 10.1021/ja3001908; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holllingworth R. M., 2001, AGROCHEMICAL DISCOVE, P238; Hornberg A, 2007, BIOCHEMISTRY-US, V46, P4815, DOI 10.1021/bi0621361; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Jeschke P, 2012, MODERN METHODS CROP, P73, DOI DOI 10.1002/9783527655908.CH4; Jordan DB, 1999, BIOORG MED CHEM LETT, V9, P1607, DOI 10.1016/S0960-894X(99)00246-2; Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098; Kamoun S, 2002, CAN J PLANT PATHOL, V24, P6, DOI 10.1080/07060660109506963; Kar S, 2013, EXPERT OPIN DRUG DIS, V8, P245, DOI 10.1517/17460441.2013.761204; Klebe G, 2000, J MOL MED, V78, P269, DOI 10.1007/s001090000084; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Kurihara N, 1998, W S AGROCHEM PLANT, P1; Lamberth C., 2012, BIOACTIVE HETEROCYCL, P3; Lamberth C, 2007, NACHR CHEM, V55, P130; Lamberth C, 2009, BIOORGAN MED CHEM, V17, P4047, DOI 10.1016/j.bmc.2008.11.037; Lindell SD, 2009, BIOORGAN MED CHEM, V17, P4035, DOI 10.1016/j.bmc.2009.03.027; Lopez-Ramos M, 2010, J CHEM INF MODEL, V50, P801, DOI 10.1021/ci900498n; LUNDQVIST T, 1994, STRUCTURE, V2, P937, DOI 10.1016/S0969-2126(94)00095-6; McCann SF, 2001, PEST MANAG SCI, V57, P153, DOI 10.1002/1526-4998(200102)57:2<153::AID-PS288>3.0.CO;2-O; McCann SF, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P1257; McDougall P., 2012, ABIM ANN BIOC IND M; Muller U, 2002, PURE APPL CHEM, V74, P2241, DOI 10.1351/pac200274122241; Nakao T, 2013, INSECT BIOCHEM MOLEC, V43, P366, DOI 10.1016/j.ibmb.2013.02.002; Okada K, 2002, PLANTA, V215, P339, DOI 10.1007/s00425-002-0762-0; Ort O, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P50; Phillips G, 2002, ORG PROCESS RES DEV, V6, P357, DOI 10.1021/op020206f; Pitterna T, 2009, BIOORGAN MED CHEM, V17, P4085, DOI 10.1016/j.bmc.2008.12.069; Plant A., 2010, AGROW SILVER JUBILEE, pXI; Rheinheimer J, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P627; Sauter H, 1999, ANGEW CHEM INT EDIT, V38, P1329, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1328::AID-ANIE1328>3.0.CO;2-1; Schleifer K.-J., 2007, PESTICIDE CHEM CROP, P77; Schnyder A, 2006, SYNLETT, P3167, DOI 10.1055/s-2006-944215; Smith SC, 2003, PESTIC OUTLOOK, V14, P21, DOI DOI 10.1039/b211205c; Sternberg JA, 2001, PEST MANAG SCI, V57, P143, DOI 10.1002/1526-4998(200102)57:2<143::AID-PS282>3.0.CO;2-8; Stetter J, 2000, ANGEW CHEM INT EDIT, V39, P1724, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1724::AID-ANIE1724>3.0.CO;2-5; Theodoridis G, 2006, ADV FLUORINE SCI, V2, P121, DOI 10.1016/S1872-0358(06)02004-5; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; Tice CM, 2002, PEST MANAG SCI, V58, P219, DOI 10.1002/ps.441; Tietjen K., 2012, MODERN METHODS CROP, P197; TOMBO GMR, 1991, ANGEW CHEM INT EDIT, V30, P1193, DOI 10.1002/anie.199111933; Varghese JN, 1999, DRUG DEVELOP RES, V46, P176, DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6; Walter H., 2012, BIOACTIVE HETEROCYCL, P175; Walter MW, 2002, NAT PROD REP, V19, P278, DOI 10.1039/b100919m; Wenger J, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P447; Winzenberg K. N., 1996, CHEM AUST, V63, P491; Witschel M., 2012, 244 ACS NAT M PHIL P; Witschel M, 2013, PEST MANAG SCI, V69, P559, DOI 10.1002/ps.3479; Witschel MC, 2011, ANGEW CHEM INT EDIT, V50, P7931, DOI 10.1002/anie.201102281; Yu LPC, 2010, P NATL ACAD SCI USA, V107, P22072, DOI 10.1073/pnas.1012039107; Zirngibl L., 1998, ANTIFUNGAL AZOLES	71	274	284	18	327	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					742	746		10.1126/science.1237227	http://dx.doi.org/10.1126/science.1237227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950530				2022-12-28	WOS:000323122200037
J	Ellison, GM; Vicinanza, C; Smith, AJ; Aquila, I; Leone, A; Waring, CD; Henning, BJ; Stirparo, GG; Papait, R; Scarfo, M; Agosti, V; Viglietto, G; Condorelli, G; Indolfi, C; Ottolenghi, S; Torella, D; Nadal-Ginard, B				Ellison, Georgina M.; Vicinanza, Carla; Smith, Andrew J.; Aquila, Iolanda; Leone, Angelo; Waring, Cheryl D.; Henning, Beverley J.; Stirparo, Giuliano Giuseppe; Papait, Roberto; Scarfo, Marzia; Agosti, Valter; Viglietto, Giuseppe; Condorelli, Gianluigi; Indolfi, Ciro; Ottolenghi, Sergio; Torella, Daniele; Nadal-Ginard, Bernardo			Adult c-kit(pos) Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair	CELL			English	Article							PROGENITOR CELLS; SELF-RENEWAL; HEART; EXPRESSION; CARDIOMYOCYTES; DIFFERENTIATION; CARDIOMYOPATHY; MYOCARDIUM; PRECURSORS; INFARCTION	The epidemic of heart failure has stimulated interest in understanding cardiac regeneration. Evidence has been reported supporting regeneration via transplantation of multiple cell types, as well as replication of postmitotic cardiomyocytes. In addition, the adult myocardium harbors endogenous c-kit(pos) cardiac stem cells (eCSCs), whose relevance for regeneration is controversial. Here, using different rodent models of diffuse myocardial damage causing acute heart failure, we show that eCSCs restore cardiac function by regenerating lost cardiomyocytes. Ablation of the eCSC abolishes regeneration and functional recovery. The regenerative process is completely restored by replacing the ablated eCSCs with the progeny of one eCSC. eCSCs recovered from the host and recloned retain their regenerative potential in vivo and in vitro. After regeneration, selective suicide of these exogenous CSCs and their progeny abolishes regeneration, severely impairing ventricular performance. These data show that c-kit(pos) eCSCs are necessary and sufficient for the regeneration and repair of myocardial damage.	[Ellison, Georgina M.; Vicinanza, Carla; Waring, Cheryl D.; Henning, Beverley J.; Torella, Daniele; Nadal-Ginard, Bernardo] Liverpool John Moores Univ, Stem Cell & Regenerat Biol Unit BioStem, Liverpool L3 3AF, Merseyside, England; [Ellison, Georgina M.; Vicinanza, Carla; Aquila, Iolanda; Leone, Angelo; Indolfi, Ciro; Torella, Daniele] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Lab Mol & Cellular Cardiol, I-88100 Catanzaro, Italy; [Agosti, Valter; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Mol Oncol Lab, I-88100 Catanzaro, Italy; [Agosti, Valter; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, CIS Genom & Mol Pathol, I-88100 Catanzaro, Italy; [Ellison, Georgina M.; Smith, Andrew J.; Nadal-Ginard, Bernardo] Kings Coll London, Sch Biomed Sci, Ctr Human & Aerosp Physiol Sci, London SE1 1UL, England; [Ellison, Georgina M.; Smith, Andrew J.; Nadal-Ginard, Bernardo] Kings Coll London, Ctr Stem Cells & Regenerat Med, London SE1 1UL, England; [Stirparo, Giuliano Giuseppe; Papait, Roberto; Condorelli, Gianluigi] Humanitas Clin & Res Ctr, I-20098 Rozzano Milan, Italy; [Papait, Roberto; Condorelli, Gianluigi] Natl Res Council Italy CNR, Inst Genet & Biomed Res, I-20098 Rozzano Milan, Italy; [Scarfo, Marzia; Viglietto, Giuseppe] IRGS Biogem, I-83031 Avellino, Italy; [Condorelli, Gianluigi] Univ Milan, I-20098 Milan, Italy; [Ottolenghi, Sergio] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy	Liverpool John Moores University; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of London; King's College London; University of London; King's College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Milan; University of Milano-Bicocca	Torella, D (corresponding author), Liverpool John Moores Univ, Stem Cell & Regenerat Biol Unit BioStem, Liverpool L3 3AF, Merseyside, England.	dtorella@unicz.it; bernardo.nadalginard@kcl.ac.uk	Papait, Roberto/AAB-8291-2022; Ellison-Hughes, Georgina M./B-4597-2016; VICINANZA, CARLA/ABF-9921-2020; Viglietto, Giuseppe/AAC-2852-2019; Aquila, Iolanda/AAC-2417-2022; Papait, Roberto/AAC-7659-2022; Condorelli, Gianluigi/Q-6736-2017	Ellison-Hughes, Georgina M./0000-0002-2733-3361; VICINANZA, CARLA/0000-0001-8660-6668; Viglietto, Giuseppe/0000-0003-2327-7515; Aquila, Iolanda/0000-0001-5096-9424; Papait, Roberto/0000-0002-9552-8259; AGOSTI, Valter/0000-0001-6785-093X; TORELLA, Daniele/0000-0002-4915-5084; Stirparo, Giuliano/0000-0002-5911-8682; INDOLFI, Ciro/0000-0003-1241-6487; Smith, Andrew/0000-0001-7283-5611; Condorelli, Gianluigi/0000-0003-0481-6843; Cottle, Beverley/0000-0001-5751-1328	CARE-MI FP7 [Health-F5-2010-242038]; Endostem FP7 [Health F5-2010-241440]; Marie Curie International Reintegration FP7 Grant [PIRG02-GA-2007-224853]; FIRB-Futuro-in-Ricerca [RBFR081CCS]; Italian Ministry of Health [GR-2008-1142673]; Associazione Italiana per la Ricerca sul Cancro (AIRC) MFAG; Istituto Superiore di Sanita [RF-CAL-2008-1261292]	CARE-MI FP7; Endostem FP7; Marie Curie International Reintegration FP7 Grant; FIRB-Futuro-in-Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC) MFAG; Istituto Superiore di Sanita	This work was supported by grants from the CARE-MI FP7 (Health-F5-2010-242038), Endostem FP7 (Health F5-2010-241440) large-scale collaborative projects, Marie Curie International Reintegration FP7 Grant (PIRG02-GA-2007-224853), FIRB-Futuro-in-Ricerca (RBFR081CCS), Italian Ministry of Health (GR-2008-1142673), Associazione Italiana per la Ricerca sul Cancro (AIRC) MFAG-2008, and Istituto Superiore di Sanita (RF-CAL-2008-1261292). We sincerely thank Tammie Bishop (University of Oxford) and Ludwig Thierfelder (Max-Delbrueck Center for Molecular Medicine) for providing the MerCreMer mice; Edmondo Battista and Filippo Causa (Center for Advanced Biomaterials for Healthcare, Italian Institute of Technology and Interdisciplinary Research Center on Biomaterials, University Federico II) for their technical help in manufacturing the fibrin-based PEGylated hydrogel; and Aurora Nocera and Emilia Dora Giovannone (CIS of Genomics and Molecular Pathology, Magna Graecia University) for their excellent technical help in cardiomyocyte FACS sorting.	Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Cairns LA, 2003, BLOOD, V102, P3954, DOI 10.1182/blood-2003-04-1296; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Ellison Georgina M, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS52, DOI 10.1038/ncpcardio0773; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Ellison Georgina M, 2010, Front Biosci (Schol Ed), V2, P641; Guenechea G, 1999, BLOOD, V93, P1097, DOI 10.1182/blood.V93.3.1097.403k04_1097_1105; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kajstura J, 2012, CIRCULATION, V126, P1869, DOI 10.1161/CIRCULATIONAHA.112.118380; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; Torella D, 2007, CELL MOL LIFE SCI, V64, P661, DOI 10.1007/s00018-007-6519-y; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Waring CD, 2014, EUR HEART J, V35, P2722, DOI 10.1093/eurheartj/ehs338; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9	38	387	402	0	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					827	842		10.1016/j.cell.2013.07.039	http://dx.doi.org/10.1016/j.cell.2013.07.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953114	Bronze			2022-12-28	WOS:000323202500014
J	Reichstein, M; Bahn, M; Ciais, P; Frank, D; Mahecha, MD; Seneviratne, SI; Zscheischler, J; Beer, C; Buchmann, N; Frank, DC; Papale, D; Rammig, A; Smith, P; Thonicke, K; van der Velde, M; Vicca, S; Walz, A; Wattenbach, M				Reichstein, Markus; Bahn, Michael; Ciais, Philippe; Frank, Dorothea; Mahecha, Miguel D.; Seneviratne, Sonia I.; Zscheischler, Jakob; Beer, Christian; Buchmann, Nina; Frank, David C.; Papale, Dario; Rammig, Anja; Smith, Pete; Thonicke, Kirsten; van der Velde, Marijn; Vicca, Sara; Walz, Ariane; Wattenbach, Martin			Climate extremes and the carbon cycle	NATURE			English	Article							PRECIPITATION MANIPULATION EXPERIMENTS; AGRICULTURAL SOIL-EROSION; EUROPE-WIDE REDUCTION; TREE MORTALITY; FIRE EMISSIONS; DIOXIDE UPTAKE; ICE STORMS; LAND-USE; FOREST; DROUGHT	The terrestrial biosphere is a key component of the global carbon cycle and its carbon balance is strongly influenced by climate. Continuing environmental changes are thought to increase global terrestrial carbon uptake. But evidence is mounting that climate extremes such as droughts or storms can lead to a decrease in regional ecosystem carbon stocks and therefore have the potential to negate an expected increase in terrestrial carbon uptake. Here we explore the mechanisms and impacts of climate extremes on the terrestrial carbon cycle, and propose a pathway to improve our understanding of present and future impacts of climate extremes on the terrestrial carbon budget.	[Reichstein, Markus; Frank, Dorothea; Mahecha, Miguel D.; Zscheischler, Jakob; Beer, Christian] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Bahn, Michael] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Ciais, Philippe] UVSQ, CNRS, CEA, IPSL,Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Seneviratne, Sonia I.; Zscheischler, Jakob; Buchmann, Nina] ETH, CH-8092 Zurich, Switzerland; [Zscheischler, Jakob] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany; [Beer, Christian] Stockholm Univ, Dept Appl Environm Sci ITM, S-10691 Stockholm, Sweden; [Beer, Christian] Bert Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Frank, David C.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Frank, David C.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Papale, Dario] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst DIBAF, I-01100 Viterbo, Italy; [Rammig, Anja; Thonicke, Kirsten] Potsdam Inst Climate Impact Res PIK, D-14773 Potsdam, Germany; [Smith, Pete] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [van der Velde, Marijn] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Vicca, Sara] Univ Antwerp, Dept Biol, Res Grp Plant & Vegetat Ecol, B-2610 Antwerp, Belgium; [Walz, Ariane] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany; [Wattenbach, Martin] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, Sect Hydrol 5 4, D-14473 Potsdam, Germany	Max Planck Society; University of Innsbruck; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Stockholm University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Tuscia University; Potsdam Institut fur Klimafolgenforschung; University of Aberdeen; International Institute for Applied Systems Analysis (IIASA); University of Antwerp; University of Potsdam; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Reichstein, M (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	markus.reichstein@bgc-jena.mpg.de	Frank, David/C-7764-2013; Seneviratne, Sonia I./G-8761-2011; Reichstein, Markus/A-7494-2011; Vicca, Sara/I-3637-2012; Ciais, Philippe/A-6840-2011; Zscheischler, Jakob/ABE-7324-2021; Smith, Pete/G-1041-2010; Walz, Ariane/F-1517-2013; Beer, Christian/D-2296-2013; Papale, Dario/W-7302-2019; Buchmann, Nina/E-6095-2011; Mahecha, Miguel D/F-2443-2010; Bahn, Michael/I-3536-2013; van der Velde, Marijn/B-3305-2009; Wattenbach, Martin/D-1482-2013	Seneviratne, Sonia I./0000-0001-9528-2917; Reichstein, Markus/0000-0001-5736-1112; Vicca, Sara/0000-0001-9812-5837; Ciais, Philippe/0000-0001-8560-4943; Zscheischler, Jakob/0000-0001-6045-1629; Smith, Pete/0000-0002-3784-1124; Walz, Ariane/0000-0001-5616-4424; Beer, Christian/0000-0002-5377-3344; Papale, Dario/0000-0001-5170-8648; Buchmann, Nina/0000-0003-0826-2980; Mahecha, Miguel D/0000-0003-3031-613X; Bahn, Michael/0000-0001-7482-9776; van der Velde, Marijn/0000-0002-9103-7081; Rammig, Anja/0000-0001-5425-8718; Frank, David/0000-0001-5463-5640; Wattenbach, Martin/0000-0002-1843-1031	European Community [FP7-ENV-2008-1-226701]; Royal Society-Wolfson Research Merit Award; Austrian Science Fund (FWF) [P 22214] Funding Source: researchfish	European Community(European Commission); Royal Society-Wolfson Research Merit Award(Royal Society of London); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work emerged from the CARBO-Extreme project, funded by the European Community's Seventh Framework Programme under grant agreement (FP7-ENV-2008-1-226701). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups (listed in the reference annotation to ref. 4 of this paper) for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. J.Z. is part of the International Max Planck Research School for Global Biogeochemical Cycles. P.S. is a Royal Society-Wolfson Research Merit Award holder. S.V. is a postdoctoral research associate of the Fund for Scientific Research-Flanders. M.B. acknowledges the Austrian Science Fund (FWF).	Adams H. D., 2010, EOS T AM GEOPHYS UN, V91, P153, DOI DOI 10.1029/2010EO170003; Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Alencar A, 2006, EARTH INTERACT, V10; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Arnone JA, 2008, NATURE, V455, P383, DOI 10.1038/nature07296; Aubinet M, 2009, AGR FOREST METEOROL, V149, P407, DOI 10.1016/j.agrformet.2008.09.003; Babst F, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045705; Baldocchi D., 2012, EOS T AM GEOPHYS UN, V93, P217, DOI [10.1029/2012EO230001, DOI 10.1029/2012EO230001]; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Chambers JQ, 2007, SCIENCE, V318, P1107, DOI 10.1126/science.1148913; Changnon SA, 1999, B AM METEOROL SOC, V80, P1819, DOI 10.1175/1520-0477(1999)080<1819:IOENOG>2.0.CO;2; Changnon SA, 2003, J APPL METEOROL, V42, P630, DOI 10.1175/1520-0450(2003)042<0630:COISIT>2.0.CO;2; Chen GS, 2012, CLIMATIC CHANGE, V114, P379, DOI 10.1007/s10584-012-0410-z; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Coles S., 2001, INTRO STAT MODELING; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; De Boeck HJ, 2011, BIOGEOSCIENCES, V8, P1121, DOI 10.5194/bg-8-1121-2011; De Boeck HJ, 2011, NEW PHYTOL, V189, P806, DOI 10.1111/j.1469-8137.2010.03515.x; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/NCLIMATE1368, 10.1038/nclimate1368]; Dinsmore KJ, 2010, GLOBAL CHANGE BIOL, V16, P2750, DOI 10.1111/j.1365-2486.2009.02119.x; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fuhrer J, 2006, CLIMATIC CHANGE, V79, P79, DOI 10.1007/s10584-006-9106-6; Ghil M, 2011, NONLINEAR PROC GEOPH, V18, P295, DOI 10.5194/npg-18-295-2011; Gilgen AK, 2009, BIOGEOSCIENCES, V6, P2525, DOI 10.5194/bg-6-2525-2009; Goebel MO, 2011, GLOBAL CHANGE BIOL, V17, P2640, DOI 10.1111/j.1365-2486.2011.02414.x; Granier A, 2007, AGR FOREST METEOROL, V143, P123, DOI 10.1016/j.agrformet.2006.12.004; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Irland LC, 2000, SCI TOTAL ENVIRON, V262, P231, DOI 10.1016/S0048-9697(00)00525-8; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jung BJ, 2012, J HYDROL, V440, P90, DOI 10.1016/j.jhydrol.2012.03.030; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kanamori H, 2005, ANNU REV EARTH PL SC, V33, P195, DOI 10.1146/annurev.earth.33.092203.122626; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lindroth A, 2009, GLOBAL CHANGE BIOL, V15, P346, DOI 10.1111/j.1365-2486.2008.01719.x; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Luyssaert S, 2012, BIOGEOSCIENCES, V9, P3357, DOI 10.5194/bg-9-3357-2012; Marcolla B, 2011, AGR FOREST METEOROL, V151, P1233, DOI 10.1016/j.agrformet.2011.04.015; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Muhr J, 2009, GLOBAL CHANGE BIOL, V15, P782, DOI 10.1111/j.1365-2486.2008.01695.x; Negron-Juarez R, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001221; Negron-Juarez RI, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043733; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Niall S, 2005, INT J CLIMATOL, V25, P1933, DOI 10.1002/joc.1233; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paris J.-D., 2012, EGU GEN ASS C; Peters W, 2010, GLOBAL CHANGE BIOL, V16, P1317, DOI 10.1111/j.1365-2486.2009.02078.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Quinton JN, 2010, NAT GEOSCI, V3, P311, DOI [10.1038/NGEO838, 10.1038/ngeo838]; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Rosenzweig C, 2002, GLOBAL ENVIRON CHANG, V12, P197, DOI 10.1016/S0959-3780(02)00008-0; Sanchez JL, 1996, J APPL METEOROL, V35, P1535, DOI 10.1175/1520-0450(1996)035<1535:CDTHSF>2.0.CO;2; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schiermeier Q, 2010, NATURE, V463, P284, DOI 10.1038/463284a; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Schwalm CR, 2010, GLOBAL CHANGE BIOL, V16, P657, DOI 10.1111/j.1365-2486.2009.01991.x; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Simelton E, 2011, FOOD SECUR, V3, P35, DOI 10.1007/s12571-011-0114-7; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; SPERRY JS, 1992, PLANT PHYSIOL, V100, P605, DOI 10.1104/pp.100.2.605; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Sun Y, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035702; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; van der Velde M, 2010, AGR ECOSYST ENVIRON, V135, P90, DOI 10.1016/j.agee.2009.08.017; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Vicca S, 2012, NEW PHYTOL, V195, P518, DOI 10.1111/j.1469-8137.2012.04224.x; Wang XB, 2006, CATENA, V66, P221, DOI 10.1016/j.catena.2006.02.006; Wang YF, 2011, SCI TOTAL ENVIRON, V410, P182, DOI 10.1016/j.scitotenv.2011.09.067; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Yu ZC, 2012, BIOGEOSCIENCES, V9, P4071, DOI 10.5194/bg-9-4071-2012; Zavalloni C, 2008, PLANT SOIL, V308, P119, DOI 10.1007/s11104-008-9612-6; Zeng HC, 2009, P NATL ACAD SCI USA, V106, P7888, DOI 10.1073/pnas.0808914106; Zhao YX, 2005, CLIMATIC CHANGE, V70, P73, DOI 10.1007/s10584-005-5938-8; Zheng BY, 2012, GLOBAL CHANGE BIOL, V18, P2899, DOI 10.1111/j.1365-2486.2012.02724.x; Zscheischler J, 2013, ECOL INFORM, V15, P66, DOI 10.1016/j.ecoinf.2013.03.004	99	1018	1072	129	1552	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					287	295		10.1038/nature12350	http://dx.doi.org/10.1038/nature12350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23955228				2022-12-28	WOS:000323112400023
J	Rando, TA; Finkel, T				Rando, Thomas A.; Finkel, Toren			Cardiac Aging and Rejuvenation A Sense of Humors?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rando, Thomas A.] Stanford Univ, Stanford, CA 94305 USA; [Finkel, Toren] NHLBI, NIH, Bethesda, MD 20892 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rando, TA (corresponding author), Stanford Univ, Stanford, CA 94305 USA.			Rando, Thomas/0000-0001-5843-8564	NIA NIH HHS [R37 AG023806, P01 AG036695, R01 AG047820] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R01AG047820, R37AG023806] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	5	12	12	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					575	576		10.1056/NEJMcibr1306063	http://dx.doi.org/10.1056/NEJMcibr1306063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	23924010				2022-12-28	WOS:000322842000016
J	Eskandarian, HA; Impens, F; Nahori, MA; Soubigou, G; Coppee, JY; Cossart, P; Hamon, MA				Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Soubigou, Guillaume; Coppee, Jean-Yves; Cossart, Pascale; Hamon, Melanie A.			A Role for SIRT2-Dependent Histone H3K18 Deacetylation in Bacterial Infection	SCIENCE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; IFN-GAMMA; SIRT2; CHROMATIN; ACETYLATION; SIRTUINS; PATTERNS; TARGETS; IDENTIFICATION	Pathogens dramatically affect host cell transcription programs for their own profit during infection, but in most cases, the underlying mechanisms remain elusive. We found that during infection with the bacterium Listeria monocytogenes, the host deacetylase sirtuin 2 (SIRT2) translocates to the nucleus, in a manner dependent on the bacterial factor InlB. SIRT2 associates with the transcription start site of a subset of genes repressed during infection and deacetylates histone H3 on lysine 18 (H3K18). Infecting cells in which SIRT2 activity was blocked or using SIRT2(-/-) mice resulted in a significant impairment of bacterial infection. Thus, SIRT2-mediated H3K18 deacetylation plays a critical role during infection, which reveals an epigenetic mechanism imposed by a pathogenic bacterium to reprogram its host.	[Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Cossart, Pascale; Hamon, Melanie A.] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Cossart, Pascale; Hamon, Melanie A.] INSERM, U604, F-75015 Paris, France; [Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Cossart, Pascale; Hamon, Melanie A.] INRA, Unite Contrat 2020, F-75015 Paris, France; [Impens, Francis] Univ Ghent VIB, Dept Med Prot Res, Ghent, Belgium; [Impens, Francis] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Soubigou, Guillaume; Coppee, Jean-Yves] Inst Pasteur, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr; hamon@pasteur.fr		Hamon, Melanie/0000-0001-5078-4083; Eskandarian, Haig Alexander/0000-0002-0610-0550; Marie-Anne, Nahori/0000-0002-4066-4528; Impens, Francis/0000-0003-2886-9616	Pasteur Institute; Inserm [U604]; Institut National de la Recherche Agronomique [USC2020]; Fondation Louis Jeantet; European Research Council [233348 MODELIST]; Fondation Le Roch Les Mousquetaires; Agence Nationale pour la Recherche; French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	Pasteur Institute; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Recherche Agronomique; Fondation Louis Jeantet; European Research Council(European Research Council (ERC)European Commission); Fondation Le Roch Les Mousquetaires; Agence Nationale pour la Recherche(French National Research Agency (ANR)); French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	We thank G. Dougan and S. Clare for their help with the Sirt2<SUP>tm1a(EUCOMM)</SUP> Wtsi mice, E. Verdin for providing the SIRT2N168 mutant, C. Becavin for his assistance with the heatmap, J. Chamot-Rooke and M. Duchateau for the use of the mass spectrometers, and K. Gevaert and B. Ruttens (VIB, Ghent University, Belgium) for providing N-hydroxysuccinimide propionate reagents. We extend a special thanks to A. Le for his time and effort during the summer of 2009. Work in the Cossart laboratory is funded by the Pasteur Institute, Inserm (U604), Institut National de la Recherche Agronomique (USC2020), the Fondation Louis Jeantet, the European Research Council (advanced grant 233348 MODELIST), the Fondation Le Roch Les Mousquetaires, and the Agence Nationale pour la Recherche grants (ERANET "LISTRESS" and EPILIS). We have received funding for this study from the French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant ANR-10-LABX-62-IBEID). H. A. E. is a doctoral student supported by the Fondation pour la Recherche Medicale, F. I. is a Postdoctoral Fellow of the Research Foundation Flanders (FWO-Vlaanderen), and P. C. is an international senior research scholar of the Howard Hughes Medical Institute. The transcriptome analysis data for this publication can be found in ArrayExpress with the accession number E-MEXP-3912.	Arbibe L, 2008, CELL MICROBIOL, V10, P1582, DOI 10.1111/j.1462-5822.2008.01170.x; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Black JC, 2008, MOL CELL, V32, P449, DOI 10.1016/j.molcel.2008.09.018; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia-Garcia JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000488; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; Rolando M, 2013, CELL HOST MICROBE, V13, P395, DOI 10.1016/j.chom.2013.03.004; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Staes A, 2011, NAT PROTOC, V6, P1130, DOI 10.1038/nprot.2011.355; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Van Damme Petra, 2013, Methods Mol Biol, V981, P115, DOI 10.1007/978-1-62703-305-3_9; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang Y, 2005, J IMMUNOL, V174, P5687, DOI 10.4049/jimmunol.174.9.5687; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zuo T, 2011, CANCER RES, V71, P1752, DOI 10.1158/0008-5472.CAN-10-3573	62	175	184	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					525	+	1238858	10.1126/science.1238858	http://dx.doi.org/10.1126/science.1238858			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908241				2022-12-28	WOS:000322586700046
J	Yang, XW; Cheng, C; Wang, YF; Qiu, L; Li, D				Yang, Xiaowei; Cheng, Chi; Wang, Yufei; Qiu, Ling; Li, Dan			Liquid-Mediated Dense Integration of Graphene Materials for Compact Capacitive Energy Storage	SCIENCE			English	Article							ELECTROCHEMICAL CAPACITORS; HIGH-PERFORMANCE; NEXT-GENERATION; CARBON; SUPERCAPACITORS; FILMS; ULTRACAPACITORS	Porous yet densely packed carbon electrodes with high ion-accessible surface area and low ion transport resistance are crucial to the realization of high-density electrochemical capacitive energy storage but have proved to be very challenging to produce. Taking advantage of chemically converted graphene's intrinsic microcorrugated two-dimensional configuration and self-assembly behavior, we show that such materials can be readily formed by capillary compression of adaptive graphene gel films in the presence of a nonvolatile liquid electrolyte. This simple soft approach enables subnanometer scale integration of graphene sheets with electrolytes to form highly compact carbon electrodes with a continuous ion transport network. Electrochemical capacitors based on the resulting films can obtain volumetric energy densities approaching 60 watt-hours per liter.	[Yang, Xiaowei; Cheng, Chi; Wang, Yufei; Qiu, Ling; Li, Dan] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia	Monash University	Li, D (corresponding author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.	dan.li2@monash.edu	Wang, Huanting/G-8399-2011; Cheng, Chi/AAC-1430-2019; Yang, Xiaowei/H-1188-2012; Qiu, Ling/K-2040-2012; Li, Dan/B-9316-2008	Wang, Huanting/0000-0002-9887-5555; Cheng, Chi/0000-0001-8596-1801; Yang, Xiaowei/0000-0002-4862-7422; Li, Dan/0000-0003-3461-5751	Australian Research Council	Australian Research Council(Australian Research Council)	The authors acknowledge the financial support from the Australian Research Council and G. P. Simon for helpful discussion. This work made use of the facilities at the Monash Centre for Electron Microscopy. D. L. and X.Y. filed an Australian provisional patent application (application no. 2013900820) on the basis of the work reported in this paper.	Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d; Burke A, 2007, ELECTROCHIM ACTA, V53, P1083, DOI 10.1016/j.electacta.2007.01.011; Cheng C, 2013, ADV MATER, V25, P13, DOI 10.1002/adma.201203567; Chmiola J, 2010, SCIENCE, V328, P480, DOI 10.1126/science.1184126; Conway BE, 2013, ELECTROCHEMICAL SUPE; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Huang X, 2012, ADV MATER, V24, P5979, DOI 10.1002/adma.201201587; Izadi-Najafabadi A, 2010, J AM CHEM SOC, V132, P18017, DOI 10.1021/ja108766y; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Linden D., 2001, HANDBOOK OF BATTERIE; Liu C, 2010, ADV MATER, V22, pE28, DOI 10.1002/adma.200903328; Luo JY, 2013, ACS NANO, V7, P1464, DOI 10.1021/nn3052378; Maier J, 2005, NAT MATER, V4, P805, DOI 10.1038/nmat1513; Miller JR, 2008, SCIENCE, V321, P651, DOI 10.1126/science.1158736; Miller JR, 2012, SCIENCE, V335, P1312, DOI 10.1126/science.1219134; Miller JR, 2010, SCIENCE, V329, P1637, DOI 10.1126/science.1194372; Murali S., 2013, NANO ENERGY, V2013; Pandolfo AG, 2006, J POWER SOURCES, V157, P11, DOI 10.1016/j.jpowsour.2006.02.065; Presser V, 2011, ADV FUNCT MATER, V21, P810, DOI 10.1002/adfm.201002094; Simon P, 2013, ACCOUNTS CHEM RES, V46, P1094, DOI 10.1021/ar200306b; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Sun YQ, 2011, ENERG ENVIRON SCI, V4, P1113, DOI 10.1039/c0ee00683a; Yang XW, 2011, ADV MATER, V23, P2833, DOI 10.1002/adma.201100261; Yang XW, 2011, ANGEW CHEM INT EDIT, V50, P7325, DOI 10.1002/anie.201100723; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770	28	1465	1507	51	1738	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					534	537		10.1126/science.1239089	http://dx.doi.org/10.1126/science.1239089			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908233				2022-12-28	WOS:000322586700049
J	MacArthur, BD; Lemischka, IR				MacArthur, Ben D.; Lemischka, Ihor R.			Statistical Mechanics of Pluripotency	CELL			English	Article							STEM-CELL; GROUND-STATE; NANOG; EXPRESSION; HETEROGENEITY; VARIABILITY; REVEALS; TRANSCRIPTION; EQUILIBRIUM; POPULATIONS		[MacArthur, Ben D.] Univ Southampton, Sch Math, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Southampton SO17 1BJ, Hants, England; [MacArthur, Ben D.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Lemischka, Ihor R.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, Dept Pharmacol & Syst Therapeut, Black Family Stem Cell Inst, New York, NY 10029 USA	University of Southampton; University of Southampton; Icahn School of Medicine at Mount Sinai	MacArthur, BD (corresponding author), Univ Southampton, Sch Math, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Southampton SO17 1BJ, Hants, England.	b.d.macarthur@soton.ac.uk		MacArthur, Ben/0000-0002-5396-9750				Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Efroni S, 2009, CELL CYCLE, V8, P43, DOI 10.4161/cc.8.1.7216; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Gardiner C., 2009, STOCHASTIC METHODS; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Liberali P, 2012, NAT CELL BIOL, V14, P1233, DOI 10.1038/ncb2648; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Marti M, 2013, NAT PROTOC, V8, P223, DOI 10.1038/nprot.2012.154; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pathria R. K., 1972, STAT MECH; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Schubert C, 2011, NATURE, V480, P133, DOI 10.1038/480133a; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Smith A, 2013, CELL STEM CELL, V13, P6, DOI 10.1016/j.stem.2013.06.016; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thomas MC, 2006, ELEMENTS INFORM THEO; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trott J, 2012, MOL BIOSYST, V8, P744, DOI 10.1039/c1mb05398a; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	53	107	109	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					484	489		10.1016/j.cell.2013.07.024	http://dx.doi.org/10.1016/j.cell.2013.07.024			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911316	Bronze			2022-12-28	WOS:000322629900004
J	Goto, A; Arah, OA; Goto, M; Terauchi, Y; Noda, M				Goto, Atsushi; Arah, Onyebuchi A.; Goto, Maki; Terauchi, Yasuo; Noda, Mitsuhiko			Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-DIABETES-ASSOCIATION; GLUCOSE CONTROL; INCREASED RISK; SENSITIVITY-ANALYSIS; TYPE-2; MORTALITY; MELLITUS; EVENTS; VETERANS; CANCER	Objectives To provide a systematic and quantitative summary of the association between severe hypoglycaemia and risk of cardiovascular disease in people with type 2 diabetes and to examine the sensitivity of the association to possible uncontrolled confounding by unmeasured comorbid severe illness using a bias analysis. Design Meta-analysis of observational studies. Data sources Medline, Embase, the Cochrane Library, and Web of Science databases were searched to February 2013, without any language restrictions. Eligibility criteria Two independent reviewers selected cohort studies that evaluated the association of severe hypoglycaemia with cardiovascular events in people with type 2 diabetes; we excluded studies from acute hospital settings. We extracted descriptive and quantitative data. Results Of 3443 citations screened, six eligible studies with 903 510 participants were identified. In the conventional random effects meta-analysis, severe hypoglycaemia was strongly associated with a higher risk of cardiovascular disease (relative risk 2.05, 95% confidence interval 1.74 to 2.42; P<0.001). The excess fraction of cardiovascular disease incidence that was attributable to severe hypoglycaemia (the population attributable fraction) was 1.56% (95% confidence interval 1.32% to 1.81%; P<0.001). Although moderate heterogeneity across the studies was suggested (I-2=73.1%; P=0.002 for heterogeneity), most subgroups showed similar results in stratified analyses. The bias analysis indicated that comorbid severe illness alone may not explain the association between hypoglycaemia and cardiovascular disease; to explain this association, comorbid severe illness would have had to be extremely strongly associated with both severe hypoglycaemia and cardiovascular disease. Conclusion Our findings suggest that severe hypoglycaemia is associated with a higher risk of cardiovascular disease; they also support the notion that avoiding severe hypoglycaemia may be important to prevent cardiovascular disease in people with type 2 diabetes.	[Goto, Atsushi; Goto, Maki; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Shinjuku Ku, Tokyo 1628655, Japan; [Goto, Atsushi; Goto, Maki; Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Arah, Onyebuchi A.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands	National Center for Global Health & Medicine - Japan; Yokohama City University; University of California System; University of California Los Angeles; University of Amsterdam; Academic Medical Center Amsterdam	Noda, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	mnoda@hosp.ncgm.go.jp	Noda, Mitsuhiko/W-3905-2019; Terauchi, Yasuo/AAO-4347-2020	Noda, Mitsuhiko/0000-0003-0413-4631; Arah, Onyebuchi/0000-0002-9067-1697	Ministry of Health, Labour and Welfare of Japan [H22-019, H25-016]; Veni career grant [916.96.059]; Netherlands Organization for Scientific Research	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Veni career grant; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was funded by health sciences research grants (comprehensive research on life-style related diseases including cardiovascular diseases and diabetes mellitus H22-019 and H25-016) from the Ministry of Health, Labour and Welfare of Japan. OAA has been supported by Veni career grant No 916.96.059 awarded by the Netherlands Organization for Scientific Research. The funders had no role in the study design, data collection, data analysis, data interpretation, writing of the report, or decision to submit the results.	Adler GK, 2009, DIABETES, V58, P360, DOI 10.2337/db08-1153; Arah OA, 2008, ANN EPIDEMIOL, V18, P637, DOI 10.1016/j.annepidem.2008.04.003; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonds DE, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-5; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; COLLIER A, 1990, DIABETIC MED, V7, P506, DOI 10.1111/j.1464-5491.1990.tb01432.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Duckworth WC, 2011, J DIABETES COMPLICAT, V25, P355, DOI 10.1016/j.jdiacomp.2011.10.003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng HP, 2012, EUR HEART J, V33, P180; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Greenland S, 2004, INT J EPIDEMIOL, V33, P1389, DOI 10.1093/ije/dyh276; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Gruden G, 2012, DIABETES CARE, V35, P1598, DOI 10.2337/dc11-1531; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Jin WL, 2011, DIABETOLOGIA, V54, P1921, DOI 10.1007/s00125-011-2141-5; Johnston SS, 2011, DIABETES CARE, V34, P1164, DOI 10.2337/dc10-1915; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McCandless LC, 2012, INT J BIOSTAT, V8, DOI 10.2202/1557-4679.1350; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; Mellbin LG, 2009, HEART, V95, P721, DOI 10.1136/hrt.2008.152835; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Noto H, 2011, ENDOCR PRACT, V17, P616, DOI 10.4158/EP10357.RA; Noto H, 2010, J DIABETES COMPLICAT, V24, P345, DOI 10.1016/j.jdiacomp.2010.06.004; Overeem K, 2007, MED EDUC, V41, P1039, DOI 10.1111/j.1365-2923.2007.02897.x; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rathmann W, 2013, DIABETES OBES METAB, V15, P55, DOI 10.1111/j.1463-1326.2012.01674.x; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Zhao Y, 2011, VALUE HEALTH, V14, pA91, DOI 10.1016/j.jval.2011.02.513; Zhao YN, 2012, DIABETES CARE, V35, P1126, DOI 10.2337/dc11-2048; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	48	282	289	3	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4533	10.1136/bmj.f4533	http://dx.doi.org/10.1136/bmj.f4533			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900314	hybrid			2022-12-28	WOS:000322821500003
J	Qian, Q; Wang, HY				Qian, Qi; Wang, Hai Yan			ALADIN: wish granted in inherited polycystic kidney disease?	LANCET			English	Editorial Material							LONG-ACTING SOMATOSTATIN; OCTREOTIDE; SAFETY		[Qian, Qi] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA; [Wang, Hai Yan] Peking Univ, Inst Nephrol, Dept Med, Div Nephrol,Hosp 1, Beijing 100034, Peoples R China	Mayo Clinic; Peking University	Wang, HY (corresponding author), Peking Univ, Inst Nephrol, Dept Med, Div Nephrol,Hosp 1, Beijing 100034, Peoples R China.	why@bjmu.edu.cn			NIDDK NIH HHS [P30 DK090728] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090728] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhandari S, 2008, J HISTOCHEM CYTOCHEM, V56, P733, DOI 10.1369/jhc.2008.950998; Caroli A, 2013, LANCET; Caroli A, 2010, CLIN J AM SOC NEPHRO, V5, P783, DOI 10.2215/CJN.05380709; CATNACH SM, 1993, GUT, V34, P270, DOI 10.1136/gut.34.2.270; Chen TL, 2000, J CLIN PHARMACOL, V40, P475, DOI 10.1177/00912700022009242; Corleto VD, 2000, ANN ONCOL, V11, P491, DOI 10.1023/A:1008398431246; Hofland LJ, 2003, ENDOCR REV, V24, P28, DOI 10.1210/er.2000-0001; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qian Q, 2008, J AM SOC NEPHROL, V19, P631, DOI 10.1681/ASN.2007050626; REISINE T, 1995, NEUROSCIENCE, V67, P777, DOI 10.1016/0306-4522(95)00072-Q; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x	14	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1469	1471		10.1016/S0140-6736(13)61541-X	http://dx.doi.org/10.1016/S0140-6736(13)61541-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	23972262	Green Accepted			2022-12-28	WOS:000326622500009
J	Liem, S; Schuit, E; Hegeman, M; Bais, J; de Boer, K; Bloemenkamp, K; Brons, J; Duvekot, H; Bijvank, BN; Franssen, M; Gaugler, I; de Graaf, I; Oudijk, M; Papatsonis, D; Pernet, P; Porath, M; Scheepers, L; Sikkema, M; Sporken, J; Visser, H; van Wijngaarden, W; Woiski, M; van Pampus, M; Mol, BW; Bekedam, D				Liem, Sophie; Schuit, Ewoud; Hegeman, Maud; Bais, Joke; de Boer, Karin; Bloemenkamp, Kitty; Brons, Jozien; Duvekot, Hans; Bijvank, Bas Nij; Franssen, Maureen; Gaugler, Ingrid; de Graaf, Irene; Oudijk, Martijn; Papatsonis, Dimitri; Pernet, Paula; Porath, Martina; Scheepers, Liesbeth; Sikkema, Marko; Sporken, Jan; Visser, Harry; van Wijngaarden, Wim; Woiski, Mallory; van Pampus, Marille; Mol, Ben Willem; Bekedam, Dick			Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial	LANCET			English	Article							DOUBLE-BLIND; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; VAGINAL PROGESTERONE; CERCLAGE PESSARY; MUCUS PLUG; RISK; INCOMPETENCE; SINGLETON; OUTCOMES; INFANTS	Background In women with a multiple pregnancy, spontaneous preterm delivery is the leading cause of perinatal morbidity and mortality. Interventions to reduce preterm birth in these women have not been successful. We assessed whether a cervical pessary could effectively prevent poor perinatal outcomes. Methods We undertook a multicentre, open-label randomised controlled trial in 40 hospitals in the Netherlands. We randomly assigned women with a multiple pregnancy between 12 and 20 weeks' gestation (1: 1) to pessary or control groups, using a web-based application with a computer-generated list with random block sizes of two to four, stratified by hospital. Participants and investigators were aware of group allocation. For women in the pessary group, a midwife or obstetrician inserted a cervical pessary between 16 and 20 weeks' gestation. Women in the control group did not receive the pessary, but otherwise received similar obstetrical care to those in the pessary group. The primary outcome was a composite of poor perinatal outcome: stillbirth, periventricular leucomalacia, severe respiratory distress syndrome, bronchopulmonary dysplasia, intraventricular haemorrhage, necrotising enterocolitis, proven sepsis, and neonatal death. Analyses were by modified intention to treat. This trial is registered in the Dutch trial registry, number NTR1858. Findings Between Sept 21, 2009, and March 9, 2012, 813 women underwent randomisation, of whom 808 were analysed (401 in the pessary group; 407 in the control group). At least one child of 53 women (13%) in the pessary group had poor perinatal outcome, compared with 55 (14%) in the control group (relative risk 0.98, 95% CI 0.69-1.39). Interpretation In unselected women with a multiple pregnancy, prophylactic use of a cervical pessary does not reduce poor perinatal outcome.	[Liem, Sophie; Hegeman, Maud; Mol, Ben Willem] Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; [Schuit, Ewoud] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Oudijk, Martijn] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Bais, Joke] Med Ctr Alkmaar, Alkmaar, Netherlands; [de Boer, Karin] Hosp Rijnstate, Arnhem, Netherlands; [Bloemenkamp, Kitty] Leiden Univ Med Ctr, Leiden, Netherlands; [Brons, Jozien] Med Spectrum Twente, Obstet & Gynaecol, Enschede, Netherlands; [Duvekot, Hans] Erasmus MC, Rotterdam, Netherlands; [Bijvank, Bas Nij] Isala Clin, Zwolle, Netherlands; [Franssen, Maureen] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Gaugler, Ingrid] Jeroen Bosch Hosp, Shertogenbosch, Netherlands; [de Graaf, Irene] Spaarne Hosp, Hoofddorp, Netherlands; [Papatsonis, Dimitri] Amphia Hosp, Breda, Netherlands; [Pernet, Paula] Kennemer Gasthuis, Haarlem, Netherlands; [Porath, Martina] Maxima Med Ctr, Veldhoven, Netherlands; [Scheepers, Liesbeth] Univ Limburg, Acad Hosp Maastricht, Maastricht, Netherlands; [Sikkema, Marko] Hosp Grp Twente, Almelo, Netherlands; [Sporken, Jan] Canisius Wilhelmina Hosp, Nijmegen, Netherlands; [Visser, Harry] Tergooi Hosp, Blaricum, Netherlands; [van Wijngaarden, Wim] Bronovo Hosp, The Hague, Netherlands; [Woiski, Mallory] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Pampus, Marille; Bekedam, Dick] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Medical Center Of Alkmaar; Rijnstate Hospital; Leiden University; Leiden University Medical Center (LUMC); Medical Spectrum Twente; Erasmus University Rotterdam; Erasmus MC; Isala Clinics; University of Groningen; Jeroen Bosch Ziekenhuis; Spaarne Hospital; Amphia Hospital; Spaarne Hospital; Maxima Medical Center; Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Canisius-Wilhelmina Hospital; Tergooi Blaricum; Haaglanden Medical Center; Bronovo Hospital; Radboud University Nijmegen; Onze Lieve Vrouwe Gasthuis Hospital	Liem, S (corresponding author), Acad Med Ctr, Postbox 22770, NL-1100 DE Amsterdam, Netherlands.	s.m.liem@amc.uva.nl	Woiski, Mallory D/AAN-6632-2021; Schuit, Ewoud/N-1869-2014; Oudijk, Martijn A/C-1520-2019; Woiski, Mallory D/L-4763-2015; Mol, Ben/I-4526-2012	Woiski, Mallory D/0000-0002-7553-5929; Schuit, Ewoud/0000-0002-9548-3214; Oudijk, Martijn A/0000-0001-8672-4365; Woiski, Mallory D/0000-0002-7553-5929; van Pampus, Maria/0000-0002-3020-8908	The Netherlands Organisation for Health Research and Development	The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The Netherlands Organisation for Health Research and Development.	Acharya Ganesh, 2006, Archives of Gynecology and Obstetrics, V273, P283, DOI 10.1007/s00404-005-0082-2; Antczak-Judycka Agnieszka, 2003, Ginekol Pol, V74, P1029; Arabin B, 2003, J PERINAT MED, V31, P122, DOI 10.1515/JPM.2003.017; Becher N, 2009, ACTA OBSTET GYN SCAN, V88, P502, DOI 10.1080/00016340902852898; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Crowther CA, 2000, COCHRANE DB SYST REV, V2; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; DeFranco EA, 2007, ULTRASOUND OBST GYN, V30, P697, DOI 10.1002/uog.5159; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Dutch Society of Obstetrics and Gynaecology, 2011, MULT PREGN GUID VERS; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; FORSTER F, 1986, ZBL GYNAKOL, V108, P230; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; Giedion A, 1973, Pediatr Radiol, V1, P145, DOI 10.1007/BF00974058; GMOSER G, 1991, Gynaekologische Rundschau, V31, P117; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Hegeman MA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-44; Hein M, 2001, AM J OBSTET GYNECOL, V185, P586, DOI 10.1067/mob.2001.116685; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Hui SYA, 2013, AM J PERINAT, V30, P283, DOI 10.1055/s-0032-1322550; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kimber-Trojnar Z, 2010, J MATERN-FETAL NEO M, V23, P1493, DOI 10.3109/14767051003678093; Liem SMS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-37; Lim AC, 2011, OBSTET GYNECOL, V118, P513, DOI 10.1097/AOG.0b013e31822ad6aa; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; McGreevy KM, 2009, CLIN CHEM, V55, P165, DOI 10.1373/clinchem.2008.106260; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OSTER S, 1966, OBSTET GYNECOL, V28, P206; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; QUAAS L, 1990, GEBURTSH FRAUENHEILK, V50, P429, DOI 10.1055/s-2008-1026276; Roman AS, 2005, J ULTRAS MED, V24, P763, DOI 10.7863/jum.2005.24.6.763; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Schaaf JM, 2011, BJOG-INT J OBSTET GY, V118, P1196, DOI 10.1111/j.1471-0528.2011.03010.x; Sieroszewski P, 2009, J MATERN-FETAL NEO M, V22, P469, DOI 10.1080/14767050802531748; VITSKY M, 1961, AM J OBSTET GYNECOL, V81, P1194, DOI 10.1016/S0002-9378(15)33352-4	42	135	148	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1341	1349		10.1016/S0140-6736(13)61408-7	http://dx.doi.org/10.1016/S0140-6736(13)61408-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23924878				2022-12-28	WOS:000325975700024
J	Beronja, S; Janki, P; Heller, E; Lien, WH; Keyes, BE; Oshimori, N; Fuchs, E				Beronja, Slobodan; Janki, Peter; Heller, Evan; Lien, Wen-Hui; Keyes, Brice E.; Oshimori, Naoki; Fuchs, Elaine			RNAi screens in mice identify physiological regulators of oncogenic growth	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; STEM-CELLS; EPIDERMAL DIFFERENTIATION; CANCER-CELLS; MOUSE SKIN; TGF-BETA; LEUKEMIA; HOMEOSTASIS; ACTIVATION	Tissue growth is the multifaceted outcome of a cell's intrinsic capabilities and its interactions with the surrounding environment. Decoding these complexities is essential for understanding human development and tumorigenesis. Here we tackle this problem by carrying out the first genome-wide RNA-interference-mediated screens in mice. Focusing on skin development and oncogenic (Hras(G12V)-induced) hyperplasia, our screens uncover previously unknown as well as anticipated regulators of embryonic epidermal growth. Among the top oncogenic screen hits are Mllt6 and the Wnt effector beta-catenin, which maintain Hras(G12V)-dependent hyperproliferation. We also expose beta-catenin as an unanticipated antagonist of normal epidermal growth, functioning through Wnt-independent intercellular adhesion. Finally, we validate functional significance in mouse and human cancers, thereby establishing the feasibility of in vivo mammalian genome-wide investigations to dissect tissue development and tumorigenesis. By documenting some oncogenic growth regulators, we pave the way for future investigations of other hits and raise promise for unearthing new targets for cancer therapies.	[Beronja, Slobodan; Janki, Peter; Heller, Evan; Lien, Wen-Hui; Keyes, Brice E.; Oshimori, Naoki; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Lien, Wen-Hui/0000-0002-2282-3169; Beronja, Slobodan/0000-0002-6769-9261	NIH [R37-AR27883, K99-AR061469]; Emerald Foundation; Human Frontiers Science Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [K99CA178197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR061469, R37AR027883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Human Frontiers Science Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Fagin for inducible oncogenic Hras mice; S. Williams, M. Schober, A. Rodriguez Folgueras, S. Dewell and D. Schramek for intellectual input; D. Oristian and N. Stokes as mouse specialists; Comparative Bioscience Center (AAALAC accredited) for care of mice in accordance with National Institutes of Health (NIH) guidelines; Genomics Resource Center (C. Zhao, Director) for sequencing; Bioimaging Center (A. North, Director) for advice; Flow Cytometry facility (S. Mazel, Director) for FACS sorting. E. F. is an Investigator of the Howard Hughes Medical Institute. This research was supported by grants from the NIH (R37-AR27883(E. F.) and K99-AR061469 (S. B.)), Emerald Foundation (E. F.) and Human Frontiers Science Program Postdoctoral Fellowship (S.B.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Beronja Slobodan, 2013, Methods Mol Biol, V961, P351, DOI 10.1007/978-1-62703-227-8_23; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Donninger H, 2010, MOL CELL BIOL, V30, P2608, DOI 10.1128/MCB.00208-09; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Miyata Y, 2010, STEM CELLS, V28, P308, DOI 10.1002/stem.270; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; PRASAD R, 1994, P NATL ACAD SCI USA, V91, P8107, DOI 10.1073/pnas.91.17.8107; R Research Development Team, 2012, R LANG ENV STAT COMP; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	44	114	115	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					185	+		10.1038/nature12464	http://dx.doi.org/10.1038/nature12464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23945586	Green Accepted			2022-12-28	WOS:000324244900033
J	Maeda, K; Anand, K; Chiapparino, A; Kumar, A; Poletto, M; Kaksonen, M; Gavin, AC				Maeda, Kenji; Anand, Kanchan; Chiapparino, Antonella; Kumar, Arun; Poletto, Mattia; Kaksonen, Marko; Gavin, Anne-Claude			Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; MOLECULAR REPLACEMENT; GLOBAL ANALYSIS; YEAST; IDENTIFICATION; SEQUENCE; LOCALIZATION; ORGANIZATION; METABOLISM	The internal organization of eukaryotic cells into functionally specialized, membrane-delimited organelles of unique composition implies a need for active, regulated lipid transport. Phosphatidylserine (PS), for example, is synthesized in the endoplasmic reticulum and then preferentially associates-through mechanisms not fully elucidated-with the inner leaflet of the plasma membrane(1-3). Lipids can travel via transport vesicles. Alternatively, several protein families knownas lipid-transfer proteins (LTPs) can extract a variety of specific lipids from biological membranes and transport them, within a hydrophobic pocket, through aqueous phases(4-7). Here we report the development of an integrated approach that combines protein fractionation and lipidomics to characterize the LTP-lipid complexes formed in vivo. We applied the procedure to 13 LTPs in the yeast Saccharomyces cerevisiae: the six Sec14 homology (Sfh) proteins and the seven oxysterol-binding homology (Osh) proteins. We found that Osh6 and Osh7 have an unexpected specificity for PS. In vivo, they participate in PS homeostasis and the transport of this lipid to the plasma membrane. The structure of Osh6 bound to PS reveals unique features that are conserved among other metazoan oxysterol-binding proteins (OSBPs) and are required for PS recognition. Our findings represent the first direct evidence, to our knowledge, for the non-vesicular transfer of PS from its site of biosynthesis (the endoplasmic reticulum) to its site of biological activity (the plasma membrane). We describe a new subfamily of OSBPs, including human ORP5 and ORP10, that transfer PS and propose new mechanisms of action for a protein family that is involved in several human pathologies such as cancer, dyslipidaemia and metabolic syndrome.	[Maeda, Kenji; Anand, Kanchan; Chiapparino, Antonella; Kumar, Arun; Poletto, Mattia; Kaksonen, Marko; Gavin, Anne-Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Gavin, AC (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gavin@embl.de		KUMAR, ARUN/0000-0001-8706-8558; Kaksonen, Marko/0000-0003-3645-7689; Chiapparino, Antonella/0000-0001-6336-2736; Maeda, Kenji/0000-0002-9080-5691; Gavin, Anne-Claude/0000-0003-4917-2340	Federal Ministry of Education and Research (BMBF) [01GS0865]; European Molecular Biology Laboratory; EU Marie Curie Actions Interdisciplinary Postdoctoral Cofunded Programme; Marie Curie reintegration grant (ERG); Danish Natural Science Research Council [09-064986/FNU]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Molecular Biology Laboratory; EU Marie Curie Actions Interdisciplinary Postdoctoral Cofunded Programme; Marie Curie reintegration grant (ERG)(European Commission); Danish Natural Science Research Council(Danish Natural Science Research Council)	We are grateful to C. Schultz and C. Muller for inspiring comments on the manuscript, and to the EMBL Proteomics and the Protein Expression and Purification Core Facilities, E. M. Vilalta, V. Rybin, O. Gallego, M. Skruzny, A. Picco, S. Glatt, F. Voigt and A. Scholz for expert help and the sharing of reagents. The authors thank the beam line staff at the European Synchrotron Radiation Facility (ESRF), beam line ID23-1, Grenoble, France where crystallographic data collection was performed. We also thank C. Muller's group and other members of M.K.'s and A.-C.G.'s groups for continuous discussions and support. We are grateful to C. Boone, S. Emr and E. Hurt for sharing reagents. This work was partially funded by the Federal Ministry of Education and Research (BMBF; 01GS0865) in the framework of the IG-Cellular System genomics to A.-C.G.; A. K. is supported by the European Molecular Biology Laboratory and the EU Marie Curie Actions Interdisciplinary Postdoctoral Cofunded Programme. K. A. acknowledges support from Marie Curie reintegration grant (ERG). K. M. is supported by the Danish Natural Science Research Council (09-064986/FNU).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beh CT, 2001, GENETICS, V157, P1117; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Churchward Matthew A, 2008, J Chem Biol, V1, P79, DOI 10.1007/s12154-008-0007-1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Slaughter BD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2370; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200	52	222	230	3	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					257	+		10.1038/nature12430	http://dx.doi.org/10.1038/nature12430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23934110				2022-12-28	WOS:000324244900048
J	Bastien, FA; Stassun, KG; Basri, G; Pepper, J				Bastien, Fabienne A.; Stassun, Keivan G.; Basri, Gibor; Pepper, Joshua			An observational correlation between stellar brightness variations and surface gravity	NATURE			English	Article							SOLAR-LIKE OSCILLATIONS; KEPLER INPUT CATALOG; PHOTOMETRIC VARIABILITY; STARS; 1ST; ASTEROSEISMOLOGY; AMPLITUDES; MISSION; GIANTS; CLASSIFICATION	Surface gravity is a basic stellar property, but it is difficult to measure accurately, with typical uncertainties of 25 to 50 per cent if measured spectroscopically(1,2) and 90 to 150 per cent if measured photometrically(3). Asteroseismology measures gravity with an uncertainty of about 2 per cent but is restricted to relatively small samples of bright stars, most of which are giants(4-6). The availability of high-precision measurements of brightness variations for more than 150,000 stars(7,8) provides an opportunity to investigate whether the variations can be used to determine surface gravities. The Fourier power of granulation on a star's surface correlates physically with surface gravity(9,10): if brightness variations on timescales of hours arise from granulation(11), then such variations should correlate with surface gravity. Here we report an analysis of archival data that reveals an observational correlation between surface gravity and root mean squared brightness variations on timescales of less than eight hours for stars with temperatures of 4,500 to 6,750 kelvin, log surface gravities of 2.5 to 4.5 (cgs units) and overall brightness variations of less than three parts per thousand. A straightforward observation of optical brightness variations therefore allows a determination of the surface gravity with a precision of better than 25 per cent for inactive Sun-like stars at main-sequence to giant stages of evolution.	[Bastien, Fabienne A.; Stassun, Keivan G.; Pepper, Joshua] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Stassun, Keivan G.] Fisk Univ, Dept Phys, Nashville, TN 37208 USA; [Basri, Gibor] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Pepper, Joshua] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA	Vanderbilt University; Fisk University; University of California System; University of California Berkeley; Lehigh University	Bastien, FA (corresponding author), Vanderbilt Univ, Dept Phys & Astron, 1807 Stn B, Nashville, TN 37235 USA.	fabienne.a.bastien@vanderbilt.edu	Basri, Gibor B/Y-4048-2018	Stassun, Keivan/0000-0002-3481-9052; Pepper, Joshua/0000-0002-3827-8417	NASA; Vanderbilt Provost Graduate Fellowship; NSF PAARE [AST-0849736]	NASA(National Aeronautics & Space Administration (NASA)); Vanderbilt Provost Graduate Fellowship; NSF PAARE(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The research described in this paper makes use of Filtergraph (http://filtergraph.vanderbilt.edu), an online data visualization tool developed at Vanderbilt University through the Vanderbilt Initiative in Data-intensive Astrophysics. We acknowledge discussions with P. Cargile, K. Carpenter, W. Chaplin, D. Huber, M. Paegert, M. Sinha and D. Weintraub. We thank D. Huber and T. Metcalfe for sharing the average asteroseismic parameters of Kepler stars with us. F.A.B. acknowledges support from a NASA Harriet Jenkins Fellowship and a Vanderbilt Provost Graduate Fellowship. F.A.B. and K.G.S. acknowledge NSF PAARE grant AST-0849736.	Basri G, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/37; Basri G, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/1/20; Basri G, 2010, ASTROPHYS J LETT, V713, pL155, DOI 10.1088/2041-8205/713/2/L155; Bastien F. A., ASTRON J UNPUB; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; BROWN TM, 1994, ANNU REV ASTRON ASTR, V32, P37; BROWN TM, 1991, ASTROPHYS J, V368, P599, DOI 10.1086/169725; Burger D., 2013, ASTRON COMP IN PRESS; Chaplin WJ, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/1/L5; Chaplin WJ, 2011, SCIENCE, V332, P213, DOI 10.1126/science.1201827; Chaplin W. J., ANN REV AST IN PRESS; Chaplin WJ, 2000, MON NOT R ASTRON SOC, V313, P32, DOI 10.1046/j.1365-8711.2000.03176.x; Christensen-Dalsgaard J, 2004, SOL PHYS, V220, P137, DOI 10.1023/B:SOLA.0000031392.43227.7d; Dumusque X, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201014097; Frohlich C, 1997, SOL PHYS, V170, P1, DOI 10.1023/A:1004969622753; Ghezzi L, 2010, ASTROPHYS J, V720, P1290, DOI 10.1088/0004-637X/720/2/1290; Gilliland RL, 2008, ASTRON J, V136, P566, DOI 10.1088/0004-6256/136/2/566; Gilliland RL, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/6; Henry GW, 2000, ASTROPHYS J SUPPL S, V130, P201, DOI 10.1086/317346; Huber D, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/143; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; Kjeldsen H, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201116789; Komm RW, 2000, ASTROPHYS J, V531, P1094, DOI 10.1086/308518; Mathur S, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/119; Pinsonneault MH, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/30; Schroder C, 2009, ASTRON ASTROPHYS, V493, P1099, DOI 10.1051/0004-6361:200810377; Stello D, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/2/L41; Strassmeier KG, 2009, ASTRON ASTROPHYS REV, V17, P251, DOI 10.1007/s00159-009-0020-6; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500	30	91	91	7	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					427	430		10.1038/nature12419	http://dx.doi.org/10.1038/nature12419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969460	Green Submitted			2022-12-28	WOS:000323316100028
J	Djulbegovic, B; Kumar, A; Glasziou, P; Miladinovic, B; Chalmers, I				Djulbegovic, Benjamin; Kumar, Ambuj; Glasziou, Paul; Miladinovic, Branko; Chalmers, Iain			Trial unpredictability yields predictable therapy gains	NATURE			English	Editorial Material									[Djulbegovic, Benjamin; Kumar, Ambuj; Miladinovic, Branko] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA; [Djulbegovic, Benjamin; Kumar, Ambuj] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Glasziou, Paul] Bond Univ, Robina, Australia; [Chalmers, Iain] James Lind Initiat, Oxford, England	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Bond University	Djulbegovic, B (corresponding author), Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu	Kumar, Ambuj/U-5268-2019; Glasziou, Paul/A-7832-2008; Miladinovic, Branko/I-4938-2012; Djulbegovic, Benjamin/I-3661-2012; KUMAR, ASHOK/AAF-4055-2021; Kumar, Ambuj/I-4940-2012	Glasziou, Paul/0000-0001-7564-073X; Miladinovic, Branko/0000-0002-7000-1258; Djulbegovic, Benjamin/0000-0003-0671-1447; KUMAR, ASHOK/0000-0002-9244-0622; 	NCI NIH HHS [R01 CA133594, R01 CA140408] Funding Source: Medline; NINDS NIH HHS [R01 NS044417, R01 NS052956] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA133594, R01CA140408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052956, R01NS044417] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chalmers I, 1997, BRIT MED J, V314, P74, DOI 10.1136/bmj.314.7073.74a; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Djulbegovic B, 2007, J MED PHILOS, V32, P79, DOI 10.1080/03605310701255719; Djulbegovic B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058711; Djulbegovic B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000024.pub3; Evans I, 2011, TESTING TREATMENTS B; FREDRICKSON DS, 1980, CONTROL CLIN TRIALS, V1, P263, DOI 10.1016/0197-2456(80)90006-9; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Micheel C., 2012, EVOLUTION TRANSLATIO; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347	10	47	46	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					395	396		10.1038/500395a	http://dx.doi.org/10.1038/500395a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	203TJ	23969443	Bronze, Green Accepted			2022-12-28	WOS:000323316100011
J	Gershlick, AH; Banning, AP; Myat, A; Verheugt, FWA; Gersh, BJ				Gershlick, Anthony H.; Banning, Adrian P.; Myat, Aung; Verheugt, Freek W. A.; Gersh, Bernard J.			Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention?	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; DOOR-TO-BALLOON; IN-HOSPITAL MORTALITY; PRIMARY ANGIOPLASTY; SYSTEM DELAY; PREHOSPITAL FIBRINOLYSIS; POOLED ANALYSIS; UNITED-STATES; TIME; ASSOCIATION	In the past ten years, primary percutaneous coronary intervention (PCI) has replaced thrombolysis as the revascularisation strategy for many patients presenting with ST-segment elevation myocardial infarction (STEMI). However, delivery of primary PCI within evidence-based timeframes is challenging, and health-care provision varies substantially worldwide. Consequently, even with the ideal circumstances of rapid initial diagnosis, long transfer delays to the catheter laboratory can occur. These delays are detrimental to outcomes for patients and can be exaggerated by variations in timing of patients' presentation and diagnosis. In this Series paper we summarise the value of immediate out-of-hospital thrombolysis for STEMI, and reconsider the potential therapeutic interface with a contemporary service for primary PCI. We review recent trial data, and explore opportunities for optimisation of STEMI outcomes with a pharmacoinvasive approach.	[Gershlick, Anthony H.] Univ Leicester, Univ Hosp Leicester NHS Trust, Glenfield Hosp, Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Banning, Adrian P.] Oxford Radcliffe Hosp NHS Trust, Dept Cardiol, Oxford, England; [Myat, Aung] Kings Coll London, BHF Ctr Res Excellence, St Thomas Hosp, Rayne Inst,Cardiovasc Div, London, England; [Verheugt, Freek W. A.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, NL-6525 ED Nijmegen, Netherlands; [Gersh, Bernard J.] Mayo Clin, Div Cardiovasc Sci, Rochester, MN USA	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Radboud University Nijmegen; Mayo Clinic	Gershlick, AH (corresponding author), Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England.	agershlick@aol.com	Verheugt, F.W.A./H-8105-2014; banning, adrian p/AAF-7229-2021	Banning, Adrian/0000-0002-2842-7861	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; Department of Health via the NIHR comprehensive Biomedical Research Centre; King's College Hospital NHS Foundation Trust; British Heart Foundation [FS/11/70/28917]; King's College London	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Department of Health via the NIHR comprehensive Biomedical Research Centre; King's College Hospital NHS Foundation Trust; British Heart Foundation(British Heart Foundation); King's College London	APB is partly funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. AM is supported by the Department of Health via the NIHR comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. AM also acknowledges financial support from the British Heart Foundation via a clinical research training fellowship (grant number FS/11/70/28917).	[Anonymous], 1986, LANCET, V1, P397; Armstrong PW, 2006, EUR HEART J, V27, P1530, DOI 10.1093/eurheartj/ehl088; Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Bonnefoy E, 2009, EUR HEART J, V30, P1598, DOI 10.1093/eurheartj/ehp156; Brodie BR, 2010, J AM COLL CARDIOL, V56, P407, DOI 10.1016/j.jacc.2010.04.020; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Chakrabarti AK, 2012, CURR OPIN CARDIOL, V27, P651, DOI 10.1097/HCO.0b013e3283587c69; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Denktas AE, 2011, JACC-CARDIOVASC INTE, V4, P599, DOI 10.1016/j.jcin.2011.02.012; Department of Health Vascular Programme Team, 2008, TREATMENT OF HEART A; Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8; Fernandez-Aviles F, 2004, LANCET, V364, P1045, DOI 10.1016/S0140-6736(04)17059-1; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; Fosbol EL, 2013, CIRCULATION, V127, P604, DOI 10.1161/CIRCULATIONAHA.112.118463; Francone M, 2009, J AM COLL CARDIOL, V54, P2145, DOI 10.1016/j.jacc.2009.08.024; Franzosi MG, 1998, CIRCULATION, V98, P2659, DOI 10.1161/01.CIR.98.24.2659; Gersh BJ, 2006, EUR HEART J, V27, P761, DOI 10.1093/eurheartj/ehi775; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gershlick AH, 2005, NEW ENGL J MED, V353, P2758, DOI 10.1056/NEJMoa050849; GIBSON CM, 1995, J AM COLL CARDIOL, V25, P582, DOI 10.1016/0735-1097(94)00423-N; Huber K, 2010, HEART, V96, P164, DOI 10.1136/hrt.2009.174953; Jollis JG, 2012, CIRCULATION, V126, P189, DOI 10.1161/CIRCULATIONAHA.111.068049; Jollis JG, 2012, CIRC-CARDIOVASC QUAL, V5, P423, DOI 10.1161/CIRCOUTCOMES.111.964668; Jollis JG, 2006, AM HEART J, V152; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Langer A, 1996, J AM COLL CARDIOL, V27, P1327, DOI 10.1016/0735-1097(96)00012-5; Lonborg J, 2012, AM HEART J, V164, P538, DOI 10.1016/j.ahj.2012.07.021; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; McNamara RL, 2006, J AM COLL CARDIOL, V47, P45, DOI 10.1016/j.jacc.2005.04.071; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Miedema MD, 2011, CIRCULATION, V124, P1636, DOI 10.1161/CIRCULATIONAHA.111.033118; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2006, CIRCULATION, V113, P1189, DOI 10.1161/CIRCULATIONAHA.105.596346; Nestler DM, 2009, CIRC-CARDIOVASC QUAL, V2, P508, DOI 10.1161/CIRCOUTCOMES.108.839225; Nielsen PH, 2011, AM J CARDIOL, V108, P776, DOI 10.1016/j.amjcard.2011.05.007; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Peterson MC, 2012, INT J CARDIOL, V157, P8, DOI 10.1016/j.ijcard.2011.06.042; Pinto DS, 2006, CIRCULATION, V114, P2019, DOI 10.1161/CIRCULATIONAHA.106.638353; Ranasinghe I, 2012, CIRC-CARDIOVASC QUAL, V5, P429, DOI 10.1161/CIRCOUTCOMES.112.965111; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; REIMER KA, 1979, LAB INVEST, V40, P633; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 1980, JAMA-J AM MED ASSOC, V25, P370; Swaminathan RV, 2013, J AM COLL CARDIOL, V61, P1688, DOI 10.1016/j.jacc.2012.11.073; Tarantini G, 2010, EUR HEART J, V31, P676, DOI 10.1093/eurheartj/ehp506; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Wang TY, 2011, JAMA-J AM MED ASSOC, V305, P2540, DOI 10.1001/jama.2011.862; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; Westerhout CM, 2011, AM HEART J, V161, P283, DOI 10.1016/j.ahj.2010.10.033	57	45	50	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					624	632		10.1016/S0140-6736(13)61454-3	http://dx.doi.org/10.1016/S0140-6736(13)61454-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953386				2022-12-28	WOS:000323422800026
J	Cao, G; Platisa, J; Pieribone, VA; Raccuglia, D; Kunst, M; Nitabach, MN				Cao, Guan; Platisa, Jelena; Pieribone, Vincent A.; Raccuglia, Davide; Kunst, Michael; Nitabach, Michael N.			Genetically Targeted Optical Electrophysiology in Intact Neural Circuits	CELL			English	Article							SENSITIVE FLUORESCENT PROTEIN; DROSOPHILA ANTENNAL LOBE; PDF NEURONS; ACTION-POTENTIALS; CIRCADIAN CONTROL; VOLTAGE SENSOR; CLOCK NEURONS; FLY BRAIN; CI-VSP; MELANOGASTER	Nervous systems process information by integrating the electrical activity of neurons in complex networks. This motivates the long-standing interest in using optical methods to simultaneously monitor the membrane potential of multiple genetically targeted neurons via expression of genetically encoded fluorescent voltage indicators (GEVIs) in intact neural circuits. No currently available GEVIs have demonstrated robust signals in intact brain tissue that enable reliable recording of individual electrical events simultaneously in multiple neurons. Here, we show that the recently developed "ArcLight" GEVI robustly reports both subthreshold events and action potentials in genetically targeted neurons in the intact Drosophila fruit fly brain and reveals electrical signals in neurite branches. In the same way that genetically encoded fluorescent sensors have revolutionized the study of intracellular Ca2+ signals, ArcLight now enables optical measurement in intact neural circuits of membrane potential, the key cellular parameter that underlies neuronal information processing.	[Cao, Guan; Pieribone, Vincent A.; Raccuglia, Davide; Kunst, Michael; Nitabach, Michael N.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Nitabach, Michael N.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Nitabach, Michael N.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Platisa, Jelena; Pieribone, Vincent A.] John B Pierce Lab, New Haven, CT 06519 USA; [Platisa, Jelena] Univ Belgrade, Fac Phys Chem, Belgrade 11000, Serbia	Yale University; Yale University; Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; University of Belgrade	Nitabach, MN (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	michael.nitabach@yale.edu	Platisa, Jelena/P-4987-2019; Platisa, Jelena/R-3785-2017	Platisa, Jelena/0000-0003-4813-609X; Platisa, Jelena/0000-0003-4813-609X; Kunst, Michael/0000-0003-4159-8056; Pieribone, Vincent/0000-0002-5836-5454; Raccuglia, Davide/0000-0003-1999-1505	National Institute of Neurological Disorders and Stroke (NINDS); National Institute of General Medical Sciences, National Institutes of Health (NIH) [R01NS055035, R01NS056443, R01GM098931, R01NS083875]; NINDS, NIH [R01NS083875, U24NS057631]; John B. Pierce Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056443, U24NS057631, R01NS083875, R01NS055035] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John B. Pierce Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Bloomington Stock Center (Bloomington, IN), Loren Looger, and Vivek Jayaraman (both at Janelia Farm Research Campus, Howard Hughes Medical Institute) for Drosophila stocks, Lawrence B. Cohen (Yale University School of Medicine) and the members of the Nitabach and Pieribone labs for discussion, and Glenn Turner (Cold Spring Harbor Laboratory) for advice concerning in vivo imaging of fly olfactory responses. Work in the laboratory of M.N.N. is supported in part by the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of General Medical Sciences, National Institutes of Health (NIH) (R01NS055035, R01NS056443, R01GM098931, and R01NS083875). Work in the laboratory of V. A. P. is supported in part by NINDS, NIH (U24NS057631 and R01NS083875) and The John B. Pierce Laboratory.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Baker BJ, 2008, BRAIN CELL BIOL, V36, P53, DOI 10.1007/s11068-008-9026-7; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Choi C, 2012, CELL REP, V2, P332, DOI 10.1016/j.celrep.2012.06.021; COHEN LB, 1968, NATURE, V218, P438, DOI 10.1038/218438a0; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Fiala Andre, 2003, Sci STKE, V2003, pPL6, DOI 10.1126/stke.2003.174.pl6; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; McCarthy EV, 2011, J NEUROSCI, V31, P8181, DOI 10.1523/JNEUROSCI.2017-10.2011; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; SALZBERG BM, 1973, NATURE, V246, P508, DOI 10.1038/246508a0; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Tian L, 2012, PROG BRAIN RES, V196, P79, DOI 10.1016/B978-0-444-59426-6.00005-7; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984	47	176	181	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					904	913		10.1016/j.cell.2013.07.027	http://dx.doi.org/10.1016/j.cell.2013.07.027			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23932121	Green Accepted, Bronze			2022-12-28	WOS:000323202500019
J	Ramaswami, M; Taylor, JP; Parker, R				Ramaswami, Mani; Taylor, J. Paul; Parker, Roy			Altered Ribostasis: RNA-Protein Granules in Degenerative Disorders	CELL			English	Review							LENGTH POLYGLUTAMINE EXPANSIONS; EUKARYOTIC STRESS GRANULES; ALZHEIMERS-DISEASE; MESSENGER-RNA; HEXANUCLEOTIDE REPEAT; DROSOPHILA MODEL; NUCLEAR FOCI; P-BODIES; TDP-43; NEURODEGENERATION	The molecular processes that contribute to degenerative diseases are not well understood. Recent observations suggest that some degenerative diseases are promoted by the accumulation of nuclear or cytoplasmic RNA-protein (RNP) aggregates, which can be related to endogenous RNP granules. RNP aggregates arise commonly in degenerative diseases because RNA-binding proteins commonly self-assemble, in part through prion-like domains, which can form self-propagating amyloids. RNP aggregates may be toxic due to multiple perturbations of posttranscriptional control, thereby disrupting the normal "ribostasis" of the cell. This suggests that understanding and modulating RNP assembly or clearance may be effective approaches to developing therapies for these diseases.	[Ramaswami, Mani] Trinity Coll Dublin, Sch Genet & Microbiol, Dublin 2, Ireland; [Ramaswami, Mani] Trinity Coll Dublin, Sch Nat Sci, Smurfit Inst Genet, Dublin 2, Ireland; [Ramaswami, Mani] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin 2, Ireland; [Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38120 USA; [Parker, Roy] Univ Colorado, Dept Biochem & Chem, Boulder, CO 80309 USA; [Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; St Jude Children's Research Hospital; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ramaswami, M (corresponding author), Trinity Coll Dublin, Sch Genet & Microbiol, Dublin 2, Ireland.	mani.ramaswami@tcd.ie; jpaultaylor@stjude.org; roy.parker@colorado.edu	Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349; Ramaswami, Mani/0000-0001-7631-0468	Science Foundation Ireland; Target ALS Foundation; US NIH [NS053825, GM045443]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R37GM045443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053825] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Target ALS Foundation; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Our research is primarily funded by: Science Foundation Ireland (M. R.); the Target ALS Foundation and US NIH NS053825 (J.P.T.); and the HHMI and US NIH GM045443 (R. P.). We acknowledge useful discussions and feedback from members of our laboratories, as well as from many colleagues, including Chris Weihl, Nancy Bonini, Mel Feaney, and Leo Pallanck. M. R. acknowledges K. VijayRaghavan and the NCBS, Bangalore for their support.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; [Anonymous], P NATL ACAD SCI US; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Bonini NM, 2011, J MOL NEUROSCI, V45, P676, DOI 10.1007/s12031-011-9548-9; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chartier A, 2006, EMBO J, V25, P2253, DOI 10.1038/sj.emboj.7601117; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Davidson YS, 2011, ACTA NEUROPATHOL, V122, P703, DOI 10.1007/s00401-011-0879-y; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; De Los Rios P, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/24/244105; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Garber K, 2009, NAT BIOTECHNOL, V27, P1070, DOI 10.1038/nbt1209-1070; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hackman P, 2013, ANN NEUROL, V73, P500, DOI 10.1002/ana.23831; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hashem V, 2009, HUM MOL GENET, V18, P2443, DOI 10.1093/hmg/ddp182; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Ishihara T, 2013, HUM MOL GENET, V22, P4136, DOI 10.1093/hmg/ddt262; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Klar J, 2013, HUM MUTAT, V34, P572, DOI 10.1002/humu.22282; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Savas JN, 2008, P NATL ACAD SCI USA, V105, P10820, DOI 10.1073/pnas.0800658105; Savas JN, 2010, J BIOL CHEM, V285, P13142, DOI 10.1074/jbc.M110.114561; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Spector David L, 2006, Cell, V127, P1071, DOI 10.1016/j.cell.2006.11.026; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Tremblay C, 2011, J NEUROPATH EXP NEUR, V70, P788, DOI 10.1097/NEN.0b013e31822c62cf; Vij N, 2011, EXPERT OPIN THER TAR, V15, P233, DOI 10.1517/14728222.2011.553610; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; White M, 2012, J NEUROSCI RES, V90, P706, DOI 10.1002/jnr.22786; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	101	398	403	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					727	736		10.1016/j.cell.2013.07.038	http://dx.doi.org/10.1016/j.cell.2013.07.038			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953108	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000323202500006
J	Marijon, E; Bougouin, W; Perier, MC; Celermajer, DS; Jouven, X				Marijon, Eloi; Bougouin, Wulfran; Perier, Marie-Cecile; Celermajer, David S.; Jouven, Xavier			Incidence of Sports-Related Sudden Death in France by Specific Sports and Sex	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Marijon, Eloi] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bougouin, Wulfran] AP HP, Paris, France; [Perier, Marie-Cecile] INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France; [Celermajer, David S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Jouven, Xavier] Sudden Death Expertise Ctr, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sydney	Marijon, E (corresponding author), Hop Europeen Georges Pompidou, Paris Cardiovasc Res Ctr, 56 Rue Leblanc, F-75737 Paris 15, France.	eloi_marijon@yahoo.fr	Bougouin, Wulfran/AAS-7565-2021	Celermajer, David/0000-0001-7640-0439				Albert CM, 1996, CIRCULATION, V93, P1170, DOI 10.1161/01.CIR.93.6.1170; Borjesson M, 2011, EUR J CARDIOV PREV R, V18, P446, DOI 10.1097/HJR.0b013e32833bo969; Drezner JA, 2008, CURR OPIN CARDIOL, V23, P494, DOI 10.1097/HCO.0b013e32830b3624; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Ministere de la Jeunesse et des Sports; Institut National du Sport et de l'Education Physique, 2002, PRAT SPORT FRANC	5	30	30	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 14	2013	310	6					641	642		10.1001/jama.2013.8711	http://dx.doi.org/10.1001/jama.2013.8711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200HI	23942684	Bronze			2022-12-28	WOS:000323058400021
J	Tassin, P; Koschny, T; Soukoulis, CM				Tassin, Philippe; Koschny, Thomas; Soukoulis, Costas M.			Graphene for Terahertz Applications	SCIENCE			English	Editorial Material							PLASMONICS; DEVICES		[Tassin, Philippe; Koschny, Thomas; Soukoulis, Costas M.] US DOE, Ames Lab, Ames, IA 50011 USA; [Tassin, Philippe; Koschny, Thomas; Soukoulis, Costas M.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Soukoulis, Costas M.] FORTH, IESL, Iraklion 71110, Crete, Greece	United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Foundation for Research & Technology - Hellas (FORTH)	Tassin, P (corresponding author), US DOE, Ames Lab, Ames, IA 50011 USA.	soukoulis@ameslab.gov	Tassin, Philippe/B-7152-2008; Soukoulis, Costas M./A-5295-2008; Koschny, Thomas/AAZ-6273-2020	Koschny, Thomas/0000-0003-4960-9266				Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/NPHOTON.2010.186, 10.1038/nphoton.2010.186]; Chen JH, 2008, NAT NANOTECHNOL, V3, P206, DOI 10.1038/nnano.2008.58; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Li T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.167401; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Tassin P, 2012, NAT PHOTONICS, V6, P259, DOI 10.1038/nphoton.2012.27; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Yan HG, 2012, NAT NANOTECHNOL, V7, P330, DOI [10.1038/nnano.2012.59, 10.1038/NNANO.2012.59]	14	180	184	4	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					620	621		10.1126/science.1242253	http://dx.doi.org/10.1126/science.1242253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929971	Green Submitted			2022-12-28	WOS:000322884800024
J	Qi, X; Qian, YH; Bao, CJ; Guo, XL; Cui, LB; Tang, FY; Ji, H; Huang, Y; Cai, PQ; Lu, B; Xu, K; Shi, C; Zhu, FC; Zhou, MH; Wang, H				Qi, Xian; Qian, Yan-Hua; Bao, Chang-Jun; Guo, Xi-Ling; Cui, Lun-Biao; Tang, Fen-Yang; Ji, Hong; Huang, Yong; Cai, Pei-Quan; Lu, Bing; Xu, Ke; Shi, Chao; Zhu, Feng-Cai; Zhou, Ming-Hao; Wang, Hua			Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN INFECTION; H5N1 VIRUS; FERRETS; ORIGIN	Objective To determine whether the novel avian influenza H7N9 virus can transmit from person to person and its efficiency. Design Epidemiological investigations conducted after a family cluster of two patients with avian H7N9 in March 2013. Setting Wuxi, Eastern China. Participants Two patients, their close contacts, and relevant environments. Samples from the patients and environments were collected and tested by real time reverse transcriptase-polymerase chain reaction (rRT-PCR), viral culture, and haemagglutination inhibition assay. Any contacts who became ill had samples tested for avian H7N9 by rRT-PCR. Paired serum samples were obtained from contacts for serological testing by haemagglutination inhibition assays. Main outcomes measures Clinical data, history of exposure before the onset of illnesses, and results of laboratory testing of pathogens and further analysis of sequences and phylogenetic tree to isolated strains. Results The index patient became ill five to six days after his last exposure to poultry. The second patient, his daughter aged 32, who provided unprotected bedside care in the hospital, had no known exposure to poultry. She developed symptoms six days after her last contact with her father. Two strains were isolated successfully from the two patients. Genome sequence and analyses of phylogenetic trees showed that both viruses were almost genetically identical. Forty three close contacts of both patients were identified. One had mild illness but had negative results for avian H7N9 by rRT-PCR. All 43 close contacts tested negative for haemagglutination inhibition antibodies specific for avian H7N9. Conclusions The infection of the daughter probably resulted from contact with her father (the index patient) during unprotected exposure, suggesting that in this cluster the virus was able to transmit from person to person. The transmissibility was limited and non-sustainable.	[Qi, Xian; Bao, Chang-Jun; Tang, Fen-Yang; Ji, Hong; Xu, Ke] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Qian, Yan-Hua; Lu, Bing; Shi, Chao] Wuxi Municipal Ctr Dis Control & Prevent, Wuxi 214023, Jiangsu, Peoples R China; [Guo, Xi-Ling; Cui, Lun-Biao] Jiangsu Prov Ctr Dis Control & Prevent, Inst Pathogen Microbiol, Minist Hlth, Key Lab Enter Pathogen Microbiol, Nanjing 210009, Jiangsu, Peoples R China; [Huang, Yong] Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [Cai, Pei-Quan] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China; [Zhu, Feng-Cai; Zhou, Ming-Hao; Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Hua] Hlth Dept Jiangsu Prov, Nanjing 210008, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; Jiangnan University; Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Zhou, MH (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China.	zmh@jscdc.cn; hua@jscdc.cn	zhou, minghao/GZA-7244-2022; cui, lunbiao/AAP-7931-2021		Innovation Platform for Public Health Emergency Preparedness and Response [ZX201109]; Jiangsu Province Key Medical Talent Foundation [RC2011084, RC2011191]; "333" Projects of Jiangsu Province; Jiangsu Province Science and Technology Support Program [BE2012769]; Jiangsu Provincial Project of Preventive Medicine [Y201026]; Wuxi Development Project of Science and Technology Bureau [CSZ00955, CSZ01051]	Innovation Platform for Public Health Emergency Preparedness and Response; Jiangsu Province Key Medical Talent Foundation; "333" Projects of Jiangsu Province; Jiangsu Province Science and Technology Support Program; Jiangsu Provincial Project of Preventive Medicine; Wuxi Development Project of Science and Technology Bureau	HW and M-HZ are partly supported by the Innovation Platform for Public Health Emergency Preparedness and Response (No ZX201109). XQ and L-BC are partly supported by the Jiangsu Province Key Medical Talent Foundation (RC2011084 and RC2011191) and the "333" Projects of Jiangsu Province. C-JB is partly supported by Jiangsu Province Science and Technology Support Program (social development: BE2012769). Y-HQ is partly supported by Jiangsu Provincial Project of Preventive Medicine (Y201026) and Wuxi Development Project of Science and Technology Bureau (CSZ00955, CSZ01051). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish. The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the Jiangsu Provincial Centers for Disease Control and Prevention or other organisations.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 2013, LANCET, V381, P1333, DOI 10.1016/S0140-6736(13)60865-X; [Anonymous], 2013, HUM INF INFL A H7N9; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Du Ry van Beest Holle M, 2005, Euro Surveill, V10, P264; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li J, 2013, SCI CHINA LIFE SCI, V56, P485, DOI 10.1007/s11427-013-4491-3; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu Q, 2013, MICROBES INFECT, V15, P432, DOI 10.1016/j.micinf.2013.04.004; Lu SH, 2013, BIOSCI TRENDS, V7, P109, DOI 10.5582/bst.2013.v7.2.109; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2568; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; World Health Organization, 2013, LAB PROC SER DET AV; Wu H, 2013, N ENGL J MED; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	30	150	162	0	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2013	347								f4752	10.1136/bmj.f4752	http://dx.doi.org/10.1136/bmj.f4752			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CT	23920350	Green Published, hybrid			2022-12-28	WOS:000323119000004
J	Ash, C; Culotta, E; Fahrenkamp-Uppenbrink, J; Malakoff, D; Smith, J; Sugden, A; Vignieri, S				Ash, Caroline; Culotta, Elizabeth; Fahrenkamp-Uppenbrink, Julia; Malakoff, David; Smith, Jesse; Sugden, Andrew; Vignieri, Sacha			Once and Future Climate Change INTRODUCTION	SCIENCE			English	Editorial Material																			0	28	28	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					472	473		10.1126/science.341.6145.472	http://dx.doi.org/10.1126/science.341.6145.472			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	193UJ	23908216				2022-12-28	WOS:000322586700030
J	Sai, H; Tan, KW; Hur, K; Asenath-Smith, E; Hovden, R; Jiang, Y; Riccio, M; Muller, DA; Elser, V; Estroff, LA; Gruner, SM; Wiesner, U				Sai, Hiroaki; Tan, Kwan Wee; Hur, Kahyun; Asenath-Smith, Emily; Hovden, Robert; Jiang, Yi; Riccio, Mark; Muller, David A.; Elser, Veit; Estroff, Lara A.; Gruner, Sol M.; Wiesner, Ulrich			Hierarchical Porous Polymer Scaffolds from Block Copolymers	SCIENCE			English	Article							PHASE-SEPARATION; CRYSTALS; MORPHOLOGIES; HOMOPOLYMER; CONFINEMENT; TRANSITIONS; ADSORPTION; MEMBRANES; MIXTURES; SURFACES	Hierarchical porous polymer materials are of increasing importance because of their potential application in catalysis, separation technology, or bioengineering. Examples for their synthesis exist, but there is a need for a facile yet versatile conceptual approach to such hierarchical scaffolds and quantitative characterization of their nonperiodic pore systems. Here, we introduce a synthesis method combining well-established concepts of macroscale spinodal decomposition and nanoscale block copolymer self-assembly with porosity formation on both length scales via rinsing with protic solvents. We used scanning electron microscopy, small-angle x-ray scattering, transmission electron tomography, and nanoscale x-ray computed tomography for quantitative pore-structure characterization. The method was demonstrated for AB-and ABC-type block copolymers, and resulting materials were used as scaffolds for calcite crystal growth.	[Sai, Hiroaki; Tan, Kwan Wee; Hur, Kahyun; Asenath-Smith, Emily; Estroff, Lara A.; Wiesner, Ulrich] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Hovden, Robert; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Hovden, Robert; Muller, David A.; Gruner, Sol M.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Jiang, Yi; Elser, Veit; Gruner, Sol M.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Riccio, Mark] Cornell Univ, Inst Biotechnol, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, CHESS, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Wiesner, U (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	ubw1@cornell.edu	Muller, David/A-7745-2010; Tan, Kwan Wee/B-6201-2014; Gruner, Sol/G-2924-2010; Tan, Kwan W./D-6942-2011; Jiang, Yi/W-5440-2018; Sai, Hiroaki/C-9970-2014	Muller, David/0000-0003-4129-0473; Gruner, Sol/0000-0002-1171-4426; Tan, Kwan W./0000-0002-8289-6503; Jiang, Yi/0000-0002-2807-1324; Sai, Hiroaki/0000-0002-4268-2148	NSF Single Investigator Award [DMR-1104773]; Singapore Energy Innovation Programme Office; NSF Materials Research Science and Engineering Centers (MRSEC) program [DMR-1120296]; CHESS; NSF; NIH/National Institute of General Medical Sciences under NSF [DMR-0936384]; Direct For Mathematical & Physical Scien [1104773, 0845212] Funding Source: National Science Foundation	NSF Single Investigator Award; Singapore Energy Innovation Programme Office; NSF Materials Research Science and Engineering Centers (MRSEC) program; CHESS(Defence Research & Development Organisation (DRDO)); NSF(National Science Foundation (NSF)); NIH/National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF Single Investigator Award (DMR-1104773). K. W. T. gratefully acknowledges the Singapore Energy Innovation Programme Office for a National Research Foundation graduate fellowship. This work made use of the SEM, transmission EM, and polymer characterization facility of the Cornell Center for Materials Research (CCMR) with support from the NSF Materials Research Science and Engineering Centers (MRSEC) program (DMR-1120296) and CHESS, which is supported by the NSF and the NIH/National Institute of General Medical Sciences under NSF award DMR-0936384. This work also used the Xradia VERSA XRM-500 instrument in the Cornell University Biotechnology Resource Center (BRC) Multiscale CT Imaging Facility. The authors gratefully acknowledge S. Strogatz (Cornell University) for fruitful discussions; J. Song (Cornell University) for providing the triblock terpolymer; and R. Dorin, R. Li, and J. Kim (Cornell University) for experimental assistance and discussion.	BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; Finnemore AS, 2009, ADV MATER, V21, P3928, DOI 10.1002/adma.200900615; Floudas G, 1999, J CHEM PHYS, V110, P652, DOI 10.1063/1.478122; Gennes P.-G. d., 1979, SCALING CONCEPTS IN, P98; GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211; Hamley I. W., 1998, THE PHYSICS OF BLOCK; Jones BH, 2011, ACS NANO, V5, P8914, DOI 10.1021/nn203096x; Kasper J. S., 1952, INTERNATIONAL TABLES, V2; Knoll W, 2011, SMALL, V7, P1384, DOI 10.1002/smll.201100026; KOIZUMI S, 1994, MACROMOLECULES, V27, P6532, DOI 10.1021/ma00100a044; LEE JS, 1988, MACROMOLECULES, V21, P274, DOI 10.1021/ma00179a057; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Li L, 2012, ANGEW CHEM INT EDIT, V51, P4089, DOI 10.1002/anie.201107867; Maki-Ontto R, 2001, ADV MATER, V13, P117, DOI 10.1002/1521-4095(200101)13:2<117::AID-ADMA117>3.0.CO;2-1; Martinez-Veracoechea FJ, 2009, MACROMOLECULES, V42, P9058, DOI 10.1021/ma901591r; Martinez-Veracoechea FJ, 2009, MACROMOLECULES, V42, P1775, DOI 10.1021/ma802427a; Matsen MW, 1996, MACROMOLECULES, V29, P7641, DOI 10.1021/ma960744q; Nakanishi K, 2008, CHEM MATER, V20, P1108, DOI 10.1021/cm702486b; OHTA T, 1995, PHYS REV E, V52, P5250, DOI 10.1103/PhysRevE.52.5250; Peinemann KV, 2007, NAT MATER, V6, P992, DOI 10.1038/nmat2038; Phillip WA, 2011, NANO LETT, V11, P2892, DOI 10.1021/nl2013554; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Rider DA, 2008, MACROMOLECULES, V41, P2250, DOI 10.1021/ma7020248; Seo M, 2011, MACROMOLECULES, V44, P9310, DOI 10.1021/ma2013942; Su BL, 2012, HIERARCHICALLY STRUCTURED POROUS MATERIALS: FROM NANOSCIENCE TO CATALYSIS, SEPARATION, OPTICS, ENERGY, AND LIFE SCIENCE, P1; Urbas AM, 2002, ADV MATER, V14, P1850, DOI 10.1002/adma.200290018; Walheim S, 1999, SCIENCE, V283, P520, DOI 10.1126/science.283.5401.520; Wang Y, 2011, ACS NANO, V5, P1928, DOI 10.1021/nn1029444; Zalusky AS, 2002, J AM CHEM SOC, V124, P12761, DOI 10.1021/ja0278584	29	216	223	12	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					530	534		10.1126/science.1238159	http://dx.doi.org/10.1126/science.1238159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908232				2022-12-28	WOS:000322586700048
J	Spence, D				Spence, Des			The pursuit of imperfection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2013	347								f4780	10.1136/bmj.f4780	http://dx.doi.org/10.1136/bmj.f4780			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BK	23908474				2022-12-28	WOS:000322822500002
J	Silber, JH; Rosenbaum, PR; Clark, AS; Giantonio, BJ; Ross, RN; Teng, Y; Wang, M; Niknam, BA; Ludwig, JM; Wang, W; Even-Shoshan, O; Fox, KR				Silber, Jeffrey H.; Rosenbaum, Paul R.; Clark, Amy S.; Giantonio, Bruce J.; Ross, Richard N.; Teng, Yun; Wang, Min; Niknam, Bijan A.; Ludwig, Justin M.; Wang, Wei; Even-Shoshan, Orit; Fox, Kevin R.			Characteristics Associated With Differences in Survival Among Black and White Women With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUVANT HORMONAL-THERAPY; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; ETHNIC-DIFFERENCES; COMORBIDITY INDEX; UNITED-STATES; FINE BALANCE; TUMOR SIZE; MEDICARE; STAGE	IMPORTANCE Difference in breast cancer survival by race is a recognized problem among Medicare beneficiaries. OBJECTIVE To determine if racial disparity in breast cancer survival is primarily attributable to differences in presentation characteristics at diagnosis or subsequent treatment. DESIGN, SETTING, AND PATIENTS Comparison of 7375 black women 65 years and older diagnosed between 1991 to 2005 and 3 sets of 7375 matched white control patients selected from 99 898 white potential controls, using data for 16 US Surveillance, Epidemiology and End Results (SEER) sites in the SEER-Medicare database. All patients received follow-up through December 31, 2009, and the black case patients were matched to 3 white control populations on demographics (age, year of diagnosis, and SEER site), presentation (demographics variables plus patient comorbid conditions and tumor characteristics such as stage, size, grade, and estrogen receptor status), and treatment (presentation variables plus details of surgery, radiation therapy, and chemotherapy). MAIN OUTCOMES AND MEASURES 5-Year survival. RESULTS The absolute difference in 5-year survival (blacks, 55.9%; whites, 68.8%) was 12.9% (95% CI, 11.5%-14.5%; P < .001) in the demographics match. This difference remained unchanged between 1991 and 2005. After matching on presentation characteristics, the absolute difference in 5-year survival was 4.4%(95% CI, 2.8%-5.8%; P < .001) and was 3.6% (95% CI, 2.3%-4.9%; P < .001) lower for blacks than for whites matched also on treatment. In the presentation match, fewer blacks received treatment (87.4% vs 91.8%; P < .001), time from diagnosis to treatment was longer (29.2 vs 22.8 days; P < .001), use of anthracyclines and taxols was lower (3.7% vs 5.0%; P < .001), and breast-conserving surgery without other treatment was more frequent (8.2% vs 7.3%; P = .04). Nevertheless, differences in survival associated with treatment differences accounted for only 0.81% of the 12.9% survival difference. CONCLUSIONS AND RELEVANCE In the SEER-Medicare database, differences in breast cancer survival between black and white women did not substantially change among women diagnosed between 1991 and 2005. These differences in survival appear primarily related to presentation characteristics at diagnosis rather than treatment differences.	[Silber, Jeffrey H.; Ross, Richard N.; Teng, Yun; Wang, Min; Niknam, Bijan A.; Ludwig, Justin M.; Wang, Wei; Even-Shoshan, Orit] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.; Clark, Amy S.; Giantonio, Bruce J.; Fox, Kevin R.] Univ Penn, Leonard & Madlyn Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Oncol, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.; Rosenbaum, Paul R.; Even-Shoshan, Orit] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Rosenbaum, Paul R.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Clark, Amy S.; Giantonio, Bruce J.; Fox, Kevin R.] Hosp Univ Penn, Div Med Oncol, Philadelphia, PA 19104 USA; [Clark, Amy S.; Giantonio, Bruce J.; Fox, Kevin R.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Silber, JH (corresponding author), Childrens Hosp Philadelphia, Ctr Outcomes Res, 3535 Market St,Ste 1029, Philadelphia, PA 19104 USA.	silber@email.chop.edu	Rosenbaum, Paul R/H-8687-2012		Agency for Healthcare Research and Quality (AHRQ); Department of Health and Human Services [R01 HS 018355]; US National Science Foundation [NSF SBS 1260782]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018355] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Department of Health and Human Services; US National Science Foundation(National Science Foundation (NSF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded through a grant from the Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (R01 HS 018355), and by the US National Science Foundation (NSF SBS 1260782). This study used the linked SEER-Medicare database.	Agency Healthcare Research and Quality, 2011, 2011 NAT HEALTHC QUA, V2011; [Anonymous], 2009, STAT AN SOFTW SYST U; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bach PB, 2002, MED CARE, V40, P19; Bishop YMM, 1975, DISCRETE MULTIVARIAT, P281; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chagpar AB, 2011, SURGERY, V150, P796, DOI 10.1016/j.surg.2011.07.066; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Cross CK, 2002, CANCER, V95, P1988, DOI 10.1002/cncr.10830; Curtis E, 2008, CANCER-AM CANCER SOC, V112, P171, DOI 10.1002/cncr.23131; Daniel SR, 2008, J COMPUT GRAPH STAT, V17, P914, DOI 10.1198/106186008X385806; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Gorey KM, 2009, BREAST CANCER RES TR, V113, P595, DOI 10.1007/s10549-008-9960-1; Grann V, 2006, SOC SCI MED, V62, P337, DOI 10.1016/j.socscimed.2005.06.038; Haas JS, 2008, CANCER-AM CANCER SOC, V113, P2166, DOI 10.1002/cncr.23828; Heller R, 2010, AM STAT, V64, P299, DOI 10.1198/tast.2010.09210; Hershman D, 2005, J CLIN ONCOL, V23, P6639, DOI 10.1200/JCO.2005.12.633; Hershman DL, 2010, J CLIN ONCOL, V28, P4120, DOI 10.1200/JCO.2009.25.9655; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; HOLT JD, 1974, BIOMETRIKA, V61, P17, DOI 10.1093/biomet/61.1.17; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kalbfleish J., 1980, STAT ANAL FAILURE TI; Kimmick G, 2009, J CLIN ONCOL, V27, P3445, DOI 10.1200/JCO.2008.19.2419; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; McBride R, 2007, CANCER-AM CANCER SOC, V110, P1201, DOI 10.1002/cncr.22884; McCarthy EP, 1998, ANN INTERN MED, V128, P729, DOI 10.7326/0003-4819-128-9-199805010-00005; National Cancer Institute, SEER MED LINK DAT; OBRIEN PC, 1987, BIOMETRICS, V43, P169, DOI 10.2307/2531957; Ooi SL, 2011, BREAST CANCER RES TR, V127, P729, DOI 10.1007/s10549-010-1191-6; Owusu C, 2008, J CLIN ONCOL, V26, P549, DOI 10.1200/JCO.2006.10.1022; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosenbaum PR, 2007, J AM STAT ASSOC, V102, P75, DOI 10.1198/016214506000001059; Rosenbaum PR, 2013, AM STAT, V67, P67, DOI 10.1080/00031305.2013.769914; Rosenbaum PR, 2010, SPRINGER SER STAT, P197, DOI 10.1007/978-1-4419-1213-8_10; Rosenbaum PR, 2005, J ROY STAT SOC B, V67, P515, DOI 10.1111/j.1467-9868.2005.00513.x; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB., 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Rubin DB, 2008, ANN APPL STAT, V2, P808, DOI 10.1214/08-AOAS187; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; SAS Institute Inc, 1999, SAS OR US GUID MATH, P39; Gorin SS, 2006, ARCH INTERN MED, V166, P2244, DOI 10.1001/archinte.166.20.2244; Silber JH, 2012, ANN SURG, V256, P79, DOI 10.1097/SLA.0b013e31825375ef; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Smith-Bindman R, 2006, ANN INTERN MED, V144, P541, DOI 10.7326/0003-4819-144-8-200604180-00004; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Thu AM, 2008, AM J SURG, V196, P500, DOI 10.1016/j.amjsurg.2008.06.027; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Warren JL, 2002, MED CARE, V40, P3; Yang D, 2012, BIOMETRICS, V68, P628, DOI 10.1111/j.1541-0420.2011.01691.x	58	215	216	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					389	397		10.1001/jama.2013.8272	http://dx.doi.org/10.1001/jama.2013.8272			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917289	Bronze, Green Submitted			2022-12-28	WOS:000322121500016
J	Sheffield, KM; Riall, TS; Han, YM; Kuo, YF; Townsend, CM; Goodwin, JS				Sheffield, Kristin M.; Riall, Taylor S.; Han, Yimei; Kuo, Yong-Fang; Townsend, Courtney M., Jr.; Goodwin, James S.			Association Between Cholecystectomy With vs Without Intraoperative Cholangiography and Risk of Common Duct Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; OPERATIVE CHOLANGIOGRAPHY; MANAGEMENT; COMPLICATIONS; ROUTINE; MULTICENTER; REPAIR; VOLUME	IMPORTANCE Significant controversy exists regarding routine intraoperative cholangiography in preventing common duct injury during cholecystectomy. OBJECTIVE To investigate the association between intraoperative cholangiography use during cholecystectomy and common duct injury. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of all Texas Medicare claims data from 2000 through 2009. We identified Medicare beneficiaries 66 years or older who underwent inpatient or outpatient cholecystectomy for biliary colic or biliary dyskinesia, acute cholecystitis, or chronic cholecystitis. We compared results from multilevel logistic regression models to the instrumental variable analyses. INTERVENTIONS Intraoperative cholangiography use during cholecystectomy was determined at the level of the patients (yes/no), hospitals (percentage intraoperative cholangiography use for all cholecystectomies at the hospital), and surgeons (percentage use for all cholecystectomies performed by the surgeon). Percentage of use at the hospital and percentage of use by surgeon were the instrumental variables. MAIN OUTCOMES AND MEASURES Patients with claims for common duct repair operations within 1 year of cholecystectomy were considered as having major common duct injury. RESULTS Of 92 932 patients undergoing cholecystectomy, 37 533 (40.4%) underwent concurrent intraoperative cholangiography and 280 (0.30%) had a common duct injury. The common duct injury rate was 0.21% among patients with intraoperative cholangiography and 0.36% among patients without it. In a logistic regression model controlling for patient, surgeon, and hospital characteristics, the odds of common duct injury for cholecystectomies performed without intraoperative cholangiography were increased compared with those performed with it (OR, 1.79 [95% CI, 1.35-2.36]; P < .001). When confounding was controlled with instrumental variable analysis, the association between cholecystectomy performed without intraoperative cholangiography and duct injury was no longer significant (OR, 1.26 [95% CI, 0.81-1.96]; P = .31). CONCLUSIONS AND RELEVANCE When confounders were controlled with instrumental variable analysis, there was no statistically significant association between intraoperative cholangiography and common duct injury. Intraoperative cholangiography is not effective as a preventive strategy against common duct injury during cholecystectomy.	[Sheffield, Kristin M.; Riall, Taylor S.; Han, Yimei; Townsend, Courtney M., Jr.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Kuo, Yong-Fang; Goodwin, James S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Riall, TS (corresponding author), Univ Texas Med Branch, 301 Univ Blvd,JSA 6-110C, Galveston, TX 77555 USA.	tsriall@utmb.edu			National Institutes of Health [K05CA134923, K07CA130983, UL1TR000071]; NATIONAL CANCER INSTITUTE [K07CA130983, K05CA134923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study is supported by grants K05CA134923, K07CA130983, and UL1TR000071 from the National Institutes of Health.	Mercado MA, 2011, HPB, V13, P767, DOI 10.1111/j.1477-2574.2011.00356.x; Ausania F, 2012, SURG ENDOSC, V26, P1193, DOI 10.1007/s00464-012-2241-4; Barauskas G, 2012, MEDICINA-LITHUANIA, V48, P138, DOI 10.3390/medicina48030019; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Buddingh KT, 2011, J AM COLL SURGEONS, V213, P267, DOI 10.1016/j.jamcollsurg.2011.03.004; Buddingh KT, 2011, J GASTROINTEST SURG, V15, P1069, DOI 10.1007/s11605-011-1413-1; CLAIR DG, 1993, ARCH SURG-CHICAGO, V128, P551; Cullen KA, 2006, GOLOSINSKIY A NATION; DeFrances CJ, NATIONAL HEALTH STAT; Fletcher DR, 1999, ANN SURG, V229, P449, DOI 10.1097/00000658-199904000-00001; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Flum DR, 2001, ARCH SURG-CHICAGO, V136, P1287, DOI 10.1001/archsurg.136.11.1287; Hamad MA, 2011, SURG ENDOSC, V25, P3747, DOI 10.1007/s00464-011-1780-4; HAUERJENSEN M, 1993, SURGERY, V113, P318; Johnson SR, 2000, SURGERY, V128, P668, DOI 10.1067/msy.2000.108422; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lau WY, 2010, ANZ J SURG, V80, P75, DOI 10.1111/j.1445-2197.2009.05205.x; Massarweh NN, 2007, J AM COLL SURGEONS, V204, P656, DOI 10.1016/j.jamcollsurg.2007.01.038; Mirizzi PL, 1937, SURG GYNECOL OBSTET, V65, P702; Nickkholgh A, 2006, SURG ENDOSC, V20, P868, DOI 10.1007/s00464-005-0425-x; Nuzzo G, 2005, ARCH SURG-CHICAGO, V140, P986, DOI 10.1001/archsurg.140.10.986; Nuzzo G, 2007, J AM COLL SURGEONS, V205, P5; Ozturk E, 2009, HEPATO-GASTROENTEROL, V56, P17; Regoly-Merei J, 1998, SURG ENDOSC-ULTRAS, V12, P294, DOI 10.1007/s004649900657; Sheffield KM, 2012, J AM COLL SURGEONS, V214, P668, DOI 10.1016/j.jamcollsurg.2011.12.033; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Strasberg SM, 2010, J AM COLL SURGEONS, V211, P132, DOI 10.1016/j.jamcollsurg.2010.02.053; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tornqvist B, 2012, BMJ-BRIT MED J, V345, pe6457; Traverso LW, 2006, SURG ENDOSC, V20, P1659, DOI 10.1007/s00464-006-0122-4; Waage A, 2006, ARCH SURG-CHICAGO, V141, P1207, DOI 10.1001/archsurg.141.12.1207; Yang Y, UNIFIED APPROACH MEA; Yegiyants S, 2008, AM SURGEON, V74, P985; Z'graggen K, 1998, SURG ENDOSC-ULTRAS, V12, P1303, DOI 10.1007/s004649900846; Zacharakis E, 2007, J LAPAROENDOSC ADV S, V17, P620, DOI 10.1089/lap.2006.0220	35	57	59	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					812	820		10.1001/jama.2013.276205	http://dx.doi.org/10.1001/jama.2013.276205			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982367	Green Accepted			2022-12-28	WOS:000323561400021
J	Smith, JM				Smith, Jeanette M.			A Garden in Nassau Winslow Homer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					778	779		10.1001/jama.2013.5275	http://dx.doi.org/10.1001/jama.2013.5275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982353				2022-12-28	WOS:000323561400001
J	Saavedra, S; Stouffer, DB				Saavedra, Serguei; Stouffer, Daniel B.			"Disentangling nestedness" disentangled	NATURE			English	Letter							MUTUALISTIC NETWORKS; ARCHITECTURE; MODEL		[Saavedra, Serguei] CSIC, EBD, Integrat Ecol Grp, E-41092 Seville, Spain; [Stouffer, Daniel B.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Canterbury	Saavedra, S (corresponding author), CSIC, EBD, Integrat Ecol Grp, Calle Amer Vespucio S-N, E-41092 Seville, Spain.	daniel.stouffer@canterbury.ac.nz	Stouffer, Daniel/C-2223-2008	Stouffer, Daniel/0000-0001-9436-9674				Allesina S, 2012, NATURE, V487, P175, DOI 10.1038/487175a; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; Zuur Alain F., 2009, P1	15	33	33	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					E1	E2		10.1038/nature12380	http://dx.doi.org/10.1038/nature12380			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969464	Green Submitted			2022-12-28	WOS:000323316100001
J	Verger, PJP; Boobis, AR				Verger, Philippe J. P.; Boobis, Alan R.			Reevaluate Pesticides for Food Security and Safety	SCIENCE			English	Editorial Material							IPCS FRAMEWORK; RELEVANCE; HUMANS; MODE		[Verger, Philippe J. P.] WHO, CH-1211 Geneva, Switzerland; [Boobis, Alan R.] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England	World Health Organization; Imperial College London	Verger, PJP (corresponding author), WHO, CH-1211 Geneva, Switzerland.	vergerp@who.int	Boobis, Alan/E-1536-2018	Boobis, Alan/0000-0003-3371-386X; Verger, Philippe/0000-0002-6650-2391	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Boobis AR, 2008, CRIT REV TOXICOL, V38, P87, DOI 10.1080/10408440701749421; Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677; CCPR, 2013, REPORT OF THE 45TH C; FAO, 2009, FEED WORLD 2050; FAO, 2013, REPORT OF THE JOINT; Phillips McDougall AgriService, 2010, INDUSTRY OVERVIEW 20; Popp J, 2013, AGRON SUSTAIN DEV, V33, P243, DOI 10.1007/s13593-012-0105-x; Solecki R, 2005, FOOD CHEM TOXICOL, V43, P1569, DOI 10.1016/j.fct.2005.04.005; WHO, 2009, ENVIRON HEALTH CRITE, V239, P1; WTO, 1994, THE WTO AGREEMENT ON	10	91	95	8	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					717	718		10.1126/science.1241572	http://dx.doi.org/10.1126/science.1241572			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201DZ	23950515				2022-12-28	WOS:000323122200023
J	Braberg, H; Jin, HY; Moehle, EA; Chan, YJA; Wang, SY; Shales, M; Benschop, JJ; Morris, JH; Qiu, CX; Hu, FQ; Tang, LK; Fraser, JS; Holstege, FCP; Hieter, P; Guthrie, C; Kaplan, CD; Krogan, NJ				Braberg, Hannes; Jin, Huiyan; Moehle, Erica A.; Chan, Yujia A.; Wang, Shuyi; Shales, Michael; Benschop, Joris J.; Morris, John H.; Qiu, Chenxi; Hu, Fuqu; Tang, Leung K.; Fraser, James S.; Holstege, Frank C. P.; Hieter, Philip; Guthrie, Christine; Kaplan, Craig D.; Krogan, Nevan J.			From Structure to Systems: High-Resolution, Quantitative Genetic Analysis of RNA Polymerase II	CELL			English	Article							START SITE SELECTION; ELONGATION COMPLEX; FUNCTIONAL DISSECTION; HIGH-THROUGHPUT; INTERACTION MAP; REVEALS LINKS; TRANSCRIPTION; YEAST; SUB1; INITIATION	RNA polymerase II (RNAPII) lies at the core of dynamic control of gene expression. Using 53 RNAPII point mutants, we generated a point mutant epistatic miniarray profile (pE-MAP) comprising similar to 60,000 quantitative genetic interactions in Saccharomyces cerevisiae. This analysis enabled functional assignment of RNAPII subdomains and uncovered connections between individual regions and other protein complexes. Using splicing microarrays and mutants that alter elongation rates in vitro, we found an inverse relationship between RNAPII speed and in vivo splicing efficiency. Furthermore, the pE-MAP classified fast and slow mutants that favor upstream and downstream start site selection, respectively. The striking coordination of polymerization rate with transcription initiation and splicing suggests that transcription rate is tuned to regulate multiple gene expression steps. The pE-MAP approach provides a powerful strategy to understand other multifunctional machines at amino acid resolution.	[Braberg, Hannes; Wang, Shuyi; Shales, Michael; Fraser, James S.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Moehle, Erica A.; Guthrie, Christine] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Benschop, Joris J.] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Braberg, Hannes; Wang, Shuyi; Shales, Michael; Fraser, James S.; Krogan, Nevan J.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Jin, Huiyan; Qiu, Chenxi; Hu, Fuqu; Tang, Leung K.; Kaplan, Craig D.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Chan, Yujia A.; Hieter, Philip] Univ British Columbia, Michael Smith Labs, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Chan, Yujia A.; Hieter, Philip] Univ British Columbia, Michael Smith Labs, Dept Biochem, Vancouver, BC V6T 1Z4, Canada; [Benschop, Joris J.; Holstege, Frank C. P.] Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; University of British Columbia; University of British Columbia; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; The J David Gladstone Institutes	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	christineguthrie@gmail.com; cdkaplan@tamu.edu; nevan.krogan@ucsf.edu	Holstege, Frank/AAM-9944-2021; Benschop, Joris j/C-7809-2012; Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X; Morris, John "Scooter"/0000-0003-0290-7979; Qiu, Chenxi/0000-0002-0314-5307; Chan, Yujia Alina/0000-0002-0731-637X; /0000-0002-7635-5604; Fraser, James/0000-0002-5080-2859	QB3 at UCSF; NIH [R01GM084448, R01GM084279, P50GM081879, R01GM098101, R01GM036659, R01GM097260, DP5OD009180]; NSF; Helen Hay Whitney Fellowship; UCSF Biophysics Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM084448, R01GM021119, R01GM097260, R01GM084279, R01GM098101, P41GM103311, R01GM036659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009180] Funding Source: NIH RePORTER	QB3 at UCSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Helen Hay Whitney Fellowship; UCSF Biophysics Graduate Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to thank members of the Krogan, Kaplan, and Guthrie labs; David Agard, Brad Cairns, Ada Cheng, C. James Ingles, Paivand Jalalian, Tanja Kortemme, Andrej Sali, and Keith Yamamoto for helpful discussion; Steve Buratowski, Olga Calvo, and Eva Nogales for sharing results prior to publication; Steve Hahn and Mike Hampsey for providing tfg2 and sua7 mutant plasmids, respectively; Colm Ryan for help with statistical analysis; and Ricardo Almeida and Jiewei Xu for assistance with growth assays. This work was supported by grants from QB3 at UCSF and the NIH (R01GM084448, R01GM084279, P50GM081879, and R01GM098101 to N.J.K.; R01GM036659 to Roger D. Kornberg for support of C. D. K. for a portion of this work; R01GM097260 to C. D. K.; R01GM021119 to C. G.; and DP5OD009180 to J.S.F.). C. G. is an ACS Research Professor of Molecular Genetics. E. A. M. was supported by an NSF graduate research fellowship. C. D. K. acknowledges a Helen Hay Whitney Fellowship for the early stages of this work. H. B. was supported by the UCSF Biophysics Graduate Program. N.J.K. is a Searle Scholar and a Keck Young Investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the acknowledged funding agencies.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Aitken S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002215; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2011, GENET RES INT, V2011, DOI 10.4061/2011/309865; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garcia A, 2012, MOL BIOL CELL, V23, P4297, DOI 10.1091/mbc.E12-04-0331; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goel S, 2012, J BIOL CHEM, V287, P557, DOI 10.1074/jbc.M111.281576; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Kaplan C, 2008, NATION, V286, P30; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2013, BBA-GENE REGUL MECH, V1829, P39, DOI 10.1016/j.bbagrm.2012.09.007; Kaplan CD, 2012, PLOS GENET, V8, P172, DOI 10.1371/journal.pgen.1002627; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Lin YY, 2012, NATURE, V482, P251, DOI 10.1038/nature10804; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Ohkuni K, 2011, CURR BIOL, V21, P1695, DOI 10.1016/j.cub.2011.08.056; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; PINTO I, 1994, J BIOL CHEM, V269, P30569; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; SPENCER F, 1990, GENETICS, V124, P237; Tan Q, 2003, MOL CELL BIOL, V23, P3329, DOI 10.1128/MCB.23.9.3329-3338.2003; Tavenet A, 2009, P NATL ACAD SCI USA, V106, P14265, DOI 10.1073/pnas.0900162106; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; Wu WH, 1999, GENETICS, V153, P643	73	98	99	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					775	788		10.1016/j.cell.2013.07.033	http://dx.doi.org/10.1016/j.cell.2013.07.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23932120	Green Accepted, Bronze			2022-12-28	WOS:000323202500010
J	Warren, JD; Rohrer, JD; Rossor, MN				Warren, Jason D.; Rohrer, Jonathan D.; Rossor, Martin N.			Frontotemporal dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOBAR DEGENERATION EPIDEMIOLOGY; BEHAVIORAL VARIANT; DIAGNOSTIC-CRITERIA; PROGRESSIVE APHASIA; CSF BIOMARKERS; PATHOLOGY; FTLD; SENSITIVITY; SIGNATURES; COGNITION		[Warren, Jason D.; Rohrer, Jonathan D.; Rossor, Martin N.] UCL, UCL Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England	University of London; University College London	Warren, JD (corresponding author), UCL, UCL Inst Neurol, Dementia Res Ctr, London WC1N 3BG, England.	jason.warren@ucl.ac.uk		Rohrer, Jonathan/0000-0002-6155-8417; Rossor, Martin/0000-0001-8215-3120; Warren, Jason/0000-0002-5405-0826	Medical Research Council [MR/J009482/1, G0801306] Funding Source: Medline; Wellcome Trust [091673] Funding Source: Medline; Department of Health Funding Source: Medline; National Institute for Health Research [NF-SI-0508-10123, NF-SI-0512-10033] Funding Source: researchfish; MRC [MR/J009482/1, G0801306] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bian H, 2008, NEUROLOGY, V70, P1827, DOI 10.1212/01.wnl.0000311445.21321.fc; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Czarnecki K, 2008, EUR J NEUROL, V15, P199, DOI 10.1111/j.1468-1331.2007.02032.x; Deakin JB, 2004, PSYCHOPHARMACOLOGY, V172, P400, DOI 10.1007/s00213-003-1686-5; Gass J, 2012, BRAIN RES, V1462, P118, DOI 10.1016/j.brainres.2012.01.047; Gorno-Tempini M L, 2011, Neurology, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; Jesso S, 2011, BRAIN, V134, P2493, DOI 10.1093/brain/awr171; Kertesz A, 2005, BRAIN, V128, P1996, DOI 10.1093/brain/awh598; Kertesz A, 2010, J NEUROL SCI, V289, P138, DOI 10.1016/j.jns.2009.08.036; Kipps CM, 2009, BRAIN, V132, P2566, DOI 10.1093/brain/awp077; Lebert F, 2004, DEMENT GERIATR COGN, V17, P355, DOI 10.1159/000077171; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Mahoney CJ, 2013, NEUROBIOL AGING, V34, P1687, DOI 10.1016/j.neurobiolaging.2012.12.002; McMillan CT, 2013, NEUROLOGY, V80, P132, DOI 10.1212/WNL.0b013e31827b9147; Mendez MF, 2007, ARCH NEUROL-CHICAGO, V64, P830, DOI 10.1001/archneur.64.6.830; Perry RJ, 2006, DEMENT GERIATR COGN, V22, P278, DOI 10.1159/000095128; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rohrer JD, 2009, NEUROLOGY, V72, P1562, DOI 10.1212/WNL.0b013e3181a4124e; Rohrer JD, 2012, DEMENT GERIATR COG S, V34, P1; Rohrer JD, 2011, CURR OPIN NEUROL, V24, P542, DOI 10.1097/WCO.0b013e32834cd442; Rohrer JD, 2011, BRAIN, V134, P2565, DOI 10.1093/brain/awr198; Rohrer JD, 2010, NEUROLOGY, V75, P603, DOI 10.1212/WNL.0b013e3181ed9c6b; Rohrer JD, 2010, NEUROIMAGE, V49, P984, DOI 10.1016/j.neuroimage.2009.08.002; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seeley WW, 2005, NEUROLOGY, V64, P1384, DOI 10.1212/01.WNL.0000158425.46019.5C; Seltman RE, 2012, CNS DRUGS, V26, P841, DOI 10.2165/11640070-000000000-00000; Vercelletto M, 2011, J ALZHEIMERS DIS, V23, P749, DOI 10.3233/JAD-2010-101632; Verwey NA, 2010, J ALZHEIMERS DIS, V20, P445, DOI 10.3233/JAD-2010-1392; Warren JD, TRENDS NEUR IN PRESS; Xiong L, 2011, J NEUROL NEUROSUR PS, V82, P254, DOI 10.1136/jnnp.2010.209916	34	170	175	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2013	347								f4827	10.1136/bmj.f4827	http://dx.doi.org/10.1136/bmj.f4827			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203WU	23920254	hybrid, Green Published			2022-12-28	WOS:000323326000001
J	Langstrom, N; Enebrink, P; Lauren, EM; Lindblom, J; Werko, S; Hanson, RK				Langstrom, Niklas; Enebrink, Pia; Lauren, Eva-Marie; Lindblom, Jonas; Werko, Sophie; Hanson, R. Karl			Preventing sexual abusers of children from reoffending: systematic review of medical and psychological interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHEMICAL CASTRATION; LIFETIME DIAGNOSIS; OFFENDERS; METAANALYSIS; DISORDERS; ASSOCIATION; RECIDIVISM; BEHAVIOR; OUTCOMES; PROGRAM	Objective To evaluate the effectiveness of current medical and psychological interventions for individuals at risk of sexually abusing children, both in known abusers and those at risk of abusing. Design Systematic review of interventions designed to prevent reoffending among known abusers and prevention for individuals at risk of sexually abusing children. Randomised controlled trials and prospective observational studies were eligible. Primary outcomes were arrests, convictions, breaches of conditions, and self reported sexual abuse of children after one year or more. Results After review of 1447 abstracts, we retrieved 167 full text studies, and finally included eight studies with low to moderate risk of bias. We found weak evidence for interventions aimed at reducing reoffending in identified sexual abusers of children. For adults, evidence from five trials was insufficient regarding both benefits and risks with psychological treatment and pharmacotherapy. For adolescents, limited evidence from one trial suggested that multisystemic therapy prevented reoffence (relative risk 0.18, 95% confidence interval 0.04 to 0.73); lack of adequate research prevented conclusions about effects of other treatments. Evidence was also inadequate regarding effectiveness of treatment for children with sexual behavioural problems in the one trial identified. Finally, we found no eligible research on preventive methods for adults and adolescents who had not sexually abused children but were at higher risk of doing so (such as those with paedophilic sexual preference). Conclusion There are major weaknesses in the scientific evidence, particularly regarding adult men, the main category of sexual abusers of children. Better coordinated and funded high quality studies including several countries are urgently needed. Until conclusive evidence is available, realistic clinical strategies might involve reduction of specific risk factors for sex crimes, such as sexual preoccupation, in abusers at risk of reoffending.	[Langstrom, Niklas] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Langstrom, Niklas] Swedish Prison & Probat Adm, Norrkoping, Sweden; [Enebrink, Pia] Karolinska Inst, Div Psychol, Dept Clin Neurosci, SE-17177 Stockholm, Sweden; [Lauren, Eva-Marie] Stockholm Cty Council, Stockholm, Sweden; [Lindblom, Jonas; Werko, Sophie] Swedish Council Hlth Technol Assessment SBU, Stockholm, Sweden; [Lindblom, Jonas; Werko, Sophie] Karolinska Inst, LIME, SE-10691 Stockholm, Sweden; [Hanson, R. Karl] Publ Safety Canada, Ottawa, ON, Canada	Karolinska Institutet; Karolinska Institutet; Stockholm County Council; Karolinska Institutet	Langstrom, N (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	niklas.langstrom@ki.se	Langstrom, Niklas/C-5615-2009	Langstrom, Niklas/0000-0002-2686-6799	Swedish Government, Department of Social Affairs	Swedish Government, Department of Social Affairs	The Swedish Government, Department of Social Affairs commissioned the systematic review and funded some of the work. The funder had no influence on the process or conclusions of the present work. SW and JL were both employed by the Swedish Council on Health Technology Assessment (SBU). The views expressed are those of the authors and not necessarily those of Public Safety Canada or the Swedish Prison and Probation Administration.	Andrews DA, 2010, PSYCHOLOGY OF CRIMINAL CONDUCT, 5TH EDITION, P1; [Anonymous], 2007, COUNC EUR TREAT SER, V201; [Anonymous], 2011, MED PSYK MET ATT FOR; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Beier KM, 2009, CHILD ABUSE NEGLECT, V33, P545, DOI 10.1016/j.chiabu.2009.04.002; Bhaumik S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f64; Borduin CM, 2009, J CONSULT CLIN PSYCH, V77, P26, DOI 10.1037/a0013035; Carpentier MY, 2006, J CONSULT CLIN PSYCH, V74, P482, DOI 10.1037/0022-006X.74.3.482; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Curtis NM, 2004, J FAM PSYCHOL, V18, P411, DOI 10.1037/0893-3200.18.3.411; Davidson PR., 1984, BEHAV TREATMENT INCA; Duggan C., 2012, PSYCHOL INTERVENTION; Forsman M, 2012, PSYCHOL MED, V42, P1977, DOI 10.1017/S0033291711003060; Freyd JJ, 2005, SCIENCE, V308, P501, DOI 10.1126/science.1108066; Gallagher C. A., 1999, CORRECTIONS MANAGEME, V3, P19; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Grubin D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c74; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HALL GCN, 1995, J CONSULT CLIN PSYCH, V63, P802, DOI 10.1037/0022-006X.63.5.802; Hanson R Karl, 2002, Sex Abuse, V14, P169, DOI 10.1023/A:1014624315814; Hanson RK, 2009, CRIM JUSTICE BEHAV, V36, P865, DOI 10.1177/0093854809338545; Hanson RK, 1998, J CONSULT CLIN PSYCH, V66, P348, DOI 10.1037/0022-006X.66.2.348; Hatzipetrou L., 2000, COCHRANE DB SYST REV, V2; Hillberg T, 2011, TRAUMA VIOLENCE ABUS, V12, P38, DOI 10.1177/1524838010386812; Jonas S, 2011, PSYCHOL MED, V41, P709, DOI 10.1017/S003329171000111X; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Kenworthy T, 2004, COCHRANE DB SYST REV, V3; Littell J, 2005, CAMPBELL SYSTEMATIC; Losel F., 2005, J EXP CRIMINOL, V1, P117, DOI [10.1007/s11292-004-6466-7, DOI 10.1007/S11292-004-6466-7]; Lovins B, 2009, PRISON J, V89, P344, DOI 10.1177/0032885509339509; Maniglio R, 2009, CLIN PSYCHOL REV, V29, P647, DOI 10.1016/j.cpr.2009.08.003; Marques JK, 2005, SEX ABUSE-J RES TR, V17, P79, DOI 10.1177/107906320501700108; Marshall LE, 2008, SEX ABUSE-J RES TR, V20, P25, DOI 10.1177/1079063208314818; McGrath RJ, 1998, CRIM JUSTICE BEHAV, V25, P203, DOI 10.1177/0093854898025002004; National Institute for Health and Care Excellence (NICE), 2013, ANT BEH COND DIS CHI; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; Nelson EC, 2006, PSYCHOL MED, V36, P1473, DOI 10.1017/S0033291706008397; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Pereda N, 2009, CLIN PSYCHOL REV, V29, P328, DOI 10.1016/j.cpr.2009.02.007; Procter E., 1996, J SEX AGGRESS, V2, P3, DOI [10.1080/13552609608413253, DOI 10.1080/13552609608413253]; Seto MC, 2010, CHILD MALTREATMENT, V15, P219, DOI 10.1177/1077559510367937; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; WIDOM CS, 1994, CHILD ABUSE NEGLECT, V18, P303, DOI 10.1016/0145-2134(94)90033-7; World Health Organization, 2002, WORLD REPORT VIOLENC; Worling JR, 2010, BEHAV SCI LAW, V28, P46, DOI 10.1002/bsl.912	46	66	67	2	89	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2013	347								f4630	10.1136/bmj.f4630	http://dx.doi.org/10.1136/bmj.f4630			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201DK	23935058	Green Published, hybrid			2022-12-28	WOS:000323120700002
J	Cole, TB; Flanagin, A				Cole, Thomas B.; Flanagin, Annette			Recovery After Violence and Human Rights Abuses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; POSTTRAUMATIC-STRESS-DISORDER; NORTHERN UGANDA; SYMPTOMS; THERAPY; PTSD; ATTITUDES; JUSTICE; TRAUMA		[Cole, Thomas B.] Univ N Carolina, Chapel Hill, NC USA; [Cole, Thomas B.; Flanagin, Annette] JAMA, Chicago, IL 60654 USA	University of North Carolina; University of North Carolina Chapel Hill	Flanagin, A (corresponding author), JAMA, 515 N State St, Chicago, IL 60654 USA.	annette.flanagin@jamanetwork.org						Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Crosby SS, 2013, JAMA-J AM MED ASSOC, V310, P519, DOI 10.1001/jama.2013.8788; Elster EA, 2013, JAMA-J AM MED ASSOC, V310, P475, DOI 10.1001/jama.2013.167481; Ertl V, 2011, JAMA-J AM MED ASSOC, V306, P503, DOI 10.1001/jama.2011.1060; Feder G, 2013, JAMA-J AM MED ASSOC, V310, P479, DOI 10.1001/jama.2013.167453; Foa EB, 2013, JAMA-J AM MED ASSOC, V310, P488, DOI 10.1001/jama.2013.8268; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Mills KL, 2012, JAMA-J AM MED ASSOC, V308, P690, DOI 10.1001/jama.2012.9071; Monson CM, 2012, JAMA-J AM MED ASSOC, V308, P700, DOI 10.1001/jama.2012.9307; North CS, 2013, JAMA-J AM MED ASSOC, V310, P507, DOI 10.1001/jama.2013.107799; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Sonis J, 2009, JAMA-J AM MED ASSOC, V302, P527, DOI 10.1001/jama.2009.1085; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tol WA, 2013, JAMA-J AM MED ASSOC, V310, P477, DOI 10.1001/jama.2013.166723	15	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					486	487		10.1001/jama.2013.218058	http://dx.doi.org/10.1001/jama.2013.218058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925618				2022-12-28	WOS:000322786400020
J	Ladapo, JA; Rodwin, BA; Ryan, AM; Trasande, L; Blustein, J				Ladapo, Joseph A.; Rodwin, Benjamin A.; Ryan, Andrew M.; Trasande, Leonardo; Blustein, Jan			Scientific Publications on Firearms in Youth Before and After Congressional Action Prohibiting Federal Research Funding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ladapo, Joseph A.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Rodwin, Benjamin A.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Ryan, Andrew M.] Weill Cornell Med Coll, Div Outcomes & Effectiveness Res, New York, NY USA; [Trasande, Leonardo] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; [Blustein, Jan] NYU, Wagner Sch Publ Serv, New York, NY 10016 USA	New York University; New York University; Cornell University; New York University; New York University	Ladapo, JA (corresponding author), NYU, Sch Med, 550 1st Ave,VZ30 6th Floor,614, New York, NY 10016 USA.	joseph.ladapo@nyumc.org	Trasande, Leonardo/ABE-6339-2020	Trasande, Leonardo/0000-0002-1928-597X; Ladapo, Joseph/0000-0002-8518-4800				Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Kellermann AL, 1997, AM J PUBLIC HEALTH, V87, P910, DOI 10.2105/AJPH.87.6.910; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Luo M, NRA STYMIES FIREARMS; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369	6	23	23	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	2013	310	5					532	534		10.1001/jama.2013.119355	http://dx.doi.org/10.1001/jama.2013.119355			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196OZ	23925624	Bronze			2022-12-28	WOS:000322786400026
J	Akizu, N; Cantagrel, V; Schroth, J; Cai, N; Vaux, K; McCloskey, D; Naviaux, RK; Van Vleet, J; Fenstermaker, AG; Silhavy, JL; Scheliga, JS; Toyama, K; Morisaki, H; Sonmez, FM; Celep, F; Oraby, A; Zaki, MS; Al-Baradie, R; Faqeih, EA; Saleh, MAM; Spencer, E; Rosti, RO; Scott, E; Nickerson, E; Gabriel, S; Morisaki, T; Holmes, EW; Gleeson, JG				Akizu, Naiara; Cantagrel, Vincent; Schroth, Jana; Cai, Na; Vaux, Keith; McCloskey, Douglas; Naviaux, Robert K.; Van Vleet, Jeremy; Fenstermaker, Ali G.; Silhavy, Jennifer L.; Scheliga, Judith S.; Toyama, Keiko; Morisaki, Hiroko; Sonmez, Fatma M.; Celep, Figen; Oraby, Azza; Zaki, Maha S.; Al-Baradie, Raidah; Faqeih, Eissa A.; Saleh, Mohammed A. M.; Spencer, Emily; Rosti, Rasim Ozgur; Scott, Eric; Nickerson, Elizabeth; Gabriel, Stacey; Morisaki, Takayuki; Holmes, Edward W.; Gleeson, Joseph G.			AMPD2 Regulates GTP Synthesis and Is Mutated in a Potentially Treatable Neurodegenerative Brainstem Disorder	CELL			English	Article							PROTEIN-SYNTHESIS; PONTOCEREBELLAR HYPOPLASIA; NUCLEOTIDE DEPLETION; YEAST; DEFICIENCY; DEAMINASE; TOXICITY; PURINE; GENE; PHOSPHORIBOSYLTRANSFERASE	Purine biosynthesis and metabolism, conserved in all living organisms, is essential for cellular energy homeostasis and nucleic acid synthesis. The de novo synthesis of purine precursors is under tight negative feedback regulation mediated by adenosine and guanine nucleotides. We describe a distinct early-onset neuro degenerative condition resulting from mutations in the adenosine monophosphate deaminase 2 gene (AMPD2). Patients have characteristic brain imaging features of pontocerebellar hypoplasia (PCH) due to loss of brainstem and cerebellar parenchyma. We found that AMPD2 plays an evolutionary conserved role in the maintenance of cellular guanine nucleotide pools by regulating the feedback inhibition of adenosine derivatives on de novo purine synthesis. AMPD2 deficiency results in defective GTP-dependent initiation of protein translation, which can be rescued by administration of purine precursors. These data suggest AMPD2-related PCH as a potentially treatable early-onset neurodegenerative disease.	[Akizu, Naiara; Cantagrel, Vincent; Schroth, Jana; Cai, Na; Vaux, Keith; Fenstermaker, Ali G.; Silhavy, Jennifer L.; Spencer, Emily; Rosti, Rasim Ozgur; Scott, Eric; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Hosp, Neurogenet Lab,Inst Genom Med, La Jolla, CA 92093 USA; [McCloskey, Douglas] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Naviaux, Robert K.] Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, Dept Med, La Jolla, CA 92093 USA; [Naviaux, Robert K.] Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, Dept Pediat, La Jolla, CA 92093 USA; [Naviaux, Robert K.] Univ Calif San Diego, Mitochondrial & Metab Dis Ctr, Dept Pathol, La Jolla, CA 92093 USA; [Van Vleet, Jeremy] Univ Calif San Diego, Glycotechnol Core Resource, La Jolla, CA 92093 USA; [Scheliga, Judith S.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA; [Toyama, Keiko; Morisaki, Hiroko; Morisaki, Takayuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Biosci & Genet, Natl Cerebral & Cardiovasc Ctr Res Inst, Osaka 5658565, Japan; [Toyama, Keiko; Morisaki, Hiroko; Morisaki, Takayuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Pathophysiol, Osaka 5658565, Japan; [Sonmez, Fatma M.] Turgut Ozal Univ, Dept Pediat Neurol, TR-06510 Ankara, Turkey; [Celep, Figen] Karadeniz Tech Univ, Dept Med Biol, TR-61080 Trabzon, Turkey; [Oraby, Azza] Cairo Univ, Childrens Hosp, Pediat Neurol Dept, Cairo 406, Egypt; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo 12311, Egypt; [Al-Baradie, Raidah] King Fahd Specialist Hosp, Dept Pediat Neurol, Dammam 31444, Saudi Arabia; [Faqeih, Eissa A.; Saleh, Mohammed A. M.] King Fahad Med City, Childrens Hosp, Dept Pediat, Med Genet Sect, Riyadh 11525, Saudi Arabia; [Nickerson, Elizabeth; Gabriel, Stacey] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Holmes, Edward W.] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; National Cerebral & Cardiovascular Center - Japan; Osaka University; Osaka University; Turgut Ozal University; Karadeniz Technical University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Fahad Medical City; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Rady Childrens Hosp, Neurogenet Lab,Inst Genom Med, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Holmes, Edward/GVR-9499-2022; Vincent, Cantagrel/H-8698-2017; EYÜPOĞLU, Figen CELEP/AAS-5109-2020; Zaki, Maha S/B-9361-2013; Vaux, Keith/R-2716-2019; Celep/J-6493-2019	Vincent, Cantagrel/0000-0002-5180-4848; Vaux, Keith/0000-0001-8738-5940; Zaki, Maha/0000-0001-7840-0002; Lipton, Stuart/0000-0002-3490-1259; Spencer, Emily/0000-0003-2650-4357	California Institute for Regenerative Medicine; UCSD Christini Fund; Jane Botsford Johnson Foundation; NIH [P01HD070494, R01NS048453, P30NS047101]; Broad Institute grant [U54HG003067]; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, P30NS047101, R01NS048453] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); UCSD Christini Fund; Jane Botsford Johnson Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute grant; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation. We also thank B. Daignan-Fornier and B. Pinson for the tet-AMD1 plasmid and helpful advice, A. Hopper and T. Yoshihisa for the sen2-41 yeast strain, E. Masliah and S. Michael for human brain specimens, and S.J. Elledge for pINDUCER20 plasmid. We thank T. Friedman, W. Nyhan, B. Barshop, R. Evans, J. Cheng, and D. Wolf for helpful discussions. N.A. was supported by the California Institute for Regenerative Medicine. R.K.N. was supported by grants from the UCSD Christini Fund and the Jane Botsford Johnson Foundation. This work was supported by the NIH (P01HD070494, R01NS048453, and P30NS047101 for imaging support), Broad Institute grant U54HG003067 (to Eric Lander), the Center for Inherited Disease Research for genotyping, and the Simons Foundation Autism Research Initiative.	Alfonzo JD, 1997, BBA-PROTEIN STRUCT M, V1341, P173, DOI 10.1016/S0167-4838(97)00068-X; ARCHER S, 1985, J CELL PHYSIOL, V124, P226, DOI 10.1002/jcp.1041240209; BARTH PG, 1993, BRAIN DEV-JPN, V15, P411, DOI 10.1016/0387-7604(93)90080-R; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Camici M, 2010, NEUROCHEM INT, V56, P367, DOI 10.1016/j.neuint.2009.12.003; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheng J, 2012, GENES CELLS, V17, P913, DOI 10.1111/gtc.12006; COHEN MB, 1981, J BIOL CHEM, V256, P8713; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Escobar-Henriques M, 2001, J BIOL CHEM, V276, P1523, DOI 10.1074/jbc.M007926200; Esposito Anthony M, 2010, J Vis Exp, DOI 10.3791/1948; Fairbanks LD, 2002, BIOCHEM J, V366, P265, DOI 10.1042/bj20020148; FISHBEIN WN, 1978, SCIENCE, V200, P545, DOI 10.1126/science.644316; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Han BW, 2006, J BIOL CHEM, V281, P14939, DOI 10.1074/jbc.M513009200; Iglesias-Gato D, 2011, GENETICS, V187, P105, DOI 10.1534/genetics.110.122135; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Maricich SM, 2011, J CHILD NEUROL, V26, P288, DOI 10.1177/0883073810380047; MEYER SL, 1989, BIOCHEMISTRY-US, V28, P8734, DOI 10.1021/bi00448a009; Mochida GH, 2012, NAT GENET, V44, P1260, DOI 10.1038/ng.2425; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; OGASAWARA N, 1987, HUM GENET, V75, P15; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407; Saint-Marc C, 2009, GENETICS, V183, P529, DOI 10.1534/genetics.109.105858; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; THOMAS CB, 1981, J CELL PHYSIOL, V107, P335, DOI 10.1002/jcp.1041070305; Thompson BL, 2010, NEURON, V67, P702, DOI 10.1016/j.neuron.2010.08.037; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; WATTS RWE, 1983, ADV ENZYME REGUL, V21, P33, DOI 10.1016/0065-2571(83)90007-9; WU CL, 1993, NAT GENET, V3, P235, DOI 10.1038/ng0393-235; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	40	70	73	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					505	517		10.1016/j.cell.2013.07.005	http://dx.doi.org/10.1016/j.cell.2013.07.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23911318	Green Accepted, Bronze			2022-12-28	WOS:000322629900006
J	Chavda, SJ; Shepherd, A; Hasford, C				Chavda, S. J.; Shepherd, A.; Hasford, C.			Cough and weight loss in a young man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HODGKINS; PATHOGENESIS		[Chavda, S. J.; Shepherd, A.; Hasford, C.] Univ Coll London Hosp, Dept Acute Med, London NW1 2BU, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Chavda, SJ (corresponding author), Univ Coll London Hosp, Dept Acute Med, London NW1 2BU, England.	selinachavda@doctors.org.uk						Armitage JO, 2010, NEW ENGL J MED, V363, P653, DOI 10.1056/NEJMra1003733; Carver JR, 2007, J CLIN ONCOL, V25, P3991, DOI 10.1200/JCO.2007.10.9777; Casasnovas O, 2012, LANCET, V379, P1767, DOI 10.1016/S0140-6736(12)60153-6; Farrell K, 2011, HISTOPATHOLOGY, V58, P15, DOI 10.1111/j.1365-2559.2010.03705.x; Gonzalez M, 2012, REV MAL RESPIR, V29, P138, DOI 10.1016/j.rmr.2011.11.015; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Macchiarini P, 2004, LANCET ONCOL, V5, P107, DOI 10.1016/S1470-2045(04)01385-3; MAHER J, 1993, THORAX, V48, P92, DOI 10.1136/thx.48.1.92; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Provan D, 2009, OXFORD HDB CLIN HAEM, P206; Townsend W, 2012, LANCET, V380, P836, DOI 10.1016/S0140-6736(12)60035-X; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2013	347								f4537	10.1136/bmj.f4537	http://dx.doi.org/10.1136/bmj.f4537			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BK	23906697				2022-12-28	WOS:000322822500001
J	Malhotra, A; Rakhit, R				Malhotra, Aseem; Rakhit, Roby			Improving the UK's performance on survival after cardiac arrest	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REGION		[Malhotra, Aseem; Rakhit, Roby] Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com; roby.rakhit@nhs.net						[Anonymous], 2013, HUFFINGTON POST; [Anonymous], 2009, BBC NEWS; Apps A, 2013, POSTGRAD MED J, V89, P376, DOI 10.1136/postgradmedj-2012-130818; ARRICH J, 2009, COCHRANE DB SYST REV, V7; BBC News, 2013, BBC NEWS; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; British Heart Foundation, POL STAT EM LIF SUPP; Cave DM, 2011, CIRCULATION, V123, P691, DOI 10.1161/CIR.0b013e31820b5328; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Figueras J, 2009, AM HEART J, V158, P1011, DOI 10.1016/j.ahj.2009.10.007; Laerdal, SURV RAT AN 7 STAV R; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; London Ambulance Service NHS Trust, 2010, CAP CARD ARR SURV RA; London Ambulance Service NHS Trust, 2012, CARD ARR ANN REP 201; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Oliver King Foundation, US; Payne P., 2013, PUGET SOUND BUS 0108; Pell JP, 2003, HEART, V89, P839, DOI 10.1136/heart.89.8.839; Perkins GD, 2012, EMERG MED J, V29, P3, DOI 10.1136/emermed-2011-200758; Resuscitation Council (UK), 2010, US AUT EXT DEF; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stub D, 2011, HEART, V97, P1489, DOI 10.1136/hrt.2011.226431; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725	23	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2013	347								f4800	10.1136/bmj.f4800	http://dx.doi.org/10.1136/bmj.f4800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BK	23902857				2022-12-28	WOS:000322822500004
J	Mateos, MV; Hernandez, MT; Giraldo, P; de la Rubia, J; de Arriba, F; Corral, LL; Rosinol, L; Paiva, B; Palomera, L; Bargay, J; Oriol, A; Prosper, F; Lopez, J; Olavarria, E; Quintana, N; Garcia, JL; Blade, J; Lahuerta, JJ; San Miguel, JF				Mateos, Maria-Victoria; Hernandez, Miguel-Teodoro; Giraldo, Pilar; de la Rubia, Javier; de Arriba, Felipe; Lopez Corral, Lucia; Rosinol, Laura; Paiva, Bruno; Palomera, Luis; Bargay, Joan; Oriol, Albert; Prosper, Felipe; Lopez, Javier; Olavarria, Eduardo; Quintana, Nuria; Garcia, Jose-Luis; Blade, Joan; Lahuerta, Juan-Jose; San Miguel, Jesus-F.			Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE-I; PROGNOSTIC-SIGNIFICANCE; ZOLEDRONIC ACID; BONE-MARROW; THALIDOMIDE; PROGRESSION; DISEASE; THERAPY; MULTICENTER; DIAGNOSIS	Background For patients with smoldering multiple myeloma, the standard of care is observation until symptoms develop. However, this approach does not identify high-risk patients who may benefit from early intervention. Methods In this randomized, open-label, phase 3 trial, we randomly assigned 119 patients with high-risk smoldering myeloma to treatment or observation. Patients in the treatment group received an induction regimen (lenalidomide at a dose of 25 mg per day on days 1 to 21, plus dexamethasone at a dose of 20 mg per day on days 1 to 4 and days 12 to 15, at 4-week intervals for nine cycles), followed by a maintenance regimen (lenalidomide at a dose of 10 mg per day on days 1 to 21 of each 28-day cycle for 2 years). The primary end point was time to progression to symptomatic disease. Secondary end points were response rate, overall survival, and safety. Results After a median follow-up of 40 months, the median time to progression was significantly longer in the treatment group than in the observation group (median not reached vs. 21 months; hazard ratio for progression, 0.18; 95% confidence interval [CI], 0.09 to 0.32; P<0.001). The 3-year survival rate was also higher in the treatment group (94% vs. 80%; hazard ratio for death, 0.31; 95% CI, 0.10 to 0.91; P=0.03). A partial response or better was achieved in 79% of patients in the treatment group after the induction phase and in 90% during the maintenance phase. Toxic effects were mainly grade 2 or lower. Conclusions Early treatment for patients with high-risk smoldering myeloma delays progression to active disease and increases overall survival.	[Mateos, Maria-Victoria; Lopez Corral, Lucia; Paiva, Bruno; San Miguel, Jesus-F.] Univ Salamanca, Hosp Univ Salamanca, Inst Biol Mol & Celular Canc, Consejo Super Invest Cient,Inst Invest Biomed Sal, E-37008 Salamanca, Spain; [Hernandez, Miguel-Teodoro] Hosp Univ Canarias, Santa Cruz De Tenerife, Spain; [Giraldo, Pilar] Hosp Univ Miguel Servet, Zaragoza, Spain; [Palomera, Luis] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain; [de la Rubia, Javier] Univ Catolica Valencia San Vicente Martir, Hosp Univ La Fe, Valencia, Spain; [de Arriba, Felipe] Hosp Gen Univ Morales Meseguer, Murcia, Spain; [Rosinol, Laura; Blade, Joan] Hosp Clin Barcelona, Barcelona, Spain; [Rosinol, Laura; Blade, Joan] Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Bargay, Joan] Hosp Sont Llatzer, Palma De Mallorca, Spain; [Oriol, Albert] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Prosper, Felipe] Univ Navarra Clin, Pamplona, Spain; [Olavarria, Eduardo] Hosp Navarra, Pamplona, Spain; [Lopez, Javier] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Quintana, Nuria; Garcia, Jose-Luis] Celgene, Madrid, Spain; [Lahuerta, Juan-Jose] Hosp 12 Octubre, E-28041 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidad de la Laguna; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital; Hospital Universitari i Politecnic La Fe; Universidad Catolica de Valencia San Vicente Martir; Meseguer General University Hospital Morales; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitari Son Llatzer; Hospital Germans Trias i Pujol; University of Navarra; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Ramon y Cajal; Hospital Universitario 12 de Octubre	San Miguel, JF (corresponding author), Univ Hosp Salamanca, Dept Hematol, Paseo San Vicente 58-182, Salamanca 37007, Spain.	sanmiguel@usal.es	Oriol, Albert/K-9923-2017; Paiva, Bruno/AAB-8881-2021; López-Corral, Lucía/A-4230-2019; San-Miguel, Jesús F./V-8977-2018; Prosper, Felipe/H-6859-2017; Llàtzer, Son/ABG-1829-2020; garcia, Juan/B-4617-2017	Oriol, Albert/0000-0001-6804-2221; Paiva, Bruno/0000-0003-1977-3815; López-Corral, Lucía/0000-0003-1908-5596; San-Miguel, Jesús F./0000-0002-9183-4857; Prosper, Felipe/0000-0001-6115-8790; Llàtzer, Son/0000-0002-6739-3916; garcia, Juan/0000-0002-2146-5726; de la Rubia, Javier/0000-0002-8354-768X				[Anonymous], 2003, J CLIN ONCOL, V21, P16; Barlogie B, 2008, BLOOD, V112, P3122, DOI 10.1182/blood-2008-06-164228; Bianchi G, 2013, LEUKEMIA, V27, P680, DOI 10.1038/leu.2012.237; D'Arena G, 2011, LEUKEMIA LYMPHOMA, V52, P771, DOI 10.3109/10428194.2011.553000; Dimopoulos M, 2009, NEW ENGL J MED, V361, P544; Dimopoulos MA, 2000, ACTA ONCOL, V39, P823; Dispenzieri A, 2008, BLOOD, V111, P785, DOI 10.1182/blood-2007-08-108357; Grignani G, 1996, BRIT J CANCER, V73, P1101, DOI 10.1038/bjc.1996.212; Hillengass J, 2010, J CLIN ONCOL, V28, P1606, DOI 10.1200/JCO.2009.25.5356; HJORTH M, 1993, EUR J HAEMATOL, V50, P95; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Larsen JT, LEUKEMIA; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Mariette X, 1999, BRIT J HAEMATOL, V104, P723, DOI 10.1046/j.1365-2141.1999.01244.x; Martin A, 2002, BRIT J HAEMATOL, V118, P239, DOI 10.1046/j.1365-2141.2002.03549.x; Moulopoulos LA, 2005, ANN ONCOL, V16, P1824, DOI 10.1093/annonc/mdi362; Musto P, 2008, CANCER-AM CANCER SOC, V113, P1588, DOI 10.1002/cncr.23783; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Perez-Persona E, 2007, BLOOD, V110, P2586, DOI 10.1182/blood-2007-05-088443; Rajkumar SV, 2010, LANCET ONCOL, V11, P14; Rajkumar SV, 2011, NEW ENGL J MED, V365, P474, DOI 10.1056/NEJMc1106428; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Rajkumar SV, 2003, LEUKEMIA, V17, P775, DOI 10.1038/sj.leu.2402866; Riccardi A, 2000, BRIT J CANCER, V82, P1254; Rosinol L, 2003, BRIT J HAEMATOL, V123, P631, DOI 10.1046/j.1365-2141.2003.04654.x; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Witzig TE, 2013, LEUKEMIA, V27, P220, DOI 10.1038/leu.2012.236	29	342	356	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					438	447		10.1056/NEJMoa1300439	http://dx.doi.org/10.1056/NEJMoa1300439			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902483				2022-12-28	WOS:000322547400010
J	Sabayan, B; Wijsman, LW; Foster-Dingley, JC; Stott, DJ; Ford, I; Buckley, BM; Sattar, N; Jukema, JW; van Osch, MJP; van der Grond, J; van Buchem, MA; Westendorp, RGJ; de Craen, AJM; Mooijaart, SP				Sabayan, Behnam; Wijsman, Liselotte W.; Foster-Dingley, Jessica C.; Stott, David J.; Ford, Ian; Buckley, Brendan M.; Sattar, Naveed; Jukema, J. Wouter; van Osch, Matthias J. P.; van der Grond, Jeroen; van Buchem, Mark A.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; Mooijaart, Simon P.			Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-MATTER HYPERINTENSITIES; CEREBRAL MICROBLEEDS; BRAIN; RISK; DISEASE; STROKE; PRAVASTATIN; ADULTS; DAMAGE	Objective To investigate the association between visit-to-visit variability in blood pressure and cognitive function in old age (>70 years). Design Prospective cohort study. Setting PROSPER (PROspective Study of Pravastatin in the Elderly at Risk) study, a collaboration between centres in Ireland, Scotland, and the Netherlands. Participants 5461 participants, mean age 75.3 years, who were at risk of cardiovascular disease. Blood pressure was measured every three months during an average of 3.2 years. Visit-to-visit variability in blood pressure was defined as the standard deviation of blood pressure measurements between visits. Main outcome measures Four domains of cognitive function, testing selective attention, processing speed, and immediate and delayed memory. In a magnetic resonance imaging substudy of 553 participants, structural brain volumes, cerebral microbleeds, infarcts, and white matter hyperintensities were measured. Results Participants with higher visit-to-visit variability in systolic blood pressure had worse performance on all cognitive tests: attention (mean difference high versus low thirds) 3.08 seconds (95% confidence interval 0.85 to 5.31), processing speed -1.16 digits coded (95% confidence interval -1.69 to -0.63), immediate memory -0.27 pictures remembered (95% confidence interval -0.41 to -0.13), and delayed memory -0.30 pictures remembered (95% confidence interval -0.49 to -0.11). Furthermore, higher variability in both systolic and diastolic blood pressure was associated with lower hippocampal volume and cortical infarcts, and higher variability in diastolic blood pressure was associated with cerebral microbleeds (all P<0.05). All associations were adjusted for average blood pressure and cardiovascular risk factors. Conclusion Higher visit-to-visit variability in blood pressure independent of average blood pressure was associated with impaired cognitive function in old age.	[Sabayan, Behnam; Wijsman, Liselotte W.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; Mooijaart, Simon P.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2300 RC Leiden, Netherlands; [Sabayan, Behnam; van Osch, Matthias J. P.; van der Grond, Jeroen; van Buchem, Mark A.] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands; [Wijsman, Liselotte W.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; Mooijaart, Simon P.] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Foster-Dingley, Jessica C.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2300 RC Leiden, Netherlands; [Stott, David J.] Univ Glasgow, Fac Med, Acad Sect Geriatr, Glasgow G12 8QQ, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; [Buckley, Brendan M.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Sattar, Naveed] Univ Glasgow, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Glasgow G12 8QQ, Lanark, Scotland; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Mooijaart, Simon P.] Inst Evidence Based Med Old Age, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; University of Glasgow; University College Cork; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mooijaart, SP (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, POB 9600, NL-2300 RC Leiden, Netherlands.	s.p.mooijaart@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Mooijaart, Simon P./A-5306-2008; Ford, Ian/ABE-6145-2020; van Buchem, Mark/AAC-9843-2022; Van Osch, Matthias/AAV-3876-2021	Jukema, J. Wouter/0000-0002-3246-8359; Mooijaart, Simon P./0000-0003-3106-3568; van Buchem, Mark/0000-0003-1881-1998; Van Osch, Matthias/0000-0001-7034-8959	Bristol-Myers Squibb, USA	Bristol-Myers Squibb, USA(Bristol-Myers Squibb)	The original PROSPER clinical trial was funded by an investigator initiated grant from Bristol-Myers Squibb, USA. However, the company had no involvement in the formulation of hypotheses, analysis of the data, or in any aspect of the preparation of this manuscript.	Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Alagiakrishnan K, 2006, POSTGRAD MED J, V82, P101, DOI 10.1136/pgmj.2005.035030; Altmann-Schneider I, 2011, STROKE, V42, P638, DOI 10.1161/STROKEAHA.110.595611; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Brickman AM, 2010, ARCH NEUROL-CHICAGO, V67, P564, DOI 10.1001/archneurol.2010.70; Cecchi E, 2011, ATHEROSCLEROSIS, V214, P249, DOI 10.1016/j.atherosclerosis.2010.09.008; Dellasega C, 1993, J Neurosci Nurs, V25, P147; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Diaz KM, 2013, J HUM HYPERTENS; Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75; Goldstein IB, 2005, NEUROLOGY, V64, P1846, DOI 10.1212/01.WNL.0000164712.24389.BB; Goldstein IB, 2002, NEUROLOGY, V59, P713, DOI 10.1212/WNL.59.5.713; Gomez-Angelats E, 2004, AM J HYPERTENS, V17, P696, DOI 10.1016/j.amjhyper.2004.05.002; Gunstad J, 2005, BLOOD PRESSURE, V14, P353, DOI 10.1080/08037050500364117; HAVEKES LM, 1987, J LIPID RES, V28, P455; Havlik RJ, 2002, STROKE, V33, P26, DOI 10.1161/hs0102.101890; Houx PJ, 2002, J NEUROL NEUROSUR PS, V73, P385, DOI 10.1136/jnnp.73.4.385; Kario K, 1997, HYPERTENSION, V30, P1504, DOI 10.1161/01.HYP.30.6.1504; Kim KI, 2008, CIRC J, V72, P293, DOI 10.1253/circj.72.293; Kim YS, 2008, CLIN SCI, V115, P255, DOI 10.1042/CS20070458; Kovari E, 2004, STROKE, V35, P410, DOI 10.1161/01.STR.0000110791.51378.4E; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; Lopez-Arrieta J M, 2002, Cochrane Database Syst Rev, pCD000147; Mancia G, 2003, J HYPERTENS, V21, pS17, DOI 10.1097/00004872-200307006-00004; Nagai M, 2012, J HYPERTENS, V30, P1556, DOI 10.1097/HJH.0b013e3283552735; Olindo S, 2003, STROKE, V34, P1593, DOI 10.1161/01.STR.0000077924.71088.02; Packard CJ, 2007, J AM GERIATR SOC, V55, P1777, DOI 10.1111/j.1532-5415.2007.01415.x; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Parati G, 2002, J HYPERTENS, V20, P1725, DOI 10.1097/00004872-200209000-00014; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sadigh-Eteghad S, 2012, NEUROSCIENCES, V17, P321; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; ten Dam VH, 2005, STROKE, V36, P1633, DOI 10.1161/01.STR.0000173162.88600.29; ten Dam VH, 2005, NEUROLOGY, V64, P1807, DOI 10.1212/01.WNL.0000161844.00797.73; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; van Es ACGM, 2011, NEUROLOGY, V77, P1446, DOI 10.1212/WNL.0b013e318232ab1d; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Widya RL, 2011, AM J CLIN NUTR, V93, P1190, DOI 10.3945/ajcn.110.006304	42	100	108	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4600	10.1136/bmj.f4600	http://dx.doi.org/10.1136/bmj.f4600			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900315	Green Accepted, hybrid			2022-12-28	WOS:000322821500004
J	Warraich, HJ				Warraich, Haider Javed			Fishing for Yeti	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Warraich, HJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA.	hwarraic@bidmc.harvard.edu							0	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					373	373		10.1001/jama.2013.66054	http://dx.doi.org/10.1001/jama.2013.66054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917284				2022-12-28	WOS:000322121500011
J	Baicker, K; Levy, H				Baicker, Katherine; Levy, Helen			Coordination versus Competition in Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Many proposals to increase the value of care focus on improved coordination. But by generating incentives for provider consolidation, these efforts may unintentionally be at odds with another strategy for improving value: promoting competition in health care markets. Many current proposals to increase the value of care delivered in the U.S. health care system focus on improved coordination and with good reason. Badly coordinated care, duplicated efforts, bungled handoffs, and failures to follow up result in too much care for some patients, too little care for others, and the wrong care for many. A host of current reform efforts aim to reduce these inefficiencies in both public and private markets. These efforts range from penalizing hospitals with higher-than-expected readmission rates, to rewarding primary care providers when patients receive higher-value care, to providing incentives for the adoption of ...	[Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Levy, Helen] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan	Baicker, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.				NIA NIH HHS [K01 AG034232] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG034232] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brill S., TIME; Federal Trade Commission, 2013, COMMUNICATION   0213; GAYNOR M, 2012, HDB HLTH EC, V2, P499; Greaney TL, 2011, NEW ENGL J MED, V364, pE1, DOI 10.1056/NEJMp1013404; Jaeckel JA, 2010, ANTITRUST, V24, P46	5	50	50	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					789	791		10.1056/NEJMp1306268	http://dx.doi.org/10.1056/NEJMp1306268			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208KB	23944255	Green Accepted			2022-12-28	WOS:000323676100002
J	Flavell, SW; Pokala, N; Macosko, EZ; Albrecht, DR; Larsch, J; Bargmann, CI				Flavell, Steven W.; Pokala, Navin; Macosko, Evan Z.; Albrecht, Dirk R.; Larsch, Johannes; Bargmann, Cornelia I.			Serotonin and the Neuropeptide PDF Initiate and Extend Opposing Behavioral States in C. elegans	CELL			English	Article							NEURAL CIRCUIT; SLEEP; PROTEIN; RECEPTORS	Foraging animals have distinct exploration and exploitation behaviors that are organized into discrete behavioral states. Here, we characterize a neuromodulatory circuit that generates long-lasting roaming and dwelling states in Caenorhabditis elegans. We find that two opposing neuromodulators, serotonin and the neuropeptide pigment dispersing factor (PDF), each initiate and extend one behavioral state. Serotonin promotes dwelling states through the MOD-1 serotonin-gated chloride channel. The spontaneous activity of serotonergic neurons correlates with dwelling behavior, and optogenetic modulation of the critical MOD-1-expressing targets induces prolonged dwelling states. PDF promotes roaming states through a Gas-coupled PDF receptor; optogenetic activation of cAMP production in PDF receptor-expressing cells induces prolonged roaming states. The neurons that produce and respond to each neuromodulator form a distributed circuit orthogonal to the classical wiring diagram, with several essential neurons that express each molecule. The slow temporal dynamics of this neuromodulatory circuit supplement fast motor circuits to organize long-lasting behavioral states.	[Flavell, Steven W.; Pokala, Navin; Macosko, Evan Z.; Albrecht, Dirk R.; Larsch, Johannes; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@mail.rockefeller.edu	Pokala, Navin/AAH-5719-2019; Macosko, Evan/X-4664-2019; Larsch, Johannes/AAN-1985-2021	Pokala, Navin/0000-0003-2323-6190; Larsch, Johannes/0000-0001-5664-433X; Bargmann, Cornelia/0000-0002-8484-0618; Flavell, Steven/0000-0001-9464-1877	G. Harold and Leila Y. Mathers Foundation; Ellison Medical Foundation; Helen Hay Whitney postdoctoral fellowship; NIH [GM07739]; Boehringer Ingelheim Fonds PhD Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Helen Hay Whitney postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. R. Horvitz, S. Mitani, the National BioResource Project (NBRP), and the Caenorhabditis Genetics Center (CGC) for strains; L. Looger for GCaMP5; A. Gordus and A. Katsov for help with data analysis; I. Shachrai for initiating optogenetic experiments; Y. Saheki, A. Bendesky, J. Garrison, J. Greene, and other members of our laboratory for helpful discussions; and S. Kuehn and R. Axel for comments on the manuscript. This work was supported by the G. Harold and Leila Y. Mathers Foundation and the Ellison Medical Foundation (C. I. B.), a Helen Hay Whitney postdoctoral fellowship (S. W. F.), NIH grant GM07739 (E.Z.M.), and a Boehringer Ingelheim Fonds PhD Fellowship (J. L.). C. I. B. is an Investigator of the Howard Hughes Medical Institute.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; Ben Arous J., 2009, NAT NEUROSCI, V4; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chase Daniel L, 2007, WormBook, P1; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Frank MG, 2002, NEUROPSYCHOPHARMACOL, V27, P869, DOI 10.1016/S0893-133X(02)00353-6; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; Omura D.T., 2008, THESIS MIT CAMBRIDGE; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Saifee O, 2011, ANESTHESIOLOGY, V115, P1162, DOI 10.1097/ALN.0b013e318239355d; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schultheis C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018766; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018	31	199	203	4	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1023	1035		10.1016/j.cell.2013.08.001	http://dx.doi.org/10.1016/j.cell.2013.08.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23972393	Bronze, Green Accepted			2022-12-28	WOS:000323767300016
J	Reck, M; Heigener, DF; Mok, T; Soria, JC; Rabe, KF				Reck, Martin; Heigener, David F.; Mok, Tony; Soria, Jean-Charles; Rabe, Klaus F.			Management of non-small-cell lung cancer: recent developments	LANCET			English	Article							FINE-NEEDLE-ASPIRATION; PHASE-III TRIAL; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; CISPLATIN PLUS GEMCITABINE; ENDOSCOPIC ULTRASOUND; 1ST-LINE TREATMENT; DOUBLE-BLIND; MAINTENANCE THERAPY; RADIATION-THERAPY; SUPPORTIVE CARE	Non-small-cell lung cancer is one of the leading causes of deaths from cancer worldwide. Therefore, improvements in diagnostics and treatments are urgently needed. In this review, we will discuss the evolution of lung cancer staging towards more non-invasive, endoscopy-based, and image-based methods, and the development of stage-adapted treatment. A special focus will be placed on the role of novel surgical approaches and modern radiotherapy strategies for early stages of disease, the effect of multimodal treatment in locally advanced disease, and ongoing developments in the treatment of patients with metastatic disease. In particular, we will include an emphasis on targeted therapies, which are based on the assumption that a treatable driver mutation or gene rearrangement is present within the tumour. Finally, the position of lung cancer treatment on the pathway to personalised therapy will be discussed.	[Reck, Martin; Heigener, David F.; Rabe, Klaus F.] Airway Res Ctr North, LungenClin Grosshansdorf, D-22927 Grosshansdorf, Germany; [Rabe, Klaus F.] Univ Kiel, Dept Med, Airway Res Ctr North, Kiel, Germany; [Mok, Tony] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong Canc Inst, State Key Lab South China, Hong Kong, Hong Kong, Peoples R China; [Soria, Jean-Charles] Inst Gustave Roussy Villejuif, Dept Med, Paris, France; [Soria, Jean-Charles] Univ South Paris, Paris, France	Grosshansdorf Hospital; University of Kiel; Chinese University of Hong Kong; Sanofi-Aventis; Sanofi France; UNICANCER; Gustave Roussy	Reck, M (corresponding author), Airway Res Ctr North, LungenClin Grosshansdorf, Dept Thorac Oncol, Woehrendamm 80, D-22927 Grosshansdorf, Germany.	m.reck@lungenclinic.de	Rabe, Klaus F./AAW-6296-2021; Reck, Martin/ABF-5721-2020; Mok, Tony Shu Kam/B-2310-2019; Soria, Jean-Charles/F-3619-2014	Rabe, Klaus F./0000-0002-7020-1401; Reck, Martin/0000-0002-5348-4462; Mok, Tony Shu Kam/0000-0002-8251-0551; 				Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Annema JT, 2010, JAMA-J AM MED ASSOC, V304, P2245, DOI 10.1001/jama.2010.1705; Annema JT, 2005, JAMA-J AM MED ASSOC, V294, P931, DOI 10.1001/jama.294.8.931; Annema JT, 2005, J CLIN ONCOL, V23, P8357, DOI 10.1200/JCO.2005.01.1965; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Auperin A, 2006, ANN ONCOL, V17, P473, DOI 10.1093/annonc/mdj117; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Barlesi F, 2011, EUR J CANCER, V47, P16, DOI 10.1016/S0959-8049(11)70133-2; Besse B, 2013, J CLIN ONCOL, V31, P1050, DOI 10.1200/JCO.2012.43.0900; Besse B, 2013, LANCET ONCOL, V14, P191, DOI 10.1016/S1470-2045(13)70018-4; Bhutani MS, 1997, GASTROINTEST ENDOSC, V45, P474, DOI 10.1016/S0016-5107(97)70176-7; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Carney DN, 2002, NEW ENGL J MED, V346, P126, DOI 10.1056/NEJM200201103460211; Ceppi P, 2006, CANCER-AM CANCER SOC, V107, P1589, DOI 10.1002/cncr.22208; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Cuaron J, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00208; Decoster L, 2012, ANN ONCOL, V23, P1387, DOI 10.1093/annonc/mdr564; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Dienemann H, 2012, ZBL CHIR, V137, P228, DOI 10.1055/s-0031-1283949; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Edelman MJ, 2012, J THORAC ONCOL, V7, P1331, DOI 10.1097/JTO.0b013e3182629e37; Felip E, 2011, ANN ONCOL, V22, P1507, DOI 10.1093/annonc/mdr150; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fischer B, 2009, NEW ENGL J MED, V361, P32, DOI 10.1056/NEJMoa0900043; Friboulet L, 2013, NEW ENGL J MED, V368, P1101, DOI 10.1056/NEJMoa1214271; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gomez-Caro A, 2011, EUR J CARDIO-THORAC, V39, P352, DOI 10.1016/j.ejcts.2010.07.002; Goss G, 2012, J CLIN ONCOL, V28; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Hamada C, 2009, J THORAC ONCOL, V4, P1511, DOI 10.1097/JTO.0b013e3181bbf1f2; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Herth FJF, 2006, EUR RESPIR J, V28, P1264, DOI 10.1183/09031936.00013806; Hetth FJF, 2008, CHEST, V133, P887, DOI 10.1378/chest.07-2535; Hirsch FR, 2013, J THORAC ONCOL, V8, P373, DOI 10.1097/JTO.0b013e31827ed0ff; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janjigian YY, 2011, J THORAC ONCOL, V6, P569, DOI 10.1097/JTO.0b013e318202bffe; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karamouzis MV, 2009, LANCET ONCOL, V10, P709, DOI 10.1016/S1470-2045(09)70137-8; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lally BE, 2006, J CLIN ONCOL, V24, P2998, DOI 10.1200/JCO.2005.04.6110; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Le Pechoux C, 2011, ONCOLOGIST, V16, P672, DOI 10.1634/theoncologist.2010-0150; Lilenbaum R, 2012, J CLIN ONCOL S, V30; Lim E, 2009, J THORAC ONCOL, V4, P1380, DOI 10.1097/JTO.0b013e3181b9ecca; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mok T, 2013, J CLIN ONCOL, V31, P1081, DOI 10.1200/JCO.2012.43.0652; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mok TSK, 2011, NAT REV CLIN ONCOL, V8, P661, DOI 10.1038/nrclinonc.2011.126; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik JH, 2011, J THORAC ONCOL, V6, P466, DOI 10.1097/JTO.0b013e31820b82e8; Patel JD, 2012, 2012 CHIC MULT S THO; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; PORT Meta-analysis Trialists Group, 2005, COCHRANE DB SYST REV, V2; Quoix EA, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.2; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Reck M, 2013, ANN ONCOL, V24, P75, DOI 10.1093/annonc/mds213; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rintoul RC, 2009, J THORAC ONCOL, V4, P44, DOI 10.1097/JTO.0b013e3181914357; Robinson CG, 2013, J THORAC ONCOL, V8, P192, DOI 10.1097/JTO.0b013e31827ce361; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sause W, 2000, CHEST, V117, P358, DOI 10.1378/chest.117.2.358; Scagliotti G, 2010, J CLIN ONCOL, V28, P1835, DOI 10.1200/JCO.2009.26.1321; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schinkel C, 2000, J CARDIOVASC SURG, V41, P637; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song WA, 2010, J THORAC ONCOL, V5, P510, DOI 10.1097/JTO.0b013e3181cd3345; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Tada H, 2012, J CLIN ONCOL S, V30; Tartour E, LANCET RESP IN PRESS; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tournoy KG, 2008, AM J RESP CRIT CARE, V177, P531, DOI 10.1164/rccm.200708-1241OC; Tournoy KG, 2009, J THORAC ONCOL, V4, P1576, DOI 10.1097/JTO.0b013e3181c1274f; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Ulivi P, 2012, INT J ONCOL, V41, P147, DOI 10.3892/ijo.2012.1432; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Meerbeeck JP, 2007, JNCI-J NATL CANCER I, V99, P442, DOI 10.1093/jnci/djk093; Varlotto J, 2013, CANCER-AM CANCER SOC, V119, P2683, DOI 10.1002/cncr.28100; Zhang RF, 2013, EUR J CANCER, V49, P1860, DOI 10.1016/j.ejca.2013.02.008	101	585	606	4	112	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					709	719		10.1016/S0140-6736(13)61502-0	http://dx.doi.org/10.1016/S0140-6736(13)61502-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206SI	23972814				2022-12-28	WOS:000323542400029
J	Volz, J; Rauschenbeutel, A				Volz, Juergen; Rauschenbeutel, Arno			Triggering an Optical Transistor with One Photon	SCIENCE			English	Editorial Material							MEMORY		[Volz, Juergen; Rauschenbeutel, Arno] Vienna Univ Technol, Vienna Ctr Quantum Sci & Technol, Atominst, A-1020 Vienna, Austria	Technische Universitat Wien	Volz, J (corresponding author), Vienna Univ Technol, Vienna Ctr Quantum Sci & Technol, Atominst, Stad Allee 2, A-1020 Vienna, Austria.	jvolz@ati.ac.at; arno.rauschenbeutel@ati.ac.at	Rauschenbeutel, Arno/C-1472-2013; Volz, Jürgen/N-6457-2016	Rauschenbeutel, Arno/0000-0003-2467-4029; Volz, Jürgen/0000-0002-3174-2141				Aoki T, 2006, NATURE, V443, P671, DOI 10.1038/nature05147; Berman P., 1994, CAVITY QUANTUM ELECT; Chen W, 2013, SCIENCE, V341, P768, DOI 10.1126/science.1238169; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Hosseini M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1175; Junge C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.213604; Lvovsky AI, 2009, NAT PHOTONICS, V3, P706, DOI 10.1038/nphoton.2009.231; Nielsen Michael A., 2002, QUANTUM COMPUTATION	9	11	12	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					725	726		10.1126/science.1242905	http://dx.doi.org/10.1126/science.1242905			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950521				2022-12-28	WOS:000323122200029
J	Heithaus, RE; Hogan, R				Heithaus, Robert Evans; Hogan, Reed			Unblinded by the Lights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heithaus, Robert Evans; Hogan, Reed] Baylor Univ, Med Ctr, Dallas, TX USA	Baylor University; Baylor University Medical Center	Heithaus, RE (corresponding author), Baylor Univ, Med Ctr, Dallas, TX USA.	evans.heithaus@baylorhealth.edu		Heithaus, Robert Evans/0000-0001-7949-0150					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					659	659		10.1056/NEJMicm1211366	http://dx.doi.org/10.1056/NEJMicm1211366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23944303				2022-12-28	WOS:000326354500012
J	Wheeler, T; von Braun, J				Wheeler, Tim; von Braun, Joachim			Climate Change Impacts on Global Food Security	SCIENCE			English	Review							VARIABILITY; GOVERNANCE; NUTRITION; CRISIS; YIELD; ICE	Climate change could potentially interrupt progress toward a world without hunger. A robust and coherent global pattern is discernible of the impacts of climate change on crop productivity that could have consequences for food availability. The stability of whole food systems may be at risk under climate change because of short-term variability in supply. However, the potential impact is less clear at regional scales, but it is likely that climate variability and change will exacerbate food insecurity in areas currently vulnerable to hunger and undernutrition. Likewise, it can be anticipated that food access and utilization will be affected indirectly via collateral effects on household and individual incomes, and food utilization could be impaired by loss of access to drinking water and damage to health. The evidence supports the need for considerable investment in adaptation and mitigation actions toward a "climate-smart food system" that is more resilient to climate change influences on food security.	[Wheeler, Tim] Univ Reading, Dept Agr, Walker Inst Climate Syst Res, Reading RG6 6AR, Berks, England; [Wheeler, Tim] Dept Int Dev, London SW1A 2EG, England; [von Braun, Joachim] Univ Bonn, Dept Econ & Tech Change, ZEF Ctr Dev Res B, D-53113 Bonn, Germany	University of Reading; University of Bonn	Wheeler, T (corresponding author), Univ Reading, Dept Agr, Walker Inst Climate Syst Res, Reading RG6 6AR, Berks, England.	t.r.wheeler@reading.ac.uk	von Braun, Joachim/AAA-7044-2020	von Braun, Joachim/0000-0001-6571-4838; Souza Jr, CARLOS/0000-0002-0205-6134	UK-China Sustainable Agriculture Innovation Network programme of the UK Department for Environment, Food and Rural Affairs, International Sustainable Development Fund [DC09-07]	UK-China Sustainable Agriculture Innovation Network programme of the UK Department for Environment, Food and Rural Affairs, International Sustainable Development Fund	We thank H. Li, Q. Zhang, and F. Zhang of CABI for conducting the bibliographic analysis. T. W. was partly supported by the UK-China Sustainable Agriculture Innovation Network programme of the UK Department for Environment, Food and Rural Affairs, International Sustainable Development Fund (DC09-07).	Arezeki A., 2011, POLICY RESEARCH WORK; Arndt C., 2012, UN UNIV WORLD INSTIT; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/NCLIMATE1916, 10.1038/nclimate1916]; Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Ban K., 2012, A MESSAGE FROM THE U; Barrientos A., 2008, SOCIAL PROTECTION FO; Beckman J, 2012, EUR REV AGRIC ECON, V39, P137, DOI 10.1093/erae/jbr041; Berazneva J, 2013, FOOD POLICY, V39, P28, DOI 10.1016/j.foodpol.2012.12.007; Bohm R, 2010, CLIMATIC CHANGE, V101, P41, DOI 10.1007/s10584-009-9649-4; Bouis HE, 2003, P NUTR SOC, V62, P403, DOI 10.1079/PNS2003262; Bruinsma J., 2003, WORLD AGRICULTURE TO; Campbell AA, 2010, J NUTR, V140, p189S, DOI 10.3945/jn.109.110718; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cline W., 2007, GLOBAL WARMING AND A; Committee on America's Climate Choices; National Research Council, 2011, AMERICAS CLIMATE CHO; de Brauw A, 2011, FOOD POLICY, V36, P28, DOI 10.1016/j.foodpol.2010.11.002; Deininger K, 2009, WORLD BANK RES OBSER, V24, P233, DOI 10.1093/wbro/lkp007; Delpla I, 2009, ENVIRON INT, V35, P1225, DOI 10.1016/j.envint.2009.07.001; FAO, 2012, TECHNICAL NOTE FAO M; FAO (Food and Agriculture Organization), 1996, ROME DECLARATION ON; FAO WFP & IFAD, 2012, THE STATE OF FOOD IN; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hashizume M, 2008, J WATER HEALTH, V6, P323, DOI 10.2166/wh.2008.062; Headey D, 2008, AGR ECON-BLACKWELL, V39, P375, DOI 10.1111/j.1574-0862.2008.00345.x; Hertel TW, 2010, GLOBAL ENVIRON CHANG, V20, P577, DOI 10.1016/j.gloenvcha.2010.07.001; High-Level Panel of Experts on Food Security and Nutrition (HLPE), 2012, HLPE REPORT NO 3; Kato K., 2011, AGRIC ECON, V42, P593; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Kundzewiczs ZW, 2007, CLIMATE CHANGE 2007, P173, DOI DOI 10.1007/S11269-006-3091-4; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Lorenz C, 2012, J HYDROMETEOROL, V13, P1397, DOI 10.1175/JHM-D-11-088.1; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Maxwell D, 1999, DEV CHANGE, V30, P825, DOI 10.1111/1467-7660.00139; Mearns LO, 1996, CLIMATIC CHANGE, V32, P257, DOI 10.1007/BF00142465; Michelsen A.M., 2000, INT J WATER RESOUR D, V16, P209, DOI [10.1080/07900620050003125, DOI 10.1080/07900620050003125]; Mirzabaev A, 2013, THESIS; Nelson GC, 2010, INT FOOD POL RES I, DOI DOI 10.2499/9780896291867; Nestel P, 2006, J NUTR, V136, P1064, DOI 10.1093/jn/136.4.1064; Nino-Zarazua M, 2012, WORLD DEV, V40, P163, DOI 10.1016/j.worlddev.2011.04.004; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Paterson RRM, 2010, FOOD RES INT, V43, P1902, DOI 10.1016/j.foodres.2009.07.010; PHIPPS TT, 1984, AM J AGR ECON, V66, P422, DOI 10.2307/1240920; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ringler C., 2011, HOW CAN AFRICAN AGRI; Ringler C, 2012, 2012 GLOBAL HUNGER I; Rogers B. L., 2002, SOCIAL PROTECTION DI; Rohde R., 2013, GEOINFOR GEOSTAT OVE, V1, P1, DOI [10.4172/2327-4581.1000101, 10.4172/gigs.1000101]; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Royal Society, 2010, CLIMATE CHANGE A SUM; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Shimi AC, 2010, DISASTER PREV MANAG, V19, P298, DOI 10.1108/09653561011052484; Silvestri S, 2012, REG ENVIRON CHANGE, V12, P791, DOI 10.1007/s10113-012-0293-6; Smith JP, 2002, J POPUL ECON, V15, P161, DOI 10.1007/PL00003837; Tans P., 2013, TRENDS IN ATMOSPHERI; Tefera T, 2012, FOOD SECUR, V4, P267, DOI 10.1007/s12571-012-0182-3; Torlesse H, 2003, J NUTR, V133, P1320; Traerup SLM, 2012, GLOBAL ENVIRON CHANG, V22, P255, DOI 10.1016/j.gloenvcha.2011.09.017; Vlek PLG, 2010, ADV SOIL SCI-SER, P57; von Braun J., 2012, INSTITUTIONS AND COM, V150-I, P298; von Braun J, 2009, FOOD SECUR, V1, P9, DOI 10.1007/s12571-008-0001-z; Wheeler T., 2013, Animal Frontiers, V3, P36, DOI 10.2527/af.2013-0006; Wheeler TR, 2000, AGR ECOSYST ENVIRON, V82, P159, DOI 10.1016/S0167-8809(00)00224-3; World Bank, 2010, WORLD BANK DEVELOPME; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Ziervogel G, 2010, WIRES CLIM CHANGE, V1, P525, DOI 10.1002/wcc.56	71	1354	1394	130	1421	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					508	513		10.1126/science.1239402	http://dx.doi.org/10.1126/science.1239402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	193UJ	23908229				2022-12-28	WOS:000322586700043
J	Pollitzer, E				Pollitzer, Elizabeth			Cell sex matters	NATURE			English	Editorial Material							FEMALE CELLS		Portia, London, England		Pollitzer, E (corresponding author), Portia, London, England.	elizabeth@portiaweb.org.uk						Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P3293, DOI 10.1002/cncr.24366; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Wizemann T. M., 2001, EXPLORING BIOL CONTR	7	39	40	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					23	24		10.1038/500023a	http://dx.doi.org/10.1038/500023a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23903733	Bronze			2022-12-28	WOS:000322514800009
J	Ruprecht, P; Plank, T				Ruprecht, Philipp; Plank, Terry			Feeding andesitic eruptions with a high-speed connection from the mantle	NATURE			English	Article							DIFFUSION-COEFFICIENTS; TRACE-ELEMENTS; IRAZU VOLCANO; COSTA-RICA; OLIVINE; MAGMA; MELTS; ARC; NI; PRESSURE	Convergent margin volcanism is ultimately fed by magmas generated in the mantle, but the connection between the mantle and the eruption at the surface is typically obscured by cooling, crystallization and magma mixing within the crust(1-3). Geophysical techniques are also not very effective in the lower and middle crust, where seismic events are rare and resolution is generally poor(4,5). It has thus been unclear how fast mantle-derived magmas transit the crust and recharge crustal magma chambers. Here we use diffusion modelling of nickel zonation profiles in primitive olivines from diverse primary melts(6-10) to show how mantle recharge may occur on timescales as short as eruptions themselves. In Irazu volcano in Costa Rica, magmas apparently ascend from their source region in the mantle through crust about 35 kilometres thick in just months to years, recharging hybrid basaltic andesites over the course of the eruption. These results show that large stratovolcanoes with shallow magma chambers(11,12) may still preserve the deep record of their mantle origin in olivine crystals. This approach-documenting magma ascent timescales from the mantle beneath a convergent margin stratovolcano-can be applied to other eruptions that record magma mixing with recharge melts. Signs of volcanic unrest are typically monitored at the surface or upper crust; new efforts should look deeper, tracking magma movement from the base of the crust to the surface in the months to years before eruptions.	[Ruprecht, Philipp; Plank, Terry] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Ruprecht, P (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W, Palisades, NY 10964 USA.	ruprecht@ldeo.columbia.edu	Plank, Terry/D-9542-2012; Ruprecht, Philipp/I-3135-2013; Ruprecht, Philipp/AAD-4047-2019	Ruprecht, Philipp/0000-0003-0429-3499; Plank, Terry/0000-0002-1665-0484	Alexander-von-Humboldt foundation; NSF [EAR0948533]	Alexander-von-Humboldt foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF))	We thank G. Alvarado for help during tephra sampling and S. Straub for discussions on olivine partitioning. The work was funded by a Feodor-Lynen Fellowship from the Alexander-von-Humboldt foundation to P.R. and NSF grant EAR0948533 to T.P. This is Lamont-Doherty Earth Observatory contribution 7695.	Alvarado GE, 2006, GEOL SOC AM SPEC PAP, V412, P259, DOI 10.1130/2006.2412(14); Alvarado Induni G. E., 1993, THESIS CHRISTIAN ALB, P1; Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; ARCULUS RJ, 1980, J PETROL, V21, P743, DOI 10.1093/petrology/21.4.743; Benjamin ER, 2007, J VOLCANOL GEOTH RES, V168, P68, DOI 10.1016/j.jvolgeores.2007.08.008; Carr MJ, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001396; Costa F, 2005, GEOLOGY, V33, P837, DOI 10.1130/G21675.1; Costa F., 2010, TIMESCALES MAGMATIC, DOI DOI 10.1002/9781444328509.CH7; Couch S, 2001, NATURE, V411, P1037, DOI 10.1038/35082540; Danyushevsky LV, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003516; Dungan MA, 2001, J PETROL, V42, P555, DOI 10.1093/petrology/42.3.555; Dzierma Y, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002936; Ghiorso MS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000217; Grove TL, 2005, CONTRIB MINERAL PETR, V148, P542, DOI 10.1007/s00410-004-0619-6; Holzapfel C, 2007, PHYS EARTH PLANET IN, V162, P186, DOI 10.1016/j.pepi.2007.04.009; JAROSEWICH E, 1987, GEOSTANDARD NEWSLETT, V11, P197, DOI 10.1111/j.1751-908X.1987.tb00027.x; Jarosewich E., 1980, GEOSTANDARD NEWSLETT, V4, P43, DOI [10.1111/j.1751-908X.1980.tb00273.x, DOI 10.1111/J.1751-908X.1980.TB00273.X]; Kent AJR, 2010, NAT GEOSCI, V3, P631, DOI 10.1038/NGEO924; KLEIN FW, 1982, J GEOPHYS RES, V87, P7719, DOI 10.1029/JB087iB09p07719; Li CS, 2010, CHEM GEOL, V275, P99, DOI 10.1016/j.chemgeo.2010.05.001; Lizarralde D., 2010, AM GEOPH UN FALL M, pT13A; Milman-Barris MS, 2008, CONTRIB MINERAL PETR, V155, P739, DOI 10.1007/s00410-007-0268-7; Norman MD, 1998, CONTRIB MINERAL PETR, V130, P240, DOI 10.1007/s004100050363; Petry C, 2004, GEOCHIM COSMOCHIM AC, V68, P4179, DOI 10.1016/j.gca.2004.02.024; Qian Q, 2010, GEOLOGY, V38, P331, DOI 10.1130/G30788.1; Ruprecht P, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002022; Ruprecht P, 2007, J VOLCANOL GEOTH RES, V165, P142, DOI 10.1016/j.jvolgeores.2007.06.002; Ruprecht P, 2012, J PETROL, V53, P841, DOI 10.1093/petrology/egs001; Rutherford MJ, 2008, REV MINERAL GEOCHEM, V69, P241, DOI 10.2138/rmg.2008.69.7; Shelly DR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049336; Sisson TW, 1998, NATURE, V391, P883, DOI 10.1038/36087; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; Spandler C, 2010, CONTRIB MINERAL PETR, V159, P791, DOI 10.1007/s00410-009-0456-8; Straub SM, 2011, EARTH PLANET SC LETT, V303, P337, DOI 10.1016/j.epsl.2011.01.013; Straub SM, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001583; Tamura Y, 2000, J PETROL, V41, P431, DOI 10.1093/petrology/41.3.431; Tarasewicz J, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008751; Taura H, 1998, PHYS CHEM MINER, V25, P469, DOI 10.1007/s002690050138; Wang ZR, 2008, CONTRIB MINERAL PETR, V156, P661, DOI 10.1007/s00410-008-0308-y; Weaver SL, 2011, EARTH PLANET SC LETT, V308, P97, DOI 10.1016/j.epsl.2011.05.040; White R W, 1966, CONTRIB MINERAL PETR, V12, p245~314; White RS, 2011, EARTH PLANET SC LETT, V304, P300, DOI 10.1016/j.epsl.2011.02.038	43	103	106	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					68	U88		10.1038/nature12342	http://dx.doi.org/10.1038/nature12342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23903749				2022-12-28	WOS:000322514800029
J	Moyer, VA; LeFevre, ML; Siu, AL; Peters, JJ; Baumann, LC; Bibbins-Domingo, K; Curry, SJ; Ebell, M; Flores, G; Garcia, FAR; Cantu, AG; Grossman, DC; Herzstein, J; Nicholson, WK; Owens, DK; Phillips, WR; Pignone, MP				Moyer, Virginia A.; LeFevre, Michael L.; Siu, Albert L.; Peters, James J.; Baumann, Linda Ciofu; Bibbins-Domingo, Kirsten; Curry, Susan J.; Ebell, Mark; Flores, Glenn; Garcia, Francisco A. R.; Cantu, Adelita Gonzales; Grossman, David C.; Herzstein, Jessica; Nicholson, Wanda K.; Owens, Douglas K.; Phillips, William R.; Pignone, Michael P.		US Preventive Serv Task Force	Primary Care Interventions to Prevent Tobacco Use in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on primary care interventions to prevent tobacco use in children and adolescents. Methods: The USPSTF reviewed the evidence on the effectiveness of primary care interventions on the rates of initiation or cessation of tobacco use in children and adolescents and on health outcomes, such as respiratory health, dental and oral health, and adult smoking. The USPSTF also reviewed the evidence on the potential harms of these interventions. Population: This recommendation applies to school-aged children and adolescents. The USPSTF has issued a separate recommendation statement on tobacco use counseling in adults and pregnant women. Recommendation: The USPSTF recommends that primary care clinicians provide interventions, including education or brief counseling, to prevent initiation of tobacco use in school-aged children and adolescents.	[Moyer, Virginia A.] Amer Board Pediat Inc, Chapel Hill, NC 27514 USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO 65211 USA; [Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Peters, James J.] Vet Affairs Med Ctr, Bronx, NY USA; [Baumann, Linda Ciofu] Univ Wisconsin, Madison, WI 53706 USA; [Bibbins-Domingo, Kirsten] Univ California, San Francisco, CA 94143 USA; [Curry, Susan J.] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA; [Ebell, Mark] Univ Georgia, Athens, GA 30602 USA; [Flores, Glenn] Univ Texas Southwestern, Dallas, TX USA; [Garcia, Francisco A. R.] Pima County Dept Hlth, Tucson, AZ USA; [Cantu, Adelita Gonzales] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; [Grossman, David C.] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Herzstein, Jessica] Air Prod, Allentown, PA USA; [Nicholson, Wanda K.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Owens, Douglas K.] Veteran Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA	University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; University of Iowa; University System of Georgia; University of Georgia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; Group Health Cooperative; Air Products & Chemicals; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Stanford University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Moyer, VA (corresponding author), Amer Board Pediat Inc, Chapel Hill, NC 27514 USA.		Phillips, William R./V-1065-2017	Phillips, William R./0000-0003-2802-4349; Pignone, Michael/0000-0002-6657-7342	U.S. Congress mandates that the Agency for Healthcare Research and Quality	U.S. Congress mandates that the Agency for Healthcare Research and Quality	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Arrazola R. A., 2010, Morbidity and Mortality Weekly Report, V59, P1063; Binns HJ, 2009, PEDIATRICS, V124, P1474, DOI 10.1542/peds.2009-2114; Community Preventive Services Task Force, 2012, RED TOB US SEC SMOK; Curry SJ, 2013, AM J COMMUN PSYCHOL, V51, P15, DOI 10.1007/s10464-012-9496-8; DiFranza JR, 2011, CURR PEDIATR REV, V7, P88, DOI 10.2174/157339611795735648; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Patnode CD, 2012, EVIDENCE SYNTHESIS; Sussman Steve, 2009, Tob Induc Dis, V5, P3, DOI 10.1186/1617-9625-5-3; U.S. Preventive Services Task Force, 2003, COUNS PREV TOB US TO; US Preventive Serv Task Force, 2009, ANN INTERN MED, V150, P551, DOI 10.7326/0003-4819-150-8-200904210-00009	11	30	30	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					552	557		10.7326/0003-4819-159-8-201310150-00697	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00697			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	23974083				2022-12-28	WOS:000326751200018
J	Gao, DX; Wu, JX; Wu, YT; Du, FH; Aroh, C; Yan, N; Sun, LJ; Chen, ZJJ				Gao, Daxing; Wu, Jiaxi; Wu, You-Tong; Du, Fenghe; Aroh, Chukwuemika; Yan, Nan; Sun, Lijun; Chen, Zhijian J.			Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses	SCIENCE			English	Article							DNA SENSOR; 2ND-MESSENGER; DINUCLEOTIDE	Retroviruses, including HIV, can activate innate immune responses, but the host sensors for retroviruses are largely unknown. Here we show that HIV infection activates cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) to produce cGAMP, which binds to and activates the adaptor protein STING to induce type I interferons and other cytokines. Inhibitors of HIV reverse transcriptase, but not integrase, abrogated interferon-beta induction by the virus, suggesting that the reverse-transcribed HIV DNA triggers the innate immune response. Knockout or knockdown of cGAS in mouse or human cell lines blocked cytokine induction by HIV, murine leukemia virus, and simian immunodeficiency virus. These results indicate that cGAS is an innate immune sensor of HIV and other retroviruses.	[Gao, Daxing; Wu, Jiaxi; Wu, You-Tong; Du, Fenghe; Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Du, Fenghe; Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Aroh, Chukwuemika; Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Aroh, Chukwuemika; Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu	Wu, Jiaxi/K-3322-2016; Gao, Daxing/J-4733-2017; Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012	Wu, Jiaxi/0000-0002-6976-4784; Gao, Daxing/0000-0002-1493-4467; Chen, Zhijian/0000-0002-8475-8251	NIH [R01-AI093967, RO1-AI098569]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967, R01AI098569] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. Chen for assistance with mass spectrometry. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Materials including the cGAS knockout cell lines may be requested upon signing of a materials transfer agreement. This work was supported by NIH grants to Z.J.C. (R01-AI093967) and N.Y. (RO1-AI098569). Z.J.C is an investigator of the Howard Hughes Medical Institute.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Medzhitov R, 2008, NATURE, V455, P591, DOI 10.1038/455591a; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	20	655	695	7	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					903	906		10.1126/science.1240933	http://dx.doi.org/10.1126/science.1240933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23929945	Green Accepted			2022-12-28	WOS:000323370600047
J	Dimond, A; Fraser, P				Dimond, Andrew; Fraser, Peter			Long Noncoding RNAs Xist in Three Dimensions	SCIENCE			English	Editorial Material							X-CHROMOSOME; CHROMATIN; DOMAINS; INACTIVATION		[Dimond, Andrew; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Dimond, A (corresponding author), Babraham Inst, Nucl Dynam Programme, Cambridge, England.	peter.fraser@babraham.ac.uk		Dimond, Andrew/0000-0002-2996-2479; Fraser, Peter/0000-0002-0041-1227	Biotechnology and Biological Sciences Research Council [BB/D014050/1, BBS/E/B/0000C151] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M765] Funding Source: researchfish; Medical Research Council [1128090] Funding Source: researchfish; BBSRC [BB/D014050/1, BBS/E/B/0000C151, BBS/E/B/0000M765] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	13	15	15	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					720	721		10.1126/science.1243257	http://dx.doi.org/10.1126/science.1243257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950517				2022-12-28	WOS:000323122200025
J	Halbach, F; Reichelt, P; Rode, M; Conti, E				Halbach, Felix; Reichelt, Peter; Rode, Michaela; Conti, Elena			The Yeast Ski Complex: Crystal Structure and RNA Channeling to the Exosome Complex	CELL			English	Article							MESSENGER-RNA; QUALITY-CONTROL; MEIOTIC RECOMBINATION; RIBOSOMAL-RNA; NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC EXOSOME; POLY(A) POLYMERASE; DEGRADATION; PROTEIN	The Ski complex is a conserved multiprotein assembly required for the cytoplasmic functions of the exosome, including RNA turnover, surveillance, and interference. Ski2, Ski3, and Ski8 assemble in a tetramer with 1: 1: 2 stoichiometry. The crystal structure of an S. cerevisiae 370 kDa core complex shows that Ski3 forms an array of 33 TPR motifs organized in N-terminal and C-terminal arms. The C-terminal arm of Ski3 and the two Ski8 subunits position the helicase core of Ski2 centrally within the complex, enhancing RNA binding. The Ski3 N-terminal arm and the Ski2 insertion domain allosterically modulate the ATPase and helicase activities of the complex. Biochemical data suggest that the Ski complex can thread RNAs directly to the exosome, coupling the helicase and the exoribonuclease through a continuous RNA channel. Finally, we identify a Ski8-binding motif common to Ski3 and Spo11, rationalizing the moonlighting properties of Ski8 in mRNA decay and meiosis.	[Halbach, Felix; Reichelt, Peter; Rode, Michaela; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Conti, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	conti@biochem.mpg.de		Conti, Elena/0000-0003-1254-5588	Boehringer Ingelheim Fonds; Max Planck Gesellschaft; European Research Council (ERC) [294371]; European Research Council (ITN RNPnet); Deutsche Forschungsgemeinschaft [DFG SFB646, SFB1035, GRK1721, FOR1680]; Deutsche Forschungsgemeinschaft (CIPSM)	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Max Planck Gesellschaft(Max Planck Society); European Research Council (ERC)(European Research Council (ERC)); European Research Council (ITN RNPnet); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (CIPSM)(German Research Foundation (DFG))	We thank the MPI-Biochemistry Core Facility and Crystallization Facility, F. Bonneau for help with biochemical assays, E. Kowalinski, J. Ebert, and D. Makino for exosome samples or plasmids, and S. Chakrabarti for Upf1 samples. We also thank the staff of the Swiss Light Source synchrotron for assistance during data collection and Z. Storchova, S. Jentsch, and the CSH course on yeast genetics for guidance and training in the in vivo experiments. We also thank M. Krause for the drawing in Figure 6B and the members of our lab for discussions and for critical reading of the manuscript. This study was supported by the Boehringer Ingelheim Fonds (to F. H.), the Max Planck Gesellschaft, the European Research Council (ERC Advanced Investigator Grant 294371 and ITN RNPnet), and the Deutsche Forschungsgemeinschaft (DFG SFB646, SFB1035, GRK1721, FOR1680, and CIPSM; to E. C.). F. H. purified proteins and conducted crystallization and structure determination as well as all in vitro assays. P. R. generated and analyzed yeast strains. M. R. carried out the insect-cell expression. E. C. supervised the project. F. H. and E. C. wrote the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bernstein J, 2010, BIOCHEMISTRY-US, V49, P10357, DOI 10.1021/bi101518x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bradley MJ, 2012, METHOD ENZYMOL, V511, P29, DOI 10.1016/B978-0-12-396546-2.00002-4; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZH, 2004, PROTEIN SCI, V13, P2673, DOI 10.1110/ps.04856504; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; JOHNSON AW, 1995, MOL CELL BIOL, V15, P2719; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Klauer AA, 2013, NUCLEIC ACIDS RES, V41, P533, DOI 10.1093/nar/gks1013; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Madrona AY, 2004, PROTEIN SCI, V13, P1557, DOI 10.1110/ps.04704704; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schrodinger LCC, 2022, PYMOL MOL GRAPHICS S; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Synowsky SA, 2008, PROTEIN SCI, V17, P119, DOI 10.1110/ps.073155908; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wang LN, 2005, RNA, V11, P1291, DOI 10.1261/rna.2060405; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	57	115	119	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 15	2013	154	4					814	826		10.1016/j.cell.2013.07.017	http://dx.doi.org/10.1016/j.cell.2013.07.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953113	Bronze			2022-12-28	WOS:000323202500013
J	Macilwain, C				Macilwain, Colin			Halt the avalanche of performance metrics	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	10	10	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					255	255		10.1038/500255a	http://dx.doi.org/10.1038/500255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AF	23955199	Bronze			2022-12-28	WOS:000323112400003
J	Chemler, SR				Chemler, Sherry R.			Copper's Contribution to Amination Catalysis	SCIENCE			English	Editorial Material							ULLMANN; CYCLOADDITION; COMPLEXES; HALIDES		SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chemler, SR (corresponding author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.	schemler@buffalo.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078383] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078383] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bissember AC, 2013, ANGEW CHEM INT EDIT, V52, P5129, DOI 10.1002/anie.201301202; Casitas A, 2013, CHEM SCI, V4, P2301, DOI 10.1039/c3sc21818j; Clark JS, 2005, CHEM COMMUN, P5175, DOI 10.1039/b509678b; Creutz SE, 2012, SCIENCE, V338, P647, DOI 10.1126/science.1226458; Gephart RT, 2012, ORGANOMETALLICS, V31, P7728, DOI 10.1021/om300840z; Harutyunyan SR, 2008, CHEM REV, V108, P2824, DOI 10.1021/cr068424k; Johnson JS, 2000, ACCOUNTS CHEM RES, V33, P325, DOI 10.1021/ar960062n; Jones GO, 2010, J AM CHEM SOC, V132, P6205, DOI 10.1021/ja100739h; Klapars A, 2002, J AM CHEM SOC, V124, P7421, DOI 10.1021/ja0260465; Kunz K, 2003, SYNLETT, P2428, DOI 10.1055/s-2003-42473; Liwosz TW, 2013, CHEM-EUR J, V19, P12771, DOI 10.1002/chem.201301800; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Paderes MC, 2013, J ORG CHEM, V78, P506, DOI 10.1021/jo3023632; Sperotto E, 2010, DALTON T, V39, P10338, DOI 10.1039/c0dt00674b; Wendlandt AE, 2011, ANGEW CHEM INT EDIT, V50, P11062, DOI 10.1002/anie.201103945; Zhang C, 2012, CHEM SOC REV, V41, P3464, DOI 10.1039/c2cs15323h; Zhao BG, 2011, J AM CHEM SOC, V133, P20890, DOI 10.1021/ja207691a; Zhou FT, 2012, J AM CHEM SOC, V134, P14326, DOI 10.1021/ja306631z; Zhu SL, 2012, J AM CHEM SOC, V134, P10815, DOI 10.1021/ja305100g	19	50	50	3	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					624	626		10.1126/science.1237175	http://dx.doi.org/10.1126/science.1237175			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929974	Green Accepted			2022-12-28	WOS:000322884800027
J	Appleby, J				Appleby, John			Does good healthcare score as highly with the public as education and protection from crime?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.appleby@kingsfund.org.uk						My world, 2013, UN GLOB SURV BETT WO; UN, 2013, HIGH LEV PAN POST 20; United Nations, 2013, MY WORLD DAT REP; United Nations, 2013, MY WORLD AN; World Health Organisation, 2013, GLOB HLTH EXP DAT	5	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2013	347								f4705	10.1136/bmj.f4705	http://dx.doi.org/10.1136/bmj.f4705			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201CY	23924654				2022-12-28	WOS:000323119500010
J	Moxon, R; Snape, MD				Moxon, Richard; Snape, Matthew D.			The price of prevention: what now for immunisation against meningococcus B?	LANCET			English	Editorial Material							DISEASE; VACCINE		[Moxon, Richard] Univ Oxford, Dept Paediat, Oxford OX3 7LE, England; [Snape, Matthew D.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England; [Snape, Matthew D.] NIHR Oxford Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Moxon, R (corresponding author), Univ Oxford, Dept Paediat, Oxford OX3 7LE, England.			Snape, Matthew/0000-0003-0531-5426				Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Committee for Medicinal Products for Human Use. European Medicines Agency, 2012, ASS REP BEXS MEN GRO; European Medicines Agency, 2012, EUR MED AG REC APPR; FINNE J, 1983, LANCET, V2, P355; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Joint Committee on Vaccination and Immunisation, 2013, JCVI INT POS STAT US; Masignani V, 2002, EXPERT OPIN BIOL TH, V2, P895, DOI 10.1517/14712598.2.8.895; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; Moxon ER, 1997, LANCET, V350, P1240, DOI 10.1016/S0140-6736(97)03259-5; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Pouwels KB, 2013, HUM VACCIN IMMUNOTHE; Public Health England, 2013, HLTH PROTECTION REPO, V7; Snape MD, 2012, VACCINE, V30, pB67, DOI 10.1016/j.vaccine.2011.12.126	16	27	28	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					369	370		10.1016/S0140-6736(13)61572-X	http://dx.doi.org/10.1016/S0140-6736(13)61572-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23911365				2022-12-28	WOS:000322638500005
J	Post, E; Bhatt, US; Bitz, CM; Brodie, JF; Fulton, TL; Hebblewhite, M; Kerby, J; Kutz, SJ; Stirling, I; Walker, DA				Post, Eric; Bhatt, Uma S.; Bitz, Cecilia M.; Brodie, Jedediah F.; Fulton, Tara L.; Hebblewhite, Mark; Kerby, Jeffrey; Kutz, Susan J.; Stirling, Ian; Walker, Donald A.			Ecological Consequences of Sea-Ice Decline	SCIENCE			English	Review							CLIMATE-CHANGE; PHYTOPLANKTON BLOOMS; PACIFIC WALRUS; FOOD QUALITY; TRENDS	After a decade with nine of the lowest arctic sea-ice minima on record, including the historically low minimum in 2012, we synthesize recent developments in the study of ecological responses to sea-ice decline. Sea-ice loss emerges as an important driver of marine and terrestrial ecological dynamics, influencing productivity, species interactions, population mixing, gene flow, and pathogen and disease transmission. Major challenges in the near future include assigning clearer attribution to sea ice as a primary driver of such dynamics, especially in terrestrial systems, and addressing pressures arising from human use of arctic coastal and near-shore areas as sea ice diminishes.	[Post, Eric; Kerby, Jeffrey] Penn State Univ, Polar Ctr, Mueller Lab 208, University Pk, PA 16802 USA; [Post, Eric; Kerby, Jeffrey] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; [Bhatt, Uma S.] Univ Alaska Fairbanks, Inst Geophys, Dept Atmospher Sci, Fairbanks, AK 99775 USA; [Bitz, Cecilia M.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Brodie, Jedediah F.] Univ British Columbia, Biodivers Res Ctr, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Brodie, Jedediah F.] Univ British Columbia, Biodivers Res Ctr, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Fulton, Tara L.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hebblewhite, Mark] Univ Montana, Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA; [Kutz, Susan J.] Univ Calgary Vet Med, Dept Ecosyst Publ Hlth, Calgary, AB T2N 4Z6, Canada; [Stirling, Ian] Univ Alberta, Dept Biol Sci, Environm Canada, Wildlife Res Div, Edmonton, AB T6G 2E9, Canada; [Stirling, Ian] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Walker, Donald A.] Univ Alaska Fairbanks, Inst Arctic Biol, Alaska Geobot Ctr, Fairbanks, AK 99775 USA; [Walker, Donald A.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Alaska System; University of Alaska Fairbanks; University of Washington; University of Washington Seattle; University of British Columbia; University of British Columbia; University of California System; University of California Santa Cruz; University of Montana System; University of Montana; University of Calgary; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; University of Alberta; University of Alberta; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Post, E (corresponding author), Penn State Univ, Polar Ctr, Mueller Lab 208, University Pk, PA 16802 USA.	esp10@psu.edu	hebblewhite, mark/G-6164-2013; Bitz, Cecilia M/S-8423-2016; Hebblewhite, Mark/AAI-8101-2020	Bitz, Cecilia M/0000-0002-9477-7499; Hebblewhite, Mark/0000-0001-5382-1361; kutz, susan/0000-0003-2352-8687; Kerby, Jeffrey/0000-0002-2739-9096; Bhatt, Uma/0000-0003-1056-3686				Bhatt U. S., 2008, ARCTIC SEA ICE DECLI, V180, P91; Bhatt US, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI315.1; Burek KA, 2008, ECOL APPL, V18, pS126, DOI 10.1890/06-0553.1; Cahoon SMP, 2012, GLOBAL CHANGE BIOL, V18, P469, DOI 10.1111/j.1365-2486.2011.02528.x; Carmichael LE, 2008, CONSERV GENET, V9, P879, DOI 10.1007/s10592-007-9413-0; CAVMTeam Circumpolar arctic vegetation map, 2003, CONSERVATION OF ARCT; Chapin FS, 2008, FRONT ECOL ENVIRON, V6, P313, DOI 10.1890/080005; Comiso JC, 2012, J CLIMATE, V25, P1176, DOI 10.1175/JCLI-D-11-00113.1; Darnis G, 2012, CLIMATIC CHANGE, V115, P179, DOI 10.1007/s10584-012-0483-8; Dutrieux LP, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044028; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Fischbach A. S., 2009, ENUMERATION OF PACIF; Gaston AJ, 2003, ARCTIC, V56, P227; Geffen E, 2007, MOL ECOL, V16, P4241, DOI 10.1111/j.1365-294X.2007.03507.x; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Hezel PJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052794; Hu YX, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012384; Ji RB, 2013, GLOBAL CHANGE BIOL, V19, P734, DOI 10.1111/gcb.12074; Kahru M, 2011, GLOBAL CHANGE BIOL, V17, P1733, DOI 10.1111/j.1365-2486.2010.02312.x; Kelly B, 2010, NATURE, V468, P891, DOI 10.1038/468891a; Kerby J, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0484; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Kumar A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045022; Lawrence DM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033985; Lee SH, 2012, DEEP-SEA RES PT II, V81-84, P18, DOI 10.1016/j.dsr2.2011.06.005; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Leu E, 2010, MAR ECOL PROG SER, V411, P49, DOI 10.3354/meps08647; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lindqvist C, 2009, ZOOL SCR, V38, P113, DOI 10.1111/j.1463-6409.2008.00364.x; MacCracken JG, 2012, ECOL EVOL, V2, P2072, DOI 10.1002/ece3.317; Markus T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005436; Moody AT, 2012, J ORNITHOL, V153, P1067, DOI 10.1007/s10336-012-0836-0; Mork T, 2011, J WILDLIFE DIS, V47, P945, DOI 10.7589/0090-3558-47.4.945; O'Corry-Crowe G, 2010, POLAR BIOL, V33, P1179, DOI 10.1007/s00300-010-0807-y; Parmentier FJW, 2013, NAT CLIM CHANGE, V3, P195, DOI [10.1038/nclimate1784, 10.1038/NCLIMATE1784]; Post E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2722; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Prowse TD, 2009, AMBIO, V38, P272, DOI 10.1579/0044-7447-38.5.272; Rausch RL, 2007, J PARASITOL, V93, P1247, DOI 10.1645/GE-3583CC.1; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Screen JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051598; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Stephenson SR, 2011, NAT CLIM CHANGE, V1, P156, DOI 10.1038/NCLIMATE1120; Stirling I, 2012, GLOBAL CHANGE BIOL, V18, P2694, DOI 10.1111/j.1365-2486.2012.02753.x; Stocker M, 2011, NATURE, V473, P285, DOI 10.1038/473285b; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Walker D.A., 2012, B AM METEOROL SOC, V93, pS138, DOI DOI 10.1175/2012BAMSSTATE0FTHECLIMATE.1); Walker DA, 2008, ABB WESTFAL MUS NATU, V70, P387; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x	53	336	350	10	523	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					519	524		10.1126/science.1235225	http://dx.doi.org/10.1126/science.1235225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908231				2022-12-28	WOS:000322586700045
J	Conwell, WD; Josephson, SA; Li, H; Saint, S; Janssen, WJ				Conwell, Walter D.; Josephson, S. Andrew; Li, Howard; Saint, Sanjay; Janssen, William J.			Weak in the Knees	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EATON MYASTHENIC SYNDROME	A 61-year-old woman presented to her primary care physician with a 4-week history of progressive leg weakness, bilateral leg pain, and difficulty walking. The weakness was symmetric and did not fluctuate during the course of the day. Foreword In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows. Stage A 61-year-old woman presented to her primary care physician with a 4-week history of progressive bilateral leg weakness, bilateral leg pain, and difficulty walking. The weakness was symmetric, without exacerbating or ameliorating factors, and did not fluctuate during the course of the day. The patient also reported depression, anxiety, memory problems, and intermittent headaches that had begun several months earlier. She had a dry mouth but no difficulty swallowing. Previously very active, she had become homebound over a period of several months because of the leg weakness. ResponseWeakness is a common symptom and can result from dysfunction of either the central nervous system (brain or spinal cord) or the peripheral nervous system (anterior horn cell, nerve, neuromuscular junction, or muscle). Bilateral symmetric weakness of the legs can also result from problems with either the central ...	[Conwell, Walter D.; Li, Howard; Janssen, William J.] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO USA; [Li, Howard] Denver Vet Affairs Med Ctr, Dept Med, Denver, CO USA; [Janssen, William J.] Natl Jewish Hlth, Dept Med, Div Pulm Med, Denver, CO 80206 USA; [Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Saint, Sanjay] Univ Michigan, Dept Vet Affairs, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; National Jewish Health; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Janssen, WJ (corresponding author), Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA.	janssenw@njhealth.org	Li, Howard/AAM-3544-2021; Saint, Sanjay/AAF-5126-2019					CHALK CH, 1990, NEUROLOGY, V40, P1552, DOI 10.1212/WNL.40.10.1552; CHAUDHRY V, 1991, ANN NEUROL, V30, P841, DOI 10.1002/ana.410300614; Heldal AT, 2009, NEUROLOGY, V73, P150, DOI 10.1212/WNL.0b013e3181ad53c2; Keogh M, 2011, COCHRANE DATABASE SY, V2; Miller FW, 2012, ANN RHEUM DIS, V71, P82, DOI 10.1136/annrheumdis-2011-200587; Titulaer MJ, 2011, EUR J NEUROL, V18, P19, DOI 10.1111/j.1468-1331.2010.03220.x; Titulaer MJ, 2008, J CLIN ONCOL, V26, P4276, DOI 10.1200/JCO.2008.17.5133; Titulaer MJ, 2011, LANCET NEUROL, V10, P1098, DOI 10.1016/S1474-4422(11)70245-9; Titulaer MJ, 2011, J CLIN ONCOL, V29, P902, DOI 10.1200/JCO.2010.32.0440; VINCENT A, 1989, TRENDS NEUROSCI, V12, P496, DOI 10.1016/0166-2236(89)90109-4	10	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					459	464		10.1056/NEJMcps1210293	http://dx.doi.org/10.1056/NEJMcps1210293			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23902486				2022-12-28	WOS:000322547400013
J	Roukens, AH; Kroep, JR; Marinkovic, M; Nout, RA; Bovee, JVMG; Vasylenko, Y; Gelderblom, H; Lutyen, GPM				Roukens, Anna H.; Kroep, Judith R.; Marinkovic, Marina; Nout, Remi A.; Bovee, Judith V. M. G.; Vasylenko, Yevgeniya; Gelderblom, Hans; Lutyen, Gre P. M.			Primary Ewing sarcoma of the iris	LANCET			English	Editorial Material									[Roukens, Anna H.; Kroep, Judith R.; Nout, Remi A.; Gelderblom, Hans] Leiden Univ Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Marinkovic, Marina; Vasylenko, Yevgeniya; Lutyen, Gre P. M.] Leiden Univ Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Bovee, Judith V. M. G.] Leiden Univ Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Roukens, AH (corresponding author), Leiden Med Ctr, Dept Clin Oncol, POB 9600, NL-2300 RC Leiden, Netherlands.	a.h.e.roukens@lumc.nl		Bovee, Judith/0000-0003-1155-0481; Kroep, Judith/0000-0003-2671-1903; Gelderblom, Hans/0000-0001-9270-8636; Nout, Remi/0000-0001-8011-2982					0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					256	256		10.1016/S0140-6736(13)60183-X	http://dx.doi.org/10.1016/S0140-6736(13)60183-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294FC	23954463				2022-12-28	WOS:000330027500034
J	Van Mieghem, T; Ryan, G				Van Mieghem, Tim; Ryan, Greg			The PLUTO trial: a missed opportunity	LANCET			English	Editorial Material							URINARY-TRACT OBSTRUCTION		[Van Mieghem, Tim; Ryan, Greg] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Ryan, G (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Toronto, ON M5G 1X5, Canada.	gryan@mtsinai.on.ca	Ryan, Greg/B-7618-2016; Greg, Ryan/AAG-6134-2020	Ryan, Greg/0000-0002-5456-7622				Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Crombleholme TM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.020; DINNEEN MD, 1993, BRIT J UROL, V72, P364, DOI 10.1111/j.1464-410X.1993.tb00734.x; ELDER JS, 1987, LANCET, V2, P1007; GOLBUS MS, 1982, AM J OBSTET GYNECOL, V142, P383, DOI 10.1016/S0002-9378(16)32377-8; Heikkila J, 2011, J UROLOGY, V186, P2392, DOI 10.1016/j.juro.2011.07.109; Khan KS, 2006, BJOG-INT J OBSTET GY, V113, P766, DOI 10.1111/j.1471-0528.2006.00972.x; Kitagawa H, 2006, J PEDIATR SURG, V41, P394, DOI 10.1016/j.jpedsurg.2005.11.035; Malin G, 2012, BJOG-INT J OBSTET GY, V119, P1455, DOI 10.1111/j.1471-0528.2012.03476.x; Morris RK, 2007, PRENATAL DIAG, V27, P900, DOI 10.1002/pd.1810; Morris RK, 2011, EARLY HUM DEV, V87, P607, DOI 10.1016/j.earlhumdev.2011.07.004; Morris RK, 2013, LANCET; Rodrigues HCML, 2011, PRENATAL DIAG, V31, P589, DOI 10.1002/pd.2756; Sarhan O, 2008, J UROLOGY, V179, P307, DOI 10.1016/j.juro.2007.08.160; Senat MV, 2004, NEW ENGL J MED, V351, P136, DOI 10.1056/NEJMoa032597	15	21	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1471	1473		10.1016/S0140-6736(13)61446-4	http://dx.doi.org/10.1016/S0140-6736(13)61446-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	23953773				2022-12-28	WOS:000326622500010
J	Seder, RA; Chang, LJ; Enama, ME; Zephir, KL; Sarwar, UN; Gordon, IJ; Holman, LA; James, ER; Billingsley, PF; Gunasekera, A; Richman, A; Chakravarty, S; Manoj, A; Velmurugan, S; Li, ML; Ruben, AJ; Li, T; Eappen, AG; Stafford, RE; Plummer, SH; Hendel, CS; Novik, L; Costner, PJM; Mendoza, FH; Saunders, JG; Nason, MC; Richardson, JH; Murphy, J; Davidson, SA; Richie, TL; Sedegah, M; Sutamihardja, A; Fahle, GA; Lyke, KE; Laurens, MB; Roederer, M; Tewari, K; Epstein, JE; Sim, BKL; Ledgerwood, JE; Graham, BS; Hoffman, SL				Seder, Robert A.; Chang, Lee-Jah; Enama, Mary E.; Zephir, Kathryn L.; Sarwar, Uzma N.; Gordon, Ingelise J.; Holman, LaSonji A.; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Richman, Adam; Chakravarty, Sumana; Manoj, Anita; Velmurugan, Soundarapandian; Li, MingLin; Ruben, Adam J.; Li, Tao; Eappen, Abraham G.; Stafford, Richard E.; Plummer, Sarah H.; Hendel, Cynthia S.; Novik, Laura; Costner, Pamela J. M.; Mendoza, Floreliz H.; Saunders, Jamie G.; Nason, Martha C.; Richardson, Jason H.; Murphy, Jittawadee; Davidson, Silas A.; Richie, Thomas L.; Sedegah, Martha; Sutamihardja, Awalludin; Fahle, Gary A.; Lyke, Kirsten E.; Laurens, Matthew B.; Roederer, Mario; Tewari, Kavita; Epstein, Judith E.; Sim, B. Kim Lee; Ledgerwood, Julie E.; Graham, Barney S.; Hoffman, Stephen L.		VRC 312 Study Team	Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine	SCIENCE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; CD8+ T-CELLS; PLASMODIUM-FALCIPARUM; LIVER STAGES; IMMUNITY; ANTIBODIES; EFFICACY; MICE	Consistent, high-level, vaccine-induced protection against human malaria has only been achieved by inoculation of Plasmodium falciparum (Pf) sporozoites (SPZ) by mosquito bites. We report that the PfSPZ Vaccine-composed of attenuated, aseptic, purified, cryopreserved PfSPZ-was safe and well tolerated when administered four to six times intravenously (IV) to 40 adults. Zero of six subjects receiving five doses and three of nine subjects receiving four doses of 1.35 x 10(5) PfSPZ Vaccine and five of six nonvaccinated controls developed malaria after controlled human malaria infection (P = 0.015 in the five-dose group and P = 0.028 for overall, both versus controls). PfSPZ-specific antibody and T cell responses were dose-dependent. These data indicate that there is a dose-dependent immunological threshold for establishing high-level protection against malaria that can be achieved with IV administration of a vaccine that is safe and meets regulatory standards.	[Seder, Robert A.; Chang, Lee-Jah; Enama, Mary E.; Zephir, Kathryn L.; Sarwar, Uzma N.; Gordon, Ingelise J.; Holman, LaSonji A.; Plummer, Sarah H.; Hendel, Cynthia S.; Novik, Laura; Costner, Pamela J. M.; Mendoza, Floreliz H.; Saunders, Jamie G.; Roederer, Mario; Tewari, Kavita; Ledgerwood, Julie E.; Graham, Barney S.] NIAID, VRC, NIH, Rockville, MD 20852 USA; [James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Richman, Adam; Chakravarty, Sumana; Manoj, Anita; Velmurugan, Soundarapandian; Ruben, Adam J.; Li, Tao; Eappen, Abraham G.; Stafford, Richard E.; Sim, B. Kim Lee; Hoffman, Stephen L.] Sanaria, Rockville, MD 20850 USA; [Li, MingLin; Stafford, Richard E.; Sim, B. Kim Lee; Hoffman, Stephen L.] Prot Potential, Rockville, MD 20850 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Rockville, MD 20852 USA; [Richardson, Jason H.; Murphy, Jittawadee; Davidson, Silas A.] Walter Reed Army Inst Res, Entomol Branch, Silver Spring, MD 20910 USA; [Richie, Thomas L.; Sedegah, Martha; Sutamihardja, Awalludin; Epstein, Judith E.] Naval Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD 20910 USA; [Fahle, Gary A.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [Lyke, Kirsten E.; Laurens, Matthew B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Laurens, Matthew B.] Howard Hughes Med Inst, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sanaria Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute	Seder, RA (corresponding author), NIAID, VRC, NIH, Rockville, MD 20852 USA.	rseder@mail.nih.gov	Richardson, Jason H/A-9441-2011; Laurens, Matthew/E-7293-2013; Roederer, Mario/G-1887-2011; Murugan, Vel/AAX-9679-2020; Murugan, Vel/AAA-3554-2019; Graham, Barney S./AAC-5898-2019	Laurens, Matthew/0000-0003-3874-581X; Murugan, Vel/0000-0002-7368-7742; Graham, Barney S./0000-0001-8112-0853; Chang, Lee-Jah/0000-0003-1766-3153; Richie, Thomas/0000-0002-2946-5456	National Institute of Allergy and Infectious Diseases (NIAID) [4R44AI055229-08, 3R44AI055229-06S1, 5R44AI058499-05, N01-AI-40096]; Howard Hughes Medical Institute;  [6000.RADI.F.A0309]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI055229, ZIAAI005107, R44AI058499, ZIAAI005047] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data presented in this manuscript are tabulated in the main figures and the supplementary materials. The clinical trial was funded and supported by the National Institute of Allergy and Infectious Diseases (NIAID) Intramural Research Program. Production and characterization of the vaccine were supported in part by NIAID Small Business Innovation Research grants 4R44AI055229-08, 3R44AI055229-06S1, and 5R44AI058499-05. Preclinical toxicology and biodistribution studies were supported in part by NIAID preclinical service contract N01-AI-40096. Molecular diagnosis was supported by the Howard Hughes Medical Institute. A materials transfer agreement will be required for the use of recombinant PfMSP-1 and PfEBA-175, HC-04 cells, and 2A10 monoclonal antibody. A number of patents on PfSPZ have been issued, allowed, or filed in the United States and internationally. The U.S. patents include S. L. Hoffman et al., U.S. Patent 7,229,627 (2007) (there is a divisional of this patent with claims directed to aseptic adult Anopheles-species mosquitoes and aseptic Plasmodium-species sporozoites, USSN 11/726,622); S. L. Hoffman et al., U.S. Patent Pub. US2005/0208078 (2005); and B. K. L. Sim, S. L. Hoffman, M. Li, R. E. Stafford, U.S. Patent Pub U.S. 2010/0183680 (2010). There is also a patent on HC-04 cells [J. Prachumsri et al., U.S. Patent 7015036 (2006)]. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency or collaborators. The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of the Army, Department of Defense, or the U.S. government. This work was supported by work unit number 6000.RADI.F.A0309. The study protocol was approved by the Naval Medical Research Center Institutional Review Board in compliance with all applicable federal regulations governing the protection of human subjects. J.E.E., T.L.R., J.H.R., J.M., and S.A.D. are military service members. This work was prepared as part of their official duties. Title 17 U.S.C. 101 defines a US. government work as a work prepared by a military service member or employee of the U.S. government as part of that person's official duties. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of the Departments of the Army, Navy, or Defense. The authors thank the vaccine trial participants for their contribution and commitment to vaccine research. We acknowledge the contributions of our NIH Clinical Center and NIAID colleagues, especially A. S. Fauci for thoughtful advice and review of the manuscript; J. Stein, J. Pierson, R. Eckes, P. Driscoll, L. Ediger, and the nursing staff of the 5NW, SCSU, 5SE-S, and 5SE-N units; our VRC colleagues, especially B. Flynn, A. Mittelman, M. Young, C. Artis, R. Hicks, and T. Abram; the EMMES Corporation; R. Thompson, F. Beams, M. Garley, A. Hoffman, and D. Dolberg of Sanaria for administrative, operations, and legal support and T. Luke for insight and inspiration; the NIAID Institutional Review Board; the NIAID Office of Communications and Government Relations; the NIH Clinical Center Investigational New Drug Pharmacy; and the NIH Clinical Center Patient Recruitment and Public Liaison Office. We appreciate the expert reviews of the Safety Monitoring Committee (A. Durbin, K. Kester, and A. Cross) and the assistance from the U.S.; Military Malaria Vaccine Program, the Walter Reed Army Institute of Research Entomology Branch, and the Naval Medical Research Center, especially A. Reyes, Y. Alcorta, G. Banania, C. Fedders, M. Dowler, T. Savransky, D. Patel, C. Brando, and K. Kobylinski.	Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Trieu A., 2011, MOL CELL PROTEOMICS, V10; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1993, J IMMUNOL, V151, P2690; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WHO, 2012, WORLD MALARIA REPORT 2012, P1	36	527	538	2	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1359	1365		10.1126/science.1241800	http://dx.doi.org/10.1126/science.1241800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	23929949	Green Published			2022-12-28	WOS:000324597200037
J	Cheung, KC; Gershenfeld, N				Cheung, Kenneth C.; Gershenfeld, Neil			Reversibly Assembled Cellular Composite Materials	SCIENCE			English	Article							AEROGELS	We introduce composite materials made by reversibly assembling a three-dimensional lattice of mass-produced carbon fiber-reinforced polymer composite parts with integrated mechanical interlocking connections. The resulting cellular composite materials can respond as an elastic solid with an extremely large measured modulus for an ultralight material (12.3 megapascals at a density of 7.2 milligrams per cubic centimeter). These materials offer a hierarchical decomposition in modeling, with bulk properties that can be predicted from component measurements and deformation modes that can be determined by the placement of part types. Because site locations are locally constrained, structures can be produced in a relative assembly process that merges desirable features of fiber composites, cellular materials, and additive manufacturing.	[Cheung, Kenneth C.; Gershenfeld, Neil] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Cheung, KC (corresponding author), MIT, Ctr Bits & Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kccheung@mit.edu			Defense Advanced Research Projects Agency's Maximum Mobility and Manipulation program [W911NF-11-1-0096]; Center for Bits and Atoms sponsors	Defense Advanced Research Projects Agency's Maximum Mobility and Manipulation program; Center for Bits and Atoms sponsors	This work was supported by Defense Advanced Research Projects Agency's Maximum Mobility and Manipulation program (W911NF-11-1-0096) and the Center for Bits and Atoms sponsors. We acknowledge the contribution of Spirit AeroSystems on composite development, as well as J. H. Kim and S. Hovsepian for research assistance. Patent applications have been filed for the design and manufacturing of reversibly assembled cellular composite materials.	Andrews EW, 2001, INT J MECH SCI, V43, P701, DOI 10.1016/S0020-7403(00)00043-6; ASHBY MF, 1989, ACTA METALL MATER, V37, P1273, DOI 10.1016/0001-6160(89)90158-2; Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5; Bertoldi K, 2010, ADV MATER, V22, P361, DOI 10.1002/adma.200901956; Deshpande VS, 2000, J MECH PHYS SOLIDS, V48, P1253, DOI 10.1016/S0022-5096(99)00082-4; Deshpande VS, 2001, J MECH PHYS SOLIDS, V49, P1747, DOI 10.1016/S0022-5096(01)00010-2; Deshpande VS, 2001, ACTA MATER, V49, P1035, DOI 10.1016/S1359-6454(00)00379-7; Dutton S., 2004, COMPOSITE MAT AIRCRA, V2nd; Finnegan K, 2007, INT J MATER RES, V98, P1264, DOI 10.3139/146.101594; FUJIBAYASHI K, 2009, NAT COMPUT, V8, P589, DOI DOI 10.1007/s11047-008-9093-9; Gibson J.L., 1997, CELLULAR SOLIDS STRU, DOI [10.1017/cbo9781139878326, DOI 10.1017/CBO9781139878326]; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Hull D., 1996, INTRO COMPOSITE MAT, V2nd; Leventis N, 2002, NANO LETT, V2, P957, DOI 10.1021/nl025690e; Ma HS, 2000, J NON-CRYST SOLIDS, V277, P127, DOI 10.1016/S0022-3093(00)00288-X; Maxwell J.C., 1864, PHILOS MAG, V27, P294, DOI [10.1080/14786446408643668, DOI 10.1080/14786446408643668]; Mazumdar SK, 2002, COMPOSITES MANUFACTU; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Popescu G., 2006, INT C DIG FABR TECHN; Qiu L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2251; REDDY AD, 1985, J AIRCRAFT, V22, P249, DOI 10.2514/3.45115; Roberts AP, 2002, J MECH PHYS SOLIDS, V50, P33, DOI 10.1016/S0022-5096(01)00056-4; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Sypeck DJ, 2001, J MATER RES, V16, P890, DOI 10.1557/JMR.2001.0117; THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805; Vasiliev VV, 2006, COMPOS STRUCT, V76, P182, DOI 10.1016/j.compstruct.2006.06.025; Xiong J, 2010, COMPOS STRUCT, V92, P2695, DOI 10.1016/j.compstruct.2010.03.010	27	146	154	9	327	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2013	341	6151					1219	1221		10.1126/science.1240889	http://dx.doi.org/10.1126/science.1240889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23950496	Green Published			2022-12-28	WOS:000324248800037
J	Betses, M; Brennan, T				Betses, Mitch; Brennan, Troyen			Abusive Prescribing of Controlled Substances - A Pharmacy View	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OPIOID PRESCRIPTION; GUIDELINES	Pharmacies have a role to play in the oversight of prescriptions for controlled substances, especially opioids. The pharmacy chain CVS recently used its aggregated information on all prescriptions filled at its stores to attempt to limit inappropriate prescribing. Public health advocates are increasingly focused on illness and deaths caused by inappropriate use of controlled substances in particular, opioid analgesics. Opioid prescriptions have increased dramatically, by more than 300% between 1999 and 2010.(1) This increase has led to substantial iatrogenic disease. Most strikingly, the number of deaths due to overdose in the United States increased from 4000 in 1999 to 16,600 in 2010.(2) Indeed, overdose is now the second-leading cause of accidental death in this country, where more than 2.4 million people were considered opioid abusers in 2010.(3) The causes of increases in prescriptions and the prevalence of ...	[Betses, Mitch; Brennan, Troyen] CVS Caremark, Woonsocket, RI USA		Betses, M (corresponding author), CVS Caremark, Woonsocket, RI USA.							Dowell D, 2013, JAMA-J AM MED ASSOC, V309, P2219, DOI 10.1001/jama.2013.5794; Drug Enforcement Administration, 2013, DEA SERV AN WALGR PH; Kunins HV, 2013, ANN INTERN MED, V158, P841, DOI 10.7326/0003-4819-158-11-201306040-00631; Lembke A, 2012, NEW ENGL J MED, V367, P1580, DOI 10.1056/NEJMp1208498; Rosenau AM, 2013, ANN INTERN MED, V158, P843, DOI 10.7326/0003-4819-158-11-201306040-00632	5	39	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					989	991		10.1056/NEJMp1308222	http://dx.doi.org/10.1056/NEJMp1308222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	23964897	Bronze			2022-12-28	WOS:000324304200004
J	Pale, CA; Vigna, L				Alberto Pale, Carlos; Vigna, Luis			African Trypanosomiasis in Argentina	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alberto Pale, Carlos; Vigna, Luis] Sanatorio Las Lomas, Buenos Aires, DF, Argentina		Pale, CA (corresponding author), Sanatorio Las Lomas, Buenos Aires, DF, Argentina.	cpale@laslomas.com.ar							0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					763	763		10.1056/NEJMicm1211777	http://dx.doi.org/10.1056/NEJMicm1211777			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964938				2022-12-28	WOS:000323349300013
J	Rosenbaum, L; Shrank, WH				Rosenbaum, Lisa; Shrank, William H.			Taking Our Medicine - Improving Adherence in the Accountability Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICATION	<p id="p002">Many U.S. patients do not adhere to prescribed medication regimens, ultimately costing the United States $100 billion to $290 billion annually. As physician payment is increasingly tied to patient outcomes, nonadherence poses new challenges and opportunities. <p id="p003">A new patient with an abnormal electrocardiogram comes to your office. He is 53, smokes, and has hypertension and hyperlipidemia. Though he comes for preoperative risk evaluation, he needs more than medical clearance he needs a primary doctor. Given his risk factors and hesitance to change his lifestyle, you recommend aspirin, a statin, and an antihypertensive. When he doesn't show up for his stress test, you call him, and he says he doesn't understand what the fuss is all about he feels fine. Why don't you wait until something is wrong with me to give me these medications? ...	[Rosenbaum, Lisa] Univ Penn, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Rosenbaum, Lisa] Univ Penn, Robert Wood Johnson Fdn Clin Scholars Program, Philadelphia, PA 19104 USA; [Shrank, William H.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Shrank, William H.] Harvard Univ, Sch Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rosenbaum, L (corresponding author), Univ Penn, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.							Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09	5	35	35	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					694	695		10.1056/NEJMp1307084	http://dx.doi.org/10.1056/NEJMp1307084			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	204FA	23964931				2022-12-28	WOS:000323349300004
J	Romming, N; Hanneken, C; Menzel, M; Bickel, JE; Wolter, B; von Bergmann, K; Kubetzka, A; Wiesendanger, R				Romming, Niklas; Hanneken, Christian; Menzel, Matthias; Bickel, Jessica E.; Wolter, Boris; von Bergmann, Kirsten; Kubetzka, Andre; Wiesendanger, Roland			Writing and Deleting Single Magnetic Skyrmions	SCIENCE			English	Article							CHIRAL MAGNET; STATES; LATTICE; DRIVEN	Topologically nontrivial spin textures have recently been investigated for spintronic applications. Here, we report on an ultrathin magnetic film in which individual skyrmions can be written and deleted in a controlled fashion with local spin-polarized currents from a scanning tunneling microscope. An external magnetic field is used to tune the energy landscape, and the temperature is adjusted to prevent thermally activated switching between topologically distinct states. Switching rate and direction can then be controlled by the parameters used for current injection. The creation and annihilation of individual magnetic skyrmions demonstrates the potential for topological charge in future information-storage concepts.	[Romming, Niklas; Hanneken, Christian; Menzel, Matthias; Bickel, Jessica E.; Wolter, Boris; von Bergmann, Kirsten; Kubetzka, Andre; Wiesendanger, Roland] Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany	University of Hamburg	von Bergmann, K (corresponding author), Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany.	kbergman@physnet.uni-hamburg.de; kubetzka@physnet.uni-hamburg.de	Wiesendanger, Roland/P-9726-2016; von Bergmann, Kirsten/S-5696-2016; Romming, Niklas/I-2571-2013; Bickel, Jessica/A-6833-2016	Wiesendanger, Roland/0000-0002-0472-4183; von Bergmann, Kirsten/0000-0002-4514-3254; Bickel, Jessica/0000-0002-7506-1831; Kubetzka, Andre/0000-0002-0053-6337	Deutsche Forschungsgemeinschaft [SFB668, GrK 1286]; European Union via the European Research Council Advanced Grant FURORE; Hamburg Cluster of Excellence NANOSPINTRONICS	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union via the European Research Council Advanced Grant FURORE(European Research Council (ERC)); Hamburg Cluster of Excellence NANOSPINTRONICS	We thank S. Krause, A. A. Khajetoorians, A. Sonntag, S. Heinze, B. Dupe, and Ch. Hubner for discussions. We acknowledge financial support from the Deutsche Forschungsgemeinschaft via grants SFB668 and GrK 1286, the European Union via the European Research Council Advanced Grant FURORE, and the Hamburg Cluster of Excellence NANOSPINTRONICS.	Adams T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237204; Bode M, 2007, NATURE, V447, P190, DOI 10.1038/nature05802; BOGDANOV A, 1994, J MAGN MAGN MATER, V138, P255, DOI 10.1016/0304-8853(94)90046-9; Ferriani P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.027201; Fert A, 2013, NAT NANOTECHNOL, V8, P152, DOI 10.1038/nnano.2013.29; Heinze S, 2011, NAT PHYS, V7, P713, DOI [10.1038/NPHYS2045, 10.1038/nphys2045]; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Kiselev NS, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/39/392001; Krause S, 2007, SCIENCE, V317, P1537, DOI 10.1126/science.1145336; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Schulz T, 2012, NAT PHYS, V8, P301, DOI [10.1038/NPHYS2231, 10.1038/nphys2231]; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; SKYRME THR, 1962, NUCL PHYS, V31, P556, DOI 10.1016/0029-5582(62)90775-7; Tchoe Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.174416; WEBER W, 1991, PHYS REV LETT, V66, P942, DOI 10.1103/PhysRevLett.66.942; Yu XZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1990; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Zang JD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136804	23	1038	1052	24	459	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					636	639		10.1126/science.1240573	http://dx.doi.org/10.1126/science.1240573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929977	Green Submitted			2022-12-28	WOS:000322884800033
J	Wang, PF; Lin, X; Liu, L; Sun, QQ; Zhou, P; Liu, XY; Liu, W; Gong, Y; Zhang, DW				Wang, Peng-Fei; Lin, Xi; Liu, Lei; Sun, Qing-Qing; Zhou, Peng; Liu, Xiao-Yong; Liu, Wei; Gong, Yi; Zhang, David Wei			A Semi-Floating Gate Transistor for Low-Voltage Ultrafast Memory and Sensing Operation	SCIENCE			English	Article							TUNNELING TRANSISTOR	As the semiconductor devices of integrated circuits approach the physical limitations of scaling, alternative transistor and memory designs are needed to achieve improvements in speed, density, and power consumption. We report on a transistor that uses an embedded tunneling field-effect transistor for charging and discharging the semi-floating gate. This transistor operates at low voltages (<= 2.0 volts), with a large threshold voltage window of 3.1 volts, and can achieve ultra-high-speed writing operations (on time scales of similar to 1 nanosecond). A linear dependence of drain current on light intensity was observed when the transistor was exposed to light, so possible applications include image sensing with high density and performance.	[Wang, Peng-Fei; Lin, Xi; Sun, Qing-Qing; Zhou, Peng; Liu, Xiao-Yong; Zhang, David Wei] Fudan Univ, Sch Microelect, State Key Lab ASIC & Syst, Shanghai 200433, Peoples R China; [Liu, Lei; Liu, Wei; Gong, Yi] Oriental Semicond, Suzhou, Peoples R China	Fudan University	Wang, PF (corresponding author), Fudan Univ, Sch Microelect, State Key Lab ASIC & Syst, Shanghai 200433, Peoples R China.	pfw@fudan.edu.cn	zhou, peng/B-1572-2009		National Natural Science Foundation of China [61176074]; National Science and Technology Major Project of China [2009ZX02039-003]; Key Technologies Research and Development Program of Jiangsu Province [BE2009055, SISPARK]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Key Technologies Research and Development Program of Jiangsu Province	This research was partially supported by the National Natural Science Foundation of China (grant no. 61176074), the National Science and Technology Major Project of China (grant no. 2009ZX02039-003), and the Key Technologies Research and Development Program of Jiangsu Province (grant no. BE2009055, SISPARK). The authors are grateful to M.-F. Li, S.-J. Ding, and A.-Q. Jiang (Fudan University) for discussions on device concepts and measurements.	Anghel C, 2011, IEEE T ELECTRON DEV, V58, P1649, DOI 10.1109/TED.2011.2128320; Aydin C, 2004, APPL PHYS LETT, V84, P1780, DOI 10.1063/1.1668321; Hansch W, 2000, THIN SOLID FILMS, V369, P387, DOI 10.1016/S0040-6090(00)00896-8; Heinrich A, 2011, SCIENCE, V332, P1039, DOI 10.1126/science.1206086; Hu Ch. C., 2009, MODERN SEMICONDUCTOR; Ieong Meikei, 2004, Science, V306, P2057, DOI 10.1126/science.1100731; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; KAHNG D, 1967, AT&T TECH J, V46, P1288, DOI 10.1002/j.1538-7305.1967.tb01738.x; KANE EO, 1959, J PHYS CHEM SOLIDS, V12, P181, DOI 10.1016/0022-3697(60)90035-4; Kao KH, 2012, IEEE T ELECTRON DEV, V59, P2070, DOI 10.1109/TED.2012.2200489; Kim I.-G., 2005, IEDM, V13, P319; Koga J, 1999, IEEE ELECTR DEVICE L, V20, P529, DOI 10.1109/55.791932; Makarov A, 2012, MICROELECTRON RELIAB, V52, P628, DOI 10.1016/j.microrel.2011.10.020; Taur Y, 1999, IEEE SPECTRUM, V36, P25, DOI 10.1109/6.774961; Wang PF, 2004, SOLID STATE ELECTRON, V48, P2281, DOI 10.1016/j.sse.2004.04.006	15	61	67	22	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					640	643		10.1126/science.1240961	http://dx.doi.org/10.1126/science.1240961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23929978				2022-12-28	WOS:000322884800034
J	Hudson, KL; Collins, FS				Hudson, Kathy L.; Collins, Francis S.			Family matters	NATURE			English	Editorial Material							GENOMIC RESEARCH; IDENTIFIABILITY		[Hudson, Kathy L.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Hudson, KL (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	kathy.hudson@nih.gov						Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Landry J. J. M., 2013, GENES GENOMES GENET; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Rodriguez LL, 2013, SCIENCE, V339, P275, DOI 10.1126/science.1234593; Skloot R., 2013, NY TIMES	7	33	34	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					141	142		10.1038/500141a	http://dx.doi.org/10.1038/500141a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197CH	23925224	Green Published			2022-12-28	WOS:000322825500011
J	Morris, RK; Malin, GL; Quinlan-Jones, E; Middleton, LJ; Hemming, K; Burke, D; Daniels, JP; Khan, KS; Deeks, J; Kilby, MD				Morris, Rachel K.; Malin, Gemma L.; Quinlan-Jones, Elisabeth; Middleton, Lee J.; Hemming, Karla; Burke, Danielle; Daniels, Jane P.; Khan, Khalid S.; Deeks, Jon; Kilby, Mark D.		Percutaneous Vesicoamniotic Shunti	Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial	LANCET			English	Article							POSTERIOR URETHRAL VALVES; POSTNATAL RENAL-FUNCTION; UROPATHY; INTERVENTION; HYDRONEPHROSIS; ULTRASOUND; DIAGNOSIS; ACCURACY	Background Fetal lower urinary tract obstruction (LUTO) is associated with high perinatal and long-term childhood mortality and morbidity. We aimed to assess the effectiveness of vesicoamniotic shunting for treatment of LUTO. Methods In a randomised trial in the UK, Ireland, and the Netherlands, women whose pregnancies with a male fetus were complicated by isolated LUTO were randomly assigned by a central telephone and web-based randomisation service to receive either the intervention (placement of vesicoamniotic shunt) or conservative management. Allocation could not be masked from clinicians or participants because of the invasive nature of the intervention. Diagnosis was by prenatal ultrasound. The primary outcome was survival of the baby to 28 days postnatally. All primary analyses were done on an intention-to-treat basis, but these results were compared with those of an as-treated analysis to investigate the effect of a fairly large proportion of crossovers. We used Bayesian methods to estimate the posterior probability distribution of the effectiveness of vesicoamniotic shunting at 28 days. The study is registered with the ISRCTN Register, number ISRCTN53328556. Findings 31 women with singleton pregnancies complicated by LUTO were included in the trial and main analysis, with 16 allocated to the vesicoamniotic shunt group and 15 to the conservative management group. The study closed early because of poor recruitment. There were 12 livebirths in each group. In the vesicoamniotic shunt group one intrauterine death occurred and three pregnancies were terminated. In the conservative management group one intrauterine death occurred and two pregnancies were terminated. Of the 16 pregnancies randomly assigned to vesicoamniotic shunting, eight neonates survived to 28 days, compared with four from the 15 pregnancies assigned to conservative management (intention-to-treat relative risk [RR] 1.88, 95% CI 0.71-4.96; p=0.27). Analysis based on treatment received showed a larger effect (3.20, 1.06-9.62; p=0.03). All 12 deaths were caused by pulmonary hypoplasia in the early neonatal period. Sensitivity analysis in which non-treatment-related terminations of pregnancy were excluded made some slight changes to point estimates only. Bayesian analysis in which the trial data were combined with elicited priors from experts suggested an 86% probability that vesicoamniotic shunting increased survival at 28 days and a 25% probability that it had a large, clinically important eff ect (defined as a relative increase of 55% or more in the proportion of neonates who survived). There was substantial short-term and long-term morbidity in both groups, including poor renal function-only two babies (both in the shunt group) survived to 2 years with normal renal function. Seven complications occurred in six fetuses from the shunt group, including spontaneous ruptured membranes, shunt blockage, and dislodgement. These complications resulted in four pregnancy losses. Interpretation Survival seemed to be higher in the fetuses receiving vesicoamniotic shunting, but the size and direction of the eff ect remained uncertain, such that benefit could not be conclusively proven. Our results suggest that the chance of newborn babies surviving with normal renal function is very low irrespective of whether or not vesicoamniotic shunting is done.	[Morris, Rachel K.; Malin, Gemma L.; Quinlan-Jones, Elisabeth; Khan, Khalid S.; Kilby, Mark D.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TG, W Midlands, England; [Hemming, Karla; Burke, Danielle; Deeks, Jon] Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham B15 2TG, W Midlands, England; [Morris, Rachel K.; Kilby, Mark D.] Birmingham Womens Hosp NHS Fdn Trust, Fetal Med Ctr, Birmingham B15 2TG, W Midlands, England; [Middleton, Lee J.; Daniels, Jane P.; Deeks, Jon] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TG, W Midlands, England	University of Birmingham; University of Birmingham; Birmingham Women's Hospital; University of Birmingham	Kilby, MD (corresponding author), Univ Birmingham, Birmingham B15 2TG, W Midlands, England.	m.d.kilby@bham.ac.uk	Deeks, Jon/AAV-5745-2020; Khan, Khalid S/AAT-8824-2020; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Hemming, karla/AAB-3391-2021	Deeks, Jon/0000-0002-8850-1971; Khan, Khalid S/0000-0001-5084-7312; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Hemming, karla/0000-0002-2226-6550; Middleton, Lee/0000-0003-4621-1922; Thilaganathan, Basky/0000-0002-5531-4301; Morris, Katie/0000-0003-1247-429X	UK National Institute of Health Research; Wellbeing of Women; Hannah Eliza Guy Charity (Birmingham Children's Hospital Charity); Medical Research Council [1587789, G0700526, G0800808] Funding Source: researchfish; National Institute for Health Research [CL-2010-09-003, 07/01/44] Funding Source: researchfish; MRC [G0700526, G0800808] Funding Source: UKRI	UK National Institute of Health Research(National Institute for Health Research (NIHR)); Wellbeing of Women(Wellbeing of Women (WoW)); Hannah Eliza Guy Charity (Birmingham Children's Hospital Charity); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding UK National Institute of Health Research, Wellbeing of Women, Hannah Eliza Guy Charity (Birmingham Children's Hospital Charity).	Abbott JF, 1998, FETAL DIAGN THER, V13, P179, DOI 10.1159/000020834; Anumba DO, 2005, PRENATAL DIAG, V25, P7, DOI 10.1002/pd.1074; BARKER AP, 1995, BRIT J UROL, V76, P649, DOI 10.1111/j.1464-410X.1995.tb07796.x; Biard JM, 2005, OBSTET GYNECOL, V106, P503, DOI 10.1097/01.AOG.0000171117.38929.eb; Chitty LS, 2003, PRENATAL DIAG, V23, P891, DOI 10.1002/pd.693; Clark TJ, 2003, OBSTET GYNECOL, V102, P367, DOI 10.1016/S0029-7844(03)00577-5; CROMBLEHOLME TM, 1990, AM J OBSTET GYNECOL, V162, P1239, DOI 10.1016/0002-9378(90)90026-4; ELDER JS, 1987, LANCET, V2, P1007; FERNBACH SK, 1993, PEDIATR RADIOL, V23, P478, DOI 10.1007/BF02012459; Freedman AL, 1997, FETAL DIAGN THER, V12, P1, DOI 10.1159/000264415; HUTTON KAR, 1994, J UROLOGY, V152, P698, DOI 10.1016/S0022-5347(17)32684-8; JOHNSON MP, 1994, AM J OBSTET GYNECOL, V170, P1770; JOHNSON MP, 1995, AM J OBSTET GYNECOL, V173, P59, DOI 10.1016/0002-9378(95)90170-1; Kaefer M, 1997, J UROLOGY, V158, P1026, DOI 10.1016/S0022-5347(01)64380-5; Khalek N, 2012, FETAL THERAPY SCI BA, P246; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Magann EF, 2000, AM J OBSTET GYNECOL, V182, P1581, DOI 10.1067/mob.2000.107325; Malin G, 2012, BJOG-INT J OBSTET GY, V119, P1455, DOI 10.1111/j.1471-0528.2012.03476.x; MANNING FA, 1986, NEW ENGL J MED, V315, P336, DOI 10.1056/NEJM198607313150532; Morris RK, 2007, PRENATAL DIAG, V27, P900, DOI 10.1002/pd.1810; Morris RK, 2010, BJOG-INT J OBSTET GY, V117, P382, DOI 10.1111/j.1471-0528.2010.02500.x; Morris RK, 2009, BJOG-INT J OBSTET GY, V116, P1290, DOI 10.1111/j.1471-0528.2009.02194.x; Morris RK, HLTH TECHNO IN PRESS; NAKAYAMA DK, 1986, J PEDIATR SURG, V21, P43, DOI 10.1016/S0022-3468(86)80651-0; NICE, 2006, FET VES AMN SHUNT LO; Pluto Collaborative Study Grp, 2007, BJOG-INT J OBSTET GY, V114, P904, DOI 10.1111/j.1471-0528.2007.01382.x; QUINTERO RA, 1995, LANCET, V346, P537, DOI 10.1016/S0140-6736(95)91381-5; STEINHARDT G, 1990, J UROLOGY, V143, P336, DOI 10.1016/S0022-5347(17)39952-4	28	183	190	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1496	1506		10.1016/S0140-6736(13)60992-7	http://dx.doi.org/10.1016/S0140-6736(13)60992-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	23953766	Green Published			2022-12-28	WOS:000326622500027
J	Wang, CJ; Huang, DJ				Wang, C. Jason; Huang, Delphine J.			The HIPAA Conundrum in the Era of Mobile Health and Communications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wang, C. Jason] Stanford Univ, Stanford, CA 94305 USA; [Huang, Delphine J.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Stanford University; University of California System; University of California San Francisco	Wang, CJ (corresponding author), Stanford Univ, CHP PCOR, 117 Encina Commons, Stanford, CA 94305 USA.	cjwang1@stanford.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008647] Funding Source: NIH RePORTER; NIH HHS [DP2 OD008647] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Hirsch RDH, 2013, BNA PRIV SECUR LAW R, P1; US Department of Health and Human Services (HHS), BREACHES AFFECTING 5	2	23	23	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1121	1122		10.1001/jama.2013.219869	http://dx.doi.org/10.1001/jama.2013.219869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23978879				2022-12-28	WOS:000324500300013
J	Balanoff, AM; Bever, GS; Rowe, TB; Norell, MA				Balanoff, Amy M.; Bever, Gabe S.; Rowe, Timothy B.; Norell, Mark A.			Evolutionary origins of the avian brain	NATURE			English	Article							ORGANIZATION; THEROPOD; EAR; CHINA; BIRDS	Features that were once considered exclusive to modern birds, such as feathers and a furcula, are now known to have first appeared in non-avian dinosaurs(1). However, relatively little is known of the early evolutionary history of the hyperinflated brain that distinguishes birds from other living reptiles and provides the important neurological capablities required by flight(2). Here we use high-resolution computed tomography to estimate and compare cranial volumes of extant birds, the early avialan Archaeopteryx lithographica, and a number of non-avian maniraptoran dinosaurs that are phylogenetically close to the origins of both Avialae and avian flight. Previous work established that avian cerebral expansion began early in theropod history and that the cranial cavity of Archaeopteryx was volumetrically intermediate between these early forms and modern birds(3,4). Our new data indicate that the relative size of the cranial cavity of Archaeopteryx is reflective of a more generalized maniraptoran volumetric signature and in several instances is actually smaller than that of other non-avian dinosaurs. Thus, bird-like encephalization indices evolved multiple times, supporting the conclusion that if Archaeopteryx had the neurological capabilities required of flight, so did at least some other non-avian maniraptorans. This is congruent with recent findings that avialans were not unique among maniraptorans in their ability to fly in some form(5,6).	[Balanoff, Amy M.; Bever, Gabe S.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Balanoff, Amy M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Bever, Gabe S.] SUNY Coll Old Westbury, New York Inst Technol, Old Westbury, NY 11568 USA; [Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA	American Museum of Natural History (AMNH); Columbia University; New York Institute Technology; State University of New York (SUNY) System; SUNY Old Westbury; University of Texas System; University of Texas Austin	Balanoff, AM (corresponding author), SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA.	abalanoff@gmail.com			NSF DDIG [DEB 0909970]; NSF [IIS-0208675, EAR-0948842]; Columbia University International Travel Fellowship	NSF DDIG(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Columbia University International Travel Fellowship	Funding for this project was provided by a NSF DDIG (DEB 0909970) to A. M. B. and M.A.N., NSF IIS-0208675 and EAR-0948842 to T. B. R. and a Columbia University International Travel Fellowship to A. M. B. The University of Texas Computed Tomography Facility and the AMNH MIF helped with computed tomographic scanning and processing imagery. M. Colbert, P. Gignac, D. Ksepka, J. Flynn and J. Meng read and provided useful comments on the text.	Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Butler A. B., 1996, COMP VERTEBRATE NEUR; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Franzosa J.W., 2004, THESIS U TEXAS; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GILL F.B., 2006, ORNITHOLOGY; Hopson J.A., 1979, P39; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Northcutt RG, 2011, SCIENCE, V332, P926, DOI 10.1126/science.1206915; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; Reiner A, 2005, ANAT REC PART A, V287A, P1080, DOI 10.1002/ar.a.20253; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe Timothy B., 2005, Journal of Mammalian Evolution, V12, P303, DOI 10.1007/s10914-005-5731-5; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Shimizu Toru, 1993, P103; Smaers JB, 2012, P NATL ACAD SCI USA, V109, P18006, DOI 10.1073/pnas.1212181109; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2012, B AM MUS NAT HIST, P5; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6	30	103	105	1	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					93	+		10.1038/nature12424	http://dx.doi.org/10.1038/nature12424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23903660				2022-12-28	WOS:000323888300038
J	Opie, LH				Opie, Lionel H.			Recording of smoking history in death notification	LANCET			English	Editorial Material							RISK-FACTORS; MORTALITY; CANCER; IMPACT		[Opie, Lionel H.] Univ Cape Town, Dept Med, Hatter Inst Cardiovasc Dis Africa, ZA-7295 Cape Town, South Africa; [Opie, Lionel H.] Groote Schuur Hosp, ZA-7295 Cape Town, South Africa	University of Cape Town; University of Cape Town	Opie, LH (corresponding author), Univ Cape Town, Dept Med, Hatter Inst Cardiovasc Dis Africa, ZA-7295 Cape Town, South Africa.	lionel.opie@uct.ac.za						Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; PETO R, 1992, BRIT MED J, V305, P829, DOI 10.1136/bmj.305.6857.829-b; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Rasmussen-Torvik LJ, 2013, CIRCULATION, V127, P1270, DOI 10.1161/CIRCULATIONAHA.112.001183; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Sakata R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7093; Sitas F, 2013, LANCET, V382, P685, DOI 10.1016/S0140-6736(13)61610-4; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; World Health Organization, 2008, WHO REPORT ON THE GL	12	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					661	662		10.1016/S0140-6736(13)61691-8	http://dx.doi.org/10.1016/S0140-6736(13)61691-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206SI	23972799				2022-12-28	WOS:000323542400004
J	Carrera, JP; Forrester, N; Wang, EY; Vittor, AY; Haddow, AD; Lopez-Verges, S; Abadia, I; Castano, E; Sosa, N; Baez, C; Estripeaut, D; Diaz, Y; Beltran, D; Cisneros, J; Cedeno, HG; da Rosa, APT; Hernandez, H; Martinez-Torres, AO; Tesh, RB; Weaver, SC				Carrera, Jean-Paul; Forrester, Naomi; Wang, Eryu; Vittor, Amy Y.; Haddow, Andrew D.; Lopez-Verges, Sandra; Abadia, Ivan; Castano, Elizabeth; Sosa, Nestor; Baez, Carmen; Estripeaut, Dora; Diaz, Yamilka; Beltran, Davis; Cisneros, Julio; Cedeno, Hector G.; Travassos da Rosa, Amelia P.; Hernandez, Humberto; Martinez-Torres, Alex O.; Tesh, Robert B.; Weaver, Scott C.			Eastern Equine Encephalitis in Latin America	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENCEPHALOMYELITIS VIRUS; VENEZUELAN ENCEPHALITIS; INTERFERON SENSITIVITY; PANAMA; INFECTION; STRAINS; EMERGENCE; DISEASE	BACKGROUND The eastern equine encephalitis (EEE) and Venezuelan equine encephalitis (VEE) viruses are pathogens that infect humans and horses in the Americas. Outbreaks of neurologic disease in humans and horses were reported in Panama from May through early August 2010. METHODS We performed antibody assays and tests to detect viral RNA and isolate the viruses in serum samples from hospitalized patients. Additional cases were identified with enhanced surveillance. RESULTS A total of 19 patients were hospitalized for encephalitis. Among them, 7 had confirmed EEE, 3 had VEE, and 1 was infected with both viruses; 3 patients died, 1 of whom had confirmed VEE. The clinical findings for patients with EEE included brain lesions, seizures that evolved to status epilepticus, and neurologic sequelae. An additional 99 suspected or probable cases of alphavirus infection were detected during active surveillance. In total, 13 cases were confirmed as EEE, along with 11 cases of VEE and 1 case of dual infection. A total of 50 cases in horses were confirmed as EEE and 8 as VEE; mixed etiologic factors were associated with 11 cases in horses. Phylogenetic analyses of isolates from 2 cases of equine infection with the EEE virus and 1 case of human infection with the VEE virus indicated that the viruses were of enzootic lineages previously identified in Panama rather than new introductions. CONCLUSIONS Cases of EEE in humans in Latin America may be the result of ecologic changes that increased human contact with enzootic transmission cycles, genetic changes in EEE viral strains that resulted in increased human virulence, or an altered host range.	[Carrera, Jean-Paul; Lopez-Verges, Sandra; Diaz, Yamilka; Beltran, Davis; Cisneros, Julio; Martinez-Torres, Alex O.] Gorgas Mem Inst Hlth, Dept Microbiol & Parasitol, Dept Res Virol & Biotechnol, Panama City, Panama; [Sosa, Nestor] Gorgas Mem Inst Hlth, Dept Microbiol & Parasitol, Gen Direct, Panama City, Panama; [Carrera, Jean-Paul; Martinez-Torres, Alex O.] Univ Panama, Lab Expt & Appl Microbiol, Panama City, Panama; [Abadia, Ivan; Castano, Elizabeth; Baez, Carmen; Estripeaut, Dora] Hosp Nino, Panama City, Panama; [Cedeno, Hector G.] Minist Hlth, Dept Epidemiol, Panama City, Panama; [Hernandez, Humberto] Natl Div Anim Hlth, Minist Agr Dev, Panama City, Panama; [Forrester, Naomi; Wang, Eryu; Vittor, Amy Y.; Haddow, Andrew D.; Travassos da Rosa, Amelia P.; Tesh, Robert B.; Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Forrester, Naomi; Wang, Eryu; Vittor, Amy Y.; Haddow, Andrew D.; Travassos da Rosa, Amelia P.; Tesh, Robert B.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Vittor, Amy Y.] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA	Universidad de Panama; Ministerio de Salud de la Republica de Panama; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Pennsylvania	Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.	sweaver@utmb.edu	Weaver, Scott C/D-6490-2011; Haddow, Andrew/C-5902-2008	Weaver, Scott C/0000-0001-8016-8556; Haddow, Andrew/0000-0002-8957-2608; Martinez-Torres, Alex Omar/0000-0002-5001-6217; Castano Guerra, Elizabeth/0000-0001-9119-8697; Carrera, Jean-Paul/0000-0002-1459-2858; Beltran, Davis/0000-0003-3183-3753	National Institutes of Health [U54-AI057156, HHSN27220100004OI, HHSN27200004/DO4]; Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama [60-4-FID09-103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by contracts from the National Institutes of Health (U54-AI057156, to Dr. Weaver; HHSN27220100004OI and HHSN27200004/DO4, to Dr. Tesh), and by a grant from Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama (60-4-FID09-103, to Mr. Carrera).	Aguilar PV, 2008, J VIROL, V82, P4920, DOI 10.1128/JVI.02514-07; Aguilar PV, 2007, AM J TROP MED HYG, V76, P293, DOI 10.4269/ajtmh.2007.76.293; Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50; Aguilar PV, 2005, J VIROL, V79, P11300, DOI 10.1128/JVI.79.17.11300-11310.2005; Alice F., 1956, B I BIOL BAHIA, V3, P3; Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; Arrigo NC, 2010, EMERG INFECT DIS, V16, P1373, DOI 10.3201/eid1609.100459; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; CORNIOU B, 1972, TROP GEOGR MED, V24, P162; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; DIETZ WH, 1980, AM J TROP MED HYG, V29, P133, DOI 10.4269/ajtmh.1980.29.133; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FRANCK PT, 1970, AM J TROP MED HYG, V19, P860, DOI 10.4269/ajtmh.1970.19.860; Gardner CL, 2008, J VIROL, V82, P10634, DOI 10.1128/JVI.01323-08; Gardner CL, 2009, VIROLOGY, V390, P338, DOI 10.1016/j.virol.2009.05.030; Johnson BW, 2011, CLIN VACCINE IMMUNOL, V18, P1486, DOI 10.1128/CVI.05129-11; JOHNSON KM, 1968, AM J TROP MED HYG, V17, P432, DOI 10.4269/ajtmh.1968.17.432; Lury Kenneth M, 2004, Emerg Radiol, V11, P46; Obaldia N., 1991, Notas Veterinarias, V1, P4; PILIERO PJ, 1994, CLIN INFECT DIS, V18, P985, DOI 10.1093/clinids/18.6.985; Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472; SABATTINI MS, 1991, MEDICINA-BUENOS AIRE, V51, P3; Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8; Smith D. W., 2009, Clinical virology, P1241; SRIHONGSE SUNTHORN, 1967, MOSQUITO NEWS, V27, P74; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; WALTON TE, 1973, J INFECT DIS, V128, P271, DOI 10.1093/infdis/128.3.271	30	72	74	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 22	2013	369	8					732	744		10.1056/NEJMoa1212628	http://dx.doi.org/10.1056/NEJMoa1212628			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204FA	23964935	Green Accepted			2022-12-28	WOS:000323349300010
J	Fudge, TJ; Steig, EJ; Markle, BR; Schoenemann, SW; Ding, QH; Taylor, KC; McConnell, JR; Brook, EJ; Sowers, T; White, JWC; Alley, RB; Cheng, H; Clow, GD; Cole-Dai, J; Conway, H; Cuffey, KM; Edwards, JS; Edwards, RL; Edwards, R; Fegyveresi, JM; Ferris, D; Fitzpatrick, JJ; Johnson, J; Hargreaves, G; Lee, JE; Maselli, OJ; Mason, W; McGwire, KC; Mitchell, LE; Mortensen, N; Neff, P; Orsi, AJ; Popp, TJ; Schauer, AJ; Severinghaus, JP; Sigl, M; Spencer, MK; Vaughn, BH; Voigt, DE; Waddington, ED; Wang, XF; Wong, GJ				Fudge, T. J.; Steig, Eric J.; Markle, Bradley R.; Schoenemann, Spruce W.; Ding, Qinghua; Taylor, Kendrick C.; McConnell, Joseph R.; Brook, Edward J.; Sowers, Todd; White, James W. C.; Alley, Richard B.; Cheng, Hai; Clow, Gary D.; Cole-Dai, Jihong; Conway, Howard; Cuffey, Kurt M.; Edwards, Jon S.; Edwards, R. Lawrence; Edwards, Ross; Fegyveresi, John M.; Ferris, David; Fitzpatrick, Joan J.; Johnson, Jay; Hargreaves, Geoffrey; Lee, James E.; Maselli, Olivia J.; Mason, William; McGwire, Kenneth C.; Mitchell, Logan E.; Mortensen, Nicolai; Neff, Peter; Orsi, Anais J.; Popp, Trevor J.; Schauer, Andrew J.; Severinghaus, Jeffrey P.; Sigl, Michael; Spencer, Matthew K.; Vaughn, Bruce H.; Voigt, Donald E.; Waddington, Edwin D.; Wang, Xianfeng; Wong, Gifford J.		WAIS Divide Project Members	Onset of deglacial warming in West Antarctica driven by local orbital forcing	NATURE			English	Article							ABRUPT CLIMATE-CHANGE; ICE-CORE; ATMOSPHERIC CO2; HIGH-RESOLUTION; CARBON-DIOXIDE; GREENLAND; SCALE; CIRCULATION; TEMPERATURE; TIMESCALES	The cause of warming in the Southern Hemisphere during the most recent deglaciation remains a matter of debate(1,2). Hypotheses for a Northern Hemisphere trigger, through oceanic redistributions of heat, are based in part on the abrupt onset of warming seen in East Antarctic ice cores and dated to 18,000 years ago, which is several thousand years after high-latitude Northern Hemisphere summer insolation intensity began increasing from its minimum, approximately 24,000 years ago(3,4). An alternative explanation is that local solar insolation changes cause the Southern Hemisphere to warm independently(2,5). Here we present results from a new, annually resolved ice-core record from West Antarctica that reconciles these two views. The records show that 18,000 years ago snow accumulation in West Antarctica began increasing, coincident with increasing carbon dioxide concentrations, warming in East Antarctica and cooling in the Northern Hemisphere(6) associated with an abrupt decrease in Atlantic meridional overturning circulation(7). However, significant warming in West Antarctica began at least 2,000 years earlier. Circum-Antarctic sea-ice decline, driven by increasing local insolation, is the likely cause of this warming. The marine-influenced West Antarctic records suggest a more active role for the Southern Ocean in the onset of deglaciation than is inferred from ice cores in the East Antarctic interior, which are largely isolated from sea-ice changes.	[Fudge, T. J.; Steig, Eric J.; Markle, Bradley R.; Schoenemann, Spruce W.; Ding, Qinghua; Conway, Howard; Neff, Peter; Schauer, Andrew J.; Waddington, Edwin D.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Steig, Eric J.; Ding, Qinghua] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Taylor, Kendrick C.; McConnell, Joseph R.; Maselli, Olivia J.; McGwire, Kenneth C.; Sigl, Michael] Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; [Brook, Edward J.; Edwards, Jon S.; Lee, James E.; Mitchell, Logan E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Sowers, Todd; Alley, Richard B.; Fegyveresi, John M.; Voigt, Donald E.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [White, James W. C.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [White, James W. C.] Dept Environm Studies, Boulder, CO 80309 USA; [White, James W. C.; Vaughn, Bruce H.] Univ Colorado, INSTAAR, Boulder, CO 80309 USA; [Alley, Richard B.; Fegyveresi, John M.; Voigt, Donald E.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, Hai; Edwards, R. Lawrence] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Clow, Gary D.] US Geol Survey, Geosci & Environm Change Sci Ctr, Lakewood, CO 80225 USA; [Cole-Dai, Jihong; Ferris, David] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Cuffey, Kurt M.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Edwards, Ross] Curtin Univ Technol, Dept Imaging & Appl Phys, Perth, WA 6102, Australia; [Fitzpatrick, Joan J.] US Geol Survey, Denver, CO 80225 USA; [Johnson, Jay; Mortensen, Nicolai] Univ Wisconsin, Space Sci Engn Ctr, Madison, WI 53706 USA; [Hargreaves, Geoffrey] US Geol Survey, Natl Ice Core Lab, Denver, CO 80225 USA; [Mason, William] EMECH Designs, Brooklyn, WI 53521 USA; [Neff, Peter] Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6012, New Zealand; [Orsi, Anais J.; Severinghaus, Jeffrey P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Popp, Trevor J.] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark; [Spencer, Matthew K.] Lake Super State Univ, Dept Geol & Phys, Sault Ste Marie, MI 49783 USA; [Wang, Xianfeng] Nanyang Technol Univ, Earth Observ Singapore, Singapore 639798, Singapore; [Wong, Gifford J.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Oregon State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey; South Dakota State University; University of California System; University of California Berkeley; Curtin University; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; Victoria University Wellington; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Copenhagen; Niels Bohr Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Dartmouth College	Fudge, TJ (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	tjfudge@uw.edu	Vaughn, Bruce/AAO-8867-2020; Wang, Xianfeng/F-1233-2014; Brook, Edward/AAB-7807-2021; Edwards, Ross/B-1433-2013; White, James W.C./A-7845-2009; ding, qinghua/G-1186-2011; Taylor, Kendrick/A-3469-2016; Neff, Peter David/ABB-7688-2021; Maselli, Olivia/A-6687-2013; Mitchell, Logan E/A-5481-2011; Steig, Eric J/G-9088-2015; Neff, Peter/B-3542-2014; Edwards, R. Lawrence/I-3124-2014; Cole-Dai, Jihong/B-2510-2009; CHENG, HAI/H-3413-2017; Markle, Bradley R/I-6132-2019	Wang, Xianfeng/0000-0002-8614-5627; Edwards, Ross/0000-0002-9233-8775; White, James W.C./0000-0001-6041-4684; Taylor, Kendrick/0000-0001-8535-1261; Mitchell, Logan E/0000-0002-8749-954X; Steig, Eric J/0000-0002-8191-5549; Edwards, R. Lawrence/0000-0002-7027-5881; Cole-Dai, Jihong/0000-0003-0921-5916; CHENG, HAI/0000-0002-5305-9458; Ferris, David/0000-0003-2336-6163; Fegyveresi, John/0000-0002-1029-6277; Neff, Peter/0000-0003-1697-0936; Markle, Bradley/0000-0002-2282-6546; Fudge, Tyler/0000-0002-6818-7479; Lee, James/0000-0002-9137-1530; Schauer, Andrew/0000-0002-5941-5396; VAUGHN, BRUCE/0000-0001-6503-957X	US National Science Foundation (NSF); NSF [0944197, 1043092, 0537930, 0944348, 0944191, 0440817, 0440819, 0230396, 0538427, 0839093, 1043518, 1043500, 05379853, 1043167, 1043528, 0539578, 0539232, 1103403, 0739780, 0637211, 0538553, 0839066, 0538657, 1043421, 1043313, 0801490]; NASA NESSF; USGS Climate and Land Use Change Program; National Natural Science Foundation of China [41230524]; Singapore National Research Foundation [NRFF2011-08]; Directorate For Geosciences [0839066, 1103403, 0839093] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1043528, 1043167, 1043092, 0944197] Funding Source: National Science Foundation; Office Of The Director [0968391] Funding Source: National Science Foundation	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA NESSF(National Aeronautics & Space Administration (NASA)); USGS Climate and Land Use Change Program(United States Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Singapore National Research Foundation(National Research Foundation, Singapore); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by US National Science Foundation (NSF). The authors appreciate the support of the WAIS Divide Science Coordination Office (M. Twickler and J. Souney) for the collection and distribution of the WAIS Divide ice core; Ice Drilling and Design and Operations (K. Dahnert) for drilling; the National Ice Core Laboratory (B. Bencivengo) for curating the core; Raytheon Polar Services (M. Kippenhan) for logistics support in Antarctica; and the 109th New York Air National Guard for airlift in Antarctica. We also thank C. Buizert and S. Marcott for discussions. The following individual NSF grants supported this work: 0944197 (E.D.W., H. Conway); 1043092, 0537930 (E.J.S.); 0944348, 0944191, 0440817, 0440819, 0230396 (K.C.T.); 0538427, 0839093 (J.R.M.); 1043518 (E.J.B.); 1043500 (T.S.); 05379853, 1043167 (J.W.C.W.); 1043528, 0539578 (R.B.A.); 0539232 (K.M.C., G.D.C.); 1103403 (R.L.E., H. Conway); 0739780 (R.E.); 0637211 (G.H.); 0538553, 0839066 (J.C.-D.), 0538657, 1043421 (J.P.S.); 1043313 (M.K.S.); 0801490 (G.J.W). Other support came from a NASA NESSF award (T.J.F.), the USGS Climate and Land Use Change Program (G.D.C., J.J.F.), the National Natural Science Foundation of China (41230524 to H. Cheng) and the Singapore National Research Foundation (NRFF2011-08 to X.W.).	ALLEY RB, 1995, J GLACIOL, V41, P503, DOI 10.3189/S0022143000034845; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bisiaux MM, 2012, ATMOS CHEM PHYS, V12, P4107, DOI 10.5194/acp-12-4107-2012; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Brook EJ, 2005, QUATERNARY SCI REV, V24, P1333, DOI 10.1016/j.quascirev.2005.02.002; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Collins LG, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002264; Crosson ER, 2008, APPL PHYS B-LASERS O, V92, P403, DOI 10.1007/s00340-008-3135-y; DahlJensen D, 2003, ANN GLACIOL-SER, V37, P207, DOI 10.3189/172756403781815492; Dansgaard W., 1969, J GLACIOL, V8, P215, DOI [10.3189/S0022143000031208, DOI 10.3189/S0022143000031208, 10.3189/s0022143000031208]; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Dlugokencky EJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006035; Fleitmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040050; Hammer CU, 1997, CLIMATIC CHANGE, V35, P1, DOI 10.1023/A:1005344225434; HERRON MM, 1980, J GLACIOL, V25, P373, DOI 10.3189/S0022143000015239; Hoffmann G, 1998, J GEOPHYS RES-ATMOS, V103, P16871, DOI 10.1029/98JD00423; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Huber C, 2006, EARTH PLANET SC LETT, V243, P61, DOI 10.1016/j.epsl.2005.12.036; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kobashi T, 2007, QUATERNARY SCI REV, V26, P1212, DOI 10.1016/j.quascirev.2007.01.009; Lee SY, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002004; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Mauget SA, 2003, J CLIMATE, V16, P2215, DOI 10.1175/2751.1; McConnell JR, 2007, SCIENCE, V317, P1381, DOI 10.1126/science.1144856; McConnell JR, 2002, ENVIRON SCI TECHNOL, V36, P7, DOI 10.1021/es011088z; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mitchell LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001441; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Nicolas JP, 2011, J CLIMATE, V24, P49, DOI 10.1175/2010JCLI3522.1; Noone D, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004228; Parrenin F, 2013, SCIENCE, V339, P1060, DOI 10.1126/science.1226368; Pasteris DR, 2012, ENVIRON SCI TECHNOL, V46, P1659, DOI 10.1021/es202668n; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Roeckner E., 1996, 21890 MAX PLANCK I M; Rothlisberger R, 2010, QUATERNARY SCI REV, V29, P296, DOI 10.1016/j.quascirev.2009.10.005; Ruth U, 2007, CLIM PAST, V3, P475, DOI 10.5194/cp-3-475-2007; Schwander J, 2001, GEOPHYS RES LETT, V28, P4243, DOI 10.1029/2000GL011981; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Sigl M, 2013, J GEOPHYS RES-ATMOS, V118, P1151, DOI 10.1029/2012JD018603; Steig E. J., 2001, ENVIRONMENT, V77, P75; Steig EJ, 2013, NAT GEOSCI, V6, P372, DOI [10.1038/ngeo1778, 10.1038/NGEO1778]; Stenni B, 2011, NAT GEOSCI, V4, P46, DOI [10.1038/ngeo1026, 10.1038/NGEO1026]; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Wilcoxon F., 1992, SPRINGER SERIES STAT, V1, P196, DOI DOI 10.2307/3001968; Wolff EW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018454	55	212	218	2	193	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					440	+		10.1038/nature12376	http://dx.doi.org/10.1038/nature12376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23945585	Green Published			2022-12-28	WOS:000323316100031
J	James, A; Pitchford, JW; Plank, MJ				James, Alex; Pitchford, Jonathan W.; Plank, Michael J.			"Disentangling nestedness" disentangled Reply	NATURE			English	Letter									[James, Alex; Plank, Michael J.] Univ Canterbury, Biomath Res Ctr, Christchurch 8040, New Zealand; [Pitchford, Jonathan W.] Univ York, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England; [Pitchford, Jonathan W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Pitchford, Jonathan W.] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England	University of Canterbury; University of York - UK; University of York - UK; University of York - UK	James, A (corresponding author), Univ Canterbury, Biomath Res Ctr, Private Bag 4800, Christchurch 8040, New Zealand.	alex.james@canterbury.ac.nz	Plank, Michael John/H-8030-2019	Plank, Michael John/0000-0002-7539-3465; James, Alex/0000-0002-1543-7139				Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Saavedra S, 2013, NATURE, V500, pE1, DOI 10.1038/nature12380; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422	7	12	13	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					E2	E3		10.1038/nature12381	http://dx.doi.org/10.1038/nature12381			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23969465				2022-12-28	WOS:000323316100002
J	Gigerenzer, G				Gigerenzer, Gerd			THE ART OF RISK COMMUNICATION HIV screening: helping clinicians make sense of test results to patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gigerenzer, Gerd] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany; [Gigerenzer, Gerd] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society; Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/A-6250-2012; Gigerenzer, Gerd/M-5595-2013	Gigerenzer, Gerd/0000-0002-6163-5419; 				Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; Centers for Disease Control and Prevention, 2007, HIV PREV SEL POP LOW; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G, 1998, AIDS CARE, V10, P197, DOI 10.1080/09540129850124451; Gigerenzer G, 1999, PSYCHOL REV, V106, P425, DOI 10.1037/0033-295X.106.2.425; Gigerenzer G., 2002, RECKONING RISK; Gigerenzer G, RISK SAVVY IN PRESS; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Piattelli-Palmarini M, 1991, BOSTONIA         MAR	10	9	9	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2013	347								f5151	10.1136/bmj.f5151	http://dx.doi.org/10.1136/bmj.f5151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	207SO	23965510	Green Published			2022-12-28	WOS:000323624300011
J	Wiviott, SD; White, HD; Ohman, EM; Fox, KAA; Armstrong, PW; Prabhakaran, D; Hafley, G; Lokhnygina, Y; Boden, WE; Hamm, C; Clemmensen, P; Nicolau, JC; Menozzi, A; Ruzyllo, W; Widimsky, P; Oto, A; Leiva-Pons, J; Pavlides, G; Winters, KJ; Roe, MT; Bhatt, DL				Wiviott, Stephen D.; White, Harvey D.; Ohman, E. Magnus; Fox, Keith A. A.; Armstrong, Paul W.; Prabhakaran, Dorairaj; Hafley, Gail; Lokhnygina, Yuliya; Boden, William E.; Hamm, Christian; Clemmensen, Peter; Nicolau, Jose C.; Menozzi, Alberto; Ruzyllo, Witold; Widimsky, Petr; Oto, Ali; Leiva-Pons, Jose; Pavlides, Gregory; Winters, Kenneth J.; Roe, Matthew T.; Bhatt, Deepak L.			Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial	LANCET			English	Article							ACUTE CORONARY SYNDROMES; ACCF/AHA FOCUSED UPDATE; PLATELET INHIBITION; DOSE CLOPIDOGREL; 2007 GUIDELINE; RISK; INTERVENTION; ASSOCIATION; STRATEGIES; MANAGEMENT	Background Treatment with prasugrel and aspirin improves outcomes compared with clopidogrel and aspirin for patients with acute coronary syndrome who have had angiography and percutaneous coronary intervention; however, no clear benefit has been shown for patients managed first with drugs only. We assessed outcomes from the TRILOGY ACS trial based on whether or not patients had coronary angiography before treatment was chosen. Methods TRILOGY ACS (ClinicalTrials.gov number NCT00699998) was a randomised controlled trial, done at more than 800 sites worldwide. Patients with non-ST-elevation acute coronary syndrome who were selected for management with revascularisation were randomly assigned to clopidogrel or prasugrel. The primary endpoint was cardiovascular death, myocardial infarction, or stroke at 30 months. In the present analysis we assessed differences in the primary endpoint by angiography status and whether the effects of treatment on the primary endpoint differed between patients who had angiography before enrolment and those who had not. Findings 7243 patients younger than 75 years were included in the TRILOGY ACS primary analysis. 3085 (43%) had angiography at baseline, 4158 (57%) had not. Fewer patients who had angiography reached the primary endpoint at 30 months compared with those who did not have angiography, according to Kaplan-Meier analysis (281/3085 [12.8%] vs 480/4158 [16.5%], adjusted hazard ratio [HR] 0.63, 95% CI 0.53-0.75; p<0.0001). The proportion of patients who reached the primary endpoint was lower in the prasugrel group than in the clopidogrel group for those who had angiography (122/1524 [10.7%] vs 159/1561 [14.9%], HR 0.77, 95% CI 0.61-0.98; p=0.032) but did not differ between groups in patients who did not have angiography (242/2096 [16.3%] vs 238/2062 [16.7%], HR 1.01, 0.84-1.20; p=0.94; p(interaction)=0.08). Overall, TIMI major bleeding and GUSTO severe bleeding were rare. Bleeding outcomes tended to be higher with prasugrel but did not differ significantly between treatment groups in either angiography cohort. Interpretation Among patients who had angiography who took prasugrel there were fewer cardiovascular deaths, myocardial infarctions, or strokes than in those who took clopidogrel. This result needs to be corroborated, but it is consistent with previous trials of more versus less intensive antiplatelet treatment. When angiography is done for acute coronary syndrome and anatomic coronary disease confirmed, the benefits and risks of intensive antiplatelet treatment exist whether the patient is treated with drugs or percutaneous coronary intervention.	[Wiviott, Stephen D.; Bhatt, Deepak L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div,TIMI Study Grp, Boston, MA 02115 USA; [White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; [Ohman, E. Magnus; Hafley, Gail; Lokhnygina, Yuliya; Roe, Matthew T.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Ohman, E. Magnus; Roe, Matthew T.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Armstrong, Paul W.] Univ Alberta, Div Cardiol, Edmonton, AB, Canada; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Boden, William E.] Albany Stratton VA Med Ctr, Albany, NY USA; [Boden, William E.] Albany Med Ctr, Albany, NY USA; [Hamm, Christian] Kerckhoff Heart & Thoraxctr, Bad Nauheim, Germany; [Clemmensen, Peter] Univ Copenhagen, Rigshosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Nicolau, Jose C.] Univ Sao Paulo, Inst Heart, Sao Paulo, Brazil; [Menozzi, Alberto] Azienda Osped Univ Parma, Div Cardiol, Parma, Italy; [Ruzyllo, Witold] Inst Cardiol, Dept Coronary Artery Dis, Warsaw, Poland; [Widimsky, Petr] Charles Univ Prague, Cardioctr, Prague, Czech Republic; [Oto, Ali] Hacettepe Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey; [Leiva-Pons, Jose] Hosp Cent Dr Morones Prieto, Dept Cardiol, San Luis Potosi, Mexico; [Pavlides, Gregory] Onassis Cardiac Surg Ctr, Div Cardiol, Kallithea, Greece; [Winters, Kenneth J.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Auckland City Hospital; Duke University; Duke University; University of Edinburgh; University of Alberta; Albany Medical College; Kerckhoff Clinic; Rigshospitalet; University of Copenhagen; Universidade de Sao Paulo; University of Parma; University Hospital of Parma; Institute of Cardiology - Poland; Charles University Prague; Hacettepe University; Hospital Central Dr. Ignacio Morones Prieto; Onassis Cardiac Surgery Center; Eli Lilly; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School	Wiviott, SD (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	swiviott@partners.org	Nicolau, Jose C/E-1487-2012; Wiviott, Stephen/HIK-2534-2022; Widimsky, Petr/P-8088-2016; Hamm, Christian W./I-3155-2017; Menozzi, Alberto/GPS-4477-2022; Fox, keith A A/I-3742-2013; Prabhakaran, Dorairaj/B-4147-2011	Nicolau, Jose C/0000-0002-9680-3689; Widimsky, Petr/0000-0001-5686-7752; Hamm, Christian W./0000-0001-6763-4161; Prabhakaran, Dorairaj/0000-0002-3172-834X; Fox, Keith/0000-0002-0140-2752; Armstrong, Paul/0000-0002-0460-3445	Daiichi Sankyo; Eli Lilly	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly)	Funding Daiichi Sankyo, Eli Lilly.	Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Chin CT, 2010, AM HEART J, V160, P16, DOI 10.1016/j.ahj.2010.04.022; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hochholzer W, 2011, CIRCULATION, V123, P2681, DOI 10.1161/CIRCULATIONAHA.110.002683; James SK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3527; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Levine GN, 2012, CATHETER CARDIO INTE, V79, P453, DOI 10.1002/ccd.23438; McAlister FA, 2007, ARCH INTERN MED, V167, P1019, DOI 10.1001/archinte.167.10.1019; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; O'Donoghue M, 2008, JAMA-J AM MED ASSOC, V300, P71, DOI 10.1001/jama.300.1.71; Patel MR, 2006, AM HEART J, V152, P641, DOI 10.1016/j.ahj.2006.02.035; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Ton VK, 2013, CLIN CARDIOL, V36, pE1, DOI 10.1002/clc.22079; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wenger NK, 2012, CLIN CARDIOL, V35, P3, DOI 10.1002/clc.20964; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	26	93	94	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 17	2013	382	9892					605	613		10.1016/S0140-6736(13)61451-8	http://dx.doi.org/10.1016/S0140-6736(13)61451-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DV	23953385				2022-12-28	WOS:000323422800024
J	Dangl, JL; Horvath, DM; Staskawicz, BJ				Dangl, Jeffery L.; Horvath, Diana M.; Staskawicz, Brian J.			Pivoting the Plant Immune System from Dissection to Deployment	SCIENCE			English	Review							LATE BLIGHT RESISTANCE; PATHOGEN-DERIVED RESISTANCE; POWDERY MILDEW RESISTANCE; DISEASE RESISTANCE; BACTERIAL-BLIGHT; INTERFAMILY TRANSFER; CONFERS RESISTANCE; TRANSGENIC POTATO; AVIRULENCE GENE; WHEAT	Diverse and rapidly evolving pathogens cause plant diseases and epidemics that threaten crop yield and food security around the world. Research over the last 25 years has led to an increasingly clear conceptual understanding of the molecular components of the plant immune system. Combined with ever-cheaper DNA-sequencing technology and the rich diversity of germ plasm manipulated for over a century by plant breeders, we now have the means to begin development of durable (long-lasting) disease resistance beyond the limits imposed by conventional breeding and in a manner that will replace costly and unsustainable chemical controls.	[Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Horvath, Diana M.] Two Blades Fdn, Evanston, IL 60201 USA; [Staskawicz, Brian J.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Berkeley	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu			HHMI; Gordon and Betty Moore Foundation; NSF; NIH; Direct For Biological Sciences [0929410] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069680] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our many colleagues who provided insight and unpublished information that contributed to the development of this review. J.L.D. is a cofounder of AgBiome, LLC. J.L.D. is a Howard Hughes Medical Institute (HHMI) Investigator, and work in his lab on this topic is funded by HHMI, the Gordon and Betty Moore Foundation, and grants from NSF. B.J.S. is a cofounder of Mendel Biotechnology, Inc., and is funded by grants from NSF and NIH.	Agrios G.N., 2005, PLANT PATHOL, V5th; Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bart R, 2012, P NATL ACAD SCI USA, V109, pE1972, DOI 10.1073/pnas.1208003109; Biffen RH, 1905, J AGR SCI, V1, P4, DOI 10.1017/S0021859600000137; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Bonardi V, 2012, CURR OPIN IMMUNOL, V24, P41, DOI 10.1016/j.coi.2011.12.006; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Borejsza-Wysocka E, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-41; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Bradeen JM, 2009, MOL PLANT MICROBE IN, V22, P437, DOI 10.1094/MPMI-22-4-0437; Bravo-Almonacid F, 2012, TRANSGENIC RES, V21, P967, DOI 10.1007/s11248-011-9584-9; Brunner S, 2012, PLANT BIOTECHNOL J, V10, P398, DOI 10.1111/j.1467-7652.2011.00670.x; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Chang C, 2013, PLANT CELL, V25, P1158, DOI 10.1105/tpc.113.109942; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dixelius C, 2012, NAT BIOTECHNOL, V30, P492, DOI 10.1038/nbt.2255; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Ferreira SA, 2002, PLANT DIS, V86, P101, DOI 10.1094/PDIS.2002.86.2.101; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Foster SJ, 2009, MOL PLANT MICROBE IN, V22, P589, DOI 10.1094/MPMI-22-5-0589; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fuchs M, 2007, ANNU REV PHYTOPATHOL, V45, P173, DOI 10.1146/annurev.phyto.45.062806.094434; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gassmann W, 2000, J BACTERIOL, V182, P7053, DOI 10.1128/JB.182.24.7053-7059.2000; Gawehns F, 2013, MICROB BIOTECHNOL, V6, P223, DOI 10.1111/1751-7915.12023; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Halterman DA, 2008, PLANT DIS, V92, P339, DOI 10.1094/PDIS-92-3-0339; Horvath DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042036; Horvath H, 2003, P NATL ACAD SCI USA, V100, P364, DOI 10.1073/pnas.0136911100; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Juma C., 2006, FINANCIAL TIMES; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim HJ, 2012, THEOR APPL GENET, V124, P923, DOI 10.1007/s00122-011-1757-7; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; Koeppel Dan, 2008, BANANA FATE FRUIT CH; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krattinger SG, 2013, THEOR APPL GENET, V126, P663, DOI 10.1007/s00122-012-2009-1; Krattinger SG, 2011, PLANT J, V65, P392, DOI 10.1111/j.1365-313X.2010.04430.x; Krens FA, 2011, TRANSGENIC RES, V20, P1113, DOI 10.1007/s11248-011-9484-z; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lewis JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-8; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; LINDBO JA, 1992, MOL PLANT MICROBE IN, V5, P144, DOI 10.1094/MPMI-5-144; Lius S, 1997, MOL BREEDING, V3, P161, DOI 10.1023/A:1009614508659; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Malinowski T, 2006, PLANT DIS, V90, P1012, DOI 10.1094/PD-90-1012; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Pavan S, 2011, THEOR APPL GENET, V123, P1425, DOI 10.1007/s00122-011-1677-6; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Polak J., 2008, J PLANT PATHOL, V90; Popp J, 2011, STUD AGRIC ECON, V113, P47, DOI 10.7896/j.1003; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rietman H, 2012, MOL PLANT MICROBE IN, V25, P910, DOI 10.1094/MPMI-01-12-0010-R; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Schornack S, 2013, ANNU REV PHYTOPATHOL, V51, P383, DOI 10.1146/annurev-phyto-082712-102255; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; STASKAWICZ BJ, 1984, P NATL ACAD SCI-BIOL, V81, P6024, DOI 10.1073/pnas.81.19.6024; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Strauss T, 2012, P NATL ACAD SCI USA, V109, P19480, DOI 10.1073/pnas.1212415109; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Sutch R.C., 2008, 14141 NBER; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; TRICOLI DM, 1995, BIO-TECHNOL, V13, P1458, DOI 10.1038/nbt1295-1458; Tripathi L, 2010, MOL PLANT PATHOL, V11, P721, DOI 10.1111/j.1364-3703.2010.00639.x; TRUVE E, 1993, BIO-TECHNOL, V11, P1048, DOI 10.1038/nbt0993-1048; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Vleeshouwers VGAA, 2011, ANNU REV PHYTOPATHOL, V49, P507, DOI 10.1146/annurev-phyto-072910-095326; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Zhao BY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002408; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhu SX, 2012, TRANSGENIC RES, V21, P89, DOI 10.1007/s11248-011-9510-1	97	690	727	27	550	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					746	751		10.1126/science.1236011	http://dx.doi.org/10.1126/science.1236011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23950531	Green Accepted, Green Submitted			2022-12-28	WOS:000323122200038
J	Little, SC; Tikhonov, M; Gregor, T				Little, Shawn C.; Tikhonov, Mikhail; Gregor, Thomas			Precise Developmental Gene Expression Arises from Globally Stochastic Transcriptional Activity	CELL			English	Article							FINGER PROTEIN; ZYGOTIC GENOME; DROSOPHILA; NOISE; HUNCHBACK; TIME; SEGMENTATION; VARIABILITY; LIMITS; RNA	Early embryonic patterning events are strikingly precise, a fact that appears incompatible with the stochastic gene expression observed across phyla. Using single-molecule mRNA quantification in Drosophila embryos, we determine the magnitude of fluctuations in the expression of four critical patterning genes. The accumulation of mRNAs is identical across genes and fluctuates by only similar to 8% between neighboring nuclei, generating precise protein distributions. In contrast, transcribing loci exhibit an intrinsic noise of similar to 45% independent of specific promoter-enhancer architecture or fluctuating inputs. Precise transcript distribution in the syncytium is recovered via straightforward spatiotemporal averaging, i.e., accumulation and diffusion of transcripts during nuclear cycles, without regulatory feedback. Common expression characteristics shared between genes suggest that fluctuations in mRNA production are context independent and are a fundamental property of transcription. The findings shed light on how the apparent paradox between stochastic transcription and developmental precision is resolved.	[Little, Shawn C.] Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA; [Tikhonov, Mikhail; Gregor, Thomas] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Tikhonov, Mikhail; Gregor, Thomas] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University	Gregor, T (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	tg2@princeton.edu		Tikhonov, Mikhail/0000-0002-9558-1121; Little, Shawn/0000-0002-2815-3696; Gregor, Thomas/0000-0001-9460-139X	NIH [P50 GM071508, R01 GM097275]; Searle Scholar Award [10-SSP-274]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM097275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge E. Wieschaus for insightful discussions and continuous support. We thank W. Bialek, S. Blythe, B. Chun, G. Deshpande, S. Di Talia, H. Garcia, S. Kyin, M. Petkova, R. Samanta, T. Schupbach, G. Tkacik, and the Bloomington Drosophila Stock Center. This work was supported by NIH Grants P50 GM071508 and R01 GM097275, and by Searle Scholar Award 10-SSP-274 to T.G.	Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cohen AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004901; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubuis JO, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.72; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; Erdmann T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.258101; FOE VE, 1983, J CELL SCI, V61, P31; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Gergen J. P., 1986, S SOC DEV BIOL, V43, P195; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; IRVINE KD, 1991, DEVELOPMENT, V111, P407; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KORNBERG TB, 1993, CURR OPIN GENET DEV, V3, P585, DOI 10.1016/0959-437X(93)90094-6; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lander AD, 2013, SCIENCE, V339, P923, DOI 10.1126/science.1224186; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Little SC, 2011, DEV CELL, V21, P2, DOI 10.1016/j.devcel.2011.06.003; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Liu F, 2013, P NATL ACAD SCI USA, V110, P6724, DOI 10.1073/pnas.1220912110; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; Mirouze N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002048; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Reiter M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr505; Saffer AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002418; Sauer F, 1996, PHILOS T ROY SOC B, V351, P579, DOI 10.1098/rstb.1996.0057; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Stewart-Ornstein J, 2012, MOL CELL, V45, P483, DOI 10.1016/j.molcel.2011.11.035; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; TSAI CC, 1994, DEVELOPMENT, V120, P1671; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0; XU T, 1993, DEVELOPMENT, V117, P1223; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	63	179	181	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 15	2013	154	4					789	800		10.1016/j.cell.2013.07.025	http://dx.doi.org/10.1016/j.cell.2013.07.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	202GQ	23953111	Green Accepted, Bronze			2022-12-28	WOS:000323202500011
J	Litton, E; Xiao, J; Ho, KM				Litton, Edward; Xiao, Jing; Ho, Kwok M.			Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC KIDNEY-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PERITONEAL-DIALYSIS PATIENTS; CHEMOTHERAPY-RELATED ANEMIA; INFLAMMATORY-BOWEL-DISEASE; CHRONIC HEART-FAILURE; EVERY 3 WEEKS; ORAL IRON; DEFICIENCY ANEMIA; FERRIC CARBOXYMALTOSE	Objectives To evaluate the efficacy and safety of intravenous iron, focusing primarily on its effects on haemoglobin, requirement for transfusion, and risk of infection. Design Systematic review and meta-analysis of randomised controlled trials investigating the safety and efficacy of intravenous iron therapy. Data sources Randomised controlled trials from Medline, Embase, and the Cochrane Central Register of Controlled Trials from 1966 to June 2013, with no language restrictions. Eligibility criteria for selecting studies Eligible trials were randomised controlled trials of intravenous iron compared with either no iron or oral iron. Crossover and observational studies were excluded. Main outcome measures Change in haemoglobin concentration and risk of allogeneic red blood cell transfusion (efficacy) and risk of infection (safety). Results Of the 75 trials meeting the inclusion criteria, 72 studies including 10 605 patients provided quantitative outcome data for meta-analysis. Intravenous iron was associated with an increase in haemoglobin concentration (standardised mean difference 6.5 g/L, 95% confidence interval 5.1 g/L to 7.9 g/L) and a reduced risk of requirement for red blood cell transfusion (risk ratio 0.74, 95% confidence interval 0.62 to 0.88), especially when intravenous iron was used with erythroid stimulating agents (ESAs) or in patients with a lower baseline plasma ferritin concentration. There were no significant interactions between the efficacy of intravenous iron and type or dose administered. Intravenous iron was, however, associated with a significant increase in risk of infection (relative risk 1.33, 95% confidence interval 1.10 to 1.64) compared with oral or no iron supplementation. The results remained similar when only high quality trials were analysed. Conclusions Intravenous iron therapy is effective in increasing haemoglobin concentration and reducing the risk of allogeneic red blood cell transfusion and could have broad applicability to a range of acute care settings. This potential benefit is counterbalanced by a potential increased risk of infection.	[Litton, Edward; Xiao, Jing; Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6000, Australia; [Litton, Edward] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Litton, E (corresponding author), Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6000, Australia.	ed.litton@health.wa.gov.au	Ho, Kwok M./E-3546-2010; litton, edward/C-5384-2017	Ho, Kwok M./0000-0002-6705-6004; litton, edward/0000-0002-5125-6829				Adhikary L, 2011, J NEPAL MED ASSOC, V51, P133; Agarwal R, 2006, AM J NEPHROL, V26, P445, DOI 10.1159/000096174; Aggarwal H K, 2003, J Assoc Physicians India, V51, P170; Al RA, 2005, OBSTET GYNECOL, V106, P1335, DOI 10.1097/01.AOG.0000185260.82466.b4; Allen RP, 2011, SLEEP MED, V12, P906, DOI 10.1016/j.sleep.2011.06.009; AlMomen AK, 1996, EUR J OBSTET GYN R B, V69, P121, DOI 10.1016/0301-2115(95)02538-3; ANG O, 1990, INT J EXP PATHOL, V71, P507; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Serrano-Trenas JA, 2011, TRANSFUSION, V51, P97, DOI 10.1111/j.1537-2995.2010.02769.x; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; Auerbach M, 2010, AM J HEMATOL, V85, P655, DOI 10.1002/ajh.21779; Bastit L, 2008, J CLIN ONCOL, V26, P1611, DOI 10.1200/JCO.2006.10.4620; Bayoumeu F, 2002, AM J OBSTET GYNECOL, V186, P518, DOI 10.1067/mob.2002.121894; Beck-da-Silva L, 2013, INT J CARDIOL, V168, P3439, DOI 10.1016/j.ijcard.2013.04.181; Bencaiova G, 2009, EUR J OBSTET GYN R B, V144, P135, DOI 10.1016/j.ejogrb.2009.03.006; Bhandal N, 2006, BJOG-INT J OBSTET GY, V113, P1248, DOI 10.1111/j.1471-0528.2006.01062.x; Birgegard G, 2010, VOX SANG, V99, P354, DOI 10.1111/j.1423-0410.2010.01368.x; Breymann C, 2008, INT J GYNECOL OBSTET, V101, P67, DOI 10.1016/j.ijgo.2007.10.009; Charytan C, 2005, NEPHRON CLIN PRACT, V100, pC55, DOI 10.1159/000085049; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Coyne DW, 2007, J AM SOC NEPHROL, V18, P975, DOI 10.1681/ASN.2006091034; Dangsuwan P, 2010, GYNECOL ONCOL, V116, P522, DOI 10.1016/j.ygyno.2009.12.004; Deeba S, 2012, J OBSTET GYN INDIA, V62, P317, DOI 10.1007/s13224-012-0222-0; Edwards TJ, 2009, BRIT J SURG, V96, P1122, DOI 10.1002/bjs.6688; Evstatiev R, 2013, CLIN GASTROENTEROL H, V11, P269, DOI 10.1016/j.cgh.2012.10.013; Fishbane S, 1999, AM J KIDNEY DIS, V34, pS47, DOI 10.1053/ajkd.1999.v34.aajkd0344b0047; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; FRIEL JK, 1995, JPEN-PARENTER ENTER, V19, P114, DOI 10.1177/0148607195019002114; Froessler B, 2013, J MATERN-FETAL NEO M, V26, P654, DOI 10.3109/14767058.2012.746299; Gafter-Gvili A, 2013, ACTA ONCOL, V52, P18, DOI 10.3109/0284186X.2012.702921; Garrido-Martin P, 2012, INTERACT CARDIOV TH, V15, P1013, DOI 10.1093/icvts/ivs344; Goodnough LT, 2012, TRANSFUSION, V52, P1584, DOI 10.1111/j.1537-2995.2011.03495.x; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; Grote L, 2009, MOVEMENT DISORD, V24, P1445, DOI 10.1002/mds.22562; Hedenus M, 2007, LEUKEMIA, V21, P627, DOI 10.1038/sj.leu.2404562; Heming N, 2012, CRIT CARE MED, V40, P2141, DOI 10.1097/CCM.0b013e31824e6713; Henry DH, 2007, ONCOLOGIST, V12, P231, DOI 10.1634/theoncologist.12-2-231; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hofmann A, 2012, CURR OPIN ANESTHESIO, V25, P66, DOI 10.1097/ACO.0b013e32834eb726; Hulin S, 2005, ANN FR ANESTH, V24, P1262, DOI 10.1016/j.annfar.2005.05.023; Isbister JP, 2011, TRANSFUS MED REV, V25, P89, DOI 10.1016/j.tmrv.2010.11.001; Karkouti K, 2006, CAN J ANAESTH, V53, P11, DOI 10.1007/BF03021522; Kasper SM, 1998, TRANSFUSION, V38, P764, DOI 10.1046/j.1537-2995.1998.38898375516.x; KDOQI, 2006, Am J Kidney Dis, V47, pS16; Khalafallah A, 2010, J INTERN MED, V268, P286, DOI 10.1111/j.1365-2796.2010.02251.x; Kim YT, 2007, GYNECOL ONCOL, V105, P199, DOI 10.1016/j.ygyno.2006.11.014; Kim YH, 2009, ACTA HAEMATOL-BASEL, V121, P37, DOI 10.1159/000210062; Kochhar PK, 2013, J OBSTET GYNAECOL RE, V39, P504, DOI 10.1111/j.1447-0756.2012.01982.x; Krayenbuehl PA, 2011, BLOOD, V118, P3222, DOI 10.1182/blood-2011-04-346304; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Li H, 2008, PERITON DIALYSIS INT, V28, P149; Li H, 2008, BLOOD PURIFICAT, V26, P151, DOI 10.1159/000113529; Li Han, 2009, Zhonghua Yi Xue Za Zhi, V89, P457; Lindgren S, 2009, SCAND J GASTROENTERO, V44, P838, DOI 10.1080/00365520902839667; Locatelli F, 2011, CONTRIB NEPHROL, V171, P255, DOI 10.1159/000327328; Lyseng-Williamson KA, 2009, DRUGS, V69, P739, DOI 10.2165/00003495-200969060-00007; Maccio A, 2010, ONCOLOGIST, V15, P894, DOI 10.1634/theoncologist.2010-0020; Macdougall IC, 1996, KIDNEY INT, V50, P1694, DOI 10.1038/ki.1996.487; Madi-Jebara SN, 2004, J CARDIOTHOR VASC AN, V18, P59, DOI 10.1053/j.jvca.2003.10.012; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Maynor L, 2007, ANN PHARMACOTHER, V41, P1476, DOI 10.1345/aph.1K187; McLean E, 2008, WORLDWIDE PREVALENCE; McMahon LP, 2010, NEPHROL DIAL TRANSPL, V25, P920, DOI 10.1093/ndt/gfp584; Meyer MP, 1996, J PEDIATR-US, V129, P258, DOI 10.1016/S0022-3476(96)70251-2; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moore R Andrew, 2011, BMC Blood Disord, V11, P4, DOI 10.1186/1471-2326-11-4; Na HS, 2011, TRANSFUSION, V51, P118, DOI 10.1111/j.1537-2995.2010.02783.x; Neeru Syal, 2012, Indian J Community Med, V37, P214, DOI 10.4103/0970-0218.103467; Notebaert E, 2007, TRANSFUSION, V47, P1905, DOI 10.1111/j.1537-2995.2007.01415.x; Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036; Olijhoek G, 2001, TRANSFUSION, V41, P957, DOI 10.1046/j.1537-2995.2001.41070957.x; Onken JE, 2014, TRANSFUSION, V54, P306, DOI 10.1111/trf.12289; Pedrazzoli P, 2008, J CLIN ONCOL, V26, P1619, DOI 10.1200/JCO.2007.12.2051; Pollak A, 2001, PEDIATRICS, V107, P78, DOI 10.1542/peds.107.1.78; Provenzano R, 2009, CLIN J AM SOC NEPHRO, V4, P386, DOI 10.2215/CJN.02840608; Qunibi WY, 2011, NEPHROL DIAL TRANSPL, V26, P1599, DOI 10.1093/ndt/gfq613; Schaller G, 2005, KIDNEY INT, V68, P2814, DOI 10.1111/j.1523-1755.2005.00754.x; SCHINDLER E, 1994, INFUSIONSTHERAPIE, V21, P236; Schroder O, 2005, AM J GASTROENTEROL, V100, P2503, DOI 10.1111/j.1572-0241.2005.00250.x; Seid MH, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.046; Shander A, 2010, TRANSFUSION, V50, P719, DOI 10.1111/j.1537-2995.2009.02492.x; Singh H, 2006, CLIN J AM SOC NEPHRO, V1, P475, DOI 10.2215/CJN.01541005; Singh K, 1998, EUR J HAEMATOL, V60, P119; Sloand JA, 2004, AM J KIDNEY DIS, V43, P663, DOI 10.1053/j.ajkd.2003.11.021; Spinowitz BS, 2008, J AM SOC NEPHROL, V19, P1599, DOI 10.1681/ASN.2007101156; Steensma DP, 2011, J CLIN ONCOL, V29, P97, DOI 10.1200/JCO.2010.30.3644; Stewart GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046042; Stoves J, 2001, NEPHROL DIAL TRANSPL, V16, P967, DOI 10.1093/ndt/16.5.967; Sunayana Verma, 2011, Journal of SAFOG (South Asian Federation of Obstetrics and Gynaecology), V3, P67; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; Torres Susan, 2006, Surg Infect (Larchmt), V7, P361, DOI 10.1089/sur.2006.7.361; van Iperen CE, 2000, CRIT CARE MED, V28, P2773, DOI 10.1097/00003246-200008000-00015; Van Wyck DB, 2007, OBSTET GYNECOL, V110, P267, DOI 10.1097/01.AOG.0000275286.03283.18; Van Wyck DB, 2009, TRANSFUSION, V49, P2719, DOI 10.1111/j.1537-2995.2009.02327.x; Van Wyck DB, 2005, KIDNEY INT, V68, P2846, DOI 10.1111/j.1523-1755.2005.00758.x; Warady BA, 2004, PEDIATR NEPHROL, V19, P655, DOI 10.1007/s00467-004-1457-5; Weisbach V, 1999, TRANSFUSION, V39, P465, DOI 10.1046/j.1537-2995.1999.39050465.x; Westad S, 2008, ACTA OBSTET GYN SCAN, V87, P916, DOI 10.1080/00016340802317802	99	220	227	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2013	347								f4822	10.1136/bmj.f4822	http://dx.doi.org/10.1136/bmj.f4822			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203ZD	23950195	Green Published, hybrid			2022-12-28	WOS:000323332700001
J	Bilham, R; Gaur, V				Bilham, Roger; Gaur, Vinod			Buildings as Weapons of Mass Destruction	SCIENCE			English	Editorial Material							INDIA; RISK		[Bilham, Roger] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bilham, Roger] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Gaur, Vinod] CSIR Ctr Math Modelling & Comp Simulat, Bangalore, Karnataka, India; [Gaur, Vinod] Indian Inst Astrophys, Bangalore 560034, Karnataka, India	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Fourth Paradigm Institute (CSIR 4PI); Department of Science & Technology (India); Indian Institute of Astrophysics (IIA)	Bilham, R (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	bilham@colorado.edu; vgaur@iiap.res.in		Bilham, Roger/0000-0002-5547-4102	Directorate For Geosciences [0739081] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Avouac JP, 2003, ADV GEOPHYS, V46, P1, DOI 10.1016/S0065-2687(03)46001-9; Bagla P, 2012, SCIENCE, V338, P1275, DOI 10.1126/science.338.6112.1275; Bilham R, 2009, B EARTHQ ENG, V2009, P1; Bilham R, 2013, TECTONOPHYSICS, V584, P166, DOI 10.1016/j.tecto.2012.03.023; England P, 2011, NAT GEOSCI, V4, P348, DOI 10.1038/ngeo1168; Gaur VK, 2012, CURR SCI INDIA, V103, P1273; Iyengar R. N., 1999, INDIAN J HIST SCI, V34, P181; Jain SK, 2005, CURR SCI INDIA, V89, P1464; Jaiswal K, 2011, EARTHQ SPECTRA, V27, P775, DOI 10.1193/1.3606398; Kumar S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006789; Rastogi B. K., 2011, CURR SCI, V103, P130; Roshan AD, 2010, NUCL ENG DES, V240, P3443, DOI 10.1016/j.nucengdes.2010.04.037; Sapkota SN, 2013, NAT GEOSCI, V6, P152, DOI 10.1038/NGEO1720; Talwani P, 1997, PURE APPL GEOPHYS, V150, P511, DOI 10.1007/s000240050091; Tiwari VM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039401; Walker R, 2004, TECTONICS, V23, DOI 10.1029/2003TC001529; WYSS M, 2004, DISASTERS SOC HAZARD, P165	17	14	14	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					618	619		10.1126/science.1238476	http://dx.doi.org/10.1126/science.1238476			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197XC	23929970				2022-12-28	WOS:000322884800023
J	Taksler, GB; Keshner, M; Fagerlin, A; Hajizadeh, N; Braithwaite, RS				Taksler, Glen B.; Keshner, Melanie; Fagerlin, Angela; Hajizadeh, Negin; Braithwaite, R. Scott			Personalized Estimates of Benefit From Preventive Care Guidelines A Proof of Concept	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL GUIDELINES; RISK-ASSESSMENT; UNITED-STATES; TIME; SATISFACTION; MANAGEMENT; PRIORITIES; FRAMEWORK; SERVICES; SMOKING	Background: The U. S. Preventive Services Task Force (USPSTF) makes recommendations for 60 distinct clinical services, but clinicians rarely have time to fully evaluate and implement the recommendations. Objective: To complete a proof of concept for prioritization and personalization of USPSTF recommendations, using patient-specific clinical characteristics. Design: Mathematical model. Data Sources: USPSTF recommendations and supporting evidence and National Vital Statistics Reports. Target Population: Nonpregnant adults. Time Horizon: Lifetime. Perspective: Individual. Intervention: USPSTF grade A and B recommendations. Outcome Measures: Personalized gain in life expectancy associated with each recommendation. Results of Base-Case Analysis: Increases in life expectancy varied more than 100-fold across USPSTF recommendations, and the rank order of benefits varied considerably among patients. For an obese man aged 62 years who smoked and had hypercholesterolemia, hypertension, and a family history of colorectal cancer, the model's top 3 recommendations (from most to least gain in life expectancy) were tobacco cessation (adding 2.8 life-years), weight loss (adding 1.6 life-years), and blood pressure control (adding 0.8 life-year). Lower-ranked recommendations were a healthier diet, aspirin use, cholesterol reduction, colonoscopy, screening for abdominal aortic aneurysm, and HIV testing (each adding 0.1 to 0.3 life-years). For a person with the same characteristics plus uncontrolled type 2 diabetes mellitus, the model's top 3 recommendations were diabetes control, tobacco cessation, and weight loss (each adding 1.4 to 1.8 life-years). Results of Sensitivity Analysis: Robust to variation of model inputs and satisfied face validity criteria. Limitation: Expected adherence rates and quality of life were not considered. Conclusion: Models of personalized preventive care may illustrate how magnitude and rank order of benefit associated with preventive guidelines vary across recommendations and patients. These predictions may help clinicians to prioritize USPSTF recommendations at the patient level.	NYU, Sch Med, New York, NY 10016 USA; Univ Michigan, Ann Arbor, MI 48109 USA	New York University; University of Michigan System; University of Michigan	Taksler, GB (corresponding author), NYU, Sch Med, Dept Populat Hlth & Med, 550 1st Ave,Translat Res Bldg,6th Floor, New York, NY 10016 USA.	glentaksler@gmail.com		hajizadeh, negin/0000-0002-6404-1018; Taksler, Glen/0000-0002-7566-7104; Braithwaite, Ronald Scott/0000-0001-7067-3655	New York University School of Medicine	New York University School of Medicine	Primary Funding Source: New York University School of Medicine.	[Anonymous], 2013, HUM GEN PROJ INF; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Braithwaite RS, 2007, ARCH INTERN MED, V167, P2361, DOI 10.1001/archinte.167.21.2361; Braithwaite RS, 2011, MED DECIS MAKING, V31, P582, DOI 10.1177/0272989X10386117; Burdi MD, 1999, HEALTH AFFAIR, V18, P134, DOI 10.1377/hlthaff.18.4.134; Calonge N, 2009, ANN INTERN MED, V150, P396; Centers for Disease Control and Prevention National Center for Health Statistics, 1999, CDC WONDER UND CAUS; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Eddy D, 2006, VALUE HEALTH, V9, P168, DOI 10.1111/j.1524-4733.2006.00097.x; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; Feldman R, 1998, CAN J PUBLIC HEALTH, V89, pI16, DOI 10.1007/BF03404494; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Fiscella K, 2008, ARCH INTERN MED, V168, P1843, DOI 10.1001/archinte.168.17.1843; Fleming C., 2005, PRIMARY CARE SCREENI; Flocke SA, 2001, J FAM PRACTICE, V50, P211; Hadley J, 1999, HEALTH SERV RES, V34, P307; Harle CA, 2012, MED DECIS MAKING, V32, P594, DOI 10.1177/0272989X11431736; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Mechanic D, 2003, JAMA-J AM MED ASSOC, V290, P941, DOI 10.1001/jama.290.7.941; Nattinger AB, 2010, ANN INTERN MED, V152, P832, DOI [10.7326/0003-4819-152-12-201006150-00027, 10.7326/0003-4819-152-7-201004060-01004]; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Nutting P A, 2001, J Am Board Fam Pract, V14, P352; Nutting PA, 2000, ARCH FAM MED, V9, P1059, DOI 10.1001/archfami.9.10.1059; O'Connor PJ, 2003, INT J QUAL HEALTH C, V15, P283, DOI 10.1093/intqhc/mzg062; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Pimlott N, 2005, CAN MED ASSOC J, V173, P1345, DOI 10.1503/cmaj.050494; Robert Wood Johnson Foundation, 2007, PREV CAR NAT PROF US; Straube S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-41; Syamlal Girija, 2011, Morbidity and Mortality Weekly Report, V60, P1305; Tai-Seale M, 2007, HEALTH SERV RES, V42, P1871, DOI 10.1111/j.1475-6773.2006.00689.x; Tarn DM, 2008, PATIENT EDUC COUNS, V72, P311, DOI 10.1016/j.pec.2008.02.019; U.S. Preventive Services Task Force, USPSTF A Z TOP GUID; Vesco K, 2011, AHRQ PUBLICATION; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336; Weinberg DS, 2008, ANN INTERN MED, V148; Woloshin S, 2008, J NATL CANCER I, V100, P845, DOI 10.1093/jnci/djn124; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	40	38	38	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					161	+		10.7326/0003-4819-159-3-201308060-00005	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201RD	23922061				2022-12-28	WOS:000323159800001
J	Uhlig, K; Patel, K; Ip, S; Kitsios, GD; Balk, EM				Uhlig, Katrin; Patel, Kamal; Ip, Stanley; Kitsios, Georgios D.; Balk, Ethan M.			Self-Measured Blood Pressure Monitoring in the Management of Hypertension A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; THERAPEUTIC INERTIA; ARTERIAL-HYPERTENSION; USUAL CARE; FOLLOW-UP; HOME; PROGRAM; PREVENTION; EDUCATION; OFFICE	Background: Clinical guidelines recommend that adults with hypertension self-monitor their blood pressure (BP). Purpose: To summarize evidence about the effectiveness of self-measured blood pressure (SMBP) monitoring in adults with hypertension. Data Sources: MEDLINE (inception to 8 February 2013) and Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (fourth quarter 2012). Study Selection: 52 prospective comparative studies of SMBP monitoring with or without additional support versus usual care or an alternative SMBP monitoring intervention in persons with hypertension. Data Extraction: Data on population, interventions, BP, other outcomes, and study method were extracted. Random-effects model meta-analyses were done. Data Synthesis: For SMBP monitoring alone versus usual care (26 comparisons), moderate-strength evidence supports a lower BP with SMBP monitoring at 6 months (summary net difference, -3.9 mm Hg and -2.4 mm Hg for systolic BP and diastolic BP) but not at 12 months. For SMBP monitoring plus additional support versus usual care (25 comparisons), high-strength evidence supports a lower BP with use of SMBP monitoring, ranging from -3.4 to -8.9 mm Hg for systolic BP and from -1.9 to -4.4 mm Hg for diastolic BP, at 12 months in good-quality studies. For SMBP monitoring plus additional support versus SMBP monitoring alone or with less intense additional support (13 comparisons), low-strength evidence fails to support a difference. Across all comparisons, evidence for clinical outcomes is insufficient. For other surrogate or intermediate outcomes, low-strength evidence fails to show differences. Limitation: Clinical heterogeneity in protocols for SMBP monitoring, additional support, BP targets, and management; follow-up of 1 year or less in most studies, with sparse clinical outcome data. Conclusion: Self-measured BP monitoring with or without additional support lowers BP compared with usual care, but the BP effect beyond 12 months and long-term benefits remain uncertain. Additional support enhances the BP-lowering effect.	[Uhlig, Katrin; Patel, Kamal; Ip, Stanley; Kitsios, Georgios D.; Balk, Ethan M.] Tufts Med Ctr, Ctr Clin Evidence Synth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	Tufts Medical Center	Uhlig, K (corresponding author), Tufts Med Ctr, Box 391,800 Washington St, Boston, MA 02111 USA.		Balk, Ethan/AAJ-2547-2020	Kitsios, Georgios/0000-0002-1018-948X	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Artinian NT, 2007, NURS RES, V56, P312, DOI 10.1097/01.NNR.0000289501.45284.6e; Artinian NT, 2001, HEART LUNG, V30, P191, DOI 10.1067/mhl.2001.112684; Bailey B, 1999, J HUM HYPERTENS, V13, P147, DOI 10.1038/sj.jhh.1000758; BINSTOCK ML, 1988, AM J HYPERTENS, V1, pS192, DOI 10.1093/ajh/1.3.192S; Bosworth HB, 2011, ARCH INTERN MED, V171, P1173, DOI 10.1001/archinternmed.2011.276; Bosworth HB, 2009, ANN INTERN MED, V151, P687, DOI 10.7326/0003-4819-151-10-200911170-00148; Bray EP, 2010, ANN MED, V42, P371, DOI 10.3109/07853890.2010.489567; Brennan T, 2010, POPUL HEALTH MANAG, V13, P65, DOI 10.1089/pop.2009.0019; Broege PA, 2001, BLOOD PRESS MONIT, V6, P139, DOI 10.1097/00126097-200106000-00004; CARNAHAN JE, 1975, AM J MED SCI, V269, P69, DOI 10.1097/00000441-197501000-00008; Cheltsova A, 2010, HYPERTENSION, V56, pE109; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dalfo i Baque A, 2005, Aten Primaria, V35, P233, DOI 10.1157/13072786; Dawes MG, 2010, FAM PRACT, V27, P472, DOI 10.1093/fampra/cmq048; DeJesus RS, 2009, VASC HEALTH RISK MAN, V5, P705; Earle KA, 2010, DIABETES TECHNOL THE, V12, P575, DOI 10.1089/dia.2009.0090; EARP JAL, 1982, AM J PUBLIC HEALTH, V72, P1146, DOI 10.2105/AJPH.72.10.1146; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; FITZGERALD DJ, 1985, IRISH MED J, V78, P216; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Fuchs SC, 2012, J HYPERTENS, V30, P75, DOI 10.1097/HJH.0b013e32834e5a4f; Godwin M, 2010, FAM PRACT, V27, P135, DOI 10.1093/fampra/cmp094; GRAN B, 1991, Scandinavian Journal of Primary Health Care, V9, P121, DOI 10.3109/02813439109026595; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Halme L, 2005, AM J HYPERTENS, V18, P1415, DOI 10.1016/j.amjhyper.2005.05.017; HAYNES RB, 1976, LANCET, V1, P1265; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; JOHNSON AL, 1978, CAN MED ASSOC J, V119, P1034; Kikuya M, 2002, J HYPERTENS, V20, P629, DOI 10.1097/00004872-200204000-00019; Madsen LB, 2008, BLOOD PRESSURE, V17, P78, DOI 10.1080/08037050801915468; Madsen LB, 2011, BLOOD PRESSURE, V20, P117, DOI 10.3109/08037051.2010.532306; Magid DJ, 2011, AM J MANAG CARE, V17, pE96; Margolius D, 2012, ANN FAM MED, V10, P199, DOI 10.1370/afm.1369; Contreras EM, 2012, ATEN PRIM, V44, P89, DOI 10.1016/j.aprim.2010.09.022; Contreras EM, 2009, ATEN PRIM, V41, P315, DOI 10.1016/j.aprim.2008.09.017; Marquez-Contreras E, 2006, J HYPERTENS, V24, P169, DOI 10.1097/01.hjh.0000198023.53859.a2; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Mehos BM, 2000, PHARMACOTHERAPY, V20, P1384, DOI 10.1592/phco.20.17.1384.34891; MIDANIK LT, 1991, PUBLIC HEALTH REP, V106, P85; MUHLHAUSER I, 1993, CLIN EXP HYPERTENS, V15, P125, DOI 10.3109/10641969309041615; Neumann CL, 2011, J HUM HYPERTENS, V25, P732, DOI 10.1038/jhh.2010.119; Ogedegbe Gbenga, 2006, J Clin Hypertens (Greenwich), V8, P174, DOI 10.1111/j.1524-6175.2006.04872.x; Omboni S, 2013, J HYPERTENS, V31, P455, DOI 10.1097/HJH.0b013e32835ca8dd; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Parati G, 2009, J HYPERTENS, V27, P198, DOI 10.1097/HJH.0b013e3283163caf; Park MJ, 2009, INT J MED INFORM, V78, P704, DOI 10.1016/j.ijmedinf.2009.06.004; Carrasco MP, 2008, IEEE T INF TECHNOL B, V12, P780, DOI 10.1109/TITB.2008.926429; Pickering TG, 2008, J CARDIOVASC NURS, V23, P299, DOI 10.1097/01.JCN.0000317429.98844.04; PIERCE JP, 1984, PREV MED, V13, P185, DOI 10.1016/0091-7435(84)90050-1; Rinfret S, 2009, CIRC-CARDIOVASC QUAL, V2, P170, DOI 10.1161/CIRCOUTCOMES.108.823765; Rogers MAM, 2001, ANN INTERN MED, V134, P1024, DOI 10.7326/0003-4819-134-11-200106050-00008; Rudd P, 2004, AM J HYPERTENS, V17, P921, DOI 10.1016/j.amjhyper.2004.06.006; SAWICKI PT, 1995, J HYPERTENS, V13, P933, DOI 10.1097/00004872-199508000-00015; de Souza WKSB, 2012, ARQ BRAS CARDIOL, V98, P167, DOI 10.1590/S0066-782X2012005000010; Shea S, 2006, J AM MED INFORM ASSN, V13, P40, DOI 10.1197/jamia.M1917; Shea Steven, 2007, Trans Am Clin Climatol Assoc, V118, P289; Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157; SOGHIKIAN K, 1992, MED CARE, V30, P855, DOI 10.1097/00005650-199209000-00009; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P2315, DOI 10.1001/jama.291.19.2315-b; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; STAHL SM, 1984, AM J PUBLIC HEALTH, V74, P704, DOI 10.2105/AJPH.74.7.704; Uhlig K, 2012, COMP EFFECTIVESNESS; van Onzenoort HAW, 2010, J HYPERTENS, V28, P622, DOI 10.1097/HJH.0b013e328334f36b; Varis J, 2010, BLOOD PRESSURE, V19, P319, DOI 10.3109/08037051003718457; Verberk WJ, 2007, HYPERTENSION, V50, P1019, DOI 10.1161/HYPERTENSIONAHA.107.094193; Verberk WJ, 2011, BLOOD PRESS MONIT, V16, P149, DOI 10.1097/MBP.0b013e328346e092; Wallace BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-55; Zarnke KB, 1997, AM J HYPERTENS, V10, P58, DOI 10.1016/S0895-7061(96)00305-6; Zillich AJ, 2005, J GEN INTERN MED, V20, P1091, DOI 10.1111/j.1525-1497.2005.0226.x	71	228	233	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					185	+		10.7326/0003-4819-159-3-201308060-00008	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00008			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201RD	23922064				2022-12-28	WOS:000323159800004
J	Lane, R				Lane, Richard			Reynaldo Martorell: driving force in maternal and child nutrition	LANCET			English	Biographical-Item																		MARTORELL R, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2013	382	9890					387	387		10.1016/S0140-6736(13)61658-X	http://dx.doi.org/10.1016/S0140-6736(13)61658-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MX	23911368	Bronze			2022-12-28	WOS:000322638500015
J	Cann, RL				Cann, Rebecca L.			Y Weigh In Again on Modern Humans	SCIENCE			English	Editorial Material							DNA		Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Cann, RL (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, 1960 East West Rd, Honolulu, HI 96822 USA.	rcann@hawaii.edu						Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Bonilla-Silva E., 2006, RACISM RACISTS COLOR; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Corona E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003447; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; Mishra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069280; Niederstatter H, 2013, FORENSIC SCI INT-GEN, V7, P593, DOI 10.1016/j.fsigen.2013.05.010; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112	13	4	4	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					465	467		10.1126/science.1242899	http://dx.doi.org/10.1126/science.1242899			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	193UJ	23908212				2022-12-28	WOS:000322586700026
J	Uda, S; Saito, TH; Kudo, T; Kokaji, T; Tsuchiya, T; Kubota, H; Komori, Y; Ozaki, Y; Kuroda, S				Uda, Shinsuke; Saito, Takeshi H.; Kudo, Takamasa; Kokaji, Toshiya; Tsuchiya, Takaho; Kubota, Hiroyuki; Komori, Yasunori; Ozaki, Yu-ichi; Kuroda, Shinya			Robustness and Compensation of Information Transmission of Signaling Pathways	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; DIFFERENTIATION; GROWTH	Robust transmission of information despite the presence of variation is a fundamental problem in cellular functions. However, the capability and characteristics of information transmission in signaling pathways remain poorly understood. We describe robustness and compensation of information transmission of signaling pathways at the cell population level. We calculated the mutual information transmitted through signaling pathways for the growth factor-mediated gene expression. Growth factors appeared to carry only information sufficient for a binary decision. Information transmission was generally more robust than average signal intensity despite pharmacological perturbations, and compensation of information transmission occurred. Information transmission to the biological output of neurite extension appeared robust. Cells may use information entropy as information so that messages can be robustly transmitted despite variation in molecular activities among individual cells.	[Uda, Shinsuke; Saito, Takeshi H.; Kudo, Takamasa; Tsuchiya, Takaho; Kubota, Hiroyuki; Komori, Yasunori; Ozaki, Yu-ichi; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Kokaji, Toshiya; Kuroda, Shinya] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Kuroda, Shinya] Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kuroda, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan.	skuroda@bi.s.u-tokyo.ac.jp			Dynamic Mechanisms of and Fundamental Technology for Biological Systems; Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics; CREST from Japan Science and Technology (JST); KAKENHI [21240025]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25830142]; Strategic International Cooperative Program (Research Exchange Type), JST; Human Frontier Science Project (HFSP) [RGP0061/2011]	Dynamic Mechanisms of and Fundamental Technology for Biological Systems; Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics; CREST from Japan Science and Technology (JST); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Cooperative Program (Research Exchange Type), JST; Human Frontier Science Project (HFSP)(Human Frontier Science Program)	We thank our laboratory members for critical reading of the manuscript and for technical assistance with the experiments and Y. Kabashima (Tokyo Institute of Technology) and K. Horimoto (Computational Biology Research Center, AIST) for helpful discussion and critical reading of manuscript. This work was supported by the Dynamic Mechanisms of and Fundamental Technology for Biological Systems and the Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, from Japan Science and Technology (JST); by a KAKENHI Scientific Research grant (A) (no. 21240025) and a Young Scientists grant (B) (no. 25830142) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); by the Strategic International Cooperative Program (Research Exchange Type), JST; and by a Human Frontier Science Project (HFSP) grant (RGP0061/2011).	Alberts B., 2008, MOL BIOL CELL, VFifth; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Cover TM, 2006, ELEMENTS OF INFORMAT; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Foehr ED, 2000, J NEUROSCI, V20, P7556; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Lenaerts T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-9; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Ozaki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009955; Pierobon M, 2011, IEEE T SIGNAL PROCES, V59, P2532, DOI 10.1109/TSP.2011.2114656; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Thomas P. J., 2003, PAPER PRESENTED AT N; Tkacik G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011910; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Tostevin F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061917; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; YOUNG SW, 1994, FEBS LETT, V338, P212, DOI 10.1016/0014-5793(94)80367-6; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	29	84	86	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					558	561		10.1126/science.1234511	http://dx.doi.org/10.1126/science.1234511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908238				2022-12-28	WOS:000322586700056
J	Moodie, C; Bauld, L; Stead, M				Moodie, Crawford; Bauld, Linda; Stead, Martine			UK government's delay on plain tobacco packaging: how much evidence is enough?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH WARNINGS; SMOKING		[Moodie, Crawford; Bauld, Linda; Stead, Martine] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland; [Moodie, Crawford] Univ Stirling, Ctr Tobacco Control Res, Stirling FK9 4LA, Scotland; [Moodie, Crawford; Bauld, Linda] Univ Stirling, Ctr Tobacco & Alcohol Studies, Stirling FK9 4LA, Scotland	University of Stirling; University of Stirling; University of Stirling	Moodie, C (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	C.S.Moodie@stir.ac.uk; Linda.Bauld@stir.ac.uk; Martine.Stead@stir.ac.uk		Stead, Martine/0000-0002-3066-4604	Cancer Research UK Funding Source: Medline; Medical Research Council [MR/K023195/1] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2008, EL GUID IMPL ART 13; [Anonymous], 2012, RESP MIN HLTH CONS P; Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Ford A, 2013, ED HLTH, V31; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4665; Maynard OM, 2013, ADDICTION, V108, P413, DOI 10.1111/j.1360-0443.2012.04028.x; Moodie C, 2012, PLAIN TOBACCO PACKAG; Moodie CS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002402; Silayoi P, 2007, EUR J MARKETING, V41, P1495, DOI 10.1108/03090560710821279; Smit ES, 2011, ADDICTION, V106, P844, DOI 10.1111/j.1360-0443.2010.03317.x; The Health and Social Care Information Centre, 2013, SMOK DRINK DRUG US Y; Wakefield MA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003175; World Health Organization, 2013, RED APP SMOK 1 EXP A	14	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2013	347								f4786	10.1136/bmj.f4786	http://dx.doi.org/10.1136/bmj.f4786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197BK	23902856	Green Submitted			2022-12-28	WOS:000322822500003
J	Fitzgerald, C; Mc Cormack, O; Reynolds, JV				Fitzgerald, Conall; Mc Cormack, Orla; Reynolds, John V.			Severe Intractable Postprandial Chest Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ESOPHAGEAL MOTILITY DISORDERS; ACHALASIA		St James Hosp, Natl Ctr Esophageal & Gastr Surg, Dublin 8, Ireland; Trinity Coll Dublin, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Reynolds, JV (corresponding author), St James Hosp, Trinity Ctr, Dublin 8, Ireland.	reynoljv@tcd.ie		Reynolds, John V/0000-0002-5501-9521				Boeckxstaens GE, 2011, NEW ENGL J MED, V364, P1807, DOI 10.1056/NEJMoa1010502; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Kahrilas PJ, 2000, CAN J GASTROENTEROL, V14, P221, DOI 10.1155/2000/389709; ORRINGER MB, 1993, J THORAC CARDIOV SUR, V105, P265, DOI 10.1016/S0022-5223(19)33811-5; Osgood H., 1889, BOSTON MED SURG J, V120, P401, DOI [10.1056/NEJM188904251201701, DOI 10.1056/NEJM188904251201701]; Park SY, 2012, J NEUROGASTROENTEROL, V18, P100, DOI 10.5056/jnm.2012.18.1.100; Patti MG, 2011, J GASTROINTEST SURG, V15, P703, DOI 10.1007/s11605-011-1478-x; Patti MG, 2005, ARCH SURG-CHICAGO, V140, P442, DOI 10.1001/archsurg.140.5.442; Tutuian Radu, 2006, Curr Treat Options Gastroenterol, V9, P283, DOI 10.1007/s11938-006-0010-y; Walzer N, 2008, GASTROENTEROL CLIN N, V37, P807, DOI 10.1016/j.gtc.2008.09.002	10	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	2013	310	4					424	425		10.1001/jama.2013.8567	http://dx.doi.org/10.1001/jama.2013.8567			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187LV	23917293				2022-12-28	WOS:000322121500020
J	Crane, PK; Walker, R; Hubbard, RA; Li, G; Nathan, DM; Zheng, H; Haneuse, S; Craft, S; Montine, TJ; Kahn, SE; McCormick, W; McCurry, SM; Bowen, JD; Larson, EB				Crane, Paul K.; Walker, Rod; Hubbard, Rebecca A.; Li, Ge; Nathan, David M.; Zheng, Hui; Haneuse, Sebastien; Craft, Suzanne; Montine, Thomas J.; Kahn, Steven E.; McCormick, Wayne; McCurry, Susan M.; Bowen, James D.; Larson, Eric B.			Glucose Levels and Risk of Dementia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; FOLLOW-UP; INSULIN; METABOLISM; EPIDEMIC; BRAIN	BACKGROUND Diabetes is a risk factor for dementia. It is unknown whether higher glucose levels increase the risk of dementia in people without diabetes. METHODS We used 35,264 clinical measurements of glucose levels and 10,208 measurements of glycated hemoglobin levels from 2067 participants without dementia to examine the relationship between glucose levels and the risk of dementia. Participants were from the Adult Changes in Thought study and included 839 men and 1228 women whose mean age at baseline was 76 years; 232 participants had diabetes, and 1835 did not. We fit Cox regression models, stratified according to diabetes status and adjusted for age, sex, study cohort, educational level, level of exercise, blood pressure, and status with respect to coronary and cerebrovascular diseases, atrial fibrillation, smoking, and treatment for hypertension. RESULTS During a median follow-up of 6.8 years, dementia developed in 524 participants (74 with diabetes and 450 without). Among participants without diabetes, higher average glucose levels within the preceding 5 years were related to an increased risk of dementia (P=0.01); with a glucose level of 115 mg per deciliter (6.4 mmol per liter) as compared with 100 mg per deciliter (5.5 mmol per liter), the adjusted hazard ratio for dementia was 1.18 (95% confidence interval [CI], 1.04 to 1.33). Among participants with diabetes, higher average glucose levels were also related to an increased risk of dementia (P=0.002); with a glucose level of 190 mg per deciliter (10.5 mmol per liter) as compared with 160 mg per deciliter (8.9 mmol per liter), the adjusted hazard ratio was 1.40 (95% CI, 1.12 to 1.76). CONCLUSIONS Our results suggest that higher glucose levels may be a risk factor for dementia, even among persons without diabetes.	[Crane, Paul K.; McCormick, Wayne; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Li, Ge] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [McCurry, Susan M.] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98195 USA; [Walker, Rod; Hubbard, Rebecca A.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Bowen, James D.] Swedish Neurosci Inst, Seattle, WA USA; [Nathan, David M.] Massachusetts Gen Hosp, Diabet Ctr, Boston, MA 02114 USA; [Nathan, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; [Haneuse, Sebastien] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Craft, Suzanne] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Swedish Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Wake Forest University	Crane, PK (corresponding author), Univ Washington, Harborview Med Ctr, Box 359780,325 9th Ave, Seattle, WA 98104 USA.	pcrane@uw.edu	Hubbard, Rebecca/Y-6500-2019; McCurry, Susan M/E-4731-2015	Hubbard, Rebecca/0000-0003-0879-0994; McCurry, Susan M/0000-0001-8624-3772; Kahn, Steven/0000-0001-7307-9002; Walker, Rod/0000-0002-8464-9805; Kielstein, Jan/0000-0001-8110-9064; Crane, Paul/0000-0003-4278-7465	National Institutes of Health [U01 AG 06781]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institutes of Health.; Supported by a grant (U01 AG 06781, to Dr. Larson) from the National Institutes of Health.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Bartl J, 2013, J NEURAL TRANSM, V120, P113, DOI 10.1007/s00702-012-0852-5; Candeias E, 2012, IUBMB LIFE, V64, P951, DOI 10.1002/iub.1098; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Correia SC, 2012, BRAIN RES, V1441, P64, DOI 10.1016/j.brainres.2011.12.063; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; HIXSON JE, 1990, J LIPID RES, V31, P545; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nalivaeva NN, 2012, J NEUROCHEM, V120, P167, DOI 10.1111/j.1471-4159.2011.07510.x; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P207; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Pandini G, 2013, ENDOCRINOLOGY, V154, P375, DOI 10.1210/en.2012-1661; Ravona-Springer R, 2012, J ALZHEIMERS DIS, V30, P299, DOI 10.3233/JAD-2012-120106; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ronnemaa E, 2009, DIABETOLOGIA, V52, P1504, DOI 10.1007/s00125-009-1393-9; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Strachan MWJ, 2011, DIABETIC MED, V28, P141, DOI 10.1111/j.1464-5491.2010.03199.x; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; van den Berg E, 2006, DIABETOLOGIA, V49, P2015, DOI 10.1007/s00125-006-0333-1; Yaffe K, 2006, J NUTR HEALTH AGING, V10, P292	30	488	508	6	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					540	548		10.1056/NEJMoa1215740	http://dx.doi.org/10.1056/NEJMoa1215740			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197HX	24195563	Green Accepted			2022-12-28	WOS:000322842000010
